PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Agnihothram, SS; Basco, MDS; Mullis, L; Foley, SL; Hart, ME; Sung, K; Azevedo, MP				Agnihothram, Sudhakar S.; Basco, Maria D. S.; Mullis, Lisa; Foley, Steven L.; Hart, Mark E.; Sung, Kidon; Azevedo, Marli P.			Infection of Murine Macrophages by Salmonella enterica Serovar Heidelberg Blocks Murine Norovirus Infectivity and Virus-induced Apoptosis	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; CELL-DEATH; ACTIVATION; BACTERIA; GASTROENTERITIS; PREVALENCE; POLYMERASE; LIFE	Gastroenteritis caused by bacterial and viral pathogens constitutes a major public health threat in the United States accounting for 35% of hospitalizations. In particular, Salmonella enterica and noroviruses cause the majority of gastroenteritis infections, with emergence of sporadic outbreaks and incidence of increased infections. Although mechanisms underlying infections by these pathogens have been individually studied, little is known about the mechanisms regulating co-infection by these pathogens. In this study, we utilized RAW 264.7 murine macrophage cells to investigate the mechanisms governing co-infection with S. enterica serovar Heidelberg and murine norovirus (MNV). We demonstrate that infection of RAW 264.7 cells with S. enterica reduces the replication of MNV, in part by blocking virus entry early in the virus life cycle, and inducing antiviral cytokines later in the infection cycle. In particular, bacterial infection prior to, or during MNV infection affected virus entry, whereas MNV entry remained unaltered when the virus infection preceded bacterial invasion. This block in virus entry resulted in reduced virus replication, with the highest impact on replication observed during conditions of co-infection. In contrast, bacterial replication showed a threefold increase in MNV-infected cells, despite the presence of antibiotic in the medium. Most importantly, we present evidence that the infection of MNV-infected macrophages by S. enterica blocked MNV-induced apoptosis, despite allowing efficient virus replication. This apoptosis blockade was evidenced by reduction in DNA fragmentation and absence of poly-ADP ribose polymerase (PARP), caspase 3 and caspase 9 cleavage events. Our study suggests a novel mechanism of pathogenesis whereby initial co-infection with these pathogens could result in prolonged infection by either of these pathogens or both together.	[Agnihothram, Sudhakar S.; Basco, Maria D. S.; Mullis, Lisa; Foley, Steven L.; Hart, Mark E.; Sung, Kidon; Azevedo, Marli P.] US FDA, Div Microbiol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA	US Food & Drug Administration (FDA)	Azevedo, MP (corresponding author), US FDA, Div Microbiol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	Marli.Azevedo@fda.hhs.gov		Foley, Steven/0000-0003-3146-4548; Azevedo, Marli/0000-0002-8591-7269	Food and Drug Administration	Food and Drug Administration(United States Department of Health & Human Services)	The Study was supported by Intramural Funding From the Food and Drug Administration.	Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Aliabadi N, 2015, EXPERT REV VACCINES, V14, P1241, DOI 10.1586/14760584.2015.1073110; Andino A, 2015, ScientificWorldJournal, V2015, P520179, DOI 10.1155/2015/520179; BAGASRA O, 1992, P NATL ACAD SCI USA, V89, P6285, DOI 10.1073/pnas.89.14.6285; BERNSTEIN MS, 1991, J CLIN INVEST, V88, P540, DOI 10.1172/JCI115337; Blyth CC, 2013, INFLUENZA OTHER RESP, V7, P168, DOI 10.1111/j.1750-2659.2012.00360.x; Bok K, 2009, J VIROL, V83, P3647, DOI 10.1128/JVI.02028-08; Chachu KA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000236; Chen YC, 1999, J VIROL, V73, P2650, DOI 10.1128/JVI.73.4.2650-2657.1999; Debbink K, 2014, CLIN INFECT DIS, V58, P1746, DOI 10.1093/cid/ciu120; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Foley SL, 2013, MICROBIOL MOL BIOL R, V77, P582, DOI 10.1128/MMBR.00015-13; Foley SL, 2011, APPL ENVIRON MICROB, V77, P4273, DOI 10.1128/AEM.00598-11; Gokulan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077866; Gonzalez MD, 2016, J CLIN MICROBIOL, V54, P142, DOI 10.1128/JCM.02361-15; Gonzalez-Galan V, 2011, CLIN MICROBIOL INFEC, V17, P1895, DOI 10.1111/j.1469-0691.2011.03506.x; Gonzalez-Hernandez MB, 2012, JOVE-J VIS EXP, DOI 10.3791/4297; GREEN SM, 1994, J GEN VIROL, V75, P1883, DOI 10.1099/0022-1317-75-8-1883; Hacker G, 2006, MED MICROBIOL IMMUN, V195, P11, DOI 10.1007/s00430-005-0239-4; Han S, 2002, ARCH PHARM RES, V25, P895, DOI 10.1007/BF02977011; Hewitt J, 2009, J APPL MICROBIOL, V107, P65, DOI 10.1111/j.1365-2672.2009.04179.x; Hwang S., 2014, CURR PROTOC MICROBIO, V33, p15K21, DOI DOI 10.1002/9780471729259.MC15K02S33; Iverson AR, 2011, J INFECT DIS, V203, P880, DOI 10.1093/infdis/jiq113; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015; Knodler LA, 2005, J BIOL CHEM, V280, P9058, DOI 10.1074/jbc.M412588200; Knodler LA, 2001, MICROBES INFECT, V3, P1321, DOI 10.1016/S1286-4579(01)01493-9; Knodler LA, 2015, CURR OPIN MICROBIOL, V23, P23, DOI 10.1016/j.mib.2014.10.010; Knodler LA, 2014, CELL HOST MICROBE, V16, P249, DOI 10.1016/j.chom.2014.07.002; Kolawole AO, 2014, J GEN VIROL, V95, P1958, DOI 10.1099/vir.0.066753-0; KRAKAUER T, 1993, J GEN VIROL, V74, P1653, DOI 10.1099/0022-1317-74-8-1653; Lahti E, 2006, PEDIATR INFECT DIS J, V25, P160, DOI 10.1097/01.inf.0000199265.90299.26; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Lemasters JJ, 2002, ANTIOXID REDOX SIGN, V4, P769, DOI 10.1089/152308602760598918; Lemasters JJ, 1998, BIOFACTORS, V8, P283, DOI 10.1002/biof.5520080316; Lindesmith LC, 2011, J VIROL, V85, P231, DOI 10.1128/JVI.01364-10; LoBue AD, 2006, VACCINE, V24, P5220, DOI 10.1016/j.vaccine.2006.03.080; McCullers JA, 2014, NAT REV MICROBIOL, V12, P252, DOI 10.1038/nrmicro3231; Metkar SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024286; Miyairi I, 2006, CURR OPIN MICROBIOL, V9, P102, DOI 10.1016/j.mib.2005.12.004; Newman KA, 2015, CAN J POLIT SCI, V48, P225, DOI 10.1017/S000842391500013X; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Peltola VT, 2006, INFECT IMMUN, V74, P2562, DOI 10.1128/IAI.74.5.2562-2567.2006; Rha B, 2013, EMERG INFECT DIS, V19, P1214, DOI 10.3201/eid1908.130483; Rodriguez MR, 2014, J VIROL, V88, P9277, DOI 10.1128/JVI.01422-14; Scallan E, 2015, FOODBORNE PATHOG DIS, V12, P492, DOI 10.1089/fpd.2014.1915; Smith AM, 2014, CURR TOP MICROBIOL, V385, P327, DOI 10.1007/82_2014_394; Soldani C, 2001, EXP CELL RES, V269, P193, DOI 10.1006/excr.2001.5293; Trivedi TK, 2013, AM J INFECT CONTROL, V41, P654, DOI 10.1016/j.ajic.2012.08.002; Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14; Weinberger DM, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001776; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05; Yen C, 2011, CLIN INFECT DIS, V53, P568, DOI 10.1093/cid/cir478; Zhong YM, 2006, J INFECTION, V53, P408, DOI 10.1016/j.jinf.2005.12.028	56	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144911	10.1371/journal.pone.0144911	http://dx.doi.org/10.1371/journal.pone.0144911			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658916	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900146
J	Holehouse, AS; Naegle, KM				Holehouse, Alex S.; Naegle, Kristen M.			Reproducible Analysis of Post-Translational Modifications in Proteomes-Application to Human Mutations	PLOS ONE			English	Article							NOONAN SYNDROME; PHOSPHORYLATION; CANCER; RESOURCE; PHOSPHOSITE; MECHANISM; EVOLUTION; DATABASE; RAF1	Background Protein post-translational modifications (PTMs) are an important aspect of protein regulation. The number of PTMs discovered within the human proteome, and other proteomes, has been rapidly expanding in recent years. As a consequence of the rate in which new PTMs are identified, analysis done in one year may result in different conclusions when repeated in subsequent years. Among the various functional questions pertaining to PTMs, one important relationship to address is the interplay between modifications and mutations. Specifically, because the linear sequence surrounding a modification site often determines molecular recognition, it is hypothesized that mutations near sites of PTMs may be more likely to result in a detrimental effect on protein function, resulting in the development of disease. Methods and Results We wrote an application programming interface (API) to make analysis of ProteomeScout, a comprehensive database of PTMs and protein information, easy and reproducible. We used this API to analyze the relationship between PTMs and human mutations associated with disease (based on the 'Clinical Significance' annotation from dbSNP). Proteins containing pathogenic mutations demonstrated a significant study bias which was controlled for by analyzing only well-studied proteins, based on their having at least one pathogenic mutation. We found that pathogenic mutations are significantly more likely to lie within eight amino acids of a phosphoserine, phosphotyrosine or ubiquitination site when compared to mutations in general, based on a Fisher's Exact test. Despite the skew of pathogenic mutations occurring on positively charged arginines, we could not account for this relationship based only on residue type. Finally, we hypothesize a potential mechanism for a pathogenic mutation on RAF1, based on its proximity to a phosphorylation site, which represents a subtle regulation difference that may explain why its biochemical effect has failed to be uncovered previously. The combination of the API and a dynamically expanding PTM database will make the reanalysis of this question and other systems-level questions easier in the future.	[Holehouse, Alex S.] Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA; [Holehouse, Alex S.; Naegle, Kristen M.] Washington Univ, Ctr Biol Syst Engn, St Louis, MO 63130 USA; [Naegle, Kristen M.] Washington Univ, Biomed Engn, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Naegle, KM (corresponding author), Washington Univ, Ctr Biol Syst Engn, St Louis, MO 63130 USA.	knaegle@wustl.edu	Holehouse, Alex/ABE-8308-2020	Holehouse, Alex/0000-0002-4155-5729; Naegle, Kristen/0000-0001-7146-9592				Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cantin GT, 2008, J PROTEOME RES, V7, P1346, DOI 10.1021/pr0705441; Chen RQ, 2009, CANCER RES, V69, P2663, DOI 10.1158/0008-5472.CAN-08-3222; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Freschi L, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.43; Gnad F, 2010, MOL CELL PROTEOMICS, V9, P2642, DOI 10.1074/mcp.M110.001594; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Huyck L, 2012, FEBS LETT, V586, P296, DOI 10.1016/j.febslet.2012.01.018; Kobayashi T, 2010, HUM MUTAT, V31, P284, DOI 10.1002/humu.21187; Kreegipuu A, 1999, NUCLEIC ACIDS RES, V27, P237, DOI 10.1093/nar/27.1.237; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; Leprevost FD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00199; Light Y, 2002, MOL CELL BIOL, V22, P4984, DOI 10.1128/MCB.22.14.4984-4996.2002; Lu CT, 2013, NUCLEIC ACIDS RES, V41, pD295, DOI 10.1093/nar/gks1229; Matlock MK, 2015, NUCLEIC ACIDS RES, V43, pD521, DOI 10.1093/nar/gku1154; Mckinney W., 2010, P PYTH SCI C, P51, DOI DOI 10.25080/MAJORA-92BF1922-00A; Minguez P, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.31; Molzan M, 2010, MOL CELL BIOL, V30, P4698, DOI 10.1128/MCB.01636-09; Moritz A, 2014, SCI SIGNAL, V3, P1; Olsen JV, 2013, MOL CELL PROTEOMICS, V12, P3444, DOI 10.1074/mcp.O113.034181; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Pearlman SM, 2011, CELL, V147, P934, DOI 10.1016/j.cell.2011.08.052; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Radivojac P, 2008, BIOINFORMATICS, V24, pI241, DOI 10.1093/bioinformatics/btn267; Reimand J, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.68; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Schweiger R, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-6; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Tan CSH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000316; Tatarova Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036310; Uyar B, 2014, MOL BIOSYST, V10, P2626, DOI 10.1039/c4mb00290c; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Wang YT, 2010, J PROTEOME RES, V9, P5582, DOI 10.1021/pr100394u; Wang Z, 2011, MOL BIOL EVOL, V28, P1131, DOI 10.1093/molbev/msq268; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Zhou HJ, 2013, J PROTEOME RES, V12, P260, DOI 10.1021/pr300630k	43	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144692	10.1371/journal.pone.0144692	http://dx.doi.org/10.1371/journal.pone.0144692			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659599	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900088
J	Palikhe, NS; Nahirney, D; Laratta, C; Gandhi, VD; Vethanayagam, D; Bhutani, M; Mayers, I; Cameron, L; Vliagoftis, H				Palikhe, Nami Shrestha; Nahirney, Drew; Laratta, Cheryl; Gandhi, Vivek Dipak; Vethanayagam, Dilini; Bhutani, Mohit; Mayers, Irvin; Cameron, Lisa; Vliagoftis, Harissios			Increased Protease-Activated Receptor-2 (PAR-2) Expression on CD14(++)CD16(+) Peripheral Blood Monocytes of Patients with Severe Asthma	PLOS ONE			English	Article							CD14(+) CD16(+) MONOCYTES; DIFFERENTIAL EXPRESSION; UP-REGULATION; ALPHA; SUBPOPULATIONS; INFLAMMATION; AIRWAYS; RANTES; CELLS; IL-8	Background Protease-Activated Receptor-2 (PAR-2), a G protein coupled receptor activated by serine proteases, is widely expressed in humans and is involved in inflammation. PAR-2 activation in the airways plays an important role in the development of allergic airway inflammation. PAR-2 expression is known to be upregulated in the epithelium of asthmatic subjects, but its expression on immune and inflammatory cells in patients with asthma has not been studied. Methods We recruited 12 severe and 24 mild/moderate asthmatics from the University of Alberta Hospital Asthma Clinics and collected baseline demographic information, medication use and parameters of asthma severity. PAR-2 expression on blood inflammatory cells was analyzed by flow cytometry. Results Subjects with severe asthma had higher PAR-2 expression on CD14(++)CD16(+) monocytes (intermediate monocytes) and also higher percentage of CD14(++)CD16(+)PAR-2(+) monocytes (intermediate monocytes expressing PAR-2) in blood compared to subjects with mild/moderate asthma. Receiver operating characteristics (ROC) curve analysis showed that the percent of CD14(++)CD16(+)PAR-2(+) in peripheral blood was able to discriminate between patients with severe and those with mild/moderate asthma with high sensitivity and specificity. In addition, among the whole populations, subjects with a history of asthma exacerbations over the last year had higher percent of CD14(++)CD16(+)PAR-2(+) cells in peripheral blood compared to subjects without exacerbations. Conclusions PAR-2 expression is increased on CD14(++)CD16(+) monocytes in the peripheral blood of subjects with severe asthma and may be a biomarker of asthma severity. Our data suggest that PAR-2 -mediated activation of CD14(++)CD16(+) monocytes may play a role in the pathogenesis of severe asthma.	[Palikhe, Nami Shrestha; Nahirney, Drew; Laratta, Cheryl; Gandhi, Vivek Dipak; Vethanayagam, Dilini; Bhutani, Mohit; Mayers, Irvin; Cameron, Lisa; Vliagoftis, Harissios] Univ Alberta, Dept Med, Div Pulm Med, Edmonton, AB, Canada; [Bhutani, Mohit; Vliagoftis, Harissios] Univ Alberta, Alberta Asthma Ctr, Edmonton, AB, Canada; [Cameron, Lisa] Univ Western Ontario, Dept Pathol, Schulich Sch Med & Dent, London, ON, Canada	University of Alberta; University of Alberta; Western University (University of Western Ontario)	Cameron, L (corresponding author), Univ Alberta, Dept Med, Div Pulm Med, Edmonton, AB, Canada.	lisa.cameron@schulich.uwo.ca; hari@ualberta.ca	Gandhi, Vivek Dipak/N-1030-2017	Gandhi, Vivek/0000-0003-4561-7277; Laratta, Cheryl/0000-0002-7656-0173	National Sanitarium Association (NSA); Canadian Institutes of Health Research (CIHR); Alberta Innovates Health Solutions (AIHS); GSK-CIHR Research Chair at the University of Alberta	National Sanitarium Association (NSA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions (AIHS); GSK-CIHR Research Chair at the University of Alberta	This work was funded by grants from the National Sanitarium Association (NSA), the Canadian Institutes of Health Research (CIHR), Alberta Innovates Health Solutions (AIHS) and by funds from the GSK-CIHR Research Chair at the University of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Alam R, 1996, AM J RESP CRIT CARE, V153, P1398, DOI 10.1164/ajrccm.153.4.8616572; [Anonymous], 2000, Am J Respir Crit Care Med, V162, P2341; Arizmendi NG, 2011, J IMMUNOL, V186, P3164, DOI 10.4049/jimmunol.0903812; Barnes PJ, 2012, J ALLERGY CLIN IMMUN, V129, P48, DOI 10.1016/j.jaci.2011.11.006; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Colognato R, 2003, BLOOD, V102, P2645, DOI 10.1182/blood-2002-08-2497; Crilly A, 2012, ANN RHEUM DIS, V71, P1049, DOI 10.1136/annrheumdis-2011-200703; Davidson CE, 2013, CLIN EXP ALLERGY, V43, P1274, DOI 10.1111/cea.12185; Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429; Ebeling C, 2005, J ALLERGY CLIN IMMUN, V115, P623, DOI 10.1016/j.jaci.2004.11.042; Fajt Merritt L, 2013, Ann Am Thorac Soc, V10 Suppl, pS158, DOI 10.1513/AnnalsATS.201303-064AW; Fajt ML, 2013, J ALLERGY CLIN IMMUN, V131, P1504, DOI 10.1016/j.jaci.2013.01.035; Feld M, 2008, J IMMUNOL, V180, P6903, DOI 10.4049/jimmunol.180.10.6903; Hijdra D, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-38; Jatakanon A, 1999, AM J RESP CRIT CARE, V160, P1532, DOI 10.1164/ajrccm.160.5.9806170; Jatakanon A, 1999, THORAX, V54, P234, DOI 10.1136/thx.54.3.234; Jiang B, 2010, CLIN EXP RHEUMATOL, V28, pS56; Johansson U, 2005, J LEUKOCYTE BIOL, V78, P967, DOI 10.1189/jlb.0704422; Knight DA, 2001, J ALLERGY CLIN IMMUN, V108, P797, DOI 10.1067/mai.2001.119025; Liang ZK, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-72; Liu BY, 2015, J IMMUNOL, V194, P5150, DOI 10.4049/jimmunol.1402409; Lopez ML, 2014, CELL IMMUNOL, V288, P47, DOI 10.1016/j.cellimm.2014.02.004; Lopez-Pedrera C, 2010, ARTHRITIS RHEUM-US, V62, P869, DOI 10.1002/art.27299; Moniuszko M, 2009, CLIN IMMUNOL, V130, P338, DOI 10.1016/j.clim.2008.09.011; Okamoto H, 2003, J DERMATOL, V30, P503, DOI 10.1111/j.1346-8138.2003.tb00424.x; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Rossol M, 2012, ARTHRITIS RHEUM-US, V64, P671, DOI 10.1002/art.33418; Shpacovitch VM, 2011, IMMUNOLOGY, V133, P329, DOI 10.1111/j.1365-2567.2011.03443.x; Terasawa T, 2015, TRANSL RES, V165, P336, DOI 10.1016/j.trsl.2014.07.008; WANG SY, 1992, IMMUNOLOGY, V77, P298; Weber C, 2000, J LEUKOCYTE BIOL, V67, P699, DOI 10.1002/jlb.67.5.699; Wu W, 2014, J ALLERGY CLIN IMMUN, V133, P1280, DOI 10.1016/j.jaci.2013.11.042; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; Zietkowski Z, 2008, RESP MED, V102, P1198, DOI 10.1016/j.rmed.2008.03.010	36	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144500	10.1371/journal.pone.0144500	http://dx.doi.org/10.1371/journal.pone.0144500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658828	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900058
J	Self, WT; Mitchell, G; Mellers, BA; Tetlock, PE; Hildreth, JAD				Self, William T.; Mitchell, Gregory; Mellers, Barbara A.; Tetlock, Philip E.; Hildreth, J. Angus D.			Balancing Fairness and Efficiency: The Impact of Identity-Blind and Identity-Conscious Accountability on Applicant Screening	PLOS ONE			English	Article							OUTCOME ACCOUNTABILITY; AFFIRMATIVE-ACTION; SOCIAL-PSYCHOLOGY; COLOR-BLINDNESS; DIVERSITY; JUDGMENT; TRUST; DISCRIMINATION; JUSTICE; MULTICULTURALISM	This study compared two forms of accountability that can be used to promote diversity and fairness in personnel selections: identity-conscious accountability (holding decision makers accountable for which groups are selected) versus identity-blind accountability (holding decision makers accountable for making fair selections). In a simulated application screening process, undergraduate participants (majority female) sorted applicants under conditions of identity-conscious accountability, identity-blind accountability, or no accountability for an applicant pool in which white males either did or did not have a human capital advantage. Under identity-conscious accountability, participants exhibited pro-female and prominority bias, particularly in the white-male-advantage applicant pool. Under identity-blind accountability, participants exhibited no biases and candidate qualifications dominated interview recommendations. Participants exhibited greater resentment toward management under identity-conscious accountability.	[Self, William T.] Univ Missouri, Henry W Bloch Sch Management, Kansas City, MO 64110 USA; [Mitchell, Gregory] Univ Virginia, Sch Law, Charlottesville, VA 22903 USA; [Mellers, Barbara A.; Tetlock, Philip E.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Hildreth, J. Angus D.] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA	University of Missouri System; University of Missouri Kansas City; University of Virginia; University of Pennsylvania; University of California System; University of California Berkeley	Mitchell, G (corresponding author), Univ Virginia, Sch Law, Charlottesville, VA 22903 USA.	pgm6u@virginia.edu	Mitchell, Gregory/L-4177-2019; Self, William/Q-4113-2019	Mitchell, Gregory/0000-0002-0622-1061; 	SHRM Foundation	SHRM Foundation	The SHRM Foundation (http://www.shrm.org/about/foundation/pages/foundationhome.aspx) provided funding for this project (grant funded November 2009) to Philip E. Tetlock and Gregory Mitchell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberson S.C., 2003, ANAL SOCIAL ISSUES P, V3, P121, DOI [DOI 10.1111/J.1530-2415.2003.00018.X, 10.1111/j.1530-2415.2003.00018.x]; Banaji M. R., 2013, BLINDSPOT HIDDEN BIA; Bartlett KT, 2009, VA LAW REV, V95, P1893; Bielby WT, 2008, CAMB COMP MANAG, P53, DOI 10.1017/CBO9780511753725.005; BLOCK J, 1961, Q SORT METHOD PERSON; Borman WC., 2012, OXFORD HDB PERSONNEL, P532; Browne KR, 2014, NEV LAW J, V14, P806; Brtek MD, 2002, J APPL PSYCHOL, V87, P185, DOI 10.1037//0021-9010.87.1.185; Cole MS, 2007, APPL PSYCHOL-INT REV, V56, P319, DOI 10.1111/j.1464-0597.2007.00288.x; Colquitt JA, 2011, ACAD MANAGE J, V54, P1183, DOI 10.5465/amj.2007.0572; Correll J, 2008, GROUP PROCESS INTERG, V11, P471, DOI 10.1177/1368430208095401; Cropanzano R, 2005, J APPL PSYCHOL, V90, P1168, DOI 10.1037/0021-9010.90.6.1168; de Langhe B, 2011, ORGAN BEHAV HUM DEC, V115, P238, DOI 10.1016/j.obhdp.2011.02.003; Derous E, 2012, J ORGAN BEHAV, V33, P544, DOI 10.1002/job.769; Dolezalek Holly, 2008, TRAINING, V45, P52; Ferris GR, 1996, J MANAGE, V22, P23, DOI 10.1177/014920639602200102; FISHER CD, 1979, J APPL PSYCHOL, V64, P533, DOI 10.1037/0021-9010.64.5.533; Ford Thomas E, 2004, J PERS SELL SALES M, V113, P113, DOI DOI 10.1080/08853134.2004.10749023; Frauendorfer D, 2013, J PERS PSYCHOL, V12, P182, DOI 10.1027/1866-5888/a000095; Fryer RG, 2009, J LEGAL STUD, V38, P1; GORDON RA, 1988, ORGAN BEHAV HUM DEC, V41, P20, DOI 10.1016/0749-5978(88)90044-1; Gordon RA, 1988, J PSYCHOL, V123, P59; Hart M., 2005, ALA L REV, V56, P741; Heilman M.E., 2008, COMMON SENSE PSYCHOL, P127, DOI DOI 10.1002/9780470696422.CH7; Heilman ME, 2006, J APPL SOC PSYCHOL, V36, P1291, DOI 10.1111/j.0021-9029.2006.00043.x; Heilman ME, 2001, J APPL PSYCHOL, V86, P574, DOI 10.1037/0021-9010.86.4.574; Kalev A, 2006, AM SOCIOL REV, V71, P589, DOI 10.1177/000312240607100404; Kidder DL, 2004, INT J CONFL MANAGE, V15, P77, DOI 10.1108/eb022908; Kilian CM, 2005, J MANAG DEV, V24, P155, DOI 10.1108/02621710510579518; Kim Soohan, 2012, REV LAW SOCIAL CHANG, V36, P171; KLIMOSKI R, 1990, ORGAN BEHAV HUM DEC, V45, P194, DOI 10.1016/0749-5978(90)90011-W; Kochan T. A., 2004, ASIA PAC J HUM RESOU, V42, P132, DOI DOI 10.1177/1038411104045352; KONRAD AM, 1995, ACAD MANAGE J, V38, P787, DOI 10.2307/256746; Krieger LH, 1998, CALIF LAW REV, V86, P1251, DOI 10.2307/3481107; Leonard B, 2000, HR MAG, V45, P37; Lerner JS, 1999, PSYCHOL BULL, V125, P255, DOI 10.1037/0033-2909.125.2.255; Matheson KJ, 2000, J APPL SOC PSYCHOL, V30, P1013, DOI 10.1111/j.1559-1816.2000.tb02508.x; McEvily B, 2003, ORGAN SCI, V14, P91, DOI 10.1287/orsc.14.1.91.12814; MELLERS B, 1988, J EXP PSYCHOL HUMAN, V14, P572; Mero NP, 2007, J MANAGE, V33, P223, DOI 10.1177/0149206306297633; MERO NP, 1995, J APPL PSYCHOL, V80, P517, DOI 10.1037/0021-9010.80.4.517; Mitchell G, 2012, PERSPECT PSYCHOL SCI, V7, P109, DOI 10.1177/1745691611432343; Monin B, 2001, J PERS SOC PSYCHOL, V81, P33, DOI 10.1037//0022-3514.81.1.33; Norton MI, 2004, J PERS SOC PSYCHOL, V87, P817, DOI 10.1037/0022-3514.87.6.817; Pager D, 2007, ANN AM ACAD POLIT SS, V609, P104, DOI 10.1177/0002716206294796; Pitesa M, 2013, J APPL PSYCHOL, V98, P550, DOI 10.1037/a0031697; Plaut VC, 2010, PSYCHOL INQ, V21, P77, DOI 10.1080/10478401003676501; Plaut VC, 2009, PSYCHOL SCI, V20, P444, DOI 10.1111/j.1467-9280.2009.02318.x; Reskin B, 2012, ANNU REV SOCIOL, V38, P17, DOI 10.1146/annurev-soc-071811-145508; Rice J, 2012, HARV BUS REV; Richard FD, 2003, REV GEN PSYCHOL, V7, P331, DOI 10.1037/1089-2680.7.4.331; Richard OC, 1998, J APPL SOC PSYCHOL, V28, P183, DOI 10.1111/j.1559-1816.1998.tb01700.x; Richeson JA, 2004, J EXP SOC PSYCHOL, V40, P417, DOI 10.1016/j.jesp.2003.09.002; Roch SG, 2005, MANAGERIAL PSYCHOL, V20, P695, DOI DOI 10.1108/02683940510631453; Schoorman FD, 2007, ACAD MANAGE REV, V32, P344, DOI 10.5465/AMR.2007.24348410; Scott JC, 2012, OXFORD HDB PERSONNEL, P485, DOI DOI 10.1093/OXFORDHB/9780199732579.013.0021; SiegelJacobs K, 1996, ORGAN BEHAV HUM DEC, V65, P1, DOI 10.1006/obhd.1996.0001; Sitkin SB, 2005, INT SOCIOL, V20, P307, DOI 10.1177/0268580905055479; TETLOCK PE, 1992, ADV EXP SOC PSYCHOL, V25, P331, DOI 10.1016/S0065-2601(08)60287-7; TETLOCK PE, 1987, J PERS SOC PSYCHOL, V52, P700, DOI 10.1037/0022-3514.52.4.700; TETLOCK PE, 1983, J PERS SOC PSYCHOL, V45, P74, DOI 10.1037/0022-3514.45.1.74; Tetlock PE, 2009, RES ORGAN BEHAV, V29, P3, DOI 10.1016/j.riob.2009.10.002; Uhlmann EL, 2005, PSYCHOL SCI, V16, P474; Unzueta MM, 2010, J EXP SOC PSYCHOL, V46, P120, DOI 10.1016/j.jesp.2009.08.017; Verkuyten M, 2007, SOC PERSONAL PSYCHOL, V1, P280, DOI 10.1111/j.1751-9004.2007.00011.x; Watkins LM, 2000, INT J SELECT ASSESS, V8, P76, DOI 10.1111/1468-2389.00135; WEGENER DT, 1995, J PERS SOC PSYCHOL, V68, P36, DOI 10.1037/0022-3514.68.1.36; Woehr D. J., 2012, OXFORD HDB PERSONNEL, P517, DOI [DOI 10.1093/OXFORDHB/9780199732579.013.0022, 10.1093/oxfordhb/9780199732579.013.0022]	68	11	11	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145208	10.1371/journal.pone.0145208	http://dx.doi.org/10.1371/journal.pone.0145208			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26660723	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900192
J	Shen, MX; Hu, M; Sun, ZQ				Shen, Minxue; Hu, Ming; Sun, Zhenqiu			Assessment of School-Based Quasi-Experimental Nutrition and Food Safety Health Education for Primary School Students in Two Poverty-Stricken Counties of West China	PLOS ONE			English	Article							ITEM RESPONSE THEORY; OBESITY PREVALENCE; IMPROVE NUTRITION; CHILDRENS FRUIT; PROGRAM; INTERVENTION; IMPACT; COMMUNITY; KNOWLEDGE; ADOLESCENTS	Background Few studies on nutrition and food safety education intervention for students in remote areas of China were reported. The study aimed to assess the questionnaire used to measure the knowledge, attitude and behavior with respect to nutrition and food safety, and to evaluate the effectiveness of a quasi-experimental nutrition and food safety education intervention among primary school students in poverty-stricken counties of west China. Methods Twelve primary schools in west China were randomly selected from Zhen'an of Shaanxi province and Huize of Yunnan province. Six geographically dispersed schools were assigned to the intervention group in a nonrandom way. Knowledge, attitude and behavior questionnaire was developed, assessed, and used for outcome measurement. Students were investigated at baseline and the end of the study respectively without follow-up. Students in intervention group received targeted nutrition and food safety lectures 0.5 hour per week for two semesters. Item response theory was applied for assessment of questionnaire, and a two-level difference-in-differences model was applied to assess the effectiveness of the intervention. Results The Cronbach's alpha of the original questionnaire was 0.84. According to item response model, 22 knowledge items, 6 attitude items and 8 behavior items showed adequate discrimination parameter and were retained. 378 and 478 valid questionnaires were collected at baseline and the end point. Differences of demographic characteristics were statistically insignificant between the two groups. Two-level difference-in-differences models showed that health education improved 2.92 (95% CI: 2.06-3.78) and 2.92 (95% CI: 1.37-4.47) in knowledge and behaviors cores respectively, but had no effect on attitude. Conclusion The questionnaire met the psychometric standards and showed good internal consistence and discrimination power. The nutrition and food safety education was effective in improving the knowledge and behavior of primary school students in the two poverty-stricken counties of China.	[Shen, Minxue; Hu, Ming; Sun, Zhenqiu] Cent South Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China	Central South University	Hu, M (corresponding author), Cent South Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China.	xysm2011@yeah.net	Shen, Minxue/P-5140-2019	Shen, Minxue/0000-0003-0441-9303	Millennium Development Goal Fund from the United Nations Educational, Scientific and Cultural Organization [4500103578]	Millennium Development Goal Fund from the United Nations Educational, Scientific and Cultural Organization	This work was supported by ID: 4500103578 from the Millennium Development Goal Fund from the United Nations Educational, Scientific and Cultural Organization, http://en.unesco.org/. ZS received the funds.	Alderman H, 2009, PUBLIC HEALTH NUTR, V12, P667, DOI 10.1017/S1368980008002619; ASHENFELTER O, 1985, REV ECON STAT, V67, P648, DOI 10.2307/1924810; Baker F., 2001, BASICS ITEM RESPONSE; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Borm GF, 2005, STAT MED, V24, P3535, DOI 10.1002/sim.2200; Burgess-Champoux TL, 2008, PUBLIC HEALTH NUTR, V11, P849, DOI 10.1017/S1368980007001346; Cheng TO, 2012, INT J CARDIOL, V157, P315, DOI 10.1016/j.ijcard.2012.03.003; Chung A, 2014, SYST REV, V3, DOI 10.1186/2046-4053-3-52; Davis EM, 2009, J AM DIET ASSOC, V109, P1227, DOI 10.1016/j.jada.2009.04.017; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Ellis RM, 2007, J R SOC PROMO HEALTH, V127, P13, DOI 10.1177/1466424007073202; Espada JP, 2015, J ADOLESCENT HEALTH, V56, P30, DOI 10.1016/j.jadohealth.2014.08.018; Fillmore H, 2014, POPUL HEALTH MANAG, V17, P141, DOI 10.1089/pop.2013.0055; Gao X, 2012, CHINA PLOS ONE, V7, DOI [10.1371/journal.pone.0044881, DOI 10.1371/JOURNAL.PONE.0044881]; GRUBER J, 1994, AM ECON REV, V84, P622; Hambleton RK, 1985, ITEM RESPONSE THEORY; Hansen LP, 2007, J ECON THEORY, V136, P1, DOI 10.1016/j.jet.2006.06.010; He MZ, 2009, PUBLIC HEALTH NUTR, V12, P2199, DOI 10.1017/S1368980009005801; Horne PJ, 2004, EUR J CLIN NUTR, V58, P1649, DOI 10.1038/sj.ejcn.1602024; Jones KD, 2014, FOOD NUTR BULL, V35, pS64, DOI 10.1177/15648265140352S110; Lakshman RR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-123; Liao WK, 2002, CHINESE J SCH HLTH, V23, P6; MEYER BD, 1995, J BUS ECON STAT, V13, P151, DOI 10.2307/1392369; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Morris S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4757; Murray DM, 2004, AM J PUBLIC HEALTH, V94, P423, DOI 10.2105/AJPH.94.3.423; Peng Zhen, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P673; Prelip M, 2012, J NUTR EDUC BEHAV, V44, P310, DOI 10.1016/j.jneb.2011.10.005; Prelip M, 2011, J SCHOOL HEALTH, V81, P520, DOI 10.1111/j.1746-1561.2011.00622.x; Reise SP, 2009, ANNU REV CLIN PSYCHO, V5, P27, DOI 10.1146/annurev.clinpsy.032408.153553; Shah P, 2010, BRIT J NUTR, V104, P427, DOI 10.1017/S0007114510000681; Shen MX, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1958-0; Stuart EA, 2014, HEALTH SERV OUTCOME, V14, P166, DOI 10.1007/s10742-014-0123-z; Thomas ML, 2011, ASSESSMENT, V18, P291, DOI 10.1177/1073191110374797; Tzioumis E, 2014, FOOD NUTR BULL, V35, P230, DOI 10.1177/156482651403500210; UNICEF-WHO-The World Bank, 2013, JOINT CHILD MALN EST; Valdivieso Lopez E, 2014, ADDICTION; Vio F, 2014, NUTR HOSP, V29, P1298, DOI 10.3305/nh.2014.29.6.7409; Wall DE, 2012, J SCHOOL HEALTH, V82, P37, DOI 10.1111/j.1746-1561.2011.00665.x; Wang Yuying, 2007, Wei Sheng Yan Jiu, V36, P203; Watt RG, 2005, B WORLD HEALTH ORGAN, V83, P711; Yang J, 2006, CHINESE J HLTH ED, V22, P269; Yu S, 2005, HLTH VOCATIONAL ED, V23, P28; Zhang JG, 2011, CHINESE J EPIDEMIOLO, V32, P12241; Zhang Ji-guo, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P902; Zhang MY, 2012, PEDIATR DIABETES, V13, P572, DOI 10.1111/j.1399-5448.2012.00877.x; Zhang X, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006471; Zhou WJ, 2014, GLOB HLTH PROMOT; 赵晓华, 2011, [中国现代医学杂志, China Journal of Modern Medicine], V21, P1551	49	12	12	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145090	10.1371/journal.pone.0145090	http://dx.doi.org/10.1371/journal.pone.0145090			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26658459	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900182
J	Silva, CO; Petersen, SB; Reis, CP; Rijo, P; Molpeceres, J; Vorum, H; Neves-Petersen, MT				Silva, Catarina Oliveira; Petersen, Steffen B.; Reis, Catarina Pinto; Rijo, Patrcia; Molpeceres, Jesus; Vorum, Henrik; Neves-Petersen, Maria Teresa			Lysozyme Photochemistry as a Function of Temperature. The Protective Effect of Nanoparticles on Lysozyme Photostability	PLOS ONE			English	Article							EGG-WHITE LYSOZYME; GOLD NANOPARTICLES; SILVER NANOPARTICLES; METAL NANOPARTICLES; N-FORMYLKYNURENINE; DISULFIDE BONDS; FLUORESCENCE; TRYPTOPHAN; DITYROSINE; PROTEINS	The presence of aromatic residues and their close spatial proximity to disulphide bridges makes hen egg white lysozyme labile to UV excitation. UVB induced photo-oxidation of tryptophan and tyrosine residues leads to photochemical products, such as, kynurenine, N-formylky-nurenine and dityrosine and to the disruption of disulphide bridges in proteins. We here report that lysozyme UV induced photochemistry is modulated by temperature, excitation power, illumination time, excitation wavelength and by the presence of plasmonic quencher surfaces, such as gold, and by the presence of natural fluorescence quenchers, such as hyaluronic acid and oleic acid. We show evidence that the photo-oxidation effects triggered by 295 nm at 20 degrees C are reversible and non-reversible at 10 degrees C, 25 degrees C and 30 degrees C. This paper provides evidence that the 295 nm damage threshold of lysozyme lies between 0.1 mu W and 0.3 mu W. Protein conformational changes induced by temperature and UV light have been detected upon monitoring changes in the fluorescence emission spectra of lysozyme tryptophan residues and SYPRO (R) Orange. Lysozyme has been conjugated onto gold nanoparticles, coated with hyaluronic acid and oleic acid (HAOA). Steady state and time resolved fluorescence studies of free and conjugated lysozyme onto HAOA gold nanoparticles reveals that the presence of the polymer decreased the rate of the observed photochemical reactions and induced a preference for short fluorescence decay lifetimes. Size and surface charge of the HAOA gold nanoparticles have been determined by dynamic light scattering and zeta potential measurements. TEM analysis of the particles confirms the presence of a gold core surrounded by a HAOA matrix. We conclude that HAOA gold nanoparticles may efficiently protect lysozyme from the photochemical effects of UVB light and this nanocarrier could be potentially applied to other proteins with clinical relevance. In addition, this study confirms that the temperature plays a critical role in the photochemical pathways a protein enters upon UV excitation.	[Silva, Catarina Oliveira; Reis, Catarina Pinto; Rijo, Patrcia] Univ Lusofona, Res Ctr Biosci & Hlth Technol, P-1749024 Lisbon, Portugal; [Silva, Catarina Oliveira; Molpeceres, Jesus] Univ Alcala de Henares, Dept Biomed Sci, Fac Pharm, E-28871 Alcala De Henares, Spain; [Petersen, Steffen B.] Aalborg Univ, Med Photon Lab, Dept Hlth Sci & Technol, Fac Med, DK-9220 Aalborg, Denmark; [Reis, Catarina Pinto] Univ Lisbon, IBEB, Biophys & Biomed Engn, Fac Sci, P-1749016 Lisbon, Portugal; [Vorum, Henrik] Aalborg Univ, Dept Ophthalmol, DK-9000 Aalborg, Denmark; [Neves-Petersen, Maria Teresa] Aalborg Univ, Dept Clin Med, DK-9000 Aalborg, Denmark	Lusofona University; Universidad de Alcala; Aalborg University; Universidade de Lisboa; Aalborg University; Aalborg University	Reis, CP (corresponding author), Univ Lusofona, Res Ctr Biosci & Hlth Technol, P-1749024 Lisbon, Portugal.	catarinapintoreis@gmail.com; nevespetersen@gmail.com	Silva, Catarina/AAV-8108-2020; /Y-9512-2019; Reis, Catarina/M-8132-2013; iMed.ULisboa, NanoBB/B-5393-2014; Rijo, Patrícia/O-2657-2015	/0000-0003-4201-0795; Reis, Catarina/0000-0002-1046-4031; Rijo, Patrícia/0000-0001-7992-8343; Oliveira Silva, Catarina/0000-0002-5077-5176; Neves-Petersen, Maria Teresa/0000-0003-3178-3709	Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/BBB-BMC/0611/2012]; European Commission [H2020-644242-SAPHELY]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors would like to thank Fundacao para a Ciencia e Tecnologia (FCT) for the financial support under the project reference PTDC/BBB-BMC/0611/2012. The authors acknowledge the funding from the European Commission through the project H2020-644242-SAPHELY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Fundacao para a Ciencia e Tecnologia (FCT) for the financial support under the project reference PTDC/BBB-BMC/0611/2012. The authors acknowledge the funding from the European Commission through the project H2020-644242-SAPHELY.	Ali MS, 2015, SPECTROCHIM ACTA A, V135, P147, DOI 10.1016/j.saa.2014.06.124; ANDERSON EA, 1948, J PHYS COLLOID CHEM, V52, P1345, DOI 10.1021/j150464a007; Anpo M, 2010, NANOSTRUCT SCI TECHN, P1, DOI 10.1007/978-0-387-48444-0; Avanti C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086244; BAYSE GS, 1972, BIOCHIM BIOPHYS ACTA, V284, P34; Blumlein A, 2013, BBA-PROTEINS PROTEOM, V1834, P2064, DOI 10.1016/j.bbapap.2013.06.001; CANFIELD RE, 1965, J BIOL CHEM, V240, P1997; Chang JY, 2002, FEBS LETT, V511, P73, DOI 10.1016/S0014-5793(01)03284-7; Chanphai P, 2015, EUR POLYM J, V67, P224, DOI 10.1016/j.eurpolymj.2015.03.069; Cockell CS, 2002, ORIGINS LIFE EVOL B, V32, P255, DOI 10.1023/A:1016507810083; Correia M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116737; Correia M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111617; Correia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050733; Correia M, 2012, J FLUORESC, V22, P323, DOI 10.1007/s10895-011-0963-7; Davies MJ, 2003, BIOCHEM BIOPH RES CO, V305, P761, DOI 10.1016/S0006-291X(03)00817-9; DIAMOND R, 1974, J MOL BIOL, V82, P371, DOI 10.1016/0022-2836(74)90598-1; DOOLEY MM, 1982, ARCH BIOCHEM BIOPHYS, V218, P459, DOI 10.1016/0003-9861(82)90368-X; Dreaden TM, 2011, J BIOL CHEM, V286, P22632, DOI 10.1074/jbc.M110.212928; Du J, 2012, ANAL LETT, V45, P2236, DOI 10.1080/00032719.2012.682237; Duran N, 2011, APPL MICROBIOL BIOT, V90, P1609, DOI 10.1007/s00253-011-3249-8; FUKUNAGA Y, 1982, J BIOCHEM-TOKYO, V92, P129, DOI 10.1093/oxfordjournals.jbchem.a133909; Geerlof A, 2006, ACTA CRYSTALLOGR D, V62, P1125, DOI 10.1107/S0907444906030307; Gracanin M, 2009, FREE RADICAL BIO MED, V47, P92, DOI 10.1016/j.freeradbiomed.2009.04.015; GROSSWEINER L I, 1976, Current Topics in Radiation Research Quarterly, V11, P141; Han Q, 2012, BIOCHEM J, V446, P253, DOI 10.1042/BJ20120416; Jacob JS, 1996, J BIOL CHEM, V271, P19950, DOI 10.1074/jbc.271.33.19950; Kerwin BA, 2007, J PHARM SCI-US, V96, P1468, DOI 10.1002/jps.20815; Kraemer KH, 1978, J INVEST DERMATOL, V70; Kurnasov O, 2003, CHEM BIOL, V10, P1195, DOI 10.1016/j.chembiol.2003.11.011; Lakowicz JR., 1999, PRINCIPLES FLUORESCE, P25; Malencik DA, 2003, AMINO ACIDS, V25, P233, DOI 10.1007/s00726-003-0014-z; Maroufi B, 2008, BBA-PROTEINS PROTEOM, V1784, P1043, DOI 10.1016/j.bbapap.2008.03.010; Marquez LA, 1995, J BIOL CHEM, V270, P30434, DOI 10.1074/jbc.270.51.30434; MEHLER AH, 1950, J BIOL CHEM, V187, P431; Mitra RN, 2008, J PHYS CHEM C, V112, P8159, DOI 10.1021/jp712106d; Moghadam TT, 2012, INT J BIOL MACROMOL, V51, P91, DOI 10.1016/j.ijbiomac.2012.04.020; Moghadam TT, 2011, INT J BIOL MACROMOL, V49, P629, DOI 10.1016/j.ijbiomac.2011.06.021; Murphy CJ, 2005, J PHYS CHEM B, V109, P13857, DOI 10.1021/jp0516846; NERLOVE M, 1966, ECONOMETRICA, V34, P235, DOI 10.2307/1909870; Neves-Petersen MT, 2010, J FLUORESC, V20, P483, DOI 10.1007/s10895-009-0570-z; Neves-Petersen MT, 2009, BIOPHYS J, V97, P211, DOI 10.1016/j.bpj.2009.01.065; Neves-Petersen MT, 2006, PROTEIN SCI, V15, P343, DOI 10.1110/ps.051885306; Neves-Petersen MT, 2002, PROTEIN SCI, V11, P588, DOI 10.1110/ps.06002; Neves-Petersen MT, 2012, UV LIGHT EFFECTS PRO; PHILLIPS DC, 1967, P NATL ACAD SCI USA, V57, P484; PIRIE A, 1972, BIOCHEM J, V128, P1365, DOI 10.1042/bj1281365; PRYOR WA, 1993, J BIOL CHEM, V268, P3120; Sattar Z, 2012, SPECTROCHIM ACTA A, V97, P1089, DOI 10.1016/j.saa.2012.07.034; Shareghi B, 2015, J IND ENG CHEM, V21, P862, DOI 10.1016/j.jiec.2014.04.024; Shen LY, 2012, J COLLOID INTERF SCI, V388, P56, DOI 10.1016/j.jcis.2012.06.079; SHUGAR D, 1952, BIOCHIM BIOPHYS ACTA, V8, P302, DOI 10.1016/0006-3002(52)90045-0; Si S, 2007, CHEM-EUR J, V13, P3160, DOI 10.1002/chem.200601492; Sun J, 2011, J CHROMATOGR B, V879, P3053, DOI 10.1016/j.jchromb.2011.09.009; Volden S, 2012, RSC ADV, V2, P11704, DOI 10.1039/c2ra21931j; Water JJ, 2014, EUR J PHARM BIOPHARM, V88, P325, DOI 10.1016/j.ejpb.2014.09.001; Wimmer R, 1997, J BIOTECHNOL, V55, P85, DOI 10.1016/S0168-1656(97)00061-8; Wu LZ, 2008, J MOL STRUCT, V882, P101, DOI 10.1016/j.molstruc.2007.09.016; Xie JB, 2011, PROTEINS, V79, P2505, DOI 10.1002/prot.23074; YAMASHITA S, 1995, BIOSCI BIOTECH BIOCH, V59, P1255, DOI 10.1271/bbb.59.1255; Yang F, 2006, BBA-PROTEINS PROTEOM, V1764, P1389, DOI 10.1016/j.bbapap.2006.06.012; Ziyarat FP, 2014, J BIOMOL STRUCT DYN, V32, P613, DOI 10.1080/07391102.2013.785919	62	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144454	10.1371/journal.pone.0144454	http://dx.doi.org/10.1371/journal.pone.0144454			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656259	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900051
J	Weidner, LD; Paris, A; Frankle, WG; Narendran, R				Weidner, Lora D.; Paris, Antonio; Frankle, W. Gordon; Narendran, Rajesh			Safety of Oral Amphetamine Administered during Positron Emission Tomography Scans in Medically Screened Humans	PLOS ONE			English	Article							INDUCED DOPAMINE RELEASE; INDUCED DISPLACEMENT; STRIATUM	Changes in endogenous dopamine levels can be detected in humans using positron emission tomography scans by measuring the amount by which a specific D-2/3 radioligand is displaced. In some cases, a challenge drug such as amphetamine is introduced to increase the amount of dopamine released into the synaptic cleft. Although intravenous amphetamine is often utilized, oral amphetamine has been shown to be just as effective in increasing endogenous dopamine levels. Based on our own use of oral amphetamine as a challenge drug, we have retroactively reviewed our study charts to determine the cardiovascular safety of 0.5 mg kg(-1) oral d-amphetamine. Of 172 amphetamine administrations in 144 individuals, only 2.8% of subjects experienced any transient adverse effects. In addition, we found no clinically relevant differences in increases of vital signs between healthy controls and patients. We therefore reaffirm the safety of 0.5 mg kg(-1) oral amphetamine in subjects previously screened for cardiovascular risk factors.	[Weidner, Lora D.; Paris, Antonio; Frankle, W. Gordon; Narendran, Rajesh] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Frankle, W. Gordon; Narendran, Rajesh] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Narendran, R (corresponding author), Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA.	narendranr@upmc.edu		Frankle, William/0000-0003-0356-4197	National Institute on Drug Abuse [R01DA026472, R01AA0188330]; National Institute of Mental Health [R01MH086523]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026472] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The projects covered in this analysis were supported by National Institute on Drug Abuse (http://www.drugabuse.gov/funding) Awards R01DA026472 and R01AA0188330, and by National Institute of Mental Health (http://www.nimh.nih.gov/funding/index.shtml) Award R01MH086523. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 1998, AM J PSYCHIAT, V155, P761; ANGRIST B, 1987, BIOL PSYCHIAT, V22, P1357, DOI 10.1016/0006-3223(87)90070-9; Cardenas L, 2004, SYNAPSE, V51, P27, DOI 10.1002/syn.10282; Cropley VL, 2008, SYNAPSE, V62, P399, DOI 10.1002/syn.20506; Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6; LARUELLE M, 1995, J NUCL MED, V36, P1182; Martinez D, 2007, AM J PSYCHIAT, V164, P622, DOI 10.1176/appi.ajp.164.4.622; Narendran R, 2009, SYNAPSE, V63, P447, DOI 10.1002/syn.20628; Riccardi P, 2006, NEUROPSYCHOPHARMACOL, V31, P1016, DOI 10.1038/sj.npp.1300916; VOLKOW ND, 1994, SYNAPSE, V16, P255, DOI 10.1002/syn.890160402; Volkow ND, 2004, MOL PSYCHIATR, V9, P557, DOI 10.1038/sj.mp.4001507; Willeit M, 2008, NEUROPSYCHOPHARMACOL, V33, P279, DOI 10.1038/sj.npp.1301400; Zack M, 2015, J PSYCHOPHARMACOL, V29, P971, DOI 10.1177/0269881115592338	13	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0140647	10.1371/journal.pone.0140647	http://dx.doi.org/10.1371/journal.pone.0140647			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656737	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000366715900003
J	Cheng, JW; Xiao, M; Kudinha, T; Xu, ZP; Sun, LY; Hou, X; Zhang, L; Fan, X; Kong, FR; Xu, YC				Cheng, Jing-Wei; Xiao, Meng; Kudinha, Timothy; Xu, Zhi-Peng; Sun, Lin-Ying; Hou, Xin; Zhang, Li; Fan, Xin; Kong, Fanrong; Xu, Ying-Chun			The Role of Glutamate Dehydrogenase (GDH) Testing Assay in the Diagnosis of Clostridium difficile Infections: A High Sensitive Screening Test and an Essential Step in the Proposed Laboratory Diagnosis Workflow for Developing Countries like China	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; BINARY TOXIN; GUIDELINES; SOCIETY; STRAIN	The incidence and severity of Clostridium difficile infection (CDI) in North America and Europe has increased significantly since the 2000s. However, CDI is not widely recognized in China and other developing countries due to limited laboratory diagnostic capacity and low awareness. Most published studies on laboratory workflows for CDI diagnosis are from developed countries, and thus may not be suitable for most developing countries. Therefore, an alternative strategy for developing countries is needed. In this study, we evaluated the performance of the Glutamate Dehydrogenase (GDH) test and its associated workflow on 416 fecal specimens from suspected CDI cases. The assay exhibited excellent sensitivity (100.0%) and specificity (92.8%), compared to culture based method, and thus could be a good screening marker for C. difficile but not for indication of toxin production. The VIDAS CDAB assay, which can detect toxin A/B directly from fecal specimens, showed good specificity (99.7%) and positive predictive value (97.2%), but low sensitivity (45.0%) and negative predictive value (88.3%), compared with PCR-based toxin gene detection. Therefore, we propose a practical and efficient GDH test based workflow strategy for the laboratory diagnosis of CDI in developing countries like China. By applying this new workflow, the CDI laboratory diagnosis rate was notably improved in our center, yet the increasing cost was kept at a minimum level. Furthermore, to gain some insights into the genetic population structure of C. difficile isolates from our hospital, we performed MLST and PCR toxin gene typing.	[Cheng, Jing-Wei; Xiao, Meng; Xu, Zhi-Peng; Hou, Xin; Zhang, Li; Fan, Xin; Xu, Ying-Chun] Chinese Acad Med Sci, Dept Clin Lab, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Cheng, Jing-Wei; Hou, Xin; Fan, Xin] Chinese Acad Med Sci, Grad Sch, Peking Union Med Coll, Beijing 100730, Peoples R China; [Kudinha, Timothy; Kong, Fanrong] Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, ICPMR Pathol West, Westmead, NSW 2145, Australia; [Kudinha, Timothy] Charles Sturt Univ, Orange, NSW, Australia; [Sun, Lin-Ying] Taishan Med Sch, Teaching & Res Sect, Clin Lab, Sch Publ Hlth, Tai An, Shandong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Sydney; Charles Sturt University; Shandong First Medical University & Shandong Academy of Medical Sciences	Xu, YC (corresponding author), Chinese Acad Med Sci, Dept Clin Lab, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China.	xycpumch@139.com	Xiao, Meng/J-6518-2017	Xiao, Meng/0000-0003-2103-7008	National Natural Science Foundation of China [81501807]; National Research Special Fund for Public Welfare Industry of Health of China [201402001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Special Fund for Public Welfare Industry of Health of China	This study was financially supported by a National Natural Science Foundation of China (grant number 81501807) and National Research Special Fund for Public Welfare Industry of Health of China (grant number 201402001). Website: http://www.nhfpc.gov.cn/zwgkzt/pkjjy1/201302/9cb220c8a5704c0a9ebf5ef65a337544.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was financially supported by a National Natural Science Foundation of China (grant number 81501807) and National Research Special Fund for Public Welfare Industry of Health of China (grant number 201402001).	Bartlett JG, 2005, NEW ENGL J MED, V353, P2503, DOI 10.1056/NEJMe058221; Bassetti M, 2012, EXPERT REV ANTI-INFE, V10, P1405, DOI [10.1586/ERI.12.135, 10.1586/eri.12.135]; Burnham CAD, 2013, CLIN MICROBIOL REV, V26, P604, DOI 10.1128/CMR.00016-13; Chen X, 2013, GASTROENTEROL REP, V1, P153, DOI 10.1093/gastro/got029; Cheng AC, 2011, MED J AUSTRALIA, V194, P353, DOI 10.5694/j.1326-5377.2011.tb03006.x; Collins DA, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-21; Crobach MJT, 2009, CLIN MICROBIOL INFEC, V15, P1053, DOI 10.1111/j.1469-0691.2009.03098.x; Culbreath K, 2012, J CLIN MICROBIOL, V50, P3073, DOI 10.1128/JCM.00992-12; Eastwood K, 2009, J CLIN MICROBIOL, V47, P3211, DOI 10.1128/JCM.01082-09; Gerding DN, 2008, CLIN INFECT DIS, V46, pS43, DOI 10.1086/521861; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Hawkey PM, 2013, J CLIN MICROBIOL, V51, P3308, DOI 10.1128/JCM.00587-13; Jin K, 2010, J BIOMED RES, V24, P411, DOI 10.1016/S1674-8301(10)60055-3; Jones AM, 2013, J INFECTION, V66, P115, DOI 10.1016/j.jinf.2012.10.019; Kawada M, 2011, J INFECT CHEMOTHER, V17, P807, DOI 10.1007/s10156-011-0267-5; Kim H, 2014, ANN LAB MED, V34, P235, DOI 10.3343/alm.2014.34.3.235; Kuwata Y, 2015, EUR J CLIN MICROBIOL, V34, P763, DOI 10.1007/s10096-014-2290-9; Lalande V, 2011, J CLIN MICROBIOL, V49, P2714, DOI 10.1128/JCM.01835-10; Murabata Mayumi, 2008, Kansenshogaku Zasshi, V82, P419; Muto CA, 2007, CLIN INFECT DIS, V45, P1266, DOI 10.1086/522654; Novak-Weekley SM, 2010, J CLIN MICROBIOL, V48, P889, DOI 10.1128/JCM.01801-09; Persson S, 2008, CLIN MICROBIOL INFEC, V14, P1057, DOI 10.1111/j.1469-0691.2008.02092.x; Planche T, 2008, LANCET INFECT DIS, V8, P777, DOI 10.1016/S1473-3099(08)70233-0; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Sharp SE, 2010, J CLIN MICROBIOL, V48, P2082, DOI 10.1128/JCM.00129-10; Stewart DB, 2013, J GASTROINTEST SURG, V17, P118, DOI 10.1007/s11605-012-2056-6; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Ticehurst JR, 2006, J CLIN MICROBIOL, V44, P1145, DOI 10.1128/JCM.44.3.1145-1149.2006; U.S. Centers for Disease Control and Prevention, 2013, ANTIBIOTIC RESISTANC; Weber I, 2013, INT J MED MICROBIOL, V303, P128, DOI 10.1016/j.ijmm.2013.02.016; Yan Q, 2013, EPIDEMIOL INFECT, V141, P195, DOI 10.1017/S0950268812000453	31	28	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144604	10.1371/journal.pone.0144604	http://dx.doi.org/10.1371/journal.pone.0144604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659011	Green Submitted, gold, Green Published			2022-12-27	WOS:000366903600064
J	Nazari, M; Mahmoudi, M; Rahmani, F; Akhlaghi, M; Beigy, M; Azarian, M; Shamsian, E; Akhtari, M; Mansouri, R				Nazari, Masoumeh; Mahmoudi, Mahdi; Rahmani, Farzaneh; Akhlaghi, Masoomeh; Beigy, Maani; Azarian, Maryam; Shamsian, Elmira; Akhtari, Maryam; Mansouri, Reza			Association of Killer Cell Immunoglobulin-Like Receptor Genes in Iranian Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							KIR GENES; DISEASE; HLA; POLYMORPHISMS; LINKAGE	Objectives Rheumatoid arthritis (RA) is a chronic inflammatory disorder characterized by persistent synovitis, ultimately leading to cartilage and bone degeneration. Natural Killer cells and CD28 null T-cells are suspected as role players in RA pathogenesis. These cells are similar in feature and function, as they both exert their cytotoxic effect via Killer Cell Immunoglobulin-Like Receptors (KIR) on their surface. KIR genes have either an inhibitory or activating effect depending on their intracytoplasmic structure. Herein we genotyped 16 KIR genes, 3 pseudo genes and 6 HLA class. genes as their corresponding ligands in RA patients and control subjects. Methods In this case-control study, KIR and HLA genes were genotyped in 400 RA patients and 372 matched healthy controls using sequence-specific primers (SSP-PCR). Differences in the frequency of genes and haplotypes were determined by chi(2) test. Results KIR2DL2, 2DL5a, 2DL5b and activating KIR: KIR2DS5 and 3DS1 were all protective against RA. KIR2DL5 removal from a full Inhibitory KIR haplotype converted the mild protection (OR = 0.56) to a powerful predisposition to RA (OR = 16.47). Inhibitory haplotype No. 7 comprising KIR2DL5 in the absence of KIR2DL1 and KIR2DL3 confers a 14-fold protective effect against RA. Conclusion Individuals carrying the inhibitory KIR haplotype No. 6 have a high potential risk for developing RA.	[Nazari, Masoumeh; Mansouri, Reza] Shahid Sadoughi Univ Med Sci, Dept Immunol, Yazd, Iran; [Nazari, Masoumeh; Mahmoudi, Mahdi; Rahmani, Farzaneh; Akhlaghi, Masoomeh; Beigy, Maani; Azarian, Maryam; Shamsian, Elmira; Akhtari, Maryam] Univ Tehran Med Sci, Rheumatol Res Ctr, Tehran, Iran; [Rahmani, Farzaneh; Beigy, Maani] Univ Tehran Med Sci, Students Sci Res Ctr, Tehran, Iran; [Rahmani, Farzaneh; Beigy, Maani] Univ Tehran Med Sci, Shariati Hosp, Rheumatol Res Ctr, Tehran, Iran; [Mansouri, Reza] Shahid Sadoughi Univ Med Sci, Dept Immunol, Yazd, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Mahmoudi, M (corresponding author), Univ Tehran Med Sci, Rheumatol Res Ctr, Tehran, Iran.	mahmoudim@tums.ac.ir; Rmansori@ssu.ac.ir	azarian, maryam/GPP-4153-2022; Mansouri, Reza/AAO-4962-2021; Akhtari, Maryam/AAD-3787-2020; Beigy, Maani/S-4091-2019	Akhtari, Maryam/0000-0002-5342-3440; Beigy, Maani/0000-0003-2963-3533; Rahmani, Farzaneh/0000-0002-0530-2054; Mahmoudi, Mahdi/0000-0002-8164-8831				Alamanos Y, 2005, AUTOIMMUN REV, V4, P130, DOI 10.1016/j.autrev.2004.09.002; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Ayo CM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003753; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carrington M, 2003, THE KIR GENE CLUSTER; Diaz-Pena R, 2010, ARTHRITIS RHEUM-US, V62, P1000, DOI 10.1002/art.27332; Gagne K, 2002, HUM IMMUNOL, V63, P271, DOI 10.1016/S0198-8859(02)00373-7; Gourraud PA, 2010, IMMUNOGENETICS, V62, P729, DOI 10.1007/s00251-010-0478-4; Khan A., 1995, METHODS DNA ISOLAT 3, P2488; Kogure T, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/65179; Kulkarni S, 2008, SEMIN IMMUNOL, V20, P343, DOI 10.1016/j.smim.2008.06.003; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Majorczyk E, 2007, GENES IMMUN, V8, P678, DOI 10.1038/sj.gene.6364433; Majorczyk E, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-256; Martin Maureen P., 2008, V415, P49, DOI 10.1007/978-1-59745-570-1_3; McGeough CM, 2012, RHEUMATOL INT, V32, P1647, DOI 10.1007/s00296-011-1838-6; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Middleton D, 2007, TISSUE ANTIGENS, V69, P577, DOI 10.1111/j.1399-0039.2007.00828.x; Moritz F, 2006, NAT CLIN PRACT RHEUM, V2, P153, DOI 10.1038/ncprheum0117; Navarro AG, 2014, J IMMUNOL, V193, P6192, DOI 10.4049/jimmunol.1400859; Orozco G, 2013, BJU INT, V111, P1148, DOI 10.1111/j.1464-410X.2012.11492.x; Rajagopalan S, 2005, J EXP MED, V201, P1025, DOI 10.1084/jem.20050499; Ramirez-De los Santos S, 2012, DIS MARKERS, V33, P201, DOI [10.3233/DMA-2012-0927, 10.1155/2012/486320]; Redelinghuys P, 2015, ANN RHEUMATIC DIS, DOI 10.1136/annrheumdis-2014-206644; Roberts CH, 2014, GENOME MED, V6, DOI 10.1186/gm537; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1234, DOI 10.1093/nar/gks1140; Ryan JC, 2001, IMMUNOL REV, V181, P126, DOI 10.1034/j.1600-065X.2001.1810110.x; Shegarfi H, 2012, SCI WORLD J, P1, DOI 10.1100/2012/491974; Tajik N, 2010, INT J IMMUNOGENET, V37, P159, DOI 10.1111/j.1744-313X.2010.00906.x; Tajik N, 2009, TISSUE ANTIGENS, V74, P22, DOI 10.1111/j.1399-0039.2009.01263.x; Tobon GJ, 2010, J AUTOIMMUN, V35, P10, DOI 10.1016/j.jaut.2009.12.009; Vilches C, 2007, TISSUE ANTIGENS, V70, P415, DOI 10.1111/j.1399-0039.2007.00923.x; Yen JH, 2006, SCAND J RHEUMATOL, V35, P124, DOI 10.1080/03009740500381252; Yen JH, 2001, J EXP MED, V193, P1159, DOI 10.1084/jem.193.10.1159	34	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0143757	10.1371/journal.pone.0143757	http://dx.doi.org/10.1371/journal.pone.0143757			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658904	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903600014
J	Atay, C; Conway, ER; Angus, D; Wiles, J; Baker, R; Chenery, HJ				Atay, Christina; Conway, Erin R.; Angus, Daniel; Wiles, Janet; Baker, Rosemary; Chenery, Helen J.			An Automated Approach to Examining Conversational Dynamics between People with Dementia and Their Carers	PLOS ONE			English	Article							OLDER-PEOPLE; COMMUNICATION SUPPORT; ALZHEIMERS-DISEASE; DISCOURSE ANALYSIS; COHERENCE; MEMORY; STRATEGIES; ADULTS	The progressive neuropathology involved in dementia frequently causes a gradual decline in communication skills. Communication partners who are unaware of the specific communication problems faced by people with dementia (PWD) can inadvertently challenge their conversation partner, leading to distress and a reduced flow of information between speakers. Previous research has produced an extensive literature base recommending strategies to facilitate conversational engagement in dementia. However, empirical evidence for the beneficial effects of these strategies on conversational dynamics is sparse. This study uses a time-efficient computational discourse analysis tool called Discursis to examine the link between specific communication behaviours and content-based conversational engagement in 20 conversations between PWD living in residential aged-care facilities and care staff members. Conversations analysed here were baseline conversations recorded before staff members underwent communication training. Care staff members spontaneously exhibited a wide range of facilitative and non-facilitative communication behaviours, which were coded for analysis of conversation dynamics within these baseline conversations. A hybrid approach combining manual coding and automated Discursis metric analysis provides two sets of novel insights. Firstly, this study revealed nine communication behaviours that, if used by the care staff member in a given turn, significantly increased the appearance of subsequent content-based engagement in the conversation by PWD. Secondly, the current findings reveal alignment between human- and computer-generated labelling of communication behaviour for 8 out of the total 22 behaviours under investigation. The approach demonstrated in this study provides an empirical procedure for the detailed evaluation of content-based conversational engagement associated with specific communication behaviours.	[Atay, Christina; Conway, Erin R.; Chenery, Helen J.] Univ Queensland, Fac Med & Biomed Sci, UQ Ctr Clin Res, Asia Pacific Ctr Neuromodulat, Herston, Qld, Australia; [Conway, Erin R.] Australian Catholic Univ, Sch Allied Hlth, Fac Hlth Sci, Banyo, Qld, Australia; [Angus, Daniel] Univ Queensland, Fac Humanities & Social Sci, Sch Commun & Arts, St Lucia, Qld, Australia; [Angus, Daniel; Wiles, Janet] Univ Queensland, Sch Informat Technol & Elect Engn, Fac Engn Architecture & Informat Technol, St Lucia, Qld, Australia; [Baker, Rosemary] Fac Med & Biomed Sci, UQ Ctr Clin Res, Herston, Qld, Australia; [Chenery, Helen J.] Bond Univ, Fac Hlth Sci & Med, Robina, Qld, Australia	University of Queensland; Australian Catholic University; University of Queensland; University of Queensland; University of Queensland; Bond University	Atay, C (corresponding author), Univ Queensland, Fac Med & Biomed Sci, UQ Ctr Clin Res, Asia Pacific Ctr Neuromodulat, Herston, Qld, Australia.	c.knuepffer@uq.edu.au	Conway, Erin R/F-3987-2010; Wiles, Janet/C-1989-2008	Conway, Erin R/0000-0002-1740-2562; Wiles, Janet/0000-0002-4051-4116; Angus, Daniel/0000-0002-1412-5096	National Health and Medical Research Council (NHMRC) [511208]; J.O. and J.R. Wicking Trust; Australian Research Council (ARC) Centre of Excellence for the Dynamics of Language;  [CE140100041]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); J.O. and J.R. Wicking Trust; Australian Research Council (ARC) Centre of Excellence for the Dynamics of Language(Australian Research Council); 	This work was supported by the National Health and Medical Research Council (NHMRC), Grant ID: 511208 and the J.O. and J.R. Wicking Trust, which is administered by ANZ Trustees. Both grants were awarded to author HJC. This work was also supported by the Australian Research Council (ARC) Centre of Excellence for the Dynamics of Language. This Grant was awarded to authors HJC and JW. Grant number CE140100041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm N, 2004, NEUROPSYCHOL REHABIL, V14, P117, DOI 10.1080/09602010343000147; Angus D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038014; Angus D, 2012, IEEE T AUDIO SPEECH, V20, P1795, DOI 10.1109/TASL.2012.2189566; Angus D, 2012, IEEE T VIS COMPUT GR, V18, P988, DOI 10.1109/TVCG.2011.100; BADDELEY A, 1986, Q J EXP PSYCHOL-A, V38, P603, DOI 10.1080/14640748608401616; BADDELEY AD, 1991, BRAIN, V114, P2521, DOI 10.1093/brain/114.6.2521; Baker R, 2015, AGEING SOC, V35, P270, DOI 10.1017/S0144686X13000640; Bloom RL, 2013, DISCOURSE ANAL APPL; Broughton M, 2011, INT J NURS STUD, V48, P1436, DOI 10.1016/j.ijnurstu.2011.05.007; Caramelli P, 1998, HDB NEUROLINGUISTICS, P463, DOI DOI 10.1016/B978-012666055-5/50036-8; Carpiac-Claver ML, 2007, HEALTH COMMUN, V22, P59, DOI 10.1080/10410230701310307; Chatwin J, 2004, COMPLEMENT THER MED, V12, P131, DOI 10.1016/j.ctim.2004.07.042; Chatwin J, 2014, DEMENTIA-LONDON, V13, P737, DOI 10.1177/1471301213485231; Clare L, 2004, NEUROPSYCHOL REHABIL, V14, P385, DOI 10.1080/09602010443000074; Conway E, SUPPORTING QUALITY C; Dijkstra K, 2004, J NEUROLINGUIST, V17, P263, DOI 10.1016/S0911-6044(03)00048-4; Dijkstra K, 2002, DISCOURSE PROCESS, V33, P53, DOI 10.1207/S15326950DP3301_03; Edberg A K, 1995, J Psychiatr Ment Health Nurs, V2, P159, DOI 10.1111/j.1365-2850.1995.tb00051.x; Eggenberger E, 2013, INT PSYCHOGERIATR, V25, P345, DOI 10.1017/S1041610212001664; ERBER NP, 1994, EUR J DISORDER COMM, V29, P269; Fairclough N., 2013, CRITICAL DISCOURSE A; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Harvey K, 2013, ROUT INTROD APPL LIN, P1; Hendryx-Bedalov PM, 1999, INT J AGING HUM DEV, V49, P127, DOI 10.2190/KQY0-VC2Q-0RG1-B9NL; Hubbard G, 2003, AGING MENT HEALTH, V7, P351, DOI 10.1080/1360786031000150685; Hubbard G, 2003, AGEING SOC, V23, P99, DOI 10.1017/S0144686X02008991; Hubbard G, 2002, J AGING STUD, V16, P155, DOI 10.1016/S0890-4065(02)00041-5; Laine M, 1998, J NEUROLINGUIST, V11, P79, DOI 10.1016/S0911-6044(98)00006-2; Liddle J, 2012, INT PSYCHOGERIATR, V1, P1; Mansah M, 2014, TAILORING DEMENTIA C, V34; McGilton KS, 2009, WORLDV EVID-BASED NU, V6, P149, DOI 10.1111/j.1741-6787.2009.00155.x; MENTIS M, 1995, J SPEECH HEAR RES, V38, P1054, DOI 10.1044/jshr.3805.1054; Miller J., 2010, SYSTEMATIC ANAL LANG; MORRIS RG, 1988, J CLIN EXP NEUROPSYC, V10, P279, DOI 10.1080/01688638808408242; MUNGAS D, 1991, GERIATRICS, V46, P54; MURDOCH BE, 1987, BRAIN LANG, V31, P122, DOI 10.1016/0093-934X(87)90064-2; Parker I., 2014, DISCOURSE DYNAMICS C; Pashek GV, 2006, J MED SPEECH-LANG PA, V14, P143; RIPICH DN, 1988, J SPEECH HEAR DISORD, V53, P8, DOI 10.1044/jshd.5301.08; Savundranayagam MY, 2005, J GERONTOL B-PSYCHOL, V60, pS48, DOI 10.1093/geronb/60.1.S48; Schegloff Emanuel A., 1984, STRUCTURE SOCIAL ACT, P266, DOI DOI 10.1017/CBO9780511665868.018; Smith ER, 2011, INT PSYCHOGERIATR, V23, P256, DOI 10.1017/S1041610210001845; SPINNLER H, 1988, COGNITIVE NEUROPSYCH, V5, P193, DOI 10.1080/02643298808252933; Ulatowska H, 1988, NEUROPSYCHOLOGICAL S, P108; UQ Dementia Care, 2012, COMM STRAT DEM CAR S; Vasse E, 2010, INT PSYCHOGERIATR, V22, P189, DOI 10.1017/S1041610209990615; VITALIANO PP, 1993, J GERONTOL, V48, pP202, DOI 10.1093/geronj/48.4.P202; Watson BM, 2015, LANG COMMUN, V41, P57, DOI 10.1016/j.langcom.2014.10.013; Wetherell M., 2001, DISCOURSE DATA GUIDE	50	9	9	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144327	10.1371/journal.pone.0144327	http://dx.doi.org/10.1371/journal.pone.0144327			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YZ	26658135	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903500019
J	Weng, HY; Fox, AS; Hessenthaler, HC; Stodola, DE; Davidson, RJ				Weng, Helen Y.; Fox, Andrew S.; Hessenthaler, Heather C.; Stodola, Diane E.; Davidson, Richard J.			The Role of Compassion in Altruistic Helping and Punishment Behavior	PLOS ONE			English	Article							SOCIAL RELATIONSHIPS; NEURAL RESPONSES; MEDITATION; COOPERATION; FAIRNESS; OTHERS	Compassion, the emotional response of caring for another who is suffering and that results in motivation to relieve suffering, is thought to be an emotional antecedent to altruistic behavior. However, it remains unclear whether compassion enhances altruistic behavior in a uniform way or is specific to sub-types of behavior such as altruistic helping of a victim or altruistic punishment of a transgressor. We investigated the relationship between compassion and subtypes of altruistic behavior using third-party paradigms where participants 1) witnessed an unfair economic exchange between a transgressor and a victim, and 2) had the opportunity to either spend personal funds to either economically a) help the victim or b) punish the transgressor. In Study 1, we examined whether individual differences in self-reported empathic concern (the emotional component of compassion) was associated with greater altruistic helping or punishment behavior in two independent samples. For participants who witnessed an unfair transaction, trait empathic concern was associated with greater helping of a victim and had no relationship to punishment. However, in those who decided to punish the transgressor, participants who reported greater empathic concern decided to punish less. In Study 2, we directly enhanced compassion using short-term online compassion meditation training to examine whether altruistic helping and punishment were increased after two weeks of training. Compared to an active reappraisal training control group, the compassion training group gave more to help the victim and did not differ in punishment of the transgressor. Together, these two studies suggest that compassion is related to greater altruistic helping of victims and is not associated with or may mitigate altruistic punishment of transgressors.	[Weng, Helen Y.; Davidson, Richard J.] Univ Calif San Francisco, Osher Ctr Integrat Med, San Francisco, CA 94143 USA; [Weng, Helen Y.; Fox, Andrew S.; Hessenthaler, Heather C.; Stodola, Diane E.; Davidson, Richard J.] Univ Wisconsin, Waisman Ctr, Ctr Invest Hlth Minds, Madison, WI 53705 USA; [Weng, Helen Y.; Fox, Andrew S.; Hessenthaler, Heather C.; Stodola, Diane E.; Davidson, Richard J.] Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Madison, WI USA; [Fox, Andrew S.; Davidson, Richard J.] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Davidson, Richard J.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA	University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Weng, HY (corresponding author), Univ Calif San Francisco, Osher Ctr Integrat Med, San Francisco, CA 94143 USA.	Helen.Weng@ucsf.edu; rjdavids@wisc.edu		Davidson, Richard/0000-0002-8506-4964	National Institutes of Health [P01-AT004952, T32-MH018931]; National Center for Complementary and Integrative Medicine at NIH [T32-AT006956, T32-AT003997]; University of Wisconsin-Madison Department of Psychology; Fetzer Institute; Impact Foundation; J. W. Kluge Foundation; Mental Insight Foundation; Mind and Life Institute; National Center for Complementary & Integrative Health [P01AT004952, T32AT003997, T32AT006956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018931] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary and Integrative Medicine at NIH; University of Wisconsin-Madison Department of Psychology; Fetzer Institute; Impact Foundation; J. W. Kluge Foundation; Mental Insight Foundation; Mind and Life Institute; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health (P01-AT004952 and T32-MH018931 - RJD, principle investigator; http://www.nih.gov/); National Center for Complementary and Integrative Medicine at NIH (T32-AT006956 at the University of Wisconsin Department of Family Medicine - B. P. Barrett, principle investigator; T32-AT003997 at the University of California, San Francisco Osher Center for Integrative Medicine - F. Hecht and J. T. Moskowitz, principal investigators; https://nccih.nih.gov/); University of Wisconsin-Madison Department of Psychology (HYW and ASF); Fetzer Institute (http://fetzer.org/), Impact Foundation (http://www.theimpactfoundation.org/), J. W. Kluge Foundation (http://www.loc.gov/loc/kluge/), Mental Insight Foundation (RJD), Mind and Life Institute (HYW; http://www.mindandlife.org/), and gifts from Bryant Wangard, Ralph Robinson, Keith and Arlene Bronstein (RJD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATSON CD, 1991, ALTRUISM QUESTION TO; Beck AT, 1987, COGNITIVE THERAPY DE; Braithwaite John, 2001, RESTORATIVE JUSTICE; Branas-Garza P, 2014, SCI REP-UK, V4, DOI 10.1038/srep06025; Brown SL, 2003, PSYCHOL SCI, V14, P320, DOI 10.1111/1467-9280.14461; Buckholtz JW, 2012, NAT NEUROSCI, V15, P655, DOI 10.1038/nn.3087; Camerer C.F., 2011, BEHAV GAME THEORY EX; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Condon P, 2013, PSYCHOL SCI, V24, P2125, DOI 10.1177/0956797613485603; Condon P, 2011, J EXP SOC PSYCHOL, V47, P698, DOI 10.1016/j.jesp.2010.11.016; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; Davidson Richard, 2001, VISIONS COMPASSION W; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; Dawes CT, 2007, NATURE, V446, P794, DOI 10.1038/nature05651; Desbordes G, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00292; Dunn EW, 2014, CURR DIR PSYCHOL SCI, V23, P41, DOI 10.1177/0963721413512503; Eisenberg N., 2007, HDB CHILD PSYCHOL, V3; Espin AM, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00214; Espin AM, 2012, P ROY SOC B-BIOL SCI, V279, P4923, DOI 10.1098/rspb.2012.2043; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Gachter S, 2009, PHILOS T R SOC B, V364, P791, DOI 10.1098/rstb.2008.0275; Goetz JL, 2010, PSYCHOL BULL, V136, P351, DOI 10.1037/a0018807; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Halifax J, 2012, CURR OPIN SUPPORT PA, V6, P228, DOI 10.1097/SPC.0b013e3283530fbe; Hein G, 2010, NEURON, V68, P149, DOI 10.1016/j.neuron.2010.09.003; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Lama HHD, 2012, RELIGION ETHICS WHOL; Leiberg S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017798; Lutz A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001897; McCall C, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00424; Pace TWW, 2009, PSYCHONEUROENDOCRINO, V34, P87, DOI 10.1016/j.psyneuen.2008.08.011; Salzberg S., 1997, LOVINGKINDNESS REVOL; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Shiota M.N., 2006, J POSIT PSYCHOL, V1, P61, DOI [10.1080/17439760500510833, DOI 10.1080/17439760500510833]; Singer T, 2009, ANN NY ACAD SCI, V1167, P41, DOI 10.1111/j.1749-6632.2009.04733.x; Sprecher S, 2005, J SOC PERS RELAT, V22, P629, DOI 10.1177/0265407505056439; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Weng HY, 2013, PSYCHOL SCI, V24, P1171, DOI 10.1177/0956797612469537	42	42	44	6	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0143794	10.1371/journal.pone.0143794	http://dx.doi.org/10.1371/journal.pone.0143794			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YZ	26655837	gold, Green Published			2022-12-27	WOS:000366903500006
J	Lee, HC; Lo, HC; Lo, DM; Su, MY; Hu, JR; Wu, CC; Chang, SN; Dai, MS; Tsai, CT; Tsai, HJ				Lee, Hung-Chieh; Lo, Hao-Chan; Lo, Dao-Ming; Su, Mai-Yan; Hu, Jia-Rung; Wu, Chin-Chieh; Chang, Sheng-Nan; Dai, Ming-Shen; Tsai, Chia-Ti; Tsai, Huai-Jen			Amiodarone Induces Overexpression of Similar to Versican b to Repress the EGFR/Gsk3b/Snail Signaling Axis during Cardiac Valve Formation of Zebrafish Embryos	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR-MATRIX; CUSHION FORMATION; G1 DOMAIN; IN-VITRO; TGF-BETA; HEART; GROWTH; EXPRESSION; CELL	Although Amiodarone, a class III antiarrhythmic drug, inhibits zebrafish cardiac valve formation, the detailed molecular pathway is still unclear. Here, we proved that Amiodarone acts as an upstream regulator, stimulating similar to versican b (s-vcanb) overexpression at zebrafish embryonic heart and promoting cdh-5 overexpression by inhibiting snail1b at atrioventricular canal (AVC), thus blocking invagination of endocardial cells and, as a result, preventing the formation of cardiac valves. A closer investigation showed that an intricate set of signaling events ultimately caused the up-regulation of cdh5. In particular, we investigated the role of EGFR signaling and the activity of Gsk3b. It was found that knockdown of EGFR signaling resulted in phenotypes similar to those of Amiodarone-treated embryos. Since the reduced phosphorylation of EGFR was rescued by knockdown of s-vcanb, it was concluded that the inhibition of EGFR activity by Amiodarone is s-vcanb-dependent. Moreover, the activity of Gsk3b, a downstream effector of EGFR, was greatly increased in both Amiodarone-treated embryos and EGFR-inhibited embryos. Therefore, it was concluded that reduced EGFR signaling induced by Amiodarone treatment results in the inhibition of Snail functions through increased Gsk3b activity, which, in turn, reduces snail1b expression, leading to the up-regulation the cdh5 at the AVC, finally resulting in defective formation of valves. This signaling cascade implicates the EGFR/Gsk3b/Snail axis as the molecular basis for the inhibition of cardiac valve formation by Amiodarone.	[Lee, Hung-Chieh; Hu, Jia-Rung; Tsai, Huai-Jen] Mackay Med Coll, Inst Biomed Sci, New Taipei, Taiwan; [Lo, Hao-Chan; Lo, Dao-Ming; Su, Mai-Yan; Tsai, Huai-Jen] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Wu, Chin-Chieh; Dai, Ming-Shen] Natl Def Med Ctr, Triserv Gen Hosp, Div Hematol Oncol, Taipei, Taiwan; [Chang, Sheng-Nan] Natl Taiwan Univ Hosp, Yun Lin Branch, Cardiovasc Ctr, Yunlin, Taiwan; [Tsai, Chia-Ti] Natl Taiwan Univ Coll Med & Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan	Mackay Medical College; National Taiwan University; National Defense Medical Center; Tri-Service General Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Tsai, CT (corresponding author), Natl Taiwan Univ Coll Med & Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan.	cttsai1999@gmail.com; hjtsai@mmc.edu.tw	DAI, M/GPS-8291-2022	TSAI, CHIA-TI/0000-0002-4853-8665; CHANG, SHENG NAN/0000-0002-2663-5042	National Taiwan University Hospital [UN102-052]; Taiwan National Science Council [NSC102-2313-B-715-001-MY3]; Tri-Service General Hospital [TSGH-C103-046]	National Taiwan University Hospital(National Taiwan University); Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital	This work was supported by the National Taiwan University Hospital (UN102-052) of CTT, by the Taiwan National Science Council (NSC102-2313-B-715-001-MY3) of HJT, and by the Tri-Service General Hospital (TSGH-C103-046) of MSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Blanco MJ, 2007, DEVELOPMENT, V134, P4073, DOI 10.1242/dev.006858; Blue GM, 2012, MED J AUSTRALIA, V197, P155, DOI 10.5694/mja12.10811; Burns TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089133; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Chen YH, 2012, REPROD TOXICOL, V33, P233, DOI 10.1016/j.reprotox.2011.12.008; Cheng W, 2006, DEV BIOL, V294, P482, DOI 10.1016/j.ydbio.2006.03.018; Du WW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026396; Goishi K, 2003, MECH DEVELOP, V120, P811, DOI 10.1016/S0925-4773(03)00068-6; Henderson DJ, 1998, CIRC RES, V83, P523, DOI 10.1161/01.RES.83.5.523; Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Iwamoto R, 2006, CELL STRUCT FUNCT, V31, P1, DOI 10.1247/csf.31.1; Kang JS, 2004, MECH DEVELOP, V121, P301, DOI 10.1016/j.mod.2004.01.007; Kruithof BPT, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.04.003; Larson JD, 2004, DEV DYNAM, V231, P204, DOI 10.1002/dvdy.20102; Latif N, 2005, J HEART VALVE DIS, V14, P218; Lee HC, 2015, ONCOTARGET IN PRESS, DOI 10.18632/oncotarget.5621; Lencinas A, 2011, BIRTH DEFECTS RES C, V93, P298, DOI 10.1002/bdrc.20222; Liu AC, 2007, HISTOL HISTOPATHOL, V22, P873, DOI 10.14670/HH-22.873; de la Pompa JL, 2012, DEV CELL, V22, P244, DOI 10.1016/j.devcel.2012.01.014; Marhaba R, 2004, J MOL HISTOL, V35, P211; MARKWALD RR, 1977, AM J ANAT, V148, P85, DOI 10.1002/aja.1001480108; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sanchez-Soria P, 2010, SEMIN CELL DEV BIOL, V21, P929, DOI 10.1016/j.semcdb.2010.09.011; Schmalfeldt M, 2000, J CELL SCI, V113, P807; Schrijver I, 1999, AM J HUM GENET, V65, P1007, DOI 10.1086/302582; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; Sherman LS, 2000, J CELL BIOL, V150, P1071, DOI 10.1083/jcb.150.5.1071; Taylor PA, 2003, INT J BIOCHEM CELL B, V35, P113, DOI 10.1016/S1357-2725(02)00100-0; Thisse C, 1999, DEVELOPMENT, V126, P229; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Wu YJ, 2004, MOL BIOL CELL, V15, P2093, DOI 10.1091/mbc.E03-09-0667; Yamagishi T, 2009, ANAT SCI INT, V84, P77, DOI 10.1007/s12565-009-0027-0; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Yamamura H, 1997, DEV BIOL, V186, P58, DOI 10.1006/dbio.1997.8559; Yang BL, 1999, J CELL BIOCHEM, V72, P210, DOI 10.1002/(SICI)1097-4644(19990201)72:2<210::AID-JCB5>3.0.CO;2-E; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702; Yutzey KE, 2005, PHYSIOLOGY, V20, P390, DOI 10.1152/physiol.00035.2005; Zanin MKB, 1999, ANAT RECORD, V256, P366; Zhang Y, 1999, J CELL BIOCHEM, V73, P445, DOI 10.1002/(SICI)1097-4644(19990615)73:4<445::AID-JCB3>3.0.CO;2-D; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje	48	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144751	10.1371/journal.pone.0144751	http://dx.doi.org/10.1371/journal.pone.0144751			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650936	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903300073
J	Yeji, F; Shibanuma, A; Oduro, A; Debpuur, C; Kikuchi, K; Owusu-Agei, S; Gyapong, M; Okawa, S; Ansah, E; Asare, GQ; Nanishi, K; Williams, J; Addei, S; Tawiah, C; Yasuoka, J; Enuameh, Y; Sakeah, E; Wontuo, P; Jimba, M; Hodgson, A				Yeji, Francis; Shibanuma, Akira; Oduro, Abraham; Debpuur, Cornelius; Kikuchi, Kimiyo; Owusu-Agei, Seth; Gyapong, Margaret; Okawa, Sumiyo; Ansah, Evelyn; Asare, Gloria Quansah; Nanishi, Keiko; Williams, John; Addei, Sheila; Tawiah, Charlotte; Yasuoka, Junko; Enuameh, Yeetey; Sakeah, Evelyn; Wontuo, Peter; Jimba, Masamine; Hodgson, Abraham		Ghana EMBRACE Implementation Res	Continuum of Care in a Maternal, Newborn and Child Health Program in Ghana: Low Completion Rate and Multiple Obstacle Factors	PLOS ONE			English	Article							FACILITY-BASED DELIVERY; SOCIOECONOMIC DETERMINANTS; NEONATAL-MORTALITY; SERVICES; BARRIERS; KENYA; BIRTH; DISTRICT; SURVIVAL; PROVINCE	Background Slow progress has been made in achieving the Millennium Development Goals 4 and 5 in Ghana. Ensuring continuum of care (at least four antenatal visits; skilled birth attendance; postnatal care within 48 hours, at two weeks, and six weeks) for mother and newborn is crucial in helping Ghana achieve these goals and beyond. This study examined the levels and factors associated with continuum of care (CoC) completion among Ghanaian women aged 15-49. Methods A retrospective cross-sectional survey was conducted among women who experienced live births between January 2011 and April 2013 in three regions of Ghana. In a two-stage random sampling method, 1,500 women with infants were selected and interviewed about maternal and newborn service usage in line with CoC. Multiple logistic regression models were used to assess factors associated with CoC completion. Results Only 8.0% had CoC completion; the greatest gap and contributor to the low CoC was detected between delivery and postnatal care within 48 hours postpartum. About 95% of women had a minimum of four antenatal visits and postnatal care at six weeks postpartum. A total of 75% had skilled assisted delivery and 25% received postnatal care within 48 hours. Factors associated with CoC completion at 95% CI were geographical location (OR = 0.35, CI 0.13-0.39), marital status (OR = 0.45; CI 0.22-0.95), education (OR = 2.71; CI 1.11-6.57), transportation (OR = 1.97; CI 1.07-3.62), and beliefs about childhood illnesses (OR = 0.34; CI0.21-0.61). Conclusion The continuum of care completion rate is low in the study site. Efforts should focus on increasing postnatal care within 48 hours and overcoming the known obstacles to increasing the continuum of care completion rate.	[Yeji, Francis; Oduro, Abraham; Debpuur, Cornelius; Williams, John; Sakeah, Evelyn; Wontuo, Peter] Navrongo Hlth Res Ctr, Navrongo, Upper East, Ghana; [Shibanuma, Akira; Kikuchi, Kimiyo; Okawa, Sumiyo; Nanishi, Keiko; Yasuoka, Junko; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Bunkyo Ku, Tokyo 1130033, Japan; [Owusu-Agei, Seth; Tawiah, Charlotte; Enuameh, Yeetey] Kintampo Hlth Res Ctr, Kintampo, Brong Ahafo, Ghana; [Gyapong, Margaret; Addei, Sheila] Dodowa Hlth Res Ctr, Dodowa, Greater Accra, Ghana; [Ansah, Evelyn; Hodgson, Abraham] Ghana Hlth Serv, Div Res & Dev, Accra, Ghana; [Asare, Gloria Quansah] Ghana Hlth Serv Headquarters, Accra, Ghana	Navrongo Health Research Center; University of Tokyo; Kintampo Health Research Centre; Ghana Health Service	Yeji, F (corresponding author), Navrongo Hlth Res Ctr, POB 114, Navrongo, Upper East, Ghana.	francis.yeji@gmail.com	Enuameh, Yeetey/AAO-7304-2020; Shibanuma, Akira/C-7652-2016; Jimba, Masamine/AAF-5630-2020; Yasuoka, Junko/GVT-8950-2022	Enuameh, Yeetey/0000-0003-3772-7425; Shibanuma, Akira/0000-0003-2058-1722; Debpuur, Cornelius/0000-0003-0968-5280; Gyapong, Margaret/0000-0002-4818-3497; ODURO, ABRAHAM/0000-0002-4191-7419; Ansah, Evelyn/0000-0003-0401-8606; Narh, Clement/0000-0002-4025-5433; Nanishi, Keiko/0000-0001-7067-8413	Japan International Cooperation Agency (JICA) Human Development Department; JICA Research Institute; District Health Management Teams of Kassena Nankana East; Kassena Nankana West; Kintampo North; Kintampo South; Shai-Osudoku; Ningo-Prampram; Dr. Joseph Green of the University of Tokyo	Japan International Cooperation Agency (JICA) Human Development Department; JICA Research Institute; District Health Management Teams of Kassena Nankana East; Kassena Nankana West; Kintampo North; Kintampo South; Shai-Osudoku; Ningo-Prampram; Dr. Joseph Green of the University of Tokyo	This paper was funded by the Japan International Cooperation Agency (JICA) Human Development Department, and JICA Research Institute (http://www.jica.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the Ministry of Foreign Affairs in Japan, the Ministry of Health in Ghana, and the Ghana Health Service (GHS). We are particularly thankful to the study participants, and the District Health Management Teams of Kassena Nankana East, Kassena Nankana West, Kintampo North, Kintampo South, Shai-Osudoku, and Ningo-Prampram, for their support for this study. We also want to thank Dr. Joseph Green of the University of Tokyo for his support. The Ghana EMBRACE Implementation Research Project is conducted by the Government of Ghana, Japan International Cooperation Agency (JICA) Human Development Department, and JICA Research Institute. The views expressed in this study are solely that of the authors and do not necessarily represent the official views of the JICA Human Development Department, the JICA Research Institute, and the GHS	Abor PA, 2011, INT J SOC ECON, V38, P628, DOI 10.1108/03068291111139258; Adjuik M, 2010, GLOBAL HEALTH ACTION, V3, P15, DOI 10.3402/gha.v3i0.5233; Afulani PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117996; Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; [Anonymous], 2015, GHANA MULTIPLE INDIC; [Anonymous], 2015, ASSESSMENT ANTENATAL; Awoonor-Williams JK, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-S2-S3; Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Bashour HN, 2008, PUBLIC HEALTH NURS, V25, P115, DOI 10.1111/j.1525-1446.2008.00688.x; Bazzano AN, 2008, TROP MED INT HEALTH, V13, P123, DOI 10.1111/j.1365-3156.2007.01981.x; Bazzano AN, 2008, INT J GYNECOL OBSTET, V102, P91, DOI 10.1016/j.ijgo.2008.02.004; Bhutta ZA, 2012, INT J GYNECOL OBSTET, V119, pS13, DOI 10.1016/j.ijgo.2012.04.001; Bohren MA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-71; Denham AR, 2010, SOC SCI MED, V71, P608, DOI 10.1016/j.socscimed.2010.04.022; Doku D, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-29; Eliason S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-261; Esena RK, 2013, INTERNATINAL J SCI T, V5, P184; Exavery A, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-35; Fotso JC, 2008, J URBAN HEALTH, V85, P428, DOI 10.1007/s11524-008-9263-1; Gao Y, 2010, REPROD HEALTH MATTER, V18, P35, DOI 10.1016/S0968-8080(10)36523-2; Ghana Health Service, 2008, NAT SAF MOTH SERV PR; Ghana Statistical Service, 2012, MULT IND CLUST SURV; Ghana Statistical Service. Ghana Health Service, 2009, GHAN DEM HLTH SURV 2; Gitimu A, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0442-2; Gyapong M, 2013, INT J EPIDEMIOL, V42, P1686, DOI 10.1093/ije/dyt197; Johnson Joseph de Graft, OPPORTUNUTUES AFRICA; Karch LB., 2012, THINKING CHILDREN UN; Kayode GA, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-165; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Khanal V, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-19; Kikuchi K, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0539-3; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Lassi ZS, 2013, J MATERN-FETAL NEO M, V26, P3, DOI 10.3109/14767058.2013.784737; Lawn JE, 2009, BJOG-INT J OBSTET GY, V116, P49, DOI 10.1111/j.1471-0528.2009.02328.x; LIEBOWITZ B, 1970, GERONTOLOGIST, V10, P11, DOI 10.1093/geront/10.1_Part_1.11; Lincetto O, 2006, OPPOR AFR NEWBORNS P; Lincetto O, 2006, ANTENATAL CARE; Martines J, 2005, LANCET, V365, P1189, DOI 10.1016/S0140-6736(05)71882-1; Mills S, 2008, MATERN CHILD HLTH J, V12, P577, DOI 10.1007/s10995-007-0289-x; Morris SS, 2000, J EPIDEMIOL COMMUN H, V54, P381, DOI 10.1136/jech.54.5.381; Moyer CA, 2014, MATERN CHILD HLTH J, V18, P109, DOI 10.1007/s10995-013-1240-y; Mrisho M, 2007, TROP MED INT HEALTH, V12, P862, DOI 10.1111/j.1365-3156.2007.01855.x; Mwangome FK, 2012, RURAL REMOTE HEALTH, V12; Naariyong S, 2012, MATERN CHILD HLTH J, V16, P1709, DOI 10.1007/s10995-011-0880-z; Nair M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004749; Nesbitt RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081089; Nettey OEA, 2010, GLOBAL HEALTH ACTION, V3, P8, DOI 10.3402/gha.v3i0.5258; Nyonator FK, 2005, HEALTH POLICY PLANN, V20, P25, DOI 10.1093/heapol/czi003; Oduro AR, 2012, INT J EPIDEMIOL, V41, P968, DOI 10.1093/ije/dys111; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Okyere E, 2010, ANN TROP PAEDIATR, V30, P321, DOI 10.1179/146532810X12858955921311; Owusu-Agyei S, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19033; Partnership for Maternal Newborn and Child Health, 2011, GLOB REV KEY INT REL; Pell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053747; Phillips JF, 2006, B WORLD HEALTH ORGAN, V84, P949, DOI 10.2471/BLT.06.030064; Project Fives Alive, 2010, BREAKTHR RES POSTN C; Rishworth AC., 2014, WOMENS NAVIGATION MA; Sines E., 2007, POSTNATAL CARE CRITI; Speizer IS, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0398-7; Story WT, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-28; Tabatabaie MG, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-5; Takahashi Kenzo, 2013, Trop Med Health, V41, P135, DOI 10.2149/tmh.2013-14; The Partnership for Maternal Newborn & Child Health, 2011, STRAT FRAM 2012 2015; Tinker A, 2005, LANCET, V365, P822, DOI 10.1016/S0140-6736(05)71016-3; Titaley CR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-232; Towns AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105972; UNICEF, 2015, STAT WORLDS CHILDR R; UNICEF, 2012, COMM CHILD SURV PROG; UNICEF, 2013, UNICEF 2013 IGME CHI; Warren C, 2006, POSTNATAL CARE OPPOR, P79; Welaga P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058924; WHO UNICEF, 2010, COUNTD 2015 DEC REP; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; World health organization, 2013, WORLD HLTH STAT 2013	74	58	58	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0142849	10.1371/journal.pone.0142849	http://dx.doi.org/10.1371/journal.pone.0142849			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YX	26650388	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903300008
J	Minarik, G; Repiska, G; Hyblova, M; Nagyova, E; Soltys, K; Budis, J; Duris, F; Sysak, R; Bujalkova, MG; Vlkova-Izrael, B; Biro, O; Nagy, B; Szemes, T				Minarik, Gabriel; Repiska, Gabriela; Hyblova, Michaela; Nagyova, Emilia; Soltys, Katarina; Budis, Jaroslav; Duris, Frantisek; Sysak, Rastislav; Bujalkova, Maria Gerykova; Vlkova-Izrael, Barbora; Biro, Orsolya; Nagy, Balint; Szemes, Tomas			Utilization of Benchtop Next Generation Sequencing Platforms Ion Torrent PGM and MiSeq in Noninvasive Prenatal Testing for Chromosome 21 Trisomy and Testing of Impact of In Silico and Physical Size Selection on Its Analytical Performance	PLOS ONE			English	Article							FREE FETAL DNA; MATERNAL PLASMA; ANEUPLOIDIES; DIAGNOSIS; BLOOD	Objectives The aims of this study were to test the utility of benchtop NGS platforms for NIPT for trisomy 21 using previously published z score calculation methods and to optimize the sample preparation and data analysis with use of in silico and physical size selection methods. Methods Samples from 130 pregnant women were analyzed by whole genome sequencing on benchtop NGS systems Ion Torrent PGM and MiSeq. The targeted yield of 3 million raw reads on each platform was used for z score calculation. The impact of in silico and physical size selection on analytical performance of the test was studied. Results Using a z score value of 3 as the cut-off, 98.11% - 100% (104-106/106) specificity and 100% (24/24) sensitivity and 99.06% - 100% (105-106/106) specificity and 100% (24/24) sensitivity were observed for Ion Torrent PGM and MiSeq, respectively. After in silico based size selection both platforms reached 100% specificity and sensitivity. Following the physical size selection z scores of tested trisomic samples increased significantly-p = 0.0141 and p = 0.025 for Ion Torrent PGM and MiSeq, respectively. Conclusions Noninvasive prenatal testing for chromosome 21 trisomy with the utilization of benchtop NGS systems led to results equivalent to previously published studies performed on high-to-ultrahigh throughput NGS systems. The in silico size selection led to higher specificity of the test. Physical size selection performed on isolated DNA led to significant increase in z scores. The observed results could represent a basis for increasing of cost effectiveness of the test and thus help with its penetration worldwide.	[Minarik, Gabriel; Repiska, Gabriela; Vlkova-Izrael, Barbora] Comenius Univ, Fac Med, Inst Mol Biomed, Bratislava, Slovakia; [Minarik, Gabriel; Hyblova, Michaela; Nagyova, Emilia; Soltys, Katarina; Duris, Frantisek; Szemes, Tomas] Comenius Univ, Fac Nat Sci, Dept Mol Biol, Bratislava, Slovakia; [Minarik, Gabriel; Vlkova-Izrael, Barbora; Szemes, Tomas] Geneton Ltd, Bratislava, Slovakia; [Budis, Jaroslav; Duris, Frantisek] Comenius Univ, Fac Math Phys & Informat, Dept Comp Sci, Bratislava, Slovakia; [Sysak, Rastislav] Comenius Univ, Fac Med, Dept Gynaecol & Obstet 1, Bratislava, Slovakia; [Bujalkova, Maria Gerykova] Medirex Inc, Dept Clin Genet, Bratislava, Slovakia; [Bujalkova, Maria Gerykova] Nemocnicna Inc, Outpatient Clin Med Genet, Malacky, Slovakia; [Biro, Orsolya; Nagy, Balint] Semmelweis Univ, Dept Obstet & Gynecol 1, H-1085 Budapest, Hungary	Comenius University Bratislava; Comenius University Bratislava; Comenius University Bratislava; Comenius University Bratislava; Semmelweis University	Minarik, G (corresponding author), Comenius Univ, Fac Med, Inst Mol Biomed, Bratislava, Slovakia.	gabriel.minarik@gmail.com	Hyblova, Michaela/GPW-9833-2022; Budis, Jaroslav/N-8117-2019; Soltys, Katarina/Q-6592-2018; hyblova, Michaela/AAS-5147-2020; Soltys, Katarina/W-1265-2017	Hyblova, Michaela/0000-0001-6519-4967; Budis, Jaroslav/0000-0002-8667-6655; Soltys, Katarina/0000-0003-3862-3329; Duris, Frantisek/0000-0001-8985-4122; Gerykova Bujalkova, Maria/0000-0001-6840-1802; Repiska, Gabriela/0000-0003-2069-8859; Szemes, Tomas/0000-0002-0900-2534	Slovak Research and Development Agency [VMSP-II-0030-09, APVV-0720-10]; Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic [VEGA-1/0285/11]; Research & Development Operational Programme - ERDF project REVOGENE - Research centre for molecular genetics - Geneton Ltd. [ITMS 26240220067]; Geneton Ltd.; Medirex Inc.; Nemocnicna Inc.	Slovak Research and Development Agency(Slovak Research and Development Agency); Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic; Research & Development Operational Programme - ERDF project REVOGENE - Research centre for molecular genetics - Geneton Ltd.; Geneton Ltd.; Medirex Inc.; Nemocnicna Inc.	The project was supported by Slovak Research and Development Agency - projects VMSP-II-0030-09 and APVV-0720-10 - GM; Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic - project VEGA-1/0285/11 - GM and Research & Development Operational Programme funded by the ERDF project REVOGENE - Research centre for molecular genetics - ITMS 26240220067 - Geneton Ltd. The funders Geneton Ltd., Medirex Inc. and Nemocnicna Inc. provided support in the form of salaries for authors GM, TS and MGB, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ashoor G, 2012, AM J OBSTET GYNECOL, V206, P322, DOI DOI 10.1016/j.ajog.2012.01.029; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Faas BHW, 2012, EXPERT OPIN BIOL TH, V12, pS19, DOI 10.1517/14712598.2012.670632; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Hiromadnikova I, 2006, DNA CELL BIOL, V25, P635, DOI 10.1089/dna.2006.25.635; Jeon YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110240; Jiang FM, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-57; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lau TK, 2012, J MATERN-FETAL NEO M, V25, P1370, DOI 10.3109/14767058.2011.635730; Li Y, 2004, CLIN CHEM, V50, P1002, DOI 10.1373/clinchem.2003.029835; Liao C, 2014, P NATL ACAD SCI USA, V111, P7415, DOI 10.1073/pnas.1321997111; Lo KK, 2014, BIOINFORMATICS, V30, P2965, DOI 10.1093/bioinformatics/btu419; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Nicolaides KH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.033; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Quail MA, 2012, ELECTROPHORESIS, V33, P3521, DOI 10.1002/elps.201200128; Rava RP, 2014, CLIN CHEM, V60, P243, DOI 10.1373/clinchem.2013.207951; Sehnert AJ, 2011, CLIN CHEM, V57, P1042, DOI 10.1373/clinchem.2011.165910; Stumm M, 2012, PRENATAL DIAG, V32, P569, DOI 10.1002/pd.3862; Wang YL, 2014, J HUM GENET, V59, P393, DOI 10.1038/jhg.2014.40; Yuan Y, 2013, CLIN CHEM, V59, P846, DOI 10.1373/clinchem.2012.196725	28	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144811	10.1371/journal.pone.0144811	http://dx.doi.org/10.1371/journal.pone.0144811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669558	Green Published, gold, Green Submitted			2022-12-27	WOS:000366719300023
J	Niknazar, M; Krishnan, GP; Bazhenov, M; Mednick, SC				Niknazar, Mohammad; Krishnan, Giri P.; Bazhenov, Maxim; Mednick, Sara C.			Coupling of Thalamocortical Sleep Oscillations Are Important for Memory Consolidation in Humans	PLOS ONE			English	Article							SLOW-WAVE SLEEP; SPINDLES; MECHANISMS; ZOLPIDEM; OXYBATE; IMPACT; MODEL	Sleep, specifically non-rapid eye movement (NREM) sleep, is thought to play a critical role in the consolidation of recent memories. Two main oscillatory activities observed during NREM, cortical slow oscillations (SO, 0.5-1.0Hz) and thalamic spindles (12-15Hz), have been shown to independently correlate with memory improvement. Yet, it is not known how these thalamocortical events interact, or the significance of this interaction, during the consolidation process. Here, we found that systemic administration of the GABAergic drug (zolpidem) increased both the phase-amplitude coupling between SO and spindles, and verbal memory improvement in humans. These results suggest that thalamic spindles that occur during transitions to the cortical SO Up state are optimal for memory consolidation. Our study predicts that the timely interactions between cortical and thalamic events during consolidation, contribute to memory improvement and is mediated by the level of inhibitory neurotransmission.	[Niknazar, Mohammad; Krishnan, Giri P.; Bazhenov, Maxim] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Niknazar, Mohammad; Mednick, Sara C.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Bazhenov, M (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, 900 Univ Ave, Riverside, CA 92521 USA.	bazhenov@salk.edu; sara.mednick@ucr.edu		mednick, sara/0000-0002-0906-3097	HHS \ NIH \ National Institute on Aging (U.S. National Institute on Aging) [R01AG046646]; DOD \ ONR \ Office of Naval Research Global (ONR Global) [MURI: N000141310672]; NIH [R01AG046646]; ONR [MURI: N000141310672]; NATIONAL INSTITUTE ON AGING [R01AG046646] Funding Source: NIH RePORTER	HHS \ NIH \ National Institute on Aging (U.S. National Institute on Aging); DOD \ ONR \ Office of Naval Research Global (ONR Global); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ONR(Office of Naval Research); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by HHS vertical bar NIH vertical bar National Institute on Aging (U.S. National Institute on Aging) - R01AG046646 [Bazhenov], DOD vertical bar ONR vertical bar Office of Naval Research Global (ONR Global) MURI: N000141310672 [Bazhenov], and HHS vertical bar NIH vertical bar National Institute on Aging (U.S. National Institute on Aging) - R01AG046646 [Mednick].; This work was supported by grants from NIH (R01AG046646) and ONR (MURI: N000141310672).	Battaglia FP, 2004, LEARN MEMORY, V11, P697, DOI 10.1101/lm.73504; Bazhenov M, 2000, J NEUROPHYSIOL, V84, P1076, DOI 10.1152/jn.2000.84.2.1076; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Chen JY, 2012, J PHYSIOL-LONDON, V590, P3987, DOI 10.1113/jphysiol.2012.227462; Crestani F, 2000, BRIT J PHARMACOL, V131, P1251, DOI 10.1038/sj.bjp.0703717; De Gennaro L, 2003, SLEEP MED REV, V7, P423, DOI 10.1053/smrv.2002.0252; Destexhe A, 1996, J NEUROPHYSIOL, V76, P2049, DOI 10.1152/jn.1996.76.3.2049; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Manoach DS, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.021.2009; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; McCormick L, 1997, SLEEP, V20, P939, DOI 10.1093/sleep/20.11.939; Mednick SC, 2013, J NEUROSCI, V33, P4494, DOI 10.1523/JNEUROSCI.3127-12.2013; Mednick SC, 2011, TRENDS NEUROSCI, V34, P504, DOI 10.1016/j.tins.2011.06.003; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; Molle M, 2002, J NEUROSCI, V22, P10941; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Oyanedel CN, 2014, BEHAV BRAIN RES, V275, P126, DOI 10.1016/j.bbr.2014.09.008; Pardi D, 2006, CNS DRUGS, V20, P993, DOI 10.2165/00023210-200620120-00004; Penny WD, 2008, J NEUROSCI METH, V174, P50, DOI 10.1016/j.jneumeth.2008.06.035; Phillips KG, 2012, NEURON, V76, P526, DOI 10.1016/j.neuron.2012.09.016; Poe GR, 2000, BRAIN RES, V855, P176, DOI 10.1016/S0006-8993(99)02310-0; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; SALVA P, 1995, CLIN PHARMACOKINET, V29, P142, DOI 10.2165/00003088-199529030-00002; Sanchez-Vives MV, 2010, J NEUROPHYSIOL, V104, P1314, DOI 10.1152/jn.00178.2010; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Siegle JH, 2014, ELIFE, V3, DOI 10.7554/eLife.03061; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Timofeev I, 2005, TRENDS CHRONOBIOLOGY, P1; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Walsh JK, 2010, SLEEP, V33, P1217, DOI 10.1093/sleep/33.9.1217; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555	36	74	76	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144720	10.1371/journal.pone.0144720	http://dx.doi.org/10.1371/journal.pone.0144720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671283	Green Published, Green Submitted, gold			2022-12-27	WOS:000366719300017
J	Chen, JQ; Ren, RX; Tan, SY; Zhang, WY; Zhang, XX; Yu, F; Xun, TR; Jiang, SB; Liu, SW; Li, L				Chen, Jinquan; Ren, Ruxia; Tan, Suiyi; Zhang, Wanyue; Zhang, Xuanxuan; Yu, Fei; Xun, Tianrong; Jiang, Shibo; Liu, Shuwen; Li, Lin			A Peptide Derived from the HIV-1 gp120 Coreceptor-Binding Region Promotes Formation of PAP248-286 Amyloid Fibrils to Enhance HIV-1 Infection	PLOS ONE			English	Article							RETROVIRAL GENE-TRANSFER; GLYCOPROTEIN GP120; ENVELOPE PROTEIN; T-CELLS; SEMEN; ENTRY; SEVI; RECEPTOR; GP41; TRANSMISSION	Background Semen is a major vehicle for HIV transmission. Prostatic acid phosphatase (PAP) fragments, such as PAP248-286, in human semen can form amyloid fibrils to enhance HIV infection. Other endogenous or exogenous factors present during sexual intercourse have also been reported to promote the formation of seminal amyloid fibrils. Methodology and Principal Findings Here, we demonstrated that a synthetic 15-residue peptide derived from the HIV-1 gp120 coreceptor-binding region, designated enhancing peptide 2 (EP2), can rapidly self-assemble into nanofibers. These EP2-derivated nanofibers promptly accelerated the formation of semen amyloid fibrils by PAP248-286, as shown by Thioflavin T (ThT) and Congo red assays. The amyloid fibrils presented similar morphology, assessed via transmission electron microscopy (TEM), in the presence or absence of EP2. Circular dichroism (CD) spectroscopy revealed that EP2 accelerates PAP248-286 amyloid fibril formation by promoting the structural transition of PAP248-286 from a random coil into a cross-beta-sheet. Newly formed semen amyloid fibrils effectively enhanced HIV-1 infection in TZM-bl cells and U87 cells by promoting the binding of HIV-1 virions to target cells. Conclusions and Significance Nanofibers composed of EP2 promote the formation of PAP248-286 amyloid fibrils and enhance HIV-1 infection.	[Chen, Jinquan; Ren, Ruxia; Tan, Suiyi; Zhang, Wanyue; Zhang, Xuanxuan; Xun, Tianrong; Liu, Shuwen; Li, Lin] Southern Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Yu, Fei; Jiang, Shibo] Shanghai Med Coll, Key Lab Med Mol Virol MOE MOH, Shanghai, Peoples R China; [Yu, Fei; Jiang, Shibo] Fudan Univ, Inst Med Microbiol, Shanghai 200433, Peoples R China; [Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA	Southern Medical University - China; Fudan University; New York Blood Center	Liu, SW (corresponding author), Southern Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China.	liusw@smu.edu.cn; li75lin@126.com	Yu, Fei/K-4953-2019; Jiang, Shibo/L-4500-2014; LI, LI/GVS-5344-2022; li, li/HII-4157-2022; Li, Li/AEM-3636-2022	Yu, Fei/0000-0001-6332-4326; Jiang, Shibo/0000-0001-8283-7135; Liu, Shuwen/0000-0001-6346-5006	Natural Science Foundation of China [81273560, 31370781]; National Key Science and Technology Special Project [2013ZX10001006]; Natural Science Foundation of Guangdong Province [S2013010014713, S2011020005207]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Science and Technology Special Project; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This study was supported by the Natural Science Foundation of China (81273560 to Lin Li and 31370781 to Shuwen Liu http://www.nsfc.gov.cn/), the National Key Science and Technology Special Project (2013ZX10001006 to Shibo Jiang http://www.most.gov.cn/kjjh/gjkjjh/), and by the Natural Science Foundation of Guangdong Province (S2013010014713 to Lin Li and S2011020005207 to Shuwen Liu http://pro.gdstc.gov.cn/egrantweb/).; We thank Wenjuan Li at the Southern Medical University for technical assistance. This study was supported by the Natural Science Foundation of China (81273560 to LL and 31370781 to SL), the National Key Science and Technology Special Project (2013ZX10001006 to SJ), and the Natural Science Foundation of Guangdong Province (S2013010014713 to LL and S2011020005207 to SL).	Anton P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002329; Arnold F, 2012, J VIROL, V86, P1244, DOI 10.1128/JVI.06121-11; BERBERIAN L, 1993, SCIENCE, V261, P1588, DOI 10.1126/science.7690497; Demirkhanyan LH, 2012, J BIOL CHEM, V287, P28821, DOI 10.1074/jbc.M112.375949; Doncel GF, 2011, AM J REPROD IMMUNOL, V65, P292, DOI 10.1111/j.1600-0897.2010.00931.x; Elias AK, 2014, BBA-PROTEINS PROTEOM, V1844, P1591, DOI 10.1016/j.bbapap.2014.06.006; Gordon LM, 2008, BBA-BIOMEMBRANES, V1778, P2127, DOI 10.1016/j.bbamem.2008.05.002; Greenwood R, 2003, ADV COLLOID INTERFAC, V106, P55, DOI 10.1016/S0001-8686(03)00105-2; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Hanaor D, 2012, J EUR CERAM SOC, V32, P235, DOI 10.1016/j.jeurceramsoc.2011.08.015; Hartman K, 2013, PEERJ, V1, DOI 10.7717/peerj.5; Huang JH, 2008, J BIOL CHEM, V283, P14994, DOI 10.1074/jbc.M800525200; Introini A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003148; Kim KA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-55; Kreisberg JF, 2006, J EXP MED, V203, P865, DOI 10.1084/jem.20051856; Li L, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-37; Li MM, 2013, AIDS RES HUM RETROV, V29, P1455, DOI [10.1089/aid.2013.0043, 10.1089/AID.2013.0043]; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Meier C, 2014, WIRES NANOMED NANOBI, V6, P438, DOI 10.1002/wnan.1275; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Olsen JS, 2012, J BIOL CHEM, V287, P11842, DOI 10.1074/jbc.M111.314336; Planque S, 2008, AUTOIMMUN REV, V7, P473, DOI 10.1016/j.autrev.2008.04.002; Planque S, 2010, AIDS, V24, P875, DOI 10.1097/QAD.0b013e3283376e88; Ponomarenko NA, 2006, BIOCHEMISTRY-US, V45, P324, DOI 10.1021/bi050675k; Rambaran RN, 2008, PRION, V2, P112, DOI 10.4161/pri.2.3.7488; Roan NR, 2014, J INFECT DIS, V210, P1062, DOI 10.1093/infdis/jiu220; Roan NR, 2014, J VIROL, V88, P7221, DOI 10.1128/JVI.00269-14; Roan NR, 2011, CELL HOST MICROBE, V10, P541, DOI 10.1016/j.chom.2011.10.010; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; ROWELL JF, 1995, J IMMUNOL, V155, P1818; Sabatte J, 2011, MICROBES INFECT, V13, P977, DOI 10.1016/j.micinf.2011.06.005; Sasahara K, 2007, J MOL BIOL, V372, P981, DOI 10.1016/j.jmb.2007.06.088; Singh AK, 2007, ALCOHOL, V41, P591, DOI 10.1016/j.alcohol.2007.08.003; Straub JE, 2011, ANNU REV PHYS CHEM, V62, P437, DOI 10.1146/annurev-physchem-032210-103526; Tan SY, 2014, FEBS LETT, V588, P1515, DOI 10.1016/j.febslet.2014.03.016; Trujillo JR, 2007, P NATL ACAD SCI USA, V104, P5097, DOI 10.1073/pnas.0611263104; UNAIDS, WORLD AIDS DAY 2014; Usmani SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4508; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Ye ZQ, 2009, BIOCHEMISTRY-US, V48, P11582, DOI 10.1021/bi901709j; Yolamanova M, 2013, NAT NANOTECHNOL, V8, P130, DOI [10.1038/nnano.2012.248, 10.1038/NNANO.2012.248]; Zhang LS, 2014, J PEPT SCI, V20, P46, DOI 10.1002/psc.2587; Zheng YH, 2001, CURR BIOL, V11, P875, DOI 10.1016/S0960-9822(01)00237-8; Zirafi O, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009634	46	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144522	10.1371/journal.pone.0144522	http://dx.doi.org/10.1371/journal.pone.0144522			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656730	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900061
J	Liang, GL; Chen, H				Liang, Guolu; Chen, Hong			Scaling Chromosomes for an Evolutionary Karyotype: A Chromosomal Tradeoff between Size and Number across Woody Species	PLOS ONE			English	Article							MECHANISMS	This study aims to examine the expected scaling relationships between chromosome size and number across woody species and to clarify the importance of the scaling for the maintenance of chromosome diversity by analyzing the scaling at the inter- & intra-chromosomal level. To achieve for the goals, chromosome trait data were extracted for 191 woody species (including 56 evergreen species and 135 deciduous species) from the available literature. Cross-species analyses revealed a tradeoff among chromosomes between chromosome size and number, demonstrating there is selective mechanism crossing chromosomes among woody species. And the explanations for the result were presented from intra-to inter-chromosome contexts that the scaling may be compromises among scale symmetry, mechanical requirements, and resource allocation across chromosomes. Therein, a 3/4 scaling pattern was observed between total chromosomes and m-chromosomes within nucleus which may imply total chromosomes may evolve from more to less. In addition, the primary evolutionary trend of karyotype and the role of m-chromosomes in the process of karyotype evolution were also discussed.	[Liang, Guolu] Southwest Univ, Dept Hort, Coll Hort & Landscape Architecture, Chongqinq, Peoples R China; [Chen, Hong] Southwest Univ, Dept Bot, Coll Hort & Landscape Architecture, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	Chen, H (corresponding author), Southwest Univ, Dept Bot, Coll Hort & Landscape Architecture, Chongqing, Peoples R China.	chenh.swu@gmail.com			National Science-Technology Support Plan Projects of China [2013BAD02B02]; Key Scientific and Technological Research Project, Chongqing Science and Technology Commission, China [CSTC2014yykfB50001]	National Science-Technology Support Plan Projects of China; Key Scientific and Technological Research Project, Chongqing Science and Technology Commission, China	This study was financially supported by the National Science-Technology Support Plan Projects of China (2013BAD02B02) and by Key Scientific and Technological Research Project, Chongqing Science and Technology Commission, China (CSTC2014yykfB50001).	Aarssen LW, 2006, J ECOL, V94, P569, DOI 10.1111/j.1365-2745.2006.01128.x; AERTS R, 1995, TRENDS ECOL EVOL, V10, P402, DOI 10.1016/S0169-5347(00)89156-9; [Anonymous], 2013, PERSP ORG BIOL TIM S, P23; Arano H., 1963, BOTAN MAGAZINE, V76, P32, DOI [10.15281/jplantres1887.76.32, DOI 10.15281/JPLANTRES1887.76.32]; Arano H., 1980, KROMOSOMO, V2, P471; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; Chen R.Y, 1993, CHROMOSOME ATLAS CHI, V1; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Cronk QC, 2004, PLANT ADAPTATION MOL; Dimitrova D, 2001, PLANT BIOLOGY, V3, P88, DOI 10.1055/s-2001-11753; Falster D. S., 2006, SMATR STANDARDISED M; IMAI HT, 1986, AM NAT, V128, P900, DOI 10.1086/284612; Jevtic P, 2014, CURR OPIN CELL BIOL, V28, P16, DOI 10.1016/j.ceb.2014.01.003; Jones K., 1978, Advances in Botanical Research, V6, P119, DOI 10.1016/S0065-2296(08)60330-4; Kieserman EK, 2011, CELL CYCLE, V10, P3863, DOI 10.4161/cc.10.22.17975; Landry CR, 2014, ADV EXPT MED BIOL; Leitch IJ., 2013, PLANT GENOME DIVERSI, V2; LEUCHTENBERGER C, 1951, P NATL ACAD SCI USA, V37, P33, DOI 10.1073/pnas.37.1.33; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Levin D. A, 2002, OX ECOL EV; Levitsky GA, 1931, B APPL BOT GEN PL BR, V27, P220; Levy DL, 2012, ANNU REV CELL DEV BI, V28, P113, DOI 10.1146/annurev-cellbio-092910-154158; Li MX, 1985, WUHAN BOT RES, V3, P297; Longo G, 2013, PERSPECTIVES ORG BIO; Losos JB, 2011, AM NAT, V177, P709, DOI 10.1086/660020; Lukhtanov VA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-109; Muratovic E, 2010, TAXON, V59, P165, DOI 10.1002/tax.591016; Niklas KJ, 2007, P NATL ACAD SCI USA, V104, P8891, DOI 10.1073/pnas.0701135104; Niklas KJ, 2015, BOST STUD PHILOS HIS, V307, P57, DOI 10.1007/978-94-017-9412-1_2; Niklas KJ, 2004, BIOL REV, V79, P871, DOI 10.1017/S1464793104006499; Paszko B, 2006, PLANT SYST EVOL, V258, P39, DOI 10.1007/s00606-005-0389-2; Peruzzi L, 2013, COMP CYTOGENET, V7, P1, DOI 10.3897/CompCytogen.v7i1.4431; Petrov DA, 2001, TRENDS GENET, V17, P23, DOI 10.1016/S0168-9525(00)02157-0; POLAK M, 1994, TRENDS ECOL EVOL, V9, P122, DOI 10.1016/0169-5347(94)90175-9; Schubert I, 2007, CURR OPIN PLANT BIOL, V10, P109, DOI 10.1016/j.pbi.2007.01.001; Schubert I, 2011, TRENDS GENET, V27, P207, DOI 10.1016/j.tig.2011.03.004; SRIVASTAVA S, 1991, GENOME, V34, P763, DOI 10.1139/g91-118; Stebbins GL, 1971, CHROMOSOMAL EVOLUTIO; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Weiss-Schneeweiss H, 2013, KARYOTYPE DIVERSITY; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 2004, PHYS TODAY, V57, P36, DOI 10.1063/1.1809090; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Wilkinson D.M., 2007, FUNDAMENTAL PROCESSE; Wise JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006013	46	14	14	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144669	10.1371/journal.pone.0144669	http://dx.doi.org/10.1371/journal.pone.0144669			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657837	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900084
J	Niyompanich, S; Srisanga, K; Jaresitthikunchai, J; Roytrakul, S; Tungpradabkul, S				Niyompanich, Suthamat; Srisanga, Kitima; Jaresitthikunchai, Janthima; Roytrakul, Sittiruk; Tungpradabkul, Sumalee			Utilization of Whole-Cell MALDI-TOF Mass Spectrometry to Differentiate Burkholderia pseudomallei Wild-Type and Constructed Mutants	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; ASSISTED-LASER-DESORPTION/IONIZATION; OXIDATIVE STRESS-RESPONSE; QUORUM-SENSING SYSTEM; RAPID IDENTIFICATION; ESCHERICHIA-COLI; CLASSIFICATION; BACTERIA; DISCRIMINATION; BIOMARKERS	Whole-cell matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (whole-cell MALDI-TOF MS) has been widely adopted as a useful technology in the identification and typing of microorganisms. This study employed the whole-cell MALDI-TOF MS to identify and differentiate wild-type and mutants containing constructed single gene mutations of Burkholderia pseudomallei, a pathogenic bacterium causing melioidosis disease in both humans and animals. Candidate biomarkers for the B. pseudomallei mutants, including rpoS, ppk, and bpsI isolates, were determined. Taxon-specific and clinical isolate-specific biomarkers of B. pseudomallei were consistently found and conserved across all average mass spectra. Cluster analysis of MALDI spectra of all isolates exhibited separate distribution. A total of twelve potential mass peaks discriminating between wild-type and mutant isolates were identified using ClinProTools analysis. Two peaks (m/z 2721 and 2748 Da) were specific for the rpoS isolate, three (m/z 3150, 3378, and 7994 Da) for ppk, and seven (m/z 3420, 3520, 3587, 3688, 4623, 4708, and 5450 Da) for bpsI. Our findings demonstrated that the rapid, accurate, and reproducible mass profiling technology could have new implications in laboratory-based rapid differentiation of extensive libraries of genetically altered bacteria.	[Niyompanich, Suthamat; Srisanga, Kitima; Tungpradabkul, Sumalee] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Jaresitthikunchai, Janthima; Roytrakul, Sittiruk] Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand	Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Tungpradabkul, S (corresponding author), Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand.	pexcotung@gmail.com		Roytrakul, Sittiruk/0000-0003-3696-8390	Thailand Research Fund [BRG5680010]; Ph.D. scholarship from RGJ (the Royal Golden Jubilee) [PHD/0341/2551]	Thailand Research Fund(Thailand Research Fund (TRF)); Ph.D. scholarship from RGJ (the Royal Golden Jubilee)	Support was provided by the Thailand Research Fund, grant number BRG5680010 to ST and the Ph.D. scholarship from RGJ (the Royal Golden Jubilee) No. PHD/0341/2551 to SN.	Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Bartpho T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037762; Brown MRW, 2004, P NATL ACAD SCI USA, V101, P16085, DOI 10.1073/pnas.0406909101; Camara JE, 2007, ANAL BIOANAL CHEM, V389, P1633, DOI 10.1007/s00216-007-1558-7; Carbonnelle E, 2011, CLIN BIOCHEM, V44, P104, DOI 10.1016/j.clinbiochem.2010.06.017; Chantratita N, 2007, J BACTERIOL, V189, P807, DOI 10.1128/JB.01258-06; Christie-Oleza JA, 2013, ENVIRON MICROBIOL, V15, P133, DOI 10.1111/j.1462-2920.2012.02812.x; Clark AE, 2013, CLIN MICROBIOL REV, V26, P547, DOI 10.1128/CMR.00072-12; Cox Christopher R, 2014, Bacteriophage, V4, pe29011; Demirev PA, 2005, ANAL CHEM, V77, P7455, DOI 10.1021/ac051419g; Demirev PA, 2008, J MASS SPECTROM, V43, P1441, DOI 10.1002/jms.1474; Dieckmann R, 2008, APPL ENVIRON MICROB, V74, P7767, DOI 10.1128/AEM.01402-08; Durighello E, 2014, ANAL CHEM, V86, P9394, DOI 10.1021/ac501840g; Fujinami Y, 2011, MICROBIOL RES, V166, P77, DOI 10.1016/j.micres.2010.02.005; Hazen TH, 2009, APPL ENVIRON MICROB, V75, P6745, DOI 10.1128/AEM.01171-09; Holland RD, 1996, RAPID COMMUN MASS SP, V10, P1227, DOI 10.1002/(SICI)1097-0231(19960731)10:10<1227::AID-RCM659>3.0.CO;2-6; Hsieh SY, 2008, MOL CELL PROTEOMICS, V7, P448, DOI 10.1074/mcp.M700339-MCP200; Inglis TJJ, 2012, AM J TROP MED HYG, V86, P1039, DOI 10.4269/ajtmh.2012.11-0454; Jangiam W, 2010, MICROBIOL IMMUNOL, V54, P389, DOI 10.1111/j.1348-0421.2010.00230.x; Karger A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-229; Ketterlinus Ralf, 2005, Biotechniques, VSuppl, P37; Kostrzewa M, 2013, PROTEOM CLIN APPL, V7, P767, DOI 10.1002/prca.201300042; Lartigue MF, 2013, INFECT GENET EVOL, V13, P230, DOI 10.1016/j.meegid.2012.10.012; Lay JO, 2001, MASS SPECTROM REV, V20, P172, DOI 10.1002/mas.10003; Lengwehasatit I, 2008, MICROB PATHOGENESIS, V44, P238, DOI 10.1016/j.micpath.2007.08.017; Lumjiaktase P, 2006, MICROBIOL-SGM, V152, P3651, DOI 10.1099/mic.0.29226-0; Marklein G, 2009, J CLIN MICROBIOL, V47, P2912, DOI 10.1128/JCM.00389-09; Mazzeo MF, 2006, APPL ENVIRON MICROB, V72, P1180, DOI 10.1128/AEM.72.2.1180-1189.2006; Murray PR, 2010, CLIN MICROBIOL INFEC, V16, P1626, DOI 10.1111/j.1469-0691.2010.03364.x; Niyompanich S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099160; Nomura F, 2015, BBA-PROTEINS PROTEOM, V1854, P528, DOI 10.1016/j.bbapap.2014.10.022; Patel R, 2013, CLIN INFECT DIS, V57, P564, DOI 10.1093/cid/cit247; Rajakaruna L, 2009, INFECT GENET EVOL, V9, P507, DOI 10.1016/j.meegid.2009.01.012; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Russell SC, 2007, ANAL CHEM, V79, P5399, DOI 10.1021/ac0705061; Ryzhov V, 2001, ANAL CHEM, V73, P746, DOI 10.1021/ac0008791; Sandrin TR, 2013, MASS SPECTROM REV, V32, P188, DOI 10.1002/mas.21359; Sauer S, 2010, NAT REV MICROBIOL, V8, P74, DOI 10.1038/nrmicro2243; Sauer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002843; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Sermswan RW, 2001, ACTA TROP, V80, P237, DOI 10.1016/S0001-706X(01)00176-0; Siegrist TJ, 2007, J MICROBIOL METH, V68, P554, DOI 10.1016/j.mimet.2006.10.012; Song Y, 2005, J BACTERIOL, V187, P785, DOI 10.1128/JB.187.2.785-790.2005; Suarez S, 2013, J MICROBIOL METH, V94, P390, DOI 10.1016/j.mimet.2013.07.021; Subsin B, 2003, J BACTERIOL, V185, P7008, DOI 10.1128/JB.185.23.7008-7014.2003; Tanigawa K, 2010, APPL ENVIRON MICROB, V76, P4055, DOI 10.1128/AEM.02698-09; Teramoto K, 2007, ANAL CHEM, V79, P8712, DOI 10.1021/ac701905r; Tungpradabkul S, 1999, MOL CELL PROBE, V13, P99, DOI 10.1006/mcpr.1999.0221; Tunpiboonsak S, 2010, J MICROBIOL, V48, P63, DOI 10.1007/s12275-010-9138-5; Ulrich RL, 2004, J MED MICROBIOL, V53, P1053, DOI 10.1099/jmm.0.45661-0; Utaisincharoen P, 2003, INFECT IMMUN, V71, P3053, DOI 10.1128/IAI.71.6.3053-3057.2003; Valade E, 2004, J BACTERIOL, V186, P2288, DOI 10.1128/JB.186.8.2288-2294.2004; Vesaratchavest M, 2006, J CLIN MICROBIOL, V44, P2553, DOI 10.1128/JCM.00629-06; Welker M, 2011, SYST APPL MICROBIOL, V34, P2, DOI 10.1016/j.syapm.2010.11.013; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Winstanley C, 1998, J MED MICROBIOL, V47, P689, DOI 10.1099/00222615-47-8-689	56	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144128	10.1371/journal.pone.0144128	http://dx.doi.org/10.1371/journal.pone.0144128			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656930	Green Published, gold			2022-12-27	WOS:000366715900027
J	Old, JM				Old, Julie M.			Immunological Insights into the Life and Times of the Extinct Tasmanian Tiger (Thylacinus cynocephalus)	PLOS ONE			English	Article							BLOOD-FORMING TISSUES; MATURE T-CELLS; POSTNATAL-DEVELOPMENT; LYMPHOID-TISSUES; BRUSHTAIL POSSUM; IMMUNE TISSUES; POUCH YOUNG; B-CELLS; LUNG; SYSTEM	The thylacine (Thylacinus cynocephalus) was Australia's largest marsupial carnivore until its extinction within the last century. There remains considerable interest and debate regarding the biology of this species. Studies of thylacine biology are now limited to preserved specimens, and parts thereof, as well as written historical accounts of its biology. This study describes the development of the immune tissues of a pouch young thylacine, one of only eleven in existence, and the only specimen to be histologically sectioned. The appearance of the immune tissue of the developing pouch young thylacine is compared to the immune tissues of extant marsupials, providing insights into the immunity, biology and ecology of the extinct thylacine.	[Old, Julie M.] Univ Western Sydney, Sch Sci & Hlth, Water & Wildlife Ecol, Locked Bag 1797, Penrith, NSW 2751, Australia	Western Sydney University	Old, JM (corresponding author), Univ Western Sydney, Sch Sci & Hlth, Water & Wildlife Ecol, Locked Bag 1797, Penrith, NSW 2751, Australia.	j.old@westernsydney.edu.au	Old, Julie/HDO-1989-2022; Old, Julie/AAE-7355-2021	Old, Julie/0000-0002-2754-7757	Western Sydney University through an Academic Development Program grant; Western Sydney University	Western Sydney University through an Academic Development Program grant; Western Sydney University	Western Sydney University funded JO through an Academic Development Program grant.r Thanks to Katie Smith of Museum Victoria for allowing me to view the thylacine slides, Leon Hughes for helpful advice and suggestions, and Western Sydney University for funding (Academic Development Program).	Adamski FM, 2000, DEV COMP IMMUNOL, V24, P491, DOI 10.1016/S0145-305X(00)00012-4; Adamski FM, 1999, J IMMUNOL, V162, P6009; Armstrong K.N., 2008, MAMMALS AUSTR, P470; ASHMAN RB, 1975, ACTA ANAT, V91, P594; Attard MRG, 2011, J ZOOL, V285, P292, DOI 10.1111/j.1469-7998.2011.00844.x; AZZALI G, 1965, AM J ANAT, V116, P449, DOI 10.1002/aja.1001160302; Baker ML, 1999, ANAT REC, V256, P354; Basden K, 1997, REPROD FERT DEVELOP, V9, P243, DOI 10.1071/R96032; Basden K, 1996, REPROD FERT DEVELOP, V8, P989, DOI 10.1071/RD9960989; Beddard F. E., 1891, Proceedings of the Zoological Society, P138; BIENENSTOCK J, 1973, LAB INVEST, V28, P693; BLOCK M, 1964, Ergeb Anat Entwicklungsgesch, V37, P237; Boardman W., 1945, Proceedings of the Linnean Society of New South Wales, V70, P1; Borthwick CR, 2014, J MORPHOL, V275, P822, DOI 10.1002/jmor.20250; Brown GD, 1974, J AUST MAM SOC, V1, P269; Buddle BM, 2000, DEV COMP IMMUNOL, V24, P517, DOI 10.1016/S0145-305X(00)00014-8; Canfield PC, 1996, J ANAT, V189, P159; Canfield PJ, 2000, DEV COMP IMMUNOL, V24, P455, DOI 10.1016/S0145-305X(00)00009-4; Cisternas PA, 1999, ANAT EMBRYOL, V200, P433, DOI 10.1007/s004290050293; Cooke MM, 2002, J ANAT, V200, P113, DOI 10.1046/j.0021-8782.2001.00019.x; Edwards MJ, 2012, DEV COMP IMMUNOL, V37, P213, DOI 10.1016/j.dci.2012.03.013; EMERY JL, 1973, J CLIN PATHOL, V26, P539, DOI 10.1136/jcp.26.7.539; Figueirido B, 2011, BIOL LETTERS, V7, P937, DOI 10.1098/rsbl.2011.0364; Foster WK, 2006, AUST J ZOOL, V54, P343, DOI 10.1071/ZO06033; GEMMELL RT, 1986, J ANAT, V148, P193; Gemmell RT, 1998, CELL TISSUE RES, V252, P683; Guiler ER, 1985, THYLACINE TRAGEDY TA; haRRiS g.P., 1808, T LINNEAN SOC LONDON, V9, P174, DOI DOI 10.1111/J.1096-3642.1818.TB00336.X; HARTWIG H, 1985, EXPERIENTIA, V41, P159, DOI 10.1007/BF02002608; HAYES TG, 1968, J MORPHOL, V124, P445, DOI 10.1002/jmor.1051240404; Haynes JI, 2001, J ZOOL, V253, P167, DOI 10.1017/S0952836901000152; Johnson CN, 2003, HOLOCENE, V13, P941, DOI 10.1191/0959683603hl682fa; JOHNSTONE J, 1898, J LINN SOC ZOOL, V25, P537, DOI DOI 10.1111/J.1096-3642.1898.TB00410.X; JONES M, 1993, J IMMUNOL, V150, P5429; Joss JL, 2009, DEV COMP IMMUNOL, V33, P152, DOI 10.1016/j.dci.2008.08.002; KRAUSE WJ, 1973, AM J ANAT, V137, P337, DOI 10.1002/aja.1001370306; Le Souef AS, 1926, WILD ANIMALS AUSTRAL; Lyne A. G., 1957, Growth, V21, P167; Makanya AN, 2001, ANAT REC, V262, P253, DOI 10.1002/1097-0185(20010301)262:3<253::AID-AR1025>3.0.CO;2-B; McKnight M., IUCN RED LIST THREAT; Menzies BR, 2012, P MICCAIBRATS, V2012, P1; Mooney N., 2008, MAMMALS AUSTR, P167; Old JM, 2004, J ANAT, V205, P25, DOI 10.1111/j.0021-8782.2004.00310.x; Old JM, 2004, DEV COMP IMMUNOL, V28, P347, DOI 10.1016/j.dci.2003.08.004; Old JM, 2003, CELLS TISSUES ORGANS, V175, P192, DOI 10.1159/000074941; Old JM, 2003, J ANAT, V203, P123, DOI 10.1046/j.1469-7580.2003.00207.x; Old JM, 2000, DEV COMP IMMUNOL, V24, P445, DOI 10.1016/S0145-305X(00)00008-2; PABST R, 1990, AM J RESP CELL MOL, V3, P131, DOI 10.1165/ajrcmb/3.2.131; Paddle R., 2000, LAST TASMANIAN TIGER; Paddle Robert, 2012, Australian Zoologist, V36, P75; Phillips BT, 2003, ZOO BIOL, V22, P497, DOI 10.1002/zoo.10092; POSKITT DC, 1984, J COMP PATHOL, V94, P481, DOI 10.1016/0021-9975(84)90036-7; ROWLANDS DT, 1964, J IMMUNOL, V93, P157; Runciman SIC, 1996, ANAT REC, V244, P193, DOI 10.1002/(SICI)1097-0185(199602)244:2<193::AID-AR7>3.0.CO;2-2; Sleightholme SR, 2015, AUST ZOOL, V37, P238; Sleightholme Stephen R., 2012, Australian Zoologist, V36, P232, DOI 10.7882/AZ.2012.027; Smith ME, 2015, SYNTH LIMNOGEOL, V1, P1, DOI 10.1007/978-94-017-9906-5_1; STANLEY NF, 1972, AUST J EXP BIOL MED, V50, P689, DOI 10.1038/icb.1972.62; Stone William H., 1996, P149; Thompson CK, 2015, AUST MAMMAL, V37, P29, DOI 10.1071/AM14025; TYNDALEBISCOE H, 2005, LIFE MARSUPIALS, pNIL6; Young L, 1997, AUST J ZOOL, V45, P423, DOI 10.1071/ZO96063; Young Lauren J., 2012, Comparative Clinical Pathology, V21, P9; Young LF, 2001, AUST J ZOOL, V49, P195, DOI 10.1071/ZO00062; Young LJ, 2003, J ANAT, V202, P315, DOI 10.1046/j.1469-7580.2003.00165.x	65	4	5	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144091	10.1371/journal.pone.0144091	http://dx.doi.org/10.1371/journal.pone.0144091			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26655868	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900026
J	Silva, VP; Moreira-Santos, M; Mateus, C; Teixeira, T; Ribeiro, R; Viegas, CA				Silva, Vera P.; Moreira-Santos, Matilde; Mateus, Carla; Teixeira, Tania; Ribeiro, Rui; Viegas, Cristina A.			Evaluation of Arthrobacter aurescens Strain TC1 as Bioaugmentation Bacterium in Soils Contaminated with the Herbicidal Substance Terbuthylazine	PLOS ONE			English	Article							TRIAZINE HERBICIDES; BIOREMEDIATION TOOL; ATRAZINE; BIODEGRADATION; TEMPERATURE; EVOLUTION; COMMUNITY; TRZN	In the last years the chloro-s-triazine active substance terbuthylazine has been increasingly used as an herbicide and may leave residues in the environment which can be of concern. The present study aimed at developing a bioaugmentation tool based on the soil bacterium Arthrobacter aurescens strain TC1 for the remediation of terbuthylazine contaminated soils and at examining its efficacy for both soil and aquatic compartments. First, the feasibility of growing the bioaugmentation bacterium inocula on simple sole nitrogen sources (ammonium and nitrate) instead of atrazine, while still maintaining its efficiency to biodegrade terbuthylazine was shown. In sequence, the successful and quick (3 days) bioremediation efficacy of ammonium-grown A. aurescens TC1 cells was proven in a natural soil freshly spiked or four-months aged with commercial terbuthylazine at a dose 10x higher than the recommended in corn cultivation, to mimic spill situations. Ecotoxicity assessment of the soil eluates towards a freshwater microalga supported the effectiveness of the bioaugmentation tool. Obtained results highlight the potential to decontaminate soil while minimizing terbuthylazine from reaching aquatic compartments via the soil-water pathway. The usefulness of this bioaugmentation tool to provide rapid environment decontamination is particularly relevant in the event of accidental high herbicide contamination. Its limitations and advantages are discussed.	[Silva, Vera P.; Mateus, Carla; Viegas, Cristina A.] Univ Lisbon, Inst Super Tecn, iBB Inst Bioengn & Biosci, P-1699 Lisbon, Portugal; [Viegas, Cristina A.] Univ Lisbon, Inst Super Tecn, Dept Bioengn, P-1699 Lisbon, Portugal; [Moreira-Santos, Matilde; Teixeira, Tania; Ribeiro, Rui] Univ Coimbra, Dept Life Sci, CFE, Coimbra, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Coimbra	Viegas, CA (corresponding author), Univ Lisbon, Inst Super Tecn, iBB Inst Bioengn & Biosci, P-1699 Lisbon, Portugal.	cristina.viegas@tecnico.ulisboa.pt	Ribeiro, Rui/C-7788-2012; Viegas, Cristina A/C-7815-2011; Moreira-Santos, Matilde/J-2609-2013	Ribeiro, Rui/0000-0002-0883-1939; Viegas, Cristina A/0000-0003-1394-0731; Moreira-Santos, Matilde/0000-0001-7067-5028	iBB-Institute for Bioengineering and Biosciences [UID/BIO/04565/2013]; European Funds for Economic and Regional Development - FEDER-through the Competitiveness Factors Operational Programme - COMPETE [PTDC/AAC-AMB/111317/2009, Pest-OE/EQB/LA0023/2011]; National Funds through the Portuguese Foundation of Science and Technology (FCT) [PTDC/AAC-AMB/111317/2009, Pest-OE/EQB/LA0023/2011]; FCT [SFRH/BPD/99800/2014]; Programa Operacional Potencial Humano of QREN Portugal; Portuguese budget through the Ministry of Education and Science	iBB-Institute for Bioengineering and Biosciences; European Funds for Economic and Regional Development - FEDER-through the Competitiveness Factors Operational Programme - COMPETE; National Funds through the Portuguese Foundation of Science and Technology (FCT); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Operacional Potencial Humano of QREN Portugal; Portuguese budget through the Ministry of Education and Science(Portuguese Foundation for Science and Technology)	This work was supported by funding received by iBB-Institute for Bioengineering and Biosciences (UID/BIO/04565/2013) and other funding (Contracts PTDC/AAC-AMB/111317/2009, Pest-OE/EQB/LA0023/2011) from European Funds for Economic and Regional Development - FEDER-through the Competitiveness Factors Operational Programme - COMPETE and National Funds through the Portuguese Foundation of Science and Technology (FCT). M Moreira-Santos thanks to FCT for a postdoctoral fellowship (reference SFRH/BPD/99800/2014), funded by Programa Operacional Potencial Humano of QREN Portugal (2014-2020) and by the Portuguese budget through the Ministry of Education and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2481; Caracciolo AB, 2010, FEMS MICROBIOL ECOL, V71, P127, DOI 10.1111/j.1574-6941.2009.00787.x; Barriuso E, 2004, J AGR FOOD CHEM, V52, P6552, DOI 10.1021/jf040245l; Carafa R, 2007, CHEMOSPHERE, V69, P1625, DOI 10.1016/j.chemosphere.2007.05.060; Changey F, 2011, GENE, V490, P18, DOI 10.1016/j.gene.2011.09.005; Chelinho S, 2012, ENVIRON TOXICOL CHEM, V31, P1564, DOI 10.1002/etc.1840; Chelinho S, 2010, J SOIL SEDIMENT, V10, P568, DOI 10.1007/s11368-009-0145-2; Chirnside AEM, 2009, SOIL BIOL BIOCHEM, V41, P2484, DOI 10.1016/j.soilbio.2009.09.005; Fiori E, 2013, AQUAT TOXICOL, V128, P79, DOI 10.1016/j.aquatox.2012.12.001; Forgacs AL, 2013, TOXICOL SCI, V134, P155, DOI 10.1093/toxsci/kft096; Fruchey I, 2003, APPL ENVIRON MICROB, V69, P3653, DOI 10.1128/AEM.69.6.3653-3657.2003; Garcia-Gonzalez V, 2003, APPL ENVIRON MICROB, V69, P6987, DOI 10.1128/AEM.69.12.6987-6993.2003; Giger W, 2009, ENVIRON SCI POLLUT R, V16, P98, DOI 10.1007/s11356-009-0156-y; Govantes F, 2009, MICROB BIOTECHNOL, V2, P178, DOI 10.1111/j.1751-7915.2008.00073.x; Jablonowski ND, 2011, ENVIRON SCI POLLUT R, V18, P328, DOI 10.1007/s11356-010-0431-y; Johannesen H, 2003, ENVIRON TOXICOL CHEM, V22, P722, DOI [10.1897/1551-5028(2003)022&lt;0722:MOAATD&gt;2.0.CO;2, 10.1002/etc.5620220407]; Jurina T, 2014, APPL MICROBIOL BIOT, V98, P7223, DOI 10.1007/s00253-014-5774-8; Kjeldsen LS, 2013, TOXICOL APPL PHARM, V272, P453, DOI 10.1016/j.taap.2013.06.028; Kolic NU, 2007, INT BIODETER BIODEGR, V60, P299, DOI 10.1016/j.ibiod.2007.05.004; Lima D, 2009, CHEMOSPHERE, V74, P187, DOI 10.1016/j.chemosphere.2008.09.083; Navarro S, 2004, CHEMOSPHERE, V57, P51, DOI 10.1016/j.chemosphere.2004.05.016; OECD, 1984, GUID TEST CHEM; Perez J, 2013, ENVIRON SCI POLLUT R, V20, P4671, DOI 10.1007/s11356-012-1443-6; PPDB, 2013, GEN INF TERB DAT PES; Shapir N, 2007, J BACTERIOL, V189, P674, DOI 10.1128/JB.01257-06; Shapir N, 2005, APPL ENVIRON MICROB, V71, P2214, DOI 10.1128/AEM.71.5.2214-2220.2005; Shapir N, 2006, J BACTERIOL, V188, P5859, DOI 10.1128/JB.00517-06; Silva E, 2011, ENVIRON MONIT ASSESS, V176, P331, DOI 10.1007/s10661-010-1586-1; Strong LC, 2002, APPL ENVIRON MICROB, V68, P5973, DOI 10.1128/AEM.68.12.5973-5980.2002; STURMAN PJ, 1995, J CONTAM HYDROL, V19, P171, DOI 10.1016/0169-7722(95)00017-P; USEPA (United States Environmental Protection Agency), 2011, TERB FIN WORK PLAN R; Wackett LP, 2002, APPL MICROBIOL BIOT, V58, P39, DOI 10.1007/s00253-001-0862-y; Wang QF, 2013, INT BIODETER BIODEGR, V77, P63, DOI 10.1016/j.ibiod.2012.11.003; Wang QF, 2012, INT BIODETER BIODEGR, V71, P61, DOI 10.1016/j.ibiod.2012.04.005	34	17	22	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144978	10.1371/journal.pone.0144978	http://dx.doi.org/10.1371/journal.pone.0144978			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26662024	gold, Green Submitted, Green Published			2022-12-27	WOS:000366715900161
J	Strojny, B; Kurantowicz, N; Sawosz, E; Grodzik, M; Jaworski, S; Kutwin, M; Wierzbicki, M; Hotowy, A; Lipinska, L; Chwalibog, A				Strojny, Barbara; Kurantowicz, Natalia; Sawosz, Ewa; Grodzik, Marta; Jaworski, Slawomir; Kutwin, Marta; Wierzbicki, Mateusz; Hotowy, Anna; Lipinska, Ludwika; Chwalibog, Andre			Long Term Influence of Carbon Nanoparticles on Health and Liver Status in Rats	PLOS ONE			English	Article							NANOSCALE GRAPHENE OXIDE; C-REACTIVE PROTEIN; GRAPHITE NANOPLATELETS; OXIDATIVE STRESS; VIVO; TOXICITY; NANODIAMONDS; MICE; BIODISTRIBUTION; GLUTATHIONE	Due to their excellent biocompatibility, carbon nanoparticles have been widely investigated for prospective biomedical applications. However, their impact on an organism with prolonged exposure is still not well understood. Here, we performed an experiment investigating diamond, graphene oxide and graphite nanoparticles, which were repeatedly administrated intraperitoneally into Wistar rats for four weeks. Some of the animals was sacrificed after the last injection, whereas the rest were sacrificed twelve weeks after the last exposure. We evaluated blood morphology and biochemistry, as well as the redox and inflammatory state of the liver. The results show the retention of nanoparticles within the peritoneal cavity in the form of prominent aggregates in proximity to the injection site, as well as the presence of some nanoparticles in the mesentery. Small aggregates were also visible in the liver serosa, suggesting possible transportation to the liver. However, none of the tested nanoparticles affected the health of animals. This lack of toxic effect may suggest the potential applicability of nanoparticles as drug carriers for local therapies, ensuring accumulation and slow release of drugs into a targeted tissue without harmful systemic side effects.	[Strojny, Barbara; Kurantowicz, Natalia; Sawosz, Ewa; Grodzik, Marta; Jaworski, Slawomir; Kutwin, Marta; Wierzbicki, Mateusz; Hotowy, Anna] Warsaw Univ Life Sci, Div Nanobiotechnol, Warsaw, Poland; [Lipinska, Ludwika] Inst Elect Mat Technol, Dept Chem Technol, Warsaw, Poland; [Chwalibog, Andre] Univ Copenhagen, Dept Vet Clin & Anim Sci, Copenhagen, Denmark	Warsaw University of Life Sciences; Institute of Electronic Materials Technology; University of Copenhagen	Chwalibog, A (corresponding author), Univ Copenhagen, Dept Vet Clin & Anim Sci, Copenhagen, Denmark.	ach@sund.ku.dk	Jaworski, Sławomir/AAI-2313-2020; Grodzik, Marta/J-9404-2015; Wierzbicki, Mateusz/ABF-5482-2020; Grodzik, Marta/AAO-4319-2021	Jaworski, Sławomir/0000-0002-4619-941X; Grodzik, Marta/0000-0001-5359-1885; Wierzbicki, Mateusz/0000-0003-3623-8929; Grodzik, Marta/0000-0001-5359-1885; Kurantowicz, Natalia/0000-0002-7036-1325; Hotowy, Anna/0000-0002-0596-1201; Kutwin, Marta/0000-0001-7059-7875; Chwalibog, Andre/0000-0001-8150-2392; Sawosz Chwalibog, Ewa/0000-0002-0016-4721; Strojny, Barbara/0000-0002-2642-5491	National Science Centre (Poland) [2011/03/B/NZ9/03387, NN311 540840]; grant NCN from the National Science Centre (Poland) [2011/03/B/NZ9/03387, NN311 540840]	National Science Centre (Poland); grant NCN from the National Science Centre (Poland)	This work was supported by the National Science Centre (Poland) grant: 2011/03/B/NZ9/03387 and NN311 540840. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This report is a part of Barbara Strojny's PhD thesis. This work was supported by grant NCN 2011/03/B/NZ9/03387 and NN311 540840 from the National Science Centre (Poland). The authors thank Dr. Michal Mikula from The Maria Sklodowska-Curie Institute of Oncology for help with the cytokine membranes.	Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Bolliger AP., 2010, SCHALMS VET HEMATOLO, V6th; Buzea C, 2007, BIOINTERPHASES, V2, pMR17, DOI 10.1116/1.2815690; Chen GH, 2004, CARBON, V42, P753, DOI 10.1016/j.carbon.2003.12.074; Chowdhury SM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02584; Cichoz-Lach H, 2014, WORLD J GASTROENTERO, V20, P8082, DOI 10.3748/wjg.v20.i25.8082; Deng XY, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/7/075101; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Franco R., 2007, Archives of Physiology and Biochemistry, V113, P234, DOI 10.1080/13813450701661198; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Grodzik M, 2011, INT J NANOMED, V6, P3041, DOI 10.2147/IJN.S25528; Hong H, 2012, ACS NANO, V6, P2361, DOI 10.1021/nn204625e; HURLIMANN J, 1966, J EXP MED, V123, P365, DOI 10.1084/jem.123.2.365; Jaworski S, 2013, INT J NANOMED, V8, P413, DOI 10.2147/IJN.S39456; Kanakia S, 2014, BIOMATERIALS, V35, P7022, DOI 10.1016/j.biomaterials.2014.04.066; Kanakia S, 2013, INT J NANOMED, V8, P2821, DOI 10.2147/IJN.S47062; Kovacic Peter, 2006, Birth Defects Research, V78, P333, DOI 10.1002/bdrc.20083; Kulakova II, 2004, PHYS SOLID STATE+, V46, P636, DOI 10.1134/1.1711440; Kurantowicz N, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-1107-9; Kurantowicz N, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-0749-y; Lalwani G, 2013, BIOMACROMOLECULES, V14, P900, DOI 10.1021/bm301995s; Leung L, 2012, DRUG METAB REV, V44, P18, DOI 10.3109/03602532.2011.605791; Li B, 2014, INT J NANOMED, V9, P4697, DOI 10.2147/IJN.S66591; Li J, 2010, BIOMATERIALS, V31, P8410, DOI 10.1016/j.biomaterials.2010.07.058; Li Z, 2011, J NANOMATER, V2011, DOI 10.1155/2011/842613; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Ma-Hock L, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-23; Niemiec T, 2011, J NANOSCI NANOTECHNO, V11, P9072, DOI 10.1166/jnn.2011.3511; Parameters CS, CLIN LAB PARAMETERS; Patlolla AK, 2011, MOL CELL BIOCHEM, V358, P189, DOI 10.1007/s11010-011-0934-y; Pessayre D, 2012, DRUG METAB REV, V44, P34, DOI 10.3109/03602532.2011.604086; Puzyr AP, 2007, DIAM RELAT MATER, V16, P2124, DOI 10.1016/j.diamond.2007.07.025; Qu GB, 2013, J ENVIRON SCI, V25, P873, DOI 10.1016/S1001-0742(12)60252-6; Ribas V, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00151; Sanchez VC, 2012, CHEM RES TOXICOL, V25, P15, DOI 10.1021/tx200339h; Sawosz E, 2015, INT J MOL SCI, V16, P25214, DOI 10.3390/ijms161025214; Schrand AM, 2009, CRIT REV SOLID STATE, V34, P18, DOI 10.1080/10408430902831987; Talukdar Y, 2014, BIOMATERIALS, V35, P4863, DOI 10.1016/j.biomaterials.2014.02.054; Vaijayanthimala V, 2012, BIOMATERIALS, V33, P7794, DOI 10.1016/j.biomaterials.2012.06.084; Wierzbicki M, 2013, INT J NANOMED, V8, P3427, DOI 10.2147/IJN.S49745; Wierzbicki M, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-195; Xiao JS, 2013, BIOMATERIALS, V34, P9648, DOI 10.1016/j.biomaterials.2013.08.056; Yang K, 2013, BIOMATERIALS, V34, P2787, DOI 10.1016/j.biomaterials.2013.01.001; Yang K, 2013, CHEM SOC REV, V42, P530, DOI 10.1039/c2cs35342c; Yang K, 2012, BIOMATERIALS, V33, P2206, DOI 10.1016/j.biomaterials.2011.11.064; Zakrzewska KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122579; Zanni E, 2012, NANO LETT, V12, P2740, DOI 10.1021/nl204388p; Zhang XY, 2010, TOXICOL LETT, V198, P237, DOI 10.1016/j.toxlet.2010.07.001; Zheng ZY, 2013, INT J MED SCI, V10, P653, DOI 10.7150/ijms.6050	49	38	39	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144821	10.1371/journal.pone.0144821	http://dx.doi.org/10.1371/journal.pone.0144821			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657282	Green Published, gold			2022-12-27	WOS:000366715900110
J	Vieira, P; Eves-van den Akker, S; Verma, R; Wantoch, S; Eisenback, JD; Kamo, K				Vieira, Paulo; Eves-van den Akker, Sebastian; Verma, Ruchi; Wantoch, Sarah; Eisenback, Jonathan D.; Kamo, Kathryn			The Pratylenchus penetrans Transcriptome as a Source for the Development of Alternative Control Strategies: Mining for Putative Genes Involved in Parasitism and Evaluation of in planta RNAi	PLOS ONE			English	Article							ROOT-KNOT NEMATODE; LESION NEMATODE; GLOBODERA-PALLIDA; RETINOL-BINDING; SEQ DATA; GENOME; PROTEIN; SEQUENCE; REVEALS; EXPRESSION	The root lesion nematode Pratylenchus penetrans is considered one of the most economically important species within the genus. Host range studies have shown that nearly 400 plant species can be parasitized by this species. To obtain insight into the transcriptome of this migratory plant-parasitic nematode, we used Illumina mRNA sequencing analysis of a mixed population, as well as nematode reads detected in infected soybean roots 3 and 7 days after nematode infection. Over 140 million paired end reads were obtained for this species, and de novo assembly resulted in a total of 23,715 transcripts. Homology searches showed significant hit matches to 58% of the total number of transcripts using different protein and EST databases. In general, the transcriptome of P. penetrans follows common features reported for other root lesion nematode species. We also explored the efficacy of RNAi, delivered from the host, as a strategy to control P. penetrans, by targeted knock-down of selected nematode genes. Different comparisons were performed to identify putative nematode genes with a role in parasitism, resulting in the identification of transcripts with similarities to other nematode parasitism genes. Focusing on the predicted nematode secreted proteins found in this transcriptome, we observed specific members to be up-regulated at the early time points of infection. In the present study, we observed an enrichment of predicted secreted proteins along the early time points of parasitism by this species, with a significant number being pioneer candidate genes. A representative set of genes examined using RT-PCR confirms their expression during the host infection. The expression patterns of the different candidate genes raise the possibility that they might be involved in critical steps of P. penetrans parasitism. This analysis sheds light on the transcriptional changes that accompany plant infection by P. penetrans, and will aid in identifying potential gene targets for selection and use to design effective control strategies against root lesion nematodes.	[Vieira, Paulo; Eisenback, Jonathan D.] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA; [Vieira, Paulo; Verma, Ruchi; Wantoch, Sarah; Kamo, Kathryn] US Natl Arboretum, Floral & Nursery Plants Res Unit, USDA, Beltsville, MD 20705 USA; [Eves-van den Akker, Sebastian] Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland	Virginia Polytechnic Institute & State University; United States Department of Agriculture (USDA); University of Dundee	Vieira, P (corresponding author), Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA.	pvieira@vt.edu	Vieira, Paulo/I-7173-2019	Vieira, Paulo/0000-0001-5627-2628	National Institute of Food and Agriculture, U.S. Department of Agriculture [11588909]; Fred C. Gloeckner Foundation; California Department of Food and Agriculture Specialty Crops Block Grant; ARS [ARS-0425046] Funding Source: Federal RePORTER	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Fred C. Gloeckner Foundation; California Department of Food and Agriculture Specialty Crops Block Grant; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This material is based upon work that is supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number 11588909. This work was also partially funded by the Fred C. Gloeckner Foundation and the California Department of Food and Agriculture 2012 Specialty Crops Block Grant.; We thank Dr. David Chitwood (Nematology Laboratory, USDA, Beltsville, MD) for providing the Pratylenchus penetrans isolate, Dr. Benjamin Matthews (Soybean Genomics and Improvement Laboratory, USDA, Beltsville, MD) for providing the pRAP17 vector and the Agrobacterium tumefaciens strain K599. We thank Prof. Godelieve Gheysen, Prof. Mike Jones and Dr. John Fosu-Nyarko for providing the transcriptome assembly of P. coffeae and P. zeae, respectively. This material is based upon work that is supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number 11588909. This work was also partially funded by the Fred C. Gloeckner Foundation and the California Department of Food and Agriculture 2012 Specialty Crops Block Grant. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Abad Pierre, 2009, P363, DOI 10.1079/9781845934927.0363; Armstrong SD, 2014, MOL CELL PROTEOMICS, V13, P2527, DOI 10.1074/mcp.M114.038539; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bauters L, 2014, MOL PLANT PATHOL, V15, P352, DOI 10.1111/mpp.12098; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Burke M, 2015, NEMATOLOGY, V17, P621, DOI 10.1163/15685411-00002901; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Castillo P, 2007, NEMATOL MONOGR PERSP, V6, P1; Chen JS, 1997, J MOL EVOL, V44, P440, DOI 10.1007/PL00006164; Cho HJ, 2000, PLANTA, V210, P195, DOI 10.1007/PL00008126; Cotton JA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r43; Dalzell JJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001176; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; Duan Cheng-Guo, 2012, Silence, V3, P5, DOI 10.1186/1758-907X-3-5; Dubreuil G, 2007, NEW PHYTOL, V176, P426, DOI 10.1111/j.1469-8137.2007.02181.x; Dutta TK, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00760; Elsworth B, 2011, INT J PARASITOL, V41, P881, DOI 10.1016/j.ijpara.2011.03.009; Espada M, 2015, MOL PLANT P IN PRESS; Esteves I, 2015, EUR J PLANT PATHOL, V141, P397, DOI 10.1007/s10658-014-0551-1; Eves-van den Akker S, 2014, GENOME BIOL EVOL, V6, P2181, DOI 10.1093/gbe/evu171; Fairfax KC, 2009, INT J PARASITOL, V39, P1561, DOI 10.1016/j.ijpara.2009.06.005; Ferrandiz C, 2000, SCIENCE, V289, P436, DOI 10.1126/science.289.5478.436; Fosu-Nyarko J, 2016, MOL PLANT PATHOL, V17, P532, DOI 10.1111/mpp.12301; Furlanetto C, 2005, NEMATOLOGY, V7, P95, DOI 10.1163/1568541054192180; Garofalo A, 2003, MED MICROBIOL IMMUN, V192, P47, DOI 10.1007/s00430-002-0158-6; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Goverse A, 2014, ANNU REV PHYTOPATHOL, V52, P243, DOI 10.1146/annurev-phyto-102313-050118; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haegeman A, 2013, MOL PLANT PATHOL, V14, P379, DOI 10.1111/mpp.12014; Haegeman A, 2011, MOL PLANT MICROBE IN, V24, P879, DOI 10.1094/MPMI-03-11-0055; Haegeman A, 2011, MOL BIOCHEM PARASIT, V178, P7, DOI 10.1016/j.molbiopara.2011.04.001; Haegeman A, 2009, MOL PLANT PATHOL, V10, P389, DOI [10.1111/J.1364-3703.2009.00539.X, 10.1111/j.1364-3703.2009.00539.x]; Hewitson JR, 2008, MOL BIOCHEM PARASIT, V160, P8, DOI 10.1016/j.molbiopara.2008.02.007; Hobert O, 2005, NEURONAL GENOME CAEN; Huang GZ, 2003, MOL PLANT MICROBE IN, V16, P376, DOI 10.1094/MPMI.2003.16.5.376; Iberkleid I, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1426-3; Ibrahim HMM, 2011, EXP PARASITOL, V127, P90, DOI 10.1016/j.exppara.2010.06.037; Jacob J, 2007, GENE, V402, P9, DOI 10.1016/j.gene.2007.07.015; Jaubert S, 2005, MOL PLANT MICROBE IN, V18, P1277, DOI 10.1094/MPMI-18-1277; Jaubert S, 2004, INT J PARASITOL, V34, P873, DOI 10.1016/j.ijpara.2004.02.008; Jayatilake DV, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-230; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Jones JT, 2004, GENE, V324, P47, DOI 10.1016/j.gene.2003.09.051; Jones MGK, 2014, ANN APPL BIOL, V164, P163, DOI 10.1111/aab.12105; Joseph S, 2012, MOL BIOCHEM PARASIT, V186, P51, DOI 10.1016/j.molbiopara.2012.09.009; Kagawa H, 1997, CELL STRUCT FUNCT, V22, P213, DOI 10.1247/csf.22.213; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Klotz C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001248; Kramer James M., 1997, Cold Spring Harbor Monograph Series, V33, P471; Kyndt T, 2013, NEMATOLOGY, V15, P519, DOI 10.1163/15685411-00002698; Leroy S, 2003, MOL BIOCHEM PARASIT, V128, P91, DOI 10.1016/S0166-6851(03)00023-9; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lozano-Torres JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004569; McCarter JP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r26; Mei YY, 2015, NEMATOLOGY, V17, P409, DOI 10.1163/15685411-00002875; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Mitreva M, 2004, MOL GENET GENOMICS, V272, P138, DOI 10.1007/s00438-004-1054-0; Nicol P, 2012, INT J PARASITOL, V42, P225, DOI 10.1016/j.ijpara.2011.11.010; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Patel N, 2010, J EXP BOT, V61, P235, DOI 10.1093/jxb/erp293; Pearson MS, 2012, J ALLERGY CLIN IMMUN, V130, P13, DOI 10.1016/j.jaci.2012.05.029; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Peymen K, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00090; Prior A, 2001, BIOCHEM J, V356, P387, DOI 10.1042/0264-6021:3560387; Nguyen QB, 2011, MOL MICROBIOL, V81, P1008, DOI 10.1111/j.1365-2958.2011.07746.x; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Robertson L, 2000, MOL BIOCHEM PARASIT, V111, P41, DOI 10.1016/S0166-6851(00)00295-4; Rotenberg D, 2004, PLANT PATHOL, V53, P294, DOI 10.1111/j.0032-0862.2004.01005.x; Rybarczyk-Mydlowska K, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-221; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Schwarz EM, 2015, NAT GENET, V47, P416, DOI 10.1038/ng.3237; Schwarz EM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r89; Sharma S, 2011, THEOR APPL GENET, V122, P1321, DOI 10.1007/s00122-011-1533-8; Tan JACH, 2013, EXP PARASITOL, V133, P166, DOI 10.1016/j.exppara.2012.11.011; Tytgat T, 2005, PARASITOL RES, V95, P50, DOI 10.1007/s00436-004-1243-0; Vieira P, 2011, J EXP BOT, V62, P1241, DOI 10.1093/jxb/erq352; VRAIN TC, 1987, CAN J PLANT PATHOL, V9, P236, DOI 10.1080/07060668709501880; WHITEHEAD AG, 1965, ANN APPL BIOL, V55, P25, DOI 10.1111/j.1744-7348.1965.tb07864.x	82	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144674	10.1371/journal.pone.0144674	http://dx.doi.org/10.1371/journal.pone.0144674			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658731	Green Published, gold			2022-12-27	WOS:000366715900085
J	Inic-Kanada, A; Stojanovic, M; Schlacher, S; Stein, E; Belij-Rammerstorfer, S; Marinkovic, E; Lukic, I; Montanaro, J; Schuerer, N; Bintner, N; Kovacevic-Jovanovic, V; Krnjaja, O; Mayr, UB; Lubitz, W; Barisani-Asenbauer, T				Inic-Kanada, Aleksandra; Stojanovic, Marijana; Schlacher, Simone; Stein, Elisabeth; Belij-Rammerstorfer, Sandra; Marinkovic, Emilija; Lukic, Ivana; Montanaro, Jacqueline; Schuerer, Nadine; Bintner, Nora; Kovacevic-Jovanovic, Vesna; Krnjaja, Ognjen; Mayr, Ulrike Beate; Lubitz, Werner; Barisani-Asenbauer, Talin			Delivery of a Chlamydial Adhesin N-PmpC Subunit Vaccine to the Ocular Mucosa Using Particulate Carriers	PLOS ONE			English	Article							GENETICALLY INACTIVATED GHOSTS; HOMOLOGOUS AEROSOL CHALLENGE; FEMALE GUINEA-PIGS; BACTERIAL GHOSTS; GENITAL-INFECTION; OUTER-MEMBRANE; ACTINOBACILLUS-PLEUROPNEUMONIAE; CANDIDATE VACCINES; UNSAFE INJECTIONS; PROTECTIVE IMMUNITY	Trachoma, caused by the intracellular bacterium Chlamydia trachomatis (Ct), remains the world's leading preventable infectious cause of blindness. Recent attempts to develop effective vaccines rely on modified chlamydial antigen delivery platforms. As the mechanisms engaged in the pathology of the disease are not fully understood, designing a subunit vaccine specific to chlamydial antigens could improve safety for human use. We propose the delivery of chlamydia-specific antigens to the ocular mucosa using particulate carriers, bacterial ghosts (BGs). We therefore characterized humoral and cellular immune responses after conjunctival and subcutaneous immunization with a N-terminal portion (amino acid 1-893) of the chlamydial polymorphic membrane protein C (PmpC) of Ct serovar B, expressed in probiotic Escherichia coli Nissle 1917 bacterial ghosts (EcN BGs) in BALB/cmice. Three immunizations were performed at two-week intervals, and the immune responses were evaluated two weeks after the final immunization in mice. In a guinea pig model of ocular infection animals were immunized in the same manner as the mice, and protection against challenge was assessed two weeks after the last immunization. N-PmpC was successfully expressed within BGs and delivery to the ocularmucosa was well tolerated without signs of inflammation. N-PmpC- specific mucosal IgA levels in tears yielded significantly increased levels in the group immunized via the conjunctiva compared with the subcutaneously immunized mice. Immunization with N-PmpC EcN BGs via both immunization routes prompted the establishment of an N-PmpC-specific IFN gamma immune response. Immunization via the conjunctiva resulted in a decrease in intensity of the transitional inflammatory reaction in conjunctiva of challenged guinea pigs compared with subcutaneously and non-immunized animals. The delivery of the chlamydial subunit vaccine to the ocular mucosa using a particulate carrier, such as BGs, induced both humoral and cellular immune responses. Further investigations are needed to improve the immunization scheme and dosage.	[Inic-Kanada, Aleksandra; Schlacher, Simone; Stein, Elisabeth; Belij-Rammerstorfer, Sandra; Montanaro, Jacqueline; Schuerer, Nadine; Bintner, Nora; Barisani-Asenbauer, Talin] Med Univ Vienna, OCUVAC Ctr Ocular Inflammat & Infect, Laura Bassi Ctr Expertise, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Stojanovic, Marijana; Marinkovic, Emilija; Lukic, Ivana; Kovacevic-Jovanovic, Vesna; Krnjaja, Ognjen; Lubitz, Werner] Inst Virol Vaccines & Sera TORLAK, Dept Res & Dev, Belgrade, Serbia; [Mayr, Ulrike Beate] BIRD C GmbH&CoKG, Vienna, Austria	Medical University of Vienna	Barisani-Asenbauer, T (corresponding author), Med Univ Vienna, OCUVAC Ctr Ocular Inflammat & Infect, Laura Bassi Ctr Expertise, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria.	talin.barisani@meduniwien.ac.at	Belij-Rammerstorfer, Sandra/B-8243-2018	Inic-Kanada, Aleksandra/0000-0001-7854-3812; Barisani-Asenbauer, Talin/0000-0002-8661-9183; Schuerer, Nadine/0000-0002-5894-2784; Belij-Rammerstorfer, Sandra/0000-0002-8637-3785; Stojanovic, Marijana/0000-0002-8204-4183; Lukic, Ivana/0000-0002-6330-471X; Stein, Elisabeth/0000-0002-1240-506X	"Laura Bassi Centers of Expertise" Program of the Austrian Federal Ministry of Economy through the Austrian Research Promotion Agency (FFG Project) [822768]; Ministry of Education, Science, and Technological Development of the Republic of Serbia [172049]; BIRD-C	"Laura Bassi Centers of Expertise" Program of the Austrian Federal Ministry of Economy through the Austrian Research Promotion Agency (FFG Project); Ministry of Education, Science, and Technological Development of the Republic of Serbia; BIRD-C	This research was funded by the "Laura Bassi Centers of Expertise" Program of the Austrian Federal Ministry of Economy through the Austrian Research Promotion Agency (FFG Project Number: 822768) and was partly supported by the Ministry of Education, Science, and Technological Development of the Republic of Serbia (Grant Number 172049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BIRD-C provided support in the form of salaries for authors BM and WL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barisani-Asenbauer T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060682; Becker E, 2014, MICROBIOLOGYOPEN, V3, P544, DOI 10.1002/mbo3.186; Boje S, 2016, IMMUNOL CELL BIOL, V94, P185, DOI 10.1038/icb.2015.79; CAMPOS M, 1995, INVEST OPHTH VIS SCI, V36, P1477; Clements CJ, 2004, VACCINE, V22, P2054, DOI 10.1016/j.vaccine.2004.01.008; Dicko M, 2000, B WORLD HEALTH ORGAN, V78, P163; DWYER RS, 1983, BRIT J OPHTHALMOL, V67, P737, DOI 10.1136/bjo.67.11.737; Eko FO, 2003, VACCINE, V21, P3663, DOI 10.1016/S0264-410X(03)00388-8; Eko FO, 2003, VACCINE, V21, P1694, DOI 10.1016/S0264-410X(02)00677-1; Fujkuyama Y, 2012, EXPERT REV VACCINES, V11, P367, DOI [10.1586/erv.11.196, 10.1586/ERV.11.196]; Gebril A, 2012, EXPERT REV VACCINES, V11, P1139, DOI [10.1586/ERV.12.81, 10.1586/erv.12.81]; Giudice EL, 2006, ADV DRUG DELIVER REV, V58, P68, DOI 10.1016/j.addr.2005.12.003; Gomes JP, 2005, MICROBES INFECT, V7, P410, DOI 10.1016/j.micinf.2004.11.014; Gomes JP, 2004, J BACTERIOL, V186, P4295, DOI 10.1128/JB.186.13.4295-4306.2004; GRAYSTON JT, 1962, J EXP MED, V115, P1009, DOI 10.1084/jem.115.5.1009; Hensel A, 1996, J BIOTECHNOL, V44, P171, DOI 10.1016/0168-1656(95)00150-6; Hensel A, 2000, VACCINE, V18, P2945, DOI 10.1016/S0264-410X(00)00107-9; Hutchings AB, 2004, J VIROL, V78, P947, DOI 10.1128/JVI.78.2.947-957.2004; Huter V, 2000, J BIOTECHNOL, V83, P161, DOI 10.1016/S0168-1656(00)00310-2; Jaffar Z, 2009, J IMMUNOL, V182, P4507, DOI 10.4049/jimmunol.0900237; Jechlinger W, 2005, VACCINE, V23, P3609, DOI 10.1016/j.vaccine.2004.11.078; Katinger A, 1999, J BIOTECHNOL, V73, P251, DOI 10.1016/S0168-1656(99)00143-1; Kelly KA, 1996, INFECT IMMUN, V64, P4976, DOI 10.1128/IAI.64.12.4976-4983.1996; Kermode M, 2004, HEALTH PROMOT INT, V19, P95, DOI 10.1093/heapro/dah110; Kersten G, 2007, EXPERT OPIN DRUG DEL, V4, P459, DOI 10.1517/17425247.4.5.459; Knop N, 2000, INVEST OPHTH VIS SCI, V41, P1270; Kudela P, 2011, J BIOTECHNOL, V153, P167, DOI 10.1016/j.jbiotec.2011.03.022; Lacy HM, 2011, INFECT IMMUN, V79, P1889, DOI 10.1128/IAI.01257-10; Langemann Timo, 2010, Bioeng Bugs, V1, P326, DOI 10.4161/bbug.1.5.12540; Levine MM, 2000, J PEDIATR GASTR NUTR, V31, P336, DOI 10.1097/00005176-200010000-00003; Liu XY, 2010, J BACTERIOL, V192, P2852, DOI 10.1128/JB.01628-09; Lu CX, 2012, INVEST OPHTH VIS SCI, V53, P2551, DOI 10.1167/iovs.11-9212; Mader HJ, 1997, VACCINE, V15, P195, DOI 10.1016/S0264-410X(96)00141-7; Marchart J, 2003, VACCINE, V21, P1415, DOI 10.1016/S0264-410X(02)00635-7; Miller MA, 1999, B WORLD HEALTH ORGAN, V77, P808; Mitragotri S, 2005, NAT REV IMMUNOL, V5, P905, DOI 10.1038/nri1728; MONNICKENDAM MA, 1983, BRIT MED BULL, V39, P187, DOI 10.1093/oxfordjournals.bmb.a071814; Montanaro J, 2015, DRUG DESIGN IN PRESS; MORRISON RP, 1989, J EXP MED, V169, P663, DOI 10.1084/jem.169.3.663; Muhammad A, 2012, EXPERT REV VACCINES, V11, P97, DOI [10.1586/ERV.11.149, 10.1586/erv.11.149]; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Nunes A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000878; Pasetti MF, 2011, IMMUNOL REV, V239, P125, DOI 10.1111/j.1600-065X.2010.00970.x; RAMSEY KH, 1988, INFECT IMMUN, V56, P1320, DOI 10.1128/IAI.56.5.1320-1325.1988; RANK RG, 1983, INFECT IMMUN, V39, P463, DOI 10.1128/IAI.39.1.463-465.1983; RANK RG, 1988, INFECT IMMUN, V56, P2243, DOI 10.1128/IAI.56.9.2243-2249.1988; RANK RG, 1995, INVEST OPHTH VIS SCI, V36, P1344; RANK RG, 1979, INFECT IMMUN, V26, P573, DOI 10.1128/IAI.26.2.573-579.1979; Rank RG, 2009, VACCINES FOR BIODEFENSE AND EMERGING AND NEGLECTED DISEASES, P845, DOI 10.1016/B978-0-12-369408-9.00044-5; Reinoso R, 2012, MUCOSAL IMMUNOL, V5, P455, DOI 10.1038/mi.2012.27; SCOTT JG, 1971, BRIT J OPHTHALMOL, V55, P189, DOI 10.1136/bjo.55.3.189; Selin LK, 1998, J EXP MED, V188, P1705, DOI 10.1084/jem.188.9.1705; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; SOMPOLINSKY D, 1992, ALLERGY, V47, P234, DOI 10.1111/j.1398-9995.1992.tb00656.x; Spiegelberg H L, 1974, Adv Immunol, V19, P259, DOI 10.1016/S0065-2776(08)60254-0; Stein E, 2013, INVEST OPHTH VIS SCI, V54, P6326, DOI 10.1167/iovs.13-12044; Tabrizi CA, 2004, CURR OPIN BIOTECH, V15, P530, DOI 10.1016/j.copbio.2004.10.004; Tifrea DF, 2013, INFECT IMMUN, V81, P1741, DOI 10.1128/IAI.00734-12; TREHARNE J D, 1991, Eye (London), V5, P299; Walcher Petra, 2004, Expert Rev Vaccines, V3, P681, DOI 10.1586/14760584.3.6.681; Walcher P, 2008, VACCINE, V26, P6832, DOI 10.1016/j.vaccine.2008.09.088; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820; WILLIAMS DM, 1981, J INFECT DIS, V143, P238, DOI 10.1093/infdis/143.2.238; WILLIAMS DM, 1984, J INFECT DIS, V149, P630, DOI 10.1093/infdis/149.4.630; Wilson DP, 2009, J INFECT DIS, V199, P1780, DOI 10.1086/599093; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039214	69	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144380	10.1371/journal.pone.0144380	http://dx.doi.org/10.1371/journal.pone.0144380			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656797	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903600041
J	Piater, B; Doerner, A; Guenther, R; Kolmar, H; Hock, B				Piater, Birgit; Doerner, Achim; Guenther, Ralf; Kolmar, Harald; Hock, Bjoern			Aptamers Binding to c-Met Inhibiting Tumor Cell Migration	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; T7 RNA-POLYMERASE; RECEPTOR TYROSINE KINASE; FACTOR/SCATTER FACTOR; MET/HGF RECEPTOR; IN-VITRO; ANTITUMOR-ACTIVITY; SIGNALING PATHWAY; SCATTER-FACTOR; SEMA DOMAIN	The human receptor tyrosine kinase c-Met plays an important role in the control of critical cellular processes. Since c-Met is frequently over expressed or deregulated in human malignancies, blocking its activation is of special interest for therapy. In normal conditions, the c-Met receptor is activated by its bivalent ligand hepatocyte growth factor (HGF). Also bivalent antibodies can activate the receptor by cross linking, limiting therapeutic applications. We report the generation of the RNA aptamer CLN64 containing 2'-fluoro pyrimidine modifications by systematic evolution of ligands by exponential enrichment (SELEX). CLN64 and a previously described single-stranded DNA (ssDNA) aptamer CLN3 exhibited high specificities and affinities to recombinant and cellular expressed c-Met. Both aptamers effectively inhibited HGF-dependent c-Met activation, signaling and cell migration. We showed that these aptamers did not induce c-Met activation, revealing an advantage over bivalent therapeutic molecules. Both aptamers were shown to bind overlapping epitopes but only CLN3 competed with HGF binding to cMet. In addition to their therapeutic and diagnostic potential, CLN3 and CLN64 aptamers exhibit valuable tools to further understand the structural and functional basis for c-Met activation or inhibition by synthetic ligands and their interplay with HGF binding.	[Piater, Birgit; Doerner, Achim; Guenther, Ralf; Hock, Bjoern] Merck KGaA, Prot Engn & Antibody Technol, Darmstadt, Germany; [Kolmar, Harald] Tech Univ Darmstadt, Inst Organ Chem & Biochem, Darmstadt, Germany	Merck KGaA; Technical University of Darmstadt	Hock, B (corresponding author), Merck KGaA, Prot Engn & Antibody Technol, Darmstadt, Germany.	Bjoern.Hock@merckgroup.com	Kolmar, Harald/AAK-8316-2021	Kolmar, Harald/0000-0002-8210-1993; Doerner, Achim/0000-0002-4741-8039				Basilico C, 2008, J BIOL CHEM, V283, P21267, DOI 10.1074/jbc.M800727200; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boltz A, 2011, J BIOL CHEM; Chao KLL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041912; Chelliserrykattil J, 2004, NAT BIOTECHNOL, V22, P1155, DOI 10.1038/nbt1001; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Christensen JG, 2003, CANCER RES, V63, P7345; Christgen M, 2007, CANCER BIOL THER, V6, P1355; Comoglio PM, 1996, GENES CELLS, V1, P347, DOI 10.1046/j.1365-2443.1996.37037.x; Cunha S, 2014, CELL REP, V6, P141, DOI 10.1016/j.celrep.2013.12.010; Date K, 1997, FEBS LETT, V420, P1, DOI 10.1016/S0014-5793(97)01475-0; DIRENZO MF, 1995, CANCER RES, V55, P1129; DIRENZO MF, 1995, CLIN CANCER RES, V1, P147; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fan SJ, 2000, ONCOGENE, V19, P2212, DOI 10.1038/sj.onc.1203566; FERRACINI R, 1995, ONCOGENE, V10, P739; Gaudino G, 1994, RON HETERODIMERIC TY; Gentile A, 2008, MET TYROSINE KINASE; Gherardi E, 2006, P NATL ACAD SCI USA, V103, P4046, DOI 10.1073/pnas.0509040103; Green LS, 1996, BIOCHEMISTRY-US, V35, P14413, DOI 10.1021/bi961544+; Holmes O, 2007, J MOL BIOL, V367, P395, DOI 10.1016/j.jmb.2006.12.061; Huang Y, 1997, BIOCHEMISTRY-US, V36, P8231, DOI 10.1021/bi962674l; Hubbard SR, 2007, CURR OPIN CELL BIOL, V19, P117, DOI 10.1016/j.ceb.2007.02.010; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; JELLINEK D, 1995, BIOCHEMISTRY-US, V34, P11363, DOI 10.1021/bi00036a009; Jin HK, 2008, CANCER RES, V68, P4360, DOI 10.1158/0008-5472.CAN-07-5960; Jin L, 1997, CANCER, V79, P749, DOI 10.1002/(SICI)1097-0142(19970215)79:4<749::AID-CNCR12>3.0.CO;2-#; Katayama R, 2013, CANCER RES, V73, P3087, DOI 10.1158/0008-5472.CAN-12-3256; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kong-Beltran M, 2004, CANCER CELL, V6, P75, DOI 10.1016/j.ccr.2004.06.013; Kozlov G, 2004, INSIGHTS FUNCTION PS; Lee JF, 2006, CURR OPIN CHEM BIOL, V10, P282, DOI 10.1016/j.cbpa.2006.03.015; Lee JH, 2000, ONCOGENE, V19, P4947, DOI 10.1038/sj.onc.1203874; LOKKER NA, 1992, EMBO J, V11, P2503, DOI 10.1002/j.1460-2075.1992.tb05315.x; Lutterbach B, 2007, CANCER RES, V67, P2081, DOI 10.1158/0008-5472.CAN-06-3495; Martens T, 2006, CLIN CANCER RES, V12, P6144, DOI 10.1158/1078-0432.CCR-05-1418; Merchant M, 2013, P NATL ACAD SCI USA, V110, pE2987, DOI 10.1073/pnas.1302725110; Meyer C, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/904750; Munshi N, 2010, MOL CANCER THER, V9, P1544, DOI 10.1158/1535-7163.MCT-09-1173; Natali PG, 1996, INT J CANCER, V69, P212, DOI 10.1002/(SICI)1097-0215(19960621)69:3<212::AID-IJC11>3.0.CO;2-9; Pacchiana G, 2010, J BIOL CHEM, V285, P36149, DOI 10.1074/jbc.M110.134031; Padilla R, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf138; Pagratis NC, 1997, NAT BIOTECHNOL, V15, P68, DOI 10.1038/nbt0197-68; Petrelli A, 2006, P NATL ACAD SCI USA, V103, P5090, DOI 10.1073/pnas.0508156103; Ponzetto C, 1996, J BIOL CHEM, V271, P14119, DOI 10.1074/jbc.271.24.14119; Prat M, 1998, J CELL SCI, V111, P237; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; Saito T, 2005, DNA CELL BIOL, V24, P624, DOI 10.1089/dna.2005.24.624; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; SOUSA R, 1995, EMBO J, V14, P4609, DOI 10.1002/j.1460-2075.1995.tb00140.x; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; Takeo S, 2001, CANCER GENET CYTOGEN, V130, P127, DOI 10.1016/S0165-4608(01)00479-4; Trusolino L, 2000, FASEB J, V14, P1629, DOI 10.1096/fj.14.11.1629; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Tuck AB, 1996, AM J PATHOL, V148, P225; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Ueki R, 2014, CHEM COMMUN, V50, P13131, DOI 10.1039/c4cc06016d; Vinkenborg JL, 2012, ANGEW CHEM INT EDIT, V51, P9176, DOI 10.1002/anie.201204174; WANG MH, 1994, SCIENCE, V266, P117, DOI 10.1126/science.7939629; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898; Zhou B, 2006, EXP EYE RES, V83, P615, DOI 10.1016/j.exer.2006.02.010	65	9	10	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0142412	10.1371/journal.pone.0142412	http://dx.doi.org/10.1371/journal.pone.0142412			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658271	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903600004
J	Yang, H; He, NP; He, YT; Li, SG; Shi, PL; Zhang, XZ				Yang, Hao; He, Nianpeng; He, Yongtao; Li, Shenggong; Shi, Peili; Zhang, Xianzhou			Stable Water Use Efficiency of Tibetan Alpine Meadows in Past Half Century: Evidence from Wool delta C-13 Values	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; INNER-MONGOLIA; GLOBAL DISTRIBUTION; ATMOSPHERIC CO2; TYPICAL STEPPE; VEGETATION; GRASSLAND; CLIMATE; C-4; HAIR	Understanding the influences of climatic changes on water use efficiency (WUE) of Tibetan alpine meadows is important for predicting their long-term net primary productivity (NPP) because they are considered very sensitive to climate change. Here, we collected wool materials produced from 1962 to 2010 and investigated the long-term WUE of an alpine meadow in Tibet on basis of the carbon isotope values of vegetation (delta C-13(veg)). The values of delta C-13(veg) decreased by 1.34% during 1962-2010, similar to changes in delta C-13 values of atmospheric CO2. Carbon isotope discrimination was highly variable and no trend was apparent in the past half century. Intrinsic water use efficiency (W-i) increased by 18 mu mol.mol(-1) (approximately 23.5%) during 1962-2010 because the increase in the intercellular CO2 concentration (46 mu mol.mol(-1)) was less than that in the atmospheric CO2 concentration (C-a, 73 mu mol.mol(-1)). In addition, Wi increased significantly with increasing growing season temperature and C-a. However, effective water use efficiency (W-e) remained relatively stable, because of increasing vapor pressure deficit. C-a, precipitation, and growing season temperature collectively explained 45% of the variation of W-e. Our findings indicate that the W-e of alpine meadows in the Tibetan Plateau remained relatively stable by physiological adjustment to elevated C-a and growing season temperature. These findings improve our understanding and the capacity to predict NPP of these ecosystems under global change scenarios.	[Yang, Hao; He, Nianpeng; He, Yongtao; Li, Shenggong; Shi, Peili; Zhang, Xianzhou] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Observat & Modeling, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Yang, H (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Observat & Modeling, Beijing 100101, Peoples R China.	yangh@igsnrr.ac.cn	Peili, SHi/AAT-6450-2021; Li, Sheng-Gong/H-5101-2012; zhang, xian/GYA-0290-2022	Li, Sheng-Gong/0000-0003-4889-9927; he, nianpeng/0000-0002-0458-5953; shi, pei li/0000-0002-1120-0003	Natural Sciences Foundation of China [31470506, 31100336]; Knowledge Innovation Project of the Chinese Academy of Sciences [201003011]	Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	This work was supported by Natural Sciences Foundation of China (http://www.nsfc.gov.cn/) grants 31470506 (NH) and 31100336 (HY), and Knowledge Innovation Project of the Chinese Academy of Sciences (http://english.igsnrr.cas.cn/) grant 201003011 (HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Auerswald K, 2009, BIOGEOSCIENCES, V6, P795, DOI 10.5194/bg-6-795-2009; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; Barbosa ICR, 2010, GLOBAL CHANGE BIOL, V16, P1171, DOI 10.1111/j.1365-2486.2009.02018.x; Cernusak LA, 2013, NEW PHYTOL, V200, P950, DOI 10.1111/nph.12423; Chen BX, 2014, AGR FOREST METEOROL, V189, P11, DOI 10.1016/j.agrformet.2014.01.002; Collatz GJ, 1998, OECOLOGIA, V114, P441, DOI 10.1007/s004420050468; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Duquesnay A, 1998, PLANT CELL ENVIRON, V21, P565, DOI 10.1046/j.1365-3040.1998.00304.x; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Hu ZM, 2008, GLOBAL CHANGE BIOL, V14, P1609, DOI 10.1111/j.1365-2486.2008.01582.x; JONES RJ, 1981, SEARCH, V12, P85; Li Ming-cai, 2007, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V27, P1216; Liu XH, 2007, PLANT ECOL, V193, P195, DOI 10.1007/s11258-006-9258-5; Liu XH, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000610; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Lu HY, 2004, BIOGEOCHEMISTRY, V70, P273; Mannel TT, 2007, GLOBAL ECOL BIOGEOGR, V16, P583, DOI 10.1111/j.1466-8238.2007.00322.x; Piao SL, 2012, GLOBAL PLANET CHANGE, V98-99, P73, DOI 10.1016/j.gloplacha.2012.08.009; Saurer M, 2004, GLOBAL CHANGE BIOL, V10, P2109, DOI 10.1111/j.1365-2486.2004.00869.x; Schnyder H., 2008, Multifunctional grasslands in a changing world, Volume 1: XXI International Grassland Congress and VIII International Rangeland Congress, Hohhot, China, 29 June-5 July 2008, P46; Schwertl M, 2005, AGR ECOSYST ENVIRON, V109, P153, DOI 10.1016/j.agee.2005.01.015; Sponheimer M, 2003, CAN J ZOOL, V81, P871, DOI 10.1139/Z03-066; Still CJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001807; Tang WJ, 2013, J GEOPHYS RES-ATMOS, V118, P13292, DOI 10.1002/2013JD020527; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; Wang SP, 2012, ECOLOGY, V93, P2365, DOI 10.1890/11-1408.1; Wittmer MHOM, 2008, BIOGEOSCIENCES, V5, P913, DOI 10.5194/bg-5-913-2008; Xie H, 2010, THEOR APPL CLIMATOL, V101, P241, DOI 10.1007/s00704-009-0215-9; [闫巍 Yan Wei], 2006, [自然资源学报, Journal of Natural Resources], V21, P756; Yang H, 2011, PLANT SOIL, V340, P303, DOI 10.1007/s11104-010-0307-4; Yang YH, 2009, J ARID ENVIRON, V73, P91, DOI 10.1016/j.jaridenv.2008.09.027; Yao S, 2000, CHINESE SCI BULL, V45, P98; Zheng SX, 2011, PLANT SOIL, V340, P141, DOI 10.1007/s11104-010-0369-3; Zhou YC, 2011, ALPINE BOT, V121, P79, DOI 10.1007/s00035-011-0093-5	37	1	2	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144752	10.1371/journal.pone.0144752	http://dx.doi.org/10.1371/journal.pone.0144752			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26660306	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903600084
J	Lee, HS; Choi, EJ; Choi, H; Lee, KS; Kim, HR; Na, BR; Kwon, MS; Jeong, GS; Choi, HG; Choi, EY; Jun, CD				Lee, Hyun-Su; Choi, Eun-Ju; Choi, Heeri; Lee, Kyung-Sik; Kim, Hye-Ran; Na, Bo-Ra; Kwon, Min-Sung; Jeong, Gil-Saeng; Choi, Hyun Gyu; Choi, Eun Young; Jun, Chang-Duk			Oral Administration of 4-Hydroxy-3-Methoxycinnamaldehyde Attenuates Atopic Dermatitis by Inhibiting T Cell and Keratinocyte Activation	PLOS ONE			English	Article							KINASE-C-THETA; PHENOLIC-COMPOUNDS; IN-VITRO; ACID	Atopic dermatitis (AD) is a skin condition caused by an imbalance of distinct subsets of T helper cells. Previously, we showed that 4-hydroxy-3-methoxycinnamaldehyde (4H3MC) inhibits T cell activation but does not induce apoptosis. Here, we examined the mechanism underlying the inhibitory effect of 4H3MC on AD both in vivo and in vitro. We sought to test the pharmacological effects of 4H3MC using a mouse model of 2, 4-'2,4-dinitrocholorobenzene' (DNCB)-and mite-induced AD. Also, we determined whether 4H3MC affects T cell differentiation and proliferation. Oral administration of 4H3MC attenuated the symptoms of DNCB-and mite-induced AD, including increased ear thickness, serum IgE levels, immune cell infiltration into inflammatory lesions, and pathogenic cytokine expression in ear tissues. In vitro, 4H3MC blocked T cell differentiation into Th1 and Th2 subtypes, as reflected by suppression of T-bet and GATA3, which are key transcription factors involved in T cell differentiation. In addition, 4H3MC downregulated T cell proliferation during Th1 and Th2 differentiation and keratinocyte activation. Collectively, these findings suggest that 4H3MC ameliorates AD symptoms by modulating the functions of effector T cells and keratinocytes.	[Lee, Hyun-Su; Lee, Kyung-Sik; Kim, Hye-Ran; Na, Bo-Ra; Kwon, Min-Sung; Jun, Chang-Duk] Gwangju Inst Sci & Technol, Sch Life Sci, Immune Synapse Res Ctr, Gwangju, South Korea; [Lee, Hyun-Su; Lee, Kyung-Sik; Kim, Hye-Ran; Na, Bo-Ra; Kwon, Min-Sung; Jun, Chang-Duk] Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Gwangju, South Korea; [Choi, Eun-Ju; Choi, Heeri] Konkuk Univ, Coll Nat Sci, Div Sport Sci, Chungju, South Korea; [Jeong, Gil-Saeng] Keimyung Univ, Coll Pharm, Daegu, South Korea; [Choi, Hyun Gyu] Yeungnam Univ, Coll Pharm, Gyongsan, South Korea; [Choi, Eun Young] Univ Ulsan, Dept Biomed Sci, Coll Med, Seoul, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Konkuk University; Keimyung University; Yeungnam University; University of Ulsan	Choi, EY (corresponding author), Univ Ulsan, Dept Biomed Sci, Coll Med, Seoul, South Korea.	choieun@ulsan.ac.kr; cdjun@gist.ac.kr			Cell Dynamics Research Program [2007-0056157]; Basic Science Program [2013R1A6A3A04064259]; National Research Foundation (NRF) grants - Ministry of Science, ICT & Future Planning (MSIP), Korea; Bioimaging Research Center at GIST	Cell Dynamics Research Program; Basic Science Program; National Research Foundation (NRF) grants - Ministry of Science, ICT & Future Planning (MSIP), Korea; Bioimaging Research Center at GIST	This work was supported by the Cell Dynamics Research Program (2007-0056157), Basic Science Program (2013R1A6A3A04064259), and the Creative Research Initiative Program (2015) through the National Research Foundation (NRF) grants funded by the Ministry of Science, ICT & Future Planning (MSIP), Korea, and Bioimaging Research Center at GIST.	Akber U, 2015, INT IMMUNOPHARMACOL, V25, P130, DOI 10.1016/j.intimp.2015.01.020; Brandt E, 2011, J CLIN CELL IMMUNOL, V2, DOI [10.4172/2155-9899.1000110.Th2, DOI 10.4172/2155-9899.1000110.TH2]; Buys LM, 2007, AM FAM PHYSICIAN, V75, P523; Cardador-Martinez A, 2002, FOOD ADDIT CONTAM, V19, P62, DOI 10.1080/02652030110062110; Cho JY, 1998, BIOSCI BIOTECH BIOCH, V62, P2273, DOI 10.1271/bbb.62.2273; Choi EJ, 2011, J ETHNOPHARMACOL, V137, P802, DOI 10.1016/j.jep.2011.06.043; Da Cunha FM, 2004, FREE RADICAL RES, V38, P1241, DOI 10.1080/10715760400016139; Grammatikos AP, 2008, ANN MED, V40, P482, DOI 10.1080/07853890802082096; Laske N, 2004, PEDIAT ALLERG IMM-UK, V15, P86, DOI 10.1046/j.0905-6157.2003.00106.x; Lee LS, 2013, MOLECULES, V18, P12548, DOI 10.3390/molecules181012548; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; NICKOLOFF BJ, 1995, J INVEST DERMATOL, V105, pS25, DOI 10.1111/1523-1747.ep12315202; Ou SY, 2004, J SCI FOOD AGR, V84, P1261, DOI 10.1002/jsfa.1873; Oyoshi MK, 2009, ADV IMMUNOL, V102, P135, DOI 10.1016/S0065-2776(09)01203-6; Pfeifhofer-Obermair C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00220; Puupponen-Pimia R, 2001, J APPL MICROBIOL, V90, P494, DOI 10.1046/j.1365-2672.2001.01271.x; Sergent T, 2010, CHEM-BIOL INTERACT, V188, P659, DOI 10.1016/j.cbi.2010.08.007; Turner PV, 2011, J AM ASSOC LAB ANIM, V50, P600; Wojdylo A, 2007, FOOD CHEM, V105, P940, DOI 10.1016/j.foodchem.2007.04.038	21	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144521	10.1371/journal.pone.0144521	http://dx.doi.org/10.1371/journal.pone.0144521			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26656486	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903500035
J	Chen, CC; Chen, CW; Ho, CK; Liu, IC; Lin, BC; Chan, TC				Chen, Chien-Chou; Chen, Chao-Wen; Ho, Chi-Kung; Liu, I-Chuan; Lin, Bo-Cheng; Chan, Ta-Chien			Spatial Variation and Resuscitation Process Affecting Survival after Out-of-Hospital Cardiac Arrests (OHCA)	PLOS ONE			English	Article							AUTOMATED EXTERNAL DEFIBRILLATORS; CARDIOPULMONARY-RESUSCITATION; POPULATION-DENSITY; PREDICTORS; OUTCOMES; REGISTRY; IMPACT; EPIDEMIOLOGY; MANAGEMENT; DEPLOYMENT	Background Ambulance response times and resuscitation efforts are critical predictors of the survival rate after out-of-hospital cardiac arrests (OHCA). On the other hand, rural-urban differences in the OHCA survival rates are an important public health issue. Methods We retrospectively reviewed the January 2011-December 2013 OHCA registry data of Kaohsiung City, Taiwan. With particular focus on geospatial variables, we aimed to unveil risk factors predicting the overall OHCA survival until hospital admission. Spatial analysis, network analysis, and the Kriging method by using geographic information systems were applied to analyze spatial variations and calculate the transport distance. Logistic regression was used to identify the risk factors for OHCA survival. Results Among the 4,957 patients, the overall OHCA survival to hospital admission was 16.5%. In the multivariate analysis, female sex (adjusted odds ratio:, AOR, 1.24 [1.06-1.45]), events in public areas (AOR: 1.30 [1.05-1.61]), exposure to automated external defibrillator (AED) shock (AOR: 1.70 [1.30-2.23]), use of laryngeal mask airway (LMA) (AOR: 1.35 [1.16-1.58]), non-trauma patients (AOR: 1.41 [1.04-1.90]), ambulance bypassed the closest hospital (AOR: 1.28 [1.07-1.53]), and OHCA within the high population density areas (AOR: 1.89 [1.55-2.32]) were positively associated with improved OHCA survival. By contrast, a prolonged total emergency medical services (EMS) time interval was negatively associated with OHCA survival (AOR: 0.98 [0.96-0.99]). Conclusions Resuscitative efforts, such as AED or LMA use, and a short total EMS time interval improved OHCA outcomes in emergency departments. The spatial heterogeneity of emergency medical resources between rural and urban areas might affect survival rate.	[Chen, Chien-Chou; Lin, Bo-Cheng; Chan, Ta-Chien] Acad Sinica, Ctr Geog Informat Sci, Res Ctr Humanities & Social Sci, Taipei 115, Taiwan; [Chen, Chao-Wen] Kaohsiung Med Univ Hosp, Dept Surg, Div Trauma, Kaohsiung, Taiwan; [Chen, Chao-Wen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Emergency Med, Kaohsiung, Taiwan; [Ho, Chi-Kung] Kaohsiung City Govt, Dept Hlth, Kaohsiung, Taiwan; [Liu, I-Chuan] Kaohsiung City Govt, Fire Bur, Kaohsiung, Taiwan	Academia Sinica - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chen, CW (corresponding author), Kaohsiung Med Univ Hosp, Dept Surg, Div Trauma, Kaohsiung, Taiwan.	kmutrauma@gmail.com; dachianpig@gmail.com	Chen, Chien-Chou/AAD-7070-2019	Chen, Chao Wen/0000-0002-8405-342X; Lin, Bo-Cheng/0000-0003-3502-6203	Academia Sinica; Ministry of Science and Technology [MOST-103-2627-M-001-006]	Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This research was mainly supported by the internal research project named "Multidisciplinary Health Cloud Research Program: Technology Development and Application of Big Health Data" funded by Academia Sinica and also partially supported by a research grant from the Ministry of Science and Technology (grants no. MOST-103-2627-M-001-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwood C, 2005, RESUSCITATION, V67, P75, DOI 10.1016/j.resuscitation.2005.03.021; Berdowski J, 2011, CIRCULATION, V124, P2225, DOI 10.1161/CIRCULATIONAHA.110.015545; Bertrand C, 2004, RESUSCITATION, V63, P175, DOI 10.1016/j.resuscitation.2004.05.011; Blom MT, 2013, RESUSCITATION, V84, P569, DOI 10.1016/j.resuscitation.2012.10.009; Boyce LW, 2015, NETH HEART J, V23, P20, DOI 10.1007/s12471-014-0617-x; Chen CY, 2013, PEDIATR SURG INT, V29, P471, DOI 10.1007/s00383-013-3302-z; Cudnik MT, 2010, RESUSCITATION, V81, P518, DOI 10.1016/j.resuscitation.2009.12.030; De Maio VJ, 2012, PREHOSP EMERG CARE, V16, P230, DOI 10.3109/10903127.2011.640419; Dyson K, 2014, RESUSCITATION, V85, P1134, DOI 10.1016/j.resuscitation.2014.05.020; Earnest A, 2012, PREHOSP EMERG CARE, V16, P256, DOI 10.3109/10903127.2011.615974; Fake AL, 2013, NEW ZEAL MED J, V126, P28; Goh ES, 2013, ANN ACAD MED SINGAP, V42, P437; Goldberg SA, 2013, CRIT CARE, V17, DOI 10.1186/cc13128; Guimaraes RJPS, 2009, ACTA TROP, V109, P181, DOI 10.1016/j.actatropica.2008.10.012; Hasegawa K, 2013, RESUSCITATION, V84, P1099, DOI 10.1016/j.resuscitation.2013.03.007; Hiltunen P, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-80; Iqbal MB, 2015, AM J CARDIOL, V115, P730, DOI 10.1016/j.amjcard.2014.12.033; Kitamura T, 2010, EUR HEART J, V31, P1365, DOI 10.1093/eurheartj/ehq059; Ko PCI, 2004, RESUSCITATION, V63, P167, DOI 10.1016/j.resuscitation.2004.04.002; Lee CC, 2011, EMERG MED J, V28, P432, DOI 10.1136/emj.2009.087593; Lin CH, 2013, RESUSCITATION, V84, P586, DOI 10.1016/j.resuscitation.2012.09.028; Lin YR, 2007, RESUSCITATION, V74, P83, DOI 10.1016/j.resuscitation.2006.11.022; Mahapatra S, 2005, RESUSCITATION, V65, P197, DOI 10.1016/j.resuscitation.2004.10.017; McNally Bryan, 2011, Morbidity and Mortality Weekly Report, V60, P1; Nielsen AM, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-34; Nordberg P, 2015, RESUSCITATION, V90, P143, DOI 10.1016/j.resuscitation.2015.02.036; Pollice A, 2010, ENVIRON MONIT ASSESS, V162, P177, DOI 10.1007/s10661-009-0786-z; Sasson C, 2011, RESUSCITATION, V82, P674, DOI 10.1016/j.resuscitation.2011.02.002; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Sladjana A, 2011, EUR J INTERN MED, V22, P386, DOI 10.1016/j.ejim.2011.04.003; Stromsoe A, 2011, RESUSCITATION, V82, P1307, DOI 10.1016/j.resuscitation.2011.04.025; Ta-Chien Chan, 2013, GEOMASKER 1 0; Tetsushi Tachikawa, 2011, NASA LAND PROCESSES; Tritsch L, 2014, RESUSCITATION, V85, P320, DOI 10.1016/j.resuscitation.2013.11.006; van de Glind EMM, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-68; Weisfeldt ML, 2011, NEW ENGL J MED, V364, P313, DOI 10.1056/NEJMoa1010663; Wibrandt I, 2015, BMC EMERG MED, V15, DOI 10.1186/s12873-015-0028-3; Wissenberg M, 2014, RESUSCITATION, V85, P1212, DOI 10.1016/j.resuscitation.2014.06.008; Writer H, 2010, BMJ CLIN EVID, V2010, P307; Yeung J, 2014, RESUSCITATION, V85, P898, DOI 10.1016/j.resuscitation.2014.02.018	40	19	19	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144882	10.1371/journal.pone.0144882	http://dx.doi.org/10.1371/journal.pone.0144882			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659851	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900133
J	Inoue, E; Watanabe, Y; Xing, JR; Kushima, I; Egawa, J; Okuda, S; Hoya, S; Okada, T; Uno, Y; Ishizuka, K; Sugimoto, A; Igeta, H; Nunokawa, A; Sugiyama, T; Ozaki, N; Someya, T				Inoue, Emiko; Watanabe, Yuichiro; Xing, Jingrui; Kushima, Itaru; Egawa, Jun; Okuda, Shujiro; Hoya, Satoshi; Okada, Takashi; Uno, Yota; Ishizuka, Kanako; Sugimoto, Atsunori; Igeta, Hirofumi; Nunokawa, Ayako; Sugiyama, Toshiro; Ozaki, Norio; Someya, Toshiyuki			Resequencing and Association Analysis of CLN8 with Autism Spectrum Disorder in a Japanese Population	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; MUTATIONS; GENES	Rare variations contribute substantially to autism spectrum disorder (ASD) liability. We recently performed whole-exome sequencing in two families with affected siblings and then carried out a follow-up study and identified ceroid-lipofuscinosis neuronal 8 (epilepsy, progressive with mental retardation) (CLN8) as a potential genetic risk factor for ASD. To further investigate the role of CLN8 in the genetic etiology of ASD, we performed resequencing and association analysis of CLN8 with ASD in a Japanese population. Resequencing the CLN8 coding region in 256 ASD patients identified five rare missense variations: g.1719291G>A (R24H), rs201670636 (F39L), rs116605307 (R97H), rs143701028 (T108M) and rs138581191 (N152S). These variations were genotyped in 568 patients (including the resequenced 256 patients) and 1017 controls. However, no significant association between these variations and ASD was identified. This study does not support a contribution of rare missense CLN8 variations to ASD susceptibility in the Japanese population.	[Inoue, Emiko; Watanabe, Yuichiro; Egawa, Jun; Hoya, Satoshi; Sugimoto, Atsunori; Igeta, Hirofumi; Nunokawa, Ayako; Someya, Toshiyuki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata, Japan; [Xing, Jingrui; Kushima, Itaru; Okada, Takashi; Uno, Yota; Ishizuka, Kanako; Ozaki, Norio] Niigata Univ, Grad Sch Med, Dept Psychiat, Niigata, Japan; [Okuda, Shujiro] Niigata Univ, Grad Sch Med & Dent Sci, Div Bioinformat, Niigata, Japan; [Nunokawa, Ayako] Oojima Hosp, Sanjo, Niigata, Japan; [Sugiyama, Toshiro] Hamamatsu Univ Sch Med, Dept Child & Adolescent Psychiat, Hamamatsu, Shizuoka 4313192, Japan	Niigata University; Niigata University; Niigata University; Hamamatsu University School of Medicine	Egawa, J (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata, Japan.	jeg5414@med.niigata-u.ac.jp	Someya, Toshiyuki/ABD-1878-2021; UNO, Yota/M-8928-2014; Okuda, Shujiro/D-1700-2016; Ozaki, Norio/M-8908-2014; Watanabe, Yuichiro/ABB-7176-2021; SUGIMOTO, Atsunori/ABD-1064-2021; Egawa, Jun/GVS-0721-2022; OKADA, Takashi/M-8902-2014	Okuda, Shujiro/0000-0002-7704-8104; Ozaki, Norio/0000-0002-7360-4898; Watanabe, Yuichiro/0000-0002-5496-5997; SUGIMOTO, Atsunori/0000-0002-6684-0016; OKADA, Takashi/0000-0001-5580-9913; Kushima, Itaru/0000-0002-0018-5178	Niigata Medical Association; Japan Foundation for Neuroscience; "Integrated Research on Neuropsychiatric Disorders" of the Strategic Research Program for Brain Sciences from the Japan Agency for Medical Research and development, AMED	Niigata Medical Association; Japan Foundation for Neuroscience; "Integrated Research on Neuropsychiatric Disorders" of the Strategic Research Program for Brain Sciences from the Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED))	This work was supported by a grant from the Niigata Medical Association, by a grant from the Japan Foundation for Neuroscience, and by a "Integrated Research on Neuropsychiatric Disorders" of the Strategic Research Program for Brain Sciences from the Japan Agency for Medical Research and development, AMED. The funders had no role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Chien WH, 2010, CLIN GENET, V78, P449, DOI 10.1111/j.1399-0004.2010.01395.x; Chien WH, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-26; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Egawa J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119413; Galizzi G, 2011, NEUROSCI LETT, V488, P258, DOI 10.1016/j.neulet.2010.11.041; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Kousi M, 2012, HUM MUTAT, V33, P42, DOI 10.1002/humu.21624; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; Lonka L, 2000, HUM MOL GENET, V9, P1691, DOI 10.1093/hmg/9.11.1691; Nunokawa A, 2010, SCHIZOPHR RES, V116, P61, DOI 10.1016/j.schres.2009.10.016; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ranta S, 2004, HUM MUTAT, V23, P300, DOI 10.1002/humu.20018; Ranta S, 1999, NAT GENET, V23, P233, DOI 10.1038/13868; Toma C, 2014, MOL PSYCHIATR, V19, P784, DOI 10.1038/mp.2013.106; Vantaggiato C, 2009, HUM MUTAT, V30, P1104, DOI 10.1002/humu.21012; Watanabe Y, 2006, SCHIZOPHR RES, V84, P29, DOI 10.1016/j.schres.2006.03.011; Wei HG, 2014, INT J DEV NEUROSCI, V36, P13, DOI 10.1016/j.ijdevneu.2014.04.004; Wei H, 2008, HUM MOL GENET, V17, P469, DOI 10.1093/hmg/ddm324; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002	23	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144624	10.1371/journal.pone.0144624	http://dx.doi.org/10.1371/journal.pone.0144624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657971	Green Published, gold			2022-12-27	WOS:000366715900075
J	Lotzin, A; Romer, G; Schiborr, J; Noga, B; Schulte-Markwort, M; Ramsauer, B				Lotzin, Annett; Romer, Georg; Schiborr, Julia; Noga, Berit; Schulte-Markwort, Michael; Ramsauer, Brigitte			Gaze Synchrony between Mothers with Mood Disorders and Their Infants: Maternal Emotion Dysregulation Matters	PLOS ONE			English	Article							STRUCTURED CLINICAL INTERVIEW; TO-FACE INTERACTION; REGULATION DIFFICULTIES; INTERRATER RELIABILITY; POSTPARTUM DEPRESSION; DISCRIMINANT VALIDITY; POSTNATAL DEPRESSION; LANGUAGE-DEVELOPMENT; ANXIETY; COORDINATION	A lowered and heightened synchrony between the mother's and infant's nonverbal behavior predicts adverse infant development. We know that maternal depressive symptoms predict lowered and heightened mother-infant gaze synchrony, but it is unclear whether maternal emotion dysregulation is related to mother-infant gaze synchrony. This cross-sectional study examined whether maternal emotion dysregulation in mothers with mood disorders is significantly related to mother-infant gaze synchrony. We also tested whether maternal emotion dysregulation is relatively more important than maternal depressive symptoms in predicting mother-infant gaze synchrony, and whether maternal emotion dysregulation mediates the relation between maternal depressive symptoms and mother-infant gaze synchrony. We observed 68 mothers and their 4- to 9-month-old infants in the Still-Face paradigm during two play interactions, before and after social stress was induced. The mothers' and infants' gaze behaviors were coded using microanalysis with the Maternal Regulatory Scoring System and Infant Regulatory Scoring System, respectively. The degree of mother-infant gaze synchrony was computed using time-series analysis. Maternal emotion dysregulation was measured by the Difficulties in Emotion Regulation Scale; depressive symptoms were assessed using the Beck Depression Inventory. Greater maternal emotion dysregulation was significantly related to heightened mother-infant gaze synchrony. The overall effect of maternal emotion dysregulation on mother-infant gaze synchrony was relatively more important than the effect of maternal depressive symptoms in the five tested models. Maternal emotion dysregulation fully mediated the relation between maternal depressive symptoms and mother-infant gaze synchrony. Our findings suggest that the effect of the mother's depressive symptoms on the mother-infant gaze synchrony may be mediated by the mother's emotion dysregulation.	[Lotzin, Annett; Schiborr, Julia; Noga, Berit; Schulte-Markwort, Michael; Ramsauer, Brigitte] Univ Med Ctr Hamburg Eppendorf, Dept Child & Adolescent Psychiat Psychotherapy &, Hamburg, Germany; [Romer, Georg] Univ Hosp Muenster, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munster, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster	Romer, G (corresponding author), Univ Hosp Muenster, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munster, Germany.	g.romer@ukmuenster.de	Lotzin, Annett/AAL-7742-2021	Lotzin, Annett/0000-0002-2834-8047	Hamburg Foundation for the Advancement for Research and Culture, Germany; Open Access Publication Fund of University of Muenster	Hamburg Foundation for the Advancement for Research and Culture, Germany; Open Access Publication Fund of University of Muenster	This work was supported by Hamburg Foundation for the Advancement for Research and Culture, Germany, http://www.kulturfoerderung.org/dizk/details.htm?idKey = showOrgaDetails&idValue=1109&selectedLocale = de; The Open Access Publication Fund of University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldao A., 2010, CLIN PSYCHOL REV, V30, P217, DOI [10.1016/j.cpr.2009.11.004, DOI 10.1016/j.cpr.2009.11.004, DOI 10.1016/J.CPR.2009.11.004]; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 2011, PASS POWER ANAL SAMP; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Baron-Cohen S., 1997, MINDBLINDNESS ESSAY; Baron-Cohen S., 1997, MALADAPT MIND CLASSI, P207; Batki A, 2000, INFANT BEHAV DEV, V23, P223, DOI 10.1016/S0163-6383(01)00037-6; Beblo T, 2011, Z PSYCHIATR PSYCH PS, V59, P133, DOI 10.1024/1661-4747/a000063; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Beebe B, 2008, INFANT MENT HEALTH J, V29, P442, DOI 10.1002/imhj.20191; Beebe B, 2008, J PSYCHOLINGUIST RES, V37, P293, DOI 10.1007/s10936-008-9078-y; Beebe B, 2007, DEV PSYCHOL, V43, P1360, DOI 10.1037/0012-1649.43.6.1360; Beebe B, 2011, INFANT MENT HEALTH J, V32, P174, DOI 10.1002/imhj.20274; Beebe B, 2010, ATTACH HUM DEV, V12, P3, DOI 10.1080/14616730903338985; BELSKY J, 1984, CHILD DEV, V55, P718, DOI 10.1111/j.1467-8624.1984.tb03810.x; Bornstein MH, 2013, DEV PSYCHOPATHOL, V25, P957, DOI 10.1017/S0954579413000308; Braarud HC, 2006, INFANT CHILD DEV, V15, P251, DOI 10.1002/icd.461; BROPHY CJ, 1988, J PERS ASSESS, V52, P334, DOI 10.1207/s15327752jpa5202_14; Buchholz ES, 1999, AM J ORTHOPSYCHIAT, V69, P9, DOI 10.1037/h0080377; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CAMPBELL SB, 1995, DEV PSYCHOL, V31, P349, DOI 10.1037/0012-1649.31.3.349; Cole PM, 2004, CHILD DEV, V75, P317, DOI 10.1111/j.1467-8624.2004.00673.x; Colonnesi C, 2012, INFANT BEHAV DEV, V35, P523, DOI 10.1016/j.infbeh.2012.02.004; Cox BJ, 1993, PSYCHOL ASSESSMENT, V5, P484, DOI DOI 10.1037/1040-3590.5.4.484; DIX T, 1991, PSYCHOL BULL, V110, P3, DOI 10.1037/0033-2909.110.1.3; Ehring T, 2008, PERS INDIV DIFFER, V44, P1574, DOI 10.1016/j.paid.2008.01.013; Endriga MC, 1997, J PEDIATR PSYCHOL, V22, P439, DOI 10.1093/jpepsy/22.4.439; Farran D. C., 1990, J APPL DEV PSYCHOL, V11, P419, DOI [10.1016/0193-3973(90)90018-F, DOI 10.1016/0193-3973(90)90018-F]; Farroni T, 2004, INFANCY, V5, P39, DOI 10.1207/s15327078in0501_2; Feldman R, 2003, INFANT MENT HEALTH J, V24, P1, DOI 10.1002/imhj.10041; Feldman R, 2007, J CHILD PSYCHOL PSYC, V48, P329, DOI 10.1111/j.1469-7610.2006.01701.x; Feldman R, 2011, INFANT BEHAV DEV, V34, P569, DOI 10.1016/j.infbeh.2011.06.008; Field T, 2010, INFANT BEHAV DEV, V33, P1, DOI 10.1016/j.infbeh.2009.10.005; Flom R., 2007, GAZE FOLLOWING ITS D; Fogel A., 2006, J DEV PROCESSES, V1, P7; Franke G.H., 2002, SYMPTOM CHECKLISTE L; Glasheen C, 2010, ARCH WOMEN MENT HLTH, V13, P61, DOI 10.1007/s00737-009-0109-y; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; GOTTMAN JM, 1981, CHILD DEV, V52, P393, DOI 10.2307/1129157; Gratz Kim L, 2006, J Psychiatr Pract, V12, P153, DOI 10.1097/00131746-200605000-00004; Gratz KL, 2006, J ABNORM PSYCHOL, V115, P850, DOI 10.1037/0021-843X.115.4.850; Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94; Greenberg LS, 2004, CLIN PSYCHOL PSYCHOT, V11, P3, DOI 10.1002/cpp.388; Haley DW, 2011, STRESS, V14, P530, DOI 10.3109/10253890.2011.560308; Hane AA, 2003, J PSYCHOLINGUIST RES, V32, P525, DOI 10.1023/A:1025494200272; Hart S, 1998, INFANT BEHAV DEV, V21, P519, DOI 10.1016/S0163-6383(98)90024-8; Hautzinger M., 1994, TESTHANDBUCH; Jaffe J, 2001, MONOGR SOC RES CHILD, V66, P1, DOI 10.1111/1540-5834.00137; Kaitz M, 2005, INFANT MENT HEALTH J, V26, P570, DOI 10.1002/imhj.20069; Kaitz M, 2010, INFANT BEHAV DEV, V33, P136, DOI 10.1016/j.infbeh.2009.12.003; KAYE K, 1980, DEV PSYCHOL, V16, P454, DOI 10.1037/0012-1649.16.5.454; Kessler RC, 2012, INT J METH PSYCH RES, V21, P169, DOI 10.1002/mpr.1359; KOPP CB, 1989, DEV PSYCHOL, V25, P343, DOI 10.1037/0012-1649.25.3.343; Koulomzin Marina, 2002, Attach Hum Dev, V4, P3, DOI 10.1080/14616730210123120; Krueger RE, 2006, ANNU REV CLIN PSYCHO, V2, P111, DOI 10.1146/annurev.clinpsy.2.022305.095213; Krull JL, 2001, MULTIVAR BEHAV RES, V36, P249, DOI 10.1207/S15327906MBR3602_06; Langton SRH, 2000, TRENDS COGN SCI, V4, P50, DOI 10.1016/S1364-6613(99)01436-9; Leclere C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113571; LIVINGOOD AB, 1983, J CLIN PSYCHOL, V39, P369, DOI 10.1002/1097-4679(198305)39:3<369::AID-JCLP2270390310>3.0.CO;2-8; Lobbestael J, 2011, CLIN PSYCHOL PSYCHOT, V18, P75, DOI 10.1002/cpp.693; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; Manian N, 2009, J CHILD PSYCHOL PSYC, V50, P1410, DOI 10.1111/j.1469-7610.2009.02166.x; MARQUARDT DW, 1970, TECHNOMETRICS, V12, P591, DOI 10.2307/1267205; Matthey S, 2003, J AFFECT DISORDERS, V74, P139, DOI 10.1016/S0165-0327(02)00012-5; McLaughlin KA, 2007, BEHAV RES THER, V45, P1735, DOI 10.1016/j.brat.2006.12.004; Mennin D. S., 2010, EMOTION REGULATION P, P356; Mennin DS, 2006, J CONTEMP PSYCHOTHER, V36, P95, DOI 10.1007/s10879-006-9012-2; Mesman J, 2009, DEV REV, V29, P120, DOI 10.1016/j.dr.2009.02.001; MESSER DJ, 1984, INFANT BEHAV DEV, V7, P167, DOI 10.1016/S0163-6383(84)80056-9; Moore GA, 2004, DEV PSYCHOL, V40, P1068, DOI 10.1037/0012-1649.40.6.1068; Morales M, 2005, INT J BEHAV DEV, V29, P259, DOI 10.1080/01650250444000432; Morales M, 1998, INFANT BEHAV DEV, V21, P373, DOI 10.1016/S0163-6383(98)90014-5; Morales M, 2000, INFANT BEHAV DEV, V23, P231, DOI 10.1016/S0163-6383(01)00038-8; Morgan CD, 1998, ASSESSMENT, V5, P197, DOI 10.1177/107319119800500210; Murray L, 1997, ARCH DIS CHILD, V77, P99, DOI 10.1136/adc.77.2.99; Murray L, 2011, J AM ACAD CHILD PSY, V50, P460, DOI 10.1016/j.jaac.2011.02.001; Neu M, 2010, JOGNN-J OBST GYN NEO, V39, P401, DOI 10.1111/j.1552-6909.2010.01152.x; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; PEERY JC, 1976, J GENET PSYCHOL, V129, P45, DOI 10.1080/00221325.1976.10534009; Pollack MH, 2005, J CLIN PSYCHIAT, V66, P22; Ramsauer B, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-24; Rivas-Vazquez RA, 2004, PROF PSYCHOL-RES PR, V35, P74, DOI 10.1037/0735-7028.35.1.74; Roemer L, 2008, J CONSULT CLIN PSYCH, V76, P1083, DOI 10.1037/a0012720; Rosenblum L.A., 1974, EFFECT INFANT ITS CA, P187; Rothbart M K, 1992, New Dir Child Dev, P7; Schmitz N, 2000, QUAL LIFE RES, V9, P185, DOI 10.1023/A:1008931926181; SKRE I, 1991, ACTA PSYCHIAT SCAND, V84, P167, DOI 10.1111/j.1600-0447.1991.tb03123.x; Teasdale JD, 2002, J CONSULT CLIN PSYCH, V70, P275, DOI 10.1037//0022-006X.70.2.275; Thompson R A, 1994, Monogr Soc Res Child Dev, V59, P25, DOI 10.2307/1166137; Tomasello M., 1992, SOC DEV, V1, P67, DOI [10.1111/j.1467-9507.1992.tb00135.x, DOI 10.1111/J.1467-9507.1992.TB00135.X]; TRONICK E, 1978, J AM ACAD CHILD PSY, V17, P1, DOI 10.1016/S0002-7138(09)62273-1; TRONICK E, 1980, MERRILL PALMER QUART, V26, P3; TRONICK ED, 1977, J COMMUN, V27, P74, DOI 10.1111/j.1460-2466.1977.tb01829.x; Tronick EZ, 1990, MATERNAL REGULATORY; Tronick EZ, 1996, INFANT REGULATORY SC; Tull MT, 2007, BEHAV THER, V38, P378, DOI 10.1016/j.beth.2006.10.006; Tull MT, 2008, J ANXIETY DISORD, V22, P750, DOI 10.1016/j.janxdis.2007.08.001; Van Egeren LA, 2001, DEV PSYCHOL, V37, P684, DOI 10.1037/0012-1649.37.5.684; Vasilev CA, 2009, J CHILD PSYCHOL PSYC, V50, P1357, DOI 10.1111/j.1469-7610.2009.02172.x; Wang MJ, 2011, J ADULT DEV, V18, P95, DOI 10.1007/s10804-010-9114-7; WARNER RM, 1987, J NONVERBAL BEHAV, V11, P57, DOI 10.1007/BF00990958; Weinberg M K, 1998, Pediatrics, V102, P1298; Weinberg MK, 2008, INFANT MENT HEALTH J, V29, P472, DOI 10.1002/imhj.20193; Weinberg MK, 1996, CHILD DEV, V67, P905, DOI 10.2307/1131869; WEINBERG MK, 1994, CHILD DEV, V65, P1503, DOI 10.2307/1131514; Werner K, 2010, TXB EMOTION REGULATI, P13, DOI DOI 10.1016/J.CPR.2016.10.005; Wittchen H.-U., 1997, SKID STRUKTURIERTES; Yale ME, 2003, DEV PSYCHOL, V39, P815, DOI 10.1037/0012-1649.39.5.815; Zanarini MC, 2001, COMPR PSYCHIAT, V42, P369, DOI 10.1053/comp.2001.24556	109	15	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144417	10.1371/journal.pone.0144417	http://dx.doi.org/10.1371/journal.pone.0144417			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26657941	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900045
J	Muraoka, Y; Tsujikawa, A; Takahashi, A; Iida, Y; Murakami, T; Ooto, S; Suzuma, K; Uji, A; Yoshimura, N				Muraoka, Yuki; Tsujikawa, Akitaka; Takahashi, Ayako; Iida, Yuto; Murakami, Tomoaki; Ooto, Sotaro; Suzuma, Kiyoshi; Uji, Akihito; Yoshimura, Nagahisa			Foveal Damage Due to Subfoveal Hemorrhage Associated with Branch Retinal Vein Occlusion	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; MACULAR EDEMA; SUBRETINAL HEMORRHAGE; SUBMACULAR HEMORRHAGE; NATURAL-HISTORY; VISUAL-ACUITY; DEGENERATION; RANIBIZUMAB; DETACHMENT; MANAGEMENT	To investigate the functional and morphologic prognoses of eyes with subfoveal hemorrhage from acute branch retinal vein occlusion (BRVO), and to examine the effect of intravitreal ranibizumab injection (IVR) on these prognoses, we assessed 81 eyes with acute BRVO, of which 38 did not receive IVR [IVR(-) group], and 43 were treated with IVR [IVR(+) group] for macular edema. The foveal morphologic changes were examined via optical coherence tomography (OCT). At initial examination, 63 eyes exhibited subfoveal hemorrhage. At final examination, the defect lengths in the foveal external limiting membrane (ELM) and ellipsoid lines in these eyes were longer, and final VA was significantly poorer, compared with eyes without subfoveal hemorrhage. In comparisons between the final measurements in eyes with subfoveal hemorrhage in the IVR(-) and IVR(+) groups, while there were no differences in initial ocular conditions, final VA was significantly better in the IVR(+) group. The defects in the ELM and ellipsoid lines in the IVR(+) group were shorter than those of the IVR(-) group (p = 0.002 in both). Final VA was correlated with the defect lengths of foveal ELM and ellipsoid lines in both the IVR(-) and IVR(+) groups (both p < 0.001). In addition, the defect lengths of foveal ELM and ellipsoid lines were closely correlated with the duration of subfoveal hemorrhage (both p < 0.001). BRVO-associated subfoveal hemorrhage caused damage to the foveal photoreceptors, and visual dysfunction. However, IVR improved these prognoses, by accelerating the absorption of the subfoveal hemorrhage.	[Muraoka, Yuki; Takahashi, Ayako; Iida, Yuto; Murakami, Tomoaki; Ooto, Sotaro; Suzuma, Kiyoshi; Uji, Akihito; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan; [Tsujikawa, Akitaka] Kagawa Univ, Fac Med, Dept Ophthalmol, Takamatsu, Kagawa 760, Japan	Kyoto University; Kagawa University	Muraoka, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan.	muraoka@kuhp.kyoto-u.ac.jp		Tsujikawa, Akitaka/0000-0003-0779-7799	Japan Society for the Promotion of Science (JSPS), Tokyo, Japan [21592256]; Japan National Society for the Prevention of Blindness, Tokyo, Japan; Novartis Pharma K.K., Tokyo, Japan; Innovative Techno-Hub for Integrated Medical Bio-Imaging of the Project for Developing Innovation Systems; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Japan Society for the Promotion of Science (JSPS), Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan National Society for the Prevention of Blindness, Tokyo, Japan(Japan National Society for the Prevention of Blindness); Novartis Pharma K.K., Tokyo, Japan; Innovative Techno-Hub for Integrated Medical Bio-Imaging of the Project for Developing Innovation Systems; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by the Japan Society for the Promotion of Science (JSPS), Tokyo, Japan (Grant-in-Aid for Scientific Research, no. 21592256), the Japan National Society for the Prevention of Blindness, Tokyo, Japan, Novartis Pharma K.K., Tokyo, Japan, the Innovative Techno-Hub for Integrated Medical Bio-Imaging of the Project for Developing Innovation Systems, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery RL, 1996, RETINA-J RET VIT DIS, V16, P183, DOI 10.1097/00006982-199616030-00001; Berrocal MH, 1996, AM J OPHTHALMOL, V122, P486, DOI 10.1016/S0002-9394(14)72107-5; Brown DM, 2011, OPHTHALMOLOGY, V118, P1594, DOI 10.1016/j.ophtha.2011.02.022; Campochiaro PA, 2014, OPHTHALMOLOGY, V121, P209, DOI 10.1016/j.ophtha.2013.08.038; Campochiaro PA, 2012, OPHTHALMOLOGICA, V227, P30, DOI 10.1159/000337157; Chang W, 2014, AM J OPHTHALMOL, V157, P1250, DOI 10.1016/j.ajo.2014.02.007; FINKELSTEIN D, 1992, ARCH OPHTHALMOL-CHIC, V110, P1427, DOI 10.1001/archopht.1992.01080220089028; FRANGIEH GT, 1982, ARCH OPHTHALMOL-CHIC, V100, P1132; GLATT H, 1982, AM J OPHTHALMOL, V94, P762, DOI 10.1016/0002-9394(82)90301-4; Green WR, 1996, OPHTHALMIC PATHOLOGY, V2, P733; Hayreh SS, 2014, PROG RETIN EYE RES, V41, P1, DOI 10.1016/j.preteyeres.2014.04.001; Hayreh SS, 2014, JAMA OPHTHALMOL, V132, P13, DOI 10.1001/jamaophthalmol.2013.5515; Heier JS, 2012, OPHTHALMOLOGY, V119, P802, DOI 10.1016/j.ophtha.2011.12.005; Humayun M, 1998, AM J OPHTHALMOL, V126, P358, DOI 10.1016/S0002-9394(98)00090-7; Kurashige Y, 2012, RETINA-J RET VIT DIS, V32, P792, DOI 10.1097/IAE.0b013e3182278b98; Lerche RC, 2001, OPHTHALMIC SURG LAS, V32, P272; Murakami T, 2012, RETINA-J RET VIT DIS, V32, P1853, DOI 10.1097/IAE.0b013e31824b824c; Muraoka Y, 2013, JPN J OPHTHALMOL, V57, P275, DOI 10.1007/s10384-013-0236-x; Notomi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053338; Ohashi H, 2004, OPHTHALMOLOGY, V111, P2050, DOI 10.1016/j.ophtha.2004.04.031; Ota M, 2007, BRIT J OPHTHALMOL, V91, P1644, DOI 10.1136/bjo.2007.118497; Rao H., 2014, CURR EYE RES, P1; Scupola A, 1999, OPHTHALMOLOGICA, V213, P97, DOI 10.1159/000027400; SHILLING JS, 1984, BRIT J OPHTHALMOL, V68, P196, DOI 10.1136/bjo.68.3.196; Spaide RF, 2003, RETINA-J RET VIT DIS, V23, P343, DOI 10.1097/00006982-200306000-00009; TOTH CA, 1992, AM J OPHTHALMOL, V113, P175, DOI 10.1016/S0002-9394(14)71530-2; TOTH CA, 1991, ARCH OPHTHALMOL-CHIC, V109, P723, DOI 10.1001/archopht.1991.01080050139046; Tsujikawa A, 2010, AM J OPHTHALMOL, V149, P291, DOI 10.1016/j.ajo.2009.09.007; Ueda-Arakawa N, 2012, JPN J OPHTHALMOL, V56, P589, DOI 10.1007/s10384-012-0191-y; Zhao XR, 2009, STROKE, V40, pS92, DOI 10.1161/STROKEAHA.108.533158	30	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144894	10.1371/journal.pone.0144894	http://dx.doi.org/10.1371/journal.pone.0144894			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26661582	Green Submitted, gold, Green Published			2022-12-27	WOS:000366715900139
J	Pettit, AP; Kipen, H; Laumbach, R; Ohman-Strickland, P; Kelly-McNeill, K; Cepeda, C; Fan, ZH; Amorosa, L; Lubitz, S; Schneider, S; Gow, A				Pettit, Ashley P.; Kipen, Howard; Laumbach, Robert; Ohman-Strickland, Pamela; Kelly-McNeill, Kathleen; Cepeda, Clarimel; Fan, Zhi-Hua; Amorosa, Louis; Lubitz, Sara; Schneider, Stephen; Gow, Andrew			Disrupted Nitric Oxide Metabolism from Type II Diabetes and Acute Exposure to Particulate Air Pollution	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; DIESEL EXHAUST; OXIDATIVE STRESS; ENDOTHELIAL FUNCTION; VASCULAR FUNCTION; ULTRAFINE PARTICLES; TRAFFIC PARTICLES; REACTIVE OXYGEN; INHALATION; INFLAMMATION	Type II diabetes is an established cause of vascular impairment. Particulate air pollution is known to exacerbate cardiovascular and respiratory conditions, particularly in susceptible populations. This study set out to determine the impact of exposure to traffic pollution, with and without particle filtration, on vascular endothelial function in Type II diabetes. Endothelial production of nitric oxide (NO) has previously been linked to vascular health. Reactive hyperemia induces a significant increase in plasma nitrite, the proximal metabolite of NO, in healthy subjects, while diabetics have a lower and more variable level of response. Twenty type II diabetics and 20 controls (ages 46-70 years) were taken on a 1.5hr roadway traffic air pollution exposure as passengers. We analyzed plasma nitrite, as a measure of vascular function, using forearm ischemia to elicit a reactive hyperemic response before and after exposure to one ride with and one without filtration of the particle components of pollution. Control subjects displayed a significant increase in plasma nitrite levels during reactive hyperemia. This response was no longer present following exposure to traffic air pollution, but did not vary with whether or not the particle phase was filtered out. Diabetics did not display an increase in nitrite levels following reactive hyperemia. This response was not altered following pollution exposure. These data suggest that components of acute traffic pollution exposure diminish vascular reactivity in non-diabetic individuals. It also confirms that type II diabetics have a preexisting diminished ability to appropriately respond to a vascular challenge, and that traffic pollution exposure does not cause a further measureable acute change in plasma nitrite levels in Type II diabetics.	[Pettit, Ashley P.] Rutgers State Univ, Grad Sch Biomed Sci, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; [Kipen, Howard; Laumbach, Robert; Fan, Zhi-Hua; Amorosa, Louis; Lubitz, Sara; Schneider, Stephen] Rutgers State Univ, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; [Kipen, Howard; Laumbach, Robert; Kelly-McNeill, Kathleen; Cepeda, Clarimel; Fan, Zhi-Hua; Gow, Andrew] Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA; [Ohman-Strickland, Pamela] Rutgers State Univ, Sch Publ Hlth, Piscataway, NJ 08854 USA; [Amorosa, Louis; Lubitz, Sara; Schneider, Stephen] Robert Wood Johnson Univ Hosp, New Brunswick, NJ 08901 USA; [Gow, Andrew] Rutgers State Univ, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Gow, A (corresponding author), Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA.	gow@rci.rutgers.edu	Gow, Andrew/AAR-2309-2020; Gow, Andrew/N-8566-2013	Gow, Andrew/0000-0003-0876-5158; Gow, Andrew/0000-0003-0876-5158; Lubitz, Sara/0000-0002-9514-6744; Pettit, Ashley P./0000-0001-5536-3245	National Institute of Environmental Health Sciences; NIEHS Center Grant [P30ES005022]; Center for Environmental Exposures and Disease, NIEHS [P30ES005022]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007148, P30ES005022] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS Center Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Center for Environmental Exposures and Disease, NIEHS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was funded by the National Institute of Environmental Health Sciences sponsored UMDNJ (now Rutgers University) Center for Environmental Exposures and Disease, NIEHS Grant #: P30ES005022. The specific website for this center can be found at http://ceed.rutgers.edu/. AG (principle) and HK were investigators. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by NIEHS Center Grant P30ES005022	Adar SD, 2007, EPIDEMIOLOGY, V18, P95, DOI 10.1097/01.ede.0000249409.81050.46; Allen JD, 2009, NITRIC OXIDE-BIOL CH, V20, P231, DOI 10.1016/j.niox.2009.01.002; Allen JD, 2005, FREE RADICAL BIO MED, V38, P1164, DOI 10.1016/j.freeradbiomed.2004.12.018; Banerjee A, 2009, TOXICOL LETT, V187, P187, DOI 10.1016/j.toxlet.2009.02.022; Barath S, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-19; Brook RD, 2002, CIRCULATION, V105, P1534, DOI 10.1161/01.CIR.0000013838.94747.64; BUSSE R, 1993, EUR HEART J, V14, P2; Campen M, 2014, INHAL TOXICOL, V26, P353, DOI 10.3109/08958378.2014.897776; Canani LH, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-54; Cines DB, 1998, BLOOD, V91, P3527; Cooper ME, 2001, AM J HYPERTENS, V14, P475, DOI 10.1016/S0895-7061(00)01323-6; Cozzi E, 2006, AM J PHYSIOL-HEART C, V291, pH894, DOI 10.1152/ajpheart.01362.2005; DeMeyer GRY, 1997, PROG CARDIOVASC DIS, V39, P325, DOI 10.1016/S0033-0620(97)80031-X; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Haller H, 1997, DRUGS, V53, P1, DOI 10.2165/00003495-199700531-00003; Hoffmann B, 2007, CIRCULATION, V116, P489, DOI 10.1161/CIRCULATIONAHA.107.693622; Hu SS, 2012, ATMOS ENVIRON, V51, P311, DOI 10.1016/j.atmosenv.2011.12.055; Huang W, 2012, AM J RESP CRIT CARE, V186, P1150, DOI 10.1164/rccm.201205-0850OC; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; IKEDA M, 1995, JPN J PHARMACOL, V68, P183, DOI 10.1254/jjp.68.183; James PE, 2004, CIRC RES, V94, P976, DOI 10.1161/01.RES.0000122044.21787.01; Kadirvelu A, 2002, MED PROGR, P4; Kelm M, 1999, CARDIOVASC RES, V41, P765, DOI 10.1016/S0008-6363(98)00259-4; Kipen HM, 2011, ENVIRON HEALTH PERSP, V119, P658, DOI 10.1289/ehp.1002784; Langrish JP, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004309; Langrish JP, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-8; Laumbach RJ, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0045-5; Laumbach RJ, 2012, J ALLERGY CLIN IMMUN, V129, P3, DOI 10.1016/j.jaci.2011.11.021; Laumbach RJ, 2010, J OCCUP ENVIRON MED, V52, P324, DOI 10.1097/JOM.0b013e3181d241fa; Lefrandt JD, 2010, CURR DIABETES REV, V6, P348, DOI 10.2174/157339910793499128; Lucking AJ, 2008, EUR HEART J, V29, P3043, DOI 10.1093/eurheartj/ehn464; Manzella D, 2005, CLIN SCI, V108, P93, DOI 10.1042/CS20040223; McCreanor J, 2007, NEW ENGL J MED, V357, P2348, DOI 10.1056/NEJMoa071535; Miller MR, 2012, FUTUR CARDIOL, V8, P577, DOI [10.2217/fca.12.43, 10.2217/FCA.12.43]; Miller MR, 2009, ENVIRON HEALTH PERSP, V117, P611, DOI 10.1289/ehp.0800235; Mills NL, 2011, EUR HEART J, V32, P2660, DOI 10.1093/eurheartj/ehr195; Mills NL, 2009, NAT CLIN PRACT CARD, V6, P36, DOI 10.1038/ncpcardio1399; Mills NL, 2005, CIRCULATION, V112, P3930, DOI 10.1161/CIRCULATIONAHA.105.588962; Mombouli JV, 1997, DRUGS, V54, P12, DOI 10.2165/00003495-199700545-00004; Ness J, 1999, CORONARY ARTERY DIS, V10, P343, DOI 10.1097/00019501-199907000-00012; Nordenhall C, 2000, EUR RESPIR J, V15, P1046, DOI 10.1034/j.1399-3003.2000.01512.x; O'Neill MS, 2005, CIRCULATION, V111, P2913, DOI 10.1161/CIRCULATIONAHA.104.517110; Peretz A, 2008, ENVIRON HEALTH PERSP, V116, P937, DOI 10.1289/ehp.11027; Peters A, 2004, NEW ENGL J MED, V351, P1721, DOI 10.1056/NEJMoa040203; Pourazar J, 2005, AM J PHYSIOL-LUNG C, V289, pL724, DOI 10.1152/ajplung.00055.2005; Rassaf T, 2006, FREE RADICAL BIO MED, V41, P295, DOI 10.1016/j.freeradbiomed.2006.04.006; Rich DQ, 2012, JAMA-J AM MED ASSOC, V307, P2068, DOI 10.1001/jama.2012.3488; Salvi SS, 2000, AM J RESP CRIT CARE, V161, P550, DOI 10.1164/ajrccm.161.2.9905052; Tabit CE, 2010, REV ENDOCR METAB DIS, V11, P61, DOI 10.1007/s11154-010-9134-4; Verma S, 2001, Cardiol Rev, V9, P250, DOI 10.1097/00045415-200109000-00003; Vesterdal LK, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-33; Wan JX, 2007, INHAL TOXICOL, V19, P177, DOI 10.1080/08958370701496145; Xu XH, 2010, ARTERIOSCL THROM VAS, V30, P2518, DOI 10.1161/ATVBAHA.110.215350; Ying ZK, 2009, TOXICOL SCI, V111, P80, DOI 10.1093/toxsci/kfp004; Ying ZK, 2009, AM J PHYSIOL-HEART C, V296, pH1540, DOI 10.1152/ajpheart.01270.2008; Zanobetti A, 2014, ENVIRON HEALTH PERSP, V122, P242, DOI 10.1289/ehp.1206136; Zhao HW, 2009, J TOXICOL ENV HEAL A, V72, P560, DOI 10.1080/15287390802706330; Zhu YF, 2008, J AIR WASTE MANAGE, V58, P424, DOI 10.3155/1047-3289.58.3.424; Zhu YF, 2007, ENVIRON SCI TECHNOL, V41, P2138, DOI 10.1021/es0618797; Zuurbier M, 2010, ENVIRON HEALTH PERSP, V118, P783, DOI 10.1289/ehp.0901622	61	6	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144250	10.1371/journal.pone.0144250	http://dx.doi.org/10.1371/journal.pone.0144250			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656561	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900035
J	Ruhl, H; Berens, C; Winterhagen, A; Muller, J; Oldenburg, J; Potzsch, B				Ruehl, Heiko; Berens, Christina; Winterhagen, Anna; Mueller, Jens; Oldenburg, Johannes; Poetzsch, Bernd			Label-Free Kinetic Studies of Hemostasis-Related Biomarkers Including D-Dimer Using Autologous Serum Transfusion	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; ANTITHROMBIN-III COMPLEXES; LINKED-IMMUNOSORBENT-ASSAY; PROTHROMBIN FRAGMENT 1+2; IN-VIVO BEHAVIOR; ACTIVATION MARKERS; HUMAN-FIBRINOGEN; MYOCARDIAL-INFARCTION; ANTI-THROMBIN; PCR ASSAY	The objective of this study was to evaluate the elimination kinetics of hemostasis-related biomarkers including the prothrombin activation fragment F1+2, thrombin-antithrombin complex (TAT), plasmin-alpha(2)-antiplasmin complex (PAP), and D-dimer in humans. Autologous serum was used as a biomarker source and infused into 15 healthy volunteers. Serum was prepared from whole blood in the presence of recombinant tissue-type plasminogen activator (final concentration 20 mu g/mL) to induce plasmin generation required for PAP and D-dimer formation. Serum transfusions (50 mL/30 min) were well tolerated by all subjects. Endogenous thrombin formation was not induced by serum infusions as measured using a highly sensitive oligonucleotide-based enzyme capture assay. Median peak levels (x-fold increase over baseline) of F1+ 2, TAT, PAP, and D-dimer of 3.7 nmol/L (28.9), 393 ng/mL (189.6), 3,829 ng/mL (7.0), and 13.4 mg/L (34.2) were achieved at the end of serum infusions. During a 48 h lasting follow-up period all biomarkers showed elimination kinetics of a two-compartment model. Median (interquartile range) terminal half-lives were 1.9 (1.3-3.6) h for F1+ 2, 0.7 (0.7-2.6) h for TAT, and 10.8 (8.8-11.4) h for PAP. With 15.8 (13.1-23.1) h the D-dimer half-life was about twice as long as previously estimated from radiolabeling studies in animals and small numbers of human subjects. The serum approach presented here allows label-free and simultaneous analysis of the elimination kinetics of various hemostasis-related biomarkers. Based on these data changes in biomarker levels could more precisely used to estimate the activity level of the hemostatic system.	[Ruehl, Heiko; Berens, Christina; Winterhagen, Anna; Mueller, Jens; Oldenburg, Johannes; Poetzsch, Bernd] Univ Hosp Bonn, Inst Expt Hematol & Transfus Med, Bonn, Germany	University of Bonn	Ruhl, H (corresponding author), Univ Hosp Bonn, Inst Expt Hematol & Transfus Med, Bonn, Germany.	heiko.ruehl@ukb.uni-bonn.de	Rühl, Heiko/AAI-3377-2021; Oldenburg, Johannes/ABB-7817-2020; Müller, Jens/A-8264-2012; Rühl, Heiko/E-3226-2017	Rühl, Heiko/0000-0003-0672-2453; Müller, Jens/0000-0001-7713-9631; Oldenburg, Johannes/0000-0002-1585-4100				Adam SS, 2009, BLOOD, V113, P2878, DOI 10.1182/blood-2008-06-165845; Agarwal S, 2000, AM J GASTROENTEROL, V95, P3218; ARDAILLOU N, 1975, THROMB DIATH HAEMOST, V34, P326; ARDAILLOU N, 1980, THROMB HAEMOSTASIS, V44, P146; ARONSON DL, 1977, J CLIN INVEST, V60, P1410, DOI 10.1172/JCI108902; BAUER KA, 1992, BLOOD, V79, P2039; BAUER KA, 1985, J CLIN INVEST, V76, P826, DOI 10.1172/JCI112040; Bozic M, 2002, THROMB RES, V108, P107, DOI 10.1016/S0049-3848(03)00007-0; CATANZARO A, 1974, J LAB CLIN MED, V83, P458; Chandler WL, 2003, BLOOD, V101, P4355, DOI 10.1182/blood-2002-08-2400; Chandler WL, 2000, HAEMOSTASIS, V30, P204; Christensen U, 1996, FEBS LETT, V387, P58, DOI 10.1016/0014-5793(96)00429-2; COLLEN D, 1979, BLOOD, V53, P313; CONWAY EM, 1987, J CLIN INVEST, V80, P1535, DOI 10.1172/JCI113239; Cushman M, 1999, ARTERIOSCL THROM VAS, V19, P493, DOI 10.1161/01.ATV.19.3.493; Di Nisio M, 2007, J THROMB HAEMOST, V5, P296, DOI 10.1111/j.1538-7836.2007.02328.x; ESTIVALS M, 1991, BRIT J HAEMATOL, V78, P421, DOI 10.1111/j.1365-2141.1991.tb04458.x; Franks JJ, 1984, PATHOPHYSIOLOGY PLAS, P265; Gorog DA, 2010, J AM COLL CARDIOL, V55, P2701, DOI 10.1016/j.jacc.2009.11.095; GREENBERG CS, 1987, AM J CLIN PATHOL, V87, P94, DOI 10.1093/ajcp/87.1.94; HAYNE OA, 1973, AM J PATHOL, V71, P219; HOLVOET P, 1985, J BIOL CHEM, V260, P2106; HOLVOET P, 1986, THROMB HAEMOSTASIS, V56, P124; KNOT EAR, 1986, THROMB HAEMOSTASIS, V55, P375; Korte W, 2001, CLIN CHEM LAB MED, V39, P627, DOI 10.1515/CCLM.2001.101; LEONARD B, 1983, THROMB RES, V30, P165, DOI 10.1016/0049-3848(83)90239-6; Manco-Johnson MJ, 2009, J THROMB HAEMOST, V7, P2064, DOI 10.1111/j.1538-7836.2009.03633.x; MCFARLANE AS, 1963, J CLIN INVEST, V42, P346, DOI 10.1172/JCI104721; Mueller J, 2005, CLIN CHEM LAB MED, V43, P827, DOI 10.1515/CCLM.2005.139; Muller J, 2007, J VIROL METHODS, V142, P127, DOI 10.1016/j.jviromet.2007.01.013; Muller J, 2011, ANGEW CHEM INT EDIT, V50, P6075, DOI 10.1002/anie.201007032; Ostermann H, 2007, THROMB HAEMOSTASIS, V98, P790, DOI 10.1160/TH07-05-0367; Ota S, 2008, CLIN APPL THROMB-HEM, V14, P279, DOI 10.1177/1076029607309176; PELZER H, 1988, THROMB HAEMOSTASIS, V59, P101; PIZZO SV, 1982, BIOCHIM BIOPHYS ACTA, V718, P177, DOI 10.1016/0304-4165(82)90217-3; Poon MC, 2006, HAEMOPHILIA, V12, P61, DOI 10.1111/j.1365-2516.2006.01336.x; Quinsey NS, 2004, INT J BIOCHEM CELL B, V36, P386, DOI 10.1016/S1357-2725(03)00244-9; Reeve E B, 1981, Ann N Y Acad Sci, V370, P680, DOI 10.1111/j.1749-6632.1981.tb29775.x; Ruhl H, 2012, THROMB HAEMOSTASIS, V107, P848, DOI 10.1160/TH11-10-0719; SHIFMAN MA, 1982, J BIOL CHEM, V257, P3243; Siller-Matula JM, 2011, THROMB HAEMOSTASIS, V106, P1020, DOI 10.1160/TH10-11-0711; Sprenger K B, 1987, J Clin Apher, V3, P185, DOI 10.1002/jca.2920030313; TEITEL JM, 1982, BLOOD, V59, P1086; Tripodi A, 1996, CLIN CHEM, V42, P664; Wells MJ, 1997, J BIOL CHEM, V272, P28574, DOI 10.1074/jbc.272.45.28574; Wells MJ, 1998, J BIOL CHEM, V273, P23440, DOI 10.1074/jbc.273.36.23440; Wells PS, 2006, JAMA-J AM MED ASSOC, V295, P199, DOI 10.1001/jama.295.2.199; WESSLER S, 1955, J CLIN INVEST, V34, P647, DOI 10.1172/JCI103114; Whitton C, 2005, THROMB HAEMOSTASIS, V93, P261, DOI 10.1160/TH04-10-0677; ZELLER FP, 1988, DRUG INTEL CLIN PHAR, V22, P6, DOI 10.1177/106002808802200101; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007	51	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145012	10.1371/journal.pone.0145012	http://dx.doi.org/10.1371/journal.pone.0145012			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658824	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900167
J	Byrnes, J; Carrington, M; Chan, YK; Pollicino, C; Dubrowin, N; Stewart, S; Scuffham, PA				Byrnes, Joshua; Carrington, Melinda; Chan, Yih-Kai; Pollicino, Christine; Dubrowin, Natalie; Stewart, Simon; Scuffham, Paul A.			Cost-Effectiveness of a Home Based Intervention for Secondary Prevention of Readmission with Chronic Heart Disease	PLOS ONE			English	Article							RANDOMIZED-TRIAL; HEALTH-CARE; MULTICENTER; MANAGEMENT; RISK; IMPACT; YOUNG	The aim of this study is to consider the cost-effectiveness of a nurse-led, home-based intervention (HBI) in cardiac patients with private health insurance compared to usual post-discharge care. A within trial analysis of the Young @ Heart multicentre, randomized controlled trial along with a micro-simulation decision analytical model was conducted to estimate the incremental costs and quality adjusted life years associated with the home based intervention compared to usual care. For the micro-simulation model, future costs, from the perspective of the funder, and effects are estimated over a twenty-year time horizon. An Incremental Cost-Effectiveness Ratio, along with Incremental Net Monetary Benefit, is evaluated using a willingness to pay threshold of $50,000 per quality adjusted life year. Sub-group analyses are conducted for men and women across three age groups separately. Costs and benefits that arise in the future are discounted at five percent per annum. Overall, home based intervention for secondary prevention in patients with chronic heart disease identified in the Australian private health care sector is not cost-effective. The estimated within trial incremental net monetary benefit is -$3,116 [95% CI: -11,145, $4,914]; indicating that the costs outweigh the benefits. However, for males and in particular males aged 75 years and above, home based intervention indicated a potential to reduce health care costs when compared to usual care (within trial: -$10,416 [95% CI: -$26,745, $5,913]; modelled analysis: -$1,980 [95% CI: -$22,843, $14,863]). This work provides a crucial impetus for future research to understand for whom disease management programs are likely to benefit most.	[Byrnes, Joshua; Scuffham, Paul A.] Griffith Univ, Ctr Appl Hlth Econ, Meadowbrook, Qld 4131, Australia; [Carrington, Melinda; Chan, Yih-Kai; Stewart, Simon] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic, Australia; [Pollicino, Christine; Dubrowin, Natalie] Bupa Australia, Melbourne, Vic, Australia	Griffith University; Australian Catholic University	Byrnes, J (corresponding author), Griffith Univ, Ctr Appl Hlth Econ, Meadowbrook, Qld 4131, Australia.	j.byrnes@griffith.edu.au	Stewart, Simon/M-3316-2016; Scuffham, Paul/AAS-8084-2021; Byrnes, Josh/AAA-4387-2021; Scuffham, Paul/B-3066-2014	Stewart, Simon/0000-0001-9032-8998; Scuffham, Paul/0000-0001-5931-642X; Scuffham, Paul/0000-0001-5931-642X; Byrnes, Joshua/0000-0001-6562-711X; Chan, Yih-Kai/0000-0003-3836-8145	Bupa Australia	Bupa Australia	The Young@Heart trial was funded by Bupa Australia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antes G, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1432; Armstrong BK, 2007, MED J AUSTRALIA, V187, P485, DOI 10.5694/j.1326-5377.2007.tb01383.x; Australian Institute of Health and Welfare, 2011, CARD DIS AUSTR FACTS; Australian Institute of Health and Welfare, 2014, HLTH EXP AUSTR 2012; Buchmueller TC, 2013, J HEALTH ECON, V32, P757, DOI 10.1016/j.jhealeco.2013.05.001; Byrnes JM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-114; Carrington MJ, 2013, EUR J CARDIOVASC NUR, V12, P337, DOI 10.1177/1474515112451702; Carrington MJ, 2013, CIRC-CARDIOVASC QUAL, V6, P379, DOI 10.1161/CIRCOUTCOMES.111.000006; Chan YK, 2012, INT J CARDIOL, V154, P52, DOI 10.1016/j.ijcard.2010.08.071; Clark AM, 2010, EUR J CARDIOV PREV R, V17, P261, DOI 10.1097/HJR.0b013e32833090ef; Clark RA, 2012, CIRCULATION, V125, P2006, DOI 10.1161/CIRCULATIONAHA.111.083394; Kotseva K, 2009, EUR J CARDIOV PREV R, V16, P121, DOI 10.1097/HJR.0b013e3283294b1d; Maru S, 2015, EUR J CARDIOVASC NUR, V14, P26, DOI 10.1177/1474515114536093; National Heart Foundation of Australia The Cardiac Society of Australia and New Zealand, 2011, GUID PREV DET MAN CH; Private Health Insurance Administration Council, 2013, PRIV INS PEOPL HOSP; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; StataCorp, 2013, STAT STAT SOFTW REL; Stewart S, 2015, EUR J HEART FAIL, V17, P620, DOI 10.1002/ejhf.272; Stewart S, 2015, LANCET, V385, P775, DOI 10.1016/S0140-6736(14)61992-9; Stewart S, 2014, INT J CARDIOL, V174, P600, DOI 10.1016/j.ijcard.2014.04.164; TreeAge Software, 2014, TREEAGE PRO 2014 R2; Viney R, 2011, VALUE HEALTH, V14, P928, DOI 10.1016/j.jval.2011.04.009; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williams JR, 2008, B WORLD HEALTH ORGAN, V86, P650, DOI 10.2471/BLT.08.050955	24	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144545	10.1371/journal.pone.0144545	http://dx.doi.org/10.1371/journal.pone.0144545			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657844	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903500038
J	Zhao, YS; Li, MF				Zhao, Yunsong; Li, Mengfei			Iterative Beam Hardening Correction for Multi-Material Objects	PLOS ONE			English	Article							ARTIFACTS; ART	In this paper, we propose an iterative beam hardening correction method that is applicable for the case with multiple materials. By assuming that the materials composing scanned object are known and that they are distinguishable by their linear attenuation coefficients at some given energy, the beam hardening correction problem is converted into a nonlinear system problem, which is then solved iteratively. The reconstructed image is the distribution of linear attenuation coefficient of the scanned object at a given energy. So there are no beam hardening artifacts in the image theoretically. The proposed iterative scheme combines an accurate polychromatic forward projection with a linearized backprojection. Both forward projection and backprojection have high degree of parallelism, and are suitable for acceleration on parallel systems. Numerical experiments with both simulated data and real data verifies the validity of the proposed method. The beam hardening artifacts are alleviated effectively. In addition, the proposed method has a good tolerance on the error of the estimated x-ray spectrum.	[Zhao, Yunsong; Li, Mengfei] Capital Normal Univ, Sch Math Sci, Beijing, Peoples R China; [Zhao, Yunsong; Li, Mengfei] Beijing Higher Inst Engn Res Ctr Testing & Imagin, Beijing, Peoples R China; [Zhao, Yunsong] Shenzhen ZhongKe TianYue Technol Co Ltd, Shenzhen, Peoples R China; [Zhao, Yunsong] Shenzhen Inst Adv Technol, Shenzhen, Peoples R China	Capital Normal University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Zhao, YS (corresponding author), Capital Normal Univ, Sch Math Sci, Beijing, Peoples R China.	zhao_yunsong@cnu.edu.cn			National Natural Science Foundation of China [61127003, 61371195, 61401289]; Shenzhen ZhongKe TianYue Technology Co., Ltd	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen ZhongKe TianYue Technology Co., Ltd	This work was supported in part by the National Natural Science Foundation of China under Grant 61127003, Grant 61371195, and Grant 61401289. Shenzhen ZhongKe TianYue Technology Co., Ltd. provided support in the form of a salary for author YSZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	ALVAREZ RE, 1976, PHYS MED BIOL, V21, P733, DOI 10.1088/0031-9155/21/5/002; ANDERSEN AH, 1984, ULTRASONIC IMAGING, V6, P81, DOI 10.1016/0161-7346(84)90008-7; Brabant L, 2012, NDT&E INT, V51, P68, DOI 10.1016/j.ndteint.2012.07.002; BROOKS RA, 1976, PHYS MED BIOL, V21, P390, DOI 10.1088/0031-9155/21/3/004; De Man B, 2001, IEEE T MED IMAGING, V20, P999, DOI 10.1109/42.959297; Dennis J.E., 1996, NUMERICAL METHODS UN, V16; Hammersberg P, 1998, J Xray Sci Technol, V8, P75; HERMAN GT, 1979, PHYS MED BIOL, V24, P81, DOI 10.1088/0031-9155/24/1/008; Hsieh Jiang, 2009, COMPUTED TOMOGRAPHY; Hubbell J., 1995, TABLES XRAY MASS ATT, DOI 10.18434/T4D01F; JENNINGS RJ, 1988, MED PHYS, V15, P588, DOI 10.1118/1.596210; Kachelriess M, 2006, MED PHYS, V33, P1269, DOI 10.1118/1.2188076; Kak A C, 1988, PRINCIPLES COMPUTERI, V33; Krumm M, 2008, NDT&E INT, V41, P242, DOI 10.1016/j.ndteint.2007.12.001; Long Y, 2014, IEEE T MED IMAGING, V33, P1614, DOI 10.1109/TMI.2014.2320284; Maass C, 2011, MED PHYS, V38, P691, DOI 10.1118/1.3533686; Mendonca P.R., 2010, SPIE MED IMAGING; Niu TY, 2011, MED PHYS, V38, P6027, DOI 10.1118/1.3651619; Sidky EY, 2005, J APPL PHYS, V97, DOI 10.1063/1.1928312; Van Gompel G, 2011, MED PHYS, V38, pS36, DOI 10.1118/1.3577758; Zhao X. F., 2007, PRATACULTURAL SCI, V3, P7; Zhao YS, 2015, IEEE T MED IMAGING, V34, P761, DOI 10.1109/TMI.2014.2373396	22	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144607	10.1371/journal.pone.0144607	http://dx.doi.org/10.1371/journal.pone.0144607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26659554	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903500047
J	Sloot, LH; van den Noort, JC; van der Krogt, MM; Bruijn, SM; Harlaar, J				Sloot, Lizeth H.; van den Noort, Josien C.; van der Krogt, Marjolein M.; Bruijn, Sjoerd M.; Harlaar, Jaap			Can Treadmill Perturbations Evoke Stretch Reflexes in the Calf Muscles?	PLOS ONE			English	Article							SPASTIC GAIT; MOVEMENT-DISORDER; SENSORY FEEDBACK; CEREBRAL-PALSY; SOLEUS MUSCLE; STANCE PHASE; WALKING; CHILDREN; MODULATION; LEG	Disinhibition of reflexes is a problem amongst spastic patients, for it limits a smooth and efficient execution of motor functions during gait. Treadmill belt accelerations may potentially be used to measure reflexes during walking, i.e. by dorsal flexing the ankle and stretching the calf muscles, while decelerations show the modulation of reflexes during a reduction of sensory feedback. The aim of the current study was to examine if belt accelerations and decelerations of different intensities applied during the stance phase of treadmill walking can evoke reflexes in the gastrocnemius, soleus and tibialis anterior in healthy subjects. Muscle electromyography and joint kinematics were measured in 10 subjects. To determine whether stretch reflexes occurred, we assessed modelled musculo-tendon length and stretch velocity, the amount of muscle activity, as well as the incidence of bursts or depressions in muscle activity with their time delays, and co-contraction between agonist and antagonist muscle. Although the effect on the ankle angle was small with 2.8 +/- 1.0 degrees, the perturbations caused clear changes in muscle length and stretch velocity relative to unperturbed walking. Stretched muscles showed an increasing incidence of bursts in muscle activity, which occurred after a reasonable electrophysiological time delay (163-191 ms). Their amplitude was related to the muscle stretch velocity and not related to co-contraction of the antagonist muscle. These effects increased with perturbation intensity. Shortened muscles showed opposite effects, with a depression in muscle activity of the calf muscles. The perturbations only slightly affected the spatio-temporal parameters, indicating that normal walking was retained. Thus, our findings showed that treadmill perturbations can evoke reflexes in the calf muscles and tibialis anterior. This comprehensive study could form the basis for clinical implementation of treadmill perturbations to functionally measure reflexes during treadmill-based clinical gait analysis.	[Sloot, Lizeth H.; van den Noort, Josien C.; van der Krogt, Marjolein M.; Harlaar, Jaap] Vrije Univ Amsterdam Med Ctr, MOVE Res Inst Amsterdam, Dept Rehabil Med, Amsterdam, Netherlands; [Bruijn, Sjoerd M.] Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [Bruijn, Sjoerd M.] Fujian Med Univ, Affiliated Hosp 1, Dept Orthoped, Fuzhou, Fujian, Peoples R China	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; Fujian Medical University	Sloot, LH (corresponding author), Vrije Univ Amsterdam Med Ctr, MOVE Res Inst Amsterdam, Dept Rehabil Med, Amsterdam, Netherlands.	l.sloot@vumc.nl	van den Noort, Josien/ABG-7503-2021; Bruijn, Sjoerd/H-9021-2013	van den Noort, Josien/0000-0002-2305-498X; Bruijn, Sjoerd/0000-0003-0290-2131; van der Krogt, Marjolein/0000-0002-9219-7183; Harlaar, Jaap/0000-0003-2889-271X; van den Noort, Josien/0000-0001-5753-4183	Dutch Technology Foundation (STW) [10733]; VENI grant from the Netherlands Organization for Scientific Research (NWO) [451-12-041]; Phelps Foundation For Spasticity and Fonds NutsOhra	Dutch Technology Foundation (STW)(Technologiestichting STW); VENI grant from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Phelps Foundation For Spasticity and Fonds NutsOhra	LHS was financially supported by the Dutch Technology Foundation (STW #10733), SMB by a VENI grant from the Netherlands Organization for Scientific Research (NWO #451-12-041) and JN by the Phelps Foundation For Spasticity and Fonds NutsOhra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen J. B., 1995, IEEE Transactions on Rehabilitation Engineering, V3, P299, DOI 10.1109/86.481969; ANGEL RW, 1963, ARCH NEUROL-CHICAGO, V8, P591, DOI 10.1001/archneur.1963.00460060021002; Bar-On L, 2014, RES DEV DISABIL, V35, P3354, DOI 10.1016/j.ridd.2014.07.053; Bar-On L, 2014, DEV MED CHILD NEUROL, V56, P932, DOI 10.1111/dmcn.12419; BERGER W, 1984, J PHYSIOL-LONDON, V357, P109, DOI 10.1113/jphysiol.1984.sp015492; BERGER W, 1985, ELECTROEN CLIN NEURO, V61, P385, DOI 10.1016/0013-4694(85)91030-2; BERGER W, 1984, J NEUROL NEUROSUR PS, V47, P1029, DOI 10.1136/jnnp.47.9.1029; Blanchette AK, 2014, J NEUROENG REHABIL, V11; Burne JA, 2005, J NEUROL NEUROSUR PS, V76, P47, DOI 10.1136/jnnp.2003.034785; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Crenna P, 1998, NEUROSCI BIOBEHAV R, V22, P571, DOI 10.1016/S0149-7634(97)00046-8; Cronin NJ, 2009, J PHYSIOL-LONDON, V587, P3375, DOI 10.1113/jphysiol.2008.162610; DELP SL, 1995, COMPUT BIOL MED, V25, P21, DOI 10.1016/0010-4825(95)98882-E; Dietz V, 2007, LANCET NEUROL, V6, P725, DOI 10.1016/S1474-4422(07)70193-X; Doorenbosch CAM, 1995, NEUROSCI LETT, V202, P61, DOI 10.1016/0304-3940(95)12201-X; DUYSENS J, 1990, EXP BRAIN RES, V82, P351; Faist M, 1999, BRAIN, V122, P567, DOI 10.1093/brain/122.3.567; Grey MJ, 2004, CAN J PHYSIOL PHARM, V82, P610, DOI 10.1139/y04-077; Hak L, 2013, J BIOMECH, V46, P905, DOI 10.1016/j.jbiomech.2012.12.017; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hodapp M, 2007, J NEUROPHYSIOL, V98, P3263, DOI 10.1152/jn.00471.2007; HOF AL, 1996, GAIT POSTURE, V4, P222; Lamontagne A, 2001, ARCH PHYS MED REHAB, V82, P1696, DOI 10.1053/apmr.2001.26810; Lance JW., 1980, SPASTICITY DISORDERE, P185; Mazzaro Nazarena, 2007, J Stroke Cerebrovasc Dis, V16, P135, DOI 10.1016/j.jstrokecerebrovasdis.2007.01.003; Nardone A, 2005, CLIN NEUROPHYSIOL, V116, P1370, DOI 10.1016/j.clinph.2005.01.015; NICHOLS TR, 1976, J NEUROPHYSIOL, V39, P119, DOI 10.1152/jn.1976.39.1.119; Nielsen J B, 2002, J Electromyogr Kinesiol, V12, P213, DOI 10.1016/S1050-6411(02)00023-8; Noel M, 2008, IEEE T NEUR SYS REH, V16, P390, DOI 10.1109/TNSRE.2008.926714; Pijnappels M, 2006, J ELECTROMYOGR KINES, V16, P137, DOI 10.1016/j.jelekin.2005.06.011; Roerdink M, 2008, J BIOMECH, V41, P2628, DOI 10.1016/j.jbiomech.2008.06.023; Rouse EJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024286; Sinitksi EH, 2012, J BIOMECH, V45, P2084, DOI 10.1016/j.jbiomech.2012.05.039; Sinkjaer T, 2000, J PHYSIOL-LONDON, V523, P817, DOI 10.1111/j.1469-7793.2000.00817.x; Sinkjaer T, 1996, J NEUROL, V243, P566, DOI 10.1007/BF00900943; Sinkjaer T, 1999, CLIN NEUROPHYSIOL, V110, P951, DOI 10.1016/S1388-2457(99)00034-6; Sloot LH, 2014, J BIOMECH, V47, P1510, DOI 10.1016/j.jbiomech.2014.02.001; Stevenson AJT, 2015, J NEUROPHYSIOL, V113, P3151, DOI 10.1152/jn.00794.2014; Van Campenhout A, 2014, GAIT POSTURE, V39, P953, DOI 10.1016/j.gaitpost.2013.12.024; van den Noort JC, 2010, ARCH PHYS MED REHAB, V91, P615, DOI 10.1016/j.apmr.2009.12.022; van der Krogt MM, 2010, J REHABIL MED, V42, P656, DOI 10.2340/16501977-0579; van Doornik J, 2007, IEEE T BIO-MED ENG, V54, P1696, DOI 10.1109/TBME.2007.894949; Willerslev-Olsen M, 2014, J NEUROPHYSIOL, V111, P746, DOI 10.1152/jn.00372.2013; YANG JF, 1991, EXP BRAIN RES, V87, P679; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	45	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144815	10.1371/journal.pone.0144815	http://dx.doi.org/10.1371/journal.pone.0144815			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669665	Green Published, gold, Green Submitted			2022-12-27	WOS:000366719300024
J	Vladimirskiy, B; Urbanczik, R; Senn, W				Vladimirskiy, Boris; Urbanczik, Robert; Senn, Walter			Hierarchical Novelty-Familiarity Representation in the Visual System by Modular Predictive Coding	PLOS ONE			English	Article							CLASSICAL RECEPTIVE-FIELD; MODELS; V1; SUPPRESSION; SELECTIVITY; COMPETITION; EMERGENCE; ALGORITHM; CORTEX; CELLS	Predictive coding has been previously introduced as a hierarchical coding framework for the visual system. At each level, activity predicted by the higher level is dynamically subtracted from the input, while the difference in activity continuously propagates further. Here we introduce modular predictive coding as a feedforward hierarchy of prediction modules without back-projections from higher to lower levels. Within each level, recurrent dynamics optimally segregates the input into novelty and familiarity components. Although the anatomical feedforward connectivity passes through the novelty-representing neurons, it is nevertheless the familiarity information which is propagated to higher levels. This modularity results in a twofold advantage compared to the original predictive coding scheme: the familiarity-novelty representation forms quickly, and at each level the full representational power is exploited for an optimized readout. As we show, natural images are successfully compressed and can be reconstructed by the familiarity neurons at each level. Missing information on different spatial scales is identified by novelty neurons and complements the familiarity representation. Furthermore, by virtue of the recurrent connectivity within each level, non-classical receptive field properties still emerge. Hence, modular predictive coding is a biologically realistic metaphor for the visual system that dynamically extracts novelty at various scales while propagating the familiarity information.	[Vladimirskiy, Boris; Urbanczik, Robert; Senn, Walter] Univ Bern, Dept Physiol, CH-3012 Bern, Switzerland	University of Bern	Senn, W (corresponding author), Univ Bern, Dept Physiol, Buhlpl 5, CH-3012 Bern, Switzerland.	Senn@cns.physio.unibe.ch	Senn, Walter/D-6308-2014	Senn, Walter/0000-0003-3622-0497	Swiss National Science Foundation (SNSF) [31003A-133094, 310030L-156863]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Science Foundation (SNSF, personal grants No. 31003A-133094 and 310030L-156863 of WS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Swiss National Science Foundation (SNSF, personal grants No. 31003A-133094 and 310030L-156863 of WS).	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Angelucci A, 2003, J PHYSIOL-PARIS, V97, P141, DOI 10.1016/j.jphysparis.2003.09.001; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; BOLZ J, 1986, NATURE, V320, P362, DOI 10.1038/320362a0; Cadieu C, 2007, J NEUROPHYSIOL, V98, P1733, DOI 10.1152/jn.01265.2006; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Chavane F, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00004; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Cohen MR, 2011, NEURON, V70, P1192, DOI 10.1016/j.neuron.2011.04.029; DAYAN P, 1995, NEURAL COMPUT, V7, P889, DOI 10.1162/neco.1995.7.5.889; Durand S, 2007, VISUAL NEUROSCI, V24, P679, DOI 10.1017/S0952523807070563; Foldiak P., 1989, IJCNN: International Joint Conference on Neural Networks (Cat. No.89CH2765-6), P401, DOI 10.1109/IJCNN.1989.118615; Fournier J, 2011, NAT NEUROSCI, V14, P1053, DOI 10.1038/nn.2861; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 2009, PHILOS T R SOC B, V364, P1211, DOI 10.1098/rstb.2008.0300; Friston KJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000211; Fyfe C, 1997, NEURAL PROCESS LETT, V6, P33, DOI 10.1023/A:1009606706736; Garrido MI, 2009, NEUROIMAGE, V48, P269, DOI 10.1016/j.neuroimage.2009.06.034; Haykin S. O., 2008, NEURAL NETWORKS LEAR; HINTON GE, 1995, SCIENCE, V268, P1158, DOI 10.1126/science.7761831; Hoyer PO, 2003, NEUROCOMPUTING, V52-4, P547, DOI 10.1016/S0925-2312(02)00782-8; Johnson RR, 1997, J NEUROSCI, V17, P7129; Karklin Y, 2009, NATURE, V457, P83, DOI 10.1038/nature07481; Koch C, 1999, NAT NEUROSCI, V2, P9, DOI 10.1038/4511; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Lee H., 2006, ADV NEURAL INFORM PR, P801, DOI DOI 10.1371/J0URNAL.P0NE.0006098; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Lieder F, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003288; MILLER KD, 1994, J NEUROSCI, V14, P409; Nyberg L, 2000, P NATL ACAD SCI USA, V97, P11120, DOI 10.1073/pnas.97.20.11120; Ohzawa I, 1997, J NEUROPHYSIOL, V77, P2879, DOI 10.1152/jn.1997.77.6.2879; Oja E, 1997, NEUROCOMPUTING, V17, P25, DOI 10.1016/S0925-2312(97)00045-3; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Plumbley MD, 2004, IEEE T NEURAL NETWOR, V15, P66, DOI 10.1109/TNN.2003.820672; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Spratling MW, 2010, J NEUROSCI, V30, P3531, DOI 10.1523/JNEUROSCI.4911-09.2010; Spratling MW, 2008, FRONT COMPUT NEUROSC, V2, P1, DOI 10.3389/neuro.10.004.2008; Stanford TR, 2010, NAT NEUROSCI, V13, P379, DOI 10.1038/nn.2485; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Thorpe SJ, 2009, NEURON, V62, P168, DOI 10.1016/j.neuron.2009.04.012; Urbanczik R, 2014, NEURON, V81, P521, DOI 10.1016/j.neuron.2013.11.030; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; Victor JD, 2009, J NEUROPHYSIOL, V102, P3414, DOI 10.1152/jn.00086.2009; Yeh CI, 2009, P NATL ACAD SCI USA, V106, P14652, DOI 10.1073/pnas.0907406106	51	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144636	10.1371/journal.pone.0144636	http://dx.doi.org/10.1371/journal.pone.0144636			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670700	Green Submitted, gold, Green Published			2022-12-27	WOS:000366719300013
J	Zhang, JY; Braun, MY				Zhang, Jinyu; Braun, Michel Y.			Protoporphyrin Treatment Modulates Susceptibility to Experimental Autoimmune Encephalomyelitis in miR-155-Deficient Mice	PLOS ONE			English	Article							HEME OXYGENASE-1; INFLAMMATION; INHIBITION	We previously identified heme oxygenase 1 (HO-1) as a specific target of miR-155, and inhibition of HO-1 activity restored the capacity of miR-155(-/-)CD4(+) T cells to promote antigendriven inflammation after adoptive transfer in antigen-expressing recipients. Protoporphyrins are molecules recognized for their modulatory effect on HO-1 expression and function. In the present study, we investigated the effect of protoporphyrin treatment on the development of autoimmunity in miR-155-deficient mice. MiR-155-mediated control of HO-1 expression in promoting T cell-driven chronic autoimmunity was confirmed since HO-1 inhibition restored susceptibility to experimental autoimmune encephalomyelitis (EAE) in miR-155deficient mice. The increased severity of the disease was accompanied by an enhanced T cell infiltration into the brain. Taken together, these results underline the importance of miR155-mediated control of HO-1 expression in regulating the function of chronically-stimulated T cells in EAE.	[Zhang, Jinyu] Third Mil Med Univ, Coll Pharm, Natl Engn Res Ctr Immunol Prod, Dept Microbiol & Biochem Pharm, Chongqing, Peoples R China; [Braun, Michel Y.] Univ Libre Bruxelles, Fac Med, Inst Med Immunol, Gosselies, Belgium	Army Medical University; Universite Libre de Bruxelles	Zhang, JY (corresponding author), Third Mil Med Univ, Coll Pharm, Natl Engn Res Ctr Immunol Prod, Dept Microbiol & Biochem Pharm, Chongqing, Peoples R China.	zhangjinyu_syd@163.com			Fonds de la Recherche Scientifique (FRS-FNRS) [3.4590.11F]; Interuniversity Attraction Poles (IAP) [P7/39]; China Scholarship Council (CSC); Alice and David Van Buuren Foundation; Rose and Jean Hoguet Foundation; Institute for Medical Immunology	Fonds de la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles (IAP)(Belgian Federal Science Policy Office); China Scholarship Council (CSC)(China Scholarship Council); Alice and David Van Buuren Foundation; Rose and Jean Hoguet Foundation; Institute for Medical Immunology	This work was supported by Fonds de la Recherche Scientifique (FRS-FNRS; grant number: 3.4590.11F), an Interuniversity Attraction Poles (IAP) (Contract P7/39), the Alice and David Van Buuren Foundation and The Rose and Jean Hoguet Foundation. JZ was supported by The China Scholarship Council (CSC) and an intramural PhD fellowship of the Institute for Medical Immunology.; This work was supported by Fonds de la Recherche Scientifique (FRS-FNRS; grant number: 3.4590.11F), an Interuniversity Attraction Poles (IAP) (Contract P7/39), the Alice and David Van Buuren Foundation and The Rose and Jean Hoguet Foundation. J.Z. was supported by The China Scholarship Council (CSC) and an intramural PhD fellowship of the Institute for Medical Immunology.	Banerjee A, 2010, EUR J IMMUNOL, V40, P225, DOI 10.1002/eji.200939381; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; Dutra FF, 2014, P NATL ACAD SCI USA, V111, pE4110, DOI 10.1073/pnas.1405023111; Hegazi RAF, 2005, J EXP MED, V202, P1703, DOI 10.1084/jem.20051047; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Louafi F, 2010, J BIOL CHEM, V285, P41328, DOI 10.1074/jbc.M110.146852; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Murugaiyan G, 2011, J IMMUNOL, V187, P2213, DOI 10.4049/jimmunol.1003952; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Pae HO, 2004, J IMMUNOL, V172, P4744, DOI 10.4049/jimmunol.172.8.4744; Pino PA, 2011, JOVE-J VIS EXP, DOI 10.3791/2348; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Zhang J, 2015, INTERNATIONAL CONFERENCE ON ADVANCES IN MANAGEMENT SCIENCE AND ENGINEERING (AMSE 2015), P155; Zhang JY, 2014, INT IMMUNOL, V26, P407, DOI 10.1093/intimm/dxu043	22	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145237	10.1371/journal.pone.0145237	http://dx.doi.org/10.1371/journal.pone.0145237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670809	Green Published, Green Submitted, gold			2022-12-27	WOS:000366719300054
J	Draberova, L; Paulenda, T; Halova, I; Potuckova, L; Bugajev, V; Bambouskova, M; Tumova, M; Draber, P				Draberova, Lubica; Paulenda, Tomas; Halova, Ivana; Potuckova, Lucie; Bugajev, Viktor; Bambouskova, Monika; Tumova, Magda; Draber, Petr			Ethanol Inhibits High-Affinity Immunoglobulin E Receptor (Fc epsilon RI) Signaling in Mast Cells by Suppressing the Function of Fc epsilon RI-Cholesterol Signalosome	PLOS ONE			English	Article							KAPPA-B ACTIVATION; LIPID RAFTS; NADPH OXIDASE; ALVEOLAR MACROPHAGES; MEMBRANE CHOLESTEROL; NEGATIVE REGULATION; GENERAL-ANESTHESIA; OXIDATIVE STRESS; PHOSPHOLIPASE-D; CHAIN ALCOHOLS	Ethanol has multiple effects on biochemical events in a variety of cell types, including the high-affinity immunoglobulin E receptor (Fc epsilon RI) signaling in antigen-activated mast cells. However, the underlying molecular mechanism remains unknown. To get better understanding of the effect of ethanol on Fc epsilon RI-mediated signaling we examined the effect of short-term treatment with non-toxic concentrations of ethanol on Fc epsilon RI signaling events in mouse bone marrow-derived mast cells. We found that 15 min exposure to ethanol inhibited antigen-induced degranulation, calcium mobilization, expression of proinflammatory cytokine genes (tumor necrosis factor-alpha, interleukin-6, and interleukin-13), and formation of reactive oxygen species in a dose-dependent manner. Removal of cellular cholesterol with methyl-beta-cyclodextrin had a similar effect and potentiated some of the inhibitory effects of ethanol. In contrast, exposure of the cells to cholesterol-saturated methyl-beta-cyclodextrin abolished in part the inhibitory effect of ethanol on calcium response and production of reactive oxygen species, supporting lipid-centric theories of ethanol action on the earliest stages of mast cell signaling. Further studies showed that exposure to ethanol and/or removal of cholesterol inhibited early Fc epsilon RI activation events, including tyrosine phosphorylation of the Fc epsilon RI beta and gamma subunits, SYK kinases, LAT adaptor protein, phospholipase C gamma, STAT5, and AKT and internalization of aggregated Fc epsilon RI. Interestingly, ethanol alone, and particularly in combination with methyl-beta-cyclodextrin, enhanced phosphorylation of negative regulatory tyrosine 507 of LYN kinase. Finally, we found that ethanol reduced passive cutaneous anaphylactic reaction in mice, suggesting that ethanol also inhibits Fc epsilon RI signaling under in vivo conditions. The combined data indicate that ethanol interferes with early antigen-induced signaling events in mast cells by suppressing the function of Fc epsilon RI-cholesterol signalosomes at the plasma membrane.	[Draberova, Lubica; Paulenda, Tomas; Halova, Ivana; Potuckova, Lucie; Bugajev, Viktor; Bambouskova, Monika; Tumova, Magda; Draber, Petr] Acad Sci Czech Republ, Inst Mol Genet, Lab Signal Transduct, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Draberova, L (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Lab Signal Transduct, Prague, Czech Republic.	draberovalu@img.cas.cz; draberpe@img.cas.cz	Paulenda, Tomas/S-1837-2017; Halova, Ivana/G-3512-2014; Bugajev, Viktor/G-3507-2014; Draber, Petr/E-1119-2018	Paulenda, Tomas/0000-0003-1323-4829; Halova, Ivana/0000-0003-3078-7986; Draber, Petr/0000-0002-3986-2025	Grant Agency of the Czech Republic [P302/12/G101]; COST-CZ-MAST from the Ministry of Education Youth and Sports of the Czech Republic [LD12073]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); COST-CZ-MAST from the Ministry of Education Youth and Sports of the Czech Republic	This work was supported by Project P302/12/G101 from the Grant Agency of the Czech Republic and Project LD12073 COST-CZ-MAST from the Ministry of Education Youth and Sports of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGASRA O, 1987, IMMUNOLOGY, V61, P63; Boe DM, 2001, J INFECT DIS, V184, P1134, DOI 10.1086/323661; Borghese CM, 2006, J PHARMACOL EXP THER, V316, P1360, DOI 10.1124/jpet.105.092452; BRAYTON RG, 1970, NEW ENGL J MED, V282, P123, DOI 10.1056/NEJM197001152820303; BRODIE C, 1994, CLIN IMMUNOL IMMUNOP, V70, P129, DOI 10.1006/clin.1994.1020; Bugajev V, 2010, FEBS LETT, V584, P4949, DOI 10.1016/j.febslet.2010.08.045; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen SY, 1996, ALCOHOL, V13, P589; CHIN JH, 1977, MOL PHARMACOL, V13, P435; Christian AE, 1997, J LIPID RES, V38, P2264; Cleyrat C, 2013, J CELL SCI, V126, P4913, DOI 10.1242/jcs.128876; Dai Q, 2006, ALCOHOL CLIN EXP RES, V30, P1436, DOI 10.1111/j.1530-0277.2006.00172.x; Dalton SR, 2003, LIVER INT, V23, P484, DOI 10.1111/j.1478-3231.2003.00874.x; Daragan VA, 2000, BIOPHYS J, V79, P406, DOI 10.1016/S0006-3495(00)76302-8; Das J, 2009, BIOCHEM J, V421, P405, DOI 10.1042/BJ20082271; DIVIRGILIO F, 1988, J IMMUNOL, V140, P915; Dolganiuc A, 2006, ALCOHOL CLIN EXP RES, V30, P76, DOI 10.1111/j.1530-0277.2006.00003.x; Draberova L, 1996, IMMUNOLOGY, V87, P141; Draberova L, 2014, MOL CELL BIOL, V34, P4285, DOI 10.1128/MCB.00983-14; Fattakhova G, 2006, TRAFFIC, V7, P673, DOI 10.1111/j.1600-0854.2006.00423.x; FRANKS NP, 1986, P NATL ACAD SCI USA, V83, P5116, DOI 10.1073/pnas.83.14.5116; FRANKS NP, 1982, NATURE, V300, P487, DOI 10.1038/300487a0; Furlow M, 2011, BIORHEOLOGY, V48, P49, DOI 10.3233/BIR-2011-0583; Ghare S, 2011, ALCOHOL CLIN EXP RES, V35, P1435, DOI 10.1111/j.1530-0277.2011.01479.x; GLASSMAN AB, 1985, ARCH PATHOL LAB MED, V109, P540; GLUCKMAN SJ, 1977, ARCH INTERN MED, V137, P1539, DOI 10.1001/archinte.137.11.1539; GLUCKMAN SJ, 1978, BLOOD, V52, P551; Gray E, 2013, BIOPHYS J, V105, P2751, DOI 10.1016/j.bpj.2013.11.005; Grutzkau A, 2004, CYTOM PART A, V61A, P62, DOI 10.1002/cyto.a.20068; Happel Kyle I, 2005, Proc Am Thorac Soc, V2, P428, DOI 10.1513/pats.200507-065JS; Heneberg P, 2010, J BIOL CHEM, V285, P12787, DOI 10.1074/jbc.M109.052555; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Karavitis J, 2012, CELL IMMUNOL, V274, P61, DOI 10.1016/j.cellimm.2012.02.002; Kennedy RH, 2012, J TOXICOL ENV HEAL A, V75, P1451, DOI 10.1080/15287394.2012.722184; Kim MJ, 2014, MOL PHARMACOL, V86, P284, DOI 10.1124/mol.114.093039; Kim MJ, 2013, TOXICOL APPL PHARM, V273, P77, DOI 10.1016/j.taap.2013.08.005; Kovarova M, 2001, MOL CELL BIOL, V21, P8318, DOI 10.1128/MCB.21.24.8318-8328.2001; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Kuehn HS, 2008, J IMMUNOL, V181, P7706, DOI 10.4049/jimmunol.181.11.7706; LI TK, 1969, ACTA CHEM SCAND, V23, P892, DOI 10.3891/acta.chem.scand.23-0892; Lisboa FA, 2009, J IMMUNOL, V183, P5104, DOI 10.4049/jimmunol.0802728; Loftsson T, 2002, J PHARM SCI, V91, P2307, DOI 10.1002/jps.10226; Ly HV, 2004, BIOPHYS J, V87, P1013, DOI 10.1529/biophysj.103.034280; Mandrekar P, 1999, INT IMMUNOL, V11, P1781, DOI 10.1093/intimm/11.11.1781; Mandrekar P, 2002, ALCOHOL CLIN EXP RES, V26, P1609, DOI 10.1097/01.ALC.0000036926.46632.57; Methner DNR, 2010, J BIOL CHEM, V285, P10310, DOI 10.1074/jbc.M109.029561; Meyer HH., 1899, ARCH EXP PATH PHARMA, V42, P109, DOI [10.1007/BF01834479, DOI 10.1007/BF01834479]; Meyer KH, 1937, T FARADAY SOC, V33, P1062, DOI 10.1039/tf9373301062; Nishijo J, 2003, CHEM PHARM BULL, V51, P1253, DOI 10.1248/cpb.51.1253; Nourissat P, 2008, HEPATOLOGY, V47, P59, DOI 10.1002/hep.21958; Olsen RW, 2014, ALCOHOL CLIN EXP RES, V38, P595, DOI 10.1111/acer.12283; Pascual-Lucas M, 2014, J NEUROCHEM, V129, P448, DOI 10.1111/jnc.12639; Patel M, 1996, ALCOHOL CLIN EXP RES, V20, P275, DOI 10.1111/j.1530-0277.1996.tb01640.x; Peoples RW, 1996, ANNU REV PHARMACOL, V36, P185, DOI 10.1146/annurev.pa.36.040196.001153; Polley A, 2013, CHEM PHYS LIPIDS, V166, P1, DOI 10.1016/j.chemphyslip.2012.11.005; Pruett SB, 2004, J IMMUNOL, V173, P2715, DOI 10.4049/jimmunol.173.4.2715; Ren H, 2012, J BIOL CHEM, V287, P27302, DOI 10.1074/jbc.M111.338921; RIMLAND D, 1980, J LAB CLIN MED, V95, P918; RIVERA J, 1988, MOL IMMUNOL, V25, P647, DOI 10.1016/0161-5890(88)90100-9; Ronald KM, 2001, J BIOL CHEM, V276, P44729, DOI 10.1074/jbc.M102800200; ROWE ES, 1985, BIOCHIM BIOPHYS ACTA, V813, P321, DOI 10.1016/0005-2736(85)90248-2; RUDOLPH AK, 1981, EUR J IMMUNOL, V11, P527, DOI 10.1002/eji.1830110617; Salous AK, 2009, BRIT J PHARMACOL, V158, P1395, DOI 10.1111/j.1476-5381.2009.00397.x; SEEMAN P, 1972, PHARMACOL REV, V24, P583; Setiawan I, 2014, J PHYS CHEM B, V118, P537, DOI 10.1021/jp410305m; Surviladze Z, 2001, EUR J IMMUNOL, V31, P1, DOI 10.1002/1521-4141(200101)31:1<1::AID-IMMU1>3.0.CO;2-W; Swindle EJ, 2007, J IMMUNOL, V179, P7059, DOI 10.4049/jimmunol.179.10.7059; Szabo G, 1999, J CLIN IMMUNOL, V19, P67, DOI 10.1023/A:1020518703050; Szabo G, 2007, J IMMUNOL, V178, P1243, DOI 10.4049/jimmunol.178.3.1243; Tobin SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087225; Toivari M, 2000, LIFE SCI, V67, P2795, DOI 10.1016/S0024-3205(00)00863-8; Tolar P, 2001, FOLIA BIOL-PRAGUE, V47, P215; Volna P, 2004, J EXP MED, V200, P1001, DOI 10.1084/jem.20041213; Yeligar SM, 2012, J IMMUNOL, V188, P3648, DOI 10.4049/jimmunol.1101278; Zhou JS, 2007, J EXP MED, V204, P2797, DOI 10.1084/jem.20071391; Zhu MH, 2015, J IMMUNOL, V195, P4492, DOI 10.4049/jimmunol.1500665; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	77	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144596	10.1371/journal.pone.0144596	http://dx.doi.org/10.1371/journal.pone.0144596			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658290	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900069
J	Munoz-Barrera, M; Aguilar, I; Monje-Casas, F				Munoz-Barrera, Marta; Aguilar, Isabel; Monje-Casas, Fernando			Dispensability of the SAC Depends on the Time Window Required by Aurora B to Ensure Chromosome Biorientation	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; PROTEIN-KINASE; MITOTIC SPINDLE; BUDDING YEAST; KINETOCHORE; COMPLEX; DISRUPTION; MICE; MISSEGREGATION; ORIENTATION	Aurora B and the spindle assembly checkpoint (SAC) collaborate to ensure the proper biorientation of chromosomes during mitosis. However, lack of Aurora B activity and inactivation of the SAC have a very different impact on chromosome segregation. This is most evident in Saccharomyces cerevisiae, since in this organism the lack of Aurora B is lethal and leads to severe aneuploidy problems, while the SAC is dispensable under normal growth conditions and mutants in this checkpoint do not show evident chromosome segregation defects. We demonstrate that the efficient repair of incorrect chromosome attachments by Aurora B during the initial stages of spindle assembly in budding yeast determines the lack of chromosome segregation defects in SAC mutants, and propose that the differential time window that Aurora B kinase requires to establish chromosome biorientation is the key factor that determines why some cells are more dependent on a functional SAC than others.	[Munoz-Barrera, Marta; Monje-Casas, Fernando] CSIC, CABIMER, E-41080 Seville, Spain; [Aguilar, Isabel; Monje-Casas, Fernando] Univ Seville, Dept Genet, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); University of Sevilla	Monje-Casas, F (corresponding author), CSIC, CABIMER, E-41080 Seville, Spain.	fernando.monje@cabimer.es	Monje-Casas, Fernando/M-3062-2014	Monje-Casas, Fernando/0000-0002-3587-2373	Junta de Andalucia [CVI-5806]; Spanish Ministry of Economy and Competitiveness [BFU2013-43718-P]; European Union (FEDER); V Research Programme (VPPI) of the University of Seville; JAE-Predoc fellowship from the Spanish National Research Council (CSIC)	Junta de Andalucia(Junta de Andalucia); Spanish Ministry of Economy and Competitiveness(Spanish Government); European Union (FEDER)(European Commission); V Research Programme (VPPI) of the University of Seville; JAE-Predoc fellowship from the Spanish National Research Council (CSIC)	This work was supported by Junta de Andalucia (CVI-5806), the Spanish Ministry of Economy and Competitiveness (BFU2013-43718-P) and the European Union (FEDER). F.M.-C was recipient of a contract from the V Research Programme (VPPI) of the University of Seville. M.M.-B. was recipient of a JAE-Predoc fellowship from the Spanish National Research Council (CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu J, 1999, J CELL BIOL, V146, P13, DOI 10.1083/jcb.146.1.13; Burds AA, 2005, P NATL ACAD SCI USA, V102, P11296, DOI 10.1073/pnas.0505053102; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Cutts SM, 1999, HUM MOL GENET, V8, P1145, DOI 10.1093/hmg/8.7.1145; D'Aquino KE, 2005, MOL CELL, V19, P223, DOI 10.1016/j.molcel.2005.06.005; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Farruggio DC, 1999, P NATL ACAD SCI USA, V96, P7306, DOI 10.1073/pnas.96.13.7306; Fernandez-Miranda G, 2011, DEVELOPMENT, V138, P2661, DOI 10.1242/dev.066381; Foijer F, 2013, P NATL ACAD SCI USA, V110, P2928, DOI 10.1073/pnas.1217388110; Hogan B, 1994, MANIPULATING MOUSE E; Jin FZ, 2013, P NATL ACAD SCI USA, V110, P21036, DOI 10.1073/pnas.1307595111; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Kitagawa R, 1999, NAT CELL BIOL, V1, P514, DOI 10.1038/70309; Kotwaliwale CV, 2007, DEV CELL, V13, P433, DOI 10.1016/j.devcel.2007.07.003; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Mirchenko L, 2010, CURR BIOL, V20, P1396, DOI 10.1016/j.cub.2010.06.023; Monje-Casas F, 2007, CELL, V128, P477, DOI 10.1016/j.cell.2006.12.040; Munoz-Barrera M, 2014, P NATL ACAD SCI USA, V111, pE3996, DOI 10.1073/pnas.1408017111; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nezi LG, 2009, CURR OPIN CELL BIOL, V21, P785, DOI 10.1016/j.ceb.2009.09.007; Nguyen HG, 2005, MOL CELL BIOL, V25, P4977, DOI 10.1128/MCB.25.12.4977-4992.2005; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Ramaswamy V, 2003, MOL CELL BIOL, V23, P9136, DOI 10.1128/MCB.23.24.9136-9149.2003; Ross KE, 2003, GENETICS, V165, P489; Snow MHL, 1977, J EMBRYOL EXP MORPH, V42, P293; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Valerio-Santiago M, 2011, J CELL BIOL, V192, P599, DOI 10.1083/jcb.201007044; Vazquez-Novelle MD, 2010, CURR BIOL, V20, P1402, DOI 10.1016/j.cub.2010.06.036; Welburn JPI, 2008, DEV CELL, V15, P645, DOI 10.1016/j.devcel.2008.10.011; Wong J, 2007, MOL BIOL CELL, V18, P3800, DOI 10.1091/mbc.E07-06-0536; Yamanaka Y, 2008, MECH DEVELOP, V125, P441, DOI 10.1016/j.mod.2008.01.011	35	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144972	10.1371/journal.pone.0144972	http://dx.doi.org/10.1371/journal.pone.0144972			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26661752	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900160
J	Somaiah, C; Kumar, A; Mawrie, D; Sharma, A; Patil, SD; Bhattacharyya, J; Swaminathan, R; Jaganathan, BG				Somaiah, Chinnapaka; Kumar, Atul; Mawrie, Darilang; Sharma, Amit; Patil, Suraj Dasharath; Bhattacharyya, Jina; Swaminathan, Rajaram; Jaganathan, Bithiah Grace			Collagen Promotes Higher Adhesion, Survival and Proliferation of Mesenchymal Stem Cells	PLOS ONE			English	Article							OSTEOGENIC DIFFERENTIATION; EXTRACELLULAR-MATRIX; BONE-MARROW; FIBRONECTIN; MIGRATION; CYTOSKELETAL; VITRONECTIN; INHIBITION; SCAFFOLD; SHAPE	Mesenchymal stem cells (MSC) can differentiate into several cell types and are desirable candidates for cell therapy and tissue engineering. However, due to poor cell survival, proliferation and differentiation in the patient, the therapy outcomes have not been satisfactory. Although several studies have been done to understand the conditions that promote proliferation, differentiation and migration of MSC in vitro and in vivo, still there is no clear understanding on the effect of non-cellular bio molecules. Of the many factors that influence the cell behavior, the immediate cell microenvironment plays a major role. In this context, we studied the effect of extracellular matrix (ECM) proteins in controlling cell survival, proliferation, migration and directed MSC differentiation. We found that collagen promoted cell proliferation, cell survival under stress and promoted high cell adhesion to the cell culture surface. Increased osteogenic differentiation accompanied by high active RHOA (Ras homology gene family member A) levels was exhibited by MSC cultured on collagen. In conclusion, our study shows that collagen will be a suitable matrix for large scale production of MSC with high survival rate and to obtain high osteogenic differentiation for therapy.	[Somaiah, Chinnapaka; Kumar, Atul; Mawrie, Darilang; Sharma, Amit; Patil, Suraj Dasharath; Jaganathan, Bithiah Grace] Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Stem Cell Biol Lab, Gauhati, Assam, India; [Swaminathan, Rajaram] Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Gauhati, Assam, India; [Bhattacharyya, Jina] Gauhati Med Coll Hosp, Dept Hematol, Gauhati, Assam, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Gauhati Medical College & Hospital	Jaganathan, BG (corresponding author), Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Stem Cell Biol Lab, Gauhati, Assam, India.	bithiahgj@iitg.ernet.in	Swaminathan, Rajaram/I-2250-2019	Swaminathan, Rajaram/0000-0003-1294-8379; Kumar, Atul/0000-0001-9682-5725	Ministry of Human Resource Development, Govt. of India.; Department of Science and Technology (DST), Govt. of India [SR/FT/LS-97/2009]; Department of Biotechnology (DBT), Govt. of India under RGYI (Rapid Grant for Young Investigator) scheme [BT/PRI/5091/GBD/27/310/2011]	Ministry of Human Resource Development, Govt. of India.; Department of Science and Technology (DST), Govt. of India(Department of Science & Technology (India)); Department of Biotechnology (DBT), Govt. of India under RGYI (Rapid Grant for Young Investigator) scheme	CS, AK, DM are supported by fellowship from Ministry of Human Resource Development, Govt. of India. This work was supported by funds from Department of Science and Technology SR/FT/LS-97/2009 (DST), Govt. of India and Department of Biotechnology (DBT), Govt. of India under RGYI (Rapid Grant for Young Investigator) scheme BT/PRI/5091/GBD/27/310/2011 to BGJ (http://www.dbtindia.nic.in/). TIRF measurement was performed in facility supported by DBT to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CS, AK, DM are supported by fellowship from Ministry of Human Resource Development, Govt. of India. This work was supported by funds from Department of Science and Technology SR/FT/LS-97/2009 (DST), Govt. of India and Department of Biotechnology (DBT), Govt. of India under RGYI (Rapid Grant for Young Investigator) scheme BT/PRI/5091/GBD/27/310/2011 to BGJ (http://www.dbtindia.nic.in/). TIRF measurement was performed in facility supported by DBT to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Bernhardt A, 2008, J MATER SCI-MATER M, V19, P269, DOI 10.1007/s10856-006-0059-0; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chazotte Brad, 2011, Cold Spring Harb Protoc, V2011, P990, DOI 10.1101/pdb.prot5648; Chen Shaoliang, 2006, J Invasive Cardiol, V18, P552; CLYMAN RI, 1990, CIRC RES, V67, P175, DOI 10.1161/01.RES.67.1.175; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Deng JH, 2006, MOL CELL BIOL, V26, P1077, DOI 10.1128/MCB.26.3.1077-1086.2006; Donzelli E, 2007, ARCH ORAL BIOL, V52, P64, DOI 10.1016/j.archoralbio.2006.07.007; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Hayakawa Kimihide, 2012, Commun Integr Biol, V5, P572, DOI 10.4161/cib.21891; Huang Y, 2013, J NANOMATER, V2013, DOI 10.1155/2013/343909; Jaganathan BG, 2010, LEUKEMIA, V24, P1791, DOI 10.1038/leu.2010.164; Jaganathan BG, 2007, STEM CELLS, V25, P1966, DOI 10.1634/stemcells.2007-0167; Kang BJ, 2013, J BIOMAT SCI-POLYM E, V24, P1233, DOI 10.1080/09205063.2012.745717; Kang YY, 2017, J TISSUE ENG REGEN M, V11, P1929, DOI 10.1002/term.2090; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kim HJ, 2012, J BIOMED MATER RES B, V100B, P1645, DOI 10.1002/jbm.b.32733; Li BJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02425; Li J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/786475; Lim SM, 2010, EXP CELL RES, V316, P2833, DOI 10.1016/j.yexcr.2010.06.010; Linhares-Lacerda L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S5-S2; Linsley C, 2013, TISSUE ENG PT A, V19, P1416, DOI [10.1089/ten.tea.2012.0523, 10.1089/ten.TEA.2012.0523]; Mathieu PS, 2012, TISSUE ENG PART B-RE, V18, P436, DOI [10.1089/ten.teb.2012.0014, 10.1089/ten.TEB.2012.0014]; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Ogura Naomi, 2004, J Oral Sci, V46, P207, DOI 10.2334/josnusd.46.207; Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106; Park JH, 2012, NEUROSURGERY, V70, P1238, DOI 10.1227/NEU.0b013e31824387f9; Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Rodrigo R, 2013, DIS MARKERS, V2013, P773, DOI 10.1155/2013/974358; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Ruster B, 2005, STEM CELLS DEV, V14, P231, DOI 10.1089/scd.2005.14.231; Sahin AO, 2012, CELL ADHES MIGR, V6, P39, DOI 10.4161/cam.18975; Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Schneider RK, 2010, BIOMATERIALS, V31, P467, DOI 10.1016/j.biomaterials.2009.09.059; Sonowal H, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-71; Thibault MM, 2007, STEM CELLS DEV, V16, P489, DOI 10.1089/scd.2006.0100; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Trappmann B, 2013, CURR OPIN BIOTECH, V24, P948, DOI 10.1016/j.copbio.2013.03.020; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/nmat3339, 10.1038/NMAT3339]; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Wang JL, 2012, J BIOMED MATER RES A, V100A, P2929, DOI 10.1002/jbm.a.34236; Xu JF, 2012, INT J MOL SCI, V13, P17104, DOI 10.3390/ijms131217104; Zhang WH, 2015, J BIOMATER TISS ENG, V5, P257, DOI 10.1166/jbt.2015.1314	49	143	147	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145068	10.1371/journal.pone.0145068	http://dx.doi.org/10.1371/journal.pone.0145068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26661657	gold, Green Submitted, Green Published			2022-12-27	WOS:000366715900179
J	Vir, P; Arrigucci, R; Lakehal, K; Davidow, AL; Pine, R; Tyagi, S; Bushkin, Y; Lardizabal, A; Gennaro, ML				Vir, Pooja; Arrigucci, Riccardo; Lakehal, Karim; Davidow, Amy L.; Pine, Richard; Tyagi, Sanjay; Bushkin, Yuri; Lardizabal, Alfred; Gennaro, Maria Laura			Single-Cell Cytokine Gene Expression in Peripheral Blood Cells Correlates with Latent Tuberculosis Status	PLOS ONE			English	Article							CD4(+) T-CELLS; FLOW-CYTOMETRY; MYCOBACTERIUM-TUBERCULOSIS; CD154 EXPRESSION; MESSENGER-RNA; ACTIVATION; INFECTION; RESPONSES; IMMUNODIAGNOSIS; OPTIMIZATION	RNA flow cytometry (FISH-Flow) achieves high-throughput measurement of single-cell gene expression by combining in-situ nucleic acid hybridization with flow cytometry. We tested whether antigen-specific T-cell responses detected by FISH-Flow correlated with latent tuberculosis infection (LTBI), a condition affecting one-third of the world population. Peripheral-blood mononuclear cells from donors, identified as positive or negative for LTBI by current medical practice, were stimulated ex vivo with mycobacterial antigen. IFNG and IL2 mRNA production was assayed by FISH-Flow. Concurrently, immunophenotypes of the cytokine mRNA-positive cells were characterized by conventional, antibody-based staining of cell-surface markers. An association was found between donor LTBI status and antigen-specific induction of IFNG and IL2 transcripts. Induction of these cytokine genes, which was detected by FISH-Flow in a quarter the time required to see release of the corresponding proteins by ELISA, occurred primarily in activated CD4+ T cells via T-cell receptor engagement. Moreover, NK cells contributed to IFNG gene induction. These results show that antigen-driven induction of T-cell cytokine mRNA is a measurable single-cell parameter of the host responses associated with latent tuberculosis. FISH-Flow read-outs contribute a multiscale dimension to the immunophenotyping afforded by antibody-based flow cytometry. Multi-scale, single-cell analyses may satisfy the need to determine disease stage and therapy response for tuberculosis and other infectious pathologies.	[Vir, Pooja; Arrigucci, Riccardo; Lakehal, Karim; Pine, Richard; Tyagi, Sanjay; Bushkin, Yuri; Gennaro, Maria Laura] Rutgers State Univ, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07102 USA; [Davidow, Amy L.] Rutgers State Univ, New Jersey Med Sch, Sch Publ Hlth, Dept Biostat, Newark, NJ 07102 USA; [Lardizabal, Alfred] Rutgers State Univ, New Jersey Med Sch, Global TB Inst, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Gennaro, ML (corresponding author), Rutgers State Univ, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07102 USA.	marila.gennaro@rutgers.edu	Vir, Pooja/ABI-3569-2020	Vir, Pooja/0000-0002-6816-5122; Davidow, Amy/0000-0002-3660-7627; Gennaro, Maria Laura/0000-0003-4801-3567; Tyagi, Sanjay/0000-0001-7303-5827	National Institutes of Health [AI-104615, AI-106036]; Rutgers Office of Research and Economic Development - New Jersey Health Foundation; NIH [AI104615, AI106036]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106036, R01AI104615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers Office of Research and Economic Development - New Jersey Health Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants [AI-104615 and AI-106036] and by an intramural grant from the Rutgers Office of Research and Economic Development, sponsored by the New Jersey Health Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Samia Ahmed for recruiting study subjects and maintaining the clinical database; Salvatore Marras for helping with HPLC purification of FISH probes; Sukhwinder Singh and the Rutgers NJMS Flow Cytometry and Immunology Core Laboratory for advice and technical support on flow cytometry; George Yap for discussing mechanistic aspects of the assay; and Janani Ravi for helping with preparation of the figures. We also thank Karl Drlica, Patricia Fitzgerald-Bocarsly, and George Yap for critical comments on the manuscript. This work was funded by NIH grants AI104615 and AI106036.	Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bhattacharyya S, 1999, INFECT IMMUN, V67, P5597, DOI 10.1128/IAI.67.11.5597-5603.1999; Bihl F, 2010, J IMMUNOL, V185, P2174, DOI 10.4049/jimmunol.1001486; Bushkin Y, 2015, J IMMUNOL, V194, P836, DOI 10.4049/jimmunol.1401515; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Caruso A, 1997, CYTOMETRY, V27, P71, DOI 10.1002/(SICI)1097-0320(19970101)27:1<71::AID-CYTO9>3.0.CO;2-O; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Chattopadhyay PK, 2006, NAT PROTOC, V1, P1, DOI 10.1038/nprot.2006.1; Chattopadhyay PK, 2012, METHODS, V57, P251, DOI 10.1016/j.ymeth.2012.02.009; Davidson B, 2012, DIAGN CYTOPATHOL, V40, P525, DOI 10.1002/dc.22809; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Fuhrmann S, 2008, CYTOM PART A, V73A, P1100, DOI 10.1002/cyto.a.20614; Hanley MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057002; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hirsch CS, 1997, P NATL ACAD SCI USA, V94, P3926, DOI 10.1073/pnas.94.8.3926; Kindt T.J., 2007, KUBY IMMUNOLOGY; Kunnath-Velayudhan S, 2011, CLIN MICROBIOL REV, V24, P792, DOI 10.1128/CMR.00014-11; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; MAINO VC, 1995, CYTOMETRY, V20, P127, DOI 10.1002/cyto.990200205; Maino VC, 2013, EXPERT REV MOL DIAGN, V13, P511, DOI 10.1586/14737159.2013.811904; McCullagh P, 1989, GEN LINEAR MODELS; Nomura L, 2008, CYTOM PART A, V73A, P984, DOI 10.1002/cyto.a.20602; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pollock KM, 2013, J INFECT DIS, V208, P952, DOI 10.1093/infdis/jit265; Porichis F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6641; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rovina N, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/464039; Sester U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017813; Sewell WA, 2011, PATHOLOGY, V43, P580, DOI 10.1097/PAT.0b013e32834a69ae; Stern JNH, 2009, IMMUNOL RES, V45, P1, DOI 10.1007/s12026-008-8024-2; Virgo PF, 2012, ANN CLIN BIOCHEM, V49, P17, DOI 10.1258/acb.2011.011128; World Health Organization, 2014, GLOB TUB REP; Yang HL, 2012, FEMS IMMUNOL MED MIC, V66, P273, DOI 10.1111/j.1574-695X.2012.01002.x	37	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144904	10.1371/journal.pone.0144904	http://dx.doi.org/10.1371/journal.pone.0144904			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658491	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900143
J	Wu, CS; Sun, YL; Nohr, EA; Olsen, J				Wu, Chun Sen; Sun, Yuelian; Nohr, Ellen Aagaard; Olsen, Jorn			Trends in All-Cause Mortality across Gestational Age in Days for Children Born at Term	PLOS ONE			English	Article							LATE-PRETERM; MORBIDITY; PERIOD; BIRTHS; RISK	Background Term birth is a gestational age from 259 days to 293 days. However trends in mortality according to gestational ages in days have not yet been described in this time period. Methods and Findings Based on nation-wide registries, we conducted a population-based cohort study among all children born at term in Denmark from 1997 to 2004 to estimate differences in mortality across gestational ages in days among singletons born at term. We studied early-neonatal mortality, neonatal mortality, infant mortality, and five-year mortality. Children were followed from birth up to the last day of the defined mortality period or December 31, 2009. A total of 360,375 singletons born between 259 and 293 days of gestation were included in the study. Mortality decreased with increasing gestational age in days and the highest mortality was observed among children born at 37 week of gestation. A similar pattern was observed when analyses were restricted to children born to by mothers without pregnancy complications. Conclusions This study demonstrates heterogeneity in mortality rates even among singletons born at term. The highest mortality was observed among children born 37 weeks of gestation, which call for cautions when inducing labor in term pregnancies just reaching 37 weeks of gestation. The findings support that 37 weeks of gestation should be defined as early term.	[Wu, Chun Sen; Nohr, Ellen Aagaard] Univ Southern Denmark, Inst Clin Res, Res Unit Gynecol & Obstet, Odense, Denmark; [Wu, Chun Sen; Nohr, Ellen Aagaard] Odense Univ Hosp, Dept Gynecol & Obstet, DK-5000 Odense, Denmark; [Wu, Chun Sen; Sun, Yuelian; Olsen, Jorn] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Aarhus University; University of California System; University of California Los Angeles	Wu, CS (corresponding author), Univ Southern Denmark, Inst Clin Res, Res Unit Gynecol & Obstet, Odense, Denmark.	cwu@health.sdu.dk	Sun, Yuelian/AFF-2622-2022	Sun, Yuelian/0000-0002-6905-0503	Danish Medical Research Council [FSS: 12-32232]; European Research Council [ERC-2010-StG-260242-PROGEURO]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission)	Chun Sen Wu is supported by the individual postdoctoral grants from the Danish Medical Research Council (FSS: 12-32232). Access to data was supported by European Research Council (ERC-2010-StG-260242-PROGEURO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 2013, DOCUMENTATION DANISH; [Anonymous], 2013, ICD 10 INT STAT CLAS, V2; Clark SL, 2011, CLIN PERINATOL, V38, P557, DOI 10.1016/j.clp.2011.06.014; Crump C, 2013, EPIDEMIOLOGY, V24, P270, DOI 10.1097/EDE.0b013e318280da0f; Donovan EF, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.01.071; Engle WA, 2011, CLIN PERINATOL, V38, P493, DOI 10.1016/j.clp.2011.06.009; Fang YMV, 2013, J MATERN-FETAL NEO M, V26, P79, DOI 10.3109/14767058.2012.728647; Jorgensen FS, 1999, ACTA OBSTET GYN SCAN, V78, P305, DOI 10.1034/j.1600-0412.1999.780406.x; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kristensen F B, 1992, Int J Technol Assess Health Care, V8 Suppl 1, P25; Kristensen J, 1996, J CLIN EPIDEMIOL, V49, P893, DOI 10.1016/0895-4356(96)00018-2; Moster D, 2010, JAMA-J AM MED ASSOC, V304, P976, DOI 10.1001/jama.2010.1271; Nguyen TH, 1999, ULTRASOUND OBST GYN, V14, P23, DOI 10.1046/j.1469-0705.1999.14010023.x; Nguyen TH, 2000, BRIT J OBSTET GYNAEC, V107, P1122, DOI 10.1111/j.1471-0528.2000.tb11111.x; Reddy UM, 2011, OBSTET GYNECOL, V117, P1279, DOI 10.1097/AOG.0b013e3182179e28; Spong CY, 2013, JAMA-J AM MED ASSOC, V309, P2445, DOI 10.1001/jama.2013.6235; Spong CY, 2011, OBSTET GYNECOL, V118, P323, DOI 10.1097/AOG.0b013e3182255999; Wetta L, 2012, OBSTET GYN CLIN N AM, V39, P89, DOI 10.1016/j.ogc.2011.12.002; Zhang X, 2009, J PEDIATR-US, V154, P358, DOI 10.1016/j.jpeds.2008.09.013	20	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144754	10.1371/journal.pone.0144754	http://dx.doi.org/10.1371/journal.pone.0144754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656842	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900102
J	Jagadeeshan, S; Shah, U; Chakrabarti, D; Singh, RS				Jagadeeshan, Santosh; Shah, Ushma; Chakrabarti, Debarti; Singh, Rama S.			Female Choice or Male Sex Drive? The Advantages of Male Body Size during Mating in Drosophila Melanogaster	PLOS ONE			English	Article							MATE CHOICE; FRUIT-FLIES; SUCCESS; COURTSHIP; EVOLUTION; BEHAVIOR; SELECTION; DIPTERA; FIELD; TIME	The mating success of larger male Drosophila melanogaster in the laboratory and the wild has been traditionally been explained by female choice, even though the reasons are generally hard to reconcile. Female choice can explain this success by virtue of females taking less time to mate with preferred males, but so can the more aggressive or persistent courtships efforts of large males. Since mating is a negotiation between the two sexes, the behaviors of both are likely to interact and influence mating outcomes. Using a series of assays, we explored these negotiations by testing for the relative influence of male behaviors and its effect on influencing female courtship arousal threshold, which is the time taken for females to accept copulation. Our results show that large males indeed have higher copulation success compared to smaller males. Competition between two males or an increasing number of males had no influence on female sexual arousal threshold;-females therefore may have a relatively fixed 'arousal threshold' that must be reached before they are ready to mate, and larger males appear to be able to manipulate this threshold sooner. On the other hand, the females' physiological and behavioral state drastically influences mating; once females have crossed the courtship arousal threshold they take less time to mate and mate indiscriminately with large and small males. Mating quicker with larger males may be misconstrued to be due to female choice; our results suggest that the mating advantage of larger males may be more a result of heightened male activity and relatively less of female choice. Body size per se may not be a trait under selection by female choice, but size likely amplifies male activity and signal outputs in courtship, allowing them to influence female arousal threshold faster.	[Jagadeeshan, Santosh; Shah, Ushma; Chakrabarti, Debarti; Singh, Rama S.] McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada	McMaster University	Singh, RS (corresponding author), McMaster Univ, Dept Biol, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.	singh@mcmaster.ca	Jagadeeshan, Santosh/AAN-9568-2021	Jagadeeshan, Santosh/0000-0002-4285-9281	National Sciences and Engineering Research Council of Canada [2012R00452]; Natural Sciences and Engineering Research Council of Canada	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was supported by the National Sciences and Engineering Research Council of Canada; grant number 2012R00452, http://www.nserc-crsng.gc.ca/index_eng.asp.; We would like to thank Jacqueline Thompson for help with culture media and fly maintenance and Ruwandi Kariyawasam for help with experiments. We would also like to thank Richard Morton for useful discussions during the course of this work, Reuven Dukas, Therese Markow, and an anonymous reviewer for useful comments on a previous version of this manuscript. This study was supported by a Natural Sciences and Engineering Research Council of Canada grant to R. S. S.	Ahuja A, 2008, GENETICS, V179, P503, DOI 10.1534/genetics.107.086363; Andersson Malte, 1994; Darwin C, 1859, ORIGIN SPECIES MEANS; Darwin C., 1871, PRINCIPLES SEXUAL SE, DOI [10.1037/12293-008, DOI 10.1037/12293-008]; Edward DA, 2013, ANIM BEHAV, V86, P269, DOI 10.1016/j.anbehav.2013.05.014; Edward DA, 2011, TRENDS ECOL EVOL, V26, P647, DOI 10.1016/j.tree.2011.07.012; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; Fisher RA, 1930, GENETICAL THEORY NAT; Friberg U, 2003, J EVOLUTION BIOL, V16, P797, DOI 10.1046/j.1420-9101.2003.00597.x; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Hunt J, 2009, J EVOLUTION BIOL, V22, P13, DOI 10.1111/j.1420-9101.2008.01633.x; Jagadeeshan S, 2006, J EVOLUTION BIOL, V19, P1058, DOI 10.1111/j.1420-9101.2006.01099.x; Markow TA, 1996, EVOL BIOL, V29, P73; MARKOW TA, 1992, HEREDITY, V69, P122, DOI 10.1038/hdy.1992.104; MARKOW TA, 1992, J INSECT BEHAV, V5, P375, DOI 10.1007/BF01049845; MARKOW TA, 1988, J COMP PSYCHOL, V102, P169, DOI 10.1037/0735-7036.102.2.169; MARKOW TA, 1987, EVOL GENET, P89; Markow TA, 1986, GENETIC SENSORY BASI, P89; Parker G.A., 1979, P123; PARTRIDGE L, 1987, ANIM BEHAV, V35, P468, DOI 10.1016/S0003-3472(87)80272-5; PARTRIDGE L, 1987, ANIM BEHAV, V35, P555, DOI 10.1016/S0003-3472(87)80281-6; PARTRIDGE L, 1983, ANIM BEHAV, V31, P871, DOI 10.1016/S0003-3472(83)80242-5; Paterson H.E.H., 1993, EVOLUTION RECOGNITIO; Pavkovic-Lucic S, 2013, EUR J ENTOMOL, V110, P31, DOI 10.14411/eje.2013.004; PITNICK S, 1991, ANIM BEHAV, V41, P735, DOI 10.1016/S0003-3472(05)80340-9; Pitnick S, 2002, P ROY SOC B-BIOL SCI, V269, P1821, DOI 10.1098/rspb.2002.2090; Qvarnstrom A, 1998, TRENDS ECOL EVOL, V13, P498, DOI 10.1016/S0169-5347(98)01513-4; ROBERTSON FW, 1960, GENET RES, V1, P288, DOI 10.1017/S0016672300000264; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Taylor ML, 2009, ANIM BIOL, V59, P391, DOI 10.1163/157075509X12499949744180; VONSCHILCHER F, 1976, ANIM BEHAV, V24, P622, DOI 10.1016/S0003-3472(76)80076-0; Wong BBM, 2005, BIOL REV, V80, P559, DOI 10.1017/S1464793105006809	32	11	11	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144672	10.1371/journal.pone.0144672	http://dx.doi.org/10.1371/journal.pone.0144672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658421	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903600076
J	Qu, C; Fu, FY; Liu, M; Zhao, HY; Liu, C; Li, JN; Tang, ZL; Xu, XF; Qiu, X; Wang, R; Lu, K				Qu, Cunmin; Fu, Fuyou; Liu, Miao; Zhao, Huiyan; Liu, Chuan; Li, Jiana; Tang, Zhanglin; Xu, Xinfu; Qiu, Xiao; Wang, Rui; Lu, Kun			Comparative Transcriptome Analysis of Recessive Male Sterility (RGMS) in Sterile and Fertile Brassica napus Lines	PLOS ONE			English	Article							CARRIER PROTEIN REDUCTASE; POLLEN-WALL BIOSYNTHESIS; ARABIDOPSIS-THALIANA; ANTHER DEVELOPMENT; EXINE FORMATION; SPOROPOLLENIN SYNTHESIS; MICROSPORE DEVELOPMENT; TAPETUM DEVELOPMENT; DIFFERENTIAL GENE; RNA-SEQ	The recessive genetic male sterility (RGMS) system plays a key role in the production of hybrid varieties in self-pollinating B. napus plants, and prevents negative cytoplasmic effects. However, the complete molecular mechanism of the male sterility during male-gametogenesis in RGMS remains to be determined. To identify transcriptomic changes that occur during the transition to male sterility in RGMS, we examined the male sterile line WSLA and male fertile line WSLB, which are near-isogenic lines (NILs) differing only in the fertility trait. We evaluated the phenotypic features and sterility stage using anatomical analysis. Comparative RNA sequencing analysis revealed that 3,199 genes were differentially expressed between WSLA andWSLB. Many of these genes are mainly involved in biological processes related to flowering, including pollen tube development and growth, pollen wall assembly and modification, and pollen exine formation and pollination. The transcript profiles of 93 genes associated with pollen wall and anther development were determined by quantitative RT-PCR in different flower parts, and classified into the following three major clades: 1) up-regulated in WSLA plants; 2) down-regulated in WSLA plants; and 3) down-regulated in buds, but have a higher expression in stigmas of WSLA than in WSLB. A subset of genes associated with sporopollenin accumulation were all up-regulated in WSLA. An excess of sporopollenin results in defective pollen wall formation, which leads to male sterility in WSLA. Some of the genes identified in this study are candidates for future research, as they could provide important insight into the molecular mechanisms underlying RGMS in WSLA.	[Qu, Cunmin; Liu, Miao; Zhao, Huiyan; Liu, Chuan; Li, Jiana; Tang, Zhanglin; Xu, Xinfu; Wang, Rui; Lu, Kun] Southwest Univ, Coll Agron & Biotechnol, Chongqing Engn Res Ctr Rapeseed, Tiansheng Rd 2, Chongqing 400716, Peoples R China; [Qu, Cunmin; Liu, Miao; Zhao, Huiyan; Liu, Chuan; Li, Jiana; Tang, Zhanglin; Xu, Xinfu; Wang, Rui; Lu, Kun] Southwest Univ, Engn Res Ctr South Upland Agr, Minist Educ, Chongqing 400716, Peoples R China; [Qu, Cunmin; Qiu, Xiao] Univ Saskatchewan, Food & Bioprod Sci, Saskatoon, SK S7N 5A8, Canada; [Fu, Fuyou] Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK S7N 02X, Canada	Southwest University - China; Southwest University - China; University of Saskatchewan; Agriculture & Agri Food Canada	Wang, R (corresponding author), Southwest Univ, Coll Agron & Biotechnol, Chongqing Engn Res Ctr Rapeseed, Tiansheng Rd 2, Chongqing 400716, Peoples R China.	ruiwang71@163.com; drlunkun@swu.edu.cn	Fu, Fuyou/B-9754-2016; Lu, Kun/C-2597-2008	Fu, Fuyou/0000-0002-5020-4496; Lu, Kun/0000-0003-1370-8633	National Science Foundation of China [U1302266, 31401412, 31571701, 31171619]; 111 Project [B12006]; 863 Project [2013AA102602]; Chongqing Project of Main Crop Variety Innovation [cstc2012ggB80008]; China Scholarship Council (CSC); earmarked fund for Modern Agro-industry Technology Research System [CARS-13]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project); 863 Project(National High Technology Research and Development Program of China); Chongqing Project of Main Crop Variety Innovation; China Scholarship Council (CSC)(China Scholarship Council); earmarked fund for Modern Agro-industry Technology Research System	This work was supported by grants from the National Science Foundation of China [U1302266, 31401412, 31571701, and 31171619, http://www.nsfc.gov.cn], the 111 Project [B12006, http://www.moe.edu.cn], the 863 Project [2013AA102602, www.most.gov.cn], the Chongqing Project of Main Crop Variety Innovation [cstc2012ggB80008, http://www.cstc.gov.cn] and the China Scholarship Council (CSC) [www.csc.edu.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by grants from the National Science Foundation of China (U1302266, 31401412, 31571701, 31171619), the 111 Project (B12006), the 863 Project (2013AA102602), the earmarked fund for Modern Agro-industry Technology Research System (CARS-13), the Chongqing Project of Main Crop Variety Innovation (cstc2012ggB80008), and the China Scholarship Council (CSC).	Aarts MGM, 1997, PLANT J, V12, P615, DOI 10.1046/j.1365-313X.1997.00615.x; Ariizumi T, 2004, PLANT J, V39, P170, DOI 10.1111/j.1365-313X.2004.02118.x; Ariizumi T, 2003, PLANT MOL BIOL, V53, P107, DOI 10.1023/B:PLAN.0000009269.97773.70; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Auger B, 2009, PLANTA, V230, P1167, DOI 10.1007/s00425-009-1017-0; Cavell AC, 1998, GENOME, V41, P62, DOI 10.1139/gen-41-1-62; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chen FX, 1993, ACTA AGR U PEKINEN S, V19, P57; Chen WW, 2011, PLANT PHYSIOL, V157, P842, DOI 10.1104/pp.111.181693; Dobritsa AA, 2010, PLANT PHYSIOL, V153, P937, DOI 10.1104/pp.110.157446; Dobritsa AA, 2009, PLANT PHYSIOL, V151, P574, DOI 10.1104/pp.109.144469; Dobritsa AA, 2009, SEX PLANT REPROD, V22, P167, DOI 10.1007/s00497-009-0101-8; Dong FM, 2012, MOL BREEDING, V30, P1193, DOI 10.1007/s11032-012-9708-9; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dun XL, 2011, PLANT J, V68, P532, DOI 10.1111/j.1365-313X.2011.04708.x; Goujon T, 2003, PLANT J, V33, P677, DOI 10.1046/j.1365-313X.2003.01654.x; He JP, 2008, THEOR APPL GENET, V117, P11, DOI 10.1007/s00122-008-0747-x; Higginson T, 2003, PLANT J, V35, P177, DOI 10.1046/j.1365-313X.2003.01791.x; Hou GZ., 1990, OIL CROP CHINA, V2, P7; Hruba P, 2005, PLANTA, V220, P931, DOI 10.1007/s00425-004-1409-0; Huang Z, 2007, THEOR APPL GENET, V115, P113, DOI 10.1007/s00122-007-0547-8; Jiang J, 2013, PLANT BIOLOGY, V15, P249, DOI 10.1111/j.1438-8677.2012.00706.x; Kimber D.S., 1995, BRASSICA OILSEEDS PR, P1; Lei B, 2014, INT J MOL SCI, V15, P6137, DOI 10.3390/ijms15046137; Li H, 2010, PLANT CELL, V22, P173, DOI 10.1105/tpc.109.070326; Matsuno M, 2009, SCIENCE, V325, P1688, DOI 10.1126/science.1174095; Morant M, 2007, PLANT CELL, V19, P1473, DOI 10.1105/tpc.106.045948; Pan T., 1988, OIL CROP CHINA, V3, P5; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Piffanelli P, 1998, SEX PLANT REPROD, V11, P65, DOI 10.1007/s004970050122; Qu CM, 2013, J EXP BOT, V64, P2885, DOI 10.1093/jxb/ert148; Sanders PM, 1999, SEX PLANT REPROD, V11, P297, DOI 10.1007/s004970050158; Schiefthaler U, 1999, P NATL ACAD SCI USA, V96, P11664, DOI 10.1073/pnas.96.20.11664; Shi J, 2011, PLANT CELL, V23, P2225, DOI 10.1105/tpc.111.087528; Sorensen AM, 2003, PLANT J, V33, P413, DOI 10.1046/j.1365-313X.2003.01644.x; Souza CD, 2009, PLANT CELL, V21, P507, DOI 10.1105/tpc.108.062513; Sun C, 2001, CHIN J OIL CROP SCI, V24, P1; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Swanson R, 2005, SEX PLANT REPROD, V18, P163, DOI 10.1007/s00497-005-0009-x; Swanson R, 2004, ANNU REV GENET, V38, P793, DOI 10.1146/annurev.genet.38.072902.092356; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wijeratne AJ, 2007, PLANT J, V52, P14, DOI 10.1111/j.1365-313X.2007.03217.x; Wilson ZA, 2009, J EXP BOT, V60, P1479, DOI 10.1093/jxb/erp095; Wu G, 2010, J AGR FOOD CHEM, V58, P2812, DOI 10.1021/jf904255b; Wu Y, 2015, SCI REPORTS, V5; Xia SQ, 2012, THEOR APPL GENET, V124, P1193, DOI 10.1007/s00122-011-1779-1; Xiao ZD, 2013, CZECH J GENET PLANT, V49, P16, DOI 10.17221/33/2012-CJGPB; Xing S, 2008, PLANT J, V53, P790, DOI 10.1111/j.1365-313X.2007.03375.x; Xu J, 2014, PLANT CELL, V26, P1544, DOI 10.1105/tpc.114.122986; Xu J, 2010, PLANT CELL, V22, P91, DOI 10.1105/tpc.109.071803; Yang C, 2007, PLANT CELL, V19, P3530, DOI 10.1105/tpc.107.054981; Yu C, 2015, EUPHYTICA, P1; Zhang W, 2006, DEVELOPMENT, V133, P3085, DOI 10.1242/dev.02463; Zhang ZB, 2007, PLANT J, V52, P528, DOI 10.1111/j.1365-313X.2007.03254.x; Zhou ZF, 2012, J EXP BOT, V63, P2041, DOI 10.1093/jxb/err405	56	27	31	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144118	10.1371/journal.pone.0144118	http://dx.doi.org/10.1371/journal.pone.0144118			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26656530	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903500013
J	Schwickert, A; Weghake, E; Bruggemann, K; Engbers, A; Brinkmann, BF; Kemper, B; Seggewiss, J; Stock, C; Ebnet, K; Kiesel, L; Riethmuller, C; Gotte, M				Schwickert, Alexander; Weghake, Esther; Brueggemann, Kathrin; Engbers, Annika; Brinkmann, Benjamin F.; Kemper, Bjoern; Seggewiss, Jochen; Stock, Christian; Ebnet, Klaus; Kiesel, Ludwig; Riethmueller, Christoph; Goette, Martin			microRNA miR-142-3p Inhibits Breast Cancer Cell Invasiveness by Synchronous Targeting of WASL, Integrin Alpha V, and Additional Cytoskeletal Elements	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; JUNCTIONAL ADHESION MOLECULE; ESTROGEN-RECEPTOR-ALPHA; N-WASP; HEPATOCELLULAR-CARCINOMA; ALPHA-V-BETA-3 INTEGRIN; INVADOPODIUM FORMATION; ACTIN CYTOSKELETON; TUMOR-CELLS; MIGRATION	MicroRNAs (miRNAs, micro ribonucleic acids) are pivotal post-transcriptional regulators of gene expression. These endogenous small non-coding RNAs play significant roles in tumorigenesis and tumor progression. miR-142-3p expression is dysregulated in several breast cancer subtypes. We aimed at investigating the role of miR-142-3p in breast cancer cell invasiveness. Supported by transcriptomic Affymetrix array analysis and confirmatory investigations at the mRNA and protein level, we demonstrate that overexpression of miR-142-3p in MDA-MB-231, MDA-MB-468 and MCF-7 breast cancer cells leads to downregulation of WASL (Wiskott-Aldrich syndrome-like, protein: N-WASP), Integrin-alpha V, RAC1, and CFL2, molecules implicated in cytoskeletal regulation and cell motility. ROCK2, IL6ST, KLF4, PGRMC2 and ADCY9 were identified as additional targets in a subset of cell lines. Decreased Matrigel invasiveness was associated with the miR-142-3p-induced expression changes. Confocal immunofluorescence microscopy, nanoscale atomic force microscopy and digital holographic microscopy revealed a change in cell morphology as well as a reduced cell volume and size. A more cortical actin distribution and a loss of membrane protrusions were observed in cells overexpressing miR-142-3p. Luciferase activation assays confirmed direct miR-142-3p-dependent regulation of the 3'-untranslated region of ITGAV and WASL. siRNA-mediated depletion of ITGAV and WASL resulted in a significant reduction of cellular invasiveness, highlighting the contribution of these factors to the miRNA-dependent invasion phenotype. While knockdown of WASL significantly reduced the number of membrane protrusions compared to controls, knockdown of ITGAV resulted in a decreased cell volume, indicating differential contributions of these factors to the miR-142-3p-induced phenotype. Our data identify WASL, ITGAV and several additional cytoskeleton-associated molecules as novel invasion-promoting targets of miR-142-3p in breast cancer.	[Schwickert, Alexander; Weghake, Esther; Brueggemann, Kathrin; Engbers, Annika; Kiesel, Ludwig; Goette, Martin] Munster Univ Hosp, Dept Gynecol & Obstet, Munster, Germany; [Brinkmann, Benjamin F.; Ebnet, Klaus] Univ Munster, ZMBE, Inst Med Biochem, Inst Associated Res Grp Cell Adhes & Cell Polar, D-48149 Munster, Germany; [Kemper, Bjoern] Univ Munster, Ctr Biomed Opt & Photon, Munster, Germany; [Kemper, Bjoern] Univ Munster, Biomed Technol Ctr, Fac Med, D-48149 Munster, Germany; [Seggewiss, Jochen] Univ Munster, Inst Human Genet, Fac Med, D-48149 Munster, Germany; [Stock, Christian] Univ Munster, Inst Physiol 2, D-48149 Munster, Germany; [Stock, Christian] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Riethmueller, Christoph] Serend Ip GmbH, Ctr Nanotechnol, Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster; University of Munster; University of Munster; Hannover Medical School	Gotte, M (corresponding author), Munster Univ Hosp, Dept Gynecol & Obstet, Munster, Germany.	martingotte@uni-muenster.de	Kiesel, Ludwig/ABC-5333-2020; Ebnet, Klaus T/C-8314-2009; Paping, Alexander/AAA-5625-2020; Götte, Martin/G-2254-2018; Gotte, M/Z-5878-2019	Kiesel, Ludwig/0000-0002-7247-9247; Ebnet, Klaus T/0000-0002-0417-7888; Paping, Alexander/0000-0003-2360-6016; Götte, Martin/0000-0003-2360-2496; Gotte, M/0000-0003-2360-2496; Kemper, Bjorn/0000-0003-3693-9397	Innovative Medizinische Forschung (IMF), Medical Faculty Munster University [I-Go 111110]; IZKF, Medical Faculty Munster University [IZKF Eb2/020/14]; BMBF [FKZ13N10937, 01DJ130022A]; Open Access Publication Fund of University of Muenster; EU H RISE-MSCA [645756]	Innovative Medizinische Forschung (IMF), Medical Faculty Munster University; IZKF, Medical Faculty Munster University; BMBF(Federal Ministry of Education & Research (BMBF)); Open Access Publication Fund of University of Muenster; EU H RISE-MSCA	This study was funded by Innovative Medizinische Forschung (IMF), Medical Faculty Munster University, grant number I-Go 111110, URL: http://campus.uni-muenster.de/imf.html; IZKF, Medical Faculty Munster University, grant numberIZKF Eb2/020/14, URL: http://campus.uni-muenster.de/izkf.html; BMBF grants FKZ13N10937 and 01DJ130022A; URL: http://www.bmbf.de/en/index.php; Open Access Publication Fund of University of Muenster (no grant number); URL: http://www.uni-muenster.de/Publizieren/service/publikationsfonds/; EU H2020 RISE-MSCA Project grant number 645756 (GLYCANC) URL:http://cordis.europa.eu/search/result_en?q=GLYCANC&searchType=simple. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2011, MOL THER, V19, P395, DOI 10.1038/mt.2010.254; Albrecht C, 2012, STEROIDS, V77, P1543, DOI 10.1016/j.steroids.2012.09.006; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bettenworth D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107317; Bischoff A, 2014, CANCER RES, V74, P5256, DOI 10.1158/0008-5472.CAN-13-3319; Bissels U, 2011, STEM CELLS, V29, P847, DOI 10.1002/stem.627; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; Chen J, 2001, J BIOL CHEM, V276, P47901, DOI 10.1074/jbc.M107574200; Chen QM, 2008, CLIN EXP METASTAS, V25, P139, DOI 10.1007/s10585-007-9132-4; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; DesMarais V, 2009, CELL MOTIL CYTOSKEL, V66, P303, DOI 10.1002/cm.20361; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Escudero-Esparza A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-43; Flamant S, 2010, HAEMATOL-HEMATOL J, V95, P1325, DOI 10.3324/haematol.2009.020636; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Giri A, 2013, FASEB J, V27, P4089, DOI 10.1096/fj.12-224352; Gligorijevic B, 2012, J CELL SCI, V125, P724, DOI 10.1242/jcs.092726; Gotte M, 2010, ONCOGENE, V29, P6569, DOI 10.1038/onc.2010.386; Havaki S, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-16; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ibrahim SA, 2014, FEBS J, V281, P5009, DOI 10.1111/febs.13026; Ibrahim SA, 2012, INT J CANCER, V131, pE884, DOI 10.1002/ijc.27629; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Janssen EAM, 2010, MODERN PATHOL, V23, P1567, DOI 10.1038/modpathol.2010.177; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Kastingschafer CS, 2015, REPROD BIOMED ONLINE, V30, P553, DOI 10.1016/j.rbmo.2015.01.002; Katoh D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.27; Kemper B, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2798639; Kemper B, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2204609; Kimura F, 2010, CANCER SCI, V101, P1133, DOI 10.1111/j.1349-7006.2010.01527.x; Kovacs EM, 2011, NAT CELL BIOL, V13, P934, DOI 10.1038/ncb2290; Kumar AV, 2014, INT J CANCER, V135, P2579, DOI 10.1002/ijc.28921; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Le Clainche C, 2007, J BIOL CHEM, V282, P426, DOI 10.1074/jbc.M607711200; Lee HH, 2008, J CELL BIOL, V181, P999, DOI 10.1083/jcb.200710187; Luo DY, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-57; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Marini F, 2011, J THROID RES, V2011, DOI 10.4061/2011/407123; Meyer T, 1998, BRIT J CANCER, V77, P530, DOI 10.1038/bjc.1998.86; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Nusblat LM, 2011, EUR J CELL BIOL, V90, P205, DOI 10.1016/j.ejcb.2010.07.012; Papalouka V, 2009, MOL CELL BIOL, V29, P6046, DOI 10.1128/MCB.00654-09; Peddibhotla SSD, 2013, MOL BIOL CELL, V24, P933, DOI 10.1091/mbc.E12-06-0481; Pereira DM, 2013, DRUG DISCOV TODAY, V18, P282, DOI 10.1016/j.drudis.2012.10.002; Plopper GE, 1998, BREAST CANCER RES TR, V51, P57, DOI 10.1023/A:1006086218174; Pollari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037361; Retta SF, 2001, MOL BIOL CELL, V12, P3126, DOI 10.1091/mbc.12.10.3126; Riethmuller C, 2006, PFLUG ARCH EUR J PHY, V453, P157, DOI 10.1007/s00424-006-0121-2; Sanchez AM, 2010, MOL ENDOCRINOL, V24, P2114, DOI 10.1210/me.2010-0252; Santos-Carballal B, 2015, SCI REP-UK, V5, DOI 10.1038/srep13567; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Shekarabi M, 2005, J NEUROSCI, V25, P3132, DOI 10.1523/JNEUROSCI.1920-04.2005; Spizzo R, 2010, CELL DEATH DIFFER, V17, P246, DOI 10.1038/cdd.2009.117; Sturge J, 2002, J CELL SCI, V115, P699; Takahashi K, 2011, J CELL BIOCHEM, V112, P3421, DOI 10.1002/jcb.23276; Tanic M, 2015, INT J CANCER, V136, P593, DOI 10.1002/ijc.29021; Thoelking G, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/26/265102; Thomas M, 2010, J BIOL CHEM, V285, P23842, DOI 10.1074/jbc.M109.097543; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wong CCL, 2009, HEPATOLOGY, V49, P1583, DOI 10.1002/hep.22836; Wong NC, 1998, CLIN EXP METASTAS, V16, P50; Wu LF, 2011, FEBS LETT, V585, P1322, DOI 10.1016/j.febslet.2011.03.067; Wu YJ, 2012, J NEURO-ONCOL, V110, P27, DOI 10.1007/s11060-012-0942-0; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yu F, 2013, INT J CANCER, V133, P2872, DOI 10.1002/ijc.28302; Zhang HQ, 2002, J CELL BIOL, V158, P1287, DOI 10.1083/jcb.200207008	72	75	77	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0143993	10.1371/journal.pone.0143993	http://dx.doi.org/10.1371/journal.pone.0143993			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657485	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903500010
J	Tong, YH; Zhu, TP; Zhao, ZL; Zhan, HJ; Jiang, FZ; Lian, HL				Tong, Yu Hua; Zhu, Tie Pei; Zhao, Ze Lin; Zhan, Hai Jing; Jiang, Fang Zheng; Lian, Heng Li			Retinal Arteriolar Morphometry Based on Full Width at Half Maximum Analysis of Spectral-Domain Optical Coherence Tomography Images	PLOS ONE			English	Article							ATHEROSCLEROSIS RISK; BLOOD-PRESSURE; RESISTANCE ARTERIES; VESSEL DIAMETERS; MICROVASCULAR ABNORMALITIES; ANTIHYPERTENSIVE TREATMENT; ESSENTIAL-HYPERTENSION; VASCULAR CHANGES; COMMUNITIES; AGE	Objectives In this study, we develop a microdensitometry method using full width at half maximum (FWHM) analysis of the retinal vascular structure in a spectral-domain optical coherence tomography (SD-OCT) image and present the application of this method in the morphometry of arteriolar changes during hypertension. Methods Two raters using manual and FWHM methods measured retinal vessel outer and lumen diameters in SD-OCT images. Inter-rater reproducibility was measured using coefficients of variation (CV), intraclass correlation coefficient and a Bland-Altman plot. OCT images from forty-three eyes of 43 hypertensive patients and 40 eyes of 40 controls were analyzed using an FWHM approach; wall thickness, wall cross-sectional area (WCSA) and wall to lumen ratio (WLR) were subsequently calculated. Results Mean difference in inter-rater agreement ranged from -2.713 to 2.658 mu m when using a manual method, and ranged from -0.008 to 0.131 mu m when using a FWHM approach. The inter-rater CVs were significantly less for the FWHM approach versus the manual method (P < 0.05). Compared with controls, the wall thickness, WCSA and WLR of retinal arterioles were increased in the hypertensive patients, particular in diabetic hypertensive patients. Conclusions The microdensitometry method using a FWHM algorithm markedly improved inter-rater reproducibility of arteriolar morphometric analysis, and SD-OCT may represent a promising noninvasive method for in vivo arteriolar morphometry.	[Tong, Yu Hua; Zhan, Hai Jing; Jiang, Fang Zheng] Zhejiang Chinese Med Univ, Quzhou Cent Hosp, Quzhou Peoples Hosp, Quzhou, Zhejiang, Peoples R China; [Zhu, Tie Pei] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Ctr Eye, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Ze Lin; Lian, Heng Li] Wenzhou Med Univ, Hosp Eye, Zhejiang Eye Hosp, Wenzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang University; Wenzhou Medical University	Zhu, TP (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 2, Ctr Eye, Hangzhou 310003, Zhejiang, Peoples R China.	zhutiepei@yahoo.com			Welfare Technology Applied Research Program Fund of Science Technology Department of Zhejiang Province [2013C33115]	Welfare Technology Applied Research Program Fund of Science Technology Department of Zhejiang Province	This work was supported by grant 2013C33115, http://www.zjkjt.gov.cn, Welfare Technology Applied Research Program Fund of Science Technology Department of Zhejiang Province (YHT).	Bouma H, 2007, MED IMAGING 2007 I 1, V6512, pU913; Brinchmann-Hansen O., 2009, ACTA OPHTHALMOL, V64, P33, DOI [DOI 10.1111/J.1755-3768.1986.TB00701.X, 10.1111/j.1755-3768.1986.tb00701.x]; Brinchmann-Hansen O., 1986, ACTA OPHTHALMOL, V179, P9; Chui TYP, 2013, INVEST OPHTH VIS SCI, V54, P7115, DOI 10.1167/iovs.13-13027; Endemann DH, 2004, HYPERTENSION, V43, P399, DOI 10.1161/01.HYP.0000112029.03691.e7; Flett AS, 2011, JACC-CARDIOVASC IMAG, V4, P150, DOI 10.1016/j.jcmg.2010.11.015; Goldenberg D, 2013, RETINA-J RET VIT DIS, V33, P1888, DOI 10.1097/IAE.0b013e31829477f2; HEAGERTY AM, 1993, HYPERTENSION, V21, P391, DOI 10.1161/01.HYP.21.4.391; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Ikram MK, 2004, INVEST OPHTH VIS SCI, V45, P2129, DOI 10.1167/iovs.03-1390; Kiernan DF, 2010, AM J OPHTHALMOL, V149, P18, DOI 10.1016/j.ajo.2009.08.037; Koch E, 2014, J HYPERTENS, V32, P890, DOI 10.1097/HJH.0000000000000095; Leung H, 2003, INVEST OPHTH VIS SCI, V44, P2900, DOI 10.1167/iovs.02-1114; Moss HE, 2014, INVEST OPHTH VIS SCI, V55, P2049, DOI 10.1167/iovs.13-13621; Mulvany MJ, 1996, HYPERTENSION, V28, P505; Muraoka Y, 2013, AM J OPHTHALMOL, V156, P706, DOI 10.1016/j.ajo.2013.05.021; Ouyang YL, 2015, GRAEF ARCH CLIN EXP, V253, P499, DOI 10.1007/s00417-014-2715-2; RASSAM SMB, 1994, BRIT J OPHTHALMOL, V78, P24, DOI 10.1136/bjo.78.1.24; Ritt M, 2008, J HYPERTENS, V26, P1427, DOI 10.1097/HJH.0b013e3282ffdc66; Ritt M, 2009, HYPERTENSION, V54, P384, DOI 10.1161/HYPERTENSIONAHA.109.133025; Schiffrin EL, 2004, AM J HYPERTENS, V17, P1192, DOI 10.1016/j.amjhyper.2004.05.023; SCHIFFRIN EL, 1993, CLIN INVEST MED, V16, P177; Schuster AKG, 2015, ACTA OPHTHALMOL, V93, pE148, DOI 10.1111/aos.12509; Sharrett AR, 1999, AM J EPIDEMIOL, V150, P263; Sherry LM, 2002, CLIN EXP OPHTHALMOL, V30, P179, DOI 10.1046/j.1442-9071.2002.00520.x; Sun C, 2009, SURV OPHTHALMOL, V54, P74, DOI 10.1016/j.survophthal.2008.10.003; Vucetic M, 2004, BRIT J OPHTHALMOL, V88, P771, DOI 10.1136/bjo.2003.018788; Wong TY, 2004, OPHTHALMOLOGY, V111, P1183, DOI 10.1016/j.ophtha.2003.09.039; Wong TY, 2003, INVEST OPHTH VIS SCI, V44, P4644, DOI 10.1167/iovs.03-0079; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P1153, DOI 10.1001/jama.287.9.1153; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P2528, DOI 10.1001/jama.287.19.2528; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5; Zhu TP, 2014, MICROVASC RES, V95, P7, DOI 10.1016/j.mvr.2014.06.007	33	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144437	10.1371/journal.pone.0144437	http://dx.doi.org/10.1371/journal.pone.0144437			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650940	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903300049
J	Ding, YM; Li, YY; Lu, LC; Zhang, RY; Zeng, LH; Wang, LL; Zhang, X				Ding, Yuemin; Li, Yuying; Lu, Lingchao; Zhang, Ruyi; Zeng, Linghui; Wang, Linlin; Zhang, Xiong			Inhibition of Nischarin Expression Promotes Neurite Outgrowth through Regulation of PAK Activity	PLOS ONE			English	Article							BINDING PROTEIN; RHO-GTPASES; CELL-MIGRATION; GROWTH CONE; PC12 CELLS; P21-ACTIVATED-KINASE-1 PAK1; NEURONAL MORPHOLOGY; EPITHELIAL-CELLS; P35/CDK5 KINASE; RAC	Nischarin is a cytoplasmic protein expressed in various organs that plays an inhibitory role in cell migration and invasion and the carcinogenesis of breast cancer cells. We previously reported that Nischarin is highly expressed in neuronal cell lines and is differentially expressed in the brain tissue of adult rats. However, the physiological function of Nischarin in neural cells remains unknown. Here, we show that Nischarin is expressed in rat primary cortical neurons but not in astrocytes. Nischarin is localized around the nucleus and dendrites. Using shRNA to knockdown the expression of endogenous Nischarin significantly increases the percentage of neurite-bearing cells, remarkably increases neurite length, and accelerates neurite extension in neuronal cells. Silencing Nischarin expression also promotes dendrite elongation in rat cortical neurons where Nischarin interacts with p21-activated kinase 1/2 (PAK1/2) and negatively regulates phosphorylation of both PAK1 and PAK2. The stimulation of neurite growth observed in cells with decreased levels of Nischarin is partially abolished by IPA3-mediated inhibition of PAK1 activity. Our findings indicate that endogenous Nischarin inhibits neurite outgrowth by blocking PAK1 activation in neurons.	[Ding, Yuemin; Lu, Lingchao; Zeng, Linghui] Zhejiang Univ City Coll, Sch Med, Dept Clin Med, Hangzhou 310015, Zhejiang, Peoples R China; [Li, Yuying] Quzhou Coll Technol, Dept Physiol, Sch Med, Quzhou 324000, Peoples R China; [Zhang, Ruyi] Jiaxing Second Hosp, Dept Pathol, Jiaxing 314000, Peoples R China; [Wang, Linlin; Zhang, Xiong] Zhejiang Univ, Sch Med, Dept Basic Med Sci, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University City College; Zhejiang University	Wang, LL (corresponding author), Zhejiang Univ, Sch Med, Dept Basic Med Sci, Hangzhou 310058, Zhejiang, Peoples R China.	wanglinlin@zju.edu.cn; xiongzhang@zju.edu.cn			National Natural Science Foundation of China [81000535, 81371953]; Natural Science Foundation of Zhejiang Province [LY14H090002, LY15H250001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by a National Natural Science Foundation of China (no. 81000535) to YD, by a Natural Science Foundation of Zhejiang Province (no. LY14H090002) to YD, by a National Natural Science Foundation of China (no. 81371953) to LW, and by a Natural Science Foundation of Zhejiang Province (no. LY15H250001) to XZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahari SK, 2004, EMBO J, V23, P2777, DOI 10.1038/sj.emboj.7600291; Alahari SK, 2004, BIOCHEM J, V377, P449, DOI 10.1042/BJ20030411; Alahari SK, 2003, EXP CELL RES, V288, P415, DOI 10.1016/S0014-4827(03)00233-7; Alahari SK, 2000, J CELL BIOL, V151, P1141, DOI 10.1083/jcb.151.6.1141; Auer M, 2011, ANN ANAT, V193, P259, DOI 10.1016/j.aanat.2011.02.015; Baranwal S, 2011, J NATL CANCER I, V103, P1513, DOI 10.1093/jnci/djr350; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bouquet C, 2007, ADV EXP MED BIOL, V621, P1, DOI 10.1007/978-0-387-76715-4_1; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Ding YM, 2008, MOL CELL BIOL, V28, P3742, DOI 10.1128/MCB.01832-07; Ding YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054563; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hayashi K, 2002, MOL CELL NEUROSCI, V20, P579, DOI 10.1006/mcne.2002.1144; Jain P, 2013, J BIOL CHEM, V288, P15495, DOI 10.1074/jbc.M112.418103; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kreis P, 2009, CELL SIGNAL, V21, P384, DOI 10.1016/j.cellsig.2008.11.001; Kuijl C, 2013, EMBO J, V32, P713, DOI 10.1038/emboj.2013.10; Langhammer CG, 2010, CYTOM PART A, V77A, P1160, DOI 10.1002/cyto.a.20954; Li F, 2012, ADDICT BIOL, V17, P392, DOI 10.1111/j.1369-1600.2011.00373.x; Li S, 2013, J NEUROSCI, V33, P790, DOI 10.1523/JNEUROSCI.1238-12.2013; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Marler KJM, 2005, MOL CELL BIOL, V25, P5226, DOI 10.1128/MCB.25.12.5226-5241.2005; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Rashid T, 2001, J BIOL CHEM, V276, P49043, DOI 10.1074/jbc.M105599200; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Saha RN, 2009, J IMMUNOL, V183, P2068, DOI 10.4049/jimmunol.0801892; Schaefer AW, 2008, DEV CELL, V15, P146, DOI 10.1016/j.devcel.2008.05.003; Schwieger J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133680; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Sebok A, 1999, J NEUROCHEM, V73, P949, DOI 10.1046/j.1471-4159.1999.0730949.x; Shin EY, 2009, BIOCHEM BIOPH RES CO, V379, P384, DOI 10.1016/j.bbrc.2008.12.066; Shin EY, 2002, J BIOL CHEM, V277, P44417, DOI 10.1074/jbc.M203754200; Thies E, 2003, J NEUROBIOL, V54, P358, DOI 10.1002/neu.10135; Wu XH, 2013, INFLAMM RES, V62, P929, DOI 10.1007/s00011-013-0631-2; Zhu PM, 2005, J NEUROSCI RES, V81, P817, DOI 10.1002/jnr.20597	40	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144948	10.1371/journal.pone.0144948	http://dx.doi.org/10.1371/journal.pone.0144948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670864	Green Published, Green Submitted, gold			2022-12-27	WOS:000366719300034
J	McClelland, D; Murray, GI				McClelland, David; Murray, Graeme I.			A Comprehensive Study of Extramural Venous Invasion in Colorectal Cancer	PLOS ONE			English	Article							VASCULAR INVASION; LYMPHOVASCULAR INVASION; PROGNOSTIC-SIGNIFICANCE; ADJUVANT CHEMOTHERAPY; CARCINOMA; SURVIVAL; STAIN; ELASTICA; RECTUM	Colorectal cancer is a common malignancy and a leading cause of cancer related death. Cancer staging following resection is key to determining any adjuvant therapy in those patients with high risk disease. In colorectal cancer, tumour stage and lymph node stage are the main pathological factors which have been considered to influence outcome. Increasing emphasis is now being placed on other factors, especially the presence of extramural venous invasion (EMVI). It is important to understand the relationship of EMVI with other pathological factors and to confirm that in an individual centre that EMVI is being detected at an appropriate rate and is of prognostic significance. This comprehensive study assesses the reporting and prognostic significance of EMVI in a single centre, using prospectively collected data from histopathology reports of a cohort of 2405 patients who underwent surgery for colorectal cancer over a nine year period. Overall, EMVI was reported in 27.9% of colorectal cancer excision specimens. In tumours (n = 1928) that had not received neoadjuvant therapy, the presence of EMVI varied significantly depending on tumour site (chi(2) = 12.03, p < 0.005), tumour stage (chi(2) = 268.188, p < 0.001), lymph node stage (chi(2) = 294.368, p < 0.001) and Dukes' stage (chi(2) = 253.753, p < 0.001). Multivariate analysis confirmed EMVI as a significant independent prognostic indicator (p < 0.001). In conclusion, the presence of EMVI as an independent prognostic indicator is shown and is related to other pathological and prognostic factors. This study emphasises the requirement for the accurate identification of EMVI in colorectal cancer excision specimens and also understanding the relationship of EMVI with other prognostic factors.	[McClelland, David] NHS Grampian, Aberdeen Royal Infirm, Dept Pathol, Aberdeen, Scotland; [Murray, Graeme I.] Univ Aberdeen, Sch Med Med Sci & Nutr, Div Appl Med, Pathol, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen	Murray, GI (corresponding author), Univ Aberdeen, Sch Med Med Sci & Nutr, Div Appl Med, Pathol, Aberdeen, Scotland.	g.i.murray@abdn.ac.uk						Abdulkader M, 2006, HISTOPATHOLOGY, V49, P487, DOI 10.1111/j.1365-2559.2006.02533.x; Barresi V, 2012, AM J SURG PATHOL, V36, P66, DOI 10.1097/PAS.0b013e31822d3008; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Betge J, 2012, CANCER-AM CANCER SOC, V118, P628, DOI 10.1002/cncr.26310; Brown GT, 2016, HISTOPATHOLOGY, V68, P556, DOI 10.1111/his.12780; Coghlin C, 2015, PROTEOM CLIN APPL, V9, P64, DOI 10.1002/prca.201400082; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; Dawson H, 2014, FRONT ONCOL, V4, P354, DOI DOI 10.3389/fonc.2014.00354; Dirschmid K, 2012, J CLIN PATHOL, V65, P619, DOI 10.1136/jclinpath-2011-200552; Gibson KM, 2014, DIS COLON RECTUM, V57, P916, DOI 10.1097/DCR.0000000000000162; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; HORN A, 1991, DIS COLON RECTUM, V34, P798, DOI 10.1007/BF02051074; Howlett CJ, 2009, J CLIN PATHOL, V62, P1021, DOI 10.1136/jcp.2009.065615; Hyslop T, 2013, J CANCER, V4, P193, DOI 10.7150/jca.5830; Kingston EF, 2007, DIS COLON RECTUM, V50, P1867, DOI 10.1007/s10350-007-9021-6; Kirsch R, 2013, AM J SURG PATHOL, V37, P200, DOI 10.1097/PAS.0b013e31826a92cd; Loughrey MB, 2014, STANDARDS DATASETS R; Meguerditchian AN, 2005, AM J SURG, V189, P707, DOI 10.1016/j.amjsurg.2005.03.012; Messenger DE, 2012, HUM PATHOL, V43, P965, DOI 10.1016/j.humpath.2011.11.015; Messenger DE, 2011, J CLIN PATHOL, V64, P983, DOI 10.1136/jclinpath-2011-200156; MINSKY BD, 1988, CANCER, V61, P1417, DOI 10.1002/1097-0142(19880401)61:7<1417::AID-CNCR2820610723>3.0.CO;2-9; Nagtegaal ID, 2015, HISTOPATHOLOGY, V66, P102, DOI 10.1111/his.12563; O'Dwyer D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027718; O'Shea A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104991; Parnaby CN, 2015, BRIT J CANCER, V113, P212, DOI 10.1038/bjc.2015.211; Petersen VC, 2002, GUT, V51, P65, DOI 10.1136/gut.51.1.65; Roxburgh CSD, 2011, J CLIN PATHOL, V64, P1142, DOI 10.1136/jclinpath-2011-200284; Roxburgh CSD, 2010, ANN SURG, V252, P989, DOI 10.1097/SLA.0b013e3181f1c60d; Signguideline. Scottish Intercollegiate Guidelines Network (SIGN), 2011, SCOTT INT GUID NETW; Sternberg A, 2002, J CLIN PATHOL, V55, P17, DOI 10.1136/jcp.55.1.17; TALBOT IC, 1981, HISTOPATHOLOGY, V5, P141, DOI 10.1111/j.1365-2559.1981.tb01774.x; van Wyk HC, 2014, CRIT REV ONCOL HEMAT, V90, P77, DOI 10.1016/j.critrevonc.2013.11.004; Vass DG, 2004, J CLIN PATHOL, V57, P769, DOI 10.1136/jcp.2003.015826; Williams G, 2007, DATASET COLORECTAL C; Woods YL, 2014, J CLIN PATHOL, V67, P499, DOI 10.1136/jclinpath-2013-202060; Young PE, 2014, J CANCER, V5, P262, DOI 10.7150/jca.7988	36	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144987	10.1371/journal.pone.0144987	http://dx.doi.org/10.1371/journal.pone.0144987			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671331	Green Published, Green Submitted, gold			2022-12-27	WOS:000366719300037
J	Vered, O; Simon-Tuval, T; Yagupsky, P; Malul, M; Cicurel, A; Davidovitch, N				Vered, Oded; Simon-Tuval, Tzahit; Yagupsky, Pablo; Malul, Miki; Cicurel, Assi; Davidovitch, Nadav			The Price of a Neglected Zoonosis: Case-Control Study to Estimate Healthcare Utilization Costs of Human Brucellosis	PLOS ONE			English	Article							BENEFIT-ANALYSIS; CONTROL STRATEGIES; VACCINATION; DIAGNOSIS	Human brucellosis has reemerged as a serious public health threat to the Bedouin population of southern Israel in recent years. Little is known about its economic implications derived from elevated healthcare utilization (HCU). Our objective was to estimate the HCU costs associated with human brucellosis from the insurer perspective. A case-control retrospective study was conducted among Clalit Health Services (CHS) enrollees. Brucellosis cases were defined as individuals that were diagnosed with brucellosis at the Clinical Microbiology Laboratory of Soroka University Medical Center in the 2010-2012 period (n = 470). Control subjects were randomly selected and matched 1: 3 by age, sex, clinic, and primary physician (n = 1,410). HCU data, demographic characteristics and comorbidities were obtained from CHS computerized database. Mean +/- SD age of the brucellosis cases was 26.6 +/- 17.6 years. 63% were male and 85% were Bedouins. No significant difference in Charlson comorbidity index was found between brucellosis cases and controls (0.41 vs. 0.45, respectively, P = 0.391). Before diagnosis (baseline), the average total annual HCU cost of brucellosis cases was slightly yet significantly higher than that of the control group ($439 vs. $382, P<0.05), however, no significant differences were found at baseline in the predominant components of HCU, i.e. hospitalizations, diagnostic procedures, and medications. At the year following diagnosis, the average total annual HCU costs of brucellosis cases was significantly higher than that of controls ($1,327 vs. $380, respectively, P<0.001). Most of the difference stems from 7.9 times higher hospitalization costs (p<0.001). Additional elevated costs were 3.6 times higher laboratory tests (P<0.001), 2.8 times higher emergency room visits (P<0.001), 1.8 times higher medication (P<0.001) and 1.3 times higher diagnostic procedures (P<0.001). We conclude that human brucellosis is associated with elevated HCU costs. Considering these results in cost-effective analyses may be crucial for both reducing health inequities and optimal allocation of health systems' scarce resources.	[Vered, Oded; Malul, Miki] Ben Gurion Univ Negev, Guilford Glazer Fac Business & Management, Dept Publ Policy & Adm, IL-84105 Beer Sheva, Israel; [Simon-Tuval, Tzahit; Davidovitch, Nadav] Ben Gurion Univ Negev, Dept Hlth Syst Management, Guilford Glazer Fac Business & Management, IL-84105 Beer Sheva, Israel; [Simon-Tuval, Tzahit; Cicurel, Assi; Davidovitch, Nadav] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Yagupsky, Pablo] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Clin Microbiol Lab, IL-84105 Beer Sheva, Israel; [Cicurel, Assi] Ben Gurion Univ Negev, Clalit Hlth Serv, Southern Dist, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Clalit Health Services	Simon-Tuval, T (corresponding author), Ben Gurion Univ Negev, Dept Hlth Syst Management, Guilford Glazer Fac Business & Management, IL-84105 Beer Sheva, Israel.	simont@bgu.ac.il	Tuval, Tzahit Simon/E-6328-2011	Tuval, Tzahit Simon/0000-0003-4518-7828; malul, miki/0000-0001-9985-8303				Anis E, 2011, ISR MED ASSOC J, V13, P359; [Anonymous], 2015, GUID ATC CLASS DDD A; Banai M, 2010, Prilozi, V31, P167; Blasco J M, 2010, Prilozi, V31, P145; Can MF, 2014, KAFKAS UNIV VET FAK, V20, P107, DOI 10.9775/kvfd.2013.9585; Can MF, 2011, KAFKAS UNIV VET FAK, V17, P601; Center for Disease Control and Prevention, 2010, CAS DEF NAT NOT DIS; Coelho AM, 2011, ARQ BRAS MED VET ZOO, V63, P1, DOI 10.1590/S0102-09352011000100001; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; Dean AS, 2012, PLOS NEGLECT TROP D, V6, DOI [10.1371/journal.pntd.0001929, 10.1371/journal.pntd.0001865]; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; del Pozo JSG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032090; Kumar A, 2010, Prilozi, V31, P219; Narrod C, 2012, ECOHEALTH, V9, P150, DOI 10.1007/s10393-012-0747-9; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Perez-Avraham G, 2001, T ROY SOC TROP MED H, V95, P301, DOI 10.1016/S0035-9203(01)90241-X; Roth F, 2003, B WORLD HEALTH ORGAN, V81, P867; Rubach MP, 2013, CURR OPIN INFECT DIS, V26, P404, DOI 10.1097/QCO.0b013e3283638104; Ruiz-Mesa JD, 2005, CLIN MICROBIOL INFEC, V11, P221, DOI 10.1111/j.1469-0691.2004.01063.x; Shemesh AA, 2013, AIR WATER BORNE DIS, V2; Yousefi-Nooraie R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007179.pub2; Zhen Q, 2013, CLIN MICROBIOL INFEC, V19, pE395, DOI 10.1111/1469-0691.12250; Zinsstag J, 2007, EMERG INFECT DIS, V13, P527, DOI 10.3201/eid1304.060381	24	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145086	10.1371/journal.pone.0145086	http://dx.doi.org/10.1371/journal.pone.0145086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669738	gold, Green Submitted, Green Published			2022-12-27	WOS:000366719300045
J	da Rosa, CVD; Azevedo, SCSF; Bazotte, RB; Peralta, RM; Buttow, NC; Pedrosa, MMD; de Godoi, VAF; Natali, MRM				da Rosa, Carlos Vinicius D.; Azevedo, Silvia C. S. F.; Bazotte, Roberto B.; Peralta, Rosane M.; Buttow, Nilza C.; Pedrosa, Maria Montserrat D.; de Godoi, Vilma A. F.; Natali, Maria Raquel M.			Supplementation with L-Glutamine and L-Alanyl-L-Glutamine Changes Biochemical Parameters and Jejunum Morphophysiology in Type 1 Diabetic Wistar Rats	PLOS ONE			English	Article							PREVENTS MUCOSAL INJURY; SMALL-INTESTINE; DIETARY GLUTAMINE; OXIDATIVE STRESS; ORAL GLUTAMINE; ALKALINE-PHOSPHATASE; MYENTERIC NEURONS; AMINO-ACIDS; SAFETY; ILEUM	We evaluated the effects of the supplementation with L-glutamine and glutamine dipeptide (GDP) on biochemical and morphophysiological parameters in streptozotocin-diabetic rats. For this purpose, thirty animals were distributed into six groups treated orally (gavage) during thirty days: non diabetic rats (Control) + saline, diabetic + saline; Control + L-glutamine (248 mg/kg), Diabetic + L-glutamine (248 mg/kg), Control + GDP (400 mg/kg), Diabetic + GDP (400 mg/kg). Diabetes was induced by an intravenous injection of streptozotocin (60 mg/kg) and confirmed by fasting glucose >= 200 mg/dL. Physiological parameters, i.e., body mass, food intake, blood glucose, water intake, urine and faeces were evaluated during supplementation. After the period of supplementation, the animals were euthanized. The blood was collected for biochemical assays (fructosamine, transaminases, lipid profile, total protein, urea, ammonia). Moreover, the jejunum was excised and stored for morphophysiological assays (intestinal enzyme activity, intestinal wall morphology, crypt proliferative index, number of serotoninergic cells from the mucosa, and vipergic neurons from the submucosal tunica). The physiological parameters, protein metabolism and intestinal enzyme activity did not change with the supplementation with L-glutamine or GDP. In diabetic animals, transaminases and fructosamine improved with L-glutamine and GDP supplementations, while the lipid profile improved with L-glutamine. Furthermore, both forms of supplementation promoted changes in jejunal tunicas and wall morphometry of control and diabetic groups, but only L-glutamine promoted maintenance of serotoninergic cells and vipergic neurons populations. On the other hand, control animals showed changes that may indicate negative effects of L-glutamine. Thus, the supplementation with L-glutamine was more efficient for maintaining intestinal morphophysiology and the supplementation with GDP was more efficient to the organism as a whole. Thus, we can conclude that local differences in absorption and metabolism could explain the differences between the supplementation with L-glutamine or GDP.	[da Rosa, Carlos Vinicius D.; Buttow, Nilza C.; Natali, Maria Raquel M.] Univ Estadual Maringa, Dept Morphol Sci, Maringa, Parana, Brazil; [Azevedo, Silvia C. S. F.; Pedrosa, Maria Montserrat D.; de Godoi, Vilma A. F.] Univ Estadual Maringa, Dept Physiol Sci, Maringa, Parana, Brazil; [Bazotte, Roberto B.] Univ Estadual Maringa, Dept Pharmacol & Therapeut, Maringa, Parana, Brazil; [Peralta, Rosane M.] Univ Estadual Maringa, Dept Biochem, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa	Natali, MRM (corresponding author), Univ Estadual Maringa, Dept Morphol Sci, Maringa, Parana, Brazil.	mrmnatali@uem.br	BAZOTTE, ROBERTO/S-5851-2019; Pedrosa, Maria Montserrat Diaz/AAW-6411-2020; PERALTA, ROSANE MARINA/J-3912-2016	PERALTA, ROSANE MARINA/0000-0001-5749-0723; Natali, Maria Raquel Marcal/0000-0002-7486-2581; Rosa, Carlos Vinicius Dalto da/0000-0001-9428-630X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES [40004015001M9]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES 40004015001M9 (http://www.capes.gov.br/) to CVDR SCSFA RBB RMP NCB VAFG MRMN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2003, ENDOCR J, V50, P271, DOI 10.1507/endocrj.50.271; Adeghate E, 2001, Arch Physiol Biochem, V109, P246, DOI 10.1076/apab.109.3.246.11587; Badole SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072817; Badole SL, 2013, CHEM-BIOL INTERACT, V203, P530, DOI 10.1016/j.cbi.2013.02.006; Alves EPB, 2010, NUTR NEUROSCI, V13, P43, DOI 10.1179/147683010X12611460763841; BERGMEYER HU, 1974, METHOD ENZYMAT AN, P1205; Bowtell JL, 1999, J APPL PHYSIOL, V86, P1770, DOI 10.1152/jappl.1999.86.6.1770; CASPARY WF, 1972, DIABETOLOGIA, V8, P412, DOI 10.1007/BF01212169; Rodrigues MLC, 2012, J PEDIAT-BRAZIL, V88, P17, DOI 10.2223/JPED.2153; Chandrasekharan B, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01611.x; CicinSain L, 1996, BEHAV BRAIN RES, V73, P285; Cruzat VF, 2014, NUTRITION, V30, P602, DOI 10.1016/j.nut.2013.10.019; Pereira RVF, 2011, DIGEST DIS SCI, V56, P3507, DOI 10.1007/s10620-011-1806-8; Furst P, 1997, NUTRITION, V13, P731, DOI 10.1016/S0899-9007(97)83035-3; Gajdosik A, 1999, GEN PHYSIOL BIOPHYS, V18, P54; Garlick PJ, 2001, J NUTR, V131, p2556S, DOI 10.1093/jn/131.9.2556S; GOLDBERG RB, 1981, DIABETES CARE, V4, P561, DOI 10.2337/diacare.4.5.561; Grider JR, 1998, GASTROENTEROLOGY, V115, P370, DOI 10.1016/S0016-5085(98)70203-3; Gupta N, 2002, ANAL BIOCHEM, V311, P98, DOI 10.1016/S0003-2697(02)00379-2; Hebert SL, 2010, CLIN NUTR, V29, P13, DOI 10.1016/j.clnu.2009.09.001; Hermes-Uliana C, 2014, DIGEST DIS SCI, V59, P937, DOI 10.1007/s10620-013-2993-2; Izbeki F, 2008, DIABETES RES CLIN PR, V80, P192, DOI 10.1016/j.diabres.2007.12.013; Jiang ZM, 1999, JPEN-PARENTER ENTER, V23, pS62, DOI 10.1177/014860719902300516; Jorgensen CS, 2001, DIGEST DIS SCI, V46, P960, DOI 10.1023/A:1010737323153; Labow BI, 2001, J NUTR, V131, p2467S, DOI 10.1093/jn/131.9.2467S; Labow BI, 2000, WORLD J SURG, V24, P1503, DOI 10.1007/s002680010269; Lalles JP, 2014, NUTR REV, V72, P82, DOI 10.1111/nure.12082; Li P, 2007, BRIT J NUTR, V98, P237, DOI 10.1017/S000711450769936X; Liu GF, 2012, WORLD J GASTROENTERO, V18, P4875, DOI 10.3748/wjg.v18.i35.4875; LORENZMEYER H, 1977, RES EXP MED, V170, P89, DOI 10.1007/BF01851379; LOWE DK, 1990, AM J CLIN NUTR, V52, P1101, DOI 10.1093/ajcn/52.6.1101; Melis GC, 2004, CURR OPIN CLIN NUTR, V7, P59, DOI 10.1097/00075197-200401000-00011; Menge BA, 2010, REGUL PEPTIDES, V160, P75, DOI 10.1016/j.regpep.2009.08.001; MILLER DL, 1977, GASTROENTEROLOGY, V73, P1326; Minguetti-Camara VC, 2014, NUTRIENTS, V6, P4520, DOI 10.3390/nu6104520; MOREL DW, 1989, J LIPID RES, V30, P1827; NAKABOU Y, 1980, METABOLISM, V29, P181, DOI 10.1016/0026-0495(80)90144-4; Nansseu JRN, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007689; Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003; Newsholme P, 2011, FRONT BIOSCI-LANDMRK, V16, P315, DOI 10.2741/3690; Noda T, 2001, METABOLISM, V50, P259, DOI 10.1053/meta.2001.21030; NORDSTROM C, 1967, J HISTOCHEM CYTOCHEM, V15, P713, DOI 10.1177/15.12.713; Oda S, 2008, REGUL TOXICOL PHARM, V50, P226, DOI 10.1016/j.yrtph.2007.10.016; Owari M, 2012, PEDIATR SURG INT, V28, P299, DOI 10.1007/s00383-011-3023-0; Paul RG, 1996, INT J BIOCHEM CELL B, V28, P1297, DOI 10.1016/S1357-2725(96)00079-9; da Silva GGP, 2011, WORLD J GASTROENTERO, V17, P898, DOI 10.3748/wjg.v17.i7.898; PORTELAGOMES GM, 1990, PATHOL RES PRACT, V186, P260, DOI 10.1016/S0344-0338(11)80544-3; Satoh J, 2003, INT J MOL MED, V12, P615; Schmidt RE, 2003, AM J PATHOL, V163, P2077, DOI 10.1016/S0002-9440(10)63565-1; Schwimmer JB, 2002, AM J PHYSIOL-GASTR L, V282, pG317, DOI 10.1152/ajpgi.2002.282.2.G317; SEE NA, 1990, J AUTONOM NERV SYST, V31, P219, DOI 10.1016/0165-1838(90)90188-O; Sengul G, 2011, TURK NEUROSURG, V21, P367, DOI 10.5137/1019-5149.JTN.4313-11.0; Sha H, 2006, WORLD J GASTROENTERO, V12, P7149, DOI 10.3748/wjg.v12.i44.7149; Sukhotnik I, 2007, DIGEST DIS SCI, V52, P1497, DOI 10.1007/s10620-006-9629-8; Swaid F, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-53; Takahara H, 2001, AM J PHYSIOL-GASTR L, V281, pG798, DOI 10.1152/ajpgi.2001.281.3.G798; TOMLINSON KC, 1992, PHARMACOL REV, V44, P103; Tronchini EA, 2013, AN ACAD BRAS CIENC, V85, P1165, DOI 10.1590/S0001-37652013005000052; Tronchini Eleandro Aparecido, 2012, Arq. Gastroenterol., V49, P284, DOI 10.1590/S0004-28032012000400010; Tsai PH, 2011, CLIN NUTR, V30, P124, DOI 10.1016/j.clnu.2010.07.005; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019; Ward E, 2003, EUR J CLIN NUTR, V57, P31, DOI 10.1038/sj.ejcn.1601517; Zanoni Jacqueline Nelisis, 2011, Arq. Gastroenterol., V48, P66, DOI 10.1590/S0004-28032011000100014; Zanoni JN, 2002, ARQ NEURO-PSIQUIAT, V60, P32, DOI 10.1590/S0004-282X2002000100007; Zarei A, 2015, AVICENNA J PHYTOMEDI, V5, P138; Zhao J, 2003, DIABETOLOGIA, V46, P1688, DOI 10.1007/s00125-003-1233-2; ZOUBI SA, 1995, VIRCHOWS ARCH, V426, P501	67	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143005	10.1371/journal.pone.0143005	http://dx.doi.org/10.1371/journal.pone.0143005			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659064	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900006
J	Jumbri, K; Rozy, MFA; Ashari, SE; Mohamad, R; Basri, M; Masoumi, HRF				Jumbri, Khairulazhar; Rozy, Mohd Fahruddin Al-Haniff; Ashari, Siti Efliza; Mohamad, Rosfarizan; Basri, Mahiran; Masoumi, Hamid Reza Fard			Optimisation and Characterisation of Lipase-Catalysed Synthesis of a Kojic Monooleate Ester in a Solvent-Free System by Response Surface Methodology	PLOS ONE			English	Article							ENZYMATIC-SYNTHESIS; ACID; RSM; PARAMETERS; TYROSINASE	Kojic acid is widely used to inhibit the browning effect of tyrosinase in cosmetic and food industries. In this work, synthesis of kojic monooleate ester (KMO) was carried out using lipase-catalysed esterification of kojic acid and oleic acid in a solvent-free system. Response Surface Methodology (RSM) based on central composite rotatable design (CCRD) was used to optimise the main important reaction variables, such as enzyme amount, reaction temperature, substrate molar ratio, and reaction time along with immobilised lipase from Candida Antarctica (Novozym 435) as a biocatalyst. The RSM data indicated that the reaction temperature was less significant in comparison to other factors for the production of a KMO ester. By using this statistical analysis, a quadratic model was developed in order to correlate the preparation variable to the response (reaction yield). The optimum conditions for the enzymatic synthesis of KMO were as follows: an enzyme amount of 2.0 wt%, reaction temperature of 83.69 degrees C, substrate molar ratio of 1: 2.37 (mmole kojic acid: oleic acid) and a reaction time of 300.0 min. Under these conditions, the actual yield percentage obtained was 42.09%, which is comparably well with the maximum predicted value of 44.46%. Under the optimal conditions, Novozym 435 could be reused for 5 cycles for KMO production percentage yield of at least 40%. The results demonstrated that statistical analysis using RSM can be used efficiently to optimise the production of a KMO ester. Moreover, the optimum conditions obtained can be applied to scale-up the process and minimise the cost.	[Jumbri, Khairulazhar; Rozy, Mohd Fahruddin Al-Haniff; Ashari, Siti Efliza; Basri, Mahiran; Masoumi, Hamid Reza Fard] Univ Putra Malaysia, Fac Sci, Dept Chem, Upm Serdang, Selangor, Malaysia; [Mohamad, Rosfarizan] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Technol Bioproc, Upm Serdang, Selangor, Malaysia; [Ashari, Siti Efliza; Basri, Mahiran; Masoumi, Hamid Reza Fard] Univ Putra Malaysia, Enzyme & Microbial Technol Res Ctr, Upm Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Ashari, SE (corresponding author), Univ Putra Malaysia, Fac Sci, Dept Chem, Upm Serdang, Selangor, Malaysia.	ctefliza@upm.edu.my	jumbri, khairulazhar/P-2679-2019; jumbri, khairulazhar/H-5737-2016; Ashari, Efliza/U-7371-2019	jumbri, khairulazhar/0000-0003-3345-6453; Mohamad, Rosfarizan/0000-0001-5672-1905	UPM-IPM [9406100]; Ministry of Science Technology and Innovation, Malaysia	UPM-IPM; Ministry of Science Technology and Innovation, Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	The work was funded by UPM-IPM (grant number 9406100) and the Ministry of Science Technology and Innovation, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; We acknowledge the financial support from UPM-IPM (grant number 9406100) and the Ministry of Science Technology and Innovation, Malaysia.	Ashari SE, 2009, J OLEO SCI, V58, P503, DOI 10.5650/jos.58.503; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Burdock FA, 2001, REGUL TOXICOL PHARM, V33, P80, DOI 10.1006/rtph.2000.1442; Chaibakhsh N, 2009, J IND MICROBIOL BIOT, V36, P1149, DOI 10.1007/s10295-009-0596-x; Chen CS, 2002, J SCI FOOD AGR, V82, P601, DOI 10.1002/jsfa.1083; Dossat V, 2002, ENZYME MICROB TECH, V30, P90, DOI 10.1016/S0141-0229(01)00453-7; El-Boulifi N, 2014, ENZYME MICROB TECH, V55, P128, DOI 10.1016/j.enzmictec.2013.10.009; Foresti ML, 2005, BIOCHEM ENG J, V25, P69, DOI 10.1016/j.bej.2005.04.002; Gunawan ER, 2005, ENZYME MICROB TECH, V37, P739, DOI 10.1016/j.enzmictec.2005.04.010; Hamzaoui AH, 2008, HYDROMETALLURGY, V90, P1, DOI 10.1016/j.hydromet.2007.09.005; Ismail A, 1999, J BIOTECHNOL, V69, P135, DOI 10.1016/S0168-1656(99)00041-3; Kaatz H, 1999, Z NATURFORSCH C, V54, P70; Khamaruddin NH, 2008, J OIL PALM RES, V20, P461; Kim H, 2004, BIOORG MED CHEM LETT, V14, P2843, DOI 10.1016/j.bmcl.2004.03.046; Krishna SH, 2001, PROCESS BIOCHEM, V37, P9; Lajis AFB, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/952452; Li Y, 2005, J AM SOC BREW CHEM, V63, P171, DOI 10.1094/ASBCJ-63-0171; Liu KJ, 1998, J AM OIL CHEM SOC, V75, P1507, DOI 10.1007/s11746-998-0086-8; Masoumi HRF, 2013, SCI WORLD J, DOI 10.1155/2013/962083; Park JY, 2010, RENEW ENERG, V35, P614, DOI 10.1016/j.renene.2009.08.007; Salina M.R., 2005, J OLEO SCI, V54, P203, DOI [10.5650/jos.54.203, DOI 10.5650/JOS.54.203]; Uher M, 2008, CESKA SLOV FARM, V49, P119; Virto C, 1999, ENZYME MICROB TECH, V24, P651, DOI 10.1016/S0141-0229(98)00153-7; Yingying L, 2009, J BIOBASED MATER BIO, V3, P324	24	21	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144664	10.1371/journal.pone.0144664	http://dx.doi.org/10.1371/journal.pone.0144664			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657030	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900083
J	Kim, DH; Kim, L; Park, W; Chang, WH; Kim, YH; Lee, SW; Kwon, GH				Kim, Da-Hye; Kim, Leahyun; Park, Wanjoo; Chang, Won Hyuk; Kim, Yun-Hee; Lee, Seong-Whan; Kwon, Gyu Hyun			Analysis of Time-Dependent Brain Network on Active and MI Tasks for Chronic Stroke Patients	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; CORTICAL MOTOR AREAS; FINGER MOVEMENTS; MENTAL PRACTICE; EEG SIGNALS; IMAGERY; CORTEX; RECOVERY; REORGANIZATION; ORGANIZATION	Several researchers have analyzed brain activities by investigating brain networks. However, there is a lack of the research on the temporal characteristics of the brain network during a stroke by EEG and the comparative studies between motor execution and imagery, which became known to have similar motor functions and pathways. In this study, we proposed the possibility of temporal characteristics on the brain networks of a stroke. We analyzed the temporal properties of the brain networks for nine chronic stroke patients by the active and motor imagery tasks by EEG. High beta band has a specific role in the brain network during motor tasks. In the high beta band, for the active task, there were significant characteristics of centrality and small-worldness on bilateral primary motor cortices at the initial motor execution. The degree centrality significantly increased on the contralateral primary motor cortex, and local efficiency increased on the ipsilateral primary motor cortex. These results indicate that the ipsilateral primary motor cortex constructed a powerful subnetwork by influencing the linked channels as compensatory effect, although the contralateral primary motor cortex organized an inefficient network by using the connected channels due to lesions. For the MI task, degree centrality and local efficiency significantly decreased on the somatosensory area at the initial motor imagery. Then, there were significant correlations between the properties of brain networks and motor function on the contralateral primary motor cortex and somatosensory area for each motor execution/imagery task. Our results represented that the active and MI tasks have different mechanisms of motor acts. Based on these results, we indicated the possibility of customized rehabilitation according to different motor tasks. We expect these results to help in the construction of the customized rehabilitation system depending on motor tasks by understanding temporal functional characteristics on brain network for a stroke.	[Kim, Da-Hye; Kim, Leahyun; Park, Wanjoo] Korea Inst Sci & Technol, Ctr Bion, Seoul, South Korea; [Kwon, Gyu Hyun] Hanyang Univ, Grad Sch Technol & Innovat Management, Seoul 133791, South Korea; [Kim, Da-Hye; Park, Wanjoo; Lee, Seong-Whan] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Kim, Leahyun] Univ Sci & Technol, Dept HCI & Robot, Seoul, South Korea; [Chang, Won Hyuk; Kim, Yun-Hee] Sungkyunkwan Univ, Dept Phys & Rehabil Med, Ctr Prevent & Rehabil, Heart Vasc & Stroke Inst,Samsung Med Ctr,Sch Med, Seoul, South Korea	Korea Institute of Science & Technology (KIST); Hanyang University; Korea University; Sungkyunkwan University (SKKU); Samsung Medical Center	Kwon, GH (corresponding author), Hanyang Univ, Grad Sch Technol & Innovat Management, Seoul 133791, South Korea.	dahyekim@kist.re.kr; ghkwon@hanyang.ac.kr	Kim, Yun-Hee/GVS-6426-2022; Kim, Yun Hee/F-4600-2014		IT R&D program of MOTIE/MISP/KEIT [10045452]; Development of Multimodal Brain-Machine Interface System Based on User Intent Recognition Project; Development of Robot-Assisted Motor Rehabilitation of the Upper Limb Using Bio-Signal Interfaces Project of the Korea Institute of Science and Technology (KIST), South Korea; ICT & Future Planning and Components & Materials Technology Development Program - Ministry of Trade, Industry Energy [10043826]; SMC-KIST Translational Research Program [SMO1140041]; National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2014R1A2A1A01005128]	IT R&D program of MOTIE/MISP/KEIT; Development of Multimodal Brain-Machine Interface System Based on User Intent Recognition Project; Development of Robot-Assisted Motor Rehabilitation of the Upper Limb Using Bio-Signal Interfaces Project of the Korea Institute of Science and Technology (KIST), South Korea; ICT & Future Planning and Components & Materials Technology Development Program - Ministry of Trade, Industry Energy; SMC-KIST Translational Research Program; National Research Foundation of Korea (NRF) - Korean government (MSIP)(National Research Foundation of Korea)	This work was partly supported by the IT R&D program of MOTIE/MISP/KEIT (10045452), the Development of Multimodal Brain-Machine Interface System Based on User Intent Recognition Project, the Development of Robot-Assisted Motor Rehabilitation of the Upper Limb Using Bio-Signal Interfaces Project of the Korea Institute of Science and Technology (KIST), South Korea, and the ICT & Future Planning and Components & Materials Technology Development Program (10043826) funded by the Ministry of Trade, Industry & Energy, as well as a grant from the SMC-KIST Translational Research Program (SMO1140041) and the National Research Foundation of Korea (NRF) funded by the Korean government (MSIP) (NRF-2014R1A2A1A01005128) (WHC & YHK).	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Andres RH, 2011, BRAIN, V134, P1777, DOI 10.1093/brain/awr094; Bai O, 2005, CLIN NEUROPHYSIOL, V116, P1213, DOI 10.1016/j.clinph.2005.01.006; Barclay-Goddard R, 2011, STROKE, V42, pE574, DOI 10.1161/STROKEAHA.111.627414; Bear M.F., 2007, NEUROSCIENCE; Borgatti SP, 2006, SOC NETWORKS, V28, P466, DOI 10.1016/j.socnet.2005.11.005; Braun SM, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-34; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chen JL, 2005, J NEUROSCI, V25, P2366, DOI 10.1523/JNEUROSCI.5071-04.2005; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; Deiber MP, 1998, NEUROIMAGE, V7, P73, DOI 10.1006/nimg.1997.0314; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; Fallani FD, 2013, NEUROIMAGE, V83, P438, DOI 10.1016/j.neuroimage.2013.06.039; Fallani FD, 2012, INT J BIFURCAT CHAOS, V22, DOI 10.1142/S0218127412501581; Fallani FD, 2010, INT J BIFURCAT CHAOS, V20, P905, DOI 10.1142/S0218127410026198; Fallani FD, 2009, ANAT REC, V292, P2023, DOI 10.1002/ar.20965; Feydy A, 2002, STROKE, V33, P1610, DOI 10.1161/01.STR.0000017100.68294.52; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; GEVINS A, 1995, TRENDS NEUROSCI, V18, P429, DOI 10.1016/0166-2236(95)94489-R; Gillen G., 2010, STROKE REHABILITATIO; Grefkes C, 2011, BRAIN, V134, P1264, DOI 10.1093/brain/awr033; Gross J, 2005, NEUROIMAGE, V26, P91, DOI 10.1016/j.neuroimage.2005.01.025; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Jung SH, 2005, ARCH PHYS MED REHAB, V86, P1706, DOI 10.1016/j.apmr.2004.11.043; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lalo E, 2007, EXP BRAIN RES, V177, P137, DOI 10.1007/s00221-006-0655-8; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Liu H, 2014, NEURAL REGEN RES, V9, P1474, DOI 10.4103/1673-5374.139465; Mauguiere F, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P79; Mima T, 2000, NEUROSCI LETT, V287, P93, DOI 10.1016/S0304-3940(00)01165-4; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Naito E, 2002, J NEUROSCI, V22, P3683; Ortigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006962; Park W, 2015, IEEE T NEUR SYS REH, V23, P351, DOI 10.1109/TNSRE.2014.2356472; Porro CA, 1996, J NEUROSCI, V16, P7688; Ramos-Murguialday A, 2013, ANN NEUROL, V74, P100, DOI 10.1002/ana.23879; Reagan D, 1989, HUMAN BRAIN ELECTROP; Roopun AK, 2006, P NATL ACAD SCI USA, V103, P15646, DOI 10.1073/pnas.0607443103; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sakkalis V, 2011, COMPUT BIOL MED, V41, P1110, DOI 10.1016/j.compbiomed.2011.06.020; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Solodkin A, 2004, CEREB CORTEX, V14, P1246, DOI 10.1093/cercor/bhh086; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Tangwiriyasakul C, 2014, CLIN NEUROPHYSIOL, V125, P1112, DOI 10.1016/j.clinph.2013.10.047; van Meer MPA, 2010, J NEUROSCI, V30, P3964, DOI 10.1523/JNEUROSCI.5709-09.2010; Wang L, 2012, 34 ANN INT C IEEE EN; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Ward NS, 2004, ARCH NEUROL-CHICAGO, V61, P1844, DOI 10.1001/archneur.61.12.1844; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WEINRICH M, 1982, J NEUROSCI, V2, P1329; World Health Organization, 2014, TOP 10 CAUS DEATH; Yan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077325; Zhang Y, 2008, NEUROSCIENCE, V156, P238, DOI 10.1016/j.neuroscience.2008.06.061	57	1	1	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0139441	10.1371/journal.pone.0139441	http://dx.doi.org/10.1371/journal.pone.0139441			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656269	Green Submitted, gold, Green Published			2022-12-27	WOS:000366715900001
J	Kita, Y; Hollo, G; Kita, R; Horie, D; Inoue, M; Hirakata, A				Kita, Yoshiyuki; Hollo, Gabor; Kita, Ritsuko; Horie, Daisuke; Inoue, Makoto; Hirakata, Akito			Differences of Intrasession Reproducibility of Circumpapillary Total Retinal Thickness and Circumpapillary Retinal Nerve Fiber Layer Thickness Measurements Made with the RS-3000 Optical Coherence Tomograph	PLOS ONE			English	Article							SPECTRAL-DOMAIN; SD-OCT; VARIABILITY; PROGRESSION; PARAMETERS	Purpose To evaluate the intrasession reproducibility of various thickness parameters used to diagnose and follow-up glaucoma, in particular circumpapillary total retinal thickness (cpTR) provided by the RS-3000 optical coherence tomograph (OCT). Methods Fifty-three healthy eyes of 28 subjects underwent three consecutive imaging with the RS-3000 Advance OCT (NIDEK, Aichi, Japan) to evaluate the intrasession reproducibility of circumpapillary total retinal thickness (cpTR), circumpapillary retinal nerve fiber layer thickness (cpRNFL), macular ganglion cell complex thickness (mGCC) and macular total retina thickness (mTR) measurements. Intraclass correlation (ICC), coefficient of variation (CV) and reproducibility coefficient (RC) were calculated for each parameter. Results The ICC and CV values for mean cpTR and cpRNFL were 0.987 and 0.897, and 0.60% and 2.81%, respectively. The RC values for the mean cpTR and cpRNFL were 5.95 mu m and 9.04 mu m, respectively. For all cpTR parameters the ICC values were higher and both the CV and RC values were lower than those for the corresponding cpRNFL parameters. The ICC and CV values for superior mGCC, inferior mGCC, superior mTR and inferior mTR were 0.983, 0.980, 0.983 and 0.988, and 0.84%, 0.98%, 0.48% and 0.43%, respectively. The RC values for superior mGCC, inferior mGCC, superior mTR and inferior mTR were 2.86 mu m, 3.12 mu m, 4.41 mu m and 4.43 mu m, respectively. Conclusions Intrasession reproducibility of cpTR, mGCC and mTR measurements made on healthy eyes was high. Repeatability of cpTR measurements was better than that of the corresponding cpRNFL measurements. These results suggest that future clinical investigations addressing detection of glaucoma and glaucomatous progression with the RS-3000 OCT may benefit from focusing on the cpTR parameters.	[Kita, Yoshiyuki; Kita, Ritsuko; Horie, Daisuke; Inoue, Makoto; Hirakata, Akito] Kyorin Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Hollo, Gabor] Semmelweis Univ, Dept Ophthalmol, H-1085 Budapest, Hungary	Kyorin University; Semmelweis University	Kita, Y (corresponding author), Kyorin Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	kitakita220@gmail.com		Kita, Yoshiyuki/0000-0001-9665-1809				Akashi A, 2013, INVEST OPHTH VIS SCI, V54, P6025, DOI 10.1167/iovs.13-12630; [Anonymous], 2015, NAVIS EX US MAN, P345; Bland JM, 1986, BMJ-BRIT MED J, V313, P744; Garas A, 2010, OPHTHALMOLOGY, V117, P738, DOI 10.1016/j.ophtha.2009.08.039; Giani A, 2012, INVEST OPHTH VIS SCI, V53, P7637, DOI 10.1167/iovs.12-10047; Golzan SM, 2011, COMPUT METH PROG BIO, V104, P206, DOI 10.1016/j.cmpb.2011.08.005; Hirasawa H, 2013, INVEST OPHTH VIS SCI, V54, P2562, DOI 10.1167/iovs.12-10552; Kim NR, 2011, INVEST OPHTH VIS SCI, V52, P3413, DOI 10.1167/iovs.10-6648; Kim NR, 2010, INVEST OPHTH VIS SCI, V51, P4646, DOI 10.1167/iovs.09-5053; Kita Y, 2013, CLIN EXP OPHTHALMOL, V41, P674, DOI 10.1111/ceo.12089; Kita Y, 2013, J GLAUCOMA, V22, P757, DOI 10.1097/IJG.0b013e31825af58a; Kita Y, 2011, JPN J OPHTHALMOL, V55, P228, DOI 10.1007/s10384-011-0017-3; Lee KS, 2013, INVEST OPHTH VIS SCI, V54, P1941, DOI 10.1167/iovs.12-11160; Leite MT, 2011, OPHTHALMOLOGY, V118, P1334, DOI 10.1016/j.ophtha.2010.11.029; Leung CKS, 2009, OPHTHALMOLOGY, V116, P1257, DOI 10.1016/j.ophtha.2009.04.013; Matlach J, 2014, INVEST OPHTH VIS SCI, V55, P6536, DOI 10.1167/iovs.14-15072; Morooka S, 2012, INVEST OPHTH VIS SCI, V53, P4805, DOI 10.1167/iovs.12-9870; Mwanza JC, 2010, INVEST OPHTH VIS SCI, V51, P5724, DOI 10.1167/iovs.10-5222; Na JH, 2012, INVEST OPHTH VIS SCI, V53, P3817, DOI 10.1167/iovs.11-9369; Naghizadeh F, 2014, J GLAUCOMA, V23, P269, DOI 10.1097/IJG.0b013e3182741c69; Nakanishi H, 2015, GRAEF ARCH CLIN EXP, V253, P1143, DOI 10.1007/s00417-015-3026-y; Pierro L, 2011, INVEST OPHTH VIS SCI, V53, P5912; Seong M, 2010, INVEST OPHTH VIS SCI, V51, P1446, DOI 10.1167/iovs.09-4258; Simavli H, 2015, AM J OPHTHALMOL, V159, P545, DOI 10.1016/j.ajo.2014.12.004; Tenkumo K, 2013, JPN J OPHTHALMOL, V57, P451, DOI 10.1007/s10384-013-0254-8; Vajaranant TS, 2011, EYE, V25, P612, DOI 10.1038/eye.2011.17; Vizzeri G, 2009, BRIT J OPHTHALMOL, V93, P775, DOI 10.1136/bjo.2008.150698; Wadhwani M, 2015, J GLAUCOMA, V24, pe109, DOI 10.1097/IJG.0000000000000203; Weinreb RN, 2011, INVEST OPHTH VIS SCI, V52, P7842, DOI 10.1167/iovs.11-7895; Wu HJ, 2011, J GLAUCOMA, V20, P470, DOI 10.1097/IJG.0b013e3181f3eb64	30	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144721	10.1371/journal.pone.0144721	http://dx.doi.org/10.1371/journal.pone.0144721			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657805	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900093
J	Li, Q; Wang, XM				Li, Qiang; Wang, Xiaoming			Into Tibet: An Early Pliocene Dispersal of Fossil Zokor (Rodentia: Spalacidae) from Mongolian Plateau to the Hinterland of Tibetan Plateau	PLOS ONE			English	Article							KUNLUN PASS BASIN; MAMMALIAN FAUNAS; ZANDA BASIN; BIOSTRATIGRAPHY; NEOGENE; GEOCHRONOLOGY; EVOLUTION; HISTORY; MIOCENE; CLIMATE	This paper reports the fossil zokors (Myospalacinae) collected from the lower Pliocene (similar to 4.4 Ma) of Zanda Basin, southwestern Tibet, which is the first record in the hinterland of Tibetan Plateau within the Himalayan Range. Materials include 29 isolated molars belonging to Prosiphneus eriksoni (Schlosser, 1924) by having characters including large size, highly fused roots, upper molars of orthomegodont type, m1 anterior cap small and centrally located, and first pair of m1 reentrants on opposing sides, high crowns, and high value of dentine tract parameters. Based on the cladistics analysis, all seven species of Prosiphneus and P. eriksoni of Zanda form a monophyletic clade. P. eriksoni from Zanda, on the other hand, is nearly the terminal taxon of this clade. The appearance of P. eriksoni in Zanda represents a significant dispersal in the early Pliocene from its center of origin in north China and Mongolian Plateau, possibly via the Hol Xil-Qiangtang hinterland in northern Tibet. The fast evolving zokors are highly adapted to open terrains at a time when regional climates had become increasingly drier in the desert zones north of Tibetan Plateau during the late Miocene to Pliocene. The occurrence of this zokor in Tibet thus suggests a rather open steppe environment. Based on fossils of large mammals, we have formulated an "out of Tibet" hypothesis that suggests earlier and more primitive large mammals from the Pliocene of Tibet giving rise to the Ice Age megafauna. However, fossil records for large mammals are still too poor to evaluate whether they have evolved from lineages endemic to the Tibetan Plateau or were immigrants from outside. The superior record of small mammals is in a better position to address this question. With relatively dense age intervals and numerous localities in much of northern Asia, fossil zokors provide the first example of an "into Tibet" scenario-earlier and more primitive taxa originated from outside of the Tibetan Plateau and the later the lineage became extinct in southwestern Tibet.	[Li, Qiang; Wang, Xiaoming] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Li, Qiang] Chinese Acad Sci, Ctr Excellence Tibetan Plateau Earth Sci, Beijing, Peoples R China; [Wang, Xiaoming] Nat Hist Museum Los Angeles Cty, Dept Vertebrate Paleontol, Los Angeles, CA USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences	Li, Q (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China.	liqiang@ivpp.ac.cn	Wang, Xiaoming/I-9033-2019	Wang, Xiaoming/0000-0003-1610-3840	Chinese Academy of Sciences [XDB03020104]; National Basic Research Program of China (973 Program) [2012CB821904]; National Natural Science Foundation of China [41472002, 40702004, 41430102]; National Science Foundation (US) [EAR-0446699, 0716507, 0958704, 1227212]; National Geographic Society [W22-08]; Division Of Earth Sciences [1227212] Funding Source: National Science Foundation	Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation (US)(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the Chinese Academy of Sciences (XDB03020104), National Basic Research Program of China (973 Program: 2012CB821904), National Natural Science Foundation of China (no. 41472002 and 40702004 to Q.L., and 41430102), National Science Foundation (US) (EAR-0446699, 0716507, 0958704, and 1227212 to X.W.), and National Geographic Society (no. W22-08 to Q.L.).	Deng T, 2011, SCIENCE, V333, P1285, DOI 10.1126/science.1206594; FAHLBUSCH V, 1983, SCI SIN B-CHEM B A M, V26, P205; Feng ZJ, 1986, MAMMALS OF XIXANG; Fortelius M, 2006, PALAEOGEOGR PALAEOCL, V238, P219, DOI 10.1016/j.palaeo.2006.03.042; Fortelius M, 2006, PALAEONTOGR ABT A, V277, P131; Fortelius M, 2014, ANNU REV EARTH PL SC, V42, P579, DOI 10.1146/annurev-earth-050212-124030; GENTRY AW, 1968, J MAMMAL, V49, P769, DOI 10.2307/1378744; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hu J.C., 1984, SICHUAN FAUNA EC, V2; Jansa SA, 2004, MOL PHYLOGENET EVOL, V31, P256, DOI 10.1016/j.ympev.2003.07.002; Kretzoi M., 1961, Vertebrata Hungarica, V3, P123; Leroy P, 1941, B FAN MEM I BIOL Z, V10, P167; Li DH, 1989, QINGHAI FAUNA EC; Li F-l., 1990, PALEONTOLOGY NGARI A, P186; Li Q, 2014, PALAEOGEOGR PALAEOCL, V411, P46, DOI 10.1016/j.palaeo.2014.06.029; Liu Li-Ping, 2013, Vertebrata Palasiatica, V51, P211; Luo ZX, 2000, FAUNA SINICA MAMMA 3, V6, P148; Maddison WP., 2021, MESQUITE MODULAR SYS; McKenna MC, 1997, CLASSIFICATION MAMMA; Nehring CWA, 1883, SITZUNGSBERICHTE GES, V1883, P19; Norris RW, 2004, MOL PHYLOGENET EVOL, V31, P972, DOI 10.1016/j.ympev.2003.10.020; O'Connor J.K., 2008, NEW MEXICO MUS NAT H, V44, P431; Pan QH, 2007, FIELD GUIDE MAMMALS; Pavlinov JY, 1987, STUDY FAUNAS SOVIET, P1; Polly P. D., 2015, EVOLUTION RODENTS AD, P246, DOI DOI 10.1017/CBO9781107360150.010; Qiu Z.X., 2004, PALAEONTOL SIN NEW C, P1; Qiu ZD., 1996, MIDDLE MIOCENE MICRO; Qiu ZD, NEOGENE RODENTS CENT; Qiu Zhu-Ding, 2006, Vertebrata Palasiatica, V44, P164; Qiu Zhu-Ding, 2013, P155; Qiu Zhuding, 2000, Senckenbergiana Lethaea, V80, P173; Rossolimo OL, 1997, DIVERSITY OF MAMMALS; Saylor J, 2008, THESIS; Saylor J, 2010, GEOSPHERE, V6, P74, DOI 10.1130/GES00507.1; Saylor J, 2010, TECTONICS, V29, DOI 10.1029/2008TC002390; Schlosser M., 1924, Palaeontologia Sinica Series C, V1, P1; Teilhard de Chardin P., 1942, Pub Inst Geo-Biol Pekin, VNo. 9, P1; Teilhard de Chardin P., 1926, Annales de Paleontologie, V15, P1; Teilhard de Chardin P., 1931, Palaeontologia Sinica Series C, V9, P1; Tseng ZJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2686; Tseng ZJ, 2013, J VERTEBR PALEONTOL, V33, P1457, DOI 10.1080/02724634.2013.775142; Wang N, 2010, SCI CHINA EARTH SCI, V53, P485, DOI 10.1007/s11430-010-0048-5; Wang SF, 2008, CHINESE SCI BULL, V53, P1393, DOI 10.1007/s11434-008-0132-9; Wang SF, 2008, INT GEOL REV, V50, P121, DOI 10.2747/0020-6814.50.2.121; Wang X, 2014, QUATERN INT, V355, P3; Wang XM, 2015, GONDWANA RES, V27, P1335, DOI 10.1016/j.gr.2014.10.014; Wang XM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0893; Wang Xiaoming, 2013, P274; Wang XM, 2013, PALAEOGEOGR PALAEOCL, V374, P81, DOI 10.1016/j.palaeo.2013.01.007; Wang Y. X., 2003, COMPLETE CHECKLIST M; Wilson D.E., 2005, MAMMAL SPECIES WORLD, V2; [徐彦龙 XU Yanlong], 2007, [地质论评, Geological Review], V53, P250; [于振江 YU Zhenjiang], 2006, [地层学杂志, Journal of Stratigraphy], V30, P223; Zhang R., 1997, DISTRIBUTION MAMMALI; Zhang XY, 1978, VERTEBRAT PALASIATIC, V16, P288; [郑绍华 Zheng Chaohua], 2004, [古脊椎动物学报, Vertebrata Palasiatica], V42, P297; Zheng CL, 1979, REPORT NGARI REGIONA, P191; ZHENG S, 1982, VERTEBRAT PALASIATIC, V20, P35; Zheng S.H, 1997, EVIDENCE EVOLUTION E, P137; Zheng S.H., 1985, LOESS ENV, P113; ZHENG SH, 1985, VERTEBRAT PALASIATIC, V23, P89; Zheng SH., 1980, PALAEONTOLOGY XIZANG, V1, P33; Zheng Shao-Hua, 2001, Vertebrata Palasiatica, V39, P215; Zheng Shaohua, 1994, National Science Museum Monographs, V8, P57; Zong G. F, 1996, CENOZOIC MAMMALS ENV	65	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144993	10.1371/journal.pone.0144993	http://dx.doi.org/10.1371/journal.pone.0144993			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658457	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900163
J	Vergara, M; Berrios, J; Martinez, I; Diaz-Barrera, A; Acevedo, C; Reyes, JG; Gonzalez, R; Altamirano, C				Vergara, Mauricio; Berrios, Julio; Martinez, Irene; Diaz-Barrera, Alvaro; Acevedo, Cristian; Reyes, Juan G.; Gonzalez, Ramon; Altamirano, Claudia			Endoplasmic Reticulum-Associated rht-PA Processing in CHO Cells: Influence of Mild Hypothermia and Specific Growth Rates in Batch and Chemostat Cultures	PLOS ONE			English	Article							HAMSTER OVARY CELLS; ER STRESS; TRANSCRIPTION LEVEL; ENDOTHELIAL-CELLS; TEMPERATURE; PRODUCTIVITY; DEGRADATION; EXPRESSION; TUNICAMYCIN; PHOSPHORYLATION	Background Chinese hamster ovary (CHO) cells are the main host for producing recombinant proteins with human therapeutic applications mainly because of their capability to perform proper folding and glycosylation processes. In addition, mild hypothermia is one of the main strategies for maximising the productivity of these systems. However, little information is available on the effect of culture temperature on the folding and degradation processes of recombinant proteins that takes place in the endoplasmic reticulum. Methods In order to evaluate the effect of the mild hypothermia on processing/endoplasmatic reticulum-associated degradation (ERAD) processes, batch cultures of CHO cells producing recombinant human tissue plasminogen activator (rht-PA) were carried out at two temperatures (37 degrees C and 33 degrees C) and treated with specific inhibitors of glycosylation and ERAD I (Ubiquitin/Proteasome system) or ERAD II (Autophagosoma/Lisosomal system) pathways. The effect of mild hypothermia was analysed separately from its indirect effect on specific cell growth rate. To do this, chemostat cultures were carried out at the same incubation conditions as the batch cultures, controlling cell growth at high (0.017 h(-1)) and low (0.012 h(-1)) dilution rates. For a better understanding of the investigated phenomenon, cell behaviour was also analysed using principal component analysis (PCA). Results and Conclusion Results suggest that rht-PA is susceptible to degradation by both ERAD pathways studied, revealing that processing and/or ERAD processes are sensitive to temperature cultivation in batch culture. Moreover, by isolating the effect of culture temperature from the effect of cell growth rate verifyed by using chemostat cultures, we have found that processing and/or ERAD processes are more sensitive to reduction in specific growth rate than low temperature, and that temperature reduction may have a positive effect on protein processing. Interestingly, PCA indicated that the integrated performance displayed by CHO cells is modulated predominantly by specific growth rate, indicating that the culture temperature has a lower weighted effect within the range of conditions evaluated in this work.	[Vergara, Mauricio; Reyes, Juan G.] Pontificia Univ Catolica Valparaiso, Inst Chem, Curauma, Chile; [Vergara, Mauricio; Berrios, Julio; Martinez, Irene; Diaz-Barrera, Alvaro; Altamirano, Claudia] Pontificia Univ Catolica Valparaiso, Sch Biochem Engn, Valparaiso 4059, Chile; [Acevedo, Cristian] Univ Tecn Federico Santa Maria, Biotechnol Ctr Dr Daniel Alkalay Lowitt, Valparaiso, Chile; [Gonzalez, Ramon] Rice Univ, Dept Chem & Biomol Engn, Houston, TX USA; [Gonzalez, Ramon] Rice Univ, Dept Bioengn, Houston, TX USA; [Altamirano, Claudia] CREAS CONICYT Reg GORE Valparaiso, Curauma, Chile	Pontificia Universidad Catolica de Valparaiso; Pontificia Universidad Catolica de Valparaiso; Universidad Tecnica Federico Santa Maria; Rice University; Rice University	Altamirano, C (corresponding author), Pontificia Univ Catolica Valparaiso, Sch Biochem Engn, Av Brasil 2085, Valparaiso 4059, Chile.	claudia.altamirano@ucv.cl	Martinez, Irene/U-5251-2017; Acevedo, Cristian A./D-5133-2011	Berrios, Julio/0000-0002-6180-0023; Reyes, Juan G./0000-0001-5541-5172; Altamirano, Claudia/0000-0002-6389-086X; Alvaro, Diaz-Barrera/0000-0002-0922-8648	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1120667, 3150373]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by the 1120667 Fondo Nacional de Desarrollo Cientifico y Tecnologico (http://www.conicyt.cl/fondecyt/) to CA, and 3150373 Fondo Nacional de Desarrollo Cientifico y Tecnologico (http://www.conicyt.cl/fondecyt/) to MV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamirano C, 2013, ELECTRON J BIOTECHN, V16, DOI 10.2225/vol16-issue3-fulltext-2; Baik JY, 2006, BIOTECHNOL BIOENG, V93, P361, DOI 10.1002/bit.20717; Becerra S, 2012, BIOCHEM ENG J, V60, P1, DOI 10.1016/j.bej.2011.10.003; Berrios J, 2011, CHEM ENG SCI, V66, P2431, DOI 10.1016/j.ces.2011.03.011; Berrios J, 2009, BIOTECHNOL LETT, V31, P1493, DOI 10.1007/s10529-009-0050-1; Bollati-Fogolin M, 2005, BIOTECHNOL PROGR, V21, P17, DOI 10.1021/bp049825t; Bonuccelli G, 2003, AM J PATHOL, V163, P1663, DOI 10.1016/S0002-9440(10)63523-7; Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; Chen FY, 2015, J MOL NEUROSCI, V55, P995, DOI 10.1007/s12031-014-0456-7; Donoso G, 2005, BIOCHEM J, V387, P897, DOI 10.1042/BJ20041312; Fox SR, 2005, BIOTECHNOL APPL BIOC, V41, P255, DOI 10.1042/BA20040066; Frigerio L, 2000, CURR BIOL, V10, pR674, DOI 10.1016/S0960-9822(00)00680-1; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Gomez N, 2012, BIOTECHNOL BIOENG, V109, P125, DOI 10.1002/bit.23288; HEMMING FW, 1982, BIOSCIENCE REP, V2, P203, DOI 10.1007/BF01136719; HICKMAN S, 1977, J BIOL CHEM, V252, P4402; HUANG ZY, 1992, J MED CHEM, V35, P2048, DOI 10.1021/jm00089a015; Hussain H, 2014, BIOTECHNOL LETT, V36, P1581, DOI 10.1007/s10529-014-1537-y; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kumar N, 2007, CYTOTECHNOLOGY, V53, P33, DOI 10.1007/s10616-007-9047-6; Lim Y, 2010, BIOTECHNOL APPL BIOC, V55, P175, DOI 10.1042/BA20090363; Mancini R, 2003, J BIOL CHEM, V278, P46895, DOI 10.1074/jbc.M302979200; Masterton RJ, 2010, BIOTECHNOL BIOENG, V105, P215, DOI 10.1002/bit.22533; Mead EJ, 2009, BIOTECHNOL BIOENG, V102, P1593, DOI 10.1002/bit.22201; Novoradovskaya N, 1998, J CLIN INVEST, V101, P2693, DOI 10.1172/JCI549; Perez GT, 1998, CAN J PHYSIOL PHARM, V76, P1033, DOI 10.1139/cjpp-76-10-11-1033; PONTREMOLI S, 1986, J BIOL CHEM, V261, P8309; Shenkman M, 2007, CELL STRESS CHAPERON, V12, P373, DOI 10.1379/CSC-281.1; Shibata T, 2002, IMMUNOL CELL BIOL, V80, P226, DOI 10.1046/j.1440-1711.2002.01079.x; SHIELDS PP, 1991, BIOCHEM BIOPH RES CO, V177, P1006, DOI 10.1016/0006-291X(91)90638-N; So JS, 2015, MOL CELL BIOL, V35, P2761, DOI 10.1128/MCB.00215-15; Trummer E, 2006, BIOTECHNOL BIOENG, V94, P1033, DOI 10.1002/bit.21013; Vergara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093865; WALES RG, 1990, REPROD FERT DEVELOP, V2, P35, DOI 10.1071/RD9900035; Yoon SK, 2006, J BIOTECHNOL, V122, P463, DOI 10.1016/j.jbiotec.2005.09.010; Yoon SK, 2003, BIOTECHNOL BIOENG, V82, P289, DOI 10.1002/bit.10566; Yoon SK, 2003, BIOTECHNOL PROGR, V19, P1383, DOI 10.1021/bp034051m	37	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144224	10.1371/journal.pone.0144224	http://dx.doi.org/10.1371/journal.pone.0144224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659083	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903600028
J	Wei, NL; Jia, YF; Wang, X; Zhang, YNA; Yuan, GQ; Zhao, BT; Wang, Y; Zhang, K; Zhang, XD; Pan, YW; Zhang, JG				Wei, Naili; Jia, Yanfei; Wang, Xiu; Zhang, Yinian; Yuan, Guoqiang; Zhao, Baotian; Wang, Yao; Zhang, Kai; Zhang, Xinding; Pan, Yawen; Zhang, Jianguo			Risk Factors for Postoperative Fibrinogen Deficiency after Surgical Removal of Intracranial Tumors	PLOS ONE			English	Article							COAGULATION; OBESITY; PLASMA; TRANSFUSION; BLOOD; PREGNANCY; INJURY; CELLS	Higher levels of fibrinogen, a critical element in hemostasis, are associated with increased postoperative survival rates, especially for patients with massive operative blood loss. Fibrinogen deficiency after surgical management of intracranial tumors may result in postoperative intracranial bleeding and severely worsen patient outcomes. However, no previous studies have systematically identified factors associated with postoperative fibrinogen deficiency. In this study, we retrospectively analyzed data from patients who underwent surgical removal of intracranial tumors in Beijing Tiantan Hospital date from 1/1/2013to12/31/2013. The present study found that patients with postoperative fibrinogen deficiency experienced more operative blood loss and a higher rate of postoperative intracranial hematoma, and they were given more blood transfusions, more plasma transfusions, and were administered larger doses of hemocoagulase compared with patients without postoperative fibrinogen deficiency. Likewise, patients with postoperative fibrinogen deficiency had poorer extended Glasgow Outcome Scale (GOSe), longer hospital stays, and greater hospital expenses than patients without postoperative fibrinogen deficiency. Further, we assessed a comprehensive set of risk factors associated with postoperative fibrinogen deficiency via multiple linear regression. We found that body mass index (BMI), the occurrence of postoperative intracranial hematoma, and administration of hemocoagulasewere positively associated with preoperative-to-postoperative plasma fibrinogen consumption; presenting with a malignant tumor was negatively associated with fibrinogen consumption. Contrary to what might be expected, intraoperative blood loss, the need for blood transfusion, and the need for plasma transfusion were not associated with plasma fibrinogen consumption. Considering our findings together, we concluded that postoperative fibrinogen deficiency is closely associated with postoperative bleeding and poor outcomes and merits careful attention. Practitioners should monitor plasma fibrinogen levels in patients with risk factors for postoperative fibrinogen deficiency. In addition, postoperative fibrinogen deficiency should be remediated as soon as possible to reduce postoperative bleeding, especially when postoperative bleeding is confirmed.	[Wei, Naili; Jia, Yanfei; Zhang, Yinian; Zhang, Xinding; Pan, Yawen] Lanzhou Univ, Dept Neurosurg, Hosp 2, Lanzhou 730030, Gansu, Peoples R China; [Wang, Xiu; Zhao, Baotian; Wang, Yao; Zhang, Kai; Zhang, Jianguo] Capital Med Univ, Dept Neurosurg, Beijing Tiantan Hosp, Beijing 100050, Peoples R China; [Yuan, Guoqiang] Lanzhou Univ, Inst Neurol, Hosp 2, Lanzhou 730030, Gansu, Peoples R China	Lanzhou University; Capital Medical University; Lanzhou University	Zhang, K (corresponding author), Capital Med Univ, Dept Neurosurg, Beijing Tiantan Hosp, Tiantanxili 6, Beijing 100050, Peoples R China.	zhangkai62035@163.com			Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding [ZYLX201305]	Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding	The present study was funded by Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding (no. ZYLX201305).	Adelmann D, 2014, BRIT J ANAESTH, V113, P628, DOI 10.1093/bja/aeu133; Bell WR, 1997, DRUGS, V54, P18, DOI 10.2165/00003495-199700543-00005; Bilge YD, 2012, PEDIATR HEMAT ONCOL, V29, P721, DOI 10.3109/08880018.2012.729649; Erber WN, 2002, TRANSFUS APHER SCI, V27, P83, DOI 10.1016/S1473-0502(02)00029-0; Hellstern P, 2002, THROMB RES, V107, pS53, DOI 10.1016/S0049-3848(02)00153-6; HIIPPALA ST, 1995, ANESTH ANALG, V81, P360, DOI 10.1097/00000539-199508000-00026; HSIEH V, 1986, NEUROCHIRURGIE, V32, P404; Kolodziejczyk J, 2013, WSPOLCZESNA ONKOL, V17, P113, DOI 10.5114/wo.2013.34611; Lang T, 2009, ANESTH ANALG, V108, P751, DOI 10.1213/ane.0b013e3181966675; Levy JH, 2014, TRANSFUSION, V54, P1389, DOI 10.1111/trf.12431; Levy JH, 2012, ANESTH ANALG, V114, P261, DOI 10.1213/ANE.0b013e31822e1853; Lovely R, 2013, J PEDIATR-US, V163, P333, DOI 10.1016/j.jpeds.2013.01.004; Luostarinen T, 2012, J ANESTH, V26, P770, DOI 10.1007/s00540-012-1400-z; Martini WZ, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-2; Mertens I, 2002, Obes Rev, V3, P85, DOI 10.1046/j.1467-789X.2002.00056.x; Neerman-Arbez M, 2007, HUM MUTAT, V28, P540, DOI 10.1002/humu.20483; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Nielsen VG, 2014, ANESTH ANALG, V118, P919, DOI 10.1213/ANE.0000000000000048; Palumbo JS, 2000, BLOOD, V96, P3302, DOI 10.1182/blood.V96.10.3302; Seifman MA, 2011, NEUROSURG REV, V34, P393, DOI 10.1007/s10143-010-0304-3; Sharma S, 2013, INT J OBSTET ANESTH, V22, P113, DOI 10.1016/j.ijoa.2012.12.004; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Simpson-Haidaris PJ, 2001, ANN NY ACAD SCI, V936, P406; Smrtka MP, 2012, THROMB RES, V129, P204, DOI 10.1016/j.thromres.2011.08.023; Sorensen B, 2011, THROMB RES, V128, pS13, DOI 10.1016/S0049-3848(12)70004-X; Vorster HH, 1999, THROMB RES, V95, P137, DOI 10.1016/S0049-3848(99)00033-X; Vu TT, 2013, J BIOL CHEM, V288, P16862, DOI 10.1074/jbc.M113.464750; Wang Zhaoyue, 2014, Zhonghua Xue Ye Xue Za Zhi, V35, P50, DOI 10.3760/cma.j.issn.0253-2727.2014.01.013; Weiss G, 2011, BLOOD COAGUL FIBRIN, V22, P727, DOI 10.1097/MBC.0b013e32834cb343; Yaddanapudi S, 2014, INDIAN J ANAESTH, V58, P538, DOI 10.4103/0019-5049.144648; Zhang L, 2011, CLIN APPL THROMB-HEM, V17, P75, DOI 10.1177/1076029609347903; Zhu JF, 2014, CHIN J CANCER, V33, DOI 10.5732/cjc.012.10307	32	9	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144551	10.1371/journal.pone.0144551	http://dx.doi.org/10.1371/journal.pone.0144551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658430	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903600056
J	Cohen, AL; Shavalian, E; Rube, M				Cohen, Anna-Lisa; Shavalian, Elliot; Rube, Moshe			The Power of the Picture: How Narrative Film Captures Attention and Disrupts Goal Pursuit	PLOS ONE			English	Article							TRANSPORTATION; COMPREHENSION; MEMORY; MODEL	Narrative transportation is described as a state of detachment that arises when one becomes immersed in the narrative of a story. Participants viewed either an intact version of an engaging 20 min film, "Bang You're Dead!," (1961) by Alfred Hitchcock (contiguous condition), or a version of the same film with scenes presented out of order (noncontiguous condition). In this latter condition, the individual scenes were intact but were presented out of chronological order. Participants were told a cover story that we were interested in the amount of gun violence depicted in films. Both groups were given the goal to remember to lift their hand every time they heard the word "gun" spoken during the film. Results revealed that participants were significantly less likely to remember to execute their goal in the contiguous condition, presumably because this narrative transported viewers' attention and thereby "hijacked" processing resources away from internal goals.	[Cohen, Anna-Lisa; Shavalian, Elliot; Rube, Moshe] Yeshiva Univ, New York, NY 10033 USA	Yeshiva University	Cohen, AL (corresponding author), Yeshiva Univ, New York, NY 10033 USA.	acohen11@yu.edu						Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bezdek MA, 2015, NEUROSCIENCE, V303, P338, DOI 10.1016/j.neuroscience.2015.06.055; Bruner J. S., 1986, ACTUAL MINDS POSSIBL, DOI DOI 10.4159/9780674029019; Busselle R, 2008, COMMUN THEOR, V18, P255, DOI 10.1111/j.1468-2885.2008.00322.x; Csikszentmihalyi M., 1990, FLOW PSYCHOL OPTIMAL; Dayan Daniel, 1976, MOVIES METHODS ANTHO, VI, P438; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gerrig Richard J., 1993, EXPERIENCING NARRATI; Green MC, 2000, J PERS SOC PSYCHOL, V79, P701, DOI 10.1037/0022-3514.79.5.701; Hasson U, 2008, J NEUROSCI, V28, P2539, DOI 10.1523/JNEUROSCI.5487-07.2008; Hasson U, 2008, PROJECTIONS, V2, P1, DOI 10.3167/proj.2008.020102; Johnson-Laird PN., 1989, FDN COGNITIVE SCI, P469; Kron A, 2010, J EXP PSYCHOL GEN, V139, P520, DOI 10.1037/a0020008; Kuhl J, 1984, Prog Exp Pers Res, V13, P99; Mar RA, 2008, PERSPECT PSYCHOL SCI, V3, P173, DOI 10.1111/j.1745-6924.2008.00073.x; Mital PK, 2011, COGN COMPUT, V3, P5, DOI 10.1007/s12559-010-9074-z; Moss J, 2007, J EXP PSYCHOL LEARN, V33, P876, DOI 10.1037/0278-7393.33.5.876; Shah JY, 2002, J EXP SOC PSYCHOL, V38, P368, DOI 10.1016/S0022-1031(02)00005-7; Shimamura AP, 2015, PSYCHOL AESTHET CREA, V9, P417, DOI 10.1037/aca0000025; Shimamura Arthur P., 2013, PSYCHOCINEMATICS EXP; Simons DJ, 1999, PERCEPTION, V28, P1059, DOI 10.1068/p2952; Smith RE, 2003, J EXP PSYCHOL LEARN, V29, P347, DOI 10.1037/0278-7393.29.3.347; Smith TJ, 2013, J VISION, V13, DOI 10.1167/13.8.16; TELLEGEN A, 1974, J ABNORM PSYCHOL, V83, P268, DOI 10.1037/h0036681; TRABASSO T, 1993, DISCOURSE PROCESS, V16, P3, DOI 10.1080/01638539309544827; van Dijk T., 1983, STRATEGIES DISCOURSE; van Laer T, 2014, J CONSUM RES, V40, P797, DOI 10.1086/673383; Zwaan RA, 1998, PSYCHOL BULL, V123, P162, DOI 10.1037/0033-2909.123.2.162	29	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144493	10.1371/journal.pone.0144493	http://dx.doi.org/10.1371/journal.pone.0144493			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YZ	26658578	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903500032
J	Rozov, SV; Porkka-Heiskanen, T; Panula, P				Rozov, Stanislav V.; Porkka-Heiskanen, Tarja; Panula, Pertti			On the Role of Histamine Receptors in the Regulation of Circadian Rhythms	PLOS ONE			English	Article							RAT SUPRACHIASMATIC NUCLEUS; CLOCK GENE-EXPRESSION; LOCOMOTOR-ACTIVITY; BEHAVIORAL CHARACTERIZATION; HISTIDINE-DECARBOXYLASE; PORTACAVAL ANASTOMOSIS; H-3 RECEPTORS; PHASE-SHIFTS; BRAIN; NEURONS	Several lines of evidence suggest a regulatory role of histamine in circadian rhythms, but little is known about signaling pathways that would be involved in such a putative role. The aim of this study was to examine whether histamine mediates its effects on the circadian system through Hrh1 or Hrh3 receptors. We assessed both diurnal and free-running locomotor activity rhythms of Hrh1(-/-) and Hrh3(-/-) mice. We also determined the expression of Per1, Per2 and Bmal1 genes in the suprachiasmatic nuclei, several areas of the cerebral cortex and striatum under symmetric 24 h light-dark cycle at zeitgeber times 14 and 6 by using radioactive in situ hybridization. We found no differences between Hrh1(-/-) and wild type mice in the length, amplitude and mesor of diurnal and free-running activity rhythms as well as in expression of Per1, Per2 and Bmal1 genes in any of the examined brain structures. The amplitude of free-running activity rhythm of the Hrh3(-/-) mice was significantly flattened, whereas the expression of the clock genes in Hrh3(-/-) mice was similar to the wild type animals in all of the assessed brain structures. Therefore, the knockout of Hrh1 receptor had no effects on the circadian rhythm of spontaneous locomotion, and a knockout of Hrh3 receptor caused a substantial reduction of free-running activity rhythm amplitude, but none of these knockout models affected the expression patterns of the core clock genes in any of the studied brain structures.	[Rozov, Stanislav V.; Panula, Pertti] Univ Helsinki, Fac Med, Neurosci Ctr, Helsinki, Finland; [Rozov, Stanislav V.; Panula, Pertti] Univ Helsinki, Dept Anat, Fac Med, Helsinki, Finland; [Porkka-Heiskanen, Tarja] Univ Helsinki, Dept Physiol, Fac Med, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Panula, P (corresponding author), Univ Helsinki, Fac Med, Neurosci Ctr, Helsinki, Finland.	pertti.panula@helsinki.fi		Stenberg, Tarja/0000-0003-1843-7625; Rozov, Stanislav/0000-0002-0352-5502; Panula, Pertti/0000-0002-1189-5132	Suomen akatemia [253416]; Sigrid Juseliuksen saatio	Suomen akatemia(Academy of Finland); Sigrid Juseliuksen saatio	This work was funded by Suomen akatemia, 253416 (http://www.aka.fi/), and Sigrid Juseliuksen saatio (http://www.sigridjuselius.fi/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2004, MOL BRAIN RES, V124, P178, DOI 10.1016/j.molbrainres.2004.02.015; Abe H, 2001, EUR J NEUROSCI, V14, P1121, DOI 10.1046/j.0953-816x.2001.01732.x; Abe H, 1998, NEUROSCI LETT, V258, P93, DOI 10.1016/S0304-3940(98)00877-5; [Anonymous], 2013, NLME LINEAR NONLINEA; BINGHAM C, 1982, CHRONOBIOLOGIA, V9, P397; Blandina P, 1996, BRIT J PHARMACOL, V119, P1656, DOI 10.1111/j.1476-5381.1996.tb16086.x; DAGERLIND A, 1992, HISTOCHEMISTRY, V98, P39, DOI 10.1007/BF00716936; EATON SJ, 1995, BRAIN RES, V695, P227, DOI 10.1016/0006-8993(95)00635-4; Eaton SJ, 1996, BRAIN RES BULL, V41, P227, DOI 10.1016/S0361-9230(96)00179-7; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Honma S, 1998, BIOCHEM BIOPH RES CO, V250, P83, DOI 10.1006/bbrc.1998.9275; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; Inoue I, 1996, P NATL ACAD SCI USA, V93, P13316, DOI 10.1073/pnas.93.23.13316; ITOWI N, 1989, NEUROENDOCRINOLOGY, V50, P187, DOI 10.1159/000125220; Karlstedt K, 2001, NEUROSCIENCE, V102, P201, DOI 10.1016/S0306-4522(00)00464-4; Kim YS, 2015, EUR J NEUROSCI, V42, P2467, DOI 10.1111/ejn.13030; LIOU SY, 1983, NEUROSCI LETT, V41, P109; Lozeva V, 2000, HEPATOLOGY, V31, P336, DOI 10.1002/hep.510310212; Lozeva V, 1998, J NEUROCHEM, V71, P1450; Masaki T, 2004, DIABETES, V53, P2250, DOI 10.2337/diabetes.53.9.2250; Masubuchi S, 2000, EUR J NEUROSCI, V12, P4206, DOI 10.1046/j.1460-9568.2000.01313.x; Michelsen KA, 2005, EUR J NEUROSCI, V22, P1997, DOI 10.1111/j.1460-9568.2005.04387.x; MONTI JM, 1990, BRAIN RES BULL, V25, P229, DOI 10.1016/0361-9230(90)90065-8; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Morisset S, 2000, NATURE, V408, P860, DOI 10.1038/35048583; PANULA P, 1984, P NATL ACAD SCI-BIOL, V81, P2572, DOI 10.1073/pnas.81.8.2572; PANULA P, 1989, NEUROSCIENCE, V28, P585, DOI 10.1016/0306-4522(89)90007-9; Rath MF, 2012, CHRONOBIOL INT, V29, P1289, DOI 10.3109/07420528.2012.728660; Saligrama N, 2013, J IMMUNOL, V191, P614, DOI 10.4049/jimmunol.1203137; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Schlicker E, 1999, FUNDAM CLIN PHARM, V13, P120, DOI 10.1111/j.1472-8206.1999.tb00330.x; Schwartz JRL, 2008, CURR NEUROPHARMACOL, V6, P367, DOI 10.2174/157015908787386050; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; STEHLE J, 1991, NEUROSCI LETT, V130, P217, DOI 10.1016/0304-3940(91)90400-N; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Takahashi K, 2002, J CLIN INVEST, V110, P1791, DOI 10.1172/JCI200215784; Takahashi K, 2006, J NEUROSCI, V26, P10292, DOI 10.1523/JNEUROSCI.2341-06.2006; Toyota H, 2002, MOL PHARMACOL, V62, P389, DOI 10.1124/mol.62.2.389; WATANABE T, 1984, BRAIN RES, V295, P13, DOI 10.1016/0006-8993(84)90811-4; Wisor JP, 2008, J NEUROSCI, V28, P7193, DOI 10.1523/JNEUROSCI.1150-08.2008; Yamamoto Y, 1997, METHOD FIND EXP CLIN, V19, P289; Yanai K, 1998, NEUROSCIENCE, V87, P479, DOI 10.1016/S0306-4522(98)00167-5	46	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144694	10.1371/journal.pone.0144694	http://dx.doi.org/10.1371/journal.pone.0144694			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26660098	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903500056
J	Tu, MY; Chen, HL; Tung, YT; Kao, CC; Hu, FC; Chen, CM				Tu, Min-Yu; Chen, Hsiao-Ling; Tung, Yu-Tang; Kao, Chao-Chih; Hu, Fu-Chang; Chen, Chuan-Mu			Short-Term Effects of Kefir-Fermented Milk Consumption on Bone Mineral Density and Bone Metabolism in a Randomized Clinical Trial of Osteoporotic Patients	PLOS ONE			English	Article							CALCIUM SUPPLEMENTATION; CASEIN PHOSPHOPEPTIDE; PARATHYROID-HORMONE; BIOACTIVE PEPTIDES; DIETARY CALCIUM; HEALTHY; ABSORPTION; INCREASES; TURNOVER; PROTEINS	Milk products are good sources of calcium that may reduce bone resorption and help prevent bone loss as well as promote bone remodeling and increase bone formation. Kefir is a product made by kefir grains that degrade milk proteins into various peptides with health-promoting effects, including antithrombotic, antimicrobial and calcium-absorption enhancing bioactivities. In a controlled, parallel, double-blind intervention study over 6 months, we investigated the effects of kefir-fermented milk (1,600 mg) supplemented with calcium bicarbonate (CaCO3, 1,500 mg) and bone metabolism in 40 osteoporosis patients, and compared them with CaCO3 alone without kefir supplements. Bone turnover markers were measured in fasting blood samples collected before therapy and at 1, 3, and 6 months. Bone mineral density (BMD) values at the spine, total hip, and hip femoral neck were assessed by dual-energy x-ray absorptiometry (DXA) at baseline and at 6 months. Among patients treated with kefir-fermented milk, the relationships between baseline turnover and 6 months changes in DXA-determined BMD were significantly improved. The serum beta C-terminal telopeptide of type I collagen (beta-CTX) in those with T-scores > -1 patients significantly decreased after three months treatment. The formation marker serum osteocalcin (OC) turned from negative to positive after 6 months, representing the effect of kefir treatment. Serum parathyroid hormone (PTH) increased significantly after treatment with kefir, but decreased significantly in the control group. PTH may promote bone remodeling after treatment with kefir for 6 months. In this pilot study, we concluded that kefir-fermented milk therapy was associated with short-term changes in turnover and greater 6-month increases in hip BMD among osteoporotic patients.	[Tu, Min-Yu; Tung, Yu-Tang; Kao, Chao-Chih; Chen, Chuan-Mu] Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan; [Tu, Min-Yu; Tung, Yu-Tang; Kao, Chao-Chih; Chen, Chuan-Mu] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 402, Taiwan; [Tu, Min-Yu] Taichung Armed Forces Gen Hosp, Dept Orthopaed Surg, Taichung 411, Taiwan; [Tu, Min-Yu] Hungkuang Univ, Dept Biomed Engn, Taichung 433, Taiwan; [Tu, Min-Yu] Natl Def Med Ctr, Sch Med, Taipei 114, Taiwan; [Chen, Hsiao-Ling] Da Yeh Univ, Dept Bioresources, Changhua 515, Taiwan; [Hu, Fu-Chang] Natl Taiwan Univ, Grad Inst Clin Med, Div Biostat, Taipei 100, Taiwan; [Hu, Fu-Chang] Natl Taiwan Univ, Coll Med, Sch Nursing, Taipei 100, Taiwan; [Chen, Chuan-Mu] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 402, Taiwan; [Chen, Chuan-Mu] Natl Chung Hsing Univ, iEGG Ctr, Taichung 402, Taiwan	National Chung Hsing University; National Chung Hsing University; Hungkuang University; National Defense Medical Center; Da Yeh University; National Taiwan University; National Taiwan University; National Chung Hsing University; National Chung Hsing University	Chen, CM (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan.	chchen1@dragon.nchu.edu.tw	Chen, Chuan-Mu/K-7049-2013	Chen, Chuan-Mu/0000-0003-2461-9150; Tung, Yu-Tang/0000-0002-4780-6496	National Science Council [NSC-99-2324-B-005-017-CC1, NSC-101-2324-B-005-002-CC1, MOST-101-2313-B-005-014-MY3, MOST-104-2313-B-005-043-MY3]; Ministry of Education, Taiwan, Republic of China, under the Aiming for the Top University plan [ATU-103-S0508]	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, Republic of China, under the Aiming for the Top University plan	This research was supported in part by grants NSC-99-2324-B-005-017-CC1, NSC-101-2324-B-005-002-CC1, MOST-101-2313-B-005-014-MY3, and MOST-104-2313-B-005-043-MY3 from the National Science Council and the Ministry of Education, Taiwan, Republic of China, under the Aiming for the Top University plan (ATU-103-S0508). The funders had no role in this design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphi B, 2009, EUR J NUTR, V48, P45, DOI 10.1007/s00394-008-0759-y; Ager JW, 2006, J MATER RES, V21, P1878, DOI 10.1557/JMR.2006.0242; Ammann P., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P43; Ammann P., 1996, OSTEOPOROSIS INT, V20, P1081; Benhamou CL, 2009, OSTEOPOROSIS INT, V20, P1085, DOI 10.1007/s00198-009-0867-4; Bennett T, 2000, BRIT J NUTR, V83, P673, DOI 10.1017/S0007114500000854; Black RE, 2002, AM J CLIN NUTR, V76, P675, DOI 10.1093/ajcn/76.3.675; BLUMSOHN A, 1994, J CLIN ENDOCR METAB, V79, P730, DOI 10.1210/jc.79.3.730; Bouhallab S, 2004, REPROD NUTR DEV, V44, P493, DOI 10.1051/rnd:2004053; Cashman KD, 2006, INT DAIRY J, V16, P1389, DOI 10.1016/j.idairyj.2006.06.017; Chang YT, 2011, J MECH BEHAV BIOMED, V4, P1412, DOI 10.1016/j.jmbbm.2011.05.011; Chen HL, 2015, OSTEOPOROSIS INT, V26, P589, DOI 10.1007/s00198-014-2908-x; Chen HL, 2014, INT J OBESITY, V38, P1172, DOI 10.1038/ijo.2013.236; DAWSONHUGHES B, 1990, NEW ENGL J MED, V323, P878, DOI 10.1056/NEJM199009273231305; Erba D, 2002, NUTRITION, V18, P743, DOI 10.1016/S0899-9007(02)00829-8; Heaney RP, 2000, J AM COLL NUTR, V19, p83S, DOI 10.1080/07315724.2000.10718088; HOROWITZ M, 1988, EUR J CLIN NUTR, V42, P775; HU JF, 1993, AM J CLIN NUTR, V58, P219, DOI 10.1093/ajcn/58.2.219; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kurland ES, 2000, J CLIN ENDOCR METAB, V85, P3069, DOI 10.1210/jc.85.9.3069; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Martini L, 2002, AM J CLIN NUTR, V76, P1345, DOI 10.1093/ajcn/76.6.1345; Matkovic V, 2004, J NUTR, V134, p701S, DOI 10.1093/jn/134.3.701S; MATKOVIC V, 1992, AM J CLIN NUTR, V55, P992, DOI 10.1093/ajcn/55.5.992; McKane WR, 1996, J CLIN ENDOCR METAB, V81, P1699, DOI 10.1210/jc.81.5.1699; Meisel H, 1999, ANTON LEEUW INT J G, V76, P207, DOI 10.1023/A:1002063805780; Moller NP, 2008, EUR J NUTR, V47, P171, DOI 10.1007/s00394-008-0710-2; MURPHY S, 1994, BRIT MED J, V308, P939, DOI 10.1136/bmj.308.6934.939; NAITO H, 1974, AGR BIOL CHEM TOKYO, V38, P1543, DOI 10.1080/00021369.1974.10861372; Narva M, 2004, EUR J NUTR, V43, P61, DOI 10.1007/s00394-004-0441-y; RECKER RR, 1985, AM J CLIN NUTR, V41, P254, DOI 10.1093/ajcn/41.2.254; REEVES RE, 1958, SCIENCE, V128, P472, DOI 10.1126/science.128.3322.472; Riggs BL, 1998, J BONE MINER RES, V13, P168, DOI 10.1359/jbmr.1998.13.2.168; Rubin MA, 2003, BONE, V33, P270, DOI 10.1016/S8756-3282(03)00194-7; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; SATO R, 1986, J NUTR SCI VITAMINOL, V32, P67, DOI 10.3177/jnsv.32.67; Scholz-Ahrens KE, 2000, BRIT J NUTR, V84, pS147; Scholz-Ahrens KE, 1991, GENE REGULATION STRU, P724; Scholz-Ahrens KE, 1996, OSTEOPOROSIS INT, V6, pS242; Suleiman S, 1997, AM J CLIN NUTR, V66, P937, DOI 10.1093/ajcn/66.4.937; Takada Y, 1997, INT DAIRY J, V7, P821, DOI 10.1016/S0958-6946(97)00073-3; Takada Y, 1996, BIOCHEM BIOPH RES CO, V223, P445, DOI 10.1006/bbrc.1996.0913; Tung YT, 2014, J DAIRY SCI, V97, P3281, DOI 10.3168/jds.2013-7505; Uenishi K, 2007, OSTEOPOROSIS INT, V18, P385, DOI 10.1007/s00198-006-0228-5; Zioupos P, 1998, BONE, V22, P57, DOI 10.1016/S8756-3282(97)00228-7	45	58	60	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144231	10.1371/journal.pone.0144231	http://dx.doi.org/10.1371/journal.pone.0144231			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26655888	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903500017
J	Weng, MT; Tsao, PN; Lin, HL; Tung, CC; Change, MC; Chang, YT; Wong, JM; Wei, SC				Weng, M. T.; Tsao, P. N.; Lin, H. L.; Tung, C. C.; Change, M. C.; Chang, Y. T.; Wong, J. M.; Wei, S. C.			Hes1 Increases the Invasion Ability of Colorectal Cancer Cells via the STAT3-MMP14 Pathway	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; SELF-RENEWAL; NOTCH; EXPRESSION; STAT3; DIFFERENTIATION; ACTIVATION; GROWTH; PROLIFERATION; FLUOROURACIL	The Notch pathway contributes to self-renewal of tumor-initiating cell and inhibition of normal colonic epithelial cell differentiation. Deregulated expression of Notch1 and Jagged1 is observed in colorectal cancer. Hairy/enhancer of split (HES) family, the most characterized targets of Notch, involved in the development of many cancers. In this study, we explored the role of Hes1 in the tumorigenesis of colorectal cancer. Knocking down Hes1 induced CRC cell senescence and decreased the invasion ability, whereas over-expression of Hes1 increased STAT3 phosphorylation activity and up-regulated MMP14 protein level. We further explored the expression of Hes1 in human colorectal cancer and found high Hes1 mRNA expression is associated with poor prognosis in CRC patients. These findings suggest that Hes1 regulates the invasion ability through the STAT3-MMP14 pathway in CRC cells and high Hes1 expression is a predictor of poor prognosis of CRC.	[Weng, M. T.] Far Eastern Mem Hosp, Dept Internal Med, New Taipei, Taiwan; [Weng, M. T.] Yuan Ze Univ, Dept Chem Engn & Mat Sci, Taoyuan, Taiwan; [Weng, M. T.; Lin, H. L.; Change, M. C.; Chang, Y. T.; Wong, J. M.; Wei, S. C.] Natl Taiwan Univ Hosp & Coll Med, Dept Internal Med, Taipei, Taiwan; [Tsao, P. N.] Natl Taiwan Univ Hosp & Coll Med, Dept Pediat, Taipei, Taiwan; [Tung, C. C.] Natl Taiwan Univ Hosp & Coll Med, Dept Integrated Diagnost & Therapeut, Taipei, Taiwan	Far Eastern Memorial Hospital; Yuan Ze University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Wei, SC (corresponding author), Natl Taiwan Univ Hosp & Coll Med, Dept Internal Med, Taipei, Taiwan.	shuchenwei@ntu.edu.tw		TSAO, PO-NIEN/0000-0002-6114-1769; CHANG, YU-TING/0000-0002-5912-3406	Liver Disease Prevention & Treatment Research Foundation, Taiwan	Liver Disease Prevention & Treatment Research Foundation, Taiwan	This work was supported by Liver Disease Prevention & Treatment Research Foundation, Taiwan, to MTW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson JM, 2007, EUR J CANCER, V43, P1764, DOI 10.1016/j.ejca.2007.05.009; Bossuyt W, 2009, PLOS BIOL, V7, P311, DOI 10.1371/journal.pbio.1000039; Chu D, 2009, J GASTROINTEST SURG, V13, P253, DOI 10.1007/s11605-008-0689-2; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Gao F, 2014, SCI REP-UK, V4, DOI 10.1038/srep03963; Gao J, 2011, PATHOL BIOL, V59, P298, DOI 10.1016/j.patbio.2010.11.001; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Giovannini C, 2012, AM J PATHOL, V181, P413, DOI 10.1016/j.ajpath.2012.04.019; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Katoh M, 2005, INT J MOL MED, V16, P493; Katoh M, 2007, INT J ONCOL, V31, P461; Kazanjian A, 2011, CURR COLORECT CANC R, V7, P121, DOI 10.1007/s11888-011-0090-5; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lee JH, 2009, MOL CANCER RES, V7, P1663, DOI 10.1158/1541-7786.MCR-09-0191; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Leow CC, 2004, CANCER RES, V64, P6050, DOI 10.1158/0008-5472.CAN-04-0290; Libutti S, 2008, DEVITA HELLMAN ROSEN, V1, P1232; Liu J, 2010, INT J GYNECOL CANCER, V20, P1109, DOI 10.1111/IGC.0b013e3181ea74ad; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Nuttall RK, 2003, MOL CANCER RES, V1, P333; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Radtke F, 2006, CURR MOL MED, V6, P275, DOI 10.2174/156652406776894527; Reedijk M, 2008, INT J ONCOL, V33, P1223, DOI 10.3892/ijo_00000112; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Sang LY, 2010, TRENDS MOL MED, V16, P17, DOI 10.1016/j.molmed.2009.11.001; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Sikandar SS, 2010, CANCER RES, V70, P1469, DOI 10.1158/0008-5472.CAN-09-2557; Song YH, 2008, MOL IMMUNOL, V45, P137, DOI 10.1016/j.molimm.2007.04.031; Sounni NE, 2003, MATRIX BIOL, V22, P55, DOI 10.1016/S0945-053X(03)00003-9; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tsareva SA, 2007, NEOPLASIA, V9, P279, DOI 10.1593/neo.06820; Ueo T, 2012, DEVELOPMENT, V139, P1071, DOI 10.1242/dev.069070; Van Cutsem E, 2012, J CLIN ONCOL, V30, P3499, DOI 10.1200/JCO.2012.42.8201; van den Brink GR, 2004, NAT GENET, V36, P277, DOI 10.1038/ng1304; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Veenendaal LM, 2008, CELL ONCOL, V30, P1; Wang XY, 2010, J CANCER RES CLIN, V136, P989, DOI 10.1007/s00432-009-0744-8; Wang ZP, 2013, CARCINOGENESIS, V34, P678, DOI 10.1093/carcin/bgs361; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Zhang Y, 2010, CANCER-AM CANCER SOC, V116, P5207, DOI 10.1002/cncr.25449; Zheng X, 2011, INFLAMM BOWEL DIS, V17, P2251, DOI 10.1002/ibd.21611; Zhu L, 2012, MED ONCOL, V29, P1037, DOI 10.1007/s12032-011-9975-z; Zugowski C, 2011, BIOL CHEM, V392, P449, DOI 10.1515/BC.2011.038	50	33	36	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144322	10.1371/journal.pone.0144322	http://dx.doi.org/10.1371/journal.pone.0144322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650241	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903300043
J	Ardizzoni, E; Fajardo, E; Saranchuk, P; Casenghi, M; Page, AL; Varaine, F; Kosack, CS; Hepple, P				Ardizzoni, Elisa; Fajardo, Emmanuel; Saranchuk, Peter; Casenghi, Martina; Page, Anne-Laure; Varaine, Francis; Kosack, Cara S.; Hepple, Pamela			Implementing the Xpert (R) MTB/RIF Diagnostic Test for Tuberculosis and Rifampicin Resistance: Outcomes and Lessons Learned in 18 Countries	PLOS ONE			English	Article							ASSAY	Background The Xpert (R) MTB/RIF (Xpert) is an automated molecular test for simultaneous detection of tuberculosis (TB) and rifampicin resistance, recommended by the World Health Organization as the preferred diagnostic method for individuals presumed to have multi-drug resistant TB (MDR-TB) or HIV-associated TB. We describe the performance of Xpert and key lessons learned during two years of implementation under routine conditions in 33 projects located in 18 countries supported by Medecins Sans Frontieres across varied geographic, epidemiological and clinical settings. Methods Xpert was used following three strategies: the first being as the initial test, with microscopy in parallel, for all presumptive TB cases; the second being only for patients at risk of MDR-TB, or with HIV-associated TB, or presumptive paediatric TB; and the third being as the initial test for these high-risk patients plus as an add-on test to microscopy in others. Routine laboratory data were collected, using laboratory registers. Qualitative data such as logistic aspects, human resources, and tool acceptance were collected using a questionnaire. Findings In total, 52,863 samples underwent Xpert testing from April 2011 to December 2012. The average MTB detection rate was 18.5%, 22.3%, and 11.6% for the three different strategies respectively. Analysis of the results on samples tested in parallel showed that using Xpert as add-on test to microscopy would have increased laboratory TB confirmation by 49.7%, versus 42.3% for Xpert replacing microscopy. The main limitation of the test was the high rate of inconclusive results, which correlated with factors such as defective modules, cartridge version (G3 vs. G4) and staff experience. Operational and logistical hurdles included infrastructure renovation, basic computer training, regular instrument troubleshooting and maintenance, all of which required substantial and continuous support. Conclusion The implementation of Xpert was feasible and significantly increased TB detection compared to microscopy, despite the high rate of inconclusive results. Xpert implementation was accompanied by considerable operational and logistical challenges. To further decentralize diagnosis, simpler, low-cost TB technologies well-suited to low-resource settings are still urgently needed.	[Ardizzoni, Elisa] Med Sans Frontieres, Inst Trop Med, Antwerp, Belgium; [Fajardo, Emmanuel; Saranchuk, Peter] Med Sans Frontieres, Southern Africa Med Unit, Cape Town, South Africa; [Casenghi, Martina] Med Sans Frontieres, Geneva, Switzerland; [Page, Anne-Laure] Med Sans Frontieres, Epictr, Paris, France; [Ardizzoni, Elisa; Varaine, Francis] Med Sans Frontieres, Paris, France; [Kosack, Cara S.] Med Sans Frontieres, Amsterdam, Netherlands; [Hepple, Pamela] Med Sans Frontieres, Manson Unit, London, England	Doctors Without Borders; Institute of Tropical Medicine (ITM); Doctors Without Borders; Doctors Without Borders; Doctors Without Borders; Doctors Without Borders; Doctors Without Borders	Ardizzoni, E (corresponding author), Med Sans Frontieres, Inst Trop Med, Antwerp, Belgium.	eardizzoni@itg.be			Medecins Sans Frontieres, a nonprofit medical humanitarian organization	Medecins Sans Frontieres, a nonprofit medical humanitarian organization	The work described in this paper was funded by Medecins Sans Frontieres, a nonprofit medical humanitarian organization. No outside funding was used in the production of this article.	[Anonymous], 2011, AUT REAL TIM NUCL AC; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cepheid, 2008, GENEXPERT DX SYST OP; Cepheid, 2012, CEPHEID XPERT MTB RI; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; Creswell J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-2; FIND, 2011, FIND REP PERF XPERT; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Human I, 2009, PLOS MED, V6, DOI [10.1371/journal, DOI 10.1371/JOURNAL]; Oberhelman RA, 2010, LANCET INFECT DIS, V10, P612, DOI 10.1016/S1473-3099(10)70141-9; Rachow A, 2012, CLIN INFECT DIS, V54, P1388, DOI 10.1093/cid/cis190; Raizada N, EXPERIENCE IMPLEMENT; Schnippel K, 2013, SAMJ S AFR MED J, V103, P101, DOI [10.7196/SAMJ.6182, 10.7196/samj.6182]; Steingart KR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009593.pub2; Stevens W, S AFRICAS REALITY CH, P205; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Weyer K, 1998, LAB SERVICES TUBER 2, VWHO/TB/98.258; WHO, 2014, GLOB TUB REP 2014; WHO, 2008, PROP RED NUMB SMEARS; World Health Organization, 2013, CONGUID UANT DRU, P2013; World Health Organization, 2008, MOL LIN PROB ASS RAP; World Health Organization, 2011, RAP IMPL XPERT MTB R; World Health Organization, 2013, US XPERT MTB RIF ASS; World Health Organization, 2011, ROADM PREV COMB DRUG	26	44	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144656	10.1371/journal.pone.0144656	http://dx.doi.org/10.1371/journal.pone.0144656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670929	Green Published, gold			2022-12-27	WOS:000366719300015
J	Schley, G; Koberle, C; Manuilova, E; Rutz, S; Forster, C; Weyand, M; Formentini, I; Kientsch-Engel, R; Eckardt, KU; Willam, C				Schley, Gunnar; Koeberle, Carmen; Manuilova, Ekaterina; Rutz, Sandra; Forster, Christian; Weyand, Michael; Formentini, Ivan; Kientsch-Engel, Rosemarie; Eckardt, Kai-Uwe; Willam, Carsten			Comparison of Plasma and Urine Biomarker Performance in Acute Kidney Injury	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ACID-BINDING PROTEIN; RENAL-ALLOGRAFT REJECTION; SERUM CYSTATIN C; CARDIAC-SURGERY; CRITICALLY-ILL; POSTOPERATIVE COMPLICATIONS; CREATININE KINETICS; PREDICTIVE-VALUE; BYPASS SURGERY	Background New renal biomarkers measured in urine promise to increase specificity for risk stratification and early diagnosis of acute kidney injury (AKI) but concomitantly may be altered by urine concentration effects and chronic renal insufficiency. This study therefore directly compared the performance of AKI biomarkers in urine and plasma. Methods This single-center, prospective cohort study included 110 unselected adults undergoing cardiac surgery with cardiopulmonary bypass between 2009 and 2010. Plasma and/or urine concentrations of creatinine, cystatin C, neutrophil gelatinase-associated lipocalin (NGAL), liver fatty acid-binding protein (L-FABP), kidney injury molecule 1 (KIM1), and albumin as well as 15 additional biomarkers in plasma and urine were measured during the perioperative period. The primary outcome was AKI defined by AKIN serum creatinine criteria within 72 hours after surgery. Results Biomarkers in plasma showed markedly better discriminative performance for preoperative risk stratification and early postoperative (within 24h after surgery) detection of AKI than urine biomarkers. Discriminative power of urine biomarkers improved when concentrations were normalized to urinary creatinine, but urine biomarkers had still lower AUC values than plasma biomarkers. Best diagnostic performance 4h after surgery had plasma NGAL (AUC 0.83), cystatin C (0.76), MIG (0.74), and L-FAPB (0.73). Combinations of multiple biomarkers did not improve their diagnostic power. Preoperative clinical scoring systems (Euro-SCORE and Cleveland Clinic Foundation Score) predicted the risk for AKI (AUC 0.76 and 0.71) and were not inferior to biomarkers. Preexisting chronic kidney disease limited the diagnostic performance of both plasma and urine biomarkers. Conclusions In our cohort plasma biomarkers had higher discriminative power for risk stratification and early diagnosis of AKI than urine biomarkers. For preoperative risk stratification of AKI clinical models showed similar discriminative performance to biomarkers. The discriminative performance of both plasma and urine biomarkers was reduced by preexisting chronic kidney disease.	[Schley, Gunnar; Koeberle, Carmen; Forster, Christian; Eckardt, Kai-Uwe] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany; [Manuilova, Ekaterina; Rutz, Sandra; Kientsch-Engel, Rosemarie] Roche Diagnost GmbH, Biomarker Assessments, Penzberg, Germany; [Weyand, Michael] Univ Erlangen Nurnberg, Dept Cardiac Surg, D-91054 Erlangen, Germany; [Formentini, Ivan] F Hoffmann La Roche Ltd, Biomarker & Expt Med, Basel, Switzerland	University of Erlangen Nuremberg; Roche Holding; University of Erlangen Nuremberg; Roche Holding	Willam, C (corresponding author), Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany.	carsten.willam@uk-erlangen.de		Schley, Gunnar/0000-0001-9929-5854				Arthur JM, 2014, KIDNEY INT, V85, P431, DOI 10.1038/ki.2013.333; Bennett M, 2008, CLIN J AM SOC NEPHRO, V3, P665, DOI 10.2215/CJN.04010907; Blume C, 2015, AM J TRANSPLANT, V15; Bolignano D, 2008, KIDNEY BLOOD PRESS R, V31, P255, DOI 10.1159/000143726; Bolignano D, 2009, CLIN J AM SOC NEPHRO, V4, P337, DOI 10.2215/CJN.03530708; Candela-Toha A, 2008, CLIN J AM SOC NEPHRO, V3, P1260, DOI 10.2215/CJN.00560208; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Coca SG, 2008, KIDNEY INT, V73, P1008, DOI 10.1038/sj.ki.5002729; Coca SG, 2012, J THORAC CARDIOV SUR, V143, P495, DOI 10.1016/j.jtcvs.2011.09.023; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dent CL, 2007, CRIT CARE, V11, DOI 10.1186/cc6192; Devarajan P, 2010, BIOMARK MED, V4, P265, DOI [10.2217/bmm.10.12, 10.2217/BMM.10.12]; Devarajan Prasad, 2008, Expert Opin Med Diagn, V2, P387, DOI 10.1517/17530059.2.4.387; Doi K, 2013, CRIT CARE, V17, DOI 10.1186/cc13104; Doi K, 2011, CRIT CARE MED, V39, P2464, DOI 10.1097/CCM.0b013e318225761a; Duthie FAI, 2014, NEPHRON CLIN PRACT, V128, P29, DOI 10.1159/000357675; Endre ZH, 2011, KIDNEY INT, V79, P1119, DOI 10.1038/ki.2010.555; Endre ZH, 2010, KIDNEY INT, V77, P1020, DOI 10.1038/ki.2010.25; Englberger L, 2010, AM J KIDNEY DIS, V56, P623, DOI 10.1053/j.ajkd.2010.04.017; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Haase M, 2011, NEPHROL DIAL TRANSPL, V26, P2109, DOI 10.1093/ndt/gfr248; Haase-Fielitz A, 2009, NEPHROL DIAL TRANSPL, V24, P3349, DOI 10.1093/ndt/gfp234; Han WK, 2009, CLIN J AM SOC NEPHRO, V4, P873, DOI 10.2215/CJN.04810908; Hauser IA, 2005, J AM SOC NEPHROL, V16, P1849, DOI 10.1681/ASN.2004100836; Ho JL, 2015, AM J KIDNEY DIS, V66, P993, DOI 10.1053/j.ajkd.2015.06.018; Huang TM, 2011, J AM SOC NEPHROL, V22, P156, DOI 10.1681/ASN.2010050553; Huen SC, 2012, ANN THORAC SURG, V93, P337, DOI 10.1016/j.athoracsur.2011.09.010; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; Jackson JA, 2011, AM J TRANSPLANT, V11, P2228, DOI 10.1111/j.1600-6143.2011.03680.x; Kashani K, 2013, CRIT CARE, V17, DOI 10.1186/cc12503; Katagiri D, 2012, ANN THORAC SURG, V93, P577, DOI 10.1016/j.athoracsur.2011.10.048; Kawai A, 2014, CLIN TRANSPLANT, V28, P749, DOI 10.1111/ctr.12375; Kiers HD, 2013, NEPHROL DIAL TRANSPL, V28, P345, DOI 10.1093/ndt/gfs518; Kim DH, 2009, CIRC J, V73, P872, DOI 10.1253/circj.CJ-08-1010; Koyner JL, 2013, AM J KIDNEY DIS, V61, P730, DOI 10.1053/j.ajkd.2012.12.006; Koyner JL, 2012, J AM SOC NEPHROL, V23, P905, DOI 10.1681/ASN.2011090907; Krawczeski CD, 2011, J AM COLL CARDIOL, V58, P2301, DOI 10.1016/j.jacc.2011.08.017; Lameire NH, 2011, KIDNEY INT, V79, P1047, DOI 10.1038/ki.2011.21; Lee SH, 2015, HEART, V101, P1562, DOI 10.1136/heartjnl-2015-307986; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Liangos O, 2010, BIOMARKERS, V15, P436, DOI 10.3109/1354750X.2010.485252; Liborio AB, 2013, NEPHROL DIAL TRANSPL, V28, P2779, DOI 10.1093/ndt/gft375; Liu YW, 2013, AM J KIDNEY DIS, V62, P1058, DOI 10.1053/j.ajkd.2013.05.014; Macedo E, 2011, KIDNEY INT, V80, P760, DOI 10.1038/ki.2011.150; McIlroy DR, 2010, CLIN J AM SOC NEPHRO, V5, P211, DOI 10.2215/CJN.04240609; McMahon GM, 2013, AM J KIDNEY DIS, V62, P165, DOI 10.1053/j.ajkd.2012.12.022; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mehta RL, 2011, CONTRIB NEPHROL, V174, P200, DOI 10.1159/000329410; Mishra J, 2005, LANCET, V365, P1231, DOI 10.1016/s0140-6736(05)74811-x; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Molnar AO, 2012, CLIN J AM SOC NEPHRO, V7, P1749, DOI 10.2215/CJN.13421211; Mori K, 2007, KIDNEY INT, V71, P967, DOI 10.1038/sj.ki.5002165; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Ng SY, 2014, J THORAC CARDIOV SUR, V147, P1875, DOI 10.1016/j.jtcvs.2013.06.049; Nickolas TL, 2008, ANN INTERN MED, V148, P810, DOI 10.7326/0003-4819-148-11-200806030-00003; Nickolas TL, 2012, KIDNEY INT, V82, P718, DOI 10.1038/ki.2012.195; Nickolas TL, 2012, J AM COLL CARDIOL, V59, P246, DOI 10.1016/j.jacc.2011.10.854; Nilsson J, 2004, ANN THORAC SURG, V77, P1235, DOI 10.1016/j.athoracsur.2003.08.034; Palomba H, 2007, KIDNEY INT, V72, P624, DOI 10.1038/sj.ki.5002419; Paragas N, 2011, NAT MED, V17, P216, DOI 10.1038/nm.2290; Parikh CR, 2014, AM J KIDNEY DIS, V63, P567, DOI 10.1053/j.ajkd.2013.09.013; Parikh CR, 2013, CLIN J AM SOC NEPHRO, V8, P1079, DOI 10.2215/CJN.10971012; Parikh CR, 2011, J AM SOC NEPHROL, V22, P1737, DOI 10.1681/ASN.2010111163; Parikh CR, 2010, ANN CLIN BIOCHEM, V47, P301, DOI 10.1258/acb.2010.010076; Portilla D, 2008, KIDNEY INT, V73, P465, DOI 10.1038/sj.ki.5002721; Prowle JR, 2011, CRIT CARE, V15, DOI 10.1186/cc10318; Ralib AM, 2012, J AM SOC NEPHROL, V23, P322, DOI 10.1681/ASN.2011040325; Reid CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053354; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Saran R, 2015, AM J KIDNEY DIS, V66, pS1, DOI 10.1053/j.ajkd.2015.05.001; Schmidt-Ott KM, 2006, CURR OPIN NEPHROL HY, V15, P442, DOI 10.1097/01.mnh.0000232886.81142.58; Schmidt-Ott KM, 2011, NEPHROL DIAL TRANSPL, V26, P762, DOI 10.1093/ndt/gfr006; Schuh MP, 2016, AM J KIDNEY DIS, V67, P56, DOI 10.1053/j.ajkd.2015.04.040; Shlipak MG, 2011, AM J KIDNEY DIS, V58, P366, DOI 10.1053/j.ajkd.2011.03.015; Siew ED, 2010, CLIN J AM SOC NEPHRO, V5, P1497, DOI 10.2215/CJN.09061209; Spahillari A, 2012, AM J KIDNEY DIS, V60, P922, DOI 10.1053/j.ajkd.2012.06.002; Tang KWA, 2015, SINGAP MED J, V56, P7, DOI 10.11622/smedj.2015003; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331; Toumpoulis IK, 2005, EUR J CARDIO-THORAC, V27, P128, DOI 10.1016/j.ejcts.2004.09.020; van de Vrie M, 2014, AM J KIDNEY DIS, V63, P573, DOI 10.1053/j.ajkd.2013.10.010; VANMASSENHOVE J, 2015, BMC NEPHROL, V16, DOI DOI 10.1186/S12882-; Vanmassenhove J, 2013, NEPHROL DIAL TRANSPL, V28, P254, DOI 10.1093/ndt/gfs380; Waikar SS, 2010, KIDNEY INT, V78, P486, DOI 10.1038/ki.2010.165; Waikar SS, 2009, J AM SOC NEPHROL, V20, P672, DOI 10.1681/ASN.2008070669; Wald R, 2010, CLIN J AM SOC NEPHRO, V5, P1373, DOI 10.2215/CJN.06350909; Yilmaz A, 2009, PEDIATR NEPHROL, V24, P2387, DOI 10.1007/s00467-009-1279-6	88	55	58	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145042	10.1371/journal.pone.0145042	http://dx.doi.org/10.1371/journal.pone.0145042			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669323	Green Published, gold, Green Submitted			2022-12-27	WOS:000366719300042
J	Yin, KF; Lei, YJ; Wen, X; Lacruz, RS; Soleimani, M; Kurtz, I; Snead, ML; White, SN; Paine, ML				Yin, Kaifeng; Lei, Yuejuan; Wen, Xin; Lacruz, Rodrigo S.; Soleimani, Manoocher; Kurtz, Ira; Snead, Malcolm L.; White, Shane N.; Paine, Michael L.			SLC26A Gene Family Participate in pH Regulation during Enamel Maturation	PLOS ONE			English	Article							CARBONIC-ANHYDRASE-II; MEDULLARY COLLECTING DUCT; DEVELOPING HAMSTER MOLARS; ANION-EXCHANGER AE2; CL-/HCO3-EXCHANGER; CYSTIC-FIBROSIS; INTRACELLULAR PH; DEVELOPING TEETH; HCO3-SECRETION; DENTAL ENAMEL	The bicarbonate transport activities of Slc26a1, Slc26a6 and Slc26a7 are essential to physiological processes in multiple organs. Although mutations of Slc26a1, Slc26a6 and Slc26a7 have not been linked to any human diseases, disruption of Slc26a1, Slc26a6 or Slc26a7 expression in animals causes severe dysregulation of acid-base balance and disorder of anion homeostasis. Amelogenesis, especially the enamel formation during maturation stage, requires complex pH regulation mechanisms based on ion transport. The disruption of stage-specific ion transporters frequently results in enamel pathosis in animals. Here we present evidence that Slc26a1, Slc26a6 and Slc26a7 are highly expressed in rodent incisor ameloblasts during maturation-stage tooth development. In maturation-stage ameloblasts, Slc26a1, Slc26a6 and Slc26a7 show a similar cellular distribution as the cystic fibrosis transmembrane conductance regulator (Cftr) to the apical region of cytoplasmic membrane, and the distribution of Slc26a7 is also seen in the cytoplasmic/subapical region, presumably on the lysosomal membrane. We have also examined Slc26a1 and Slc26a7 null mice, and although no overt abnormal enamel phenotypes were observed in Slc26a1(-/-) or Slc26a7(-/-) animals, absence of Slc26a1 or Slc26a7 results in up-regulation of Cftr, Ca2, Slc4a4, Slc4a9 and Slc26a9, all of which are involved in pH homeostasis, indicating that this might be a compensatory mechanism used by ameloblasts cells in the absence of Slc26 genes. Together, our data show that Slc26a1, Slc26a6 and Slc26a7 are novel participants in the extracellular transport of bicarbonate during enamel maturation, and that their functional roles may be achieved by forming interaction units with Cftr.	[Yin, Kaifeng; Wen, Xin; Snead, Malcolm L.; Paine, Michael L.] Univ So Calif, Herman Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA USA; [Lei, Yuejuan] Guangxi Med Univ, Affiliated Stomatol Hosp, Dept Operat & Endodont, Nanning, Guangxi, Peoples R China; [Lacruz, Rodrigo S.] NYU, Coll Dent, Basic Sci & Craniofacial Biol, New York, NY USA; [Soleimani, Manoocher] Univ Cincinnati, Dept Med, Res Serv, Vet Affairs Med Ctr, Cincinnati, OH USA; [Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Div Nephrol, Los Angeles, CA 90095 USA; [White, Shane N.] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA	University of Southern California; Guangxi Medical University; New York University; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Paine, ML (corresponding author), Univ So Calif, Herman Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA USA.	paine@usc.edu	soleimani, m/U-6889-2017; Lacruz, Rodrigo/AGY-8090-2022	soleimani, m/0000-0002-3446-8870; 	 [DE019629];  [DE013045];  [DK077162]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R00DE022799, R01DE019629, R01DE013045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE013045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077162] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided to MLP, DE019629, http://www.nidcr.nih.gov/, MLP designed the experiments and prepared the manuscript, MLS, DE013045, http://www.nidcr.nih.gov/, MLS prepared the manuscript and IK, DK077162, http://www.niddk.nih.gov/Pages/default.aspx, IK prepared the manuscript.	Alper SL, 2013, MOL ASPECTS MED, V34, P494, DOI 10.1016/j.mam.2012.07.009; Andrejewski N, 1999, J BIOL CHEM, V274, P12692, DOI 10.1074/jbc.274.18.12692; Arquitt CK, 2002, J DENT RES, V81, P492, DOI 10.1177/154405910208100712; Bertrand CA, 2009, J GEN PHYSIOL, V133, P421, DOI 10.1085/jgp.200810097; Bronckers A, 2010, BONE, V46, P1188, DOI 10.1016/j.bone.2009.12.002; Bronckers ALJJ, 2011, EUR J ORAL SCI, V119, P185, DOI 10.1111/j.1600-0722.2011.00901.x; Bronckers ALJJ, 2009, J EXP ZOOL PART B, V312B, P375, DOI 10.1002/jez.b.21267; Chang EH, 2011, CELLS TISSUES ORGANS, V194, P249, DOI 10.1159/000324248; Chavez JC, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094037; Dawson PA, 2010, J CLIN INVEST, V120, P706, DOI 10.1172/JCI31474; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; DOGTEROM AA, 1983, J BIOL BUCCALE, V11, P15; DOGTEROM AA, 1983, J DENT RES, V62, P789, DOI 10.1177/00220345830620070201; Duan X, 2014, J DENT RES, V93, P117, DOI 10.1177/0022034513507066; Duan X, 2011, J DENT RES, V90, P175, DOI 10.1177/0022034510385687; Freel RW, 2006, AM J PHYSIOL-GASTR L, V290, pG719, DOI 10.1152/ajpgi.00481.2005; Hayashi H, 2009, AM J PHYSIOL-CELL PH, V296, pC1279, DOI 10.1152/ajpcell.00638.2008; Hihnala S, 2006, MOL HUM REPROD, V12, P107, DOI 10.1093/molehr/gal009; Homma K, 2010, BBA-BIOMEMBRANES, V1798, P1029, DOI 10.1016/j.bbamem.2010.02.001; Hu JCC, 2007, ORTHOD CRANIOFAC RES, V10, P45, DOI 10.1111/j.1601-6343.2007.00384.x; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Jalali R., 2014, CELL TISSUE RES; Jiang ZR, 2006, NAT GENET, V38, P474, DOI 10.1038/ng1762; Josephsen K, 2010, AM J PHYSIOL-CELL PH, V299, pC1299, DOI 10.1152/ajpcell.00218.2010; Lacruz RS, 2013, J BONE MINER RES, V28, P672, DOI 10.1002/jbmr.1779; Lacruz RS, 2011, EUR J ORAL SCI, V119, P149, DOI 10.1111/j.1600-0722.2011.00881.x; Lacruz RS, 2012, J CELL PHYSIOL, V227, P2264, DOI 10.1002/jcp.22965; Lacruz RS, 2012, J CELL PHYSIOL, V227, P1776, DOI 10.1002/jcp.22911; Lacruz RS, 2010, J BIOL CHEM, V285, P24432, DOI 10.1074/jbc.M110.115188; Lacruz RS, 2010, BIOCHEM BIOPH RES CO, V393, P883, DOI 10.1016/j.bbrc.2010.02.116; Lacruz RS, 2010, CALCIFIED TISSUE INT, V86, P91, DOI 10.1007/s00223-009-9326-7; LIN HM, 1994, CALCIFIED TISSUE INT, V55, P38, DOI 10.1007/BF00310167; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd J B, 1996, Subcell Biochem, V27, P361; Lyaruu DM, 2008, MATRIX BIOL, V27, P119, DOI 10.1016/j.matbio.2007.09.006; LYMAN GE, 1977, AM J PHYSIOL, V232, pF364, DOI 10.1152/ajprenal.1977.232.4.F364; McKee MD, 2013, J DENT RES, V92, P721, DOI 10.1177/0022034513490958; Nanci A, 2008, TEN CATE S ORAL HIST; Paine ML, 2008, J DENT RES, V87, P391, DOI 10.1177/154405910808700415; Petrovic S, 2004, AM J PHYSIOL-RENAL, V286, pF161, DOI 10.1152/ajprenal.00219.2003; Petrovic S, 2003, AM J PHYSIOL-CELL PH, V285, pC608, DOI 10.1152/ajpcell.00084.2003; Petrovic S, 2003, AM J PHYSIOL-GASTR L, V284, pG1093, DOI 10.1152/ajpgi.00454.2002; Reibring CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096007; SASAKI S, 1991, ARCH ORAL BIOL, V36, P227, DOI 10.1016/0003-9969(91)90090-H; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shapiro JL, 2007, CELL MOL LIFE SCI, V64, P244, DOI 10.1007/s00018-006-6429-4; Simmer JP, 2002, CONNECT TISSUE RES, V43, P441, DOI 10.1080/03008200290001159; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Singh AK, 2008, ACTA PHYSIOL, V193, P357, DOI 10.1111/j.1748-1716.2008.01854.x; Smith C E, 1996, Adv Dent Res, V10, P159; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Smith CE, 1996, ANAT REC, V245, P186, DOI 10.1002/(SICI)1097-0185(199606)245:2<186::AID-AR7>3.0.CO;2-V; Smith CE, 2006, EUR J ORAL SCI, V114, P147, DOI 10.1111/j.1600-0722.2006.00273.x; Snead CM, 2011, EUR J ORAL SCI, V119, P136, DOI 10.1111/j.1600-0722.2011.00867.x; Sui W, 2003, J DENT RES, V82, P388, DOI 10.1177/154405910308200512; Sun XM, 2008, CELL PHYSIOL BIOCHEM, V21, P95, DOI 10.1159/000113751; Takagi T, 1998, CONNECT TISSUE RES, V38, P181, DOI 10.3109/03008209809017035; Toyosawa S, 1996, CELL TISSUE RES, V285, P217, DOI 10.1007/s004410050639; Wang XG, 2010, J CELL PHYSIOL, V225, P709, DOI 10.1002/jcp.22267; Wang YX, 2006, EMBO J, V25, P5049, DOI 10.1038/sj.emboj.7601387; Wen X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097318; Wright J T, 1996, Adv Dent Res, V10, P270; Wright JT, 1996, J DENT RES, V75, P966, DOI 10.1177/00220345960750041101; Xie QH, 2002, AM J PHYSIOL-RENAL, V283, pF826, DOI 10.1152/ajprenal.00079.2002; Xu J, 2006, J AM SOC NEPHROL, V17, P956, DOI 10.1681/ASN.2005111174; Xu J, 2009, J BIOL CHEM, V284, P29470, DOI 10.1074/jbc.M109.044396; Yadav MC, 2012, J BONE MINER RES, V27, P1722, DOI 10.1002/jbmr.1619; Yin KF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-998; Zou Y, 2007, BIOCHEM J, V408, P347, DOI 10.1042/BJ20070881	69	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144703	10.1371/journal.pone.0144703	http://dx.doi.org/10.1371/journal.pone.0144703			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671068	gold, Green Submitted, Green Published			2022-12-27	WOS:000366719300016
J	Choi, J; Yoon, HI; Lee, J; Keum, KC; Kim, GE; Kim, YB				Choi, Jinhyun; Yoon, Hong In; Lee, Jeongshim; Keum, Ki Chang; Kim, Gwi Eon; Kim, Yong Bae			Optimal Extent of Prophylactic Irradiation of Paraaortic Lymph Nodes in Patients with Uterine Cervical Cancer	PLOS ONE			English	Article							GYNECOLOGIC-ONCOLOGY-GROUP; RADIATION-THERAPY; CONCURRENT CHEMOTHERAPY; FIELD IRRADIATION; STAGE-IB; CARCINOMA; SURVIVAL; CHEMORADIOTHERAPY; RADIOTHERAPY; TOMOGRAPHY	Purpose The purpose of this study was to determine optimal extent of prophylactic irradiation of paraaortic lymph nodes (PALN) in patients with uterine cervical cancer who had metastatic pelvic LNs. Methods and Materials We retrospectively evaluated 103 patients with cervical cancer and pelvic lymph nodemetastasis who were treated with prophylactic semi-extended field radiotherapy (SEFRT) between 1990 and 2012. The semi-extended field included PALN below the second lumbar spine with prescribed doses of 45 to 50 Gy. Survival outcomes were calculated using the Kaplan-Meier method, and acute and late toxicities were scored using the Radiation Therapy Oncology Group and European Organisation for Research and Treatment of Cancer toxicity criteria. Results The median follow-up after SEFRT was 61 (range 5-296) months. Overall, 28 patients (27.2%) experienced treatment failures, which were classified as local in 8 patients (7.8%), regional in 8 patients (7.8%), and distant in 13 patients (12.6%). Of the regional failures, only two involved PALN failure around the renal artery or the renal hilum area at the upper margin of the semi-extended field. At 5 years, the overall survival was 82%. Grade 3 or higher acute gastrointestinal and genitourinary toxicities occurred in one and two patients, respectively. As a late toxicity, one patient developed grade 3 small bowel obstruction. Conclusion Prophylactic SEFRT provided favorable outcomes with little acute or late gastrointestinal toxicity. For prophylaxis of PALN recurrences, upper part of PALN might not need to be included in patients with uterine cervical cancer and metastatic pelvic LNs.	[Choi, Jinhyun; Yoon, Hong In; Lee, Jeongshim; Keum, Ki Chang; Kim, Gwi Eon; Kim, Yong Bae] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea; [Yoon, Hong In] Yonsei Univ, Coll Med, Brain Korea Plus Project Med Sci 21, Dept Pharmacol, Seoul, South Korea; [Kim, Gwi Eon] Jeju Natl Univ, Sch Med, Dept Radiat Oncol, Jeju, South Korea; [Kim, Yong Bae] Yonsei Univ, Coll Med, Yonsei Song Dang Inst Canc Res, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Jeju National University; Yonsei University; Yonsei University Health System	Kim, YB (corresponding author), Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea.	ybkim3@yuhs.ac		Keum, Ki Chang/0000-0003-4123-7998; Yoon, Hong In/0000-0002-2106-6856; Kim, Yong Bae/0000-0001-7573-6862				Al Asiri M, 2014, CANCER MANAG RES, V6, P339, DOI 10.2147/CMAR.S68262; Atahan IL, 2007, INT J GYNECOL CANCER, V17, P833, DOI 10.1111/j.1525-1438.2007.00895.x; Beadle BM, 2010, INT J RADIAT ONCOL, V76, P1396, DOI 10.1016/j.ijrobp.2009.04.009; BERMAN ML, 1984, GYNECOL ONCOL, V19, P8, DOI 10.1016/0090-8258(84)90151-3; Choi HJ, 2006, CANCER-AM CANCER SOC, V106, P914, DOI 10.1002/cncr.21641; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; DELGADO G, 1989, GYNECOL ONCOL, V35, P314, DOI 10.1016/0090-8258(89)90070-X; Eifel PJ, 2004, J CLIN ONCOL, V22, P872, DOI 10.1200/JCO.2004.07.197; EIFEL PJ, 1994, INT J RADIAT ONCOL, V29, P9, DOI 10.1016/0360-3016(94)90220-8; Follen M, 2003, CANCER, V98, P2028, DOI 10.1002/cncr.11679; Goff BA, 1999, GYNECOL ONCOL, V74, P436, DOI 10.1006/gyno.1999.5472; Grigsby PW, 2001, J CLIN ONCOL, V19, P3745, DOI 10.1200/JCO.2001.19.17.3745; Kuku S, 2013, BRIT J CANCER, V109, P1504, DOI 10.1038/bjc.2013.491; Liang JA, 2008, CLIN ONCOL-UK, V20, P683, DOI 10.1016/j.clon.2008.06.007; Liang JA, 2014, INT J GYNECOL CANCER, V24, P901, DOI 10.1097/IGC.0b013e31829f4dc5; Ouldamer L, 2012, ACTA OBSTET GYN SCAN, V91, P893, DOI 10.1111/j.1600-0412.2012.01443.x; Park SG, 2014, CANCER RES TREAT, V46, P374, DOI 10.4143/crt.2013.084; Peters WA, 2000, J CLIN ONCOL, V18, P1606, DOI 10.1200/JCO.2000.18.8.1606; Pinto PS, 2004, RADIOGRAPHICS, V24, P809, DOI 10.1148/rg.243035086; ROSENBERGER A, 1971, AMER J ROENTGENOL RA, V111, P807, DOI 10.2214/ajr.111.4.807; ROTMAN M, 1995, JAMA-J AM MED ASSOC, V274, P387, DOI 10.1001/jama.274.5.387; SPECTOR JG, 1991, OTOLARYNG HEAD NECK, V104, P58, DOI 10.1177/019459989110400112; STEHMAN FB, 1991, CANCER, V67, P2776, DOI 10.1002/1097-0142(19910601)67:11<2776::AID-CNCR2820671111>3.0.CO;2-L; Stryker JA, 2000, GYNECOL ONCOL, V79, P399, DOI 10.1006/gyno.2000.5977; Vale CL, 2010, CLIN ONCOL-UK, V22, P590, DOI 10.1016/j.clon.2010.06.002	25	5	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145158	10.1371/journal.pone.0145158	http://dx.doi.org/10.1371/journal.pone.0145158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659867	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900188
J	Dinardo, CL; Santos, HC; Vaquero, AR; Martelini, AR; Dallan, LAO; Alencar, AM; Krieger, JE; Pereira, AC				Dinardo, Carla Luana; Santos, Hadassa Campos; Vaquero, Andre Ramos; Martelini, Andre Ricardo; Oliveira Dallan, Luis Alberto; Alencar, Adriano Mesquita; Krieger, Jose Eduardo; Pereira, Alexandre Costa			Smoking and Female Sex: Independent Predictors of Human Vascular Smooth Muscle Cells Stiffening	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ARTERIAL STIFFNESS; AORTIC STIFFNESS; CARDIOVASCULAR RISK; DIABETES-MELLITUS; WOMEN; HYPERTENSION; HYPERTROPHY; EXPRESSION; MECHANISM	Aims Recent evidence shows the rigidity of vascular smooth muscle cells (VSMC) contributes to vascular mechanics. Arterial rigidity is an independent cardiovascular risk factor whose associated modifications in VSMC viscoelasticity have never been investigated. This study's objective was to evaluate if the arterial rigidity risk factors aging, African ancestry, female sex, smoking and diabetes mellitus are associated with VMSC stiffening in an experimental model using a human derived vascular smooth muscle primary cell line repository. Methods Eighty patients subjected to coronary artery bypass surgery were enrolled. VSMCs were extracted from internal thoracic artery fragments and mechanically evaluated using Optical Magnetic Twisting Cytometry assay. The obtained mechanical variables were correlated with the clinical variables: age, gender, African ancestry, smoking and diabetes mellitus. Results The mechanical variables Gr, G'r and G"r had a normal distribution, demonstrating an inter-individual variability of VSMC viscoelasticity, which has never been reported before. Female sex and smoking were independently associated with VSMC stiffening: Gr (apparent cell stiffness) p = 0.022 and p = 0.018, R-2 0.164; G'r (elastic modulus) p = 0.019 and p = 0.009, R-2 0.184 and G"r (dissipative modulus) p = 0.011 and p = 0.66, R-2 0.141. Conclusion Female sex and smoking are independent predictors of VSMC stiffening. This pro-rigidity effect represents an important element for understanding the vascular rigidity observed in post-menopausal females and smokers, as well as a potential therapeutic target to be explored in the future. There is a significant inter-individual variation of VSMC viscoelasticity, which is slightly modulated by clinical variables and probably relies on molecular factors.	[Dinardo, Carla Luana; Santos, Hadassa Campos; Vaquero, Andre Ramos; Martelini, Andre Ricardo; Krieger, Jose Eduardo; Pereira, Alexandre Costa] Univ Sao Paulo, Sch Med, Heart Inst InCor, Lab Genet & Mol Cardiol, Sao Paulo, Brazil; [Alencar, Adriano Mesquita] Univ Sao Paulo, Inst Phys, Lab Microrheol & Mol Physiol, Sao Paulo, Brazil; [Oliveira Dallan, Luis Alberto] Univ Sao Paulo, Sch Med, Heart Inst InCor, Coronary Surg Unit, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Dinardo, CL (corresponding author), Univ Sao Paulo, Sch Med, Heart Inst InCor, Lab Genet & Mol Cardiol, Sao Paulo, Brazil.	caludinardo@gmail.com	Alencar, Adriano M/L-5071-2013; Stefanadis, Christodoulos/ABH-2232-2020; Pereira, Alexandre/HHN-1038-2022	Alencar, Adriano M/0000-0001-9324-2698; Stefanadis, Christodoulos/0000-0001-5974-6454; dallan, luis alberto/0000-0002-8655-8966	 [2012/21103-0]		This work was supported by Grant #2012/21103-0, Sao Paulo Research Foundation (FAPESP).	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Atef ME, 2014, AM J PHYSIOL-CELL PH, V307, pC97, DOI 10.1152/ajpcell.00337.2013; Barua RS, 2003, CIRCULATION, V107, P2342, DOI 10.1161/01.CIR.0000066691.52789.BE; Blacher J, 1999, HYPERTENSION, V33, P1111, DOI 10.1161/01.HYP.33.5.1111; Cardena MMSG, 2014, INT J CARDIOL, V176, P527, DOI 10.1016/j.ijcard.2014.07.039; Center SHG, 2014, HUM GEN DIV PROJ; Coutinho T, 2013, J AM COLL CARDIOL, V61, P96, DOI 10.1016/j.jacc.2012.08.997; Cucina A, 2000, SURGERY, V127, P72, DOI 10.1067/msy.2000.102422; Dinardo CL, 2014, AM J PHYSIOL-HEART C, V306, pH505, DOI 10.1152/ajpheart.00655.2013; Dinardo CL, 2012, BIORHEOLOGY, V49, P365, DOI 10.3233/BIR-120621; Durier S, 2003, CIRCULATION, V108, P1845, DOI 10.1161/01.CIR.0000091407.86925.7A; Fabry B, 2001, J APPL PHYSIOL, V91, P986, DOI 10.1152/jappl.2001.91.2.986; Galmiche G, 2014, HYPERTENSION, V63, P520, DOI 10.1161/HYPERTENSIONAHA.113.01967; Giannattasio C, 1996, ATHEROSCLEROSIS, V124, P249, DOI 10.1016/0021-9150(96)05834-0; Hata K, 2012, TOB INDUC DIS, V10, DOI 10.1186/1617-9625-10-11; Ichihara A, 2002, NEPHROL DIAL TRANSPL, V17, P1513, DOI 10.1093/ndt/17.8.1513; Jacob-Ferreira ALB, 2010, EUR J PHARMACOL, V627, P216, DOI 10.1016/j.ejphar.2009.10.057; Santos PCJD, 2011, AM J HYPERTENS, V24, P278, DOI 10.1038/ajh.2010.244; LEVENSON J, 1987, ARTERIOSCLEROSIS, V7, P572, DOI 10.1161/01.ATV.7.6.572; Liu WF, 2012, CARDIOVASC RES, V95, P215, DOI 10.1093/cvr/cvs168; Louis H, 2007, AM J PHYSIOL-HEART C, V293, pH2597, DOI 10.1152/ajpheart.00299.2007; Mitchell GF, 2008, HYPERTENSION, V51, P1123, DOI 10.1161/HYPERTENSIONAHA.107.108175; Mullick AE, 2001, AM J PHYSIOL-HEART C, V281, pH2204, DOI 10.1152/ajpheart.2001.281.5.H2204; Osborne-Pellegrin M, 2010, AM J PHYSIOL-HEART C, V299, pH144, DOI 10.1152/ajpheart.00040.2010; Park CY, 2010, AM J PHYSIOL-CELL PH, V298, pC1245, DOI 10.1152/ajpcell.00417.2009; Qiu HY, 2010, CIRC RES, V107, P615, DOI 10.1161/CIRCRESAHA.110.221846; Regnault V, 2012, J AM COLL CARDIOL, V59, P1771, DOI 10.1016/j.jacc.2012.01.044; SALOMAA V, 1995, CIRCULATION, V91, P1432, DOI 10.1161/01.CIR.91.5.1432; Segers P, 2007, HYPERTENSION, V49, P1248, DOI 10.1161/HYPERTENSIONAHA.106.085480; Sehgel NL, 2013, AM J PHYSIOL-HEART C, V305, pH1281, DOI 10.1152/ajpheart.00232.2013; Stefanadis C, 1999, AM J PHYSIOL-HEART C, V276, pH658, DOI 10.1152/ajpheart.1999.276.2.H658; Takami T, 2011, VASC HEALTH RISK MAN, V7, P633, DOI 10.2147/VHRM.S25798; Tarnoki A, 2015, J HYPERTENS, V33, pE29, DOI 10.1097/01.hjh.0000467426.41935.74; Tomiyama H, 2010, J AM COLL CARDIOL, V55, P1979, DOI 10.1016/j.jacc.2009.12.042; Waddell TK, 2001, J HYPERTENS, V19, P2205, DOI 10.1097/00004872-200112000-00014; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; Zhou EH, 2012, J R SOC INTERFACE, V9, P1144, DOI 10.1098/rsif.2011.0733	38	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145062	10.1371/journal.pone.0145062	http://dx.doi.org/10.1371/journal.pone.0145062			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26661469	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900178
J	Dong, ZQ; Hu, N; Zhang, J; Chen, TT; Cao, MY; Li, HQ; Lei, XJ; Chen, P; Lu, C; Pan, MH				Dong, Zhan-Qi; Hu, Nan; Zhang, Jun; Chen, Ting-Ting; Cao, Ming-Ya; Li, Hai-Qing; Lei, Xue-Jiao; Chen, Peng; Lu, Cheng; Pan, Min-Hui			Oligomerization of Baculovirus LEF-11 Is Involved in Viral DNA Replication	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; BINDING; EXPRESSION; GENE; IDENTIFICATION; LOCALIZATION; PROMOTER; IE1; ACTIVATION; SILKWORM	We have previously reported that baculovirus Bombyx mori nucleopolyhedrovirus (BmNPV) late expression factor 11 (lef-11) is associated with viral DNA replication and have demonstrated that it potentially interacts with itself; however, whether LEF-11 forms oligomers and the impact of LEF-11 oligomerization on viral function have not been substantiated. In this study, we first demonstrated that LEF-11 is capable of forming oligomers. Additionally, a series of analyses using BmNPV LEF-11 truncation mutants indicated that two distinct domains control LEF-11 oligomerization (aa 42-61 and aa 72-101). LEF-11 truncation constructs were inserted into a lef-11-knockout BmNPV bacmid, which was used to demonstrate that truncated LEF-11 lacking either oligomerization domain abrogates viral DNA replication. Finally, site-directed mutagenesis was used to determine that the conserved hydrophobic residues Y58&I59 (representing Y58 and I59), I85 and L88&L89 (representing L88 and L89) are required for LEF-11 oligomerization and viral DNA replication. Collectively, these data indicate that BmNPV LEF-11 oligomerization influences viral DNA replication.	[Dong, Zhan-Qi; Hu, Nan; Zhang, Jun; Chen, Ting-Ting; Cao, Ming-Ya; Li, Hai-Qing; Lei, Xue-Jiao; Chen, Peng; Lu, Cheng; Pan, Min-Hui] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China; [Lu, Cheng; Pan, Min-Hui] Southwest Univ, Key Lab Sericulture Funct Genom & Biotechnol, Minist Agr, Chongqing 400716, Peoples R China; [Zhang, Jun] Chongqing Med Univ, Inst Life Sci, Chongqing 400716, Peoples R China	Southwest University - China; Ministry of Agriculture & Rural Affairs; Southwest University - China; Chongqing Medical University	Lu, C (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China.	lucheng@swu.edu.cn; pmh0476@hotmail.com	Zhang, Jun/AGZ-7722-2022	Dong, Zhanqi/0000-0002-0607-4241	National High-Tech R&D Program of China [2013AA102507]; National Natural Science Foundation of China [31172269, 31272505, 31472152]; China Agriculture Research System [CARS-22]; Fundamental Research Funds for the Central Universities [XDJK2015D002]	National High-Tech R&D Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National High-Tech R&D Program of China (No. 2013AA102507), the National Natural Science Foundation of China (Nos. 31172269, 31272505 and 31472152), the China Agriculture Research System (CARS-22) and Fundamental Research Funds for the Central Universities (XDJK2015D002).	Carstens EB, 2002, VIRUS RES, V83, P13, DOI 10.1016/S0168-1702(01)00401-4; Chen T, 2004, J VIROL, V78, P329, DOI 10.1128/JVI.78.1.329-339.2004; Dong ZQ, 2014, VIRUS RES, V184, P62, DOI 10.1016/j.virusres.2014.02.009; Downie K, 2013, J GEN VIROL, V94, P2530, DOI 10.1099/vir.0.056267-0; Evans JT, 1997, J VIROL, V71, P3114, DOI 10.1128/JVI.71.4.3114-3119.1997; Hashem GM, 1999, NUCLEIC ACIDS RES, V27, P3371, DOI 10.1093/nar/27.16.3371; Hefferon KL, 2003, CAN J MICROBIOL, V49, P157, DOI [10.1139/w03-022, 10.1139/W03-022]; Kingsley DH, 1999, MOL BIOL CELL, V10, P4191, DOI 10.1091/mbc.10.12.4191; Kremer A, 1998, VIROLOGY, V249, P336, DOI 10.1006/viro.1998.9288; Lin GY, 2002, J VIROL, V76, P2770, DOI 10.1128/JVI.76.6.2770-2779.2002; Lin GY, 2001, J GEN VIROL, V82, P2289, DOI 10.1099/0022-1317-82-9-2289; Liu G, 1999, VIROLOGY, V253, P125, DOI 10.1006/viro.1998.9485; Mikhailov VS, 2006, VIROLOGY, V346, P469, DOI 10.1016/j.virol.2005.11.027; Mikhailov VS, 2005, J BIOL CHEM, V280, P29444, DOI 10.1074/jbc.M503235200; Mikhailov VS, 2000, VIROLOGY, V270, P180, DOI 10.1006/viro.2000.0270; Mikhailov VS, 2002, J VIROL, V76, P2287, DOI 10.1128/JVI.76.5.2287-2297.2002; Mikhailov VS, 1998, DOKL AKAD NAUK+, V361, P405; Mikhallov VS, 2008, VIROLOGY, V370, P415, DOI 10.1016/j.virol.2007.09.001; MORR J, 1995, FEBS LETT, V368, P495, DOI 10.1016/0014-5793(95)00721-K; Muchova K, 2002, ACTA CRYSTALLOGR D, V58, P1542, DOI 10.1107/S0907444902014336; Okano K, 1999, J VIROL, V73, P110, DOI 10.1128/JVI.73.1.110-119.1999; Olson VA, 2002, J VIROL, V76, P9505, DOI 10.1128/JVI.76.18.9505-9515.2002; Olson VA, 2001, J VIROL, V75, P6042, DOI 10.1128/JVI.75.13.6042-6051.2001; Pan MH, 2010, TISSUE CELL, V42, P42, DOI 10.1016/j.tice.2009.07.002; Pathakamuri JA, 2002, J VIROL, V76, P5598, DOI 10.1128/JVI.76.11.5598-5604.2002; TODD JW, 1995, J VIROL, V69, P968, DOI 10.1128/JVI.69.2.968-974.1995; Vanarsdall AL, 2005, VIROLOGY, V331, P175, DOI 10.1016/j.virol.2004.10.024; WANG HGH, 1991, J VIROL METHODS, V31, P113, DOI 10.1016/0166-0934(91)90149-T; Wu YT, 1999, J VIROL, V73, P5473, DOI 10.1128/JVI.73.7.5473-5480.1999; Zhang J, 2014, VIRUS RES, V184, P111, DOI 10.1016/j.virusres.2014.02.020; Zhang J, 2014, ANTIVIR RES, V104, P143, DOI 10.1016/j.antiviral.2014.01.017	31	17	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144930	10.1371/journal.pone.0144930	http://dx.doi.org/10.1371/journal.pone.0144930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660313	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900152
J	Hamilton, ML; Warwick, J; Terry, A; Allen, MJ; Napier, JA; Sayanova, O				Hamilton, Mary L.; Warwick, Joanna; Terry, Anya; Allen, Michael J.; Napier, Johnathan A.; Sayanova, Olga			Towards the Industrial Production of Omega-3 Long Chain Polyunsaturated Fatty Acids from a Genetically Modified Diatom Phaeodactylum tricornutum	PLOS ONE			English	Article							EICOSAPENTAENOIC ACID; CONTINUOUS-CULTURE; FISH-OIL; MICROALGAE; ACCUMULATION; GROWTH; NITROGEN; BIOMASS; RICH; OMEGA-3-FATTY-ACIDS	The marine diatom Phaeodactylum tricornutum can accumulate up to 30% of the omega-3 long chain polyunsaturated fatty acid (LC-PUFA) eicosapentaenoic acid (EPA) and, as such, is considered a good source for the industrial production of EPA. However, P. tricornutum does not naturally accumulate significant levels of the more valuable omega-3 LC-PUFA docosahexaenoic acid (DHA). Previously, we have engineered P. tricornutum to accumulate elevated levels of DHA and docosapentaenoic acid (DPA) by overexpressing heterologous genes encoding enzyme activities of the LC-PUFA biosynthetic pathway. Here, the transgenic strain Pt_Elo5 has been investigated for the scalable production of EPA and DHA. Studies have been performed at the laboratory scale on the cultures growing in up to 1 L flasks a 3.5 L bubble column, a 550 L closed photobioreactor and a 1250 L raceway pond with artificial illumination. Detailed studies were carried out on the effect of different media, carbon sources and illumination on omega-3 LC-PUFAs production by transgenic strain Pt_Elo5 and wild type P. tricornutum grown in 3.5 L bubble columns. The highest content of DHA (7.5% of total fatty acids, TFA) in transgenic strain was achieved in cultures grown in seawater salts, Instant Ocean (IO), supplemented with F/2 nutrients (F2N) under continuous light. After identifying the optimal conditions for omega-3 LC-PUFA accumulation in the small-scale experiments we compared EPA and DHA levels of the transgenic strain grown in a larger fence-style tubular photobioreactor and a raceway pond. We observed a significant production of DHA over EPA, generating an EPA/DPA/DHA profile of 8.7%/4.5%/12.3% of TFA in cells grown in a photobioreactor, equivalent to 6.4 mu g/mg dry weight DHA in a mid-exponentially growing algal culture. Omega-3 LC-PUFAs production in a raceway pond at ambient temperature but supplemented with artificial illumination (110 mu mol photons m(-2)s(-1)) on a 16:8h light: dark cycle, in natural seawater and F/2 nutrients was 24.8% EPA and 10.3% DHA. Transgenic strain grown in RP produced the highest levels of EPA (12.8%) incorporated in neutral lipids. However, the highest partitioning of DHA in neutral lipids was observed in cultures grown in PBR (7.1%). Our results clearly demonstrate the potential for the development of the transgenic Pt_Elo5 as a platform for the commercial production of EPA and DHA.	[Hamilton, Mary L.; Napier, Johnathan A.; Sayanova, Olga] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden AL5 2JQ, Herts, England; [Warwick, Joanna; Terry, Anya; Allen, Michael J.] Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Plymouth Marine Laboratory	Sayanova, O (corresponding author), Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden AL5 2JQ, Herts, England.	olga.sayanova@rothamsted.ac.uk	Allen, Michael J/C-1248-2011	Allen, Michael J/0000-0001-8504-7171; Napier, Johnathan/0000-0003-3580-3607	Biotechnology and Biological Sciences Research Council (BBSRC), UK; EC-FP7 KBBE, GIAVAP consortium [266401]; Phyconet, a BBSRC Network in Industrial Biotechnology and Bioenergy (NIBB), (PHYCPoC-01); Natural Environment Research Council (NERC); BBSRC [BBS/E/C/00005207, BB/L002957/1] Funding Source: UKRI; NERC [pml010007] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005207, BB/L002957/1] Funding Source: researchfish; Natural Environment Research Council [pml010007] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC), UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EC-FP7 KBBE, GIAVAP consortium; Phyconet, a BBSRC Network in Industrial Biotechnology and Bioenergy (NIBB), (PHYCPoC-01)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Rothamsted Research receives grant-aided support from the Biotechnology and Biological Sciences Research Council (BBSRC), UK. Plymouth Marine Laboratory receives grant-aided support from the Natural Environment Research Council (NERC). This project was partially funded by EC-FP7 KBBE, as part of the GIAVAP consortium (project ID 266401) and by Phyconet, a BBSRC Network in Industrial Biotechnology and Bioenergy (NIBB), (PHYCPoC-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Rothamsted Research receives grant-aided support from the Biotechnology and Biological Sciences Research Council (BBSRC), UK. Plymouth Marine Laboratory receives grant-aided support from the Natural Environment Research Council (NERC). This project was partially funded by EC-FP7 KBBE, as part of the GIAVAP consortium (project ID 266401) and by Phyconet, a BBSRC Network in Industrial Biotechnology and Bioenergy (NIBB), (PHYCPoC-01).	Adarme-Vega TC, 2014, CURR OPIN BIOTECH, V26, P14, DOI 10.1016/j.copbio.2013.08.003; Alonso DL, 1998, PHYTOCHEMISTRY, V47, P1473, DOI 10.1016/S0031-9422(97)01080-7; Alonso DL, 2000, PHYTOCHEMISTRY, V54, P461, DOI 10.1016/S0031-9422(00)00084-4; ARAO T, 1987, PHYTOCHEMISTRY, V26, P2573, DOI 10.1016/S0031-9422(00)83880-7; Armenta RE, 2013, J AM OIL CHEM SOC, V90, P167, DOI 10.1007/s11746-012-2154-3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Cartens M, 1996, J AM OIL CHEM SOC, V73, P1025, DOI 10.1007/BF02523411; Ceron Garcia MC, 2000, J APPL PHYCOL, V12, P239; Chauton MS, 2015, AQUACULTURE, V436, P95, DOI 10.1016/j.aquaculture.2014.10.038; De Riso V, 2009, NUCLEIC ACIDS RES, V37, P1; Draaisma RB, 2013, CURR OPIN BIOTECH, V24, P169, DOI 10.1016/j.copbio.2012.09.012; Garces M, 1993, ANAL BIOCHEM, V211, P139; Garcia MCC, 2005, PROCESS BIOCHEM, V40, P297, DOI 10.1016/j.procbio.2004.01.016; Gardner RD, 2012, J APPL PHYCOL, V24, P1311, DOI 10.1007/s10811-011-9782-0; Grima EM, 1996, J APPL PHYCOL, V8, P359, DOI 10.1007/BF02178579; GRIMA EM, 1994, BIOTECHNOL APPL BIOC, V20, P279; Hamilton ML, 2014, METAB ENG, V22, P3, DOI 10.1016/j.ymben.2013.12.003; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Koller M, 2014, ALGAL RES, V6, P52, DOI 10.1016/j.algal.2014.09.002; Liang Y, 2006, J PHOTOCH PHOTOBIO B, V82, P161, DOI 10.1016/j.jphotobiol.2005.11.002; Mus F, 2013, APPL MICROBIOL BIOT, V97, P3625, DOI 10.1007/s00253-013-4747-7; Reis A, 1996, BIORESOURCE TECHNOL, V55, P83, DOI 10.1016/0960-8524(95)00157-3; Ruiz-Lopez N, 2014, PLANT J, V77, P198, DOI 10.1111/tpj.12378; Ryckebosch E, 2014, FOOD CHEM, V160, P393, DOI 10.1016/j.foodchem.2014.03.087; Siaut M, 2007, GENE, V406, P23, DOI 10.1016/j.gene.2007.05.022; Benavides AMS, 2013, BIOMASS BIOENERG, V54, P115, DOI 10.1016/j.biombioe.2013.03.016; Tonon T, 2002, PHYTOCHEMISTRY, V61, P15, DOI 10.1016/S0031-9422(02)00201-7; Wen ZY, 2003, BIOTECHNOL ADV, V21, P273, DOI 10.1016/S0734-9750(03)00051-X; YONGMANITCHAI W, 1991, APPL ENVIRON MICROB, V57, P419, DOI 10.1128/AEM.57.2.419-425.1991; YONGMANITCHAI W, 1992, J AM OIL CHEM SOC, V69, P584, DOI 10.1007/BF02636113	31	71	72	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144054	10.1371/journal.pone.0144054	http://dx.doi.org/10.1371/journal.pone.0144054			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658738	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000366715900024
J	Makadzange, AT; Higgins-Biddle, M; Chimukangara, B; Birri, R; Gordon, M; Mahlanza, T; McHugh, G; van Dijk, JH; Bwakura-Dangarembizi, M; Ndung'u, T; Masimirembwa, C; Phelps, B; Amzel, A; Ojikutu, BO; Walker, BD; Ndhlovu, CE				Makadzange, A. T.; Higgins-Biddle, M.; Chimukangara, B.; Birri, R.; Gordon, M.; Mahlanza, T.; McHugh, G.; van Dijk, J. H.; Bwakura-Dangarembizi, M.; Ndung'u, T.; Masimirembwa, C.; Phelps, B.; Amzel, A.; Ojikutu, B. O.; Walker, B. D.; Ndhlovu, C. E.			Clinical, Virologic, Immunologic Outcomes and Emerging HIV Drug Resistance Patterns in Children and Adolescents in Public ART Care in Zimbabwe	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; MIDDLE-INCOME COUNTRIES; SUB-SAHARAN AFRICA; INFECTED CHILDREN; REVERSE-TRANSCRIPTASE; HIV-1-INFECTED CHILDREN; CD4; CHALLENGES; ADHERENCE; RESPONSES	Objective To determine immunologic, virologic outcomes and drug resistance among children and adolescents receiving care during routine programmatic implementation in a low-income country. Methods A cross-sectional evaluation with collection of clinical and laboratory data for children (0-<10 years) and adolescents (10-19 years) attending a public ART program in Harare providing care for pediatric patients since 2004, was conducted. Longitudinal data for each participant was obtained from the clinic based medical record. Results Data from 599 children and adolescents was evaluated. The participants presented to care with low CD4 cell count and CD4%, median baseline CD4% was lower in adolescents compared with children (11.0% vs. 15.0%, p<0.0001). The median age at ART initiation was 8.0 years (IQR 3.0, 12.0); median time on ART was 2.9 years (IQR 1.7, 4.5). On ART, median CD4% improved for all age groups but remained below 25%. Older age (>= 5 years) at ART initiation was associated with severe stunting (HAZ <-2: 53.3% vs. 28.4%, p<0.0001). Virologic failure rate was 30.6% and associated with age at ART initiation. In children, nevira-pine based ART regimen was associated with a 3-fold increased risk of failure (AOR: 3.5; 95% CI: 1.3, 9.1, p = 0.0180). Children (<10y) on ART for >= 4 years had higher failure rates than those on ART for < 4 years (39.6% vs. 23.9%, p = 0.0239). In those initiating ART as adolescents, each additional year in age above 10 years at the time of ART initiation (AOR 0.4 95% CI: 0.1, 0.9, p = 0.0324), and each additional year on ART ( AOR 0.4, 95% CI 0.2, 0.9, p = 0.0379) were associated with decreased risk of virologic failure. Drug resistance was evident in 67.6% of sequenced virus isolates. Conclusions During routine programmatic implementation of HIV care for children and adolescents, delayed age at ART initiation has long-term implications on immunologic recovery, growth and virologic outcomes.	[Makadzange, A. T.; Walker, B. D.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Higgins-Biddle, M.; Ojikutu, B. O.] John Snow Inc, Boston, MA USA; [Makadzange, A. T.; Chimukangara, B.; Birri, R.; Mahlanza, T.; McHugh, G.; van Dijk, J. H.; Ndhlovu, C. E.] Univ Zimbabwe, Coll Hlth Sci, Dept Med, Harare, Zimbabwe; [Bwakura-Dangarembizi, M.] Univ Zimbabwe, Dept Pediat, Coll Hlth Sci, Harare, Zimbabwe; [Gordon, M.; Ndung'u, T.] Univ KwaZulu Natal, HIV Pathogenesis Program, Durban, South Africa; [Chimukangara, B.; Masimirembwa, C.] African Inst Biomed Sci, Harare, Zimbabwe; [Phelps, B.; Amzel, A.] US Agcy Int Dev, Washington, DC 20523 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Zimbabwe; University of Zimbabwe; University of Kwazulu Natal; United States Agency for International Development (USAID)	Makadzange, AT (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.	amakadzange@mgh.harvard.edu	Chimukangara, Ben/AAD-6669-2019; Ndhlovu, Chiratidzo Ellen/N-8763-2013; Bwakura-Dangarembizi, Mutsa/D-5686-2018	Chimukangara, Ben/0000-0002-8391-4531; Ndhlovu, Chiratidzo Ellen/0000-0001-7863-7974; Bwakura-Dangarembizi, Mutsa/0000-0001-7751-6177; Masimirembwa, Collen/0000-0002-4053-212X; Ndung'u, Thumbi/0000-0003-2962-3992; Gordon, Michelle/0000-0001-9945-1394; Ojikutu, Bisola/0000-0001-7957-8881; Makadzange, Azure Tariro/0000-0001-5330-1470	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Agency for International Development [GHH-I-00-07-00059-00]; USAID; USAID through JSI; University of Zimbabwe College of Health Sciences	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Agency for International Development(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); USAID(United States Agency for International Development (USAID)); USAID through JSI(United States Agency for International Development (USAID)); University of Zimbabwe College of Health Sciences	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Agency for International Development under the terms of contract no. GHH-I-00-07-00059-00, with the contractor as John Snow Inc. The University of Zimbabwe College of Health Sciences was a sub-grantee with Professor Chiratidzo Ndhlovu as the Principal Investigator. USAID funding supported salaries for research personnel, consultant fees, reagents and supplies for the conduct of the proposed study. John Snow Inc. employees who were involved in the study were Molly Higgins-Biddle and Bisola Ojikutu. Molly Higgins-Biddle provided statistical support for the study during the period of data analysis. Dr. Bisola Ojikutu was the Senior Technical Advisor for JSI. Molly Higgins-Biddle was involved in the data analysis, and both were involved with the review of the manuscript. USAID employees Benjamin Phelps and Anouk Amzel provided technical support to the granting agency but were not involved in the study design, data collection, analysis, decision to publish or preparation of the manuscript. In summary the funder (USAID) provided support in the form of salaries through JSI for some of the authors (MH-B and BO), consultant fees (ATM) and University of Zimbabwe research staff. The funder did not have any additional role in study design, data collection or the decision to publish. The specific roles of the authors are articulated in the 'author contributions' section.	Adetokunboh O, 2015, J INFECT PUBLIC HLTH; Avila C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-673; Banks Lauren, 2012, J AIDS Clin Res, V3, P141; Chohan BH, 2015, AIDS RES HUM RETROVI; Davies MA, 2012, TROP MED INT HEALTH, V17, P1386, DOI 10.1111/j.1365-3156.2012.03073.x; Derache A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117430; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Emmett SD, 2010, JAIDS-J ACQ IMM DEF, V54, P368, DOI 10.1097/QAI.0b013e3181cf4882; Fitzgerald F, 2013, J INFECT DIS, V207, pS85, DOI 10.1093/infdis/jit115; Foundation KF, 2012, FIN RESP AIDS LOW MI; Galarraga O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067565; Haberer Jessica, 2009, Curr HIV/AIDS Rep, V6, P194, DOI 10.1007/s11904-009-0026-8; Hazra R, 2010, ANNU REV MED, V61, P169, DOI 10.1146/annurev.med.050108.151127; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kantor R, 2002, AIDS RES HUM RETROV, V18, P1407, DOI 10.1089/088922202320935483; Kekitiinwa A, 2013, LANCET, V381, P1391, DOI [10.1016/S0140-6736(12)62198-9, DOI 10.1016/S0140-6736(12)62198-9]; Kekitiinwa A, 2008, JAIDS-J ACQ IMM DEF, V49, P384, DOI 10.1097/QAI.0b013e31818cdef5; Lapadula G, 2013, AIDS, V27, P769, DOI 10.1097/QAD.0b013e32835cb747; Lewis J, 2012, J INFECT DIS, V205, P548, DOI 10.1093/infdis/jir787; Leyenaar JK, 2010, PEDIATR INFECT DIS J, V29, P340, DOI 10.1097/INF.0b013e3181bf8ecb; Lowe S, 2010, PEDIATR INFECT DIS J, V29, P346, DOI 10.1097/INF.0b013e3181c15da4; Lowenthal ED, 2014, LANCET INFECT DIS, V14, P627, DOI 10.1016/S1473-3099(13)70363-3; Meyers TM, 2011, PEDIATR INFECT DIS J, V30, P974, DOI 10.1097/INF.0b013e31822539f6; Mugasha C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115171; Mutwa PR, 2014, PEDIATR INFECT DIS J, V33, P63, DOI 10.1097/INF.0b013e31829e6b9f; Palmisano L, 2009, HIV MED, V10, P477, DOI 10.1111/j.1468-1293.2009.00715.x; Patel K, 2008, CLIN INFECT DIS, V46, P507, DOI 10.1086/526524; Persaud D, 2007, J INFECT DIS, V195, P1402, DOI 10.1086/513871; Puthanakit T, 2009, PEDIATR INFECT DIS J, V28, P488, DOI 10.1097/INF.0b013e318194eea6; Reddi Anand, 2007, BMC Pediatr, V7, P13, DOI 10.1186/1471-2431-7-13; Skovdal M, 2011, AIDS CARE, V23, P957, DOI 10.1080/09540121.2010.542298; Soh CH, 2003, LANCET, V362, P2045, DOI 10.1016/S0140-6736(03)15098-2; Sohn AH, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18555; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; Sutcliffe CG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-54; UNAIDS, 2013, UNAIDSJC25021E; UNAIDS, 2014, 90 90 90 AMB TREATM; van Dijk JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019006; Van Dyke RB, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.4.e61; WHO, 2013, GLOB UPD HIV TREATM; WHO, 2006, CONS GUID US ANT DRU; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2004, SCAL ANT THER RES LT; World Health Organization, 2010, ANT THER HIV INF INF; Zanoni BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049591	45	37	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144057	10.1371/journal.pone.0144057	http://dx.doi.org/10.1371/journal.pone.0144057			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658814	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900025
J	Rashedi, E; Nussbaum, MA				Rashedi, Ehsan; Nussbaum, Maury A.			Mathematical Models of Localized Muscle Fatigue: Sensitivity Analysis and Assessment of Two Occupationally-Relevant Models	PLOS ONE			English	Article							BLOOD-FLOW; VOLUNTARY CONTRACTIONS; RECOVERY; EXERCISE; FAILURE; TIME	Muscle fatigue models (MFM) have broad potential application if they can accurately predict muscle capacity and/or endurance time during the execution of diverse tasks. As an initial step toward facilitating improved MFMs, we assessed the sensitivity of selected existing models to their inherent parameters, specifically that model the fatigue and recovery processes, and the accuracy of model predictions. These evaluations were completed for both prolonged and intermittent isometric contractions, and were based on model predictions of endurance times. Based on a recent review of the literature, four MFMs were initially chosen, from which a preliminary assessment led to two of these being considered for more comprehensive evaluation. Both models had a higher sensitivity to their fatigue parameter. Predictions of both models were also more sensitive to the alteration of their parameters in conditions involving lower to moderate levels of effort, though such conditions may be of most practical, contemporary interest or relevance. Although both models yielded accurate predictions of endurance times during prolonged contractions, their predictive ability was inferior for more complex ( intermittent) conditions. When optimizing model parameters for different loading conditions, the recovery parameter showed considerably larger variability, which might be related to the inability of these MFMs in simulating the recovery process under different loading conditions. It is argued that such models may benefit in future work from improving their representation of recovery process, particularly how this process differs across loading conditions.	[Rashedi, Ehsan; Nussbaum, Maury A.] Virginia Tech, Dept Ind & Syst Engn, Blacksburg, VA 24061 USA; [Nussbaum, Maury A.] Virginia Tech, Dept Biomed Engn & Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Nussbaum, MA (corresponding author), Virginia Tech, Dept Ind & Syst Engn, Blacksburg, VA 24061 USA.	nussbaum@vt.edu	Nussbaum, Maury A/A-9655-2008	Nussbaum, Maury A/0000-0002-1887-8431				Bentley TA, 2001, APPL ERGON, V32, P127, DOI 10.1016/S0003-6870(00)00048-X; BiglandRitchie B, 1995, ADV EXP MED BIOL, V384, P361; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; Carpentier A, 2001, J PHYSIOL-LONDON, V534, P903, DOI 10.1111/j.1469-7793.2001.00903.x; Chaffin D., 2006, OCCUPATIONAL BIOMECH, V2nd; Enoka RM, 2008, J PHYSIOL-LONDON, V586, P11, DOI 10.1113/jphysiol.2007.139477; Frey-Law LA, 2012, J BIOMECH, V45, P1803, DOI 10.1016/j.jbiomech.2012.04.018; FUJIMOTO T, 1993, J SPORT MED PHYS FIT, V33, P107; FULCO CS, 1994, J APPL PHYSIOL, V77, P179, DOI 10.1152/jappl.1994.77.1.179; HAMBY DM, 1994, ENVIRON MONIT ASSESS, V32, P135, DOI 10.1007/BF00547132; Hsiao H, 2001, ERGONOMICS, V44, P537, DOI 10.1080/00140130110034480; Hunter SK, 2009, MUSCLE NERVE, V39, P42, DOI 10.1002/mus.21203; James A, 2012, J APPL PHYSIOL, V113, P1643, DOI 10.1152/japplphysiol.00800.2012; Law LAF, 2010, ERGONOMICS, V53, P109, DOI 10.1080/00140130903389068; Looft JM, 2014, ADAPTATION AND VALID; Ma LA, 2011, INT J IND ERGONOM, V41, P10, DOI 10.1016/j.ergon.2010.11.005; Ma L, 2009, INT J IND ERGONOM, V39, P211, DOI 10.1016/j.ergon.2008.04.004; Pitcher JB, 1997, CLIN EXP PHARMACOL P, V24, P471, DOI 10.1111/j.1440-1681.1997.tb01229.x; Rashedi E, 2015, INT J HUMAN FACTORS, V5, P61, DOI DOI 10.1504/IJHFMS.2015.068119; Rashedi E, 2014, ERGONOMICS, V57, P1864, DOI 10.1080/00140139.2014.952682; Rempel D, 2010, J OCCUP ENVIRON HYG, V7, P194, DOI 10.1080/15459620903558491; Rowell L, 1993, HUMAN CARDIOVASCULAR; Sih B, 2012, INT J SPORTS MED, V33, P258, DOI 10.1055/s-0031-1297958; Sonne MW, 2016, ERGONOMICS, V59, P85, DOI 10.1080/00140139.2015.1051597; Sparto PJ, 1997, J ORTHOP SPORT PHYS, V25, P3, DOI 10.2519/jospt.1997.25.1.3; Vedsted P, 2006, EUR J APPL PHYSIOL, V96, P165, DOI 10.1007/s00421-004-1216-0; Vollestad NK, 1997, J NEUROSCI METH, V74, P219, DOI 10.1016/S0165-0270(97)02251-6; Xia T, 2014, ADVANCES IN PHYSICAL, V15, P231; Xia T, 2008, J BIOMECH, V41, P3046, DOI 10.1016/j.jbiomech.2008.07.013; Zhang Q, 2004, ACTA PHYSIOL SCAND, V180, P57, DOI 10.1046/j.0001-6772.2003.01215.x	30	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143872	10.1371/journal.pone.0143872	http://dx.doi.org/10.1371/journal.pone.0143872			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656741	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900020
J	Sigurdsson, S; Forsberg, L; Aspelund, T; van der Geest, RJ; van Buchem, MA; Launer, LJ; Gudnason, V; van Osch, MJ				Sigurdsson, Sigurdur; Forsberg, Lars; Aspelund, Thor; van der Geest, Rob J.; van Buchem, Mark A.; Launer, Lenore J.; Gudnason, Vilmundur; van Osch, Matthias J.			Feasibility of Using Pseudo-Continuous Arterial Spin Labeling Perfusion in a Geriatric Population at 1.5 Tesla	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; ELDERLY SUBJECTS; 3.0 T; REPRODUCIBILITY; MRI; RELIABILITY; BRAIN; AGE; LOCALIZATION; RISK	Objectives To evaluate the feasibility of using pseudo-continuous arterial spin labeling (pCASL) perfusion in a geriatric population at 1.5-Tesla. Materials and Methods In 17 participants (mean age 78.8 +/- 1.63 years) we assessed; 1) inter-session repeatability and reliability of resting state perfusion in 27 brain regions; 2) brain activation using finger-tapping as a means to evaluate the ability to detect flow differences; 3) reliability by comparing cerebral blood flow (CBF) with pCASL to CBF with phase contrast (PC-MR). Results The CBF (mean +/- standard deviation (SD)) for the whole brain grey matter (GM) was 40.6 +/- 8.4 and 41.4 +/- 8.7 ml/100g/min for the first and second scan respectively. The within-subject standard deviation (SDw), the repeatability index (RI) and intra-class correlation coefficient (ICC) across the 27 regions ranged from 1.1 to 7.9, 2.2 to 15.5 and 0.35 to 0.98 respectively. For whole brain GM the SDw, RI and ICC were 1.6, 3.2 and 0.96 respectively. The between-subject standard deviation (SDB) was larger than the SDw for all regions. Comparison of CBF at rest and activation on a voxel level showed significantly higher perfusion during finger tapping in the motor-and somatosensory regions. The mean CBF for whole brain GM was 40.6 +/- 8.4 ml/100g/min at rest and 42.6 +/- 8.6 ml/100g/min during activation. Finally the reliability of pCASL against the reference standard of PC-MR was high (ICC = 0.80). The mean CBF for whole brain measured with PC-MRI was 54.3 +/- 10.1 ml/100g/min and 38.3 +/- 7.8 ml/100g/min with pCASL. Conclusions The results demonstrate moderate to high levels of repeatability and reliability for most brain regions, comparable to what has been reported for younger populations. The performance of pCASL at 1.5-Tesla shows that region-specific perfusion measurements with this technique are feasible in studies of a geriatric population.	[Sigurdsson, Sigurdur; Aspelund, Thor; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Forsberg, Lars; Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [van der Geest, Rob J.; van Buchem, Mark A.; van Osch, Matthias J.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, NIH, Bethesda, MD 20892 USA	Icelandic Heart Association; University of Iceland; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Sigurdsson, S (corresponding author), Iceland Heart Assoc, Kopavogur, Iceland.	sigurdur@hjarta.is	Van Osch, Matthias/AAV-3876-2021; Aspelund, Thor/K-7022-2019; Gudnason, Vilmundur/AAE-7126-2019; van der Geest, Rob J/J-8193-2015; van Buchem, Mark/AAC-9843-2022	Van Osch, Matthias/0000-0001-7034-8959; Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; van der Geest, Rob J/0000-0002-9084-5597; van Buchem, Mark/0000-0003-1881-1998				Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Asllani I, 2008, NEUROIMAGE, V39, P1246, DOI 10.1016/j.neuroimage.2007.10.015; Asllani I, 2009, HUM BRAIN MAPP, V30, P2927, DOI 10.1002/hbm.20719; BARKHOF E, 1994, ACTA RADIOL, V35, P123, DOI 10.1177/028418519403500204; Barth M, 1997, CELL MOL BIOL, V43, P783; Bastos-Leite AJ, 2008, AM J NEURORADIOL, V29, P1296, DOI 10.3174/ajnr.A1091; Bland JM, 1996, BRIT MED J, V313, P744; Bland JM, 1996, BRIT MED J, V313, P106, DOI 10.1136/bmj.313.7049.106; Brickman AM, 2009, PSYCHIAT RES-NEUROIM, V172, P117, DOI 10.1016/j.pscychresns.2008.11.006; Chen JJ, 2011, NEUROIMAGE, V55, P468, DOI 10.1016/j.neuroimage.2010.12.032; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Fernandez-Seara MA, 2005, MAGN RESON MED, V54, P1241, DOI 10.1002/mrm.20674; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Hermes M, 2007, MAGN RESON MATER PHY, V20, P103, DOI 10.1007/s10334-007-0073-3; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Hodkinson DJ, 2013, NEUROIMAGE-CLIN, V3, P301, DOI 10.1016/j.nicl.2013.09.004; Jahng GH, 2005, RADIOLOGY, V234, P909, DOI 10.1148/radiol.2343031499; Jain V, 2012, RADIOLOGY, V263, P527, DOI 10.1148/radiol.12111509; Jiang L, 2010, MAGN RESON IMAGING, V28, P1283, DOI 10.1016/j.mri.2010.05.002; Kilroy E, 2014, J MAGN RESON IMAGING, V39, P931, DOI 10.1002/jmri.24246; Liu YN, 2012, MAGN RESON MED, V68, P912, DOI 10.1002/mrm.23286; Mutke MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087143; Mutsaerts HJMM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104108; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023; Petersen ET, 2010, NEUROIMAGE, V49, P104, DOI 10.1016/j.neuroimage.2009.07.068; Sigurdsson S, 2012, NEUROIMAGE, V59, P3862, DOI 10.1016/j.neuroimage.2011.11.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sonntag WE, 1997, ENDOCRINOLOGY, V138, P3515, DOI 10.1210/en.138.8.3515; Spilt A, 2002, J MAGN RESON IMAGING, V16, P1, DOI 10.1002/jmri.10133; van Gelderen P, 2008, MAGN RESON MED, V59, P788, DOI 10.1002/mrm.21515; van Osch MJP, 2009, MAGN RESON MED, V62, P165, DOI 10.1002/mrm.22002; Vidorreta M, 2013, NEUROIMAGE, V66, P662, DOI 10.1016/j.neuroimage.2012.10.087; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; Wang JJ, 2002, MAGN RESON MED, V48, P242, DOI 10.1002/mrm.10211; Wang Y, 2011, NEUROIMAGE, V54, P1188, DOI 10.1016/j.neuroimage.2010.08.043; Wintermark M, 2005, STROKE, V36, pE83, DOI 10.1161/01.STR.0000177884.72657.8b; Wolk DA, 2012, CURR OPIN NEUROL, V25, P421, DOI 10.1097/WCO.0b013e328354ff0a; Xu GF, 2010, NMR BIOMED, V23, P286, DOI 10.1002/nbm.1462; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Zhang Q, 2012, J ALZHEIMERS DIS, V32, P677, DOI 10.3233/JAD-2012-120964; Zhang X, 2013, MAGN RESON MED, V70, P1082, DOI 10.1002/mrm.24550	42	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144743	10.1371/journal.pone.0144743	http://dx.doi.org/10.1371/journal.pone.0144743			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659363	gold, Green Submitted, Green Published			2022-12-27	WOS:000366715900100
J	Danskin, B; Denman, D; Valley, M; Ollerenshaw, D; Williams, D; Groblewski, P; Reid, C; Olsen, S; Waters, J				Danskin, Bethanny; Denman, Daniel; Valley, Matthew; Ollerenshaw, Douglas; Williams, Derric; Groblewski, Peter; Reid, Clay; Olsen, Shawn; Waters, Jack			Optogenetics in Mice Performing a Visual Discrimination Task: Measurement and Suppression of Retinal Activation and the Resulting Behavioral Artifact	PLOS ONE			English	Article							OPTICAL-PROPERTIES; COEXPRESSION; NEURONS; TISSUES; CORTEX	Optogenetic techniques are used widely to perturb and interrogate neural circuits in behaving animals, but illumination can have additional effects, such as the activation of endogenous opsins in the retina. We found that illumination, delivered deep into the brain via an optical fiber, evoked a behavioral artifact in mice performing a visually guided discrimination task. Compared with blue (473 nm) and yellow (589 nm) illumination, red (640 nm) illumination evoked a greater behavioral artifact and more activity in the retina, the latter measured with electrical recordings. In the mouse, the sensitivity of retinal opsins declines steeply with wavelength across the visible spectrum, but propagation of light through brain tissue increases with wavelength. Our results suggest that poor retinal sensitivity to red light was overcome by relatively robust propagation of red light through brain tissue and stronger illumination of the retina by red than by blue or yellow light. Light adaptation of the retina, via an external source of illumination, suppressed retinal activation and the behavioral artifact without otherwise impacting behavioral performance. In summary, long wavelength optogenetic stimuli are particularly prone to evoke behavioral artifacts via activation of retinal opsins in the mouse, but light adaptation of the retina can provide a simple and effective mitigation of the artifact.	[Danskin, Bethanny; Denman, Daniel; Valley, Matthew; Ollerenshaw, Douglas; Williams, Derric; Groblewski, Peter; Reid, Clay; Olsen, Shawn; Waters, Jack] Allen Inst Brain Sci, Seattle, WA 98109 USA	Allen Institute for Brain Science	Waters, J (corresponding author), Allen Inst Brain Sci, 551 N 34th St, Seattle, WA 98109 USA.	jackw@alleninstitute.org		Valley, Matthew/0000-0002-7204-5457; denman, daniel/0000-0003-1075-1265; Danskin, Bethanny/0000-0002-4832-1220	Allen Institute for Brain Science; National Institute of Neurological Disorders and Stroke [NS078067]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078067] Funding Source: NIH RePORTER	Allen Institute for Brain Science; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by the Allen Institute for Brain Science and award number NS078067 from the National Institute of Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful for the hard work and technical support of the many staff members in the Allen Institute. We also thank A. Nagy (Mount Sinai Hospital in Toronto) for providing the G4 ES cell line, used in the development of the Ai32D and Ai35D mouse lines. Funding was provided by the Allen Institute for Brain Science and award number NS078067 from the National Institute of Neurological Disorders and Stroke. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of health and National Institute of Neurological Disorders and Stroke. We thank the Allen Institute founders, Paul G Allen and Jody Allen, for their vision, encouragement and support.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Chuong AS, 2014, NAT NEUROSCI, V17, P1123, DOI 10.1038/nn.3752; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Daniele LL, 2011, VISION RES, V51, P447, DOI 10.1016/j.visres.2010.12.017; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Jacobs GH, 2004, VISION RES, V44, P1615, DOI 10.1016/j.visres.2004.01.016; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; Kravitz AV, 2013, BRAIN RES, V1511, P21, DOI 10.1016/j.brainres.2012.11.018; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Pinto L, 2013, NAT NEUROSCI, V16, P1857, DOI 10.1038/nn.3552; Sidor MM, 2015, JOVE-J VIS EXP, DOI 10.3791/51483; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Yaroslavsky AN, 2002, PHYS MED BIOL, V47, P2059, DOI 10.1088/0031-9155/47/12/305; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120	24	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144760	10.1371/journal.pone.0144760	http://dx.doi.org/10.1371/journal.pone.0144760			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657323	Green Published, gold			2022-12-27	WOS:000366903600088
J	Gizzo, S; Noventa, M; Vitagliano, A; Dall'Asta, A; D'Antona, D; Aldrich, CJ; Quaranta, M; Frusca, T; Patrelli, TS				Gizzo, Salvatore; Noventa, Marco; Vitagliano, Amerigo; Dall'Asta, Andrea; D'Antona, Donato; Aldrich, Clive J.; Quaranta, Michela; Frusca, Tiziana; Patrelli, Tito Silvio			An Update on Maternal Hydration Strategies for Amniotic Fluid Improvement in Isolated Oligohydramnios and Normohydramnios: Evidence from a Systematic Review of Literature and Meta-Analysis	PLOS ONE			English	Article							3RD-TRIMESTER ISOLATED OLIGOHYDRAMNIOS; THERAPY IMPROVES; ORAL HYDRATION; INTRAVENOUS HYDRATION; PERINATAL OUTCOMES; PREGNANCY OUTCOMES; INDEX; VOLUME; TERM; QUANTITY	Objective Several trials aimed at evaluating the efficacy of maternal hydration (MH) in increasing amniotic-fluid-volume (AFV) in pregnancies with isolated oligohydramnios or normohydramnos have been conducted. Unfortunately, no evidences support this intervention in routine-clinical-practice. The aim of this systematic-literature-review and meta-analysis was to collect all data regarding proposed strategies and their efficacy in relation to each clinical condition for which MH-therapy was performed with the aim of increasing amniotic-fluid (AF) and improving perinatal outcomes. Materials and Methods A systematic literature search was conducted in electronic-database MEDLINE, EMBASE, ScienceDirect and the Cochrane-Library in the time interval between 1991 and 2014. Following the identification of eligible trials, we estimated the methodological quality of each study (using QADAS-2) and clustered patients according to the following outcome measures: route of administration (oral versus intravenous versus combined), total daily dose of fluids administered (<2000 versus >2000), duration of hydration therapy: (1 day, >1 day but <1 week, >1 week), type of fluid administered (isotonic versus hypotonic versus combination). Results In isolated-oligohydramnios (IO), maternal oral hydration is more effective than intravenous hydration and hypotonic solutions superior to isotonic solutions. The improvement in AFV appears to be time-dependent rather than daily-dose dependent. Regarding normohydramnios pregnancies, all strategies seem equivalent though the administration of hypotonic-fluid appears to have a slightly greater effect than isotonic-fluid. Regarding perinatal outcomes, data is fragmentary and heterogeneous and does not allow us to define the real clinical utility of MH. Conclusions Available data suggests that MH may be a safe, well-tolerated and useful strategy to improve AFV especially in cases of IO. In view of the numerous obstetric situations in which a reduced AFV may pose a threat, particularly to the fetus, the possibility of increasing AFV with a simple and inexpensive practice like MH-therapy may have potential clinical applications. Considering the various strategies of maternal hydration implemented in the treatment of IO, better results were observed when treatment was based on a combination of intravenous (for a period of 1 day) and oral (for a period of at least 14 days) hypotonic fluids (>= 2000ml).	[Gizzo, Salvatore; Noventa, Marco; Vitagliano, Amerigo; D'Antona, Donato] Univ Padua, Dept Woman & Child Hlth, Padua, Italy; [Gizzo, Salvatore; Aldrich, Clive J.] Northampton Gen Hosp, NHS Trust, Dept Obstet & Gynecol, Northampton, England; [Dall'Asta, Andrea; Frusca, Tiziana; Patrelli, Tito Silvio] Univ Parma, Dept Surg Sci, I-43100 Parma, Italy; [Quaranta, Michela] Univ Verona, Dept Obstet & Gynaecol, I-37100 Verona, Italy; [Patrelli, Tito Silvio] Vicenza Gen Hosp, Vicenza, Italy	University of Padua; University of Parma; University of Verona; ULSS 8 Berica; Ospedale San Bortolo di Vicenza	Noventa, M (corresponding author), Univ Padua, Dept Woman & Child Hlth, Padua, Italy.	marco.noventa@gmail.com	Dall'Asta, Andrea/K-4774-2018; Noventa, Marco/ABB-4669-2020	Dall'Asta, Andrea/0000-0001-7201-0206; Noventa, Marco/0000-0002-7809-6001				Akter M D, 2012, Mymensingh Med J, V21, P723; Ashwal E, 2014, ARCH GYNECOL OBSTET, V290, P875, DOI 10.1007/s00404-014-3292-7; Borges VTM, 2011, BRAZ J MED BIOL RES, V44, P263, DOI 10.1590/S0100-879X2011007500009; Burgos J, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.031; Burgos J, 2011, INT J GYNECOL OBSTET, V112, P48, DOI 10.1016/j.ijgo.2010.07.023; Casey BM, 2000, AM J OBSTET GYNECOL, V182, P909, DOI 10.1016/S0002-9378(00)70345-0; Chandra PC, 2000, J REPROD MED, V45, P337; Chauhan SP, 1999, AM J OBSTET GYNECOL, V181, P1473, DOI 10.1016/S0002-9378(99)70393-5; Chauhan SP, 2007, AM J PERINAT, V24, P215, DOI 10.1055/s-2007-972926; Deka D, 2001, INT J GYNECOL OBSTET, V73, P155, DOI 10.1016/S0020-7292(00)00354-4; Doi S, 1998, OBSTET GYNECOL, V92, P525, DOI 10.1016/S0029-7844(98)00242-7; Fait G, 2003, J REPROD MED, V48, P187; FLACK NJ, 1995, AM J OBSTET GYNECOL, V173, P1186, DOI 10.1016/0002-9378(95)91350-5; Ghafarnejad M, 2009, J OBSTET GYNAECOL RE, V35, P895, DOI 10.1111/j.1447-0756.2009.01043.x; Gizzo S, 2014, CLIN CHEM LAB ME AUG; Gizzo S, ULTRASOUND MED BIOL; Gizzo S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/638093; Gizzo S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114190; Gizzo S, 2014, OBSTET GYNECOL, V124, P837, DOI 10.1097/AOG.0000000000000487; Gizzo S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/783598; Gizzo S, 2014, ARCH GYNECOL OBSTET, V290, P21, DOI 10.1007/s00404-014-3212-x; Gizzo S, 2014, J PERINAT MED, V42, P339, DOI 10.1515/jpm-2013-0160; Gizzo S, 2013, SCI WORLD J, DOI 10.1155/2013/254901; Gizzo S, 2013, REPROD SCI, V20, P1011, DOI 10.1177/1933719112468951; Gizzo S, 2013, FERTIL STERIL, V99, P2097, DOI 10.1016/j.fertnstert.2013.02.013; Gizzo S, 2013, FERTIL STERIL, V99, P496, DOI 10.1016/j.fertnstert.2012.10.019; Hofmeyr GJ, 2002, COCHRANE DB SYST REV, V1; KILPATRICK SJ, 1993, OBSTET GYNECOL, V81, P49; KILPATRICK SJ, 1991, OBSTET GYNECOL, V78, P1098; Lorzadeh N., 2008, RES J OBSTET GYNECOL, V1, P25, DOI [10.3923/rjog.2008.25.29, DOI 10.3923/RJOG.2008.25.29]; Nabhan AF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006593.pub2; Nabhan AF, 2009, INT J GYNECOL OBSTET, V104, P184, DOI 10.1016/j.ijgo.2008.10.018; Ozgu-Erdinc AS, 2014, J OBSTET GYNAECOL RE, V40, P1540, DOI 10.1111/jog.12371; Patrelli TS, 2014, J ULTRAS MED, V33, P922, DOI 10.7863/ultra.33.5.922.1; Patrelli TS, 2012, J MATERN-FETAL NEO M, V25, P2570, DOI 10.3109/14767058.2012.715220; Patrelli TS, 2012, J ULTRAS MED, V31, P239, DOI 10.7863/jum.2012.31.2.239; Ross M G, 2001, J Matern Fetal Med, V10, P2, DOI 10.1080/714904292; Ross Michael G, 2007, Am J Obstet Gynecol, V196, pe17, DOI 10.1016/j.ajog.2006.09.032; Rossi AC, 2013, EUR J OBSTET GYN R B, V169, P149, DOI 10.1016/j.ejogrb.2013.03.011; Shahnazi Mahnaz, 2012, J Caring Sci, V1, P123, DOI 10.5681/jcs.2012.018; Sherer DM, 2002, AM J PERINAT, V19, P253, DOI 10.1055/s-2002-33084; Ulker K, 2014, J ULTRAS MED, V33, P922, DOI 10.7863/ultra.33.5.922; Ulker K, 2013, J ULTRAS MED, V32, P955, DOI 10.7863/ultra.32.6.955; Umber A, 2010, ANNALS, V16, P1; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Yan-Rosenberg L, 2007, J MATERN-FETAL NEO M, V20, P715, DOI 10.1080/14767050701516204	46	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144334	10.1371/journal.pone.0144334	http://dx.doi.org/10.1371/journal.pone.0144334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658482	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903600036
J	Saeb, S; Kording, K; Mohr, DC				Saeb, Sohrab; Koerding, Konrad; Mohr, David C.			Making Activity Recognition Robust against Deceptive Behavior	PLOS ONE			English	Article							MOTION SENSORS	Healthcare services increasingly use the activity recognition technology to track the daily activities of individuals. In some cases, this is used to provide incentives. For example, some health insurance companies offer discount to customers who are physically active, based on the data collected from their activity tracking devices. Therefore, there is an increasing motivation for individuals to cheat, by making activity trackers detect activities that increase their benefits rather than the ones they actually do. In this study, we used a novel method to make activity recognition robust against deceptive behavior. We asked 14 subjects to attempt to trick our smartphone-based activity classifier by making it detect an activity other than the one they actually performed, for example by shaking the phone while seated to make the classifier detect walking. If they succeeded, we used their motion data to retrain the classifier, and asked them to try to trick it again. The experiment ended when subjects could no longer cheat. We found that some subjects were not able to trick the classifier at all, while others required five rounds of retraining. While classifiers trained on normal activity data predicted true activity with similar to 38% accuracy, training on the data gathered during the deceptive behavior increased their accuracy to similar to 84%. We conclude that learning the deceptive behavior of one individual helps to detect the deceptive behavior of others. Thus, we can make current activity recognition robust to deception by including deceptive activity data from a few individuals.	[Saeb, Sohrab; Mohr, David C.] Northwestern Univ, Dept Prevent Med, Ctr Behav Intervent Technol, Chicago, IL 60611 USA; [Saeb, Sohrab; Koerding, Konrad] Northwestern Univ, Dept Rehabil & Phys Med, Rehabil Inst Chicago, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Shirley Ryan AbilityLab	Saeb, S (corresponding author), Northwestern Univ, Dept Prevent Med, Ctr Behav Intervent Technol, Chicago, IL 60611 USA.	s-saeb@northwestern.edu	; Kording, Konrad/A-1233-2007	Mohr, David/0000-0002-5443-7596; Kording, Konrad/0000-0001-8408-4499	US National Institute of Mental Health [P20MH090318, R01MH100482]; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH090318, R01MH100482] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded by research grants P20MH090318 and R01MH100482 from the US National Institute of Mental Health: https://www.nimh.nih.gov. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MV, 2012, FRONT NEUROL, V3, P158, DOI DOI 10.3389/FNEUR.2012.00158; Alshurafa N, 2014, 2014 11TH INTERNATIONAL CONFERENCE ON WEARABLE AND IMPLANTABLE BODY SENSOR NETWORKS (BSN), P92, DOI 10.1109/BSN.2014.38; Antos SA, 2014, J NEUROSCI METH, V231, P22, DOI 10.1016/j.jneumeth.2013.09.015; AUBERTTULKENS G, 1987, AM REV RESPIR DIS, V136, P851, DOI 10.1164/ajrccm/136.4.851; Bao L, 2004, LECT NOTES COMPUT SC, V3001, P1, DOI 10.1007/978-3-540-24646-6_1; Brand M, 1997, LEARNING CONCISE MOD; Breiman L., 2001, MACH LEARN, V45, P5; Criminisi A., 2011, MSRTR2011114, V5, P12; Dobkin BH, 2011, NEUROREHAB NEURAL RE, V25, P788, DOI 10.1177/1545968311425908; Helal Abdelsalam, 2009, J Diabetes Sci Technol, V3, P141; KLESGES RC, 1985, AM J EPIDEMIOL, V122, P400, DOI 10.1093/oxfordjournals.aje.a114121; Matula M, 1988, IEEE ENG MED BIOL SO, P29; Mazilu S., 2012, 2012 6th International Conference on Pervasive Computing Technologies for Healthcare, P123, DOI 10.4108/icst.pervasivehealth.2012.248680; McKenna MJ, 1988, COMPUTER VIDEO ANAL, P274; Mearian L, 2015, INSURANCE CO NOW OFF; Mortazavi B., 2012, Proceedings of the 2012 Ninth International Conference on Wearable and Implantable Body Sensor Networks (BSN 2012), P28, DOI 10.1109/BSN.2012.18; Olson P, 2015, FITBIT DATA NOW BEIN; Reddy VR, 2014, LECT NOTES COMPUT SC, V8511, P305, DOI 10.1007/978-3-319-07230-2_30; REDMOND DP, 1985, BEHAV RES METH INSTR, V17, P659, DOI 10.3758/BF03200979; Shoaib M, 2014, SENSORS-BASEL, V14, P10146, DOI 10.3390/s140610146; Tacconi D, 2008, 2008 2ND INTERNATIONAL CONFERENCE ON PERVASIVE COMPUTING TECHNOLOGIES FOR HEALTHCARE, P93; Tomlein Michal, 2012, Proceedings of the International Conference on Health Informatics. HEALTHINF 2012, P401	22	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144795	10.1371/journal.pone.0144795	http://dx.doi.org/10.1371/journal.pone.0144795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659118	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903600092
J	Matsumoto, CS; Shinoda, K; Terauchi, G; Matsumoto, H; Mizota, A; Miyake, Y				Matsumoto, Celso Soiti; Shinoda, Kei; Terauchi, Gaku; Matsumoto, Harue; Mizota, Atsushi; Miyake, Yozo			Assessment of Macular Function during Vitrectomy: New Approach Using Intraoperative Focal Macular Electroretinograms	PLOS ONE			English	Article							VISUAL SENSATIONS; EYES; DYSTROPHY; MUTATION; REMOVAL; ERGS	Purpose To describe a new technique to record focal macular electroretinograms (FMERGs) during vitrectomy to assess macular function. Methods Intraoperative FMERGs (iFMERGs) were recorded in ten patients (10 eyes) who undergo vitrectomy. iFMERGs were elicited by focal macular stimulation. The stimulus light was directed to the macular area through a 25 gauge (25G) glass fiber optic bundle. Background light was delivered through a dual chandelier-type light fiber probe. Focal macular responses elicited with combinations of stimulus and background luminances were analyzed. Results A stimulus luminance that was approximately 1.75 log units brighter than the background light was able to elicit focal macular responses that were not contaminated by stray light responses. Thus, a stimulus luminance of 160 cd/m(2) delivered on a background of 3 cd/m(2) elicited iFMEGs from only the stimulated area. This combination of stimulus and background luminances did not elicit a response when the stimulus was projected onto the optic nerve head. The iFMERGs elicited by a 10 degrees stimulus with a duration of 100 ms and an inter-stimulus interval of 150 ms consisted of an a-, b-, and d-waves, the oscillatory potentials, and the photopic negative response (PhNR). Conclusions Focal ERGs with all components can be recorded from the macula and other retinal areas during vitreous surgery. This new technique will allow surgeons to assess the function of focal areas of the retina intraoperatively.	[Matsumoto, Celso Soiti; Shinoda, Kei; Terauchi, Gaku; Mizota, Atsushi] Teikyo Univ, Sch Med, Dept Ophthalmol, Itabashi Ku, Tokyo 1738605, Japan; [Matsumoto, Celso Soiti; Matsumoto, Harue] Matsumoto Eye Clin, Tokushima, Japan; [Miyake, Yozo] Aichi Med Univ, Nagakute, Aichi 4801195, Japan	Teikyo University; Aichi Medical University	Shinoda, K (corresponding author), Teikyo Univ, Sch Med, Dept Ophthalmol, Itabashi Ku, Kaga 2-11-1, Tokyo 1738605, Japan.	shinodak@med.teikyo-u.ac.jp	Shinoda, Kei/ABC-7993-2020	Shinoda, Kei/0000-0002-1543-9345	Ministry of Education, Culture, Sports, Science and Technology, Japan [25462735]; Ministry of Health, Labor, and Welfare, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	Support of this study was provided by the Ministry of Education, Culture, Sports, Science and Technology, Japan (ID 25462735), and by the Ministry of Health, Labor, and Welfare, Japan.	Charles S., 2012, RETINA, P1696; Choshi T, 2003, JPN J OPHTHALMOL, V47, P356, DOI 10.1016/S0021-5155(03)00073-X; Hayashi T, 2012, OPTOMETRY VISION SCI, V89, P684, DOI 10.1097/OPX.0b013e31824eea32; HORIGUCHI M, 1991, ARCH OPHTHALMOL-CHIC, V109, P1127, DOI 10.1001/archopht.1991.01080080087035; Kabuto T, 2012, MOL VIS, V18, P1031; Kawaguchi N, 2006, AM J OPHTHALMOL, V141, P407, DOI 10.1016/j.ajo.2005.09.007; Kitakawa T, 2012, DOC OPHTHALMOL, V124, P249, DOI 10.1007/s10633-012-9318-1; Matsumoto CS, 2012, J VISION, V12, DOI 10.1167/12.3.6; MIYAKE Y, 1990, DOC OPHTHALMOL, V75, P111, DOI 10.1007/BF00146547; Miyake Y, 1998, GRAEF ARCH CLIN EXP, V236, P13, DOI 10.1007/s004170050036; MIYAKE Y, 1981, Nippon Ganka Gakkai Zasshi, V85, P1521; MIYAKE Y, 1991, ARCH OPHTHALMOL-CHIC, V109, P1123, DOI 10.1001/archopht.1991.01080080083034; MIYAKE Y, 1990, JPN J OPHTHALMOL, V34, P225; MIYAKE Y, 1988, AM J OPHTHALMOL, V106, P546, DOI 10.1016/0002-9394(88)90583-1; MIYAKE Y, 1993, AM J OPHTHALMOL, V116, P576, DOI 10.1016/S0002-9394(14)73199-X; Miyake Y, 2012, RETINA, P202; Nakamura M, 2002, AM J OPHTHALMOL, V133, P278, DOI 10.1016/S0002-9394(01)01304-6; Nishihara H, 2008, INVEST OPHTH VIS SCI, V49, P3121, DOI 10.1167/iovs.08-1835; Niwa T, 2003, INVEST OPHTH VIS SCI, V44, P1652, DOI 10.1167/iovs.02-0404; Ogino K, 2013, INVEST OPHTH VIS SCI, V54, P3771, DOI 10.1167/iovs.12-11494; SANDBERG MA, 1979, AM J OPHTHALMOL, V88, P702, DOI 10.1016/0002-9394(79)90669-X; Shimada Y, 2003, INVEST OPHTH VIS SCI, V44, P1245, DOI 10.1167/iovs.02-0527; Shinoda K, 2011, ELECTRORETINOGRAMS, P33; SHIROYAMA N, 1990, Nippon Ganka Gakkai Zasshi, V94, P1048; Sugisaka E, 2007, AM J OPHTHALMOL, V144, P245, DOI 10.1016/j.ajo.2007.05.001; Sugisaka E, 2006, OPHTHALMOLOGY, V113, P1886; Tanikawa A, 1999, AM J OPHTHALMOL, V127, P559, DOI 10.1016/S0002-9394(98)00447-4; Terasaki H, 1998, AM J OPHTHALMOL, V125, P204, DOI 10.1016/S0002-9394(99)80093-2; Terasaki H, 2001, INVEST OPHTH VIS SCI, V42, P229; Yamada K, 2006, DOC OPHTHALMOL, V113, P83, DOI 10.1007/s10633-006-9017-x	30	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144627	10.1371/journal.pone.0144627	http://dx.doi.org/10.1371/journal.pone.0144627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658489	gold, Green Published			2022-12-27	WOS:000366903500049
J	Kitterer, D; Segerer, S; Alscher, MD; Braun, N; Latus, J				Kitterer, Daniel; Segerer, Stephan; Alscher, M. Dominik; Braun, Niko; Latus, Joerg			Puumala Hantavirus-Induced Hemorrhagic Fever with Renal Syndrome Must Be Considered across the Borders of Nephrology to Avoid Unnecessary Diagnostic Procedures	PLOS ONE			English	Article							INDUCED NEPHROPATHIA-EPIDEMICA; INFECTIONS; PREVENTION	Background Nephropathia epidemica (NE), a milder form of hemorrhagic fever with renal syndrome, is caused by Puumala virus and is characterized by acute kidney injury and thrombocytopenia. Methods A cross-sectional prospective survey of 456 adult patients with serologically confirmed NE was performed. Results Of the 456 investigated patients, 335 had received inpatient treatment. At time of admission to hospital, 72% of the patients had still an AKI and thrombocytopenia was present in 64% of the patients. The 335 patients were treated in 29 different hospitals and 6 of which had nephrology departments. 10 out of 335 patients received treatment in university hospitals and 63% of patients admitted themselves to hospital. Initially, the patients were admitted to 12 different clinical departments (29% of the patients were referred to a nephrology department) and during the course of the disease, 8% of the patients were transferred to another department in the same hospital and 3% were transferred to a nephrology department at another hospital. Regarding diagnostic procedures, in 28% of the inpatients computed tomography to exclude pulmonary embolism or due to severe gastrointestinal symptoms, lumbar puncture to exclude meningitis, magnetic resonance tomography of the brain owing to suspected stroke because of visual disorders, gastroscopy, or colonoscopy due to gastrointestinal symptoms was performed at time of admission to hospital. Conclusions NE must be considered by physicians across the borders of nephrology to avoid unnecessary diagnostic procedures especially in areas where NE is endemic.	[Kitterer, Daniel; Alscher, M. Dominik; Latus, Joerg] Robert Bosch Krankenhaus, Div Gen Med & Nephrol, Dept Internal Med, Stuttgart, Germany; [Segerer, Stephan] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Braun, Niko] Nephrol Ctr, Stuttgart, Germany	Bosch; Robert Bosch Krankenhaus; University of Zurich; University Zurich Hospital	Latus, J (corresponding author), Robert Bosch Krankenhaus, Div Gen Med & Nephrol, Dept Internal Med, Stuttgart, Germany.	joerg.latus@rbk.de		Segerer, Stephan/0000-0002-1936-9719				Braun N, 2010, NEPHROL DIAL TRANSPL, V25, P2997, DOI 10.1093/ndt/gfq118; Goeijenbier M, 2014, EURO SURVEILLANCE B, V19; Krautkramer E, 2013, KIDNEY INT, V83, P23, DOI 10.1038/ki.2012.360; Kruger DH, 2013, DTSCH ARZTEBL INT, V110, P461, DOI 10.3238/arztebl.2013.0461; Kruger DH, 2011, HUM VACCINES, V7, P685, DOI 10.4161/hv.7.6.15197; Kruger DH, 2001, MICROBES INFECT, V3, P1129, DOI 10.1016/S1286-4579(01)01474-5; Laine O, 2010, THROMB RES, V126, P154, DOI 10.1016/j.thromres.2010.05.025; Latus J, 2015, KIDNEY BLOOD PRESS R, V40, P22, DOI 10.1159/000368479; Latus J, 2015, NEPHROL DIAL TRANSPL, V30, P245, DOI 10.1093/ndt/gfu319; Latus J, 2015, EMERG INFECT DIS, V21, P76, DOI 10.3201/eid2101.140861; Latus J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098397; Latus J, 2012, J CLIN VIROL, V53, P156, DOI 10.1016/j.jcv.2011.11.003; LEE HW, 1989, PROG MED VIROL, V36, P62; Libraty DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035402; Mertz GJ, 2006, CURR OPIN INFECT DIS, V19, P437, DOI 10.1097/01.qco.0000244048.38758.1f; MUSTONEN J, 1994, SCAND J INFECT DIS, V26, P7, DOI 10.3109/00365549409008583; Osadebe Lynda U., 2012, Morbidity and Mortality Weekly Report, V61, P952; Outinen TK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-132; Vaheri A, 2013, NAT REV MICROBIOL, V11, P539, DOI 10.1038/nrmicro3066; Vapalahti O, 2003, LANCET INFECT DIS, V3, P653, DOI 10.1016/S1473-3099(03)00774-6	20	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144622	10.1371/journal.pone.0144622	http://dx.doi.org/10.1371/journal.pone.0144622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650941	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000366903300061
J	Lu, HY; Chen, YW; Lan, QF; Liao, HJ; Wu, J; Xiao, HY; Dickerson, CA; Wu, P; Pan, QJ				Lu, Haiyan; Chen, Yanwen; Lan, Qiaofen; Liao, Huanjin; Wu, Jing; Xiao, Haiyan; Dickerson, Carol A.; Wu, Ping; Pan, Qingjun			Factors That Influence a Mother's Willingness to Preserve Umbilical Cord Blood: A Survey of 5120 Chinese Mothers	PLOS ONE			English	Article							STEM-CELLS; REGENERATIVE MEDICINE; TRANSPLANTATION; BANKING; ENGRAFTMENT; DISORDERS; KNOWLEDGE; STORAGE; STATE	Background Umbilical Cord blood (UCB), which contains a substantive number of stem cells, could be widely used in transplants to treat a variety of oncologic, genetic, hematologic, and immunodeficiency disorders. However, only a small portion of mothers preserve or donate their UCB in China. The limited availability of UCB has hampered stem cell research and therapy nowadays. To date, no systemic investigations regarding factors that influence a mother's willingness to preserve UCB have been performed in China. In the current study, we are trying to determine those factors which will provide useful information for national health policy development and will raise awareness of the importance of UCB preservation. Methods During 2011 to 2013, 5120 mothers with the average age of 26.1 +/- 8.4 years were included in this study. Those mothers participated in a standardized survey. The information gathered consisted of delivery time, occupation, level of education, knowledge of preservation of UCB, willingness to store UCB, and related concerns. The results have been analyzed with SPSS 16.0. Results The results showed that first-time mothers showed a greater willingness to preserve their UCB (73.3%) compared to those having their second (48.9%) or third child (40.3%). Mothers who were employed at Government Agencies and Organizations were more willing to preserve their UCB (87.3%) than those employed at factories (62.0%), and those who were unemployed (27.3%). Mothers holding master's or college degrees were more willing to preserve their UCB (72.5% and 71.1%, respectively) than mothers with high school diplomas (48.7%) or those who only went to preliminary school or middle school (40.7%). The two strongest factors that influenced an unwillingness to preserve UCB were the high cost and concerns regarding the safety of the preservation. Conclusions The results showed that mothers with higher education or those having better occupations are more likely to preserve their UCB in China. These mothers have related knowledge and understand the importance of the preservation and they could more readily afford the relatively high cost. The government, clinicians and UCB banks should combine efforts to take measures, such as increasing public knowledge of the importance of UCB preservation and decreasing the high cost for its storage will most likely increase the frequency of UCB preservation which will further benefit stem cell research and therapy.	[Lu, Haiyan; Chen, Yanwen; Lan, Qiaofen; Liao, Huanjin; Wu, Jing; Wu, Ping; Pan, Qingjun] Guangdong Med Coll, Affiliated Hosp, Clin Res Ctr, Zhanjiang, Guangdong, Peoples R China; [Lu, Haiyan; Chen, Yanwen; Lan, Qiaofen; Liao, Huanjin; Wu, Jing; Wu, Ping; Pan, Qingjun] Guangdong Med Coll, Affiliated Hosp, Inst Nephrol, Zhanjiang, Guangdong, Peoples R China; [Xiao, Haiyan; Dickerson, Carol A.] Georgia Regents Univ, Dept Anesthesiol & Perioperat Med, Augusta, GA USA	Guangdong Medical University; Guangdong Medical University; University System of Georgia; Augusta University	Wu, P (corresponding author), Guangdong Med Coll, Affiliated Hosp, Clin Res Ctr, Zhanjiang, Guangdong, Peoples R China.	wping62@126.com; stilwapan@gmail.com						Ali H, 2010, ACTA NEUROBIOL EXP, V70, P316; Ballen KK, 2005, BLOOD, V105, P3786, DOI 10.1182/blood-2004-10-4125; Barker JN, 2003, NAT REV CANCER, V3, P526, DOI 10.1038/nrc1125; Broder SM, 2013, TRANSFUSION, V53, P679, DOI 10.1111/j.1537-2995.2012.03785.x; Broxmeyer HE, 2012, ANN NY ACAD SCI, V1266, P151, DOI 10.1111/j.1749-6632.2012.06509.x; Damaris Christensen, 2005, JNCI-J NATL CANCER I, V97, P253; Delaney C, 2010, EXPERT REV HEMATOL, V3, P273, DOI [10.1586/ehm.10.24, 10.1586/EHM.10.24]; Dinc H, 2009, INT NURS REV, V56, P250, DOI 10.1111/j.1466-7657.2008.00689.x; Elmoazzen H, 2015, METHODS MOL BIOL, V1257, P369, DOI 10.1007/978-1-4939-2193-5_18; Fasouliotis SJ, 2000, EUR J OBSTET GYN R B, V90, P13, DOI 10.1016/S0301-2115(99)00214-6; Guillaume A, 2014, J MATERN-FETAL NEO M, V14, P1; Han MX, 2013, MED J AUSTRALIA, V199, P288, DOI 10.5694/mja12.10835; Hernandez J, 2011, CURR STEM CELL RES T, V6, P273, DOI 10.2174/157488811796575323; Jaing TH, 2014, CELL TRANSPLANT, V23, P493, DOI 10.3727/096368914X678300; Kanno Hiroshi, 2013, World J Stem Cells, V5, P163, DOI 10.4252/wjsc.v5.i4.163; Karagiorgou LZ, 2013, BLOOD TRANSFUS, P1; Kurtzberg J, 2009, CURR OPIN PEDIATR, V21, P22, DOI 10.1097/MOP.0b013e32832130bc; MPhil Jon Smythe, 2007, STEM CELLS, V25, P2087; Oran B, 2012, HEMATOL-AM SOC HEMAT, P215, DOI 10.1182/asheducation-2012.1.215; Pawson Rachel, 2014, Midwives, V17, P50; Perlow JH, 2006, J REPROD MED, V51, P642; Suen SSH, 2011, ACTA OBSTET GYN SCAN, V90, P1005, DOI 10.1111/j.1600-0412.2011.01201.x; Sun J, 2010, TRANSFUSION, V50, P1980, DOI 10.1111/j.1537-2995.2010.02720.x; Volarevic V, 2011, BRIT MED BULL, V99, P155, DOI 10.1093/bmb/ldr027; Zhong XY, 2010, ANN NY ACAD SCI, V1205, P17, DOI 10.1111/j.1749-6632.2010.05659.x	25	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144001	10.1371/journal.pone.0144001	http://dx.doi.org/10.1371/journal.pone.0144001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650509	Green Submitted, gold, Green Published			2022-12-27	WOS:000366903300033
J	Arrabal, S; Lucena, MA; Canduela, MJ; Ramos-Uriarte, A; Rivera, P; Serrano, A; Pavon, FJ; Decara, J; Vargas, A; Baixeras, E; Martin-Rufian, M; Marquez, J; Fernandez-Llebrez, P; De Roos, B; Grandes, P; de Fonseca, FR; Suarez, J				Arrabal, Sergio; Angel Lucena, Miguel; Josune Canduela, Miren; Ramos-Uriarte, Almudena; Rivera, Patricia; Serrano, Antonia; Javier Pavon, Francisco; Decara, Juan; Vargas, Antonio; Baixeras, Elena; Martin-Rufian, Mercedes; Marquez, Javier; Fernandez-Llebrez, Pedro; De Roos, Baukje; Grandes, Pedro; Rodriguez de Fonseca, Fernando; Suarez, Juan			Pharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in Muscle	PLOS ONE			English	Article							ENDOCANNABINOID SYSTEM; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; ADIPOSE-TISSUE; ANTAGONIST; RIMONABANT; OVERWEIGHT; EXPRESSION; WEIGHT; BIOENERGETICS	Cannabinoid CB1 receptors peripherally modulate energy metabolism. Here, we investigated the role of CB1 receptors in the expression of glucose/pyruvate/tricarboxylic acid (TCA) metabolism in rat abdominal muscle. Dihydrolipoamide dehydrogenase (DLD), a flavoprotein component (E3) of alpha-ketoacid dehydrogenase complexes with diaphorase activity in mitochondria, was specifically analyzed. After assessing the effectiveness of the CB1 receptor antagonist AM251 (3 mg kg(-1), 14 days) on food intake and body weight, we could identified seven key enzymes from either glycolytic pathway or TCA cycle-regulated by both diet and CB1 receptor activity-through comprehensive proteomic approaches involving two-dimensional electrophoresis and MALDI-TOF/LC-ESI trap mass spectrometry. These enzymes were glucose 6-phosphate isomerase (GPI), triosephosphate isomerase (TPI), enolase (Eno3), lactate dehydrogenase (LDHa), glyoxalase-1 (Glo1) and the mitochondrial DLD, whose expressions were modified by AM251 in hypercaloric diet-induced obesity. Specifically, AM251 blocked high-carbohydrate diet (HCD)-induced expression of GPI, TPI, Eno3 and LDHa, suggesting a down-regulation of glucose/pyruvate/lactate pathways under glucose availability. AM251 reversed the HCD-inhibited expression of Glo1 and DLD in the muscle, and the DLD and CB1 receptor expression in the mitochondrial fraction. Interestingly, we identified the presence of CB1 receptors at the membrane of striate muscle mitochondria. DLD over-expression was confirmed in muscle of CB1-/- mice. AM251 increased the pyruvate dehydrogenase and glutathione reductase activity in C2C12 myotubes, and the diaphorase/oxidative activity in the mitochondria fraction. These results indicated an up-regulation of methylglyoxal and TCA cycle activity. Findings suggest that CB1 receptors in muscle modulate glucose/pyruvate/lactate pathways and mitochondrial oxidative activity by targeting DLD.	[Arrabal, Sergio; Angel Lucena, Miguel; Rivera, Patricia; Serrano, Antonia; Javier Pavon, Francisco; Decara, Juan; Vargas, Antonio; Baixeras, Elena; Rodriguez de Fonseca, Fernando; Suarez, Juan] Univ Malaga, UGC Salud Mental, Inst Invest Biomed Malaga IBIMA, Hosp Univ Reg Malaga, E-29071 Malaga, Spain; [Arrabal, Sergio; Rivera, Patricia; Serrano, Antonia; Javier Pavon, Francisco; Decara, Juan; Vargas, Antonio; Baixeras, Elena; Rodriguez de Fonseca, Fernando; Suarez, Juan] Inst Salud Carlos III, CIBER OBN, Madrid, Spain; [Josune Canduela, Miren; Ramos-Uriarte, Almudena; Grandes, Pedro] Univ Basque Country UPV EHU, Dept Neurosci, Leioa, Spain; [Martin-Rufian, Mercedes] Univ Malaga, ECAI Prote, Inst Invest Biomed Malaga IBIMA, E-29071 Malaga, Spain; [Marquez, Javier] Univ Malaga, Dept Biol Mol & Bioquim, Inst Invest Biomed Malaga IBIMA, E-29071 Malaga, Spain; [Fernandez-Llebrez, Pedro] Univ Malaga, Dept Biol Celular Genet & Fisiol, Inst Invest Biomed Malaga IBIMA, E-29071 Malaga, Spain; [De Roos, Baukje] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland	Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Basque Country; Universidad de Malaga; Universidad de Malaga; Universidad de Malaga; University of Aberdeen	de Fonseca, FR (corresponding author), Univ Malaga, UGC Salud Mental, Inst Invest Biomed Malaga IBIMA, Hosp Univ Reg Malaga, E-29071 Malaga, Spain.	fernando.rodriguez@ibima.eu; juan.suarez@ibima.eu	marquez, javier/K-3289-2012; Grandes, Pedro/AAA-1627-2019; Suarez, Juan/I-5188-2015; Ramos, Almudena/AAS-1563-2020; Pavón Morón, Francisco Javier/AAG-9721-2020; Grandes, Pedro/H-7494-2015; Decara Del Olmo, Juan Manuel/I-1931-2015	marquez, javier/0000-0003-3317-3963; Suarez, Juan/0000-0001-5254-9802; Ramos, Almudena/0000-0002-2632-1625; Pavón Morón, Francisco Javier/0000-0002-5256-8904; RODRIGUEZ DE FONSECA, FERNANDO/0000-0002-4516-5795; Grandes, Pedro/0000-0003-3947-4230; Alonso-Alconada, Daniel/0000-0002-9874-2947; Arrabal Nunez, Sergio/0000-0002-0600-9634; Rivera, Patricia/0000-0002-0478-6667; Decara Del Olmo, Juan Manuel/0000-0002-9868-015X; BAIXERAS, ELENA/0000-0001-6955-2434	CIBERobn [CB06/03/1008)]; Ministerio de Economia y Competitividad (MINECO) [BFU2012-33334]; Instituto de Salud Carlos III (ISCIII); UE-ERDF [CP12/03109, CTS-8221, CVI-6656, SAS111224, CP14/00173]; Red de Trastornos Adictivos [RD12/0028/0001, RD12/0028/0004, RD12/0028/0013]; Basque Country Government [BCG IT764-13]; Consejeria de Economia, Innovaciin y Ciencia; Junta de Andalucia; Consejeria de Salud; University of the Basque Country UPV/EHU [UFI11/41]; National System of Health [CP12/03109]; ISCIII [CP14/00212]	CIBERobn; Ministerio de Economia y Competitividad (MINECO); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); UE-ERDF; Red de Trastornos Adictivos(Instituto de Salud Carlos III); Basque Country Government(Basque Government); Consejeria de Economia, Innovaciin y Ciencia; Junta de Andalucia(Junta de Andalucia); Consejeria de Salud; University of the Basque Country UPV/EHU; National System of Health; ISCIII(Instituto de Salud Carlos III)	This work was supported by CIBERobn (CB06/03/1008), Ministerio de Economia y Competitividad (MINECO) (PG: BFU2012-33334), Instituto de Salud Carlos III (ISCIII), MINECO, cofunded by UE-ERDF program (JS: CP12/03109), Red de Trastornos Adictivos (FRF: RD12/0028/0001, PG: RD12/0028/0004, JM: RD12/0028/0013), The Basque Country Government (PG: BCG IT764-13), Consejeria de Economia, Innovaciin y Ciencia, Junta de Andalucia, UE-ERDF (FRF: CTS-8221, JM: CVI-6656), Consejeria de Salud, Junta de Andalucia, UE-ERDF (FRF: SAS111224), and University of the Basque Country UPV/EHU (PG: UFI11/41). JS, FJP and AS hold "Miguel Servet" research contracts from the National System of Health, ISCIII, UE-ERDF (CP12/03109, CP14/00212, and CP14/00173 respectively).	Alonso M, 2012, BRIT J PHARMACOL, V165, P2274, DOI 10.1111/j.1476-5381.2011.01698.x; Athanasiou A, 2007, BIOCHEM BIOPH RES CO, V364, P131, DOI 10.1016/j.bbrc.2007.09.107; Bae N, 2012, ANAL BIOCHEM, V428, P1, DOI 10.1016/j.ab.2012.05.016; BARTOVA A, 1976, J BIOL CHEM, V251, P5002; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Benard G, 2012, NAT NEUROSCI, V15, P558, DOI 10.1038/nn.3053; Bermudez-Silva FJ, 2007, EUR J PHARMACOL, V565, P207, DOI 10.1016/j.ejphar.2007.02.066; Cavuoto P, 2007, MOL CELL ENDOCRINOL, V267, P63, DOI 10.1016/j.mce.2006.12.038; Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; Christopoulou FD, 2011, J CLIN PHARM THER, V36, P10, DOI 10.1111/j.1365-2710.2010.01164.x; Constantin-Teodosiu D, 2013, DIABETES METAB J, V37, P301, DOI 10.4093/dmj.2013.37.5.301; Crespillo A, 2011, BIOCHEM J, V433, P175, DOI 10.1042/BJ20100751; de Roos B, 2005, FASEB J, V19, P813, DOI 10.1096/fj.04-2974fje; Di Marzo V, 2008, DIABETOLOGIA, V51, P1356, DOI 10.1007/s00125-008-1048-2; Di Marzo V, 2011, HANDB EXP PHARMACOL, V203, P75, DOI 10.1007/978-3-642-17214-4_4; Engeli S, 2008, J NEUROENDOCRINOL, V20, P110, DOI 10.1111/j.1365-2826.2008.01683.x; Hebert-Chatelain E, 2014, MOL METAB, V3, P495, DOI 10.1016/j.molmet.2014.03.007; Hebert-Chatelain E, 2014, MOL METAB, V3, P339, DOI 10.1016/j.molmet.2014.03.008; Hojlund K, 2008, ENDOCRIN METAB CLIN, V37, P713, DOI 10.1016/j.ecl.2008.06.006; Iannotti FA, 2014, P NATL ACAD SCI USA, V111, pE2472, DOI 10.1073/pnas.1406728111; Klyachko NL, 2005, J BIOL CHEM, V280, P16106, DOI 10.1074/jbc.M414285200; Lipina C, 2014, AM J PHYSIOL-ENDOC M, V307, pE1, DOI 10.1152/ajpendo.00100.2014; Liu YL, 2005, INT J OBESITY, V29, P183, DOI 10.1038/sj.ijo.0802847; Mailloux RJ, 2015, REDOX BIOL, V4, P381, DOI 10.1016/j.redox.2015.02.001; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Matias I, 2008, MOL CELL ENDOCRINOL, V286, pS66, DOI 10.1016/j.mce.2008.01.026; Pagano C, 2008, J NEUROENDOCRINOL, V20, P124, DOI 10.1111/j.1365-2826.2008.01690.x; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Pavon FJ, 2008, J NEUROENDOCRINOL, V20, P116, DOI 10.1111/j.1365-2826.2008.01693.x; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Riedel G, 2009, BRIT J PHARMACOL, V156, P1154, DOI 10.1111/j.1476-5381.2008.00107.x; Rivera P, 2013, EUR J NEUROSCI, V37, P105, DOI 10.1111/ejn.12012; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551; Tedesco L, 2008, DIABETES, V57, P2028, DOI 10.2337/db07-1623; Tedesco L, 2010, DIABETES, V59, P2826, DOI 10.2337/db09-1881; Tiyerili V, 2010, BASIC RES CARDIOL, V105, P465, DOI 10.1007/s00395-010-0090-7; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Vida M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090016; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; Yu J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115167, 10.1371/journal.pone.0112628]	44	21	22	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145244	10.1371/journal.pone.0145244	http://dx.doi.org/10.1371/journal.pone.0145244			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671069	Green Published, gold, Green Submitted			2022-12-27	WOS:000366719300056
J	Behmenburg, F; Dorsch, M; Huhn, R; Mally, D; Heinen, A; Hollmann, MW; Berger, MM				Behmenburg, Friederike; Dorsch, Marianne; Huhn, Ragnar; Mally, David; Heinen, Andre; Hollmann, Markus W.; Berger, Marc M.			Impact of Mitochondrial Ca2+-Sensitive Potassium (mBK(Ca)) Channels in Sildenafil-Induced Cardioprotection in Rats	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; ISCHEMIA-REPERFUSION INJURY; INDUCED RELAXATION; BKCA CHANNELS; HUMAN BLADDER; NITRIC-OXIDE; ACTIVATION; MECHANISM; PHOSPHORYLATION; PHOSPHODIESTERASE	Background Mitochondrial large-conductance Ca2+-sensitive potassium (mBK(Ca)) channels are involved in myocardial ischemic preconditioning. Their role in sildenafil-induced cardioprotection is unknown. We investigated whether sildenafil-induced acute cardioprotection is mediated by activation of mBKCa channels in the rat heart in vitro. Methods Male Wistar rats (n = 8 per group) were randomized and anesthetized with pentobarbital (90 mg/kg). Hearts were isolated, mounted on a Langendorff system and perfused with Krebs-Henseleit buffer at a constant pressure of 80 mmHg. Hearts underwent 30 min of global ischemia followed by 60 min of reperfusion. At the end of the experiments infarct size was determined by TTC staining. In the control group rats were not further treated. Sildenafil (3 mu M) was administered over 10 min before the beginning of ischemia. The mBKCa channel inhibitor paxilline (1 mu M) was administered with and without sildenafil before the onset of ischemia. The pathway underlying sildenafil-induced cardioprotection was further investigated with the protein kinase G blocker KT5823 (1 mu M). Myocardial cGMP concentration was measured by ELISA. Data (mean +/- SD) were analysed with a one and two-way analysis of variance as appropriate. Results In control animals infarct size was 52 +/- 8%. Sildenafil increased cGMP concentration and reduced infarct size to 35 +/- 6% (P<0.05 vs. control). Paxilline and KT5823 completely blocked sildenafil-induced cardioprotection (paxilline+sildenafil: 50 +/- 8%, KT5823+sildenafil: 45 +/- 8%; both P<0.05 vs. sildenafil). Functional heart parameters and coronary flow were not different between the study groups. Conclusion This study shows that in male rats protein kinase G-dependent opening of mBK(Ca) channels plays a pivotal role in sildenafil-induced cardioprotection.	[Behmenburg, Friederike; Dorsch, Marianne; Huhn, Ragnar; Mally, David] Univ Hosp Dusseldorf, Dept Anesthesiol, Dusseldorf, Germany; [Heinen, Andre] Univ Dusseldorf, Dept Cardiovasc Physiol, Dusseldorf, Germany; [Hollmann, Markus W.] Univ Amsterdam, Acad Med Ctr, Dept Anesthesiol, LEICA, NL-1105 AZ Amsterdam, Netherlands; [Berger, Marc M.] Paracelsus Med Univ, Salzburg Gen Hosp, Dept Anesthesiol Perioperat & Gen Crit Care Med, Salzburg, Austria	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; University of Amsterdam; Academic Medical Center Amsterdam; Paracelsus Private Medical University	Huhn, R (corresponding author), Univ Hosp Dusseldorf, Dept Anesthesiol, Dusseldorf, Germany.	Ragnar.Huhn@med.uni-duesseldorf.de	Berger, Marc/AAN-2887-2020; Huhn, Ragnar/X-6466-2018	Huhn, Ragnar/0000-0002-3114-7190; Berger, Marc Moritz/0000-0001-6771-3193				Balderas E, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00104; Bentzen BH, 2009, PFLUG ARCH EUR J PHY, V457, P979, DOI 10.1007/s00424-008-0583-5; Borchert GH, 2013, EXP BIOL MED, V238, P233, DOI 10.1177/1535370212474596; Cattaneo MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029680; Clements RT, 2015, CIRC J, V79, P455, DOI 10.1253/circj.CJ-15-0015; Das A, 2014, PHARM THER; Das A, 2008, J BIOL CHEM, V283, P29572, DOI 10.1074/jbc.M801547200; Das A, 2009, AM J PHYSIOL-HEART C, V296, pH1236, DOI 10.1152/ajpheart.00100.2009; Das S, 2002, DRUG EXP CLIN RES, V28, P213; Deenadayalu V, 2012, AM J PHYSIOL-HEART C, V302, pH115, DOI 10.1152/ajpheart.00046.2011; Dikmen A, 2013, NITRIC OXIDE-BIOL CH, V31, pS38, DOI 10.1016/j.niox.2013.06.072; Frassdorf J, 2010, CAN J ANESTH, V57, P767, DOI 10.1007/s12630-010-9325-1; Fusco F, 2012, EUR UROL, V62, P1174, DOI 10.1016/j.eururo.2012.07.025; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; Gragasin FS, 2004, FASEB J, V18, P1382, DOI 10.1096/fj.04-1978com; Heinen A, 2014, EXP GERONTOL, V56, P99, DOI 10.1016/j.exger.2014.03.029; Huhn R, 2010, BRIT J ANAESTH, V105, P589, DOI 10.1093/bja/aeq213; Huhn R, 2012, EXP GERONTOL, V47, P116, DOI 10.1016/j.exger.2011.11.003; Koneru S, 2008, J CELL MOL MED, V12, P2651, DOI 10.1111/j.1582-4934.2008.00319.x; Kukreja RC, 2011, EXP CLIN CARDIOL, V16, pE30; Lai MH, 2014, AM J PHYSIOL-HEART C, V307, pH1327, DOI 10.1152/ajpheart.00354.2014; Lee KH, 2014, CLIN EXP PHARMACOL P, V41, P763, DOI 10.1111/1440-1681.12290; Madhani M, 2010, AM J PHYSIOL-HEART C, V299, pH827, DOI 10.1152/ajpheart.00129.2010; Milano G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027910; Ockaili R, 2002, AM J PHYSIOL-HEART C, V283, pH1263, DOI 10.1152/ajpheart.00324.2002; Oger S, 2010, BRIT J PHARMACOL, V160, P1135, DOI 10.1111/j.1476-5381.2010.00748.x; Reffelmann T, 2003, CARDIOVASC RES, V59, P441, DOI 10.1016/S0008-6363(03)00435-8; Salloum F, 2003, CIRC RES, V92, P595, DOI 10.1161/01.RES.0000066853.09821.98; Salloum FN, 2008, AM J PHYSIOL-HEART C, V294, pH1398, DOI [10.1152/ajpheart.ajpheart.91438.2007, 10.1152/ajpheart.91438.2007]; Sanchez M, 1996, NEUROPHARMACOLOGY, V35, P963, DOI 10.1016/0028-3908(96)00137-2; Schmitt N, 2014, PHYSIOL REV, V94, P609, DOI 10.1152/physrev.00022.2013; Shintani Y, 2004, J MOL CELL CARDIOL, V37, P1213, DOI 10.1016/j.yjmcc.2004.09.012; Tantini B, 2005, BASIC RES CARDIOL, V100, P131, DOI 10.1007/s00395-004-0504-5; Thebaud B, 2002, PEDIATR RES, V52, P19, DOI 10.1203/00006450-200207000-00006; Wang XY, 2008, J MOL CELL CARDIOL, V44, P105, DOI 10.1016/j.yjmcc.2007.10.006; World Health Organization (WHO), 2013, TOP 10 CAUS DEATH; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	39	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144737	10.1371/journal.pone.0144737	http://dx.doi.org/10.1371/journal.pone.0144737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671662	Green Published, Green Submitted, gold			2022-12-27	WOS:000366719300020
J	Halford, WP; Geltz, J; Messer, RJ; Hasenkrug, KJ				Halford, William P.; Geltz, Joshua; Messer, Ronald J.; Hasenkrug, Kim J.			Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2	PLOS ONE			English	Article							CD8(+) T-CELLS; GENITAL HERPES; ADENOVIRUS VECTORS; TRIGEMINAL GANGLIA; GLYCOPROTEIN-B; SAFETY PROFILE; NERVOUS-SYSTEM; DEFICIENT MICE; CD43 FUNCTIONS; E-SELECTIN	Herpes simplex virus 2 (HSV-2) 0 Delta NLS is a live HSV-2 ICP0(-) mutant vaccine strain that is profoundly attenuated in vivo due to its interferon-hypersensitivity. Recipients of the HSV-2 0.NLS vaccine are resistant to high-dose HSV-2 challenge as evidenced by profound reductions in challenge virus spread, shedding, disease and mortality. In the current study, we investigated the requirements for HSV-2 0 Delta NLS vaccine-induced protection. Studies using (UV)-inactivated HSV-2 0 Delta NLS revealed that self-limited replication of the attenuated virus was required for effective protection from vaginal or ocular HSV-2 challenge. Diminished antibody responses in recipients of the UV-killed HSV-2 vaccine suggested that antibodies might be playing a critical role in early protection. This hypothesis was investigated in B-cell-deficient mu MT mice. Vaccination with live HSV-2 0 Delta NLS induced equivalent CD8(+) T cell responses in wild-type and mu MT mice. Vaccinated mu MT mice shed similar to 40-fold more infectious HSV-2 at 24 hours post-challenge relative to vaccinated wild-type (B-cell(+)) mice, and most vaccinated mu MT mice eventually succumbed to a slowly progressing HSV-2 challenge. Importantly, passive transfer of HSV-2 antiserum restored full protection to HSV-2 0 Delta NLS-vaccinated mu MT mice. The results demonstrate that B cells are required for complete vaccine-induced protection against HSV-2, and indicate that virus-specific antibodies are the dominant mediators of early vaccine-induced protection against HSV-2.	[Halford, William P.; Geltz, Joshua] So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL 62702 USA; [Messer, Ronald J.; Hasenkrug, Kim J.] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	Southern Illinois University System; Southern Illinois University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Halford, WP (corresponding author), So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL 62702 USA.	halford@siumed.edu			National Institutes of Health [R21 AI081072]; SIU School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000753, R21AI081072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SIU School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was provided by the National Institutes of Health grant R21 AI081072 and startup funds to William Halford from the SIU School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide P, 2007, J INVEST DERMATOL, V127, P1964, DOI 10.1038/sj.jid.5700805; Allen UD, 2014, PAED CHILD HEALT-CAN, V19, P201, DOI 10.1093/pch/19.4.201; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Bergmann CC, 2001, J IMMUNOL, V167, P1575, DOI 10.4049/jimmunol.167.3.1575; Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008; Chentoufi AA, 2010, J IMMUNOL, V184, P2561, DOI 10.4049/jimmunol.0902322; Coleman JL, 2013, HUM VACC IMMUNOTHER, V9, P729, DOI 10.4161/hv.23289; Crucian B, 2006, CLIN VACCINE IMMUNOL, V13, P403, DOI 10.1128/CVI.13.3.403-408.2006; Dervillez X, 2013, J IMMUNOL, V191, P5124, DOI 10.4049/jimmunol.1301415; Dervillez X, 2012, FUTURE VIROL, V7, P371, DOI 10.2217/FVL.12.22; Dittmer U, 1999, NAT MED, V5, P189, DOI 10.1038/5550; Divito S, 2006, IMMUNOL RES, V36, P119, DOI 10.1385/IR:36:1:119; Dolan BP, 2011, CELL MOL LIFE SCI, V68, P1481, DOI 10.1007/s00018-011-0656-z; Doll Katherine L, 2013, Methods Mol Biol, V923, P493; Dudley KL, 2000, VIROLOGY, V270, P454, DOI 10.1006/viro.2000.0298; Duley AK, 2012, J IMMUNOL, V189, P2521, DOI 10.4049/jimmunol.1201125; Dunkelberger JR, 2010, MOL IMMUNOL, V47, P2176, DOI 10.1016/j.molimm.2010.05.008; Dutton JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076407; ELLIS WD, 1975, PREP BIOCHEM, V5, P179, DOI 10.1080/00327487508061569; EVERETT RD, 1984, EMBO J, V3, P3135, DOI 10.1002/j.1460-2075.1984.tb02270.x; Everett RD, 2000, BIOESSAYS, V22, P761, DOI 10.1002/1521-1878(200008)22:8<761::AID-BIES10>3.0.CO;2-A; Flagg EW, 2011, PEDIATRICS, V127, pE1, DOI 10.1542/peds.2010-0134; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Galea SA, 2008, J INFECT DIS, V197, pS165, DOI 10.1086/522125; GEBHARDT BM, 1988, INVEST OPHTH VIS SCI, V29, P1683; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Geltz JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116091; Goulleret N, 2010, VACCINE, V28, P5878, DOI 10.1016/j.vaccine.2010.06.056; Halford WP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-44; Halford WP, 2014, EXPERT REV VACCINES, V13, P691, DOI 10.1586/14760584.2014.910121; Halford WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065523; Halford WP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017748; Halford WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012251; Halford WP, 2001, J VIROL, V75, P6143, DOI 10.1128/JVI.75.13.6143-6153.2001; Halford WP, 2001, J VIROL, V75, P3240, DOI 10.1128/JVI.75.7.3240-3249.2001; HANKE T, 1991, J VIROL, V65, P1177, DOI 10.1128/JVI.65.3.1177-1186.1991; Harle P, 2002, VIROLOGY, V293, P295, DOI 10.1006/viro.2001.1280; Homann D, 1998, J VIROL, V72, P9208, DOI 10.1128/JVI.72.11.9208-9216.1998; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Khan AA, 2015, J VIROL, V89, P6619, DOI 10.1128/JVI.00788-15; Khanna KM, 2003, IMMUNITY, V18, P593, DOI 10.1016/S1074-7613(03)00112-2; Koelle DM, 2008, CLIN VACCINE IMMUNOL, V15, P773, DOI 10.1128/CVI.00020-08; Koelle DM, 1998, J CLIN INVEST, V101, P1500, DOI 10.1172/JCI1758; Konno H, 2014, MICROBES INFECT, V16, P998, DOI 10.1016/j.micinf.2014.10.002; Laing KJ, 2012, CLIN EXP IMMUNOL, V167, P47, DOI 10.1111/j.1365-2249.2011.04502.x; Lester SN, 2014, J MOL BIOL, V426, P1246, DOI 10.1016/j.jmb.2013.11.024; Lingappa JR, 2007, DRUGS, V67, P155, DOI 10.2165/00003495-200767020-00001; Liu T, 2000, J EXP MED, V191, P1459, DOI 10.1084/jem.191.9.1459; Looker KJ, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0114989, 10.1371/journal.pone.0140765]; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Matsumoto M, 2005, J IMMUNOL, V175, P8042, DOI 10.4049/jimmunol.175.12.8042; Messer RJ, 2004, P NATL ACAD SCI USA, V101, P12260, DOI 10.1073/pnas.0404769101; Mo A, 2011, VACCINE, V29, P8530, DOI 10.1016/j.vaccine.2011.07.011; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; NAGAFUCHI S, 1979, J GEN VIROL, V44, P715, DOI 10.1099/0022-1317-44-3-715; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; OAKES JE, 1975, INFECT IMMUN, V12, P166, DOI 10.1128/IAI.12.1.166-172.1975; Orr MT, 2007, J IMMUNOL, V178, P4731, DOI 10.4049/jimmunol.178.8.4731; PARR MB, 1994, LAB INVEST, V70, P369; Pascual A, 2011, CLIN MICROBIOL INFEC, V17, P1907, DOI 10.1111/j.1469-0691.2011.03641.x; Preacher K. J., 2001, CALCULATION FISHERS; Rai D, 2009, J IMMUNOL, V183, P7672, DOI 10.4049/jimmunol.0902874; Richardus JH, 2013, VACCINE, V31, P6136, DOI 10.1016/j.vaccine.2013.06.081; RIEDMANN EM, 2014, HUM VACC IMMUNOTHER, V10, P255; Rivera A, 2001, INT IMMUNOL, V13, P1583, DOI 10.1093/intimm/13.12.1583; Rupp R, 2008, EXPERT OPIN EMERG DR, V13, P41, DOI 10.1517/14728214.13.1.41 ; Sarma JV, 2011, CELL TISSUE RES, V343, P227, DOI 10.1007/s00441-010-1034-0; Schiffer JT, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00209; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Shlapobersky M, 2012, J GEN VIROL, V93, P1305, DOI 10.1099/vir.0.040055-0; SIMMONS A, 1992, J EXP MED, V175, P1337, DOI 10.1084/jem.175.5.1337; Skoberne M, 2013, J VIROL, V87, P3930, DOI 10.1128/JVI.02745-12; Speck P, 1998, J GEN VIROL, V79, P561, DOI 10.1099/0022-1317-79-3-561; St Leger AJ, 2011, J IMMUNOL, V186, P3927, DOI 10.4049/jimmunol.1003735; Sudfeld CR, 2013, SEX TRANSM INFECT, V89, P561, DOI 10.1136/sextrans-2012-050869; TELLEZ A, 1970, TRANSFUSION, V10, P223, DOI 10.1111/j.1537-2995.1970.tb00733.x; Theil D, 2003, AM J PATHOL, V163, P2179, DOI 10.1016/S0002-9440(10)63575-4; Thompson MR, 2014, J BIOL CHEM, V289, P23568, DOI 10.1074/jbc.M114.554147; Tronstein E, 2011, JAMA-J AM MED ASSOC, V305, P1441, DOI 10.1001/jama.2011.420; Wald A, 1997, J CLIN INVEST, V99, P1092, DOI 10.1172/JCI119237; Wald A, 2011, VACCINE, V29, P8520, DOI 10.1016/j.vaccine.2011.09.046; Yewdell JW, 2001, J CELL SCI, V114, P845; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792	86	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145228	10.1371/journal.pone.0145228	http://dx.doi.org/10.1371/journal.pone.0145228			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670699	Green Published, Green Submitted, gold			2022-12-27	WOS:000366719300053
J	Pegan, TM; Rumelt, RB; Dzielski, SA; Ferraro, MM; Flesher, LE; Young, N; Freeman, AC; Freeman, BG				Pegan, Teresa M.; Rumelt, Reid B.; Dzielski, Sarah A.; Ferraro, Mary Margaret; Flesher, Lauren E.; Young, Nathaniel; Freeman, Alexandra Class; Freeman, Benjamin G.			Asymmetric Response of Costa Rican White-Breasted Wood-Wrens (Henicorhina leucosticta) to Vocalizations from Allopatric Populations	PLOS ONE			English	Article							SPECIES RECOGNITION; TERRITORIAL RESPONSES; SPARROWS RESPOND; SONG; SPECIATION; LIMITS; FEMALE; DIVERGENCE; BIRDS	Divergence in song between allopatric populations can contribute to premating reproductive isolation in territorial birds. Song divergence is typically measured by quantifying divergence in vocal traits using audio recordings, but field playback experiments provide a more direct way to behaviorally measure song divergence between allopatric populations. The White-breasted Wood-Wren (Henicorhina leucosticta; hereafter WBWW) is an abundant Neotropical species with four mitochondrial clades (in Central America, the Darien, the Choco and the Amazon) that are deeply divergent (similar to 5-16% sequence divergence). We assessed the possibility that the WBWWas currently defined may represent multiple biological species by conducting both statistical analysis of vocal characters and field playback experiments within three clades (Central America, Choco and Amazon). Our analysis of vocal traits revealed that Central American songs overlapped in acoustic space with Choco songs, indicating vocal similarity between these two populations, but that Central American songs were largely divergent from Amazonian songs. Playback experiments in the Caribbean lowlands of Costa Rica revealed that Central American WBWWs typically responded aggressively to songs from the Choco population but did not respond to playback of songs from the Amazonian population, echoing the results of the vocal trait analysis. This marked difference in behavioral response demonstrates that the songs of Central American and Amazonian WBWWs (but not Central American and Choco WBWWs) have diverged sufficiently that Central American WBWWs no longer recognize song from Amazonian WBWWs as a signal to elicit territorial defense. This suggests that significant premating reproductive isolation has evolved between these two populations, at least from the perspective of the Central American population, and is consistent with the possibility that Central American and Amazonian populations represent distinct biological species. We conclude by advocating for the further use of field playback experiments to assess premating reproductive isolation (and species limits) between allopatric songbird populations, a situation where behavioral systematics can answer questions that phylogenetic systematics cannot.	[Pegan, Teresa M.; Dzielski, Sarah A.; Ferraro, Mary Margaret; Flesher, Lauren E.; Young, Nathaniel; Freeman, Benjamin G.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA; [Freeman, Alexandra Class; Freeman, Benjamin G.] Cornell Lab Ornithol, Ithaca, NY USA	Cornell University; Cornell University	Freeman, BG (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA.	bgf27@cornell.edu	Pegan, Teresa/AAF-8612-2021		National Science Foundation [2011083591]; Cornell Lab of Ornithology	National Science Foundation(National Science Foundation (NSF)); Cornell Lab of Ornithology	This work was funded by National Science Foundation Graduate Research Fellowship Grant 2011083591 to BGF (http://www.nsf.gov), and Cornell Lab of Ornithology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank La Selva staff, particularly K. A. Gonzalez, for facilitating field research, Macaulay Library staff for providing song recordings, and I. Lovette, J. Fitzpatrick and the Lab of Ornithology for supporting the field course during which we conducted playback experiments. D. Toews and two anonymous reviewers provided valuable comments. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. 2011083591.	Aguilar C, 2016, MITOCHONDRIAL DNA A, V27, P956, DOI 10.3109/19401736.2014.926503; Areta JI, 2013, CONDOR, V115, P131, DOI 10.1525/cond.2012.120039; Barraclough TG, 2000, AM NAT, V155, P419, DOI 10.1086/303332; Benites P, 2015, J AVIAN BIOL, V46, P55, DOI 10.1111/jav.00447; BirdLife International & NatureServe, 2014, BIRD SPEC DISTR MAPS; Block NL, 2015, ECOL EVOL, V5, P3743, DOI 10.1002/ece3.1639; Boyle WA, 2015, BIOL CONSERV, V188, P11, DOI 10.1016/j.biocon.2015.01.004; Brewer D., 2001, WRENS DIPPERS THRASH; Chaves JC, 2010, CONDOR, V112, P718, DOI 10.1525/cond.2010.100098; Class AM, 2011, CONDOR, V113, P438, DOI 10.1525/cond.2011.100068; Colbeck GJ, 2010, ANIM BEHAV, V80, P311, DOI 10.1016/j.anbehav.2010.05.013; Coyne J.A., 2004, SPECIATION; Cure C, 2012, ANIM BEHAV, V84, DOI 10.1016/j.anbehav.2012.04.039; Danner JE, 2011, AM NAT, V178, P53, DOI 10.1086/660283; Dingle C, 2006, AUK, V123, P119, DOI 10.1642/0004-8038(2006)123[0119:EZATPR]2.0.CO;2; Lara CE, 2012, AUK, V129, P537, DOI 10.1525/auk.2012.12028; Vargas LE, 2011, J TROP ECOL, V27, P65, DOI 10.1017/S026646741000060X; Feo TJ, 2015, AUK, V132, P248, DOI 10.1642/AUK-14-108.1; Flesher L, 2015, NEOTROPICAL BIRDS ON; Gill FB, 2014, AUK, V131, P150, DOI 10.1642/AUK-13-206.1; Hudson EJ, 2014, J HERED, V105, P821, DOI 10.1093/jhered/esu041; Irwin DE, 2001, IBIS, V143, P233, DOI 10.1111/j.1474-919X.2001.tb04479.x; Isler ML, 1998, AUK, V115, P577, DOI 10.2307/4089407; Jankowski JE, 2010, ECOLOGY, V91, P1877, DOI 10.1890/09-2063.1; Lelevier M, 2008, THESIS; Mason NA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0967; McEntee JP, 2014, BEHAV ECOL, V25, P1380, DOI 10.1093/beheco/aru136; Mortega KG, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0085-6; Nelson DA, 2004, BEHAVIOUR, V141, P53, DOI 10.1163/156853904772746600; Pigot AL, 2013, ECOL LETT, V16, P330, DOI 10.1111/ele.12043; PRESCOTT DRC, 1987, WILSON BULL, V99, P611; Price T, 2008, SPECIATION BIRDS; R Development Core Team, 2014, R LANG ENV STAT COMP; Reif J, 2015, ANIM BEHAV, V104, P131, DOI 10.1016/j.anbehav.2015.03.016; SEARCY WA, 1990, ANIM BEHAV, V40, P1119, DOI 10.1016/S0003-3472(05)80178-2; SEARCY WA, 1988, NATURE, V332, P152, DOI 10.1038/332152a0; Seddon N, 2010, P ROY SOC B-BIOL SCI, V277, P2475, DOI 10.1098/rspb.2010.0210; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Sosa-Lopez JR, 2014, AUK, V131, P41, DOI 10.1642/AUK-13-161.1; Stouffer PC, 2013, AUK, V130, P529, DOI 10.1525/auk.2013.12179; Stutchbury B.J.M., 2001, BEHAV ECOLOGY TROPIC; The Cornell Lab of Ornithology, 2014, BIOAC RES PROGR RAV; Tobias JA, 2010, IBIS, V152, P724, DOI 10.1111/j.1474-919X.2010.01051.x; Toews DPL, 2008, MOL ECOL, V17, P2691, DOI 10.1111/j.1365-294X.2008.03769.x; Toews DPL, 2015, AUK, V132, P78, DOI 10.1642/AUK-14-138.1; Uy JAC, 2009, EVOLUTION, V63, P153, DOI 10.1111/j.1558-5646.2008.00530.x; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Weir JT, 2011, AM NAT, V177, P462, DOI 10.1086/658910	48	11	12	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144949	10.1371/journal.pone.0144949	http://dx.doi.org/10.1371/journal.pone.0144949			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671001	gold, Green Submitted, Green Published			2022-12-27	WOS:000366719300035
J	Vicenzino, B; McPoil, TG; Stephenson, A; Paul, SK				Vicenzino, Bill; McPoil, Thomas G.; Stephenson, Aoife; Paul, Sanjoy K.			Orthosis-Shaped Sandals Are as Efficacious as In-Shoe Orthoses and Better than Flat Sandals for Plantar Heel Pain: A Randomized Control Trial	PLOS ONE			English	Article							FOOT ORTHOSES; FASCIITIS	Objective To investigate efficacy of a contoured sandal being marketed for plantar heel pain with comparison to a flat flip-flop and contoured in-shoe insert/orthosis. Method 150 volunteers aged 50 (SD: 12) years with plantar heel pain (>4 weeks) were enrolled after responding to advertisements and eligibility determined by telephone and at first visit. Participants were randomly allocated to receive commercially available contoured sandals (n = 49), flat flip-flops (n = 50) or over the counter, pre-fabricated full-length foot orthotics (n = 51). Primary outcomes were a 15-point Global Rating of Change scale (GROC: 1 = a very great deal worse, 15 = a very great deal better), 13 to 15 representing an improvement and the 20-item Lower Extremity Function Scale (LEFS) on which participants rate 20 common weight bearing activities and activities of daily living on a 5-point scale (0 = extreme difficulty, 4 = no difficulty). Secondary outcomes were worst level of heel pain in the preceding week, and the foot and ankle ability measure. Outcomes were collected blind to allocation. Analyses were done on an intention to treat basis with 12 weeks being the primary outcome time of interest. Results The contoured sandal was 68% more likely to report improvement in terms of GROC compared to flat flip-flop. On the LEFS the contoured sandal was 61% more likely than flat flip-flop to report improvement. The secondary outcomes in the main reflected the primary outcomes, and there were no differences between contoured sandal and shoe insert. Conclusions and Relevance Physicians can have confidence in supporting a patient's decision to wear contoured sandals or in-shoe orthoses as one of the first and simple strategies to manage their heel pain.	[Vicenzino, Bill; McPoil, Thomas G.; Stephenson, Aoife] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [McPoil, Thomas G.] Regis Univ, Rueckert Hartman Coll Hlth Profess, Denver, CO USA; [Paul, Sanjoy K.] QIMR Berghofer Med Res Inst, Herston, Qld, Australia	University of Queensland; Regis University; QIMR Berghofer Medical Research Institute	Vicenzino, B (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia.	b.vicenzino@uq.edu.au	Paul, Sanjoy K/F-8199-2010; Vicenzino, Bill/A-8492-2011	Paul, Sanjoy K/0000-0003-0848-7194; Vicenzino, Bill/0000-0003-0253-5933; Stephenson, Aoife/0000-0001-8766-5272	Commonwealth of Australia National Health and Medical Research Council; Vionics International (United States of America)	Commonwealth of Australia National Health and Medical Research Council; Vionics International (United States of America)	Commonwealth of Australia National Health and Medical Research Council and Vionics International (United States of America). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binkley JM, 1999, PHYS THER, V79, P371; Birkenstock, 2014, PLANT FASC HEEL PAIN; Butterworth PA, 2012, OBES REV, V13, P630, DOI 10.1111/j.1467-789X.2012.00996.x; CORNWALL MW, 1992, J AM PODIAT MED ASSN, V82, P371, DOI 10.7547/87507315-82-7-371; Crawford F, 2003, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD000416; Escalona-Marfil C, 2014, J FOOT ANKLE RES, V7, DOI 10.1186/s13047-014-0038-5; Goff JD, 2011, AM FAM PHYSICIAN, V84, P676; Irving DB, 2006, J SCI MED SPORT, V9, P11, DOI 10.1016/j.jsams.2006.02.004; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Kogler GF, 1996, CLIN BIOMECH, V11, P243, DOI 10.1016/0268-0033(96)00019-8; Landorf K, 2008, CLIN EVIDENCE, V2, P1111; Landorf KB, 2006, ARCH INTERN MED, V166, P1305, DOI 10.1001/archinte.166.12.1305; Martin RRL, 2005, FOOT ANKLE INT, V26, P968, DOI 10.1177/107110070502601113; Mills K, 2010, BRIT J SPORT MED, V44, P1035, DOI 10.1136/bjsm.2009.066977; Mills K, 2010, MED SCI SPORT EXER, V42, P1966, DOI 10.1249/MSS.0b013e3181dbacc8; Redmond AC, 2006, CLIN BIOMECH, V21, P89, DOI 10.1016/j.clinbiomech.2005.08.002; Riddle D, 2003, J BONE JOINT SURG AM, V85A, P872, DOI 10.2106/00004623-200305000-00015; Riddle DL, 2004, FOOT ANKLE INT, V25, P303, DOI 10.1177/107110070402500505; Rome K., 2001, FOOT, V11, P119, DOI 10.1054/foot.2001.0698; Tong Kuo Bianchini, 2010, Am J Orthop (Belle Mead NJ), V39, P227; Vicenzino B., 2014, MANAGEMENT CHRONIC C, P110; Vionic Shoes, 2014, HEEL PAIN; Yucel U, 2013, PROSTHET ORTHOT INT, V37, P471, DOI 10.1177/0309364613478328	23	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0142789	10.1371/journal.pone.0142789	http://dx.doi.org/10.1371/journal.pone.0142789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669302	Green Published, gold			2022-12-27	WOS:000366719300002
J	Chang, YH; Deng, CR; Dore, AJ; Zhuang, GS				Chang, Yunhua; Deng, Congrui; Dore, Anthony J.; Zhuang, Guoshun			Human Excreta as a Stable and Important Source of Atmospheric Ammonia in the Megacity of Shanghai	PLOS ONE			English	Article							RIVER DELTA REGION; EMISSION INVENTORY; REACTIVE NITROGEN; POLLUTION; AEROSOLS; POLLUTANTS; SULFATE	Although human excreta as a NH3 source has been recognized globally, this source has never been quantitatively determined in cities, hampering efforts to fully assess the causes of urban air pollution. In the present study, the exhausts of 15 ceiling ducts from collecting septic tanks in 13 buildings with 6 function types were selected to quantify NH3 emission rates in the megacity of Shanghai. As a comparison, the ambient NH3 concentrations across Shanghai were also measured at 13 atmospheric monitoring sites. The concentrations of NH3 in the ceiling ducts (2809(-2661)(+5803) mu g m(-3)) outweigh those of the open air (similar to 10 mu g m(-3)) by 2-3 orders of magnitude, and there is no significant difference between different seasons. delta N-15 values of NH3 emitted from two ceiling ducts are also seasonally consistent, suggesting that human excreta may be a stable source of NH3 in urban areas. The NH3 concentration levels were variable and dependent on the different building types and the level of human activity. NH3 emission rates of the six residential buildings (RBNH3) were in agreement with each other. Taking occupation time into account, we confined the range of the average NH3 emission factor for human excreta to be 2-4 times (with the best estimate of 3 times) of the averaged RBNH3 of 66.0 +/- 58.9 g NH3 capita(-1) yr(-1). With this emission factor, the population of similar to 21 million people living in the urban areas of Shanghai annually emitted approximately 1386 Mg NH3, which corresponds to over 11.4% of the total NH3 emissions in the Shanghai urban areas. The spatial distribution of NH3 emissions from human excreta based on population data was calculated for the city of Shanghai at a high-resolution (100x100 m). Our results demonstrate that human excreta should be included in official ammonia emission inventories.	[Chang, Yunhua; Deng, Congrui; Zhuang, Guoshun] Fudan Univ, Dept Environm Sci & Engn, Ctr Atmospher Chem Study, Shanghai 200433, Peoples R China; [Deng, Congrui] Fudan Univ, Dept Environm Sci & Engn, Shanghai Key Lab Atmospher Particle Pollut & Prev, Shanghai 200433, Peoples R China; [Dore, Anthony J.] Ctr Ecol & Hydrol, Penicuik, Midlothian, Scotland	Fudan University; Fudan University; UK Centre for Ecology & Hydrology (UKCEH)	Deng, CR (corresponding author), Fudan Univ, Dept Environm Sci & Engn, Ctr Atmospher Chem Study, Shanghai 200433, Peoples R China.	congruideng@fudan.edu.cn; gzhuang@fudan.edu.cn		Chang, Yunhua/0000-0002-1622-5330	National Natural Science Foundation of China [21377029, 21277030, 41405115]; Natural Environment Research Council [ceh010010] Funding Source: researchfish	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported financially by National Natural Science Foundation of China (Grant Nos. 21377029, 21277030 and 41405115) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada T, 2006, J HEALTH SCI, V52, P585, DOI 10.1248/jhs.52.585; Asman WAH, 1998, NEW PHYTOL, V139, P27, DOI 10.1046/j.1469-8137.1998.00180.x; BUIJSMAN E, 1987, ATMOS ENVIRON, V21, P1009, DOI 10.1016/0004-6981(87)90230-7; Chang Y., 2014, ATMOS CHEM PHYS DISC, V14, P8495, DOI DOI 10.5194/ACPD-14-8495-2014; Chang YH, 2012, ENVIRON SCI TECHNOL, V46, P13035, DOI 10.1021/es304806k; Cui SH, 2013, P NATL ACAD SCI USA, V110, P2052, DOI 10.1073/pnas.1221638110; Driscoll CT, 2003, BIOSCIENCE, V53, P357, DOI 10.1641/0006-3568(2003)053[0357:NPITNU]2.0.CO;2; Felix JD, 2013, RAPID COMMUN MASS SP, V27, P2239, DOI 10.1002/rcm.6679; Fu X, 2013, ATMOS ENVIRON, V70, P39, DOI 10.1016/j.atmosenv.2012.12.034; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gong LW, 2013, ATMOS ENVIRON, V77, P893, DOI 10.1016/j.atmosenv.2013.04.079; HEALY TV, 1970, J GEOPHYS RES, V75, P2317, DOI 10.1029/JC075i012p02317; Huang C, 2011, ATMOS CHEM PHYS, V11, P4105, DOI 10.5194/acp-11-4105-2011; Huang RJ, 2014, NATURE, V514, P218, DOI 10.1038/nature13774; Huang X, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004161; Iyobe T, 2004, J HEALTH SCI, V50, P148; Kong L, 2014, COMING GRIPS AMMONIA; Li KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067018; Liu DW, 2014, ANAL CHEM, V86, P3787, DOI 10.1021/ac403756u; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Meng ZY, 2011, ATMOS CHEM PHYS, V11, P6139, DOI 10.5194/acp-11-6139-2011; Moller D, 1982, Z Gesamte Hyg, V28, P797; Olivier JGJ, 1998, ENVIRON POLLUT, V102, P135, DOI 10.1016/S0269-7491(98)80026-2; Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646; Reis S, 2009, ATMOS CHEM PHYS, V9, P7657, DOI 10.5194/acp-9-7657-2009; Riddick SN, 2012, ATMOS ENVIRON, V55, P319, DOI 10.1016/j.atmosenv.2012.02.052; Roe SM, 2004, ESTIMATING AMMONIA E; Rumsey IC, 2014, ATMOS CHEM PHYS, V14, P5639, DOI 10.5194/acp-14-5639-2014; Schneider A, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/2/024008; Seinfeld J.H., 2012, ATMOSPHERIC CHEM PHY; Smith D, 2008, RAPID COMMUN MASS SP, V22, P783, DOI 10.1002/rcm.3434; Sutton MA, 2000, ATMOS ENVIRON, V34, P855, DOI 10.1016/S1352-2310(99)00362-3; Sutton MA, 2011, NATURE, V472, P159, DOI 10.1038/472159a; Wang SX, 2011, ENVIRON SCI TECHNOL, V45, P9293, DOI 10.1021/es2022347; Wang Y, 2013, ATMOS CHEM PHYS, V13, P2635, DOI 10.5194/acp-13-2635-2013; Williams PT, 2005, WASTE TREATMENT AND DISPOSAL, 2ND EDITION, P1, DOI 10.1002/0470012668; Xu W, 2014, ATMOS POLLUT RES, V5, P455, DOI 10.5094/APR.2014.053; Yao XH, 2013, BIOGEOSCIENCES, V10, P7913, DOI 10.5194/bg-10-7913-2013; Ye XN, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/024019; Yi K, 2011, SENSORS, V14, P3207	40	19	21	4	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144661	10.1371/journal.pone.0144661	http://dx.doi.org/10.1371/journal.pone.0144661			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656636	Green Published, gold, Green Accepted			2022-12-27	WOS:000366715900081
J	Paula, DP; Souza, LM; Andow, DA				Paula, Debora P.; Souza, Lucas M.; Andow, David A.			Sequestration and Transfer of Cry Entomotoxin to the Eggs of a Predaceous Ladybird Beetle	PLOS ONE			English	Article							BT RICE; PYRROLIZIDINE ALKALOIDS; ARTHROPOD PREDATORS; TOXIN; EXPOSURE; PLANTS; MAIZE	In the past 10 years, sequestration of Cry toxins and transfer to offspring has been indicated in three insect species in laboratory studies. This work directly demonstrates the sequestration and intergenerational transfer of Cry1F by the parents of the aphidophagous coccinellid predator, Harmonia axyridis, to its offspring. Recently emerged adults (10 individual couples/cage/treatment) were exposed during 20 days to aphids (100 Myzus persicae each day) that fed on a holidic diet containing 20 mu g/mL Cry1F (and a control-group). Egg batches and neonate larvae were monitored daily, and counted and weighed for immunodetection of Cry1F by ELISA. At the end of the bioassay, the parents were weighed and analyzed by ELISA. Cry1F was detected in the offspring, both eggs and neonate larvae, of exposed H. axyridis adults. On average the neonate larvae had 60% of the Cry1F concentration of the eggs from the same egg batch. The Cry1F concentration in the adults was positively correlated with the concentration in their eggs. These three results provided independent evidence of transfer to offspring. No detrimental effects of Cry1F were observed on the age of first reproduction, total number of eggs laid per female, age-specific fecundity, egg development time, hatching rate, or fertility rate. The occurrence and generality of intergenerational transfer of Cry toxins should be investigated in the field to determine its potential ecological implications.	[Paula, Debora P.; Souza, Lucas M.] Embrapa Genet Resources & Biotechnol, BR-70770917 Brasilia, DF, Brazil; [Andow, David A.] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Minnesota System; University of Minnesota Twin Cities	Paula, DP (corresponding author), Embrapa Genet Resources & Biotechnol, Parque Estacao Biol,W5 Norte,POB 02372, BR-70770917 Brasilia, DF, Brazil.	debora.pires@embrapa.br	de Souza, Lucas Machado/J-8621-2012	Machado de Souza, Lucas/0000-0001-8589-9534	USDA Regional Research Project [NC205]	USDA Regional Research Project	The work was supported by USDA Regional Research Project NC205. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, SAS 9 4 TS LEV 1M2 X; Arpaia S, 2010, COLLECTION BIOSAFETY, V5, P2; BENN M, 1979, EXPERIENTIA, V35, P731, DOI 10.1007/BF01968208; Carey JR, 2001, ANNU REV ENTOMOL, V46, P79, DOI 10.1146/annurev.ento.46.1.79; Chen M, 2009, ECOTOXICOLOGY, V18, P230, DOI 10.1007/s10646-008-0276-z; DADD RH, 1966, EXPERIENTIA, V22, P832, DOI 10.1007/BF01897447; Douglas AE, 2007, APHIDS AS CROP PESTS, P115, DOI 10.1079/9780851998190.0115; DUFFEY SS, 1980, ANNU REV ENTOMOL, V25, P447, DOI 10.1146/annurev.en.25.010180.002311; Gao MQ, 2010, ENVIRON ENTOMOL, V39, P2039, DOI 10.1603/EN10035; Harwood JD, 2005, MOL ECOL, V14, P2815, DOI 10.1111/j.1365-294X.2005.02611.x; James C., 2014, GLOBAL STATUS COMMER; Koch RL, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.32; Lovei GL, 2009, ENVIRON ENTOMOL, V38, P293, DOI 10.1603/022.038.0201; Nakasu EYT, 2013, ENTOMOL EXP APPL, V148, P105, DOI 10.1111/eea.12082; Obrist LB, 2006, ECOL ENTOMOL, V31, P143, DOI 10.1111/j.0307-6946.2006.00762.x; Paula D.P., 2015, ENTOMOL EXP IN PRESS; Paula DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095422; Paula DP, 2015, ENVIRON POLLUT; Reudler Talsma JH, 2007, THESIS; ROTHSCHILD M, 1973, J ENTOMOL SER A, V48, P89; Siebert MW, 2009, J ECON ENTOMOL, V102, P1301, DOI 10.1603/029.102.0357; Stephens EJ, 2012, AGR ECOSYST ENVIRON, V156, P72, DOI 10.1016/j.agee.2012.05.002; Torres JB, 2006, AGR FOREST ENTOMOL, V8, P191, DOI 10.1111/j.1461-9563.2006.00298.x; USEPA, 2013, HLTH EFF GLOSS GLOSS; WITTE L, 1990, NATURWISSENSCHAFTEN, V77, P540, DOI 10.1007/BF01139268; Yu HG, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093710, 10.1371/journal.pone.0103973]; Zhang GF, 2006, ENVIRON ENTOMOL, V35, P143, DOI 10.1603/0046-225X-35.1.143; Zhang Qing-ling, 2013, Yingyong Shengtai Xuebao, V24, P1647; Zwahlen Claudia, 2005, Environmental Biosafety Research, V4, P113, DOI 10.1051/ebr:2005014	29	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144895	10.1371/journal.pone.0144895	http://dx.doi.org/10.1371/journal.pone.0144895			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26661738	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900140
J	Zaleska, M; Fogl, C; Kho, AL; Ababou, A; Ehler, E; Pfuhl, M				Zaleska, Mariola; Fogl, Claudia; Kho, Ay Lin; Ababou, Abdessamad; Ehler, Elisabeth; Pfuhl, Mark			The Cardiac Stress Response Factor Ms1 Can Bind to DNA and Has a Function in the Nucleus	PLOS ONE			English	Article							STRIATED-MUSCLE ACTIVATOR; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; FORKHEAD DOMAIN; PROTEIN; PHOSPHORYLATION; STARS; HELIX; GENE; RECOGNITION	Ms1 (also known as STARS and ABRA) has been shown to act as an early stress response gene in processes as different as hypertrophy in skeletal and cardiac muscle and growth of collateral blood vessels. It is important for cardiac development in zebrafish and is upregulated in mouse models for cardiac hypertrophy as well as in human failing hearts. Ms1 possesses actin binding sites at its C-terminus and is usually found in the cell bound to actin filaments in the cytosol or in sarcomeres. We determined the NMR structure of the only folded domain of Ms1 comprising the second actin binding site called actin binding domain 2 (ABD2, residues 294-375), and found that it is similar to the winged helix-turn-helix fold adopted mainly by DNA binding domains of transcriptional factors. In vitro experiments show specific binding of this domain, in combination with a newly discovered AT-hook motif located N-terminally, to the sequence (A/C/G) AAA (C/A). NMR and fluorescence titration experiments confirm that this motif is indeed bound specifically by the recognition helix. In neonatal rat cardiomyocytes endogenous Ms1 is found in the nucleus in a spotted pattern, reminiscent of PML bodies. In adult rat cardiomyocytes Ms1 is exclusively found in the sarcomere. A nuclear localisation site in the N-terminus of the protein is required for nuclear localisation. This suggests that Ms1 has the potential to act directly in the nucleus through specific interaction with DNA in development and potentially as a response to stress in adult tissues.	[Zaleska, Mariola; Kho, Ay Lin; Ehler, Elisabeth; Pfuhl, Mark] Kings Coll London, Cardiovasc & Randall Div, London WC2R 2LS, England; [Fogl, Claudia] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Ababou, Abdessamad] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	University of London; King's College London; University of Leicester; University of Cambridge	Pfuhl, M (corresponding author), Kings Coll London, Cardiovasc & Randall Div, London WC2R 2LS, England.	mark.pfuhl@kcl.ac.uk	Kho, Ay Lin/M-4214-2013	Kho, Ay Lin/0000-0002-9753-2091; Pfuhl, Mark/0000-0001-9592-6639; Ehler, Elisabeth/0000-0001-5646-5964	Departmental BBSRC studentship; BHF Centre of Excellence at KCL, studentship programme; MRC [MR/J010456/1]; BHF Centre of Research Excellence at King's College London; BBSRC; MRC [G0400153, G0600251] Funding Source: UKRI; British Heart Foundation [PG/11/123/29317] Funding Source: researchfish; Medical Research Council [MR/J010456/1, G0600251, G0400153] Funding Source: researchfish	Departmental BBSRC studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BHF Centre of Excellence at KCL, studentship programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BHF Centre of Research Excellence at King's College London; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Departmental BBSRC studentship to Claudia Fogl, administered by the then Department of Biochemistry, University of Leicester, no grant number (http://www.bbsrc.ac.uk). It was also supported by the BHF Centre of Excellence at KCL, studentship programme, PhD studentship to Mariola Zaleska via Mark Pfuhl, no grant number (https://www.bhf.org.uk). AK is paid from MRC grant MR/J010456/1 which was awarded to Prof M Gautel, KCL.; We would like to thank Andrea Koekemoer and Nilesh Samani for the gift of full length mouse Ms1 cloned Into the mammalian expression vector pcDNA 3.1(+); Xiaowen Yang and the protein expression lab (PROTEX) at the University of Leicester for the cloning of bacterial expression constructs; Fred Muskett and Andrew Atkinson for help with NMR spectrometers and structure calculation; Steven Terry for help with HeLa & COS cells; Dr. Shiney Reji, St. Thomas Hospital, London for the preparation of ARCs and Mathias Gautel for help and support. MZ was funded through a PhD studentship awarded through the BHF Centre of Research Excellence at King's College London, CF was funded through a BBSRC studentship to the University of Leicster, AK is funded through the MRC (MR/J010456/1).	ANDERSON WF, 1981, NATURE, V290, P754, DOI 10.1038/290754a0; Arai A, 2002, J BIOL CHEM, V277, P24453, DOI 10.1074/jbc.M202216200; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Barrientos T, 2007, J BIOL CHEM, V282, P8393, DOI 10.1074/jbc.M607549200; BERG OG, 1982, BIOPHYS CHEM, V15, P41, DOI 10.1016/0301-4622(82)87015-4; Bianchi A, 1999, EMBO J, V18, P5735, DOI 10.1093/emboj/18.20.5735; Boura E, 2007, J BIOL CHEM, V282, P8265, DOI 10.1074/jbc.M605682200; Chong NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040966; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fogl C, 2011, PROTEINS; Fonfria-Subiros E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037120; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Harreman MT, 2004, J BIOL CHEM, V279, P20613, DOI 10.1074/jbc.M401720200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Iskratsch T, 2013, CELL MOL LIFE SCI, V70, P893, DOI 10.1007/s00018-012-1154-7; Iskratsch T, 2010, J CELL BIOL, V191, P1159, DOI 10.1083/jcb.201005060; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; Koekemoer AL, 2009, FEBS LETT, V583, P2964, DOI 10.1016/j.febslet.2009.08.011; Kuwahara K, 2007, J CLIN INVEST, V117, P1324, DOI 10.1172/JCI31240; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LAI E, 1993, P NATL ACAD SCI USA, V90, P10421, DOI 10.1073/pnas.90.22.10421; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lee TY, 2011, NUCLEIC ACIDS RES, V39, pD777, DOI 10.1093/nar/gkq970; Lin JZ, 2011, PROTEIN SCI, V20, P216, DOI 10.1002/pro.548; Luciani JJ, 2006, J CELL SCI, V119, P2518, DOI 10.1242/jcs.02965; Mahadeva H, 2002, FEBS LETT, V521, P100, DOI 10.1016/S0014-5793(02)02833-8; MCKAY DB, 1981, NATURE, V290, P744, DOI 10.1038/290744a0; Murphy TC, 2004, INVEST OPHTH VIS SCI, V45, P2531, DOI 10.1167/iovs.04-0167; Ounzain S, 2012, MOL CELL BIOL, V32, P1830, DOI 10.1128/MCB.06374-11; Pang TL, 2010, J CELL SCI, V123, P3745, DOI 10.1242/jcs.064709; REEVES R, 1990, J BIOL CHEM, V265, P8573; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; Risner LE, 2013, J BIOL CHEM, V288, P29901, DOI 10.1074/jbc.M113.474858; Sarvan S, 2011, NAT STRUCT MOL BIOL, V18, P857, DOI 10.1038/nsmb.2093; Schroder S, 2011, BIOCHEM J, V435, P651, DOI 10.1042/BJ20101810; Pham TH, 2013, NUCLEIC ACIDS RES, V41, P6391, DOI 10.1093/nar/gkt355; Troidl K, 2009, ARTERIOSCL THROM VAS, V29, P2093, DOI 10.1161/ATVBAHA.109.195305; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; Vacha P, 2013, BIOPHYS CHEM, V184, P68, DOI 10.1016/j.bpc.2013.09.002; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wallace MA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00469; Zhang M, 2006, CIRCULATION, V113, P1235, DOI 10.1161/CIRCULATIONAHA.105.581397; Zhang X, 2012, P NATL ACAD SCI USA, V109, P12485, DOI 10.1073/pnas.1207821109; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666	52	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144614	10.1371/journal.pone.0144614	http://dx.doi.org/10.1371/journal.pone.0144614			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656831	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900071
J	Zavalkoff, S; Korah, N; Quach, C				Zavalkoff, Samara; Korah, Nadine; Quach, Caroline			Presence of a Physician Safety Champion Is Associated with a Reduction in Urinary Catheter Utilization in the Pediatric Intensive Care Unit	PLOS ONE			English	Article							CLINICAL-PRACTICE; SURVEILLANCE; PREVENTION	Background Safety champions are effective in a variety of safety initiatives; however, there are no reports of their role in hospital-acquired infections prevention. Objective We aimed to describe the association of the presence of a physician safety champion with our urinary catheter device utilization ratios (DUR) in the Pediatric Intensive Care Unit (PICU). Methods Our PICU has incidence rates of catheter-associated urinary tract infections (CAUTI) and urinary catheter DUR above the 90th percentile. Using a quasi-experimental design, we compared our DUR when the PICU team was exposed and unexposed (champion's maternity leaves) to a physician safety champion. Hospital acquired infection (HAI) surveillance of all PICU admissions between April 1st 2009 and June 29th 2013 was done prospectively. To ensure stable acuity of the patient population over time, we used the central venous catheter (CVC) DUR as a control. Results The urinary catheter DUR was 0.44 (95% confidence interval [CI] 0.42-0.45) during the unexposed period versus 0.39 (95% CI 0.38-0.40) during the exposed period, for an absolute difference of 0.05 (95% CI 0.03-0.06; p<0.0001). The overall CVC DUR increased from 0.57 (95% CI 0.55-0.58) during the unexposed period to 0.63 (95% CI 0.61-0.64) during the exposed period, an absolute increase of 0.06 (95% CI 0.04-0.08; p<0.0001). Comparing the exposed and unexposed periods, adjusting for time trend, we observed a 17% decrease in the urinary catheter DUR when the safety champion was present (odds ratio [OR] 0.83; 95% CI 0.77-0.90). The rate of catheter-associated urinary tract infections did not change. Conclusions The presence of a unit-based safety champion can have a positive impact on urinary catheter DUR in a PICU.	[Zavalkoff, Samara] McGill Univ, Montreal Childrens Hosp, Dept Pediat, Div Crit Care,Hlth Ctr, Montreal, PQ H3H 1P3, Canada; [Korah, Nadine] McGill Univ, Montreal Childrens Hosp, Dept Pediat, Div Gen Pediat,Hlth Ctr, Montreal, PQ H3H 1P3, Canada; [Quach, Caroline] McGill Univ, Montreal Childrens Hosp, Dept Pediat, Infect Control,Hlth Ctr, Montreal, PQ H3H 1P3, Canada; [Quach, Caroline] McGill Univ, Dept Pediat, Div Infect Dis, Montreal, PQ H3A 2T5, Canada; [Quach, Caroline] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Zavalkoff, S (corresponding author), McGill Univ, Montreal Childrens Hosp, Dept Pediat, Div Crit Care,Hlth Ctr, Montreal, PQ H3H 1P3, Canada.	samara.zavalkoff@mcgill.ca	Quach, Caroline/AAT-6987-2021	Quach, Caroline/0000-0002-1170-9475				Ash JS, 2003, INT J MED INFORM, V69, P235, DOI 10.1016/S1386-5056(02)00107-7; Campbell J, 2008, CRIT CARE NURS Q, V31, P251, DOI 10.1097/01.CNQ.0000325050.91473.0b; Dodek P, 2004, ANN INTERN MED, V141, P305, DOI 10.7326/0003-4819-141-4-200408170-00011; Dopson S, 2002, HEALTH CARE MANAGE R, V27, P35, DOI 10.1097/00004010-200207000-00005; Doumit G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000125.pub3; Dudeck MA, 2013, AM J INFECT CONTROL, V41, P286, DOI 10.1016/j.ajic.2013.01.002; Frank JR, 2008, SAFETY COMPETENCIES; Graham ID, 2002, CAN J SURG, V45, P132; Grenny J, 2008, INFLUENCER POWER CHA; Hendy J, 2012, SOC SCI MED, V74, P348, DOI 10.1016/j.socscimed.2011.02.009; Horan TC, 1997, AM J INFECT CONTROL, V25, P112, DOI 10.1016/S0196-6553(97)90037-7; Horan TC, 1997, AM J INFECT CONTROL, V25, P73, DOI 10.1016/S0196-6553(97)90031-6; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Horan TC, 2011, INFECT CONT HOSP EP, V32, P1143, DOI 10.1086/662588; Klevens RM, 2002, PUBLIC HLTH REP, V122, P160; Kohn LT, 2000, ERR IS HUMAN BUILDIN; Lo E, 2014, INFECT CONT HOSP EP, V35, pS32, DOI DOI 10.1086/675718; Maher L, 2010, SUSTAINABILITY MODEL; Muething SE, 2012, PEDIATRICS, V130, pE423, DOI 10.1542/peds.2011-3566; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Quach C, 2014, INFECT CONT HOSP EP, V35, P158, DOI 10.1086/674862; Shaw EK, 2012, J AM BOARD FAM MED, V25, P676, DOI 10.3122/jabfm.2012.05.110281; Solomon DH, 1998, JAMA-J AM MED ASSOC, V280, P2020, DOI 10.1001/jama.280.23.2020; Soo Stephanie, 2009, Healthc Q, V12 Spec No Patient, P123; Thompson GN, 2006, J ADV NURS, V53, P691, DOI 10.1111/j.1365-2648.2006.03775.x; Weingart SN, 2009, J NURS CARE QUAL, V24, P203, DOI 10.1097/NCQ.0b013e318195168d	26	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144222	10.1371/journal.pone.0144222	http://dx.doi.org/10.1371/journal.pone.0144222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26666216	Green Published, gold			2022-12-27	WOS:000366715900033
J	Bordas, R; Lefevre, C; Veeckmans, B; Pitt-Francis, J; Fetita, C; Brightling, CE; Kay, D; Siddiqui, S; Burrowes, KS				Bordas, Rafel; Lefevre, Christophe; Veeckmans, Bart; Pitt-Francis, Joe; Fetita, Catalin; Brightling, Christopher E.; Kay, David; Siddiqui, Salman; Burrowes, Kelly S.			Development and Analysis of Patient-Based Complete Conducting Airways Models	PLOS ONE			English	Article							COMPUTATIONAL FLUID-DYNAMICS; 3-DIMENSIONAL MODEL; BRONCHIAL TREE; VENTILATION DEFECTS; PRESSURE DROP; HUMAN LUNGS; RESISTANCE; ASTHMA; CT; HETEROGENEITY	The analysis of high-resolution computed tomography (CT) images of the lung is dependent on inter-subject differences in airway geometry. The application of computational models in understanding the significance of these differences has previously been shown to be a useful tool in biomedical research. Studies using image-based geometries alone are limited to the analysis of the central airways, down to generation 6-10, as other airways are not visible on high-resolution CT. However, airways distal to this, often termed the small airways, are known to play a crucial role in common airway diseases such as asthma and chronic obstructive pulmonary disease (COPD). Other studies have incorporated an algorithmic approach to extrapolate CT segmented airways in order to obtain a complete conducting airway tree down to the level of the acinus. These models have typically been used for mechanistic studies, but also have the potential to be used in a patient-specific setting. In the current study, an image analysis and modelling pipeline was developed and applied to a number of healthy (n = 11) and asthmatic (n = 24) CT patient scans to produce complete patient-based airway models to the acinar level (mean terminal generation 15.8 +/- 0.47). The resulting models are analysed in terms of morphometric properties and seen to be consistent with previous work. A number of global clinical lung function measures are compared to resistance predictions in the models to assess their suitability for use in a patient-specific setting. We show a significant difference (p < 0.01) in airways resistance at all tested flow rates in complete airway trees built using CT data from severe asthmatics (GINA 3-5) versus healthy subjects. Further, model predictions of airways resistance at all flow rates are shown to correlate with patient forced expiratory volume in one second (FEV1) (Spearman rho = -0.65, p < 0.001) and, at low flow rates (0.00017 L/s), FEV1 over forced vital capacity (FEV1/FVC) (rho = -0.58, p < 0.001). We conclude that the pipeline and anatomical models can be used directly in mechanistic modelling studies and can form the basis for future patient-based modelling studies.	[Bordas, Rafel; Pitt-Francis, Joe; Kay, David; Burrowes, Kelly S.] Univ Oxford, Dept Comp Sci, Computat Biol, Oxford, England; [Lefevre, Christophe; Fetita, Catalin] Inst Mines Telecom, Telecom SudParis, CNRS, ARTEMIS Dept,UMR 8145, Paris, France; [Veeckmans, Bart] Materialise NV, Leuven, Belgium; [Brightling, Christopher E.; Siddiqui, Salman] Univ Leicester, Inst Lung Hlth, Dept Infect Immun & Inflammat, Leicester, Leics, England	University of Oxford; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); IMT - Institut Mines-Telecom; IMT Atlantique; Institut Polytechnique de Paris; UDICE-French Research Universities; Universite Paris Cite; University of Leicester	Bordas, R (corresponding author), Univ Oxford, Dept Comp Sci, Computat Biol, Oxford, England.	rafel.bordas@cs.ox.ac.uk		brightling, chris/0000-0002-9345-4903; Burrowes, Kelly/0000-0002-6369-2951; Kay, David/0000-0003-4984-3669; Pitt-Francis, Joe/0000-0002-5094-5403; Siddiqui, Salman/0000-0003-3770-7870; Bordas, Rafel/0000-0002-0856-544X	European Union [270194]	European Union(European Commission)	This work was funded by the European Union Framework 7 AirPROM (Airway Disease Predicting Outcomes through Patient Specific Computational Modelling) project (Grant Agreement No. 270194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burrowes KS, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0057; Campana L, 2009, J APPL PHYSIOL, V106, P1293, DOI 10.1152/japplphysiol.91428.2008; Choi JS, 2011, THESIS; De Backer JW, 2008, J BIOMECH, V41, P106, DOI 10.1016/j.jbiomech.2007.07.009; De Backer JW, 2010, RADIOLOGY, V257, P854, DOI 10.1148/radiol.10100322; Fetita C., 2009, P 2 INT WORKSHOP PUL, P215; Fetita C, 2010, PROC SPIE, V7625, DOI 10.1117/12.844445; Fetita CI, 2004, IEEE T MED IMAGING, V23, P1353, DOI 10.1109/TMI.2004.826945; Gillis HL, 1999, ANN BIOMED ENG, V27, P14, DOI 10.1114/1.161; Gonem S, 2014, CLIN EXP ALLERGY, V44, P499, DOI 10.1111/cea.12257; Gupta S, 2014, J ALLERGY CLIN IMMUN, V133, P729, DOI 10.1016/j.jaci.2013.09.039; HAEFELIBLEUER B, 1988, ANAT RECORD, V220, P401, DOI 10.1002/ar.1092200410; Hedges KL, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2014.0090; HORSFIEL.K, 1971, J APPL PHYSIOL, V31, P207, DOI 10.1152/jappl.1971.31.2.207; HORSFIELD K, 1976, RESP PHYSIOL, V26, P351, DOI 10.1016/0034-5687(76)90005-0; Hunter P, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0004; HYATT RE, 1963, J CLIN INVEST, V42, P29, DOI 10.1172/JCI104693; Ismail M, 2013, INT J NUMER METH BIO, V29, P1285, DOI 10.1002/cnm.2577; Kim M, 2015, INT J NUMER IN PRESS; Kindlmann GL, 2009, IEEE T VIS COMPUT GR, V15, P1415, DOI 10.1109/TVCG.2009.177; Kitaoka H, 1999, J APPL PHYSIOL, V87, P2207, DOI 10.1152/jappl.1999.87.6.2207; Leary D, 2014, J APPL PHYSIOL, V117, P353, DOI 10.1152/japplphysiol.00881.2013; Leary D, 2012, J APPL PHYSIOL, V112, P167, DOI 10.1152/japplphysiol.00633.2011; Lutchen KR, 1997, J APPL PHYSIOL, V83, P1192, DOI 10.1152/jappl.1997.83.4.1192; Lutchen KR, 2001, AM J RESP CRIT CARE, V164, P207, DOI 10.1164/ajrccm.164.2.2008119; Ma BS, 2006, ANN BIOMED ENG, V34, P1691, DOI 10.1007/s10439-006-9184-7; Montaudon M, 2009, RADIOLOGY, V253, P844, DOI 10.1148/radiol.2533090303; PEDLEY TJ, 1970, RESP PHYSIOL, V9, P387, DOI 10.1016/0034-5687(70)90094-0; PEDLEY TJ, 1970, RESP PHYSIOL, V9, P371, DOI 10.1016/0034-5687(70)90093-9; Politi AZ, 2010, J THEOR BIOL, V266, P614, DOI 10.1016/j.jtbi.2010.07.032; Schultz T, 2010, IEEE T VIS COMPUT GR, V16, P109, DOI 10.1109/TVCG.2009.44; Serra J., 1983, IMAGE ANAL MATH MORP; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Swan AJ, 2012, J THEOR BIOL, V300, P222, DOI 10.1016/j.jtbi.2012.01.042; Tawhai MH, 2000, ANN BIOMED ENG, V28, P793, DOI 10.1114/1.1289457; Tawhai MH, 2004, J APPL PHYSIOL, V97, P2310, DOI 10.1152/japplphysiol.00520.2004; Tawhai MH, 2001, RESP PHYSIOL, V127, P249, DOI 10.1016/S0034-5687(01)00239-0; Tgavalekos NT, 2005, J APPL PHYSIOL, V99, P2388, DOI 10.1152/japplphysiol.00391.2005; Tgavalekos NT, 2003, ANN BIOMED ENG, V31, P363, DOI 10.1114/1.1557972; Van Holsbeke CS, 2013, RESP CARE, pe127; Weibel E.R., 1963, MORPHOMETRY HUMAN LU, DOI DOI 10.1007/978-3-642-87553-3; Wongviriyawong C, 2012, J APPL PHYSIOL, V112, P237, DOI 10.1152/japplphysiol.01400.2010; Yin YB, 2010, J BIOMECH, V43, P2159, DOI 10.1016/j.jbiomech.2010.03.048	43	33	34	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144105	10.1371/journal.pone.0144105	http://dx.doi.org/10.1371/journal.pone.0144105			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656288	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903600023
J	Gonzalez-Alcaide, G; Park, J; Huamani, C; Belinchon, I; Ramos, JM				Gonzalez-Alcaide, Gregorio; Park, Jinseo; Huamani, Charles; Belinchon, Isabel; Ramos, Jose M.			Evolution of Cooperation Patterns in Psoriasis Research: Co-Authorship Network Analysis of Papers in Medline (1942-2013)	PLOS ONE			English	Article							BIBLIOMETRIC ANALYSIS; SCIENTIFIC COLLABORATION; COAUTHORSHIP NETWORKS; MULTI-AUTHORSHIP; PUVA-ETRETINATE; DOUBLE-BLIND; PUBLICATION; PLACEBO; WORLDWIDE; ARTICLES	Background Although researchers have worked in collaboration since the origins of modern science and the publication of the first scientific journals in the eighteenth century, this phenomenon has acquired exceptional importance in the last several decades. Since the mid-twentieth century, new knowledge has been generated from within an ever-growing network of investigators, working cooperatively in research groups across countries and institutions. Cooperation is a crucial determinant of academic success. Objective The aim of the present paper is to analyze the evolution of scientific collaboration at the micro level, with regard to the scientific production generated on psoriasis research. Methods A bibliographic search in the Medline database containing the MeSH terms "psoriasis" or "psoriatic arthritis" was carried out. The search results were limited to articles, reviews and letters. After identifying the co-authorships of documents on psoriasis indexed in the Medline database (1942-2013), various bibliometric indicators were obtained, including the average number of authors per document and degree of multi-authorship over time. In addition, we performed a network analysis to study the evolution of certain features of the co-authorship network as a whole: average degree, size of the largest component, clustering coefficient, density and average distance. We also analyzed the evolution of the giant component to characterize the changing research patterns in the field, and we calculated social network indicators for the nodes, namely betweenness and closeness. Results The main active research clusters in the area were identified, along with their authors of reference. Our analysis of 28,670 documents sheds light on different aspects related to the evolution of scientific collaboration in the field, including the progressive increase in the mean number of co-authors (which stood at 5.17 in the 2004-2013 decade), and the rise in multi-authored papers signed by many different authors (in the same decade, 25.77% of the documents had between 6 and 9 co-authors, and 10.28% had 10 or more). With regard to the network indicators, the average degree gradually increased up to 10.97 in the study period. The percentage of authors pertaining to the largest component also rose to 73.02% of the authors. The clustering coefficient, on the other hand, remained stable throughout the entire 70-year period, with values hovering around 0.9. Finally, the average distance peaked in the decades 1974-1983 (8.29) and 1984-2003 (8.12) then fell over the next two decades, down to 5.25 in 2004-2013. The construction of the co-authorship network (threshold of collaboration >= 10 co-authored works) revealed a giant component of 161 researchers, containing 6 highly cohesive sub-components. Conclusions Our study reveals the existence of a growing research community in which collaboration is increasingly important. We can highlight an essential feature associated with scientific collaboration: multi-authored papers, with growing numbers of collaborators contributing to them, are becoming more and more common, therefore the formation of research groups of increasing depth (specialization) and breadth (multidisciplinarity) is now a cornerstone of research success.	[Gonzalez-Alcaide, Gregorio] Univ Valencia, Dept Hist Sci & Documentat, Valencia, Spain; [Park, Jinseo] Korea Inst Sci & Technol Informat, Deajeon, South Korea; [Huamani, Charles] Inst Nacl Salud, Lima, Peru; [Belinchon, Isabel] Hosp Gen Univ Alicante, Dept Dermatol, Alicante, Spain; [Ramos, Jose M.] Univ Miguel Hernandez Elche, Dept Med, Alicante, Spain; [Ramos, Jose M.] Hosp Gen Univ Alicante, Dept Internal Med, Alicante, Spain	University of Valencia; Korea Institute of Science & Technology Information (KISTI); Instituto Nacional de Salud - Peru; General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; General University Hospital of Alicante	Gonzalez-Alcaide, G (corresponding author), Univ Valencia, Dept Hist Sci & Documentat, Valencia, Spain.	gregorio.gonzalez@uv.es	Ramos, Jose M./B-6420-2018; Huamaní, Charles/AAA-6790-2021; Gonzalez-Alcaide, Gregorio/K-7679-2014	Ramos, Jose M./0000-0002-6501-9867; Huamaní, Charles/0000-0003-2090-6531; Park, Jinseo/0000-0003-1899-1861; Gonzalez-Alcaide, Gregorio/0000-0003-3853-5222	Generalitat Valenciana [GV/2015/049]	Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work has been supported by the Generalitat Valenciana (Project GV/2015/049). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bales ME, 2011, AM J PREV MED, V41, P112, DOI 10.1016/j.amepre.2011.03.018; BAYER AE, 1991, J HIGH EDUC, V62, P613, DOI 10.2307/1982193; Bian J, 2014, J BIOMED INFORM, V52, P130, DOI 10.1016/j.jbi.2014.01.015; Bozeman B, 2013, J TECHNOL TRANSFER, V38, P1, DOI 10.1007/s10961-012-9281-8; Braun T, 2001, SCIENTOMETRICS, V51, P499, DOI 10.1023/A:1019643002560; Burt R. S, 1992, STRUCTURAL HOLES; Chandra A, 2015, MOL IMMUNOL, V64, P313, DOI 10.1016/j.molimm.2014.12.014; Chaudhari U, 2001, LANCET, V357, P1842, DOI 10.1016/S0140-6736(00)04954-0; Chow DS, 2015, AM J ROENTGENOL, V204, pW52, DOI 10.2214/AJR.14.12852; CRANE D, 1969, AM SOCIOL REV, V34, P335, DOI 10.2307/2092499; de Montjoye YA, 2014, SCI REP-UK, V4, DOI 10.1038/srep05277; De Solla Price D. J., 1963, LITTLE SCI BIG SCI, DOI 10.7312/pric91844; Della Mea V, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S26; Flanagin A, 1998, JAMA-J AM MED ASSOC, V280, P222, DOI 10.1001/jama.280.3.222; Glanzel W, 2002, LIBR TRENDS, V50, P461; Glanzel W., 2005, HDB QUANTITATIVE SCI, P257, DOI [DOI 10.1007/1-4020-2755-9_12, DOI 10.1007/1-4020-2755-9]; Goff KL, 2015, BRIT J DERMATOL, V172, P1665, DOI 10.1111/bjd.13715; Gonzalez Alcaide G, 2014, REV ESP DOC CIENT, V37, pe62, DOI [10.3989/redc.2014.4.1186, DOI 10.3989/REDC.2014.4.1186]; Gonzalez-Alcaide G, 2013, REV SOC BRAS MED TRO, V46, P719, DOI 10.1590/0037-8682-0207-2013; Gonzalez-Alcaide G, 2013, ALCOHOL CLIN EXP RES, V37, pE381, DOI 10.1111/j.1530-0277.2012.01934.x; Gonzalez-Alcaide G, 2012, REV INST MED TROP SP, V54, P219, DOI 10.1590/S0036-46652012000400007; Gonzalez-Teruel A, 2015, SCIENTOMETRICS, V103, P687, DOI 10.1007/s11192-015-1548-z; GORDON MD, 1980, SCIENTOMETRICS, V2, P193, DOI 10.1007/BF02016697; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Gutierrez-Vela Maria M, 2012, J Clin Exp Dent, V4, pe112, DOI 10.4317/jced.50646; Huang SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103733; Ioannidis JPA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101698; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; Jamshidi AR, 2013, RHEUMATOL INT, V33, P361, DOI 10.1007/s00296-012-2428-y; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1; Katz JS, 1997, SCIENTOMETRICS, V40, P541, DOI 10.1007/BF02459299; Kennedy MS, 2014, J NURS SCHOLARSHIP, V46, P416, DOI 10.1111/jnu.12093; Kretschmer H, 2004, SCIENTOMETRICS, V60, P409, DOI 10.1023/B:SCIE.0000034383.86665.22; Kshitij A, 2015, SCIENTOMETRICS, V102, P285, DOI 10.1007/s11192-014-1310-y; Lambiotte R, 2009, J INFORMETR, V3, P180, DOI 10.1016/j.joi.2009.03.007; Laudel G, 2002, RES EVALUAT, V11, P3, DOI 10.3152/147154402781776961; LAWRENCE CM, 1984, BRIT J DERMATOL, V110, P221, DOI 10.1111/j.1365-2133.1984.tb07471.x; Lebwohl M, 2003, LANCET, V361, P1197, DOI 10.1016/S0140-6736(03)12954-6; Long JC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001434; Mali F, 2012, UNDERST COMPLEX SYST, P195, DOI 10.1007/978-3-642-23068-4_6; Malliaros FD, 2013, PHYS REP, V533, P95, DOI 10.1016/j.physrep.2013.08.002; Nabout JC, 2015, SCIENTOMETRICS, V102, P357, DOI 10.1007/s11192-014-1385-5; NARIN F, 1991, SCIENTOMETRICS, V21, P313, DOI 10.1007/BF02093973; Newman ME, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, DOI 10.1103/PhysRevE.69.026113]; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; PARKER S, 1984, BRIT J DERMATOL, V110, P215, DOI 10.1111/j.1365-2133.1984.tb07470.x; Pavlovsky L, 2009, CLIN EXP DERMATOL, V34, pE91, DOI 10.1111/j.1365-2230.2008.03199.x; Persson O, 2004, SCIENTOMETRICS, V60, P421, DOI 10.1023/B:SCIE.0000034384.35498.7d; PETERS HPF, 1991, SCIENTOMETRICS, V20, P235, DOI 10.1007/BF02018157; Price D. de S., 1975, CI INFORM RIO DE JAN, V4, P27; Ram S, 2014, DESIDOC J LIB INF TE, V34, P46, DOI 10.14429/djlit.34.5945; Ramos JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-55; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X; Richard MA, 2013, J EUR ACAD DERMATOL, V27, P2, DOI 10.1111/jdv.12162; Sahu SR, 2014, SCIENTOMETRICS, V98, P2161, DOI 10.1007/s11192-013-1127-0; Schneider J.W, 2009, CELEBRATING SCHOLARL, V5, P9, DOI DOI 1458990/FILE/1458992.PDF#PAGE=11; Schoeffel N, 2010, J EUR ACAD DERMATOL, V24, P85, DOI 10.1111/j.1468-3083.2009.03293.x; SCHUBERT A, 1991, SCIENTOMETRICS, V20, P317, DOI 10.1007/BF02018161; Tsay MY, 2005, J MED LIBR ASSOC, V93, P450; Vanni T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093376; Velden T, 2010, SCIENTOMETRICS, V85, P219, DOI 10.1007/s11192-010-0224-6; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Whitfield J, 2008, NATURE, V455, P720, DOI 10.1038/455720a; WILLKENS RF, 1984, ARTHRITIS RHEUM-US, V27, P376, DOI 10.1002/art.1780270403; Wu B, 2009, SWSM 09, P33; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; Yu Q, 2013, INT J CARDIOL, V167, P631, DOI 10.1016/j.ijcard.2012.09.134; Yu Q, 2011, SCIENTOMETRICS, V89, P553, DOI 10.1007/s11192-011-0465-z; Zare-Farashbandi F, 2014, J RES MED SCI, V19, P41; Zhang CC, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-52; Zhao ZG, 2011, INT J OPHTHALMOL-CHI, V4, P115, DOI 10.3980/j.issn.2222-3959.2011.02.01	73	20	20	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144837	10.1371/journal.pone.0144837	http://dx.doi.org/10.1371/journal.pone.0144837			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658481	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903600094
J	Vas, J; Andersen, IL				Vas, Judit; Andersen, Inger Lise			Density-Dependent Spacing Behaviour and Activity Budget in Pregnant, Domestic Goats (Capra hircus)	PLOS ONE			English	Article							GROUP-SIZE; SOCIAL INTERACTIONS; FEEDING-BEHAVIOR; DAIRY GOATS; SHEEP; EWES; AGE; REQUIREMENTS; ASSOCIATIONS; ORGANIZATION	Very little is known about the spacing behaviour in social groups of domestic goats (Capra hircus) in the farm environment. In this experiment, we studied interindividual distances, movement patterns and activity budgets in pregnant goats housed at three different densities. Norwegian dairy goats were kept in stable social groups of six animals throughout pregnancy at 1, 2 or 3 m(2) per individual and their spacing behaviours (i.e. distance travelled, nearest and furthest neighbour distance) and activity budgets (e.g. resting, feeding, social activities) were monitored. Observations were made in the first, second and last thirds of pregnancy in the mornings, at noon and in the afternoons of each of these phases (4.5 hours per observation period). The findings show that goats held at animal densities of 2 and 3 m(2) moved longer distances when they had more space per animal and kept larger nearest and furthest neighbour distances when compared to the 1 m(2) per animal density. Less feeding activity was observed at the high animal density compared to the medium and low density treatments. The phase of gestation also had an impact on almost all behavioural variables. Closer to parturition, animals moved further distances and the increase in nearest and furthest neighbour distance was more pronounced at the lower animal densities. During the last period of gestation, goats spent less time feeding and more on resting, social behaviours and engaging in other various activities. Our data suggest that more space per goat is needed for goats closer to parturition than in the early gestation phase. We concluded that in goats spacing behaviour is density-dependent and changes with stages of pregnancy and activities. Finally, the lower density allowed animals to express individual preferences regarding spacing behaviour which is important in ensuring good welfare in a farming situation.	[Vas, Judit; Andersen, Inger Lise] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway	Norwegian University of Life Sciences	Vas, J (corresponding author), Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway.	b.vas.judit@gmail.com	Vas, Judit/GRJ-7640-2022		EU	EU(European Commission)	This study was conducted in frame of the Animal Welfare Indicators project (AWIN), which was financed by the EU VII Framework programme (FP7-KBBE-2010-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADENUGA MK, 1991, SMALL RUMINANT RES, V4, P245, DOI 10.1016/0921-4488(91)90148-J; Andersen IL, 2007, APPL ANIM BEHAV SCI, V108, P89, DOI 10.1016/j.applanim.2006.10.015; ARNOLD GW, 1981, APPL ANIM ETHOL, V7, P239, DOI 10.1016/0304-3762(81)90081-X; ARNOLD GW, 1985, APPL ANIM BEHAV SCI, V14, P173, DOI 10.1016/0168-1591(85)90028-0; ARNOLD GW, 1978, ETHOLOGY FREE RANGIN, P51; Arnould U, 2003, APPL ANIM BEHAV SCI, V84, P281, DOI 10.1016/j.applanim.2003.07.003; Aschwanden J, 2008, APPL ANIM BEHAV SCI, V114, P116, DOI 10.1016/j.applanim.2008.02.002; Aschwanden J, 2008, PHYSIOL BEHAV, V95, P641, DOI 10.1016/j.physbeh.2008.09.016; Aschwanden J, 2009, APPL ANIM BEHAV SCI, V119, P171, DOI 10.1016/j.applanim.2009.04.005; Aschwanden J, 2009, APPL ANIM BEHAV SCI, V119, P180, DOI 10.1016/j.applanim.2009.04.004; Averos X, 2010, ANIMAL, V4, P777, DOI 10.1017/S1751731109991613; Averos X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094767; Averos X, 2014, APPL ANIM BEHAV SCI, V150, P17, DOI 10.1016/j.applanim.2013.11.002; Boe KE, 2006, APPL ANIM BEHAV SCI, V98, P249, DOI 10.1016/j.applanim.2005.10.001; Boe KE, 2013, APPL ANIM BEHAV SCI, V147, P112, DOI 10.1016/j.applanim.2013.04.024; Boe KE, 2010, APPL ANIM BEHAV SCI, V125, P109, DOI 10.1016/j.applanim.2010.04.011; Calhim S, 2006, ANIM BEHAV, V72, P31, DOI 10.1016/j.anbehav.2005.08.013; Chojnacki RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094253; Cvikel N, 2015, CURR BIOL, V25, P206, DOI 10.1016/j.cub.2014.11.010; Dettmer AM, 2014, PSYCHONEUROENDOCRINO, V42, P59, DOI 10.1016/j.psyneuen.2014.01.002; Ehrlenbruch R, 2010, APPL ANIM BEHAV SCI, V126, P105, DOI 10.1016/j.applanim.2010.06.004; Ehrlenbruch R, 2010, APPL ANIM BEHAV SCI, V122, P35, DOI 10.1016/j.applanim.2009.11.004; Estevez I, 2007, APPL ANIM BEHAV SCI, V103, P185, DOI 10.1016/j.applanim.2006.05.025; evez I. R. C., 1997, ETOLOGIA, V5, P19; Faerevik G, 2007, APPL ANIM BEHAV SCI, V108, P215, DOI 10.1016/j.applanim.2007.01.010; Fedele V, 2002, LIVEST PROD SCI, V74, P19, DOI 10.1016/S0301-6226(01)00285-8; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; GEIST V, 1974, AM ZOOL, V14, P205, DOI 10.1093/icb/14.1.205; Gonyou HW, 2006, J ANIM SCI, V84, P229, DOI 10.2527/2006.841229x; Gorgulu M, 2008, SMALL RUMINANT RES, V78, P41, DOI 10.1016/j.smallrumres.2008.04.004; Haugland I, 2010, EFFEKT AKTIVITET RES; Hediger H., 1955, STUDIES PSYCHOL BEHA; HUTSON GD, 1984, APPL ANIM BEHAV SCI, V12, P111, DOI 10.1016/0168-1591(84)90101-1; Jorgensen GHM, 2011, ETHOLOGY, V117, P597, DOI 10.1111/j.1439-0310.2011.01908.x; Jorgensen GHM, 2007, APPL ANIM BEHAV SCI, V107, P239, DOI 10.1016/j.applanim.2006.10.007; Jorgensen GHM, 2009, SMALL RUMINANT RES, V87, P57, DOI 10.1016/j.smallrumres.2009.10.002; KEELING L, 1995, APPL ANIM BEHAV SCI, V44, P171, DOI 10.1016/0168-1591(95)00612-V; Leone EH, 2008, POULTRY SCI, V87, P3, DOI 10.3382/ps.2007-00026; Leone EH, 2008, ANIM BEHAV, V76, P1673, DOI 10.1016/j.anbehav.2008.08.004; Leone EH, 2007, APPL ANIM BEHAV SCI, V102, P39, DOI 10.1016/j.applanim.2006.03.004; LICKLITER RE, 1987, APPL ANIM BEHAV SCI, V19, P137, DOI 10.1016/0168-1591(87)90210-3; Liste G, 2015, APPL ANIM BEHAV SCI, V163, P144, DOI 10.1016/j.applanim.2014.11.013; Loretz C, 2004, APPL ANIM BEHAV SCI, V87, P275, DOI 10.1016/j.applanim.2004.01.005; Mangalam M, 2013, ANIM BEHAV, V85, P763, DOI 10.1016/j.anbehav.2013.01.019; MANSON FJ, 1990, APPL ANIM BEHAV SCI, V26, P69, DOI 10.1016/0168-1591(90)90088-U; McBride G., 1971, P53; Michelena P, 2009, BEHAV ECOL, V20, P145, DOI 10.1093/beheco/arn126; Michelena P, 2008, APPL ANIM BEHAV SCI, V112, P81, DOI 10.1016/j.applanim.2007.06.020; Miranda-de la Lama GC, 2011, APPL ANIM BEHAV SCI, V134, P48, DOI 10.1016/j.applanim.2011.06.004; NEWBERRY RC, 1990, APPL ANIM BEHAV SCI, V25, P125, DOI 10.1016/0168-1591(90)90075-O; NIELSEN BL, 1995, LIVEST PROD SCI, V44, P73, DOI 10.1016/0301-6226(95)00060-X; OBRIEN PH, 1988, APPL ANIM BEHAV SCI, V21, P209, DOI 10.1016/0168-1591(88)90110-4; Olofsson J, 1999, J DAIRY SCI, V82, P69, DOI 10.3168/jds.S0022-0302(99)75210-0; Hai PV, 2014, APPL ANIM BEHAV SCI, V159, P50, DOI 10.1016/j.applanim.2014.07.004; Robbers Y, 2015, PHYSIOL BEHAV, V139, P351, DOI 10.1016/j.physbeh.2014.11.020; ROSENBLUM LA, 1964, ANIM BEHAV, V12, P338, DOI 10.1016/0003-3472(64)90021-1; Sanches C, 1998, CHICKITIZER SOFTWARE; Serment A, 2012, APPL ANIM BEHAV SCI, V141, P130, DOI 10.1016/j.applanim.2012.08.004; SHANK C C, 1972, Zeitschrift fuer Tierpsychologie, V30, P488; Shi JB, 2006, J ETHOL, V24, P117, DOI 10.1007/s10164-005-0170-6; Sibbald AM, 2000, APPL ANIM BEHAV SCI, V70, P49, DOI 10.1016/S0168-1591(00)00145-3; Simensen E, 2010, ACTA AGR SCAND A-AN, V60, P187, DOI 10.1080/09064702.2010.509809; Skotnicka E, 2003, COMP BIOCHEM PHYS C, V134, P385, DOI 10.1016/S1532-0456(03)00007-3; Vas J, 2013, APPL ANIM BEHAV SCI, V147, P117, DOI 10.1016/j.applanim.2013.04.009	64	10	10	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144583	10.1371/journal.pone.0144583	http://dx.doi.org/10.1371/journal.pone.0144583			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657240	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903500044
J	Balvan, J; Gumulec, J; Raudenska, M; Krizova, A; Stepka, P; Babula, P; Kizek, R; Adam, V; Masarik, M				Balvan, Jan; Gumulec, Jaromir; Raudenska, Martina; Krizova, Aneta; Stepka, Petr; Babula, Petr; Kizek, Rene; Adam, Vojtech; Masarik, Michal			Oxidative Stress Resistance in Metastatic Prostate Cancer: Renewal by Self-Eating	PLOS ONE			English	Article							NF-KAPPA-B; CELL-DEATH; INDUCED MITOPHAGY; FLOW-CYTOMETRY; SOMATIC-CELLS; UP-REGULATION; AUTOPHAGY; PLURIPOTENCY; SENESCENCE; APOPTOSIS	Resistant cancer phenotype is a key obstacle in the successful therapy of prostate cancer. The primary aim of our study was to explore resistance mechanisms in the advanced type of prostate cancer cells (PC-3) and to clarify the role of autophagy in these processes. We performed time-lapse experiment (48 hours) with ROS generating plumbagin by using multimodal holographic microscope. Furthermore, we also performed the flow-cytometric analysis and the qRT-PCR gene expression analysis at 12 selected time points. TEM and confocal microscopy were used to verify the results. We found out that autophagy (namely mitophagy) is an important resistance mechanism. The major ROS producing mitochondria were coated by an autophagic membrane derived from endoplasmic reticulum and degraded. According to our results, increasing ROS resistance may be also accompanied by increased average cell size and polyploidization, which seems to be key resistance mechanism when connected with an escape from senescence. Many different types of cellcell interactions were recorded including entosis, vesicular transfer, eating of dead or dying cells, and engulfment and cannibalism of living cells. Entosis was disclosed as a possible mechanism of polyploidization and enabled the long-term survival of cancer cells. Significantly reduced cell motility was found after the plumbagin treatment. We also found an extensive induction of pluripotency genes expression (NANOG, SOX2, and POU5F1) at the time-point of 20 hours. We suppose, that overexpression of pluripotency genes in the portion of prostate tumour cell population exposed to ROS leads to higher developmental plasticity and capability to faster respond to changes in the extracellular environment that could ultimately lead to an alteration of cell fate.	[Balvan, Jan; Gumulec, Jaromir; Raudenska, Martina; Masarik, Michal] Masaryk Univ, Fac Med, Dept Pathol Physiol, CZ-62500 Brno, Czech Republic; [Balvan, Jan; Gumulec, Jaromir; Raudenska, Martina; Krizova, Aneta; Kizek, Rene; Adam, Vojtech] Brno Univ Technol, Cent European Inst Technol, CZ-61600 Brno, Czech Republic; [Krizova, Aneta] TESCAN Brno Sro, Brno, Czech Republic; [Stepka, Petr; Babula, Petr] Masaryk Univ, Fac Med, Dept Physiol, CZ-62500 Brno, Czech Republic; [Kizek, Rene; Adam, Vojtech] Mendel Univ Brno, Dept Chem & Biochem, CZ-61300 Brno, Czech Republic	Masaryk University Brno; Brno University of Technology; Masaryk University Brno; Mendel University in Brno	Masarik, M (corresponding author), Masaryk Univ, Fac Med, Dept Pathol Physiol, Kamenice 5, CZ-62500 Brno, Czech Republic.	masarik@med.muni.cz	Křížová, Aneta/G-8475-2014; Gumulec, Jaromir/D-7638-2012; Adam, Vojtech/D-7686-2012; Raudenska, Martina/F-9187-2012; Křížová, Aneta/ABC-9504-2021; Masarik, Michal/D-9920-2012; Babula, Petr/AAL-6510-2020; Balvan, Jan/I-2945-2012; Stepka, Petr/AAX-5425-2020	Gumulec, Jaromir/0000-0002-9658-3444; Adam, Vojtech/0000-0002-8527-286X; Raudenska, Martina/0000-0001-8258-6671; Křížová, Aneta/0000-0002-9919-6204; Masarik, Michal/0000-0003-1172-7195; Stepka, Petr/0000-0003-4918-3103; Kizek, Rene/0000-0002-0467-6169	Faculty of Medicine, Masaryk University; Specific University Research Grant [MUNI/A/1549/2014, MUNI/A/1326/2014]; Ministry of Education, Youth and Sports of the Czech Republic; commercial company (TESCAN)	Faculty of Medicine, Masaryk University; Specific University Research Grant; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); commercial company (TESCAN)	This work was supported by funds from the Faculty of Medicine, Masaryk University to junior researcher (Michal Masarik) and by the project MUNI/A/1549/2014 and MUNI/A/1326/2014 with the support of the Specific University Research Grant, as provided by the Ministry of Education, Youth and Sports of the Czech Republic in the year 2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial company (TESCAN) provided support in the form of salary for author Aneta Krizova, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abreu M, 2012, PLOS ONE, P7; Aitken RJ, 2012, J BIOL CHEM, V287, P33048, DOI 10.1074/jbc.M112.366690; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Balvan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121674; Barbieri CE, 2013, EUR UROL, V64, P567, DOI 10.1016/j.eururo.2013.05.029; BARER R, 1957, J OPT SOC AM, V47, P545, DOI 10.1364/JOSA.47.000545; Basu HS, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-2899; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bertram J, 2006, PROSTATE, V66, P895, DOI 10.1002/pros.20411; Bockler S, 2014, DEV CELL, V28, P450, DOI 10.1016/j.devcel.2014.01.012; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buchheit CL, 2014, NAT REV CANCER, V14, P632, DOI 10.1038/nrc3789; CARROLL AG, 1993, PROSTATE, V23, P123, DOI 10.1002/pros.2990230206; Castro FAV, 2008, PLOS ONE, P3; Chan LLY, 2012, AUTOPHAGY, V8, P1371, DOI 10.4161/auto.21028; Choucair K, 2012, BMC CANCER, P12; DAVIES HG, 1952, NATURE, V169, P541, DOI 10.1038/169541a0; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Erenpreisa J, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-92; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Gumulec J, 2014, INT J ONCOL, V44, P923, DOI 10.3892/ijo.2013.2223; Gustin JA, 2001, J BIOL CHEM, V276, P27740, DOI 10.1074/jbc.M102559200; Howe EN, 2012, PLOS ONE, P7; Ibrahim P, 1997, LETT APPL MICROBIOL, V25, P437, DOI 10.1111/j.1472-765X.1997.tb00013.x; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Kohsaka S, 2011, BIOCHEM BIOPH RES CO, V410, P878, DOI 10.1016/j.bbrc.2011.06.082; Kolman P, 2010, OPT EXPRESS, V18, P21990, DOI 10.1364/OE.18.021990; Krajcovic M, 2013, MOL BIOL CELL, V24, P3736, DOI 10.1091/mbc.E13-07-0408; Krajcovic M, 2011, NAT CELL BIOL, V13, P324, DOI 10.1038/ncb2174; Kroemer G, 2014, CELL RES, V24, P1280, DOI 10.1038/cr.2014.133; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Lim LY, 2009, BRIT J CANCER, V101, P1606, DOI 10.1038/sj.bjc.6605335; Ling GQ, 2012, ONCOL LETT, V4, P1264, DOI 10.3892/ol.2012.916; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Liu YQ, 2013, ACTA PHARMACOL SIN, V34, P1183, DOI 10.1038/aps.2013.68; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Mancuso P, 2009, CLIN CANCER RES, V15, P3640, DOI 10.1158/1078-0432.CCR-09-0591; Marullo R, 2013, PLOS ONE, P8; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Menendez JA, 2011, CELL CYCLE, V10, P3658, DOI 10.4161/cc.10.21.18128; Mitchell R, 2014, STEM CELLS, V32, P2178, DOI 10.1002/stem.1721; Nakajima S, 2011, FEBS LETT, V585, P2249, DOI 10.1016/j.febslet.2011.05.047; Panov A, 2013, PLOS ONE, P8; Parganlija D, 2014, PLOS ONE, P9; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Powolny AA, 2008, PHARM RES-DORDR, V25, P2171, DOI 10.1007/s11095-008-9533-3; Qian W, 2005, AM J PHYSIOL-CELL PH, V289, pC1466, DOI 10.1152/ajpcell.00265.2005; Roca H, 2008, J BIOL CHEM, V283, P25057, DOI 10.1074/jbc.M801073200; Roca H, 2008, AUTOPHAGY, V4, P969, DOI 10.4161/auto.6822; RUBIN SJ, 1991, J SURG ONCOL, V46, P31, DOI 10.1002/jso.2930460108; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Salmina K, 2010, EXP CELL RES, V316, P2099, DOI 10.1016/j.yexcr.2010.04.030; Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200; Saunders A, 2013, STEM CELLS, V31, P1227, DOI 10.1002/stem.1384; Sedletska Yuliya, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P251, DOI 10.2174/1568011053765967; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Slaby T, 2013, OPT EXPRESS, V21, P14747, DOI 10.1364/OE.21.014747; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Sun Q, 2014, CELL RES, V24, P1299, DOI 10.1038/cr.2014.138; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003; Udovich JA, 2009, J MICROSC-OXFORD, V234, P124, DOI 10.1111/j.1365-2818.2009.03153.x; Wlodkowic D, 2011, METHODS MOL BIOL, V740, P81, DOI 10.1007/978-1-61779-108-6_10; Wu Z, 2006, PROSTATE, V66, P1114, DOI 10.1002/pros.20447; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zemskova M, 2010, MOL CANCER RES, V8, P1126, DOI 10.1158/1541-7786.MCR-10-0174; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang H, 2015, J BIOL CHEM, V290, P1129, DOI 10.1074/jbc.M114.590943; Zhang L, 2014, BIOMED RES INT; Zhang S, 2014, ONCOGENE, V33, P116, DOI 10.1038/onc.2013.96; Zhang SW, 2014, INT J CANCER, V134, P508, DOI 10.1002/ijc.28319	77	17	17	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145016	10.1371/journal.pone.0145016	http://dx.doi.org/10.1371/journal.pone.0145016			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671576	Green Submitted, Green Published, gold			2022-12-27	WOS:000366719300039
J	Seboxa, T; Amogne, W; Abebe, W; Tsegaye, T; Azazh, A; Hailu, W; Fufa, K; Grude, N; Henriksen, TH				Seboxa, Teshale; Amogne, Wondwossen; Abebe, Workeabeba; Tsegaye, Tewodros; Azazh, Aklilu; Hailu, Workagegnehu; Fufa, Kebede; Grude, Nils; Henriksen, Thor-Henrik			High Mortality from Blood Stream Infection in Addis Ababa, Ethiopia, Is Due to Antimicrobial Resistance	PLOS ONE			English	Article							BETA-LACTAMASE PRODUCTION; ESCHERICHIA-COLI; EPIDEMIOLOGY; SEPSIS; PNEUMONIAE; BACTEREMIA; SEPTICEMIA; MORBIDITY; OUTCOMES; PATIENT	Background Managing blood stream infection in Africa is hampered by lack of bacteriological support needed for antimicrobial stewardship, and background data needed for empirical treatment. A combined pro-and retrospective approach was used to overcome thresholds in clinical research in Africa. Methods Outcome and characteristics including age, HIV infection, pancytopenia and bacteriological results were studied in 292 adult patients with two or more SIRS criteria using univariate and confirming multivariate logistic regression models. Expected randomly distributed resistance covariation was compared with observed co-resistance among gram-negative enteric bacteria in 92 paediatric blood culture isolates that had been harvested in the same hospital during the same period of time. Results Mortality was fivefold increased among patients with positive blood culture results [50.0% vs. 9.8%; OR 11.24 (4.38-25.88), p < 0.0001], and for this group of patients mortality was significantly associated with antimicrobial resistance [OR 23.28 (3.3-164.4), p = 0.002]. All 11 patients with Enterobacteriaceae resistant to 3rd. generation cephalosporins died. Eighty-nine patients had pancytopenia grade 3-4. Among patients with negative blood culture results, mortality was significantly associated with pancytopenia [OR 3.12 (1.32-7.39), p = 0.01]. HIV positivity was not associated with increased mortality. Antimicrobial resistance that concerned gram-negative enteric bacteria, regardless of species, was characterized by co-resistance between third generation cephalosporins, gentamicin, chloramphenicol, and co-trimoxazole. Conclusion Mortality was strongly associated with growth of bacteria resistant to empirical treatment, and these patients were dead or dying when bacteriological reports arrived. Because of coresistance, alternative efficient antibiotics would not have been available in Ethiopia for 8/11 Enterobacteriaceae-infected patients with isolates resistant to third generation cephalosporins. Strong and significant resistance covariation between 3rd. generation cephalosporins, chloramphenicol, gentamicin, and co-trimoxazole was identified. Pronounced pancytopenia was common and associated with increased mortality. HIV positive patients had no excess mortality.	[Seboxa, Teshale; Amogne, Wondwossen; Tsegaye, Tewodros; Hailu, Workagegnehu; Henriksen, Thor-Henrik] Univ Addis Ababa, Sch Med, Dept Internal Med, Addis Ababa, Ethiopia; [Abebe, Workeabeba] Univ Addis Ababa, Sch Med, Dept Pediat & Child Hlth, Addis Ababa, Ethiopia; [Azazh, Aklilu] Univ Addis Ababa, Sch Med, Dept Emergency & Crit Care Med, Addis Ababa, Ethiopia; [Fufa, Kebede] Black Lion Hosp, Dept Microbiol, Addis Ababa, Ethiopia; [Grude, Nils] Vestfold Hosp Trust, Dept Microbiol, Tonsberg, Norway; [Henriksen, Thor-Henrik] Vestfold Hosp Trust, Dept Med, Tonsberg, Norway	Addis Ababa University; Addis Ababa University; Addis Ababa University	Henriksen, TH (corresponding author), Univ Addis Ababa, Sch Med, Dept Internal Med, Addis Ababa, Ethiopia.	thor-henrik.henriksen@siv.no	Amogne, Wondwossen/AGM-9855-2022; Degu, Wondwossen Amogne/GON-3590-2022	Ayele, Tewodros/0000-0003-0705-0222	Vestfold Hospital Trust, Norway	Vestfold Hospital Trust, Norway	The project was financed by research grants from Vestfold Hospital Trust, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu Agersew, 2012, BMC Res Notes, V5, P197, DOI 10.1186/1756-0500-5-197; Ani C, 2015, CRIT CARE MED, V43, P65, DOI 10.1097/CCM.0000000000000555; [Anonymous], 2005, PRINCIPLES PRACTICE; Ashley EA, 2011, TROP MED INT HEALTH, V16, P1167, DOI 10.1111/j.1365-3156.2011.02822.x; Biadgilign S, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-15; Blomberg B, 2005, J CLIN MICROBIOL, V43, P745, DOI 10.1128/JCM.43.2.745-749.2005; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; CHARLSON ME, 1987, J CHRON DIS, V40, P705, DOI 10.1016/0021-9681(87)90107-X; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen CJ, 2014, CLIN MICROBIOL INFEC, V20, P605, DOI 10.1111/1469-0691.12705; Cheng WL, 2016, J MICROBIOL IMMUNOL, V49, P208, DOI 10.1016/j.jmii.2014.05.003; Feasey NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092226; FRIEDLAND IR, 1992, ANTIMICROB AGENTS CH, V36, P1596, DOI 10.1128/AAC.36.8.1596; Cuervo SI, 2014, BIOMEDICA, V34, P170, DOI [10.7705/biomedica.v34i0.1680, 10.1590/S0120-41572014000500020]; Ito S, 2006, INTERNAL MED, V45, P303, DOI 10.2169/internalmedicine.45.1535; Kindie AD DM, 2014, 31 WORLD C BIOM LAB; Kuenzli E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-528; Kumar A, 2006, J INFECT DIS, V193, P251, DOI 10.1086/498909; Laupland KB, 2004, CRIT CARE MED, V32, P992, DOI 10.1097/01.CCM.0000119424.31648.1E; LAW BJ, 1984, PEDIATR RES, V18, P314, DOI 10.1203/00006450-198404000-00002; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Leistner R, 2014, INFECTION, V42, P991, DOI 10.1007/s15010-014-0670-9; Leistner R, 2014, INFECT DRUG RESIST, V7, P57, DOI 10.2147/IDR.S56984; LINDTJORN B, 1989, ETHIOPIAN MED J, V27, P27; MacVane SH, 2014, J HOSP MED, V9, P232, DOI 10.1002/jhm.2157; McGregor JC, 2005, AM J EPIDEMIOL, V161, P483, DOI 10.1093/aje/kwi068; MOSS W, 1992, ETHIOPIAN MED J, V30, P197; NORM-VET, NORM NORM VET CONS A; OLI K, 1990, CENT AFR J MED, V36, P68; OSLER W, 1892, PRINCIPLES PRACTICE, P114; Rothman KJ, 1986, MODERN EPIDEMIOLOGY, V1, P77; Schrag SJ, 2012, PEDIATR INFECT DIS J, V31, P821, DOI 10.1097/INF.0b013e31825c4b5a; Shallcross LJ, 2014, J ANTIMICROB CHEMOTH, V69, P2883, DOI 10.1093/jac/dku346; Shitaye Demissie, 2010, Ethiop Med J, V48, P11; STEINBIGLER P, 1995, INTERNIST, V36, P608; Tham Johan, 2013, Infect Drug Resist, V6, P93, DOI 10.2147/IDR.S46290; US Department of Health and Human Servies, 2010, COMMON TERMINOLOGY C; Velaphi S, 2009, ANN TROP PAEDIATR, V29, P101, DOI 10.1179/146532809X440716; Vlieghe E, 2009, INT J ANTIMICROB AG, V34, P295, DOI 10.1016/j.ijantimicag.2009.04.015; WHO, 2014, DRUG THER B, V52, P77; Willems E, 2013, INT J ANTIMICROB AG, V41, P99, DOI 10.1016/j.ijantimicag.2012.07.006; Willmann M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-515; World Health Organization, 2014, ANT RES GLOB REP SUR	43	35	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144944	10.1371/journal.pone.0144944	http://dx.doi.org/10.1371/journal.pone.0144944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670718	Green Published, Green Submitted, gold			2022-12-27	WOS:000366719300033
J	Stivers, PJ; Harmonay, L; Hicks, A; Mehmet, H; Morris, M; Robinson, GM; Strack, PR; Savage, MJ; Zaller, DM; Zwierzynski, I; Brandish, PE				Stivers, Peter J.; Harmonay, Lauren; Hicks, Alexandra; Mehmet, Huseyin; Morris, Melody; Robinson, Gain M.; Strack, Peter R.; Savage, Mary J.; Zaller, Dennis M.; Zwierzynski, Izabela; Brandish, Philip E.			Pharmacological Inhibition of O-GlcNAcase Does Not Increase Sensitivity of Glucocorticoid Receptor-Mediated Transrepression	PLOS ONE			English	Article							RNA-POLYMERASE-II; NF-KAPPA-B; TERMINAL DOMAIN; INSENSITIVE ASTHMA; IN-VIVO; C-MYC; PHOSPHORYLATION; GLCNACYLATION; CELLS; TRANSCRIPTION	Glucocorticoid signaling regulates target genes by multiple mechanisms, including the repression of transcriptional activities of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) though direct protein-protein interactions and subsequent O-GlcNAcylation of RNA polymerase II (pol II). Recent studies have shown that overexpression of O-linked beta-N-acetylglucosamine transferase (OGT), which adds an O-linked beta-N-acetylglucosamine (O-GlcNAc) group to the C-terminal domain of RNA pol II, increases the transrepression effects of glucocorticoids (GC). As O-GlcNAcase (OGA) is an enzyme that removes O-GlcNAc from O-GlcNAcylated proteins, we hypothesized that the potentiation of GC effects following OGT overexpression could be similarly observed via the direct inhibition of OGA, inhibiting O-GlcNAc removal from pol II. Here we show that despite pharmacological evidence of target engagement by a selective small molecule inhibitor of OGA, there is no evidence for a sensitizing effect on glucocorticoid-mediated effects on TNF-alpha promoter activity, or gene expression generally, in human cells. Furthermore, inhibition of OGA did not potentiate glucocorticoid-induced apoptosis in several cancer cell lines. Thus, despite evidence for O-GlcNAc modification of RNA pol II in GR-mediated transrepression, our data indicate that pharmacological inhibition of OGA does not potentiate or enhance glucocorticoid-mediated transrepression.	[Stivers, Peter J.; Harmonay, Lauren; Hicks, Alexandra; Mehmet, Huseyin; Morris, Melody; Robinson, Gain M.; Strack, Peter R.; Zaller, Dennis M.; Brandish, Philip E.] Merck & Co Inc, Boston, MA 02115 USA; [Savage, Mary J.; Zwierzynski, Izabela] Merck & Co Inc, Rahway, NJ 07065 USA	Merck & Company; Merck & Company	Stivers, PJ (corresponding author), Merck & Co Inc, Boston, MA 02115 USA.	peter.stivers@merck.com			Merck Co., Inc.	Merck Co., Inc.(Merck & Company)	The work was funded entirely by Merck & Co., Inc. The funder provided support in the form of salaries for authors PS, LH, AH, HM, MM, PS, MS, DZ, IZ, PB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adcock IM, 2008, CURR ALLERGY ASTHM R, V8, P171, DOI 10.1007/s11882-008-0028-4; Adcock IM, 2003, J ENDOCRINOL, V178, P347, DOI 10.1677/joe.0.1780347; Bachmaier R, 2009, ONCOGENE, V28, P1280, DOI 10.1038/onc.2008.484; Chan MTS, 1998, J ALLERGY CLIN IMMUN, V101, P594, DOI 10.1016/S0091-6749(98)70165-4; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Gu L, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-150; Gu YC, 2010, CANCER RES, V70, P6344, DOI 10.1158/0008-5472.CAN-09-1887; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Herr I, 2009, RESULTS PROBL CELL D, V49, P191, DOI 10.1007/400_2008_20; Hilgers RHP, 2012, AM J PHYSIOL-HEART C, V303, pH513, DOI 10.1152/ajpheart.01175.2011; Inaba H, 2010, LANCET ONCOL, V11, P1096, DOI 10.1016/S1470-2045(10)70114-5; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li MD, 2012, J BIOL CHEM, V287, P12904, DOI 10.1074/jbc.M111.303792; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; Marwick JA, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-33; Marwick JA, 2009, AM J RESP CRIT CARE, V179, P542, DOI 10.1164/rccm.200810-1570OC; Medh RD, 1998, CANCER RES, V58, P3684; Mercado N, 2011, J PHARMACOL EXP THER, V337, P465, DOI 10.1124/jpet.110.175950; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035277; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/NCHEMBIO.797, 10.1038/nchembio.797]; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zijlstra GJ, 2012, EUR RESPIR J, V39, P439, DOI 10.1183/09031936.00017911	32	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145151	10.1371/journal.pone.0145151	http://dx.doi.org/10.1371/journal.pone.0145151			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670328	Green Published, Green Submitted, gold			2022-12-27	WOS:000366719300050
J	Caballero, IC; Sakla, AJ; Detwiler, JT; Le Gall, M; Behmer, ST; Criscione, CD				Caballero, Isabel C.; Sakla, Andrew J.; Detwiler, Jillian T.; Le Gall, Marion; Behmer, Spencer T.; Criscione, Charles D.			Physiological Status Drives Metabolic Rate in Mediterranean Geckos Infected with Pentastomes	PLOS ONE			English	Article							HEMIDACTYLUS-TURCICUS; HYPAXIAL MUSCLES; HOST; PARASITE; LIZARD; IGUANA	Negative effects of parasites on their hosts are well documented, but the proximate mechanisms by which parasites reduce their host's fitness are poorly understood. For example, it has been suggested that parasites might be energetically demanding. However, a recent meta-analysis suggests that they have statistically insignificant effects on host resting metabolic rate (RMR). It is possible, though, that energetic costs associated with parasites are only manifested during and/or following periods of activity. Here, we measured CO2 production (a surrogate for metabolism) in Mediterranean geckos (Hemidactylus turcicus) infected with a lung parasite, the pentastome Raillietiella indica, under two physiological conditions: rested and recently active. In rested geckos, there was a negative, but non-significant association between the number of pentastomes (i.e., infection intensity) and CO2 production. In recently active geckos (chased for 3 minutes), we recorded CO2 production from its maximum value until it declined to a stationary phase. We analyzed this decline as a 3 phase function (initial decline, secondary decline, stationary). Geckos that were recently active showed, in the secondary phase, a significant decrease in CO2 production as pentastome intensity increased. Moreover, duration of the secondary phase showed a significant positive association with the number of pentastomes. These results suggest that the intensity of pentastome load exerts a weak effect on the metabolism of resting geckos, but a strong physiological effect on geckos that have recently been active; we speculate this occurs via mechanical constraints on breathing. Our results provide a potential mechanism by which pentastomes can reduce gecko fitness.	[Caballero, Isabel C.; Sakla, Andrew J.; Criscione, Charles D.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Detwiler, Jillian T.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Le Gall, Marion] Penn State Univ, Dept Entomol, State Coll, PA USA; [Behmer, Spencer T.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; University of Manitoba; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Texas A&M University System; Texas A&M University College Station	Caballero, IC (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	icabal@tamu.edu	Le Gall, Marion/AFK-8033-2022	Le Gall, Marion/0000-0002-8358-0332; Sakla, Andrew/0000-0002-2410-0394	Texas A&M University Online Access to Knowledge (OAK) Fund - University Libraries; Office of the Vice President for Research	Texas A&M University Online Access to Knowledge (OAK) Fund - University Libraries; Office of the Vice President for Research	The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Emily Kasl and Nick Stokes assisted with sampling geckos. CDC's cat Phoenix demonstrated that there are natural events that can stress geckos. The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho JM, 1990, HELMINTH COMMUNITIES; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALI JH, 1981, SYST PARASITOL, V3, P193, DOI 10.1007/BF00014851; BENNETT AF, 1973, COMP BIOCHEM PHYSIOL, V46, P653, DOI 10.1016/0300-9629(73)90119-9; CARRIER D, 1990, J EXP BIOL, V152, P453; CARRIER DR, 1989, J EXP BIOL, V143, P435; Chappell MA, 1999, FUNCT ECOL, V13, P163, DOI 10.1046/j.1365-2435.1999.00265.x; Criscione CD, 2001, J PARASITOL, V87, P1273, DOI 10.1645/0022-3395(2001)087[1273:TGPHCO]2.0.CO;2; Criscione CD, 2001, COMP PARASITOL, V68, P149; DALLAL GE, 1986, AM STAT, V40, P294, DOI 10.2307/2684607; Downs CJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2636; Goater TM, 2014, PARASITISM: THE DIVERSITY AND ECOLOGY OF ANIMAL PARASITES, 2ND EDITION, P1; Goldberg Stephen R., 2004, Bishop Museum Occasional Papers, V79, P58; Hechinger Ryan F., 2012, P234; Kelehear C, 2013, OIKOS, V122, P1317, DOI 10.1111/j.1600-0706.2013.00292.x; Kelehear C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024936; Klein W, 2010, RESP PHYSIOL NEUROBI, V173, pS26, DOI 10.1016/j.resp.2010.04.019; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; PENCE DB, 1988, COPEIA, P565; Poore GCB, 2012, SYST PARASITOL, V82, P211, DOI 10.1007/s11230-012-9363-x; R Core Team, 2013, R LANG ENV STAT COMP; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Riley J, 1999, PARASITOLOGY, V119, pS89, DOI 10.1017/S0031182000084651; Robar N, 2011, CAN J ZOOL, V89, P1146, DOI 10.1139/Z11-084; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; ROSE FL, 1968, AM MIDL NAT, V79, P159, DOI 10.2307/2423161; SCHALL JJ, 1982, SCIENCE, V217, P1057, DOI 10.1126/science.7112113; SCHALL JJ, 1986, J HERPETOL, V20, P318, DOI 10.2307/1564498; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Scholnick DA, 2012, J HERPETOL, V46, P643, DOI 10.1670/11-146; Schwanz LE, 2006, J EXP BIOL, V209, P5029, DOI 10.1242/jeb.02601; Serrano E, 2014, EPIDEMIOL INFECT, V142, P1533, DOI 10.1017/S0950268813002100; Shaw DJ, 1995, PARASITOLOGY, V111, pS111, DOI 10.1017/S0031182000075855; Shaw DJ, 1998, PARASITOLOGY, V117, P597, DOI 10.1017/S0031182098003448; Sorci G, 2013, PARASITE IMMUNOL, V35, P350, DOI 10.1111/pim.12047; VELLEMAN PF, 1981, AM STAT, V35, P234, DOI 10.2307/2683296; Viney ME, 2014, ECOIMMUNOLOGY; Weinstein RB, 1999, PHYSIOL BIOCHEM ZOOL, V72, P732, DOI 10.1086/316710	38	13	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144477	10.1371/journal.pone.0144477	http://dx.doi.org/10.1371/journal.pone.0144477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657838	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900056
J	Carbajo, D; Magi, S; Itoh, M; Kawaji, H; Lassmann, T; Arner, E; Forrest, ARR; Carninci, P; Hayashizaki, Y; Daub, CO; Okada-Hatakeyama, M; Mar, JC				Carbajo, Daniel; Magi, Shigeyuki; Itoh, Masayoshi; Kawaji, Hideya; Lassmann, Timo; Arner, Erik; Forrest, Alistair R. R.; Carninci, Piero; Hayashizaki, Yoshihide; Daub, Carsten O.; Okada-Hatakeyama, Mariko; Mar, Jessica C.		FANTOM Consortium	Application of Gene Expression Trajectories Initiated from ErbB Receptor Activation Highlights the Dynamics of Divergent Promoter Usage	PLOS ONE			English	Article							PROTEIN-INTERACTION DATABASE; MOLECULAR INTERACTION DATABASE; TRANSCRIPTION FACTORS; CELL-DIFFERENTIATION; NETWORK; UPDATE; IREFINDEX; PRODUCTS; RESOURCE; DURATION	Understanding how cells use complex transcriptional programs to alter their fate in response to specific stimuli is an important question in biology. For the MCF-7 human breast cancer cell line, we applied gene expression trajectory models to identify the genes involved in driving cell fate transitions. We modified trajectory models to account for the scenario where cells were exposed to different stimuli, in this case epidermal growth factor and heregulin, to arrive at different cell fates, i.e. proliferation and differentiation respectively. Using genome-wide CAGE time series data collected from the FANTOM5 consortium, we identified the sets of promoters that were involved in the transition of MCF-7 cells to their specific fates versus those with expression changes that were generic to both stimuli. Of the 1,552 promoters identified, 1,091 had stimulus-specific expression while 461 promoters had generic expression profiles over the time course surveyed. Many of these stimulus-specific promoters mapped to key regulators of the ERK (extracellular signal-regulated kinases) signaling pathway such as FHL2 (four and a half LIM domains 2). We observed that in general, generic promoters peaked in their expression early on in the time course, while stimulus-specific promoters tended to show activation of their expression at a later stage. The genes that mapped to stimulus-specific promoters were enriched for pathways that control focal adhesion, p53 signaling and MAPK signaling while generic promoters were enriched for cell death, transcription and the cell cycle. We identified 162 genes that were controlled by an alternative promoter during the time course where a subset of 37 genes had separate promoters that were classified as stimulus-specific and generic. The results of our study highlighted the degree of complexity involved in regulating a cell fate transition where multiple promoters mapping to the same gene can demonstrate quite divergent expression profiles.	[Carbajo, Daniel; Mar, Jessica C.] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10467 USA; [Magi, Shigeyuki; Okada-Hatakeyama, Mariko] RIKEN Ctr Integrat Med Sci, Lab Integrated Cellular Syst, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Itoh, Masayoshi; Kawaji, Hideya; Lassmann, Timo; Arner, Erik; Forrest, Alistair R. R.; Carninci, Piero; Daub, Carsten O.] RIKEN Ctr Life Sci Technol, Div Genom Technol, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Itoh, Masayoshi; Kawaji, Hideya; Lassmann, Timo; Arner, Erik; Forrest, Alistair R. R.; Carninci, Piero; Hayashizaki, Yoshihide; Daub, Carsten O.] RIKEN Omics Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Itoh, Masayoshi; Kawaji, Hideya; Hayashizaki, Yoshihide] RIKEN Prevent Med & Diag Innovat Program, Wako, Saitama, Japan; [Lassmann, Timo] Univ Western Australia, Telethon Kids Inst, Subiaco, WA, Australia; [Arner, Erik] Karolinska Inst, Dept Med, Stockholm, Sweden; [Arner, Erik] Karolinska Univ Hosp, Ctr Metab & Endocrinol, Stockholm, Sweden; [Forrest, Alistair R. R.] Univ Western Australia, QEII Med Ctr, Harry Perkins Inst Med Res, Nedlands, WA 6009, Australia; [Forrest, Alistair R. R.] Univ Western Australia, Med Res Ctr, Nedlands, WA 6009, Australia; [Daub, Carsten O.] Karolinska Inst, Dept Biosci, Stockholm, Sweden; [Daub, Carsten O.] Karolinska Inst, Nutr & Sci Life Lab, Stockholm, Sweden; [Mar, Jessica C.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; RIKEN; RIKEN; RIKEN; RIKEN; Telethon Kids Institute; University of Western Australia; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia; Karolinska Institutet; Karolinska Institutet; Yeshiva University; Albert Einstein College of Medicine	Okada-Hatakeyama, M (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Integrated Cellular Syst, Tsurumi Ku, Yokohama, Kanagawa, Japan.	marikoh@riken.jp; jessica.mar@einstein.yu.edu	Lassmann, Timo/A-8271-2008; Kere, Juha/A-9179-2008; Hide, Winston/R-3815-2019; Hayashizaki, Yoshihide/N-6590-2015; Carninci, Piero/K-1568-2014; Mackay-Sim, Alan/C-3431-2008; Daub, Carsten O/A-7436-2010; Katayama, Shintaro/F-2958-2010; Kawaji, Hideya/N-5116-2015; Wolvetang, Ernst jurgen/D-6644-2017; Lassmann, Timo/HCH-4313-2022; Hide, Winston Hide/C-7217-2009; Hide, Winston A/V-2727-2017; Itoh, Masayoshi/N-5363-2015; Wells, Christine/A-5071-2010; Bodega, Beatrice/I-4644-2018	Lassmann, Timo/0000-0002-0138-2691; Kere, Juha/0000-0003-1974-0271; Hide, Winston/0000-0002-8621-3271; Carninci, Piero/0000-0001-7202-7243; Mackay-Sim, Alan/0000-0003-4446-5371; Daub, Carsten O/0000-0002-3295-8729; Katayama, Shintaro/0000-0001-7581-5157; Kawaji, Hideya/0000-0002-0575-0308; Wolvetang, Ernst jurgen/0000-0002-2146-6614; Lassmann, Timo/0000-0002-0138-2691; Hide, Winston Hide/0000-0002-8621-3271; Hide, Winston A/0000-0002-8621-3271; Itoh, Masayoshi/0000-0002-1772-318X; Mar, Jessica/0000-0002-5147-9299; Meehan, Terrence/0000-0003-1980-3228; Ekwall, Karl/0000-0002-3029-4041; Knox, Alan/0000-0002-5906-4143; Wells, Christine/0000-0003-3133-3628; IIDA, Kei/0000-0001-7130-8705; Forrest, Alistair/0000-0003-4543-1675; Huminiecki, Lukasz/0000-0003-1943-4450; Burroughs, A. Max/0000-0002-2229-8771; Bodega, Beatrice/0000-0003-0527-9234; Moro, Kazuyo/0000-0002-7377-1303; Heutink, Peter/0000-0001-5218-1737; Arner, Erik/0000-0003-1225-4908; Alam, Intikhab/0000-0001-5306-847X	Research Grant for RIKEN Omics Science Center from MEXT; Grant of the Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from the MEXT, Japan; Research Grant from MEXT; MEXT; Grants-in-Aid for Scientific Research [26240044] Funding Source: KAKEN	Research Grant for RIKEN Omics Science Center from MEXT; Grant of the Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from the MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Grant from MEXT; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	FANTOM5 was made possible by the following grants: Research Grant for RIKEN Omics Science Center from MEXT to YH; Grant of the Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from the MEXT, Japan to YH; Research Grant from MEXT to the RIKEN Center for Life Science Technologies; Research Grant to RIKEN Preventive Medicine and Diagnosis Innovation Program from MEXT to YH.	Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Califano D, 2000, J BIOL CHEM, V275, P19297, DOI 10.1074/jbc.M905866199; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chawla K, 2013, BIOINFORMATICS, V29, P2519, DOI 10.1093/bioinformatics/btt432; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Dawson JA, 2012, BIOMETRICS, V68, P455, DOI 10.1111/j.1541-0420.2011.01688.x; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jung HY, 2010, J BIOL CHEM, V285, P54, DOI 10.1074/jbc.M109.045229; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Mar JC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000626; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Mora A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-455; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; Nasarre P, 2003, NEOPLASIA, V5, P83, DOI 10.1016/S1476-5586(03)80020-9; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Purcell NH, 2004, MOL CELL BIOL, V24, P1081, DOI 10.1128/MCB.24.3.1081-1095.2004; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Saeki Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-545; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; Scott MGH, 2006, MOL CELL BIOL, V26, P3432, DOI 10.1128/MCB.26.9.3432-3445.2006; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Tarcic G, 2012, FASEB J, V26, P1582, DOI 10.1096/fj.11-194654; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zwang YR, 2011, MOL CELL, V42, P524, DOI 10.1016/j.molcel.2011.04.017	45	1	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144176	10.1371/journal.pone.0144176	http://dx.doi.org/10.1371/journal.pone.0144176			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658111	Green Published, gold			2022-12-27	WOS:000366715900029
J	Chen, HX; Lu, CP; Jiang, H; Peng, JH				Chen, Haixia; Lu, Changping; Jiang, Hui; Peng, Jinhui			Global Transcriptome Analysis Reveals Distinct Aluminum-Tolerance Pathways in the Al-Accumulating Species Hydrangea macrophylla and Marker Identification	PLOS ONE			English	Article							REGULATES MULTIPLE GENES; PLASMA-MEMBRANE; ACTIVATED CITRATE; ARABIDOPSIS; TRANSPORTER; PLANT; MECHANISMS; TOXICITY; PROTON; DETOXIFICATION	Hydrangea (Hydrangea macrophylla) is a well known Al-accumulating plant, showing a high level of aluminum (Al) tolerance and accumulation. Although the physiological mechanisms for detoxification of Al and the roles of Al in blue hydrangea sepals have been reported, the molecular mechanisms of Al tolerance and accumulation are poorly understood in hydrangea. In this study, we conducted a genome-wide transcriptome analysis of Al-response genes in the roots and leaves of hydrangea by RNA sequencing (RNA-seq). The assembly of hydrangea transcriptome provides a rich source for gene identification and mining molecular markers, including single nucleotide polymorphism (SNP) and simple sequence repeat (SSR). A total of 401,215 transcripts with an average length of 810.77bp were assembled, generating 256,127 unigenes. After annotation, 4,287 genes in the roots and 730 genes in the leaves were up-regulated by Al exposure, while 236 genes in the roots and 719 genes in the leaves were down-regulated, respectively. Many transporters, including MATE and ABC families, were involved in the process of Al-citrate complex transporting from the roots in hydrangea. A plasma membrane Al uptake transporter, Nramp aluminum transporter was up-regulated in roots and leaves under Al stress, indicating it may play an important role in Al tolerance by reducing the level of toxic Al. Although the exact roles of these candidate genes remain to be examined, these results provide a platform for further functional analysis of the process of detoxification of Al in hydrangea.	[Chen, Haixia; Lu, Changping; Jiang, Hui; Peng, Jinhui] Hunan Agr Univ, Coll Hort & Landscape, Changsha 410128, Hunan, Peoples R China	Hunan Agricultural University	Chen, HX (corresponding author), Hunan Agr Univ, Coll Hort & Landscape, Changsha 410128, Hunan, Peoples R China.	chenhaixia1996@126.com			National Natural Science Foundation of China [31201656]; Scientific Research Fund of Hunan Provincial Education Department [14B093]; Hunan co-innovation center for utilization of botanicals functional ingredients	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department); Hunan co-innovation center for utilization of botanicals functional ingredients	The authors thank the scientific research fund of Hunan co-innovation center for utilization of botanicals functional ingredients. This work was supported by grants from the National Natural Science Foundation of China (31201656) and Scientific Research Fund of Hunan Provincial Education Department (14B093).	Cardoso-Silva CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088462; Chang YC, 1999, PLANT CELL ENVIRON, V22, P1009, DOI 10.1046/j.1365-3040.1999.00467.x; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; COSGROVE D J, 1989, Planta (Heidelberg), V177, P121, DOI 10.1007/BF00392162; Fan W, 2014, PLANT CELL ENVIRON, V37, P1586, DOI 10.1111/pce.12258; Frelet-Barrand A, 2008, PLANT CELL PHYSIOL, V49, P557, DOI 10.1093/pcp/pcn034; Garcia-Oliveira AL, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-134; Gould B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124424; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hanikenne M, 2011, CURR OPIN PLANT BIOL, V14, P252, DOI 10.1016/j.pbi.2011.04.003; Hotta H, 2008, ANAL SCI, V24, P795, DOI 10.2116/analsci.24.795; Huang CF, 2009, PLANT CELL, V21, P655, DOI 10.1105/tpc.108.064543; Iuchi S, 2007, P NATL ACAD SCI USA, V104, P9900, DOI 10.1073/pnas.0700117104; Janicka-Russak M, 2008, J EXP BOT, V59, P3721, DOI 10.1093/jxb/ern219; KOCHIAN LV, 1995, ANNU REV PLANT PHYS, V46, P237, DOI 10.1146/annurev.pp.46.060195.001321; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li JY, 2014, P NATL ACAD SCI USA, V111, P6503, DOI 10.1073/pnas.1318975111; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Liu JP, 2009, PLANT J, V57, P389, DOI 10.1111/j.1365-313X.2008.03696.x; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Ma JF, 2000, PLANT CELL PHYSIOL, V41, P383, DOI 10.1093/pcp/41.4.383; Ma JF, 1997, PLANT PHYSL, V113, P033; Negishi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043189; Ohno T, 2003, PLANT CELL PHYSIOL, V44, P156, DOI 10.1093/pcp/pcg025; Ohyama Y, 2013, PLANT PHYSIOL, V162, P1937, DOI 10.1104/pp.113.218958; Peng YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090636; Rogers EE, 2002, PLANT CELL, V14, P1787, DOI 10.1105/tpc.001495; Ryan PR, 2001, ANNU REV PLANT PHYS, V52, P527, DOI 10.1146/annurev.arplant.52.1.527; Sawaki Y, 2009, PLANT PHYSIOL, V150, P281, DOI 10.1104/pp.108.134700; Schreiber HD, 2011, BIOMETALS, V24, P1005, DOI 10.1007/s10534-011-9458-x; Schumacher K, 2010, CURR OPIN PLANT BIOL, V13, P724, DOI 10.1016/j.pbi.2010.07.003; Tabuchi A, 2001, PHYSIOL PLANTARUM, V112, P353, DOI 10.1034/j.1399-3054.2001.1120308.x; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; Xia JX, 2010, P NATL ACAD SCI USA, V107, P18381, DOI 10.1073/pnas.1004949107; Yamaji N, 2009, PLANT CELL, V21, P3339, DOI 10.1105/tpc.109.070771; Yamamoto Y, 2001, PLANT PHYSIOL, V125, P199, DOI 10.1104/pp.125.1.199; Yang XY, 2011, PLANT CELL ENVIRON, V34, P2138, DOI 10.1111/j.1365-3040.2011.02410.x; Yokosho K, 2014, PLANT CELL PHYSIOL, V55, P2077, DOI 10.1093/pcp/pcu135; Yokosho K, 2011, PLANT J, V68, P1061, DOI 10.1111/j.1365-313X.2011.04757.x; Yu L, 2010, J EXP BOT, V61, P1625, DOI 10.1093/jxb/erq028; Zhu HF, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0395-z	42	20	25	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144927	10.1371/journal.pone.0144927	http://dx.doi.org/10.1371/journal.pone.0144927			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660093	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900151
J	Di, JL; Rutherford, S; Wu, JL; Song, B; Ma, L; Chen, JY; Chu, C				Di, Jiangli; Rutherford, Shannon; Wu, Jiuling; Song, Bo; Ma, Lan; Chen, Jingyi; Chu, Cordia			Knowledge of Cervical Cancer Screening among Women across Different Socio-Economic Regions of China	PLOS ONE			English	Article							ATTITUDES; BARRIERS; BELIEFS; HEALTH; URBAN	Background and Objective China has a high burden of cervical cancer (CC) and wide disparities in CC burden exist among different socio-economic regions. In order to reduce these disparities, China's government launched the National Cervical Cancer Screening Program in Rural Areas (NCCSPRA) in 2009. Understanding the factors associated with underutilization of CC screening among target populations is important to improve the screening participation rate, and a high participation rate is key to achieving the goals of a screening program. However, data on the knowledge of CC among target populations in program areas is lacking in China. This study will investigate the knowledge of CC prevention and control among women in specific project counties to develop a better understanding of factors that might influence CC screening participation in order to improve the implementation of the NCCSPRA. Materials and Methods A cross-sectional survey was conducted and face-to-face interview questionnaires were completed by 308 women who received CC screening services in 6 project counties of NCCSPRA across different socio-economic regions of China. ANOVA and Chi-square tests were used to compare the knowledge rates and scores across the different subgroups. Logistic regression was conducted to examine factors associated with knowledge level. Results The overall CC knowledge rate of the target population was only 19.5%. Regional socioeconomic level, advice from doctors, age, and educational status were strong predictors of knowledge level of CC screening. Significantly lower knowledge rates and scores were identified in older women (55-64 years old), less educated women (with primary school or illiterate), women in less developed regions and women who did not receive any advice about screening results from doctors. Conclusion The knowledge of CC screening among women in the project counties of NCCSPRA was found to be very poor. Given the importance of knowledge in encouraging women to participate in screening is key to reducing CC burden in rural women in China, it is urgent that a targeted health promotion intervention is developed and implemented in project counties, especially targeting older women, women with less education and women in less developed regions, and focus on improving their CC knowledge and encouraging them to communicate with health care providers. The health promotion intervention targeting health care providers is also important to improve their knowledge of CC and provide best advice to women.	[Di, Jiangli; Wu, Jiuling; Song, Bo; Ma, Lan; Chen, Jingyi] China CDC, Natl Ctr Women & Childrens Hlth, Beijing, Peoples R China; [Di, Jiangli; Rutherford, Shannon; Chu, Cordia] Griffith Univ, Brisbane, Qld 4111, Australia	Chinese Center for Disease Control & Prevention; National Center for Women & Children's Health, Chinese Center for Disease Control & Prevention; Griffith University	Di, JL (corresponding author), China CDC, Natl Ctr Women & Childrens Hlth, Beijing, Peoples R China.	dijiangli@chinawch.org.cn; 590@chinawch.org.cn		Chu, Cordia/0000-0002-3683-5638				Al-Naggar RA, 2010, ASIAN PAC J CANCER P, V11, P867; Ali SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011059; [Anonymous], 2009, LANCET, V374, P358; [Anonymous], 2014, LANCET, V384, P2000; [Anonymous], 2009, MAN PLAN RUR AR CERV; Anttila A, 2009, EUR J CANCER, V45, P2649, DOI 10.1016/j.ejca.2009.07.020; Denny-Smith T, 2006, J AM ACAD NURSE PRAC, V18, P62, DOI 10.1111/j.1745-7599.2006.00100.x; Duffett-Leger LA, 2008, JOGNN-J OBST GYN NEO, V37, P572, DOI 10.1111/j.1552-6909.2008.00276.x; Francis SA, 2011, VACCINE, V29, P8760, DOI 10.1016/j.vaccine.2011.07.116; Getahun F, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-2; GLOBOCAN, 2014, GLOBOCAN 2012 EST CA; Goss PE, 2014, LANCET ONCOL, V15, P489, DOI 10.1016/S1470-2045(14)70029-4; Hoque Monjurul, 2008, East Afr J Public Health, V5, P111; Huang Y, 2011, ASIAN PAC J CANCER P, V12, P203; International Agency for Research on Cancer (IARC), 2005, IARC HDB CANC PREV, V10, P45; Jia Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067005; Jian WY, 2010, HEALTH AFFAIR, V29, P2189, DOI 10.1377/hlthaff.2009.0989; Leite MF, 2014, J HUMAN GROWTH DEV, V24, P208; MOH, 2012, REC PROC MAJ WOM CHI; MOH, 2012, WOM HLTH COMM HLTH; MOH, 2006, RES ASS RES POL WOM; Mutyaba Twaha, 2006, BMC Med Educ, V6, P13, DOI 10.1186/1472-6920-6-13; NBS, 2014, NAT DAT; NCC DPCB NHFPC, 2012, CHIN CANC REG ANN RE; NCC DPCB NHFPC, 2013, CHIN CANC REG ANN RE; NOCPC NCCR DPCB, 2010, CHIN CANC REG ANN RE; Nwankwo KC, 2011, EUR J CANCER CARE, V20, P362, DOI 10.1111/j.1365-2354.2009.01175.x; Powe BD, 2003, CANCER NURS, V26, P454; Shea J, 2013, J CLIN NURS, V22, P3310, DOI 10.1111/jocn.12420; Tebeu PM, 2008, INT J GYNECOL CANCER, V18, P761, DOI 10.1111/j.1525-1438.2007.01066.x; WHO, 2014, COMPR CERV CANC CONT; WHO, 2006, COMPR CERV CANC CONT; Wong LP, 2010, EUR J OBSTET GYN R B, V148, P90, DOI 10.1016/j.ejogrb.2009.10.002; Yanikkerem E, 2013, J CANCER EDUC, V28, P375, DOI 10.1007/s13187-012-0409-1	34	11	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144819	10.1371/journal.pone.0144819	http://dx.doi.org/10.1371/journal.pone.0144819			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26657110	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900109
J	Discamps, E; Henshilwood, CS				Discamps, Emmanuel; Henshilwood, Christopher Stuart			Intra-Site Variability in the Still Bay Fauna at Blombos Cave: Implications for Explanatory Models of the Middle Stone Age Cultural and Technological Evolution	PLOS ONE			English	Article							SOUTH-AFRICA; HOWIESONS POORT; HUNTING STRATEGIES; HUMAN-BEHAVIOR; BONE; CAPE; INNOVATION; PATTERNS; CRITIQUE; LAYERS	To explain cultural and technological innovations in the Middle Stone Age (MSA) of southern Africa, scholars invoke several factors. A major question in this research theme is whether MSA technocomplexes are adapted to a particular set of environmental conditions and subsistence strategies or, on the contrary, to a wide range of different foraging behaviours. While faunal studies provide key information for addressing these factors, most analyses do not assess intra-technocomplex variability of faunal exploitation (i.e. variability within MSA phases). In this study, we assess the spatial variability of the Still Bay fauna in one phase (M1) of the Blombos Cave sequence. Analyses of taxonomic composition, taphonomic alterations and combustion patterns reveal important faunal variability both across space (lateral variation in the post-depositional history of the deposits, spatial organisation of combustion features) and over time (fine-scale diachronic changes throughout a single phase). Our results show how grouping material prior to zooarchaeological interpretations (e.g. by layer or phase) can induce a loss of information. Finally, we discuss how multiple independent subdivisions of archaeological sequences can improve our understanding of both the timing of different changes (for example in technology, culture, subsistence, environment) and how they may be inter-related.	[Discamps, Emmanuel; Henshilwood, Christopher Stuart] Univ Bergen, Inst Archaeol Hist Culture & Religious Studies, Bergen, Norway; [Discamps, Emmanuel] Univ Bordeaux 1, CNRS UMR PACEA 5199, F-33405 Talence, France; [Henshilwood, Christopher Stuart] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2000 Johannesburg, South Africa	University of Bergen; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; University of Witwatersrand	Discamps, E (corresponding author), Univ Bergen, Inst Archaeol Hist Culture & Religious Studies, Oysteinsgate 3, Bergen, Norway.	ediscamps@gmail.com	Henshilwood, Christopher S/K-3806-2014	Henshilwood, Christopher S/0000-0002-2818-293X; Discamps, Emmanuel/0000-0002-2464-0761	AHKR department at the University of Bergen, Norway; National Research Foundation/Department of Science and Technology; University of Bergen	AHKR department at the University of Bergen, Norway; National Research Foundation/Department of Science and Technology(Department of Science & Technology (India)); University of Bergen	Faunal data collection by ED was funded by the AHKR department at the University of Bergen, Norway. Financial support for the BBC project was provided to CSH by a National Research Foundation/Department of Science and Technology funded Chair at the University of the Witwatersrand, South Africa and by the University of Bergen.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Archer W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132428; Badenhorst S, 2014, AFR ARCHAEOL REV, V31, P25, DOI 10.1007/s10437-014-9154-7; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Bird DW, 2006, J ARCHAEOL RES, V14, P143, DOI 10.1007/s10814-006-9003-6; Blasco R, 2013, QUATERNARY SCI REV, V70, P124, DOI 10.1016/j.quascirev.2013.03.008; BRAIN C K, 1974, Annals of the Transvaal Museum, V29, P1; Cain CR, 2005, J ARCHAEOL SCI, V32, P873, DOI 10.1016/j.jas.2005.01.005; Clark JL, 2008, J HUM EVOL, V54, P886, DOI 10.1016/j.jhevol.2007.12.004; Clark Jamie L., 2013, P9; Clark JL, 2013, CURR ANTHROPOL, V54, pS269, DOI 10.1086/673386; Clark JL, 2010, J ARCHAEOL SCI, V37, P2650, DOI 10.1016/j.jas.2010.06.001; Conard NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130001; Costamagno S., 2009, INT SERIES, V1914, P65; Discamps Emmanuel, 2012, Journal of Taphonomy, V10, P291; Dusseldorp GL, 2014, AZANIA, V49, P317, DOI 10.1080/0067270X.2014.937080; Dusseldorp GL, 2012, QUATERN INT, V270, P70, DOI 10.1016/j.quaint.2011.02.011; Gravina B, 2015, J HUM EVOL, V84, P83, DOI 10.1016/j.jhevol.2015.04.005; Haaland M, 2012, THESIS; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Henshilwood CS, 2014, J ARCHAEOL SCI, V45, P284, DOI 10.1016/j.jas.2014.01.033; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Henshilwood CS, 2003, CURR ANTHROPOL, V44, P627, DOI 10.1086/377665; Henshilwood CS, 1997, J ARCHAEOL SCI, V24, P659, DOI 10.1006/jasc.1996.0148; Henshilwood CS, 2001, J ARCHAEOL SCI, V28, P421, DOI 10.1006/jasc.2000.0638; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Jacobs Z, 2013, J ARCHAEOL SCI, V40, P579, DOI 10.1016/j.jas.2012.06.037; Jerardino A., 1995, S AFR ARCHAEOL B, V50, P21, DOI [DOI 10.2307/3889271, 10.2307/3889271]; Klein RG, 2000, EVOL ANTHROPOL, V9, P17, DOI 10.1002/(SICI)1520-6505(2000)9:1<17::AID-EVAN3>3.0.CO;2-A; Lombard M, 2008, BAR INT SERIES, V1849, P46; Lyman L.D., 1994, VERTEBRATE TAPHONOMY, DOI DOI 10.1017/CBO9781139878302; Marean CW, 1998, J HUM EVOL, V35, P111, DOI 10.1006/jhev.1998.0224; McCall GS, 2007, J ARCHAEOL SCI, V34, P1738, DOI 10.1016/j.jas.2006.12.015; McCall GS, 2012, AFR ARCHAEOL REV, V29, P7, DOI 10.1007/s10437-012-9107-y; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Nel T., 2013, THESIS; Porraz G, 2013, J ARCHAEOL SCI, V40, P3542, DOI 10.1016/j.jas.2013.02.024; Reynard JP, 2016, QUATERN INT, V404, P2, DOI 10.1016/j.quaint.2015.07.041; Reynard Jerome P., 2014, Annals of the Ditsong National Museum of Natural History, V4, P9; Shennan S, 2001, CAMB ARCHAEOL J, V11, P5, DOI 10.1017/S0959774301000014; Steele TE, 2009, VERTEBR PALEOBIOL PA, P113, DOI 10.1007/978-1-4020-9699-0_8; Stiner MC, 2001, J ARCHAEOL SCI, V28, P643, DOI 10.1006/jasc.2000.0634; STINER MC, 1995, J ARCHAEOL SCI, V22, P223, DOI 10.1006/jasc.1995.0024; Thompson JC, 2010, SETTLEMENT DYNAMICS, P1; Thompson JC, 2014, J HUM EVOL, V67, P33, DOI 10.1016/j.jhevol.2013.09.010; Thompson JC, 2014, J ARCHAEOL SCI, V41, P214, DOI 10.1016/j.jas.2013.08.017; Thompson JC, 2011, J HUM EVOL, V60, P746, DOI 10.1016/j.jhevol.2011.01.013; Vanhaeren M, 2013, J HUM EVOL, V64, P500, DOI 10.1016/j.jhevol.2013.02.001; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; Villa P, 2009, J ARCHAEOL SCI, V36, P441, DOI 10.1016/j.jas.2008.09.028; Wurz S, 2013, CURR ANTHROPOL, V54, pS305, DOI 10.1086/673283; Ziegler M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2897	52	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144866	10.1371/journal.pone.0144866	http://dx.doi.org/10.1371/journal.pone.0144866			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CY9GR	26658195	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900125
J	Hadlari, T; Swindles, GT; Galloway, JM; Bell, KM; Sulphur, KC; Heaman, LM; Beranek, LP; Fallas, KM				Hadlari, Thomas; Swindles, Graeme T.; Galloway, Jennifer M.; Bell, Kimberley M.; Sulphur, Kyle C.; Heaman, Larry M.; Beranek, Luke P.; Fallas, Karen M.			1.8 Billion Years of Detrital Zircon Recycling Calibrates a Refractory Part of Earth's Sedimentary Cycle	PLOS ONE			English	Article							NORTHWESTERN CANADA; CORDILLERAN MIOGEOCLINE; U-PB; PROVENANCE; GEOCHRONOLOGY; STRATA; YUKON; LAURENTIA; EVOLUTION; TERRANE	Detrital zircon studies are providing new insights on the evolution of sedimentary basins but the role of sedimentary recycling remains largely undefined. In a broad region of northwestern North America, this contribution traces the pathway of detrital zircon sand grains from Proterozoic sandstones through Phanerozoic strata and argues for multi-stage sedimentary recycling over more than a billion years. As a test of our hypothesis, integrated palynology and detrital zircon provenance provides clear evidence for erosion of Carboniferous strata in the northern Cordillera as a sediment source for Upper Cretaceous strata. Our results help to calibrate Earth's sedimentary cycle by showing that recycling dominates sedimentary provenance for the refractory mineral zircon.	[Hadlari, Thomas; Galloway, Jennifer M.; Fallas, Karen M.] Geol Survey Canada, Calgary, AB T2L 2A7, Canada; [Swindles, Graeme T.] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Bell, Kimberley M.; Sulphur, Kyle C.] Univ Calgary, Dept Geosci, Calgary, AB, Canada; [Heaman, Larry M.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB, Canada; [Beranek, Luke P.] Mem Univ Newfoundland, Dept Earth Sci, St John, NF, Canada	Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; University of Leeds; University of Calgary; University of Alberta; Memorial University Newfoundland	Hadlari, T (corresponding author), Geol Survey Canada, 3303 33Rd St Nw, Calgary, AB T2L 2A7, Canada.	thomas.hadlari@canada.ca	Swindles, Graeme/AAU-4321-2020	Swindles, Graeme/0000-0001-8039-1790; galloway, jennifer/0000-0002-4548-6396; Hadlari, Thomas/0000-0002-1264-0051; Fallas, Karen/0000-0002-5645-9561	Geological Survey of Canada	Geological Survey of Canada(Natural Resources Canada)	This work was supported by internal project funding to TH, JG, and KF which was provided by the Geological Survey of Canada through the GEM program.; We acknowledge full support of the Geological Survey of Canada and this is a CALE contribution. Special thanks to Drs. RH Rainbird, WG Davis, and AR Sweet.	Beranek LP, 2011, TECTONICS, V30, DOI 10.1029/2010TC002849; Beranek LP, 2010, GEOL SOC AM BULL, V122, P1899, DOI 10.1130/B30120.1; Beranek LP, 2010, CAN J EARTH SCI, V47, P53, DOI 10.1139/E09-065; Colpron M., 2006, PALEOZOIC EVOLUTION, V45, P131; Condie KC, 2009, GONDWANA RES, V15, P228, DOI 10.1016/j.gr.2008.06.001; Cook FA, 2004, TECTONICS, V23, DOI 10.1029/2002TC001412; Dickinson WR, 2009, GEOLOGY, V37, P503, DOI 10.1130/G25646A.1; Furlanetto F, 2009, YUKON EXPLORATION GE, P125; Furlanetto F, 2013, PRECAMBRIAN RES, V224, P512, DOI 10.1016/j.precamres.2012.10.010; Hadlari T, 2012, GEOL SOC AM BULL, V124, P1155, DOI 10.1130/B30530.1; Hadlari T, 2014, MAR PETROL GEOL, V57, P173, DOI 10.1016/j.marpetgeo.2014.05.019; Lane LS, 2014, GEOL SOC AM BULL, V126, P398, DOI 10.1130/B30848.1; Lemieux Y, 2011, CAN J EARTH SCI, V48, P515, DOI 10.1139/E10-056; Piercey SJ, 2009, GEOSPHERE, V5, P439, DOI 10.1130/GES00505.1; Rainbird RH, 1997, J GEOL, V105, P1, DOI 10.1086/606144; Rohr TS, 2008, J GEOL SOC LONDON, V165, P755, DOI 10.1144/0016-76492007-102; Snyder DB, 2009, GEOL SOC SPEC PUBL, V318, P257, DOI 10.1144/SP318.9; Thorkelson DJ, 2005, CAN J EARTH SCI, V42, P1045, DOI 10.1139/e04-075	18	27	27	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144727	10.1371/journal.pone.0144727	http://dx.doi.org/10.1371/journal.pone.0144727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658165	Green Published, gold			2022-12-27	WOS:000366715900095
J	Ibbotson, P; Kearvell-White, J				Ibbotson, Paul; Kearvell-White, Jennifer			Inhibitory Control Predicts Grammatical Ability	PLOS ONE			English	Article							PAST-TENSE; CHILDREN; LANGUAGE; PRODUCTIVITY; SEMANTICS; RETREAT; GAZE; SLI	We present evidence that individual variation in grammatical ability can be predicted by individual variation in inhibitory control. We tested 81 5-year-olds using two classic tests from linguistics and psychology (Past Tense and the Stroop). Inhibitory control was a better predicator of grammatical ability than either vocabulary or age. Our explanation is that giving the correct response in both tests requires using a common cognitive capacity to inhibit unwanted competition. The implications are that understanding the developmental trajectory of language acquisition can benefit from integrating the developmental trajectory of non-linguistic faculties, such as executive control.	[Ibbotson, Paul; Kearvell-White, Jennifer] Open Univ, Fac Educ & Languages, Milton Keynes MK7 6BJ, Bucks, England	Open University - UK	Ibbotson, P (corresponding author), Open Univ, Fac Educ & Languages, Milton Keynes MK7 6BJ, Bucks, England.	paul.ibbotson@open.ac.uk		Ibbotson, Paul/0000-0001-8346-0616				Ambridge B, 2012, LANGUAGE, V88, P45, DOI 10.1353/lan.2012.0000; Ambridge B, 2012, COGNITION, V123, P260, DOI 10.1016/j.cognition.2012.01.002; Archibald SJ, 1999, CHILD NEUROPSYCHOL, V5, P115, DOI 10.1076/chin.5.2.115.3167; Bialystok E, 2005, NEUROIMAGE, V24, P40, DOI 10.1016/j.neuroimage.2004.09.044; Bybee Joan, 2010, LANGUAGE USAGE COGNI; Chomsky N., 1957, SYNTACTIC STRUCTURES; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; Conti-Ramsden G, 2011, INT J LANG COMM DIS, V46, P243, DOI 10.3109/13682822.2010.487884; Croft William, 1991, SYNTACTIC CATEGORIES; de Bruin A, 2015, PSYCHOL SCI, V26, P99, DOI 10.1177/0956797614557866; Dunn M., 2007, PEABODY PICTURE VOCA; GIVON Talmy, 1995, FUNCTIONALISM GRAMMA; Goldberg Adele, 2006, CONSTRUCTIONS WORK N; Henry LA, 2012, J CHILD PSYCHIAT PSY, V50; Ibbotson P, 2012, COGNITIVE SCI, V36, P1; Ibbotson P, 2013, COGN LINGUIST, V24, P457, DOI 10.1515/cog-2013-0020; Langacker R. W., 1991, FDN COGNITIVE GRAMMA, V2; Langacker Ronald, 1987, FDN COGNITIVE GRAMMA, V1; Leon-Carrion J, 2004, INT J NEUROSCI, V114, P1291, DOI 10.1080/00207450490476066; Levinson S., 2009, BEHAV BRAIN SCI, V32; Marchman VA, 1997, COGNITIVE SCI, V21, P283; Marchman VA, 1999, J SPEECH LANG HEAR R, V42, P206, DOI 10.1044/jslhr.4201.206; Nappa R, 2009, LANG LEARN DEV, V5, P203, DOI 10.1080/15475440903167528; Pinker Steven., 1989, LEARNABILITY COGNITI; PLUNKETT K, 1993, COGNITION, V48, P21, DOI 10.1016/0010-0277(93)90057-3; Rice ML, 2004, J SPEECH LANG HEAR R, V47, P816, DOI 10.1044/1092-4388(2004/061); Taylor J.R., 2002, COGNITIVE GRAMMAR; Tomasello M., 2003, CONSTRUCTING LANGUAG; van Heuven WJB, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00374	29	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145030	10.1371/journal.pone.0145030	http://dx.doi.org/10.1371/journal.pone.0145030			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CY9GR	26659926	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000366715900172
J	Rawson, R; Anilkumar, A; Newbury, RO; Bafna, V; Aquino, M; Palmquist, J; Hoffman, HM; Mueller, JL; Dohil, R; Broide, DH; Aceves, SS				Rawson, Renee; Anilkumar, Arjun; Newbury, Robert O.; Bafna, Vineet; Aquino, Melissa; Palmquist, Jacob; Hoffman, Hal M.; Mueller, James L.; Dohil, Ranjan; Broide, David H.; Aceves, Seema S.			The TGF beta 1 Promoter SNP C-509T and Food Sensitization Promote Esophageal Remodeling in Pediatric Eosinophilic Esophagitis	PLOS ONE			English	Article							DISEASE SEVERITY; DIETARY THERAPY; CHILDREN; ASSOCIATION; EXPRESSION; VARIANTS; ALLERGY; RISK; GENE; IDENTIFICATION	Background Eosinophilic esophagitis (EoE) is a chronic antigen mediated disease associated with substantial esophageal remodeling and fibrosis. The functional TGF beta 1 promoter SNP C-509 associates with renal fibrosis and asthma. The effect of TGF beta 1 genotype and EoE severity or potential gene-environment interactions have not been previously reported in EoE. Methods Genotype at TGF beta 1 C-509T and remodeling was analyzed in 144 subjects with EoE. The severity of remodeling and inflammation was analyzed in the context of IgE sensitization to food antigens and C-509T genotype. Results The TGF beta 1 promoter C-509 genotypes CC, CT, and TT were 35%, 52%, and 13%, respectively. Sixty-six percent of subjects were sensitized to foods by positive skin prick test (SPT) or serum specific IgE. TT genotype subjects had significantly more TGF beta 1 (CC subjects = 1300 per mm(2); TT = 2250 per mm(2)) (p<0.05) and tryptase (CC subjects = 145 per mm(2): TT = 307 per mm(2)) (p<0.05) positive cells and higher epithelial remodeling scores (2.4 vs 3.7, p<0.001) than CC subjects. The differences in TGF beta 1 and tryptase positive cells as well as fibrosis were significantly increased when there was concurrent food sensitization. Food sensitization alone did not associate with any parameters of inflammation or remodeling. Conclusions Our data support a gene-environment interaction between food and genotype at C-509 that modulates disease severity in EoE. Since EoE subjects often continue to consume foods to which they are sensitized, these findings may have clinical relevance for disease management.	[Rawson, Renee; Anilkumar, Arjun; Aquino, Melissa; Palmquist, Jacob; Hoffman, Hal M.; Mueller, James L.; Broide, David H.; Aceves, Seema S.] Univ Calif San Diego, Div Allergy, Immunol, La Jolla, CA 92093 USA; [Rawson, Renee; Anilkumar, Arjun; Hoffman, Hal M.; Mueller, James L.; Aceves, Seema S.] Univ Calif San Diego, Ctr Infect Immun & Inflammat, La Jolla, CA 92093 USA; [Dohil, Ranjan] Univ Calif San Diego, Div Pediat Gastroenterol & Nutr, La Jolla, CA 92093 USA; [Rawson, Renee; Newbury, Robert O.; Aquino, Melissa; Palmquist, Jacob; Hoffman, Hal M.; Mueller, James L.; Dohil, Ranjan; Aceves, Seema S.] Rady Childrens Hosp, San Diego, CA USA; [Rawson, Renee; Newbury, Robert O.; Aquino, Melissa; Palmquist, Jacob; Hoffman, Hal M.; Mueller, James L.; Dohil, Ranjan; Aceves, Seema S.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Anilkumar, Arjun; Hoffman, Hal M.; Broide, David H.; Aceves, Seema S.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Newbury, Robert O.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Bafna, Vineet] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Aceves, SS (corresponding author), Univ Calif San Diego, Div Allergy, Immunol, La Jolla, CA 92093 USA.	saceves@ucsd.edu	Bafna, Vineet/AAY-8111-2020	Bafna, Vineet/0000-0002-5810-6241; Broide, David/0000-0001-8405-9090	DOD [FA100044]; NIH/NIAID [AI 092135, AI 107779, AI 70535, AI 72115]; ART/APFED HOPE Award; Hearst Foundation; CEGIR part of the Rare Diseases Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR), NCATS [U54 AI117804]; NIAID; NIDDK; NIH of CTSA [UL1TR000100, UL1TR001442]; NCATS; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000100, UL1TR001442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092135, U54AI117804, U19AI070535, R01AI107779, R01AI072115] Funding Source: NIH RePORTER	DOD(United States Department of Defense); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ART/APFED HOPE Award; Hearst Foundation; CEGIR part of the Rare Diseases Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR), NCATS; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH of CTSA; NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by DOD FA100044 (D.H.B, S.A.), NIH/NIAID AI 092135 (S.A), ART/APFED HOPE Award (S.A.), NIH/NIAID AI 107779 (D.H.B.), AI 70535 (D.H.B.), AI 72115 (D.H.B.), Hearst Foundation (R.D.), Dr. Aceves also has funding from CEGIR (U54 AI117804) part of the Rare Diseases Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR), NCATS, and is funded through collaboration between NIAID, NIDDK, and NCATS. The UCSD/RCHSD database is supported by the NIH grant UL1TR000100 of CTSA funding prior to August 13, 2015 and grant UL1TR001442 of CTSA funding beginning August 13, 2015 and beyond. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonia JP, 2013, J ALLERGY CLIN IMMUN, V132, P378, DOI 10.1016/j.jaci.2013.02.030; Aceves SS, 2010, ALLERGY, V65, P109, DOI 10.1111/j.1398-9995.2009.02142.x; Aceves SS, 2014, CLIN GASTROENTEROL H, V12, P1216, DOI 10.1016/j.cgh.2013.09.007; Aceves SS, 2009, ANN ALLERG ASTHMA IM, V103, P401, DOI 10.1016/S1081-1206(10)60359-6; Aceves SS, 2007, J ALLERGY CLIN IMMUN, V119, P206, DOI 10.1016/j.jaci.2006.10.016; Beppu L, 2014, J PEDIAT GASTROENTER; Beppu LY, 2014, J ALLERGY C IN PRESS; Caldwell JM, 2010, J ALLERGY CLIN IMMUN, V125, P879, DOI 10.1016/j.jaci.2010.01.038; Che Z, 2014, HUM IMMUNOL, V75, P141, DOI 10.1016/j.humimm.2013.11.008; Cho JY, 2014, J PEDIATR GASTR NUTR, V59, P10, DOI 10.1097/MPG.0000000000000343; Dellon ES, 2014, GASTROINTEST ENDOSC, V79, P577, DOI 10.1016/j.gie.2013.10.027; Dohil R, 2010, GASTROENTEROLOGY, V139, P418, DOI 10.1053/j.gastro.2010.05.001; Frischmeyer-Guerrerio PA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006448; Greenhawt Matthew, 2013, Gastroenterology, V144, P1560, DOI 10.1053/j.gastro.2013.04.034; Henderson CJ, 2012, J ALLERGY CLIN IMMUN, V129, P1570, DOI 10.1016/j.jaci.2012.03.023; Hill DJ, 2000, J PEDIATR-US, V137, P475, DOI 10.1067/mpd.2000.108207; Jyonouchi S, 2011, J ALLERGY CLIN IMMUN, V128, P102, DOI 10.1016/j.jaci.2011.02.026; Khalil MS, 2005, NEPHRON EXP NEPHROL, V101, pE31, DOI 10.1159/000086227; Korsapati H, 2009, GUT, V58, P1056, DOI 10.1136/gut.2008.168146; Kuchen T, 2014, ALLERGY, V69, P1248, DOI 10.1111/all.12455; Lexmond WS, 2014, AM J GASTROENTEROL, V109, P646, DOI 10.1038/ajg.2014.12; Liacouras Chris A, 2011, Gastroenterol Hepatol (N Y), V7, P264; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Lieberman JA, 2012, ALLERGY, V67, P1299, DOI 10.1111/j.1398-9995.2012.02881.x; Lin ZY, 2013, THER ADV GASTROENTER, V6, P97, DOI 10.1177/1756283X12470017; Lucendo AJ, 2011, J ALLERGY CLIN IMMUN, V128, P1037, DOI 10.1016/j.jaci.2011.08.007; Maloney JM, 2011, J ALLERGY CLIN IMMUN, V128, P214, DOI 10.1016/j.jaci.2011.04.024; Nicodeme F, 2013, CLIN GASTROENTEROL H, V11, P1101, DOI 10.1016/j.cgh.2013.03.020; Panek M, 2014, INT J MOL MED, V34, P975, DOI 10.3892/ijmm.2014.1894; Persad R, 2012, J PEDIATR GASTR NUTR, V55, P251, DOI 10.1097/MPG.0b013e31824b6391; Rodriguez-Sanchez J, 2014, ALLERGY, V69, P936, DOI 10.1111/all.12420; Rothenberg ME, 2010, NAT GENET, V42, P289, DOI 10.1038/ng.547; Salam MT, 2007, AM J RESP CRIT CARE, V176, P1192, DOI 10.1164/rccm.200704-561OC; Schoepfer AM, 2013, GASTROENTEROLOGY, V145, P1230, DOI 10.1053/j.gastro.2013.08.015; Sharma S, 2009, AM J RESP CRIT CARE, V179, P356, DOI 10.1164/rccm.200808-1268OC; Sherrill JD, 2010, J ALLERGY CLIN IMMUN, V126, P160, DOI 10.1016/j.jaci.2010.04.037; Silverman ES, 2004, AM J RESP CRIT CARE, V169, P214, DOI 10.1164/rccm.200307-973OC; Spergel JM, 2012, J ALLERGY CLIN IMMUN, V130, P461, DOI 10.1016/j.jaci.2012.05.021; Straumann A, 2011, CLIN GASTROENTEROL H, V9, P400, DOI 10.1016/j.cgh.2011.01.017; Tampe B, 2014, NEPHROL DIAL TRANSPL, V29, P72, DOI 10.1093/ndt/gft025; Vicario M, 2010, GUT, V59, P12, DOI 10.1136/gut.2009.178020; Wen T, 2014, J ALLERGY C IN PRESS; Yen EH, 2010, J PEDIATR GASTR NUTR, V51, P584, DOI 10.1097/MPG.0b013e3181de7685	43	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144651	10.1371/journal.pone.0144651	http://dx.doi.org/10.1371/journal.pone.0144651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656423	gold, Green Submitted, Green Published			2022-12-27	WOS:000366715900080
J	Taus, NS; Cunha, CW; Marquard, J; O'Toole, D; Li, H				Taus, Naomi S.; Cunha, Cristina W.; Marquard, Jana; O'Toole, Donal; Li, Hong			Cross-Reactivity of Neutralizing Antibodies among Malignant Catarrhal Fever Viruses	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; SHEEP NASAL SECRETIONS; OVINE HERPESVIRUS 2; ALCELAPHINE HERPESVIRUS-1; EXPERIMENTAL-INFECTION; EAST-AFRICA; RUMINANTS	Some members of the gamma herpesvirus genus Macavirus are maintained in nature as subclinical infections in well-adapted ungulate hosts. Transmission of these viruses to poorly adapted hosts, such as American bison and cattle, can result in the frequently fatal disease malignant catarrhal fever (MCF). Based on phylogenetic analysis, the MCF viruses (MCFV) cluster into two subgroups corresponding to the reservoir hosts' subfamilies: Alcelaphinae/Hippotraginae and Caprinae. Antibody cross-reactivity among MCFVs has been demonstrated using techniques such as enzyme linked immunosorbent and immunofluorescence assays. However, minimal information is available as to whether virus neutralizing antibodies generated against one MCFV cross react with other members of the genus. This study tested the neutralizing activity of serum and plasma from select MCFV-infected reservoir hosts against alcelaphine herpesvirus 1 (AlHV-1) and ovine herpesvirus 2 (OvHV-2). Neutralizing antibody activity against AlHV-1 was detected in samples from infected hosts in the Alcelaphinae and Hippotraginae subfamilies, but not from hosts in the Caprinae subfamily. OvHV-2 neutralizing activity was demonstrated in samples from goats (Caprinae) but not from wildebeest (Alcelaphinae). These results show that neutralizing antibody cross reactivity is present to MCFVs within a virus subgroup but not between subgroups. This information is important for diagnosing infection with MCFVs and in the development of vaccines against MCF.	[Taus, Naomi S.; Li, Hong] ARS, Anim Dis Res Unit, USDA, Pullman, WA 99164 USA; [Taus, Naomi S.; Cunha, Cristina W.; Marquard, Jana; Li, Hong] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [O'Toole, Donal] Univ Wyoming, Wyoming State Vet Lab, Laramie, WY 82071 USA	United States Department of Agriculture (USDA); Washington State University; University of Wyoming	Taus, NS (corresponding author), ARS, Anim Dis Res Unit, USDA, Pullman, WA 99164 USA.	tausns@vetmed.wsu.edu	Cunha, Cristina/AAC-6120-2021; Cunha, Cristina/V-7622-2019	Cunha, Cristina/0000-0002-8168-5448; 	United States Department of Agriculture, Agricultural Research Service [CWU 5348-32000-032-00D]	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded by the United States Department of Agriculture, Agricultural Research Service (CWU 5348-32000-032-00D). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cunha CW, 2015, VET MICROBIOL, V2, P209; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; Gailbreath KL, 2008, VET MICROBIOL, V132, P65, DOI 10.1016/j.vetmic.2008.04.035; Giangaspero M, 2013, J VET MED SCI, V75, P815, DOI 10.1292/jvms.12-0424; Hart J, 2007, J GEN VIROL, V88, P28, DOI 10.1099/vir.0.82284-0; Heuschele W. P., 1984, Proceedings of the United States Animal Health Association, V88, P640; Li H, 2006, J VET DIAGN INVEST, V18, P119, DOI 10.1177/104063870601800120; Li H, 2005, J GEN VIROL, V86, P3021, DOI 10.1099/vir.0.81238-0; Li H, 2004, J CLIN MICROBIOL, V42, P5558, DOI 10.1128/JCM.42.12.5558-5564.2004; LI H, 1995, J GEN VIROL, V76, P123, DOI 10.1099/0022-1317-76-1-123; LI H, 1994, J CLIN MICROBIOL, V32, P1674, DOI 10.1128/JCM.32.7.1674-1679.1994; Li H, 2001, J VET DIAGN INVEST, V13, P361, DOI 10.1177/104063870101300417; Li H, 2014, ANNU REV ANIM BIOSCI, V2, P209, DOI 10.1146/annurev-animal-022513-114156; Li H, 2013, J VIROL METHODS, V188, P104, DOI 10.1016/j.jviromet.2012.12.008; PLOWRIGHT W, 1967, RES VET SCI, V8, P129; REID HW, 1975, RES VET SCI, V18, P269, DOI 10.1016/S0034-5288(18)33577-X; ROSSITER PB, 1981, J COMP PATHOL, V91, P303, DOI 10.1016/0021-9975(81)90036-0; Russell GC, 2013, J GEN VIROL, V94, P2515, DOI 10.1099/vir.0.055673-0; Schultheiss PC, 2000, J VET DIAGN INVEST, V12, P497, DOI 10.1177/104063870001200602; SEAL BS, 1989, AM J VET RES, V50, P1447; Taus NS, 2005, J GEN VIROL, V86, P575, DOI 10.1099/vir.0.80707-0	21	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145073	10.1371/journal.pone.0145073	http://dx.doi.org/10.1371/journal.pone.0145073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658281	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900181
J	Narayan, O; Leung, MCH; Wong, DTL; Meredith, IT; Cameron, JD				Narayan, Om; Leung, Michael C. H.; Wong, Dennis T. L.; Meredith, Ian T.; Cameron, James D.			Percutaneous Coronary Intervention Enhances Accelerative Wave Intensity in Coronary Arteries	PLOS ONE			English	Article							FRACTIONAL FLOW RESERVE; LEFT-VENTRICULAR HYPERTROPHY; PRESSURE MEASUREMENT; PHYSIOLOGICAL-BASIS; HUMANS; STENOSIS; HYPEREMIA; ADENOSINE; DISEASE; INTRACORONARY	Background The systolic forward travelling compression wave (sFCW) and diastolic backward travelling decompression waves (dBEW) predominantly accelerate coronary blood flow. The effect of a coronary stenosis on the intensity of these waves in the distal vessel is unknown. We investigated the relationship between established physiological indices of hyperemic coronary flow and the intensity of the two major accelerative coronary waves identified by Coronary Wave Intensity analysis (CWIA). Methodology/Principal Findings Simultaneous intracoronary pressure and velocity measurement was performed during adenosine induced hyperemia in 17 patients with pressure/Doppler flow wires positioned distal to the target lesion. CWI profiles were generated from this data. Fractional Flow Reserve (FFR) and Coronary Flow Velocity Reserve (CFVR) were calculated concurrently. The intensity of the dBEW was significantly correlated with FFR (R = -0.70, P = 0.003) and CFVR (R = -0.73, P = 0.001). The intensity of the sFCW was also significantly correlated with baseline FFR (R = 0.71, p = 0.002) and CFVR (R = 0.59, P = 0.01). Stenting of the target lesion resulted in a median 178% (interquartile range 55-280%) (P<0.0001) increase in sFCW intensity and a median 117% (interquartile range 27-509%) (P = 0.001) increase in dBEW intensity. The increase in accelerative wave intensity following PCI was proportionate to the baseline FFR and CFVR, such that stenting of lesions associated with the greatest flow limitation (lowest FFR and CFVR) resulted in the largest increases in wave intensity. Conclusions Increasing ischemia severity is associated with proportionate reductions in cumulative intensity of both major accelerative coronary waves. Impaired diastolic microvascular decompression may represent a novel, important pathophysiologic mechanism driving the reduction in coronary blood flow in the setting of an epicardial stenosis.	[Narayan, Om] Monash Univ, Monash Cardiovasc Res Ctr, MonashHeart, Melbourne, Vic 3004, Australia; Monash Univ, Sch Clin Sci Monash Hlth, Melbourne, Vic 3004, Australia	Monash University; Monash University	Narayan, O (corresponding author), Monash Univ, Monash Cardiovasc Res Ctr, MonashHeart, Melbourne, Vic 3004, Australia.	om_narayan@hotmail.com	Cameron, james/GQP-4595-2022	Cameron, james/0000-0003-0589-0367	National Health and Medical Research Council Postgraduate Scholarship [1039186]; Monash Medical Centre Clinical Academic Fellowship (Australia)	National Health and Medical Research Council Postgraduate Scholarship(National Health and Medical Research Council (NHMRC) of Australia); Monash Medical Centre Clinical Academic Fellowship (Australia)	ON is the recipient of a National Health and Medical Research Council Postgraduate Scholarship (Grant number 1039186, http://www.nhmrc.gov.au/) and a Monash Medical Centre Clinical Academic Fellowship (Australia). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bishop AH, 2004, AM HEART J, V147, P792, DOI 10.1016/j.ahj.2003.12.009; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Davies JE, 2006, CIRCULATION, V113, P1768, DOI 10.1161/CIRCULATIONAHA.105.603050; Davies JE, 2006, AM J PHYSIOL-HEART C, V290, pH878, DOI 10.1152/ajpheart.00751.2005; Davies JE, 2011, CIRCULATION, V124, P1565, DOI 10.1161/CIRCULATIONAHA.110.011916; De Bruyne B, 2003, CIRCULATION, V107, P1877, DOI 10.1161/01.CIR.0000061950.24940.88; GOULD KL, 1990, CARDIOVASC INTER RAD, V13, P5, DOI 10.1007/BF02576930; GOULD KL, 1978, CIRC RES, V43, P242, DOI 10.1161/01.RES.43.2.242; GOULD KL, 1978, AM J CARDIOL, V41, P267, DOI 10.1016/0002-9149(78)90165-0; GOULD KL, 1974, AM J CARDIOL, V33, P87, DOI 10.1016/0002-9149(74)90743-7; HOUGHTON JL, 1990, J AM COLL CARDIOL, V15, P43, DOI 10.1016/0735-1097(90)90173-M; Johnson NP, 2012, JACC-CARDIOVASC IMAG, V5, P193, DOI 10.1016/j.jcmg.2011.09.020; KERN MJ, 1989, J AM COLL CARDIOL, V13, P1042, DOI 10.1016/0735-1097(89)90259-3; Kolyva C, 2008, AM J PHYSIOL-HEART C, V295, pH482, DOI 10.1152/ajpheart.00223.2008; Lim CCS, 2011, J AM COLL CARDIOL, V57, P653, DOI 10.1016/j.jacc.2010.07.058; Lopez-Palop R, 2004, HEART, V90, P95, DOI 10.1136/heart.90.1.95; Park DW, 2013, EUR HEART J, V34, P1662, DOI 10.1093/eurheartj/eht048; Parker KH, 2009, MED BIOL ENG COMPUT, V47, P175, DOI 10.1007/s11517-009-0439-y; Pijls NHJ, 2000, CIRCULATION, V102, P2371, DOI 10.1161/01.CIR.102.19.2371; PIJLS NHJ, 1995, CIRCULATION, V92, P3183, DOI 10.1161/01.CIR.92.11.3183; Pijls NHJ, 2000, CATHETER CARDIO INTE, V49, P1; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Rolandi MC, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0405-1; Siebes M, 2009, MED BIOL ENG COMPUT, V47, P233, DOI 10.1007/s11517-009-0448-x; Sun YH, 2000, J APPL PHYSIOL, V89, P1636, DOI 10.1152/jappl.2000.89.4.1636; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Tyberg JV, 2009, MED BIOL ENG COMPUT, V47, P221, DOI 10.1007/s11517-008-0430-z; van de Hoef TP, 2013, NAT REV CARDIOL, V10, P439, DOI 10.1038/nrcardio.2013.86; Vaz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073990; WEISS JL, 1976, J CLIN INVEST, V58, P751, DOI 10.1172/JCI108522; WILSON RF, 1990, CIRCULATION, V82, P1595, DOI 10.1161/01.CIR.82.5.1595	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0142998	10.1371/journal.pone.0142998	http://dx.doi.org/10.1371/journal.pone.0142998			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658896	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903600008
J	Osorio-Zambrano, WF; Davey, S				Osorio-Zambrano, William F.; Davey, Scott			Chk1 Activation Protects Rad9A from Degradation as Part of a Positive Feedback Loop during Checkpoint Signalling	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; SCF-BETA-TRCP; NUCLEAR-LOCALIZATION; IONIZING-RADIATION; MAMMALIAN-CELLS; SOMATIC WEE1; FACTOR-C; PHOSPHORYLATION; KINASE; CLASPIN	Phosphorylation of Rad9A at S387 is critical for establishing a physical interaction with TopBP1, and to downstream activation of Chk1 for checkpoint activation. We have previously demonstrated a phosphorylation of Rad9A that occurs at late time points in cells exposed to genotoxic agents, which is eliminated by either Rad9A overexpression, or conversion of S387 to a non-phosphorylatable analogue. Based on this, we hypothesized that this late Rad9A phosphorylation is part of a feedback loop regulating the checkpoint. Here, we show that Rad9A is hyperphosphorylated and accumulates in cells exposed to bleomycin. Following the removal of bleomycin, Rad9A is polyubiquitinated, and Rad9A protein levels drop, indicating an active degradation process for Rad9A. Chk1 inhibition by UCN-01 or siRNA reduces Rad9A levels in cells synchronized in S-phase or exposed to DNA damage, indicating that Chk1 activation is required for Rad9A stabilization in S-phase and during checkpoint activation. Together, these results demonstrate a positive feedback loop involving Rad9A-dependend activation of Chk1, coupled with Chk1-dependent stabilization of Rad9A that is critical for checkpoint regulation.	[Osorio-Zambrano, William F.; Davey, Scott] Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Kingston, ON K7L 3N6, Canada; [Osorio-Zambrano, William F.; Davey, Scott] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada; [Davey, Scott] Queens Univ, Dept Oncol, Kingston, ON K7L 3N6, Canada; [Davey, Scott] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Queens University - Canada; McMaster University; Queens University - Canada; Queens University - Canada; Queens University - Canada	Davey, S (corresponding author), Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Kingston, ON K7L 3N6, Canada.	scott.davey@queensu.ca		Osorio Zambrano, William Frend/0000-0001-7901-7654	Canadian Breast Cancer Foundation-Ontario Chapter	Canadian Breast Cancer Foundation-Ontario Chapter	This work was supported by operating funds from the Canadian Breast Cancer Foundation-Ontario Chapter (SD), and by infrastructure support through the Canada Foundation for Innovation Leaders Opportunity Fund, and the Ontario Research Fund (SD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldin V, 2002, J BIOL CHEM, V277, P35176, DOI 10.1074/jbc.M204430200; Bassermann F, 2013, BIOCH BIOPHYS ACTA; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Booher RN, 1997, J BIOL CHEM, V272, P22300, DOI 10.1074/jbc.272.35.22300; Broustas CG, 2012, J CELL BIOCHEM, V113, P742, DOI 10.1002/jcb.23424; Card DAG, 2010, J BIOL CHEM, V285, P15653, DOI 10.1074/jbc.M109.096156; Chen MJ, 2001, J BIOL CHEM, V276, P16580, DOI 10.1074/jbc.M008871200; Cheng CK, 2005, CANCER RES, V65, P8646, DOI 10.1158/0008-5472.CAN-04-4243; Chini C, 2006, ONCOGENE, V25, P4165, DOI 10.1038/sj.onc.1209447; Choudhury AD, 2004, J BIOL CHEM, V279, P33909, DOI 10.1074/jbc.M403646200; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Dang TY, 2005, GENES CELLS, V10, P287, DOI 10.1111/j.1365-2443.2005.00840.x; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Dore AS, 2009, MOL CELL, V34, P735, DOI 10.1016/j.molcel.2009.04.027; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Greer DA, 2003, CANCER RES, V63, P4829; Griffith JD, 2002, J BIOL CHEM, V277, P15233, DOI 10.1074/jbc.C200129200; Groth A, 2003, EMBO J, V22, P1676, DOI 10.1093/emboj/cdg151; Hirai I, 2002, J BIOL CHEM, V277, P25722, DOI 10.1074/jbc.M203079200; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Katsuno Y, 2009, P NATL ACAD SCI USA, V106, P3184, DOI 10.1073/pnas.0809350106; Kelly R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085859; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kubota S, 2014, J BIOL CHEM, V289, P5730, DOI 10.1074/jbc.M113.546655; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Latif C, 2004, J CELL SCI, V117, P3489, DOI 10.1242/jcs.01204; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lieberman HB, 2011, J MOL CELL BIOL, V3, P39, DOI 10.1093/jmcb/mjq039; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Liu QH, 2000, GENE DEV, V14, P1448; Liu S, 2006, MOL CELL BIOL, V26, P6056, DOI 10.1128/MCB.00492-06; Loegering D, 2004, J BIOL CHEM, V279, P18641, DOI 10.1074/jbc.M313536200; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nakanishi M, 2010, CHROMOSOME RES, V18, P103, DOI 10.1007/s10577-009-9086-2; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Niida H, 2007, MOL CELL BIOL, V27, P2572, DOI 10.1128/MCB.01611-06; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Parker AE, 1998, J BIOL CHEM, V273, P18340, DOI 10.1074/jbc.273.29.18340; Poon RYC, 1997, CANCER RES, V57, P5168; Rauen M, 2000, J BIOL CHEM, V275, P29767, DOI 10.1074/jbc.M005782200; Roos-Mattjus P, 2003, J BIOL CHEM, V278, P24428, DOI 10.1074/jbc.M301544200; Sato K, 2012, CURR BIOL, V22, P1659, DOI 10.1016/j.cub.2012.07.034; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; SEYNAEVE CM, 1994, MOL PHARMACOL, V45, P1207; Sierant ML, 2010, CELL CYCLE, V9, P548, DOI 10.4161/cc.9.3.10553; Smits VAJ, 2006, CURR BIOL, V16, P150, DOI 10.1016/j.cub.2005.11.066; Sohn SY, 2009, J MOL BIOL, V390, P490, DOI 10.1016/j.jmb.2009.05.028; Sorensen CS, 2004, CELL CYCLE, V3, P941; St Onge RP, 2003, J BIOL CHEM, V278, P26620, DOI 10.1074/jbc.M303134200; St Onge RP, 2001, J BIOL CHEM, V276, P41898, DOI 10.1074/jbc.M105152200; St Onge RP, 1999, MOL BIOL CELL, V10, P1985; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Takeishi Y, 2010, GENES CELLS, V15, P761, DOI 10.1111/j.1365-2443.2010.01418.x; Uto K, 2004, EMBO J, V23, P3386, DOI 10.1038/sj.emboj.7600328; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Volkmer E, 1999, J BIOL CHEM, V274, P567, DOI 10.1074/jbc.274.2.567; Wang JN, 2012, J BIOL CHEM, V287, P25501, DOI 10.1074/jbc.M112.350397; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; Wilsker D, 2008, P NATL ACAD SCI USA, V105, P20752, DOI 10.1073/pnas.0806917106; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Yoshida K, 2003, EMBO J, V22, P1431, DOI 10.1093/emboj/cdg134; Yoshida K, 2002, MOL CELL BIOL, V22, P3292, DOI 10.1128/MCB.22.10.3292-3300.2002; Zhao B, 2002, J BIOL CHEM, V277, P46609, DOI 10.1074/jbc.M201233200; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou Zhanru, 2013, ScientificWorldJournal, V2013, P458797, DOI 10.1155/2013/458797; Zhu A, 2008, CANCER RES, V68, P1267, DOI 10.1158/0008-5472.CAN-07-2304	75	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144434	10.1371/journal.pone.0144434	http://dx.doi.org/10.1371/journal.pone.0144434			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658951	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903600045
J	Shirkhorshidi, AS; Aghabozorgi, S; Teh Ying Wah				Shirkhorshidi, Ali Seyed; Aghabozorgi, Saeed; Teh Ying Wah			A Comparison Study on Similarity and Dissimilarity Measures in Clustering Continuous Data	PLOS ONE			English	Article							GENE-EXPRESSION DATA; SERIES	Similarity or distance measures are core components used by distance-based clustering algorithms to cluster similar data points into the same clusters, while dissimilar or distant data points are placed into different clusters. The performance of similarity measures is mostly addressed in two or three-dimensional spaces, beyond which, to the best of our knowledge, there is no empirical study that has revealed the behavior of similarity measures when dealing with high-dimensional datasets. To fill this gap, a technical framework is proposed in this study to analyze, compare and benchmark the influence of different similarity measures on the results of distance-based clustering algorithms. For reproducibility purposes, fifteen publicly available datasets were used for this study, and consequently, future distance measures can be evaluated and compared with the results of the measures discussed in this work. These datasets were classified as low and high-dimensional categories to study the performance of each measure against each category. This research should help the research community to identify suitable distance measures for datasets and also to facilitate a comparison and evaluation of the newly proposed similarity or distance measures with traditional ones.	[Shirkhorshidi, Ali Seyed; Teh Ying Wah] Univ Malaya, Fac Comp Sci & Informat Technol, Dept Informat Syst, Kuala Lumpur 50603, Malaysia; [Aghabozorgi, Saeed] IBM Canada Ltd, Emerging Technol, IBM Analyt, Platform, Markham, ON L6F 1C7, Canada	Universiti Malaya; International Business Machines (IBM)	Shirkhorshidi, AS (corresponding author), Univ Malaya, Fac Comp Sci & Informat Technol, Dept Informat Syst, Kuala Lumpur 50603, Malaysia.	shirkhorshidi_ali@yahoo.co.uk	Shirkhorshidi, Ali Seyed/A-1255-2016; TEH, YING WAH/B-9938-2010; Teh, Ying Wah/ABD-6534-2020	Shirkhorshidi, Ali Seyed/0000-0002-2063-8664; TEH, YING WAH/0000-0002-3202-7035; Teh, Ying Wah/0000-0002-3202-7035	University of Malaya [RP028C-14AET]; IBM Canada Ltd	University of Malaya(Universiti Malaya); IBM Canada Ltd(International Business Machines (IBM))	This work is supported by University of Malaya Research Grant no vote RP028C-14AET. IBM Canada Ltd funder provided support in the form of salaries for author [SA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aghabozorgi S, 2015, INFORM SYST, V53, P16, DOI 10.1016/j.is.2015.04.007; Al Khalifa A, 2009, J CHEM INF MODEL, V49, P1193, DOI 10.1021/ci8004644; An Lingling, 2012, ISRN Bioinform, V2012, P537217, DOI 10.5402/2012/537217; [Anonymous], SPEECH IM PROC UN; Bache Kevin, 2013, UCI MACHINE LEARNING; BEZDEK JC, 1984, COMPUT GEOSCI, V10, P191, DOI 10.1016/0098-3004(84)90020-7; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Boriah S., 2008, P 8 SIAM INT C DAT M, P243, DOI 10.1137/1.9781611972788.22; Cha S, 2007, CITY, V1, DOI DOI 10.1007/S00167-009-0884-Z; Cui WC, 2013, INT J BIOMED IMAGING, V2013, DOI 10.1155/2013/930301; Cumming G, 2013, UNDERSTANDING NEW ST; de Souto MCP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-497; Deshpande R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068664; Dunham M.H., 2003, DATA MINING INTRO AD; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Fu LM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-3; Gan G, 2007, ASA SIAM SER STAT AP, V20, P1, DOI 10.1137/1.9780898718348; Gionis A, 2005, ACM T KNOWL DISCOV D, V1, DOI [10.1109/ICDE.2005.34, DOI 10.1109/ICDE.2005.34]; Han J., 2006, DATA MINING CONCEPTS, DOI 10.1016/C2009-0-61819-5; Hand D., 2001, DRUG SAFETY; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Iglesias F, 2013, ENERGIES, V6, P579, DOI 10.3390/en6020579; Ignaccolo R, 2013, ENVIRON ECOL STAT, V20, P109, DOI 10.1007/s10651-012-0210-7; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Janos Abonyi BF, 2007, CLUSTER ANAL DATA MI; Ji M, 2013, ABSTR APPL ANAL, DOI 10.1155/2013/183410; Jiang DX, 2004, IEEE T KNOWL DATA EN, V16, P1370, DOI 10.1109/TKDE.2004.68; Carbajal-Hernandez JJ, 2012, ATMOS ENVIRON, V60, P37, DOI 10.1016/j.atmosenv.2012.06.004; Lourenco F, 2004, BINARY BASED SIMILAR, P1; Mao JC, 1996, IEEE T NEURAL NETWOR, V7, P16, DOI 10.1109/72.478389; Meyer FG, 2005, MED IMAGE ANAL, V9, P51, DOI 10.1016/j.media.2004.07.002; Mohebi A, 2016, SOFTWARE PRACT EXPER, V46, P107, DOI 10.1002/spe.2341; Moolgavkar SH, 2013, ENVIRON HEALTH PERSP, V121, P73, DOI 10.1289/ehp.1104507; Mooney R., 2000, WORKSH ART INT WEB S, P58; Perlibakas V, 2004, PATTERN RECOGN LETT, V25, P711, DOI 10.1016/j.patrec.2004.01.011; Peters G, 2006, PATTERN RECOGN, V39, P1481, DOI 10.1016/j.patcog.2006.02.002; Santos JM, 2009, LECT NOTES COMPUT SC, V5769, P175, DOI 10.1007/978-3-642-04277-5_18; SCHLOTZHAUER S. D, 2007, ELEMENTARY STAT USIN; Shen W., 2013, P 4 INT C FUT EN SYS, P51, DOI [10.1145/2487166.2487173, DOI 10.1145/2487166.2487173]; Shirkhorshidi AS, 2014, LECT NOTES COMPUT SC, V8583, P707, DOI 10.1007/978-3-319-09156-3_49; Van Wijk J. J., 1999, Proceedings 1999 IEEE Symposium on Information Visualization (InfoVis'99), P4, DOI 10.1109/INFVIS.1999.801851; Veenman CJ, 2002, IEEE T PATTERN ANAL, V24, P1273, DOI 10.1109/TPAMI.2002.1033218; Wang H., 2002, P 2002 ACM SIGMOD IN, P394, DOI DOI 10.1145/564691.564737; Wilson DR, 1997, J ARTIF INTELL RES, V6, P1, DOI 10.1613/jair.346; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141; Ye J, 2011, J NEUROSCI METH, V199, P336, DOI 10.1016/j.jneumeth.2011.05.016; ZAHN CT, 1971, IEEE T COMPUT, VC 20, P68, DOI 10.1109/T-C.1971.223083; Zhang Z, 2006, INT C PATT RECOG, P1135	49	174	179	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144059	10.1371/journal.pone.0144059	http://dx.doi.org/10.1371/journal.pone.0144059			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658987	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903600019
J	Zeng, FF; Zhao, ZF; Yan, MJ; Zhou, W; Zhang, Z; Zhang, AJ; Lu, ZX; Wang, MQ				Zeng, Fang-Fang; Zhao, Zhen-Fei; Yan, Miao-Jun; Zhou, Wen; Zhang, Zan; Zhang, Aijun; Lu, Zhong-Xian; Wang, Man-Qun			Identification and Comparative Expression Profiles of Chemoreception Genes Revealed from Major Chemoreception Organs of the Rice Leaf Folder, Cnaphalocrocis medinalis (Lepidoptera: Pyralidae)	PLOS ONE			English	Article							ODORANT-BINDING PROTEINS; IONOTROPIC GLUTAMATE RECEPTORS; SEX-PHEROMONE RECEPTOR; CHEMOSENSORY PROTEINS; FUNCTIONAL-CHARACTERIZATION; SPODOPTERA-EXIGUA; ANOPHELES-GAMBIAE; APIS-MELLIFERA; BEET ARMYWORM; AEDES-AEGYPTI	To better understand the olfactory mechanisms in the rice leaf folder, Cnaphalocrocis medinalis (Guene), a serious pest of rice in Asia, we established six partial transcriptomes from antennae, protarsus, and reproductive organs of male and female adults. A total of 102 transcripts were identified, including 29 odorant receptors (ORs), 15 ionotropic receptors (IRs), 30 odorant-binding proteins (OBPs), 26 chemosensory proteins (CSPs), and 2 sensory neuron membrane proteins (SNMPs). The expression patterns of these genes were calculated by fragments per kilobase of exon per million fragments mapped (FPKM) and validated by real-time quantitative PCR (RT-qPCR). Some transcripts were exclusively expressed in specific organs, such as female protarsus, whereas others were universally expressed, this varied expression profile may provide insights into the specific functions mediated by chemoreception proteins in insects. To the best of our knowledge, among the 102 identified transcripts, 81 are novel and have never been reported before. In addition, it also is the first time that ORs and IRs are identified in C. medinalis. Our findings significantly enhance the currently limited understanding olfactory mechanisms of the olfactory mechanisms underlying the chemoreception system in C. medinalis.	[Zeng, Fang-Fang; Zhao, Zhen-Fei; Yan, Miao-Jun; Zhou, Wen; Zhang, Zan; Wang, Man-Qun] Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan 430070, Peoples R China; [Zhang, Aijun] ARS, Invas Insect Biocontrol & Behav Lab, BARC West, USDA, Beltsville, MD 20705 USA; [Lu, Zhong-Xian] Zhejiang Acad Agr Sci, Inst Plant Protect & Microbiol, Hangzhou 310021, Zhejiang, Peoples R China	Huazhong Agricultural University; United States Department of Agriculture (USDA); Zhejiang Academy of Agricultural Sciences	Wang, MQ (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan 430070, Peoples R China.	mqwang@mail.hzau.edu.cn	Wang, Man-Qun/AAO-3802-2020		National High Technology Research and Development Program of China (863 Program) [2014AA10A605]; China Agriculture Research System [CARS-01-17]; Fundamental Research Funds for the Central Universities [2013PY046]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); China Agriculture Research System; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported and funded by the National High Technology Research and Development Program of China (863 Program) (No. 2014AA10A605), the China Agriculture Research System (Grant No. CARS-01-17) and the Fundamental Research Funds for the Central Universities (2013PY046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ai MR, 2013, J NEUROSCI, V33, P10741, DOI 10.1523/JNEUROSCI.5419-12.2013; Atteson K, 1999, ALGORITHMICA, V25, P251, DOI 10.1007/PL00008277; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, SCIENCE, V326, P382, DOI 10.1126/science.1181998; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Berg BG, 2002, J COMP NEUROL, V446, P123, DOI 10.1002/cne.10180; Briand L, 2002, EUR J BIOCHEM, V269, P4586, DOI 10.1046/j.1432-1033.2002.03156.x; Calvello M, 2005, INSECT BIOCHEM MOLEC, V35, P297, DOI 10.1016/j.ibmb.2005.01.002; Cao DP, 2014, INT J BIOL SCI, V10, P846, DOI 10.7150/ijbs.9297; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corcoran JA, 2015, EPIPHYAS POSTVITTANA; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Forstner Maike, 2006, Invertebrate Neuroscience, V6, P177, DOI 10.1007/s10158-006-0032-0; Gong DP, 2007, INSECT BIOCHEM MOLEC, V37, P266, DOI 10.1016/j.ibmb.2006.11.012; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Gong L, 2012, B ENTOMOL RES, V102, P600, DOI 10.1017/S0007485312000168; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Jacquin-Joly E, 2004, J CHEM ECOL, V30, P2359, DOI 10.1007/s10886-004-7941-3; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jacquin-Joly E, 2012, INT J BIOL SCI, V8, P1036, DOI 10.7150/ijbs.4469; KHAN ZR, 1988, INSECT SCI APPL, V9, P129, DOI 10.1017/S1742758400005919; Kitabayashi AN, 1998, INSECT BIOCHEM MOLEC, V28, P785, DOI 10.1016/S0965-1748(98)00058-7; Korsching S, 2002, CURR OPIN NEUROBIOL, V12, P387, DOI 10.1016/S0959-4388(02)00348-3; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu CC, 2013, INSECT BIOCHEM MOLEC, V43, P747, DOI 10.1016/j.ibmb.2013.05.009; Liu S, 2013, ARCH INSECT BIOCHEM, V82, P29, DOI 10.1002/arch.21069; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matthews R.W., 2009, INSECT BEHAV; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Montagne N, 2012, EUR J NEUROSCI, V36, P2588, DOI 10.1111/j.1460-9568.2012.08183.x; Morita A.H.A.S., 1985, COMPREHENSIVE INSECT, P133; Nichols Z, 2008, INSECT BIOCHEM MOLEC, V38, P398, DOI 10.1016/j.ibmb.2007.11.003; Olivier V, 2011, INSECT MOL BIOL, V20, P189, DOI 10.1111/j.1365-2583.2010.01057.x; Padmavathi C, 2013, J APPL ENTOMOL, V137, P249, DOI 10.1111/j.1439-0418.2012.01741.x; Pelletier J, 2011, J INSECT PHYSIOL, V57, P915, DOI 10.1016/j.jinsphys.2011.04.003; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Rogers ME, 1997, J BIOL CHEM, V272, P14792, DOI 10.1074/jbc.272.23.14792; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sato K., 2009, RESULTS PROBL CELL D, P203; Siciliano P, 2014, SNIFFING OUT CHEMOSE; Sun M, 2013, PLUTELLA XYLLOSTELLA; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vogt RG, 1981, PHEROMONE BINDING IN; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Wanner KW, 2008, INSECT MOL BIOL, V17, P621, DOI 10.1111/j.1365-2583.2008.00836.x; Xiu WM, 2007, J CHEM ECOL, V33, P947, DOI 10.1007/s10886-007-9277-2; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Zeng FF, 2013, BIOCHEM BIOPH RES CO, V433, P463, DOI 10.1016/j.bbrc.2013.03.038; Zhang DD, 2010, J INSECT PHYSIOL, V56, P586, DOI 10.1016/j.jinsphys.2009.12.002; Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117054; Zhang Y., 2013, J NANOMATER, V2013, P7, DOI DOI 10.1371/J0URNAL.P0NE.0069715; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x	63	21	23	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144267	10.1371/journal.pone.0144267	http://dx.doi.org/10.1371/journal.pone.0144267			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657286	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903600033
J	Kuster, K; Cousin, ME; Jemmi, T; Schupbach-Regula, G; Magouras, I				Kuster, Karin; Cousin, Marie-Eve; Jemmi, Thomas; Schuepbach-Regula, Gertraud; Magouras, Ioannis			Expert Opinion on the Perceived Effectiveness and Importance of On-Farm Biosecurity Measures for Cattle and Swine Farms in Switzerland	PLOS ONE			English	Article							EQUINE INFLUENZA OUTBREAK; WILD BOAR; PIG HERDS; INFECTIOUS-DISEASES; RISK-FACTORS; PERCEPTIONS; AUSTRALIA; SPREAD; BIOCONTAINMENT; VETERINARIANS	Biosecurity is crucial for safeguarding livestock from infectious diseases. Despite the plethora of biosecurity recommendations, published scientific evidence on the effectiveness of individual biosecurity measures is limited. The objective of this study was to assess the perception of Swiss experts about the effectiveness and importance of individual on-farm biosecurity measures for cattle and swine farms (31 and 30 measures, respectively). Using a modified Delphi method, 16 Swiss livestock disease specialists (8 for each species) were interviewed. The experts were asked to rank biosecurity measures that were written on cards, by allocating a score from 0 (lowest) to 5 (highest). Experts ranked biosecurity measures based on their importance related to Swiss legislation, feasibility, as well as the effort required for implementation and the benefit of each biosecurity measure. The experts also ranked biosecurity measures based on their effectiveness in preventing an infectious agent from entering and spreading on a farm, solely based on transmission characteristics of specific pathogens. The pathogens considered by cattle experts were those causing Bluetongue (BT), Bovine Viral Diarrhea (BVD), Foot and Mouth Disease (FMD) and Infectious Bovine Rhinotracheitis (IBR). Swine experts expressed their opinion on the pathogens causing African Swine Fever (ASF), Enzootic Pneumonia (EP), Porcine Reproductive and Respiratory Syndrome (PRRS), as well as FMD. For cattle farms, biosecurity measures that improve disease awareness of farmers were ranked as both most important and most effective. For swine farms, the most important and effective measures identified were those related to animal movements. Among all single measures evaluated, education of farmers was perceived by the experts to be the most important and effective for protecting both Swiss cattle and swine farms from disease. The findings of this study provide an important basis for recommendation to farmers and policy makers.	[Kuster, Karin; Schuepbach-Regula, Gertraud; Magouras, Ioannis] Univ Bern, Vet Publ Hlth Inst, Vetsuisse Fac, CH-3097 Liebefeld, Switzerland; [Cousin, Marie-Eve] Swiss Fed Inst Technol, Consumer Behav, Inst Environm Decis IED, CH-8092 Zurich, Switzerland; [Jemmi, Thomas] Fed Food Safety & Vet Off FSVO, CH-3003 Bern, Switzerland	University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich	Magouras, I (corresponding author), Univ Bern, Vet Publ Hlth Inst, Vetsuisse Fac, Schwarzenburgstr 155, CH-3097 Liebefeld, Switzerland.	ioannis.magouras@vetsuisse.unibe.ch	Schüpbach-Regula, Gertraud/S-1971-2017	Schüpbach-Regula, Gertraud/0000-0002-2310-7105; Magouras, Ioannis/0000-0002-9282-8512	Federal Food Safety and Veterinary Office (FSVO) [1.11.19]; Veterinary Public Health Institute, University of Bern	Federal Food Safety and Veterinary Office (FSVO); Veterinary Public Health Institute, University of Bern	The project was funded by the Federal Food Safety and Veterinary Office (FSVO), grant No 1.11.19 (http://www.blv.admin.ch/index.html?lang=en). The funding was received by Prof. Gertraud Schupbach, director of the Veterinary Public Health Institute, University of Bern. The co-author T. Jemmi who is employed by the FSVO assisted in the planning and design of the study but had no infuence in any step of data collection, analysis and interpretation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funded by the Federal Food Safety and Veterinary Office (FSVO). We would like to thank each of the participating experts for their contribution to this project.	Braun U, 2013, SCHWEIZ ARCH TIERH, V155, P123, DOI 10.1024/0036-7281/a000428; Brennan ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028139; Bundesamt fur Statistik, 2012, SCHW LANDW TASCH; Burgman MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022998; Casal J, 2007, PREV VET MED, V82, P138, DOI 10.1016/j.prevetmed.2007.05.012; Cross P, 2009, VET REC, V165, P397, DOI 10.1136/vr.165.14.397; Ellis-Iversen J, 2010, PREV VET MED, V93, P276, DOI 10.1016/j.prevetmed.2009.11.005; European Commission, 2007, NEW AN HLTH STRAT EU; Fasina FO, 2012, PREV VET MED, V103, P178, DOI 10.1016/j.prevetmed.2011.09.016; Fellstrom C., 2012, INFECT ECOL EPIDEMIO, V2, P17093, DOI [DOI 10.3402/IEE.V2I0.17093, 10.3402/iee.v2i0.17093]; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; Firestone SM, 2013, PREV VET MED, V110, P28, DOI 10.1016/j.prevetmed.2013.02.003; Firestone SM, 2011, PREV VET MED, V100, P53, DOI 10.1016/j.prevetmed.2011.03.002; Gelaude P, 2014, POULTRY SCI, V93, P2740, DOI 10.3382/ps.2014-04002; Graham JP, 2008, PUBLIC HEALTH REP, V123, P282, DOI 10.1177/003335490812300309; Gunn GJ, 2008, PREV VET MED, V84, P310, DOI 10.1016/j.prevetmed.2007.12.003; Gustafson LL, 2013, PREV VET MED, V109, P1, DOI 10.1016/j.prevetmed.2012.11.019; Hintze J, 2012, NCSS 8; Hoe FGH, 2006, J DAIRY SCI, V89, P2297, DOI 10.3168/jds.S0022-0302(06)72301-3; Horst HS, 1996, PREV VET MED, V27, P183, DOI 10.1016/0167-5877(95)01003-3; Hsu CC, 2007, PARE, V12, P1; Kuhnert P, 2014, VET MICROBIOL, V174, P261, DOI 10.1016/j.vetmic.2014.08.022; Laanen M, 2013, VET J, V198, P508, DOI 10.1016/j.tvjl.2013.08.029; Lindberg A, 2005, PREV VET MED, V72, P55, DOI 10.1016/j.prevetmed.2005.07.018; Linstone H. A., 1975, DELPHI METHOD TECHNI; Mangen MJJ, 2002, PREV VET MED, V56, P141, DOI 10.1016/S0167-5877(02)00155-1; Maunsell F, 2008, VET CLIN N AM-FOOD A, V24, P155, DOI 10.1016/j.cvfa.2007.10.007; Moore DA, 2008, JAVMA-J AM VET MED A, V233, P249, DOI 10.2460/javma.233.2.249; Morgan M. G., 2001, RISK COMMUNICATION M; Mur L, 2012, TRANSBOUND EMERG DIS, V59, P526, DOI 10.1111/j.1865-1682.2012.01308.x; Nampanya S, 2012, TRANSBOUND EMERG DIS, V59, P117, DOI 10.1111/j.1865-1682.2011.01247.x; Nathues C, 2016, TRANSBOUND EMERG DIS, V63, pE251, DOI 10.1111/tbed.12262; Noremark M, 2010, TRANSBOUND EMERG DIS, V57, P225, DOI 10.1111/j.1865-1682.2010.01140.x; Noremark M, 2014, ACTA VET SCAND, V56, DOI 10.1186/1751-0147-56-28; Noremark M, 2009, PREV VET MED, V90, P1, DOI 10.1016/j.prevetmed.2009.03.008; Oidtmann BC, 2011, PREV VET MED, V102, P329, DOI 10.1016/j.prevetmed.2011.07.016; Pinto CJ, 2003, PREV VET MED, V59, P139, DOI 10.1016/S0167-5877(03)00074-6; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Presi P, 2011, PREV VET MED, V99, P112, DOI 10.1016/j.prevetmed.2011.01.012; Pritchard G, 2005, IN PRACTICE, V27, P230; Ribbens S, 2008, PREV VET MED, V83, P228, DOI 10.1016/j.prevetmed.2007.07.009; Sarrazin S, 2014, PREV VET MED, V117, P129, DOI 10.1016/j.prevetmed.2014.07.014; Sawford K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-182; Sayers RG, 2013, VET J, V197, P259, DOI 10.1016/j.tvjl.2012.11.017; Schemann K, 2012, PREV VET MED, V106, P97, DOI 10.1016/j.prevetmed.2012.01.013; Schemann K, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-152; Schembri N, 2015, PREV VET MED, V118, P104, DOI 10.1016/j.prevetmed.2014.11.008; Schley D, 2009, J R SOC INTERFACE, V6, P455, DOI 10.1098/rsif.2008.0306; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Siegwart N, 2006, VET J, V172, P386, DOI 10.1016/j.tvjl.2005.07.018; Simon-Grife M, 2013, PREV VET MED, V110, P223, DOI 10.1016/j.prevetmed.2012.11.028; Thrusfield M, 1997, VET EPIDEMIOLOGY, V2nd, P182; Toma L, 2013, PREV VET MED, V108, P321, DOI 10.1016/j.prevetmed.2012.11.009; Van Steenwinkel S, 2011, PREV VET MED, V98, P259, DOI 10.1016/j.prevetmed.2010.12.004; Villarroel A, 2007, JAVMA-J AM VET MED A, V230, P808, DOI 10.2460/javma.230.6.808; WAHID (World Animal Health Information Database), 2015, WORLD AN HLTH INF DA; Wells SJ, 2000, J DAIRY SCI, V83, P2380, DOI 10.3168/jds.S0022-0302(00)75127-7; Willgert KJE, 2011, GEOSPATIAL HEALTH, V5, P227, DOI 10.4081/gh.2011.175; Wu N, 2011, J WILDLIFE DIS, V47, P868, DOI 10.7589/0090-3558-47.4.868	59	33	33	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144533	10.1371/journal.pone.0144533	http://dx.doi.org/10.1371/journal.pone.0144533			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26656893	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903500036
J	Provazzi, PJS; Mukherjee, S; Hanson, AM; Nogueira, ML; Carneiro, BM; Frick, DN; Rahal, P				Provazzi, Paola J. S.; Mukherjee, Sourav; Hanson, Alicia M.; Nogueira, Mauricio L.; Carneiro, Bruno M.; Frick, David N.; Rahal, Paula			Analysis of the Enzymatic Activity of an NS3 Helicase Genotype 3a Variant Sequence Obtained from a Relapse Patient	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; NONSTRUCTURAL PROTEIN 5A; RNA HELICASE; IN-VIVO; MUTATIONAL ANALYSIS; SERINE PROTEINASE; CRYSTAL-STRUCTURE; CDNA-CLONE; SUBGENOMIC REPLICON; MOLECULAR-CLONING	The hepatitis C virus (HCV) is a species of diverse genotypes that infect over 170 million people worldwide, causing chronic inflammation, cirrhosis and hepatocellular carcinoma. HCV genotype 3a is common in Brazil, and it is associated with a relatively poor response to current direct-acting antiviral therapies. The HCV NS3 protein cleaves part of the HCV polyprotein, and cellular antiviral proteins. It is therefore the target of several HCV drugs. In addition to its protease activity, NS3 is also an RNA helicase. Previously, HCV present in a relapse patient was found to harbor a mutation known to be lethal to HCV genotype 1b. The point mutation encodes the amino acid substitution W501R in the helicase RNA binding site. To examine how the W501R substitution affects NS3 helicase activity in a genotype 3a background, wild type and W501R genotype 3a NS3 alleles were sub-cloned, expressed in E. coli, and the recombinant proteins were purified and characterized. The impact of the W501R allele on genotype 2a and 3a subgenomic replicons was also analyzed. Assays monitoring helicase-catalyzed DNA and RNA unwinding revealed that the catalytic efficiency of wild type genotype 3a NS3 helicase was more than 600 times greater than the W501R protein. Other assays revealed that the W501R protein bound DNA less than 2 times weaker than wild type, and both proteins hydrolyzed ATP at similar rates. In Huh7.5 cells, both genotype 2a and 3a subgenomic HCV replicons harboring the W501R allele showed a severe defect in replication. Since the W501R allele is carried as a minor variant, its replication would therefore need to be attributed to the trans-complementation by other wild type quasispecies.	[Provazzi, Paola J. S.; Carneiro, Bruno M.; Rahal, Paula] Sao Paulo State Univ UNESP, Dept Biol, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil; [Mukherjee, Sourav; Hanson, Alicia M.; Frick, David N.] Univ Wisconsin, Dept Chem & Biochem, Milwaukee, WI 53217 USA; [Nogueira, Mauricio L.] Sao Jose do Rio Preto Med Sch, Virol Lab, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil	Universidade Estadual Paulista; University of Wisconsin System; University of Wisconsin Milwaukee	Provazzi, PJS (corresponding author), Sao Paulo State Univ UNESP, Dept Biol, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.	paolaprovazzi@gmail.com	Carneiro, Bruno/J-5870-2013; Nogueira, Mauricio L/B-7599-2012; Provazzi, Paola Jocelan Scarin/A-1864-2016; Carneiro, Bruno/P-2415-2019; Rahal, Paula/D-3871-2012	Nogueira, Mauricio L/0000-0003-1102-2419; Rahal, Paula/0000-0001-5693-6148; Frick, David/0000-0002-2434-7223; Carneiro, Bruno/0000-0002-2355-7907	State of Sao Paulo [FAPESP - 2009/02887-7, 2009/14256-1]; National Council for Scientific and Technological Development [CNPq - 151316/2013-9]; National Institutes of Health Grants [R01 AI088001]; UWM Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088001] Funding Source: NIH RePORTER	State of Sao Paulo; National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UWM Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Foundation for Research Support of the State of Sao Paulo (FAPESP - 2009/02887-7; 2009/14256-1), The National Council for Scientific and Technological Development (CNPq - 151316/2013-9), National Institutes of Health Grants R01 AI088001 and a Research Growth Initiative Award from the UWM Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amako Y, 2009, J VIROL, V83, P9237, DOI 10.1128/JVI.00958-09; [Anonymous], 2013, SOV PACK INS; Appel N, 2005, J VIROL, V79, P896, DOI 10.1128/JVI.79.2.896-909.2005; Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; Appleby TC, 2011, J MOL BIOL, V405, P1139, DOI 10.1016/j.jmb.2010.11.034; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Asselah T, 2011, LIVER INT, V31, P68, DOI 10.1111/j.1478-3231.2010.02411.x; Barritt AS, 2012, GASTROENTEROLOGY, V142, P1314, DOI 10.1053/j.gastro.2012.02.013; BARTENSCHLAGER R, 1995, J VIROL, V69, P198, DOI 10.1128/JVI.69.1.198-205.1995; BARTENSCHLAGER R, 1995, J VIROL, V69, P7519, DOI 10.1128/JVI.69.12.7519-7528.1995; BARTENSCHLAGER R, 1994, J VIROL, V68, P5045, DOI 10.1128/JVI.68.8.5045-5055.1994; Belon CA, 2008, BIOTECHNIQUES, V45, P433, DOI 10.2144/000112834; Bittar C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062393; Bittar C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-36; BUKH J, 1995, SEMIN LIVER DIS, V15, P41, DOI 10.1055/s-2007-1007262; Cha Agnes, 2014, P T, V39, P345; Chao L, 1999, J VIROL, V73, P8798, DOI 10.1128/JVI.73.10.8798-8807.1999; Cho YG, 1998, J VIROL METHODS, V72, P109, DOI 10.1016/S0166-0934(98)00010-X; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Domingo E., 1996, VIRAL HEPAT REV, V2, P15; Eigen M, 1996, TRENDS MICROBIOL, V4, P216, DOI 10.1016/0966-842X(96)20011-3; Farci P, 2011, SEMIN LIVER DIS, V31, P356, DOI 10.1055/s-0031-1297925; Forns X, 1997, P NATL ACAD SCI USA, V94, P13909, DOI 10.1073/pnas.94.25.13909; Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1; Jardim ACG, 2009, INFECT GENET EVOL, V9, P689, DOI 10.1016/j.meegid.2008.11.001; Gomez J, 1999, J VIRAL HEPATITIS, V6, P3, DOI 10.1046/j.1365-2893.1999.t01-1-6120131.x; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Hanson AM, 2012, METHOD ENZYMOL, V511, P463, DOI 10.1016/B978-0-12-396546-2.00021-8; Herod MR, 2014, J VIROL, V88, P2748, DOI 10.1128/JVI.03588-13; HIJIKATA M, 1993, J VIROL, V67, P4665, DOI 10.1128/JVI.67.8.4665-4675.1993; HOLLAND JJ, 1992, CURR TOP MICROBIOL, V176, P1; Jardim ACG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-61; Kalinina O, 2002, J VIROL, V76, P4034, DOI 10.1128/JVI.76.8.4034-4043.2002; KATO N, 1990, P NATL ACAD SCI USA, V87, P9524, DOI 10.1073/pnas.87.24.9524; Kazakov T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004817; Khromykh AA, 1999, J VIROL, V73, P10272, DOI 10.1128/JVI.73.12.10272-10280.1999; KIM DW, 1995, BIOCHEM BIOPH RES CO, V215, P160, DOI 10.1006/bbrc.1995.2447; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Kim JW, 2003, J VIROL, V77, P571, DOI 10.1128/JVI.77.1.571-582.2003; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LaPlante SR, 2014, J MED CHEM, V57, P2074, DOI 10.1021/jm401432c; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Li KL, 2012, J MED CHEM, V55, P3319, DOI 10.1021/jm300021v; LIN C, 1995, J VIROL, V69, P4373, DOI 10.1128/JVI.69.7.4373-4380.1995; LIN C, 1995, P NATL ACAD SCI USA, V92, P7622, DOI 10.1073/pnas.92.17.7622; Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997; Liu WJ, 2002, J VIROL, V76, P10766, DOI 10.1128/JVI.76.21.10766-10775.2002; Mackintosh SG, 2006, J BIOL CHEM, V281, P3528, DOI 10.1074/jbc.M512100200; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Moerke Nathan J, 2009, Curr Protoc Chem Biol, V1, P1, DOI 10.1002/9780470559277.ch090102; Mukherjee S, 2012, NUCLEIC ACIDS RES, V40, P8607, DOI 10.1093/nar/gks623; Ndjomou J, 2012, ANTIVIR RES, V96, P245, DOI 10.1016/j.antiviral.2012.08.006; Noppornpanth S, 2007, J VIROL, V81, P12496, DOI 10.1128/JVI.01059-07; Noppornpanth S, 2006, J VIROL, V80, P7569, DOI 10.1128/JVI.00312-06; OKAMOTO H, 1992, VIROLOGY, V190, P894, DOI 10.1016/0042-6822(92)90933-G; Paolini C, 2000, J GEN VIROL, V81, P1649, DOI 10.1099/0022-1317-81-7-1649; Preugschat F, 2000, BIOCHEMISTRY-US, V39, P5174, DOI 10.1021/bi9923860; Provazzi Paola Js, 2010, BMC Res Notes, V3, P196, DOI 10.1186/1756-0500-3-196; Saeed M, 2012, EFFICIENT REPLICATIO; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; Sugiyama K, 2009, J VIROL, V83, P6922, DOI 10.1128/JVI.02674-08; SUZICH JA, 1993, J VIROL, V67, P6152, DOI 10.1128/JVI.67.10.6152-6158.1993; Tai CL, 1996, J VIROL, V70, P8477, DOI 10.1128/JVI.70.12.8477-8484.1996; Tai CL, 2001, J VIROL, V75, P8289, DOI 10.1128/JVI.75.17.8289-8297.2001; TAKAMIZAWA A, 1991, J VIROL, V65, P1105, DOI 10.1128/JVI.65.3.1105-1113.1991; Targett-Adams P, 2005, J GEN VIROL, V86, P3075, DOI 10.1099/vir.0.81334-0; TOMEI L, 1993, J VIROL, V67, P4017, DOI 10.1128/JVI.67.7.4017-4026.1993; Tomei L, 1996, J GEN VIROL, V77, P1065, DOI 10.1099/0022-1317-77-5-1065; Trepo C, 1999, CURR OPIN INFECT DIS, V12, P481, DOI 10.1097/00001432-199910000-00011; Yanagi M, 1998, VIROLOGY, V244, P161, DOI 10.1006/viro.1998.9092; Yanagi M, 1997, P NATL ACAD SCI USA, V94, P8738, DOI 10.1073/pnas.94.16.8738; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463; Yokoyama K, 2011, ARCH VIROL, V156, P1591, DOI 10.1007/s00705-011-1038-4	78	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144638	10.1371/journal.pone.0144638	http://dx.doi.org/10.1371/journal.pone.0144638			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658750	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903500050
J	Liu, CH; Guan, H; Wang, YD; Chen, M; Xu, B; Zhang, L; Lu, K; Tao, T; Zhang, XW; Huang, YQ				Liu, Chunhui; Guan, Han; Wang, Yiduo; Chen, Ming; Xu, Bin; Zhang, Lei; Lu, Kai; Tao, Tao; Zhang, Xiaowen; Huang, Yeqing			miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR; HEPATOCELLULAR-CARCINOMA; TUMOR-GROWTH; NSCLC CELLS; MICRORNA-195; METASTASIS; SUPPRESSES; INVASION; EXPRESSION	Prostate cancer (PCa) is one of the leading causes of deaths in America. The major cause of mortality can be attributed to metastasis. Cancer metastasis involves sequential and interrelated events. miRNAs and epithelial-mesenchymal transition (EMT) are implicated in this process. miR-195 is downregulated in many human cancers. However, the roles of miR-195 in PCa metastasis and EMT remain unclear. In this study, data from Memorial Sloan Kettering Cancer Center (MSKCC) prostate cancer database were re-analysed to detect miR-195 expression and its roles in PCa. miR-195 was then overexpressed in castration-resistant PCa cell lines, DU-145 and PC-3. The role of miR-195 in migration and invasion in vitro was also investigated, and common markers in EMT were evaluated through Western blot analysis. A luciferase reporter assay was conducted to confirm the target gene of miR-195; were validated in PCa cells. In MSKCC data re-analyses, miR-195 was poorly expressed in metastatic PCa; miR-195 could be used to diagnose metastatic PCa by measuring the corresponding expression. Area under the receiver operating characteristic curve (AUC-ROC) was 0.705 (P = 0.017). Low miR-195 expression was characterised with a shorter relapse-free survival (RFS) time. miR-195 overexpression suppressed cell migration, invasion and EMT. Fibroblast growth factor 2 (FGF2) was confirmed as a direct target of miR-195. FGF2 knockdown also suppressed migration, invasion and EMT; by contrast, increased FGF2 partially reversed the suppressive effect of miR-195. And data from ONCOMINE prostate cancer database showed that PCa patients with high FGF2 expression showed shorter RFS time (P = 0.046). Overall, this study demonstrated that miR-195 suppressed PCa cell metastasis by downregulating FGF2. miR-195 restoration may be considered as a new therapeutic method to treat metastatic PCa.	[Liu, Chunhui; Guan, Han; Wang, Yiduo; Chen, Ming; Xu, Bin; Zhang, Lei; Lu, Kai; Tao, Tao; Zhang, Xiaowen; Huang, Yeqing] Southeast Univ, Affiliated Zhongda Hosp, Dept Urol, Nanjing 210009, Jiangsu, Peoples R China; [Liu, Chunhui; Guan, Han; Wang, Yiduo; Chen, Ming; Xu, Bin; Zhang, Lei; Lu, Kai; Tao, Tao; Zhang, Xiaowen; Huang, Yeqing] Southeast Univ, Sch Med, Surg Res Ctr, Inst Urol, Nanjing 210009, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Chen, M (corresponding author), Southeast Univ, Affiliated Zhongda Hosp, Dept Urol, 87 Dingjia Bridge Hunan Rd, Nanjing 210009, Jiangsu, Peoples R China.	mingchenseu@126.com		Xu, Bin/0000-0002-5099-6673	National Natural Science Foundation of China [81370849, 81300472, 81202034]; Natural Science Foundation of Jiangsu Province [BL2013032, BK2012336]; Nanjing City [201201053]; Southeast University [3290002402]; Science Foundation of Ministry of Education of China [20120092120071]; Fundamental Research Funds for the Central Universities; Scientific Research Innovation Project of University in Jiangsu Province [KYLX_0203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Nanjing City; Southeast University; Science Foundation of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Scientific Research Innovation Project of University in Jiangsu Province	This study was supported by National Natural Science Foundation of China (81370849, 81300472, and 81202034), Natural Science Foundation of Jiangsu Province (BL2013032 and BK2012336) and Nanjing City (201201053) and Southeast University (3290002402), Science Foundation of Ministry of Education of China (20120092120071), Fundamental Research Funds for the Central Universities and Scientific Research Innovation Project of University in Jiangsu Province (KYLX_0203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by National Natural Science Foundation of China (81370849, 81300472, and 81202034), Natural Science Foundation of Jiangsu Province (BL2013032 and BK2012336) and Nanjing City (201201053) and Southeast University (3290002402), Science Foundation of Ministry of Education of China (20120092120071), Fundamental Research Funds for the Central Universities and Scientific Research Innovation Project of University in Jiangsu Province (KYLX_0203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer M, 2014, TUMOR BIOL, V35, P11301, DOI 10.1007/s13277-014-2445-4; [Anonymous], [No title captured]; Chen J, 2014, J CELL PHYSIOL, V229, P1647, DOI 10.1002/jcp.24610; Cheng ZS, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.51; Cronauer MV, 2003, EUR UROL, V43, P309, DOI 10.1016/S0302-2838(03)00005-8; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Deng HX, 2013, GENE, V518, P351, DOI 10.1016/j.gene.2012.12.103; Diaz-Lopez A, 2014, CANCER MANAG RES, V6, P205, DOI 10.2147/CMAR.S38156; Farhat FS, 2012, CRIT REV ONCOL HEMAT, V84, P149, DOI 10.1016/j.critrevonc.2012.02.012; Giri D, 1999, CLIN CANCER RES, V5, P1063; GOSPODAROWICZ D, 1974, P NATL ACAD SCI USA, V71, P2295, DOI 10.1073/pnas.71.6.2295; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo HZ, 2014, TUMOR BIOL, V35, P8861, DOI 10.1007/s13277-014-2153-0; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee JG, 2006, INVEST OPHTH VIS SCI, V47, P2358, DOI 10.1167/iovs.05-1490; Lin YW, 2012, FEBS LETT, V586, P442, DOI 10.1016/j.febslet.2012.01.027; Liu L, 2010, BIOCHEM BIOPH RES CO, V400, P236, DOI 10.1016/j.bbrc.2010.08.046; Liu ZC, 2014, BBA-GEN SUBJECTS, V1840, P3096, DOI 10.1016/j.bbagen.2014.07.018; Mao JH, 2012, ONCOL LETT, V4, P1125, DOI 10.3892/ol.2012.863; Masola V, 2012, J BIOL CHEM, V287, P1478, DOI 10.1074/jbc.M111.279836; Nomura S, 2008, BRIT J CANCER, V99, P305, DOI 10.1038/sj.bjc.6604473; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Ru P, 2012, MOL CANCER THER, V11, P1166, DOI 10.1158/1535-7163.MCT-12-0100; Sakuma K, 2012, P NATL ACAD SCI USA, V109, P7776, DOI 10.1073/pnas.1111135109; Semenas J, 2012, CURR DRUG TARGETS, V13, P1308, DOI 10.2174/138945012802429615; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sun XH, 2015, TUMOR BIOL, V36, P2127, DOI 10.1007/s13277-014-2822-z; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vidigal JA, 2015, TRENDS CELL BIOL, V25, P137, DOI 10.1016/j.tcb.2014.11.004; Wang L, 2014, MOL MED REP, V10, P473, DOI 10.3892/mmr.2014.2178; Wang XL, 2014, TUMOR BIOL, V35, P8765, DOI 10.1007/s13277-014-2140-5; Wang XQ, 2012, MED ONCOL, V29, P919, DOI 10.1007/s12032-011-9880-5; Wen X, 2014, AM J CLIN EXP UROL, V2, P219; Xu B, 2012, PROSTATE, V72, P1171, DOI 10.1002/pros.22466; Yang Y, 2014, MOL MED REP, V10, P2643, DOI 10.3892/mmr.2014.2526; Zhang JC, 2012, BIOCHEM BIOPH RES CO, V417, P1100, DOI 10.1016/j.bbrc.2011.12.121; Zhao FL, 2014, MOL BIOL REP, V41, P5913, DOI 10.1007/s11033-014-3466-1; Zhou BS, 2013, CANCER LETT, V333, P159, DOI 10.1016/j.canlet.2013.01.028	42	53	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144073	10.1371/journal.pone.0144073	http://dx.doi.org/10.1371/journal.pone.0144073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650737	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903300035
J	Stefan, LM; Gomez-Diaz, E; Elguero, E; Proctor, HC; McCoy, KD; Gonzalez-Solis, J				Stefan, Laura M.; Gomez-Diaz, Elena; Elguero, Eric; Proctor, Heather C.; McCoy, Karen D.; Gonzalez-Solis, Jacob			Niche Partitioning of Feather Mites within a Seabird Host, Calonectris borealis	PLOS ONE			English	Article							ACARI AVENZOARIIDAE; STABLE-ISOTOPES; MODELS; SHEARWATERS; COMPETITION; BEHAVIOR; BIRDS; DIET; TRANSMISSION; PREFERENCES	According to classic niche theory, species can coexist in heterogeneous environments by reducing interspecific competition via niche partitioning, e.g. trophic or spatial partitioning. However, support for the role of competition on niche partitioning remains controversial. Here, we tested for spatial and trophic partitioning in feather mites, a diverse and abundant group of arthropods. We focused on the two dominant mite species, Microspalax brevipes and Zachvatkinia ovata, inhabiting flight feathers of the Cory's shearwater, Calonectris borealis. We performed mite counts across and within primary and tail feathers on free-living shearwaters breeding on an oceanic island (Gran Canaria, Canary Islands). We then investigated trophic relationships between the two mite species and the host using stable isotope analyses of carbon and nitrogen on mite tissues and potential host food sources. The distribution of the two mite species showed clear spatial segregation among feathers; M. brevipes showed high preference for the central wing primary feathers, whereas Z. ovata was restricted to the two outermost primaries. Morphological differences between M. brevipes and Z. ovata support an adaptive basis for the spatial segregation of the two mite species. However, the two mites overlap in some central primaries and statistical modeling showed that Z. ovata tends to outcompete M. brevipes. Isotopic analyses indicated similar isotopic values for the two mite species and a strong correlation in carbon signatures between mites inhabiting the same individual host suggesting that diet is mainly based on shared host-associated resources. Among the four candidate tissues examined (blood, feather remains, skin remains and preen gland oil), we conclude that the diet is most likely dominated by preen gland oil, while the contribution of exogenous material to mite diets is less marked. Our results indicate that ongoing competition for space and resources plays a central role in structuring feather mite communities. They also illustrate that symbiotic infracommunities are excellent model systems to study trophic ecology, and can improve our understanding of mechanisms of niche differentiation and species coexistence.	[Stefan, Laura M.; Gonzalez-Solis, Jacob] Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain; [Stefan, Laura M.; Gonzalez-Solis, Jacob] Univ Barcelona, Dept Biol Anim, Barcelona, Spain; [Gomez-Diaz, Elena] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Stefan, Laura M.; Elguero, Eric; McCoy, Karen D.] UM, CNRS, IRD, Ctr IRD,MIVEGEC Res Unit,UMR 5290, Montpellier, France; [Proctor, Heather C.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Barcelona; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Alberta	Stefan, LM (corresponding author), Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain.	laura.stefan@ub.edu	Gonzalez-Solis, Jacob/AAZ-5338-2021; Gómez-Díaz, Elena/AAA-9141-2019; González-Solís, Jacob/AAB-1161-2019; Gonzalez-Solis, Jacob/C-3942-2008; Proctor, Heather C./A-2677-2014; Gómez-Díaz, Elena/G-2503-2011; McCoy, Karen D/F-7061-2012	Gonzalez-Solis, Jacob/0000-0002-8691-9397; Gómez-Díaz, Elena/0000-0002-4146-9003; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Proctor, Heather C./0000-0002-4920-9556; Gómez-Díaz, Elena/0000-0002-4146-9003; McCoy, Karen D/0000-0002-8972-3808	University of Barcelona; Ministerio de Ciencia e Innovacion, Spain; Ministerio de Ciencia e Innovacion (Spain) [CGL2006-01315/BOS, CGL2009-11278/BOS]; CNRS (France); IRD (France); Fondos FEDER; Marie Curie Reintegration Grant [ERG-2010276838]	University of Barcelona; Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); IRD (France); Fondos FEDER(European Commission); Marie Curie Reintegration Grant(European Commission)	The present investigation was performed during the postgraduate project of LS supported by a PhD grant from the University of Barcelona. EG-D was supported by a JdC contract from the Ministerio de Ciencia e Innovacion, Spain. Financial support was provided by CGL2006-01315/BOS and CGL2009-11278/BOS from Ministerio de Ciencia e Innovacion (Spain), the CNRS and IRD (France) and Fondos FEDER for JGS, KM and LS, and by a Marie Curie Reintegration Grant to EG-D (ERG-2010276838).	Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; ATYEO WT, 1991, FOLIA PARASIT, V38, P327; Blanco G, 2001, J AVIAN BIOL, V32, P271, DOI 10.1111/j.0908-8857.2001.320310.x; Bolker BM, 2013, METHODS ECOL EVOL, V4, P501, DOI 10.1111/2041-210X.12044; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bridge ES, 2003, INT J ACAROL, V29, P389, DOI 10.1080/01647950308684356; Brown CR, 2006, CAN J ZOOL, V84, P1307, DOI 10.1139/Z06-110; CHOE JC, 1989, OECOLOGIA, V79, P10, DOI 10.1007/BF00378233; Clayton Dale H., 2010, Open Ornithology Journal, V3, P41, DOI 10.2174/1874453201003010041; CLAYTON DH, 1994, ANIM BEHAV, V47, P195, DOI 10.1006/anbe.1994.1022; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; Dabert J, 1999, EXP APPL ACAROL, V23, P437, DOI 10.1023/A:1006180705101; Dabert Jacek, 1992, Genus (Wroclaw), V3, P1; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Deudero S, 2002, DIS AQUAT ORGAN, V52, P77, DOI 10.3354/dao052077; Dubinin V. B., 1951, Fauna USSR Moscow, V6, P1; Fernandez-Gonzalez S, 2015, INT J PARASITOL, V45, P655, DOI 10.1016/j.ijpara.2015.04.003; Figuerola J, 2003, ANIM BEHAV, V65, P551, DOI 10.1006/anbe.2003.2072; Friggens MM, 2005, OIKOS, V108, P76, DOI 10.1111/j.0030-1299.2005.13275.x; Galvan I, 2008, J EVOLUTION BIOL, V21, P133, DOI 10.1111/j.1420-9101.2007.01459.x; Galvan I, 2012, J AVIAN BIOL, V43, P273, DOI 10.1111/j.1600-048X.2012.05686.x; Gomez-Diaz E, 2008, ECOGRAPHY, V31, P477, DOI 10.1111/j.0906-7590.2008.05330.x; Gomez-Diaz E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010454; Harbison CW, 2009, INT J PARASITOL, V39, P569, DOI 10.1016/j.ijpara.2008.09.014; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Jovani R, 2006, CAN J ZOOL, V84, P729, DOI 10.1139/Z06-042; Jovani R, 2004, J AVIAN BIOL, V35, P16, DOI 10.1111/j.0908-8857.2004.03213.x; Jovani R, 2001, J PARASITOL, V87, P1187, DOI 10.1645/0022-3395(2001)087[1187:AHFAMM]2.0.CO;2; Krantz G., 2009, MANUAL ACAROLOGY; LEIBOLD MA, 1995, ECOLOGY, V76, P1371, DOI 10.2307/1938141; LEVIN DA, 1970, AM NAT, V104, P455, DOI 10.1086/282680; LEVINS RICHARD, 1968; Mestre A, 2011, J PARASITOL, V97, P237, DOI 10.1645/GE-2585.1; Mironov S.V., 1989, Parazitologicheskii Sbornik, V36, P91; Mironov SV, 2008, J PARASITOL, V94, P1243, DOI 10.1645/GE-1579.1; Mironov SV, 2015, SYST PARASITOL, V90, P91, DOI 10.1007/s11230-014-9532-1; Morin P., 1999, COMMUNITY ECOL; Mouillot D, 2003, J ANIM ECOL, V72, P757, DOI 10.1046/j.1365-2656.2003.00749.x; PATRICK MJ, 1991, ECOLOGY, V72, P755, DOI 10.2307/2937218; Perez-Tris J, 2002, BIOL J LINN SOC, V76, P481, DOI 10.1046/j.1095-8312.2002.00083.x; Persson ME, 2007, J FISH BIOL, V71, P441, DOI 10.1111/j.1095-8649.2007.01500.x; Pilosof S, 2012, PARASITOLOGY, V139, P1739, DOI 10.1017/S0031182012001205; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Proctor HC, 2004, J PARASITOL, V90, P60, DOI 10.1645/GE-57R; Proctor HC, 2003, ANNU REV ENTOMOL, V48, P185, DOI 10.1146/annurev.ento.48.091801.112725; Ramos R, 2009, OECOLOGIA, V160, P97, DOI 10.1007/s00442-008-1273-x; Ramos R, 2012, FRONT ECOL ENVIRON, V10, P258, DOI 10.1890/110140; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; Reed DL, 2000, J PARASITOL, V86, P951, DOI 10.1645/0022-3395(2000)086[0951:SPOHHB]2.0.CO;2; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; Stefan LM, 2014, FOLIA PARASIT, V61, P90, DOI 10.14411/fp.2014.009; Stefan LM, 2013, ZOOTAXA, V3682, P105, DOI 10.11646/zootaxa.3682.1.4; Voigt CC, 2006, CAN J ZOOL, V84, P397, DOI 10.1139/z06-007; WALLACE RK, 1981, T AM FISH SOC, V110, P72, DOI 10.1577/1548-8659(1981)110&lt;72:AAODI&gt;2.0.CO;2; Wiles PR, 2000, CAN J ZOOL, V78, P1397, DOI 10.1139/cjz-78-8-1397	58	12	12	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144728	10.1371/journal.pone.0144728	http://dx.doi.org/10.1371/journal.pone.0144728			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650672	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903300070
J	Barniv, D; Nelken, I				Barniv, Dana; Nelken, Israel			Auditory Streaming as an Online Classification Process with Evidence Accumulation	PLOS ONE			English	Article							PERCEPTUAL ORGANIZATION; MODEL; ADAPTATION; SEGREGATION; DYNAMICS; CORTEX; COMMON; NOISE	When human subjects hear a sequence of two alternating pure tones, they often perceive it in one of two ways: as one integrated sequence (a single "stream" consisting of the two tones), or as two segregated sequences, one sequence of low tones perceived separately from another sequence of high tones (two "streams"). Perception of this stimulus is thus bistable. Moreover, subjects report on-going switching between the two percepts: unless the frequency separation is large, initial perception tends to be of integration, followed by toggling between integration and segregation phases. The process of stream formation is loosely named "auditory streaming". Auditory streaming is believed to be a manifestation of human ability to analyze an auditory scene, i.e. to attribute portions of the incoming sound sequence to distinct sound generating entities. Previous studies suggested that the durations of the successive integration and segregation phases are statistically independent. This independence plays an important role in current models of bistability. Contrary to this, we show here, by analyzing a large set of data, that subsequent phase durations are positively correlated. To account together for bistability and positive correlation between subsequent durations, we suggest that streaming is a consequence of an evidence accumulation process. Evidence for segregation is accumulated during the integration phase and vice versa; a switch to the opposite percept occurs stochastically based on this evidence. During a long phase, a large amount of evidence for the opposite percept is accumulated, resulting in a long subsequent phase. In contrast, a short phase is followed by another short phase. We implement these concepts using a probabilistic model that shows both bistability and correlations similar to those observed experimentally.	[Barniv, Dana; Nelken, Israel] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel; [Nelken, Israel] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Neurobiol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Barniv, D (corresponding author), Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel.	dana.barniv@mail.huji.ac.il	Nelken, Israel/B-7753-2011	Nelken, Israel/0000-0002-6645-107X	Israel Science Foundation [72/2009, 390/2013]; Israel Ministry of Science [3-8674]; Laboratoire Internationale Associee (LEA) FINNEPS	Israel Science Foundation(Israel Science Foundation); Israel Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Laboratoire Internationale Associee (LEA) FINNEPS	IN was supported by grants 72/2009 and 390/2013 from the Israel Science Foundation, by grant 3-8674 from the Israel Ministry of Science in the framework of the collaboration France-Israel, and by the Laboratoire Internationale Associee (LEA) FINNEPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou LV, 2011, HEARING RES, V280, P228, DOI 10.1016/j.heares.2011.06.001; Beauvois MW, 1996, J ACOUST SOC AM, V99, P2270, DOI 10.1121/1.415414; Bregman A. S., 1990, AUDITORY SCENE ANALY; BREGMAN AS, 1978, J EXP PSYCHOL HUMAN, V4, P380, DOI 10.1037/0096-1523.4.3.380; Deike S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00461; Denham S.L., 2013, LEARN PERCEPT, V5, P73, DOI [10.1556/LP.5.2013.Suppl2.6, DOI 10.1556/LP.5.2013.SUPPL2.6]; Elhilali M, 2009, NEURON, V61, P317, DOI 10.1016/j.neuron.2008.12.005; Elhilali M, 2008, J ACOUST SOC AM, V124, P3751, DOI 10.1121/1.3001672; Fishman YI, 2001, HEARING RES, V151, P167, DOI 10.1016/S0378-5955(00)00224-0; Gigante G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000430; HARTMANN WM, 1991, MUSIC PERCEPT, V9, P155; Hupe JM, 2008, J VISION, V8, DOI 10.1167/8.7.1; Kaelbling LP, 1996, J ARTIF INTELL RES, V4, P237, DOI 10.1613/jair.301; Kuznetsova A., 2015, LMERTEST TESTS LINEA; Marti D, 2013, NEURAL COMPUT, V25, P1, DOI 10.1162/NECO_a_00383; McCabe SL, 1997, J ACOUST SOC AM, V101, P1611, DOI 10.1121/1.418176; McVay JC, 2012, J EXP PSYCHOL LEARN, V38, P525, DOI 10.1037/a0025896; Micheyl C, 2005, NEURON, V48, P139, DOI 10.1016/j.neuron.2005.08.039; Mill RW, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002925; Moreno-Bote R, 2007, J NEUROPHYSIOL, V98, P1125, DOI 10.1152/jn.00116.2007; Pastukhov A, 2011, J VISION, V11, DOI 10.1167/11.10.12; Pressnitzer D, 2008, CURR BIOL, V18, P1124, DOI 10.1016/j.cub.2008.06.053; Pressnitzer D, 2006, CURR BIOL, V16, P1351, DOI 10.1016/j.cub.2006.05.054; R Core Team, 2015, LANG ENV STAT COMP I; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Shpiro A, 2007, J NEUROPHYSIOL, V97, P462, DOI 10.1152/jn.00604.2006; Shpiro A, 2009, J COMPUT NEUROSCI, V27, P37, DOI 10.1007/s10827-008-0125-3; van Ee R, 2009, J OPT SOC AM A, V26, P2612, DOI 10.1364/JOSAA.26.002612; van Noorden L., 1975, TEMPORAL COHERENCE I; WALKER P, 1978, PSYCHOL BULL, V85, P376, DOI 10.1037/0033-2909.85.2.376; Wang DL, 2008, COGN NEURODYNAMICS, V2, P7, DOI 10.1007/s11571-007-9035-8; Wrigley SN, 2004, IEEE T NEURAL NETWOR, V15, P1151, DOI 10.1109/TNN.2004.832710	32	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144788	10.1371/journal.pone.0144788	http://dx.doi.org/10.1371/journal.pone.0144788			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9HZ	26671774	Green Published, gold, Green Submitted			2022-12-27	WOS:000366719300021
J	Chen, K; Li, EC; Xu, ZX; Li, TY; Xu, C; Qin, JG; Chen, LQ				Chen, Ke; Li, Erchao; Xu, Zhixin; Li, Tongyu; Xu, Chang; Qin, Jian G.; Chen, Liqiao			Comparative Transcriptome Analysis in the Hepatopancreas Tissue of Pacific White Shrimp Litopenaeus vannamei Fed Different Lipid Sources at Low Salinity	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; ACETYL-COA SYNTHETASE; CHINESE MITTEN CRAB; ERIOCHEIR-SINENSIS; PENAEUS-VANNAMEI; STRESS TOLERANCE; BODY-COMPOSITION; JUVENILE SHRIMP; GENE-EXPRESSION; NA+/K+-ATPASE	RNA-seq was used to compare the transcriptomic response of hepatopancreas in juvenile Litopenaeus vannamei fed three diets with different lipid sources, including beef tallow (BT), fish oil (FO), and an equal combination of soybean oil + BT + linseed oil (SBL) for 8 weeks at 3 practical salinity unit (psu). A total of 9622 isogenes were annotated in 316 KEGG pathways and 39, 42 and 32 pathways significantly changed in the paired comparisons of FO vs SBL, BT vs SBL, or FO vs BT, respectively. The pathways of glycerolipid metabolism, linoleic acid metabolism, arachidonic acid metabolism, glycerophospholipid metabolism, fatty acid biosynthesis, fatty acid elongation, fatty acid degradation, and biosynthesis of unsaturated fatty acid were significantly changed in all paired comparisons between dietary lipid sources, and the pathways of glycerolipid metabolism, linoleic acid metabolism, arachidonic acid metabolism and glycerophospholipid metabolism significantly changed in the FO vs SBL and BT vs SBL comparisons. These pathways are associated with energy metabolism and cell membrane structure. The results indicate that lipids sources affect the adaptation of L. vannamei to low salinity by providing extra energy or specific fatty acids to change gill membrane structure and control iron balance. The results of this study lay a foundation for further understanding lipid or fatty acid metabolism in L. vannamei at low salinity.	[Chen, Ke; Li, Erchao; Xu, Zhixin; Li, Tongyu; Xu, Chang; Chen, Liqiao] E China Normal Univ, Sch Life Sci, Lab Aquaculture Nutr & Environm Hlth, Shanghai 200241, Peoples R China; [Qin, Jian G.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia	East China Normal University; Flinders University South Australia	Li, EC (corresponding author), E China Normal Univ, Sch Life Sci, Lab Aquaculture Nutr & Environm Hlth, Shanghai 200241, Peoples R China.	ecli@bio.ecnu.edu.cn; lqchen@bio.ecnu.edu.cn	Li, Tongyu/GQA-7514-2022	Qin, Jianguang/0000-0003-2448-8058; Chen, Liqiao/0000-0003-0138-7828; LI, Erchao/0000-0001-8495-2241	National Natural Science Foundation of China [31472291, 31172422]; Special Fund for Agro-scientific Research in the Public Interest [201203065]; E-Institute of Shanghai Municipal Education Commission [E03009]; ECNU innovation fund	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; E-Institute of Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); ECNU innovation fund	This research was supported by grants from the National Natural Science Foundation of China (No. 31472291, 31172422), the Special Fund for Agro-scientific Research in the Public Interest (No. 201203065), and partly by the E-Institute of Shanghai Municipal Education Commission (No. E03009) and ECNU innovation fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This research was supported by grants from the National Natural Science Foundation of China (No. 31472291, 31172422), the Special Fund for Agro-scientific Research in the Public Interest (No. 201203065), and partly by the E-Institute of Shanghai Municipal Education Commission (No. E03009) and ECNU innovation fund.	Barger PM, 2000, TRENDS CARDIOVAS MED, V10, P238, DOI 10.1016/S1050-1738(00)00077-3; Birukawa N, 2005, ZOOL SCI, V22, P1245, DOI 10.2108/zsj.22.1245; Bradbury MW, LIPID METABOLISM LIV; Brosche T, 1998, EXP GERONTOL, V33, P363, DOI 10.1016/S0531-5565(98)00014-X; Capdevila JH, 2000, J LIPID RES, V41, P163; Charmantier Guy, 2009, P165; Chen K, 2015, AQUACULT REP, V2, P163, DOI 10.1016/j.aqrep.2015.10.003; Chen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131503; Chen K, 2014, J SHELLFISH RES, V33, P825, DOI 10.2983/035.033.0317; Cheng KM, 2006, AQUACULTURE, V251, P472, DOI 10.1016/j.aquaculture.2005.06.022; Chien YH, 2003, AQUACULTURE, V216, P177, DOI 10.1016/S0044-8486(02)00056-X; Clavero-Salas A, 2007, FISH SHELLFISH IMMUN, V23, P459, DOI 10.1016/j.fsi.2007.01.010; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davis D.A., 2002, AVANCES NUTR ACUICOL, P73; Davis DA, 2005, J WORLD AQUACULT SOC, V36, P416, DOI 10.1111/j.1749-7345.2005.tb00346.x; Deering MJ, 1997, AQUACULTURE, V151, P131, DOI 10.1016/S0044-8486(96)01480-9; Freire CA, 2008, COMP BIOCHEM PHYS A, V151, P272, DOI 10.1016/j.cbpa.2007.05.008; Frye C A, 2009, Minerva Ginecol, V61, P541; Funder JW, 1997, RECENT PROG HORM RES, V52, P247; Funder JW, 1996, RECENT PROGR HORMONE, V52, P61; Goepfert S, 2007, CURR OPIN PLANT BIOL, V10, P245, DOI 10.1016/j.pbi.2007.04.007; Gonzalez-Felix ML, 2002, AQUACULTURE, V207, P151, DOI 10.1016/S0044-8486(01)00797-9; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012; Gupta BBP, 2002, CURR SCI INDIA, V83, P1103; Hardwick JP, 2008, BIOCHEM PHARMACOL, V75, P2263, DOI 10.1016/j.bcp.2008.03.004; Hurtado MA, 2007, COMP BIOCHEM PHYS A, V147, P703, DOI 10.1016/j.cbpa.2006.07.002; JUMP DB, 1994, J LIPID RES, V35, P1076; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim JK, 2007, J EXP BOT, V58, P415, DOI 10.1093/jxb/erl216; Kroetz DL, 2002, CURR OPIN LIPIDOL, V13, P273, DOI 10.1097/00041433-200206000-00007; Laramore S, 2001, J WORLD AQUACULT SOC, V32, P385, DOI 10.1111/j.1749-7345.2001.tb00464.x; Lemos D, 2001, J EXP MAR BIOL ECOL, V261, P55, DOI 10.1016/S0022-0981(01)00260-X; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li CC, 2010, FISH SHELLFISH IMMUN, V28, P121, DOI 10.1016/j.fsi.2009.10.003; Li C, 2012, FISH SHELLFISH IMMUN, V32, P816, DOI 10.1016/j.fsi.2012.02.004; Li EC, 2008, AQUACULTURE, V274, P80, DOI 10.1016/j.aquaculture.2007.11.001; Li EC, 2007, AQUACULTURE, V265, P385, DOI 10.1016/j.aquaculture.2007.02.018; Li EC, 2014, PHYSIOL GENOMICS, V46, P177, DOI 10.1152/physiolgenomics.00191.2013; Li EC, 2010, J WORLD AQUACULT SOC, V41, P756, DOI 10.1111/j.1749-7345.2010.00417.x; Li YY, 2008, COMP BIOCHEM PHYS B, V151, P183, DOI 10.1016/j.cbpb.2008.06.013; Li YY, 2010, P NATL ACAD SCI USA, V107, P16840, DOI 10.1073/pnas.1008429107; Lim C, 1997, AQUACULTURE, V151, P143, DOI 10.1016/S0044-8486(96)01500-1; Liu Y, 2007, AQUACULTURE, V265, P351, DOI 10.1016/j.aquaculture.2007.02.010; Luvizotto-Santos R, 2003, J EXP ZOOL PART A, V295A, P200, DOI 10.1002/jez.a.10219; Martins TG, 2006, AQUACULTURE, V252, P525, DOI 10.1016/j.aquaculture.2005.07.022; McNamara JC, 2004, MAR FRESHW BEHAV PHY, V37, P193, DOI 10.1080/10236240400006208; Metzler-Zebeli BU, 2009, WORLD POULTRY SCI J, V65, P419, DOI 10.1017/S0043933909000300; Monroig O, 2012, AQUACULTURE, V350, P63, DOI 10.1016/j.aquaculture.2012.04.017; Palacios E, 2004, AQUACULTURE, V234, P497, DOI 10.1016/j.aquaculture.2003.12.001; Palacios E, 2004, J EXP MAR BIOL ECOL, V299, P201, DOI 10.1016/j.jembe.2003.09.007; PEQUEUX A, 1995, J CRUSTACEAN BIOL, V15, P1, DOI 10.2307/1549010; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ponce-Palafox J, 1997, AQUACULTURE, V157, P107, DOI 10.1016/S0044-8486(97)00148-8; Rainbow PS, 2001, J EXP MAR BIOL ECOL, V264, P1, DOI 10.1016/S0022-0981(01)00289-1; Ranallo RF, 1998, SPORTS MED, V26, P29, DOI 10.2165/00007256-199826010-00003; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romano N, 2012, AQUACULTURE, V334, P12, DOI 10.1016/j.aquaculture.2011.12.035; Roy LA, 2007, AQUACULTURE, V262, P461, DOI 10.1016/j.aquaculture.2006.10.011; Salem M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036264; Sargent JR, 1995, J APPL ICHTHYOL, V11, P183, DOI 10.1111/j.1439-0426.1995.tb00018.x; Schriner JE, 1996, GENOMICS, V34, P317, DOI 10.1006/geno.1996.0292; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Smith S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-375; SODERQUIST CA, 1994, METHOD INHIBITING SC; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Sui L, 2007, AQUACULTURE, V273, P139, DOI 10.1016/j.aquaculture.2007.09.016; Suprayudi MA, 2004, AQUACULTURE, V231, P403, DOI 10.1016/S0044-8486(03)00542-8; Tocher DR, 2000, FISH PHYSIOL BIOCHEM, V23, P59, DOI 10.1023/A:1007807201093; TOUSSANT MJ, 1981, J NUTR, V111, P146, DOI 10.1093/jn/111.1.146; Tseng YC, 2008, COMP BIOCHEM PHYS C, V148, P419, DOI 10.1016/j.cbpc.2008.04.009; Van Anholt RD, 2004, J EXP BIOL, V207, P3419, DOI 10.1242/jeb.01166; Wang LU, 2005, FISH SHELLFISH IMMUN, V18, P269, DOI 10.1016/j.fsi.2004.07.008; Wang RJ, 2012, FRESHW SCI, V31, P695, DOI 10.1899/11-149.1; Wang X, 2014, AQUAC RES; Wang XD, 2014, J SHELLFISH RES, V33, P511, DOI 10.2983/35.033.0220; Wang YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037316; Xia JH, 2013, DNA RES, V20, P449, DOI 10.1093/dnares/dst022; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu J., 2013, PLOS ONE, V8; Zeng DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057515; Zhou QC, 2007, AQUACULT NUTR, V13, P222, DOI 10.1111/j.1365-2095.2007.00470.x	82	27	27	10	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144889	10.1371/journal.pone.0144889	http://dx.doi.org/10.1371/journal.pone.0144889			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670122	Green Published, Green Submitted, gold			2022-12-27	WOS:000366719300028
J	Atal, I; Trinquart, L; Porcher, R; Ravaud, P				Atal, Ignacio; Trinquart, Ludovic; Porcher, Raphael; Ravaud, Philippe			Differential Globalization of Industry- and Non-Industry-Sponsored Clinical Trials	PLOS ONE			English	Article								Background Mapping the international landscape of clinical trials may inform global health research governance, but no large-scale data are available. Industry or non-industry sponsorship may have a major influence in this mapping. We aimed to map the global landscape of industry- and non-industry-sponsored clinical trials and its evolution over time. Methods We analyzed clinical trials initiated between 2006 and 2013 and registered in the WHO International Clinical Trials Registry Platform (ICTRP). We mapped single-country and international trials by World Bank's income groups and by sponsorship (industry-vs. non-industry), including its evolution over time from 2006 to 2012. We identified clusters of countries that collaborated significantly more than expected in industry-and non-industry-sponsored international trials. Results 119,679 clinical trials conducted in 177 countries were analysed. The median number of trials per million inhabitants in high-income countries was 100 times that in low-income countries (116.0 vs. 1.1). Industry sponsors were involved in three times more trials per million inhabitants than non-industry sponsors in high-income countries (75.0 vs. 24.5) and in ten times fewer trials in low-income countries (0.08 vs. 1.08). Among industry-and non-industry- sponsored trials, 30.3% and 3.2% were international, respectively. In the industry-sponsored network of collaboration, Eastern European and South American countries collaborated more than expected; in the non-industry-sponsored network, collaboration among Scandinavian countries was overrepresented. Industry-sponsored international trials became more inter-continental with time between 2006 and 2012 (from 54.8% to 67.3%) as compared with non-industry-sponsored trials (from 42.4% to 37.2%). Conclusions Based on trials registered in the WHO ICTRP we documented a substantial gap between the globalization of industry- and non-industry-sponsored clinical research. Only 3% of academic trials but 30% of industry trials are international. The latter appeared to be conducted in preferentially selected countries.	[Atal, Ignacio; Trinquart, Ludovic; Porcher, Raphael; Ravaud, Philippe] Hop Hotel Dieu, Ctr Epidemiol Clin, F-75181 Paris, France; [Atal, Ignacio; Trinquart, Ludovic; Porcher, Raphael; Ravaud, Philippe] INSERM, U1153, Paris, France; [Trinquart, Ludovic; Ravaud, Philippe] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Atal, Ignacio; Porcher, Raphael; Ravaud, Philippe] Univ Paris 05, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Columbia University; UDICE-French Research Universities; Universite Paris Cite	Trinquart, L (corresponding author), Hop Hotel Dieu, Ctr Epidemiol Clin, F-75181 Paris, France.	ludovic.trinquart@htd.aphp.fr	Trinquart, Ludovic/H-4961-2019; ravaud, philippe/C-1694-2009	Trinquart, Ludovic/0000-0002-3028-4900; Porcher, Raphael/0000-0002-5277-4679; Ravaud, Philippe/0000-0001-8264-9206; Atal, Ignacio/0000-0002-7323-6511	Fondation pour la Recherche Medicale, France [DEQ20101221475]	Fondation pour la Recherche Medicale, France(Fondation pour la Recherche Medicale)	This work was supported by an academic grant (DEQ20101221475) for the programme Equipe Espoirs de la Recherche, from the Fondation pour la Recherche Medicale, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boccia S, 2016, J CLIN EPIDEMIOL, V70, P176, DOI 10.1016/j.jclinepi.2015.09.009; Chakma Justin, 2013, NEW ENGL J MED, P3, DOI [10.1056/NEJMp1313927, DOI 10.1056/NEJMP1313927]; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Connell L, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001711; CONNOR EF, 1979, ECOLOGY, V60, P1132, DOI 10.2307/1936961; Dal-Re R, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007513; Demotes-Mainard J, 2005, LANCET, V365, P107, DOI 10.1016/S0140-6736(05)17720-4; Dickersin K, 2012, JAMA-J AM MED ASSOC, V307, P1861, DOI 10.1001/jama.2012.4230; Drain PK, 2014, NAT REV DRUG DISCOV, V13, P166, DOI 10.1038/nrd4260; Dye C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006971; Edler D., 2013, MAPEQUATION SOFTWARE; Emdin CA, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/BMJ.h117, 10.1136/bmj.h117]; Evans JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090147; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Hansen DL, 2011, ANALYZING SOCIAL MEDIA NETWORKS WITH NODEXL: INSIGHTS FROM A CONNECTED WORLD, P11, DOI 10.1016/B978-0-12-382229-1.00002-3; Karlberg JPE, 2007, NAT REV DRUG DISCOV, V2007, P1; Lang TD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001228; Lazzeri V, 1983, EUROVOC TERMINOL, P31; Matee MI, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-249; OECD, 2011, OECD GLOB SCI FORUM; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Pan RK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00902; Pang T, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001008; Patsopoulos NA, 2006, BMJ-BRIT MED J, V332, P1061, DOI 10.1136/bmj.38768.420139.80; R Core Team, 2021, R LANGUAGE ENV STAT; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rottingen JA, 2013, LANCET, V382, P1286, DOI 10.1016/S0140-6736(13)61046-6; Sista Nirupama Deshmane, 2011, Clin Investig (Lond), V1, P1609; Soreide K, 2013, LANCET, V382, P1140, DOI 10.1016/S0140-6736(13)61455-5; Sox HC, 2008, ANN INTERN MED, V149, P279, DOI 10.7326/0003-4819-149-4-200808190-00012; Stamatakis E, 2010, UNDUE IND INFLUENCES, P1, DOI [10.1111/eci.12074, DOI 10.1111/ECI.12074]; Terry RF, 2014, SCIENCE, V345, P1302, DOI 10.1126/science.1258737; Thiers FA, 2008, NAT REV DRUG DISCOV, V7, P13, DOI 10.1038/nrd2441; Trimble EL, 2009, J CLIN ONCOL, V27, P5109, DOI 10.1200/JCO.2009.22.5771; Viergever RF, 2013, B WORLD HEAL ORGAN, P416; Viergever RF, 2014, CLIN TRIALS, V9, P12, DOI [10.1371/journal.pone.0084727, DOI 10.1371/JOURNAL.PONE.0084727]; Viergever RF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008932; Weber WEJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3572; WHO, INT CLIN TRIALS REG; Wick M, 2011, S SPAC TIM INT GEOGR	41	40	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145122	10.1371/journal.pone.0145122	http://dx.doi.org/10.1371/journal.pone.0145122			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658791	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900185
J	Jomura, M; Akashi, Y; Itoh, H; Yuki, R; Sakai, Y; Maruyama, Y				Jomura, Mayuko; Akashi, Yuhei; Itoh, Hiromu; Yuki, Risa; Sakai, Yoshimi; Maruyama, Yutaka			Biotic and Abiotic Factors Controlling Respiration Rates of Above- and Belowground Woody Debris of Fagus crenata and Quercus crispula in Japan	PLOS ONE			English	Article							PINUS-RADIATA; CARBON CONCENTRATION; CONIFEROUS FOREST; TEMPERATE FOREST; DOWNED LOGS; NEW-ZEALAND; DECOMPOSITION; MOISTURE; ROOTS; DECAY	As a large, long-term pool and source of carbon and nutrients, woody litter is an important component of forest ecosystems. The objective of this study was to estimate the effect of the factors that regulate the rate of decomposition of coarse and fine woody debris (CFWD) of dominant tree species in a cool-temperate forest in Japan. Respiration rates of dead stems, branches, and coarse and fine roots of Fagus crenata and Quercus crispula felled 4 years prior obtained in situ ranged from 20.9 to 500.1 mg CO2 [kg dry wood](-1) h(-1) in a one-time measurement in summer. Respiration rate had a significant negative relationship with diameter; in particular, that of a sample of Q. crispula with a diameter of >15 cm and substantial heartwood was low. It also had a significant positive relationship with moisture content. The explanatory variables diameter, [N], wood density, and moisture content were interrelated. The most parsimonious path model showed 14 significant correlations among 8 factors and respiration. Diameter and [C] had large negative direct effects on CFWD respiration rate, and moisture content and species had medium positive direct effects. [N] and temperature did not have direct or indirect effects, and position and wood density had indirect effects. The model revealed some interrelationships between controlling factors. We discussed the influence of the direct effects of explanatory variables and the influence especially of species and position. We speculate that the small R-2 value of the most parsimonious model was probably due to the omission of microbial biomass and activity. These direct and indirect effects and interrelationships between explanatory variables could be used to develop a process-based CFWD decomposition model.	[Jomura, Mayuko; Akashi, Yuhei; Itoh, Hiromu; Yuki, Risa; Maruyama, Yutaka] Nihon Univ, Coll Bioresource Sci, Dept Forest Sci & Resources, Fujisawa, Kanagawa, Japan; [Sakai, Yoshimi] Forestry & Forest Prod Res Inst, Kyusyu Res Ctr, Kumamoto, Kumamoto, Japan	Nihon University; Forestry & Forest Products Research Institute - Japan	Jomura, M (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Forest Sci & Resources, Fujisawa, Kanagawa, Japan.	joumura.mayuko@nihon-u.ac.jp		Jomura, Mayuko/0000-0002-9858-3771	Nihon University College of Bioresource Sciences Research Grant; Grants-in-Aid for Scientific Research [25450227] Funding Source: KAKEN	Nihon University College of Bioresource Sciences Research Grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Nihon University College of Bioresource Sciences Research Grant (2012).; This work was funded by a Nihon University College of Bioresource Sciences Research Grant (2012). We thank Hideki Tarumi, of Nihon University, for helping to collect samples.	Augusto L, 2014, GCB BIOENERG, DOI [10.1111/gcbb.121271-13, DOI 10.1111/GCBB.121271-13]; Augusto L, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008059; Baker JS, 2008, FOR ECOL MANAG, V255, P598; Berg B., 2003, DECOMPOSITION PROCES; Bert D, 2006, FOREST ECOL MANAG, V222, P279, DOI 10.1016/j.foreco.2005.10.030; Bond-Lamberty B, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000839; Chambers JQ, 2001, BIOGEOCHEMISTRY, V52, P115, DOI 10.1023/A:1006473530673; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Chen H, 2000, FOREST ECOL MANAG, V138, P51, DOI 10.1016/S0378-1127(00)00411-4; Cornwell WK, 2009, GLOBAL CHANGE BIOL, V15, P2431, DOI 10.1111/j.1365-2486.2009.01916.x; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; Elias M, 2003, CAN J FOREST RES, V33, P1039, DOI [10.1139/x03-018, 10.1139/X03-018]; FFPRI, 2003, FFPRI WOOD IND HDB; Forrester JA, 2012, FOREST ECOL MANAG, V265, P124, DOI 10.1016/j.foreco.2011.10.038; Fox J, 2015, CRAN R PROJECT STAT; Fukasawa Y, 2009, J FOREST RES-JPN, V14, P20, DOI 10.1007/s10310-008-0098-0; Fukasawa Y, 2009, CAN J FOREST RES, V39, P1606, DOI 10.1139/X09-080; Garrett LG, 2008, FOREST ECOL MANAG, V255, P3839, DOI 10.1016/j.foreco.2008.03.031; Garrett LG, 2012, FOREST ECOL MANAG, V269, P116, DOI 10.1016/j.foreco.2011.12.030; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Gough CM, 2007, FOREST ECOL MANAG, V244, P60, DOI 10.1016/j.foreco.2007.03.039; Grace JB., 2015, STRUCTURAL EQUATION; Guo JF, 2014, PLANT SOIL, V385, P149, DOI 10.1007/s11104-014-2205-7; Hagemann U, 2010, FOREST ECOL MANAG, V260, P1762, DOI 10.1016/j.foreco.2010.08.018; Harmon ME, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001495; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; HARMON ME, 1995, BIOTROPICA, V27, P305, DOI 10.2307/2388916; Herrmann S, 2013, SCAND J FOREST RES, V28, P346, DOI 10.1080/02827581.2012.747622; Hiscox J, 2015, FUNGAL ECOL, V14, P24, DOI 10.1016/j.funeco.2014.11.001; Hood I. A., 2011, New Zealand Plant Protection, V64, P188; Janisch JE, 2005, ECOSCIENCE, V12, P151, DOI 10.2980/i1195-6860-12-2-151.1; Jomura M, 2007, TELLUS B, V59, P211, DOI 10.1111/j.1600-0889.2006.00234.x; Jomura M, 2008, FOREST ECOL MANAG, V255, P149, DOI 10.1016/j.foreco.2007.09.002; Kuyah S, 2012, AGR ECOSYST ENVIRON, V158, P225, DOI 10.1016/j.agee.2012.05.010; Liu WJ, 2013, FOREST ECOL MANAG, V310, P623, DOI 10.1016/j.foreco.2013.09.013; Mackensen J, 2003, SOIL BIOL BIOCHEM, V35, P177, DOI 10.1016/S0038-0717(02)00255-9; MARRA JL, 1994, CAN J FOREST RES, V24, P1811, DOI 10.1139/x94-234; Matsuoka S., 1970, B GOVT FOREST EXPT S, V232, P109; Naesset E, 1999, CAN J FOREST RES, V29, P372, DOI 10.1139/cjfr-29-3-372; Namm BH, 2011, PSWGTR19X HUMB STAT; Ohtsuka T, 2014, ECOL RES, V29, P91, DOI 10.1007/s11284-013-1102-5; Olajuyigbe S, 2012, FORESTRY, V85, P485, DOI 10.1093/forestry/cps045; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; Preston CM, 2006, BIOGEOSCIENCES, V3, P397, DOI 10.5194/bg-3-397-2006; Progar RA, 2000, OECOLOGIA, V124, P426, DOI 10.1007/PL00008868; Rajala T, 2010, CAN J FOREST RES, V40, P2384, DOI 10.1139/X10-176; Rayner ADM, 1988, FUNGAL DECOMPOSITION; Renninger HJ, 2014, J GEOPHYS RES-BIOGEO, V119, P630, DOI 10.1002/2013JG002542; Rinkes ZL, 2014, FRONT MICROBIOL, V4, P21; Rowland L, 2013, ECOSYSTEMS, V16, P1294, DOI 10.1007/s10021-013-9684-x; Schowalter TD, 2002, WOOD FIBER SCI, V34, P158; Takenami K., 1964, Journal of the Japan Wood Research Society, V10, P22; Vanderhoof M, 2013, BIOGEOCHEMISTRY, V114, P299, DOI 10.1007/s10533-012-9810-4; Wang CK, 2002, OECOLOGIA, V132, P374, DOI 10.1007/s00442-002-0987-4; Wu JB, 2010, SCAND J FOREST RES, V25, P500, DOI 10.1080/02827581.2010.524166; Yoneda T., 1978, JIBP [Japanese Committee for the International Biological Program] Synthesis, V18, P258; YONEDA T, 1975, Japanese Journal of Ecology, V25, P40; YONEDA T, 1975, Japanese Journal of Ecology, V25, P132; Yoon TK, 2014, J FOREST RES-JPN, V19, P249, DOI 10.1007/s10310-013-0412-3; [No title captured]	60	6	6	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145113	10.1371/journal.pone.0145113	http://dx.doi.org/10.1371/journal.pone.0145113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658727	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900184
J	Maeda, J; Yurkon, CR; Fujii, Y; Fujisawa, H; Kato, S; Brents, CA; Uesaka, M; Fujimori, A; Kitamura, H; Kato, TA				Maeda, Junko; Yurkon, Charles R.; Fujii, Yoshihiro; Fujisawa, Hiroshi; Kato, Sayaka; Brents, Colleen A.; Uesaka, Mitsuru; Fujimori, Akira; Kitamura, Hisashi; Kato, Takamitsu A.			Solution Radioactivated by Hadron Radiation Can Increase Sister Chromatid Exchanges	PLOS ONE			English	Article							IN-BEAM PET; INTERCELLULAR COMMUNICATION; FRAGMENT REACTION; LOW FLUENCES; ION BEAMS; CELLS; IRRADIATION; INITIATION; PARTICLES; INDUCTION	When energetic particles irradiate matter, it becomes activated by nuclear reactions. Radioactivation induced cellular effects are not clearly understood, but it could be a part of bystander effects. This investigation is aimed at understanding the biological effects from radioactivation in solution induced by hadron radiation. Water or phosphate buffered saline was activated by being exposed to hadron radiation including protons, carbon- and iron-ions. 1 mL of radioactivated solution was transferred to flasks with Chinese hamster ovary (CHO) cells cultured in 5 mL of complete media. The induction of sister chromatid exchanges (SCE) was used to observe any increase in DNA damage responses. The energy spectrum and the half-lives of the radioactivation were analyzed by NaI scintillation detector in order to identify generated radionuclides. In the radioactivated solution, 511 keV gamma-rays were observed, and their half-lives were approximately 2 min, 10 min, and 20 min. They respectively correspond to the beta+ decay of O-15, N-13, and C-11. The SCE frequencies in CHO cells increased depending on the amount of radioactivation in the solution. These were suppressed with a 2-hour delayed solution transfer or pretreatment with dimethyl sulfoxide (DMSO). Our results suggest that the SCE induction by radioactivated solution was mediated by free radicals produced by the annihilated gamma-rays. Since the SCE induction and DMSO modulation are also reported in radiation-induced bystander effects, our results imply that radioactivation of the solution may have some contribution to the bystander effects from hadron radiation. Further investigations are required to assess if radioactivation effects would attribute an additional level of cancer risk of the hadron radiation therapy itself.	[Maeda, Junko; Yurkon, Charles R.; Kato, Sayaka; Brents, Colleen A.; Kato, Takamitsu A.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Fujii, Yoshihiro] Ibaraki Prefectural Univ Hlth Sci, Dept Radiol Sci, Inashiki, Ibaraki, Japan; [Fujisawa, Hiroshi; Uesaka, Mitsuru] Univ Tokyo, Grad Sch Engn, Tokyo, Japan; [Fujimori, Akira] Natl Inst Radiol Sci, Int Open Lab, Res Ctr Charged Particle Therapy, Chiba 260, Japan; [Kitamura, Hisashi] Natl Inst Radiol Sci, Res Dev & Support Ctr, Chiba 260, Japan	Colorado State University; University of Tokyo; National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology	Kato, TA (corresponding author), Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA.	Takamitsu.Kato@Colostate.edu	Kato, Takamitsu A/D-7969-2015; Kitamura, Hisashi/AAH-5031-2020	Kitamura, Hisashi/0000-0002-3449-7364; Kato, Takamitsu/0000-0002-6263-600X	Dr. Akiko Ueno Radiobiology Fund; National Institute of Radiological Sciences President Special Grant	Dr. Akiko Ueno Radiobiology Fund; National Institute of Radiological Sciences President Special Grant	This research is partially funded by Dr. Akiko Ueno Radiobiology Fund (TAK) and National Institute of Radiological Sciences President Special Grant (HF, TAK).	Azzam EI, 2003, ONCOGENE, V22, P7050, DOI 10.1038/sj.onc.1206961; Azzam EI, 1998, RADIAT RES, V150, P497, DOI 10.2307/3579865; Azzam EI, 2001, P NATL ACAD SCI USA, V98, P473, DOI 10.1073/pnas.011417098; Bedford JS, 2002, RADIAT RES, V158, P251, DOI 10.1667/0033-7587(2002)158[0251:HACHIR]2.0.CO;2; Blyth BJ, 2011, RADIAT RES, V176, P139, DOI 10.1667/RR2548.1; Fujibuchi T, 2012, RADIAT PROT DOSIM, V148, P168, DOI 10.1093/rpd/ncr005; Fujibuchi T, 2009, RADIOL PHYS TECHNOL, V2, P159, DOI 10.1007/s12194-009-0060-7; Fujisawa H, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-91; Kanai T, 1999, INT J RADIAT ONCOL, V44, P201, DOI 10.1016/S0360-3016(98)00544-6; Kozlovsky B, 2002, ASTROPHYS J SUPPL S, V141, P523, DOI 10.1086/340545; LATT SA, 1980, AM J HUM GENET, V32, P297; Lyng FM, 2000, BRIT J CANCER, V83, P1223, DOI 10.1054/bjoc.2000.1433; Matsufuji N, 2003, PHYS MED BIOL, V48, P1605, DOI 10.1088/0031-9155/48/11/309; Matsumoto K, 2009, MAGN RESON MED, V61, P1033, DOI 10.1002/mrm.21958; Miyatake A, 2013, MED PHYS, V40, DOI 10.1118/1.4818057; Miyatake A, 2010, MED PHYS, V37, P4445, DOI 10.1118/1.3462559; Muller H, 2006, PHYS MED BIOL, V51, P1779, DOI 10.1088/0031-9155/51/7/010; MUNRO TR, 1970, RADIAT RES, V42, P451, DOI 10.2307/3572962; Nagasawa H, 2002, MUTAT RES-FUND MOL M, V508, P121, DOI 10.1016/S0027-5107(02)00193-8; NAGASAWA H, 1992, CANCER RES, V52, P6394; NAGASAWA H, 1990, MUTAT RES, V244, P233, DOI 10.1016/0165-7992(90)90134-6; Nishio T, 2005, MED PHYS, V32, P1070, DOI 10.1118/1.1879692; Pawelke J, 1996, PHYS MED BIOL, V41, P279, DOI 10.1088/0031-9155/41/2/006; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; PERRY P, 1975, NATURE, V258, P121, DOI 10.1038/258121a0; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Ra SJ, 2011, J KOREAN PHYS SOC, V59, P703, DOI 10.3938/jkps.59.703; Schall I, 1996, NUCL INSTRUM METH B, V117, P221, DOI 10.1016/0168-583X(96)00325-4; SCHARDT D, 1995, ADV SPACE RES, V17, P87; Schettino G, 2003, RADIAT RES, V160, P505, DOI 10.1667/RR3060; Siva S, 2015, CANCER LETT, V356, P82, DOI 10.1016/j.canlet.2013.09.018; TOBEY RA, 1970, J CELL BIOL, V46, P151, DOI 10.1083/jcb.46.1.151; Vincke H, 2011, RADIAT PROT DOSIM, V146, P434, DOI 10.1093/rpd/ncr245; Vinnikov V, 2012, MUTAT RES-FUND MOL M, V731, P107, DOI 10.1016/j.mrfmmm.2011.12.006; Wilson DM, 2007, MUTAT RES-FUND MOL M, V616, P11, DOI 10.1016/j.mrfmmm.2006.11.017; WOLFF S, 1975, EXP CELL RES, V93, P23, DOI 10.1016/0014-4827(75)90418-8; Zhou HN, 2000, P NATL ACAD SCI USA, V97, P2099, DOI 10.1073/pnas.030420797	37	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144619	10.1371/journal.pone.0144619	http://dx.doi.org/10.1371/journal.pone.0144619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657140	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900072
J	Pearce, G; Pinnock, H; Epiphaniou, E; Parke, HL; Heavey, E; Griffiths, CJ; Greenhalgh, T; Sheikh, A; Taylor, SJC				Pearce, Gemma; Pinnock, Hilary; Epiphaniou, Eleni; Parke, Hannah L.; Heavey, Emily; Griffiths, Christopher J.; Greenhalgh, Trish; Sheikh, Aziz; Taylor, Stephanie J. C.			Experiences of Self-Management Support Following a Stroke: A Meta-Review of Qualitative Systematic Reviews	PLOS ONE			English	Review							REHABILITATION; EFFICACY; CARE	Background Supporting self-management in stroke patients improves psychological and functional outcomes but evidence on how to achieve this is sparse. We aimed to synthesise evidence from systematic reviews of qualitative studies in an overarching meta-review to inform the delivery and development of self-management support interventions. Methods We systematically searched eight electronic databases including MEDLINE, EMBASE and CINAHL for qualitative systematic reviews (published January 1993 to June 2012). We included studies exploring patients', carers' or health care professionals' experiences relevant to self-management support following a stroke, including studies describing the lived experience of surviving a stroke. We meta-synthesised the included review findings using a meta-ethnographic framework. Results Seven reviews, reporting 130 unique studies, were included. Themes emerging from the reviews were pertinent, consistent and showed data saturation; though explicit mention of self-management support was rare. Our meta-review highlighted the devastating impact of stroke on patients' self-image; the varying needs for self-management support across the trajectory of recovery; the need for psychological and emotional support throughout recovery particularly when physical recovery plateaus; the considerable information needs of patients and carers which also vary across the trajectory of recovery; the importance of good patient-professional communication; the potential benefits of goal-setting and action-planning; and the need for social support which might be met by groups for stroke survivors. Conclusions The observed data saturation suggests that, currently, no further qualitative research simply describing the lived experience of stroke is needed; we propose that it would be more useful to focus on qualitative research informing self-management support interventions and their implementation. Our findings demonstrate both the on-going importance of self-management support and the evolving priorities throughout the stages of recovery following a stroke. The challenge now is to ensure these findings inform routine practice and the development of interventions to support self-management amongst stroke survivors.	[Pearce, Gemma] Coventry Univ, CTEHR, Coventry, W Midlands, England; [Pinnock, Hilary; Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Epiphaniou, Eleni; Parke, Hannah L.; Griffiths, Christopher J.; Taylor, Stephanie J. C.] Barts & London Queen Marys Sch Med & Dent, Ctr Primary Care & Publ Hlth, mEsh, Blizard Inst, London, England; [Heavey, Emily] Univ York, Social Policy Res Unit, York YO10 5DD, N Yorkshire, England; [Greenhalgh, Trish] Univ Oxford, Div Med Sci, Nuffield Dept Primary Care Hlth Sci, Oxford, England	Coventry University; University of Edinburgh; University of London; Queen Mary University London; University of York - UK; University of Oxford	Taylor, SJC (corresponding author), Barts & London Queen Marys Sch Med & Dent, Ctr Primary Care & Publ Hlth, mEsh, Blizard Inst, London, England.	s.j.c.taylor@qmul.ac.uk	TAYLOR, STEPHANIE/GYV-4768-2022; Greenhalgh, Trisha/B-1825-2015; Pearce, Gary/S-3830-2017	Greenhalgh, Trisha/0000-0003-2369-8088; Taylor, Stephanie/0000-0001-7454-6354; Sheikh, Aziz/0000-0001-7022-3056; Pearce, Gemma/0000-0002-2928-0048; Heavey, Emily/0000-0003-0920-7705; Pearce, Gary/0000-0003-3959-2616	National Institute for Health Research Health Services and Delivery Research Programme [11/1014/04]; Primary Care Research Career Award from the Chief Scientist's Office of the Scottish Government; National Institute for Health Research [11/1014/04, NF-SI-0512-10031] Funding Source: researchfish	National Institute for Health Research Health Services and Delivery Research Programme; Primary Care Research Career Award from the Chief Scientist's Office of the Scottish Government; National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the National Institute for Health Research Health Services and Delivery Research Programme (project number 11/1014/04. http://www.nets.nihr.ac.uk/projects/hsdr/11101404). The funders wrote the brief, called for applications, arranged peer review, and approved the study design, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript. HP was supported at the time of the study by a Primary Care Research Career Award from the Chief Scientist's Office of the Scottish Government.	Adams KM, 2004, SUMM 1 ANN CROSS QUA; [Anonymous], 2010, MULT CHRON COND STRA; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Barnett-Page E, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-59; Boger E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130990; Boger EJ, 2013, DISABIL REHABIL, V35, P1415, DOI 10.3109/09638288.2012.737080; BURY M, 1991, SOCIOL HEALTH ILL, V13, P451, DOI 10.1111/j.1467-9566.1991.tb00522.x; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Carandang R, 2006, JAMA-J AM MED ASSOC, V296, P2939, DOI 10.1001/jama.296.24.2939; Corbin J. M., 1988, UNENDING WORK CARE M; Department of Health, 2004, IMPR CHRON DIS MAN; Department of Health, 2001, EXP PAT NEW APPR CHR; Dixon-Woods M, 2008, J EVAL CLIN PRACT, V7, P125; Dixon-Woods Mary, 2005, J Health Serv Res Policy, V10, P45, DOI 10.1258/1355819052801804; Eilertsen G, 2013, J ADV NURS, V69, P514, DOI 10.1111/jan.12002; Erving Goffman, 1959, PRESENTATION SELF EV; Gallacher K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001473; Goffman E., 1963, STIGMA NOTES MANAGEM; Greenhalgh T, 2005, BRIT MED J, V331, P1064, DOI 10.1136/bmj.38636.593461.68; Hole E, 2014, SCI WORLD J, DOI 10.1155/2014/349151; Jones E. E., 1964, INGRATIATION SOCIAL; Jones F, 2011, DISABIL REHABIL, V33, P797, DOI 10.3109/09638288.2010.511415; Kung Jason, 2010, Open Dent J, V4, P84, DOI 10.2174/1874210601004020084; Lamb M, 2008, INT J EVID-BASED HEA, V6, P173, DOI 10.1111/j.1479-6988.2008.00079.x; Leary M. R, 2019, SELF PRESENTATION IM; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; LORIG K, 1984, GERONTOLOGIST, V24, P455; Lorig K R, 2001, Eff Clin Pract, V4, P256; Lui MHL, 2005, STROKE, V36, P2514, DOI 10.1161/01.STR.0000185743.41231.85; McCorkle R, 2011, CA-CANCER J CLIN, V61, P50, DOI 10.3322/caac.20093; McKevitt C, 2004, STROKE, V35, P1499, DOI 10.1161/01.STR.0000127532.64840.36; Murray J, 2003, BRIT J GEN PRACT, V53, P137; Noblit G.W., 1988, METAETHNOGRAPHY SYNT, V11; Parke HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131448; Peoples H, 2011, SCAND J OCCUP THER, V18, P163, DOI 10.3109/11038128.2010.509887; Pinnock H, 2014, HLTH SERV DELIV RES, P2, DOI DOI 10.3310/HSDR02530; Reed MC, 2012, DISABIL REHABIL, V34, P553, DOI 10.3109/09638288.2011.613511; Salter K, 2008, J REHABIL MED, V40, P595, DOI 10.2340/16501977-0238; Sarre S, 2014, DISABIL REHABIL, V36, P716, DOI 10.3109/09638288.2013.814724; Satink T, 2013, ARCH PHYS MED REHAB, V94, P1171, DOI 10.1016/j.apmr.2013.01.011; Secretary of State for Health, 2006, OUR HLTH OUR CAR OUR; Walsh ME, 2015, DISABIL REHABIL, V37, P1599, DOI 10.3109/09638288.2014.974834; Wanless D, 2001, SECURING OUR FUTURE; WHO, 2002, INNOVATIVE CARE CHRO; Williams S, 2013, BRIT J OCCUP THER, V76, P370, DOI 10.4276/030802213X13757040168351	45	41	41	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0141803	10.1371/journal.pone.0141803	http://dx.doi.org/10.1371/journal.pone.0141803			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26657458	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900004
J	Soufan, O; Ba-Alawi, W; Afeef, M; Essack, M; Rodionov, V; Kalnis, P; Bajic, VB				Soufan, Othman; Ba-Alawi, Wail; Afeef, Moataz; Essack, Magbubah; Rodionov, Valentin; Kalnis, Panos; Bajic, Vladimir B.			Mining Chemical Activity Status from High-Throughput Screening Assays	PLOS ONE			English	Article							THYROID-STIMULATING HORMONE; BLOOD-PRESSURE; IN-SILICO; INTERACTION NETWORKS; RECEPTOR; ACCURACY; PUBCHEM; MODELS; SYSTEM	High-throughput screening (HTS) experiments provide a valuable resource that reports biological activity of numerous chemical compounds relative to their molecular targets. Building computational models that accurately predict such activity status (active vs. inactive) in specific assays is a challenging task given the large volume of data and frequently small proportion of active compounds relative to the inactive ones. We developed a method, DRAMOTE, to predict activity status of chemical compounds in HTP activity assays. For a class of HTP assays, our method achieves considerably better results than the current state-of-the-art-solutions. We achieved this by modification of a minority oversampling technique. To demonstrate that DRAMOTE is performing better than the other methods, we performed a comprehensive comparison analysis with several other methods and evaluated them on data from 11 PubChem assays through 1,350 experiments that involved approximately 500,000 interactions between chemicals and their target proteins. As an example of potential use, we applied DRAMOTE to develop robust models for predicting FDA approved drugs that have high probability to interact with the thyroid stimulating hormone receptor (TSHR) in humans. Our findings are further partially and indirectly supported by 3D docking results and literature information. The results based on approximately 500,000 interactions suggest that DRAMOTE has performed the best and that it can be used for developing robust virtual screening models. The datasets and implementation of all solutions are available as a MATLAB toolbox online at www.cbrc.kaust.edu.sa/dramote and can be found on Figshare.	[Soufan, Othman; Ba-Alawi, Wail; Afeef, Moataz; Essack, Magbubah; Bajic, Vladimir B.] King Abdullah Univ Sci & Technol KAUST, Computat Biosci Res Ctr CBRC, Thuwal 239556900, Saudi Arabia; [Rodionov, Valentin] King Abdullah Univ Sci & Technol KAUST, KAUST Catalysis Ctr KCC, Thuwal 239556900, Saudi Arabia; [Kalnis, Panos] King Abdullah Univ Sci & Technol KAUST, Infocloud Grp, Comp Elect & Math Sci & Engn Div CEMSE, Thuwal 239556900, Saudi Arabia	King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology	Bajic, VB (corresponding author), King Abdullah Univ Sci & Technol KAUST, Computat Biosci Res Ctr CBRC, Thuwal 239556900, Saudi Arabia.	vladimir.bajic@kaust.edu.sa	Soufan, Othman/AAB-9324-2020; Soufan, Othman/AAZ-5986-2020; Essack, Magbubah/R-2773-2019; alawi, Wail Ba/E-6680-2016; Essack, Magbubah/G-5008-2013; Kalnis, Panos/H-2826-2014; Bajic, Vladimir/D-2810-2009; Ba Alawi, Wail/M-4890-2016	Soufan, Othman/0000-0002-4410-1853; alawi, Wail Ba/0000-0002-5218-6113; Essack, Magbubah/0000-0003-2709-5356; Kalnis, Panos/0000-0002-5060-1360; Bajic, Vladimir/0000-0001-5435-4750; Ba Alawi, Wail/0000-0002-2747-4703	KAUST; King Abdullah of Science and Technology (KAUST)	KAUST(King Abdullah University of Science & Technology); King Abdullah of Science and Technology (KAUST)	The authors thank Dr. Hammad Naveed, Ahmed Elshewy, Loqmane Seridi, Dr. Salim Bougouffa, Haitham Ashoor and Dr. Mahmut Uludag for multiple insightful and valuable discussions about experimental design and results presentation. The computational analysis for this study was performed on Dragon and SnapDragon compute clusters of Computational Bioscience Research Center at King Abdullah University of Science and Technology (KAUST). This study is supported by the KAUST base research funds of VBB and PK.; This study is supported by the King Abdullah of Science and Technology (KAUST) base research funds of VBB and PK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhondi SA, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/1758-2946-7-S1-S10; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Asvold BO, 2007, J CLIN ENDOCR METAB, V92, P841, DOI 10.1210/jc.2006-2208; Barua S, 2014, IEEE T KNOWL DATA EN, V26, P405, DOI 10.1109/TKDE.2012.232; Bishop Christopher M., 2006, PATTERN RECOGNITION; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Braga-Neto UM, 2004, BIOINFORMATICS, V20, P374, DOI 10.1093/bioinformatics/btg419; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bresso E, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-207; Bunkhumpornpat C, 2009, LECT NOTES ARTIF INT, V5476, P475, DOI 10.1007/978-3-642-01307-2_43; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chawla N. V., 2004, P OCEAN DRILLING PRO, V6, P1, DOI [DOI 10.2973/ODP.PROC.IR.207.2004, DOI 10.1145/1007730.1007733]; Chawla N. V., 2011, ARXIV11061813; Chen P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S15-S4; Cheng TJ, 2011, J CHEM INF MODEL, V51, P229, DOI 10.1021/ci100364a; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; Dudley JT, 2011, BRIEF BIOINFORM; Forman G., 2003, Journal of Machine Learning Research, V3, P1289, DOI 10.1162/153244303322753670; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hagmann M, 1997, J CARDIOVASC PHARM, V29, P444, DOI 10.1097/00005344-199704000-00003; Han LY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-401; Hao M, 2014, ANAL CHIM ACTA, V806, P117, DOI 10.1016/j.aca.2013.10.050; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Japkowicz N., 2000, Learning from Imbalanced Data Sets. Papers from the AAAI Workshop (Technical Report WS-00-05), P10; Jian WX, 2013, SINGAP MED J, V54, P401, DOI 10.11622/smedj.2013142; Kim J, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S16-S2; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Kong X, 2010, P 16 ACM SIGKDD INT; Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795; Landrum G., 2010, RDKIT Q2, VQ2, P1; Li QL, 2009, BIOINFORMATICS, V25, P3310, DOI 10.1093/bioinformatics/btp589; Liu X, 2013, BIOINFORMATICS; Liu X, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-33; Maitin-Shepard J, 2010, ROB AUT ICRA 2010 IE; MITCHELL T, 1989, ANNU REV COMPUT SCI, V4, P417; Munkhdalai T, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/1758-2946-7-S1-S9; Nagamine N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000397; Naik P, 2010, BIOORGAN MED CHEM, V18, P8418, DOI 10.1016/j.bmc.2010.10.043; Novianti PW, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0610-4; OBOYLE NM, 2011, J CHEMINFORMATICS, V3, DOI [DOI 10.1186/1758-2946-3-33, 10.1186/1758-2946-3-33]; PubChem, 2009, PUBCHEM SUBSTR FING; Rafati-Afshar AA, 2013, SYST MAN CYB SMC 201; Rao HB, 2010, J COMPUT CHEM, V31, P752, DOI 10.1002/jcc.21347; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sakakibara Y, 2012, BIOINFORMATICS, V28, P745, DOI 10.1093/bioinformatics/bts031; Santoni FA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001008; Schierz AC, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-21; Schneidman-Duhovny D, 2004, CURR MED CHEM, V11, P91, DOI 10.2174/0929867043456223; Soufan O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117988; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; Tang Y, 2006, GRAN COMP 2006 IEEE; Tang YC, 2009, IEEE T SYST MAN CY B, V39, P281, DOI 10.1109/TSMCB.2008.2002909; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Turchi F, 2011, AM J HYPERTENS, V24, P1274, DOI 10.1038/ajh.2011.144; Van Hulse J., 2007, P 24 INT C MACH LEAR, P935; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596; Wang X, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-28; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Webb SJ, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-8; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Xie XQ, 2008, J CHEM INF MODEL, V48, P465, DOI 10.1021/ci700193u; Yang SY, 2014, J STEROID BIOCHEM, V143, P460, DOI 10.1016/j.jsbmb.2014.07.001; Zakharov AV, 2014, J CHEM INF MODEL, V54, P705, DOI 10.1021/ci400737s; Zhu L, 2010, J COMPUT CHEM, V31, P1478, DOI 10.1002/jcc.21433	68	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144426	10.1371/journal.pone.0144426	http://dx.doi.org/10.1371/journal.pone.0144426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658480	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900048
J	Sun, JW; Kranzler, HR; Bi, JB				Sun, Jiangwen; Kranzler, Henry R.; Bi, Jinbo			An Effective Method to Identify Heritable Components from Multivariate Phenotypes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PRINCIPAL-COMPONENTS; OPIOID USE; DEPENDENCE; REGRESSION; COCAINE; SUBTYPES; TRAIT	Multivariate phenotypes may be characterized collectively by a variety of low level traits, such as in the diagnosis of a disease that relies on multiple disease indicators. Such multivariate phenotypes are often used in genetic association studies. If highly heritable components of a multivariate phenotype can be identified, it can maximize the likelihood of finding genetic associations. Existing methods for phenotype refinement perform unsupervised cluster analysis on low-level traits and hence do not assess heritability. Existing heritable component analytics either cannot utilize general pedigrees or have to estimate the entire covariance matrix of low-level traits from limited samples, which leads to inaccurate estimates and is often computationally prohibitive. It is also difficult for these methods to exclude fixed effects from other covariates such as age, sex and race, in order to identify truly heritable components. We propose to search for a combination of low-level traits and directly maximize the heritability of this combined trait. A quadratic optimization problem is thus derived where the objective function is formulated by decomposing the traditional maximum likelihood method for estimating the heritability of a quantitative trait. The proposed approach can generate linearly-combined traits of high heritability that has been corrected for the fixed effects of covariates. The effectiveness of the proposed approach is demonstrated in simulations and by a case study of cocaine dependence. Our approach was computationally efficient and derived traits of higher heritability than those by other methods. Additional association analysis with the derived cocaine-use trait identified genetic markers that were replicated in an independent sample, further confirming the utility and advantage of the proposed approach.	[Sun, Jiangwen; Bi, Jinbo] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA; [Kranzler, Henry R.] Univ Penn, Treatment Res Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kranzler, Henry R.] Philadelphia VAMC, Philadelphia, PA USA	University of Connecticut; University of Pennsylvania; Pennsylvania Medicine	Bi, JB (corresponding author), Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA.	jinbo@engr.uconn.edu	kranzler, henry/AAS-1113-2020	kranzler, henry/0000-0002-1018-0450	NIH; Study of Addiction: Genetics and Environment (SAGE) through the NIH Genes, Environment and Health Initiative [GEI] [U01 HG004422]; Gene Environment Association Studies (GENEVA) under GEI; NIH [R01DA037349]; NSF [DBI-1356655]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037349] Funding Source: NIH RePORTER; Direct For Biological Sciences [1356655] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Study of Addiction: Genetics and Environment (SAGE) through the NIH Genes, Environment and Health Initiative [GEI]; Gene Environment Association Studies (GENEVA) under GEI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Joel Gelernter, M.D., from Yale University who was instrumental in recruiting, characterizing, and genotyping the subjects in the SSADDA dataset used here. Kathleen Brady, M. D., Ph.D., of the Medical University of South Carolina, Roger Weiss, M.D., of McLean Hospital and Harvard Medical School, and David Oslin, M.D., of the University of Pennsylvania Perelman School of Medicine oversaw study recruitment at their respective sites. Funding support for that work was provided by NIH.; Funding support for the Study of Addiction: Genetics and Environment (SAGE) was provided through the NIH Genes, Environment and Health Initiative [GEI] (U01 HG004422). SAGE is one of the genome-wide association studies funded as part of the Gene Environment Association Studies (GENEVA) under GEI. The dataset used for the analyses described in this manuscript were obtained from dbGaP at http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000092.v1.p1 through dbGaP accession number phs000092.v1.p.; This work was supported by NIH grant R01DA037349 and NSF grant DBI-1356655.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Balding DJ, 2008, HDB STAT GENETICS; Berry DP, 2012, J ANIM SCI, V90, P109, DOI 10.2527/jas.2011-4245; Bi JB, 2014, AM J MED GENET B, V165, P148, DOI 10.1002/ajmg.b.32216; Bierut LJ, 2008, DRUG ALCOHOL DEPEN, V95, P14, DOI 10.1016/j.drugalcdep.2007.11.023; Boligon AA, 2009, S AFR J ANIM SCI, V39, P145; Chan G, 2011, ADDICTION, V106, P1146, DOI 10.1111/j.1360-0443.2011.03390.x; Connor EE, 2012, FEED EFFICIENCY BEEF; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; de los Campos G, 2010, NAT REV GENET, V11, P880, DOI 10.1038/nrg2898; Gelernter J, 2014, MOL PSYCHIATR, V19, P717, DOI 10.1038/mp.2013.99; Gelernter J, 2014, MOL PSYCHIATR, V19, P41, DOI 10.1038/mp.2013.145; Gelernter J, 2014, BIOL PSYCHIAT, V76, P66, DOI 10.1016/j.biopsych.2013.08.034; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hu VW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019067; Karp R. M., 2002, NOT AM MATH SOC, V49, P544; Klei L, 2008, GENET EPIDEMIOL, V32, P9, DOI 10.1002/gepi.20257; Kranzler HR, 2008, ADDICT BEHAV, V33, P41, DOI 10.1016/j.addbeh.2007.05.011; LANGE K, 1976, ANN HUM GENET, V39, P485, DOI 10.1111/j.1469-1809.1976.tb00156.x; Lange K, 2013, BIOINFORMATICS, V29, P1568, DOI 10.1093/bioinformatics/btt187; Lehrmann E, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000114; Li MX, 2012, HUM GENET, V131, P747, DOI 10.1007/s00439-011-1118-2; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Meier L, 2008, J R STAT SOC B, V70, P53, DOI 10.1111/j.1467-9868.2007.00627.x; National Institutes of Health, 2009, STUD ADD GEN ENV SAG; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Ott J, 1999, HUM HERED, V49, P106, DOI 10.1159/000022854; Oualkacha K, 2012, STAT APPL GENET MOL, V11, DOI 10.2202/1544-6115.1711; Pierucci-Lagha A, 2007, DRUG ALCOHOL DEPEN, V91, P85, DOI 10.1016/j.drugalcdep.2007.04.014; Soriano FX, 2009, EPIGENETICS-US, V4, P152, DOI 10.4161/epi.4.3.8753; Sun JW, 2012, ADDICT BEHAV, V37, P1138, DOI 10.1016/j.addbeh.2012.05.010; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vapnik V., 1998, STAT LEARNING THEORY; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Wang JC, 2012, ANNU REV GENOM HUM G, V13, P241, DOI 10.1146/annurev-genom-090711-163844; Wang YJ, 2007, HUM HERED, V64, P182, DOI 10.1159/000102991; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340	38	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144418	10.1371/journal.pone.0144418	http://dx.doi.org/10.1371/journal.pone.0144418			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658140	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900046
J	van Loon, K; van Zaane, B; Bosch, EJ; Kalkman, CJ; Peelen, LM				van Loon, Kim; van Zaane, Bas; Bosch, Els J.; Kalkman, Cor J.; Peelen, Linda M.			Non-Invasive Continuous Respiratory Monitoring on General Hospital Wards: A Systematic Review	PLOS ONE			English	Review							INTENSIVE-CARE-UNIT; DIAGNOSTIC-ACCURACY; MORTALITY; IMPACT; DOCUMENTATION; ADMISSIONS; ALARMS; TRIAL	Background Failure to recognize acute deterioration in hospitalized patients may contribute to cardiopulmonary arrest, unscheduled intensive care unit admission and increased mortality. Purpose In this systematic review we aimed to determine whether continuous non-invasive respiratory monitoring improves early diagnosis of patient deterioration and reduces critical incidents on hospital wards. Data Sources Studies were retrieved from Medline, Embase, CINAHL, and the Cochrane library, searched from 1970 till October 25, 2014. Study Selection Electronic databases were searched using keywords and corresponding synonyms 'ward', 'continuous', 'monitoring' and 'respiration'. Pediatric, fetal and animal studies were excluded. Data Extraction Since no validated tool is currently available for diagnostic or intervention studies with continuous monitoring, methodological quality was assessed with a modified tool based on modified STARD, CONSORT, and TREND statements. Data Synthesis Six intervention and five diagnostic studies were included, evaluating the use of eight different devices for continuous respiratory monitoring. Quantitative data synthesis was not possible because intervention, study design and outcomes differed considerably between studies. Outcomes estimates for the intervention studies ranged from RR 0.14 (0.03, 0.64) for cardiopulmonary resuscitation to RR 1.00 (0.41, 2.35) for unplanned ICU admission after introduction of continuous respiratory monitoring, Limitations The methodological quality of most studies was moderate, e.g. 'before-after' designs, incomplete reporting of primary outcomes, and incomplete clinical implementation of the monitoring system. Conclusions Based on the findings of this systematic review, implementation of routine continuous non- invasive respiratory monitoring on general hospital wards cannot yet be advocated as results are inconclusive, and methodological quality of the studies needs improvement. Future research in this area should focus on technology explicitly suitable for low care settings and tailored alarm and treatment algorithms.	[van Loon, Kim; van Zaane, Bas; Bosch, Els J.; Kalkman, Cor J.; Peelen, Linda M.] Univ Med Ctr Utrecht, Div Anesthesiol Intens Care & Emergency Med, Utrecht, Netherlands; [Peelen, Linda M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Loon, K (corresponding author), Univ Med Ctr Utrecht, Div Anesthesiol Intens Care & Emergency Med, Utrecht, Netherlands.	K.vanLoon-3@umcutrecht.nl	Kalkman, Cor/O-3215-2019	Kalkman, Cor/0000-0002-8372-6960				ANDERSON W, 1992, J CLIN ANESTH, V4, P289, DOI 10.1016/0952-8180(92)90131-J; Bellomo R, 2003, MED J AUSTRALIA, V179, P283, DOI 10.5694/j.1326-5377.2003.tb05548.x; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Brown H, 2014, AM J MED, V115, P421; Buist M, 2004, RESUSCITATION, V62, P137, DOI 10.1016/j.resuscitation.2004.03.005; Burgess LPA, 2009, J ADV NURS, V65, P1844, DOI 10.1111/j.1365-2648.2009.05048.x; Campbell Michael J, 2012, BMJ, V344, pe1001, DOI 10.1136/bmj.e1001; Chambrin MC, 2001, CRIT CARE, V5, P184, DOI 10.1186/cc1021; Cretikos M, 2007, RESUSCITATION, V73, P62, DOI 10.1016/j.resuscitation.2006.08.020; Cretikos MA, 2008, MED J AUSTRALIA, V188, P657; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Edworthy J, 2006, BRIT J ANAESTH, V97, P12, DOI 10.1093/bja/ael114; Ferrante di Ruffano L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e686; FIESELMANN JF, 1993, J GEN INTERN MED, V8, P354, DOI 10.1007/BF02600071; Flisberg P, 2002, J CLIN ANESTH, V14, P129, DOI 10.1016/S0952-8180(01)00369-5; Folke M, 2003, MED BIOL ENG COMPUT, V41, P377, DOI 10.1007/BF02348078; Goldhill DR, 2004, BRIT J ANAESTH, V92, P882, DOI 10.1093/bja/aeh113; Goldhill DR, 1999, ANAESTHESIA, V54, P529, DOI 10.1046/j.1365-2044.1999.00837.x; Hagenouw RRPM, 2007, CURR OPIN ANESTHESIO, V20, P590, DOI 10.1097/ACO.0b013e3282f10dff; Hassanien AE, 2013, COMPUT BIOL CHEM, V47, P37, DOI 10.1016/j.compbiolchem.2013.04.007; Hillman K, 2005, LANCET, V365, P2091; Hillman KM, 2001, INTERN MED J, V31, P343, DOI 10.1046/j.1445-5994.2001.00077.x; Hravnak M, 2008, ARCH INTERN MED, V168, P1300, DOI 10.1001/archinte.168.12.1300; Hravnak M, 2011, CRIT CARE MED, V39, P65, DOI 10.1097/CCM.0b013e3181fb7b1c; Jacobs JL, 2007, J ADV NURS, V57, P472, DOI 10.1111/j.1365-2648.2006.04161.x; Jonsson T, 2011, NURS CRIT CARE, V16, P164, DOI 10.1111/j.1478-5153.2011.00427.x; Kisner D, 2009, EUR J CARDIO-THORAC, V35, P111, DOI 10.1016/j.ejcts.2008.08.015; Lighthall GK, 2009, RESUSCITATION, V80, P1264, DOI 10.1016/j.resuscitation.2009.08.012; McGain F, 2008, MED J AUSTRALIA, V189, P380, DOI 10.5694/j.1326-5377.2008.tb02083.x; Moons KGM, 2004, CLIN CHEM, V50, P473, DOI 10.1373/clinchem.2003.024752; Ochroch EA, 2006, ANESTH ANALG, V102, P868, DOI 10.1213/01.ane.0000195583.76486.c4; Rosenberg AL, 2000, CHEST, V118, P492, DOI 10.1378/chest.118.2.492; Rosenberg AL, 2001, CRIT CARE MED, V29, P511, DOI 10.1097/00003246-200103000-00008; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Taenzer AH, 2011, ANESTHESIOLOGY, V115, P421, DOI 10.1097/ALN.0b013e318219d633; Taenzer AH, 2010, ANESTHESIOLOGY, V112, P282, DOI 10.1097/ALN.0b013e3181ca7a9b; Van den Bruel A, 2007, J CLIN EPIDEMIOL, V60, P1116, DOI 10.1016/j.jclinepi.2007.03.015; Watkinson PJ, 2006, ANAESTHESIA, V61, P1031, DOI 10.1111/j.1365-2044.2006.04818.x; Whiting P, 2000, BMC MED RES METHODOL, V3, P25; Zimlichman E, 2012, J HOSP MED, V7, P628, DOI 10.1002/jhm.1963	41	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144626	10.1371/journal.pone.0144626	http://dx.doi.org/10.1371/journal.pone.0144626			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658343	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900076
J	Wang, LJ; Wang, JG; Zhang, XY; Li, J; Wei, XY; Cheng, J; Ling, Q; Xie, HY; Zhou, L; Xu, X; Zheng, SS				Wang, Lijun; Wang, Jianguo; Zhang, Xuanyu; Li, Jie; Wei, Xuyong; Cheng, Jun; Ling, Qi; Xie, Haiyang; Zhou, Lin; Xu, Xiao; Zheng, Shusen			Diagnostic Value of Preoperative Needle Biopsy for Tumor Grading Assessment in Hepatocellular Carcinoma	PLOS ONE			English	Article							LIVER-TRANSPLANTATION; MICROVASCULAR INVASION; NATIONWIDE SURVEY; RESECTION; IMPACT; COMPLICATIONS; METASTASIS; RECURRENCE; EXPRESSION; SELECTION	Background Needle core biopsy (NCB) is one of the most widely used and accepted methods for the diagnosis of focal hepatic lesions. Although many studies have assessed the diagnostic accuracy of NCB in predicting the tumor grade, it is still under debate. Objective To identify the influence of number of biopsies on NCB diagnostic accuracy. Methods 153 patients with HCC were selected from patients who received preoperative NCB under the guidance of ultrasonography in our hospital. The diagnostic reference standard was the surgical pathologic diagnosis. Results Using a 3-tier grading scheme (well, moderate and poor), the accuracy of NCB has no significant differences among different number of passes in HCC <= 5cm. For HCC > 5 <= 8cm, the increasing number of passes could increase the diagnostic accuracy (63.3%, 81.8%, and 84.8% for passes one, two, and three, respectively). While in HCC>8cm, the diagnostic accuracy of passes one, two, and three were 62.1%, 69%, and 75.8%, respectively. Conclusions The accuracy of NCB in assessing tumor grading associated with tumor size and number of passes. Meanwhile, a minimum of two passes should be performed to get better accuracy in patients with HCC > 5cm.	[Wang, Lijun] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China; [Cheng, Jun; Ling, Qi; Xu, Xiao; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Jianguo; Zhang, Xuanyu; Li, Jie; Wei, Xuyong; Ling, Qi; Xie, Haiyang; Zhou, Lin; Zheng, Shusen] Minist Publ Hlth, Key Lab Combined Multiorgan Transplantat, Hangzhou, Zhejiang, Peoples R China; [Xie, Haiyang; Zhou, Lin; Xu, Xiao; Zheng, Shusen] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Xu, X (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China.	zdyyxx@163.com; zyzss@zju.edu.cn			National High-tech R&D Program of China (863 Program) [2012AA020204]; National science and technology major projects [2012ZX10002010-001-005]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Chang Jiang Scholars Program; Program for New Century Excellent Talents in University" of the Ministry of Education of China	National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); National science and technology major projects; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Chang Jiang Scholars Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program for New Century Excellent Talents in University" of the Ministry of Education of China(Program for New Century Excellent Talents in University (NCET))	This study was supported by the National High-tech R&D Program of China (863 Program) (No. 2012AA020204), National science and technology major projects (No. 2012ZX10002010-001-005), Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents, Chang Jiang Scholars Program and "Program for New Century Excellent Talents in University" of the Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki AK, 2008, NATURE, V456, P443, DOI 10.1038/456443c; Barreto SG, 2013, ANZ J SURG, V83, P331, DOI 10.1111/j.1445-2197.2012.06196.x; Braune C, 2001, Z GASTROENTEROL, V39, P789, DOI 10.1055/s-2001-17188; Cheah YL, 2012, LIVER CANCER, V1, P183, DOI 10.1159/000343832; Cillo U, 2004, ANN SURG, V239, P150, DOI 10.1097/01.sla.0000109146.72827.76; Colecchia A, 2011, J HEPATOL, V54, P300, DOI 10.1016/j.jhep.2010.06.037; Davison JM, 2014, MODERN PATHOL, V27, P1521, DOI 10.1038/modpathol.2014.37; Diamond DL, 2006, HEPATOLOGY, V44, P299, DOI 10.1002/hep.21318; Durand F, 2001, J HEPATOL, V35, P254, DOI 10.1016/S0168-8278(01)00108-8; Esnaola NF, 2002, J GASTROINTEST SURG, V6, P224, DOI 10.1016/S1091-255X(01)00015-4; Frilling A, 2002, ANN SURG, V235, P604, DOI 10.1097/00000658-200204000-00023; FROEHLICH F, 1993, DIGEST DIS SCI, V38, P1480, DOI 10.1007/BF01308607; Han DH, 2013, J GASTROEN HEPATOL, V28, P1384, DOI 10.1111/jgh.12200; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Ikai I, 2004, CANCER-AM CANCER SOC, V101, P796, DOI 10.1002/cncr.20426; Iwatsuki S, 2000, J AM COLL SURGEONS, V191, P389, DOI 10.1016/S1072-7515(00)00688-8; Kaido T, 2013, SURGERY, V154, P1053, DOI 10.1016/j.surg.2013.04.056; KENMOCHI K, 1987, LIVER, V7, P18; Llovet JM, 1998, HEPATOLOGY, V27, P1572, DOI 10.1002/hep.510270616; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Ng KKC, 2004, ARCH SURG-CHICAGO, V139, P193, DOI 10.1001/archsurg.139.2.193; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Pawlik TM, 2007, ANN SURG, V245, P435, DOI 10.1097/01.sla.0000250420.73854.ad; PERRAULT J, 1978, GASTROENTEROLOGY, V74, P103; Roayaie S, 2002, ANN SURG, V235, P533, DOI 10.1097/00000658-200204000-00012; Shah SA, 2007, SURGERY, V141, P330, DOI 10.1016/j.surg.2006.06.028; Shin E, 2014, PATHOL ONCOL RES, V20, P667, DOI 10.1007/s12253-014-9747-0; Soga T, 2011, J HEPATOL, V55, P896, DOI 10.1016/j.jhep.2011.01.031; Sutcliffe R, 2006, BRIT J SURG, V93, P11, DOI 10.1002/bjs.5198; Tamura S, 2001, ARCH SURG-CHICAGO, V136, P25, DOI 10.1001/archsurg.136.1.25; Thorgeirsson SS, 2006, J HEPATOL, V44, P798, DOI 10.1016/j.jhep.2006.01.008; Uenishi T, 2001, DIGEST SURG, V18, P225, DOI 10.1159/000050137; Wang JB, 2013, DISASTER ADV, V6, P93; Wu LM, 2013, HEPATOB PANCREAT DIS, V12, P54, DOI 10.1016/S1499-3872(13)60006-5; Xu X, 2016, GUT, V65, P1035, DOI 10.1136/gutjnl-2014-308513; Yao FY, 2007, AM J TRANSPLANT, V7, P2587, DOI 10.1111/j.1600-6143.2007.01965.x; Yao FY, 2001, HEPATOLOGY, V33, P1394, DOI 10.1053/jhep.2001.24563; Zheng SS, 2008, TRANSPLANTATION, V85, P1726, DOI 10.1097/TP.0b013e31816b67e4; Zhou Zhanru, 2013, ScientificWorldJournal, V2013, P458797, DOI 10.1155/2013/458797	39	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144216	10.1371/journal.pone.0144216	http://dx.doi.org/10.1371/journal.pone.0144216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658912	gold, Green Published			2022-12-27	WOS:000366715900032
J	Wang, XC; Xue, QH; Yan, FX; Liu, JP; Li, SJ; Hu, SS				Wang, Xiaocou; Xue, Qinghua; Yan, Fuxia; Liu, Jinping; Li, Shoujun; Hu, Shengshou			Ulinastatin Protects against Acute Kidney Injury in Infant Piglets Model Undergoing Surgery on Hypothermic Low-Flow Cardiopulmonary Bypass	PLOS ONE			English	Article							N-ACETYLCYSTEINE; RENAL INJURY; INFLAMMATION; INHIBITOR; DURATION	Objective Infants are more vulnerable to kidney injuries induced by inflammatory response syndrome and ischemia-reperfusion injury following cardiopulmonary bypass especially with prolonged hypothermic low-flow (HLF). This study aims to evaluate the protective role of ulinastatin, an anti-inflammatory agent, against acute kidney injuries in infant piglets model undergoing surgery on HLF cardiopulmonary bypass. Methods Eighteen general-type infant piglets were randomly separated into the ulinastatin group (Group U, n = 6), the control group (Group C, n = 6), and the sham operation group (Group S, n = 6), and anaesthetized. The groups U and C received following experimental procedure: median thoracotomy, routine CPB and HLF, and finally weaned from CPB. The group S only underwent sham median thoracotomy. Ulinastatin at a dose of 5,000 units/kg body weight and a certain volume of saline were administrated to animals of the groups U and C at the beginning of CPB and at aortic declamping, respectively. Venous blood samples were collected at 3 different time points: after anesthesia induction in all experimental groups, 5 minutes, and 120 minutes after CPB in the Groups U and C. Markers for inflammation and acute kidney injury were tested in the collected plasma. N-acetyl-beta-D-glucosaminidase (NAG) from urine, markers of oxidative stress injury and TUNEL-positive cells in kidney tissues were also detected. Results The expressions of plasma inflammatory markers and acute kidney injury markers increased both in Group U and Group C at 5 min and 120 min after CPB. Also, numbers of TUNEL-positive cells and oxidative stress markers in kidney rose in both groups. At the time point of 120-min after CPB, compared with the Group C, some plasma inflammatory and acute kidney injury markers as well as TUNEL-positive cells and oxidative stress markers in kidney were significantly reduced in the Group U. Histologic analyses showed that HLF promoted acute tubular necrosis and dilatation. Conclusions HLF cardiopulmonary bypass surgery could intensify systemic inflammatory responses and oxidative stress on infant piglets, thus causing acute kidney injury. Ulinastatin might reduce such inflammatory response and oxidative stress and the extent of kidney injury.	[Wang, Xiaocou] Wenzhou Med Univ, Affiliated Hosp 2, Dept Anesthesiol Crit Care & Pain Med, Wenzhou, Zhejiang, Peoples R China; [Wang, Xiaocou; Xue, Qinghua; Yan, Fuxia] Chinese Acad Med Sci, Dept Anesthesiol, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Wang, Xiaocou; Xue, Qinghua; Yan, Fuxia; Liu, Jinping; Li, Shoujun; Hu, Shengshou] Peking Union Med Coll, Beijing 100021, Peoples R China; [Liu, Jinping] Chinese Acad Med Sci, Dept Cardiopulm Bypass, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Li, Shoujun; Hu, Shengshou] Chinese Acad Med Sci, Dept Surg, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China	Wenzhou Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Yan, FX (corresponding author), Chinese Acad Med Sci, Dept Anesthesiol, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China.	yanfuxia@sina.com			National Key Basic Research Development Program (973 Program); Ministry of Science and Technology of People's Republic of China [2010CB529507]	National Key Basic Research Development Program (973 Program)(National Basic Research Program of China); Ministry of Science and Technology of People's Republic of China(Ministry of Science and Technology, China)	This research was supported by a grant funded from the National Key Basic Research Development Program (973 Program) and by a project funded by the Ministry of Science and Technology of People's Republic of China (Project name: Basic research of congenital heart disease formation, development and intervention; Grant Recipient: Shengshou Hu; Grant Number: 2010CB529507; [http://www.most.gov.cn/]).	Nguyen B, 2014, J THORAC CARDIOV SUR, V148, P690, DOI 10.1016/j.jtcvs.2013.12.048; Blinder JJ, 2012, J THORAC CARDIOV SUR, V143, P368, DOI 10.1016/j.jtcvs.2011.06.021; Brown JR, 2010, ANN THORAC SURG, V90, P1142, DOI 10.1016/j.athoracsur.2010.04.039; Day J R S, 2005, Int J Surg, V3, P129, DOI 10.1016/j.ijsu.2005.04.002; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Goebel U, 2010, ANESTH ANALG, V111, P29, DOI 10.1213/ANE.0b013e3181e0cca4; Herget-Rosenthal S, 2004, KIDNEY INT, V66, P1115, DOI 10.1111/j.1523-1755.2004.00861.x; Jiang C, 2013, EXP THER MED, V5, P197, DOI 10.3892/etm.2012.737; Kanai T, 2011, CIRCULATION, V124, P2822, DOI 10.1161/CIRCULATIONAHA.111.028423; Kumar AB, 2012, J CARDIOTHOR VASC AN, V26, P64, DOI 10.1053/j.jvca.2011.07.007; Li XY, 2015, EXP THER MED, V9, P411, DOI 10.3892/etm.2014.2088; Mariscalco G, 2011, ANN THORAC SURG, V92, P1539, DOI 10.1016/j.athoracsur.2011.04.123; Moussavian MR, 2007, TRANSPL INT, V20, P884, DOI 10.1111/j.1432-2277.2007.00538.x; Nakanishi K, 2006, CRIT CARE MED, V34, P1351, DOI 10.1097/01.CCM.0000215110.55899.AE; Nishiyama T, 2001, CRIT CARE MED, V29, P1979, DOI 10.1097/00003246-200110000-00021; Park KH, 2010, J KOREAN MED SCI, V25, P128, DOI 10.3346/jkms.2010.25.1.128; Pastuszko P, 2012, J THORAC CARDIOV SUR, V143, P1436, DOI 10.1016/j.jtcvs.2012.01.018; Qu XF, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-107; Seitz S, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13744; Sleeman P, 2013, CRIT CARE, V17, DOI 10.1186/cc13092; Sugita T, 2002, J CARDIOVASC SURG, V43, P437; [王晓凑 Wang Xiaocou], 2012, [实用儿科临床杂志, Journal of Applied Clinical Pediatrics], V27, P50; Zhang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113973; Zhu JQ, 2007, J THORAC CARDIOV SUR, V133, P696, DOI 10.1016/j.jtcvs.2006.09.046	24	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144516	10.1371/journal.pone.0144516	http://dx.doi.org/10.1371/journal.pone.0144516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656098	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900060
J	Willems, C; Herdzin, J; Martens, S				Willems, Charlotte; Herdzin, Johannes; Martens, Sander			Individual Differences in Temporal Selective Attention as Reflected in Pupil Dilation	PLOS ONE			English	Article							WORKING-MEMORY; BLINK; TASK; MAGNITUDE	Background Attention is restricted for the second of two targets when it is presented within 200-500 ms of the first target. This attentional blink (AB) phenomenon allows one to study the dynamics of temporal selective attention by varying the interval between the two targets (T1 and T2). Whereas the AB has long been considered as a robust and universal cognitive limitation, several studies have demonstrated that AB task performance greatly differs between individuals, with some individuals showing no AB whatsoever. Methodology/Principal Findings Here, we studied these individual differences in AB task performance in relation to differences in attentional timing. Furthermore, we investigated whether AB magnitude is predictive for the amount of attention allocated to T1. For both these purposes pupil dilation was measured, and analyzed with our recently developed deconvolution method. We found that the dynamics of temporal attention in small versus large blinkers differ in a number of ways. Individuals with a relatively small AB magnitude seem better able to preserve temporal order information. In addition, they are quicker to allocate attention to both T1 and T2 than large blinkers. Although a popular explanation of the AB is that it is caused by an unnecessary overinvestment of attention allocated to T1, a more complex picture emerged from our data, suggesting that this may depend on whether one is a small or a large blinker. Conclusion The use of pupil dilation deconvolution seems to be a powerful approach to study the temporal dynamics of attention, bringing us a step closer to understanding the elusive nature of the AB. We conclude that the timing of attention to targets may be more important than the amount of allocated attention in accounting for individual differences.	[Willems, Charlotte; Herdzin, Johannes; Martens, Sander] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands; [Willems, Charlotte; Herdzin, Johannes; Martens, Sander] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands	University of Groningen; University of Groningen	Willems, C (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands.	charlot.willems@gmail.com		Martens, Sander/0000-0001-8237-7984	Research School of Behavioral and Cognitive Neurosciences	Research School of Behavioral and Cognitive Neurosciences	This work was supported by the Research School of Behavioral and Cognitive Neurosciences - CW/SM, http://www.rug.nl/research/behavioural-cognitive-neurosciences/?lang = en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, V19; Akyurek EG, 2012, J EXP PSYCHOL HUMAN, V38, P1448, DOI 10.1037/a0027610; Arnell KM, 2006, MEM COGNITION, V34, P1472, DOI 10.3758/BF03195912; Arnell KM, 2010, PSYCHOL RES-PSYCH FO, V74, P1, DOI 10.1007/s00426-008-0200-4; Colzato LS, 2007, PSYCHON B REV, V14, P1051, DOI 10.3758/BF03193090; Di Lollo V, 2005, PSYCHOL RES-PSYCH FO, V69, P191, DOI 10.1007/s00426-004-0173-x; DUX PE, 2008, PLOS ONE, V3; Feinstein JS, 2004, CONSCIOUS COGN, V13, P323, DOI 10.1016/j.concog.2003.10.004; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; HOEKS B, 1993, BEHAV RES METH INSTR, V25, P16, DOI 10.3758/BF03204445; Klein C, 2011, INTELLIGENCE, V39, P27, DOI 10.1016/j.intell.2010.11.004; Kuznetsova A., 2013, LMERTEST TESTS RANDO; MacLean MH, 2012, ATTEN PERCEPT PSYCHO, V74, P1080, DOI 10.3758/s13414-012-0338-4; MacLean MH, 2012, BRAIN COGNITION, V78, P218, DOI 10.1016/j.bandc.2011.12.010; MacLean MH, 2010, COGNITION EMOTION, V24, P1431, DOI 10.1080/02699930903417897; Martens S, 2006, ACTA PSYCHOL, V123, P204, DOI 10.1016/j.actpsy.2006.01.001; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; Martens S, 2009, EXP PSYCHOL, V56, P33, DOI 10.1027/1618-3169.56.1.33; McArthur G, 1999, NEUROREPORT, V10, P3691, DOI 10.1097/00001756-199911260-00042; McLaughlin EN, 2001, Q J EXP PSYCHOL-A, V54, P169, DOI 10.1080/02724980042000075; McLean GMT, 2009, SCI STUD READ, V13, P334, DOI 10.1080/10888430903001365; Olivers CNL, 2007, PSYCHOL RES-PSYCH FO, V71, P126, DOI 10.1007/s00426-005-0029-z; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Olivers CNL, 2005, PSYCHOL SCI, V16, P265, DOI 10.1111/j.0956-7976.2005.01526.x; Preacher KJ, 2005, PSYCHOL METHODS, V10, P178, DOI 10.1037/1082-989X.10.2.178; R Development Core Team, 2012, R LANG ENV STAT COMP; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Sarkar D., 2019, NLME LINEAR NONLINEA; Shapiro K, 2006, NEUROREPORT, V17, P163, DOI 10.1097/01.wnr.0000195670.37892.1a; Slagter HA, 2012, J COGNITIVE NEUROSCI, V24, P1932, DOI 10.1162/jocn_a_00255; Slagter HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010556; Taatgen NA, 2009, COGNITIVE PSYCHOL, V59, P1, DOI 10.1016/j.cogpsych.2008.12.002; Troche SJ, 2013, COGN PROCESS, V14, P273, DOI 10.1007/s10339-013-0553-5; van Vugt MK, 2014, CONSCIOUS COGN, V23, P32, DOI 10.1016/j.concog.2013.11.001; Visser TAW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033265; Vogel EK, 2002, PSYCHON B REV, V9, P739, DOI 10.3758/BF03196329; Wierda SM, 2012, P NATL ACAD SCI USA, V109, P8456, DOI 10.1073/pnas.1201858109; Wierda SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015024; Willems C, 2015, J COGN NEUROSCI ACCE; Willems C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066185; Wyble B, 2009, J EXP PSYCHOL HUMAN, V35, P787, DOI 10.1037/a0013902	41	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145056	10.1371/journal.pone.0145056	http://dx.doi.org/10.1371/journal.pone.0145056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26660976	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900176
J	Xu, CY; Shi, XM; Ji, A; Shi, LN; Zhou, C; Cui, YQ				Xu, Changyan; Shi, Xiaomei; Ji, An; Shi, Lina; Zhou, Chen; Cui, Yunqi			Fabrication and Characteristics of Reduced Graphene Oxide Produced with Different Green Reductants	PLOS ONE			English	Article							GRAPHITE OXIDE; AQUEOUS DISPERSIONS; CHEMICAL-REDUCTION; RAMAN-SPECTROSCOPY; FACILE SYNTHESIS; VITAMIN-C; NANOSHEETS; FILMS; CONDUCTIVITY; HYDRAZINE	There has been an upsurge of green reductants for the preparation of graphene materials taking consideration of human health and the environment in recent years. In this paper, reduced graphene oxides (RGOs) were prepared by chemical reduction of graphene oxide (GO) with three green reductants, L-ascorbic acid (L-AA), D-glucose (D-GLC) and tea poly-phenol (TP), and comparatively characterized by X-ray photoelectron spectroscopy (XPS), Fourier transform infrared (FTIR) spectra, Raman spectra and electrical conductivity analysis. Results showed that all these three reductants were effective to remove oxygen-containing functional groups in GO and restore the electrical conductivity of the obtained RGO. The RGO sample with L-ascorbic acid as a reductant and reduced with the existence of ammonia had the highest electrical conductivity (9.8 S.cm(-1)) among all the obtained RGO samples. The mechanisms regarding to the reduction of GO and the dispersion of RGO in water were also proposed. It is the good dispersibility of reduced graphene oxide in water that will facilitate its further use in composite materials and conductive ink.	[Xu, Changyan; Shi, Xiaomei; Ji, An; Shi, Lina; Zhou, Chen; Cui, Yunqi] Nanjing Forestry Univ, Packaging Engn Dept, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University	Xu, CY (corresponding author), Nanjing Forestry Univ, Packaging Engn Dept, Nanjing, Jiangsu, Peoples R China.	changyanxu1999@163.com	Cui, Yunqi/GXH-1829-2022	Xu, Changyan/0000-0003-4370-9784	Education Department of Jiangsu Province; Science and Technology Department of Jiangsu Province; Nanjing Forestry University; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Research and popularization of key techniques of functional electromagnetic shielding composites [BC2013432]; Research and innovation project of the academic degree graduate students in Jiangsu Province [KYLX15_0935]	Education Department of Jiangsu Province; Science and Technology Department of Jiangsu Province; Nanjing Forestry University; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Research and popularization of key techniques of functional electromagnetic shielding composites; Research and innovation project of the academic degree graduate students in Jiangsu Province	The first Project name is "A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)." It can be accessed at http://jsycw.ec.js.edu.cn/. The funding institution is The Education Department of Jiangsu Province. The second Project name is "Research and popularization of key techniques of functional electromagnetic shielding composites (Grant No. BC2013432)." It can be accessed at http://210.73.128.105/cpsb/CPSB/login.jsp?typ = nolog. The funding institution is Science and Technology Department of Jiangsu Province. CYX received these two fundings. The third Project name is "Research and innovation project of the academic degree graduate students in Jiangsu Province (KYLX15_0935)." It can be accessed at http://gsnfu.njfu.edu.cn/html/69/13965.html. The funding institution is Nanjing Forestry University. XMS received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financially supported by "A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)", "Research and popularization of key techniques of functional electromagnetic shielding composites (Grant No. BC2013432)" and "Research and innovation project of the academic degree graduate students in Jiangsu Province (KYLX15_0935)."	Amini S, 2011, J MATER SCI, V46, P6255, DOI 10.1007/s10853-011-5432-9; Chen D, 2012, CHEM REV, V112, P6027, DOI 10.1021/cr300115g; Chua CK, 2013, J MATER CHEM A, V1, P1892, DOI 10.1039/c2ta00665k; Dua V, 2010, ANGEW CHEM INT EDIT, V49, P2154, DOI 10.1002/anie.200905089; Fan XB, 2008, ADV MATER, V20, P4490, DOI 10.1002/adma.200801306; Feng YY, 2012, CARBOHYD POLYM, V87, P644, DOI 10.1016/j.carbpol.2011.08.039; Fernandez-Merino MJ, 2010, J PHYS CHEM C, V114, P6426, DOI 10.1021/jp100603h; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052; Finn DJ, 2014, J MATER CHEM C, V2, P925, DOI 10.1039/c3tc31993h; Gao J, 2010, CHEM MATER, V22, P2213, DOI 10.1021/cm902635j; Gao YH, 2014, IND ENG CHEM RES, V53, P16777, DOI 10.1021/ie502675z; He DF, 2014, AICHE J, V60, P2757, DOI 10.1002/aic.14499; Hernandez Y, 2008, NAT NANOTECHNOL, V3, P563, DOI 10.1038/nnano.2008.215; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Ismach A, 2010, NANO LETT, V10, P1542, DOI 10.1021/nl9037714; Kang D, 2015, MATER CHEM PHYS, V149, P129, DOI 10.1016/j.matchemphys.2014.09.055; Kim K, 2014, CARBON, V66, P172, DOI 10.1016/j.carbon.2013.08.055; Kong D, 2012, LANGMUIR, V28, P13467, DOI 10.1021/la301775d; Kudin KN, 2008, NANO LETT, V8, P36, DOI 10.1021/nl071822y; Lee D, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.06FD21; Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451; Liao RJ, 2011, J PHYS CHEM C, V115, P20740, DOI 10.1021/jp2068683; Liu PB, 2013, MATER LETT, V91, P125, DOI 10.1016/j.matlet.2012.09.085; Loryuenyong V, 2013, ADV MATER SCI ENG, V2013, DOI 10.1155/2013/923403; Luo DC, 2011, J PHYS CHEM C, V115, P11327, DOI 10.1021/jp110001y; Mao F, 2015, J MATER SCI, V50, P6518, DOI 10.1007/s10853-015-9212-9; Marks J, 1985, VITAMINS THEIR ROLE; Moon IK, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1067; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Obata S, 2013, CARBON, V55, P126, DOI 10.1016/j.carbon.2012.12.018; Pantea D, 2003, APPL SURF SCI, V217, P181, DOI 10.1016/S0169-4332(03)00550-6; Park S, 2011, CARBON, V49, P3019, DOI 10.1016/j.carbon.2011.02.071; Pasrija D, 2015, LWT-FOOD SCI TECHNOL, V64, P289, DOI 10.1016/j.lwt.2015.05.054; Pei SF, 2010, CARBON, V48, P4466, DOI 10.1016/j.carbon.2010.08.006; Shao YL, 2015, CHEM SOC REV, V44, P3639, DOI 10.1039/c4cs00316k; Shin HJ, 2009, ADV FUNCT MATER, V19, P1987, DOI 10.1002/adfm.200900167; Song P, 2012, RSC ADV, V2, P1168, DOI 10.1039/c1ra00934f; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Staudenmaier L., 1898, EUR J INORG CHEM, V31, P1481, DOI 10.1002/cber.18980310237; Su XQ, 2013, ADV POWDER TECHNOL, V24, P317, DOI 10.1016/j.apt.2012.08.003; Sutter P, 2009, NAT MATER, V8, P171, DOI 10.1038/nmat2392; Pham TA, 2011, COLLOID SURFACE A, V384, P543, DOI 10.1016/j.colsurfa.2011.05.019; Tung VC, 2009, NAT NANOTECHNOL, V4, P25, DOI 10.1038/NNANO.2008.329; Venkanna M, 2014, AIP CONF PROC, V1591, P574, DOI 10.1063/1.4872679; WANG Y, 1990, CHEM MATER, V2, P557, DOI 10.1021/cm00011a018; Wang Y, 2011, ACS APPL MATER INTER, V3, P1127, DOI 10.1021/am1012613; Xu YX, 2008, J AM CHEM SOC, V130, P5856, DOI 10.1021/ja800745y; Yang XM, 2010, POLYMER, V51, P3431, DOI 10.1016/j.polymer.2010.05.034; Zhang JL, 2010, CHEM COMMUN, V46, P1112, DOI 10.1039/b917705a; Zhao N, 2014, J PHYS CHEM SOLIDS, V75, P1141, DOI 10.1016/j.jpcs.2014.05.008; Zhao WF, 2010, J MATER CHEM, V20, P5817, DOI 10.1039/c0jm01354d; Zhou TN, 2011, COMPOS SCI TECHNOL, V71, P1266, DOI 10.1016/j.compscitech.2011.04.016; Zhou XZ, 2010, CHEM COMMUN, V46, P6974, DOI 10.1039/c0cc01681k; Zhu CZ, 2010, ACS NANO, V4, P2429, DOI 10.1021/nn1002387	56	78	80	7	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144842	10.1371/journal.pone.0144842	http://dx.doi.org/10.1371/journal.pone.0144842			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658644	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900116
J	Zhou, HX; Jiang, Y; Nie, LW; Yin, HZ; Li, HF; Dong, XM; Zhao, FF; Zhang, HH; Pu, YG; Huang, ZF; Song, JL; Sun, ET				Zhou, Huaxing; Jiang, Yuan; Nie, Liuwang; Yin, Huazong; Li, Haifeng; Dong, Xianmei; Zhao, Feifei; Zhang, Huanhuan; Pu, Youguang; Huang, Zhenfeng; Song, Jiaolian; Sun, Entao			The Historical Speciation of Mauremys Sensu Lato: Ancestral Area Reconstruction and Interspecific Gene Flow Level Assessment Provide New Insights	PLOS ONE			English	Article							FRESH-WATER TURTLE; TESTUDINES; PHYLOGEOGRAPHY; PHYLOGENY; SELECTION; JAPONICA; ORIGIN; MA	Mauremys sensu lato was divided into Mauremys, Chinemys, Ocadia, and Annamemys based on earlier research on morphology. Phylogenetic research on this group has been controversial because of disagreements regarding taxonomy, and the historical speciation is still poorly understood. In this study, 32 individuals of eight species that are widely distributed in Eurasia were collected. The complete mitochondrial (mt) sequences of 14 individuals of eight species were sequenced. Phylogenetic relationships, interspecific divergence times, and ancestral area reconstructions were explored using mt genome data (10,854 bp). Subsequent interspecific gene flow level assessment was performed using five unlinked polymorphic microsatellite loci. The Bayesian and maximum likelihood analyses revealed a paraphyletic relationship among four old genera (Mauremys, Annamemys, Chinemys, and Ocadia) and suggested the four old genera should be merged into the genus (Mauremys). Ancestral area reconstruction and divergence time estimation suggested Southeast Asia may be the area of origin for the common ancestral species of this genus and genetic drift may have played a decisive role in species divergence due to the isolated event of a glacial age. However, M. japonica may have been speciated due to the creation of the island of Japan. The detection of extensive gene flow suggested no vicariance occurred between Asia and Southeast Asia. Inconsistent results between gene flow assessment and phylogenetic analysis revealed the hybrid origin of M. mutica (Southeast Asian). Here ancestral area reconstruction and interspecific gene flow level assessment were first used to explore species origins and evolution of Mauremys sensu lato, which provided new insights on this genus.	[Zhou, Huaxing; Nie, Liuwang; Yin, Huazong; Li, Haifeng; Dong, Xianmei; Zhao, Feifei; Zhang, Huanhuan; Pu, Youguang; Huang, Zhenfeng; Song, Jiaolian] Prov Key Lab Conservat & Exploitat Res Biol Resou, Wuhu, Anhui, Peoples R China; [Zhou, Huaxing; Nie, Liuwang; Yin, Huazong; Li, Haifeng; Zhang, Huanhuan] Anhui Normal Univ, Life Sci Coll, Wuhu, Peoples R China; [Jiang, Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China; [Sun, Entao] Wannan Med Coll, Dept Med Parasitol, Wuhu, Peoples R China	Anhui Normal University; Chinese Academy of Sciences; Institute of Zoology, CAS; Wannan Medical College	Nie, LW (corresponding author), Prov Key Lab Conservat & Exploitat Res Biol Resou, Wuhu, Anhui, Peoples R China.	lwnie@mail.ahnu.edu.cn	jiang, anyi/GPT-0379-2022	Nie, Liu-Wang/0000-0003-2660-5799; Zhou, Huaxing/0000-0002-5569-0083	National Natural Science Foundation of China (NSFC) [31372198, 30970351]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (NSFC, No. 31372198 and 30970351)(http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; Barth D, 2004, ZOOL SCR, V33, P213, DOI 10.1111/j.0300-3256.2004.00150.x; Barth Dana, 2003, Salamandra, V38, P233; Dornburg A, 2011, SYST BIOL, V60, P519, DOI 10.1093/sysbio/syr019; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duellman WE, 1999, PATTERNS DISTRIBUTIO; Feldman Chris R., 2004, Asiatic Herpetological Research, V10, P28; Fritz U, 2006, ZOOL SCR, V35, P97, DOI 10.1111/j.1463-6409.2005.00218.x; Green M.R., 2012, MOL CLONING LAB MANU; Hartl Daniel L., 1997; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hirayama R., 1984, Studia Geologica Salmanticensia Volumen Especial, V1, P141; Honda M, 2002, J ZOOL SYST EVOL RES, V40, P195, DOI 10.1046/j.1439-0469.2002.00176.x; Jijun L., 2001, QUAT SCI, V21, P381, DOI DOI 10.3321/J.ISSN:1001-7410.2001.05.001; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lourenco JM, 2012, MOL PHYLOGENET EVOL, V62, P496, DOI 10.1016/j.ympev.2011.10.022; Maruyama S, 1997, ISL ARC, V6, P121, DOI 10.1111/j.1440-1738.1997.tb00043.x; Le M, 2014, ORG DIVERS EVOL, V14, P279, DOI 10.1007/s13127-014-0169-3; Parham JF, 2001, ASIAN HERPETOL RES, V9, P71; Qi Y, 2014, MOL ECOL, V23, P5575, DOI 10.1111/mec.12960; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; Spinks PQ, 2004, MOL PHYLOGENET EVOL, V32, P164, DOI 10.1016/j.ympev.2003.12.015; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stuart BL, 2007, CONSERV GENET, V8, P169, DOI 10.1007/s10592-006-9159-0; Suzuki D, 2011, J ZOOL SYST EVOL RES, V49, P141, DOI 10.1111/j.1439-0469.2010.00577.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vamberger M, 2014, ZOOL SCR, V43, P313, DOI 10.1111/zsc.12055; Vamberger M, 2013, ORG DIVERS EVOL, V13, P77, DOI 10.1007/s13127-012-0102-6; van Dijk PP, 2012, CHELON RES MONOGR, V5, DOI [DOI 10.3854/CRM.5.000.CHECKLIST.V7.2014, 10.3854/crm.5.000]; Wink Michael, 2001, Zoologische Abhandlungen (Dresden), V51, P41; Yeh F.C., 1997, MOL BIOL BIOTECHNOL, V10, P295; Yu Y, 2015, MOL PHYLOGENET EVOL, V87, P46, DOI 10.1016/j.ympev.2015.03.008; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhang LQ, 2012, MOL BIOL REP, V39, P8315, DOI 10.1007/s11033-012-1681-1; Zhou T, 2004, ATLAS IDENTIFICATION	37	10	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144711	10.1371/journal.pone.0144711	http://dx.doi.org/10.1371/journal.pone.0144711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657158	Green Published, gold			2022-12-27	WOS:000366715900091
J	Dixit, M; Raghuvanshi, A; Gupta, CP; Kureel, J; Mansoori, MN; Shukla, P; John, AA; Singh, K; Purohit, D; Awasthi, P; Singh, D; Goel, A				Dixit, Manisha; Raghuvanshi, Ashutosh; Gupta, Chandra Prakash; Kureel, Jyoti; Mansoori, Mohd Nizam; Shukla, Priyanka; John, Aijaz A.; Singh, Kavita; Purohit, Dipak; Awasthi, Pallavi; Singh, Divya; Goel, Atul			Medicarpin, a Natural Pterocarpan, Heals Cortical Bone Defect by Activation of Notch and Wnt Canonical Signaling Pathways	PLOS ONE			English	Article							OSTEOGENIC ACTIVITY; REGENERATION; INJURY; INFLAMMATION; DEFICIENCY; COMPONENTS; CATENIN	We evaluated the bone regeneration and healing effect of Medicarpin (med) in cortical bone defect model that heals by intramembranous ossification. For the study, female Sprague-Dawley rats were ovariectomized and rendered osteopenic. A drill hole injury was generated in mid femoral bones of all the animals. Med treatment was commenced the day after and continued for 15 days. PTH was taken as a reference standard. Fifteen days post-treatment, animals were sacrificed. Bones were collected for histomorphometry studies at the injury site by micro-computed tomography (mu CT) and confocal microscopy. RNA and protein was harvested from newly generated bone. For immunohistochemistry, 5 mu m sections of decalcified femur bone adjoining the drill hole site were cut. By mu CT analysis and calcein labeling of newly generated bone it was found that med promotes bone healing and new bone formation at the injury site and was comparable to PTH in many aspects. Med treatment led to increase in the Runx-2 and osteocalcin signals indicating expansion of osteo-progenitors at the injury site as evaluated by qPCR and immunohistochemical localization. It was observed that med promoted bone regeneration by activating canonical Wnt and notch signaling pathway. This was evident by increased transcript and protein levels of Wnt and notch signaling components in the defect region. Finally, we confirmed that med treatment leads to elevated bone healing in pre-osteoblasts by co localization of beta catenin with osteoblast marker alkaline phosphatase. In conclusion, med treatment promotes new bone regeneration and healing at the injury site by activating Wnt/canonical and notch signaling pathways. This study also forms a strong case for evaluation of med in delayed union and non-union fracture cases.	[Dixit, Manisha; Kureel, Jyoti; Mansoori, Mohd Nizam; Shukla, Priyanka; John, Aijaz A.; Singh, Divya] CSIR Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India; [Dixit, Manisha; Kureel, Jyoti; Mansoori, Mohd Nizam; Shukla, Priyanka; John, Aijaz A.; Singh, Divya] CSIR Cent Drug Res Inst, Ctr Res Anabol Skeletal Targets Hlth & Illness AS, Lucknow, Uttar Pradesh, India; [Raghuvanshi, Ashutosh; Gupta, Chandra Prakash; Purohit, Dipak; Awasthi, Pallavi; Goel, Atul] CSIR Cent Drug Res Inst, Div Med & Proc Chem, Lucknow, Uttar Pradesh, India; [Singh, Kavita] CSIR Cent Drug Res Inst, Sophisticated Anal & Instrumentat Facil, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Singh, D (corresponding author), CSIR Cent Drug Res Inst, Div Endocrinol, BS 10-1,Sect 10, Lucknow, Uttar Pradesh, India.	divya_singh@cdri.res.in; atul_goel@cdri.res.in			Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI); Department of Biotechnology; Council of Scientific and Industrial Research; University Grants Commission, Government of India	Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI); Department of Biotechnology; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, Government of India(University Grants Commission, India)	Study supported by Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI), Fellowship grants from the Department of Biotechnology (MD), Council of Scientific and Industrial Research (AR, CPG, JK, MNM, KS, AAJ), University Grants Commission (PS), Government of India.; Fellowship grants from the Department of Biotechnology (MD), Council of Scientific and Industrial Research (AR, CPG, JK, MNM, KS, AAJ), University Grants Commission (PS), Government of India. Authors are thankful to SAIF division for use of confocal microscopy facility and Mr. G.K Nagar for histology related experiments.	Barnes GL, 2008, J BONE JOINT SURG AM, V90A, P120, DOI 10.2106/JBJS.G.01443; Bhargavan B, 2012, J NUTR BIOCHEM, V23, P27, DOI 10.1016/j.jnutbio.2010.11.002; Brandi ML, 2012, EXPERT OPIN INV DRUG, V21, P1169, DOI 10.1517/13543784.2012.696610; Campbell TM, 2003, CALCIFIED TISSUE INT, V73, P49, DOI 10.1007/s00223-002-2120-4; COUSO JP, 1994, CELL, V79, P259, DOI 10.1016/0092-8674(94)90195-3; Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66; Dishowitz MI, 2012, J ORTHOP RES, V30, P296, DOI 10.1002/jor.21518; Durao SFO, 2012, INT J ORAL MAX IMPL, V27, P1400; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Espinosa L, 2003, J BIOL CHEM, V278, P32227, DOI 10.1074/jbc.M304001200; Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, P1; Gittens SA, 2004, J PHARM PHARM SCI, V7, P27; Goel AK., 2014, U.S. Patent, Patent No. [8,686,028, 8686028]; Goel A, 2013, CHEM REV, V113, P1614, DOI 10.1021/cr300219y; Goel A, 2012, ORG BIOMOL CHEM, V10, P9583, DOI 10.1039/c2ob25722j; Kakar S, 2007, J BONE MINER RES, V22, P1903, DOI 10.1359/JBMR.070724; Lenton K, 2011, GENESIS, V49, P784, DOI 10.1002/dvg.20768; Lin GL, 2011, J CELL BIOCHEM, V112, P3491, DOI 10.1002/jcb.23287; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; Matsushita Y, 2013, J BIOL CHEM, V288, P19973, DOI 10.1074/jbc.M113.454652; Maurya R, 2009, BIOORG MED CHEM LETT, V19, P610, DOI 10.1016/j.bmcl.2008.12.064; McBride-Gagyi SH, 2015, BONE, V81, P533, DOI 10.1016/j.bone.2015.09.003; McGee-Lawrence ME, 2013, BIOCHEM BIOPH RES CO, V441, P886, DOI 10.1016/j.bbrc.2013.10.155; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Monfoulet L, 2010, BONE, V46, P447, DOI 10.1016/j.bone.2009.09.007; Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18; Pandey R, 2010, MENOPAUSE, V17, P602, DOI 10.1097/gme.0b013e3181d0f7f0; Pietrogrande L, 2009, INT J WOMENS HEALTH, V1, P193; Sharan K, 2011, J BONE MINER RES, V26, P2096, DOI 10.1002/jbmr.434; Shen J, 2013, TISSUE ENG PT A, V19, P2390, DOI [10.1089/ten.tea.2012.0519, 10.1089/ten.TEA.2012.0519]; Sikon A, 2010, INT J WOMENS HEALTH, V2, P37; Tanaka K, 2010, BONE, V47, P1006, DOI 10.1016/j.bone.2010.08.016; Tyagi AM, 2010, MOL CELL ENDOCRINOL, V325, P101, DOI 10.1016/j.mce.2010.05.016; Warden SJ, 2009, BONE, V44, P485, DOI 10.1016/j.bone.2008.11.007; Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.tea.2010.0555, 10.1089/ten.TEA.2010.0555]	36	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144541	10.1371/journal.pone.0144541	http://dx.doi.org/10.1371/journal.pone.0144541			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657206	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903600053
J	Hasegawa, K; Tanaka, S; Fujiki, F; Morimoto, S; Nakajima, H; Tatsumi, N; Nakata, J; Takashima, S; Nishida, S; Tsuboi, A; Oka, Y; Oji, Y; Kumanogoh, A; Sugiyama, H; Hosen, N				Hasegawa, Kana; Tanaka, Satomi; Fujiki, Fumihiro; Morimoto, Soyoko; Nakajima, Hiroko; Tatsumi, Naoya; Nakata, Jun; Takashima, Satoshi; Nishida, Sumiyuki; Tsuboi, Akihiro; Oka, Yoshihiro; Oji, Yusuke; Kumanogoh, Atsushi; Sugiyama, Haruo; Hosen, Naoki			An Immunocompetent Mouse Model for MLL/AF9 Leukemia Reveals the Potential of Spontaneous Cytotoxic T-Cell Response to an Antigen Expressed in Leukemia Cells	PLOS ONE			English	Article							WT1 PEPTIDE VACCINATION; TUMOR; LYMPHOCYTES; RECEPTOR; TRANSFORMATION; TRANSPLANTATION; IDENTIFICATION; MAINTENANCE; PROGENITOR; REMISSION	Leukemia differs substantially with respect to stromal milieu from tumors that progress locally as solid masses, and the physiological importance of immunosurveillance in leukemia remains unclear. However, currently available mouse leukemia models have critical limitations in the context of analyzing immunological regulation of leukemia development. In this study, we transferred mouse MLL/AF9 leukemia-initiating cells into immunocompetent recipient mice without any pre-conditioning such as irradiation, and then analyzed the spontaneous T cell response to an immunogenic antigen expressed in leukemia cells. When the minimum numbers of leukemia-initiating cells for engraftment were transferred, leukemia cells were eradicated by the adaptive immune response in most, if not all, wild-type mice, but not in Rag2(-/-) recipient mice, which lack adaptive immunity. By contrast, mice transplanted with larger numbers of leukemia cells always developed leukemia. In mice with advanced leukemia, antigen-specific CTLs were also expanded, but were unresponsive to antigen stimulation and expressed high levels of PD-1 and LAG-3. These results provide the first clear demonstration that the spontaneous CTL response to a tumor-cell antigen has the potential to eradicate leukemia, whereas antigen-specific CTLs are exhausted in animals with advanced leukemia. This immunocompetent mouse leukemia model provides a useful platform for developing effective immunotherapies against leukemia.	[Hasegawa, Kana; Fujiki, Fumihiro; Nakajima, Hiroko; Oka, Yoshihiro] Osaka Univ, Dept Canc Immunol, Grad Sch Med, Suita, Osaka, Japan; [Hasegawa, Kana; Tanaka, Satomi; Morimoto, Soyoko; Tatsumi, Naoya; Sugiyama, Haruo] Osaka Univ, Dept Funct Diagnost Sci, Grad Sch Med, Suita, Osaka, Japan; [Nakata, Jun; Tsuboi, Akihiro] Osaka Univ, Dept Canc Immunotherapy, Grad Sch Med, Suita, Osaka, Japan; [Takashima, Satoshi; Nishida, Sumiyuki; Oka, Yoshihiro; Kumanogoh, Atsushi] Osaka Univ, Dept Resp Med Allergy & Rheumat Dis, Grad Sch Med, Suita, Osaka, Japan; [Oka, Yoshihiro; Kumanogoh, Atsushi] Osaka Univ, Dept Immunopathol, Immunol Frontier Res Ctr WP1, Suita, Osaka, Japan; [Oji, Yusuke; Hosen, Naoki] Osaka Univ, Dept Canc Stem Cell Biol, Grad Sch Med, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Osaka University	Hosen, N (corresponding author), Osaka Univ, Dept Canc Stem Cell Biol, Grad Sch Med, Suita, Osaka, Japan.	hnaoki@imed3.med.osaka-u.ac.jp		Nakata, Jun/0000-0002-7494-1204	Ministry of Education, Culture, Sports, Science and Technology of Japan [23130509]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research (Grant 23130509) (to N.H.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bai AL, 2008, P NATL ACAD SCI USA, V105, P13003, DOI 10.1073/pnas.0805599105; Bocchia M, 1996, BLOOD, V87, P3587, DOI 10.1182/blood.V87.9.3587.bloodjournal8793587; Chapuis AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004916; Chiba Y, 2010, JPN J CLIN ONCOL, V40, P395, DOI 10.1093/jjco/hyp196; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; DuPage M, 2011, CANCER CELL, V19, P72, DOI 10.1016/j.ccr.2010.11.011; Feuerer M, 2003, NAT MED, V9, P1151, DOI 10.1038/nm914; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Gao LQ, 2000, BLOOD, V95, P2198, DOI 10.1182/blood.V95.7.2198.007k38_2198_2203; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Greiner J, 2005, BLOOD, V106, P938, DOI 10.1182/blood-2004-12-4787; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hashii Y, 2012, LEUKEMIA, V26, P530, DOI 10.1038/leu.2011.226; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Keilholz U, 2009, BLOOD, V113, P6541, DOI 10.1182/blood-2009-02-202598; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Liu XV, 2012, J IMMUNOL, V189, P1826, DOI 10.4049/jimmunol.1200965; Lyman MA, 2004, J IMMUNOL, V172, P6558, DOI 10.4049/jimmunol.172.11.6558; Maeda T, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.29; Masaki A, 2013, J IMMUNOL, V191, P135, DOI 10.4049/jimmunol.1202692; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Molldrem JJ, 1997, BLOOD, V90, P2529, DOI 10.1182/blood.V90.7.2529.2529_2529_2534; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Muller-Schmah C, 2012, ANN HEMATOL, V91, P27, DOI 10.1007/s00277-011-1332-y; Mumprecht S, 2009, BLOOD, V114, P1528, DOI 10.1182/blood-2008-09-179697; Nakata J, 2014, LEUKEMIA, V28, P1316, DOI 10.1038/leu.2013.374; Ohminami H, 2000, BLOOD, V95, P286; Oka Y, 2004, P NATL ACAD SCI USA, V101, P13885, DOI 10.1073/pnas.0405884101; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Rusakiewicz S, 2009, CANCER IMMUNOL IMMUN, V58, P1449, DOI 10.1007/s00262-009-0703-x; Sachs Z, 2014, BLOOD, V124, P3274, DOI 10.1182/blood-2013-08-521708; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Slany RK, 1998, MOL CELL BIOL, V18, P122, DOI 10.1128/MCB.18.1.122; So CW, 2004, BLOOD, V103, P3192, DOI 10.1182/blood-2003-10-3722; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Speiser DE, 1997, J EXP MED, V186, P645, DOI 10.1084/jem.186.5.645; Stubbs MC, 2008, LEUKEMIA, V22, P66, DOI 10.1038/sj.leu.2404951; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Zhang L, 2013, J CLIN INVEST, V123, P1999, DOI 10.1172/JCI63980; Zhang L, 2009, BLOOD, V114, P1545, DOI 10.1182/blood-2009-03-206672	50	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144594	10.1371/journal.pone.0144594	http://dx.doi.org/10.1371/journal.pone.0144594			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658107	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903600061
J	Muelken, P; Schmidt, CE; Shelley, D; Tally, L; Harris, AC				Muelken, Peter; Schmidt, Clare E.; Shelley, David; Tally, Laura; Harris, Andrew C.			A Two-Day Continuous Nicotine Infusion Is Sufficient to Demonstrate Nicotine Withdrawal in Rats as Measured Using Intracranial Self-Stimulation	PLOS ONE			English	Article							BRAIN REWARD FUNCTION; REINFORCEMENT THRESHOLD; TOBACCO; SENSITIZATION; DEPENDENCE; RECEPTORS; EXPOSURE; NEUROBIOLOGY; TOLERANCE; ADDICTION	Avoidance of the negative affective (emotional) symptoms of nicotine withdrawal (e.g., anhedonia, anxiety) contributes to tobacco addiction. Establishing the minimal nicotine exposure conditions required to demonstrate negative affective withdrawal signs in animals, as well as understanding moderators of these conditions, could inform tobacco addiction-related research, treatment, and policy. The goal of this study was to determine the minimal duration of continuous nicotine infusion required to demonstrate nicotine withdrawal in rats as measured by elevations in intracranial self-stimulation (ICSS) thresholds (anhedonia-like behavior). Administration of the nicotinic acetylcholine receptor antagonist mecamylamine (3.0 mg/kg, s.c.) on alternate test days throughout the course of a 2-week continuous nicotine infusion (3.2 mg/kg/day via osmotic minipump) elicited elevations in ICSS thresholds beginning on the second day of infusion. Magnitude of antagonist-precipitated withdrawal did not change with further nicotine exposure and mecamylamine injections, and was similar to that observed in a positive control group receiving mecamylamine following a 14-day nicotine infusion. Expression of a significant withdrawal effect was delayed in nicotine-infused rats receiving mecamylamine on all test days rather than on alternate test days. In a separate study, rats exhibited a transient increase in ICSS thresholds following cessation of a 2-day continuous nicotine infusion (3.2 mg/kg/day). Magnitude of this spontaneous withdrawal effect was similar to that observed in rats receiving a 9-day nicotine infusion. Our findings demonstrate that rats exhibit antagonist-precipitated and spontaneous nicotine withdrawal following a 2-day continuous nicotine infusion, at least under the experimental conditions studied here. Magnitude of these effects were similar to those observed in traditional models involving more prolonged nicotine exposure. Further development of these models, including evaluation of more clinically relevant nicotine dosing regimens and other measures of nicotine withdrawal (e.g., anxiety-like behavior, somatic signs), may be useful for understanding the development of the nicotine withdrawal syndrome.	[Muelken, Peter; Schmidt, Clare E.; Shelley, David; Tally, Laura; Harris, Andrew C.] Minneapolis Med Res Fdn Inc, Minneapolis, MN 55404 USA; [Muelken, Peter] Univ Minnesota, Dept Ecol Evolut & Behav, Minneapolis, MN 55455 USA; [Schmidt, Clare E.] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA; [Harris, Andrew C.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Harris, Andrew C.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA	Minneapolis Medical Research Foundation; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Harris, AC (corresponding author), Minneapolis Med Res Fdn Inc, Minneapolis, MN 55404 USA.	harr0547@umn.edu			Minneapolis Medical Research Foundation (MMRF) Translational Addiction Research Program [07639]	Minneapolis Medical Research Foundation (MMRF) Translational Addiction Research Program	This work was funded by Minneapolis Medical Research Foundation (MMRF) Translational Addiction Research Program, award #07639, awarded to A.C.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker TB, 2004, PSYCHOL REV, V111, P33, DOI 10.1037/0033-295X.111.1.33; Balfour DJK, 2015, CURR TOP BEHAV NEURO, V24, P99, DOI 10.1007/978-3-319-13482-6_4; Benowitz NL, 2008, AM J MED, V121, pS3, DOI 10.1016/j.amjmed.2008.01.015; BENOWITZ NL, 1982, CLIN PHARMACOL THER, V32, P758, DOI 10.1038/clpt.1982.233; BENOWITZ NL, 1984, CLIN PHARMACOL THER, V35, P499, DOI 10.1038/clpt.1984.67; BLASIG J, 1973, PSYCHOPHARMACOLOGIA, V33, P19; Bruijnzeel AW, 2007, NEUROPSYCHOPHARMACOL, V32, P955, DOI 10.1038/sj.npp.1301192; Bruijnzeel AW, 2010, PSYCHOPHARMACOLOGY, V212, P485, DOI 10.1007/s00213-010-1970-0; Bruijnzeel AW, 2009, BIOL PSYCHIAT, V66, P110, DOI 10.1016/j.biopsych.2009.01.010; Carlezon WA, 2007, NAT PROTOC, V2, P2987, DOI 10.1038/nprot.2007.441; CARNEY RM, 1984, NEW ENGL J MED, V310, P614, DOI 10.1056/NEJM198403083101002; Cohen Ami, 2013, Front Psychiatry, V4, P41, DOI 10.3389/fpsyt.2013.00041; Craig EL, 2014, DRUG METAB DISPOS, V42, P1447, DOI 10.1124/dmd.114.058719; Cryan JF, 2003, PSYCHOPHARMACOLOGY, V168, P347, DOI 10.1007/s00213-003-1445-7; Damaj MI, 2003, J PHARMACOL EXP THER, V307, P526, DOI 10.1124/jpet.103.054908; Dani JA, 1996, NEURON, V16, P905, DOI 10.1016/S0896-6273(00)80112-9; Dani JA, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012138; Debruyne D, 2003, J PHARM SCI-US, V92, P1051, DOI 10.1002/jps.10302; DiFranza JR, 2007, ARCH PEDIAT ADOL MED, V161, P704, DOI 10.1001/archpedi.161.7.704; DiFranza JR, 2007, NICOTINE TOB RES, V9, P9, DOI 10.1080/14622200601078277; DiFranza JR, 2012, BRAIN SCI, V2, P523, DOI 10.3390/brainsci2040523; DiFranza JR, 2010, HARM REDUCT J, V7, DOI 10.1186/1477-7517-7-26; DiFranza JR, 2005, NICOTINE TOB RES, V7, P9, DOI 10.1080/14622200412331328538; Donny EC, 1998, PSYCHOPHARMACOLOGY, V136, P83, DOI 10.1007/s002130050542; Donny EC, 2012, NICOTINE TOB RES, V14, P1319, DOI 10.1093/ntr/nts162; Doubeni CA, 2010, PEDIATRICS, V125, P1127, DOI 10.1542/peds.2009-0238; Epping-Jordan MP, 1998, NATURE, V393, P76, DOI 10.1038/30001; Etter JF, 2006, ADDICTION, V101, P362, DOI 10.1111/j.1360-0443.2005.01289.x; Fenster CP, 1999, J NEUROSCI, V19, P4804; Gould TJ, 2014, BRAIN RES, V1559, P1, DOI 10.1016/j.brainres.2014.02.038; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Grebenstein P, 2013, PHARMACOL BIOCHEM BE, V114, P70, DOI 10.1016/j.pbb.2013.10.020; Grebenstein PE, 2015, DRUG ALCOHOL DEPEN, V151, P181, DOI 10.1016/j.drugalcdep.2015.03.030; Harris AC, 2005, PSYCHOPHARMACOLOGY, V178, P353, DOI 10.1007/s00213-005-2155-0; Harris AC, 2013, PSYCHOPHARMACOLOGY, V225, P291, DOI 10.1007/s00213-012-2814-x; Harris AC, 2011, PSYCHOPHARMACOLOGY, V217, P153, DOI 10.1007/s00213-011-2273-9; Harris AC, 2010, PHARMACOL BIOCHEM BE, V96, P217, DOI 10.1016/j.pbb.2010.05.008; Harrison AA, 2001, NEUROPSYCHOPHARMACOL, V25, P55, DOI 10.1016/S0893-133X(00)00237-2; Harrison AA, 2001, J PHARMACOL EXP THER, V297, P316; Hatsukami DK, 2013, NICOTINE TOB RES, V15, P1003, DOI 10.1093/ntr/nts214; Hatsukami DK, 2010, TOB CONTROL, V19, DOI 10.1136/tc.2009.035584; Hilario MRF, 2012, NEUROPSYCHOPHARMACOL, V37, P2661, DOI 10.1038/npp.2012.130; Hughes JR, 2007, NICOTINE TOB RES, V9, P329, DOI 10.1080/14622200701188927; HUGHES JR, 1990, RES ADV ALCOHOL DRUG, V10, P317; HUGHES JR, 1986, ARCH GEN PSYCHIAT, V43, P289; HUSTONLYONS D, 1992, PHARMACOL BIOCHEM BE, V41, P755, DOI 10.1016/0091-3057(92)90223-3; Igari M, 2014, NEUROPSYCHOPHARMACOL, V39, P445, DOI 10.1038/npp.2013.216; Jackson KJ, 2015, NEUROPHARMACOLOGY, V96, P223, DOI 10.1016/j.neuropharm.2014.11.009; Johnson PM, 2008, PHARMACOL BIOCHEM BE, V90, P409, DOI 10.1016/j.pbb.2008.03.024; Kenny PJ, 2005, J NEUROSCI, V25, P6208, DOI 10.1523/JNEUROSCI.4785-04.2005; Kenny PJ, 2003, J PHARMACOL EXP THER, V306, P1068, DOI 10.1124/jpet.103.052027; Kenny PJ, 2001, PHARMACOL BIOCHEM BE, V70, P531, DOI 10.1016/S0091-3057(01)00651-7; Killen JD, 2003, ADDICT BEHAV, V28, P461, DOI 10.1016/S0306-4603(01)00266-0; Kirshenbaum A, 2015, PSYCHOPHARMACOLOGY, V232, P1583, DOI 10.1007/s00213-014-3792-y; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; LeSage MG, 2002, PHARMACOL BIOCHEM BE, V72, P279, DOI 10.1016/S0091-3057(01)00775-4; Littleton J, 2001, ADDICTION, V96, P87, DOI 10.1046/j.1360-0443.2001.961877.x; Liu JA, 2004, PHARMACOL BIOCHEM BE, V79, P101, DOI 10.1016/j.pbb.2004.06.006; Malin David H, 2009, Handb Exp Pharmacol, P401, DOI 10.1007/978-3-540-69248-5_14; Manbeck KE, 2014, PHARMACOL BIOCHEM BE, V116, P84, DOI 10.1016/j.pbb.2013.11.002; MARKOU A, 1992, PHYSIOL BEHAV, V51, P111, DOI 10.1016/0031-9384(92)90211-J; Markou A, 2008, PHILOS T R SOC B, V363, P3159, DOI 10.1098/rstb.2008.0095; MARKS MJ, 1983, J PHARMACOL EXP THER, V226, P817; Marshall DL, 1997, J NEUROCHEM, V68, P1511; MORRISON CF, 1974, PSYCHOPHARMACOLOGIA, V38, P25, DOI 10.1007/BF00421284; MURRIN LC, 1987, LIFE SCI, V40, P1699, DOI 10.1016/0024-3205(87)90020-8; Nguyen HN, 2004, J NEUROCHEM, V90, P40, DOI 10.1111/j.1471-4159.2004.02482.x; O'Dell LE, 2007, NEUROTOXICOL TERATOL, V29, P17, DOI 10.1016/j.ntt.2006.11.003; O'Dell LE, 2006, PSYCHOPHARMACOLOGY, V186, P612, DOI 10.1007/s00213-006-0383-6; O'Loughlin J, 2003, AM J PREV MED, V25, P219, DOI 10.1016/S0749-3797(03)00198-3; OCHOA ELM, 1990, MOL NEUROBIOL, V4, P251, DOI 10.1007/BF02780343; Overstreet DH, 2002, ALCOHOL CLIN EXP RES, V26, P1259, DOI 10.1097/01.ALC.0000023983.10615.D7; Paolini M, 2011, BIOCHEM PHARMACOL, V82, P996, DOI 10.1016/j.bcp.2011.07.075; Piasecki TM, 2003, J ABNORM PSYCHOL, V112, P14, DOI 10.1037/0021-843X.112.1.14; Roiko SA, 2009, PHARMACOL BIOCHEM BE, V93, P105, DOI 10.1016/j.pbb.2009.04.011; Samaha AN, 2005, BIOL PSYCHIAT, V57, P351, DOI 10.1016/j.biopsych.2004.11.040; SCHWARTZ RD, 1983, SCIENCE, V220, P214, DOI 10.1126/science.6828889; Skjei KL, 2003, PSYCHOPHARMACOLOGY, V168, P280, DOI 10.1007/s00213-003-1414-1; Sofuoglu M, 2012, DRUG ALCOHOL DEPEN, V125, P1, DOI 10.1016/j.drugalcdep.2012.04.023; Sorge RE, 2009, J PHARMACOL EXP THER, V330, P633, DOI 10.1124/jpet.109.154641; Swan GE, 1996, ADDICT BEHAV, V21, P481, DOI 10.1016/0306-4603(95)00070-4; Vann RE, 2006, PSYCHOPHARMACOLOGY, V184, P482, DOI 10.1007/s00213-005-0037-0; Vieira-Brock PL, 2013, NICOTINE TOB RES, V15, P1839, DOI 10.1093/ntr/ntt067; Wang H, 2005, BRAIN RES REV, V48, P420, DOI 10.1016/j.brainresrev.2004.09.003; Watkins S S, 2000, Nicotine Tob Res, V2, P19; Watkins SS, 2000, J PHARMACOL EXP THER, V292, P1053; Wileyto P, 2009, TOB CONTROL, V18, P387, DOI 10.1136/tc.2009.030189; Zeller M, 2009, TOB CONTROL, V18, P324, DOI 10.1136/tc.2008.027318	88	3	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144553	10.1371/journal.pone.0144553	http://dx.doi.org/10.1371/journal.pone.0144553			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658557	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903600057
J	Sater, MRA; Lamelas, A; Wang, GL; Clark, TA; Roltgen, K; Mane, S; Korlach, J; Pluschke, G; Schmid, CD				Sater, Mohamad R. Abdul; Lamelas, Araceli; Wang, Guilin; Clark, Tyson A.; Roeltgen, Katharina; Mane, Shrikant; Korlach, Jonas; Pluschke, Gerd; Schmid, Christoph D.			DNA Methylation Assessed by SMRT Sequencing Is Linked to Mutations in Neisseria meningitidis Isolates	PLOS ONE			English	Article							RESTRICTION-MODIFICATION SYSTEMS; SINGLE-MOLECULE; CYTOSINE METHYLATION; ESCHERICHIA-COLI; MISMATCH REPAIR; GENOME; EVOLUTION; GONORRHOEAE; MECHANISMS; RESOLUTION	The Gram-negative bacterium Neisseria meningitidis features extensive genetic variability. To present, proposed virulence genotypes are also detected in isolates from asymptomatic carriers, indicating more complex mechanisms underlying variable colonization modes of N. meningitidis. We applied the Single Molecule, Real-Time (SMRT) sequencing method from Pacific Biosciences to assess the genome-wide DNA modification profiles of two genetically related N. meningitidis strains, both of serogroup A. The resulting DNA methylomes revealed clear divergences, represented by the detection of shared and of strain-specific DNA methylation target motifs. The positional distribution of these methylated target sites within the genomic sequences displayed clear biases, which suggest a functional role of DNA methylation related to the regulation of genes. DNA methylation in N. meningitidis has a likely underestimated potential for variability, as evidenced by a careful analysis of the ORF status of a panel of confirmed and predicted DNA methyltransferase genes in an extended collection of N. meningitidis strains of serogroup A. Based on high coverage short sequence reads, we find phase variability as a major contributor to the variability in DNA methylation. Taking into account the phase variable loci, the inferred functional status of DNA methyltransferase genes matched the observed methylation profiles. Towards an elucidation of presently incompletely characterized functional consequences of DNA methylation in N. meningitidis, we reveal a prominent colocalization of methylated bases with Single Nucleotide Polymorphisms (SNPs) detected within our genomic sequence collection. As a novel observation we report increased mutability also at 6mA methylated nucleotides, complementing mutational hotspots previously described at 5mC methylated nucleotides. These findings suggest a more diverse role of DNA methylation and Restriction-Modification (RM) systems in the evolution of prokaryotic genomes.	[Sater, Mohamad R. Abdul; Lamelas, Araceli; Roeltgen, Katharina; Pluschke, Gerd; Schmid, Christoph D.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Sater, Mohamad R. Abdul; Lamelas, Araceli; Roeltgen, Katharina; Pluschke, Gerd; Schmid, Christoph D.] Univ Basel, Basel, Switzerland; [Wang, Guilin; Mane, Shrikant] Yale Univ, Yale Ctr Genom Anal, New Haven, CT USA; [Clark, Tyson A.; Korlach, Jonas] Pacif Biosci, Menlo Pk, CA USA; [Sater, Mohamad R. Abdul; Schmid, Christoph D.] SIB, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Yale University; Swiss Institute of Bioinformatics	Schmid, CD (corresponding author), Swiss Trop & Publ Hlth Inst, Socinstr 57, Basel, Switzerland.	Christoph.Schmid@unibas.ch	Cabello, Araceli Lamelas/Q-6726-2018; Cabello, Araceli Lamelas/AAC-6066-2019	Cabello, Araceli Lamelas/0000-0002-1939-5642; Cabello, Araceli Lamelas/0000-0002-1939-5642; Clark, Tyson/0000-0002-7779-3227; Sater, Mohamad/0000-0003-1912-0590	Forschungsfonds of the University of Basel [DZX2056]; Pacific Biosciences	Forschungsfonds of the University of Basel; Pacific Biosciences	This work was supported by the Forschungsfonds of the University of Basel (grant "DZX2056" to CS). Additional support in the form of salaries for authors (TC and JK are employees of Pacific Biosciences), and contributions of reagents and materials (GW and MS from the Yale Center for Genomic Analysis). The funders did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ambur OH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039742; Arber W, 2000, FEMS MICROBIOL REV, V24, P1, DOI 10.1111/j.1574-6976.2000.tb00529.x; Bart A, 2001, INFECT IMMUN, V69, P1816, DOI 10.1128/IAI.69.3.1816-1820.2001; Bendall ML, 2013, J BACTERIOL, V195, P4966, DOI 10.1128/JB.00935-13; Bentley SD, 2007, PLOS GENET, V3, P230, DOI 10.1371/journal.pgen.0030023; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; Cao B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4951; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Clark TA, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-4; Clark TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1146; Claus H, 2000, J BACTERIOL, V182, P1296, DOI 10.1128/JB.182.5.1296-1303.2000; Croucher NJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1196; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; EHRLICH M, 1986, BIOSCIENCE REP, V6, P387, DOI 10.1007/BF01116426; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Fang G, 2012, NAT BIOTECHNOL, V30, P1232, DOI 10.1038/nbt.2432; Feng ZX, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002935; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Furuta Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004272; Gawthorne JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032337; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Iseli C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000579; Ishikawa K, 2010, DNA RES, V17, P325, DOI 10.1093/dnares/dsq027; Jen FEC, 2014, ANTIMICROB AGENTS CH, V58, P4219, DOI 10.1128/AAC.00004-14; Jolley KA, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-34; Kong Y, 2013, GENOME BIOL EVOL, V5, P1611, DOI 10.1093/gbe/evt116; Kozdon JB, 2013, P NATL ACAD SCI USA, V110, pE4658, DOI 10.1073/pnas.1319315110; Krebes J, 2014, NUCLEIC ACIDS RES, V42, P2415, DOI 10.1093/nar/gkt1201; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kwiatek A, 2010, J BACTERIOL, V192, P3951, DOI 10.1128/JB.00098-10; Lamelas A, 2014, MBIO, V5, DOI 10.1128/mBio.01974-14; Lee H, 2012, P NATL ACAD SCI USA, V109, pE2774, DOI 10.1073/pnas.1210309109; Leimkugel J, 2007, PLOS MED, V4, P535, DOI 10.1371/journal.pmed.0040101; Lluch-Senar M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003191; Maiden MCJ, 2013, CLIN INFECT DIS, V56, P364, DOI 10.1093/cid/cis896; Maiden MCJ, 2008, CURR OPIN MICROBIOL, V11, P467, DOI 10.1016/j.mib.2008.09.002; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Manso AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6055; Marinus MG, 2009, FEMS MICROBIOL REV, V33, P488, DOI 10.1111/j.1574-6976.2008.00159.x; Marri PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011835; Molina N, 2008, GENOME RES, V18, P148, DOI 10.1101/gr.6759507; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Paul S, 2013, NATURE, V495, P512, DOI 10.1038/nature11989; Powers JG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-675; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Richardson AR, 2001, MOL MICROBIOL, V40, P645, DOI 10.1046/j.1365-2958.2001.02408.x; RITCHOT N, 1990, GENE, V86, P103, DOI 10.1016/0378-1119(90)90120-G; Roberts RJ, 2013, GENOME BIOL, V14, DOI [10.1186/gb-2013-14-7-405, 10.1186/gb-2013-14-6-405]; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Rocha EPC, 2008, ANNU REV GENET, V42, P211, DOI 10.1146/annurev.genet.42.110807.091653; Schadt EE, 2013, GENOME RES, V23, P129, DOI 10.1101/gr.136739.111; Schoen C, 2011, J BACTERIOL, V193, P2064, DOI 10.1128/JB.00084-11; Seib KL, 2015, NUCLEIC ACIDS RES, V43, P4150, DOI 10.1093/nar/gkv219; Shell SS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003419; Srikhanta YN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000400; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Trivedi K, 2011, TRENDS MICROBIOL, V19, P456, DOI 10.1016/j.tim.2011.06.006; Walsh CP, 2006, CURR TOP MICROBIOL, V301, P283	62	10	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144612	10.1371/journal.pone.0144612	http://dx.doi.org/10.1371/journal.pone.0144612			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656597	gold, Green Accepted, Green Published			2022-12-27	WOS:000366903600068
J	Trevisanuto, D; Bertuola, F; Lanzoni, P; Cavallin, F; Matediana, E; Manzungu, OW; Gomez, E; Da Dalt, L; Putoto, G				Trevisanuto, Daniele; Bertuola, Federica; Lanzoni, Paolo; Cavallin, Francesco; Matediana, Eduardo; Manzungu, Olivier Wingi; Gomez, Ermelinda; Da Dalt, Liviana; Putoto, Giovanni			Effect of a Neonatal Resuscitation Course on Healthcare Providers' Performances Assessed by Video Recording in a Low-Resource Setting	PLOS ONE			English	Article							MORTALITY; BIRTH	Background We assessed the effect of an adapted neonatal resuscitation program (NRP) course on healthcare providers' performances in a low-resource setting through the use of video recording. Methods A video recorder, mounted to the radiant warmers in the delivery rooms at Beira Central Hospital, Mozambique, was used to record all resuscitations. One-hundred resuscitations (50 before and 50 after participation in an adapted NRP course) were collected and assessed based on a previously published score. Results All 100 neonates received initial steps; from these, 77 and 32 needed bag-mask ventilation (BMV) and chest compressions (CC), respectively. There was a significant improvement in resuscitation scores in all levels of resuscitation from before to after the course: for "initial steps", the score increased from 33% (IQR 28-39) to 44% (IQR 39-56), p<0.0001; for BMV, from 20% (20-40) to 40% (40-60), p = 0.001; and for CC, from 0% (0-10) to 20% (0-50), p = 0.01. Times of resuscitative interventions after the course were improved in comparison to those obtained before the course, but remained non-compliant with the recommended algorithm. Conclusions Although resuscitations remained below the recommended standards in terms of quality and time of execution, clinical practice of healthcare providers improved after participation in an adapted NRP course. Video recording was well-accepted by the staff, useful for objective assessment of performance during resuscitation, and can be used as an educational tool in a low-resource setting.	[Trevisanuto, Daniele; Bertuola, Federica; Da Dalt, Liviana] Univ Padua, Sch Med, Dept Women & Children Hlth, Azienda Osped Padova, Padua, Italy; [Lanzoni, Paolo; Putoto, Giovanni] Doctors Africa CUAMM, Padua, Italy; [Matediana, Eduardo] Beira Cent Hosp, Dept Obstet & Gynecol, Beira, Mozambique; [Manzungu, Olivier Wingi; Gomez, Ermelinda] Beira Cent Hosp, Dept Pediat, Beira, Mozambique	University of Padua; Azienda Ospedaliera - Universita di Padova	Trevisanuto, D (corresponding author), Univ Padua, Sch Med, Dept Women & Children Hlth, Azienda Osped Padova, Padua, Italy.	trevo@pediatria.unipd.it	Putoto, Giovanni/ABG-2069-2020; van Griensven, Martijn/F-5808-2012	van Griensven, Martijn/0000-0001-5104-9881	Associazione Pulcino, Italy	Associazione Pulcino, Italy	Associazione Pulcino, Italy supported the study providing funds for video cameras. The funders had no role in the study design or conduct; the management, analysis, or interpretation of the data; the preparation, review, or approval of the report; or the decision to submit the manuscript for publication.	American Heart Association American Academy of Pediatrics, 2011, NEON RES TXB; Brugada M, 2011, NEONATOLOGY, V100, P99, DOI 10.1159/000322009; Carbine DN, 2000, PEDIATRICS, V106, P654, DOI 10.1542/peds.106.4.654; Carlo WA, 2010, NEW ENGL J MED, V362, P614, DOI 10.1056/NEJMsa0806033; Dickson KE, 2014, LANCET, V384, P438, DOI 10.1016/S0140-6736(14)60582-1; Ersdal HL, 2013, RESUSCITATION, V84, P1422, DOI 10.1016/j.resuscitation.2013.04.005; Ersdal HL, 2012, PEDIATRICS, V129, pE1238, DOI 10.1542/peds.2011-3134; Jabbour M, 1996, ANN EMERG MED, V28, P690, DOI 10.1016/S0196-0644(96)70095-1; Kattwinkel J, 2010, PEDIATRICS, V126, pE1400, DOI 10.1542/peds.2010-2972E; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lee ACC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S12; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; McCarthy LK, 2013, J PEDIATR-US, V163, P1553, DOI 10.1016/j.jpeds.2013.06.007; O'Donnell CPF, 2008, ARCH DIS CHILD-FETAL, V93, pF82, DOI 10.1136/adc.2007.118505; Opiyo N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001599; Perlman JM, 2015, CIRCULATION, V132, pS204, DOI 10.1161/CIR.0000000000000276; Schilleman K, 2012, RESUSCITATION, V83, P1135, DOI 10.1016/j.resuscitation.2012.01.036; Singhal N, 2012, RESUSCITATION, V83, P90, DOI 10.1016/j.resuscitation.2011.07.010; Trevisanuto D, 2007, PEDIATR ANESTH, V17, P28, DOI 10.1111/j.1460-9592.2006.02001.x; UNICEF, 2017, LEVELS TRENDS CHILD; Wall SN, 2009, INT J GYNECOL OBSTET, V107, pS47, DOI 10.1016/j.ijgo.2009.07.013; WHO, 2014, HLTH REL MILL DEV GO; World Health Organization,, 2012, GUID BAS NEWB RES; Xu T, 2014, RESUSCITATION, V85, P253, DOI 10.1016/j.resuscitation.2013.10.020	24	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144443	10.1371/journal.pone.0144443	http://dx.doi.org/10.1371/journal.pone.0144443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659661	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903600047
J	Izu, LT; Banyasz, T; Ye, CI				Izu, Leighton T.; Banyasz, Tamas; Ye Chen-Izu			Optimizing Population Variability to Maximize Benefit	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; NOISE; DIVERSITY; GENE; PERFORMANCE; EXPRESSION; EPIDEMICS; DYNAMICS; REVEALS; YEAST	Variability is inherent in any population, regardless whether the population comprises humans, plants, biological cells, or manufactured parts. Is the variability beneficial, detrimental, or inconsequential? This question is of fundamental importance in manufacturing, agriculture, and bioengineering. This question has no simple categorical answer because research shows that variability in a population can have both beneficial and detrimental effects. Here we ask whether there is a certain level of variability that can maximize benefit to the population as a whole. We answer this question by using a model composed of a population of individuals who independently make binary decisions; individuals vary in making a yes or no decision, and the aggregated effect of these decisions on the population is quantified by a benefit function (e.g. accuracy of the measurement using binary rulers, aggregate income of a town of farmers). Here we show that an optimal variance exists for maximizing the population benefit function; this optimal variance quantifies what is often called the "right mix" of individuals in a population.	[Izu, Leighton T.; Banyasz, Tamas; Ye Chen-Izu] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Banyasz, Tamas] Univ Debrecen, Dept Physiol, Debrecen, Hungary; [Ye Chen-Izu] Univ Calif Davis, Dept Med, Davis, CA 95616 USA; [Ye Chen-Izu] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California Davis; University of Debrecen; University of California System; University of California Davis; University of California System; University of California Davis	Izu, LT (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	ltizu@ucdavis.edu		Chen-Izu, Ye/0000-0003-4818-9570	National Institutes of Health, National Heart, Blood, and Lung Institute [R01HL090880]; National Institutes of Health, National Institute on Aging [R03 AG031944]; University of California, Davis Startup Funds, University of California, Davis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123526, R01HL090880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG031944] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of California, Davis Startup Funds, University of California, Davis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant number R01HL090880, National Institutes of Health, National Heart, Blood, and Lung Institute (http://www.nhlbi.nih.gov/), grant recipients: LTI and YC; grant number R03 AG031944 (YC), National Institutes of Health, National Institute on Aging (http://www.nia.nih.gov/); and University of California, Davis Startup Funds, University of California, Davis (http://ucdavis.edu (LTI)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MW, 1971, BIOSCIENCE, V21, P1067, DOI 10.2307/1295991; Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Alesina A, 2005, J ECON LIT, V43, P762, DOI 10.1257/002205105774431243; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Bishir J., 1999, Forest Genetics, V6, P149; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; BOX G, 1988, MECH ENG, V110, P32; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; Eichin M. W., 1989, Proceedings 1989 IEEE Symposium on Security and Privacy (Cat. No.89CH2703-7), P326, DOI 10.1109/SECPRI.1989.36307; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Etchenique R, 2004, AM J PHYS, V72, P159, DOI 10.1119/1.1613274; Furusawa Chikara, 2005, Biophysics (Nagoya-shi), V1, P25, DOI 10.2142/biophysics.1.25; Goh T. N., 2002, Quality Engineering, V14, P659, DOI 10.1081/QEN-120003565; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Johannsen W, 1911, AM NAT, V45, P129, DOI 10.1086/279202; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; LIPSHITZ SP, 1992, J AUDIO ENG SOC, V40, P355; McNichol D, PRIMER SIGNAL DETECT; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Nordstrom F, 2006, ABB REV, P6; Ozcan S, 1997, YEAST, V13, P127; Page SE, DIFFERENCE POWER DIV; Pruitt JN, 2011, P ROY SOC B-BIOL SCI, V278, P1209, DOI 10.1098/rspb.2010.1700; Putnam RD, 2007, SCAND POLIT STUD, V30, P137, DOI 10.1111/j.1467-9477.2007.00176.x; Schneider FB, 2009, IEEE SECUR PRIV, P15; Seger J., 1987, Oxford Surveys in Evolutionary Biology, V4, P182; Sih A, 2005, BEHAVIOUR, V142, P1417, DOI 10.1163/156853905774539454; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Stamp M, 2004, COMMUN ACM, V47, P120, DOI 10.1145/971617.971650; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; ULLSTRUP AJ, 1972, ANNU REV PHYTOPATHOL, V10, P37, DOI 10.1146/annurev.py.10.090172.000345; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; WATSON WE, 1993, ACAD MANAGE J, V36, P590, DOI 10.2307/256593; Wilson DS, 1998, PHILOS T R SOC B, V353, P199, DOI 10.1098/rstb.1998.0202	37	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143475	10.1371/journal.pone.0143475	http://dx.doi.org/10.1371/journal.pone.0143475			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650247	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903300019
J	Petta, S; Marrone, O; Torres, D; Buttacavoli, M; Camma, C; Di Marco, V; Licata, A; Lo Bue, A; Parrinello, G; Pinto, A; Salvaggio, A; Tuttolomondo, A; Craxi, A; Bonsignore, MR				Petta, Salvatore; Marrone, Oreste; Torres, Daniele; Buttacavoli, Maria; Camma, Calogero; Di Marco, Vito; Licata, Anna; Lo Bue, Anna; Parrinello, Gaspare; Pinto, Antonio; Salvaggio, Adriana; Tuttolomondo, Antonino; Craxi, Antonio; Bonsignore, Maria Rosaria			Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							CHRONIC INTERMITTENT HYPOXIA; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; OBESE-PATIENTS; CAROTID-BODY; RISK-FACTORS; STEATOHEPATITIS; SEVERITY; HISTOLOGY; INJURY	Background/Aims We assessed whether obstructive sleep apnea (OSA) and nocturnal hypoxemia are associated with severity of liver fibrosis and carotid atherosclerosis in patients with biopsy-proven NAFLD and low prevalence of morbid obesity. Secondary aim was to explore the association of OSA and hypoxemia with NASH and severity of liver pathological changes. Methods Consecutive patients (n = 126) with chronically elevated ALT and NAFLD underwent STOP-BANG questionnaire to estimate OSA risk and ultrasonographic carotid assessment. In patients accepting to perform cardiorespiratory polygraphy (PG, n = 50), OSA was defined as an apnea/hypopnea index >= 5. A carotid atherosclerotic plaque was defined as a focal thickening > 1.3 mm. Results Prevalence of high OSA risk was similar in patients refusing or accepting PG (76% vs 68%, p = 0.17). Among those accepting PG, overall OSA prevalence was significantly higher in patients with F2-F4 fibrosis compared to those without (72% vs 44%; p = 0.04). Significant fibrosis was independently associated with mean nocturnal oxygen saturation (SaO(2))<95% (OR 3.21, 95%C.I. 1.02-7.34; p = 0.04). Prevalence of OSA tended to be higher in patients with, than in those without, carotid plaques (64% vs 40%; p = 0.08). Carotid plaques were independently associated with % time at SaO2<90% > 1 (OR 6.30, 95% C. I. 1.02-12.3; p = 0.01). Conclusions In NAFLD patients with chronically elevated ALT at low prevalence of morbid obesity, OSA was highly prevalent and indexes of SaO(2) resulted independently associated with severity of liver fibrosis and carotid atherosclerosis. These data suggest to consider sleep disordered breathing as a potential additional therapeutic target in severe NAFLD patients.	[Petta, Salvatore; Camma, Calogero; Di Marco, Vito; Licata, Anna; Craxi, Antonio] Univ Palermo, DiBiMIS, Sez Gastroenterol & Epatol, Palermo, Italy; [Marrone, Oreste; Lo Bue, Anna; Salvaggio, Adriana] CNR, Inst Biomed & Mol Immunol, Palermo, Italy; [Torres, Daniele; Parrinello, Gaspare; Pinto, Antonio; Tuttolomondo, Antonino] Univ Palermo, DiBiMIS, Sez Med Interna, Palermo, Italy; [Buttacavoli, Maria; Bonsignore, Maria Rosaria] Univ Palermo, DiBiMIS, Sez Malattie Cardio Resp & Endocrino Metabol, Palermo, Italy	University of Palermo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); University of Palermo; University of Palermo	Petta, S (corresponding author), Univ Palermo, DiBiMIS, Sez Gastroenterol & Epatol, Palermo, Italy.	petsa@inwind.it	Marrone, Oreste/ABB-6945-2020; Di Marco, Vito/AAC-4612-2022; Bonsignore, Maria/U-6440-2017	Marrone, Oreste/0000-0001-6819-7928; Bonsignore, Maria/0000-0002-4875-7796; Pinto, Antonio/0000-0002-8083-3699	PRIN [2010C4JJWB_001]	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This study was funded by grants from the PRIN 2010-2011 (Prot. N. 2010C4JJWB_001).; This study was funded by grants from the PRIN 2010-2011 (Prot. N. 2010C4JJWB_001). The authors are grateful to Mr Fabio Artisi, who was recipient of some of the funds for this research, for technical help for polygraphic recordings.	Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Ali SS, 2014, SLEEP MED REV, V18, P379, DOI 10.1016/j.smrv.2014.01.004; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; [Anonymous], 1992, SAS TECHNICAL REPORT; Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Aron-Wisnewsky J, 2012, J HEPATOL, V56, P225, DOI 10.1016/j.jhep.2011.04.022; Baguet JP, 2005, CHEST, V128, P3407, DOI 10.1378/chest.128.5.3407; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Buttacavoli M, 2016, ULTRASOUND MED BIOL, V42, P104, DOI 10.1016/j.ultrasmedbio.2015.08.009; Campos GM, 2008, HEPATOLOGY, V47, P1916, DOI 10.1002/hep.22241; Chesson Jr A. L., 2007, THE AASM MANUAL FOR; Chou TC, 2015, SLEEP MED, V16, P955, DOI 10.1016/j.sleep.2015.02.542; Chung F, 2012, BRIT J ANAESTH, V108, P768, DOI 10.1093/bja/aes022; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0; Conde SV, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00418; Corey KE, 2015, DIGEST DIS SCI, V60, P2523, DOI 10.1007/s10620-015-3650-8; Daltro C, 2010, OBES SURG, V20, P1536, DOI 10.1007/s11695-010-0212-1; Dongiovanni P, 2013, CURR PHARM DESIGN, V19, P5219, DOI 10.2174/13816128113199990381; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429; Fracanzani AL, 2008, AM J MED, V121, P72, DOI 10.1016/j.amjmed.2007.08.041; Gunnarsson SI, 2014, ARTERIOSCL THROM VAS, V34, P2338, DOI 10.1161/ATVBAHA.114.303965; Jablonski KL, 2013, NUTR METAB CARDIOVAS, V23, P792, DOI 10.1016/j.numecd.2012.12.006; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jouet P, 2007, OBES SURG, V17, P478, DOI 10.1007/s11695-007-9085-3; Kallivitz ER, 2007, J CLIN GASTROENTEROL, V41, P918, DOI 10.1097/01.mcg.0000225692.62121.55; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lin QC, 2015, SLEEP BREATH, V19, P273, DOI 10.1007/s11325-014-1008-7; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mishra P, 2008, LIVER INT, V28, P1080, DOI 10.1111/j.1478-3231.2008.01822.x; Nobili V, 2015, THORAX, V70, P769, DOI 10.1136/thoraxjnl-2015-206782; Nobili V, 2014, AM J RESP CRIT CARE, V189, P66, DOI 10.1164/rccm.201307-1339OC; Petta S, 2011, ALIMENT PHARM THER, V34, P757, DOI 10.1111/j.1365-2036.2011.04788.x; Petta S, 2010, CURR PHARM DESIGN, V16, P741, DOI 10.2174/138161210790883787; Petta S, 2009, DIGEST LIVER DIS, V41, P615, DOI 10.1016/j.dld.2009.01.004; Petta S, 2015, J HEPATOL, V62, P928, DOI 10.1016/j.jhep.2014.11.030; Petta S, 2011, DIGEST LIVER DIS, V43, P404, DOI 10.1016/j.dld.2010.12.013; Polotsky VY, 2009, AM J RESP CRIT CARE, V179, P228, DOI 10.1164/rccm.200804-608OC; Pulixi EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096349; Qi JC, 2015, SLEEP BREATH; Savransky V, 2008, CIRC RES, V103, P1173, DOI 10.1161/CIRCRESAHA.108.178533; Savransky V, 2007, AM J PHYSIOL-GASTR L, V293, pG871, DOI 10.1152/ajpgi.00145.2007; Savransky V, 2007, HEPATOLOGY, V45, P1007, DOI 10.1002/hep.21593; Savransky V, 2009, EXP PHYSIOL, V94, P228, DOI 10.1113/expphysiol.2008.044883; Singh H, 2005, DIGEST DIS SCI, V50, P2338, DOI 10.1007/s10620-005-3058-y; Sundaram SS, 2014, J PEDIATR-US, V164, P699, DOI 10.1016/j.jpeds.2013.10.072; Suzuki T, 2004, SLEEP, V27, P129, DOI 10.1093/sleep/27.1.129; Tanne F, 2005, HEPATOLOGY, V41, P1290, DOI 10.1002/hep.20725; Targher G, 2008, DIABETOLOGIA, V51, P444, DOI 10.1007/s00125-007-0897-4; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; van der Poorten D, 2008, HEPATOLOGY, V48, P449, DOI 10.1002/hep.22350	54	31	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0142210	10.1371/journal.pone.0142210	http://dx.doi.org/10.1371/journal.pone.0142210			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672595	Green Published, gold, Green Submitted			2022-12-27	WOS:000366722700004
J	Cao, H; Rao, YF; Liu, L; Lin, J; Yang, HY; Zhang, XG; Chen, Z				Cao, Heng; Rao, Yuefeng; Liu, Lin; Lin, Jin; Yang, Hongyu; Zhang, Xingguo; Chen, Zhong			The Efficacy and Safety of Leflunomide for the Treatment of Lupus Nephritis in Chinese Patients: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ERYTHEMATOSUS; THERAPY; CYCLOPHOSPHAMIDE; TRIALS	Objective To evaluate the clinical efficacy and safety of leflunomide as a new immunosuppressive medicine in lupus nephritis (LN) through a meta-analysis. Methods A systematic review evaluating the efficacy and safety of leflunomide compared with cyclophosphamide in adult patients with LN was performed. Data from relevant randomized controlled trials (RCTs) performed before December 2014 was collected from several databases (PubMed, Embase, Cochrane Library, CNKI and CBM). No language restrictions were applied. Efficacy outcomes included overall remission, SLE Disease Activity Index (SLEDAI) score, 24-hour proteinuria and serum creatinine. Safety data were analyzed. The effects of treatment on these outcomes were summarized as relative risks (RRs) with 95% confidence intervals (CIs) and mean differences were pooled using a fixed or random effects model. Results Eleven RCTs with Jadad score of 3 or greater were identified and included a total of 254 patients. Cyclophosphamide was served as the control drug in all trials. The SLEDAI score, urine protein level and serum creatinine decreased significantly following leflunomide treatment (P<0.05). Leflunomide was superior to cyclophosphamide in achieving complete and total remission, but no difference in SLEDAI score was found between these two treatments (P>0.05). Additionally, patients receiving leflunomide treatment showed favorable renal function profiles, especially regarding the 24-hour proteinuria (mean difference: -0.58, 95% CI: -0.78 similar to-0.37, P<0.01) and serum creatinine (mean difference: -0.20, 95% CI: -0.39 similar to-0.01, P<0.05). In the safety comparison, leflunomide was safer than cyclophosphamide regarding adverse drug reactions (ADRs), including liver damage (RR = 0.53, 95% CI: 0.33 similar to 0.87, P<0.05), alopecia (RR = 0.38, 95% CI: 0.17 similar to 0.85, P< 0.05), leukopenia (RR = 0.25, 95% CI: 0.08 similar to 0.77, P<0.05) and infection (RR = 0.54, 95% CI: 0.32 similar to 0.92, P<0.05), without increased risk of gastrointestinal reaction, rash or herpes zoster infection. Conclusions Leflunomide is a promising therapy for LN treatment, primarily because of the comparable efficacy and favorable safety profile determined by this meta-analysis of RCTs. Larger RCTs with longer duration of observation are necessary to provide strong evidence of the efficacy and safety of leflunomide in LN patients.	[Cao, Heng; Lin, Jin] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Rheumatol, Hangzhou 310003, Zhejiang, Peoples R China; [Rao, Yuefeng; Liu, Lin; Yang, Hongyu; Zhang, Xingguo] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Pharm, Hangzhou 310003, Zhejiang, Peoples R China; [Rao, Yuefeng; Liu, Lin; Chen, Zhong] Zhejiang Univ, Dept Pharmacol, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Rao, YF (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Pharm, Hangzhou 310003, Zhejiang, Peoples R China.	raoyf@zju.edu.cn; chenzhong@zju.edu.cn	zhang, xu/GYE-3558-2022; zhang, xuan/GQO-8953-2022; zhang, xuan/AAN-9914-2020; zhang, xian/GYA-0290-2022; Zhang, xiaoyu/GXA-3206-2022; zhang, xu/GRX-9733-2022	zhang, xuan/0000-0001-8775-1699; zhang, xuan/0000-0001-8775-1699; 	National Natural Science Foundations of China [81400958]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundations of China (Grant No. 81400958). None of the authors have any conflicts of interest.; This study was supported by the National Natural Science Foundations of China (Grant No. 81400958). None of the authors have any conflicts of interest.	Bartlett R R, 1988, Scand J Rheumatol Suppl, V75, P290; Breedveld FC, 2000, ANN RHEUM DIS, V59, P841, DOI 10.1136/ard.59.11.841; [曹励欧 CAO Liou], 2007, [中华肾脏病杂志, Chinese Journal of Nephrology], V23, P3; Chen KY, 2010, JILIN MED J, V31, P2615; Chen YH, 2003, CHINESE J MISDIAGNOS, V3, P1508; Dong J, 2011, CHINESE J PRACT MED, V38, P28; Hahn BH, 2012, ARTHRIT CARE RES, V64, P797, DOI 10.1002/acr.21664; He CY, 2012, RHEUMATOL INT, V32, P633, DOI 10.1007/s00296-010-1630-z; Houssiau FA, 2002, ARTHRITIS RHEUM-US, V46, P2121, DOI 10.1002/art.10461; Ishaq M, 2011, MOD RHEUMATOL, V21, P375, DOI 10.1007/s10165-010-0405-4; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jadad AR, 1998, RANDOMISED CONTROLLE; Lan L, 2012, J ZHEJIANG UNIV-SC B, V13, P731, DOI 10.1631/jzus.B1200057; Liu LL, 2012, DRUGS, V72, P1521, DOI 10.2165/11635030-000000000-00000; Mo H, 2010, GUANGXI MED J, V32, P668; Pan XZTW, 2010, INTERNAL MED, V5, P243; Peng XP, 2011, HAINAN MED J, V22, P44; POPOVIC S, 1987, AGENTS ACTIONS, V21, P284, DOI 10.1007/BF01966492; Remer CF, 2001, LUPUS, V10, P480, DOI 10.1191/096120301678416033; Tam LS, 2004, LUPUS, V13, P601, DOI 10.1191/0961203304lu1067sr; Wang HY, 2008, LUPUS, V17, P638, DOI 10.1177/0961203308089408; Wu GC, 2013, CHINESE REMEDIES CLI, P1389; Wu GC, 2013, RHEUMATOL INT, V33, P273, DOI 10.1007/s00296-012-2508-z; Wu SB, 2008, J MOD CHINESE MED W, V17, P2599; Xia YO, 2012, MED REC, V18, P465; Zhang FS, 2009, RHEUMATOL INT, V29, P1331, DOI 10.1007/s00296-009-0861-3; Zhu Y, 2013, HEBEI MED J, V35, P1815; 李军平, 2007, [苏州大学学报. 医学版, Suzhou University Journal of Medical Science], V27, P282	28	22	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144548	10.1371/journal.pone.0144548	http://dx.doi.org/10.1371/journal.pone.0144548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670616	Green Published, Green Submitted, gold			2022-12-27	WOS:000366719300012
J	Ghosh, C; Manjunath, GB; Konai, MM; Uppu, DSSM; Hoque, J; Paramanandham, K; Shome, BR; Haldar, J				Ghosh, Chandradhish; Manjunath, Goutham B.; Konai, Mohini M.; Uppu, Divakara S. S. M.; Hoque, Jiaul; Paramanandham, Krishnamoorthy; Shome, Bibek R.; Haldar, Jayanta			Aryl-Alkyl-Lysines: Agents That Kill Planktonic Cells, Persister Cells, Biofilms of MRSA and Protect Mice from Skin-Infection	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; COMBAT BACTERIAL-RESISTANCE; ANTIMICROBIAL PEPTIDES; ANTIBACTERIAL ACTIVITY; SMALL MOLECULES; ERADICATE BIOFILMS; BARRIER FUNCTION; CYSTIC-FIBROSIS; HOST-DEFENSE; MEMBRANE	Development of synthetic strategies to combat Staphylococcal infections, especially those caused by methicillin resistant Staphyloccus aureus (MRSA), needs immediate attention. In this manuscript we report the ability of aryl-alkyl-lysines, simple membrane active small molecules, to treat infections caused by planktonic cells, persister cells and biofilms of MRSA. A representative compound, NCK-10, did not induce development of resistance in planktonic cells in multiple passages and retained activity in varying environments of pH and salinity. At low concentrations the compound was able to depolarize and permeabilize the membranes of S. aureus persister cells rapidly. Treatment with the compound not only eradicated pre-formed MRSA biofilms, but also brought down viable counts in bacterial biofilms. In a murine model of MRSA skin infection, the compound was more effective than fusidic acid in bringing down the bacterial burden. Overall, this class of molecules bears potential as antibacterial agents against skin-infections.	[Ghosh, Chandradhish; Manjunath, Goutham B.; Konai, Mohini M.; Uppu, Divakara S. S. M.; Hoque, Jiaul; Haldar, Jayanta] Jawaharlal Nehru Ctr Adv Sci Res, New Chem Unit, Chem Biol & Med Chem Lab, Bengaluru 560064, Karnataka, India; [Paramanandham, Krishnamoorthy; Shome, Bibek R.] Natl Inst Vet Epidemiol & Dis Informat NIVEDI Ram, Yelahanka, Bengaluru 560064, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Veterinary Epidemiology & Disease Informatics	Haldar, J (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, New Chem Unit, Chem Biol & Med Chem Lab, Bengaluru 560064, Karnataka, India.	jayanta@jncasr.ac.in	Uppu, Divakara SSM/U-1848-2019	Uppu, Divakara SSM/0000-0002-7271-9538; Shome, Bibek/0000-0003-4741-7076; PARAMANANDHAM, KRISHNAMOORTHY/0000-0001-7495-1333	grant "Ramanujan Fellowship" from the Department of Science and Technology (DST), Govt. of India [SR/S2/RJN-43/2009]	grant "Ramanujan Fellowship" from the Department of Science and Technology (DST), Govt. of India	This work was supported by the grant "Ramanujan Fellowship" [SR/S2/RJN-43/2009] from the Department of Science and Technology (DST), Govt. of India.	Barraud N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084220; Bayer AS, 2013, ANN NY ACAD SCI, V1277, P139, DOI 10.1111/j.1749-6632.2012.06819.x; Bremner JB, 2010, ANGEW CHEM INT EDIT, V49, P537, DOI 10.1002/anie.200904392; Chen CM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-98; Chen X, 2011, APPL ENVIRON MICROB, V77, P4878, DOI 10.1128/AEM.02440-10; Chiller K, 2001, J INVEST DERM SYMP P, V6, P170, DOI 10.1046/j.0022-202x.2001.00043.x; Friedrich C, 1999, ANTIMICROB AGENTS CH, V43, P1542, DOI 10.1128/AAC.43.7.1542; Ghosh C, 2015, CHEMMEDCHEM, V10, P1606, DOI 10.1002/cmdc.201500299; Ghosh C, 2014, J MED CHEM, V57, P1428, DOI 10.1021/jm401680a; Goldfeder Y, 2010, ANTIMICROB AGENTS CH, V54, P2590, DOI 10.1128/AAC.01656-09; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Haug BE, 2008, J MED CHEM, V51, P4306, DOI 10.1021/jm701600a; Hoque J, 2015, CHEM COMMUN, V51, P13670, DOI 10.1039/c5cc05159b; Hoque J, 2015, J MED CHEM, V58, P5486, DOI 10.1021/acs.jmedchem.5b00443; Hu YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011818; Hurdle JG, 2011, NAT REV MICROBIOL, V9, P62, DOI 10.1038/nrmicro2474; Huynh KK, 2007, MICROBIOL MOL BIOL R, V71, P452, DOI 10.1128/MMBR.00003-07; Isaksson J, 2011, J MED CHEM, V54, P5786, DOI 10.1021/jm200450h; Jantsch J, 2015, CELL METAB, V21, P493, DOI 10.1016/j.cmet.2015.02.003; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Kim JS, 2011, ANTIMICROB AGENTS CH, V55, P5380, DOI 10.1128/AAC.00708-11; Koh JJ, 2015, J MED CHEM, V58, P739, DOI 10.1021/jm501285x; Konai MM, 2015, BIOCONJUGATE CHEM, V26, P2442, DOI 10.1021/acs.bioconjchem.5b00494; Konai MM, 2014, J MED CHEM, V57, P9409, DOI 10.1021/jm5013566; Kumar K, 2013, J ANTIMICROB CHEMOTH, V68, P1465, DOI 10.1093/jac/dkt045; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lundberg CV, 2013, INT J ANTIMICROB AG, V42, P272, DOI 10.1016/j.ijantimicag.2013.05.008; Mascio CTM, 2007, ANTIMICROB AGENTS CH, V51, P4255, DOI 10.1128/AAC.00824-07; Mensa B, 2014, ANTIMICROB AGENTS CH, V58, P5136, DOI 10.1128/AAC.02955-14; Mohamed MF, 2014, DRUG DES DEV THER, V8, P1979, DOI 10.2147/DDDT.S72129; Nardis C, 2013, Ann Ig, V25, P443, DOI 10.7416/ai.2013.1946; Ooi N, 2010, J ANTIMICROB CHEMOTH, V65, P72, DOI 10.1093/jac/dkp409; Pan JC, 2013, BIOORG MED CHEM LETT, V23, P4648, DOI 10.1016/j.bmcl.2013.06.011; Patel JB, 2009, CLIN INFECT DIS, V49, P935, DOI 10.1086/605495; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; Roche ED, 2012, ANTIMICROB AGENTS CH, V56, P4508, DOI 10.1128/AAC.00467-12; Savage VJ, 2013, ANTIMICROB AGENTS CH, V57, P1968, DOI 10.1128/AAC.02008-12; Schmid-Wendtner MH, 2006, SKIN PHARMACOL PHYS, V19, P296, DOI 10.1159/000094670; Schmidt NW, 2014, ACS NANO, V8, P8786, DOI 10.1021/nn502201a; Siberry GK, 2003, CLIN INFECT DIS, V37, P1257, DOI 10.1086/377501; Thati Venubabu, 2011, Indian J Med Res, V134, P704, DOI 10.4103/0971-5916.91001; Uppu DSSM, 2016, BIOMATERIALS, V74, P131, DOI 10.1016/j.biomaterials.2015.09.042; Wilson P, 2003, J ANTIMICROB CHEMOTH, V51, P186, DOI 10.1093/jac/dkg104; Yarlagadda V, 2015, INT J ANTIMICROB AG, V45, P627, DOI 10.1016/j.ijantimicag.2015.02.013; Yarlagadda V, 2014, J MED CHEM, V57, P4558, DOI 10.1021/jm500270w	46	30	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144094	10.1371/journal.pone.0144094	http://dx.doi.org/10.1371/journal.pone.0144094			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669634	Green Published, Green Submitted, gold			2022-12-27	WOS:000366719300004
J	Lim, Y; Han, SW; Yoon, JH; Lee, JM; Lee, JM; Paeng, JC; Won, JK; Kang, GH; Jeong, SY; Park, KJ; Lee, KH; Kim, JH; Kim, TY				Lim, Yoojoo; Han, Sae-Won; Yoon, Jeong Hee; Lee, Jeong Min; Lee, Jung Min; Paeng, Jin Chul; Won, Jae-Kyung; Kang, Gyeong Hoon; Jeong, Seung-Yong; Park, Kyu Joo; Lee, Kyung-Hun; Kim, Jee Hyun; Kim, Tae-You			Clinical Implication of Anti-Angiogenic Effect of Regorafenib in Metastatic Colorectal Cancer	PLOS ONE			English	Article							RESPONSE EVALUATION CRITERIA; RENAL-CELL CARCINOMA; PHASE-3 TRIAL; LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; COMPUTED-TOMOGRAPHY; TARGETED THERAPY; TUMOR CAVITATION; MODIFIED RECIST; BAY 73-4506	Background Regorafenib induces distinct radiological changes that represent its anti-angiogenic effect. However, clinical implication of the changes is unclear. Methods Tumor attenuation as measured by Hounsfield units (HU) in contrast-enhanced computed tomography (CT) and cavitary changes of lung metastases were analyzed in association with treatment outcome of metastatic colorectal cancer patients (N = 80) treated with regorafenib in a prospective study. Results 141 lesions in 72 patients were analyzed with HU. After 2 cycles of regorafenib, 87.5% of patients showed decrease of HU (Median change -23.9%, range -61.5%-20.7%). Lesional attenuation change was modestly associated with metabolic changes of 18-fluoro-deoxyglucose positron emission tomography-CT (Pearson's r = 0.37, p = 0.002). Among 53 patients with lung metastases, 17 (32.1%) developed cavitary changes. There were no differences in disease control rate, progression-free survival, or overall survival according to the radiological changes. At the time of progressive disease (PD) according to RECIST 1.1, HU was lower than baseline in 86.0% (43/50) and cavitary change of lung metastasis persisted without refilling in 84.6% (11/13). Conclusion Regorafenib showed prominent anti-angiogenic effect in colorectal cancer, but the changes were not associated with treatment outcome. However, the anti-angiogenic effects persisted at the time of PD, which suggests that we may need to develop new treatment strategies.	[Lim, Yoojoo; Han, Sae-Won; Lee, Kyung-Hun; Kim, Tae-You] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Han, Sae-Won; Kim, Tae-You] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Yoon, Jeong Hee; Lee, Jeong Min] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Lee, Jung Min; Paeng, Jin Chul] Seoul Natl Univ Hosp, Dept Nucl Med, Seoul 110744, South Korea; [Won, Jae-Kyung; Kang, Gyeong Hoon] Seoul Natl Univ Hosp, Dept Pathol, Seoul 110744, South Korea; [Jeong, Seung-Yong; Park, Kyu Joo] Seoul Natl Univ Hosp, Dept Surg, Seoul 110744, South Korea; [Kim, Jee Hyun] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, Geyonggi Do, South Korea; [Kim, Tae-You] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, TY (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.	kimty@snu.ac.kr	Kang, Gyeong Hoon/F-1051-2010; Lee, Jeong Min/V-3429-2019; Yoon, Jeong Hee/ABA-5127-2021	Kang, Gyeong Hoon/0000-0003-2380-6675; Lee, Jeong Min/0000-0003-0561-8777; Yoon, Jeong Hee/0000-0002-9925-9973; Won, Jae-Kyung/0000-0003-1459-8093; Lim, Yoojoo/0000-0002-4181-2916	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [HI14C1277]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI, http://www.khidi.or.kr), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1277), to TYK. Regorafenib was provided by Bayer Pharma AG (http://pharma.bayer.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elkacem L, 2013, MOL CANCER THER, V12, P1322, DOI 10.1158/1535-7163.MCT-12-1162; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Choi H, 2007, J CLIN ONCOL, V25, P1753, DOI 10.1200/JCO.2006.07.3049; Chun YS, 2009, JAMA-J AM MED ASSOC, V302, P2338, DOI 10.1001/jama.2009.1755; Crabb SJ, 2009, J CLIN ONCOL, V27, P404, DOI 10.1200/JCO.2008.16.2545; Cyran CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076009; Demetri GD, 2013, LANCET, V381, P295, DOI 10.1016/S0140-6736(12)61857-1; Edeline J, 2012, CANCER-AM CANCER SOC, V118, P147, DOI 10.1002/cncr.26255; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Jeffers M, 2013, ASCO M S, V31, P381; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Lenz HJ, 2013, ASCO M, V31, P3514; Li J, 2015, LANCET ONCOL, V16, P619, DOI 10.1016/S1470-2045(15)70156-7; Marom EM, 2008, J THORAC ONCOL, V3, P351, DOI 10.1097/JTO.0b013e318168c7e9; Nishino M, 2012, CANCER IMAGING, V12, P225, DOI 10.1102/1470-7330.2012.0027; O'Connor JPB, 2012, CLIN CANCER RES, V18, P6588, DOI 10.1158/1078-0432.CCR-12-1501; Ricotta R, 2013, LANCET, V381, P1537, DOI 10.1016/S0140-6736(13)60976-9; Schmieder R, 2014, INT J CANCER, V135, P1487, DOI 10.1002/ijc.28669; Shinagare AB, 2014, EUR J CANCER, V50, P981, DOI 10.1016/j.ejca.2013.11.037; Smith AD, 2010, AM J ROENTGENOL, V194, P1470, DOI 10.2214/AJR.09.3456; Smith AD, 2010, AM J ROENTGENOL, V194, P157, DOI 10.2214/AJR.09.2941; Strumberg D, 2012, BRIT J CANCER, V106, P1722, DOI 10.1038/bjc.2012.153; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864	24	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145004	10.1371/journal.pone.0145004	http://dx.doi.org/10.1371/journal.pone.0145004			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671465	Green Published, gold, Green Submitted			2022-12-27	WOS:000366719300038
J	Garcia-Ramirez, RA; Ramirez-Venegas, A; Quintana-Carrillo, R; Camarena, AE; Falfan-Valencia, R; Meja-Arangure, JM				Alejandro Garcia-Ramirez, Roman; Ramirez-Venegas, Alejandra; Quintana-Carrillo, Roger; Eduardo Camarena, Angel; Falfan-Valencia, Ramces; Manuel Meja-Arangure, Juan			TNF, IL6, and IL1B Polymorphisms Are Associated with Severe Influenza A (H1N1) Virus Infection in the Mexican Population	PLOS ONE			English	Article							CYTOKINE GENE POLYMORPHISMS; NECROSIS-FACTOR PRODUCTION; INFLAMMATORY CYTOKINES; SEVERE PNEUMONIA; INTERLEUKIN-1-BETA; ALPHA; RISK; LTA	Background Hypercytokinemia is the main immunopathological mechanism contributing to a more severe clinical course in influenza A (H1N1) virus infections. Most patients infected with the influenza A (H1N1) pdm09 virus had increased systemic levels of pro-inflammatory cytokines; including interleukin IL-6, IL-8, and tumor necrosis factor-alpha (TNF-alpha). We propose that single-nucleotide polymorphisms (SNPs) in the promoter regions of pro-inflammatory genes are associated with the severity of influenza A (H1N1) pdm09 virus infection. Methods 145 patients with influenza A (H1N1) (pA/H1N1), 133 patients with influenza-like illness (ILI), and 360 asymptomatic healthy contacts (AHCs) were included. Eleven SNPs were genotyped in six genes (TNF, LT, IL1B, IL6, CCL1, and IL8) using real-time PCR; the ancestral genotype was used for comparison. Genotypes were correlated with 27 clinical severity variables. Ten cytokines (GM-CSF, TNF-alpha, IL-2, IL-1 beta, IL-6, IL-8, IFN-gamma, IL-10, IL-5, and IL-4) were measured on a Luminex 100. Results The IL6 rs1818879 (GA) heterozygous genotype was associated with severe influenza A (H1N1) virus infection (odds ratio [OR] = 5.94, 95% confidence interval [CI] 3.05-11.56), and two IL1B SNPs, rs16944 AG and rs3136558 TC, were associated with a decreased risk of infection (OR = 0.52 and OR = 0.51, respectively). Genetic susceptibility was determined (pA/H1N1 vs. AHC): the LTA rs909253 TC heterozygous genotype conferred greater risk (OR = 1.9), and a similar association was observed with the IL1B rs3136558 CC genotype (OR = 1.89). Additionally, severely ill patients were compared with moderately ill patients. The TNF- 238 GA genotype was associated with an increased risk of disease severity (OR = 16.06, p = 0.007). Compared with ILIs, patients with severe pA/H1N1 infections exhibited increased serum IL- 5 (p<0.001) and IL- 6 (p = 0.007) levels. Conclusions The TNF gene was associated with disease severity, whereas IL1B and IL6 SNPs were associated with influenza A (H1N1) virus infection.	[Alejandro Garcia-Ramirez, Roman; Manuel Meja-Arangure, Juan] IMSS, Coordinat Hlth Res, Mexico City 06720, DF, Mexico; [Alejandro Garcia-Ramirez, Roman] Univ Nacl Autonoma Mexico, Grad Program Biol Sci, Mexico City 04360, DF, Mexico; [Alejandro Garcia-Ramirez, Roman; Eduardo Camarena, Angel; Falfan-Valencia, Ramces] Natl Inst Resp Dis, HLA Lab, Mexico City 14080, DF, Mexico; [Ramirez-Venegas, Alejandra; Quintana-Carrillo, Roger] Natl Inst Resp Dis, Res Dept Smoking & COPD, Mexico City 14080, DF, Mexico	Instituto Mexicano del Seguro Social; Universidad Nacional Autonoma de Mexico	Falfan-Valencia, R (corresponding author), Natl Inst Resp Dis, HLA Lab, Mexico City 14080, DF, Mexico.	rfalfanv@iner.gob.mx; juan.mejiaa@imss.gob.mx	Mejia-Arangure, Juan Manuel/T-6743-2019; Falfán-Valencia, Ramcés/M-7331-2018	Mejia-Arangure, Juan Manuel/0000-0001-8027-6231; Falfán-Valencia, Ramcés/0000-0001-6877-8124	Mexican Institute of Social Security [FIS/IMSS/PROT/G13/1212, CONACyT-FOSIS SALUD2009-C02-126699]; Coordinacion de Investigacion en Salud of the IMSS	Mexican Institute of Social Security; Coordinacion de Investigacion en Salud of the IMSS	This paper constitutes a partial fulfillment of the Graduate Program in Biological Sciences of the National Autonomous University of Mexico (UNAM) for RAGR. RA Garcia-Ramirez acknowledges the academic support provided by the National Council of Science and Technology (CONACyT) and Posgrado en Ciencias Biologicas, UNAM. The authors thank the Coordinacion de Investigacion en Salud of the IMSS for covering the translation and publishing costs. This study was funded by the Mexican Institute of Social Security, Grants FIS/IMSS/PROT/G13/1212 and CONACyT-FOSIS SALUD2009-C02-126699.; This paper constitutes a partial fulfillment of the Graduate Program in Biological Sciences of the National Autonomous University of Mexico (UNAM) for RAGR. RA Garcia-Ramirez acknowledges the academic support provided by the National Council of Science and Technology (CONACyT) and Posgrado en Ciencias Biologicas, UNAM. The authors thank the Coordinacion de Investigacion en Salud of the IMSS for covering the translation and publishing costs. This study was funded by the Mexican Institute of Social Security, Grants FIS/IMSS/PROT/G13/1212 and CONACyT-FOSIS SALUD2009-C02-126699.	Antonopoulou A, 2012, INT J INFECT DIS, V16, pE204, DOI 10.1016/j.ijid.2011.11.012; Atan D, 2013, MOL VIS, V19, P184; Belfer I, 2004, GENES IMMUN, V5, P505, DOI 10.1038/sj.gene.6364118; Bermejo-Martin JF, 2010, CRIT CARE, V14, DOI 10.1186/cc9259; Borja-Aburto VH, 2012, ARCH MED RES, V43, P563, DOI 10.1016/j.arcmed.2012.09.005; Broekhuizen R, 2005, AM J CLIN NUTR, V82, P1059, DOI 10.1093/ajcn/82.5.1059; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Chiaretti A, 2013, INT J INFECT DIS, V17, pE1186, DOI 10.1016/j.ijid.2013.07.006; Chiaretti A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/495848; Chowell Gerardo, 2012, PLoS Curr, V4, pRRN1306, DOI 10.1371/currents.RRN1306; DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303; Davila J., 2014, PLOS CURR-TREE LIFE, V6, DOI [10.1371/currents.outbreaks.a855a92f19db1d90ca955f5e908d6631, DOI 10.1371/CURRENTS.OUTBREAKS.A855A92F19DB1D90CA955F5E908D6631, DOI 10.1371/CURRENTS.0UTBREAKS.A855A92F19DB1D90CA955F5E908D6631]; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Estella A, 2011, J INFECT DEV COUNTR, V5, P540, DOI 10.3855/jidc.1618; Jimenez-Corona ME, 2012, SALUD PUBLICA MEXICO, V54, P607, DOI 10.1590/S0036-36342012000600009; Gomez-Gomez A, 2010, EMERG INFECT DIS, V16, P27, DOI 10.3201/eid1601.090941; Hagau N, 2010, CRIT CARE, V14, DOI 10.1186/cc9324; Iglesias ALH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021838; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; JULKUNEN I, 1985, J VIROL METHODS, V10, P75, DOI 10.1016/0166-0934(85)90091-6; Kerr JR, 2003, J CLIN PATHOL, V56, P725, DOI 10.1136/jcp.56.10.725; Knight JC, 1999, P ASSOC AM PHYSICIAN, V111, P290, DOI 10.1046/j.1525-1381.1999.99237.x; Lanas A, 2001, GENES IMMUN, V2, P415, DOI 10.1038/sj.gene.6363798; Lee N, 2011, ANTIVIR THER, V16, P237, DOI 10.3851/IMP1722; Liu YX, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-37; Martinez-Ocana J, 2013, J CLIN VIROL, V58, P108, DOI 10.1016/j.jcv.2013.05.013; Matsushita K, 2006, ARTERIOSCL THROM VAS, V26, P871, DOI 10.1161/01.ATV.0000208363.85388.8f; MEDURI GU, 1995, CHEST, V108, P1303, DOI 10.1378/chest.108.5.1303; Morales-Garcia G, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-299; Nishida M, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-27; Paich HA, 2013, OBESITY, V21, P2377, DOI 10.1002/oby.20383; Paquette SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038214; Romanova EN, 2013, TERAPEVT ARKH, V85, P58; Seki M, 2004, EUR RESPIR J, V24, P143, DOI 10.1183/09031936.04.00126103; Sinha S, MALAR J, V20, P13; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Wu CL, 2003, CRIT CARE MED, V31, P812, DOI 10.1097/01.CCM.0000054865.47068.58; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Yu XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028680; Zuniga J, 2011, AUTOIMMUNITY, V44, P562, DOI 10.3109/08916934.2011.592885	41	42	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144832	10.1371/journal.pone.0144832	http://dx.doi.org/10.1371/journal.pone.0144832			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657940	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900113
J	Bueno-Silva, B; Kawamoto, D; Ando-Suguimoto, ES; Alencar, SM; Rosalen, PL; Mayer, MPA				Bueno-Silva, Bruno; Kawamoto, Dione; Ando-Suguimoto, Ellen S.; Alencar, Severino M.; Rosalen, Pedro L.; Mayer, Marcia P. A.			Brazilian Red Propolis Attenuates Inflammatory Signaling Cascade in LPS-Activated Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; CHEMICAL-COMPOSITION; CYTOKINE PRODUCTION; ETHANOL EXTRACTS; INTERFERON-GAMMA; BOTANICAL ORIGIN; DOWN-REGULATION; GREEN PROPOLIS; IN-VITRO; PROTEIN	Although previous studies suggested an anti-inflammatory property of Brazilian red propolis (BRP), the mechanisms involved in the anti-inflammatory effects of BRP and its activity on macrophages were still not elucidated. This study aimed to evaluate whether BRP attenuates the inflammatory effect of LPS on macrophages and to investigate its underlying mechanisms. BRP was added to RAW 264.7 murine macrophages after activation with LPS. NO production, cell viability, cytokines profile were evaluated. Activation of inflammatory signaling pathways and macrophage polarization were determined by RT-qPCR and Western blot. BRP at 50 mu g/ml inhibited NO production by 78% without affecting cell viability. Cd80 and Cd86 were upregulated whereas mrc1 was down regulated by BRP indicating macrophage polarization at M1. BRP attenuated the production of pro-inflammatory mediators IL-12, GM-CSF, IFN-gamma, IL-1 beta in cell supernatants although levels of TNF-alpha and IL-6 were slightly increased after BRP treatment. Levels of IL-4, IL-10 and TGF-beta were also reduced by BRP. BRP significantly reduced the up-regulation promoted by LPS of transcription of genes in inflammatory signaling (Pdk1, Pak1, Nfkb1, Mtcp1, Gsk3b, Fos and Elk1) and of Il1 beta and Il1f9 (fold-change rate >5), which were further confirmed by the inhibition of NF-kappa B and MAPK signaling pathways. Furthermore, the upstream adaptor MyD88 adaptor-like (Mal), also known as TIRAP, involved in TLR2 and TLR4 signaling, was down-regulated in BRP treated LPS-activated macrophages. Given that BRP inhibited multiple signaling pathways in macrophages involved in the inflammatory process activated by LPS, our data indicated that BRP is a noteworthy food-source for the discovery of new bioactive compounds and a potential candidate to attenuate exhacerbated inflammatory diseases.	[Bueno-Silva, Bruno; Kawamoto, Dione; Ando-Suguimoto, Ellen S.; Mayer, Marcia P. A.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, SP, Brazil; [Alencar, Severino M.] ESALQ USP, Coll Agr Luiz de Queiroz, Piracicaba, SP, Brazil; [Rosalen, Pedro L.] Univ Campinas UNICAMP, Piracicaba Dent Sch, Dept Physiol Sci, Piracicaba, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas	Mayer, MPA (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, SP, Brazil.	mpamayer@icb.usp.br	Rosalen, Pedro Luiz/I-3718-2012; Bueno-Silva, Bruno/J-3097-2012; Alencar, Severino Matias/B-7743-2012; Mayer, Marcia/D-4645-2012	Rosalen, Pedro Luiz/0000-0003-0812-4027; Bueno-Silva, Bruno/0000-0003-3275-5910; Alencar, Severino Matias/0000-0002-6637-7973; Mayer, Marcia/0000-0002-5910-8433; Kawamoto, Dione/0000-0002-6702-7000	Sao Paulo Research Foundation (FAPESP) [2012/14323-3, 2012/01500-4]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Grant #2012/14323-3 and Grant #2012/01500-4 from Sao Paulo Research Foundation (FAPESP). URL: http://www.fapesp.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando-Suguimoto ES, 2014, CYTOKINE, V66, P46, DOI 10.1016/j.cyto.2013.12.014; Bandara M, 2010, IMMUNOL CELL BIOL, V88, P727, DOI 10.1038/icb.2010.26; Barberis L, 2008, THROMB HAEMOSTASIS, V99, P279, DOI 10.1160/TH07-10-0632; Bernard NJ, 2013, IUBMB LIFE, V65, P777, DOI 10.1002/iub.1201; Besnard A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00035; Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Bueno-Silva B, 2013, BIOFOULING, V29, P1233, DOI 10.1080/08927014.2013.834050; Bueno-Silva B, 2013, J AGR FOOD CHEM, V61, P4546, DOI 10.1021/jf305468f; Burgermeister E, 2007, MOL CELL BIOL, V27, P803, DOI 10.1128/MCB.00601-06; Burkly LC, 2011, CYTOKINE, V56, P109, DOI 10.1016/j.cyto.2011.07.425; BUTCHER C, 1994, J IMMUNOL, V153, P701; Chan ED, 2001, INFECT IMMUN, V69, P2001, DOI 10.1128/IAI.69.4.2001-2010.2001; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; da Cunha MG, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/256287; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Davoodi J, 2010, INT J BIOCHEM CELL B, V42, P958, DOI 10.1016/j.biocel.2010.02.008; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Fialka I, 1996, J CELL BIOL, V132, P1115, DOI 10.1083/jcb.132.6.1115; Foster AM, 2014, J IMMUNOL, V192, P6053, DOI 10.4049/jimmunol.1301481; Franchin M, 2012, J ETHNOPHARMACOL, V143, P709, DOI 10.1016/j.jep.2012.07.040; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gresnigt MS, 2013, SEMIN IMMUNOL, V25, P458, DOI 10.1016/j.smim.2013.11.003; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Gupta Charu, 2014, J Complement Integr Med, V11, P151; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; HEWETT SJ, 1993, NEUROSCI LETT, V164, P229, DOI 10.1016/0304-3940(93)90898-U; Hodgkinson CP, 2008, ARTERIOSCL THROM VAS, V28, P2275, DOI 10.1161/ATVBAHA.108.175992; Inui S, 2014, NAT PROD RES, V28, P1293, DOI 10.1080/14786419.2014.898146; Ishihara M, 2009, ONCOL REP, V22, P349, DOI 10.3892/or_00000444; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Janssens S, 2002, CURR BIOL, V12, P467, DOI 10.1016/S0960-9822(02)00712-1; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kelley SL, 2013, J IMMUNOL, V190, P1304, DOI 10.4049/jimmunol.1202446; Kim DI, 2012, J CLIN IMMUNOL, V32, P340, DOI 10.1007/s10875-011-9628-1; Kim S, 2011, BIOCHEM PHARMACOL, V81, P1343, DOI 10.1016/j.bcp.2011.03.012; Labonte AC, 2014, MOL CELLS, V37, P275, DOI 10.14348/molcells.2014.2374; Laine J, 2002, J BIOL CHEM, V277, P3743, DOI 10.1074/jbc.M107069200; Lee SM, 2011, INFLAMM RES, V60, P807, DOI 10.1007/s00011-011-0336-3; Lepri SR, 2014, HUM CELL, V27, P78, DOI 10.1007/s13577-012-0051-6; Lima LDC, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-177; Lopez BGC, 2014, FOOD CHEM, V146, P174, DOI 10.1016/j.foodchem.2013.09.063; Machado J. L, 2012, EVID-BASED COMPL ALT, V2012, P10, DOI [10.1155/2012/157652, DOI 10.1155/2012/157652]; Mackova A, 2013, NAT PROD COMMUN, V8, P1509; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Matsumoto H, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-68; Miranda MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125101; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nakayama M, 2000, J EXP MED, V192, P1373, DOI 10.1084/jem.192.9.1373; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Oldoni TLC, 2011, SEP PURIF TECHNOL, V77, P208, DOI 10.1016/j.seppur.2010.12.007; Park YK, 2002, J AGR FOOD CHEM, V50, P2502, DOI 10.1021/jf011432b; Paulino N, 2008, EUR J PHARMACOL, V587, P296, DOI 10.1016/j.ejphar.2008.02.067; Paulino N, 2006, PLANTA MED, V72, P899, DOI 10.1055/s-2006-947185; Qiu CL, 2014, CELL PHYSIOL BIOCHEM, V33, P784, DOI 10.1159/000358652; Rankin CT, 2000, NAT GENET, V24, P262, DOI 10.1038/73472; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Saravanan S, 2014, EUR J PHARM SCI, V56, P70, DOI 10.1016/j.ejps.2014.02.005; Sathaliyawala T, 2010, IMMUNITY, V33, P597, DOI 10.1016/j.immuni.2010.09.012; Silva BB, 2008, EVID-BASED COMPL ALT, V5, P313, DOI 10.1093/ecam/nem059; Smolen JS, 2014, ANN RHEUM DIS, V73, P1616, DOI 10.1136/annrheumdis-2013-205137; St-Denis A, 1998, J BIOL CHEM, V273, P32787, DOI 10.1074/jbc.273.49.32787; Stein RC, 2001, ENDOCR-RELAT CANCER, V8, P237, DOI 10.1677/erc.0.0080237; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tang Y, 1998, P NATL ACAD SCI USA, V95, P5139, DOI 10.1073/pnas.95.9.5139; Wei Q, 2005, J BIOL CHEM, V280, P18081, DOI 10.1074/jbc.M413607200; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; Williams LM, 2004, IMMUNOLOGY, V113, P281, DOI 10.1111/j.1365-2567.2004.01988.x; Wu SQ, 2002, BLOOD, V100, P4454, DOI 10.1182/blood-2002-02-0415	69	46	47	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144954	10.1371/journal.pone.0144954	http://dx.doi.org/10.1371/journal.pone.0144954			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660901	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900155
J	Candelaria, NR; Weldon, R; Muthusamy, S; Nguyen-Vu, T; Addanki, S; Yoffou, PH; Karaboga, H; Blessing, AM; Bollu, LR; Miranda, RC; Lin, CY				Candelaria, Nicholes R.; Weldon, Ryan; Muthusamy, Selvaraj; Trang Nguyen-Vu; Addanki, Sridevi; Yoffou, Paule-Helena; Karaboga, Husna; Blessing, Alicia M.; Bollu, Lakshmi Reddy; Miranda, Rajesh C.; Lin, Chin-Yo			Alcohol Regulates Genes that Are Associated with Response to Endocrine Therapy and Attenuates the Actions of Tamoxifen in Breast Cancer Cells	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; PREMENOPAUSAL WOMEN; TUMOR PROGRESSION; RISK-FACTORS; IN-VITRO; CONSUMPTION; EXPRESSION; ERK1/2; TRANSCRIPTION; TRANSDUCTION	Hereditary, hormonal, and behavioral factors contribute to the development of breast cancer. Alcohol consumption is a modifiable behavior that is linked to increased breast cancer risks and is associated with the development of hormone-dependent breast cancers as well as disease progression and recurrence following endocrine treatment. In this study we examined the molecular mechanisms of action of alcohol by applying molecular, genetic, and genomic approaches in characterizing its effects on estrogen receptor (ER)-positive breast cancer cells. Treatments with alcohol promoted cell proliferation, increased growth factor signaling, and up-regulated the transcription of the ER target gene GREB1 but not the canonical target TFF1/pS2. Microarray analysis following alcohol treatment identified a large number of alcohol-responsive genes, including those which function in apoptotic and cell proliferation pathways. Furthermore, expression profiles of the responsive gene sets in tumors were strongly associated with clinical outcomes in patients who received endocrine therapy. Correspondingly, alcohol treatment attenuated the anti-proliferative effects of the endocrine therapeutic drug tamoxifen in ER-positive breast cancer cells. To determine the contribution and functions of responsive genes, their differential expression in tumors were assessed between outcome groups. The proto-oncogene BRAF was identified as a novel alcohol-and estrogen-induced gene that showed higher expression in patients with poor outcomes. Knock-down of BRAF, moreover, prevented the proliferation of breast cancer cells. These findings not only highlight the mechanistic basis of the effects of alcohol on breast cancer cells and increased risks for disease incidents and recurrence, but may facilitate the discovery and characterization of novel oncogenic pathways and markers in breast cancer research and therapeutics.	[Candelaria, Nicholes R.; Weldon, Ryan; Muthusamy, Selvaraj; Trang Nguyen-Vu; Addanki, Sridevi; Yoffou, Paule-Helena; Karaboga, Husna; Blessing, Alicia M.; Lin, Chin-Yo] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77004 USA; [Bollu, Lakshmi Reddy] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Miranda, Rajesh C.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Neurosci & Expt Therapeut, Bryan, TX USA; [Miranda, Rajesh C.] Texas A&M Hlth Sci Ctr, Coll Med, Womens Hlth Neurosci Program, Bryan, TX USA	University of Houston System; University of Houston; University of Houston System; University of Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Lin, CY (corresponding author), Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77004 USA.	clin23@central.uh.edu		Blessing, Alicia/0000-0002-3083-049X; Miranda, Rajesh/0000-0002-8359-892X; Muthusamy, Selvaraj/0000-0003-4498-848X	State of Texas Emerging Technologies Fund [300-9-1958]	State of Texas Emerging Technologies Fund	The Center for Nuclear Receptors and Cell Signaling at the University of Houston is supported by the State of Texas Emerging Technologies Fund (grant number 300-9-1958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ADACHI J, 1991, J STUD ALCOHOL, V52, P448, DOI 10.15288/jsa.1991.52.448; Banerjee S, 2008, CANCER RES, V68, P7606, DOI 10.1158/0008-5472.CAN-08-1461; Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543; BOYD NF, 1995, CANCER EPIDEM BIOMAR, V4, P727; Castiel A, 2011, J CELL SCI, V124, P532, DOI 10.1242/jcs.079731; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Chen WY, 2011, JAMA-J AM MED ASSOC, V306, P1884, DOI 10.1001/jama.2011.1590; Chumsri S, 2011, J STEROID BIOCHEM, V125, P13, DOI 10.1016/j.jsbmb.2011.02.001; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Das SK, 2007, LIFE SCI, V81, P177, DOI 10.1016/j.lfs.2007.05.005; DORGAN JF, 1994, CANCER CAUSE CONTROL, V5, P53, DOI 10.1007/BF01830726; Egan KM, 1998, CANCER EPIDEM BIOMAR, V7, P359; Enger SM, 1999, BRIT J CANCER, V79, P1308, DOI 10.1038/sj.bjc.6690210; Erez A, 2007, CANCER RES, V67, P4022, DOI 10.1158/0008-5472.CAN-07-0064; Etique N, 2006, BREAST CANC, V15, P17; Etique N, 2007, INT J ONCOL, V31, P1509; Fan SJ, 2000, CANCER RES, V60, P5635; Farmer P, 2005, BREAST CANC RES S2, V7, p[P2, 11], DOI DOI 10.1186/BCR1122; Fillmore MT, 2011, AM J ADDICTION, V20, P468, DOI 10.1111/j.1521-0391.2011.00156.x; FORMAN MR, 1995, AM J CLIN NUTR, V62, P131, DOI 10.1093/ajcn/62.1.131; GAPSTUR SM, 1995, CANCER EPIDEM BIOMAR, V4, P313; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Graves LM, 2000, NATURE, V403, P328, DOI 10.1038/35002111; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; HERRINTON LJ, 1993, CANCER, V71, P3029, DOI 10.1002/1097-0142(19930515)71:10<3029::AID-CNCR2820711024>3.0.CO;2-K; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Keshamouni VG, 2002, J BIOL CHEM, V277, P22558, DOI 10.1074/jbc.M202351200; Key J, 2006, CANCER CAUSE CONTROL, V17, P759, DOI 10.1007/s10552-006-0011-0; Kim-Kaneyama JR, 2000, J BIOL CHEM, V275, P20685, DOI 10.1074/jbc.M908723199; Kirschner RD, 2010, CELL CYCLE, V9, P2177, DOI 10.4161/cc.9.11.11844; Kwan ML, 2010, J CLIN ONCOL, V28, P4410, DOI 10.1200/JCO.2010.29.2730; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Li CI, 2010, J NATL CANC I; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Meng QH, 2000, BIOCHEM BIOPH RES CO, V273, P448, DOI 10.1006/bbrc.2000.2942; Mill CP, 2009, BREAST CANCER-TARGET, V1, P31; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; NASCA PC, 1994, AM J EPIDEMIOL, V140, P980, DOI 10.1093/oxfordjournals.aje.a117205; Park SK, 2000, PHARMACOGENETICS, V10, P301, DOI 10.1097/00008571-200006000-00004; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Seitz HK, 2012, ALCOHOL ALCOHOLISM, V47, P204, DOI 10.1093/alcalc/ags011; Singletary KW, 2001, JAMA-J AM MED ASSOC, V286, P2143, DOI 10.1001/jama.286.17.2143; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun L, 2014, BIOCHEM BIOPH RES CO, V449, P444, DOI 10.1016/j.bbrc.2014.05.048; Trentham-Dietz A, 2000, CANCER EPIDEM BIOMAR, V9, P697; Vorderstrasse BA, 2012, BREAST CANCER RES TR, V136, P729, DOI 10.1007/s10549-012-2275-2; Wen GY, 2011, CANCER LETT, V308, P23, DOI 10.1016/j.canlet.2011.04.010; Wen J, 2009, ONCOGENE, V28, P575, DOI 10.1038/onc.2008.405; YIRMIYA R, 1992, BRAIN BEHAV IMMUN, V6, P74, DOI 10.1016/0889-1591(92)90061-R; Zhang QS, 2013, CARCINOGENESIS, V34, P28, DOI 10.1093/carcin/bgs316; Zhang SMM, 2007, AM J EPIDEMIOL, V165, P667, DOI 10.1093/aje/kwk054; Zhong Q, 2014, ONCOTARGET, V5, P12410, DOI 10.18632/oncotarget.2678; Zolfaghari R, 2012, AM J PHYSIOL-GASTR L, V303, pG578, DOI 10.1152/ajpgi.00234.2012	59	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145061	10.1371/journal.pone.0145061	http://dx.doi.org/10.1371/journal.pone.0145061			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26661278	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900177
J	Ho, BL; Cheng, SC; Shi, L; Wang, TY; Ho, KI; Chou, CY				Ho, Bo-Lin; Cheng, Shu-Chun; Shi, Lin; Wang, Ting-Yun; Ho, Kuan-I; Chou, Chi-Yuan			Critical Assessment of the Important Residues Involved in the Dimerization and Catalysis of MERS Coronavirus Main Protease	PLOS ONE			English	Article							RESPIRATORY-SYNDROME-CORONAVIRUS; PAPAIN-LIKE PROTEASE; FUNCTIONAL-CHARACTERIZATION; SUBSTRATE-SPECIFICITY; THIOPURINE ANALOGS; CRYSTAL-STRUCTURES; 3C-LIKE PROTEASE; SARS; MECHANISM; BAT	Background A highly pathogenic human coronavirus (CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), has emerged in Jeddah and other places in Saudi Arabia, and has quickly spread to European and Asian countries since September 2012. Up to the 1st October 2015 it has infected at least 1593 people with a global fatality rate of about 35%. Studies to understand the virus are necessary and urgent. In the present study, MERS-CoV main protease (M-pro) is expressed; the dimerization of the protein and its relationship to catalysis are investigated. Methods and Results The crystal structure of MERS-CoV M-pro indicates that it shares a similar scaffold to that of other coronaviral M-pro and consists of chymotrypsin-like domains I and II and a helical domain III of five helices. Analytical ultracentrifugation analysis demonstrated that MERS-CoV M-pro undergoes a monomer to dimer conversion in the presence of a peptide substrate. Glu169 is a key residue and plays a dual role in both dimerization and catalysis. The mutagenesis of other residues found on the dimerization interface indicate that dimerization of MERS-CoV M-pro is required for its catalytic activity. One mutation, M298R, resulted in a stable dimer with a higher level of proteolytic activity than the wild-type enzyme. Conclusions MERS-CoV M-pro shows substrate-induced dimerization and potent proteolytic activity. A critical assessment of the residues important to these processes provides insights into the correlation between dimerization and catalysis within the coronaviral M-pro family.	[Chou, Chi-Yuan] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chou, CY (corresponding author), Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan.	cychou@ym.edu.tw		Chou, Chi-Yuan/0000-0002-3400-171X	Ministry of Science and Technology, Taiwan [103-2320-B-010-025, 104-2320-B-010-034]; National Yang-Ming University (Aim for Top University Plan from Ministry of Education); Ministry of Science and Technology of Taiwan, ROC; National Core Facility Program for Biotechnology; NYMU	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Yang-Ming University (Aim for Top University Plan from Ministry of Education); Ministry of Science and Technology of Taiwan, ROC; National Core Facility Program for Biotechnology; NYMU	This research was supported by grants from Ministry of Science and Technology, Taiwan (103-2320-B-010-025 and 104-2320-B-010-034) to CYC. We also thank National Yang-Ming University for its financial support (Aim for Top University Plan from Ministry of Education). Portions of this research were carried out at the National Synchrotron Radiation Research Center, a national user facility supported by the Ministry of Science and Technology of Taiwan, ROC. The Synchrotron Radiation Protein Crystallography Facility is supported by the National Core Facility Program for Biotechnology.; This research was supported by grants from Ministry of Science and Technology, Taiwan (103-2320-B-010-025 and 104-2320-B-010-034) to CYC. We also thank NYMU for its financial support (Aim for Top University Plan from Ministry of Education). Portions of this research were carried out at the National Synchrotron Radiation Research Center, a national user facility supported by the Ministry of Science and Technology of Taiwan, ROC. The Synchrotron Radiation Protein Crystallography Facility is supported by the National Core Facility Program for Biotechnology.	Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Anderson LJ, 2012, NEW ENGL J MED, V367, P1850, DOI 10.1056/NEJMe1212300; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Chan JFW, 2012, J INFECTION, V65, P477, DOI 10.1016/j.jinf.2012.10.002; Cheng KW, 2015, ANTIVIR RES, V115, P9, DOI 10.1016/j.antiviral.2014.12.011; Cheng SC, 2010, BIOPHYS J, V98, P1327, DOI 10.1016/j.bpj.2009.12.4272; Chou CY, 2008, BIOCHEM PHARMACOL, V75, P1601, DOI 10.1016/j.bcp.2008.01.005; Chou CY, 2014, ACTA CRYSTALLOGR D, V70, P572, DOI 10.1107/S1399004713031040; Chou CY, 2011, METHODS, V54, P76, DOI 10.1016/j.ymeth.2010.11.002; Chou CY, 2004, BIOCHEMISTRY-US, V43, P14958, DOI 10.1021/bi0490237; Chou YW, 2012, ARCH BIOCHEM BIOPHYS, V520, P74, DOI 10.1016/j.abb.2012.02.015; Drexler JF, 2014, ANTIVIR RES, V101, P45, DOI 10.1016/j.antiviral.2013.10.013; Eckerle I, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-359; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan KQ, 2004, J BIOL CHEM, V279, P1637, DOI 10.1074/jbc.M310875200; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hsieh YH, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-4; Hsu MF, 2005, J BIOL CHEM, V280, P31257, DOI 10.1074/jbc.M502577200; Ithete NL, 2013, EMERG INFECT DIS, V19, P1697, DOI 10.3201/eid1910.130946; Kilianski A, 2013, J VIROL, V87, P11955, DOI 10.1128/JVI.02105-13; Lin MH, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-54; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Needle D, 2015, ACTA CRYSTALLOGR D, V71, P1102, DOI 10.1107/S1399004715003521; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Tomar S, 2015, J BIOL CHEM, V290, P19403, DOI 10.1074/jbc.M115.651463; Wu AD, 2015, VIRUS RES, V208, P56, DOI 10.1016/j.virusres.2015.05.018; Wu CG, 2013, ACTA CRYSTALLOGR D, V69, P747, DOI 10.1107/S0907444913001315; Xue XY, 2008, J VIROL, V82, P2515, DOI 10.1128/JVI.02114-07; Yang HT, 2003, P NATL ACAD SCI USA, V100, P13190, DOI 10.1073/pnas.1835675100; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang SN, 2010, PROTEIN CELL, V1, P371, DOI 10.1007/s13238-010-0044-8	36	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144865	10.1371/journal.pone.0144865	http://dx.doi.org/10.1371/journal.pone.0144865			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658006	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900124
J	Kemp, DW; Rivers, AR; Kemp, KM; Lipp, EK; Porter, JW; Wares, JP				Kemp, Dustin W.; Rivers, Adam R.; Kemp, Keri M.; Lipp, Erin K.; Porter, James W.; Wares, John P.			Spatial Homogeneity of Bacterial Communities Associated with the Surface Mucus Layer of the Reef-Building Coral Acropora palmata	PLOS ONE			English	Article							DIVERSITY; DISEASE; RNA; SEQUENCES; COMPLEX; UNIFRAC; SEARCH	Coral surface mucus layer (SML) microbiota are critical components of the coral holobiont and play important roles in nutrient cycling and defense against pathogens. We sequenced 16S rRNA amplicons to examine the structure of the SML microbiome within and between colonies of the threatened Caribbean reef-building coral Acropora palmata in the Florida Keys. Samples were taken from three spatially distinct colony regions-uppermost (high irradiance), underside (low irradiance), and the colony base-representing microhabitats that vary in irradiance and water flow. Phylogenetic diversity (PD) values of coral SML bacteria communities were greater than surrounding seawater and lower than adjacent sediment. Bacterial diversity and community composition was consistent among the three microhabitats. Cyanobacteria, Bacteroidetes, Alphaproteobacteria, and Proteobacteria, respectively were the most abundant phyla represented in the samples. This is the first time spatial variability of the surface mucus layer of A. palmata has been studied. Homogeneity in the microbiome of A. palmata contrasts with SML heterogeneity found in other Caribbean corals. These findings suggest that, during non-stressful conditions, host regulation of SML microbiota may override diverse physiochemical influences induced by the topographical complexity of A. palmata. Documenting the spatial distribution of SML microbes is essential to understanding the functional roles these microorganisms play in coral health and adaptability to environmental perturbations.	[Kemp, Dustin W.; Kemp, Keri M.; Porter, James W.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Rivers, Adam R.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Lipp, Erin K.] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA; [Wares, John P.] Univ Georgia, Dept Genet, Athens, GA 30602 USA	University System of Georgia; University of Georgia; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Kemp, DW (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	DKemp1@uga.edu		Kemp, Dustin/0000-0002-9396-1518; Wares, John/0000-0003-1827-0669; Rivers, Adam/0000-0002-3703-834X; Kemp, Keri/0000-0003-3538-852X; Lipp, Erin/0000-0002-8066-0636	National Science Foundation Ecology of Infectious Diseases [1015342]; Directorate For Geosciences [1015342] Funding Source: National Science Foundation	National Science Foundation Ecology of Infectious Diseases(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research project was supported by the National Science Foundation Ecology of Infectious Diseases grant #1015342 awarded to JWP, EKL, and JPW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank MOTE Tropical Research Laboratory and Erich Bartels for laboratory and boat support. Meredith Meyers provided dive and sample collection assistance and Ron Eytan was very helpful with sample analysis and software support. All samples were collected under the permit FKNMS-2010-131-A1. This research project was supported by the National Science Foundation Ecology of Infectious Diseases grant #1015342 awarded to JWP, EKL, and JPW	Acinas SG, 2006, FEMS MICROBIOLOGY EC, V24, P27; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bak RPM, 1974, PROCEEDINGS 2ND INTE; Baums IB, 2014, MOL ECOLOGY; Bostrom KH, 2004, LIMNOL OCEANOGR-METH, V2, P365, DOI 10.4319/lom.2004.2.365; Bourne DG, 2013, ISME J, V7, P1452, DOI 10.1038/ismej.2012.172; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Bythell JC, 2011, J EXP MAR BIOL ECOL, V408, P88, DOI 10.1016/j.jembe.2011.07.028; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Closek CJ, 2014, ISME J, V8, P2411, DOI 10.1038/ismej.2014.85; Daniels CA, 2011, MAR ECOL PROG SER, V426, P29, DOI 10.3354/meps09024; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FUHRMAN JA, 1993, APPL ENVIRON MICROB, V59, P1294, DOI 10.1128/AEM.59.5.1294-1302.1993; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamada M, 2013, MOL BIOL EVOL, V30, P167, DOI 10.1093/molbev/mss213; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Kaandorp JA, 2001, THE ALGORITHMIC BEAU; Kaiser E, 1997, APPL ENVIRON MICROB, V63, P4026, DOI 10.1128/AEM.63.10.4026-4031.1997; Kemp DW, 2008, CORAL REEFS, V27, P289, DOI 10.1007/s00338-007-0333-8; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Krediet CJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2328; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; McKew BA, 2012, APPL ENVIRON MICROB, V78, P5229, DOI 10.1128/AEM.07764-11; Meyer JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100316; Morrow KM, 2012, APPL ENVIRON MICROB, V78, P6438, DOI 10.1128/AEM.01162-12; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Oksanen J., 2007, COMMUN ECOL PACK, P631; Pantos O, 2006, DIS AQUAT ORGAN, V69, P79, DOI 10.3354/dao069079; Pantos O, 2015, ISME J, V9, P1916, DOI 10.1038/ismej.2015.3; Petrova OE, 2012, J BACTERIOL, V194, P2413, DOI 10.1128/JB.00003-12; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rohwer F, 2001, CORAL REEFS, V20, P85; Rohwer F, 2002, MARINE ECOLOGY PROGR, V243; Roos PJ, 1967, GROWTH AND OCCURRENC; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Sebens KP, 1998, MAR BIOL, V131, P347, DOI 10.1007/s002270050328; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Team RC, 2014, R A LANGUAGE AND ENV; Toller WW, 2001, BIOL BULL, V201, P348, DOI 10.2307/1543613; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang QT, 2002, BIOTECHNIQUES, V33, P788, DOI 10.2144/02334st02; Whitehead LF, 2003, J EXP BIOL, V206, P3149, DOI 10.1242/jeb.00539; Yellowlees D, 2008, PLANT CELL ENVIRON, V31, P679, DOI 10.1111/j.1365-3040.2008.01802.x	52	11	11	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143790	10.1371/journal.pone.0143790	http://dx.doi.org/10.1371/journal.pone.0143790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659364	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900018
J	Ben Daya, I; Chen, AIH; Shafiee, MJ; Wong, A; Yeow, JTW				Ben Daya, Ibrahim; Chen, Albert I. H.; Shafiee, Mohammad Javad; Wong, Alexander; Yeow, John T. W.			Compensated Row-Column Ultrasound Imaging System Using Fisher Tippett Multilayered Conditional Random Field Model	PLOS ONE			English	Article							ADDRESSED ARRAYS	3-D ultrasound imaging offers unique opportunities in the field of non destructive testing that cannot be easily found in A-mode and B-mode images. To acquire a 3-D ultrasound image without a mechanically moving transducer, a 2-D array can be used. The row column technique is preferred over a fully addressed 2-D array as it requires a significantly lower number of interconnections. Recent advances in 3-D row-column ultrasound imaging systems were largely focused on sensor design. However, these imaging systems face three intrinsic challenges that cannot be addressed by improving sensor design alone: speckle noise, sparsity of data in the imaged volume, and the spatially dependent point spread function of the imaging system. In this paper, we propose a compensated row-column ultrasound image reconstruction system using Fisher-Tippett multilayered conditional random field model. Tests carried out on both simulated and real row-column ultrasound images show the effectiveness of our proposed system as opposed to other published systems. Visual assessment of the results show our proposed system's potential at preserving detail and reducing speckle. Quantitative analysis shows that our proposed system outperforms previously published systems when evaluated with metrics such as Peak Signal to Noise Ratio, Coefficient of Correlation, and Effective Number of Looks. These results show the potential of our proposed system as an effective tool for enhancing 3-D row-column imaging.	[Ben Daya, Ibrahim; Chen, Albert I. H.; Shafiee, Mohammad Javad; Wong, Alexander; Yeow, John T. W.] Univ Waterloo, Dept Syst Design Engn, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Yeow, JTW (corresponding author), Univ Waterloo, Dept Syst Design Engn, Waterloo, ON N2L 3G1, Canada.	jyeow@uwaterloo.ca	Wong, Alexander/GZM-2929-2022; MohammadShafiee, MohammadReza/J-2988-2013; Yeow, John/H-2111-2018	Wong, Alexander/0000-0002-5295-2797; Yeow, John/0000-0002-0740-8055	Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program; Ontario Ministry of Research and Innovation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This research was funded by the Natural Sciences and Engineering Research Council of Canada, the Canada Research Chairs Program, and the Ontario Ministry of Research and Innovation.	Achim A, 2001, IEEE T MED IMAGING, V20, P772, DOI 10.1109/42.938245; [Anonymous], 2001, CONDITIONAL RANDOM F; Blake A, 2011, MARKOV RANDOM FIELDS FOR VISION AND IMAGE PROCESSING, P1; Boroomand A, 2013, BIOMED OPT EXPRESS, V4, P2032, DOI 10.1364/BOE.4.002032; Chen AIH, 2011, IEEE INT ULTRA SYM, P1755, DOI 10.1109/ULTSYM.2011.0438; Chen K., 2014, 2014 5 EUR WORKSH VI, P1; Chen KL, 2014, IEEE INT ULTRA SYM, P317, DOI 10.1109/ULTSYM.2014.0078; Christiansen TL, 2015, IEEE T ULTRASON FERR, V62, P959, DOI 10.1109/TUFFC.2014.006819; Demore CEM, 2009, IEEE T ULTRASON FERR, V56, P1252, DOI 10.1109/TUFFC.2009.1167; Dolui S, 2012, VARIABLE SPLITTING K; Fritsch C, 2006, IEEE T ULTRASON FERR, V53, P1820, DOI 10.1109/TUFFC.2006.114; Futian Yao, 2010, Proceedings 2010 IEEE International Conference on Intelligent Systems and Knowledge Engineering (ISKE 2010), P197, DOI 10.1109/ISKE.2010.5680882; Jensen J. A., 1996, Medical & Biological Engineering & Computing, V34, P351; Jensen JA, 1999, LINEAR DESCRIPTIONS; Kazemzadeh F, 2014, SPIE P, P9217; Koch A, 2012, IEEE INT ULTRA SYM, P36, DOI 10.1109/ULTSYM.2012.0010; Logan Andrew S., 2009, 2009 IEEE International Ultrasonics Symposium, P984, DOI 10.1109/ULTSYM.2009.5441621; Logan AS, 2011, IEEE T ULTRASON FERR, V58, P1266, DOI 10.1109/TUFFC.2011.1937; Logan AS, 2010, DESIGN FABRICATION C; Michailovich O, 2007, IEEE T IMAGE PROCESS, V16, P3005, DOI 10.1109/TIP.2007.910179; Michailovich OV, 2006, IEEE T ULTRASON FERR, V53, P64, DOI 10.1109/TUFFC.2006.1588392; Morton CE, 2003, ULTRASON, P968; Nageswari CS, 2013, 2013 INTERNATIONAL CONFERENCE ON GREEN COMPUTING, COMMUNICATION AND CONSERVATION OF ENERGY (ICGCE), P174, DOI 10.1109/ICGCE.2013.6823423; Osman A, 2012, IOP CONF SER-MAT SCI, V42, DOI 10.1088/1757-899X/42/1/012005; Rasmussen MF, 2015, IEEE T ULTRASON FERR, V62, P947, DOI 10.1109/TUFFC.2014.006531; Rasmussen MF, 2013, IEEE INT ULTRA SYM, P1452, DOI 10.1109/ULTSYM.2013.0370; Sanches J, 2005, IEEE INT C IM PROC, V3, P597; Shafiee MJ, IEEE C IM P IN PRESS; Shruthi G., 2012, INT J COMPUT APPL, V45, P14; Sivakumar R., 2010, 2010 IEEE Conference on Open Systems (ICOS 2010), P80, DOI 10.1109/ICOS.2010.5720068; Smith RA, 2009, INSIGHT, V51, P82, DOI 10.1784/insi.2009.51.2.82; Srivastava R, 2010, OPT LASER ENG, V48, P626, DOI 10.1016/j.optlaseng.2009.09.012; Szabo TL, 2004, DIAGNOSTIC ULTRASOUN; Tanaka K, 2010, J PHYS CONF SER, V233, DOI 10.1088/1742-6596/233/1/012013; Wu SB, 2013, IEEE ENG MED BIO, P1148, DOI 10.1109/EMBC.2013.6609709	35	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0142817	10.1371/journal.pone.0142817	http://dx.doi.org/10.1371/journal.pone.0142817			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658577	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903600006
J	Farr, A; Kiss, H; Hagmann, M; Machal, S; Holzer, I; Kueronya, V; Husslein, PW; Petricevic, L				Farr, Alex; Kiss, Herbert; Hagmann, Michael; Machal, Susanne; Holzer, Iris; Kueronya, Verena; Husslein, Peter Wolf; Petricevic, Ljubomir			Role of Lactobacillus Species in the Intermediate Vaginal Flora in Early Pregnancy: A Retrospective Cohort Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; BACTERIAL VAGINOSIS; PRETERM DELIVERY; LATE MISCARRIAGE; GRAM STAIN; BIRTH; METAANALYSIS; WOMEN; CLINDAMYCIN; PREVENTION	Background Poor obstetrical outcomes are associated with imbalances in the vaginal flora. The present study evaluated the role of vaginal Lactobacillus species in women with intermediate vaginal flora with regard to obstetrical outcomes. Methods We retrospectively analysed data from all women with singleton pregnancies who had undergone routine screening for asymptomatic vaginal infections at our tertiary referral centre between 2005 and 2014. Vaginal smears were Gram-stained and classified according to the Nugent scoring system as normal flora (score 0-3), intermediate vaginal flora (4-6), or bacterial vaginosis (7-10). Only women with intermediate vaginal flora were investigated. Women with a Nugent score of 4 were categorised into those with and without Lactobacilli. Follow-up smears were obtained 4-6 weeks after the initial smears. Descriptive data analysis, the Welch's t-test, the Fisher's exact test, and multiple regression analysis with adjustment for confounders were performed. Gestational age at delivery and birth weight were the outcome measures. Results At antenatal screening, 529/8421 women presented with intermediate vaginal flora. Amongst these, 349/529 (66%) had a Nugent score of 4, 94/529 (17.8%) a Nugent score of 5, and 86/529 (16.2%) a Nugent score of 6. Amongst those with a Nugent score of 4, 232/349 (66.5%) women were in the Lactobacilli group and 117/349 (33.5%) in the Non-Lactobacilli group. The preterm delivery rate was significantly lower in the Lactobacilli than in the Non-Lactobacilli group (OR 0.34, CI 0.21-0.55; p<0.001). Mean birth weight was 2979 +/- 842 g and 2388 +/- 1155 g in the study groups, respectively (MD 564.12, CI 346.23-781.92; p<0.001). On follow-up smears, bacterial vaginosis rates were 9% in the Lactobacilli and 7.8% in the Non-Lactobacilli group. Conclusions The absence of vaginal Lactobacillus species and any bacterial colonisation increases the risks of preterm delivery and low birth weight in women with intermediate vaginal flora in early pregnancy.	[Farr, Alex; Kiss, Herbert; Machal, Susanne; Holzer, Iris; Kueronya, Verena; Husslein, Peter Wolf; Petricevic, Ljubomir] Med Univ Vienna, Div Obstet & Fetomaternal Med, Dept Obstet & Gynaecol, Vienna, Austria; [Hagmann, Michael] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Sect Med Stat, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Petricevic, L (corresponding author), Med Univ Vienna, Div Obstet & Fetomaternal Med, Dept Obstet & Gynaecol, Vienna, Austria.	ljubomir.petricevic@meduniwien.ac.at						Brocklehurst P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000262.pub4; Brown HK, 2014, INT J EPIDEMIOL, V43, P802, DOI 10.1093/ije/dyt251; Donati L, 2010, ARCH GYNECOL OBSTET, V281, P589, DOI 10.1007/s00404-009-1318-3; Donders GG, 2009, BJOG-INT J OBSTET GY, V116, P1315, DOI 10.1111/j.1471-0528.2009.02237.x; Donders GGG, 2007, BEST PRACT RES CL OB, V21, P355, DOI 10.1016/j.bpobgyn.2007.01.002; Farr A, 2015, BIRTH-ISS PERINAT C, V42, P173, DOI 10.1111/birt.12154; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Guerra B, 2006, EUR J OBSTET GYN R B, V128, P40, DOI 10.1016/j.ejogrb.2005.12.024; HAY PE, 1994, BRIT MED J, V308, P295, DOI 10.1136/bmj.308.6924.295; HILLIER SL, 1992, AM J OBSTET GYNECOL, V166, P938, DOI 10.1016/0002-9378(92)91368-K; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Honda H, 2014, SCI REP-UK, V4, DOI 10.1038/srep04799; Ison CA, 2002, SEX TRANSM INFECT, V78, P413, DOI 10.1136/sti.78.6.413; Kiss H, 2004, BMJ-BRIT MED J, V329, P371, DOI 10.1136/bmj.38169.519653.EB; Lamont RF, 2011, AM J OBSTET GYNECOL, V205, P177, DOI 10.1016/j.ajog.2011.03.047; Leitich H, 2003, AM J OBSTET GYNECOL, V188, P752, DOI 10.1067/mob.2003.167; Leitich H, 2003, AM J OBSTET GYNECOL, V189, P139, DOI 10.1067/mob.2003.339; Leitich H, 2007, BEST PRACT RES CL OB, V21, P375, DOI 10.1016/j.bpobgyn.2006.12.005; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Parma M, 2014, ALTERN THER HEALTH M, V20, P52; Petricevic L, 2014, SCI REP-UK, V4, DOI 10.1038/srep05136; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; SPERNOL R, 1985, WIEN MED WOCHENSCHR, V135, P65; SPIEGEL CA, 1991, CLIN MICROBIOL REV, V4, P485, DOI 10.1128/CMR.4.4.485-502.1991; Ugwumadu A, 2003, LANCET, V361, P983, DOI 10.1016/S0140-6736(03)12823-1	25	14	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144181	10.1371/journal.pone.0144181	http://dx.doi.org/10.1371/journal.pone.0144181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658473	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903600027
J	Longley, RJ; Halbroth, BR; Ewer, KJ; Hill, AVS; Spencer, AJ				Longley, Rhea J.; Halbroth, Benedict R.; Ewer, Katie J.; Hill, Adrian V. S.; Spencer, Alexandra J.			Identification of Immunodominant Responses to the Plasmodium falciparum Antigens PfUIS3, PfLSA1 and PfLSAP2 in Multiple Strains of Mice	PLOS ONE			English	Article							LIVER-STAGE ANTIGEN-1; T-CELL IMMUNOGENICITY; SPOROZOITE INOCULATION; MALARIA SPOROZOITES; PROTECTIVE EFFICACY; VACCINE; IMMUNIZATION; IMMUNITY; PROTEIN; EPITOPE	Malaria, caused by the Plasmodium parasite, remains a serious global public health concern. A vaccine could have a substantial impact on eliminating this disease, alongside other preventative measures. We recently described the development of three novel, viral vectored vaccines expressing either of the antigens PfUIS3, PfLSA1 and PfLSAP2. Each vaccination regimen provided high levels of protection against chimeric parasite challenge in a mouse model, largely dependent on CD8(+) T cells. In this study we aimed to further characterize the induced cellular immune response to these vaccines. We utilized both the IFN gamma enzyme-linked immunosorbent spot assay and intracellular cytokine staining to achieve this aim. We identified immunodominant peptide responses for CD4(+) and CD8(+) T cells for each of the antigens in BALB/c, C57BL/6 and HLA-A2 transgenic mice, creating a useful tool for researchers for subsequent study of these antigens. We also compared these immunodominant peptides with those generated from epitope prediction software, and found that only a small proportion of the large number of epitopes predicted by the software were identifiable experimentally. Furthermore, we characterized the polyfunctionality of the induced CD8(+) T cell responses. These findings contribute to our understanding of the immunological mechanisms underlying these protective vaccines, and provide a useful basis for the assessment of these and related vaccines as clinical constructs.	[Longley, Rhea J.; Halbroth, Benedict R.; Ewer, Katie J.; Hill, Adrian V. S.; Spencer, Alexandra J.] Univ Oxford, Jenner Inst, Oxford, England	University of Oxford; Jenner Institute	Longley, RJ (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	Longley.r@wehi.edu.au	Spencer, Alexandra/AAE-6494-2019; Ewer, Katie J/B-4328-2011; Longley, Rhea J/C-9573-2018	Spencer, Alexandra/0000-0001-7958-6961; Ewer, Katie J/0000-0001-9827-9836; Longley, Rhea J/0000-0002-4510-5602; Halbroth, Benedict/0000-0002-1253-2843; Hill, Adrian/0000-0003-0900-9629	Wellcome Trust [095540/Z/11/Z]; Rhodes Trust; Nuffield Department of Medicine Studentship; European Union [316655]	Wellcome Trust(Wellcome TrustEuropean Commission); Rhodes Trust; Nuffield Department of Medicine Studentship; European Union(European Commission)	This work has been funded by a grant from the Wellcome Trust (095540/Z/11/Z) with additional funding by the Rhodes Trust and a Nuffield Department of Medicine Studentship to support RJL. BRH receives funding from the European Union Seventh Framework Programme FP7/2012-2016 under grant agreement number 316655 (VACTRAIN). AVSH is a Jenner Institute Investigator; AJS is a James Martin Fellow. The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann-Leitner ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071610; Berthoud TK, 2011, CLIN INFECT DIS, V52, P1, DOI 10.1093/cid/ciq015; Brando C, 2007, INFECT IMMUN, V75, P838, DOI 10.1128/IAI.01075-06; Cummings JF, 2010, VACCINE, V28, P5135, DOI 10.1016/j.vaccine.2009.08.046; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; FIDOCK DA, 1994, J IMMUNOL, V153, P190; Gilbert SC, 2002, VACCINE, V20, P1039, DOI 10.1016/S0264-410X(01)00450-9; GOTCH F, 1987, NATURE, V326, P881, DOI 10.1038/326881a0; Hill AVS, 2010, HUM VACCINES, V6, P78, DOI 10.4161/hv.6.1.10116; HOFFMAN SL, 1989, SCIENCE, V244, P1078, DOI 10.1126/science.2524877; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Longley RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11820; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Plowe CV, 2009, J INFECT DIS, V200, P1646, DOI 10.1086/646613; Prieur E, 2004, P NATL ACAD SCI USA, V101, P290, DOI 10.1073/pnas.0307158101; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reyes-Sandoval A, 2012, MOL THER, V20, P1633, DOI 10.1038/mt.2012.25; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; Riley EM, 2013, NAT MED, V19, P168, DOI 10.1038/nm.3083; ROCK KL, 1992, P NATL ACAD SCI USA, V89, P8918, DOI 10.1073/pnas.89.19.8918; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; Rozen S, 2000, Methods Mol Biol, V132, P365; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Siau A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000121; Sidney J, 1996, IMMUNOL TODAY, V17, P261, DOI 10.1016/0167-5699(96)80542-1; Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2; The RTS, 2015, LANCET, V386, P31, DOI DOI 10.1016/S0140-6736(15)60721-8; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Weiss WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031247; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; Yang XD, 2009, REV MED VIROL, V19, P77, DOI 10.1002/rmv.602	40	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144515	10.1371/journal.pone.0144515	http://dx.doi.org/10.1371/journal.pone.0144515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659715	Green Submitted, gold, Green Published			2022-12-27	WOS:000366903600050
J	Tiwary, E; Hegde, S; Purushotham, S; Deivanayagam, C; Srivastava, O				Tiwary, Ekta; Hegde, Shylaja; Purushotham, Sangeetha; Deivanayagam, Champion; Srivastava, Om			Interaction of beta A3-Crystallin with Deamidated Mutants of alpha A- and alpha B-Crystallins	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; CHAPERONE-LIKE ACTIVITY; HUMAN SENILE CATARACTOGENESIS; SURFACE-PLASMON RESONANCE; AGE-DEPENDENT DEAMIDATION; GAMMA-D-CRYSTALLIN; HUMAN LENS; BOVINE LENS; FUNCTIONAL-PROPERTIES; BACKBONE CLEAVAGE	Interaction among crystallins is required for the maintenance of lens transparency. Deamidation is one of the most common post-translational modifications in crystallins, which results in incorrect interaction and leads to aggregate formation. Various studies have established interaction among the alpha- and beta-crystallins. Here, we investigated the effects of the deamidation of alpha A- and alpha B-crystallins on their interaction with beta A3-crystallin using surface plasmon resonance (SPR) and fluorescence lifetime imaging microscopy-fluorescence resonance energy transfer (FLIM-FRET) methods. SPR analysis confirmed adherence of WT alpha A- and WT alpha B-crystallins and their deamidated mutants with beta A3-crystallin. The deamidated mutants of alpha A-crystallin (alpha A N101D and alpha A N123D) displayed lower adherence propensity for beta A3-crystallin relative to the binding affinity shown by WT alpha A-crystallin. Among alpha B-crystallin mutants, alpha B N78D displayed higher adherence propensity whereas alpha B N146D mutant showed slightly lower binding affinity for beta A3-crystallin relative to that shown by WT alpha B-crystallin. Under the in vivo condition (FLIM-FRET), both alpha A-deamidated mutants (alpha A N101D and alpha A N123D) exhibited strong interaction with beta A3-crystallin (32 +/- 4% and 36 +/- 4% FRET efficiencies, respectively) compared to WT alpha A-crystallin (18 +/- 4%). Similarly, the alpha B N78D and alpha B N146D mutants showed strong interaction (36 +/- 4% and 22 +/- 4% FRET efficiencies, respectively) with beta A3-crystallin compared to 18 +/- 4% FRET efficiency of WT alpha B-crystallin. Further, FLIM-FRET analysis of the C-terminal domain (CTE), N-terminal domain (NTD), and core domain (CD) of alpha A- and alpha B-crystallins with beta A3-crystallin suggested that interaction sites most likely reside in the alpha A CTE and alpha B NTD regions, respectively, as these domains showed the highest FRET efficiencies. Overall, results suggest that similar to WT alpha A- and WT alpha B-crystallins, the deamidated mutants showed strong interaction for beta A3-crystallin. Variable in vitro and in vivo interactions are most likely due to the mutant's large size oligomers, reduced hydrophobicity, and altered structures. Together, the results suggest that deamidation of alpha-crystallin may facilitate greater interaction and the formation of large oligomers with other crystallins, and this may contribute to the cataractogenic mechanism.	[Tiwary, Ekta; Hegde, Shylaja; Srivastava, Om] Univ Alabama Birmingham, Sch Optometry, Dept Vis Sci, Birmingham, AL 35294 USA; [Purushotham, Sangeetha; Deivanayagam, Champion] Univ Alabama Birmingham, Dept Vis Sci, Struct Biol Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Srivastava, O (corresponding author), Univ Alabama Birmingham, Sch Optometry, Dept Vis Sci, Birmingham, AL 35294 USA.	srivasta@uab.edu		Deivanayagam, Champion/0000-0003-2972-1824	National Eye Institution [EY06400]; NATIONAL EYE INSTITUTE [R01EY006400] Funding Source: NIH RePORTER	National Eye Institution; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funded by National Eye Institution, EY06400 (https://nei.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andley UP, 2008, INT J BIOCHEM CELL B, V40, P317, DOI 10.1016/j.biocel.2007.10.034; Asomugha CO, 2011, MOL VIS, V17, P2356; Augusteyn Robert C, 2004, Clin Exp Optom, V87, P356; Bhattacharyya J, 2006, BIOCHEMISTRY-US, V45, P3069, DOI 10.1021/bi0518141; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; Cohen D, 2007, INVEST OPHTH VIS SCI, V48, P2208, DOI 10.1167/iovs.06-1019; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Feil IK, 2001, J BIOL CHEM, V276, P12024, DOI 10.1074/jbc.M010856200; Ferrini W, 2004, INVEST OPHTH VIS SCI, V45, P1436, DOI 10.1167/iovs.03-0760; Flaugh SL, 2006, J BIOL CHEM, V281, P30782, DOI 10.1074/jbc.M603882200; Ghosh JG, 2005, BIOCHEMISTRY-US, V44, P14854, DOI 10.1021/bi0503910; Ghosh JG, 2006, BIOCHEMISTRY-US, V45, P13847, DOI 10.1021/bi061471m; Graw J, 1999, PROG RETIN EYE RES, V18, P235, DOI 10.1016/S1350-9462(98)00018-4; GROENEN PJTA, 1993, FEBS LETT, V322, P69, DOI 10.1016/0014-5793(93)81113-E; Gupta R, 2004, J BIOL CHEM, V279, P44258, DOI 10.1074/jbc.M405648200; Gupta R, 2004, INVEST OPHTH VIS SCI, V45, P206, DOI 10.1167/iovs.03-0720; Gupta R, 2009, J BIOL CHEM, V284, P18481, DOI 10.1074/jbc.M109.013789; Hains PG, 2010, INVEST OPHTH VIS SCI, V51, P3107, DOI 10.1167/iovs.09-4308; Hanson SRA, 2000, EXP EYE RES, V71, P195, DOI 10.1006/exer.2000.0868; Harrington V, 2004, MOL VIS, V10, P476; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Kamei A, 2002, BIOL PHARM BULL, V25, P611, DOI 10.1248/bpb.25.611; Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lampi KJ, 2001, EXP EYE RES, V72, P279, DOI 10.1006/exer.2000.0950; Liu BF, 2005, MOL VIS, V11, P321; Lu SS, 2007, MOL VIS, V13, P1154; LUBSEN NH, 1988, PROG BIOPHYS MOL BIO, V51, P47, DOI 10.1016/0079-6107(88)90010-7; Lund AL, 1996, EXP EYE RES, V63, P661, DOI 10.1006/exer.1996.0160; Ma ZX, 1998, EXP EYE RES, V67, P21, DOI 10.1006/exer.1998.0482; MERCK KB, 1993, MOL BIOL REP, V18, P209, DOI 10.1007/BF01674432; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; ORTWERTH BJ, 1992, EXP EYE RES, V54, P103, DOI 10.1016/0014-4835(92)90074-3; Peschek J, 2013, P NATL ACAD SCI USA, V110, pE3780, DOI 10.1073/pnas.1308898110; Ponce A, 2005, MOL VIS, V11, P752; Rajan S, 2006, MOL CELL BIOCHEM, V288, P125, DOI 10.1007/s11010-006-9128-4; Reddy GB, 2006, IUBMB LIFE, V58, P632, DOI 10.1080/15216540601010096; Santhoshkumar P, 2008, J BIOL CHEM, V283, P8477, DOI 10.1074/jbc.M705876200; Schuck P, 1997, ANNU REV BIOPH BIOM, V26, P541, DOI 10.1146/annurev.biophys.26.1.541; Sharma KK, 2000, J BIOL CHEM, V275, P3767, DOI 10.1074/jbc.275.6.3767; Srivastava OP, 2008, MOL VIS, V14, P1872; Srivastava OP, 2004, J BIOL CHEM, V279, P10901, DOI 10.1074/jbc.M308884200; SRIVASTAVA OP, 1983, EXP EYE RES, V36, P363, DOI 10.1016/0014-4835(83)90118-5; SRIVASTAVA OP, 1983, EXP EYE RES, V36, P695, DOI 10.1016/0014-4835(83)90107-0; Srivastava OP, 2003, MOL VIS, V9, P110; Takata T, 2007, BIOCHEMISTRY-US, V46, P8861, DOI 10.1021/bi700487q; Takemoto L, 2000, MOL VIS, V6, P164; Takemoto L, 2001, EXP EYE RES, V72, P559, DOI 10.1006/exer.2001.0983; Takemoto L, 2001, CURR EYE RES, V22, P148, DOI 10.1076/ceyr.22.2.148.5524; Takemoto L, 1999, MOL VIS, V5, pU1; Takemoto L, 2008, EXP EYE RES, V87, P496, DOI 10.1016/j.exer.2008.08.018; Wang SSS, 2010, MOL VIS, V16, P2777; Wilmarth PA, 2006, J PROTEOME RES, V5, P2554, DOI 10.1021/pr050473a; Zhang ZL, 2003, EXP EYE RES, V77, P259, DOI 10.1016/S0014-4835(03)00159-3	56	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144621	10.1371/journal.pone.0144621	http://dx.doi.org/10.1371/journal.pone.0144621			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657544	Green Submitted, gold, Green Published			2022-12-27	WOS:000366903600070
J	Yoo, TK; Min, JW; Kim, MK; Lee, E; Kim, J; Lee, HB; Kang, YJ; Kim, YG; Moon, HG; Moon, K; Cho, N; Noh, DY; Han, W				Yoo, Tae-Kyung; Min, Jun Won; Kim, Min Kyoon; Lee, Eunshin; Kim, Jongjin; Lee, Han-Byoel; Kang, Young Joon; Kim, Yun-Gyoung; Moon, Hyeong-Gon; Moon, Kyung; Cho, Nariya; Noh, Dong-Young; Han, Wonshik			In Vivo Tumor Growth Rate Measured by US in Preoperative Period and Long Term Disease Outcome in Breast Cancer Patients	PLOS ONE			English	Article							DOUBLING TIME; PROGNOSIS; MAMMOGRAPHY; ASSOCIATION; ULTRASOUND; CARCINOMA; DENSITY; SIZE; KI67	Objective The aim of our study was to evaluate the effect of tumor growth rate, calculated from tumor size measurements by US, on breast cancer patients' outcome. Patients and Methods Breast cancer patients who received at least two serial breast ultrasonographies (US) in our institution during preoperative period and were surgically treated between 2002 and 2010 were reviewed. Tumor growth rate was determined by specific growth rate (SGR) using the two time point tumor sizes by US. Results A total of 957 patients were analyzed. The median duration between initial and second US was 28 days (range, 8-140). The median initial tumor size was 1.7cm (range, 0.4-7.0) and median second size was 1.9cm (range, 0.3-7.2). 523(54.6%) cases had increase in size. The median SGR(x10(-2)) was 0.59 (range, -11.90 similar to 31.49) and mean tumor doubling time was 14.51 days. Tumor growth rate was higher when initial tumor size was smaller. Lymphovascular invasion, axillary lymph node metastasis, and higher histologic grade were significantly associated with higher SGR. SGR was significantly associated with disease-free survival (DFS) in a univariate analysis (p = 0.04), but not in a multivariate Cox analysis (p > 0.05). High SGR was significantly associated with worse DFS in a subgroup of initial tumor size > 2cm (p = 0.018), but not in those with tumor size < 2cm (p > 0.05). Conclusion Our results showed that tumor growth rate measured by US in a relatively short time interval was associated with other worse prognostic factors and DFS, but it was not an independent prognostic factor in breast cancer patients.	[Yoo, Tae-Kyung; Kim, Min Kyoon; Lee, Eunshin; Kim, Jongjin; Lee, Han-Byoel; Kang, Young Joon; Kim, Yun-Gyoung; Moon, Hyeong-Gon; Noh, Dong-Young; Han, Wonshik] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; [Min, Jun Won] Dankook Univ, Coll Med, Dept Surg, Cheonan, South Korea; [Moon, Kyung; Cho, Nariya] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Moon, Hyeong-Gon; Noh, Dong-Young; Han, Wonshik] Seoul Natl Univ, Coll Med, Canc Res Inst, Lab Breast Canc Biol, Seoul, South Korea	Seoul National University (SNU); Dankook University; Seoul National University (SNU); Seoul National University (SNU)	Han, W (corresponding author), Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea.	hanw@snu.ac.kr	Han, Wonshik/B-3699-2008	Han, Wonshik/0000-0001-7310-0764; Moon, Hyeong-Gon/0000-0002-9981-0286	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2015R1A2A2A01008264]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1277]	National Research Foundation of Korea (NRF) - Korea government (MSIP); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	Supported in part by a National Research Foundation of Korea (NRF) Grant funded by the Korea government (MSIP) (grant number: 2015R1A2A2A01008264) and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1277). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported in part by a National Research Foundation of Korea (NRF) Grant funded by the Korea government (MSIP) (grant number: 2015R1A2A2A01008264) and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1277)	Boisserie-Lacroix M, 2013, ONCOLOGIST, V18, P802, DOI 10.1634/theoncologist.2013-0380; Bosch AM, 2003, EUR J RADIOL, V48, P285, DOI 10.1016/S0720-048X(03)00081-0; Chen ZJ, 2004, AM J EPIDEMIOL, V159, P140, DOI 10.1093/aje/kwh028; Costantini M, 2012, CLIN BREAST CANCER, V12, P331, DOI 10.1016/j.clbc.2012.07.002; El-Bastawissi AY, 2001, ANN EPIDEMIOL, V11, P257, DOI 10.1016/S1047-2797(00)00225-8; Friberg S, 1997, J SURG ONCOL, V65, P284, DOI 10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2; GALANTE E, 1986, BRIT J CANCER, V54, P833, DOI 10.1038/bjc.1986.247; Ganz Patricia A., 2000, Breast J, V6, P324, DOI 10.1046/j.1524-4741.2000.20042.x; Hart D, 1998, BRIT J CANCER, V78, P382, DOI 10.1038/bjc.1998.503; HEUSER L, 1979, CANCER, V43, P1888, DOI 10.1002/1097-0142(197905)43:5<1888::AID-CNCR2820430545>3.0.CO;2-M; HEUSER LS, 1984, CANCER, V53, P96, DOI 10.1002/1097-0142(19840101)53:1<96::AID-CNCR2820530117>3.0.CO;2-A; Jacquemier J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2249; Kontzoglou K, 2013, ONCOLOGY-BASEL, V84, P219, DOI 10.1159/000346475; KUROISHI T, 1990, JPN J CANCER RES, V81, P454, DOI 10.1111/j.1349-7006.1990.tb02591.x; KUSAMA S, 1972, CANCER-AM CANCER SOC, V30, P594, DOI 10.1002/1097-0142(197208)30:2<594::AID-CNCR2820300241>3.0.CO;2-2; Mehrara E, 2007, CANCER RES, V67, P3970, DOI 10.1158/0008-5472.CAN-06-3822; Mehrara E, 2009, ACTA ONCOL, V48, P591, DOI 10.1080/02841860802616736; Moon HG, 2010, J CLIN ONCOL, V28, P1692, DOI 10.1200/JCO.2009.25.9226; PEARLMAN AW, 1976, CANCER, V38, P1826, DOI 10.1002/1097-0142(197610)38:4<1826::AID-CNCR2820380460>3.0.CO;2-L; PEER PGM, 1993, CANCER, V71, P3547, DOI 10.1002/1097-0142(19930601)71:11<3547::AID-CNCR2820711114>3.0.CO;2-C; Ryu EB, 2014, EUR RADIOL, V24, P2227, DOI 10.1007/s00330-014-3256-0; SPRATT JS, 1986, CANCER RES, V46, P970; TABBANE F, 1989, CANCER, V64, P2081, DOI 10.1002/1097-0142(19891115)64:10<2081::AID-CNCR2820641019>3.0.CO;2-7; VONFOURNIER D, 1980, CANCER-AM CANCER SOC, V45, P2198; Wagner JL, 2011, ANN SURG, V254, P119, DOI 10.1097/SLA.0b013e318217e97f; Weedon-Fekjaer H, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2092	26	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144144	10.1371/journal.pone.0144144	http://dx.doi.org/10.1371/journal.pone.0144144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657267	Green Submitted, gold, Green Published			2022-12-27	WOS:000366903500014
J	Le Chenadec, J; Scott-Algara, D; Blanche, S; Didier, C; Montange, T; Viard, JP; Dollfus, C; Avettand-Fenoel, V; Rouzioux, C; Warszawski, J; Buseyne, F				Le Chenadec, Jerome; Scott-Algara, Daniel; Blanche, Stephane; Didier, Celine; Montange, Thomas; Viard, Jean-Paul; Dollfus, Catherine; Avettand-Fenoel, Veronique; Rouzioux, Christine; Warszawski, Josiane; Buseyne, Florence			Gag-Specific CD4 and CD8 T-Cell Proliferation in Adolescents and Young Adults with Perinatally Acquired HIV-1 Infection Is Associated with Ethnicity - The ANRS-EP38IMMIP Study	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HEPATITIS-C VIRUS; IMMUNE-RESPONSES; HIV-1-INFECTED CHILDREN; INFLUENZA VACCINATION; VIRAL SUPPRESSION; DISEASE HISTORY; LYMPHOCYTES; REPLICATION; VIREMIA	The ANRS-EP38-IMMIP study aimed to provide a detailed assessment of the immune status of perinatally infected youths living in France. We studied Gag-specific CD4 and CD8 T-cell proliferation and the association between the proliferation of these cells, demographic factors and HIV disease history. We included 93 youths aged between 15 and 24 years who had been perinatally infected with HIV. Sixty-nine had undergone valid CFSE-based T-cell proliferation assays. Gag-specific proliferation of CD4 and CD8 T cells was detected in 12 (16%) and 30 (38%) patients, respectively. The Gag-specific proliferation of CD4 and CD8 T cells was more frequently observed in black patients than in patients from other ethnic groups (CD4: 32% vs. 4%, P = 0.001; CD8: 55% vs. 26%, P = 0.02). Among aviremic patients, the duration of viral suppression was shorter in CD8 responders than in CD8 nonresponders (medians: 54 vs. 20 months, P = 0.04). Among viremic patients, CD8 responders had significantly lower plasma HIV RNA levels than CD8 nonresponders (2.7 vs. 3.7 log(10) HIV-RNA copies/ml, P = 0.02). In multivariate analyses including sex and HIV-1 subtype as covariables, Gag-specific CD4 T-cell proliferation was associated only with ethnicity, whereas Gag-specific CD8 T-cell proliferation was associated with both ethnicity and the duration of viral suppression. Both CD4 and CD8 responders reached their nadir CD4 T-cell percentages at younger ages than their nonresponder counterparts (6 vs. 8 years, P = 0.04 for both CD4 and CD8 T-cell proliferation). However, these associations were not significant inmultivariate analysis. In conclusion, after at least 15 years of HIV infection, Gag-specific T-cell proliferation was found to be more frequent in black youths than in patients of other ethnic groups, despite all the patients being born in the same country, with similar access to care.	[Le Chenadec, Jerome; Warszawski, Josiane] INSERM, U1018, CESP, F-94275 Le Kremlin Bicetre, France; [Scott-Algara, Daniel; Didier, Celine] Inst Pasteur, Unite Regulat Infect Retrovirales, Paris, France; [Blanche, Stephane] Hop Necker Enfants Malad, AP HP, Unite Immunol & Hematol Pediat, Paris, France; [Montange, Thomas; Buseyne, Florence] Inst Pasteur, Unite Epidemiol & Physiopathol Virus Oncogenes, Paris, France; [Montange, Thomas; Buseyne, Florence] CNRS, UMR 3569, Paris, France; [Viard, Jean-Paul; Avettand-Fenoel, Veronique; Rouzioux, Christine] Univ Paris 05, Sorbonne Paris Cite, Fac Med, EA7327, Paris, France; [Viard, Jean-Paul] Hop Hotel Dieu, AP HP, Ctr Diagnost & Therapeut, F-75181 Paris, France; [Dollfus, Catherine] Hop Trousseau, AP HP, Serv Hematol & Oncol Pediat, F-75571 Paris, France; [Avettand-Fenoel, Veronique; Rouzioux, Christine] Hop Necker Enfants Malad, AP HP, Lab Virol, Paris, France; [Warszawski, Josiane] Univ Paris 11, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay	Buseyne, F (corresponding author), Inst Pasteur, Unite Epidemiol & Physiopathol Virus Oncogenes, Paris, France.	florence.buseyne@pasteur.fr	Buseyne, Florence/AAH-4133-2021; Scott, Daniel/AFK-5428-2022; Avettand-Fenoel, Véronique/O-6285-2017; Viard, Jean-Paul/O-6467-2017	Buseyne, Florence/0000-0002-9323-7837; Avettand-Fenoel, Véronique/0000-0002-7022-2990; Viard, Jean-Paul/0000-0001-5946-8896; Scott-Algara, Daniel/0000-0003-1851-503X	"Agence Nationale de recherche sur le SIDA et les Hepatites" (ANRS) [2006-232, 2009-165]; Fondation AREVA	"Agence Nationale de recherche sur le SIDA et les Hepatites" (ANRS)(ANRSFrench National Research Agency (ANR)); Fondation AREVA	This work was supported by the 2006-232 and 2009-165 grants from "Agence Nationale de recherche sur le SIDA et les Hepatites" (ANRS, www.anrs.fr) and by "Fondation AREVA" (http://www.areva.com/FR/groupe-910/fondation-implication-societalepour-un-developpement-durable.html). The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Abbas UL, 2002, P NATL ACAD SCI USA, V99, P13377, DOI 10.1073/pnas.212518999; Angel JB, 2001, J INFECT DIS, V183, P546, DOI 10.1086/318547; Avettand-Fenoel V, 2012, J INFECT DIS, V205, P1520, DOI 10.1093/infdis/jis233; Avettand-Fenol V, 2009, J MED VIROL, V81, P217, DOI 10.1002/jmv.21390; Bangham CRM, 2009, EUR J IMMUNOL, V39, P1700, DOI 10.1002/eji.200939451; Beck CR, 2012, J INFECT DIS, V206, P1250, DOI 10.1093/infdis/jis487; Blanche S, 2014, CLIN INFECT DIS, V58, P573, DOI 10.1093/cid/cit729; Borkowsky W, 2000, J INFECT DIS, V182, P96, DOI 10.1086/315672; Borkowsky W, 2008, AIDS RES HUM RETROV, V24, P401, DOI 10.1089/aid.2007.0110; Buseyne F, 2005, J INFECT DIS, V192, P1781, DOI 10.1086/497152; Buseyne F, 2005, AIDS RES HUM RETROV, V21, P719, DOI 10.1089/aid.2005.21.719; Buseyne F, 2002, J INFECT DIS, V186, P1589, DOI 10.1086/345482; Buseyne F, 1998, VIROLOGY, V250, P316, DOI 10.1006/viro.1998.9373; Buseyne F, 2006, VIROLOGY, V354, P271, DOI 10.1016/j.virol.2006.07.014; Chakrabarti LA, 2010, CURR OPIN IMMUNOL, V22, P488, DOI 10.1016/j.coi.2010.06.006; Chitnis V, 2003, CLIN IMMUNOL, V107, P36, DOI 10.1016/S1521-6616(02)00051-7; Coplan PM, 2005, J INFECT DIS, V191, P1427, DOI 10.1086/428450; Coussens AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003468; Deeken JF, 2012, CLIN INFECT DIS, V55, P1228, DOI 10.1093/cid/cis613; Deeks SG, 2002, AIDS, V16, pS157, DOI 10.1097/00002030-200216004-00022; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Dollfus C, 2010, CLIN INFECT DIS, V51, P214, DOI 10.1086/653674; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Douek DC, 2000, LANCET, V355, P1875, DOI 10.1016/S0140-6736(00)02293-5; Feeney ME, 2003, J IMMUNOL, V171, P6968, DOI 10.4049/jimmunol.171.12.6968; Ferrand RA, 2009, AIDS, V23, P2039, DOI 10.1097/QAD.0b013e32833016ce; Foster C, 2010, EXPERT REV ANTI-INFE, V8, P1403, DOI 10.1586/ERI.10.129; Frange P, 2013, CLIN MICROBIOL INFEC, V19, pE252, DOI 10.1111/1469-0691.12127; Gardner EM, 2006, VACCINE, V24, P1609, DOI 10.1016/j.vaccine.2005.09.058; Golden-Mason L, 2008, J IMMUNOL, V180, P3637, DOI 10.4049/jimmunol.180.6.3637; Hainaut M, 2011, CLIN EXP IMMUNOL, V165, P77, DOI 10.1111/j.1365-2249.2011.04403.x; Haralambieva IH, 2013, HUM IMMUNOL, V74, P1263, DOI 10.1016/j.humimm.2013.06.031; Haslett PAJ, 2000, J INFECT DIS, V181, P1264, DOI 10.1086/315381; Hudson LL, 2007, SEMIN IMMUNOL, V19, P297, DOI 10.1016/j.smim.2007.10.002; Kharbanda M, 2000, AIDS, V14, P2229, DOI 10.1097/00002030-200010200-00003; King DJS, 2001, CLIN EXP IMMUNOL, V126, P280, DOI 10.1046/j.1365-2249.2001.01665.x; Kolber MA, 2007, HIV MED, V8, P401, DOI 10.1111/j.1468-1293.2007.00479.x; Lacabaratz-Porret C, 2004, JAIDS-J ACQ IMM DEF, V36, P594, DOI 10.1097/00126334-200405010-00007; Lange CG, 2002, CLIN IMMUNOL, V102, P154, DOI 10.1006/clim.2001.5164; Levy Y, 2005, AIDS, V19, P279; Malhotra U, 2001, J CLIN INVEST, V107, P505, DOI 10.1172/JCI11275; McDermott AB, 2012, AIDS, V26, P1281, DOI 10.1097/QAD.0b013e328353bcaf; Mohm JM, 2004, J CLIN VIROL, V30, P239, DOI 10.1016/j.jcv.2003.11.009; Oxenius A, 2002, P NATL ACAD SCI USA, V99, P13747, DOI 10.1073/pnas.202372199; Palmer BE, 2002, J VIROL, V76, P5925, DOI 10.1128/JVI.76.12.5925-5936.2002; Papasavvas E, 2003, J INFECT DIS, V188, P873, DOI 10.1086/377645; Pensieroso S, 2006, AIDS, V20, P1893, DOI 10.1097/01.aids.0000244211.33876.6f; Portales P, 2003, AIDS, V17, P505, DOI 10.1097/00002030-200303070-00005; Sandberg JK, 2003, J IMMUNOL, V170, P4403, DOI 10.4049/jimmunol.170.8.4403; Sarzotti M, 2003, J IMMUNOL, V170, P2711, DOI 10.4049/jimmunol.170.5.2711; Scott ZA, 2003, J IMMUNOL, V170, P5786, DOI 10.4049/jimmunol.170.11.5786; Scott-Algara D, 2010, JAIDS-J ACQ IMM DEF, V53, P553, DOI 10.1097/QAI.0b013e3181cf060f; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Sharp ER, 2005, J INFECT DIS, V192, P1772, DOI 10.1086/462423; Shiu C, 2009, J VIROL, V83, P9731, DOI 10.1128/JVI.00570-09; Sugimoto K, 2003, HEPATOLOGY, V37, P590, DOI 10.1053/jhep.2003.50103; Tenorio AR, 2003, JAIDS-J ACQ IMM DEF, V34, P491, DOI 10.1097/00126334-200312150-00007; Tobin NH, 2013, IMMUNOL REV, V254, P143, DOI 10.1111/imr.12074; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wagner TA, 2013, J VIROL, V87, P1770, DOI 10.1128/JVI.01985-12; Weinberg A, 2003, CLIN DIAGN LAB IMMUN, V10, P821, DOI 10.1128/CDLI.10.5.821-825.2003; Zhang Z, 2006, CHINESE MED J-PEKING, V119, P1949, DOI 10.1097/00029330-200612010-00003	62	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144706	10.1371/journal.pone.0144706	http://dx.doi.org/10.1371/journal.pone.0144706			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650393	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903300068
J	Daughters, K; Manstead, ASR; Hubble, K; Rees, A; Thapar, A; van Goozen, SHM				Daughters, Katie; Manstead, Antony S. R.; Hubble, Kelly; Rees, Aled; Thapar, Anita; van Goozen, Stephanie H. M.			Salivary Oxytocin Concentrations in Males following Intranasal Administration of Oxytocin: A Double-Blind, Cross-Over Study	PLOS ONE			English	Article							PLASMA OXYTOCIN; SOCIAL-BEHAVIOR; NASAL	The use of intranasal oxytocin (OT) in research has become increasingly important over the past decade. Although researchers have acknowledged a need for further investigation of the physiological effects of intranasal administration, few studies have actually done so. In the present double-blind cross-over study we investigated the longevity of a single 24 IU dose of intranasal OT measured in saliva in 40 healthy adult males. Salivary OT concentrations were significantly higher in the OT condition, compared to placebo. This significant difference lasted until the end of testing, approximately 108 minutes after administration, and peaked at 30 minutes. Results showed significant individual differences in response to intranasal OT administration. To our knowledge this is the largest and first all-male within-subjects design study to demonstrate the impact of intranasal OT on salivary OT concentrations. The results are consistent with previous research in suggesting that salivary OT is a valid matrix for OT measurement. The results also suggest that the post-administration 'wait-time' prior to starting experimental tasks could be reduced to 30 minutes, from the 45 minutes typically used, thereby enabling testing during peak OT concentrations. Further research is needed to ascertain whether OT concentrations after intranasal administration follow similar patterns in females, and different age groups.	[Daughters, Katie; Manstead, Antony S. R.; Hubble, Kelly; van Goozen, Stephanie H. M.] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales; [Rees, Aled] Cardiff Univ, Inst Mol & Expt Med, Sch Med, Cardiff CF10 3AX, S Glam, Wales; [Thapar, Anita] Cardiff Univ, Inst Psychol Med & Clin Neurosci, Sch Med, Cardiff CF10 3AX, S Glam, Wales	Cardiff University; Cardiff University; Cardiff University	van Goozen, SHM (corresponding author), Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales.	vangoozens@cardiff.ac.uk	Thapar, Anita/AAH-5555-2020; Manstead, Antony S R/D-1476-2009	Thapar, Anita/0000-0002-3689-737X; Manstead, Antony S R/0000-0001-7540-2096; Hubble, Kelly/0000-0002-9280-6268; Daughters, Katie/0000-0001-5889-8464; Rees, Aled/0000-0002-1165-9092	ESRC DTC PHD studentships [ES/J500197/1]; Institute of Psychological Medicine and Clinical Neuroscience at Cardiff University; Economic and Social Research Council [1228040, 1085185] Funding Source: researchfish; Medical Research Council [MR/L010305/1] Funding Source: researchfish	ESRC DTC PHD studentships(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Institute of Psychological Medicine and Clinical Neuroscience at Cardiff University; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research was supported by ESRC DTC PHD studentships (ES/J500197/1) awarded to KD and KH, and a Wellcome Trust seed-corn grant from the Institute of Psychological Medicine and Clinical Neuroscience at Cardiff University awarded to SHMvG and AT.	Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; [Anonymous], 2014, INTERINTRAASSAY COEF; [Anonymous], 2014, PRODUCT TECHNICAL B; [Anonymous], 2013, PRODUCT MANUAL OXYTO; Bakermans-Kranenburg MJ, 2011, SOCIAL COGNITIVE AFF; Carter CS, 2007, ANN NY ACAD SCI, V1098, P312, DOI 10.1196/annals.1384.006; Christensen JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116172; Churchland PS, 2012, HORM BEHAV, V61, P392, DOI 10.1016/j.yhbeh.2011.12.003; Dal Monte O, 2014, CSF BLOOD OXYTOCIN C; De Dreu CKW, 2012, PSYCHONEUROENDOCRINO, V37, P871, DOI 10.1016/j.psyneuen.2011.10.003; Feldman R, 2010, HORM BEHAV, V58, P669, DOI 10.1016/j.yhbeh.2010.06.005; Fischer-Shofty M, 2013, SCHIZOPHR RES, V146, P357, DOI 10.1016/j.schres.2013.01.006; Fischer-Shofty M, 2010, NEUROPSYCHOLOGIA, V48, P179, DOI 10.1016/j.neuropsychologia.2009.09.003; Goebel-Stengel M, 2011, ANAL BIOCHEM, V414, P38, DOI 10.1016/j.ab.2011.02.009; Gossen A, 2012, NEUROPEPTIDES, V46, P211, DOI 10.1016/j.npep.2012.07.001; Grewen KM, 2010, PSYCHOPHYSIOLOGY, V47, P625, DOI 10.1111/j.1469-8986.2009.00968.x; Grewen KM, 2005, PSYCHOSOM MED, V67, P531, DOI 10.1097/01.psy.0000170341.88395.47; Guastella AJ, 2013, PSYCHONEUROENDOCRINO, V38, P612, DOI 10.1016/j.psyneuen.2012.11.019; Hollander E, 2003, NEUROPSYCHOPHARMACOL, V28, P193, DOI 10.1038/sj.npp.1300021; Hollander E, 2007, BIOL PSYCHIAT, V61, P498, DOI 10.1016/j.biopsych.2006.05.030; Huffmeijer R, 2012, NEUROENDOCRINOL LETT, V33, P21; Kirkpatrick MG, 2014, PSYCHONEUROENDOCRINO, V46, P23, DOI 10.1016/j.psyneuen.2014.04.006; Leng G., 2015, BIOL PSYCHIAT; Marttin E, 1998, ADV DRUG DELIVER REV, V29, P13, DOI 10.1016/S0169-409X(97)00059-8; McCullough ME, 2013, NEUROSCI BIOBEHAV R, V37, P1485, DOI 10.1016/j.neubiorev.2013.04.018; Modi ME, 2014, PSYCHONEUROENDOCRINO, V45, P49, DOI 10.1016/j.psyneuen.2014.02.011; Neumann ID, 2013, PSYCHONEUROENDOCRINO, V38, P1985, DOI 10.1016/j.psyneuen.2013.03.003; Paloyelis Y., 2014, BIOL PSYCHIAT; Quintana DS, 2014, NEUROSCIENCE BIOBEHA; Riem MME, 2013, PSYCHONEUROENDOCRINO, V38, P1418, DOI 10.1016/j.psyneuen.2012.12.023; Striepens N, 2013, SCI REPORTS, P3; Van IJzendoorn MH, 2012, FRONTIERS NEUROSCIEN, P6; Veening JG, 2013, NEUROSCI BIOBEHAV R, V37, P1445, DOI 10.1016/j.neubiorev.2013.04.012; Walum H, 2015, BIOL PSYCHIAT; Weisman O, 2012, PSYCHONEUROENDOCRINO, V37, P1582, DOI 10.1016/j.psyneuen.2012.02.014; White-Traut R, 2009, DEV PSYCHOBIOL, V51, P367, DOI 10.1002/dev.20376	36	46	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145104	10.1371/journal.pone.0145104	http://dx.doi.org/10.1371/journal.pone.0145104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669935	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000366719300047
J	Chakraborty, P; Bjork, P; Kallberg, E; Olsson, A; Riva, M; Morgelin, M; Liberg, D; Ivars, F; Leanderson, T				Chakraborty, Paramita; Bjork, Per; Kallberg, Eva; Olsson, Anders; Riva, Matteo; Morgelin, Matthias; Liberg, David; Ivars, Fredrik; Leanderson, Tomas			Vesicular Location and Transport of S100A8 and S100A9 Proteins in Monocytoid Cells	PLOS ONE			English	Article							MYELOID-RELATED PROTEIN-14; CALCIUM-BINDING PROTEINS; MRP14; DIFFERENTIATION; INTERLEUKIN-1-BETA; IDENTIFICATION; TRANSLOCATION; NEUTROPHILS; MIGRATION; MEMBRANE	We show here, by using surface biotinylation, followed by Western blotting or surface plasmon resonance analysis, that very low levels of S100A8 and/or S100A9 can be detected on the surface of THP-1 cells or freshly isolated human monocytes. This was supported by immune-electron microscopy where we observed membrane-associated expression of the proteins restricted to small patches. By using confocal microscopy we could determine that S100A8 and S100A9 protein in THP-1 cells or freshly isolated human monocytes was mostly present in vesicular structures. This finding was confirmed using immune-electron microscopy. Subcellular fractionation and confocal microscopy showed that these vesicular structures are mainly early endosomes and endolysosomes. Our subsequent studies showed that accumulation of S100A8 and S100A9 in the endolysosomal compartment is associated with induction of their release from the cells. Furthermore, an inhibitor of lysosomal activity could modulate the release of S100A8 and S100A9 in the extracellular milieu. Our current results suggest that the S100A8 and S100A9 proteins are primarily associated with certain kinds of cytosolic vesicles and may be secreted via an endolysosomal pathway.	[Chakraborty, Paramita; Kallberg, Eva; Ivars, Fredrik; Leanderson, Tomas] Lund Univ, Immunol Grp, Lund, Sweden; [Bjork, Per; Olsson, Anders; Riva, Matteo; Liberg, David; Leanderson, Tomas] Act Biotech AB, Lund, Sweden; [Morgelin, Matthias] Lund Univ, Div Infect Med, Lund, Sweden	Lund University; Lund University	Leanderson, T (corresponding author), Lund Univ, Immunol Grp, Lund, Sweden.	tomas.leanderson@med.lu.se	Chakraborty, Paramita/AAL-9606-2020	Chakraborty, Paramita/0000-0002-0320-8697; Riva, Matteo/0000-0003-2697-6717	Swedish Cancer Foundation [140520]; Kocks Foundation; Osterlund Foundation; Active Biotech AB	Swedish Cancer Foundation; Kocks Foundation; Osterlund Foundation; Active Biotech AB	This work was supported by the Swedish Cancer Foundation (Grant # 140520), Kocks Foundation and Osterlund Foundation. Active Biotech AB provided support in the form of salaries for authors TL, PB, DL, AO and MR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributors" section.	Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Benoit S, 2006, BRIT J DERMATOL, V155, P62, DOI 10.1111/j.1365-2133.2006.07198.x; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Bober M, 2010, J INNATE IMMUN, V2, P160, DOI 10.1159/000232587; Bode G, 2008, J BIOL CHEM, V283, P31776, DOI 10.1074/jbc.M803908200; Burke M, 2014, J PROTEOME RES, V13, P836, DOI 10.1021/pr400879c; DALE I, 1985, AM J CLIN PATHOL, V84, P24, DOI 10.1093/ajcp/84.1.24; Daniels GM, 1998, METHOD ENZYMOL, V296, P307; de Araujo Mariana Eca Guimaraes, 2008, V424, P317, DOI 10.1007/978-1-60327-064-9_25; Diercks BP, 2013, SCAND J IMMUNOL, V77, P169, DOI 10.1111/sji.12015; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Fialka I, 1999, J BIOL CHEM, V274, P26233, DOI 10.1074/jbc.274.37.26233; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Glass MJ, 2006, NEUROSCIENCE, V143, P547, DOI 10.1016/j.neuroscience.2006.08.051; GOEBELER M, 1995, BIOCHEM J, V309, P419, DOI 10.1042/bj3090419; Healy AM, 2006, CIRCULATION, V113, P2278, DOI 10.1161/CIRCULATIONAHA.105.607333; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Jia J, 2014, CELL, V159, P623, DOI 10.1016/j.cell.2014.09.032; Kerkhoff C, 2005, FASEB J, V19, P467, DOI 10.1096/fj.04-2377fje; Lominadze G, 2005, J IMMUNOL, V174, P7257, DOI 10.4049/jimmunol.174.11.7257; Lood C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3314; Mambula SS, 2006, J IMMUNOL, V177, P7849, DOI 10.4049/jimmunol.177.11.7849; Marty V, 2005, GLIA, V49, P511, DOI 10.1002/glia.20138; McCormick MM, 2005, J BIOL CHEM, V280, P41521, DOI 10.1074/jbc.M509442200; Nacken W, 2004, FEBS LETT, V572, P289, DOI 10.1016/j.febslet.2004.07.024; New SEP, 2013, CIRC RES, V113, P72, DOI 10.1161/CIRCRESAHA.113.301036; Pasquali C, 1999, J CHROMATOGR B, V722, P89, DOI 10.1016/S0378-4347(98)00314-4; Rammes A, 1997, J BIOL CHEM, V272, P9496; Riva M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061832; ROTH J, 1993, BLOOD, V82, P1875; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Stroncek DF, 2005, J TRANSL MED, V3, P1, DOI 10.1186/1479-5876-3-36; Trischler M, 1999, J CELL SCI, V112, P4773; vandenBos C, 1996, J IMMUNOL, V156, P1247; VODOVOTZ Y, 1995, J IMMUNOL, V154, P2914; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Vogl T, 2012, INT J MOL SCI, V13, P2893, DOI 10.3390/ijms13032893	43	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145217	10.1371/journal.pone.0145217	http://dx.doi.org/10.1371/journal.pone.0145217			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26661255	gold, Green Published			2022-12-27	WOS:000366715900193
J	Eidizadeh, A; Khajehalichalehshtari, M; Freyer, D; Trendelenburg, G				Eidizadeh, Abass; Khajehalichalehshtari, Manuel; Freyer, Dorette; Trendelenburg, George			Assessment of the Therapeutic Potential of Metallothionein-II Application in Focal Cerebral Ischemia In Vitro and In Vivo	PLOS ONE			English	Article							MEDIATED NEUROPROTECTION; NEURONAL INJURY; NITRIC-OXIDE; ROLES; MICE; REGENERATION; PROTEINS; PROTECTS; SURVIVAL; STROKE	Metallothionein-II (MT-II) is an ubiquitously expressed small-molecular-weight protein and highly induced in various species and tissues upon stress, inflammation, and ischemia. MT-deficiency exacerbates ischemic injury in rodent stroke models in vitro and in vivo. However, there is conflicting data on the potential neuroprotective effect of exogenously applied metallothionein. Thus, we applied MT-II in an in vitro stroke model and intraperitoneally (i.p.) in two in vivo standard models of transient middle cerebral artery occlusion (MCAO) (a 'stringent' one [ 60min MCAO/48h reperfusion] and a 'mild' one [30min MCAO/72h reperfusion]), as well as i.v. together with recombinant tissue plasminogen activator (rtPA) to evaluate if exogenous MT-II-application protects against ischemic stroke. Whereas MT-II did not protect against 60min MCAO, there was a significant reduction of direct and indirect infarct volumes and neurological deficit in the MT-II (i.p.) treated animals in the 'mild' model at 3d after MCAO. Furthermore, MT-II also improved survival of the mice after MCAO, suppressed TNF-alpha mRNA induction in ischemic brain tissue, and protected primary neuronal cells against oxygen-glucose-deprivation in vitro. Thus, exogenous application of MT-II protects against ischemic injury in vitro and in vivo. However, long-term studies with different species and larger sampling sizes are required before a clinical use can be envisaged.	[Eidizadeh, Abass; Khajehalichalehshtari, Manuel; Trendelenburg, George] Univ Med Ctr Gottingen, Dept Neurol, D-37075 Gottingen, Germany; [Freyer, Dorette] Charite Univ Med Ctr, Dept Neurol, D-10117 Berlin, Germany	University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Trendelenburg, G (corresponding author), Univ Med Ctr Gottingen, Dept Neurol, Robert Koch Str 40, D-37075 Gottingen, Germany.	george.trendelenburg@med.uni-goettingen.de		Eidizadeh, Abass/0000-0001-8910-3150	Ministry of Science and Culture of Lower Saxony (Niedersachsenstipendium); Georg-August-University Gottingen Foundation	Ministry of Science and Culture of Lower Saxony (Niedersachsenstipendium); Georg-August-University Gottingen Foundation	This work was supported by the Ministry of Science and Culture of Lower Saxony (Niedersachsenstipendium) to AE and Georg-August-University Gottingen Foundation to GT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambjorn M, 2008, J NEUROCHEM, V104, P21, DOI 10.1111/j.1471-4159.2007.05036.x; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Borghesi LA, 1996, CELL STRESS CHAPERON, V1, P99, DOI 10.1379/1466-1268(1996)001<0099:SPAAOI>2.3.CO;2; Bruer U, 1997, FEBS LETT, V414, P117, DOI 10.1016/S0014-5793(97)00954-X; Campagne MV, 1999, P NATL ACAD SCI USA, V96, P12870; Chung RS, 2008, J NEUROCHEM, V104, P14, DOI 10.1111/j.1171-4159.2007.05026.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cuajungco MP, 1997, NEUROBIOL DIS, V4, P137, DOI 10.1006/nbdi.1997.0163; Diaz-Ruiz A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/436429; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Ebadi M, 2005, MOL BRAIN RES, V134, P67, DOI 10.1016/j.molbrainres.2004.09.011; Edmands SD, 2009, ANESTHESIOLOGY, V110, P538, DOI 10.1097/ALN.0b013e3181974bba; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; Hacke Werner, 2008, N Engl J Med, V359, P1317, DOI 10.1056/NEJMoa0804656; Haq F, 2003, MUTAT RES-FUND MOL M, V533, P211, DOI 10.1016/j.mrfmmm.2003.07.014; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Harhausen D, 2010, J IMMUNOL, V184, P6407, DOI 10.4049/jimmunol.0902342; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Howells C, 2010, FEBS J, V277, P2931, DOI 10.1111/j.1742-4658.2010.07718.x; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ito Y, 2013, CURR PHARM BIOTECHNO, V14, P400, DOI 10.2174/1389201011314040003; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Koumura A, 2009, BRAIN RES, V1292, P148, DOI 10.1016/j.brainres.2009.07.050; Kumari MVR, 1998, FREE RADICAL RES, V29, P93, DOI 10.1080/10715769800300111; Lautenschlager M, 2000, NEUROSCIENCE, V97, P383, DOI 10.1016/S0306-4522(99)00599-0; Leung JYK, 2012, CELL MOL LIFE SCI, V69, P809, DOI 10.1007/s00018-011-0790-7; Levene HB, 2007, J NEUROSCI METH, V164, P304, DOI 10.1016/j.jneumeth.2007.05.007; Lewis KE, 2012, HISTOL HISTOPATHOL, V27, P1459, DOI 10.14670/HH-27.1459; Lynes MA, 2006, EXP BIOL MED, V231, P1548, DOI 10.1177/153537020623100915; Malavolta M, 2012, REJUV RES, V15, P140, DOI 10.1089/rej.2011.1261; Neal JW, 1996, NEUROPATH APPL NEURO, V22, P243; Penkowa M, 1999, J NEUROSCI, V19, P2535; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHWARZ MA, 1995, P NATL ACAD SCI USA, V92, P4452, DOI 10.1073/pnas.92.10.4452; SEARLE PF, 1984, MOL CELL BIOL, V4, P1221, DOI 10.1128/MCB.4.7.1221; Sohn EJ, 2012, BBA-GEN SUBJECTS, V1820, P1647, DOI 10.1016/j.bbagen.2012.06.012; Trendelenburg G, 2002, J NEUROSCI, V22, P5879; UITENBROEK D. G, 1997, SISA BINOMIAL; VALLEE BL, 1995, NEUROCHEM INT, V27, P23, DOI 10.1016/0197-0186(94)00165-Q; West AK, 2008, NEUROTOXICOLOGY, V29, P489, DOI 10.1016/j.neuro.2007.12.006; West AK, 2011, J BIOL INORG CHEM, V16, P1115, DOI 10.1007/s00775-011-0817-4; Ziegler G, 2011, J CEREBR BLOOD F MET, V31, P757, DOI 10.1038/jcbfm.2010.161	46	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144035	10.1371/journal.pone.0144035	http://dx.doi.org/10.1371/journal.pone.0144035			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658636	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900023
J	Gao, HL; Dong, LH; Li, FR; Zhang, LJ				Gao, Huilin; Dong, Lihu; Li, Fengri; Zhang, Lianjun			Evaluation of Four Methods for Predicting Carbon Stocks of Korean Pine Plantations in Heilongjiang Province, China	PLOS ONE			English	Article							BIOMASS EXPANSION FACTORS; BELOW-GROUND BIOMASS; ALLOMETRIC EQUATIONS; TREE; FOREST; STAND; MODEL; ERROR; SYSTEM; SEQUESTRATION	A total of 89 trees of Korean pine (Pinus koraiensis) were destructively sampled from the plantations in Heilongjiang Province, P.R. China. The sample trees were measured and calculated for the biomass and carbon stocks of tree components (i.e., stem, branch, foliage and root). Both compatible biomass and carbon stock models were developed with the total biomass and total carbon stocks as the constraints, respectively. Four methods were used to evaluate the carbon stocks of tree components. The first method predicted carbon stocks directly by the compatible carbon stocks models (Method 1). The other three methods indirectly predicted the carbon stocks in two steps: (1) estimating the biomass by the compatible biomass models, and (2) multiplying the estimated biomass by three different carbon conversion factors (i.e., carbon conversion factor 0.5 (Method 2), average carbon concentration of the sample trees (Method 3), and average carbon concentration of each tree component (Method 4)). The prediction errors of estimating the carbon stocks were compared and tested for the differences between the four methods. The results showed that the compatible biomass and carbon models with tree diameter (D) as the sole independent variable performed well so that Method 1 was the best method for predicting the carbon stocks of tree components and total. There were significant differences among the four methods for the carbon stock of stem. Method 2 produced the largest error, especially for stem and total. Methods 3 and Method 4 were slightly worse than Method 1, but the differences were not statistically significant. In practice, the indirect method using the mean carbon concentration of individual trees was sufficient to obtain accurate carbon stocks estimation if carbon stocks models are not available.	[Gao, Huilin; Dong, Lihu; Li, Fengri] Northeast Forestry Univ, Sch Forestry, Dept Forest Management, Harbin, Heilongjiang, Peoples R China; [Zhang, Lianjun] SUNY Coll Environm Sci & Forestry, Dept Forest & Nat Resources Management, Old Westbury, NY USA	Northeast Forestry University - China; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Li, FR (corresponding author), Northeast Forestry Univ, Sch Forestry, Dept Forest Management, Harbin, Heilongjiang, Peoples R China.	fengrili@126.com			Ministry of Science and Technology of the People's Republic of China [2011BAD37B02]; Fundamental Research Funds for the Central Universities [2572015AA23]; Program for Changjiang Scholars and Innovative Research Team in University [IRT_15R09]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This research was financially supported by the Ministry of Science and Technology of the People's Republic of China, Project# 2011BAD37B02, the Fundamental Research Funds for the Central Universities (Project 2572015AA23) and the Program for Changjiang Scholars and Innovative Research Team in University (IRT_15R09).	Alvarez E, 2012, FOREST ECOL MANAG, V267, P297, DOI 10.1016/j.foreco.2011.12.013; Antonio N, 2007, CAN J FOREST RES, V37, P895, DOI 10.1139/X06-276; Bastien-Henri S, 2010, FOREST ECOL MANAG, V260, P403, DOI 10.1016/j.foreco.2010.04.035; Bi HQ, 2004, TREES-STRUCT FUNCT, V18, P467, DOI 10.1007/s00468-004-0333-z; Bond-Lamberty B, 2002, CAN J FOREST RES, V32, P1441, DOI [10.1139/x02-063, 10.1139/X02-063]; Breidenbach J, 2012, EUR J FOREST RES, V131, P1255, DOI 10.1007/s10342-012-0596-7; Chai T, 2014, GEOSCI MODEL DEV, V7, P1247, DOI 10.5194/gmd-7-1247-2014; Chaturvedi RK, 2015, FOREST ECOL MANAG, V339, P11, DOI 10.1016/j.foreco.2014.12.002; Cheng JZ, 2015, AGR FOREST METEOROL, V203, P88, DOI 10.1016/j.agrformet.2015.01.004; de Mello AA, 2012, SILVA FENN, V46, P333, DOI 10.14214/sf.44; Dong LH, 2016, SCAND J FOREST RES, V31, P399, DOI 10.1080/02827581.2015.1060257; Dong LH, 2015, FOREST SCI, V61, P35, DOI 10.5849/forsci.13-193; Dong LH, 2014, FOREST ECOL MANAG, V329, P306, DOI 10.1016/j.foreco.2014.05.050; Fassnacht FE, 2014, REMOTE SENS ENVIRON, V154, P102, DOI 10.1016/j.rse.2014.07.028; Fiedler CE, 2010, FOREST SCI, V56, P18; Gezan SA, 2006, FOREST SCI, V52, P108; Gonzalez P, 2015, FOREST ECOL MANAG, V348, P68, DOI 10.1016/j.foreco.2015.03.040; Green C, 2007, EUR J FOREST RES, V126, P179, DOI 10.1007/s10342-005-0093-3; Iglay RB, 2014, FOREST ECOL MANAG, V328, P69, DOI 10.1016/j.foreco.2014.05.029; Jenkins JC, 2003, FOREST SCI, V49, P12; Jha KK, 2015, J FORESTRY RES, V26, P589, DOI 10.1007/s11676-015-0053-9; Ngo KM, 2013, FOREST ECOL MANAG, V296, P81, DOI 10.1016/j.foreco.2013.02.004; Kenzo T, 2010, FOREST ECOL MANAG, V260, P875, DOI 10.1016/j.foreco.2010.06.006; Lambert MC, 2005, CAN J FOREST RES, V35, P1996, DOI 10.1139/X05-112; Lehtonen A, 2007, ANN FOREST SCI, V64, P133, DOI 10.1051/forest:2006097; McRoberts RE, 2014, FOREST SCI, V60, P34, DOI 10.5849/forsci.12-141; Navar J, 2009, FOREST ECOL MANAG, V257, P427, DOI 10.1016/j.foreco.2008.09.028; Park A, 2015, FOREST ECOL MANAG, V340, P70, DOI 10.1016/j.foreco.2014.12.011; Parresol BR, 1999, FOREST SCI, V45, P573; Parresol BR, 2001, CAN J FOREST RES, V31, P865, DOI 10.1139/cjfr-31-5-865; Petersson H, 2012, FOREST ECOL MANAG, V270, P78, DOI 10.1016/j.foreco.2012.01.004; Picard N, 2015, ANN FOREST SCI, V72, P811, DOI 10.1007/s13595-014-0434-9; Planck NRV, 2015, TREES-STRUCT FUNCT, V29, P449, DOI 10.1007/s00468-014-1123-x; SAS Institute Inc, 2011, SAS STAT 9 3 US GUID; SAS Institute Inc, 2011, SAS ETS 9 3 US GUID; Socha J, 2007, EUR J FOREST RES, V126, P263, DOI 10.1007/s10342-006-0144-4; Tang S, 2015, STAT FDN BIOMATHEMAT; Tang SZ, 2001, ECOL MODEL, V142, P285, DOI 10.1016/S0304-3800(01)00326-X; Vallet P, 2006, FOREST ECOL MANAG, V229, P98, DOI 10.1016/j.foreco.2006.03.013; van Breugel M, 2011, FOREST ECOL MANAG, V262, P1648, DOI 10.1016/j.foreco.2011.07.018; Gil MV, 2011, BIOMASS BIOENERG, V35, P243, DOI 10.1016/j.biombioe.2010.08.004; WALLACH D, 1989, ECOL MODEL, V44, P299, DOI 10.1016/0304-3800(89)90035-5; Wang CK, 2006, FOREST ECOL MANAG, V222, P9, DOI 10.1016/j.foreco.2005.10.074; Zabek LM, 2006, FOREST ECOL MANAG, V223, P291, DOI 10.1016/j.foreco.2005.11.009; Zeng W, 2014, FOR ECOSYST, V1, P1; Zhang YJ, 2004, FOREST SCI, V50, P65; Zianis D, 2003, ANN FOREST SCI, V60, P439, DOI 10.1051/forest:2003036; Zianis D, 2008, FOREST ECOL MANAG, V256, P1400, DOI 10.1016/j.foreco.2008.07.002	48	4	8	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145017	10.1371/journal.pone.0145017	http://dx.doi.org/10.1371/journal.pone.0145017			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659257	Green Published, gold			2022-12-27	WOS:000366715900169
J	Han, Y; Zhang, B; Qin, XT; Li, MY; Guo, YL				Han, Yao; Zhang, Bin; Qin, Xiaoting; Li, Mingyang; Guo, Yulong			Investigation of a miRNA-Induced Gene Silencing Technique in Petunia Reveals Alterations in miR173 Precursor Processing and the Accumulation of Secondary siRNAs from Endogenous Genes	PLOS ONE			English	Article							HAIRPIN RNA CONSTRUCTS; TRANS-ACTING SIRNAS; ARTIFICIAL MICRORNAS; FUNCTIONAL GENOMICS; ANTISENSE RNA; ONE-STEP; PLANTS; ARABIDOPSIS; BIOGENESIS; CLONING	MIGS (miRNA-induced gene silencing) is a straightforward and efficient gene silencing technique in Arabidopsis. It works by exploiting miR173 to trigger the production of phasiRNAs (phased small interfering RNAs). MIGS can be used in plant species other than Arabidopsis by co-expression of miR173 and target gene fragments fused to an upstream miR173 target site. However, the efficiency and technical mechanisms have not been thoroughly investigated in other plants. In this work, two vectors, pMIGS-chs and pMIGS-pds, were constructed and transformed into petunia plants. The transgenic plants showed CHS (chalcone synthase) and PDS (phytoene desaturase) gene-silencing phenotypes respectively, indicating that MIGS functions in petunia. MIGS-chs plants were used to investigate the mechanisms of this technique in petunia. Results of 50-RACE showed that the miR173 target site was cleaved at the expected position and that endogenous CHS genes were cut at multiple positions. Small RNA deep sequencing analysis showed that the processing of Arabidopsis miR173 precursors in MIGS-chs transgenic petunia plants did not occur in exactly the same way as in Arabidopsis, suggesting differences in the machinery of miRNA processing between plant species. Small RNAs in-phase with the miR173 cleavage register were produced immediately downstream from the cleavage site and out-of-phase small RNAs were accumulated at relatively high levels from processing cycle 5 onwards. Secondary siRNAs were generated from multiple sites of endogenous CHS-A and CHS-J genes, indicating that miR173 cleavage induced siRNAs have the same ability to initiate siRNA transitivity as the siRNAs functioning in co-suppression and hpRNA silencing. On account of the simplicity of vector construction and the transitive amplification of signals from endogenous transcripts, MIGS is a good alternative gene silencing method for plants, especially for silencing a cluster of homologous genes with redundant functions.	[Han, Yao; Zhang, Bin; Qin, Xiaoting; Li, Mingyang; Guo, Yulong] Southwest Univ, Coll Hort & Landscape Architecture, Chongqing Engn Res Ctr Floriculture, Key Lab Hort Sci Southern Mt Reg,Minist Educ, Chongqing, Peoples R China	Southwest University - China	Guo, YL (corresponding author), Southwest Univ, Coll Hort & Landscape Architecture, Chongqing Engn Res Ctr Floriculture, Key Lab Hort Sci Southern Mt Reg,Minist Educ, Chongqing, Peoples R China.	yulong@swu.edu.cn			National Natural Science Foundation of China [31272199]; '111' Project [B12006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); '111' Project(Ministry of Education, China - 111 Project)	This work was supported by National Natural Science Foundation of China (31272199, http://www.nsfc.gov.cn/) and the '111' Project (B12006, http://www.moe.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Chen HM, 2007, P NATL ACAD SCI USA, V104, P3318, DOI 10.1073/pnas.0611119104; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Cho YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076954; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; Conner Anthony J., 2009, P395, DOI 10.1007/978-0-387-84796-2_19; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; de Felippes FF, 2012, PLANT J, V70, P541, DOI 10.1111/j.1365-313X.2011.04896.x; De Paoli E, 2009, RNA, V15, P1965, DOI 10.1261/rna.1706109; Fei QL, 2013, PLANT CELL, V25, P2400, DOI 10.1105/tpc.113.114652; Felippes FF, 2009, EMBO REP, V10, P264, DOI 10.1038/embor.2008.247; Gilchrist E, 2010, BRIEF FUNCT GENOMICS, V9, P103, DOI 10.1093/bfgp/elp059; Guo YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098783; Gutierrez-Nava MD, 2008, PLANT PHYSIOL, V147, P543, DOI 10.1104/pp.108.118307; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Jiang YX, 2013, PLANTA, V238, P325, DOI 10.1007/s00425-013-1896-y; Kasai M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-63; KOES RE, 1989, GENE, V81, P245, DOI 10.1016/0378-1119(89)90185-6; Koseki M, 2005, PLANT CELL PHYSIOL, V46, P1879, DOI 10.1093/pcp/pci192; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; McHale M, 2013, PLANT J, V76, P519, DOI 10.1111/tpj.12306; Mlotshwa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001755; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Montgomery TA, 2008, P NATL ACAD SCI USA, V105, P20055, DOI 10.1073/pnas.0810241105; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Purkayastha A, 2009, PLANT PHYSIOL BIOCH, V47, P967, DOI 10.1016/j.plaphy.2009.09.001; Rajeswaran R, 2012, NUCLEIC ACIDS RES, V40, P6241, DOI 10.1093/nar/gks242; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Senthil-Kumar M, 2011, TRENDS PLANT SCI, V16, P656, DOI 10.1016/j.tplants.2011.08.006; Song L, 2010, CURR BIOL, V20, P37, DOI 10.1016/j.cub.2009.10.076; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; Velten J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030141; Voinnet O, 2008, TRENDS PLANT SCI, V13, P317, DOI 10.1016/j.tplants.2008.05.004; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Watson JM, 2005, FEBS LETT, V579, P5982, DOI 10.1016/j.febslet.2005.08.014; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Xu GY, 2010, NEW PHYTOL, V187, P240, DOI 10.1111/j.1469-8137.2010.03253.x; Yan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038186; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zhang CQ, 2012, BIOINFORMATICS, V28, P2561, DOI 10.1093/bioinformatics/bts500; Zhang ZYJ, 2014, PLANTA, V239, P1139, DOI 10.1007/s00425-014-2054-x	52	8	9	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144909	10.1371/journal.pone.0144909	http://dx.doi.org/10.1371/journal.pone.0144909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658695	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900144
J	Hermes, C; Mettler, R; Santiago-Alarcon, D; Segelbacher, G; Schaefer, HM				Hermes, Claudia; Mettler, Raeann; Santiago-Alarcon, Diego; Segelbacher, Gernot; Schaefer, H. Martin			Spatial Isolation and Temporal Variation in Fitness and Condition Facilitate Divergence in a Migratory Divide	PLOS ONE			English	Article							DISRUPTIVE SELECTION; SYMPATRIC SPECIATION; SEDENTARY BLACKCAPS; SYLVIA-ATRICAPILLA; HABITAT PREFERENCE; BREEDING GROUNDS; EVOLUTION; HETEROZYGOSITY; MICROEVOLUTION; DIVERSITY	A novel migratory polymorphism evolved within the last 60 years in blackcaps (Sylvia atricapilla) breeding sympatrically in southwestern Germany. While most individuals winter in the traditional areas in the Mediterranean, a growing number of blackcaps started migrating to Britain instead. The rapid microevolution of this new strategy has been attributed to assortative mating and better physical condition of birds wintering in Britain. However, the isolating barriers as well as the physical condition of birds are not well known. In our study, we examined whether spatial isolation occurred among individuals with distinct migratory behaviour and birds with different arrival dates also differed in physical and genetic condition. We caught blackcaps in six consecutive years upon arrival on the breeding grounds and assigned them via stable isotope analysis to their wintering areas. Analysis of the vegetation structure within blackcap territories revealed different microhabitat preferences of birds migrating to distinct wintering areas. Blackcaps arriving early on the breeding grounds had higher survival rates, better body condition and higher multilocus heterozygosities than later arriving birds. We did however not find an effect of parasite infection status on arrival time. Our results suggest that early arriving birds have disproportionate effects on population dynamics. Allochrony and habitat isolation may thus act together to facilitate ongoing divergence in hybrid zones, and migratory divides in particular.	[Hermes, Claudia; Mettler, Raeann; Santiago-Alarcon, Diego; Schaefer, H. Martin] Univ Freiburg, Dept Evolutionary Biol & Anim Ecol, Fac Biol, Freiburg, Germany; [Santiago-Alarcon, Diego] Inst Ecol AC, Biol & Conservac Vertebrados, Xalapa, Veracruz, Mexico; [Segelbacher, Gernot] Univ Freiburg, Fac Environm & Nat Resources, Dept Wildlife Ecol & Management, Freiburg, Germany	University of Freiburg; Instituto de Ecologia - Mexico; University of Freiburg	Hermes, C (corresponding author), Univ Freiburg, Dept Evolutionary Biol & Anim Ecol, Fac Biol, Freiburg, Germany.	claudia.hermes@wildlife.uni-freiburg.de	Santiago-Alarcon, Diego/G-2485-2018; Santiago-Alarcon, Diego/AAF-3641-2020; Segelbacher, Gernot/F-3633-2011	Santiago-Alarcon, Diego/0000-0002-4914-5580; Santiago-Alarcon, Diego/0000-0002-4914-5580; Segelbacher, Gernot/0000-0002-8024-7008	Deutsche Forschungsgmeinschaft [1008/6-1]; Alexander von Humboldt-Stiftung; Wissenschaftliche Gesellschaft Freiburg; German Research Foundation (DFG); Albert Ludwigs University Freiburg; DFG [1008/6-1]	Deutsche Forschungsgmeinschaft; Alexander von Humboldt-Stiftung(Alexander von Humboldt Foundation); Wissenschaftliche Gesellschaft Freiburg; German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg; DFG(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgmeinschaft (www.dfg.de, grant number 1008/6-1 to HMS), the Alexander von Humboldt-Stiftung (www.humboldt-foundation.de, postdoctoral grant to DS-A) and Wissenschaftliche Gesellschaft Freiburg (www.wissges.uni-freiburg.de, grant to HMS and GS). The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Gregor Rolshausen, Marius Adrion and Nicola Moratscheck for their help with collecting field data. Isotope analyses were performed by Keith A. Hobson and Len I. Wassenaar (Environment Canada, Saskatoon, Canada). This research was funded by DFG grant 1008/6-1. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing.	Aksoy S, 2013, MOL ECOL RESOUR, V13, P341, DOI 10.1111/1755-0998.12061; Asghar M, 2011, J AVIAN BIOL, V42, P530, DOI 10.1111/j.1600-048X.2011.05281.x; BAIRLEIN F, 1978, Journal fuer Ornithologie, V119, P14, DOI 10.1007/BF01642970; BAIRLEIN F, 1980, Journal fuer Ornithologie, V121, P325, DOI 10.1007/BF01643331; Balloux F, 2004, MOL ECOL, V13, P3021, DOI 10.1111/j.1365-294X.2004.02318.x; Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; Bearhop S, 2003, FUNCT ECOL, V17, P270, DOI 10.1046/j.1365-2435.2003.00725.x; Beltman JB, 2005, THEOR POPUL BIOL, V67, P189, DOI 10.1016/j.tpb.2005.01.001; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; BERTHOLD P, 1995, BIRD STUDY, V42, P89, DOI 10.1080/00063659509477155; Berthold P, 1990, MONCHSGRASMUCKE SYLV; Bibby C.J., 1995, METHODEN FELDORNITHO; Brelsford A, 2009, EVOLUTION, V63, P3050, DOI 10.1111/j.1558-5646.2009.00777.x; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; de la Hera I, 2012, J AVIAN BIOL, V43, P333, DOI 10.1111/j.1600-048X.2012.05804.x; DeGroote LW, 2010, J AVIAN BIOL, V41, P147, DOI 10.1111/j.1600-048X.2009.04782.x; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Filchak KE, 2000, NATURE, V407, P739, DOI 10.1038/35037578; Forstmeier W, 2012, MOL ECOL, V21, P3237, DOI 10.1111/j.1365-294X.2012.05593.x; FRANSSON T, 1995, J AVIAN BIOL, V26, P39, DOI 10.2307/3677211; Fraser KC, 2008, AVIAN CONSERV ECOL, V3; Friesen VL, 2007, P NATL ACAD SCI USA, V104, P18589, DOI 10.1073/pnas.0700446104; Glutz von Blotzheim U.N., 1991, HDB VOGEL MITTELEURO; Gwinner E, 1990, BIRD MIGRATION PHYSL; Hansson B, 2001, P ROY SOC B-BIOL SCI, V268, P1287, DOI 10.1098/rspb.2001.1640; HELBIG AJ, 1994, NATURWISSENSCHAFTEN, V81, P184, DOI 10.1007/BF01134540; Hobson KA, 2004, OECOLOGIA, V141, P477, DOI 10.1007/s00442-004-1671-7; HOILEITNER M, 1995, BEHAV ECOL SOCIOBIOL, V37, P399, DOI 10.1007/BF00170587; Kondrashov AS, 1998, P ROY SOC B-BIOL SCI, V265, P2273, DOI 10.1098/rspb.1998.0570; Mettler R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081365; Moller AP, 2011, J EVOLUTION BIOL, V24, P676, DOI 10.1111/j.1420-9101.2010.02202.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Olano-Marin J, 2011, EVOLUTION, V65, P3175, DOI 10.1111/j.1558-5646.2011.01369.x; Olano-Marin J, 2011, MOL ECOL, V20, P4028, DOI 10.1111/j.1365-294X.2011.05177.x; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Perez-Tris J, 2002, J ANIM ECOL, V71, P211, DOI 10.1046/j.1365-2656.2002.00590.x; Phillimore AB, 2008, AM NAT, V171, P646, DOI 10.1086/587074; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RICE WR, 1988, AM NAT, V131, P911, DOI 10.1086/284831; RICE WR, 1984, EVOLUTION, V38, P1251, DOI 10.1111/j.1558-5646.1984.tb05647.x; RICHMAN AD, 1992, NATURE, V355, P817, DOI 10.1038/355817a0; Rolshausen G, 2009, CURR BIOL, V19, P2097, DOI 10.1016/j.cub.2009.10.061; Rolshausen G, 2010, OECOLOGIA, V162, P175, DOI 10.1007/s00442-009-1445-3; Ruegg K, 2012, J EVOLUTION BIOL, V25, P1741, DOI 10.1111/j.1420-9101.2012.02554.x; Sandberg R, 1996, OIKOS, V77, P577, DOI 10.2307/3545949; Santiago-Alarcon D, 2011, PARASITOLOGY, V138, P824, DOI 10.1017/S0031182011000515; Santure AW, 2010, MOL ECOL, V19, P1439, DOI 10.1111/j.1365-294X.2010.04554.x; Segelbacher G, 2008, MOL ECOL RESOUR, V8, P1108, DOI 10.1111/j.1755-0998.2008.02171.x; SMITH JM, 1966, AM NAT, V100, P637, DOI 10.1086/282457; Valkiunas G, 2006, J PARASITOL, V92, P1123, DOI 10.1645/GE-3564-RN.1; Valkiunas G, 2008, J PARASITOL, V94, P1395, DOI 10.1645/GE-1570.1; Vallin N, 2011, INT J ECOL, V2011, P1; Wassenaar LI, 2007, ISOT ENVIRON HEALT S, V39, P211	54	0	1	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144264	10.1371/journal.pone.0144264	http://dx.doi.org/10.1371/journal.pone.0144264			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656955	Green Published, gold			2022-12-27	WOS:000366715900036
J	Khan, SU; Ali, N; Abbas, Z				Khan, Sami Ullah; Ali, Nasir; Abbas, Zaheer			Hydromagnetic Flow and Heat Transfer over a Porous Oscillating Stretching Surface in a Viscoelastic Fluid with Porous Medium	PLOS ONE			English	Article							STAGNATION POINT FLOW; MICROPOLAR FLUID; MHD FLOW; SHEET; 2ND-GRADE; SUCTION; MASS	An analysis is carried out to study the heat transfer in unsteady two-dimensional boundary layer flow of a magnetohydrodynamics (MHD) second grade fluid over a porous oscillating stretching surface embedded in porous medium. The flow is induced due to infinite elastic sheet which is stretched periodically. With the help of dimensionless variables, the governing flow equations are reduced to a system of non-linear partial differential equations. This system has been solved numerically using the finite difference scheme, in which a coordinate transformation is used to transform the semi-infinite physical space to a bounded computational domain. The influence of the involved parameters on the flow, the temperature distribution, the skin-friction coefficient and the local Nusselt number is shown and discussed in detail. The study reveals that an oscillatory sheet embedded in a fluid-saturated porous medium generates oscillatory motion in the fluid. The amplitude and phase of oscillations depends on the rheology of the fluid as well as on the other parameters coming through imposed boundary conditions, inclusion of body force term and permeability of the porous medium. It is found that amplitude of flow velocity increases with increasing visco-elastic and mass suction/injection parameters. However, it decreases with increasing the strength of the applied magnetic field. Moreover, the temperature of fluid is a decreasing function of viscoelastic parameter, mass suction/injection parameter and Prandtl number.	[Khan, Sami Ullah; Ali, Nasir] Int Islamic Univ, Dept Math & Stat, Islamabad 44000, Pakistan; [Abbas, Zaheer] Islamia Univ Bahawalpur, Dept Math, Bahawalpur 63100, Pakistan	International Islamic University, Pakistan; Islamia University of Bahawalpur	Khan, SU (corresponding author), Int Islamic Univ, Dept Math & Stat, Islamabad 44000, Pakistan.	sk_iiu@yahoo.com	Abbas, Zaheer/ABD-6378-2021; Ali, Nasir/ABB-1446-2021; Sami, Khan Ullah/AAZ-6520-2021; Abbas, Zaheer/AAZ-4317-2021; Abbas, Zaheer/AAZ-4295-2021	Abbas, Zaheer/0000-0002-1300-7098; Abbas, Zaheer/0000-0002-1300-7098				Abbas Z, 2008, INT J NONLIN MECH, V43, P783, DOI 10.1016/j.ijnonlinmec.2008.04.009; Abbas Z, 2009, INT J NUMER METH FL, V59, P443, DOI 10.1002/fld.1825; Ali Nasir, 2015, Nonlinear Engineering. Modeling and Application, V4, P223, DOI 10.1515/nleng-2015-0019; Ali N, 2015, COMPUTER ME IN PRESS, DOI [10.1080/10255842.2015, DOI 10.1080/10255842.2015]; Ali N, 2015, Z NATURFORSCH A, V70, P567, DOI 10.1515/zna-2014-0273; Baag S, 2014, J KING SAUD IN PRESS; Cortell R, 2006, INT J HEAT MASS TRAN, V49, P1851, DOI 10.1016/j.ijheatmasstransfer.2005.11.013; Cortell R, 2006, INT J NONLIN MECH, V41, P78, DOI 10.1016/j.ijnonlinmec.2005.04.008; DANDAPAT BS, 1989, INT J NONLINEAR MECH, V24, P215, DOI 10.1016/0020-7462(89)90040-1; Davidson P.A., 2001, INTRO MAGNETOHYDRODY, P431, DOI [DOI 10.1017/CB09780511626333, 10.1017/CBO9780511626333, DOI 10.1017/CBO9780511626333]; Gul T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126698; Gul T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103843; Hayat T, 2008, INT J HEAT MASS TRAN, V51, P4528, DOI 10.1016/j.ijheatmasstransfer.2007.12.022; Ishak A, 2008, MECCANICA, V43, P411, DOI 10.1007/s11012-007-9103-5; Javed T, 2015, CAN J PHYS, V93, P1138, DOI 10.1139/cjp-2014-0270; Khan NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095423; MCLEOD JB, 1987, ARCH RATION MECH AN, V98, P385, DOI 10.1007/BF00276915; Mishra SR, 2015, ALEX ENG J, V54, P681, DOI 10.1016/j.aej.2015.04.010; Mishra SR, 2013, INT J HEAT MASS TRAN, V57, P433, DOI 10.1016/j.ijheatmasstransfer.2012.10.053; Mishra S. R., 2013, WORLD APPL SCI J, V28, P1275; Mohanty B, 2015, ALEX ENG J, V54, P223, DOI 10.1016/j.aej.2015.03.010; Nazar R, 2004, INT J NONLIN MECH, V39, P1227, DOI [10.1016/j.ijnonlinmec.2003.08.007, 10.1016/j.ijnonlinemec.2003.08.007]; RAJAGOPAL KR, 1984, RHEOL ACTA, V23, P213, DOI 10.1007/BF01332078; ROLLINS D, 1991, ACTA MECH, V89, P167, DOI 10.1007/BF01171253; SAKIADIS BC, 1961, AICHE J, V7, P26, DOI 10.1002/aic.690070108; Sheikh M, 2015, J MAG MAGNE IN PRESS, P3043; Tripathy RS, 2015, ALEX ENG J, V54, P673, DOI 10.1016/j.aej.2015.04.012; WANG CY, 1988, ACTA MECH, V72, P261, DOI 10.1007/BF01178312; Wang YQ, 2008, NONLINEAR ANAL-REAL, V9, P1269, DOI 10.1016/j.nonrwa.2007.02.016; Wang YQ, 2007, INT J NONLINEAR MECH, V42, P432, DOI 10.1016/j.ijnonlinmec.2007.01.003; Zheng LC, 2013, ACTA MECH SINICA-PRC, V29, P667, DOI 10.1007/s10409-013-0066-6	31	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144299	10.1371/journal.pone.0144299	http://dx.doi.org/10.1371/journal.pone.0144299			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657931	Green Submitted, gold, Green Published			2022-12-27	WOS:000366715900037
J	Lamas, L; Santana, F; Heiner, M; Ugrinowitsch, C; Fellingham, G				Lamas, Leonardo; Santana, Felipe; Heiner, Matthew; Ugrinowitsch, Carlos; Fellingham, Gilbert			Modeling the Offensive-Defensive Interaction and Resulting Outcomes in Basketball	PLOS ONE			English	Article							MATCH; GOAL	Purpose We analyzed the interaction between offensive (i.e. space creation dynamics -SCDs) and defensive (i.e. space protection dynamics-SPDs) actions in six play outcomes (free shot, contested shot, new SCD, reset, foul, and turnover) in Spanish professional basketball games. Method Data consisted of 1548 SCD-SPD-outcome triples obtained from six play-off games. We used Bayesian methods to compute marginal probabilities of six outcomes following five different SCDs. We also computed probabilities of the six outcomes following the 16 most frequent SCD-SPD combinations. Results The pick action (e.g. pick and roll, pop and pop) was the most prevalent SCD (33%). However, this SCD did not produce the highest probability of a free shot (0.235). The highest probability of a free shot followed the SCD without ball (0.409). The pick was performed not only to attempt scoring but also to initiate offenses, as it produced the highest probability leading to a new SCD (0.403). Additionally, the SPD performed influenced the outcome of the SCD. This reinforces the notion that the opposition (offensive-defensive interaction) should be considered. To the best of our knowledge, in team sports, this is the first study to successfully model the tactical features involved in offense-defense interactions. Our analyses revealed that the high frequency of occurrence of some SCDs may be justified not only by an associated high probability of free shots but also by the possibility of progressively create more space in the defense (i.e. a new SCD as outcome). In the second case, it evidences offensive strategic features of progressive disruption of the defensive system through the concatenation of subsequent offensive actions.	[Lamas, Leonardo] Univ Brasilia, Fac Phys Educ, Brasilia, DF, Brazil; [Santana, Felipe; Ugrinowitsch, Carlos] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Heiner, Matthew] Univ Calif Santa Cruz, Dept Appl Math & Stat, Santa Cruz, CA 95064 USA; [Fellingham, Gilbert] Brigham Young Univ, Dept Stat, Provo, UT 84602 USA	Universidade de Brasilia; Universidade de Sao Paulo; University of California System; University of California Santa Cruz; Brigham Young University	Lamas, L (corresponding author), Univ Brasilia, Fac Phys Educ, Brasilia, DF, Brazil.	llamas@unb.br	Lamas, Leonardo/Q-9767-2018; Ugrinowitsch, Carlos/A-3925-2010	Lamas, Leonardo/0000-0003-2682-9856; Ugrinowitsch, Carlos/0000-0001-8547-419X; Heiner, Matthew/0000-0002-7944-5517	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/19164-0]; Conselho Nacional de Pesquisa [304205/2011-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grant number 2012/19164-0 (LL) and Conselho Nacional de Pesquisa, grant number 304205/2011-7 (CU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, R LANG ENV STAT COMP; Baghal T, 2012, J QUANTITATIVE ANAL, V1; Benavoli A., 2011, IJCAI 2011 P INT JOI, P2107; Bourbousson J, 2010, J SPORT SCI, V28, P349, DOI 10.1080/02640410903503640; Cade W, 2013, SESUG, P1; Cervone D, 2014, MIT SLOAN SPORTS AN, P1; Correia V, 2013, J SPORT SCI, V31, P546, DOI 10.1080/02640414.2012.738926; Crum P, 2013, SPACE CREATION DYNAM; Davids K, 2005, SCI FOOTBALL P 5 WOR, VV, P537; Erculj F, 2015, PLOS ONE, V6, P1; Eticey P., 2014, MIT SLOAN SPORTS AN; Kubatko J, 2007, J QUANT ANAL SPORTS, V3, DOI 10.2202/1559-0410.1070; Lamas L, 2011, INT J PERF ANAL SPOR, V11, P71, DOI 10.1080/24748668.2011.11868530; Lamas L, 2014, INT J PERF ANAL SPOR, V14, P307, DOI 10.1080/24748668.2014.11868723; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Martin AD, 2011, J STAT SOFTW, V42, P1; Miller, 1986, J SPORT BEHAV, V9, P38; Oh M, 2015, MIT SLOAN SPORTS AN, P2; Oliver D, 2004, BASKETBALL ON PAPER; Page GL, 2014, J QUANTITATIVE ANAL, V4; Ruiz M, 2014, J QUANT ANAL SPORTS, V10, P27, DOI 10.1515/jqas-2013-0060; Santana Felipe L., 2015, Motriz: rev. educ. fis., V21, P34, DOI 10.1590/S1980-65742015000100005; Strumbelj E, 2012, INT J FORECASTING, V28, P532, DOI 10.1016/j.ijforecast.2011.01.004; Vilar L, 2014, HUM MOVEMENT SCI, V33, P14, DOI 10.1016/j.humov.2013.08.012	24	20	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144435	10.1371/journal.pone.0144435	http://dx.doi.org/10.1371/journal.pone.0144435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659134	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900049
J	Lee, JY; Kim, YT; Kim, S; Lee, B; Lim, MC; Kim, JW; Won, YJ				Lee, Jung-Yun; Kim, Young Tae; Kim, Sunghoon; Lee, Boram; Lim, Myong Cheol; Kim, Jae-Weon; Won, Young-Joo			Prognosis of Cervical Cancer in the Era of Concurrent Chemoradiation from National Database in Korea: A Comparison between Squamous Cell Carcinoma and Adenocarcinoma	PLOS ONE			English	Article							UTERINE CERVIX; IN-SITU; INCIDENCE TRENDS; SURVIVAL; WOMEN; MUTATIONS; GENE	In 1999, the National Cancer Institute issued a clinical advisory strongly touting the advantage of cisplatin-based chemoradiation (CCRT) for cervical cancer patients requiring radiation for their treatment. This study aimed to compare survival outcomes of cervical squamous cell carcinoma and adenocarcinoma before and after the advent of CCRT. Data were obtained from the Korea National Cancer Incidence Database for patients who were diagnosed with cervical cancers between 1993 and 2012. We compared survival according to histologic subtypes in cervical cancer patients diagnosed before (1993-1997), during (1998-2002), and after (2003-2012) the introduction of CCRT. A total of 80,766 patients were identified, including 64,531 (79.9%) women with squamous cell carcinomas and 7,265 (9.0%) with adenocarcinoma. With the introduction of CCRT, survival trends gradually increased in patients of both histologic subtypes with regional tumors. However, survival was significantly higher in squamous cell carcinoma than in adenocarcinoma patients regardless of treatment modalities (surgery alone, P < 0.001; surgery followed by CCRT, P < 0.001; or primary CCRT, P = 0.003). Multivariate analysis showed that adenocarcinoma was an independent negative prognostic factor for survival regardless of the time period (before CCRT, hazard ratio (HR) = 1.49; 95% confidence interval (CI), 1.37-1.62; after introduction of CCRT, HR = 1.40; 95% CI, 1.30-1.50). Although the survival of adenocarcinoma has improved after the introduction of CCRT, adenocarcinoma is still associated with worse overall survival compared to squamous cell carcinoma in the era of CCRT.	[Lee, Jung-Yun; Kim, Young Tae; Kim, Sunghoon] Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Inst Womens Life Med Sci, Seoul, South Korea; [Lee, Boram; Won, Young-Joo] Natl Canc Ctr, Canc Registrat & Stat Branch, Goyang, South Korea; [Lim, Myong Cheol] Natl Canc Ctr, Gynecol Canc Branch, Goyang, South Korea; [Lim, Myong Cheol] Natl Canc Ctr, Ctr Uterine Canc, Goyang, South Korea; [Kim, Jae-Weon] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea	Yonsei University; Yonsei University Health System; National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Seoul National University (SNU)	Won, YJ (corresponding author), Natl Canc Ctr, Canc Registrat & Stat Branch, Goyang, South Korea.	astra67@ncc.re.kr		Kim, Jae-Weon/0000-0003-1835-9436; Kim, Sunghoon/0000-0002-1645-7473; kim, sunghoon/0000-0002-1570-3230; Lee, Jung-Yun/0000-0001-7948-1350; Kim, Young Tae/0000-0002-7347-1052	National Cancer Center Grant [NCC-1310220]	National Cancer Center Grant	This work was supported by the National Cancer Center Grant (NCC-1310220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Bray F, 2005, CANCER EPIDEM BIOMAR, V14, P2191, DOI 10.1158/1055-9965.EPI-05-0231; Brenner H, 1996, CANCER-AM CANCER SOC, V78, P2004, DOI 10.1002/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-#; Chung HH, 2006, INT J GYNECOL CANCER, V16, P1833, DOI 10.1111/j.1525-1438.2006.00708.x; Contag SA, 2004, GYNECOL ONCOL, V95, P610, DOI 10.1016/j.ygyno.2004.08.021; de Gonzalez AB, 2007, INT J CANCER, V120, P885, DOI 10.1002/ijc.22357; Galic V, 2012, GYNECOL ONCOL, V125, P287, DOI 10.1016/j.ygyno.2012.01.012; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Jung KW, 2013, CANCER RES TREAT, V45, P162, DOI 10.4143/crt.2013.45.3.162; Katanyoo K, 2012, GYNECOL ONCOL, V125, P292, DOI 10.1016/j.ygyno.2012.01.034; Lee EJ, 2010, ONCOL RES, V18, P401; Lee JY, 2014, J GYNECOL ONCOL, V25, P174, DOI 10.3802/jgo.2014.25.3.174; Lee YY, 2011, GYNECOL ONCOL, V120, P439, DOI 10.1016/j.ygyno.2010.11.022; Lim MC, 2013, J GYNECOL ONCOL, V24, P298, DOI 10.3802/jgo.2013.24.4.298; National Institutes of Health-National Cancer Institute News Advisory, 1999, NCI ISS CLIN ANN CER; Oh CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072012; Renshaw AA, 2004, ARCH PATHOL LAB MED, V128, P153; Rose PG, 2014, GYNECOL ONCOL, V135, P208, DOI 10.1016/j.ygyno.2014.08.018; Sasieni P, 2009, INT J CANCER, V125, P525, DOI 10.1002/ijc.24410; Schoolland M, 2002, CANCER CYTOPATHOL, V96, P330, DOI 10.1002/cncr.10886; Segi M., 1960, CANC MORTALITY SELEC; Thornton M, 2010, STANDARDS CANC REGIS; Tomita N, 2012, INT J RADIAT ONCOL, V83, P1506, DOI 10.1016/j.ijrobp.2011.10.013; Tornesello ML, 2013, GYNECOL ONCOL, V128, P442, DOI 10.1016/j.ygyno.2012.11.017; Wang SS, 2004, CANCER-AM CANCER SOC, V100, P1035, DOI 10.1002/cncr.20064; Wright AA, 2013, CANCER-AM CANCER SOC, V119, P3776, DOI 10.1002/cncr.28288; Young Jr JL, 2001, NIH PUB, V01-4969; Zaino RJ, 2002, INT J GYNECOL PATHOL, V21, P314, DOI 10.1097/00004347-200210000-00002	28	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144887	10.1371/journal.pone.0144887	http://dx.doi.org/10.1371/journal.pone.0144887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660311	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900134
J	Scott, N; McBryde, E; Kirwan, A; Stoove, M				Scott, Nick; McBryde, Emma; Kirwan, Amy; Stoove, Mark			Modelling the Impact of Condom Distribution on the Incidence and Prevalence of Sexually Transmitted Infections in an Adult Male Prison System	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS INFECTION; SOUTH-WALES PRISONS; HIV TRANSMISSION; AUSTRALIA; SEX; OUTBREAK; SYPHILIS	Aims To determine the effects of 1) a condom distribution program and 2) a condom distribution program combined with opt-out sexually transmitted infection (STI) screening on the transmission and prevalence of STIs in a prison system. Methods Using data from an implementation evaluation of a state-wide prison condom program and parameter estimates from available literature, a deterministic model was developed to quantify the incidence and prevalence of sexually transmitted HIV, hepatitis B, chlamydia, syphilis and gonorrhoea across 14 Victorian prisons. The model included individual prison populations (by longer (>2 years) or shorter sentence lengths) and monthly prisoner transfers. For each STI, simulations were compared: without any intervention; with a condom distribution program; and with a combined condom and opt-out STI screening at prison reception intervention program. Results Condoms reduced the annual incidence of syphilis by 99% (N = 66 averted cases); gonorrhoea by 98% (N = 113 cases); hepatitis B by 71% (N = 5 cases); chlamydia by 27% (N = 196 cases); and HIV by 50% (N = 2 cases every 10 years). Condom availability changed the in-prison epidemiology of gonorrhoea and syphilis from self-sustaining to levels unlikely to result in infection outbreaks; however, condoms did not reduce chlamydia prevalence below a self-sustaining level due to its high infectiousness, high prevalence and low detection rate. When combined with a screening intervention program, condoms reduced chlamydia prevalence further, but not below a self-sustaining level. The low prevalence of HIV and hepatitis B in Australian prisons meant the effects of condoms were predicted to be small. Conclusion Condoms are predicted to effectively reduce the incidence of STIs in prison and are predicted to control syphilis and gonorrhoea transmission, however even combined with a screening on arrival program may be insufficient to reduce chlamydia prevalence below self-sustaining levels. To control chlamydia transmission additional screening of the existing prison population would be required.	[Scott, Nick; McBryde, Emma; Kirwan, Amy; Stoove, Mark] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic 3004, Australia; [Scott, Nick; Stoove, Mark] Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic 3008, Australia; [McBryde, Emma] James Cook Univ, Australian Inst Trop Hlth & Med, Townsville, Qld 4811, Australia; [McBryde, Emma] Univ Melbourne, Dept Med, Parkville, Vic 3050, Australia	Burnet Institute; Monash University; James Cook University; University of Melbourne	Scott, N (corresponding author), Burnet Inst, Ctr Populat Hlth, Melbourne, Vic 3004, Australia.	Nick.Scott@Burnet.edu.au	; McBryde, Emma/D-2220-2018	Stoove, Mark/0000-0003-2887-1409; McBryde, Emma/0000-0002-9570-9172	Justice Health, Victorian Department of Justice	Justice Health, Victorian Department of Justice	The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program. The authors wish to thank Justice Health, Victorian Department of Justice, for funding this modelling component as part of a broader evaluation of their condom implementation program. The authors also wish to thank Justice Health and Corrections Victoria for the provision of some of the operations data utilised in the modelling.; Justice Health, Victorian Department of Justice funded this modelling study as part of a broader evaluation of their condom implementation program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHW, 2011, THE HEALTH OF AUSTRA; ALCABES P, 1988, NEW YORK STATE J MED, V88, P495; Anglemyer A, 2013, JAMA-J AM MED ASSOC, V310, P1619, DOI [10.1001/jama.2013.278328, 10.1002/14651858.CD009153.pub3]; Australian Government Department of Health, 2014, THIRD NATIONAL SEXUA; Baggaley RF, 2010, INTERNATIONAL JOURNA; Braithwaite J, 2002, BRIT J CRIMINOL, V42, P563, DOI 10.1093/bjc/42.3.563; Butler T, 2003, THE 2001 NEW SOUTH W; Butler T, 2011, NATIONAL PRISON ENTR; Butler T, 2010, SEXUAL HEALTH AND BE; Butler T, 2008, AUST NZ J PUBL HEAL, V32, P73, DOI 10.1111/j.1753-6405.2008.00169.x; Butler T, 2002, AUST NZ J PUBL HEAL, V26, P390, DOI 10.1111/j.1467-842X.2002.tb00193.x; Butler T, 2011, DRUG ALCOHOL REV, V30, P188, DOI 10.1111/j.1465-3362.2010.00216.x; Calzavara L, 1998, RESEAU JURIDIQUE CAN, V5, P9; Chen JL, 2002, AM J PUBLIC HEALTH, V92, P1473, DOI 10.2105/AJPH.92.9.1473; CROFTS N, 1995, BRIT MED J, V310, P285, DOI 10.1136/bmj.310.6975.285; Dolan K, 2004, J LAW MED ETHICS, V32, P124, DOI 10.1111/j.1748-720X.2004.tb00457.x; Dolan K, 2007, LANCET INFECT DIS, V7, P32, DOI 10.1016/S1473-3099(06)70685-5; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Forrest G, 2009, INT J PRISON HEALTH, V5, P233, DOI 10.1080/17449200903343274; Gray RT, 2009, J INFECT DIS, V199, P1680, DOI 10.1086/598983; Grulich AE, 2003, AUST NZ J PUBL HEAL, V27, P234, DOI 10.1111/j.1467-842X.2003.tb00814.x; Guy R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071436; Heale P, 2003, SURVEY OF HARMS IN V; Hellard M E, 2004, Sex Health, V1, P107, DOI 10.1071/SH03018; HEYMANN DL, 2008, CONTROL OF COMMUNICA; Holmes KK, 2004, B WORLD HEALTH ORGAN, V82, P454; Hunt DR, 2009, AM J GASTROENTEROL, V104, P1024, DOI 10.1038/ajg.2008.143; Iversen J, 2012, AUSTRALIAN NEEDLE AN; Jurgens R, 1996, HIV AIDS IN PRISONS; Krebs CP, 2002, AIDS EDUC PREV, V14, P53, DOI 10.1521/aeap.14.7.53.23865; Lewis D, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-113; Melbourne Sexual Health Centre, 2012, CHLAMYDIA GONORRHOEA; Richters J, 2008, SEXUAL HEALTH AND BE; Rosenberg NE, 2015, CURR OPIN HIV AIDS, V10, P61, DOI 10.1097/COH.0000000000000121; Sylla M, 2010, AM J PUBLIC HEALTH, V100, P982, DOI 10.2105/AJPH.2009.172452; The Kirby Institute, 2014, HIV VIRAL HEPATITIS; Tucker JD, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-296; Vynnycky E, 2010, AN INTRODUCTION TO I; Werb D, 2008, J PUBLIC HEALTH-UK, V30, P126, DOI 10.1093/pubmed/fdn021; Wilson DP, 2010, SEX TRANSM INFECT, V86, P117, DOI 10.1136/sti.2009.036673; Winter R, 2009, FINAL REPORT TO THE; Wolfe MI, 2001, AM J PUBLIC HEALTH, V91, P1220, DOI 10.2105/AJPH.91.8.1220; World Health Organisation (WHO), 2005, PREVALENCE AND INCID; World Health Organisation (WHO), 2015, CONSOLIDATED GUIDELI; Yap L, 2007, SEX TRANSM INFECT, V83, P219, DOI 10.1136/sti.2006.022996	45	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144869	10.1371/journal.pone.0144869	http://dx.doi.org/10.1371/journal.pone.0144869			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26658518	gold, Green Accepted, Green Published			2022-12-27	WOS:000366715900127
J	Asaridou, SS; Hagoort, P; McQueen, JM				Asaridou, Salomi S.; Hagoort, Peter; McQueen, James M.			Effects of Early Bilingual Experience with a Tone and a Non-Tone Language on Speech-Music Integration	PLOS ONE			English	Article							PITCH; PERCEPTION	We investigated music and language processing in a group of early bilinguals who spoke a tone language and a non-tone language (Cantonese and Dutch). We assessed online speech-music processing interactions, that is, interactions that occur when speech and music are processed simultaneously in songs, with a speeded classification task. In this task, participants judged sung pseudowords either musically (based on the direction of the musical interval) or phonologically (based on the identity of the sung vowel). We also assessed longer-term effects of linguistic experience on musical ability, that is, the influence of extensive prior experience with language when processing music. These effects were assessed with a task in which participants had to learn to identify musical intervals and with four pitch-perception tasks. Our hypothesis was that due to their experience in two different languages using lexical versus intonational tone, the early Cantonese-Dutch bilinguals would outperform the Dutch control participants. In online processing, the Cantonese-Dutch bilinguals processed speech and music more holistically than controls. This effect seems to be driven by experience with a tone language, in which integration of segmental and pitch information is fundamental. Regarding longer-term effects of linguistic experience, we found no evidence for a bilingual advantage in either the music-interval learning task or the pitch-perception tasks. Together, these results suggest that being a Cantonese-Dutch bilingual does not have any measurable longer-term effects on pitch and music processing, but does have consequences for how speech and music are processed jointly.	[Asaridou, Salomi S.; Hagoort, Peter; McQueen, James M.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Asaridou, Salomi S.; Hagoort, Peter; McQueen, James M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [McQueen, James M.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands	Max Planck Society; Radboud University Nijmegen; Radboud University Nijmegen	Asaridou, SS (corresponding author), Univ Calif Irvine, Sch Med, Dept Neurol, Irvine, CA 92717 USA.	sasarido@uci.edu	Hagoort, Peter/B-7417-2012; McQueen, James M./B-2212-2010	McQueen, James M./0000-0003-3734-6286	International Max Planck Research School	International Max Planck Research School	This work was supported by an International Max Planck Research School doctoral fellowship awarded to SSA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 2009, PHILOS T R SOC B, V364, P285, DOI 10.1098/rstb.2008.0253; Asaridou SS, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00321; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bauer RS., 1997, GRUYTER, DOI [10.1515/9783110823707, DOI 10.1515/9783110823707]; Bent T, 2006, J EXP PSYCHOL HUMAN, V32, P97, DOI 10.1037/0096-1523.32.1.97; Bialystok E, 2015, PSYCHOL SCI, V26, P944, DOI 10.1177/0956797615573759; Bialystok Ellen, 2001, ANNU REV APPL LINGUI, V21, P169, DOI [DOI 10.1017/S0267190501000101, 10.1017/S0267190501000101]; Bidelman GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060676; Bidelman GM, 2011, BRAIN COGNITION, V77, P1, DOI 10.1016/j.bandc.2011.07.006; Bidelman GM, 2011, J COGNITIVE NEUROSCI, V23, P425, DOI 10.1162/jocn.2009.21362; Boersma P, 2021, PRAAT DOING PHONETIC; Bradley E. D., 2013, REV RES HUMAN LEARNI, V1; CAMPBELL R, 1995, BRIT J DEV PSYCHOL, V13, P61, DOI 10.1111/j.2044-835X.1995.tb00664.x; Chandrasekaran B, 2007, BRAIN RES, V1128, P148, DOI 10.1016/j.brainres.2006.10.064; Cooper A, 2012, J ACOUST SOC AM, V131, P4756, DOI 10.1121/1.4714355; de Bruin A, 2015, PSYCHOL SCI, V26, P99, DOI 10.1177/0956797614557866; Foxton JM, 2004, BRAIN, V127, P801, DOI 10.1093/brain/awh105; Garner W. R., 1983, PERCEPTION COGNITION, P1, DOI DOI 10.1016/S0896-6273(02)00897-8; GARNER WR, 1970, COGNITIVE PSYCHOL, V1, P225, DOI 10.1016/0010-0285(70)90016-2; Giuliano RJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00146; Gordon RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009889; Hart J., 1998, INTONATION SYSTEMS S, P96; Hove MJ, 2010, PSYCHON B REV, V17, P310, DOI 10.3758/PBR.17.3.310; Iverson P, 2003, COGNITION, V87, pB47, DOI 10.1016/S0010-0277(02)00198-1; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Khouw E, 2007, J PHONETICS, V35, P104, DOI 10.1016/j.wocn.2005.10.003; Kim KHS, 1997, NATURE, V388, P171, DOI 10.1038/40623; Kolinsky R, 2009, COGNITION, V112, P1, DOI 10.1016/j.cognition.2009.02.014; LEE L, 1993, PERCEPT PSYCHOPHYS, V53, P157, DOI 10.3758/BF03211726; Li P, 2006, BEHAV RES METHODS, V38, P202, DOI 10.3758/BF03192770; Macmillan NA, 2005, DETECTION THEORY USE; Marie C, 2012, CORTEX, V48, P447, DOI 10.1016/j.cortex.2010.11.006; Mechelli A, 2004, NATURE, V431, P757, DOI 10.1038/431757a; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parbery-Clark A, 2009, J NEUROSCI, V29, P14100, DOI 10.1523/JNEUROSCI.3256-09.2009; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Patel AD, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00142; Peretz I, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00145; Pfordresher PQ, 2009, ATTEN PERCEPT PSYCHO, V71, P1385, DOI 10.3758/APP.71.6.1385; REPP BH, 1990, J PHONETICS, V18, P481, DOI 10.1016/S0095-4470(19)30410-3; Ressel V, 2012, J NEUROSCI, V32, P16597, DOI 10.1523/JNEUROSCI.1996-12.2012; Rodriguez-Fornells A, 2006, LANG LEARN, V56, P133, DOI 10.1111/j.1467-9922.2006.00359.x; Schon D, 2010, NEUROIMAGE, V51, P450, DOI 10.1016/j.neuroimage.2010.02.023; Singh L, 2012, COGNITION, V124, P128, DOI 10.1016/j.cognition.2012.05.008; Stevens CJ, 2013, PSYCHOL MUSIC, V41, P59, DOI 10.1177/0305735611415749; Wong PCM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033424	46	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144225	10.1371/journal.pone.0144225	http://dx.doi.org/10.1371/journal.pone.0144225			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1ZA	26659377	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903600029
J	Kanemaru, K; Noguchi, E; Tokunaga, T; Nagai, K; Hiroyama, T; Nakamura, Y; Tahara-Hanaoka, S; Shibuya, A				Kanemaru, Kazumasa; Noguchi, Emiko; Tokunaga, Takahiro; Nagai, Kei; Hiroyama, Takashi; Nakamura, Yukio; Tahara-Hanaoka, Satoko; Shibuya, Akira			Tie2 Signaling Enhances Mast Cell Progenitor Adhesion to Vascular Cell Adhesion Molecule1 (VCAM-1) through alpha 4 beta 1 Integrin	PLOS ONE			English	Article							BONE-MARROW; IMMUNOGLOBULIN-E; IN-VIVO; INFLAMMATORY RESPONSES; EXPRESSION CLONING; PERIPHERAL-BLOOD; RECEPTOR; ACTIVATION; LIGAND; ANGIOPOIETIN-2	Mast cell (MC) activation contributes considerably to immune responses, such as host protection and allergy. Cell surface immunoreceptors expressed on MCs play an important role in MC activation. Although various immunoreceptors on MCs have been identified, the regulatory mechanism of MC activation is not fully understood. To understand the regulatory mechanisms of MC activation, we used gene expression analyses of human and mouse MCs to identify a novel immunoreceptor expressed on MCs. We found that Tek, which encodes Tie2, was preferentially expressed in the MCs of both humans and mice. However, Tie2 was not detected on the cell surface of the mouse MCs of the peritoneal cavity, ear skin, or colon lamina propria. In contrast, it was expressed on mouse bone marrow-derived MCs and bone marrow MC progenitors (BM-MCps). Stimulation of Tie2 by its ligand angiopoietin- 1 induced tyrosine phosphorylation of Tie2 in MEDMC-BRC6, a mouse embryonic stem cell-derived mast cell line, and enhanced MEDMC-BRC6 and mouse BM-MCp adhesion to vascular cell adhesion molecule-1 (VCAM-1) through alpha 4 beta 1 integrin. These results suggest that Tie2 signaling induces alpha 4 beta 1 integrin activation on BM-MCps for adhesion to VCAM-1.	[Kanemaru, Kazumasa; Nagai, Kei; Tahara-Hanaoka, Satoko; Shibuya, Akira] Univ Tsukuba, Fac Med, Dept Immunol, Tsukuba, Ibaraki, Japan; [Noguchi, Emiko; Tokunaga, Takahiro] Univ Tsukuba, Fac Med, Dept Med Genet, Tsukuba, Ibaraki, Japan; [Tahara-Hanaoka, Satoko; Shibuya, Akira] Univ Tsukuba, Life Sci Ctr, TARA, Tsukuba, Ibaraki, Japan; [Nakamura, Yukio] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Noguchi, Emiko; Tahara-Hanaoka, Satoko; Shibuya, Akira] Core Res Evolut Sci & Technol AMED CREST, Tokyo, Japan; [Nakamura, Yukio] RIKEN BioResource Ctr, Cell Engn Div, Tsukuba, Ibaraki, Japan; [Tokunaga, Takahiro] Univ Fukui, Dept Otorhinolaryngol Head & Neck Surg, Fukui 910, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba; RIKEN; University of Fukui	Shibuya, A (corresponding author), Univ Tsukuba, Fac Med, Dept Immunol, Tsukuba, Ibaraki, Japan.	ashibuya@md.tsukuba.ac.jp	Nakamura, Yukio/A-5263-2016	Nakamura, Yukio/0000-0001-8056-4946; Nagai, Kei/0000-0001-5050-5291	Ministry of Education, Culture, Sports, Science and Technology of Japan;  [13J00798]; Grants-in-Aid for Scientific Research [15K15659] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by grants to AS, EN and ST-H, provided by the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was also supported in part by grants to KK, provided by Grant- in-Aid for Japan Society for the Promotion of Science Fellows (grant number 13J00798). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonia JP, 2006, BLOOD, V108, P1588, DOI 10.1182/blood-2005-12-012781; Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Boyce JA, 2002, BLOOD, V99, P2890, DOI 10.1182/blood.V99.8.2890; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; Cheng LE, 2013, IMMUNITY, V38, P166, DOI 10.1016/j.immuni.2012.09.022; Collington SJ, 2010, J IMMUNOL, V184, P6114, DOI 10.4049/jimmunol.0904177; Collmann E, 2013, J ALLERGY CLIN IMMUN, V132, P959, DOI 10.1016/j.jaci.2013.03.008; Dahlin JS, 2015, MOL IMMUNOL, V63, P9, DOI 10.1016/j.molimm.2014.01.018; Dahlin JS, 2012, J IMMUNOL, V189, P3869, DOI 10.4049/jimmunol.1201200; Dahlin JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020261; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; GURISH MF, 1992, J EXP MED, V175, P1003, DOI 10.1084/jem.175.4.1003; Gurish MF, 2001, J EXP MED, V194, P1243, DOI 10.1084/jem.194.9.1243; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; Hallgren J, 2007, P NATL ACAD SCI USA, V104, P20478, DOI 10.1073/pnas.0709651104; Harfouche R, 2006, AM J PHYSIOL-HEART C, V291, pH1635, DOI 10.1152/ajpheart.01318.2005; Hiroyama T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001544; Hitomi K, 2010, NAT IMMUNOL, V11, P601, DOI 10.1038/ni.1886; Hurst SD, 1999, J IMMUNOL, V163, P5937; Izawa K, 2012, IMMUNITY, V37, P827, DOI 10.1016/j.immuni.2012.08.018; Kim I, 2000, ONCOGENE, V19, P4549, DOI 10.1038/sj.onc.1203800; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Koh GY, 2013, TRENDS MOL MED, V19, P31, DOI 10.1016/j.molmed.2012.10.010; Koksal BT, 2014, ALLERGY ASTHMA PROC, V35, P482, DOI 10.2500/aap.2014.35.3793; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Kurashima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2023; Lee OH, 2006, MOL CANCER RES, V4, P915, DOI 10.1158/1541-7786.MCR-06-0184; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Levesque JP, 2010, LEUKEMIA, V24, P1979, DOI 10.1038/leu.2010.214; Levesque JP, 2001, BLOOD, V98, P1289, DOI 10.1182/blood.V98.5.1289; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Makinde TO, 2011, AM J RESP CELL MOL, V44, P384, DOI 10.1165/rcmb.2009-0330OC; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Migalovich-Sheikhet H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00238; Moon KY, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-143; Nagai K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076160; Nakahashi-Oda C, 2012, J EXP MED, V209, P1493, DOI 10.1084/jem.20120096; Pennock JL, 2004, BLOOD, V103, P2655, DOI 10.1182/blood-2003-09-3146; Pepinsky RB, 2002, BIOCHEMISTRY-US, V41, P7125, DOI 10.1021/bi020024d; Ratajczak MZ, 2015, LEUKEMIA, V29, P1452, DOI 10.1038/leu.2015.66; Saito H, 2006, NAT PROTOC, V1, P2178, DOI 10.1038/nprot.2006.344; Shik D, 2010, CLIN EXP ALLERGY, V40, P700, DOI 10.1111/j.1365-2222.2010.03501.x; Takakura N, 1998, IMMUNITY, V9, P677, DOI 10.1016/S1074-7613(00)80665-2; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Taketomi Y, 2013, NAT IMMUNOL, V14, P554, DOI 10.1038/ni.2586; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; Yamakawa D, 2013, J BIOL CHEM, V288, P12469, DOI 10.1074/jbc.M112.433979; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825; Yu M, 2006, J CLIN INVEST, V116, P1633, DOI 10.1172/JCI25702; Zhou BO, 2015, ELIFE, V4, DOI 10.7554/eLife.05521	56	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144436	10.1371/journal.pone.0144436	http://dx.doi.org/10.1371/journal.pone.0144436			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659448	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903600046
J	Lu, WY; Chen, JY; Chang, CF; Weng, WC; Lee, WT; Shieh, JS				Lu, Wen-Yu; Chen, Jyun-Yu; Chang, Chi-Feng; Weng, Wen-Chin; Lee, Wang-Tso; Shieh, Jiann-Shing			Multiscale Entropy of Electroencephalogram as a Potential Predictor for the Prognosis of Neonatal Seizures	PLOS ONE			English	Article							IMMATURE BRAIN; TIME-SERIES; EEG; COMPLEXITY; MECHANISMS; MANAGEMENT; EPILEPSY; STATE	Objective Increasing animal studies supported the harmful effects of prolonged or frequent neonatal seizures in developing brain, including increased risk of later epilepsy. Various nonlinear analytic measures had been applied to investigate the change of brain complexity with age. This study focuses on clarifying the relationship between later epilepsy and the changes of electroencephalogram (EEG) complexity in neonatal seizures. Methods EEG signals from 19 channels of the whole brain from 32 neonates below 2 months old were acquired. The neonates were classified into 3 groups: 9 were normal controls, 9 were neonatal seizures without later epilepsy, and 14 were neonatal seizures with later epilepsy. Sample entropy (SamEn), multiscale entropy (MSE) and complexity index (CI) were analyzed. Results Although there was no significant change in SamEn, the CI values showed significantly decreased over Channels C3, C4, and Cz in patients with neonatal seizures and later epilepsy compared with control group. More multifocal epileptiform discharges in EEG, more abnormal neuroimaging findings, and higher incidence of future developmental delay were noted in the group with later epilepsy. Conclusions Decreased MSE and CI values in patients with neonatal seizures and later epilepsy may reflect the mixed effects of acute insults, underlying brain immaturity, and prolonged seizures-related injuries. The analysis of MSE and CI can therefore provide a quantifiable and accurate way to decrypt the mystery of neonatal seizures, and could be a promising predictor.	[Lu, Wen-Yu] New Taipei City Hosp, Dept Pediat, Taipei, Taiwan; [Lu, Wen-Yu; Weng, Wen-Chin; Lee, Wang-Tso] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Chen, Jyun-Yu; Chang, Chi-Feng; Shieh, Jiann-Shing] Yuan Ze Univ, Dept Mech Engn, Taoyuan, Taiwan; [Weng, Wen-Chin; Lee, Wang-Tso] Natl Taiwan Univ Hosp, Clin Ctr Neurosci & Behav, Taipei, Taiwan; [Lee, Wang-Tso] Natl Taiwan Univ, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan; [Shieh, Jiann-Shing] Yuan Ze Univ, Innovat Ctr Big Data & Digital Convergence, Taoyuan, Taiwan	New Taipei City Hospital; National Taiwan University; National Taiwan University Hospital; Yuan Ze University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Yuan Ze University	Lee, WT (corresponding author), Natl Taiwan Univ Hosp, Dept Pediat, 1 Chang Te St, Taipei 10016, Taiwan.	leeped@hotmail.com		Lee, Wang-Tso/0000-0003-3231-9764; weng, wen-chin/0000-0002-6923-9138	Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan - Ministry of Science and Technology [NSC 102-2911-I-008-001]	Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan - Ministry of Science and Technology	This research was financially supported by Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan, which is sponsored by the Ministry of Science and Technology (Grant Number: NSC 102-2911-I-008-001).	AHMED MU, 2011, C P IEEE ENG MED BIO, P810, DOI DOI 10.1109/IEMBS.2011.6090185; Catarino A, 2011, CLIN NEUROPHYSIOL, V122, P2375, DOI 10.1016/j.clinph.2011.05.004; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, COMPUT CARDIOL, V29, P137, DOI 10.1109/CIC.2002.1166726; Costa MD, 2008, CARDIOVASC ENG, V8, P88, DOI 10.1007/s10558-007-9049-1; Dubois J, 2008, CEREB CORTEX, V18, P1444, DOI 10.1093/cercor/bhm180; Friedman L, 2014, LIFE SCI, V94, P92, DOI 10.1016/j.lfs.2013.11.003; Glass HC, 2009, J CHILD NEUROL, V24, P591, DOI 10.1177/0883073808327832; Glowinski D., 2010, MM 10PROCEEDINGS ACM, P1035; Hecox K, 2003, NEUROCOMPUTING, V52-4, P779, DOI 10.1016/S0925-2312(02)00774-9; Janjarasjitt S, 2008, CLIN NEUROPHYSIOL, V119, P1812, DOI 10.1016/j.clinph.2008.03.024; Kight KE, 2014, NEUROBIOL DIS, V72, P136, DOI 10.1016/j.nbd.2014.05.027; Lai YH, 2013, PEDIATR NEONATOL, V54, P166, DOI 10.1016/j.pedneo.2013.01.001; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; Mizrahi EM, 2001, PEDIATRIC EPILEPSY: DIAGNOSIS AND THERAPY, SECOND EDITION, P145; Mizuno T, 2010, CLIN NEUROPHYSIOL, V121, P1438, DOI 10.1016/j.clinph.2010.03.025; Nardou R, 2013, SEMIN FETAL NEONAT M, V18, P175, DOI 10.1016/j.siny.2013.02.003; Ni L, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/618743; Ouyang GX, 2013, EPILEPSY RES, V104, P246, DOI 10.1016/j.eplepsyres.2012.11.003; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pitkanen A, 2014, NEUROBIOL DIS, V72, P224, DOI 10.1016/j.nbd.2014.05.037; Pressler RM, 2013, SEMIN FETAL NEONAT M, V18, P216, DOI 10.1016/j.siny.2013.04.005; Rakhade SN, 2008, J NEUROSCI, V28, P7979, DOI 10.1523/JNEUROSCI.1734-08.2008; Ramantani G, 2013, EPILEPTIC DISORD, V15, P365, DOI 10.1684/epd.2013.0619; Sanchez RM, 2001, EPILEPSIA, V42, P577, DOI 10.1046/j.1528-1157.2001.12000.x; Scher MS, 2005, J CLIN NEUROPHYSIOL, V22, P159; SCHOUTEN JC, 1994, PHYS REV E, V49, P126, DOI 10.1103/PhysRevE.49.126; Stafstrom CE, 2006, EPILEPSIA, V47, P1407, DOI 10.1111/j.1528-1167.2006.00674_1.x; Takahashi T, 2010, NEUROIMAGE, V51, P173, DOI 10.1016/j.neuroimage.2010.02.009; Thibeault-Eybalin MP, 2009, PEDIATR NEUROL, V40, P175, DOI 10.1016/j.pediatrneurol.2008.10.026; Torisu H, 2014, BRAIN DEV-JPN, V36, P342, DOI [10.1016/j.braindev.2013.05.009, 10.1016/j.braindev.2014.01.016]; Vakorin VA, 2011, J NEUROSCI, V31, P6405, DOI 10.1523/JNEUROSCI.3153-10.2011; van Rooij LGM, 2013, SEMIN FETAL NEONAT M, V18, P209, DOI 10.1016/j.siny.2013.01.001; van Rooij LGM, 2013, PEDIATR DRUGS, V15, P9, DOI 10.1007/s40272-012-0005-1; Weng WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134083; Zhang X, 2013, IEEE J BIOMED HEALTH, V17, P470, DOI 10.1109/JBHI.2013.2241071	36	29	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144732	10.1371/journal.pone.0144732	http://dx.doi.org/10.1371/journal.pone.0144732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658680	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903600081
J	Sharma, R; Sastry, GN				Sharma, Reetu; Sastry, G. Narahari			Deciphering the Dynamics of Non-Covalent Interactions Affecting Thermal Stability of a Protein: Molecular Dynamics Study on Point Mutant of Thermus thermophilus Isopropylmalate Dehydrogenase	PLOS ONE			English	Article							3-ISOPROPYLMALATE DEHYDROGENASE; CRYSTAL-STRUCTURES; GLOBULAR-PROTEINS; ENZYMES; THERMOSTABILITY; STABILIZATION; MECHANISM; DESIGN	Thermus thermophilius isopropylmalate dehydrogenase catalyzes oxidative decarboxylation and dehydrogenation of isopropylmalate. Substitution of leucine to alanine at position 172 enhances the thermal stability among the known point mutants. Exploring the dynamic properties of non-covalent interactions such as saltbridges, hydrogen bonds and hydrophobic interactions to explain thermal stability of a protein is interesting in its own right. In this study dynamic changes in the non-covalent interactions are studied to decipher the deterministic features of thermal stability of a protein considering a case study of a point mutant in Thermus thermophilus isopropylmalate dehydrogenase. A total of four molecular dynamic simulations of 0.2 mu s were carried out on wild type and mutant's functional dimers at 300 K and 337 K. Higher thermal stability of the mutant as compared to wild type is revealed by root mean square deviation, root mean square fluctuations and C alpha-C alpha distance with an increase in temperature from 300 K to 337 K. Most of the regions of wild type fluctuate higher than the corresponding regions of mutant with an increase in temperature. C alpha-C alpha distance analysis suggests that long distance networks are significantly affected in wild type as compared to the mutant. Short lived contacts are higher in wild type, while long lived contacts are lost at 337 K. The mutant forms less hydrogen bonds with water as compared to wild type at 337 K. In contrast to wild type, the mutant shows significant increase in unique saltbridges, hydrogen bonds and hydrophobic contacts at 337 K. The current study indicates that there is a strong inter-dependence of thermal stability on the way in which non-covalent interactions reorganize, and it is rewarding to explore this connection in single mutant studies.	[Sharma, Reetu; Sastry, G. Narahari] CSIR Indian Inst Chem Technol, Ctr Mol Modeling, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT)	Sastry, GN (corresponding author), CSIR Indian Inst Chem Technol, Ctr Mol Modeling, Hyderabad 500007, Andhra Pradesh, India.	nsastry@gmail.com		Sharma, Reetu/0000-0002-3300-9832	Genomics and Informatics Solutions for Integrating Biology [GENESIS BSC0121]; Department of Science and Technology (DST)	Genomics and Informatics Solutions for Integrating Biology; Department of Science and Technology (DST)(Department of Science & Technology (India))	The authors thank Genomics and Informatics Solutions for Integrating Biology (GENESIS BSC0121) and Department of Science and Technology (DST) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Genomics and Informatics Solutions for Integrating Biology (GENESIS BSC0121) and Department of Science and Technology (DST) for financial support.	Akanuma S, 1997, FEBS LETT, V410, P141, DOI 10.1016/S0014-5793(97)00540-1; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; Chourasia M, 2011, INT J BIOL MACROMOL, V48, P540, DOI 10.1016/j.ijbiomac.2011.01.008; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Guang-Hong Z, 2007, CHINESE PHYS LETT, V24; Haney PJ, 1999, P NATL ACAD SCI USA, V96, P3578, DOI 10.1073/pnas.96.7.3578; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IKEDA K, 1967, PROG THEOR PHYS, V38, P584, DOI 10.1143/PTP.38.584; IMADA K, 1991, J MOL BIOL, V222, P725, DOI 10.1016/0022-2836(91)90508-4; IPPOLITO JA, 1990, J MOL BIOL, V215, P457, DOI 10.1016/S0022-2836(05)80364-X; Jelesarov Ilian, 2009, V490, P227, DOI 10.1007/978-1-59745-367-7_10; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kotsuka T, 1996, J BACTERIOL, V178, P723, DOI 10.1128/jb.178.3.723-727.1996; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Mahadevi AS, 2013, CHEM REV, V113, P2100, DOI 10.1021/cr300222d; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Manjunath K, 2013, J CHEM INF MODEL, V53, P2448, DOI 10.1021/ci400306m; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; MORIYAMA H, 1995, J BIOCHEM-TOKYO, V117, P408, DOI 10.1093/jb/117.2.408; Nagata C, 1996, ACTA CRYSTALLOGR D, V52, P623, DOI 10.1107/S0907444995016623; Nurachman Z, 2000, PROTEIN ENG, V13, P253, DOI 10.1093/protein/13.4.253; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PERUTZ MF, 1975, NATURE, V255, P256, DOI 10.1038/255256a0; Qu CX, 1997, PROTEIN ENG, V10, P45, DOI 10.1093/protein/10.1.45; Qu CX, 2001, ACTA CRYSTALLOGR D, V57, P225, DOI 10.1107/S0907444900017388; RUSSELL RJM, 1994, STRUCTURE, V2, P1157, DOI 10.1016/S0969-2126(94)00118-9; Saha S, 2015, J PHYS CHEM B, V119, P11121, DOI 10.1021/acs.jpcb.5b03005; Sakurai M, 1996, ACTA CRYSTALLOGR D, V52, P124, DOI 10.1107/S0907444995007190; Schrodinger L., 2020, PYMOL; Srivani P, 2008, CURR PHARM DESIGN, V14, P3854, DOI 10.2174/138161208786898653; Srivastava HK, 2011, J CHEM INF MODEL, V51, P558, DOI 10.1021/ci100474n; Sterpone F, 2009, J PHYS CHEM B, V113, P131, DOI 10.1021/jp805199c; STICKLE DF, 1992, J MOL BIOL, V226, P1143, DOI 10.1016/0022-2836(92)91058-W; Stojanovic S. D., 2009, OPEN STRUCT BIOL J, V3, P34, DOI DOI 10.2174/1874199100903010034; Suzuki T, 2002, PROTEIN ENG, V15, P471, DOI 10.1093/protein/15.6.471; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Thompson MJ, 1999, J MOL BIOL, V290, P595, DOI 10.1006/jmbi.1999.2889; van den Burg B, 2003, CURR OPIN MICROBIOL, V6, P213, DOI 10.1016/S1369-5274(03)00060-2; VANDENBURG B, 1994, EUR J BIOCHEM, V220, P981; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Vieille C, 1996, Biotechnol Annu Rev, V2, P1, DOI 10.1016/S1387-2656(08)70006-1; Vijay D, 2010, CHEM PHYS LETT, V485, P235, DOI 10.1016/j.cplett.2009.12.012; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; Wallon G, 1997, J MOL BIOL, V266, P1016, DOI 10.1006/jmbi.1996.0797	47	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144294	10.1371/journal.pone.0144294	http://dx.doi.org/10.1371/journal.pone.0144294			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657745	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903600035
J	Sui, YJ; Wu, F; Lv, JF; Li, HX; Li, X; Du, ZW; Sun, MY; Zheng, YH; Yang, LF; Zhong, LL; Zhang, XY; Zhang, GZ				Sui, Yujie; Wu, Fei; Lv, Junfeng; Li, Hongxia; Li, Xin; Du, Zhenwu; Sun, Meiyan; Zheng, Yuhao; Yang, Longfei; Zhong, Lili; Zhang, Xingyi; Zhang, Guizhen			Identification of the Novel TMEM16A Inhibitor Dehydroandrographolide and Its Anticancer Activity on SW620 Cells	PLOS ONE			English	Article							CA2+-ACTIVATED CL-CHANNEL; TUMOR-GROWTH; ANO1; EXPRESSION; CARCINOMA; HEAD	TMEM16A, a calcium-activated chloride channel (CaCC), is highly amplified and expressed in human cancers and is involved in the growth and metastasis of some malignancies. Inhibition of TMEM16A represents a novel pharmaceutical approach for the treatment of cancers and metastases. The purpose of this study is to identify a new TMEM16A inhibitor, investigate the effects of this inhibitor on the proliferation and metastasis of TMEM16A-amplified SW620 cells, and to elucidate the underlying molecular mechanism in vitro. We identified a novel small-molecule TMEM16A inhibitor dehydroandrographolide (DP). By using patch clamp electrophysiology, we showed that DP inhibited TMEM16A chloride currents in Fisher rat thyroid (FRT) cells that were transfected stably with human TMEM16A and in TMEM16A-overexpressed SW620 cells but did not alter cystic fibrosis transmembrane conductance regulator (CFTR) chloride currents. Further functional studies showed that DP suppressed the proliferation of SW620 cells in a dose-and time-dependent manner using MTT assays. Moreover, DP significantly inhibited migration and invasion of SW620 cells as detected by wound-healing and transwell assays. Further mechanistic study demonstrated that knockdown of human TMEM16A decreased the inhibitory effect of DP on the proliferation of SW620 cells and that TMEM16A-dependent cells (SW620 and HCT116) were more sensitive to DP than TMEM16A-independent cells (SW480 and HCT8). In addition, we found that treatment of SW620 cells with DP led to a decrease in TMEM16A protein levels but had no effect on TMEM16A mRNA levels. The current work reveals that DP, a novel TMEM16A inhibitor, exerts its anticancer activity on SW620 cells partly through a TMEM16A-dependent mechanism, which may introduce a new targeting approach for an antitumour therapy in TMEM16A-amplified cancers.	[Sui, Yujie; Li, Xin; Du, Zhenwu; Sun, Meiyan; Zheng, Yuhao; Yang, Longfei; Zhong, Lili; Zhang, Guizhen] Jilin Univ, Key Lab Mol & Chem Genet Crit Human Dis Jilin Pro, Bethune Hosp 2, Changchun 130023, Peoples R China; [Wu, Fei] Jilin Univ, Dept Gynecol & Obstet, Bethune Hosp 2, Changchun 130023, Peoples R China; [Lv, Junfeng] Jilin Univ, Dept Radiol, Bethune Hosp 2, Changchun 130023, Peoples R China; [Li, Hongxia] Jilin Univ, Dept Dermatol, Bethune Hosp 1, Changchun 130023, Peoples R China; [Zhang, Xingyi] Jilin Univ, Dept Thorac Surg, Bethune Hosp 2, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University; Jilin University; Jilin University	Zhang, XY (corresponding author), Jilin Univ, Dept Thorac Surg, Bethune Hosp 2, Changchun 130023, Peoples R China.	xingyizhang@live.com; Zhang4083@163.com	Yang, Longfei/B-4223-2018	Yang, Longfei/0000-0003-4153-9670	China Postdoctoral Science Foundation [2014M551198]; Jilin Province health and Family Planning Commission Project [2014Q024]; Jilin University experimental technology project [409020720137]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jilin Province health and Family Planning Commission Project; Jilin University experimental technology project	This study was supported by China Postdoctoral Science Foundation (No. 2014M551198), Jilin Province health and Family Planning Commission Project (No. 2014Q024) and Jilin University experimental technology project in 2015 (409020720137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERVALL JA, 1995, CANCER, V76, P853, DOI 10.1002/1097-0142(19950901)76:5<853::AID-CNCR2820760520>3.0.CO;2-6; Bill A, 2014, J BIOL CHEM, V289, P11029, DOI 10.1074/jbc.M114.549188; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Carles A, 2006, ONCOGENE, V25, P1821, DOI 10.1038/sj.onc.1209203; Carneiro A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-98; Chen H, 2014, BIOORG MED CHEM LETT, V24, P2353, DOI 10.1016/j.bmcl.2014.03.060; Cheung HY, 2005, PLANTA MED, V71, P1106, DOI 10.1055/s-2005-873128; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; Guang RJ, 2000, CANCER RES, V60, P749; Jacobsen KS, 2013, PFLUG ARCH EUR J PHY, V465, P1753, DOI 10.1007/s00424-013-1315-z; Liu SH, 2014, BIOCHEM PHARMACOL, V87, P229, DOI 10.1016/j.bcp.2013.10.014; Liu W, 2012, CANCER LETT, V326, P41, DOI 10.1016/j.canlet.2012.07.015; Matsuba S, 2014, J PHARMACOL EXP THER, V351, P510, DOI 10.1124/jpet.114.217315; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Qu ZQ, 2014, CANCER MED-US, V3, P453, DOI 10.1002/cam4.232; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Sauter DRP, 2015, PFLUG ARCH EUR J PHY, V467, P1495, DOI 10.1007/s00424-014-1598-8; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shen KK, 2014, CHEM-BIOL INTERACT, V218, P99, DOI 10.1016/j.cbi.2014.04.020; Shiwarski DJ, 2014, CLIN CANCER RES, V20, P4673, DOI 10.1158/1078-0432.CCR-14-0363; Stanich JE, 2011, AM J PHYSIOL-GASTR L, V301, pG1044, DOI 10.1152/ajpgi.00196.2011; Sui YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115443; Tian YM, 2012, J CELL SCI, V125, P4991, DOI 10.1242/jcs.109553; Tung YT, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/305898; Urrego D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0094; Wanitchakool P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0096; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yao Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038030	30	21	22	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144715	10.1371/journal.pone.0144715	http://dx.doi.org/10.1371/journal.pone.0144715			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657333	gold, Green Submitted, Green Published			2022-12-27	WOS:000366903600080
J	Biller, OM; Adler, LS; Irwin, RE; McAllister, C; Palmer-Young, EC				Biller, Olivia Masi; Adler, Lynn S.; Irwin, Rebecca E.; McAllister, Caitlin; Palmer-Young, Evan C.			Possible Synergistic Effects of Thymol and Nicotine against Crithidia bombi Parasitism in Bumble Bees	PLOS ONE			English	Article							SELF-MEDICATION; ESSENTIAL OILS; TRYPANOSOME PARASITE; ANTIMICROBIAL ACTIVITY; PATHOGENIC BACTERIA; NECTAR-NICOTINE; GUT MICROBIOTA; DOSE-RESPONSE; HOST; INFECTION	Floral nectar contains secondary compounds with antimicrobial properties that can affect not only plant-pollinator interactions, but also interactions between pollinators and their parasites. Although recent work has shown that consumption of plant secondary compounds can reduce pollinator parasite loads, little is known about the effects of dosage or compound combinations. We used the generalist pollinator Bombus impatiens and its obligate gut parasite Crithidia bombi to study the effects of nectar chemistry on host-parasite interactions. In two experiments we tested (1) whether the secondary compounds thymol and nicotine act synergistically to reduce parasitism, and (2) whether dietary thymol concentration affects parasite resistance. In both experiments, uninfected Bombus impatiens were inoculated with Crithidia and then fed particular diet treatments for 7 days, after which infection levels were assessed. In the synergism experiment, thymol and nicotine alone and in combination did not significantly affect parasite load or host mortality. However, the thymol-nicotine combination treatment reduced log-transformed parasite counts by 30% relative to the control group (P = 0.08). For the experiment in which we manipulated thymol concentration, we found no significant effect of any thymol concentration on Crithidia load, but moderate (2 ppm) thymol concentrations incurred a near-significant increase in mortality (P = 0.054). Our results tentatively suggest the value of a mixed diet for host immunity, yet contrast with research on the antimicrobial activity of dietary thymol and nicotine in vertebrate and other invertebrate systems. We suggest that future research evaluate genetic variation in Crithidia virulence, multi-strain competition, and Crithidia interactions with the gut microbe community that may mediate antimicrobial activities of secondary compounds.	[Biller, Olivia Masi; Adler, Lynn S.; McAllister, Caitlin; Palmer-Young, Evan C.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Irwin, Rebecca E.] Dartmouth Coll, Dept Biol, Hanover, NH 03755 USA	University of Massachusetts System; University of Massachusetts Amherst; Dartmouth College	Palmer-Young, EC (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	epalmery@cns.umass.edu	Palmer-Young, Evan/AFL-1225-2022	Palmer-Young, Evan/0000-0002-9258-2073; Biller, Olivia/0000-0001-9832-1838	National Science Foundation (NSF) [NSFDEB-1258096]; NSF GRFP [DGE-0907995]; NSF DDIG [NSFDEB-1501907]; National Research Initiative (NRI) Arthropod and Nematode Biology and Management Program of the United States Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service (CSREES) [USDA-AFRI 2013-02536]; Garden Club of America Centennial Pollinator Fellowship; Direct For Biological Sciences [1501907] Funding Source: National Science Foundation; Division Of Environmental Biology [1638866] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF DDIG(National Science Foundation (NSF)); National Research Initiative (NRI) Arthropod and Nematode Biology and Management Program of the United States Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service (CSREES); Garden Club of America Centennial Pollinator Fellowship; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by the National Science Foundation (NSF; www.nsf.gov) under NSFDEB-1258096 (to LSA and REI), NSF GRFP (Grant DGE-0907995 to ECP-Y), and NSF DDIG (Grant NSFDEB-1501907 to ECP-Y and LSA); by the National Research Initiative (NRI) Arthropod and Nematode Biology and Management Program of the United States Department of Agriculture (USDA; www.usda.gov) Cooperative State Research, Education, and Extension Service (CSREES) Grant USDA-AFRI 2013-02536 (to LSA and REI); and by the Garden Club of America (www.gcamerica.org) Centennial Pollinator Fellowship (to ECP-Y). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott J, 2014, ECOL ENTOMOL, V39, P273, DOI 10.1111/een.12110; Adler LS, 2005, ECOLOGY, V86, P2968, DOI 10.1890/05-0118; Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; Adler LS, 2012, ECOL LETT, V15, P1140, DOI 10.1111/j.1461-0248.2012.01838.x; Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; [Anonymous], 2014, LANG ENV STAT COMP; Baer B, 2003, OIKOS, V101, P563, DOI 10.1034/j.1600-0706.2003.12395.x; BAKER HG, 1977, BOT GAZ, V138, P183, DOI 10.1086/336914; BAKER HG, 1977, APIDOLOGIE, V8, P349, DOI 10.1051/apido:19770405; Baracchi D, 2015, F1000 RES, P4; BARBOSA P, 1991, ECOLOGY, V72, P1567, DOI 10.2307/1940956; Barribeau SM, 2014, P NATL ACAD SCI USA, V111, P3496, DOI 10.1073/pnas.1318628111; BELL RR, 1983, J NUTR, V113, P2479, DOI 10.1093/jn/113.12.2479; BERTSCH A, 1984, OECOLOGIA, V62, P325, DOI 10.1007/BF00384264; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Brown MJF, 2003, J ANIM ECOL, V72, P994, DOI 10.1046/j.1365-2656.2003.00770.x; Brown MJF, 2000, OIKOS, V91, P421, DOI 10.1034/j.1600-0706.2000.910302.x; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; Charpentier G, 2014, PEST MANAG SCI, V70, P140, DOI 10.1002/ps.3539; Cisarovsky G, 2012, J EVOLUTION BIOL, V25, P1053, DOI 10.1111/j.1420-9101.2012.02507.x; Cisarovsky G, 2014, ENTOMOL EXP APPL, V152, P209, DOI 10.1111/eea.12218; Colla S, 2011, GUIDE BUMBLE BEES E; Colla SR, 2006, BIOL CONSERV, V129, P461, DOI 10.1016/j.biocon.2005.11.013; Cordes N, 2012, J INVERTEBR PATHOL, V109, P209, DOI 10.1016/j.jip.2011.11.005; Costa C, 2010, APIDOLOGIE, V41, P141, DOI 10.1051/apido/2009070; Daferera DJ, 2000, J AGR FOOD CHEM, V48, P2576, DOI 10.1021/jf990835x; de Roode JC, 2013, SCIENCE, V340, P150, DOI 10.1126/science.1235824; Detzel Andreas, 1993, Chemoecology, V4, P8, DOI 10.1007/BF01245891; Drescher N, 2014, OECOLOGIA, V176, P943, DOI 10.1007/s00442-014-3070-z; DURRER S, 1994, P ROY SOC B-BIOL SCI, V258, P299, DOI 10.1098/rspb.1994.0176; Erler S, 2014, ECOL EVOL, V4, P3960, DOI 10.1002/ece3.1252; Floris I, 2004, J ECON ENTOMOL, V97, P187, DOI 10.1603/0022-0493-97.2.187; Fox J., 2019, R COMPANION APPL REG, V.; Gegear RJ, 2005, ANIM BEHAV, V70, P209, DOI 10.1016/j.anbehav.2004.09.025; Gegear RJ, 2006, P ROY SOC B-BIOL SCI, V273, P1073, DOI 10.1098/rspb.2005.3423; Gherman BI, 2014, BEHAV ECOL SOCIOBIOL, V68, P1777, DOI 10.1007/s00265-014-1786-8; Gillespie S, 2010, ECOL ENTOMOL, V35, P737, DOI 10.1111/j.1365-2311.2010.01234.x; Gonzalez-Teuber M, 2009, PLANT SIGNAL BEHAV, V4, P809, DOI 10.4161/psb.4.9.9393; Goulson D, 2004, APIDOLOGIE, V35, P55, DOI 10.1051/apido:2003062; Guyot C, 1998, J AGR FOOD CHEM, V46, P625, DOI 10.1021/jf970510l; Heil M, 2011, TRENDS PLANT SCI, V16, P191, DOI 10.1016/j.tplants.2011.01.003; HIEBERT SM, 1983, ECOLOGY, V64, P399, DOI 10.2307/1937086; Hodgson DJ, 2004, J EVOLUTION BIOL, V17, P1018, DOI 10.1111/j.1420-9101.2004.00750.x; Kearns CA, 1997, BIOSCIENCE, V47, P297, DOI 10.2307/1313191; Koch H, 2012, ECOL LETT, V15, P1095, DOI 10.1111/j.1461-0248.2012.01831.x; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Kohler A, 2012, J INSECT PHYSIOL, V58, P286, DOI 10.1016/j.jinsphys.2011.12.002; Kordali S, 2008, BIORESOURCE TECHNOL, V99, P8788, DOI 10.1016/j.biortech.2008.04.048; Korner P, 2005, ENTOMOL SCI, V8, P151, DOI 10.1111/j.1479-8298.2005.00113.x; Lefevre T, 2012, J ANIM ECOL, V81, P70, DOI 10.1111/j.1365-2656.2011.01901.x; Lefevre T, 2010, ECOL LETT, V13, P1485, DOI 10.1111/j.1461-0248.2010.01537.x; LIPA JJ, 1988, ACTA PROTOZOOL, V27, P287; Logan A, 2005, PARASITOLOGY, V130, P637, DOI 10.1017/S0031182005007304; Macheboeuf D, 2008, ANIM FEED SCI TECH, V145, P335, DOI 10.1016/j.anifeedsci.2007.05.044; Manson JS, 2010, OECOLOGIA, V162, P81, DOI 10.1007/s00442-009-1431-9; MARTINI M, 1990, BOT ACTA, V103, P343, DOI 10.1111/j.1438-8677.1990.tb00172.x; Mason PA, 2014, OECOLOGIA, V176, P477, DOI 10.1007/s00442-014-3029-0; McArt SH, 2014, ECOL LETT, V17, P624, DOI 10.1111/ele.12257; Michiels J, 2007, LIVEST SCI, V109, P157, DOI 10.1016/j.livsci.2007.01.132; Nicolson Susan W., 2007, P215, DOI 10.1007/978-1-4020-5937-7_5; Nicolson SW, 1998, AM ZOOL, V38, P418; Nicolson SW, 2008, PHYSIOL ENTOMOL, V15, P433, DOI [10.1111/j.1365-3032.1990.tb00532, DOI 10.1111/J.1365-3032.1990.TB00532]; Noakes TD, 2006, BRIT J SPORT MED, V40, P567, DOI 10.1136/bjsm.2005.020354; Otterstatter MC, 2006, PARASITOLOGY, V133, P749, DOI 10.1017/S003118200600120X; Otterstatter MC, 2005, BEHAV ECOL SOCIOBIOL, V58, P383, DOI 10.1007/s00265-005-0945-3; Oussalah M, 2007, FOOD CONTROL, V18, P414, DOI 10.1016/j.foodcont.2005.11.009; Pavia CS, 2000, J MED MICROBIOL, V49, P675, DOI 10.1099/0022-1317-49-7-675; Pina-Vaz C, 2004, J EUR ACAD DERMATOL, V18, P73, DOI 10.1111/j.1468-3083.2004.00886.x; Pinheiro J, R PACKAGE VERSION; Plepys D, 2002, OIKOS, V99, P69, DOI 10.1034/j.1600-0706.2002.990107.x; Popp M, 2012, MICROBIOLOGYOPEN, V1, P362, DOI 10.1002/mbo3.35; Raguso RA, 2015, ECOLOGY, V96, P617, DOI 10.1890/14-1474.1; Richards LA, 2012, J CHEM ECOL, V38, P1276, DOI 10.1007/s10886-012-0190-y; Richardson LL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2471; Sadd BM, 2013, PARASITE IMMUNOL, V35, P339, DOI 10.1111/pim.12043; Salathe RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022054; Santoro GF, 2007, PARASITOL RES, V100, P783, DOI 10.1007/s00436-006-0326-5; Schiestl FP, 1999, P ENTOMOL SOC WASH, V101, P880; Schmid-Hempel P, 2004, PARASITOLOGY, V129, P147, DOI 10.1017/S0031182004005542; Schmid-Hempel R, 2014, J ANIM ECOL, V83, P823, DOI 10.1111/1365-2656.12185; Schmid-Hempel R, 2010, J EUKARYOT MICROBIOL, V57, P337, DOI 10.1111/j.1550-7408.2010.00480.x; SHYKOFF JA, 1991, APIDOLOGIE, V22, P117, DOI 10.1051/apido:19910204; Silva EM, 2000, J ECON ENTOMOL, V93, P1216, DOI 10.1603/0022-0493-93.4.1216; Singaravelan N, 2006, J CHEM ECOL, V32, P49, DOI 10.1007/s10886-006-9350-2; Singaravelan N, 2005, J CHEM ECOL, V31, P2791, DOI 10.1007/s10886-005-8394-z; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Singer MS, 2004, AM NAT, V164, P423, DOI 10.1086/423152; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Stephenson AG, 2012, NEW PHYTOL, V193, P827, DOI 10.1111/j.1469-8137.2011.04035.x; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Thomson JD, 2015, ARTHROPOD-PLANT INTE, V9, P1, DOI 10.1007/s11829-014-9350-z; THORPE KW, 1986, J CHEM ECOL, V12, P1329, DOI 10.1007/BF01012352; Tognazzo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049137; Ulrich Y, 2011, J EVOLUTION BIOL, V24, P354, DOI 10.1111/j.1420-9101.2010.02172.x; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; Zaidi MI, 2012, AFR J MICROBIOL RES, V6, P5134, DOI 10.5897/AJMR11.1209	100	36	36	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144668	10.1371/journal.pone.0144668	http://dx.doi.org/10.1371/journal.pone.0144668			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657643	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903500054
J	King, AD; Chow, SKK; Yu, KH; Mo, FKF; Yeung, DKW; Yuan, J; Law, BKH; Bhatia, KS; Vlantis, AC; Ahuja, AT				King, Ann D.; Chow, Steven Kwok Keung; Yu, Kwok-Hung; Mo, Frankie Kwok Fai; Yeung, David K. W.; Yuan, Jing; Law, Benjamin King Hong; Bhatia, Kunwar S.; Vlantis, Alexander C.; Ahuja, Anil T.			DCE-MRI for Pre-Treatment Prediction and Post-Treatment Assessment of Treatment Response in Sites of Squamous Cell Carcinoma in the Head and Neck	PLOS ONE			English	Article							CONTRAST-ENHANCED-MRI; NEOADJUVANT CHEMOTHERAPY; RADIATION-THERAPY; TUMOR RESPONSE; BREAST-CANCER; RADIOTHERAPY; REGRESSION; OUTCOMES	Background and Purpose It is important to identify patients with head and neck squamous cell carcinoma (SCC) who fail to respond to chemoradiotherapy so that they can undergo post-treatment salvage surgery while the disease is still operable. This study aimed to determine the diagnostic performance of dynamic contrast enhanced (DCE)-MRI using a pharmacokinetic model for pre-treatment predictive imaging, as well as post-treatment diagnosis, of residual SCC at primary and nodal sites in the head and neck. Material and Methods Forty-nine patients with 83 SCC sites (primary and/or nodal) underwent pre-treatment DCE-MRI, and 43 patients underwent post-treatment DCE-MRI, of which 33 SCC sites had a residual mass amenable to analysis. Pre-treatment, post-treatment and % change in the mean K-trans, k(ep), v(e) and AUGC were obtained from SCC sites. Logistic regression was used to correlate DCE parameters at each SCC site with treatment response at the same site, based on clinical outcome at that site at a minimum of two years. Results None of the pre-treatment DCE-MRI parameters showed significant correlations with SCC site failure (SF) (29/83 sites) or site control (SC) (54/83 sites). Post-treatment residual masses with SF (14/33) had significantly higher k(ep) (p = 0.05), higher AUGC (p = 0.02), and lower % reduction in AUGC (p = 0.02), than residual masses with SC (19/33), with the% change in AUGC remaining significant on multivariate analysis. Conclusion Pre-treatment DCE-MRI did not predict which SCC sites would fail treatment, but post-treatment DCE-MRI showed potential for identifying residual masses that had failed treatment.	[King, Ann D.; Law, Benjamin King Hong; Bhatia, Kunwar S.; Ahuja, Anil T.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China; [Chow, Steven Kwok Keung] Univ Wollongong, Fac Engn & Informat Sci, Sch Phys, Wollongong, NSW 2522, Australia; [Yu, Kwok-Hung] Alpha Oncol Ctr, Hong Kong, Hong Kong, Peoples R China; [Mo, Frankie Kwok Fai; Yeung, David K. W.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Yuan, Jing] Hong Kong Sanat & Hosp, Med Phys & Res Dept, Hong Kong, Hong Kong, Peoples R China; [Vlantis, Alexander C.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Otorhinolaryngol Head & Neck Surg, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; University of Wollongong; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	King, AD (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China.	king2015@cuhk.edu.hk	Mo, Frankie/AAC-9230-2022; Law, Benjamin King Hong/J-2179-2016; Ahuja, Anil T/H-4031-2017; King, Ann D/C-9845-2011; Yuan, Jing/E-4236-2013; Chow, Steven Kwok Keung/GNH-4779-2022; Mo, Frankie/AAG-8079-2021; Vlantis, Alexander/J-9785-2017	Mo, Frankie/0000-0002-0566-3212; Law, Benjamin King Hong/0000-0003-3836-8196; Ahuja, Anil T/0000-0002-0726-5402; King, Ann D/0000-0002-5280-8349; Yuan, Jing/0000-0001-8112-3608; Chow, Kwok Keung/0000-0002-7201-4888; Vlantis, Alexander/0000-0003-3109-5236	Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK4660/08, SEG_CUHK02]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	The work described in this paper was fully supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. CUHK4660/08 and SEG_CUHK02).	Agrawal S, 2012, CLIN RADIOL, V67, pE1, DOI 10.1016/j.crad.2012.03.005; Ah-See MLW, 2008, CLIN CANCER RES, V14, P6580, DOI 10.1158/1078-0432.CCR-07-4310; Baba Y, 1997, INT J RADIAT ONCOL, V37, P783, DOI 10.1016/S0360-3016(96)00595-0; Cao Y, 2011, SEMIN RADIAT ONCOL, V21, P147, DOI 10.1016/j.semradonc.2010.11.001; Chawla S, 2011, AM J NEURORADIOL, V32, P778, DOI 10.3174/ajnr.A2376; Chawla S, 2013, AM J ROENTGENOL, V200, P35, DOI 10.2214/AJR.12.9432; Chikui T, 2012, J MAGN RESON IMAGING, V36, P589, DOI 10.1002/jmri.23704; George ML, 2001, BRIT J SURG, V88, P1628, DOI 10.1046/j.0007-1323.2001.01947.x; Gollub MJ, 2012, EUR RADIOL, V22, P821, DOI 10.1007/s00330-011-2321-1; Hoskin PJ, 1999, BRIT J RADIOL, V72, P1093, DOI 10.1259/bjr.72.863.10700827; Huang SH, 2013, INT J RADIAT ONCOL, V87, P1078, DOI 10.1016/j.ijrobp.2013.08.049; Isles MG, 2008, CLIN OTOLARYNGOL, V33, P210, DOI 10.1111/j.1749-4486.2008.01688.x; Khalifa F, 2014, MED PHYS, V41, DOI 10.1118/1.4898202; Kim S, 2010, AM J NEURORADIOL, V31, P262, DOI 10.3174/ajnr.A1817; Li SP, 2012, J MAGN RESON IMAGING, V35, P745, DOI 10.1002/jmri.22838; Ng SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115933; Ng SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072230; O'Sullivan B, 2012, RADIOTHER ONCOL, V103, P49, DOI 10.1016/j.radonc.2012.02.009; Pickles MD, 2005, BREAST CANCER RES TR, V91, P1, DOI 10.1007/s10549-004-5819-2; Shukla-Dave A, 2012, INT J RADIAT ONCOL, V82, P1837, DOI 10.1016/j.ijrobp.2011.03.006; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Tomura N, 2005, AM J OTOLARYNG, V26, P163, DOI 10.1016/j.amjoto.2004.11.011; Wang P, 2012, MED PHYS, V39, P5277, DOI 10.1118/1.4737022; Wasser K, 2003, EUR RADIOL, V13, P1213, DOI 10.1007/s00330-002-1730-6; Yoo DS, 2012, CLIN CANCER RES, V18, P1404, DOI 10.1158/1078-0432.CCR-11-1982; Yuan J, 2012, QUANT IMAGING MED SU, V2, P21, DOI [10.3978/j.issn.2223-4292.2012.01.06, 10.3978/j.issn.2223-4292.2012.11.04]; Zahra MA, 2007, LANCET ONCOL, V8, P63, DOI 10.1016/S1470-2045(06)71012-9	28	16	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144770	10.1371/journal.pone.0144770	http://dx.doi.org/10.1371/journal.pone.0144770			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657972	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903500059
J	Rice, S; Koziel, JA				Rice, Somchai; Koziel, Jacek A.			Characterizing the Smell of Marijuana by Odor Impact of Volatile Compounds: An Application of Simultaneous Chemical and Sensory Analysis	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; MASS SPECTROMETRY-OLFACTOMETRY; ION MOBILITY SPECTROMETRY; GAS-CHROMATOGRAPHY; HEADSPACE VOLATILES; CANNABIS-SATIVA; EXPLOSIVES; EFFICACY; DRUGS; AROMA	Recent US legislation permitting recreational use of marijuana in certain states brings the use of marijuana odor as probable cause for search and seizure to the forefront of forensic science, once again. This study showed the use of solid-phase microextraction with multi-dimensional gas chromatography-mass spectrometry and simultaneous human olfaction to characterize the total aroma of marijuana. The application of odor activity analysis offers an explanation as to why high volatile chemical concentration does not equate to most potent odor impact of a certain compound. This suggests that more attention should be focused on highly odorous compounds typically present in low concentrations, such as nonanal, decanol, o-cymene, benzaldehyde, which have more potent odor impact than previously reported marijuana headspace volatiles.	[Rice, Somchai; Koziel, Jacek A.] Iowa State Univ, Interdept Toxicol Grad Program, Ames, IA 50011 USA; [Rice, Somchai; Koziel, Jacek A.] Iowa State Univ, Agr & Biosyst Engn, Ames, IA USA	Iowa State University; Iowa State University	Koziel, JA (corresponding author), Iowa State Univ, Interdept Toxicol Grad Program, Ames, IA 50011 USA.	koziel@iastate.edu	Rice, Somchai/O-1426-2015; Koziel, Jacek A./B-5483-2014; Rice, Somchai/AAG-8148-2019	Rice, Somchai/0000-0001-8868-3202; Koziel, Jacek A./0000-0002-2387-0354; Rice, Somchai/0000-0001-8868-3202				Acree T., 2004, FLAVORNET HUMAN ODOR; *AIHA, 1989, OD THRESH CHEM EST O; [Anonymous], 1994, GOOD SCENTS CO INFOR; Bertoli A, 2010, IND CROP PROD, V32, P329, DOI 10.1016/j.indcrop.2010.05.012; Cai LS, 2007, J CHROMATOGR A, V1147, P66, DOI 10.1016/j.chroma.2007.02.044; Devos M., 1990, STANDARDIZED HUMAN O; Doty RL, 2004, LAW HUMAN BEHAV, V28, P223, DOI 10.1023/B:LAHU.0000022324.13389.ea; Ferreira V, 2002, J AGR FOOD CHEM, V50, P4048, DOI 10.1021/jf0115645; Furton KG, 2001, TALANTA, V54, P487, DOI 10.1016/S0039-9140(00)00546-4; Furton KG, 2000, J CHROMATOGR SCI, V38, P297, DOI 10.1093/chromsci/38.7.297; Furton KG, 1998, M INV FOR SCI TECHN, V3576, P41; Grosch Werner, 1994, Flavour and Fragrance Journal, V9, P147, DOI 10.1002/ffj.2730090403; Guth H, 1997, J AGR FOOD CHEM, V45, P3027, DOI 10.1021/jf970280a; HOOD LVS, 1973, NATURE, V242, P402, DOI 10.1038/242402a0; HOOD LVS, 1978, J CHROMATOGR, V166, P499, DOI 10.1016/S0021-9673(00)95633-4; Jezierski T, 2014, FORENSIC SCI INT, V237, P112, DOI 10.1016/j.forsciint.2014.01.013; Kabir A, 2013, TRAC-TREND ANAL CHEM, V45, P264, DOI 10.1016/j.trac.2012.11.013; Kongshaug KE, 1999, CHROMATOGRAPHIA, V50, P247, DOI 10.1007/BF02490660; Lai H, 2008, ANAL BIOANAL CHEM, V392, P105, DOI 10.1007/s00216-008-2229-z; Lai H, 2008, J SEP SCI, V31, P402, DOI 10.1002/jssc.200700292; Lit L, 2011, ANIM COGN, V14, P387, DOI 10.1007/s10071-010-0373-2; Lo YCM, 2008, J ENVIRON QUAL, V37, P521, DOI 10.2134/jeq2006.0382; Lorenzo N, 2003, ANAL BIOANAL CHEM, V376, P1212, DOI 10.1007/s00216-003-2018-7; Macias Michael S., 2008, American Biotechnology Laboratory, V26, P26; MARIN AB, 1992, J AGR FOOD CHEM, V40, P650, DOI 10.1021/jf00016a026; OSMAN A, 1985, J FORENSIC SCI SOC, V25, P377, DOI 10.1016/S0015-7368(85)72417-6; Parker DB, 2012, T ASABE, V55, P2357; PATTON S., 1957, FOOD RES, V22, P316; Porto C. da, 2014, International Journal of Applied Research in Natural Products, V7, P8; Rather M. A., 2011, Journal of Pharmacy Research, V4, P2651; Rice S.K., 2015, THESIS; Rice S, 2015, FORENSIC SCI INT, V257, P257, DOI 10.1016/j.forsciint.2015.08.027; Ross SA, 1996, J NAT PROD, V59, P49, DOI 10.1021/np960004a; Rothschild M, 2005, BOT J LINN SOC, V147, P387, DOI 10.1111/j.1095-8339.2005.00417.x; Vance E, 2008, NATURE, V455, P726, DOI 10.1038/455726a	35	38	39	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144160	10.1371/journal.pone.0144160	http://dx.doi.org/10.1371/journal.pone.0144160			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657499	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903500015
J	Schulz, J; Dumke, J; Hinse, D; Dreier, J; Habig, C; Kemper, N				Schulz, Jochen; Dumke, Jessika; Hinse, Dennis; Dreier, Jens; Habig, Christin; Kemper, Nicole			Organic Turkey Flocks: A Reservoir of Streptococcus gallolyticus subspecies gallolyticus	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; MRSA CC398; BOVIS; STRAINS; ENDOCARDITIS; ASSOCIATION; ENTEROCOCCI; INFECTION; HUMANS; COLI	Streptococcus gallolyticus subspecies gallolyticus (S. gallolyticus) can colonise the gastro-intestinal tract of humans and animals and is known to cause similar infections in both humans and animals. Data about the spread or prevalence in farm animals are missing. In this study, Trypton Soya Agar was modified to a selective medium enabling the isolation and quantification of S. gallolyticus from faecal samples. The bacterium was observed in 82 out of 91 faecal samples obtained from 18 different organic turkey flocks. The prevalence of shedding birds was estimated by the number of positive fresh droppings and reached up to 100% on most farms. Furthermore, for the first time S. gallolyticus was quantified in faeces from poultry flocks. The median of colony forming units (CFU) per gramme faeces was 3.6 x 105CFU/g. Typing of one isolate from each positive faecal sample by multilocus sequence typing delivered 24 sequence types (STs). Most of the isolates belonged to the clonal complex CC58. The same STs of this complex were detected in up to six different flocks. Partly, these flocks were located in various regions and stocked with varying breeding lines. Regarding the biochemical profiles of the same STs from different farms, the results did not contradict a spread of specific STs in the organic turkey production. Moreover, checking the pubMLST database revealed that STs found in this study were also found in other animal species and in humans. The high detection rate and the number of S. gallolyticus in turkey faeces indicate that this bacterium probably belongs to the common microbiota of the gastrointestinal tract of turkeys from organic flocks. Furthermore, the findings of this study support the suggestion of a possible interspecies transmission.	[Dumke, Jessika; Hinse, Dennis; Dreier, Jens] Ruhr Univ Bochum, Inst Lab & Transfus Med, Bad Oeynhausen, Germany	Ruhr University Bochum	Schulz, J (corresponding author), Univ Vet Med Hannover, Inst Anim Hyg Anim Welf & Farm Anim Behav, Hannover, Germany.	jochen.schulz@tiho-hannover.de	Schulz, Jochen/AAA-7340-2021; Dreier, Jens/F-1134-2013	Schulz, Jochen/0000-0002-9747-6763; Dreier, Jens/0000-0002-1337-7750; Kemper, Nicole/0000-0003-0092-4302				Abdulamir AS, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-11; Adejumo, 2014, ADV MICROBIOLOGY, V4, P774, DOI [10.4236/aim.2014.412085, DOI 10.4236/AIM.2014.412085]; Baele M, 2000, VET MICROBIOL, V71, P103, DOI 10.1016/S0378-1135(99)00169-8; Beck M, 2008, J CLIN MICROBIOL, V46, P2966, DOI 10.1128/JCM.00078-08; Boleij A, 2011, J INFECT DIS, V203, P1101, DOI 10.1093/infdis/jiq169; Chadfield MS, 2007, J CLIN MICROBIOL, V45, P822, DOI 10.1128/JCM.00922-06; Christensen N., 2009, Surveillance (Wellington), V36, P13; Cools D, 2001, APPL SOIL ECOL, V17, P53, DOI 10.1016/S0929-1393(00)00133-5; Corredoira J, 2008, CLIN MICROBIOL INFEC, V14, P190, DOI 10.1111/j.1469-0691.2007.01913.x; Cuny C, 2009, INT J MED MICROBIOL, V299, P100; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Devriese LA, 1999, VET MICROBIOL, V70, P87, DOI 10.1016/S0378-1135(99)00124-8; Devriese LA, 1998, J CLIN MICROBIOL, V36, P3520, DOI 10.1128/JCM.36.12.3520-3523.1998; Droual R, 1997, AVIAN PATHOL, V26, P433, DOI 10.1080/03079459708419225; Dumke J, 2014, J CLIN MICROBIOL, V52, P2472, DOI 10.1128/JCM.03329-13; Dumke J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126507; Ellmerich S, 2000, CARCINOGENESIS, V21, P753, DOI 10.1093/carcin/21.4.753; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Giannitsioti E, 2007, CLIN MICROBIOL INFEC, V13, P770, DOI 10.1111/j.1469-0691.2007.01753.x; Habig C, 2013, DGS MAGAZIN, V36, P35; Hinse D, 2011, SYST APPL MICROBIOL, V34, P52, DOI 10.1016/j.syapm.2010.11.010; Hogg R, 2009, VET REC, V165, P297, DOI 10.1136/vetrec.165.10.297-a; Jans C, 2015, INFECT GENET EVOL, V33, P419, DOI 10.1016/j.meegid.2014.09.017; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kimpe A, 2003, AVIAN DIS, V47, P559, DOI 10.1637/6081; Kimpe A, 2002, AVIAN PATHOL, V31, P393, DOI 10.1080/03079450220141679; Kock R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055040; Lin IH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020519; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Marcinakova M, 2005, CZECH J ANIM SCI, V50, P341, DOI 10.17221/4175-CJAS; Martin S.W., 1987, VET EPIDEMIOLOGY PRI; OSAWA R, 1990, APPL ENVIRON MICROB, V56, P3609, DOI 10.1128/AEM.56.11.3609-3611.1990; Poyart C, 2002, INT J SYST EVOL MICR, V52, P1247, DOI 10.1099/00207713-52-4-1247; Sasaki E, 2004, J VET MED SCI, V66, P1467, DOI 10.1292/jvms.66.1467; Schulz J, 2011, AVIAN PATHOL, V40, P243, DOI 10.1080/03079457.2010.544290; Sekizaki T, 2008, AVIAN DIS, V52, P183, DOI 10.1637/8048-070307-Case; Sillanpaa J, 2008, FEMS MICROBIOL LETT, V289, P104, DOI 10.1111/j.1574-6968.2008.01378.x; Snyder ML, 1940, J INFECT DIS, V67, P113, DOI 10.1093/infdis/67.2.113; van den Bogaard AE, 2002, J ANTIMICROB CHEMOTH, V49, P497, DOI 10.1093/jac/49.3.497; Van Hoorebeke S, 2010, PREV VET MED, V94, P94, DOI 10.1016/j.prevetmed.2009.11.022; Welton LA, 1998, ANTIMICROB AGENTS CH, V42, P705, DOI 10.1128/AAC.42.3.705; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924	42	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144412	10.1371/journal.pone.0144412	http://dx.doi.org/10.1371/journal.pone.0144412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657757	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903500027
J	Williams, PH; Byvaltsev, AM; Cederberg, B; Berezin, MV; Odegaard, F; Rasmussen, C; Richardson, LL; Huang, JX; Sheffield, CS; Williams, ST				Williams, Paul H.; Byvaltsev, Alexandr M.; Cederberg, Bjorn; Berezin, Mikhail V.; Odegaard, Frode; Rasmussen, Claus; Richardson, Leif L.; Huang, Jiaxing; Sheffield, Cory S.; Williams, Suzanne T.			Genes Suggest Ancestral Colour Polymorphisms Are Shared across Morphologically Cryptic Species in Arctic Bumblebees	PLOS ONE			English	Article							HYMENOPTERA APIDAE; MITOCHONDRIAL-DNA; MOLECULAR SYSTEMATICS; BARCODES HYMENOPTERA; INTEGRATIVE TAXONOMY; BEES BOMBUS; DELIMITATION; PATTERNS; PHYLOGENY; WORLDWIDE	Our grasp of biodiversity is fine-tuned through the process of revisionary taxonomy. If species do exist in nature and can be discovered with available techniques, then we expect these revisions to converge on broadly shared interpretations of species. But for the primarily arctic bumblebees of the subgenus Alpinobombus of the genus Bombus, revisions by some of the most experienced specialists are unusual for bumblebees in that they have all reached different conclusions on the number of species present. Recent revisions based on skeletal morphology have concluded that there are from four to six species, while variation in colour pattern of the hair raised questions as to whether at least seven species might be present. Even more species are supported if we accept the recent move away from viewing species as morphotypes to viewing them instead as evolutionarily independent lineages (EILs) using data from genes. EILs are recognised here in practice from the gene coalescents that provide direct evidence for their evolutionary independence. We show from fitting both general mixed Yule/coalescent (GMYC) models and Poisson-tree-process (PTP) models to data for the mitochondrial COI gene that there is support for nine species in the subgenus Alpinobombus. Examination of the more slowly evolving nuclear PEPCK gene shows further support for a previously unrecognised taxon as a new species in northwestern North America. The three pairs of the most morphologically similar sister species are separated allopatrically and prevented from interbreeding by oceans. We also find that most of the species show multiple shared colour patterns, giving the appearance of mimicry among parts of the different species. However, reconstructing ancestral colour-pattern states shows that speciation is likely to have cut across widespread ancestral polymorphisms, without or largely without convergence. In the particular case of Alpinobombus, morphological, colour-pattern, and genetic groups show little agreement, which may help to explain the lack of agreement among previous taxonomic revisions.	[Williams, Paul H.; Williams, Suzanne T.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Byvaltsev, Alexandr M.] Novosibirsk State Univ, Dept Gen Biol & Ecol, Novosibirsk 630090, Russia; [Cederberg, Bjorn] Swedish Univ Agr Sci, Swedish Species Informat Ctr, Uppsala, Sweden; [Berezin, Mikhail V.] Moscow Zoo, Entomol Dept Insectarium, Moscow, Russia; [Odegaard, Frode] Norwegian Inst Nat Res, N-7004 Trondheim, Norway; [Rasmussen, Claus] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Richardson, Leif L.] Univ Vermont, Gund Inst Ecol Econ, Burlington, VT USA; [Huang, Jiaxing] Chinese Acad Agr Sci, Minist Agr, Inst Apicultural Res, Key Lab Insect Pollinator Biol, Beijing 100193, Peoples R China; [Sheffield, Cory S.] Royal Saskatchewan Museum, Regina, SK, Canada	Natural History Museum London; Novosibirsk State University; Swedish University of Agricultural Sciences; Norwegian Institute Nature Research; Aarhus University; University of Vermont; Chinese Academy of Agricultural Sciences; Institute of Apicultural Research, CAAS; Ministry of Agriculture & Rural Affairs	Williams, PH (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.	paw@nhm.ac.uk	Rasmussen, Claus/J-6714-2012; Rasmussen, Claus/X-4760-2019; Sheffield, Cory/I-4812-2019; Byvaltsev, Alexandr M/B-9961-2017; Williams, Suzanne T/A-9604-2008; Byvaltsev, Alexandr/Q-4549-2019	Rasmussen, Claus/0000-0003-1529-6548; Sheffield, Cory/0000-0003-0603-7333; Williams, Suzanne T/0000-0003-2995-5823; Byvaltsev, Alexandr/0000-0001-6555-5646	Grant of the President of the Russian Federation [MK-6176.2015.4]; Saskatchewan Ministry of Agriculture; Canada-Saskatchewan Growing Forward 2 bi-lateral agreement [20130112]; Carlsberg Foundation [2009-01-0534, 2011-01-0463]; Research Council of Norway [266134/F50]; Norwegian Biodiversity Information Centre [70184209]; Taxonomy Initiative of the Norwegian Biodiversity Information Centre [70184228]; Agricultural Science and Technology Innovation Program, China [CAAS-ASTIP-2015-IAR]; National Science Foundation [NSF-DBI 0956388, NSF-DBI 0956340]; Direct For Biological Sciences [0956340] Funding Source: National Science Foundation	Grant of the President of the Russian Federation; Saskatchewan Ministry of Agriculture; Canada-Saskatchewan Growing Forward 2 bi-lateral agreement; Carlsberg Foundation(Carlsberg Foundation); Research Council of Norway(Research Council of Norway); Norwegian Biodiversity Information Centre; Taxonomy Initiative of the Norwegian Biodiversity Information Centre; Agricultural Science and Technology Innovation Program, China; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The database of species' distributions in Russia was created with the financial support from a Grant of the President of the Russian Federation for young Russian scientists (grant MK-6176.2015.4) (to AB). DNA barcodes for some of the material were funded by the Saskatchewan Ministry of Agriculture and the Canada-Saskatchewan Growing Forward 2 bi-lateral agreement (grant 20130112) (to CS). Work in Greenland was supported by the Carlsberg Foundation (grants 2009-01-0534 and 2011-01-0463) (to CR). DNA barcodes for some of the Norwegian material were funded by the Research Council of Norway (grant 266134/F50) and the Norwegian Biodiversity Information Centre (grant 70184209). The Norwegian part of the project was funded by the Taxonomy Initiative of the Norwegian Biodiversity Information Centre (grant 70184228) (to FO). DNA sequencing for some of the material was funded by the Agricultural Science and Technology Innovation Program, China (grant CAAS-ASTIP-2015-IAR) (to JH). Part of the database of species' distributions in North America was created with financial support from grants from the National Science Foundation to John Ascher, Douglas Yanega, and Jerome Rozen (grants NSF-DBI 0956388 and NSF-DBI 0956340) (to LR). The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors received no specific funding for this work.	Ackery PR, 1984, MILKWEED BUTTERFLIES; Barrio IC, 2013, ARCTIC, V66, P429; BARROWCLOUGH GF, 1982, AUK, V99, P601; Baum D, 2012, TREE THINKING INTRO; Bertsch A, 2005, INSECT SOC, V52, P45, DOI 10.1007/s00040-004-0761-1; Bertsch Andreas, 2004, Beitraege zur Entomologie, V54, P365; Bolton Barry, 2007, Memoirs of the American Entomological Institute (Gainesville), V80, P52; Brigham-Grette J, 2001, QUATERNARY SCI REV, V20, P15, DOI 10.1016/S0277-3791(00)00134-7; Cameron SA, 2007, BIOL J LINN SOC, V91, P161, DOI 10.1111/j.1095-8312.2007.00784.x; Cardoso A, 2009, MOL ECOL, V18, P648, DOI 10.1111/j.1365-294X.2008.04048.x; Carolan JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029251; Cristiano MP, 2012, APIDOLOGIE, V43, P527, DOI 10.1007/s13592-012-0122-4; De Meulemeester T, 2012, APPROCHE INTEGRATIVE; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duennes MA, 2012, MOL PHYLOGENET EVOL, V64, P219, DOI 10.1016/j.ympev.2012.03.018; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Elias SA, 2013, ENCY QUATERNARY SCI, P191, DOI DOI 10.1016/B978-0-444-53643-3.00116-3; Estoup A, 1996, MOL ECOL, V5, P19, DOI 10.1111/j.1365-294X.1996.tb00288.x; Friese H., 1910, Zoologische Jahrbuecher Jena Abteilungen f Systematik, V29; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gjershaug JO, 2013, ZOOTAXA, V3716, P431, DOI 10.11646/zootaxa.3716.3.6; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hines HM, 2008, SYST BIOL, V57, P58, DOI 10.1080/10635150801898912; Hines HM, 2012, ZOOL J LINN SOC-LOND, V166, P805, DOI 10.1111/j.1096-3642.2012.00861.x; Huang JX, 2015, APIDOLOGIE, V46, P250, DOI 10.1007/s13592-014-0319-9; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurd P. D. Jr., 1979, Catalog of Hymenoptera in America north of Mexico. Volume 2. Apocrita (Aculeata)., P1741; International Commission on Zoological Nomenclature (ICZN), 1999, INT CODE ZOOLOGICAL; Kronforst MR, 2012, PIGM CELL MELANOMA R, V25, P411, DOI 10.1111/j.1755-148X.2012.01014.x; Kruger E., 1951, Teil Tijdschr Ent Amsterdam, V93, P141; Lecocq T, 2015, APIDOLOGIE; Lecocq T, 2014, ANIMAL CONSERVATION; Lecocq T, 2015, ZOOL SCR, V44, P281, DOI 10.1111/zsc.12107; Lecocq T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-263; Leliaert F, 2014, EUR J PHYCOL, V49, P179, DOI 10.1080/09670262.2014.904524; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; LOKEN A, 1973, Norsk Entomologisk Tidsskrift, V20, P1; Maddison, 2018, MESQUITE MODULAR SYS; Maddison D. R., 2000, MACCLADE 4 ANAL PHYL; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Magnacca KN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-174; Mallet J., 1997, TRENDS ECOL EVOL, V12, P453, DOI DOI 10.1016/S0169-5347(97)85758-8; Mayr E., 1963, ANIMAL SPECIES EVOLU; Michener C. D., 2007, BEES WORLD; MILLIRON HE, 1973, MEM ENTOMOL SOC CAN, P81, DOI 10.4039/entm10589fv; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Monaghan MT, 2005, PHILOS T R SOC B, V360, P1925, DOI 10.1098/rstb.2005.1724; Neumeyer R, 2014, ZOOKEYS, P67, DOI 10.3897/zookeys.400.6611; Pamilo P, 1997, ENTOMOL FENNICA, V7, P187, DOI 10.33338/ef.83908; PANFILOV D. V., 1960, BIULL MOSKOV OBSHCHESTVA ISPYTATELEI PRIRODY OTDEL BIOL, V65, P53; Papadopoulou A, 2008, PHILOS T R SOC B, V363, P2987, DOI 10.1098/rstb.2008.0066; Paterson H.E.H., 1985, Transvaal Museum Monograph, P21; PEKKARINEN A, 1979, Acta Zoologica Fennica, P1; Pittioni B, 1939, KONOWIA, V17, P244; PLOWRIGHT RC, 1980, EVOLUTION, V34, P622, DOI 10.2307/2408017; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Pringle H, 2014, SCIENCE, V343, P961, DOI 10.1126/science.343.6174.961; Radoszkowski O., 1884, B MOSKOVSKOGO OBSHCH, V59, P51; Rapti Z, 2014, BIOL J LINN SOC, V113, P384, DOI 10.1111/bij.12356; RASMONT P, 1984, Spixiana, V7, P135; Rasmont P., 1983, NOTES FAUNIQUES GEMB, V7, P1; Rasmont P, 2008, ANN SOC ENTOMOL FR, V44, P243, DOI 10.1080/00379271.2008.10697559; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; REINIG W F, 1981, Spixiana, V4, P159; Reinig WF, 1935, J GENET, V30, P321, DOI 10.1007/BF02982243; Reinig WF, 1939, VERHANDLUNGEN DTSCH, V12, P170; RICHARDS K W, 1973, Quaestiones Entomologicae, V9, P115; Richards O. W., 1931, TROMSO MUSEUMS ARSHE, V50, P1; Richards OW, 1929, P ROYAL ENTOMOLOGICA, V3, P75; Rougerie R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101108; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Skorikov A. S., 1937, Entomologiske Meddelelser, V20, P37; Skorikov A. S., 1931, ABHANDLUNGEN PAMIR E, P175; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Strange JP, 2009, APIDOLOGIE, V40, P134, DOI 10.1051/apido/2008070; SVENSSON BG, 1979, ENTOMOL SCAND, V10, P275; SVENSSON BG, 1977, ZOON, V5, P63; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terzo M, 2005, APIDOLOGIE, V36, P85, DOI 10.1051/apido:2004072; Tkalcu B., 1968, Annotationes Zoologicae et Botanicae Bratislava, VNo. 52, P1; TKALCU B, 1989, ACTA ENTOMOL BOHEMOS, V86, P39; Vogt O., 1909, SITZUNGSBERICHTE GES, V1909, P28; Vogt Oskar, 1911, Sitzungsberichte der Gesellschaft Naturforschender Freunde zu Berlin, V1911; von Dalla Torre KW, 1880, NATURHISTORIKER, V2, P40; Williams P.H., 1991, Bulletin of the British Museum (Natural History) Entomology, V60, P1; Williams P, 2007, BIOL J LINN SOC, V92, P97, DOI 10.1111/j.1095-8312.2007.00878.x; Williams PH, 2013, APIDOLOGIE, V44, P121, DOI 10.1007/s13592-012-0161-x; Williams PH, 2012, SYST BIODIVERS, V10, P21, DOI 10.1080/14772000.2012.664574; Williams PH, 2011, ZOOL J LINN SOC-LOND, V163, P813, DOI 10.1111/j.1096-3642.2011.00729.x; Williams Paul H., 2010, Insecta Matsumurana, V66, P115; Williams PH, 2008, APIDOLOGIE, V39, P637, DOI 10.1051/apido:2008048; Williams Paul H., 1998, Bulletin of the Natural History Museum Entomology Series, V67, P79; Williams PH, 1997, P ROY SOC B-BIOL SCI, V264, P141, DOI 10.1098/rspb.1997.0021; Williams PH, 2014, BUMBLE BEES N AM IDE; Williams ST, 2006, MOL PHYLOGENET EVOL, V39, P33, DOI 10.1016/j.ympev.2005.12.017; WILSON EO, 1953, SYST ZOOL, V2, P97, DOI 10.2307/2411818; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zink RM, 2004, P ROY SOC B-BIOL SCI, V271, P561, DOI 10.1098/rspb.2003.2617; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	105	15	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144544	10.1371/journal.pone.0144544	http://dx.doi.org/10.1371/journal.pone.0144544			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657658	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000366903500037
J	Wang, JW; Lin, GT; Alwaal, A; Zhang, XY; Wang, GF; Jia, XY; Banie, L; Villalta, J; Lin, CS; Lue, TF				Wang, Jianwen; Lin, Guiting; Alwaal, Amjad; Zhang, Xiaoyu; Wang, Guifang; Jia, Xingyuan; Banie, Lia; Villalta, Jacqueline; Lin, Ching-Shwun; Lue, Tom F.			Kinetics of Label Retaining Cells in the Developing Rat Kidneys	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; FILAMENT PROTEIN NESTIN; STEM-CELLS; STEM/PROGENITOR CELLS; ADULT KIDNEY; PROGENITOR CELLS; PROXIMAL TUBULE; LINEAGE; MARKER; DIFFERENTIATION	Background The kidney is a specialized low-regenerative organ with several different types of cellular lineages. The BrdU label-retaining cell (LRCs) approach has been used as part of a strategy to identify tissue-specific stem cells in the kidney; however, because the complementary base pairing in double-stranded DNA blocks the access of the anti-BrdU antibody to BrdU subunits, the stem cell marker expression in BrdU-labeled cells are often difficult to detect. In this study, we introduced a new cell labeling and detection method in which BrdU was replaced with 5-ethynyl-2-deoxyuridine (EdU) and examined the time-dependent dynamic changes of EdU-labeled cells and potential stem/progenitor markers in the development of kidney. Methods Newborn rats were intraperitoneally injected with EdU, and their kidneys were harvested respectively at different time points at 1 day, 3 days, 1 week, 2 weeks, and 6 weeks post-injection. The kidney tissues were processed for EdU and cellular markers by immunofluorescence staining. Results At the early stage, LRCs labeled by EdU were 2176.0 +/- 355.6 cells at day one in each renal tissue section, but dropped to 168 +/- 48.4 cells by week 6. As time increased, the numbers of LRCs were differentially expressed in the renal cortex and papilla. At the postnatal day one, nearly twice as many cells in the cortex were EdU-labeled as compared to the papilla (28.6 +/- 3.6% vs. 15.6 +/- 3.4%, P<0.05), while there were more LRCs within the renal papilla since the postnatal week one, and at the postnatal week 6, one third as many cells in the cortex were EdU-labeled as compared to the papilla (2.5 +/- 0.1% vs. 7.7 +/- 2.7%, P<0.05). The long-term LRCs at 6-week time point were associated exclusively with the glomeruli in the cortex and the renal tubules in the papilla. At 6 weeks, the EdU-labeled LRCs combined with expression of CD34, RECA-1, Nestin, and Synaptopodin were discretely but widely distributed within the glomeruli; Stro-1 around the glomeruli; and alpha-smooth muscle actin (SMA) in arteries. Conversely, co-expression of CD34, RECA-1, and Nestin with the long term EdU-labeled LRCs was significantly lower in renal tubules (P<0.01), while Stro-1 and Synaptopodin were not detected. Conclusion Our data found that at 6-week time point, EdU-labeled LRCs existing in the glomeruli expressed undifferentiated podocyte and endothelial markers at high rates, while those in the renal tubules expressed Nestin and vascular markers at low rates. To understand the characterization and localization of these EdU-LRCs, further studies will be needed to test cell lineage tracing, clonogenicity and differentiation potency, and the contributions to the regeneration of the kidney in response to renal injury/repair.	[Wang, Jianwen; Jia, Xingyuan] Capital Med Univ, Beijing ChaoYang Hosp, Dept Urol, Beijing 100020, Peoples R China; [Wang, Jianwen; Lin, Guiting; Alwaal, Amjad; Zhang, Xiaoyu; Wang, Guifang; Banie, Lia; Villalta, Jacqueline; Lin, Ching-Shwun; Lue, Tom F.] Univ Calif San Francisco, Sch Med, Dept Urol, Knuppe Mol Urol Lab, San Francisco, CA 94143 USA	Capital Medical University; University of California System; University of California San Francisco	Wang, JW (corresponding author), Capital Med Univ, Beijing ChaoYang Hosp, Dept Urol, 8 Gongtinanlu, Beijing 100020, Peoples R China.	wjianw99@sina.cn	Zhang, xiaoyu/GXA-3206-2022					Aggarwal S, 2013, STEM CELL TRANSL MED, V2, P1011, DOI 10.5966/sctm.2013-0097; Barker N, 2012, CELL REP, V2, P540, DOI 10.1016/j.celrep.2012.08.018; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bertram JF, 2000, ANAT REC, V258, P128; Bickenbach JR, 1998, EXP CELL RES, V244, P184, DOI 10.1006/excr.1998.4163; Blanpain C, 2013, NAT REV MOL CELL BIO, V14, P489, DOI 10.1038/nrm3625; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; Chen J, 2006, J AM SOC NEPHROL, V17, P1283, DOI 10.1681/ASN.2005101032; Dekel B, 2006, J AM SOC NEPHROL, V17, P3300, DOI 10.1681/ASN.2005020195; DUIJVESTIJN AM, 1992, LAB INVEST, V66, P459; Duvillie B, 2003, DIABETES, V52, P2035, DOI 10.2337/diabetes.52.8.2035; Florek M, 2005, CELL TISSUE RES, V319, P15, DOI 10.1007/s00441-004-1018-z; Gangenahalli GU, 2006, STEM CELLS DEV, V15, P305, DOI 10.1089/scd.2006.15.305; Humphreys BD, 2011, P NATL ACAD SCI USA, V108, P9226, DOI 10.1073/pnas.1100629108; Kim K, 2008, INT J CLIN EXP PATHO, V1, P232; Kitamura S, 2015, STEM CELLS, V33, P774, DOI 10.1002/stem.1891; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; Langworthy M, 2009, J AM SOC NEPHROL, V20, P311, DOI 10.1681/ASN.2008010094; Lasagni L, 2010, J AM SOC NEPHROL, V21, P1612, DOI 10.1681/ASN.2010010048; Lin CS, 2012, CYTOTHERAPY, V14, P1159, DOI 10.3109/14653249.2012.729817; Lin GT, 2015, STEM CELLS DEV, V24, P264, DOI 10.1089/scd.2014.0360; Lin GT, 2012, CYTOTHERAPY, V14, P240, DOI 10.3109/14653249.2011.627918; Lin GT, 2011, STEM CELLS DEV, V20, P1747, DOI 10.1089/scd.2010.0564; Lin GT, 2009, CYTOTHERAPY, V11, P864, DOI 10.3109/14653240903180084; Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131; Lopez MLSS, 2004, DEV CELL, V6, P719; Macconi D, 2009, AM J PATHOL, V174, P797, DOI 10.2353/ajpath.2009.080227; Maeshima Akito, 2007, Clin Exp Nephrol, V11, P269, DOI 10.1007/s10157-007-0500-9; Maeshima A, 2006, J AM SOC NEPHROL, V17, P188, DOI 10.1681/ASN.2005040370; McCampbell KK, 2012, BIOCHEM J, V444, P153, DOI 10.1042/BJ20120176; Mora CF, 2012, STEM CELLS DEV, V21, P296, DOI 10.1089/scd.2010.0470; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; NARBAITZ R, 1991, ANAT EMBRYOL, V183, P353; Ning HX, 2011, BIOCHEM BIOPH RES CO, V413, P353, DOI 10.1016/j.bbrc.2011.08.104; Oliver JA, 2004, J CLIN INVEST, V114, P795, DOI 10.1172/JCI200420921; Oliver JA, 2009, J AM SOC NEPHROL, V20, P2315, DOI 10.1681/ASN.2008111203; Patschan D, 2007, KIDNEY INT, V71, P744, DOI 10.1038/sj.ki.5002102; Pippin JW, 2013, AM J PATHOL, V183, P542, DOI 10.1016/j.ajpath.2013.04.024; Rakic P, 2002, NAT REV NEUROSCI, V3, P65, DOI 10.1038/nrn700; Romagnani P, 2015, NAT REV NEPHROL, V11, P420, DOI 10.1038/nrneph.2015.67; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Shkreli M, 2012, NAT MED, V18, P111, DOI 10.1038/nm.2550; Stern CD, 2001, NAT CELL BIOL, V3, pE216, DOI 10.1038/ncb0901-e216; Tsuji K, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/537204; Vogetseder A, 2005, HISTOCHEM CELL BIOL, V124, P97, DOI 10.1007/s00418-005-0023-y; Wagner N, 2006, AM J PHYSIOL-REG I, V291, pR779, DOI 10.1152/ajpregu.00219.2006; Ward HH, 2011, BBA-MOL BASIS DIS, V1812, P1344, DOI 10.1016/j.bbadis.2011.01.010; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Zhang H, 2012, UROLOGY, V79, DOI [10.1016/j.urology.2011.10.051, DOI 10.1016/J.UROL0GY.2011.10.051]; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589; Zou J, 2006, VIRCHOWS ARCH, V448, P485, DOI 10.1007/s00428-005-0134-9	52	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144734	10.1371/journal.pone.0144734	http://dx.doi.org/10.1371/journal.pone.0144734			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650841	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903300072
J	Azzoni, L; Barbour, R; Papasavvas, E; Glencross, DK; Stevens, WS; Cotton, MF; Violari, A; Montaner, LJ				Azzoni, Livio; Barbour, Russell; Papasavvas, Emmanouil; Glencross, Deborah K.; Stevens, Wendy S.; Cotton, Mark F.; Violari, Avy; Montaner, Luis J.			Early ART Results in Greater Immune Reconstitution Benefits in HIV-Infected Infants: Working with Data Missingness in a Longitudinal Dataset	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; T-CELL-ACTIVATION; MICROBIAL TRANSLOCATION; INTERLEUKIN-7 LEVELS; PLASMA-LEVELS; CHILDREN; RECOVERY; SUBSETS; RESPONSES; PREDICT	Background Early initiation of anti-retroviral treatment (ART) decreases mortality as compared to deferred treatment, but whether it preserves immune cells from early loss or promotes their recovery remains undefined. Determination of complex immunological endpoints in infants is often marred by missing data due to missed visits and/or inadequate sampling. Specialized methods are required to address missingness and facilitate data analysis. Methods We characterized the changes in cellular and humoral immune parameters over the first year of life in 66 HIV-infected infants (0-1 year of age) enrolled in the CHER study starting therapy within 12 weeks of birth (n = 42) or upon disease progression (n = 24). A convenience cohort of 23 uninfected infants aged 0-6 months born to mothers with HIV-1 infection was used as controls. Flow cytometry and ELISA were used to evaluate changes in natural killer (NK) cells, plasmacytoid dendritic cells (pDC), and CD4(+) or CD8(+) T-cell frequencies. Data missingness was assessed using Little's test. Complete datasets for analysis were created using Multiple Imputation (MI) or Bayesian modeling and multivariate analysis was conducted on the imputed datasets. Results HIV-1-infected infants had greater frequency of CD4(+) T cells with naive phenotype, as well as higher serum IL-7 levels than HIV exposed/uninfected infants. The elevated data missingness was completely at random, allowing the use of both MI and Bayesian modeling. Both methods indicate that early ART initiation results in higher CD4(+) T cell frequency, lower expression of CD95 in CD8(+) T cell, and preservation of naive T cell subsets. In contrast, innate immune effectors appeared to be similar independently of the timing of ART initiation. Conclusions Early ART initiation in infants with perinatal HIV infection reduces immune activation and preserves an early expansion of naive T-cells with undiminished innate cell numbers, giving greater immune reconstitution than achieved with deferred ART. Both statistical approaches concurred in this finding.	[Azzoni, Livio; Papasavvas, Emmanouil; Montaner, Luis J.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Barbour, Russell] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Glencross, Deborah K.; Stevens, Wendy S.] Univ Witwatersrand, Dept Mol Med & Hematol, Johannesburg, South Africa; [Glencross, Deborah K.; Stevens, Wendy S.] Natl Hlth Lab Serv, Johannesburg, South Africa; [Cotton, Mark F.] Univ Stellenbosch, Dept Paediat & Child Hlth, Childrens Infect Dis Clin Res Unit, Cape Town, South Africa; [Violari, Avy] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa	The Wistar Institute; Yale University; University of Witwatersrand; National Health Laboratory Service; Stellenbosch University; University of Witwatersrand	Montaner, LJ (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	Montaner@wistar.org	Cotton, Mark/AAQ-9936-2020	Cotton, Mark/0000-0003-2559-6034; Glencross, Deborah/0000-0001-7106-769X	National Institute of Allergy and Infectious Disease (NIAID) [AI062512]; Philadelphia Foundation (Robert I. Jacobs Fund); Stengel-Miller family; Commonwealth of Pennsylvania; Commonwealth Universal Research Enhancement Program; Pennsylvania Department of Health; National Cancer Institute Wistar Cancer Center [P30 CA10815]; NIMH [5P30MH062294-12]; Center for Interdisciplinary Research on AIDS; National Institute of Allergy and Infectious Diseases (NIAID) of the US National Institutes for Health (NIH), through the Comprehensive International Program of Research on AIDS (CIPRA) network [U19 AI53217]; Departments of Health of the Western Cape; Gauteng, South Africa; GlaxoSmithKline plc; Dean of Yale's School of Public Health; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI053217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Philadelphia Foundation (Robert I. Jacobs Fund); Stengel-Miller family; Commonwealth of Pennsylvania; Commonwealth Universal Research Enhancement Program; Pennsylvania Department of Health; National Cancer Institute Wistar Cancer Center; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Center for Interdisciplinary Research on AIDS; National Institute of Allergy and Infectious Diseases (NIAID) of the US National Institutes for Health (NIH), through the Comprehensive International Program of Research on AIDS (CIPRA) network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Departments of Health of the Western Cape; Gauteng, South Africa; GlaxoSmithKline plc(GlaxoSmithKline); Dean of Yale's School of Public Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was primarily supported by a grant to L.J. Montaner by the National Institute of Allergy and Infectious Disease (NIAID AI062512, www.niaid.nih.gov). Additional support was provided by The Philadelphia Foundation (Robert I. Jacobs Fund), https://www.philafound.org; The Stengel-Miller family, AIDS funds from the Commonwealth of Pennsylvania and from the Commonwealth Universal Research Enhancement Program (www.portal.state.pa.us/portal/server.pt/community/health_research_program_cure/14189), Pennsylvania Department of Health (www.health.pa.gov), as well as by the National Cancer Institute Wistar Cancer Center Grant (P30 CA10815, www.cancer.gov/). Dr. Barbour's work was supported by NIMH grant 5P30MH062294-12 (https://www.nimh.nih.gov) to Paul Cleary, Dean of Yale's School of Public Health. This grant supports the Center for Interdisciplinary Research on AIDS. Support for the CIPRA-SA CHER study was provided by the National Institute of Allergy and Infectious Diseases (NIAID, www.niaid.nih.gov) of the US National Institutes for Health (NIH), through the Comprehensive International Program of Research on AIDS (CIPRA) network, grant number U19 AI53217. The Departments of Health of the Western Cape (https://www.westerncape.gov.za/dept/health) and Gauteng (www.health.gpg.gov.za), South Africa and GlaxoSmithKline plc (www.gsk.com) provided additional support. The CIPRA-SA CHER study was conducted under the supervision of the USA Food and Drug Administration (IND n. 71494). The content of this publication does not necessarily reflect the views or policies of NIAID, nor does mention of trade names, commercial projects, or organizations imply endorsement by the US Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2005, BLOOD, V106, P3366, DOI 10.1182/blood-2005-03-1100; Anselmi A, 2007, CLIN EXP IMMUNOL, V150, P442, DOI 10.1111/j.1365-2249.2007.03526.x; Azzoni L, 2005, J INFECT DIS, V191, P1451, DOI 10.1086/429300; Azzoni L, 2002, J IMMUNOL, V168, P5764, DOI 10.4049/jimmunol.168.11.5764; Azzoni L, 2007, AIDS, V21, P293, DOI 10.1097/QAD.0b013e328012b85f; Blackwell M, 2017, SOCIOL METHOD RES, V46, P342, DOI 10.1177/0049124115589052; Blanco A, 2008, J IMMUNOL, V180, P530, DOI 10.4049/jimmunol.180.1.530; BONAGURA VR, 1992, J PEDIATR-US, V121, P195, DOI 10.1016/S0022-3476(05)81187-4; Boulassel MR, 2007, VIRAL IMMUNOL, V20, P649, DOI 10.1089/vim.2007.0047; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Cagigi A, 2014, PEDIATR INFECT DIS J, V33, pE126, DOI 10.1097/INF.0000000000000144; Chehimi J, 2002, J IMMUNOL, V168, P4796, DOI 10.4049/jimmunol.168.9.4796; Chiappini E, 2003, JAIDS-J ACQ IMM DEF, V33, P601, DOI 10.1097/00126334-200308150-00008; Coetzee LM, 2009, CYTOM PART B-CLIN CY, V76B, P375, DOI 10.1002/cyto.b.20478; Correa R, 2003, J CLIN IMMUNOL, V23, P401, DOI 10.1023/A:1025325718213; Cotton MF, 2013, LANCET, V382, P1555, DOI 10.1016/S0140-6736(13)61409-9; Crawly M., 2005, STAT INTRO USING R; DeSouza CM, 2009, J BIOPHARM STAT, V19, P1055, DOI 10.1080/10543400903242795; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gorelick MH, 2006, J CLIN EPIDEMIOL, V59, P1115, DOI 10.1016/j.jclinepi.2004.11.029; Holmes TH, 2014, J IMMUNOL METHODS, V414, P32, DOI 10.1016/j.jim.2014.08.001; Honaker J, 2011, J STAT SOFTW, V45, P1; Honaker J, 2010, AM J POLIT SCI, V54, P561, DOI 10.1111/j.1540-5907.2010.00447.x; Imai K, 2008, J COMPUT GRAPH STAT, V17, P892, DOI 10.1198/106186008X384898; Jordan KA, 2006, VIROLOGY, V347, P117, DOI 10.1016/j.virol.2005.12.002; Kaambwa Billingsley, 2012, BMC Res Notes, V5, P330, DOI 10.1186/1756-0500-5-330; Kopka J, 2005, J CLIN VIROL, V33, P237, DOI 10.1016/j.jcv.2004.11.014; Le J, 2014, THER DRUG MONIT, V36, P510, DOI 10.1097/FTD.0000000000000039; Little R. J. A., 1987, STAT ANAL MISSING DA; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Little TD, 2014, J PEDIATR PSYCHOL, V39, P151, DOI 10.1093/jpepsy/jst048; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Madhi SA, 2010, J INFECT DIS, V202, P355, DOI 10.1086/653704; Mansoor N, 2009, CLIN IMMUNOL, V130, P280, DOI 10.1016/j.clim.2008.09.006; Mansourian M, 2014, J TROP PEDIATRICS, V60, P61, DOI 10.1093/tropej/fmt078; Mason A, 2012, BAYESIAN ANAL, V7, P109, DOI 10.1214/12-BA704; Newell M-L, 1994, PEDIATRICS, V94, P815; Owen MJ, 2013, EVERYONES STAT SOFTW; Papasavvas E, 2011, PEDIATR INFECT DIS J, V30, P877, DOI 10.1097/INF.0b013e31821d141e; Pensierosoa S, 2009, P NATL ACAD SCI USA, V106, P7939, DOI 10.1073/pnas.0901702106; PLAEGERMARSHALL S, 1994, CLIN IMMUNOL IMMUNOP, V71, P19, DOI 10.1006/clin.1994.1046; Rainwater-Lovett K, 2014, JAIDS-J ACQ IMM DEF, V67, P455, DOI 10.1097/QAI.0000000000000342; Resino S, 2006, J ANTIMICROB CHEMOTH, V57, P798, DOI 10.1093/jac/dkl032; Resino S, 2001, CLIN EXP IMMUNOL, V125, P266, DOI 10.1046/j.1365-2249.2001.01612.x; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Rosso R, 2010, SCAND J IMMUNOL, V71, P45, DOI 10.1111/j.1365-3083.2009.02345.x; Rubin D, 2008, MULTIPLE IMPUTATION; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Ruel T, 2009, CLIN IMMUNOL, V131, P410, DOI 10.1016/j.clim.2009.01.016; Sharland M, 2002, HIV Med, V3, P215, DOI 10.1046/j.1468-1293.2002.00120.x; Simani OE, 2014, AIDS, V28, P531, DOI 10.1097/QAD.0000000000000127; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Ssewanyana I, 2009, AIDS RES HUM RETROV, V25, P65, DOI 10.1089/aid.2008.0138; Steyerberg EW, 2007, J CLIN EPIDEMIOL, V60, P979, DOI 10.1016/j.jclinepi.2007.03.003; Tobin NH, 2014, CURR HIV-AIDS REP, V11, P1, DOI 10.1007/s11904-013-0189-1; VOICULESCU C, 1994, FEMS IMMUNOL MED MIC, V9, P217, DOI 10.1111/j.1574-695X.1994.tb00496.x; Wallet MA, 2010, AIDS, V24, P1281, DOI 10.1097/QAD.0b013e328339e228; White IR, 2010, STAT MED, V29, P2920, DOI 10.1002/sim.3944; Wiens JJ, 2008, J SYST EVOL, V46, P307, DOI 10.3724/SP.J.1002.2008.08040; Woodward P, 2005, J STAT SOFTW, V14; Woodward P, 2011, BAYESIAN ANAL MADE S; Xiao L, 2014, J AM STAT ASSOC, V109, P1, DOI 10.1080/01621459.2013.830070; Ye P, 2004, CURR HIV RES, V2, P177, DOI 10.2174/1570162043484898; Ziegner U, 1999, CLIN DIAGN LAB IMMUN, V6, P718, DOI 10.1128/CDLI.6.5.718-724.1999	65	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145320	10.1371/journal.pone.0145320	http://dx.doi.org/10.1371/journal.pone.0145320			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671450	Green Published, gold			2022-12-27	WOS:000366719300058
J	Hayden, B; Soto, DX; Jardine, TD; Graham, BS; Cunjak, RA; Romakkaniemi, A; Linnansaari, T				Hayden, Brian; Soto, David X.; Jardine, Tim D.; Graham, Brittany S.; Cunjak, Richard A.; Romakkaniemi, Atso; Linnansaari, Tommi			Small Tails Tell Tall Tales - Intra-Individual Variation in the Stable Isotope Values of Fish Fin	PLOS ONE			English	Article							AQUATIC FOOD WEBS; CARBON; NITROGEN; DELTA-C-13; HYDROGEN; RATIOS; SCALES; DIET; GROWTH; TISSUE	Background Fish fin is a widely used, non-lethal sample material in studies using stable isotopes to assess the ecology of fishes. However, fish fin is composed of two distinct tissues (ray and membrane) which may have different stable isotope values and are not homogeneously distributed within a fin. As such, estimates of the stable isotope values of a fish may vary according to the section of fin sampled. Methods To assess the magnitude of this variation, we analysed carbon (delta C-13), nitrogen (delta N-15), hydrogen (delta H-2) and oxygen (delta O-18) stable isotopes of caudal fin fromjuvenile, riverine stages of Atlantic salmon (Salmo salar) and brown trout (Salmo trutta). Individual fins were sub-sectioned into tip, mid and base, of which a further subset were divided into ray and membrane. Findings Isotope variation between fin sections, evident in all four elements, was primarily related to differences between ray and membrane. Base sections were(13)C depleted relative to tip (similar to 1 %) with equivalent variation evident between ray and membrane. A similar trend was evident in delta H-2, though the degree of variation was far greater (similar to 10%). Base and ray sections were O-18 enriched (similar to 2%) relative to tip and membrane, respectively. Ray and membrane sections displayed longitudinal variation in N-15 mirroring that of composite fin (similar to 1%), indicating that variation in(15)N values was likely related to ontogenetic variation. Conclusions To account for the effects of intra-fin variability in stable isotope analyses we suggest that researchers sampling fish fin, in increasing priority, 1) also analyse muscle (or liver) tissue from a subsample of fish to calibrate their data, or 2) standardize sampling by selecting tissue only from the extreme tip of a fin, or 3) homogenize fins prior to analysis.	[Hayden, Brian; Soto, David X.; Jardine, Tim D.; Graham, Brittany S.; Cunjak, Richard A.; Linnansaari, Tommi] Univ New Brunswick, Dept Biol, New Brunswick, NB E3B 5A3, Canada; [Soto, David X.] Environm Canada, Saskatoon, SK, Canada; [Jardine, Tim D.] Univ Saskatchewan, Toxicol Ctr, Sch Environm & Sustainabil, Saskatoon, SK, Canada; [Graham, Brittany S.] Natl Inst Water & Atmospher Res NIWA, Wellington, New Zealand; [Romakkaniemi, Atso] Nat Resources Inst Finland, Oulu, Finland	University of New Brunswick; Environment & Climate Change Canada; University of Saskatchewan; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Natural Resources Institute Finland (Luke)	Hayden, B (corresponding author), Univ New Brunswick, Dept Biol, New Brunswick, NB E3B 5A3, Canada.	brian.hayden@unb.ca	Soto, David X./B-2017-2018; Jardine, Timothy Donald/AFZ-4837-2022	Soto, David X./0000-0003-4210-293X; Jardine, Timothy/0000-0002-5917-9792	Finnish-Swedish Transboundary River Commission [A 13/7]; Canadian Research Chair [1-132477-45-01]; NSERC [1-50006-40-01]	Finnish-Swedish Transboundary River Commission; Canadian Research Chair(Canada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by the Finnish-Swedish Transboundary River Commission (grant number: A 13/7) to AR and TL and by Canadian Research Chair (grant number: 1-132477-45-01) and NSERC Discovery (grant number: 1-50006-40-01) grants to RAC. The authors are indebted to the technical staff of the Natural Resources Institute Finland who assisted during field sampling, and the technical staff of the Stable Isotopes in Nature Laboratory who prepared and analysed the samples.; This work was funded by the Finnish-Swedish Transboundary River Commission (grant number: A 13/7) to AR and TL and by Canadian Research Chair (grant number: 1-132477-45-01) and NSERC Discovery (grant number: 1-550006-40-01) grants to RAC. The authors are indebted to the technical staff of the Natural Resources Institute Finland who assisted during field sampling, and the technical staff of the Stable Isotopes in Nature Laboratory who prepared and analysed the samples.	[Anonymous], 2014, R LANG ENV STAT COMP; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Cable J, 2011, HYDROL PROCESS, V25, P2228, DOI 10.1002/hyp.7982; Cano-Rocabayera O, 2015, ENVIRON BIOL FISH, V98, P925, DOI 10.1007/s10641-014-0328-6; Cherel Y, 2009, BIOL LETTERS, V5, P830, DOI 10.1098/rsbl.2009.0552; Cole JJ, 2011, P NATL ACAD SCI USA, V108, P1975, DOI 10.1073/pnas.1012807108; Darimont CT, 2002, CAN J ZOOL, V80, P1638, DOI 10.1139/Z02-149; Doucett RR, 2007, ECOLOGY, V88, P1587, DOI 10.1890/06-1184; Doucett RR, 1996, CAN J FISH AQUAT SCI, V53, P2058, DOI 10.1139/cjfas-53-9-2058; Dutton A, 2005, HYDROL PROCESS, V19, P4121, DOI 10.1002/hyp.5876; Fincel MJ, 2012, FISHERIES MANAG ECOL, V19, P283, DOI 10.1111/j.1365-2400.2011.00830.x; Finlay JC, 2001, ECOLOGY, V82, P1052, DOI 10.2307/2679902; Flammang BE, 2014, ZOOLOGY, V117, P86, DOI 10.1016/j.zool.2013.10.001; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Fry B., 2006, STABLE ISOTOPE ECOLO; Graham CT, 2014, HYDROBIOLOGIA, V721, P45, DOI 10.1007/s10750-013-1636-0; Graham CT, 2013, ISOT ENVIRON HEALT S, V49, P555, DOI 10.1080/10256016.2013.808635; Grey J, 2009, FRESHWATER BIOL, V54, P1663, DOI 10.1111/j.1365-2427.2009.02215.x; Hayden B, 2014, J ANIM ECOL, V83, P1501, DOI 10.1111/1365-2656.12233; Hette-Tronquart N, 2012, RAPID COMMUN MASS SP, V26, P1603, DOI 10.1002/rcm.6265; Hobson KA, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00018.1; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Hobson KA, 2008, TERR ECOL SER, V2, P1; Hutchinson JJ, 2006, J FISH BIOL, V69, P1874, DOI 10.1111/j.1095-8649.2006.01234.x; ICES, 2015, REP BALT SALM TROUT; Jardine TD, 2011, MAR FRESHWATER RES, V62, P83, DOI 10.1071/MF10211; Kelly MH, 2006, N AM J FISH MANAGE, V26, P921, DOI 10.1577/M05-084.1; Kiljunen M, 2006, J APPL ECOL, V43, P1213, DOI 10.1111/j.1365-2664.2006.01224.x; Larsson S, 2011, ENVIRON BIOL FISH, V92, P361, DOI 10.1007/s10641-011-9846-7; Merritt R. W., 2008, INTRO AQUATIC INSECT; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; Parris KM, 2010, J APPL ECOL, V47, P227, DOI 10.1111/j.1365-2664.2009.01755.x; Persson ME, 2007, ENVIRON POLLUT, V145, P131, DOI 10.1016/j.envpol.2006.03.036; Phillips DL, 2006, OECOLOGIA, V147, P195, DOI 10.1007/s00442-005-0292-0; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Reitsema LJ, 2013, AM J HUM BIOL, V25, P445, DOI 10.1002/ajhb.22398; Roussel JM, 2014, GLOBAL CHANGE BIOL, V20, P523, DOI 10.1111/gcb.12293; SODERBERG RW, 1987, PROG FISH CULT, V49, P280, DOI 10.1577/1548-8640(1987)49<280:EORDOG>2.0.CO;2; Soto DX, 2013, FUNCT ECOL, V27, P535, DOI 10.1111/1365-2435.12054; Suzuki KW, 2005, CAN J FISH AQUAT SCI, V62, P671, DOI 10.1139/F04-231; Thomas SM, 2015, J ANIM ECOL, V84, P861, DOI 10.1111/1365-2656.12326; Trueman CN, 2012, J FISH BIOL, V81, P826, DOI 10.1111/j.1095-8649.2012.03361.x; Valladares S, 2012, AQUAT ECOL, V46, P363, DOI 10.1007/s10452-012-9407-y; Vander Zanden MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116182; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Wassenaar LI, 2000, ENVIRON SCI TECHNOL, V34, P2354, DOI 10.1021/es990804i; Willis TJ, 2013, MAR BIOL, V160, P1633, DOI 10.1007/s00227-013-2216-6	48	22	22	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145154	10.1371/journal.pone.0145154	http://dx.doi.org/10.1371/journal.pone.0145154			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670464	gold, Green Published, Green Submitted			2022-12-27	WOS:000366719300051
J	Hsueh, YH; Lin, KS; Ke, WJ; Hsieh, CT; Chiang, CL; Tzou, DY; Liu, ST				Hsueh, Yi-Huang; Lin, Kuen-Song; Ke, Wan-Ju; Hsieh, Chien-Te; Chiang, Chao-Lung; Tzou, Dong-Ying; Liu, Shih-Tung			The Antimicrobial Properties of Silver Nanoparticles in Bacillus subtilis Are Mediated by Released Ag+ Ions	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTIBACTERIAL ACTIVITY; TOXICITY; MECHANISM; CYTOTOXICITY; BIOCONTROL; MICROSCOPY; STABILITY; EXPOSURE; MATRIX	The superior antimicrobial properties of silver nanoparticles (Ag NPs) are well-documented, but the exact mechanisms underlying Ag-NP microbial toxicity remain the subject of intense debate. Here, we show that Ag-NP concentrations as low as 10 ppm exert significant toxicity against Bacillus subtilis, a beneficial bacterium ubiquitous in the soil. Growth arrest and chromosomal DNA degradation were observed, and flow cytometric quantification of propidium iodide (PI) staining also revealed that Ag-NP concentrations of 25 ppm and above increased membrane permeability. RedoxSensor content analysis and Phag-GFP expression analysis further indicated that reductase activity and cytosolic protein expression decreased in B. subtilis cells treated with 10-50 ppm of Ag NPs. We conducted X-ray absorption near-edge structure (XANES) and extended X-ray absorption fine structure (EXAFS) analyses to directly clarify the valence and fine structure of Ag atoms in B. subtilis cells placed in contact with Ag NPs. The results confirmed the Ag species in Ag NP-treated B. subtilis cells as Ag2O, indicating that Ag-NP toxicity is likely mediated by released Ag+ ions from Ag NPs, which penetrate bacterial cells and are subsequently oxidized intracellularly to Ag2O. These findings provide conclusive evidence for the role of Ag+ ions in Ag-NP microbial toxicity, and suggest that the impact of inappropriately disposed Ag NPs to soil and water ecosystems may warrant further investigation.	[Hsueh, Yi-Huang] Yuan Ze Univ, Grad Sch Biotechnol & Bioengn, Taoyuan, Taiwan; [Lin, Kuen-Song; Hsieh, Chien-Te; Chiang, Chao-Lung; Tzou, Dong-Ying] Yuan Ze Univ, Dept Chem Engn & Mat Sci, Taoyuan, Taiwan; [Ke, Wan-Ju; Liu, Shih-Tung] Chang Gung Univ, Grad Inst Biomed Sci, Taoyuan, Taiwan; [Ke, Wan-Ju; Liu, Shih-Tung] Chang Gung Univ, Res Ctr Bacterial Pathogenesis, Taoyuan, Taiwan	Yuan Ze University; Yuan Ze University; Chang Gung University; Chang Gung University	Hsueh, YH (corresponding author), Yuan Ze Univ, Grad Sch Biotechnol & Bioengn, Taoyuan, Taiwan.	yihhsueh@saturn.yzu.edu.tw	Chiang, Chao-Lung/AAF-1568-2019		Yuan Ze University, Taiwan [3070111]	Yuan Ze University, Taiwan	This work was supported by Grant 3070111 from Yuan Ze University, Taiwan, to Yi-Huang Hsueh.	Bais HP, 2004, PLANT PHYSIOL, V134, P307, DOI 10.1104/pp.103.028712; Biswas A, 2012, ADV COLLOID INTERFAC, V170, P2, DOI 10.1016/j.cis.2011.11.001; Bloemberg GV, 2001, CURR OPIN PLANT BIOL, V4, P343, DOI 10.1016/S1369-5266(00)00183-7; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Chaloupka K, 2010, TRENDS BIOTECHNOL, V28, P580, DOI 10.1016/j.tibtech.2010.07.006; Chowdhury S, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-365; Christy A. Jegatha, 2012, Advances in Natural Sciences: Nanoscience & Nanotechnology, V3, DOI 10.1088/2043-6262/3/3/035013; Colman BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057189; de Lima R, 2012, J APPL TOXICOL, V32, P867, DOI 10.1002/jat.2780; Dibrov P, 2002, ANTIMICROB AGENTS CH, V46, P2668, DOI 10.1128/AAC.46.8.2668-2670.2002; Dobias J, 2013, ENVIRON SCI TECHNOL, V47, P4140, DOI 10.1021/es304023p; Docter D, 2014, BEILSTEIN J NANOTECH, V5, P1380, DOI 10.3762/bjnano.5.151; Dubas ST, 2006, COLLOID SURFACE A, V289, P105, DOI 10.1016/j.colsurfa.2006.04.012; Duncan TV, 2011, J COLLOID INTERF SCI, V363, P1, DOI 10.1016/j.jcis.2011.07.017; Earl AM, 2008, TRENDS MICROBIOL, V16, P269, DOI 10.1016/j.tim.2008.03.004; El Badawy AM, 2011, ENVIRON SCI TECHNOL, V45, P283, DOI 10.1021/es1034188; Fabrega J, 2011, ENVIRON INT, V37, P517, DOI 10.1016/j.envint.2010.10.012; Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P7285, DOI 10.1021/es803259g; Gajbhiye A, 2010, WORLD J MICROB BIOT, V26, P1187, DOI 10.1007/s11274-009-0287-9; Gambino M, 2015, J APPL MICROBIOL, V118, P1103, DOI 10.1111/jam.12779; Holt KB, 2005, BIOCHEMISTRY-US, V44, P13214, DOI 10.1021/bi0508542; Hsueh YH, 2007, APPL ENVIRON MICROB, V73, P7225, DOI 10.1128/AEM.00690-07; Hsueh YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128457; Iravani S, 2014, RES PHARM SCI, V9, P385; Ivask A, 2014, ACS NANO, V8, P374, DOI 10.1021/nn4044047; Kalyuzhnaya MG, 2008, ISME J, V2, P696, DOI 10.1038/ismej.2008.32; Kawata K, 2009, ENVIRON SCI TECHNOL, V43, P6046, DOI 10.1021/es900754q; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kim SW, 2011, APPL MICROBIOL BIOT, V92, P1045, DOI 10.1007/s00253-011-3611-x; Kumar M, 2015, PLASMONICS IN PRESS; Kumar M, 2011, J APPL PHYS, V109, DOI 10.1063/1.3555593; Kumar M, 2010, PHYSICA E, V42, P1940, DOI 10.1016/j.physe.2010.03.002; Kvitek L, 2008, J PHYS CHEM C, V112, P5825, DOI 10.1021/jp711616v; Levard C, 2012, ENVIRON SCI TECHNOL, V46, P6900, DOI 10.1021/es2037405; Lytle FW, 1999, J SYNCHROTRON RADIAT, V6, P123, DOI 10.1107/S0909049599001260; Ma J, 2003, NANOTECHNOLOGY, V14, P619, DOI 10.1088/0957-4484/14/6/310; Mader U, 2012, NUCLEIC ACIDS RES, V40, pD1278, DOI 10.1093/nar/gkr923; McFarland AD, 2003, NANO LETT, V3, P1057, DOI 10.1021/nl034372s; MEITZNER G, 1992, J PHYS CHEM-US, V96, P4960, DOI 10.1021/j100191a043; Miao AJ, 2009, ENVIRON POLLUT, V157, P3034, DOI 10.1016/j.envpol.2009.05.047; Mishra YK, 2008, NUCL INSTRUM METH B, V266, P1804, DOI 10.1016/j.nimb.2008.01.040; Mishra YK, 2007, SCRIPTA MATER, V56, P629, DOI 10.1016/j.scriptamat.2006.12.008; Mueller NC, 2008, ENVIRON SCI TECHNOL, V42, P4447, DOI 10.1021/es7029637; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Nesvizhskii AI, 1999, J SYNCHROTRON RADIAT, V6, P315, DOI 10.1107/S0909049599001697; Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06; Prabhu S, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-32; Raffi M, 2008, J MATER SCI TECHNOL, V24, P192; Ravel B, 2005, PHYS SCRIPTA, VT115, P1007; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Ravel B, 2012, J SYNCHROTRON RADIAT, V19, P869, DOI 10.1107/S0909049512036886; Ruparelia JP, 2008, ACTA BIOMATER, V4, P707, DOI 10.1016/j.actbio.2007.11.006; Salata OV, 2004, J Nanobiotechnology, V2, P3, DOI 10.1186/1477-3155-2-3; Suresh AK, 2012, LANGMUIR, V28, P2727, DOI 10.1021/la2042058; Tankhiwale R, 2009, COLLOID SURFACE B, V69, P164, DOI 10.1016/j.colsurfb.2008.11.004; Tenzer S, 2013, NAT NANOTECHNOL, V8, P772, DOI 10.1038/nnano.2013.181; Tiwari V., 2014, J NANOMED NANOTECHNO, V5, P246, DOI [10.4172/2157-7439.1000246, DOI 10.4172/2157-7439.1000246]; Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w; Yamanaka M, 2005, APPL ENVIRON MICROB, V71, P7589, DOI 10.1128/AEM.71.11.7589-7593.2005; Youssef AM, 2014, INT J BIOL MACROMOL, V69, P185, DOI 10.1016/j.ijbiomac.2014.05.047; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995; Zhang N, 2011, PLANT SOIL, V344, P87, DOI 10.1007/s11104-011-0729-7	62	95	97	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144306	10.1371/journal.pone.0144306	http://dx.doi.org/10.1371/journal.pone.0144306			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669836	gold, Green Submitted, Green Published			2022-12-27	WOS:000366719300006
J	Maijer, KI; Neumann, E; Muller-Ladner, U; Drop, DACAD; Ramwadhdoebe, TH; Choi, IYK; Gerlag, DM; de Hair, MJH; Tak, PP				Maijer, Karen I.; Neumann, Elena; Mueller-Ladner, Ulf; Drop, Daniel A. C. A. D.; Ramwadhdoebe, Tamara H.; Choi, Ivy Y. K.; Gerlag, Danielle M.; de Hair, Maria J. H.; Tak, Paul P.			Serum Vaspin Levels Are Associated with the Development of Clinically Manifest Arthritis in Autoantibody-Positive Individuals	PLOS ONE			English	Article							NF-KAPPA-B; RHEUMATOID-ARTHRITIS; RISK-FACTORS; SYNOVIAL INFLAMMATION; AMERICAN-COLLEGE; DISEASE-ACTIVITY; LEPTIN LEVELS; ADIPONECTIN; ADIPOKINES; RESISTIN	Objectives We have previously shown that overweight may increase the risk of developing rheumatoid arthritis (RA) in autoantibody positive individuals. Adipose tissue could contribute to the development of RA by production of various bioactive peptides. Therefore, we examined levels of adipokines in serum and synovial tissue of subjects at risk of RA. Methods Fifty-one individuals positive for immunoglobulin M rheumatoid factor (IgM-RF) and/or anticitrullinated protein antibodies (ACPA), without arthritis, were included in this prospective study. Levels of adiponectin, vaspin, resistin, leptin, chemerin and omentin were determined in baseline fasting serum samples (n = 27). Synovial tissue was obtained by arthroscopy at baseline and we examined the expression of adiponectin, resistin and visfatin by immunohistochemistry. Results The development of clinically manifest arthritis after follow-up was associated with baseline serum vaspin levels (HR1.5 (95% CI 1.1 to 2.2); p = 0.020), also after adjustment for overweight (HR1.7 (95% CI 1.1 to 2.5); p = 0.016). This association was not seen for other adipokines. Various serum adipokine levels correlated with BMI (adiponectin r = -0.538, leptin r = 0.664; chemerin r = 0.529) and systemic markers of inflammation such as CRP levels at baseline (adiponectin r = -0.449, omentin r = -0.557, leptin r = 0.635, chemerin r = 0.619, resistin r = 0.520) and ESR (leptin r = 0.512, chemerin r = 0.708), p-value < 0.05. Synovial expression of adiponectin, resistin and visfatin was not associated with development of clinically manifest arthritis. Conclusions In this exploratory study, serum adipokines were associated with an increased inflammatory state in autoantibody-positive individuals at risk of developing RA. Furthermore, serum vaspin levels may assist in predicting the development of arthritis in these individuals.	[Maijer, Karen I.; Drop, Daniel A. C. A. D.; Ramwadhdoebe, Tamara H.; Choi, Ivy Y. K.; Gerlag, Danielle M.; de Hair, Maria J. H.; Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Neumann, Elena; Mueller-Ladner, Ulf] Univ Giessen, Dept Internal Med & Rheumatol, Kerckhoff Klin, Bad Nauheim, Germany	University of Amsterdam; Academic Medical Center Amsterdam; Justus Liebig University Giessen; Kerckhoff Clinic	Tak, PP (corresponding author), Univ Cambridge, Cambridge, England.	paul-peter.x.tak@gsk.com	Neumann, Elena/A-1418-2011		Dutch Arthritis Foundation [06-1-303, 11-1-407]; Netherlands Organisation for Health Research and Development (ZonMw) [200310003]; Innovative Medicines Initiative (IMI) EU [115142]; Seventh Framework Programme (FP7) Euro-TEAM consortium [305549]; Bundesministerium fur Bildung und Forschung (BMBF) [01EC1002C]; Deutsche Forschungsgemeinschaft (DFG) [NE1174/5.1]	Dutch Arthritis Foundation; Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Innovative Medicines Initiative (IMI) EU; Seventh Framework Programme (FP7) Euro-TEAM consortium; Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Dutch Arthritis Foundation [grant numbers 06-1-303, 11-1-407 for DMG], the Netherlands Organisation for Health Research and Development (ZonMw) [grant number 200310003 for DMG], the Innovative Medicines Initiative (IMI) EU funded project BeTheCure [grant number 115142 for DMG], the Seventh Framework Programme (FP7) Euro-TEAM consortium [grant number 305549 for DMG], Bundesministerium fur Bildung und Forschung (BMBF) [grant number 01EC1002C for EN], and Deutsche Forschungsgemeinschaft (DFG) [grant number NE1174/5.1 for EN]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; ALTMAN R, 1990, ARTHRITIS RHEUM, V33, P1601, DOI 10.1002/art.1780331101; Bigaard J, 2005, INT J OBESITY, V29, P778, DOI 10.1038/sj.ijo.0802976; Bokarewa M, 2005, J IMMUNOL, V174, P5789, DOI 10.4049/jimmunol.174.9.5789; Bokarewa M, 2003, ANN RHEUM DIS, V62, P952, DOI 10.1136/ard.62.10.952; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Crowson CS, 2013, ARTHRIT CARE RES, V65, P71, DOI 10.1002/acr.21660; de Boer TN, 2012, OSTEOARTHR CARTILAGE, V20, P846, DOI 10.1016/j.joca.2012.05.002; de Hair MJH, 2014, ARTHRITIS RHEUMATOL, V66, P513, DOI 10.1002/art.38273; de Hair MJH, 2013, ANN RHEUM DIS, V72, P1654, DOI 10.1136/annrheumdis-2012-202254; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Gerlag D, 2005, BEST PRACT RES CL RH, V19, P387, DOI 10.1016/j.berh.2005.01.005; Gerlag DM, 2012, ANN RHEUM DIS, V71, P638, DOI 10.1136/annrheumdis-2011-200990; Gunaydin R, 2006, SOUTH MED J, V99, P1078, DOI 10.1097/01.smj.0000240625.27772.79; Hizmetli S, 2007, RHEUMATOL INT, V27, P335, DOI 10.1007/s00296-006-0264-7; Jung CH, 2011, BIOCHEM BIOPH RES CO, V413, P264, DOI 10.1016/j.bbrc.2011.08.083; Kaneko K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3475; Kontny E, 2012, ANN RHEUM DIS, V71, P262, DOI 10.1136/annrheumdis-2011-200123; Kraan MC, 1998, ARTHRITIS RHEUM, V41, P1481, DOI 10.1002/1529-0131(199808)41:8<1481::AID-ART19>3.0.CO;2-O; Lahiri M, 2012, RHEUMATOLOGY, V51, P499, DOI 10.1093/rheumatology/ker299; Lee SW, 2007, RHEUMATOL INT, V27, P537, DOI 10.1007/s00296-006-0253-x; Lehrke M, 2009, EUR J ENDOCRINOL, V161, P339, DOI 10.1530/EJE-09-0380; Li HL, 2013, ATHEROSCLEROSIS, V228, P61, DOI 10.1016/j.atherosclerosis.2013.02.013; Lu B, 2014, ANN RHEUM DIS, V73, P1914, DOI 10.1136/annrheumdis-2014-205459; Migita K, 2006, CLIN EXP RHEUMATOL, V24, P698; Myasoedova E, 2010, ARTHRITIS RHEUM-US, V62, P1576, DOI 10.1002/art.27425; Neumeier M, 2006, J LEUKOCYTE BIOL, V79, P803, DOI 10.1189/jlb.0905521; Otero M, 2006, RHEUMATOLOGY, V45, P944, DOI 10.1093/rheumatology/kel157; Otero M, 2006, ANN RHEUM DIS, V65, P1198, DOI 10.1136/ard.2005.046540; Otero M, 2006, DRUG NEWS PERSPECT, V19, P21, DOI 10.1358/dnp.2006.19.1.966243; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Ozgen M, 2010, ARCH MED RES, V41, P457, DOI 10.1016/j.arcmed.2010.08.012; Pedersen Jens K, 2007, Open Rheumatol J, V1, P18, DOI 10.2174/1874312900701010018; Pedersen M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2022; Phalitakul S, 2011, PHARMACOL RES, V64, P493, DOI 10.1016/j.phrs.2011.06.001; Schaffler A, 2003, JAMA-J AM MED ASSOC, V290, P1709, DOI 10.1001/jama.290.13.1709-c; Scotece M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/125458; Senolt L, 2007, ANN RHEUM DIS, V66, P458, DOI 10.1136/ard.2006.054734; Senolt L, 2010, ANN RHEUM DIS, V69, P1410, DOI 10.1136/ard.2009.119735; Stofkova A, 2009, Endocr Regul, V43, P157; TAK PP, 1995, ARTHRITIS RHEUM, V38, P1457, DOI 10.1002/art.1780381012; TAK PP, 1995, CLIN IMMUNOL IMMUNOP, V77, P236, DOI 10.1006/clin.1995.1149; Tan WF, 2009, SEMIN ARTHRITIS RHEU, V38, P420, DOI 10.1016/j.semarthrit.2008.01.017; Tsao TS, 2002, J BIOL CHEM, V277, P29359, DOI 10.1074/jbc.C200312200; van de Sande MGH, 2011, ANN RHEUM DIS, V70, P423, DOI 10.1136/ard.2010.139550; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130	49	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144932	10.1371/journal.pone.0144932	http://dx.doi.org/10.1371/journal.pone.0144932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670468	gold, Green Published, Green Submitted			2022-12-27	WOS:000366719300031
J	Xue, H; Wang, JL; Hou, JH; Li, JJ; Gao, JS; Chen, SH; Zhu, H; Wu, SL				Xue, Hao; Wang, Jianli; Hou, Jinhong; Li, Junjuan; Gao, Jingsheng; Chen, Shuohua; Zhu, Hang; Wu, Shouling			Prehypertension and Chronic Kidney Disease in Chinese Population: Four-Year Follow-Up Study	PLOS ONE			English	Article							RISK-FACTORS; BLOOD-PRESSURE; PREVALENCE; HYPERTENSION; ADULTS; PARTICIPANTS; ASSOCIATION	Hypertension is a well established cause of chronic kidney disease (CKD). However, the effect of prehypertension on risk of CKD is controversial. The aim of this study is to determine whether prehypertension increases the risk of CKD events in the Chinese population. We enrolled 20,034 with prehypertension and 12,351 with ideal blood pressure in this prospective study. CKD was defined as an estimated glomerular filtration rate (eGFR) <60 ml/min 1.73m(2). The new occurrences of CKD events were collected during follow-up. Cumulative survival and freedom for the occurrence of new CKD events was analyzed using the Kaplan-Meier approach. Multivariate Cox Regression was used to analyze the effect of prehypertension on CKD. The median follow-up time was 47 (interquartile range 44-51) months. 601 new onset CKD events occurred during the follow-up period. The cumulative incidence of new CKD events was higher in the prehypertensive population than that in the ideal blood pressure population (2.10% vs 1.46%, P = 0.0001). Multivariate Cox Regression showed that relative risks (RRs) for the new onset CKD events in the prehypertensive population were 1.69 (95% confidence intervals (CI): 1.41 similar to 2.04, P = 0.001) higher than those in the ideal blood pressure population. Similarly, the risks were 1.68 (95% CI: 1.33 similar to 2.13 P = 0.001) times higher in females and 2.14 (95% CI: 1.58 similar to 2.91 P = 0.001) times higher in males by adjustment for traditional CV risk factors. Our findings demonstrated prehypertension is an independent risk factor for the occurrence of new CKD events in the Chinese population.	[Xue, Hao; Zhu, Hang] Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing 100853, Peoples R China; [Wang, Jianli; Hou, Jinhong; Li, Junjuan; Gao, Jingsheng; Chen, Shuohua; Wu, Shouling] Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China	Chinese People's Liberation Army General Hospital; North China University of Science & Technology	Zhu, H (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, 28 Fuxing Rd, Beijing 100853, Peoples R China.	zhuhang301@126.com; drwusl@163.com	wang, jian/GVS-0711-2022; Xue, Hao/GXV-4717-2022		Chinese PLA General Hospital Clinical Sustaining Project [2012FC-TSYS-4003]; Capital Public Health Cultivation Project [Z141100002114029]	Chinese PLA General Hospital Clinical Sustaining Project; Capital Public Health Cultivation Project	This work was supported by Chinese PLA General Hospital Clinical Sustaining Project (NO. 2012FC-TSYS-4003) and the Capital Public Health Cultivation Project (NO. Z141100002114029).	Altun B, 2012, KIDNEY BLOOD PRESS R, V36, P36, DOI 10.1159/000339025; [Anonymous], 2012, AM J KIDNEY DIS, V39, pS1; Chen W, 2009, NEPHROL DIAL TRANSPL, V24, P1205, DOI 10.1093/ndt/gfn604; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Guo XF, 2013, CURR HYPERTENS REP, V15, P703, DOI 10.1007/s11906-013-0403-y; Holmes David, 2013, Nat Rev Nephrol, V9, P695, DOI 10.1038/nrneph.2013.215; Huang YL, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-177; Huang YL, 2014, AM J KIDNEY DIS, V63, P76, DOI 10.1053/j.ajkd.2013.07.024; Kanno A, 2012, NEPHROL DIAL TRANSPL, V27, P3218, DOI 10.1093/ndt/gfs054; Kim MJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-960; Kubo M, 2003, KIDNEY INT, V63, P1508, DOI 10.1046/j.1523-1755.2003.00886.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin B, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-36; Liu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102000; Mahmoodi BK, 2012, LANCET, V380, P1649, DOI 10.1016/S0140-6736(12)61272-0; Meng XJ, 2012, CIRC J, V76, P900, DOI 10.1253/circj.CJ-11-1118; Munkhaugen J, 2009, AM J KIDNEY DIS, V54, P638, DOI 10.1053/j.ajkd.2009.03.023; Ninomiya T, 2007, J AM SOC NEPHROL, V18, P2135, DOI 10.1681/ASN.2007010067; O'Seaghdha CM, 2009, HYPERTENSION, V54, P509, DOI 10.1161/HYPERTENSIONAHA.108.128413; Tohidi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045304; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Wu SL, 2012, CIRC-CARDIOVASC QUAL, V5, P487, DOI 10.1161/CIRCOUTCOMES.111.963694; Yano Y, 2012, KIDNEY INT, V81, P293, DOI 10.1038/ki.2011.346; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zheng LQ, 2010, J HYPERTENS, V28, P1158, DOI 10.1097/HJH.0b013e3283378568	25	18	20	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144438	10.1371/journal.pone.0144438	http://dx.doi.org/10.1371/journal.pone.0144438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670101	Green Submitted, Green Published, gold			2022-12-27	WOS:000366719300008
J	Blevins, TP; Mitchell, MC; Korom, M; Wang, H; Yu, YY; Morrison, LA; Belshe, RB				Blevins, Tamara P.; Mitchell, Michelle C.; Korom, Maria; Wang, Hong; Yu, Yinyi; Morrison, Lynda A.; Belshe, Robert B.			Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses	PLOS ONE			English	Article							GLYCOPROTEIN-C; INFECTED-CELLS; COMPLEMENT; PROTECTION; VACCINE; INFECTIVITY; TYPE-1; HSV-2; IMMUNIZATION; COMPONENT	We report a rapid, higher throughput method for measuring neutralizing antibody to herpes simplex virus (HSV) in human sera. Clinical isolates and sera from the Herpevac Trial for Women were used in a colorimetric assay in which infection of tissue culture (lack of neutralization) was indicated by substrate metabolism by beta-galactosidase induced in the ELVIS cell line. The neutralization assay was optimized by addition of guinea pig complement, which particularly enhanced neutralizing antibody titers to HSV-2. Higher neutralizing antibody titers were also achieved using virus particles isolated from the supernatant of infected cells rather than lysate of infected cells as the source of virus. The effect of assay incubation time and incubation time with substrate were also optimized. We found that incubating with substrate until a standard optical density of 1.0 was reached permitted a better comparison among virus isolates, and achieved reliable measurement of neutralizing antibody activity. Interestingly, in contrast to results in the absence of complement, addition of complement allowed sera from HSV-2 gD-vaccinated subjects to neutralize HSV-1 and HSV-2 clinical and laboratory isolates with equal potency.	[Blevins, Tamara P.; Mitchell, Michelle C.; Yu, Yinyi; Belshe, Robert B.] St Louis Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO USA; [Korom, Maria; Wang, Hong; Morrison, Lynda A.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA	Saint Louis University; Saint Louis University	Morrison, LA (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA.	morrisla@slu.edu		Blevins, Tamara/0000-0003-1955-2641	National Institutes of Health [10E-12-0106]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health contract 10E-12-0106 to Robert Belshe. The funders had no role in study design, data collection and analysis or preparation of the manuscript, but authorization to publish was given.	ACKERMANN M, 1984, J VIROL, V52, P108, DOI 10.1128/JVI.52.1.108-118.1984; Ashley RL, 1997, VIRAL IMMUNOL, V10, P213, DOI 10.1089/vim.1997.10.213; Awasthi S, 2014, J INFECT DIS, V210, P571, DOI 10.1093/infdis/jiu177; Awasthi S, 2011, J VIROL, V85, P10472, DOI 10.1128/JVI.00849-11; Belshe RB, 2014, J INFECT DIS, V209, P828, DOI 10.1093/infdis/jit651; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Bernstein DI, 2011, VACCINE, V29, P2071, DOI 10.1016/j.vaccine.2011.01.005; Campadelli-Fiume G, 2012, CURR OPIN VIROL, V2, P28, DOI 10.1016/j.coviro.2011.12.001; Cooper D, 2004, VACCINE, V23, P236, DOI 10.1016/j.vaccine.2004.05.011; DOUTLIK S, 1989, ACTA VIROL, V33, P435; Dudek TE, 2011, J INFECT DIS, V203, P1434, DOI 10.1093/infdis/jir047; DUFF R, 1971, J VIROL, V8, P469, DOI 10.1128/JVI.8.4.469-477.1971; EJERCITO PM, 1968, J GEN VIROL, V2, P357, DOI 10.1099/0022-1317-2-3-357; FRIEDMAN HM, 1984, NATURE, V309, P633, DOI 10.1038/309633a0; GARLAND SM, 1995, J VIROL METHODS, V55, P285, DOI 10.1016/0166-0934(95)00061-9; Hajishengallis G, 2010, TRENDS IMMUNOL, V31, P154, DOI 10.1016/j.it.2010.01.002; HEINEMAN HS, 1967, J IMMUNOL, V99, P214; HUEMER HP, 1993, ARCH VIROL, V130, P353, DOI 10.1007/BF01309666; KAHLON J, 1986, J CLIN MICROBIOL, V23, P725, DOI 10.1128/JCM.23.4.725-730.1986; KNIPE DM, 1982, J VIROL, V43, P314, DOI 10.1128/JVI.43.1.314-324.1982; LANGENBERG AGM, 1995, ANN INTERN MED, V122, P889, DOI 10.7326/0003-4819-122-12-199506150-00001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCNEARNEY TA, 1987, J EXP MED, V166, P1525, DOI 10.1084/jem.166.5.1525; Morrison LA, 1996, VIROLOGY, V220, P402, DOI 10.1006/viro.1996.0328; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RATNER JJ, 1980, INFECT IMMUN, V27, P113, DOI 10.1128/IAI.27.1.113-117.1980; SCHMIDT NJ, 1975, INFECT IMMUN, V12, P728, DOI 10.1128/IAI.12.4.728-732.1975; SHIMIZU F, 1977, INFECT IMMUN, V16, P531, DOI 10.1128/IAI.16.2.531-536.1977; SMITH KO, 1964, P SOC EXP BIOL MED, V115, P814, DOI 10.3181/00379727-115-29045; STABELL EC, 1992, J VIROL METHODS, V38, P195, DOI 10.1016/0166-0934(92)90110-Y; SZE P, 1992, VIRUS RES, V26, P141, DOI 10.1016/0168-1702(92)90153-Z; YOSHINO K, 1966, J IMMUNOL, V96, P196	32	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144738	10.1371/journal.pone.0144738	http://dx.doi.org/10.1371/journal.pone.0144738			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658766	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900098
J	Bodewes, R; Garcia, AR; Brasseur, SM; Conteras, GJS; van de Bildt, MWG; Koopmans, MPG; Osterhaus, ADME; Kuiken, T				Bodewes, Rogier; Garcia, Ana Rubio; Brasseur, Sophie M.; Conteras, Guillermo J. Sanchez; van de Bildt, Marco W. G.; Koopmans, Marion P. G.; Osterhaus, Albert D. M. E.; Kuiken, Thijs			Seroprevalence of Antibodies against Seal Influenza A(H10N7) Virus in Harbor Seals and Gray Seals from the Netherlands	PLOS ONE			English	Article							B VIRUS	In the spring and summer 2014, an outbreak of seal influenza A(H10N7) virus infection occurred among harbor seals (Phoca vitulina) off the coasts of Sweden and Denmark. This virus subsequently spread to harbor seals off the coasts of Germany and the Netherlands. While thousands of seals were reported dead in Sweden, Denmark and Germany, only a limited number of seals were found dead in the Netherlands. To determine the extent of exposure of seals in the Netherlands to influenza A/H10N7 virus, we measured specific antibody titers in serum samples from live-captured seals and seals admitted for rehabilitation in the Netherlands by use of a hemagglutination inhibition assay and an ELISA. In harbor seals in 2015, antibodies against seal influenza A(H10N7) virus were detected in 41% (32 out of 78) pups, 10% (5 out of 52) weaners, and 58% (7 out of 12) subadults or adults. In gray seals (Halichoerus grypus) in 2015, specific antibodies were not found in the pups (n = 26), but in 26% (5 out of 19) of the older animals. These findings indicate that, despite apparent low mortality, infection with seal influenza A(H10N7) virus was geographically widespread and also occurred in grey seals.	[Bodewes, Rogier; van de Bildt, Marco W. G.; Koopmans, Marion P. G.; Osterhaus, Albert D. M. E.; Kuiken, Thijs] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Garcia, Ana Rubio; Conteras, Guillermo J. Sanchez] Seal Rehabil & Res Ctr, Pieterburen, Netherlands; [Brasseur, Sophie M.] Wageningen Univ, IMARES Inst Marine Resources & Ecosyst Studies, Texel, Netherlands; [Koopmans, Marion P. G.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Osterhaus, Albert D. M. E.] Artemis One Hlth, Utrecht, Netherlands; [Osterhaus, Albert D. M. E.] Univ Vet Med Hannover, Res Ctr Emerging Infect & Zoonoses, Hannover, Germany	Erasmus University Rotterdam; Erasmus MC; Wageningen University & Research; Netherlands National Institute for Public Health & the Environment; University of Veterinary Medicine Hannover, Foundation	Bodewes, R (corresponding author), Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecth, Netherlands.	rogier.bodewes@gmail.com	Koopmans, Marion/Y-9170-2019	Koopmans, Marion/0000-0002-5204-2312; Bodewes, Rogier/0000-0002-0689-7889; Sanchez Contreras, Guillermo J./0000-0002-7664-2531; Kuiken, Thijs/0000-0001-5501-9049	European Commission [643476]; ZonMW grant [91213058]	European Commission(European CommissionEuropean Commission Joint Research Centre); ZonMW grant	This study was financially supported by the European Commission H2020 programme under contract number 643476 (www.compare_europe.eu) and ZonMW grant 91213058 (www.nwo.nl/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony SJ, 2012, MBIO, V3, DOI 10.1128/mBio.00166-12; Bodewes R, 2015, EMERG INFECT DIS, V21, P720, DOI 10.3201/eid2104.141675; Bodewes R, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.2; Bodewes R, 2013, EMERG INFECT DIS, V19, P511, DOI 10.3201/eid1903.120965; CALLAN RJ, 1995, J GEN VIROL, V76, P199, DOI 10.1099/0022-1317-76-1-199; de Wit E, 2004, VIRUS RES, V103, P155, DOI 10.1016/j.virusres.2004.02.028; Fereidouni S, 2014, ECOHEALTH; GERACI JR, 1984, CAN J FISH AQUAT SCI, V41, P151, DOI 10.1139/f84-015; Goldstein T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062259; Koninklijk Nederlands Meteorologisch Instituut (KNMI), DAGG WEER NED; Krog JS, 2015, EMERG INFECT DIS, V21, P684, DOI 10.3201/eid2104.141484; Osterhaus ADME, 2000, SCIENCE, V288, P1051, DOI 10.1126/science.288.5468.1051; Palmer DF, 1975, ADV LAB TECHNIQUES I, P25; Rijks JM, 2005, EMERG INFECT DIS, V11, P1945, DOI 10.3201/eid1112.050596; ROSS PS, 1994, VET IMMUNOL IMMUNOP, V42, P331, DOI 10.1016/0165-2427(94)90077-9; WEBSTER RG, 1981, VIROLOGY, V113, P712, DOI 10.1016/0042-6822(81)90200-2; Zohari S, 2014, EUROSURVEILLANCE, V19	17	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144899	10.1371/journal.pone.0144899	http://dx.doi.org/10.1371/journal.pone.0144899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658347	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900142
J	Chang, MC; Lin, LD; Wu, MT; Chan, CP; Chang, HH; Lee, MS; Sun, TY; Jeng, PY; Yeung, SY; Lin, HJ; Jeng, JH				Chang, Mei-Chi; Lin, Li-Deh; Wu, Min-Tsz; Chan, Chiu-Po; Chang, Hsiao-Hua; Lee, Ming-Shu; Sun, Tzu-Ying; Jeng, Po-Yuan; Yeung, Sin-Yuet; Lin, Hsueh-Jen; Jeng, Jiiang-Huei			Effects of Camphorquinone on Cytotoxicity, Cell Cycle Regulation and Prostaglandin E-2 Production of Dental Pulp Cells: Role of ROS, ATM/Chk2, MEK/ERK and Hemeoxygenase-1	PLOS ONE			English	Article							CARBOXYLESTERASE EXPRESSION; CYCLOOXYGENASE-2 EXPRESSION; RESIN; APOPTOSIS; TEGDMA; INITIATORS; ACTIVATION; PATHWAYS; SURVIVAL; KINASES	Camphorquinone (CQ) is a popularly-used photosensitizer in composite resin restoration. In this study, the effects of CQ on cytotoxicity and inflammation-related genes and proteins expression of pulp cells were investigated. The role of reactive oxygen species (ROS), ATM/Chk2/p53 and hemeoxygenase-1 (HO-1) and MEK/ERK signaling was also evaluated. We found that ROS and free radicals may play important role in CQ toxicity. CQ (1 and 2 mM) decreased the viability of pulp cells to about 70% and 50% of control, respectively. CQ also induced G(2)/M cell cycle arrest and apoptosis of pulp cells. The expression of type I collagen, cdc2, cyclin B, and cdc25C was inhibited, while p21, HO-1 and cyclooxygenase-2 (COX-2) were stimulated by CQ. CQ also activated ATM, Chk2, and p53 phosphorylation and GADD45 alpha expression. Besides, exposure to CQ increased cellular ROS level and 8-isoprostane production. CQ also stimulated COX-2 expression and PGE(2) production of pulp cells. The reduction of cell viability caused by CQ can be attenuated by N-acetyl-L-cysteine (NAC), catalase and superoxide dismutase (SOD), but can be promoted by Zinc protoporphyin (ZnPP). CQ stimulated ERK1/2 phosphorylation, and U0126 prevented the CQ-induced COX-2 expression and prostaglandin E-2 (PGE(2)) production. These results indicate that CQ may cause cytotoxicity, cell cycle arrest, apoptosis, and PGE(2) production of pulp cells. These events could be due to stimulation of ROS and 8-isoprostane production, ATM/Chk2/p53 signaling, HO-1, COX-2 and p21 expression, as well as the inhibition of cdc2, cdc25C and cyclin B1. These results are important for understanding the role of ROS in pathogenesis of pulp necrosis and pulpal inflammation after clinical composite resin filling.	[Chang, Mei-Chi] Chang Gung Univ Sci & Technol, Biomed Sci Team, Taoyuan, Taiwan; [Lin, Li-Deh; Wu, Min-Tsz; Chang, Hsiao-Hua; Lee, Ming-Shu; Sun, Tzu-Ying; Jeng, Jiiang-Huei] Grad Inst Clin Dent, Lab Dent Pharmacol Toxicol & Mat Biocompatibil, Taipei, Taiwan; [Lin, Li-Deh; Wu, Min-Tsz; Chang, Hsiao-Hua; Lee, Ming-Shu; Sun, Tzu-Ying; Jeng, Jiiang-Huei] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Lin, Li-Deh; Wu, Min-Tsz; Chang, Hsiao-Hua; Lee, Ming-Shu; Sun, Tzu-Ying; Jeng, Jiiang-Huei] Natl Taiwan Univ Hosp, Dept Dent, Taipei, Taiwan; [Chan, Chiu-Po; Yeung, Sin-Yuet] Chang Gung Mem Hosp, Dept Dent, Taipei 10591, Taiwan; [Jeng, Po-Yuan] Univ Cardenal Herrera, CEU, Sch Dent, Valencia, Spain; [Lin, Hsueh-Jen] Show Chwan Mem Hosp, Dept Dent, Changhua, Taiwan	Chang Gung University of Science & Technology; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; Universidad CEU Cardenal Herrera; Show Chwan Memorial Hospital	Jeng, JH (corresponding author), Grad Inst Clin Dent, Lab Dent Pharmacol Toxicol & Mat Biocompatibil, Taipei, Taiwan.	jhjeng@ntu.edu.tw		LIN, LI-DEH/0000-0002-6050-7394	Ministry of Science and Technology [NSC102-2314-B-255-003-MY2, NSC102-2628-B-255-001-MY3, NSC101-2320-B-255-002, NSC-100-2314-B-002-094, NSC-101-2320-B-255-002, NSC102-2314-B002-051-MY2]; National Taiwan University Hospital (NTUH); Chang Gung Memorial Hospital [CMRPF1C0011, CMRPF1C0012, NMRPF3C0091, NMRPF3C0061]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Taiwan University Hospital (NTUH); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study is supported by grants from Ministry of Science and Technology (NSC102-2314-B-255-003-MY2, NSC102-2628-B-255-001-MY3, NSC101-2320-B-255-002, NSC-100-2314-B-002-094, NSC-101-2320-B-255-002, and NSC102-2314-B002-051-MY2), National Taiwan University Hospital (NTUH) and Chang Gung Memorial Hospital (CMRPF1C0011, CMRPF1C0012, NMRPF3C0091, NMRPF3C0061), and National Taiwan University Hospital (NTUH).; This study is supported by grants from Chang Gung Memorial Hospital (CMRPF1C0011, CMRPF1C0012, NMRPF3C0091, NMRPF3C0061) and Ministry of Science and Technology (NSC102-2314-B-255-003-MY2, NSC102-2628-B-255-001-MY3, NSC101-2320-B-255-002, NSC-100-2314-B-002-094, NSC-101-2320-B-255-002, and NSC102-2314-B002-051-MY2), National Taiwan University Hospital (NTUH) and National Taiwan University Hospital (NTUH).	Chang HH, 2005, BIOMATERIALS, V26, P745, DOI 10.1016/j.biomaterials.2004.03.021; Chang HH, 2014, ACTA BIOMATER, V10, P722, DOI 10.1016/j.actbio.2013.10.006; Chang MC, 2006, INT ENDOD J, V39, P819, DOI 10.1111/j.1365-2591.2006.01156.x; Chang MC, 2012, ACTA BIOMATER, V8, P1380, DOI 10.1016/j.actbio.2011.09.011; Chang MC, 2010, INT ENDOD J, V43, P461, DOI 10.1111/j.1365-2591.2010.01699.x; Chang MC, 2010, BIOMATERIALS, V31, P8164, DOI 10.1016/j.biomaterials.2010.07.049; Chang MC, 2009, BIOMATERIALS, V30, P4070, DOI 10.1016/j.biomaterials.2009.04.034; Chang MC, 2009, J ENDODONT, V35, P508, DOI 10.1016/j.joen.2008.12.023; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Chung SW, 2009, CELL MICROBIOL, V11, P199, DOI 10.1111/j.1462-5822.2008.01261.x; Eckhardt A, 2009, BIOMATERIALS, V30, P2006, DOI 10.1016/j.biomaterials.2008.12.045; Engelmann J, 2005, J BIOMED MATER RES B, V75B, P272, DOI 10.1002/jbm.b.30360; Ferenbach DA, 2010, NEPHRON EXP NEPHROL, V115, pE33, DOI 10.1159/000313828; Ferracane JL, 2006, DENT MATER, V22, P211, DOI 10.1016/j.dental.2005.05.005; Geurtsen W, 1998, J BIOMED MATER RES, V41, P474, DOI 10.1002/(SICI)1097-4636(19980905)41:3<474::AID-JBM18>3.0.CO;2-I; Geurtsen W, 1999, J BIOMED MATER RES, V48, P772, DOI 10.1002/(SICI)1097-4636(1999)48:6<772::AID-JBM2>3.0.CO;2-X; Guven G, 2007, J ENDODONT, V33, P18, DOI 10.1016/j.joen.2006.07.014; Hebling J, 1999, J ENDODONT, V25, P676, DOI 10.1016/S0099-2399(99)80354-9; Huang FM, 2003, BIOMATERIALS, V24, P1869, DOI 10.1016/S0142-9612(02)00584-7; Krifka S, 2013, BIOMATERIALS, V34, P4555, DOI 10.1016/j.biomaterials.2013.03.019; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Masuki K, 2007, DENT MATER J, V26, P861, DOI 10.4012/dmj.26.861; McClay DR, 1999, EXP CELL RES, V253, P296, DOI 10.1006/excr.1999.4723; McGarvey TW, 2000, UROL ONCOL, V5, P71, DOI 10.1016/S1078-1439(99)00003-4; Michelsen VB, 2007, J CHROMATOGR B, V850, P83, DOI 10.1016/j.jchromb.2006.11.003; Miyauchi M, 1996, J ENDODONT, V22, P600, DOI 10.1016/S0099-2399(96)80029-X; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Samuelsen JT, 2007, DENT MATER, V23, P34, DOI 10.1016/j.dental.2005.11.037; Silva GAB, 2006, OPER DENT, V31, P297, DOI 10.2341/05-65; Spagnuolo G, 2004, J DENT RES, V83, P703, DOI 10.1177/154405910408300909; Spagnuolo G, 2008, J ENDODONT, V34, P684, DOI 10.1016/j.joen.2008.02.040; Spahl W, 1998, J DENT, V26, P137, DOI 10.1016/S0300-5712(96)00086-3; Stansbury J W, 2000, J Esthet Dent, V12, P300, DOI 10.1111/j.1708-8240.2000.tb00239.x; TAIRA M, 1988, J DENT RES, V67, P24, DOI 10.1177/00220345880670010401; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Volk J, 2009, DENT MATER, V25, P1556, DOI 10.1016/j.dental.2009.07.009	40	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143663	10.1371/journal.pone.0143663	http://dx.doi.org/10.1371/journal.pone.0143663			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658076	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900015
J	Day, PE; Ntani, G; Crozier, SR; Mahon, PA; Inskip, HM; Cooper, C; Harvey, NC; Godfrey, KM; Hanson, MA; Lewis, RM; Cleal, JK				Day, Pricilla E.; Ntani, Georgia; Crozier, Sarah R.; Mahon, Pam A.; Inskip, Hazel M.; Cooper, Cyrus; Harvey, Nicholas C.; Godfrey, Keith M.; Hanson, Mark A.; Lewis, Rohan M.; Cleal, Jane K.			Maternal Factors Are Associated with the Expression of Placental Genes Involved in Amino Acid Metabolism and Transport	PLOS ONE			English	Article							BIRTH-WEIGHT; IN-UTERO; SIZE; PREGNANCY; SMOKING; SYSTEM; GROWTH; SEX; RESTRICTION; EXPOSURE	Introduction Maternal environment and lifestyle factors may modify placental function to match the mother's capacity to support the demands of fetal growth. Much remains to be understood about maternal influences on placental metabolic and amino acid transporter gene expression. We investigated the influences of maternal lifestyle and body composition (e.g. fat and muscle content) on a selection of metabolic and amino acid transporter genes and their associations with fetal growth. Methods RNA was extracted from 102 term Southampton Women's Survey placental samples. Expression of nine metabolic, seven exchange, eight accumulative and three facilitated transporter genes was analyzed using quantitative real-time PCR. Results Increased placental LAT2 (p = 0.01), y(+)LAT2 (p = 0.03), aspartate aminotransferase 2 (p = 0.02) and decreased aspartate aminotransferase 1 (p = 0.04) mRNA expression associated with pre-pregnancy maternal smoking. Placental mRNA expression of TAT1 (p = 0.01), ASCT1 (p = 0.03), mitochondrial branched chain aminotransferase (p = 0.02) and glutamine synthetase (p = 0.05) was positively associated with maternal strenuous exercise. Increased glutamine synthetase mRNA expression (r = 0.20, p = 0.05) associated with higher maternal diet quality (prudent dietary pattern) pre-pregnancy. Lower LAT4 (r = -0.25, p = 0.05) and aspartate aminotransferase 2 mRNA expression (r = -0.28, p = 0.01) associated with higher early pregnancy diet quality. Lower placental ASCT1 mRNA expression associated with measures of increased maternal fat mass, including pre-pregnancy BMI (r = -0.26, p = 0.01). Lower placental mRNA expression of alanine aminotransferase 2 associated with greater neonatal adiposity, for example neonatal subscapular skinfold thickness (r = -0.33, p = 0.001). Conclusion A number of maternal influences have been linked with outcomes in childhood, independently of neonatal size; our finding of associations between placental expression of transporter and metabolic genes and maternal smoking, physical activity and diet raises the possibility that their effects are mediated in part through alterations in placental function. The observed changes in placental gene expression in relation to modifiable maternal factors are important as they could form part of interventions aimed at maintaining a healthy lifestyle for the mother and for optimal fetal development.	[Day, Pricilla E.; Godfrey, Keith M.; Hanson, Mark A.; Lewis, Rohan M.; Cleal, Jane K.] Univ Southampton, Inst Dev Sci, Southampton SO16 6YD, Hants, England; [Ntani, Georgia; Crozier, Sarah R.; Mahon, Pam A.; Inskip, Hazel M.; Cooper, Cyrus; Harvey, Nicholas C.; Godfrey, Keith M.] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton SO16 6YD, Hants, England; [Cooper, Cyrus; Harvey, Nicholas C.; Godfrey, Keith M.; Hanson, Mark A.] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton SO16 6YD, Hants, England; [Cooper, Cyrus; Harvey, Nicholas C.; Godfrey, Keith M.; Hanson, Mark A.] Univ Hosp Southampton NHS Fdn Trust, Southampton SO16 6YD, Hants, England; [Cooper, Cyrus] Univ Oxford, NIHR Musculoskeletal Biomed Res Unit, Nuffield Orthoped Ctr, Oxford OX3 7HE, England; [Lewis, Rohan M.; Cleal, Jane K.] Univ Southampton, Inst Life Sci, Southampton SO17 1BJ, Hants, England	University of Southampton; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Nuffield Orthopaedic Centre; University of Oxford; University of Southampton	Cleal, JK (corresponding author), Univ Southampton, Inst Dev Sci, Tremona Rd, Southampton SO16 6YD, Hants, England.	j.k.cleal@southampton.ac.uk	Hanson, Mark/AAE-8236-2019; Lewis, Rohan/C-9350-2011; Cleal, Jane/AAC-9070-2019; Cleal, Jane/AAC-5062-2019; Inskip, Hazel/L-5467-2018	Hanson, Mark/0000-0002-6907-613X; Lewis, Rohan/0000-0003-4044-9104; Cleal, Jane/0000-0001-7978-4327; Cooper, Cyrus/0000-0003-3510-0709; Godfrey, Keith/0000-0002-4643-0618; Harvey, Nicholas/0000-0002-8194-2512; Inskip, Hazel/0000-0001-8897-1749; Crozier, Sarah/0000-0002-9524-1127	Medical Research Council [MC_US_A620_0033]; Wessex Medical Research; Arthritis Research UK; National Osteoporosis Society; International Osteoporosis Foundation; Cohen Trust; NIHR Southampton Biomedical Research Centre; University of Southampton; University Hospital Southampton NHS Foundation Trust; NIHR Musculoskeletal Biomedical Research Unit; University of Oxford; Dunhill Medical Trust; Gerald Kerkut Charitable Trust; National Institute for Health Research through the NIHR Southampton Biomedical Research Centre; European Union [289346]; MRC [MC_U147585819, MC_UP_A620_1017, G0400491, MC_U147585827, MC_UU_12011/4] Funding Source: UKRI; British Heart Foundation [RG/07/009/23120] Funding Source: researchfish; Medical Research Council [MC_U147585827, MC_UP_A620_1014, MC_UU_12011/4, MC_UU_12011/1, MC_UP_A620_1017, MC_U147585819, U1475000001, G0400491, MC_U147585824] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10085, NF-SI-0508-10082] Funding Source: researchfish; Versus Arthritis [17702] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wessex Medical Research; Arthritis Research UK(Versus Arthritis); National Osteoporosis Society; International Osteoporosis Foundation; Cohen Trust; NIHR Southampton Biomedical Research Centre; University of Southampton; University Hospital Southampton NHS Foundation Trust; NIHR Musculoskeletal Biomedical Research Unit; University of Oxford; Dunhill Medical Trust(Dunhill Medical Trust); Gerald Kerkut Charitable Trust; National Institute for Health Research through the NIHR Southampton Biomedical Research Centre; European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis)	This work was supported by grants from the Medical Research Council (MC_US_A620_0033), Wessex Medical Research, Arthritis Research UK, National Osteoporosis Society, International Osteoporosis Foundation, Cohen Trust, NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, and NIHR Musculoskeletal Biomedical Research Unit, University of Oxford. Participants were drawn from a cohort study funded by the Medical Research Council and the Dunhill Medical Trust. PED was supported by the Gerald Kerkut Charitable Trust. KMG is supported by the National Institute for Health Research through the NIHR Southampton Biomedical Research Centre and by the European Union's Seventh Framework Programme (FP7/2007-2013), project EarlyNutrition under grant agreement no 289346.	Alwasel SH, 2014, PLACENTA, V35, P365, DOI 10.1016/j.placenta.2014.03.003; Alwasel SH, 2010, PLACENTA, V31, P607, DOI 10.1016/j.placenta.2010.04.010; Armitage P., 2002, STAT METHODS MED RES; Bhardwaj A, 2014, POSTGRAD MED J, V90, P450, DOI 10.1136/postgradmedj-2013-132377; Chitty L. S., 2008, CHARTS RECOMMENDED C; Cleal JK, 2011, J PHYSIOL-LONDON, V589, P987, DOI 10.1113/jphysiol.2010.198549; Cleal JK, 2010, PLACENTA, V31, P556, DOI 10.1016/j.placenta.2010.03.006; Cleal JK, 2009, PLACENTA, V30, P1002, DOI 10.1016/j.placenta.2009.09.002; Crozier SR, 2006, EUR J CLIN NUTR, V60, P1391, DOI 10.1038/sj.ejcn.1602469; Day PEL, 2013, PLACENTA, V34, P1223, DOI 10.1016/j.placenta.2013.10.003; Diaz P, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121798; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Ericsson A, 2005, AM J PHYSIOL-REG I, V288, pR656, DOI 10.1152/ajpregu.00407.2004; FRISANCHO AR, 1974, AM J CLIN NUTR, V27, P1052, DOI 10.1093/ajcn/27.8.1052; Fukuhara D, 2007, AM J PATHOL, V170, P888, DOI 10.2353/ajpath.2007.060428; Gabory A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047986; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Harris ST, 2015, MATERN CHILD HLTH J, V19, P528, DOI 10.1007/s10995-014-1534-8; Harrison GG, 1988, ANTHROPOMETRIC STAND, P55; HEYMSFIELD SB, 1982, AM J CLIN NUTR, V36, P680, DOI 10.1093/ajcn/36.4.680; Howard A, 2004, J NUTR, V134, P2957, DOI 10.1093/jn/134.11.2957; Inskip HM, 2006, INT J EPIDEMIOL, V35, P42, DOI 10.1093/ije/dyi202; Jansson N, 2003, PLACENTA, V24, P191; Jauniaux E, 2007, EARLY HUM DEV, V83, P699, DOI 10.1016/j.earlhumdev.2007.07.016; Kavitha JV, 2014, FASEB J, V28, P1294, DOI 10.1096/fj.13-242271; Lee JI, 2008, PHYSIOL GENOMICS, V33, P218, DOI 10.1152/physiolgenomics.00263.2007; Lewis RM, 2013, PLACENTA, V34, pS46, DOI 10.1016/j.placenta.2012.10.010; Lewis RM, 2010, PLACENTA, V31, P418, DOI 10.1016/j.placenta.2010.02.001; Mahon P. A., 2009, Norsk Epidemiologi, V19, P45; Malek A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-61; Markunas CA, 2014, ENVIRON HEALTH PERSP, V122, P1147, DOI 10.1289/ehp.1307892; Mund M, 2013, INT J ENV RES PUB HE, V10, P6485, DOI 10.3390/ijerph10126485; NAEYE RL, 1987, HUM PATHOL, V18, P387, DOI 10.1016/S0046-8177(87)80170-3; Pike KC, 2010, THORAX, V65, P1099, DOI 10.1136/thx.2010.134742; Pirlich M, 2006, CLIN NUTR, V25, P563, DOI 10.1016/j.clnu.2006.03.005; POZEFSKY T, 1976, J CLIN INVEST, V57, P444, DOI 10.1172/JCI108295; Ravaglia G, 2002, BRIT J NUTR, V88, P563, DOI 10.1079/BJN2002700; Robinson SM, 2004, EUR J CLIN NUTR, V58, P1174, DOI 10.1038/sj.ejcn.1601946; Roos S, 2009, AM J PHYSIOL-CELL PH, V296, pC142, DOI 10.1152/ajpcell.00330.2008; Roos S, 2009, BIOCHEM SOC T, V37, P295, DOI 10.1042/BST0370295; ROYSTON P, 1995, STAT MED, V14, P1417, DOI 10.1002/sim.4780141303; Saif Z, 2014, PLACENTA, V35, P260, DOI 10.1016/j.placenta.2014.01.012; Sattar N, 2004, DIABETES, V53, P2855, DOI 10.2337/diabetes.53.11.2855; Schulz KF, 2005, LANCET, V365, P1591, DOI 10.1016/S0140-6736(05)66461-6; Sengers BG, 2010, EXP PHYSIOL, V95, P829, DOI 10.1113/expphysiol.2010.052902; Shah PS, 2010, ACTA OBSTET GYN SCAN, V89, P862, DOI 10.3109/00016349.2010.486827; Shibata E, 2008, PLACENTA, V29, P879, DOI 10.1016/j.placenta.2008.07.001; Suter M, 2010, METABOLISM, V59, P1481, DOI 10.1016/j.metabol.2010.01.013; van Abeelen AFM, 2011, PLACENTA, V32, P694, DOI 10.1016/j.placenta.2011.06.012; Wang N, 2014, PLACENTA, V35, P437, DOI 10.1016/j.placenta.2014.04.006; Weissgerber TL, 2010, J APPL PHYSIOL, V108, P1217, DOI 10.1152/japplphysiol.00008.2010; Winder NR, 2011, PLACENTA, V32, P806, DOI 10.1016/j.placenta.2011.09.001; Xie XL, 2013, FOOD CHEM TOXICOL, V59, P137, DOI 10.1016/j.fct.2013.05.044; Yamagata K, 2006, NEUROSCIENCE, V143, P729, DOI 10.1016/j.neuroscience.2006.08.050	54	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143653	10.1371/journal.pone.0143653	http://dx.doi.org/10.1371/journal.pone.0143653			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657885	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000366715900014
J	Faupel-Badger, JM; Nelson, DE; Izmirlian, G; Ross, KH; Raue, K; Tsakraklides, S; Miyaoka, A; Spiegelman, M				Faupel-Badger, Jessica M.; Nelson, David E.; Izmirlian, Grant; Ross, Katherine H.; Raue, Kimberley; Tsakraklides, Sophia; Miyaoka, Atsushi; Spiegelman, Maura			Independent Association of Postdoctoral Training with Subsequent Careers in Cancer Prevention	PLOS ONE			English	Article							PROGRAM; WEB	The purpose of this study was to examine the career paths of alumni from the National Cancer Institute (NCI) Cancer Prevention Fellowship Program (CPFP), a structured in-house postdoctoral training program of 3-4 years duration, and specifically what proportion of the alumni were currently performing cancer prevention-related activities. The analyses here included 119 CPFP alumni and 85 unsuccessful CPFP applicants, all of whom completed postdoctoral training between 1987-2011 and are currently employed. Postdoctoral training experiences and current career outcomes data were collected via online surveys. Differences between groups were assessed using chi-square and Fisher's exact test p-values and subsequent regression analyses adjusted for differences between the groups. Compared to 15.3% of unsuccessful CPFP applicants, 52.1% of CPFP alumni (odds ratio [OR] = 4.99, 95% confidence interval [95% CI): 1.91-13.0) were currently spending the majority of their time working in cancer prevention. Among those doing any cancer prevention-focused work, 54.3% of CPFP alumni spent the majority of their time performing cancer prevention research activities when compared to 25.5% of unsuccessful applicants (OR = 4.26, 95% CI: 1.38-13.2). In addition to the independent effect of the NCI CPFP, scientific discipline, and employment sector were also associated with currently working in cancer prevention and involvement in cancer prevention research-related activities. These results from a structured postdoctoral training program are relevant not only to the cancer prevention community but also to those interested in evaluating alignment of postdoctoral training programs with available and desired career paths more broadly.	[Faupel-Badger, Jessica M.] NIGMS, Bethesda, MD 20892 USA; [Nelson, David E.; Ross, Katherine H.] NCI, Canc Prevent Fellowship Program, Canc Prevent Div, Bethesda, MD 20892 USA; [Izmirlian, Grant] NCI, Biometry Res Grp, Canc Prevent Div, Bethesda, MD 20892 USA; [Raue, Kimberley; Tsakraklides, Sophia; Miyaoka, Atsushi; Spiegelman, Maura] Westat Corp, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Westat	Faupel-Badger, JM (corresponding author), NIGMS, Bethesda, MD 20892 USA.	badgerje@mail.nih.gov		Faupel-Badger, Jessica/0000-0001-9729-3660	National Institutes of Health Evaluation Set-Aside Program	National Institutes of Health Evaluation Set-Aside Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the National Institutes of Health Evaluation Set-Aside Program. NIH Staff provided input on the survey questions but did not participate in the collection of data. Westat staff analyzed the data and provided an anonymized dataset to NIH staff for regression analysis.	Advisory Committee to the NIH Director, 2012, BIOM RES WORKF WORK; Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; Chang S, 2005, ACAD MED, V80, P261, DOI 10.1097/00001888-200503000-00011; Chang S, 2013, J CANC ED S2, V27, pS118; Chang SN, 2014, CANCER EPIDEM BIOMAR, V23, P1133, DOI 10.1158/1055-9965.EPI-14-0194; Chang S, 2009, CANCER EPIDEM BIOMAR, V18, P2348, DOI 10.1158/1055-9965.EPI-09-0664; Colditz GA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003218; Committee on Science Engineering and Public Policy (COSEPUP), 2014, POSTD EXP REV; Committee on Science Engineering and Public Policy (COSEPUP), 2000, ENH POSTD EXP SCI EN; Community Preventive Services Task Force, GUID COMM PREV SERV; Faupel-Badger J, 2013, J CANCER EDUC, V28, P18, DOI 10.1007/s13187-012-0437-x; Faupel-Badger JM, 2015, CBE-LIFE SCI EDUC, V14, DOI 10.1187/cbe.14-06-0102; Husten C G, 1993, J Cancer Educ, V8, P281; Kochanek KD, 2013, NCHS DATA BRIEF, V2014, P1; Manfreda KL, 2008, INT J MARKET RES, V50, P79, DOI 10.1177/147078530805000107; Millar MM, 2011, PUBLIC OPIN QUART, V75, P249, DOI 10.1093/poq/nfr003; Pion GM, 2008, EVAL HEALTH PROF, V31, P335, DOI 10.1177/0163278708324434; Polka JK, 2015, MOL BIOL CELL, V26, P1413, DOI 10.1091/mbc.E14-10-1432; R Core Team, 2021, R LANGUAGE ENV STAT; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; U.S. Department of Health and Human Services, OFF DIS PREV HLTH PR; U.S. Preventive Services Task Force, REC PRIM CAR PRACT	22	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144880	10.1371/journal.pone.0144880	http://dx.doi.org/10.1371/journal.pone.0144880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659381	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900131
J	Gackowski, D; Zarakowska, E; Starczak, M; Modrzejewska, M; Olinski, R				Gackowski, Daniel; Zarakowska, Ewelina; Starczak, Marta; Modrzejewska, Martyna; Olinski, Ryszard			Tissue-Specific Differences in DNA Modifications (5-Hydroxymethylcytosine, 5-Formylcytosine, 5-Carboxylcytosine and 5-Hydroxymethyluracil) and Their Interrelationships	PLOS ONE			English	Article							STEM-CELL DNA; METHYLATION; DERIVATIVES; OXIDATION; 5-METHYLCYTOSINE; THYMINE; BRAIN	Background Replication-independent active/enzymatic demethylation may be an important process in the functioning of somatic cells. The most plausible mechanisms of active 5-methylcytosine demethylation, leading to activation of previously silenced genes, involve ten-eleven translocation (TET) proteins that participate in oxidation of 5-methylcytosine to 5-hydroxymethylcytosine which can be further oxidized to 5-formylcytosine and 5-carboxylcytosine. Recently, 5-hydroxymethylcytosine was demonstrated to be a relatively stable modification, and the previously observed substantial differences in the level of this modification in various murine tissues were shown to depend mostly on cell proliferation rate. Some experimental evidence supports the hypothesis that 5-hydroxymethyluracil may be also generated by TET enzymes and has epigenetic functions. Results Using an isotope-dilution automated online two-dimensional ultra-performance liquid chromatography with tandem mass spectrometry, we have analyzed, for the first time, all the products of active DNA demethylation pathway: 5-methyl-2'-deoxycytidine, 5-hydroxymethyl-2'-deoxycytidine, 5-formyl-2'-deoxycytidine and 5-carboxyl-2'-deoxycytidine, as well as 5-hydroxymethyl-2'-deoxyuridine, in DNA isolated from various rat and porcine tissues. A strong significant inverse linear correlation was found between the proliferation rate of cells and the global level of 5-hydroxymethyl-2'-deoxycytidine in both porcine (R-2 = 0.88) and rat tissues (R-2 = 0.83); no such relationship was observed for 5-formyl-2'-deoxycytidine and 5-carboxyl-2'-deoxycytidine. Moreover, a substrate-product correlation was demonstrated for the two consecutive steps of iterative oxidation pathway: between 5-hydroxymethyl-2'-deoxycytidine and its product 5-formyl-2'-deoxycytidine, as well as between 5-formyl-2'-deoxycytidine and 5-carboxyl-2'-deoxycytidine (R-2 = 0.60 and R-2 = 0.71, respectively). Conclusions Good correlations within the substrate-product sets of iterative oxidation pathway may suggest that a part of 5-formyl-2'-deoxycytidine and/or 5-carboxyl-2'-deoxycytidine can be directly linked to a small portion of 5-hydroxymethyl-2'-deoxycytidine which defines the active demethylation process.	[Gackowski, Daniel; Zarakowska, Ewelina; Starczak, Marta; Modrzejewska, Martyna; Olinski, Ryszard] Nicolaus Copernicus Univ, Coll Med Bydgoszcz, Dept Clin Biochem, Bydgoszcz, Poland	Nicolaus Copernicus University	Olinski, R (corresponding author), Nicolaus Copernicus Univ, Coll Med Bydgoszcz, Dept Clin Biochem, Bydgoszcz, Poland.	ryszardo@cm.umk.pl	Zarakowska, Ewelina/G-7912-2014; Starczak, Marta/P-4773-2019; Gackowski, Daniel/G-5693-2012; Modrzejewska, Martyna/GZK-3475-2022; Modrzejewska, Martyna/P-8977-2019; Olinski, Ryszard/E-9607-2014	Zarakowska, Ewelina/0000-0003-0508-7777; Starczak, Marta/0000-0003-4098-7412; Gackowski, Daniel/0000-0002-7259-1511; Modrzejewska, Martyna/0000-0002-9464-8419; Olinski, Ryszard/0000-0001-9927-8755	National Science Centre [DEC-2012/07/B/NZ1/00008]; National Science Center	National Science Centre(National Science Centre, Poland); National Science Center(National Science Centre, Poland)	This work was supported by the National Science Centre (RO) DEC-2012/07/B/NZ1/00008, https://www.ncn.gov.pl/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Martin Bachman for providing his raw data on the cell proliferation rate, and Prof. Tomasz Drewa and his coworkers for supplying Wistar rats used in this study. The study was funded in part by a grant from the National Science Center (decision no. DEC-2012/07/B/NZ1/00008).	Bachman M, 2015, NAT CHEM BIOL, V11, P555, DOI 10.1038/nchembio.1848; Bachman M, 2014, NAT CHEM, V6, P1049, DOI [10.1038/nchem.2064, 10.1038/NCHEM.2064]; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Cao HC, 2006, J AM SOC MASS SPECTR, V17, P1335, DOI 10.1016/j.jasms.2006.05.019; DIVAKAR KJ, 1982, J CHEM SOC PERK T 1, P1171, DOI 10.1039/p19820001171; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guz J, 2008, MUTAT RES-FUND MOL M, V640, P170, DOI 10.1016/j.mrfmmm.2007.12.013; Hashimoto H, 2014, NATURE, V506, P391, DOI 10.1038/nature12905; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hu LL, 2015, NATURE, V527, P118, DOI 10.1038/nature15713; Kamiya H, 2002, J BIOCHEM, V132, P551, DOI 10.1093/oxfordjournals.jbchem.a003256; Kellinger MW, 2012, NAT STRUCT MOL BIOL, V19, P831, DOI 10.1038/nsmb.2346; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Pfaffeneder T, 2014, NAT CHEM BIOL, V10, P574, DOI [10.1038/NCHEMBIO.1532, 10.1038/nchembio.1532]; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Rahman AAHA, 2001, TETRAHEDRON LETT, V42, P1061; Schiesser S, 2012, ANGEW CHEM INT EDIT, V51, P6516, DOI 10.1002/anie.201202583; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Shibutani T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05220; Song CX, 2013, TRENDS BIOCHEM SCI, V38, P480, DOI 10.1016/j.tibs.2013.07.003; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Tang Y, 2015, ANAL CHEM, V87, P3445, DOI 10.1021/ac504786r; Wagner M, 2015, ANGEW CHEM INT EDIT, V54, P12511, DOI 10.1002/anie.201502722; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019	27	28	29	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144859	10.1371/journal.pone.0144859	http://dx.doi.org/10.1371/journal.pone.0144859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660343	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900121
J	Huang, Y; Xie, J; Wang, T				Huang, Yu; Xie, Jun; Wang, Tao			A Fluorescence-Based Genetic Screen to Study Retinal Degeneration in Drosophila	PLOS ONE			English	Article							NERVOUS-SYSTEM; HUMAN SCO1; PROTEIN; TRANSPORT; RAB6; EYE; MUTANTS; ENCODES; CHANNEL; MODEL	The Drosophila visual system has been proved to be a powerful genetic model to study eye disease such as retinal degeneration. Here, we describe a genetic method termed "Rh1::GFP ey-flp/hid" that is based on the fluorescence of GFP-tagged major rhodopsin Rh1 in the eyes of living flies and can be used to monitor the integrity of photoreceptor cells. Through combination of this method and ERG recording, we examined a collection of 667 mutants and identified 18 genes that are required for photoreceptor cell maintenance, photoresponse, and rhodopsin synthesis. Our findings demonstrate that this "Rh1::GFP eyflp/hid" method enables high-throughput F1 genetic screens to rapidly and precisely identify mutations of retinal degeneration.	[Huang, Yu; Xie, Jun; Wang, Tao] Natl Inst Biol Sci, Beijing, Peoples R China; [Xie, Jun] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China	National Institute of Biological Sciences, Beijing; China Agricultural University	Wang, T (corresponding author), Natl Inst Biol Sci, Beijing, Peoples R China.	wangtao1006@nibs.ac.cn		Wang, Tao/0000-0002-2395-3483	'973' grant from the Chinese Ministry of Science [2014CB849700]	'973' grant from the Chinese Ministry of Science	This work was supported by a '973' grant (2014CB849700) to T.W. from the Chinese Ministry of Science. T.W. contributed to the study design, analysis, dicision to publish and preparation of the manuscript.; We thank Dr. Craig Montell, Dr. Nansi Colley, Dr. William Pak, the Bloomington Stock Center, and the Kyoto Drosophila Genetic Resource Center for fly stocks and reagents. We thank Xianglei Yu and Futing An for assistance with the genetic screen and thank Ying Wang for preparing sections for EM. We thank David O'Keefe for critical reading of the manuscript. This work was supported by a '973' grant (2014CB849700) to T.W. from the Chinese Ministry of Science.	Agam K, 2000, J NEUROSCI, V20, P5748, DOI 10.1523/JNEUROSCI.20-15-05748.2000; Anflous K, 2001, J BIOL CHEM, V276, P1954, DOI 10.1074/jbc.M006587200; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BURG MG, 1993, EMBO J, V12, P911, DOI 10.1002/j.1460-2075.1993.tb05732.x; Charng WL, 2014, CURR OPIN NEUROBIOL, V27, P158, DOI 10.1016/j.conb.2014.03.001; Chen J, 2005, PLOS BIOL, V3, P207, DOI 10.1371/journal.pbio.0030059; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Dourlen P, 2015, METHODS MOL BIOL, V1254, P351, DOI 10.1007/978-1-4939-2152-2_25; Dourlen P, 2013, JOVE-J VIS EXP, DOI 10.3791/50610; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; Gambis A, 2011, DEV BIOL, V351, P128, DOI 10.1016/j.ydbio.2010.12.040; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HOTTA Y, 1970, P NATL ACAD SCI USA, V67, P1156, DOI 10.1073/pnas.67.3.1156; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Januschke J, 2007, DEVELOPMENT, V134, P3419, DOI 10.1242/dev.008078; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kuo Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.351; Laird FM, 2008, J NEUROSCI, V28, P1997, DOI 10.1523/JNEUROSCI.4231-07.2008; Leary SC, 2004, HUM MOL GENET, V13, P1839, DOI 10.1093/hmg/ddh197; Lee S, 2007, DEV NEUROBIOL, V67, P1533, DOI 10.1002/dneu.20526; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Lloyd TE, 2012, NEURON, V74, P344, DOI 10.1016/j.neuron.2012.02.026; Martinez O, 1997, P NATL ACAD SCI USA, V94, P1828, DOI 10.1073/pnas.94.5.1828; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; Mayer T, 1996, J BIOL CHEM, V271, P16097, DOI 10.1074/jbc.271.27.16097; Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Montell C, 2012, TRENDS NEUROSCI, V35, P356, DOI 10.1016/j.tins.2012.03.004; Newsome TP, 2000, DEVELOPMENT, V127, P851; Ohyama T, 2007, J CELL BIOL, V179, P1481, DOI 10.1083/jcb.200710061; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; PAK WL, 1970, NATURE, V227, P518, DOI 10.1038/227518b0; Park J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013151; Pichaud F, 2001, DEVELOPMENT, V128, P815; Popescu DC, 2006, J NEUROSCI, V26, P8570, DOI 10.1523/JNEUROSCI.1478-06.2006; Porcelli D, 2010, MITOCHONDRION, V10, P433, DOI 10.1016/j.mito.2010.04.002; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; Satoh T, 2013, DEVELOPMENT, V140, P385, DOI 10.1242/dev.083683; SCHNEUWLY S, 1989, P NATL ACAD SCI USA, V86, P5390, DOI 10.1073/pnas.86.14.5390; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Shetty KM, 1998, J BIOL CHEM, V273, P20425, DOI 10.1074/jbc.273.32.20425; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; Short B, 2002, CURR BIOL, V12, P1792, DOI 10.1016/S0960-9822(02)01221-6; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; STEPHENSON RS, 1983, SYM SOC EXP BIOL, P477; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Stowers RS, 1999, GENETICS, V152, P1631; Tong C, 2011, NEURON, V71, P447, DOI 10.1016/j.neuron.2011.06.040; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Wang T, 2005, J CELL BIOL, V171, P685, DOI 10.1083/jcb.200508030; Wang T, 2008, NEURON, V57, P56, DOI 10.1016/j.neuron.2007.11.020; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Wang T, 2006, J NEUROSCI, V26, P12816, DOI 10.1523/JNEUROSCI.3673-06.2006; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Xiong B, 2013, TRENDS NEUROSCI, V36, P652, DOI 10.1016/j.tins.2013.08.003; XU T, 1993, DEVELOPMENT, V117, P1223; Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	62	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144925	10.1371/journal.pone.0144925	http://dx.doi.org/10.1371/journal.pone.0144925			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659849	gold, Green Published			2022-12-27	WOS:000366715900150
J	Kronen, M; Berg, IA				Kronen, Miriam; Berg, Ivan A.			Mesaconase/Fumarase FumD in Escherichia coli O157:H7 and Promiscuity of Escherichia coli Class I Fumarases FumA and FumB	PLOS ONE			English	Article							3-METHYLASPARTATE AMMONIA-LYASE; BACTERIUM RHODOSPIRILLUM-RUBRUM; L-CITRAMALATE HYDROLYASE; ISOLEUCINE BIOSYNTHESIS; CLOSTRIDIUM-TETANOMORPHUM; METHYLOBACTERIUM-EXTORQUENS; CITRATE LYASE; PATHWAY; CYCLE; PURIFICATION	Mesaconase catalyzes the hydration of mesaconate (methylfumarate) to (S)-citramalate. The enzyme participates in the methylaspartate pathway of glutamate fermentation as well as in the metabolism of various C-5-dicarboxylic acids such as mesaconate or L-threo-beta-methylmalate. We have recently shown that Burkholderia xenovorans uses a promiscuous class I fumarase to catalyze this reaction in the course of mesaconate utilization. Here we show that classical Escherichia coli class I fumarases A and B (FumA and FumB) are capable of hydrating mesaconate with 4% (FumA) and 19% (FumB) of the catalytic efficiency k(cat)/K-m, compared to the physiological substrate fumarate. Furthermore, the genomes of 14.8% of sequenced Enterobacteriaceae (26.5% of E. coli, 90.6% of E. coli O157:H7 strains) possess an additional class I fumarase homologue which we designated as fumarase D (FumD). All these organisms are (opportunistic) pathogens. fumD is clustered with the key genes for two enzymes of the methylaspartate pathway of glutamate fermentation, glutamate mutase and methylaspartate ammonia lyase, converting glutamate to mesaconate. Heterologously produced FumD was a promiscuous mesaconase/fumarase with a 2- to 3-fold preference for mesaconate over fumarate. Therefore, these bacteria have the genetic potential to convert glutamate to (S)-citramalate, but the further fate of citramalate is still unclear. Our bioinformatic analysis identified several other putative mesaconase genes and revealed that mesaconases probably evolved several times from various class I fumarases independently. Most, if not all iron-dependent fumarases, are capable to catalyze mesaconate hydration.	[Kronen, Miriam; Berg, Ivan A.] Univ Freiburg, Fak Biol, Mikrobiol, D-79106 Freiburg, Germany	University of Freiburg	Berg, IA (corresponding author), Univ Freiburg, Fak Biol, Mikrobiol, Hugstetter Str 55, D-79106 Freiburg, Germany.	ivan.berg@biologie.uni-freiburg.de	Berg, Ivan/AAZ-3917-2020	Kronen, Miriam/0000-0001-8486-7872; Berg, Ivan/0000-0002-1864-4969	Deutsche Forschungsgemeinschaft [BE 4822/2-2, BE 4822/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (BE 4822/2-2 and Heisenberg Fellowship BE 4822/1-2 to I.A.B.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADIBI SA, 1973, J CLIN INVEST, V52, P1586, DOI 10.1172/JCI107335; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ASANO Y, 1994, BIOSCI BIOTECH BIOCH, V58, P223, DOI 10.1271/bbb.58.223; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Berg IA, 2009, MICROBIOLOGY+, V78, P16, DOI 10.1134/S0026261709010032; BERGMEYER HU, 1975, Z KLIN CHEM KLIN BIO, V13, P507; BLAIR AH, 1966, J BIOL CHEM, V241, P400; Boiangiu CD, 2005, J MOL MICROB BIOTECH, V10, P105, DOI 10.1159/000091558; Borjian F, 2016, ISME J, V10, P546, DOI 10.1038/ismej.2015.132; BOTT M, 1994, MOL MICROBIOL, V14, P347, DOI 10.1111/j.1365-2958.1994.tb01295.x; Bott M, 1997, ARCH MICROBIOL, V167, P78, DOI 10.1007/s002030050419; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown G, 2008, BIOCHEMISTRY-US, V47, P5724, DOI 10.1021/bi800097h; BUCKEL W, 1976, EUR J BIOCHEM, V64, P255, DOI 10.1111/j.1432-1033.1976.tb10295.x; CHARON NW, 1974, J BACTERIOL, V117, P203, DOI 10.1128/JB.117.1.203-211.1974; Degu A, 2011, PLANTA, V234, P501, DOI 10.1007/s00425-011-1411-2; EIKMANNS B, 1983, ARCH MICROBIOL, V136, P111, DOI 10.1007/BF00404783; Feliciano PR, 2012, INT J BIOL MACROMOL, V51, P25, DOI 10.1016/j.ijbiomac.2012.04.025; Flint DH, 1996, CHEM REV, V96, P2315, DOI 10.1021/cr950041r; FLINT DH, 1994, ARCH BIOCHEM BIOPHYS, V311, P509, DOI 10.1006/abbi.1994.1269; Fuchs G, 2014, J BIOTECHNOL, V192, P314, DOI 10.1016/j.jbiotec.2014.02.015; Gerike U, 1998, MICROBIOL-UK, V144, P929, DOI 10.1099/00221287-144-4-929; Herter S, 2001, J BACTERIOL, V183, P4305, DOI 10.1128/JB.183.14.4305-4316.2001; Howell DM, 1999, J BACTERIOL, V181, P331, DOI 10.1128/JB.181.1.331-333.1999; Huber H, 2008, P NATL ACAD SCI USA, V105, P7851, DOI 10.1073/pnas.0801043105; Ivanovsky RN, 1997, FEMS MICROBIOL LETT, V153, P399, DOI 10.1016/S0378-1097(97)00280-2; KATO Y, 1995, APPL MICROBIOL BIOT, V43, P901; Kato Y, 1997, ARCH MICROBIOL, V168, P457, DOI 10.1007/s002030050522; Khomyakova M, 2011, SCIENCE, V331, P334, DOI 10.1126/science.1196544; Kim OB, 2007, ARCH MICROBIOL, V188, P583, DOI 10.1007/s00203-007-0279-9; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kronen M, 2015, APPL ENVIRON MICROB, V81, P5632, DOI 10.1128/AEM.00822-15; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leroy B, 2015, MICROBIOL-SGM, V161, P1061, DOI 10.1099/mic.0.000067; Lu PL, 2013, CELL RES, V23, P635, DOI 10.1038/cr.2013.13; Mori K, 1999, BIOCHEMISTRY-US, V38, P13170, DOI 10.1021/bi9911738; Otten A, 2015, METAB ENG, V30, P156, DOI 10.1016/j.ymben.2015.06.003; Peltz ED, 2015, J TRAUMA ACUTE CARE, V78, P742, DOI 10.1097/TA.0000000000000589; REANEY SK, 1993, J GEN MICROBIOL, V139, P403, DOI 10.1099/00221287-139-3-403; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Risso C, 2008, J BACTERIOL, V190, P2266, DOI 10.1128/JB.01841-07; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sasikaran J, 2014, NAT CHEM BIOL, V10, P371, DOI 10.1038/nchembio.1482; Schneider K, 2000, BIOCHEMISTRY-US, V39, P9438, DOI 10.1021/bi000401r; SHIBATA H, 1985, J BACTERIOL, V164, P762, DOI 10.1128/JB.164.2.762-768.1985; Shimoyama T, 2007, FEMS MICROBIOL LETT, V270, P207, DOI 10.1111/j.1574-6968.2007.00665.x; Sonntag F, 2015, APPL MICROBIOL BIOT, V99, P3407, DOI 10.1007/s00253-015-6418-3; Sonntag F, 2014, APPL MICROBIOL BIOT, V98, P4533, DOI 10.1007/s00253-013-5456-y; Steinmetz PA, 2014, MOL MICROBIOL, V94, P218, DOI 10.1111/mmi.12759; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SUZUKI S, 1977, J BIOCHEM-TOKYO, V81, P1917, DOI 10.1093/oxfordjournals.jbchem.a131654; SUZUKI S, 1976, J BIOCHEM-TOKYO, V80, P867, DOI 10.1093/oxfordjournals.jbchem.a131349; Textor S, 1997, ARCH MICROBIOL, V168, P428, DOI 10.1007/s002030050518; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tseng CP, 2001, J BACTERIOL, V183, P461, DOI 10.1128/JB.183.2.461-467.2001; van Vugt-Lussenburg BMA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055549; van Vugt-Lussenburg BMA, 2009, MICROBIOL-SGM, V155, P3015, DOI 10.1099/mic.0.030320-0; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; VanKuijk BLM, 1996, ARCH MICROBIOL, V165, P126; Veetil VP, 2012, BIOCHEMISTRY-US, V51, P4237, DOI 10.1021/bi300430j; WANG CC, 1969, J BIOL CHEM, V244, P2516; WANG CC, 1969, J BIOL CHEM, V244, P2527; Wang JY, 2015, METAB ENG, V30, P190, DOI 10.1016/j.ymben.2015.06.001; WOODS SA, 1988, BIOCHIM BIOPHYS ACTA, V954, P14, DOI 10.1016/0167-4838(88)90050-7; Xu H, 2004, J BACTERIOL, V186, P5400, DOI 10.1128/JB.186.16.5400-5409.2004; YUMOTO N, 1988, BIOCHEM BIOPH RES CO, V153, P1236, DOI 10.1016/S0006-291X(88)81360-3; ZEHR BD, 1989, ANAL BIOCHEM, V182, P157, DOI 10.1016/0003-2697(89)90734-3	68	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145098	10.1371/journal.pone.0145098	http://dx.doi.org/10.1371/journal.pone.0145098			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658641	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900183
J	Li, XM; Su, XO				Li, Xiaomin; Su, Xiaoou			Assessment of the Polychlorinated Biphenyl (PCB) Occurrence in Copper Sulfates and the Influential Role of PCB Levels on Grapes	PLOS ONE			English	Article							DIBENZO-P-DIOXINS; POLYBROMINATED DIPHENYL ETHERS; DIETARY EXPOSURE; AREA; CHINA; PCDD/FS; SAMPLES; SOIL; TEMPERATURE; PCDD/PCDF	Copper sulfates (CuSO4) are widely used as the primary component of fungicides in the grape industry. The agricultural-grade CuSO4 that we collected from Chinese nationwide markets were found to be contaminated by polychlorinated dibenzo-p-dioxins and dibenzofurans and high levels of polychlorinated biphenyls (Sigma(19)PCBs: 0.32 similar to 9.51 ng/g). In the following research, we studied the impact of CuSO4 application on PCB levels in grape products through a field experiment, and conducted a national survey to speculate the role that CuSO4 played on the occurrence of PCB in grapes. In the field experiment, an obvious increase of PCBs in grape leaves (from 174 to 250 pg/g fw) was observed after Bordeaux mixture (the main component of which is CuSO4) application. As to the main PCB congener in CuSO4, the most toxic CB 126 (toxic equivalency factor = 0.1) also increased in grape peels (from 1.66 to 2.93 pg/g fw) after pesticide spray. Both the correlation study and the principal component analysis indicated that environmental factors were dominant PCB contributors to grapes, and grapes from e-waste dismantling area containing the highest PCBs also proved the notion. It is worth noting that this report describes the first research examining PCBs in CuSO4 and its influence on agricultural products to date.	[Li, Xiaomin; Su, Xiaoou] Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Beijing 100081, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS	Li, XM (corresponding author), Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Beijing 100081, Peoples R China.	lixiaomin@caas.cn; suxiaoou@caas.cn	Li, Xiaomin/ABI-2638-2020	Li, Xiaomin/0000-0002-9037-211X	special Fund for Agro-scientific Research in the Public Interest [201203088]; National Natural Science Foundation of China [21307157]; State Key Laboratory of Environmental Chemistry and Ecotoxicology [KF2012-08]	special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Environmental Chemistry and Ecotoxicology	The special Fund for Agro-scientific Research in the Public Interest (201203088) sponsored the rent of the experimental site and article publishment. (SXO) NRLs: www.moa.gov.cn/. The National Natural Science Foundation of China (NO. 21307157) sponsored the standard purchase and reagent and material purchase. (LXM) NRLs: www.nsfc.gov.cn/. The State Key Laboratory of Environmental Chemistry and Ecotoxicology (KF2012-08) sponsored sample collection, reagent and material purchase and analysis cost. (LXM) NRLs: et.rcees.ac.cn/.	Altarawneh M, 2009, PROG ENERG COMBUST, V35, P245, DOI 10.1016/j.pecs.2008.12.001; Aries E, 2006, CHEMOSPHERE, V65, P1470, DOI 10.1016/j.chemosphere.2006.04.020; Aslan S, 2010, CHEMOSPHERE, V80, P1213, DOI 10.1016/j.chemosphere.2010.06.008; Bocio A, 2005, ENVIRON RES, V97, P1, DOI 10.1016/j.envres.2004.01.012; Brun LA, 2001, ENVIRON POLLUT, V111, P293, DOI 10.1016/S0269-7491(00)00067-1; Chaignon V, 2003, ENVIRON POLLUT, V123, P229, DOI 10.1016/S0269-7491(02)00374-3; Chen JW, 2006, ENVIRON POLLUT, V144, P510, DOI 10.1016/j.envpol.2006.01.039; Fu JJ, 2012, CHEMOSPHERE, V88, P330, DOI 10.1016/j.chemosphere.2012.03.006; Grassi P, 2010, CHEMOSPHERE, V79, P292, DOI 10.1016/j.chemosphere.2010.01.028; Haws LC, 2006, TOXICOL SCI, V89, P4, DOI 10.1093/toxsci/kfi294; HERMANSON MH, 2015, US ENV SCI TECHNOL, V49, P855; HULSTER A, 1994, ENVIRON SCI TECHNOL, V28, P1110, DOI 10.1021/es00055a021; Komp P, 1997, ENVIRON SCI TECHNOL, V31, P886, DOI 10.1021/es960590u; Li YM, 2009, ENVIRON SCI TECHNOL, V43, P1030, DOI 10.1021/es802138w; Liu HX, 2006, ANAL CHIM ACTA, V557, P314, DOI 10.1016/j.aca.2005.10.001; Liu PY, 2015, CHEMOSPHERE, V118, P253, DOI 10.1016/j.chemosphere.2014.09.037; Lu DS, 2015, CHEMOSPHERE, V137, P14, DOI 10.1016/j.chemosphere.2015.04.043; Mihats D, 2015, CHEMOSPHERE, V126, P53, DOI 10.1016/j.chemosphere.2015.02.006; Moolenaar SW, 1998, J ENVIRON QUAL, V27, P828, DOI 10.2134/jeq1998.00472425002700040017x; MULLER JF, 1993, CHEMOSPHERE, V27, P195, DOI 10.1016/0045-6535(93)90293-E; Ogura I, 2004, ENVIRON SCI TECHNOL, V38, P3279, DOI 10.1021/es0354622; Okay OS, 2009, CHEMOSPHERE, V76, P159, DOI 10.1016/j.chemosphere.2009.03.051; Pan Y, 2013, CHEMOSPHERE, V92, P765, DOI 10.1016/j.chemosphere.2013.04.003; Papadopoulos A, 2004, CHEMOSPHERE, V57, P413, DOI 10.1016/j.chemosphere.2004.07.006; Pozo K, 2006, ENVIRON SCI TECHNOL, V40, P4867, DOI 10.1021/es060447t; Schmid P, 2005, CHEMOSPHERE, V58, P227, DOI 10.1016/j.chemosphere.2004.08.045; United Nation Environment Program (UNEP), STOCKH CONV PERS ORG; Van den Berg M, 1998, ENVIRON HEALTH PERSP, V106, P775, DOI 10.1289/ehp.98106775; Wagrowski DM, 1998, ENVIRON SCI TECHNOL, V32, P2389, DOI 10.1021/es9706920; Wang P, 2014, SCI REP-UK, V4, DOI 10.1038/srep05975; Wen S, 2009, CHEMOSPHERE, V74, P981, DOI 10.1016/j.chemosphere.2008.10.002; WHO (World Health Organization), 1998, ASS HLTH RISK DIOX R; Xing GH, 2010, CHEMOSPHERE, V81, P1239, DOI 10.1016/j.chemosphere.2010.09.032; Xing Y, 2005, CHEMOSPHERE, V60, P731, DOI 10.1016/j.chemosphere.2005.05.001; Yeo HG, 2004, SCI TOTAL ENVIRON, V324, P261, DOI 10.1016/j.scitotenv.2003.10.031; Zhang Z, 2008, ENVIRON SCI TECHNOL, V42, P6514, DOI 10.1021/es8004078; Zheng MH, 1996, CHEMOSPHERE, V32, P595	37	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144896	10.1371/journal.pone.0144896	http://dx.doi.org/10.1371/journal.pone.0144896			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658158	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900141
J	Rivera-Perez, JI; Cano, RJ; Narganes-Storde, Y; Chanlatte-Baik, L; Toranzos, GA				Rivera-Perez, Jessica I.; Cano, Raul J.; Narganes-Storde, Yvonne; Chanlatte-Baik, Luis; Toranzos, Gary A.			Retroviral DNA Sequences as a Means for Determining Ancient Diets	PLOS ONE			English	Article							MOLECULAR ANALYSIS; DIVERSITY	For ages, specialists from varying fields have studied the diets of the primeval inhabitants of our planet, detecting diet remains in archaeological specimens using a range of morphological and biochemical methods. As of recent, metagenomic ancient DNA studies have allowed for the comparison of the fecal and gut microbiomes associated to archaeological specimens from various regions of the world; however the complex dynamics represented in those microbial communities still remain unclear. Theoretically, similar to eukaryote DNA the presence of genes from key microbes or enzymes, as well as the presence of DNA from viruses specific to key organisms, may suggest the ingestion of specific diet components. In this study we demonstrate that ancient virus DNA obtained from coprolites also provides information reconstructing the host's diet, as inferred from sequences obtained from pre-Columbian coprolites. This depicts a novel and reliable approach to determine new components as well as validate the previously suggested diets of extinct cultures and animals. Furthermore, to our knowledge this represents the first description of the eukaryotic viral diversity found in paleofaeces belonging to pre-Columbian cultures.	[Rivera-Perez, Jessica I.; Toranzos, Gary A.] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA; [Cano, Raul J.] Calif Polytech State Univ San Luis Obispo, Dept Biol Sci, Ctr Applicat Biotechnol, San Luis Obispo, CA 93407 USA; [Narganes-Storde, Yvonne; Chanlatte-Baik, Luis] Univ Puerto Rico, Ctr Archaeol Res, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; California State University System; California Polytechnic State University San Luis Obispo; University of Puerto Rico	Rivera-Perez, JI (corresponding author), Univ Puerto Rico, Dept Biol, Rio Piedras Campus, San Juan, PR 00936 USA.	jessica.i.rivera88@gmail.com			Research Initiative for Scientific Enhancement Program of the University of Puerto Rico (UPR), NIH Grant [5R25GM061151-13]; Department of Defense (DOD Grant) [W911NF-11-1-0218]; Steve Massey (Laboratory of Bioinformatics, UPR); Department of Biology of the UPR; Dean's office	Research Initiative for Scientific Enhancement Program of the University of Puerto Rico (UPR), NIH Grant; Department of Defense (DOD Grant); Steve Massey (Laboratory of Bioinformatics, UPR); Department of Biology of the UPR; Dean's office	This study was partially funded by the Research Initiative for Scientific Enhancement Program of the University of Puerto Rico (UPR), NIH Grant No. 5R25GM061151-13. Funds for sequencing came from a Department of Defense grant to the University of Puerto Rico (DOD Grant No. W911NF-11-1-0218) and from Steve Massey (Laboratory of Bioinformatics, UPR). Additional funds came from the Department of Biology of the UPR and the Dean's office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso CL, 2000, J VIROL, V74, P3815, DOI 10.1128/JVI.74.8.3815-3831.2000; Alcover JA, 1999, BIOL J LINN SOC, V66, P57, DOI 10.1006/bijl.1998.0260; Alvarez AJ, 1996, ENVIRON TOXIC WATER, V11, P129, DOI 10.1002/(SICI)1098-2256(1996)11:2<129::AID-TOX8>3.0.CO;2-B; [Anonymous], 1996, J ARCHAEOL METHOD TH, DOI [10.1007/BF02229401, DOI 10.1007/BF02229401]; Appelt S, 2014, APPL ENVIRON MICROB, V80, P2648, DOI 10.1128/AEM.03242-13; Appelt S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088376; Boeke J, 1997, RETROVIRUSES, P1; Bolte AL, 1999, AVIAN PATHOL, V28, P415, DOI 10.1080/03079459994434; Brace S, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2371; Cano RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106833; Cano RJ, 2000, AM J PHYS ANTHROPOL, V112, P297; Canter Ronald. Yucatan Channel and Trade, 2006, FAMSI J ANC AM; Chanlatte Baik L, 2005, CULTURA LA HUECA; Chanlatte-Baik L, 1983, VIEQUES PUERTO RICO; Cotton B, 2013, LAS VEGAS WORLDCOMP, V2013, P1; Crisp A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0607-3; de Araujo A.J.G., 1985, Memorias do Instituto Oswaldo Cruz, V80, P141, DOI 10.1590/S0074-02761985000200003; de las Casas FB, 1967, APOLOGETICA HIST SUM, VII; Drancourt Michel, 2008, P55; Fulton T, 2014, ANCIENT DNA METHODS; Gilbert C, 2010, NATURE, V464, P1347, DOI 10.1038/nature08939; Hofreiter M, 2000, MOL ECOL, V9, P1975, DOI 10.1046/j.1365-294X.2000.01106.x; Hollocher TC, 2014, SOC SEDIMENT GEOL, V16, P547; HORNE PD, 1985, J ARCHAEOL SCI, V12, P299, DOI 10.1016/0305-4403(85)90035-4; Laffoon JE, 2014, J ANTHROPOL ARCHAEOL, V35, P220, DOI 10.1016/j.jaa.2014.06.004; Leach JD, 2010, BRIT J NUTR, V103, P1558, DOI 10.1017/S0007114510000966; Lee A, 2013, PHIL T R SOC B, V368, P1; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Minot S, 2013, P NATL ACAD SCI USA, V110, P12450, DOI 10.1073/pnas.1300833110; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Narganes-Sorde Y, 2002, CULTURA SALADOIDE PU; Nelson PN, 2004, CLIN EXP IMMUNOL, V138, P1, DOI 10.1111/j.1365-2249.2004.02592.x; Nelson PN, 2003, J CLIN PATHOL-MOL PA, V56, P11, DOI 10.1136/mp.56.1.11; Ng TFF, 2014, P NATL ACAD SCI USA, V111, P16842, DOI 10.1073/pnas.1410429111; Oviedo F de, HIST GEN NATURAL IND; Pagan-Jimenez J, 2007, ARCHAEOPRESS PUBLISH; Poinar HN, 2001, P NATL ACAD SCI USA, V98, P4317, DOI 10.1073/pnas.061014798; Ramos Reniel Rodriguez, 2013, Life-The Excitement of Biology, V1, P83, DOI 10.9784/LEB1(1)Rodriguez.09; REINHARD KJ, 1988, HOMO, V37, P217; Santiago-Rodriguez TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065191; Sistiaga A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101045; Song WJ, 2004, J VIROL, V78, P12576, DOI 10.1128/JVI.78.22.12576-12590.2004; Tito RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051146; Turvey ST, 2007, BIOL LETTERS, V3, P193, DOI 10.1098/rsbl.2006.0585; Weiss RA, 2013, PHIL T R SOC B, V368, P1; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813	46	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144951	10.1371/journal.pone.0144951	http://dx.doi.org/10.1371/journal.pone.0144951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660678	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900154
J	Xie, F; Varghese, F; Pakhomov, AG; Semenov, I; Xiao, S; Philpott, J; Zemlin, C				Xie, Fei; Varghese, Frency; Pakhomov, Andrei G.; Semenov, Iurii; Xiao, Shu; Philpott, Jonathan; Zemlin, Christian			Ablation of Myocardial Tissue With Nanosecond Pulsed Electric Fields	PLOS ONE			English	Article							PULMONARY VEIN STENOSIS; RADIOFREQUENCY CATHETER ABLATION; ATRIAL-FIBRILLATION ABLATION; PARKINSON-WHITE-SYNDROME; OF-THE-ART; IRREVERSIBLE ELECTROPORATION; SUPRA-ELECTROPORATION; LESION DEPTH; THERAPY; SAFETY	Background Ablation of cardiac tissue is an essential tool for the treatment of arrhythmias, particularly of atrial fibrillation, atrial flutter, and ventricular tachycardia. Current ablation technologies suffer from substantial recurrence rates, thermal side effects, and long procedure times. We demonstrate that ablation with nanosecond pulsed electric fields (nsPEFs) can potentially overcome these limitations. Methods We used optical mapping to monitor electrical activity in Langendorff-perfused New Zealand rabbit hearts (n = 12). We repeatedly inserted two shock electrodes, spaced 2-4 mm apart, into the ventricles (through the entire wall) and applied nanosecond pulsed electric fields (nsPEF) (5-20 kV/cm, 350 ns duration, at varying pulse numbers and frequencies) to create linear lesions of 12-18 mm length. Hearts were stained either with tetrazolium chloride (TTC) or propidium iodide (PI) to determine the extent of ablation. Some stained lesions were sectioned to obtain the three-dimensional geometry of the ablated volume. Results In all animals (12/12), we were able to create nonconducting lesions with less than 2 seconds of nsPEF application per site and minimal heating (<0.2 degrees C) of the tissue. The geometry of the ablated volume was smoother and more uniform throughout the wall than typical for RF ablation. The width of the lesions could be controlled up to 6 mm via the electrode spacing and the shock parameters. Conclusions Ablation with nsPEFs is a promising alternative to radiofrequency (RF) ablation of AF. It may dramatically reduce procedure times and produce more consistent lesion thickness than RF ablation.	[Xie, Fei; Varghese, Frency; Zemlin, Christian] Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA 23529 USA; [Xie, Fei; Varghese, Frency; Pakhomov, Andrei G.; Semenov, Iurii; Xiao, Shu; Zemlin, Christian] Old Dominion Univ, Ctr Bioelect, Norfolk, VA USA; [Philpott, Jonathan] Eastern Virginia Med Sch, Dept Surg, Norfolk, VA 23501 USA	Old Dominion University; Old Dominion University; Eastern Virginia Medical School	Zemlin, C (corresponding author), Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA 23529 USA.	czemlin@odu.edu		Semenov, Iurii/0000-0002-0302-1355				Ang R, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0631-7; Arena CB, 2012, BIOPHYS J, V103, P2033, DOI 10.1016/j.bpj.2012.09.017; Bertaglia E, 2007, HEART RHYTHM, V4, P1265, DOI 10.1016/j.hrthm.2007.06.016; Chen R, 2014, EUR J CANCER, V50, P2705, DOI 10.1016/j.ejca.2014.07.006; Cummings JE, 2006, ANN INTERN MED, V144, P572, DOI 10.7326/0003-4819-144-8-200604180-00007; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Gal P, 2014, INT J CARDIOL, V176, P891, DOI 10.1016/j.ijcard.2014.08.034; Gerstenfeld ER, 2003, J CARDIOVASC ELECTR, V14, P685, DOI 10.1046/j.1540-8167.2003.03013.x; Gowrishankar TR, 2006, BIOCHEM BIOPH RES CO, V349, P643, DOI 10.1016/j.bbrc.2006.08.097; Gowrishankar TR, 2006, BIOCHEM BIOPH RES CO, V341, P1266, DOI 10.1016/j.bbrc.2006.01.094; Gowrishankar TR, 2003, P NATL ACAD SCI USA, V100, P3203, DOI 10.1073/pnas.0636434100; Hargrave B, 2013, GENE THER, V20, P151, DOI 10.1038/gt.2012.15; Holmes DR, 2009, JACC-CARDIOVASC INTE, V2, P267, DOI 10.1016/j.jcin.2008.12.014; JACKMAN WM, 1991, NEW ENGL J MED, V324, P1605, DOI 10.1056/NEJM199106063242301; Joshi R. P., 2010, Critical Reviews in Biomedical Engineering, V38, P255, DOI 10.1615/CritRevBiomedEng.v38.i3.20; Jourda F, 2015, EUROPACE, V17, P225, DOI 10.1093/europace/euu215; Kearney K, 2014, ANN CARDIOTHORAC SUR, V3, P15, DOI 10.3978/j.issn.2225-319X.2014.01.03; Khairy P, 2003, CIRCULATION, V107, P2045, DOI 10.1161/01.CIR.0000058706.82623.A1; Khan AR, 2014, CIRC-ARRHYTHMIA ELEC, V7, P853, DOI 10.1161/CIRCEP.114.001853; Kotnik T, 2000, IEEE T BIO-MED ENG, V47, P1074, DOI 10.1109/10.855935; Kuwahara T, 2014, EUROPACE, V16, P834, DOI 10.1093/europace/eut368; Lavee J, 2007, HEART SURG FORUM, V10, pE162, DOI 10.1532/HSF98.20061202; Lee G, 2012, LANCET, V380, P1509, DOI 10.1016/S0140-6736(12)61463-9; Mankowski J, 2000, IEEE T PLASMA SCI, V28, P102, DOI 10.1109/27.842875; NAKAGAWA H, 1995, CIRCULATION, V91, P2264, DOI 10.1161/01.CIR.91.8.2264; Natale A, 2013, NAT REV CARDIOL, V10, P63, DOI 10.1038/nrcardio.2012.198; Neven K, 2014, CIRC-ARRHYTHMIA ELEC, V7, P913, DOI 10.1161/CIRCEP.114.001607; Panfilov AV, 2006, HEART RHYTHM, V3, P862, DOI 10.1016/j.hrthm.2005.12.022; Pappone C, 2004, CIRCULATION, V109, P2724, DOI 10.1161/01.CIR.0000131866.44650.46; Philpott JM, 2015, ANN THORAC SURG, V100, P1541, DOI 10.1016/j.athoracsur.2015.07.006; Piccini JP, 2011, J INTERV CARD ELECTR, V32, P233, DOI 10.1007/s10840-011-9603-z; Rostamian A, 2014, J INTERV CARD ELECTR, V40, P63, DOI 10.1007/s10840-014-9885-z; Santangeli P, 2014, CIRC-ARRHYTHMIA ELEC, V7, P739, DOI 10.1161/CIRCEP.113.000629; Saviz M, 2014, J ELECT BIOIMPEDANCE, V69, P9; Scheinman MM, 2005, PACE, V28, P152, DOI 10.1111/j.1540-8159.2005.09461.x; Schleifer JW, 2013, CARDIOL CLIN, V31, P595, DOI 10.1016/j.ccl.2013.07.007; Semenov I, 2015, BBA-BIOMEMBRANES, V1848, P2118, DOI 10.1016/j.bbamem.2015.06.018; Son RS, 2014, J MEMBRANE BIOL, V247, P1209, DOI 10.1007/s00232-014-9699-z; Spragg DD, 2008, J CARDIOVASC ELECTR, V19, P627, DOI 10.1111/j.1540-8167.2008.01181.x; Wang YT, 2012, AM J PHYSIOL-HEART C, V303, pH439, DOI 10.1152/ajpheart.01121.2011; Wikswo JP, 1995, BIOPHYS J, V69, P2195, DOI 10.1016/S0006-3495(95)80115-3; Winkle RA, 2014, HEART RHYTHM, V11, P963, DOI 10.1016/j.hrthm.2014.03.013; Wittkampf FHM, 2012, CIRC-ARRHYTHMIA ELEC, V5, P581, DOI 10.1161/CIRCEP.111.970079; Woods CE, 2014, CIRC RES, V114, P1532, DOI 10.1161/CIRCRESAHA.114.302362; Wu SH, 2013, INT J CARDIOL, V169, P35, DOI 10.1016/j.ijcard.2013.08.083; Xiao DY, 2013, BIOELECTROMAGNETICS, V34, P512, DOI 10.1002/bem.21796; Yang HM, 2007, CARDIOVASC PATHOL, V16, P51, DOI 10.1016/j.carpath.2006.07.007; Yokoyama K, 2006, CIRCULATION, V113, P11, DOI 10.1161/CIRCULATIONAHA.105.540062; Zhao JC, 2015, INT J MOL SCI, V16, P10834, DOI 10.3390/ijms160510834	49	19	19	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144833	10.1371/journal.pone.0144833	http://dx.doi.org/10.1371/journal.pone.0144833			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658139	gold, Green Submitted, Green Published			2022-12-27	WOS:000366715900114
J	Lundgren, BR; Connolly, MP; Choudhary, P; Brookins-Little, TS; Chatterjee, S; Raina, R; Nomura, CT				Lundgren, Benjamin R.; Connolly, Morgan P.; Choudhary, Pratibha; Brookins-Little, Tiffany S.; Chatterjee, Snigdha; Raina, Ramesh; Nomura, Christopher T.			Defining the Metabolic Functions and Roles in Virulence of the rpoN1 and rpoN2 Genes in Ralstonia solanacearum GMI1000	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; SIGMA-FACTOR; ESCHERICHIA-COLI; SEQUENCES; ASSIMILATION; CLONING; OPERON; IDENTIFICATION; RECOGNITION; CATABOLISM	The alternative sigma factor RpoN is a unique regulator found among bacteria. It controls numerous processes that range from basic metabolism to more complex functions such as motility and nitrogen fixation. Our current understanding of RpoN function is largely derived from studies on prototypical bacteria such as Escherichia coli. Bacillus subtilis and Pseudomonas putida. Although the extent and necessity of RpoN-dependent functions differ radically between these model organisms, each bacterium depends on a single chromosomal rpoN gene to meet the cellular demands of RpoN regulation. The bacterium Ralstonia solanacearum is often recognized for being the causative agent of wilt disease in crops, including banana, peanut and potato. However, this plant pathogen is also one of the few bacterial species whose genome possesses dual rpoN genes. To determine if the rpoN genes in this bacterium are genetically redundant and interchangeable, we constructed and characterized Delta rpoN1, Delta rpoN2 and Delta rpoN1 Delta rpoN2 mutants of R. solanacearum GMI1000. It was found that growth on a small range of metabolites, including dicarboxylates, ethanol, nitrate, ornithine, proline and xanthine, were dependent on only the rpoN1 gene. Furthermore, the rpoN1 gene was required for wilt disease on tomato whereas rpoN2 had no observable role in virulence or metabolism in R. solanacearum GMI1000. Interestingly, plasmid-based expression of rpoN2 did not fully rescue the metabolic deficiencies of the Delta rpoN1 mutants; full recovery was specific to rpoN1. In comparison, only rpoN2 was able to genetically complement a Delta rpoN E. coli mutant. These results demonstrate that the RpoN1 and RpoN2 proteins are not functionally equivalent or interchangeable in R. solanacearum GMI1000.	[Lundgren, Benjamin R.; Connolly, Morgan P.; Brookins-Little, Tiffany S.; Nomura, Christopher T.] SUNY Coll Environm Sci & Forestry, Dept Chem, Syracuse, NY 13210 USA; [Choudhary, Pratibha; Chatterjee, Snigdha; Raina, Ramesh] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; [Nomura, Christopher T.] SUNY Coll Environm Sci & Forestry, Ctr Appl Microbiol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; Syracuse University; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Nomura, CT (corresponding author), SUNY Coll Environm Sci & Forestry, Dept Chem, Syracuse, NY 13210 USA.	ctnomura@esf.edu		Chatterjee, Snigdha/0000-0003-0506-7426	National Institutes of Health [R15 GM104880-01A1]; National Science Foundation [CBET 1263905]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM104880] Funding Source: NIH RePORTER; Directorate For Engineering [1263905] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by National Institutes of Health (www.nih.gov) Grant R15 GM104880-01A1 awarded to CTN and National Science Foundation (www.nsf.gov) Grant CBET 1263905 awarded to CTN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali NO, 2001, J BACTERIOL, V183, P2497; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barrios H, 1999, NUCLEIC ACIDS RES, V27, P4305, DOI 10.1093/nar/27.22.4305; Bush M, 2012, MICROBIOL MOL BIOL R, V76, P497, DOI 10.1128/MMBR.00006-12; Cannon W, 1999, GENE DEV, V13, P357, DOI 10.1101/gad.13.3.357; Chaney M, 2001, GENE DEV, V15, P2282, DOI 10.1101/gad.205501; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Conway K, 2012, SIGMA 54 PROMOTER DA; Dalsing BL, 2014, J BACTERIOL, V196, P949, DOI 10.1128/JB.01378-13; Doucleff M, 2007, J MOL BIOL, V369, P1070, DOI 10.1016/j.jmb.2007.04.019; FRUND C, 1989, J BACTERIOL, V171, P6539; Gallegos MT, 1999, J MOL BIOL, V288, P539, DOI 10.1006/jmbi.1999.2704; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; Hayward AC, 2001, LAB GUIDE IDENTIFICA, P151; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Jacobs JM, 2012, MBIO, V3, DOI 10.1128/mBio.00114-12; JENKINS LS, 1987, J BACTERIOL, V169, P2096, DOI 10.1128/jb.169.5.2096-2102.1987; Kang YW, 2002, MOL MICROBIOL, V46, P427, DOI 10.1046/j.1365-2958.2002.03187.x; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; KULLIK I, 1991, J BACTERIOL, V173, P1125, DOI 10.1128/jb.173.3.1125-1138.1991; Lundgren BR, 2014, J BACTERIOL, V196, P2543, DOI 10.1128/JB.01615-14; MACALUSO A, 1990, J BACTERIOL, V172, P7249, DOI 10.1128/jb.172.12.7249-7255.1990; MERRICK MJ, 1993, MOL MICROBIOL, V10, P903, DOI 10.1111/j.1365-2958.1993.tb00961.x; Muse WB, 1998, J BACTERIOL, V180, P1166, DOI 10.1128/JB.180.5.1166-1173.1998; NOHNO T, 1986, MOL GEN GENET, V205, P260, DOI 10.1007/BF00430437; Palacios S, 2004, MICROBIOL-SGM, V150, P3877, DOI 10.1099/mic.0.27299-0; Poggio S, 2002, MOL MICROBIOL, V46, P75, DOI 10.1046/j.1365-2958.2002.03158.x; Poggio S, 2006, J BIOL CHEM, V281, P27205, DOI 10.1074/jbc.M601735200; Ray SK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00229; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; SASSEDWIGHT S, 1990, CELL, V62, P945, DOI 10.1016/0092-8674(90)90269-K; Schobert M, 1999, MICROBIOL-SGM, V145, P471, DOI 10.1099/13500872-145-2-471; Southern E, 2000, NUCLEIC ACIDS RES, V28, P2563, DOI 10.1093/nar/28.13.2563; Studholme DJ, 2000, FEMS MICROBIOL LETT, V186, P1; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Suvorova IA, 2012, J BACTERIOL, V194, P3234, DOI 10.1128/JB.00163-12; Syed A, 1998, J BACTERIOL, V180, P5619, DOI 10.1128/JB.180.21.5619-5625.1998; Taniyama K, 2012, J BACTERIOL, V194, P1447, DOI 10.1128/JB.06590-11; Taylor M, 1996, MOL MICROBIOL, V22, P1045, DOI 10.1046/j.1365-2958.1996.01547.x; Tralau T, 2007, J BACTERIOL, V189, P6743, DOI 10.1128/JB.00889-07; Valentini M, 2011, J BACTERIOL, V193, P4307, DOI 10.1128/JB.05074-11; WONG CN, 1994, J MOL BIOL, V236, P81, DOI 10.1006/jmbi.1994.1120; Yurgel SN, 2004, FEMS MICROBIOL REV, V28, P489, DOI 10.1016/j.femsre.2004.04.002; Zimmer DP, 2000, P NATL ACAD SCI USA, V97, P14674, DOI 10.1073/pnas.97.26.14674	44	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144852	10.1371/journal.pone.0144852	http://dx.doi.org/10.1371/journal.pone.0144852			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659655	Green Submitted, gold, Green Published			2022-12-27	WOS:000366903600097
J	Woo, JS; Hwang, SJ; Kim, HS; Kim, JB; Kim, WS; Kim, KS; Jeong, MH; Kim, W				Woo, Jong Shin; Hwang, Seung Joon; Kim, Hyun Soo; Kim, Jin Bae; Kim, Woo-Shik; Kim, Kwon Sam; Jeong, Myung Ho; Kim, Weon		Korea Acute Myocardial Infarction	Effects of Statin Therapy on Clinical Outcomes of Survivors of Acute Myocardial Infarction with Severe Systolic Heart Failure	PLOS ONE			English	Article							COENZYME Q(10); ROSUVASTATIN; GUIDELINES; MANAGEMENT; MORTALITY; CHOLESTEROL	Objective Large randomized trials have failed to show a beneficial effect of statin treatment in chronic HF. The investigators tried to evaluate the long-term effects of statin therapy in patients with new onset heart failure (HF) following acute myocardial infarction (AMI). Methods Between January 2008 and December 2011, a total of 13,616 AMI patients were enrolled in the Korea Acute Myocardial Infarction Registry (KAMIR) which was a prospective, multicenter, nationwide, web-based database of AMI in Korea. From this database, we studied 1,055 patients with AMI who had newly developed severe acute HF [left ventricular ejection fraction <= 40%] and were discharged alive. The patients were divided into two groups, a statin group (n = 756) and a no-statin group (n = 299). We investigated the one-year major adverse cardiovascular events (MACEs), including all-cause mortality, MI, and any revascularization of each group. We then performed a propensity-score matched analysis. Results In the original cohort, one-year MACEs were similar between the two groups (16.5% vs. 14.7% in the statin or no-statin groups; p = 0.47). Propensity-score matching yielded 256 pairs, and in that population we observed comparable results in terms of MACEs (18.0% vs. 12.5% in the statin or no-statin groups, p = 0.11) and mortality (5.1% vs. 3.5% in the statin or no-statin groups, p = 0.51). Cox-regression analysis revealed that statin therapy was not an independent predictor for occurrence of a MACE [Hazard ratio (HR) 1.11, 95% CI 0.79-1.57, p = 0.54] or all-cause mortality (HR 1.42, 95% CI 0.75-2.70, p = 0.28). Conclusion Statin therapy was not associated with a reduction in the long-term occurrence of MACEs or mortality in survivors of AMI with severe acute HF in this retrospective cohort study.	[Woo, Jong Shin; Hwang, Seung Joon; Kim, Hyun Soo; Kim, Jin Bae; Kim, Woo-Shik; Kim, Kwon Sam; Kim, Weon] Kyung Hee Univ, Div Cardiol, Dept Internal Med, Kyung Hee Univ Hosp, Seoul, South Korea; [Jeong, Myung Ho] Chonnam Natl Univ Hosp, Div Cardiol, Dept Med, Gwangju, South Korea	Kyung Hee University; Kyung Hee University Hospital; Chonnam National University; Chonnam National University Hospital	Kim, W (corresponding author), Kyung Hee Univ, Div Cardiol, Dept Internal Med, Kyung Hee Univ Hosp, Seoul, South Korea.	mylovekw@hanmail.net		Seong, In-Whan/0000-0003-4628-0258; Jeong, Jin-Ok/0000-0003-0763-4754				Anker SD, 2006, INT J CARDIOL, V112, P234, DOI 10.1016/j.ijcard.2006.03.057; [Anonymous], BMJ; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Davignon J, 2004, CIRCULATION, V109, P39, DOI 10.1161/01.CIR.0000131517.20177.5a; Deichmann R, 2010, OCHSNER J, V10, P16; Dobre D, 2013, EUR J HEART FAIL, V15, P221, DOI 10.1093/eurjhf/hfs128; Go AS, 2006, JAMA-J AM MED ASSOC, V296, P2105, DOI 10.1001/jama.296.17.2105; Grundy SM, 2013, J CLIN LIPIDOL, V7, P561, DOI 10.1016/j.jacl.2013.10.001; Horwich TB, 2002, J CARD FAIL, V8, P216, DOI 10.1054/jcaf.2002.126519a; Kim HK, 2014, KOREAN J INTERN MED, V29, P703, DOI 10.3904/kjim.2014.29.6.703; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Krum H, 2007, INT J CARDIOL, V119, P48, DOI 10.1016/j.ijcard.2006.07.106; Kushner FG, 2009, CATHETER CARDIO INTE, V74, pE25, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; McMurray JJV, 2010, J AM COLL CARDIOL, V56, P1196, DOI 10.1016/j.jacc.2010.02.075; Molyneux SL, 2008, J AM COLL CARDIOL, V52, P1435, DOI 10.1016/j.jacc.2008.07.044; Mozaffarian D, 2004, AM J CARDIOL, V93, P1124, DOI 10.1016/j.amjcard.2004.01.039; Ramasubbu K, 2008, J AM COLL CARDIOL, V51, P415, DOI 10.1016/j.jacc.2007.10.009; Rauchhaus M, 2000, LANCET, V356, P930, DOI 10.1016/S0140-6736(00)02690-8; Rauchhaus M, 2003, J AM COLL CARDIOL, V42, P1933, DOI 10.1016/j.jacc.2003.07.016; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Sankaranarayanan Rajiv, 2010, Congest Heart Fail, V16, P181, DOI 10.1111/j.1751-7133.2010.00165.x; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	26	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144602	10.1371/journal.pone.0144602	http://dx.doi.org/10.1371/journal.pone.0144602			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658751	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903600063
J	Tsai, JR; Liu, PL; Chen, YH; Chou, SH; Cheng, YJ; Hwang, JJ; Chong, IW				Tsai, Jong-Rung; Liu, Po-Len; Chen, Yung-Hsiang; Chou, Shah-Hwa; Cheng, Yu-Jen; Hwang, Jhi-Jhu; Chong, Inn-Wen			Curcumin Inhibits Non-Small Cell Lung Cancer Cells Metastasis through the Adiponectin/NF-kappa b/MMPs Signaling Pathway	PLOS ONE			English	Article							INDUCED APOPTOSIS; PROSTATE-CANCER; DOWN-REGULATION; NUDE-MICE; B PATHWAY; EXPRESSION; ADENOCARCINOMA; INVASION; RESISTIN; LEPTIN	Adipose tissue is now considered as an endocrine organ involved in metabolic and inflammatory reactions. Adiponectin, a 244-amino acid peptide hormone, is associated with insulin resistance and carcinogenesis. Curcumin (diferuloylmethane) is the principal curcuminoid of the popular Indian spice, turmeric. Curcumin possesses antitumor effects, including the inhibition of neovascularization and regulation of cell cycle and apoptosis. However, the effects of adiponectin and curcumin on non-small cell lung cancer (NSCLC) remain unclear. In this study, we evaluated the expression of adiponectin in paired tumors and normal lung tissues from 77 patients with NSCLC using real-time polymerase chain reaction, western blotting, and immunohistochemistry. Kaplan-Meier survival analysis showed that patients with low adiponectin expression ratio (<1) had significantly longer survival time than those with high expression ratio (>1) (p = 0.015). Curcumin inhibited the migratory and invasive ability of A549 cells via the inhibition of adiponectin expression by blocking the adiponectin receptor 1. Curcumin treatment also inhibited the in vivo tumor growth of A549 cells and adiponectin expression. These results suggest that adiponectin can be a prognostic indicator of NSCLC. The effect of curcumin in decreasing the migratory and invasive ability of A549 cells by inhibiting adiponectin expression is probably mediated through NF-kappa B/MMP pathways. Curcumin could be an important potential adjuvant therapeutic agent for lung cancer in the future.	[Tsai, Jong-Rung; Liu, Po-Len; Chou, Shah-Hwa; Hwang, Jhi-Jhu; Chong, Inn-Wen] Kaohsiung Med Univ, Dept Resp Therapy, Coll Med, Kaohsiung, Taiwan; [Tsai, Jong-Rung; Hwang, Jhi-Jhu] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Yung-Hsiang] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Chou, Shah-Hwa] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Chest Surg, Kaohsiung, Taiwan; [Cheng, Yu-Jen] I Shou Univ, Dept Hlth Management, Div Thorac Surg, Dept Surg,E Da Hosp, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; E-Da Hospital; I Shou University	Chong, IW (corresponding author), Kaohsiung Med Univ, Dept Resp Therapy, Coll Med, Kaohsiung, Taiwan.	chong@kmu.edu.tw	Chen, Yung-Hsiang/K-6766-2015	Chen, Yung-Hsiang/0000-0002-8756-5113; Tsai, Jong rung/0000-0002-3222-0409	National Science Council of R.O.C, Taiwan [NSC 100 - 2320 - B - 037 - 012 - MY2, NSC 100-2320-B-037-012-MY2]	National Science Council of R.O.C, Taiwan	This study was supported by the grants NSC 100 - 2320 - B - 037 - 012 - MY2 from the National Science Council of R.O.C, Taiwan to Jong-Rung Tsai. The National Science Council of R.O.C, Taiwan is a government organization which is external to the authors' university. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the grants NSC 100-2320-B-037-012-MY2 from the National Science Council of R.O.C, Taiwan to Jong-Rung Tsai. The National Science Council of R.O.C, Taiwan is a government organization which is external to our university. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghafar J, 2013, TOHOKU J EXP MED, V229, P153, DOI 10.1620/tjem.229.153; Aggarwal BB, 2005, CLIN CANCER RES, V11, P7490, DOI 10.1158/1078-0432.CCR-05-1192; Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Barb D, 2007, AM J CLIN NUTR, V86, p858S, DOI 10.1093/ajcn/86.3.858S; Barb D, 2006, EXPERT OPIN INV DRUG, V15, P917, DOI 10.1517/13543784.15.8.917; Brakenhielm E, 2004, P NATL ACAD SCI USA, V101, P2476, DOI 10.1073/pnas.0308671100; Chen HW, 2008, CANCER RES, V68, P7428, DOI 10.1158/0008-5472.CAN-07-6734; Chen QY, 2010, ONCOL REP, V23, P1285, DOI 10.3892/or_00000762; Chiu YC, 2009, CARCINOGENESIS, V30, P1651, DOI 10.1093/carcin/bgp156; Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; Gottschling S, 2012, CANCER GENOM PROTEOM, V9, P275; Hong JH, 2006, PROSTATE CANCER P D, V9, P147, DOI 10.1038/sj.pcan.4500856; Housa D, 2008, PHYSIOL RES, V57, P451, DOI 10.33549/physiolres.931156; Ishikawa M, 2007, CANCER SCI, V98, P1120, DOI 10.1111/j.1349-7006.2007.00486.x; Karapanagiotou EM, 2008, LUNG CANCER, V61, P391, DOI 10.1016/j.lungcan.2008.01.018; Kerenidi T, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0507-x; Koerner A, 2005, BEST PRACT RES CL EN, V19, P525, DOI 10.1016/j.beem.2005.07.008; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Lee YK, 2009, ANN NY ACAD SCI, V1171, P489, DOI 10.1111/j.1749-6632.2009.04699.x; Li YG, 2012, FEBS J, V279, P2247, DOI 10.1111/j.1742-4658.2012.08607.x; Liu PL, 2010, MOL NUTR FOOD RES, V54, pS196, DOI 10.1002/mnfr.200900550; MacDougald OA, 2007, CELL METAB, V6, P159, DOI 10.1016/j.cmet.2007.08.010; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; Man K, 2010, CLIN CANCER RES, V16, P967, DOI 10.1158/1078-0432.CCR-09-1487; Mareel M, 2006, ACTA CHIR BELG, V106, P635; Meier U, 2004, CLIN CHEM, V50, P1511, DOI 10.1373/clinchem.2004.032482; MENON LG, 1995, CANCER LETT, V95, P221, DOI 10.1016/0304-3835(95)03887-3; Menon LG, 1999, CANCER LETT, V141, P159, DOI 10.1016/S0304-3835(99)00098-1; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Negi PS, 1999, J AGR FOOD CHEM, V47, P4297, DOI 10.1021/jf990308d; Petridou ET, 2007, ONCOLOGY-BASEL, V73, P261, DOI 10.1159/000127424; Petridou ET, 2011, METABOLISM, V60, P1100, DOI 10.1016/j.metabol.2010.12.002; Prasad S, 2014, CANCER RES TREAT, V46, P2, DOI 10.4143/crt.2014.46.1.2; Sarhadi V, 2006, J PATHOL, V209, P206, DOI 10.1002/path.1960; SATOSKAR RR, 1986, INT J CLIN PHARM TH, V24, P651; Shehzad A, 2013, BIOFACTORS, V39, P27, DOI 10.1002/biof.1065; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Tsai JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091331; Ukkola O, 2002, J MOL MED, V80, P696, DOI 10.1007/s00109-002-0378-7; Watson JL, 2010, MOL CARCINOGEN, V49, P13, DOI 10.1002/mc.20571; Wikman H, 2002, ONCOGENE, V21, P5804, DOI 10.1038/sj.onc.1205726; Wu SH, 2010, ANTICANCER RES, V30, P2125; Ziemke F, 2010, AM J CLIN NUTR, V91, p258S, DOI 10.3945/ajcn.2009.28449C	44	62	64	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144462	10.1371/journal.pone.0144462	http://dx.doi.org/10.1371/journal.pone.0144462			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26656720	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903500028
J	Ferreira, RB; Faivovich, J; Beard, KH; Pombal, JP				Ferreira, Rodrigo B.; Faivovich, Julian; Beard, Karen H.; Pombal, Jose P., Jr.			The First Bromeligenous Species of Dendropsophus (Anura: Hylidae) from Brazil's Atlantic Forest	PLOS ONE			English	Article							ESPIRITO-SANTO; AMAZON BASIN; PHYLOGENETIC-RELATIONSHIPS; RAIN-FOREST; SOUTHEASTERN; HYLA; AMPHIBIA; TREEFROG; FROG; BROMELIADS	We describe a new treefrog species of Dendropsophus collected on rocky outcrops in the Brazilian Atlantic Forest. Ecologically, the new species can be distinguished from all known congeners by having a larval phase associated with rainwater accumulated in bromeliad phytotelms instead of temporary or lentic water bodies. Phylogenetic analysis based on molecular data confirms that the new species is a member of Dendropsophus; our analysis does not assign it to any recognized species group in the genus. Morphologically, based on comparison with the 96 known congeners, the new species is diagnosed by its small size, framed dorsal color pattern, and short webbing between toes IV-V. The advertisement call is composed of a moderate-pitched two-note call (similar to 5 kHz). The territorial call contains more notes and pulses than the advertisement call. Field observations suggest that this new bromeligenous species uses a variety of bromeliad species to breed in, and may be both territorial and exhibit male parental care.	[Ferreira, Rodrigo B.; Beard, Karen H.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Ferreira, Rodrigo B.; Beard, Karen H.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Ferreira, Rodrigo B.] Univ Vila Velha, Lab Ecol Populacoes & Conservacao, Vila Velha, ES, Brazil; [Faivovich, Julian] Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Herpetol, Buenos Aires, DF, Argentina; [Faivovich, Julian] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Buenos Aires, DF, Argentina; [Pombal, Jose P., Jr.] Univ Fed Rio de Janeiro, Museu Nacl, Dept Vertebrados, Rio De Janeiro, RJ, Brazil	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Centro Universitario Vila Velha; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); University of Buenos Aires; Universidade Federal do Rio de Janeiro	Ferreira, RB (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.	rodrigoecologia@yahoo.com.br	Faivovich, Julián/A-9887-2008; Pombal, Jose P/C-6365-2015; Beard, Karen/B-7177-2011	Pombal, Jose P/0000-0003-4900-630X; Beard, Karen/0000-0003-4997-2495; Faivovich, Julian/0000-0001-7157-8131; Ferreira, Rodrigo/0000-0001-6099-5116	Herpetologists' League, Ecology Center at Utah State University; Dr. Dinesh and Kalpana Patel Fellowship; IdeaWild; Jack Berryman Institute; Rufford Foundation; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICTs 2011-1895, 2013-404]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 1112008010 2422]; Sao Paulo Research Foundation (FAPESP) [2012/10000-5, 2013/50741-7]; CNPq; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Utah Agricultural Experiment Station, Utah State University; Centro Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [231020/2013-9]	Herpetologists' League, Ecology Center at Utah State University; Dr. Dinesh and Kalpana Patel Fellowship; IdeaWild; Jack Berryman Institute; Rufford Foundation; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Utah Agricultural Experiment Station, Utah State University; Centro Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	RBF received funding from The Herpetologists' League, Ecology Center at Utah State University, Dr. Dinesh and Kalpana Patel Fellowship, IdeaWild, Jack Berryman Institute, the Rufford Foundation and Centro Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; 231020/2013-9). JF thanks Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT; PICTs 2011-1895, 2013-404), the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET; PIP 1112008010 2422), and Sao Paulo Research Foundation (FAPESP; 2012/10000-5 and 2013/50741-7). JPP received financial support from CNPq and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). This research was supported by the Utah Agricultural Experiment Station, Utah State University, and approved as journal paper number 8807. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHL ERNST, 1933, ZOOL ANZ, V104, P25; Almeida Antonio de Padua, 2011, Check List, V7, P542; American and Veterinary Medical Association, 2013, GUID EUTH AN, P102; [Anonymous], 2014, R LANG ENV STAT COMP; Audacity Team, 2014, AUDACITY R FREE AUDI; Bokermann W., 1964, NEOTROPICA, V10, P2; Bokermann W. C. A., 1962, Neotropica, V8, P81; BOKERMANN W C A, 1968, Journal of Herpetology, V1, P25, DOI 10.2307/1563259; BOKERMANN WERNER C. A., 1962, ATAS SOC BIOL RIO DE JANEIRO, V6, P52; Canedo Clarissa, 2010, South American Journal of Herpetology, V5, P199, DOI 10.2994/057.005.0305; CARAMASCHI U, 1983, Revista Brasileira de Biologia, V43, P195; Carvalho-e-Silva Sergio Potsch, 2003, Rev. Bras. Zool., V20, P553, DOI 10.1590/S0101-81752003000300029; CEBEA/CFMV-Comissao de Etica Bioetica e Bem-Estar Animal, 2013, GUIA BRAS BOAS PRAT, P22; Cochran D.M., 1970, B US NATL MUSEUM, V288, P1, DOI DOI 10.5962/BHL.PART.6346; Cruz C.A.G., 2000, B MUSEU NACL, V434, P1; DUELLMAN W E, 1978, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Duellman W.E., 1983, P33; DUELLMAN W E, 1973, Herpetologica, V29, P219; DUELLMAN W E, 1982, Amphibia-Reptilia, V3, P153, DOI 10.1163/156853882X00383; Duellman W.E., 1970, Monograph Mus nat Hist Univ Kans, V1, P1; DUELLMAN W E, 1969, Herpetologica, V25, P241; Duellman W.E., 1974, Occasional Papers Mus Nat Hist Univ Kans, VNo. 23, P1; Duellman W. E., 1986, BIOL AMPHIBIANS; Duellman WE, 2001, HYLID FROGS MIDDLE A; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Faivovich J, 2014, S AM J HERPETOL, V9, P207, DOI 10.2994/SAJH-D-14-00032.1; Farris JS, 1996, CLADISTICS, V12, P99, DOI 10.1111/j.1096-0031.1996.tb00196.x; Ferreira RB, 2012, J HERPETOL, V46, P19, DOI 10.1670/09-040; Ferreira RB, 2012, IHERINGIA SER ZOOL, V102, P163, DOI 10.1590/S0073-47212012000200008; Fouquet A, 2011, ZOOTAXA, P59, DOI 10.11646/zootaxa.3035.1.3; Frost D. R., 2015, AMPHIBIAN SPECIES WO; Gehara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103958; Goin CJ, 1966, Q J FLORIDA ACAD SCI, V29, P29; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goloboff P, 2008, CLADISTICS, V24, P91; Gomes M, 1966, IHERINGIA SER ZOOL, V80, P33; Guarnizo CE, 2012, HERPETOLOGICA, V68, P523, DOI 10.1655/HERPETOLOGICA-D-10-00038; Haddad CFB, 2005, BIOSCIENCE, V55, P207, DOI 10.1641/0006-3568(2005)055[0207:RMIFAT]2.0.CO;2; Haddad CFB, 2013, ANFIBIOS MATA ATLANT; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HEYER W R, 1977, Papeis Avulsos de Zoologia (Sao Paulo), V31, P141; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jungfer KH, 2010, SALAMANDRA, V46, P204; Jungfer KH, 1999, AMPHIBIA-REPTILIA, V20, P235, DOI 10.1163/156853899507040; KAPLAN M, 1991, J HERPETOL, V25, P313, DOI 10.2307/1564589; KAPLAN M, 1994, J HERPETOL, V28, P79, DOI 10.2307/1564684; Kaplan M, 1977, J HERPETOL, V31, P230; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kohler J, 2005, J HERPETOL, V39, P43, DOI 10.1670/0022-1511(2005)039[0043:ANSOSH]2.0.CO;2; Kohler J, 2001, STUD NEOTROP FAUNA E, V36, P105, DOI 10.1076/snfe.36.2.105.2135; Kollman L. J. C., 2007, ESPECIES FLORA AMEAC, P144; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lescure J., 2000, COLLECTION PATRIMOIN, V45; Lourenco-De-Moraes R, 2014, ZOOTAXA, V3846, P348, DOI 10.11646/zootaxa.3846.3.2; Lourenco-De-Moraes R, 2013, J HERPETOL, V47, P575, DOI 10.1670/11-326; Lutz B., 1973, BRAZILIAN SPECIES HY; Mageski Marcio, 2014, Boletim do Museu de Biologia Mello Leitao Nova Serie, V34, P97; Mageski Marcio, 2014, Herpetology Notes, V7, P363; Ortega-Andrade HM, 2013, ZOOTAXA, V3652, P163, DOI 10.11646/zootaxa.3652.1.6; Melin D., 1941, Goteborgs Vetenskaps Samhalles Handlingar (6), V1B, P1; Mendes Sergio L., 2000, Boletim do Museu de Biologia Mello Leitao, V11-12, P7; Mijares-Urrutia A, 2000, J HERPETOL, V34, P80, DOI 10.2307/1565242; Mijares-Urrutia Abraham, 1998, Revista Brasileira de Biologia, V58, P659, DOI 10.1590/S0034-71081998000400013; Miller M.A., 2010, P GAT COMP ENV WORKS; Moravec J, 2006, ZOOTAXA, P23; Motta AP, 2012, ZOOTAXA, P18, DOI 10.11646/zootaxa.3249.1.2; Napoli M., 1998, B MUS NAC NOVA SER Z, V391, P1; Napoli Marcelo Felgueiras, 2000, Alytes (Paris), V17, P165; Napoli Marcelo Felgueiras, 1999, Alytes (Paris), V16, P165; Orrico VGD, 2014, ZOOTAXA, V3881, P341, DOI 10.11646/zootaxa.3881.4.3; Passamani M, 2011, MAMMALIA, V75, P83, DOI 10.1515/MAMM.2010.064; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Peixoto Oswaldo Luiz, 1995, Revista Universidade Rural Serie Ciencias da Vida, V17, P75; Pertel W, 2010, CALDASIA, V32, P149; Pimenta Bruno V. S., 2014, Arquivos de Zoologia (Sao Paulo), V45, P1; Pombal JP, 2003, J HERPETOL, V37, P453, DOI 10.1670/220-01A; Pombal Jr J.P., 1998, B MUSEU NACL ZOOLOGI, V390, P1; Porembski Stefan, 1998, Diversity and Distributions, V4, P107, DOI 10.1046/j.1365-2699.1998.00013.x; Rivera-Correa M, 2013, ZOOTAXA, V3686, P447, DOI 10.11646/zootaxa.3686.4.3; Rivera-Correa M, 2012, ZOOTAXA, P50; RIVERO J A, 1971, Caribbean Journal of Science, V11, P1; RIVERO JUAN A., 1961, BULL MUS COMP ZOOL HARVARD UNIV, V126, P1; Rizzini CT, 1979, TRATADO FITOGEOGRAFI; Roedder Dennis, 2007, Salamandra, V43, P91; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Silva-Soares T, 2010, ZOOTAXA, P63; Suarez P, 2013, CYTOGENET GENOME RES, V141, P295, DOI 10.1159/000354997; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; Thomaz L. D., 1997, B MUSEU BIOL MELLO L, V7, P3; Toledo LF, 2014, ACTA ETHOLOGICA; Touchon JC, 2008, P NATL ACAD SCI USA, V105, P7495, DOI 10.1073/pnas.0711579105; Venables WN., 2002, MODERN APPL STAT S 4; VIGLE GO, 1990, HERPETOLOGICA, V46, P467; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Wendt Tania, 2010, Boletim do Museu de Biologia Mello Leitao Nova Serie, V27, P21; WEYGOLDT P, 1987, STUD NEOTROP FAUNA E, V22, P237, DOI 10.1080/01650528709360736; WEYGOLDT P, 1981, Salamandra, V17, P1	97	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0142893	10.1371/journal.pone.0142893	http://dx.doi.org/10.1371/journal.pone.0142893			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650515	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903300009
J	About, F; Oudot-Mellakh, T; Niay, J; Rabiega, P; Pedergnana, V; Duffy, D; Sultanik, P; Cagnot, C; Carrat, F; Marcellin, P; Zoulim, F; Larrey, D; Hezode, C; Fontaine, H; Bronowicki, JP; Pol, S; Albert, ML; Theodorou, I; Cobat, A; Abel, L				About, Fredegonde; Oudot-Mellakh, Tiphaine; Niay, Jonathan; Rabiega, Pascaline; Pedergnana, Vincent; Duffy, Darragh; Sultanik, Philippe; Cagnot, Carole; Carrat, Fabrice; Marcellin, Patrick; Zoulim, Fabien; Larrey, Dominique; Hezode, Christophe; Fontaine, Helene; Bronowicki, Jean-Pierre; Pol, Stanislas; Albert, Matthew L.; Theodorou, Ioannis; Cobat, Aurelie; Abel, Laurent		ANRS CO20-CUPIC Study Grp	Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study	PLOS ONE			English	Article							HEPATITIS-C VIRUS; INDUCED HEMOLYTIC-ANEMIA; GENOTYPE 1 INFECTION; GENETIC-VARIATION; PLUS RIBAVIRIN; DOSE REDUCTION; TELAPREVIR; VARIANTS; BOCEPREVIR; PROTECT	Background Human genetic factors influence the outcome of pegylated interferon and ribavirin hepatitis C therapy. We explored the role of IL28B, APOH and ITPA SNPs on the outcomes of triple therapy including telaprevir or boceprevir in patients with compensated cirrhosis chronically infected with HCV-1. Patients and Methods A total of 256 HCV-1 Caucasian treatment-experienced patients with compensated cirrhosis from the ANRS CO20-CUPIC cohort were genotyped for a total of 10 candidate SNPs in IL28B (rs12979860 and rs368234815), APOH (rs8178822, rs12944940, rs10048158, rs52797880, rs1801689 and rs1801690) and ITPA (rs1127354 and rs7270101). We tested the association of IL28B and APOH SNPs with sustained virological response and of ITPA SNPs with anemia related phenotypes by means of logistic regression assuming an additive genetic model. Results None of the six APOH SNPs were associated with sustained virological response. The favorable alleles of the IL28B SNPs rs12979860 and rs368234815 were associated with sustained virological response (rs12979860: OR = 2.35[1.50-3.70], P = 2x10(-4)). Refined analysis showed that the effect of IL28B SNPs on sustained virological response was restricted to prior PegIFN/RBV relapse (OR = 3.80[1.82-8.92], P = 8x10(-4)). We also confirmed the association between ITPA low activity alleles and protection against early hemoglobin decline in triple therapy (P = 2x10(-5)). Conclusion Our results suggest that the screening of rs12979860 may remain interesting for decision making in prior relapse HCV-1 Caucasian patients with compensated cirrhosis eligible for a telaprevir-or boceprevir-based therapy.	[About, Fredegonde; Pedergnana, Vincent; Cobat, Aurelie] Inst Natl Sante & Rech Med INSERM U1163, Necker Branch, Lab Human Genet Infect Dis, Paris, France; [About, Fredegonde; Pedergnana, Vincent; Cobat, Aurelie; Abel, Laurent] Paris Descartes Univ, Imagine Inst, Paris, France; [Oudot-Mellakh, Tiphaine; Niay, Jonathan; Theodorou, Ioannis] INSERM U1135, Grp Hosp Pitie Salpetriere, AP HP, Ctr Immunol & Malad Infectieuses Paris CIMI,Lab I, Paris, France; [Oudot-Mellakh, Tiphaine; Niay, Jonathan] Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, Plateforme Genom Inserm ANRS, Paris, France; [Rabiega, Pascaline; Carrat, Fabrice] Univ Paris 06, INSERM, Univ Sorbonne, Inst Pierre Louis Epidemiol & Sante Publ IPLESP U, Paris, France; [Pedergnana, Vincent] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Duffy, Darragh; Albert, Matthew L.] Inst Pasteur, Dept Immunol, Ctr Human Immunol, F-75724 Paris, France; [Duffy, Darragh; Albert, Matthew L.] INSERM, U818, Inst Pasteur, Dept Immunol,Lab Dendrit Cell, Paris, France; [Sultanik, Philippe; Fontaine, Helene] Univ Paris 05, Hop Cochin, AP HP, Dept Hepatol, Paris, France; [Sultanik, Philippe; Fontaine, Helene; Pol, Stanislas; Albert, Matthew L.] INSERM, UMS20, Inst Pasteur, Paris, France; [Cagnot, Carole] Inserm ANRS France Rech Nord & Sud Sida HIV Hepat, Unit Basic & Clin Res Viral Hepatitis, Paris, France; [Carrat, Fabrice] Hop St Antoine, AP HP, Serv Sante Publ, F-75571 Paris, France; [Marcellin, Patrick] Hop Beaujon, Serv Hepatol, Clichy, France; [Zoulim, Fabien] CNRS 5286, INSERM, UMR 11052, CRCL, Lyon 03, France; [Zoulim, Fabien] Univ Lyon 1, F-69622 Villeurbanne, France; [Zoulim, Fabien] Hop Croix Rousse, Serv Hepatol & Gastroenterol, Hosp Civils Lyon, F-69317 Lyon, France; [Larrey, Dominique] CHU St Eloi Hosp, Liver Unit, Montpellier, France; [Hezode, Christophe] UPEC, Hop Henri Mondor, AP HP, Dept Gastroenterol & Hepatol, Creteil, France; [Hezode, Christophe] UPEC, INSERM U955, IMRB, Creteil, France; [Bronowicki, Jean-Pierre] Univ Lorraine, CHU Nancy, INSERM U954, Dept Hepatogastroenterol, Vandoeuvre Les Nancy, France; [Abel, Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10021 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Oxford; Wellcome Centre for Human Genetics; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre de Recherche en cancerologie (CRCL); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Rockefeller University	Cobat, A (corresponding author), Inst Natl Sante & Rech Med INSERM U1163, Necker Branch, Lab Human Genet Infect Dis, Paris, France.	aurelie.cobat@inserm.fr; laurent.abel@inserm.fr	Hezode, Christophe/U-4659-2018; Abel, Laurent/H-8888-2017; Cobat, Aurélie/H-4722-2017; Carrat, Fabrice/AAU-8480-2020; Zoulim, Fabien/ABD-5594-2021; Dubuisson, Jean/E-6813-2016	Abel, Laurent/0000-0001-7016-6493; Cobat, Aurélie/0000-0001-7209-6257; Carrat, Fabrice/0000-0002-8672-7918; Zoulim, Fabien/0000-0002-2245-0083; Pedergnana, Vincent/0000-0002-7852-5339; Paradis, Valerie/0000-0003-3142-3762; Pawlotsky, Jean-Michel/0000-0003-0745-7559; Albert, TRAN/0000-0003-0003-5361; cyrille, feray/0000-0002-8627-9676; rosa, isabelle/0000-0001-6879-3148; Dubuisson, Jean/0000-0003-1626-7693; Bedossa, Pierre/0000-0002-8487-7322; Cacoub, Patrice/0000-0002-6727-4992; Cales, Paul/0000-0003-4866-5274; Di Martino, Vincent/0000-0002-2022-690X; , Poynard/0000-0002-3726-7230; About, Fredegonde/0000-0002-3561-8041	INSERM-ANRS (France REcherche Nord & sud Sida-HIV Hepatites-FRENSH) [2010-A01273-36]; Institut National de la Sante et de la Recherche Medicale (INSERM); University Paris Descartes; French National Research Agency (ANR) under the "Investments for the future" program [ANR-10-IAHU-01]; Association Francaise pour l'Etude du Foie (AFEF); Fondation pour la Recherche Medicale (FRM) [FDM20140630671]	INSERM-ANRS (France REcherche Nord & sud Sida-HIV Hepatites-FRENSH)(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Paris Descartes; French National Research Agency (ANR) under the "Investments for the future" program(French National Research Agency (ANR)); Association Francaise pour l'Etude du Foie (AFEF); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by INSERM-ANRS (France REcherche Nord & sud Sida-HIV Hepatites-FRENSH, Grant no 2010-A01273-36, http://www.anrs.fr), Institut National de la Sante et de la Recherche Medicale (INSERM, http://www.inserm.fr), University Paris Descartes (http://www.parisdescartes.fr), the French National Research Agency (ANR, http://www.agence-nationale-recherche.fr) under the "Investments for the future" program (grant noANR-10-IAHU-01), and in part by the Association Francaise pour l'Etude du Foie (AFEF, http://www.afef.asso.fr). FA is the recipient of a fellowship from Fondation pour la Recherche Medicale (FRM, Grant no FDM20140630671, http://www.frm.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghemo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095881; Ahmed WH, 2013, WORLD J GASTROENTERO, V19, P1387, DOI 10.3748/wjg.v19.i9.1387; Akuta N, 2013, J CLIN MICROBIOL, V51, P2862, DOI 10.1128/JCM.01129-13; Athanasiadis G, 2013, J THROMB HAEMOST, V11, P521, DOI 10.1111/jth.12120; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Casanova JL, 2013, ANNU REV GENOM HUM G, V14, P215, DOI 10.1146/annurev-genom-091212-153448; CASSADER M, 1994, ATHEROSCLEROSIS, V110, P45, DOI 10.1016/0021-9150(94)90066-3; Chayama K, 2011, J INFECT DIS, V204, P84, DOI 10.1093/infdis/jir210; Clark PJ, 2013, J VIRAL HEPATITIS, V20, P858, DOI 10.1111/jvh.12113; Eskesen AN, 2012, EUR J GASTROEN HEPAT, V24, P890, DOI 10.1097/MEG.0b013e3283546efd; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hezode C, 2014, GASTROENTEROLOGY, V147, P132, DOI 10.1053/j.gastro.2014.03.051; Hezode C, 2013, J HEPATOL, V59, P434, DOI 10.1016/j.jhep.2013.04.035; Holmes JA, 2012, J VIRAL HEPATITIS, V19, P677, DOI 10.1111/jvh.12003; Jacobson IM, 2011, J HEPATOL, V54, pS542, DOI 10.1016/S0168-8278(11)61371-8; Leduc MS, 2008, J LIPID RES, V49, P2648, DOI 10.1194/jlr.M800155-JLR200; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mehdi H, 1999, HUM GENET, V105, P63, DOI 10.1007/s004390051065; Mehdi H, 2003, EUR J BIOCHEM, V270, P230, DOI 10.1046/j.1432-1033.2003.03379.x; Pol S, 2013, J HEPATOL, V58, P883, DOI 10.1016/j.jhep.2012.12.023; Poordad F, 2012, GASTROENTEROLOGY, V143, P608, DOI 10.1053/j.gastro.2012.05.011; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rau M, 2013, J HEPATOL, V58, P669, DOI 10.1016/j.jhep.2012.11.027; Shimada N, 2014, HEPATOL RES OFF 0310; Shipkova M, 2006, CLIN CHEM, V52, P240, DOI 10.1373/clinchem.2005.059501; Sterling RK, 2015, ALIMENT PHARM THER, V41, P671, DOI 10.1111/apt.13095; Sultanik P, 2015, LIVER INT; Suresh S, 2009, J RHEUMATOL, V36, P315, DOI 10.3899/jrheum.080482; Suzuki F, 2011, HEPATOLOGY, V53, P415, DOI 10.1002/hep.24058; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P1181, DOI 10.1053/j.gastro.2010.06.016; Tsubota A, 2014, J GASTROEN HEPATOL, V29, P144, DOI 10.1111/jgh.12402; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	36	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145105	10.1371/journal.pone.0145105	http://dx.doi.org/10.1371/journal.pone.0145105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670100	Green Submitted, gold, Green Published			2022-12-27	WOS:000366719300048
J	Kawano, S; Kakehashi, M				Kawano, Shoko; Kakehashi, Masayuki			Substantial Impact of School Closure on the Transmission Dynamics during the Pandemic Flu H1N1-2009 in Oita, Japan	PLOS ONE			English	Article							ABSOLUTE-HUMIDITY; INFLUENZA; INTERVENTIONS; SURVIVAL	Background School closure is considered as an effective measure to prevent pandemic influenza. Although Japan has implemented many class, grade, and whole school closures during the early stage of the pandemic 2009, the effectiveness of such a school closure has not been analysed appropriately. In addition, analysis based on evidence or data from a large population has yet to be performed. We evaluated the preventive effect of school closure against the pandemic (H1N1) 2009 and examined efficient strategies of reactive school closure. Materials and Methods Data included daily reports of reactive school closures and the number of infected students in the pandemic in Oita City, Japan. We used a regression model that incorporated a time delay to analyse the daily data of school closure based on a time continuous susceptible-exposed- infected-removed model of infectious disease spread. The delay was due to the time-lag from transmission to case reporting. We simulated the number of students infected daily with and without school closure and evaluated the effectiveness. Results The model with a 3-day delay from transmission to reporting yielded the best fit using R-2 (the coefficient of determination). This result suggests that the recommended period of school closure is more than 4 days. Moreover, the effect of school closure in the simulation of school closure showed the following: the number of infected students decreased by about 24% at its peak, and the number of cumulative infected students decreased by about 8.0%. Conclusions School closure was an effective intervention for mitigating the spread of influenza and should be implemented for more than 4 days. School closure has a remarkable impact on decreasing the number of infected students at the peak, but it does not substantially decrease the total number of infected students.	[Kawano, Shoko] Hiroshima Univ, Grad Sch Hlth Sci, Hiroshima, Japan; [Kakehashi, Masayuki] Hiroshima Univ, Inst Biomed & Hlth Sci, Hiroshima, Japan	Hiroshima University; Hiroshima University	Kawano, S (corresponding author), Hiroshima Univ, Grad Sch Hlth Sci, Hiroshima, Japan.	kawanoshoko@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23390133]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research "Scientific Research (B) (General)" of the Ministry of Education, Culture, Sports, Science and Technology, Japan (grant 23390133) https://www.jsps.go.jp/j-grantsinaid/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INFECT AGENTS SURVEI; Bell D, 2006, EMERG INFECT DIS, V12, P88; Cabinet Secretariat, NAT ACT PLAN PAND IN; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Centers for Disease Control and Prevention, 2009, H1N1 OV PAND; Earn DJD, 2012, ANN INTERN MED, V156, P173, DOI 10.7326/0003-4819-156-3-201202070-00005; Eda Kunio, 2012, Kansenshogaku Zasshi, V86, P274; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Halder N, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-221; HARPER GJ, 1961, J HYG-CAMBRIDGE, V59, P479, DOI 10.1017/S0022172400039176; Hasui M, 2012, J AMBULATORY GEN PED, V15, P13; He DH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1345; Infectious Disease Surveillance Center, INC INFL ILLN NUMB A; Jackson C, 2011, EMERG INFECT DIS, V17, P245, DOI 10.3201/eid1702.100458; Kawaguchi R, 2009, EMERG INFECT DIS, V15, P1685, DOI 10.3201/eid1510.091029; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; Miller JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010425; Milne GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004005; Ministry of Education Culture Sports Science and Technology, 2009, CURR SIT EACH PREF P; Ministry of Health Labour and Welfare, 2009, GUID SCH CLOS BAS ID; Ministry of Health Labour and Welfare, IMPL BAS MEAS PAND F; Morimoto Tomoko, 2010, Environmental Health and Preventive Medicine, V15, P151, DOI 10.1007/s12199-009-0122-9; Neuzil KM, 2002, ARCH PEDIAT ADOL MED, V156, P986, DOI 10.1001/archpedi.156.10.986; Nishiura H, 2009, EUROSURVEILLANCE, V14; Shaman J, 2011, AM J EPIDEMIOL, V173, P127, DOI 10.1093/aje/kwq347; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Shiino T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011057; Shimizu N, 2012, NIHON KANSENKANKYO G, V27, P96; Shoji M, 1985, J TUBERCULOSIS LEPRO, V37, P327; Shoji M, 2009, JPN J CLIN EXP MED, V86, P1517; Shoji M, 1988, J TUBERCULOSIS LEPRO, V40, P95; Shoji M, 2011, TOHOKU J EXP MED, V224, P251, DOI 10.1620/tjem.224.251; Statistics Japan, CENS 2009; Sugisaki K, 2008, J JPN PEDIAT SOC, V112, P696; Sugisaki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074716; Sugiura H, 2010, JAPANESE J SCH HLTH, V52, P214; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P166, DOI 10.1017/S0950268807008369; World Health Organization, MEAS SCH STT; Yamamoto S, 2012, J HLTH WELFARE STAT, V59, P9	41	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144839	10.1371/journal.pone.0144839	http://dx.doi.org/10.1371/journal.pone.0144839			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669757	Green Submitted, Green Published, gold			2022-12-27	WOS:000366719300025
J	Moon, HG; Kim, N; Jeong, S; Lee, M; Moon, H; Kim, J; Yoo, TK; Lee, HB; Kim, J; Noh, DY; Han, W				Moon, Hyeong-Gon; Kim, Namshin; Jeong, Seongmun; Lee, Minju; Moon, HyunHye; Kim, Jongjin; Yoo, Tae-Kyung; Lee, Han-Byoel; Kim, Jisun; Noh, Dong-Young; Han, Wonshik			The Clinical Significance and Molecular Features of the Spatial Tumor Shapes in Breast Cancers	PLOS ONE			English	Article							METASTASIS; SUBTYPES; MORPHOLOGY; INTERFACE; INVASION; SIZE	Each breast cancer has its unique spatial shape, but the clinical importance and the underlying mechanism for the three-dimensional tumor shapes are mostly unknown. We collected the data on the three-dimensional tumor size and tumor volume data of invasive breast cancers from 2,250 patients who underwent surgery between Jan 2000 and Jul 2007. The degree of tumor eccentricity was estimated by using the difference between the spheroid tumor volume and ellipsoid tumor volume (spheroid-ellipsoid discrepancy, SED). In 41 patients, transcriptome and exome sequencing data obtained. Estimation of more accurate tumor burden by calculating ellipsoid tumor volumes did not improve the outcome prediction when compared to the traditional longest diameter measurement. However, the spatial tumor eccentricity, which was measured by SED, showed significant variation between the molecular subtypes of breast cancer. Additionally, the degree of tumor eccentricity was associated with well-known prognostic factors of breast cancer such as tumor size and lymph node metastasis. Transcriptome data from 41 patients showed significant association between MMP13 and spatial tumor shapes. Network analysis and analysis of TCGA gene expression data suggest that MMP13 is regulated by ERBB2 and S100A7A. The present study validates the usefulness of the current tumor size method in determining tumor stages. Furthermore, we show that the tumors with high eccentricity are more likely to have aggressive tumor characteristics. Genes involved in the extracellular matrix remodeling can be candidate regulators of the spatial tumor shapes in breast cancer.	[Moon, Hyeong-Gon; Kim, Jongjin; Yoo, Tae-Kyung; Lee, Han-Byoel; Kim, Jisun; Noh, Dong-Young; Han, Wonshik] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; [Moon, Hyeong-Gon; Lee, Minju; Moon, HyunHye; Kim, Jongjin; Yoo, Tae-Kyung; Lee, Han-Byoel; Kim, Jisun; Noh, Dong-Young; Han, Wonshik] Seoul Natl Univ, Coll Med, Canc Res Inst, Lab Breast Canc Biol, Seoul, South Korea; [Moon, Hyeong-Gon; Moon, HyunHye; Han, Wonshik] Seoul Natl Univ, Coll Med, Genome Med Inst, Seoul, South Korea; [Kim, Namshin; Jeong, Seongmun] Korea Res Inst Biosci & Biotechnol, Genome Inst, Epigen Res Ctr, Daejeon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Han, W (corresponding author), Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea.	hanw@snu.ac.kr	Kim, Namshin/Q-6491-2017; Han, Wonshik/B-3699-2008	Kim, Namshin/0000-0001-6361-274X; Han, Wonshik/0000-0001-7310-0764; Jeong, Seongmun/0000-0002-0038-461X; Moon, Hyeong-Gon/0000-0002-9981-0286; KIM, JISUN/0000-0002-4884-6107	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A2005929, 2015R1D1A1A02061904]; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [A1220200]; grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C3405, HI14C1277]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea; grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was supported by (MHG) Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A2005929 and 2015R1D1A1A02061904), by the grant from the National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (A1220200); (WH) the grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI14C3405); (DYN) the grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI14C1277).	Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Bae MS, 2015, ACTA RADIOL, V56, P269, DOI 10.1177/0284185114524197; Bao L, 2014, BIOINFORMATICS; Bearer EL, 2009, CANCER RES, V69, P4493, DOI 10.1158/0008-5472.CAN-08-3834; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen MK, 2004, CANCER-AM CANCER SOC, V100, P2160, DOI 10.1002/cncr.20210; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Ichikawa Y, 2014, ONCOL LETT, V8, P977, DOI 10.3892/ol.2014.2271; Jiang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058329; Kim J, 2015, GENE CHROMOSOME CANC, V54, P681, DOI 10.1002/gcc.22279; Miller CA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003665; Moon HG, 2013, ANN ONCOL, V24, P2298, DOI 10.1093/annonc/mdt187; Moon HG, 2009, J CLIN ONCOL, V27, P5899, DOI 10.1200/JCO.2009.22.4436; MORRISON SD, 1983, J NATL CANCER I, V71, P407; Nannuru KC, 2010, CANCER RES, V70, P3494, DOI 10.1158/0008-5472.CAN-09-3251; Nasser MW, 2015, CANCER RES, V75, P974, DOI 10.1158/0008-5472.CAN-14-2161; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Perry SW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-411; Salz T, 2015, MOL CANCER RES, V13, P461, DOI 10.1158/1541-7786.MCR-14-0389; Singletary SE, 2006, CA-CANCER J CLIN, V56, P37, DOI 10.3322/canjclin.56.1.37; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Szabo A, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00087; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Uematsu T, 2009, RADIOLOGY, V250, P638, DOI 10.1148/radiol.2503081054; Vizoso FJ, 2007, BRIT J CANCER, V96, P903, DOI 10.1038/sj.bjc.6603666; Wapnir IL, 1996, BREAST CANCER RES TR, V41, P15, DOI 10.1007/BF01807032; Wolf R, 2009, CANCER LETT, V277, P101, DOI 10.1016/j.canlet.2008.11.032; Yeo EJ, 2014, CANCER RES, V74, P2962, DOI 10.1158/0008-5472.CAN-13-2421	29	15	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0143811	10.1371/journal.pone.0143811	http://dx.doi.org/10.1371/journal.pone.0143811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669540	Green Published, gold			2022-12-27	WOS:000366719300003
J	Sorrentino, D; Marino, M; Dassopoulos, T; Zarifi, D; Del Bianco, T				Sorrentino, Dario; Marino, Marco; Dassopoulos, Themistocles; Zarifi, Dimitra; Del Bianco, Tiziana			Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn's Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; THERAPY; MAINTENANCE; SERUM; REMISSION; OUTCOMES; COHORT; AGENTS	Objective In patients with postoperative recurrence of Crohn's disease endoscopic and clinical remission can be maintained for up to 1 year with low infliximab doses (3 mg/Kg). However, in theory low-dose infliximab treated patients could develop subtherapeutic trough levels, infiximab antibodies, and might loose response to therapy. To verify this hypothesis infliximab pharmacokinetics and clinical/endoscopic response were checked in a group of patients treated in the long term with low infliximab doses. Design Infliximab antibodies, infliximab levels, highly-sensitive CRP and fecal calprotectin were measured during the 8-week interval in 5 consecutive patients in clinical (Crohn's Disease Activity Index < 150) and endoscopic (Rutgeerts scores 0-1) remission after one year of therapy with infliximab 3 mg/Kg. For comparison with reported standards, infliximab pharmacokinetics and inflammatory parameters were also tested in 6 Crohn's disease patients who did not undergo surgery and who were in clinical remission while on infliximab 5 mg/Kg. Patients on low infliximab dose also underwent colonoscopy after 18 additional months of therapy. Results Highly sensitive CRP and fecal calprotectin increased in all patients during the 8-week interval. Infliximab trough levels were lower in patients treated with the low dose compared to controls (mean +/- SE: 2.0 +/- 0.3 vs 4.75 +/- 0.83 mu g/mL respectively p<0.05). Infliximab antibodies were present in two of the subjects treated with low infliximab dose and in none of the controls. However, in low dose-treated patients after 18 additional months of therapy endoscopy continued to show mucosal remission and none of them developed clinical recurrence or side effects. Conclusions Patients treated with low infliximab doses had lower trough levels compared to patients treated with 5 mg/Kg and some developed antibodies to infliximab. However, low infliximab doses sustained clinical and endoscopic remission for a total of 30 months of treatment.	[Sorrentino, Dario] Virginia Tech, Caril Sch Med, Div Gastroenterol, IBD Ctr, Roanoke, VA USA; [Sorrentino, Dario; Marino, Marco; Zarifi, Dimitra; Del Bianco, Tiziana] Univ Udine, Sch Med, Dept Clin & Expt Med Sci, I-33100 Udine, Italy; [Dassopoulos, Themistocles] Baylor Univ, Med Ctr, Baylor Ctr IBD, Dallas, TX USA	Virginia Polytechnic Institute & State University; University of Udine; Baylor University; Baylor University Medical Center	Sorrentino, D (corresponding author), Virginia Tech, Caril Sch Med, Div Gastroenterol, IBD Ctr, Roanoke, VA USA.	drsorrentino@carilionclinic.org	Sorrentino, Dario/K-7253-2019					BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Cassinotti A, 2009, INFLAMM BOWEL DIS, V15, P1264, DOI 10.1002/ibd.20899; Casteele NV, 2015, GUT, V64, P1539, DOI 10.1136/gutjnl-2014-307883; Hanauer SB, 2007, GUT, V56, P1181, DOI 10.1136/gut.2006.115980; Hashash JG, 2013, EXPERT REV GASTROENT, V7, P501, DOI 10.1586/17474124.2013.814933; Imaeda H, 2014, J GASTROENTEROL, V49, P674, DOI 10.1007/s00535-013-0829-7; Levesque BG, 2014, ALIMENT PHARM THER, V39, P1126, DOI 10.1111/apt.12733; Louis E, 2012, GASTROENTEROLOGY, V142, P63, DOI 10.1053/j.gastro.2011.09.034; Lowenberg M, 2014, GASTROENTEROLOGY, V146, pS450; Nanda KS, 2013, AM J GASTROENTEROL, V108, P40, DOI 10.1038/ajg.2012.363; O'Meara S, 2014, INFLAMM BOWEL DIS, V20, P1, DOI 10.1097/01.MIB.0000436951.80898.6d; Ordas I, 2012, CLIN GASTROENTEROL H, V10, P1079, DOI 10.1016/j.cgh.2012.06.032; Peyrin-Biroulet L, 2012, INFLAMM BOWEL DIS, V18, P2201, DOI 10.1002/ibd.23016; Pittet V, 2013, J CROHNS COLITIS, V7, P820, DOI 10.1016/j.crohns.2013.04.013; Regueiro M, 2014, CLIN GASTROENTEROL H, V12, P1494, DOI 10.1016/j.cgh.2013.12.035; RUTGEERTS P, 1984, GUT, V25, P665, DOI 10.1136/gut.25.6.665; Smart C, 2014, EXPERT REV PHARM OUT, V14, P589, DOI 10.1586/14737167.2014.950235; Sorrentino D, 2014, INFLAMM BOWEL DIS, V20, P757, DOI 10.1097/01.MIB.0000442680.47427.bf; Sorrentino D, 2013, NAT REV GASTRO HEPAT, V10, P413, DOI 10.1038/nrgastro.2013.69; Sorrentino D, 2010, CLIN GASTROENTEROL H, V8, P591, DOI 10.1016/j.cgh.2010.01.016; Steenholdt C, 2014, AM J GASTROENTEROL, V109, P1055, DOI 10.1038/ajg.2014.106; Steenholdt C, 2014, GUT, V63, P919, DOI 10.1136/gutjnl-2013-305279; Vande Casteele N, 2013, AM J GASTROENTEROL, V108, P962, DOI 10.1038/ajg.2013.12; Vaughn BP, 2014, INFLAMM BOWEL DIS, V20, P1996, DOI 10.1097/MIB.0000000000000156; Wang SL, 2012, J IMMUNOL METHODS, V382, P177, DOI 10.1016/j.jim.2012.06.002; Waugh AWG, 2010, ALIMENT PHARM THER, V32, P1129, DOI 10.1111/j.1365-2036.2010.04446.x	26	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144900	10.1371/journal.pone.0144900	http://dx.doi.org/10.1371/journal.pone.0144900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670274	Green Published, gold, Green Submitted			2022-12-27	WOS:000366719300029
J	Hanratty, J; Livingstone, N; Robalino, S; Terwee, CB; Glod, M; Oono, IP; Rodgers, J; Macdonald, G; McConachie, H				Hanratty, Jennifer; Livingstone, Nuala; Robalino, Shannon; Terwee, Caroline B.; Glod, Magdalena; Oono, Inalegwu P.; Rodgers, Jacqui; Macdonald, Geraldine; McConachie, Helen			Systematic Review of the Measurement Properties of Tools Used to Measure Behaviour Problems in Young Children with Autism	PLOS ONE			English	Review							TREATMENT END-POINT; RANDOMIZED CONTROLLED-TRIAL; EARLY INTERVENTION; SPECTRUM DISORDER; DEVELOPMENTAL DISORDERS; REPETITIVE BEHAVIORS; PRESCHOOL-CHILDREN; PROBLEMS-INVENTORY; PARENTING STRESS; RUPP AUTISM	Background Behaviour problems are common in young children with autism spectrum disorder (ASD). There are many different tools used to measure behavior problems but little is known about their validity for the population. Objectives To evaluate the measurement properties of behaviour problems tools used in evaluation of intervention or observational research studies with children with ASD up to the age of six years. Methods Behaviour measurement tools were identified as part of a larger, two stage, systematic review. First, sixteen major electronic databases, as well as grey literature and research registers were searched, and tools used listed and categorized. Second, using methodological filters, we searched for articles examining the measurement properties of the tools in use with young children with ASD in ERIC, MEDLINE, EMBASE, CINAHL, and PsycINFO. The quality of these papers was then evaluated using the COSMIN checklist. Results We identified twelve tools which had been used to measure behaviour problems in young children with ASD, and fifteen studies which investigated the measurement properties of six of these tools. There was no evidence available for the remaining six tools. Two questionnaires were found to be the most robust in their measurement properties, the Child Behavior Checklist and the Home Situations Questionnaire-Pervasive Developmental Disorders version. Conclusions We found patchy evidence on reliability and validity, for only a few of the tools used to measure behaviour problems in young children with ASD. More systematic research is required on measurement properties of tools for use in this population, in particular to establish responsiveness to change which is essential in measurement of outcomes of intervention.	[Hanratty, Jennifer; Livingstone, Nuala; Macdonald, Geraldine] Queens Univ Belfast, Sch Sociol Social Policy & Social Work, Belfast, Antrim, North Ireland; [Robalino, Shannon; Glod, Magdalena; Oono, Inalegwu P.; McConachie, Helen] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Terwee, Caroline B.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Rodgers, Jacqui] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Queens University Belfast; Newcastle University - UK; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Newcastle University - UK	McConachie, H (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	helenmcconachie@ncl.ac.uk	Robalino, Shannon/GRS-6021-2022; Robalino, Shannon/N-4113-2015	Robalino, Shannon/0000-0002-6359-1827; Rodgers, Jacqui/0000-0002-1759-316X; Macdonald, Geraldine/0000-0002-6846-7235; Terwee, Caroline/0000-0003-4570-2826	UK National Institute for Health Research under the Health Technology Assessment programme [11/22/03]; Research and Development Division of the Public Health Agency, Northern Ireland; UK National Institute for Health Research (NIHR) under the Health Technology Assessment (HTA) programme [11/22/03]	UK National Institute for Health Research under the Health Technology Assessment programme; Research and Development Division of the Public Health Agency, Northern Ireland; UK National Institute for Health Research (NIHR) under the Health Technology Assessment (HTA) programme	This work was supported by the UK National Institute for Health Research under the Health Technology Assessment programme (Project: 11/22/03 to HM, NL, CT, JR and GM), and the Research and Development Division of the Public Health Agency, Northern Ireland to GM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The paper describes part of the evidence synthesis commissioned by the UK National Institute for Health Research (NIHR) under the Health Technology Assessment (HTA) programme (Project: 11/22/03). The views expressed are those of the authors and not necessarily those of the National Health Service, NIHR or Department of Health. The authors are also grateful for additional support provided by the Research and Development Division of the Public Health Agency, Northern Ireland. The authors are grateful for the contributions to the full review process of the remaining members of the MeASURe collaboration: Gillian Baird, Bryony Beresford, Tony Charman, Deborah Garland, Jonathan Green, Paul Gringras, Glenys Jones, James Law, Ann Le Couteur, Elaine McColl, Chris Morris, Jeremy Parr, Andrew Pickles, Emily Simonoff, Katrina Williams.	Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; Adrien JL, 2001, AUTISM, V5, P249, DOI 10.1177/1362361301005003003; Aman M.G., 1986, ABERRANT BEHAV CHECK; Aman MG, 1996, RES DEV DISABIL, V17, P41, DOI 10.1016/0891-4222(95)00039-9; Anagnostou E, 2015, AUTISM, V19, P622, DOI 10.1177/1362361314542955; APA, 1994, DIAGN STAT MAN MENT; Arick J., 2003, FOCUS ON AUTISM AND, V18, P75, DOI DOI 10.1177/108835760301800201; Arnold LE, 2012, J AM ACAD CHILD PSY, V51, P1173, DOI 10.1016/j.jaac.2012.08.028; Arnold LE, 2003, J AM ACAD CHILD PSY, V42, P1443, DOI 10.1097/00004583-200312000-00011; Baghdadli A, 2012, J AUTISM DEV DISORD, V42, P1314, DOI 10.1007/s10803-011-1357-z; Baker JK, 2010, J AUTISM DEV DISORD, V40, P988, DOI 10.1007/s10803-010-0948-4; Barkley R.A., 1987, ADV BEHAVIORAL ASSES, V3, P157; Bearss K, 2015, JAMA-J AM MED ASSOC, V313, P1524, DOI 10.1001/jama.2015.3150; Bearss K, 2013, NEUROPSYCHIATRY-LOND, V3, P169, DOI 10.2217/NPY.13.14; Bearss K, 2013, J AUTISM DEV DISORD, V43, P829, DOI 10.1007/s10803-012-1624-7; Bolte EE, 2013, J AUTISM DEV DISORD, V43, P2491, DOI 10.1007/s10803-013-1798-7; Bourke-Taylor H, 2010, CHILD CARE HLTH DEV, V36, P491, DOI 10.1111/j.1365-2214.2009.01055.x; Brinkley J, 2007, J AUTISM DEV DISORD, V37, P1949, DOI 10.1007/s10803-006-0327-3; Bryce CI, 2013, J AUTISM DEV DISORD, V43, P236, DOI 10.1007/s10803-012-1564-2; Chowdhury M, 2010, J INTELL DISABIL RES, V54, P281, DOI 10.1111/j.1365-2788.2010.01259.x; Chowdhury M, 2016, AUTISM, V20, P528, DOI 10.1177/1362361315593941; Chuang IC, 2012, RES AUTISM SPECT DIS, V6, P988, DOI 10.1016/j.rasd.2012.01.002; Escalona A, 2001, J AUTISM DEV DISORD, V31, P513, DOI 10.1023/A:1012273110194; Farmer CA, 2009, RES DEV DISABIL, V30, P1155, DOI 10.1016/j.ridd.2009.03.001; Gwet K. L., 2010, HDB INTERRATER RELIA; Hartley SL, 2008, J INTELL DISABIL RES, V52, P819, DOI 10.1111/j.1365-2788.2008.01065.x; Hartley SL, 2009, J AUTISM DEV DISORD, V39, P1715, DOI 10.1007/s10803-009-0810-8; Hass MR, 2010, REM SPEC EDUC, V33, P173, DOI DOI 10.1177/0741932510383160.16670084; Herring S, 2006, J INTELL DISABIL RES, V50, P874, DOI 10.1111/j.1365-2788.2006.00904.x; Hill-Chapman CR, 2013, RES DEV DISABIL, V34, P1498, DOI 10.1016/j.ridd.2013.01.004; Howlin P., 2009, J INFORM, V114; Hus V, 2013, J CHILD PSYCHOL PSYC, V54, P216, DOI 10.1111/j.1469-7610.2012.02589.x; Jahromi LB, 2013, RES AUTISM SPECT DIS, V7, P235, DOI 10.1016/j.rasd.2012.08.012; Kaat AJ, 2014, J AUTISM DEV DISORD, V44, P1103, DOI 10.1007/s10803-013-1970-0; Kamphaus R. W., 2007, BEHAV EMOTIONAL SCRE; Karabekiroglu K, 2009, CHILD PSYCHIAT HUM D, V40, P99, DOI 10.1007/s10578-008-0108-7; Kuhlthau K, 2013, RES AUTISM SPECT DIS, V7, P1035, DOI 10.1016/j.rasd.2013.04.006; Lecavalier L, 2006, J INTELL DISABIL RES, V50, P172, DOI 10.1111/j.1365-2788.2005.00732.x; Lecavalier L, 2004, J AUTISM DEV DISORD, V34, P709, DOI 10.1007/s10803-004-5291-1; Lecavalier L, 2014, J AUTISM DEV DISORD, V44, P1128, DOI 10.1007/s10803-013-1974-9; LECOUTEUR A, 1989, J AUTISM DEV DISORD, V19, P363, DOI 10.1007/BF02212936; Lord C., 2002, AUTISM DIAGNOSTIC OB; Mahan S, 2011, RES AUTISM SPECT DIS, V5, P119, DOI 10.1016/j.rasd.2010.02.007; Matson JL, 2009, RES AUTISM SPECT DIS, V3, P336, DOI 10.1016/j.rasd.2008.08.001; Matson JL, 2009, RES AUTISM SPECT DIS, V3, P714, DOI 10.1016/j.rasd.2009.01.008; McConachie H., 2015, HLTH TECHNOLOGY ASSE, V19; Meek SE, 2012, RES AUTISM SPECT DIS, V6, P815, DOI 10.1016/j.rasd.2011.11.001; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Mooney EL, 2006, EUR CHILD ADOLES PSY, V15, P12, DOI 10.1007/s00787-006-0499-6; O'Donnell S, 2012, AM J OCCUP THER, V66, P586, DOI 10.5014/ajot.2012.004168; Oono IP, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009774.pub2; Osborne LA, 2009, EXCEPT CHILDREN, V76, P54, DOI 10.1177/001440290907600103; Ospina MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003755; Pandolfi V, 2012, RES AUTISM SPECT DIS, V6, P96, DOI 10.1016/j.rasd.2011.03.009; Pandolfi V, 2009, J AUTISM DEV DISORD, V39, P986, DOI 10.1007/s10803-009-0716-5; Peters-Scheffer N, 2010, RES DEV DISABIL, V31, P1678, DOI 10.1016/j.ridd.2010.04.008; Reed P, 2007, EXCEPT CHILDREN, V73, P417, DOI 10.1177/001440290707300402; Reed P, 2013, J AUTISM DEV DISORD, V43, P471, DOI 10.1007/s10803-012-1594-9; Reese RM, 2005, J AUTISM DEV DISORD, V35, P419, DOI 10.1007/s10803-005-5032-0; Remington B, 2007, AM J MENT RETARD, V112, P418, DOI 10.1352/0895-8017(2007)112[418:EIBIOF]2.0.CO;2; Rickards AL, 2009, CHILD CARE HLTH DEV, V35, P593, DOI 10.1111/j.1365-2214.2009.00953.x; Rivard M, 2014, J AUTISM DEV DISORD, V44, P1609, DOI 10.1007/s10803-013-2028-z; ROBBINS FR, 1992, AM J MENT RETARD, V96, P631; Roberts J, 2011, RES AUTISM SPECT DIS, V5, P1553, DOI 10.1016/j.rasd.2011.03.001; Rojahn J, 2012, J INTELL DISABIL RES, V56, P527, DOI 10.1111/j.1365-2788.2011.01507.x; Rojahn J, 2001, J AUTISM DEV DISORD, V31, P577, DOI 10.1023/A:1013299028321; Rojahn J, 2009, RES AUTISM SPECT DIS, V3, P989, DOI 10.1016/j.rasd.2009.06.002; Ruble L, 2012, J AUTISM DEV DISORD, V42, P1974, DOI 10.1007/s10803-012-1446-7; Scahill L, 2015, AUTISM, V19, P38, DOI 10.1177/1362361313510069; Sigafoos J, 1997, BRIT J LEARN DISABIL, V25, P13; Smith IM, 2010, AJIDD-AM J INTELLECT, V115, P504, DOI 10.1352/1944-7558-115.6.504; Smith T, 2000, AM J MENT RETARD, V105, P508; Smith T, 2000, AM J MENT RETARD, V105, P269, DOI 10.1352/0895-8017(2000)105<0269:RTOIEI>2.0.CO;2; Smith T, 2001, AM J MENT RETARD, V106, P208; Streiner D. L., 2015, HLTH MEASUREMENT SCA, V5<feminine, DOI [10.1093/med/9780199685219.001.0001, DOI 10.1093/MED/9780199685219.001.0001, 10.1093/MED/9780199685219.001.0001]; Taylor JL, 2012, J AUTISM DEV DISORD, V42, P1411, DOI 10.1007/s10803-011-1375-x; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Terwee CB, 2009, QUAL LIFE RES, V18, P1115, DOI 10.1007/s11136-009-9528-5; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Tonge B, 2014, AUTISM, V18, P166, DOI 10.1177/1362361312458186; Werner E, 2005, J AUTISM DEV DISORD, V35, P337, DOI 10.1007/s10803-005-3301-6; WHO, 2001, WHO INT CLASS FUNCT; Wigham S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085268; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yoder Paul J, 2013, Evid Based Commun Assess Interv, V7, P150	86	23	23	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144649	10.1371/journal.pone.0144649	http://dx.doi.org/10.1371/journal.pone.0144649			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26659821	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900079
J	ter Horst, AC; Koppen, M; Selen, LPJ; Medendorp, WP				ter Horst, Arjan C.; Koppen, Mathieu; Selen, Luc P. J.; Medendorp, W. Pieter			Reliability-Based Weighting of Visual and Vestibular Cues in Displacement Estimation	PLOS ONE			English	Article							SELF-MOTION PERCEPTION; LINEAR DISPLACEMENT; HEADING PERCEPTION; MULTISENSORY INTEGRATION; SPATIAL MEMORY; OPTIC FLOW; DISTANCE; MSTD; DISCRIMINATION; ACCELERATION	When navigating through the environment, our brain needs to infer how far we move and in which direction we are heading. In this estimation process, the brain may rely on multiple sensory modalities, including the visual and vestibular systems. Previous research has mainly focused on heading estimation, showing that sensory cues are combined by weighting them in proportion to their reliability, consistent with statistically optimal integration. But while heading estimation could improve with the ongoing motion, due to the constant flow of information, the estimate of how far we move requires the integration of sensory information across the whole displacement. In this study, we investigate whether the brain optimally combines visual and vestibular information during a displacement estimation task, even if their reliability varies from trial to trial. Participants were seated on a linear sled, immersed in a stereoscopic virtual reality environment. They were subjected to a passive linear motion involving visual and vestibular cues with different levels of visual coherence to change relative cue reliability and with cue discrepancies to test relative cue weighting. Participants performed a two-interval two-alternative forced-choice task, indicating which of two sequentially perceived displacements was larger. Our results show that humans adapt their weighting of visual and vestibular information from trial to trial in proportion to their reliability. These results provide evidence that humans optimally integrate visual and vestibular information in order to estimate their body displacement.	[ter Horst, Arjan C.; Koppen, Mathieu; Selen, Luc P. J.; Medendorp, W. Pieter] Radboud Univ Nijmegen, Donders Insitute Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	ter Horst, AC (corresponding author), Radboud Univ Nijmegen, Donders Insitute Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	a.terhorst@donders.ru.nl	Medendorp, W. Pieter/A-7369-2010; Selen, Luc/A-6066-2009	Medendorp, W. Pieter/0000-0001-9615-4220; Selen, Luc/0000-0001-5774-5415	European Research Council [EU-ERC 283567]; Netherlands Organisation for Scientific Research [NWO-VICI: 453-11-001, NWOVENI: 451-10-017]	European Research Council(European Research Council (ERC)European Commission); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work is supported by grants from the European Research Council (EU-ERC 283567) and the Netherlands Organisation for Scientific Research (NWO-VICI: 453-11-001; NWOVENI: 451-10-017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelaki DE, 2000, J NEUROPHYSIOL, V84, P2113, DOI 10.1152/jn.2000.84.4.2113; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Angelaki DE, 2011, J PHYSIOL-LONDON, V589, P825, DOI 10.1113/jphysiol.2010.194720; Angelaki DE, 2009, CURR OPIN NEUROBIOL, V19, P452, DOI 10.1016/j.conb.2009.06.008; BERTHOZ A, 1995, SCIENCE, V269, P95, DOI 10.1126/science.7604286; Bremmer F, 1999, EXP BRAIN RES, V127, P33, DOI 10.1007/s002210050771; Butler JS, 2011, SEEING PERCEIVING, V24, P453, DOI 10.1163/187847511X588070; Butler JS, 2010, J VISION, V10, DOI 10.1167/10.11.23; Campos JL, 2012, EXP BRAIN RES, V218, P551, DOI 10.1007/s00221-012-3048-1; Campos JL, 2012, FRONTIERS NEUROSCIEN; de Winkel KN, 2010, J VISION, V10, DOI 10.1167/10.12.1; Drugowitsch J, 2014, ELIFE, V3, DOI 10.7554/eLife.03005; Fetsch CR, 2012, NAT NEUROSCI, V15, P146, DOI 10.1038/nn.2983; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Fetsch CR, 2011, SENSORY CUE INTEGRAT; Frenz H, 2005, VISION RES, V45, P1679, DOI 10.1016/j.visres.2004.12.019; GIBSON JJ, 1950, AM J PSYCHOL, V63, P367, DOI 10.2307/1418003; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; Gu Y, 2010, NEURON, V66, P596, DOI 10.1016/j.neuron.2010.04.026; Harris LR, 2000, EXP BRAIN RES, V135, P12, DOI 10.1007/s002210000504; ISRAEL I, 1993, J NEUROPHYSIOL, V70, P1270, DOI 10.1152/jn.1993.70.3.1270; ISRAEL I, 1989, J NEUROPHYSIOL, V62, P247, DOI 10.1152/jn.1989.62.1.247; Israel I, 1997, J NEUROPHYSIOL, V77, P3180, DOI 10.1152/jn.1997.77.6.3180; Kingma H, 2005, BMC EAR NOSE THROAT, V5, DOI 10.1186/1472-6815-5-5; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Kontsevich LL, 1999, VISION RES, V39, P2729, DOI 10.1016/S0042-6989(98)00285-5; MacNeilage PR, 2010, J NEUROSCI, V30, P9084, DOI 10.1523/JNEUROSCI.1304-10.2010; Redlick FP, 2001, VISION RES, V41, P213, DOI 10.1016/S0042-6989(00)00243-1; Sun HJ, 2004, EXP BRAIN RES, V154, P246, DOI 10.1007/s00221-003-1652-9; Wright WG, 2005, J VESTIBUL RES-EQUIL, V15, P185	32	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145015	10.1371/journal.pone.0145015	http://dx.doi.org/10.1371/journal.pone.0145015			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658990	Green Published, gold			2022-12-27	WOS:000366715900168
J	Weis, C; Hess, A; Budinsky, L; Fabry, B				Weis, Christian; Hess, Andreas; Budinsky, Lubos; Fabry, Ben			In-Vivo Imaging of Cell Migration Using Contrast Enhanced MRI and SVM Based Post-Processing	PLOS ONE			English	Article							LYMPH-NODES; TRACKING; NANOPARTICLES; CANCER	The migration of cells within a living organism can be observed with magnetic resonance imaging (MRI) in combination with iron oxide nanoparticles as an intracellular contrast agent. This method, however, suffers from low sensitivity and specificty. Here, we developed a quantitative non-invasive in-vivo cell localization method using contrast enhanced multiparametric MRI and support vector machines (SVM) based post-processing. Imaging phantoms consisting of agarose with compartments containing different concentrations of cancer cells labeled with iron oxide nanoparticles were used to train and evaluate the SVM for cell localization. From the magnitude and phase data acquired with a series of T-2(+)-weighted gradient-echo scans at different echo-times, we extracted features that are characteristic for the presence of superparamagnetic nanoparticles, in particular hyper-and hypointensities, relaxation rates, short-range phase perturbations, and perturbation dynamics. High detection quality was achieved by SVM analysis of the multiparametric featurespace. The in-vivo applicability was validated in animal studies. The SVM detected the presence of iron oxide nanoparticles in the imaging phantoms with high specificity and sensitivity with a detection limit of 30 labeled cells per mm(3), corresponding to 19 mu M of iron oxide. As proof-of-concept, we applied the method to follow the migration of labeled cancer cells injected in rats. The combination of iron oxide labeled cells, multiparametric MRI and a SVM based post processing provides high spatial resolution, specificity, and sensitivity, and is therefore suitable for non-invasive in-vivo cell detection and cell migration studies over prolonged time periods.	[Weis, Christian; Fabry, Ben] Univ Erlangen Nurnberg, Biophys Grp, D-91054 Erlangen, Germany; [Weis, Christian] Univ Heidelberg Hosp, Clin Diagnost & Intervent Radiol, Heidelberg, Germany; [Hess, Andreas; Budinsky, Lubos] Univ Erlangen Nurnberg, Pharmacol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg	Weis, C (corresponding author), Univ Erlangen Nurnberg, Biophys Grp, D-91054 Erlangen, Germany.	christian.weis@med.uni-heidelberg.de	Fabry, Ben/AAT-5717-2020; Fabry, Ben/C-5496-2013	Fabry, Ben/0000-0003-1737-0465; Fabry, Ben/0000-0003-1737-0465; Budinsky, Lubos/0000-0003-2171-0098				Andreas K, 2012, BIOMATERIALS, V33, P4515, DOI 10.1016/j.biomaterials.2012.02.064; Baumjohann D, 2006, EUR J IMMUNOL, V36, P2544, DOI 10.1002/eji.200535742; Bowen CV, 2002, MAGNET RESON MED, V48, P52, DOI 10.1002/mrm.10192; Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141; Bulte JWM, 1999, P NATL ACAD SCI USA, V96, P15256, DOI 10.1073/pnas.96.26.15256; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Foster P, 2008, NEOPLASIA, V10, P207, DOI 10.1593/neo.07937; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hahn DA, 2010, IEEE T MED IMAGING, V29, P1140, DOI 10.1109/TMI.2010.2041358; Hong H, 2010, CURR TOP MED CHEM, V10, P1237, DOI 10.2174/156802610791384234; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Kostura L, 2004, NMR BIOMED, V17, P513, DOI 10.1002/nbm.925; Kovesi P, 2000, PSYCHOL RES-PSYCH FO, V64, P136, DOI 10.1007/s004260000024; Li BN, 2011, COMPUT BIOL MED, V41, P1, DOI 10.1016/j.compbiomed.2010.10.007; Liu TA, 2010, MAGN RESON IMAGING, V28, P1383, DOI 10.1016/j.mri.2010.06.011; Long CM, 2009, EXPERT OPIN BIOL TH, V9, P293, DOI 10.1517/14712590802715723 ; Rice BW, 2001, J BIOMED OPT, V6, P432, DOI 10.1117/1.1413210; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; Wang Paul C, 2012, J Basic Clin Med, V1, P1; Weis C, 2014, MAGN RESON MED, V71, P1896, DOI 10.1002/mrm.24832	22	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0140548	10.1371/journal.pone.0140548	http://dx.doi.org/10.1371/journal.pone.0140548			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656497	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900002
J	Yu, FSK; Yip, BHK; Kung, K; Fung, CSC; Wong, CKM; Lam, AT; Mercer, SW; Wong, SYS				Yu, Frances S. K.; Yip, Benjamin H. K.; Kung, Kenny; Fung, Colman S. C.; Wong, Carmen K. M.; Lam, Augustine T.; Mercer, Stewart W.; Wong, Samuel Y. S.			The Association of Types of Training and Practice Settings with Doctors' Empathy and Patient Enablement among Patients with Chronic Illness in Hong Kong	PLOS ONE			English	Article							GENERAL-PRACTICE CONSULTATIONS; PRIMARY-CARE; FAMILY MEDICINE; PHYSICIAN EMPATHY; INSTRUMENT PEI; SATISFACTION; RELIABILITY; QUALITY; VALIDITY; OUTCOMES	Background The increase in non-communicable disease (NCD) is becoming a global health problem and there is an increasing need for primary care doctors to look after these patients although whether family doctors are adequately trained and prepared is unknown. Objective This study aimed to determine if doctors with family medicine (FM) training are associated with enhanced empathy in consultation and enablement for patients with chronic illness as compared to doctors with internal medicine training or without any postgraduate training in different clinic settings. Methods This was a cross-sectional questionnaire survey using the validated Chinese version of the Consultation and Relational Empathy (CARE) Measure as well as Patient Enablement Instrument (PEI) for evaluation of quality and outcome of care. 14 doctors from hospital specialist clinics (7 with family medicine training, and 7 with internal medicine training) and 13 doctors from primary care clinics (7 with family medicine training, and 6 without specialist training) were recruited. In total, they consulted 823 patients with chronic illness. The CARE Measure and PEI scores were compared amongst doctors in these clinics with different training background: family medicine training, internal medicine training and those without specialist training. Generalized estimation equation (GEE) was used to account for cluster effects of patients nested with doctors. Results Within similar clinic settings, FM trained doctors had higher CARE score than doctors with no FM training. In hospital clinics, the difference of the mean CARE score for doctors who had family medicine training (39.2, SD = 7.04) and internal medicine training (35.5, SD = 8.92) was statistically significant after adjusting for consultation time and gender of the patient. In the community care clinics, the mean CARE score for doctors with family medicine training and those without specialist training were 32.1 (SD = 7.95) and 29.2 (SD = 7.43) respectively, but the difference was not found to be significant. For PEI, patients receiving care from doctors in the hospital clinics scored significantly higher than those in the community clinics, but there was no significant difference in PEI between patients receiving care from doctors with different training backgrounds within similar clinic setting. Conclusion Family medicine training was associated with higher patient perceived empathy for chronic illness patients in the hospital clinics. Patient enablement appeared to be associated with clinic settings but not doctors' training background. Training in family medicine and a clinic environment that enables more patient doctor time might help in enhancing doctors' empathy and enablement for chronic illness patients.	[Yu, Frances S. K.; Lam, Augustine T.] Hosp Author, New Territories East Cluster, Dept Family Med, Hong Kong, Hong Kong, Peoples R China; [Yip, Benjamin H. K.; Wong, Carmen K. M.; Wong, Samuel Y. S.] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Mercer, Stewart W.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Kung, Kenny; Fung, Colman S. C.] Univ Hong Kong, Dept Family Med & Primary Care, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; University of Glasgow; University of Hong Kong	Wong, SYS (corresponding author), Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	yeungshanwong@cuhk.edu.hk	WONG, Samuel Yeung Shan/D-7311-2013; Yip, Benjamin/AAC-7845-2019	WONG, Samuel Yeung Shan/0000-0003-0934-6385; Yip, Benjamin/0000-0002-4749-7611; Mercer, Stewart William/0000-0002-1703-3664	Hong Kong College of Family Physician (HKCFP) Research Fellowship	Hong Kong College of Family Physician (HKCFP) Research Fellowship	This study was funded by the Hong Kong College of Family Physician (HKCFP) Research Fellowship 2010 (http://www.hkcfp.org.hk/index.php/tw/hkcfp-research-fellowship). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, OCCAS PAP R COLL GEN; [Anonymous], 2011, GLOBAL STATUS REPORT; BORGIEL AEM, 1989, CAN MED ASSOC J, V140, P1035; Census and Statistics Department, 2013, 50 CENS STAT DEP; Fung CSC, 2009, FAM PRACT, V26, P398, DOI 10.1093/fampra/cmp044; Haughney John, 2007, Prim Care Respir J, V16, P89; Hojat M, 2011, ACAD MED, V86, P359, DOI 10.1097/ACM.0b013e3182086fe1; Howie JGR, 1998, FAM PRACT, V15, P165, DOI 10.1093/fampra/15.2.165; Howie JGR, 1999, BMJ-BRIT MED J, V319, P738, DOI 10.1136/bmj.319.7212.738; Jaturapatporn D, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-14; Lam CLK, 2010, FAM PRACT, V27, P395, DOI 10.1093/fampra/cmq021; Little P, 2001, BRIT MED J, V323, P908, DOI 10.1136/bmj.323.7318.908; Lo Y Y C, 2011, Hong Kong Med J, V17, P33; MAHEUX B, 1992, CAN MED ASSOC J, V146, P901; Martin Carmel M, 2009, Asia Pac Fam Med, V8, P1, DOI 10.1186/1447-056X-8-1; Mead N, 2008, BRIT J GEN PRACT, V58, P346, DOI 10.3399/bjgp08X280218; Mercer SW, 2008, PATIENT EDUC COUNS, V73, P240, DOI 10.1016/j.pec.2008.07.022; Mercer SW, 2007, ANN FAM MED, V5, P503, DOI 10.1370/afm.778; Mercer SW, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-6; Mercer SW, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-43; Mercer SW, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-46; Mercer SW, 2005, FAM PRACT, V22, P328, DOI 10.1093/fampra/cmh730; Mercer SW, 2004, FAM PRACT, V21, P699, DOI 10.1093/fampra/cmh621; Mercer SW, 2002, BRIT J GEN PRACT, V52, pS9; Mercer SW, 2002, BRIT J GEN PRACT, V52, P901; Mercer SW, 2011, HONG KONG MED J, V17, ps25; Mercer SW, 2008, CLIN GOV, V13, P128, DOI DOI 10.1108/14777270810867320; Mercer SW., 2008, CLIN GOV, V13, P269, DOI [10.1108/14777270810912969, DOI 10.1108/14777270810912969]; Neumann M, 2007, PATIENT EDUC COUNS, V69, P63, DOI 10.1016/j.pec.2007.07.003; Ock M, 2014, BMC FAM PRACT, V15, DOI 10.1186/s12875-014-0178-5; Rakel D, 2011, PATIENT EDUC COUNS, V85, P390, DOI 10.1016/j.pec.2011.01.009; Sans-Corrales M, 2006, FAM PRACT, V23, P308, DOI 10.1093/fampra/cmi112; World Health Organization, 2005, PREPARING A HEALTH C; World Health Organization, 2013, GLOB ACT PLAN PREV C; Zantinge EM, 2007, PATIENT EDUC COUNS, V67, P93, DOI 10.1016/j.pec.2007.02.006	35	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144492	10.1371/journal.pone.0144492	http://dx.doi.org/10.1371/journal.pone.0144492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26658427	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000366715900057
J	Kang, JI; Hong, JY; Lee, HJ; Bae, SY; Jung, C; Park, HJ; Lee, SK				Kang, Ji In; Hong, Ji-Young; Lee, Hye-Jung; Bae, Song Yi; Jung, Cholomi; Park, Hyen Joo; Lee, Sang Kook			Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; EPITHELIAL-MESENCHYMAL TRANSITIONS; POTENT INHIBITORY-ACTIVITY; DAPHNANE DITERPENE ESTERS; COA-CARBOXYLASE-ALPHA; DNA TOPOISOMERASE-I; MTOR COMPLEX; GROWTH; DISEASE; GENKWA	Yuanhuacine (YC), a daphnane diterpenoid from the flowers of Daphne genkwa, exhibited a potential growth inhibitory activity against human non-small cell lung cancer (NSCLC) cells. YC also suppressed the invasion and migration of lung cancer cells. However, the precise molecular mechanisms remain to be elucidated. In the present study, we report that YC significantly activated AMP-activated protein kinase (AMPK) signaling pathway and suppressed mTORC2-mediated downstream signaling pathway in H1993 human NSCLC cells. AMPK plays an important role in energy metabolism and cancer biology. Therefore, activators of AMPK signaling pathways can be applicable to the treatment of cancer. YC enhanced the expression of p-AMPK alpha. The co-treatment of YC and compound C (an AMPK inhibitor) or metformin (an AMPK activator) also confirmed that YC increases p-AMPK alpha. YC also suppressed the activation of the mammalian target of rapamycin (mTOR) expression, a downstream target of AMPK. Further study revealed that YC modulatesm TORC2-associated downstream signaling pathways with a decreased expressions of p-Akt, p-protein kinase C alpha (PKC alpha), p-ras-related C3 botulinum toxin substrate 1 (Rac1) and filamentous actin (F-actin) that are known to activate cell growth and organize actin cytoskeleton. In addition, YC inhibited the tumor growth in H1993 cell-implanted xenograft nude mouse model. These data suggest the YC could be a potential candidate for cancer chemotherapeutic agents derived from natural products by regulating AMPK/mTORC2 signaling pathway and actin cytoskeleton organization.	[Kang, Ji In; Hong, Ji-Young; Lee, Hye-Jung; Bae, Song Yi; Jung, Cholomi; Park, Hyen Joo; Lee, Sang Kook] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea	Seoul National University (SNU)	Lee, SK (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea.	sklee61@snu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013R1A1A2012389, 20100024361]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2013R1A1A2012389 and No. 20100024361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Beckers A, 2007, CANCER RES, V67, P8180, DOI 10.1158/0008-5472.CAN-07-0389; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Chao YC, 2009, AM J RESP CRIT CARE, V179, P123, DOI 10.1164/rccm.200803-456OC; Chapuis N, 2010, LEUKEMIA, V24, P1686, DOI 10.1038/leu.2010.170; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; HALL IH, 1982, J PHARM SCI, V71, P1263, DOI 10.1002/jps.2600711120; Hardie DG, 1999, BIOCHEM J, V338, P717, DOI 10.1042/0264-6021:3380717; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; He WD, 2002, MINI-REV MED CHEM, V2, P185, DOI 10.2174/1389557024605492; Hong JY, 2010, CHEM PHARM BULL, V58, P234, DOI 10.1248/cpb.58.234; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang JX, 2009, CANCER RES, V69, P6107, DOI 10.1158/0008-5472.CAN-09-0975; Hwang HJ, 2006, J NUTR BIOCHEM, V17, P356, DOI 10.1016/j.jnutbio.2005.08.009; Hwang JT, 2009, NEW BIOTECHNOL, V26, P17, DOI 10.1016/j.nbt.2009.03.005; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim GD, 2013, MAR DRUGS, V11, P1087, DOI 10.3390/md11041087; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li JN, 2001, CANCER RES, V61, P1493; Lin YC, 2010, J AGR FOOD CHEM, V58, P9511, DOI 10.1021/jf1019533; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Mohamet L, 2011, J ONCOL, V2011, DOI 10.1155/2011/352616; Mooney MH, 2008, BRIT J PHARMACOL, V153, P1669, DOI 10.1038/bjp.2008.37; Park BY, 2007, J ETHNOPHARMACOL, V111, P496, DOI 10.1016/j.jep.2006.12.023; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shane ER, 2013, J CHIROPR MED, V12, P252, DOI 10.1016/j.jcm.2013.08.001; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Spiro SG, 2005, AM J RESP CRIT CARE, V172, P523, DOI 10.1164/rccm.200504-531OE; Spiro SG, 2010, RESPIROLOGY, V15, P44, DOI 10.1111/j.1440-1843.2009.01674.x; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Suzuki A, 2005, J BIOL CHEM, V280, P31557, DOI 10.1074/jbc.M503714200; Tang W, 1992, CHINESE DRUGS PLANT, P429, DOI DOI 10.1007/978-3-642-73739-8_54; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhan ZJ, 2005, BIOORGAN MED CHEM, V13, P645, DOI 10.1016/j.bmc.2004.10.054; Zhang RW, 2014, J BIOL CHEM, V289, P6394, DOI 10.1074/jbc.M113.513960; Zhang SX, 2006, BIOORGAN MED CHEM, V14, P3888, DOI 10.1016/j.bmc.2006.01.055; Zhang SX, 2009, J DRUG TARGET, V17, P286, DOI 10.1080/10611860902737912	50	20	22	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144368	10.1371/journal.pone.0144368	http://dx.doi.org/10.1371/journal.pone.0144368			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656173	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903600039
J	Omer, T; Intes, X; Hahn, J				Omer, Travis; Intes, Xavier; Hahn, Juergen			Temporal Data Set Reduction Based on D-Optimality for Quantitative FLIM-FRET Imaging	PLOS ONE			English	Article							WIDE-FIELD ILLUMINATION; PHASOR APPROACH; PROTEIN INTERACTIONS; TIME-DOMAIN; FLUORESCENCE; TOMOGRAPHY; MICROSCOPY; ACTIVATION; DESIGN; PAIR	Fluorescence lifetime imaging (FLIM) when paired with Forster resonance energy transfer (FLIM-FRET) enables the monitoring of nanoscale interactions in living biological samples. FLIM-FRET model-based estimation methods allow the quantitative retrieval of parameters such as the quenched (interacting) and unquenched (non-interacting) fractional populations of the donor fluorophore and/or the distance of the interactions. The quantitative accuracy of such model-based approaches is dependent on multiple factors such as signal-to-noise ratio and number of temporal points acquired when sampling the fluorescence decays. For high-throughput or in vivo applications of FLIM-FRET, it is desirable to acquire a limited number of temporal points for fast acquisition times. Yet, it is critical to acquire temporal data sets with sufficient information content to allow for accurate FLIM-FRET parameter estimation. Herein, an optimal experimental design approach based upon sensitivity analysis is presented in order to identify the time points that provide the best quantitative estimates of the parameters for a determined number of temporal sampling points. More specifically, the D-optimality criterion is employed to identify, within a sparse temporal data set, the set of time points leading to optimal estimations of the quenched fractional population of the donor fluorophore. Overall, a reduced set of 10 time points (compared to a typical complete set of 90 time points) was identified to have minimal impact on parameter estimation accuracy (approximate to 5%), with in silico and in vivo experiment validations. This reduction of the number of needed time points by almost an order of magnitude allows the use of FLIM-FRET for certain high-throughput applications which would be infeasible if the entire number of time sampling points were used.	[Omer, Travis; Intes, Xavier; Hahn, Juergen] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA; [Hahn, Juergen] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Hahn, J (corresponding author), Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.	hahnj@rpi.edu	Hahn, Juergen/H-8025-2019	Hahn, Juergen/0000-0002-1078-4203	National Science Foundation [CBET 0941313, CBET 1149407]; National Institute of Health [R01 AI110642, R01 EB19443]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB019443] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [1149407] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the National Science Foundation (http://www.nsf.gov/) under awards CBET 0941313 (TO, JH) and CBET 1149407 (XI) and National Institute of Health (http://www.nih.gov/) Grants R01 AI110642 (JH) and R01 EB19443 (XI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080269; Atkinson AC., 2007, OPTIMUM EXPT DESIGNS; Barroso MM, 2011, J HISTOCHEM CYTOCHEM, V59, P237, DOI 10.1369/0022155411398487; Becker W, 2012, J MICROSC-OXFORD, V247, P119, DOI 10.1111/j.1365-2818.2012.03618.x; Berezin MY, 2010, CHEM REV, V110, P2641, DOI 10.1021/cr900343z; Bonami P, 2008, DISCRETE OPTIM, V5, P186, DOI 10.1016/j.disopt.2006.10.011; Chang CW, 2007, METHOD CELL BIOL, V81, P495, DOI 10.1016/S0091-679X(06)81024-1; Chen J, 2011, MED PHYS, V38, P5788, DOI 10.1118/1.3641827; Chen J, 2011, BIOMED OPT EXPRESS, V2, P871, DOI 10.1364/BOE.2.000871; Chen Y, 2003, REV SCI INSTRUM, V74, P3466, DOI 10.1063/1.1583864; Cubeddu R, 2002, J PHYS D APPL PHYS, V35, pR61, DOI 10.1088/0022-3727/35/9/201; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Dette H, 1997, J ROY STAT SOC B MET, V59, P97, DOI 10.1111/1467-9868.00056; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Ducros N, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.020503; Elangovan M, 2002, J MICROSC-OXFORD, V205, P3, DOI 10.1046/j.0022-2720.2001.00984.x; Fereidouni F, 2013, OPT EXPRESS, V21, P11769, DOI 10.1364/OE.21.011769; Franceschini G, 2008, CHEM ENG SCI, V63, P4846, DOI 10.1016/j.ces.2007.11.034; Grant DM, 2008, BIOPHYS J, V95, pL69, DOI 10.1529/biophysj.108.139204; Gratton E, 2003, J BIOMED OPT, V8, P381, DOI 10.1117/1.1586704; Hinde E, 2013, P NATL ACAD SCI USA, V110, P135, DOI 10.1073/pnas.1211882110; Keller SB, 2008, ANAL CHEM, V80, P7876, DOI 10.1021/ac801252q; Khinkis Leonid A, 2003, Nonlinearity Biol Toxicol Med, V1, P363, DOI 10.1080/15401420390249925; KIEFER J, 1959, J ROY STAT SOC B, V21, P272; Kreutz C, 2009, FEBS J, V276, P923, DOI 10.1111/j.1742-4658.2008.06843.x; Kumar S, 2011, CHEMPHYSCHEM, V12, P609, DOI 10.1002/cphc.201000874; Lakowicz J.R., 2006, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; LAKOWICZ JR, 1994, CELL CALCIUM, V15, P7, DOI 10.1016/0143-4160(94)90100-7; Lang P, 2006, NAT REV DRUG DISCOV, V5, P343, DOI 10.1038/nrd2008; Leray A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069335; Lewis GA, 1998, PHARM EXPT DESIGN; Luo KQ, 2001, BIOCHEM BIOPH RES CO, V283, P1054, DOI 10.1006/bbrc.2001.4896; Masters BR, 2010, ENCY LIFE SCI ELS, DOI DOI 10.1002/9780470015902.A0022093; McGinty J, 2011, BIOMED OPT EXPRESS, V2, P1907, DOI 10.1364/BOE.2.001907; Miyawaki A, 2011, ANNU REV BIOCHEM, V80, P357, DOI 10.1146/annurev-biochem-072909-094736; Muller HK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097540; Niedre MJ, 2008, P NATL ACAD SCI USA, V105, P19126, DOI 10.1073/pnas.0804798105; Nobis M, 2013, CANCER RES, V73, P4674, DOI 10.1158/0008-5472.CAN-12-4545; Omer T, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.8.086023; Periasamy A, 2008, METHOD CELL BIOL, V89, P569, DOI 10.1016/S0091-679X(08)00622-5; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; Pian Q, 2015, OPT LETT, V40, P431, DOI 10.1364/OL.40.000431; Rajoria Shilpi, 2014, Curr Mol Imaging, V3, P144; Rowley MI, 2011, PROC SPIE, V7903, DOI 10.1117/12.873890; Ruck A, 2009, SLIM MULTISPECTRAL F, V7183, DOI DOI 10.1117/12.809101; Ruck A, 2007, MICROSC RES TECHNIQ, V70, P485, DOI 10.1002/jemt.20433; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Seong JY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1414; Shcherbo D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-24; Sinsuebphon N, 2014, PROC SPIE, V8937, DOI 10.1117/12.2040097; Stringari C, 2011, P NATL ACAD SCI USA, V108, P13582, DOI 10.1073/pnas.1108161108; Talati R, 2014, METHODS, V66, P139, DOI 10.1016/j.ymeth.2013.08.017; Tichauer KM, 2011, BIOMED OPT EXPRESS, V2, P3021, DOI 10.1364/BOE.2.003021; Tramier M, 2006, MICROSC RES TECHNIQ, V69, P933, DOI 10.1002/jemt.20370; TURANYI T, 1990, J MATH CHEM, V5, P203, DOI 10.1007/BF01166355; Ucinski D., 2004, OPTIMAL MEASUREMENT; Vandenberghe L, 1998, SIAM J MATRIX ANAL A, V19, P499, DOI 10.1137/S0895479896303430; Venugopal Vivek, 2012, Biomed Opt Express, V3, P3161, DOI 10.1364/BOE.3.003161; Venugopal V, 2010, OPT LETT, V35, P3189, DOI 10.1364/OL.35.003189; Vogel Steven S, 2006, Sci STKE, V2006, pre2; Wallrabe H, 2007, MOL BIOL CELL, V18, P2226, DOI 10.1091/mbc.E06-08-0700; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; WALTER E, 1990, AUTOMATICA, V26, P195, DOI 10.1016/0005-1098(90)90116-Y; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Zhao LL, 2014, OPT LETT, V39, P4156, DOI 10.1364/OL.39.004156; Zhao LL, 2014, BIOMED OPT EXPRESS, V5, P944, DOI 10.1364/BOE.5.000944; Zhao LL, 2013, OPT LETT, V38, P3976, DOI 10.1364/OL.38.003976; Zheng G, 2004, J PORPHYR PHTHALOCYA, V8, P1106, DOI 10.1142/S1088424604000477	68	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144421	10.1371/journal.pone.0144421	http://dx.doi.org/10.1371/journal.pone.0144421			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658308	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903600042
J	Snyder, SM; Li, W; O'Brien, JE; Howard, MO				Snyder, Susan M.; Li, Wen; O'Brien, Jennifer E.; Howard, Matthew O.			The Effect of US University Students' Problematic Internet Use on Family Relationships: A Mixed-Methods Investigation	PLOS ONE			English	Article							PROPOSED DIAGNOSTIC-CRITERIA; ALCOHOL-USE; ADDICTION; ASSOCIATION; ADOLESCENTS; BEHAVIOR	This is the first study to investigate how college students in the U.S. with problematic Internet use perceive the role the Internet plays within their families of origin. The sample included 27 U.S. university students who self-identified as excessive Internet users. Participants reported spending more than 25 hours a week on the Internet on non-school or non-work-related activities and reported Internet-associated health and/or psychosocial problems. This study provides descriptive statistics from participants' completion of two problematic Internet use measures (i.e., Young's Diagnostic Questionnaire and the Compulsive Internet Use Scale) and reports findings from four focus groups. Three themes emerged from the focus groups: (1) family connectedness, (2) family conflict/family disconnection, and (3) family Internet overuse. The findings of this study are a first step toward the design of effective interventions for problematic Internet use among U.S. college students and serve to inform clinical practice and health policy in this area.	[Snyder, Susan M.] Georgia State Univ, Sch Social Work, Atlanta, GA 30303 USA; [Li, Wen; O'Brien, Jennifer E.; Howard, Matthew O.] Univ N Carolina, Sch Social Work, Chapel Hill, NC 27599 USA	University System of Georgia; Georgia State University; University of North Carolina; University of North Carolina Chapel Hill	Howard, MO (corresponding author), Univ N Carolina, Sch Social Work, Chapel Hill, NC 27599 USA.	mohoward@email.unc.edu	Snyder, Susan M/AAN-2386-2021	Snyder, Susan M/0000-0002-6909-336X; , Wen/0000-0003-1631-0161	Armfield-Reeves Innovation Fund [29201 S0013]	Armfield-Reeves Innovation Fund	Armfield-Reeves Innovation Fund (Award Number: 29201 S0013) provided all of the funding for this study; there were no other sources of funding or support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard KW, 2005, CYBERPSYCHOL BEHAV, V8, P7, DOI 10.1089/cpb.2005.8.7; Beard KW, 2001, CYBERPSYCHOL BEHAV, V4, P377, DOI 10.1089/109493101300210286; Black DW, 2006, PSYCHIAT RES, V141, P295, DOI 10.1016/j.psychres.2005.12.005; Chen YF, 2008, CYBERPSYCHOL BEHAV, V11, P467, DOI 10.1089/cpb.2007.0128; Choi K, 2009, PSYCHIAT CLIN NEUROS, V63, P455, DOI 10.1111/j.1440-1819.2009.01925.x; DeCuir-Gunby JT, 2011, FIELD METHOD, V23, P136, DOI 10.1177/1525822X10388468; Dogra R, 2012, DYSPHRENIA, V3; Dowling NA, 2009, CYBERPSYCHOL BEHAV, V12, P21, DOI 10.1089/cpb.2008.0162; Grant JE, 2003, COMPR PSYCHIAT, V44, P437, DOI 10.1016/S0010-440X(03)00150-0; Grant JE, 2010, AM J DRUG ALCOHOL AB, V36, P233, DOI 10.3109/00952990.2010.491884; Hoover S.M., 2004, MEDIA HOME FAMILY; Juhnke Gerald A., 2006, COUNSELING ADDICTED; Kennedy T. L. M., 2008, NETWORKED FAMILIES; Ko CH, 2008, CYBERPSYCHOL BEHAV, V11, P571, DOI 10.1089/cpb.2008.0199; Ko CH, 2009, ARCH PEDIAT ADOL MED, V163, P937, DOI 10.1001/archpediatrics.2009.159; Krueger R.A., 2015, FOCUS GROUPS PRACTIC; Lam LT, 2009, INJURY PREV, V15, P403, DOI 10.1136/ip.2009.021949; Li WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133165; Li W, 2014, COMPUT HUM BEHAV, V31, P393, DOI 10.1016/j.chb.2013.11.004; Manago AM, 2012, DEV PSYCHOL, V48, P369, DOI 10.1037/a0026338; Mesch G. S., 2006, Information Communication & Society, V9, P473, DOI 10.1080/13691180600858705; Mesch GS, 2003, SOC SCI QUART, V84, P1038, DOI 10.1046/j.0038-4941.2003.08404016.x; Mesch GS, 2006, J FAM COMMUN, V6, P119, DOI 10.1207/s15327698jfc0602_2; Moreno MA, 2011, ARCH PEDIAT ADOL MED, V165, P797, DOI 10.1001/archpediatrics.2011.58; O'Brien JE, J EVID INF IN PRESS; OMNI, 1996, TOOLK COND FOC GROUP; Padgett D.K., 2016, QUALITATIVE METHODS, V36; Shek DTL., 2013, NEUROSCIENCE 21 CENT, pp. 2775, DOI DOI 10.1007/978-1-4614-1997-6_108; Takeuchi L., 2011, NEW COVIEWING DESIGN; Turkle S., 2017, ALONE TOGETHER WHY W; U. S. Pew Research Center Pew Internet & American Life Project, 2012, COLL STUDENTS TECHNO; Wilcox K, 2013, J CONSUM RES, V40, P90, DOI 10.1086/668794; Williams AL, 2011, FAM CONSUM SCI RES J, V40, P150, DOI 10.1111/j.1552-3934.2011.02101.x; Worthan J, 2011, NY TIMES; Yen JY, 2009, PSYCHIAT CLIN NEUROS, V63, P218, DOI 10.1111/j.1440-1819.2009.01943.x; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; Young KS, 2004, AM BEHAV SCI, V48, P402, DOI 10.1177/0002764204270278	37	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144005	10.1371/journal.pone.0144005	http://dx.doi.org/10.1371/journal.pone.0144005			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1ZA	26658077	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903600017
J	Kachele, M; Hennige, AM; Machann, J; Hieronimus, A; Lamprinou, A; Machicao, F; Schick, F; Fritsche, A; Stefan, N; Nurnberg, B; Haring, HU; Staiger, H				Kaechele, Martin; Hennige, Anita M.; Machann, Juergen; Hieronimus, Anja; Lamprinou, Apostolia; Machicao, Fausto; Schick, Fritz; Fritsche, Andreas; Stefan, Norbert; Nuernberg, Bernd; Haering, Hans-Ulrich; Staiger, Harald			Variation in the Phosphoinositide 3-Kinase Gamma Gene Affects Plasma HDL-Cholesterol without Modification of Metabolic or Inflammatory Markers	PLOS ONE			English	Article							G-BETA-GAMMA; INSULIN SENSITIVITY; CARDIOVASCULAR RISK; ACTIVATION; OBESITY; NIACIN; INHIBITION; PI3K-GAMMA; RESISTANCE; GLUCOSE	Objective Phosphoinositide 3-kinase gamma (PI3K gamma) is a G-protein-coupled receptor-activated lipid kinase mainly expressed in leukocytes and cells of the cardiovascular system. PI3K gamma plays an important signaling role in inflammatory processes. Since subclinical inflammation is a hallmark of atherosclerosis, obesity-related insulin resistance, and pancreatic beta-cell failure, we asked whether common genetic variation in the PI3K gamma gene (PIK3CG) contributes to body fat content/distribution, serum adipokine/cytokine concentrations, alterations in plasma lipid profiles, insulin sensitivity, insulin release, and glucose homeostasis. Study Design Using a tagging single nucleotide polymorphism (SNP) approach, we analyzed genotype-phenotype associations in 2,068 German subjects genotyped for 10 PIK3CG SNPs and characterized by oral glucose tolerance tests. In subgroups, data from hyperinsulinaemic-euglycaemic clamps, magnetic resonance spectroscopy of the liver, whole-body magnetic resonance imaging, and intravenous glucose tolerance tests were available, and peripheral blood mononuclear cells (PBMCs) were used for gene expression analysis. Results After appropriate adjustment, none of the PIK3CG tagging SNPs was significantly associated with body fat content/distribution, adipokine/cytokine concentrations, insulin sensitivity, insulin secretion, or blood glucose concentrations (p>0.0127, all; Bonferroni-corrected alpha-level: 0.0051). However, six non-linked SNPs displayed at least nominal associations with plasma HDL-cholesterol concentrations, two of them (rs4288294 and rs116697954) reaching the level of study-wide significance (p = 0.0003 and p = 0.0004, respectively). More precisely, rs4288294 and rs116697954 influenced HDL2-, but not HDL3-, cholesterol. With respect to the SNPs' in vivo functionality, rs4288294 was significantly associated with PIK3CG mRNA expression in PBMCs. Conclusions We could demonstrate that common genetic variation in the PIK3CG locus, possibly via altered PIK3CG gene expression, determines plasma HDL-cholesterol concentrations. Since HDL2-, but not HDL3-, cholesterol is influenced by PIK3CG variants, PI3K gamma may play a role in HDL clearance rather than in HDL biogenesis. Even though the molecular pathways connecting PI3K gamma and HDL metabolism remain to be further elucidated, this finding could add a novel aspect to the pathophysiological role of PI3K gamma in atherogenesis.	[Kaechele, Martin; Hieronimus, Anja; Lamprinou, Apostolia; Fritsche, Andreas; Stefan, Norbert; Haering, Hans-Ulrich; Staiger, Harald] Univ Tubingen Hosp, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Tubingen, Germany; [Hennige, Anita M.; Machann, Juergen; Hieronimus, Anja; Lamprinou, Apostolia; Machicao, Fausto; Schick, Fritz; Fritsche, Andreas; Stefan, Norbert; Haering, Hans-Ulrich; Staiger, Harald] Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Tubingen, Germany; [Hennige, Anita M.; Machann, Juergen; Hieronimus, Anja; Lamprinou, Apostolia; Machicao, Fausto; Schick, Fritz; Fritsche, Andreas; Stefan, Norbert; Haering, Hans-Ulrich; Staiger, Harald] German Ctr Diabet Res DZD, Tubingen, Germany; [Machann, Juergen; Schick, Fritz] Univ Tubingen Hosp, Sect Expt Radiol, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Fritsche, Andreas] Univ Tubingen Hosp, Dept Internal Med, Div Nutr & Prevent Med, Tubingen, Germany; [Nuernberg, Bernd] Univ Tubingen Hosp, Dept Expt & Clin Pharmacol & Toxicol, Div Pharmacol & Expt Therapy, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Staiger, H (corresponding author), Univ Tubingen Hosp, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Tubingen, Germany.	harald.staiger@med.uni-tuebingen.de		Nurnberg, Bernd/0000-0002-5995-6555; Staiger, Harald/0000-0002-9507-5333; Stefan, Norbert/0000-0002-2186-9595; Schick, Fritz/0000-0002-4231-3406	German Federal Ministry of Education and Research (BMBF) [01GI0925]; Deutsche Forschungsgemeinschaft [STE 1096/3-1]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported in part by a grant (01GI0925) from the German Federal Ministry of Education and Research (BMBF) to the German Centre for Diabetes Research (DZD e.V.). Norbert Stefan is supported by a Heisenberg professorship from the Deutsche Forschungsgemeinschaft (STE 1096/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzinger JJ, 2012, J LIPID RES, V53, P34, DOI 10.1194/jlr.M018887; Barber DF, 2005, NAT MED, V11, P933, DOI 10.1038/nm1291; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Becattini B, 2011, P NATL ACAD SCI USA, V108, pE854, DOI 10.1073/pnas.1106698108; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Brock C, 2003, J CELL BIOL, V160, P89, DOI 10.1083/jcb.200210115; Chang JD, 2007, P NATL ACAD SCI USA, V104, P8077, DOI 10.1073/pnas.0702663104; Dbouk HA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003264; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fougerat A, 2008, CIRCULATION, V117, P1310, DOI 10.1161/CIRCULATIONAHA.107.720466; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Haynes R, 2013, EUR HEART J, V34, P1279, DOI 10.1093/eurheartj/eht055; Herzberg-Schafer SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014194; Hirsch E, 2007, J ENDOCRINOL, V194, P243, DOI 10.1677/JOE-07-0097; Jean S, 2014, J CELL SCI, V127, P923, DOI 10.1242/jcs.093773; Kantartzis K, 2008, DIABETES CARE, V31, P366, DOI 10.2337/dc07-1558; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Keene D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4379; Kurig B, 2009, P NATL ACAD SCI USA, V106, P20312, DOI 10.1073/pnas.0905506106; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Machann J, 2006, MAGN RESON MED, V55, P913, DOI 10.1002/mrm.20825; Machann J, 2005, J MAGN RESON IMAGING, V21, P455, DOI 10.1002/jmri.20292; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; PATSCH W, 1989, CLIN CHEM, V35, P265; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Rohatgi A, 2014, NEW ENGL J MED, V371, P2383, DOI 10.1056/NEJMoa1409065; Rubenfire M, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0349-3; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Stefan N, 2005, DIABETOLOGIA, V48, P2282, DOI 10.1007/s00125-005-1948-3; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Tripathy D, 2003, DIABETES CARE, V26, P1395, DOI 10.2337/diacare.26.5.1395; Vadas O, 2013, P NATL ACAD SCI USA, V110, P18862, DOI 10.1073/pnas.1304801110; van Greevenbroek MMJ, 2013, NETH J MED, V71, P174; Welty FK, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0400-4; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Williams PT, 2011, ATHEROSCLEROSIS, V214, P196, DOI 10.1016/j.atherosclerosis.2010.10.024; Wymann MP, 2013, ANN NY ACAD SCI, V1280, P44, DOI 10.1111/nyas.12037	39	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144494	10.1371/journal.pone.0144494	http://dx.doi.org/10.1371/journal.pone.0144494			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658747	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903500033
J	Asselah, T; Zeuzem, S; Soriano, V; Bronowicki, JP; Lohse, AW; Mullhaupt, B; Schuchmann, M; Bourliere, M; Buti, M; Roberts, SK; Gane, EJ; Stern, JO; Voss, F; Baum, P; Gallivan, JP; Bocher, WO; Mensa, FJ				Asselah, Tarik; Zeuzem, Stefan; Soriano, Vicente; Bronowicki, Jean-Pierre; Lohse, Ansgar W.; Muellhaupt, Beat; Schuchmann, Marcus; Bourliere, Marc; Buti, Maria; Roberts, Stuart K.; Gane, Edward J.; Stern, Jerry O.; Voss, Florian; Baum, Patrick; Gallivan, John-Paul; Boecher, Wulf O.; Mensa, Federico J.			ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection	PLOS ONE			English	Article							SOFOSBUVIR PLUS RIBAVIRIN; C VIRUS-INFECTION; HEPATITIS-C; ABT-450/R-OMBITASVIR; POLYMORPHISM; TELAPREVIR; DASABUVIR; THERAPY; PEGINTERFERON	Background & Aim Whether inosine triphosphatase (ITPA) gene polymorphisms predict anemia during interferon-free therapy in chronic hepatitis C virus (HCV)-infected patients is unknown. We examined the relationship between two ITPA polymorphisms, anemia, and sustained virological response 12 weeks post-treatment (SVR12) in patients receiving the NS3/4A protease inhibitor faldaprevir, the non-nucleoside polymerase inhibitor deleobuvir, and ribavirin. Methods HCV genotype 1-infected, treatment-naive patients (N = 362) were randomized and treated in one of five treatment arms with faldaprevir and deleobuvir with or without ribavirin. Two ITPA polymorphisms (rs1127354 and rs6051702) were genotyped and defined as ITPA-deficient (rs1127354 AA or AC; rs6051702 CC or CA) or ITPA-non-deficient (rs1127354 CC; rs6051702 AA) according to their association with ITPA deficiency. Baseline and ontreatment variables associated with anemia and SVR12 were identified using logistic regression. Results In the pooled ribavirin-containing arms, 10.1% (32/316) of patients experienced on-treatment hemoglobin <10 g/dL, and 32.6%(103/316) experienced on-treatment hemoglobin <10 g/dL or a change from baseline >= 3.5 g/dL. Of the latter group, 99% (102/103) had the ITPA-non-deficient rs1127354 genotype. Other variables associated with on-treatment hemoglobin <10 g/dL or a decrease >= 3.5 g/dL were age, baseline hemoglobin, rs6051702 genotype, and plasma ribavirin concentration. In a multivariate analysis, high plasma ribavirin concentration, low baseline hemoglobin, HCV genotype 1b, and IL28B genotype CC were associated with higher SVR12. Conclusions The ITPA rs1127354 CC and rs6051702 AA genotypes may predict ribavirin-induced anemia during treatment with interferon-free, ribavirin-containing regimens. With this interferon- free regimen, SVR was associated with ribavirin levels, but not with anemia or ITPA genotypes.	[Asselah, Tarik] Univ Paris Diderot, DHU UNITY, Serv Hepatol, Hop Beaujon,INSERM,CRI,UMR S 1149, Clichy, France; [Zeuzem, Stefan] JW Goethe Univ Hosp, Frankfurt, Germany; [Soriano, Vicente] Hosp Carlos III, Dept Infect Dis, Madrid, Spain; [Bronowicki, Jean-Pierre] Univ Lorraine, Ctr Hosp Univ Nancy, INSERM, U954, Vandoeuvre Les Nancy, France; [Lohse, Ansgar W.] Univ Hosp Hamburg Eppendorf, Med Klin & Poliklin 1, Hamburg, Germany; [Muellhaupt, Beat] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Schuchmann, Marcus] Univ Hosp Mainz, Dept Internal Med 1, Mainz, Germany; [Bourliere, Marc] Hop St Joseph, Serv Hepatogastroenterol, Marseille, France; [Buti, Maria] Hosp Univ Valle de Hebron, Liver Unit, Barcelona, Spain; [Buti, Maria] CIBERehd Inst Carlos III, Barcelona, Spain; [Roberts, Stuart K.] Alfred Hosp, Dept Gastroenterol, Melbourne, Vic, Australia; [Gane, Edward J.] Auckland Clin Studies, Auckland, New Zealand; [Stern, Jerry O.; Mensa, Federico J.] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Voss, Florian; Baum, Patrick; Gallivan, John-Paul; Boecher, Wulf O.] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; [Baum, Patrick] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Hospital Carlos III; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Zurich; University Zurich Hospital; University Hospital Mainz; Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Florey Institute of Neuroscience & Mental Health; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim	Asselah, T (corresponding author), Univ Paris Diderot, DHU UNITY, Serv Hepatol, Hop Beaujon,INSERM,CRI,UMR S 1149, Clichy, France.	tarik.asselah@bjn.aphp.fr	Müllhaupt, Beat/O-3744-2016; Zeuzem, Stefan/AAE-7435-2019; Soriano, Vicente/O-5730-2018	Müllhaupt, Beat/0000-0002-9020-8192; Soriano, Vicente/0000-0002-4624-5199; Buti Ferret, Maria/0000-0002-0732-3078	Boehringer Ingelheim Pharma GmbH Co. KG; Boehringer Ingelheim	Boehringer Ingelheim Pharma GmbH Co. KG(Boehringer Ingelheim); Boehringer Ingelheim(Boehringer Ingelheim)	This study was wholly funded and supported by Boehringer Ingelheim Pharma GmbH & Co. KG. The funder was involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript. Medical writing assistance, supported financially by Boehringer Ingelheim, was provided by Jennifer Tobin of Choice Healthcare Solutions during the preparation of this manuscript.	AASLD, REC TEST MAN TREAT H; Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Asselah T, 2010, J HEPATOL, V53, P971, DOI 10.1016/j.jhep.2010.06.007; Chayama K, 2011, J INFECT DIS, V204, P84, DOI 10.1093/infdis/jir210; Estrabaud E, 2012, J HEPATOL, V57, P706, DOI 10.1016/j.jhep.2012.06.001; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; Ferenci P, 2015, J HEPATOL IN PRESS; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Hezode C, 2015, LANCET, V385, P2502, DOI 10.1016/S0140-6736(15)60159-3; Hitomi Y, 2011, GASTROENTEROLOGY, V140, P1314, DOI 10.1053/j.gastro.2010.12.038; Holmes JA, 2014, HEPATOLOGY, V59, P2152, DOI 10.1002/hep.27022; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Maasoumy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055285; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Ochi H, 2010, GASTROENTEROLOGY, V139, P1190, DOI 10.1053/j.gastro.2010.06.071; Ogawa E, 2013, J HEPATOL, V59, P667, DOI 10.1016/j.jhep.2013.05.017; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Ruane PJ, 2015, J HEPATOL, V62, P1040, DOI 10.1016/j.jhep.2014.10.044; Schinazi R, 2014, LIVER INT, V34, P69, DOI 10.1111/liv.12423; Sulkowski MS, 2013, HEPATOLOGY, V57, P974, DOI 10.1002/hep.26096; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P1181, DOI 10.1053/j.gastro.2010.06.016; Zeuzem S, 2013, NEW ENGL J MED, V369, P630, DOI 10.1056/NEJMoa1213557; Zeuzem S, 2011, GASTROENTEROLOGY, V141, P2047, DOI 10.1053/j.gastro.2011.08.051	27	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144004	10.1371/journal.pone.0144004	http://dx.doi.org/10.1371/journal.pone.0144004			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650626	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000366903300034
J	Castellano, CA; Baillargeon, JP; Nugent, S; Tremblay, S; Fortier, M; Imbeault, H; Duval, J; Cunnane, SC				Castellano, Christian-Alexandre; Baillargeon, Jean-Patrice; Nugent, Scott; Tremblay, Sebastien; Fortier, Melanie; Imbeault, Helene; Duval, Julie; Cunnane, Stephen C.			Regional Brain Glucose Hypometabolism in Young Women with Polycystic Ovary Syndrome: Possible Link to Mild Insulin Resistance	PLOS ONE			English	Article							COGNITIVE FUNCTION; METABOLISM; DISEASE; AGE; ASSOCIATION; SENSITIVITY; ADULTS	Objective To investigate whether cerebral metabolic rate of glucose (CMRglu) is altered in normal weight young women with polycystic ovary syndrome (PCOS) who exhibit mild insulin resistance. Materials and methods Seven women with PCOS were compared to eleven healthy female controls of similar age, education and body mass index. Regional brain glucose uptake was quantified using FDG with dynamic positron emission tomography and magnetic resonance imaging, and its potential relationship with insulin resistance assessed using the updated homeostasis model assessment (HOMA2-IR). A battery of cognitive tests was administered to evaluate working memory, attention and executive function. Results The PCOS group had 10% higher fasting glucose and 40% higher HOMA2-IR (p <= 0.035) compared to the Controls. The PCOS group had 9-14% lower CMRglu in specific regions of the frontal, parietal and temporal cortices (p <= 0.018). A significant negative relation was found between the CMRglu and HOMA2-IR mainly in the frontal, parietal and temporal cortices as well as in the hippocampus and the amygdala (p <= 0.05). Globally, cognitive performance was normal in both groups but scores on the PASAT test of working memory tended to be low in the PCOS group. Conclusions The PCOS group exhibited a pattern of low regional CMRglu that correlated inversely with HOMA2-IR in several brain regions and which resembled the pattern seen in aging and early Alzheimer's disease. These results suggest that a direct association between mild insulin resistance and brain glucose hypometabolism independent of overweight or obesity can exist in young adults in their 20s. Further investigation of the influence of insulin resistance on brain glucose metabolism and cognition in younger and middle-aged adults is warranted.	[Castellano, Christian-Alexandre; Nugent, Scott; Fortier, Melanie; Cunnane, Stephen C.] Univ Sherbrooke, Geriatr Inst, Res Ctr Aging, Sherbrooke, PQ J1K 2R1, Canada; [Imbeault, Helene; Duval, Julie] Univ Sherbrooke, Geriatr Inst, Hlth & Social Sci Ctr, Sherbrooke, PQ J1K 2R1, Canada; [Castellano, Christian-Alexandre; Nugent, Scott; Cunnane, Stephen C.] Univ Sherbrooke, Dept Physiol & Pharmacol, Sherbrooke, PQ J1K 2R1, Canada; [Baillargeon, Jean-Patrice; Cunnane, Stephen C.] Univ Sherbrooke, Dept Med, Sherbrooke, PQ J1K 2R1, Canada; [Baillargeon, Jean-Patrice] Ctr Hosp Univ Sherbrooke, Res Ctr, Sherbrooke, PQ, Canada; [Tremblay, Sebastien] Univ Sherbrooke, Sherbrooke Mol Imaging Ctr, Sherbrooke, PQ J1K 2R1, Canada; [Tremblay, Sebastien] Univ Sherbrooke, Dept Nucl Med & Radiobiol, Sherbrooke, PQ J1K 2R1, Canada; [Duval, Julie] Ctr Hosp Univ Sherbrooke, Dept Neurol, Sherbrooke, PQ, Canada	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Castellano, CA (corresponding author), Univ Sherbrooke, Geriatr Inst, Res Ctr Aging, Sherbrooke, PQ J1K 2R1, Canada.	Alexandre.Castellano@USherbrooke.ca		Baillargeon, Jean-Patrice/0000-0002-1336-081X; Castellano, Christian-Alexandre/0000-0002-3425-4522	Canadian Institutes of Health Research (CIHR); Fonds de Recherche du Quebec-Sante (FRQS); Universite de Sherbrooke	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante (FRQS); Universite de Sherbrooke	This work was supported by Canadian Institutes of Health Research (CIHR), Fonds de Recherche du Quebec-Sante (FRQS), and Universite de Sherbrooke. SCC is a Universite de Sherbrooke Research Chair in Brain Metabolism and Cognition during Aging. SN is supported by PhD training award from the FRQS.	Abete I, 2008, J HUM NUTR DIET, V21, P591, DOI 10.1111/j.1365-277X.2008.00902.x; Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225; Barnard L, 2007, PSYCHONEUROENDOCRINO, V32, P906, DOI 10.1016/j.psyneuen.2007.06.010; Barry JA, 2013, HUM REPROD, V28, P2832, DOI 10.1093/humrep/det335; Bendlin B, 2013, ALZHEIMERS DEMENT, V9, P411; Bingham EM, 2002, DIABETES, V51, P3384, DOI 10.2337/diabetes.51.12.3384; Blazquez E, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00161; Bosco D, 2011, J CELL MOL MED, V15, P1807, DOI 10.1111/j.1582-4934.2011.01318.x; Bove RM, 2013, OBESITY, V21, P1343, DOI 10.1002/oby.20212; Buvat I., 2007, MED NUCL, V31, P165, DOI [10.1016/j.mednuc.2007.03.003, DOI 10.1016/J.MEDNUC.2007.03.003]; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Castellano CA, 2015, J ALZHEIMERS DIS, V43, P1343, DOI 10.3233/JAD-141074; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Corbould A, 2008, DIABETES-METAB RES, V24, P520, DOI 10.1002/dmrr.872; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Cunnane S, 2011, NUTRITION, V27, P3, DOI 10.1016/j.nut.2010.07.021; Delis DC, 2001, DELIS KAPLAN EXECUTI; DeUgarte CM, 2005, FERTIL STERIL, V83, P1454, DOI 10.1016/j.fertnstert.2004.11.070; DUARA R, 1984, ANN NEUROL, V16, P702, DOI 10.1002/ana.410160613; Dukart J, 2013, NEUROIMAGE-CLIN, V3, P84, DOI 10.1016/j.nicl.2013.07.005; DUNAIF A, 1992, DIABETES, V41, P1257, DOI 10.2337/diabetes.41.10.1257; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fulghesu AM, 2006, FERTIL STERIL, V86, P398, DOI 10.1016/j.fertnstert.2006.01.024; Garcia-Casares N, 2014, J ALZHEIMERS DIS, V40, P375, DOI 10.3233/JAD-131736; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hirvonen J, 2011, DIABETES, V60, P443, DOI 10.2337/db10-0940; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Marano CM, 2014, PSYCHIAT RES-NEUROIM, V222, P84, DOI 10.1016/j.pscychresns.2014.01.009; Miller KK, 2004, PSYCHIAT RES-NEUROIM, V132, P197, DOI 10.1016/j.pscychresns.2004.09.003; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Nugent S, 2015, BIOGERONTOL IN PRESS; Nugent S, 2014, AM J PHYSIOL-ENDOC M, V306, pE1315, DOI 10.1152/ajpendo.00067.2014; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Poitrenaud J., 1995, NEUROPSYCHOLOGIE CLI; Rabasa-Lhoret R, 2003, J CLIN ENDOCR METAB, V88, P4917, DOI 10.1210/jc.2002-030316; Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608; ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914; Schattmann L, 2007, HORM BEHAV, V51, P587, DOI 10.1016/j.yhbeh.2007.02.007; Schuur M, 2010, EUR J EPIDEMIOL, V25, P561, DOI 10.1007/s10654-010-9476-y; Van der Linden M, 2004, EVALUATION TROUBLES, P25; Wang GJ, 2008, OBESITY, V16, pS88, DOI 10.1038/oby.2008.469; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Willette AA, 2015, JAMA NEUROL, V72, P1013, DOI 10.1001/jamaneurol.2015.0613; Willette AA, 2015, DIABETES, V64, P1933, DOI 10.2337/db14-1507; Zheng YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063332	48	18	19	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144116	10.1371/journal.pone.0144116	http://dx.doi.org/10.1371/journal.pone.0144116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650926	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903300037
J	Hillier, NK; Kavanagh, RMB				Hillier, N. Kirk; Kavanagh, Rhys M. B.			Differential Octopaminergic Modulation of Olfactory Receptor Neuron Responses to Sex Pheromones in Heliothis virescens	PLOS ONE			English	Article							SPODOPTERA-LITTORALIS LEPIDOPTERA; ANTENNAL LOBE; MACROGLOMERULAR COMPLEX; PHOTOPERIOD CUES; PLANT VOLATILES; MOTH; FEMALE; ODOR; EXPRESSION; HAWKMOTH	Octopamine is an important neuromodulator of neural function in invertebrates. Octopamine increases male moth sensitivity to female sex pheromones, however, relatively little is known as to the role of octopamine in the female olfactory system, nor its possible effects on the reception of non-pheromone odorants. The purpose of this study was to determine relative effects of octopamine on the sensitivity of the peripheral olfactory system in male and female Heliothis virescens. Single sensillum recording was conducted in both sexes following injection with octopamine or Ringer solution, and during odorant stimulation with conspecific female sex pheromone or host plant volatiles. Results indicate that octopamine plays a significant modulatory role in female sex pheromone detection in female moths; and that male and female pheromone detection neurons share distinct pharmacological and physiological similarities in H. virescens despite sexual dimorphism at the antennal level.	[Hillier, N. Kirk; Kavanagh, Rhys M. B.] Acadia Univ, Dept Biol, Wolfville, NS B4P 2R6, Canada	Acadia University	Hillier, NK (corresponding author), Acadia Univ, Dept Biol, 33 Westwood Ave, Wolfville, NS B4P 2R6, Canada.	khillier@acadiau.ca	Hillier, Neil/AAM-7270-2020		NSERC Discovery grant [356109-2008 RGPIN]; Canada Foundation for Innovation [22087]; Atlantic Canada Opportunities Agency - Atlantic Innovation Fund [197853]; Nova Scotia Research Innovation Trust; Acadia University funds	NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Atlantic Canada Opportunities Agency - Atlantic Innovation Fund; Nova Scotia Research Innovation Trust; Acadia University funds	Funded by an NSERC Discovery grant (356109-2008 RGPIN) to NKH, Canada Foundation for Innovation (22087) to NKH, Atlantic Canada Opportunities Agency - Atlantic Innovation Fund (197853) to NKH, the Nova Scotia Research Innovation Trust, Acadia University funds to NKH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Christopher Ogbuah for assistance with rearing moths. Funding for this project was provided by an NSERC Discovery Grant to N.K.H. Infrastructure support was also provided by the Canadian Foundation for Innovation, Atlantic Canada Opportunities Agency-Atlantic Innovation Fund, the Nova Scotia Research Innovation Trust, and Acadia University.	ALMAAS TJ, 1991, J CHEM ECOL, V17, P953, DOI 10.1007/BF01395602; ANTON S, 1994, J COMP NEUROL, V350, P199, DOI 10.1002/cne.903500205; Baker TC, 2004, J COMP PHYSIOL A, V190, P155, DOI 10.1007/s00359-003-0483-2; Barrozo RB, 2010, J EXP BIOL, V213, P1100, DOI 10.1242/jeb.040139; Berg BG, 2002, J COMP NEUROL, V446, P123, DOI 10.1002/cne.10180; Berg BG, 1998, J COMP PHYSIOL A, V183, P669, DOI 10.1007/s003590050290; Brigaud I, 2009, CELL TISSUE RES, V335, P455, DOI 10.1007/s00441-008-0722-5; Callahan FE, 2000, INSECT BIOCHEM MOLEC, V30, P507, DOI 10.1016/S0965-1748(00)00027-8; Cunningham JP, 2004, J EXP BIOL, V207, P87, DOI 10.1242/jeb.00733; Dacks AM, 2005, J COMP NEUROL, V488, P255, DOI 10.1002/cne.20556; Dacks AM, 2006, INSECT BIOCHEM MOLEC, V36, P741, DOI 10.1016/j.ibmb.2006.07.002; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; EVANS PD, 1982, J PHYSIOL-LONDON, V324, P93, DOI 10.1113/jphysiol.1982.sp014102; Farooqui T, 2007, NEUROCHEM RES, V32, P1511, DOI 10.1007/s11064-007-9344-7; Flecke C, 2009, J COMP PHYSIOL A, V195, P529, DOI 10.1007/s00359-009-0429-4; GODDE J, 1989, J NEUROSCI METH, V29, P77, DOI 10.1016/0165-0270(89)90111-8; Grosmaitre X, 2001, CHEM SENSES, V26, P653, DOI 10.1093/chemse/26.6.653; Hammer M, 1998, LEARN MEMORY, V5, P146; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; HANSSON BS, 1991, J COMP NEUROL, V312, P264, DOI 10.1002/cne.903120209; Hansson BS, 2002, TRENDS NEUROSCI, V25, P270, DOI 10.1016/S0166-2236(02)02140-9; HANSSON BS, 1989, PHYSIOL ENTOMOL, V14, P147, DOI 10.1111/j.1365-3032.1989.tb00946.x; Harrewijn Paul, 1995, Chemoecology, V5-6, P55, DOI 10.1007/BF01259434; Hillier NK, 2007, J COMP PHYSIOL A, V193, P649, DOI 10.1007/s00359-007-0220-3; Hillier NK, 2006, J COMP PHYSIOL A, V192, P199, DOI 10.1007/s00359-005-0061-x; Homberg U, 1994, PROG ZOOL, V40; Homberg U, 1999, INSECT OLFACTION; Kaissling K.-E, 1995, EXPT CELL BIOL TASTE, P361; Keil TA., 1999, INSECT OLFACTION; KENNEDY JS, 1974, SCIENCE, V184, P999, DOI 10.1126/science.184.4140.999; Krannich S, 2008, J NEUROPHYSIOL, V100, P2866, DOI 10.1152/jn.01400.2007; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Lam F, 2013, PEPTIDES, V41, P66, DOI 10.1016/j.peptides.2012.03.034; Lelito JP, 2008, J CHEM ECOL, V34, P725, DOI 10.1007/s10886-008-9475-6; Lim H, 2008, ANIM BEHAV, V75, P673, DOI 10.1016/j.anbehav.2007.07.021; Lim H, 2007, J CHEM ECOL, V33, P1257, DOI 10.1007/s10886-007-9291-4; LINN CE, 1992, ARCH INSECT BIOCHEM, V20, P265, DOI 10.1002/arch.940200404; LINN CE, 1986, ARCH INSECT BIOCHEM, V3, P161, DOI 10.1002/arch.940030206; LINN CE, 1992, ARCH INSECT BIOCHEM, V20, P285, DOI 10.1002/arch.940200405; LINN CE, 1984, ARCH INSECT BIOCHEM, V1, P331, DOI 10.1002/arch.940010405; Lott JK, 2007, THESIS; Menzel R, 1999, BEHAV NEUROSCI, V113, P744, DOI 10.1037/0735-7044.113.4.744; OCHIENG SA, 1995, TISSUE CELL, V27, P221, DOI 10.1016/S0040-8166(95)80024-7; ORCHARD I, 1985, J NEUROBIOL, V16, P171, DOI 10.1002/neu.480160303; ORCHARD I, 1984, J INSECT PHYSIOL, V30, P901, DOI 10.1016/0022-1910(84)90066-0; Pophof B, 2000, J COMP PHYSIOL A, V186, P307, DOI 10.1007/s003590050431; Pophof B, 2002, J COMP PHYSIOL A, V188, P659, DOI 10.1007/s00359-002-0343-5; Riffell JA, 2013, SCIENCE, V339, P200, DOI 10.1126/science.1225483; Roelofs W.L., 1987, UCLA (University of California Los Angeles) Symposia on Molecular and Cellular Biology New Series, V49, P67; SAS Institute Inc, 2012, NEW FEAT JMP 10; Schneider D, 1998, J COMP PHYSIOL A, V182, P153, DOI 10.1007/s003590050166; SEABROOK WD, 1987, J CHEM ECOL, V13, P1443, DOI 10.1007/BF01012290; Skiri HT, 2004, CHEM SENSES, V29, P253, DOI 10.1093/chemse/bjh026; Sokal RR, 1995, BIOMETRY; Stelinski LL, 2003, J INSECT PHYSIOL, V49, P845, DOI 10.1016/S0022-1910(03)00136-7; Stengl M, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00133; Vickers NJ, 1998, J COMP NEUROL, V400, P35; Vickers NJ, 2003, CHEM SENSES, V28, P325, DOI 10.1093/chemse/28.4.325; VonNickischRosenegk E, 1996, INSECT BIOCHEM MOLEC, V26, P817, DOI 10.1016/S0965-1748(96)00031-8; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Zhukovskaya MI, 2012, CHEM SENSES, V37, P421, DOI 10.1093/chemse/bjr121	61	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143179	10.1371/journal.pone.0143179	http://dx.doi.org/10.1371/journal.pone.0143179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650832	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903300012
J	Pisor, AC; Gurven, M				Pisor, Anne C.; Gurven, Michael			Corruption and the Other(s): Scope of Superordinate Identity Matters for Corruption Permissibility	PLOS ONE			English	Article							SOCIAL IDENTITY; GENERALIZED TRUST; MODEL SELECTION; EVOLUTION; RISK; COOPERATION; DIVERSITY; ALTRUISM; NETWORKS; BEHAVIOR	The decision to engage in corruption-public and private corruption, nepotism, and embezzlement-is often attributed to rational actors maximizing benefits to themselves. However, the importance of reciprocal relationships in humans suggests that an actor may weigh the costs of harms of her corrupt behavior to individuals who may generate future benefits for her. We hypothesize that actors who have a larger circle of actual and potential social partners will have more individuals to consider when generating harms and will thus be less likely to find corrupt acts permissible than actors with smaller circles of valued others. Using data from the World Values Survey and European Values Study (WVS), we explore whether participants with a larger geographic identity or a greater number of group memberships (i.e. a larger scope of actual and potential social partners) are less likely to find accepting bribes permissible. We find mixed support for our hypotheses, but consistently find that WVS participants with local, country, continent, or world geographic identities are less likely to find accepting a bribe permissible than those with regional identities-that is, actors whose primary identities that encompass more than their region find corruption less permissible. We discuss the importance of considering an actor's valuation of others when modeling corruption persistence, noting that establishing scopes of positive valuation is a precursor to predicting where actors will target benefits and shunt costs.	[Pisor, Anne C.; Gurven, Michael] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Pisor, AC (corresponding author), Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA.	acpisor@gmail.com	Pisor, Anne C/C-4756-2019	Gurven, Michael/0000-0002-5661-527X				Abdallah S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1044; Akerlof GA, 2000, Q J ECON, V115, P715, DOI 10.1162/003355300554881; Akerlof GA, 2010, IDENTITY ECONOMICS: HOW OUR IDENTITIES SHAPE OUR WORK, WAGES, AND WELL-BEING, P1; Alesina A, 2005, J ECON LIT, V43, P762, DOI 10.1257/002205105774431243; Allen-Arave W, 2008, EVOL HUM BEHAV, V29, P305, DOI 10.1016/j.evolhumbehav.2008.03.002; [Anonymous], 2010, CORRUPTION EMISSION; Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; Atkinson QD, 2011, EVOL HUM BEHAV, V32, P41, DOI 10.1016/j.evolhumbehav.2010.07.008; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bahry DL, 2006, J ECON BEHAV ORGAN, V60, P37, DOI 10.1016/j.jebo.2004.07.005; Banerjee A., 2013, MIRACLE MICROFINANCE; Bardhan P, 2006, WORLD DEV, V34, P341, DOI 10.1016/j.worlddev.2005.03.011; Bardhan P, 1997, J ECON LIT, V35, P1320; Bates D, 2013, IME4 LINEAR MIXED EF; Beck U., 2006, COSMOPOLITAN VISION; Benjamin DJ, 2010, AM ECON REV, V100, P1913, DOI 10.1257/aer.100.4.1913; Bowles S, 2004, J ECON BEHAV ORGAN, V55, P1, DOI 10.1016/j.jebo.2003.06.005; Branas-Garza P, 2010, GAME ECON BEHAV, V69, P249, DOI 10.1016/j.geb.2009.10.014; Brewer MB, 2005, PERS SOC PSYCHOL B, V31, P428, DOI 10.1177/0146167204271710; Brewer MB, 1996, INT J INTERCULT REL, V20, P291, DOI 10.1016/0147-1767(96)00020-X; Bubandt N, 2006, J ROY ANTHROPOL INST, V12, P413, DOI 10.1111/j.1467-9655.2006.00298.x; Buchan NR, 2009, P NATL ACAD SCI USA, V106, P4138, DOI 10.1073/pnas.0809522106; Cameron L, 2009, J PUBLIC ECON, V93, P843, DOI 10.1016/j.jpubeco.2009.03.004; Carpenter JP, 2004, J ECON BEHAV ORGAN, V55, P533, DOI 10.1016/j.jebo.2003.11.007; Collier P, 2001, ECON POLICY, P127; COSMIDES L, 1994, AM ECON REV, V84, P327; Cosmides L., 2005, HDB EVOLUTIONARY PSY, P584; Davis J.B., 2011, INDIVIDUALS IDENTITY; de Sardan JPO, 1999, J MOD AFR STUD, V37, P25, DOI 10.1017/S0022278X99002992; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Dincer OC, 2008, ECON LETT, V99, P98, DOI 10.1016/j.econlet.2007.06.003; Dollar D, 2001, J ECON BEHAV ORGAN, V46, P423, DOI 10.1016/S0167-2681(01)00169-X; Dong B, 2012, J ECON PSYCHOL, V33, P609, DOI 10.1016/j.joep.2011.12.001; Dovidio JF, 1998, J PERS SOC PSYCHOL, V75, P109, DOI 10.1037/0022-3514.75.1.109; Drury AC, 2006, INT POLIT SCI REV, V27, P121, DOI 10.1177/0192512106061423; Dunbar RIM, 2008, GROUP DYN-THEOR RES, V12, P7, DOI 10.1037/1089-2699.12.1.7; Eckel CC, 1998, ECON J, V108, P726, DOI 10.1111/1468-0297.00311; Engel C, 2011, EXP ECON, V14, P583, DOI 10.1007/s10683-011-9283-7; Ensminger J., 1992, MAKING MARKET I TRAN; Ensminger J., 2007, GETTING BOTTOM CORRU, P1; Fafchamps M, 2003, J DEV ECON, V71, P261, DOI 10.1016/S0304-3878(03)00029-4; Fessler DMT, 2003, DAHL WS ENV, P7; Fukuyama F, 2001, THIRD WORLD Q, V22, P7; Gaertner S. L, 2001, REDUCING INTERGROUP; GAERTNER SL, 1994, SMALL GR RES, V25, P224, DOI 10.1177/1046496494252005; Godoy R, 2005, J ANTHROPOL RES, V61, P157, DOI 10.3998/jar.0521004.0061.202; Goette L, 2006, AM ECON REV, V96, P212, DOI 10.1257/000282806777211658; Goette L, 2012, AM ECON J-MICROECON, V4, P101, DOI 10.1257/mic.4.1.101; Gupta S., 2002, ECON GOV, V3, P23, DOI DOI 10.1007/S101010100039; Gurven M, 2000, EVOL HUM BEHAV, V21, P263, DOI 10.1016/S1090-5138(00)00032-5; Gurven M, 2015, HUM ECOL, V43, P515, DOI 10.1007/s10745-015-9764-y; Haddad L., 2003, EC DEV CULTURAL CHAN, V51, P573, DOI [DOI 10.1086/374986, 10.1086/374986]; Haidt J, 2009, SOCIAL PSYCHOL BASES, P371, DOI [10.1093/acprof:oso/9780195320916.003.015, DOI 10.1093/ACPROF:OSO/9780195320916.003.015]; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Harrison E, 2006, OXF DEV STUD, V34, P15, DOI 10.1080/13600810500495915; Henrich J, 2010, SEARCH HOMO EC BEHAV, V91; Henrich J, 2009, EVOL HUM BEHAV, V30, P244, DOI 10.1016/j.evolhumbehav.2009.03.005; HOLLANDER EP, 1958, PSYCHOL REV, V65, P117, DOI 10.1037/h0042501; Hooghe M, 2007, CAN J POLIT SCI, V40, P709, DOI 10.1017/S0008423907070722; Hooper PL, 2010, J THEOR BIOL, V265, P633, DOI 10.1016/j.jtbi.2010.05.034; Hruschka D, 2014, HUM NATURE-INT BIOS, V25, P567, DOI 10.1007/s12110-014-9217-0; Hruschka DJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00559; Hunt J, 2007, J DEV ECON, V84, P574, DOI 10.1016/j.jdeveco.2007.02.003; Jain AK, 2001, J ECON SURV, V15, P71, DOI 10.1111/1467-6419.00133; Johnson C, 2012, ANN ASSOC AM GEOGR, V102, P863, DOI 10.1080/00045608.2011.602934; Kaplan H, 2002, AM J HUM BIOL, V14, P233, DOI 10.1002/ajhb.10041; Khatri N, 2006, J INT BUS STUD, V37, P61, DOI 10.1057/palgrave.jibs.8400171; Kingston C, 2008, J ECON BEHAV ORGAN, V67, P90, DOI 10.1016/j.jebo.2007.06.001; KRAMER RM, 1984, J PERS SOC PSYCHOL, V46, P1044, DOI 10.1037/0022-3514.46.5.1044; La Porta R, 1999, J LAW ECON ORGAN, V15, P222, DOI 10.1093/jleo/15.1.222; Landa J.T., 1994, TRUST ETHNICITY IDEN; Ledeneva A, 2009, SOC RES, V76, P257; Lindstedt C, 2010, INT POLIT SCI REV, V31, P301, DOI 10.1177/0192512110377602; Luo YD, 2008, INT BUS REV, V17, P188, DOI 10.1016/j.ibusrev.2008.02.002; MAURO P, 1995, Q J ECON, V110, P681, DOI 10.2307/2946696; Mishra A, 2006, WORLD DEV, V34, P349, DOI 10.1016/j.worlddev.2005.03.010; MURPHY RF, 1956, ECON DEV CULT CHANGE, V4, P335, DOI 10.1086/449720; Nettle D, 2000, ECON DEV CULT CHANGE, V48, P335, DOI 10.1086/452461; Newson L, 2009, POPUL DEV REV, V35, P117, DOI 10.1111/j.1728-4457.2009.00263.x; Olken BA, 2009, J PUBLIC ECON, V93, P950, DOI 10.1016/j.jpubeco.2009.03.001; Pascual-Ezama D, 2015, J ECON BEHAV ORGAN, V116, P379, DOI 10.1016/j.jebo.2015.04.020; Paxton P, 2007, SOC FORCES, V86, P47, DOI 10.1353/sof.2007.0107; Posner DN, 2004, AM J POLIT SCI, V48, P849, DOI 10.1111/j.0092-5853.2004.00105.x; PUTNAM RD, 1995, J DEMOCRACY, V0006; Puurtinen M, 2015, EVOL HUM BEHAV, V36, P211, DOI 10.1016/j.evolhumbehav.2014.11.005; R Core Team, 2013, R LANG ENV STAT COMP; Raagmaa G, 2002, EUR PLAN STUD, V10, P55, DOI 10.1080/09654310120099263; Rand DG, 2014, RELIG BRAIN BEHAV, V4, P31, DOI 10.1080/2153599X.2013.775664; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Roberts G, 1998, P ROY SOC B-BIOL SCI, V265, P427, DOI 10.1098/rspb.1998.0312; Robson AJ, 2001, J ECON LIT, V39, P11, DOI 10.1257/jel.39.1.11; Rose-Ackerman Bonnie J., 2016, CORRUPTION GOVT CAUS, DOI 10.1017/CBO9781139175098; Shariff AF, 2007, PSYCHOL SCI, V18, P803, DOI 10.1111/j.1467-9280.2007.01983.x; Singh-Manoux A, 2005, PSYCHOSOM MED, V67, P855, DOI 10.1097/01.psy.0000188434.52941.a0; Smith E.A., 1988, HUNTERS GATHERERS, VI, P222; Sugiyama LS, 2004, AM J PHYS ANTHROPOL, V123, P371, DOI 10.1002/ajpa.10325; Swamy A, 2000, GENDER CORRUPTION, V39; Szolnoki A, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026104; Todd PM, 2003, J ECON PSYCHOL, V24, P143, DOI 10.1016/S0167-4870(02)00200-3; Tooby J, 2006, MANAG DECIS ECON, V27, P103, DOI 10.1002/mde.1287; Tooby J, 2008, HANDBOOK OF APPROACH AND AVOIDANCE MOTIVATION, P251; Torgler B., 2006, Journal of Bioeconomics, V8, P133, DOI 10.1007/s10818-006-9003-0; Treisman D, 2000, J PUBLIC ECON, V76, P399, DOI 10.1016/S0047-2727(99)00092-4; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Ubeda F, 2011, EVOLUTION, V65, P1127, DOI 10.1111/j.1558-5646.2010.01194.x; Uslaner E.M., 2005, NEW I EC CORRUPTION; Uslaner EM, 2000, POLIT SCI QUART, V115, P569, DOI 10.2307/2657610; van Vugt M., 2007, OXFORD HDB EVOLUTION, DOI [10.1093/oxfordhb/9780198568308.013.0036, DOI 10.1093/OXFORDHB/9780198568308.013.0036]; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Warren M.E., 2008, HDB SOCIAL CAPITAL, P122; Werner C, 2000, HUM ORGAN, V59, P11, DOI 10.17730/humo.59.1.w2582tqj18v3880p; Williams G. C., 1966, P307; WINTERHALDER B, 1986, J ANTHROPOL ARCHAEOL, V5, P369, DOI 10.1016/0278-4165(86)90017-6; World Economic Forum, 2013, GLOB AG COUNC ANT TR; Yang DY, 2008, J ECON BEHAV ORGAN, V65, P654, DOI 10.1016/j.jebo.2006.02.008; You JS, 2005, AM SOCIOL REV, V70, P136	116	6	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144542	10.1371/journal.pone.0144542	http://dx.doi.org/10.1371/journal.pone.0144542			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YX	26650395	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903300056
J	Deusch, O; O'Flynn, C; Colyer, A; Swanson, KS; Allaway, D; Morris, P				Deusch, Oliver; O'Flynn, Ciaran; Colyer, Alison; Swanson, Kelly S.; Allaway, David; Morris, Penelope			A Longitudinal Study of the Feline Faecal Microbiome Identifies Changes into Early Adulthood Irrespective of Sexual Development	PLOS ONE			English	Article							COLI NISSLE 1917; GUT MICROBIOME; MEGASPHAERA-ELSDENII; FOOD-INTAKE; PROTEIN; RUMEN; CATS; OVARIOHYSTERECTOMY; HOUSEHOLDS; INDUCTION	Companion animals provide an excellent model for studies of the gut microbiome because potential confounders such as diet and environment can be more readily controlled for than in humans. Additionally, domestic cats and dogs are typically neutered early in life, enabling an investigation into the potential effect of sex hormones on the microbiome. In a longitudinal study to investigate the potential effects of neutering, neutering age and gender on the gut microbiome during growth, the faeces of kittens (16 male, 14 female) were sampled at 18, 30 and 42 weeks of age. DNA was shotgun sequenced on the Illumina platform and sequence reads were annotated for taxonomy and function by comparison to a database of protein coding genes. In a statistical analysis of diversity, taxonomy and functional potential of the microbiomes, age was identified as the only factor with significant associations. No significant effects were detected for gender, neutering, or age when neutered (19 or 31 weeks). At 18 weeks of age the microbiome was dominated by the genera Lactobacillus and Bifidobacterium (35% and 20% average abundance). Structural and functional diversity was significantly increased by week 30 but there was no further significant increase. At 42 weeks of age the most abundant genera were Bacteroides (16%), Prevotella (14%) and Megasphaera (8%). Significant differences in functional potential included an enrichment for genes in energy metabolism (carbon metabolism and oxidative phosphorylation) and depletion in cell motility (flagella and chemotaxis). We conclude that the feline faecal microbiome is predominantly determined by age when diet and environment are controlled for. We suggest this finding may also be informative for studies of the human microbiome, where control over such factors is usually limited.	[Deusch, Oliver; O'Flynn, Ciaran; Colyer, Alison; Allaway, David; Morris, Penelope] WALTHAM Ctr Pet Nutr, Freeby Lane, Melton Mowbray, Leics, England; [Swanson, Kelly S.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Swanson, Kelly S.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Swanson, Kelly S.] Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA	Mars; WALTHAM Petcare Science Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Deusch, O (corresponding author), WALTHAM Ctr Pet Nutr, Freeby Lane, Melton Mowbray, Leics, England.	deuscoli@effem.com		Allaway, David/0000-0003-4602-8933; Swanson, Kelly/0000-0001-5518-3076; Deusch, Oliver/0000-0003-3378-6129	Mars Petcare UK	Mars Petcare UK	This work was funded by Mars Petcare UK. The WALTHAM Centre of Pet Nutrition is the fundamental research centre for Mars Petcare.	Allaway D., 2013, The WALTHAM International Sciences Symposium 2013: from pet food to pet care - bridging the gap, Portland, Oregon, USA, 1-4 October, 2013. Abstracts, P59; Arora SK, 1998, INFECT IMMUN, V66, P1000, DOI 10.1128/IAI.66.3.1000-1007.1998; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Barry KA, 2010, J ANIM SCI, V88, P2978, DOI 10.2527/jas.2009-2464; Barry KA, 2012, J PROTEOME RES, V11, P5924, DOI 10.1021/pr3006809; Belsito KR, 2009, J ANIM SCI, V87, P594, DOI 10.2527/jas.2008-0887; Biagi G, 2013, AM J VET RES, V74, P90, DOI 10.2460/ajvr.74.1.90; Cave NJ, 2007, NEW ZEAL VET J, V55, P113, DOI 10.1080/00480169.2007.36752; Chu K, 2009, JAVMA-J AM VET MED A, V234, P1023, DOI 10.2460/javma.234.8.1023; COUNOTTE GHM, 1981, APPL ENVIRON MICROB, V42, P649, DOI 10.1128/AEM.42.4.649-655.1981; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Davis IJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083158; Deusch O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101021; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Faya M, 2013, THERIOGENOLOGY, V80, P584, DOI 10.1016/j.theriogenology.2013.05.026; Finegold SM, 2002, CLIN INFECT DIS, V35, pS6, DOI 10.1086/341914; Flynn MF, 1996, J AM VET MED ASSOC, V209, P1572; German AJ, 2006, J NUTR, V136, p2031S, DOI 10.1093/jn/136.7.2031S; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Hashizume K, 2003, J NUTR, V133, P3187, DOI 10.1093/jn/133.10.3187; Hoenig M, 2002, AM J VET RES, V63, P634, DOI 10.2460/ajvr.2002.63.634; Hooda S, 2013, BRIT J NUTR, V109, P1637, DOI 10.1017/S0007114512003479; Hopkins MJ, 2005, FEMS MICROBIOL ECOL, V54, P77, DOI 10.1016/j.femsec.2005.03.001; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Kanakupt K, 2011, J ANIM SCI, V89, P1376, DOI 10.2527/jas.2010-3201; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Konstantinov SR, 2006, ENVIRON MICROBIOL, V8, P1191, DOI 10.1111/j.1462-2920.2006.01009.x; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Li A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07417; Li J, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0316-1; Liu JM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks828; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Marx H, 2011, J BACTERIOL, V193, P5578, DOI 10.1128/JB.05861-11; Morris RL, 2013, NAT REV MICROBIOL, V11, P205, DOI 10.1038/nrmicro2970; Murray JK, 2008, VET REC, V163, P381, DOI 10.1136/vr.163.13.381; Murray JK, 2009, VET REC, V164, P137, DOI 10.1136/vr.164.5.137; O'Sullivan O, 2013, J ANTIMICROB CHEMOTH, V68, P214, DOI 10.1093/jac/dks348; Rajilic-Stojanovic M, 2013, ENVIRON MICROBIOL, V15, P1146, DOI 10.1111/1462-2920.12023; Rodrigues Hoffmann A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083197; Root MV, 1997, VET RADIOL ULTRASOUN, V38, P42, DOI 10.1111/j.1740-8261.1997.tb01601.x; Ross EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073056; RUSSELL JB, 1978, APPL ENVIRON MICROB, V36, P319, DOI 10.1128/AEM.36.2.319-329.1978; Schlee M, 2007, INFECT IMMUN, V75, P2399, DOI 10.1128/IAI.01563-06; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHARPE ME, 1973, J GEN MICROBIOL, V77, P37, DOI 10.1099/00221287-77-1-37; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Steinle N, 2013, FASEB J, V27; Su Y, 2008, FEMS MICROBIOL ECOL, V66, P546, DOI 10.1111/j.1574-6941.2008.00529.x; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Tasteyre A, 2001, INFECT IMMUN, V69, P7937, DOI 10.1128/IAI.69.12.7937-7940.2001; Troge A, 2012, INT J MED MICROBIOL, V302, P304, DOI 10.1016/j.ijmm.2012.09.004; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Wehkamp J, 2004, INFECT IMMUN, V72, P5750, DOI 10.1128/IAI.72.10.5750-5758.2004; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Ye YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000465; Yoshida Y, 2009, ANIM SCI J, V80, P709, DOI 10.1111/j.1740-0929.2009.00692.x; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	69	36	36	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144881	10.1371/journal.pone.0144881	http://dx.doi.org/10.1371/journal.pone.0144881			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659594	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900132
J	Holmstrom, O; Linder, N; Lundin, M; Moilanen, H; Suutala, A; Turkki, R; Joensuu, H; Isola, J; Diwan, V; Lundin, J				Holmstrom, Oscar; Linder, Nina; Lundin, Mikael; Moilanen, Hannu; Suutala, Antti; Turkki, Riku; Joensuu, Heikki; Isola, Jorma; Diwan, Vinod; Lundin, Johan			Quantification of Estrogen Receptor-Alpha Expression in Human Breast Carcinomas With a Miniaturized, Low-Cost Digital Microscope: A Comparison with a High-End Whole Slide-Scanner	PLOS ONE			English	Article							AUTOMATED IMAGE-ANALYSIS; CANCER; ER; SENSITIVITY; POPULATION; DIAGNOSIS; PR	Introduction A significant barrier to medical diagnostics in low-resource environments is the lack of medical care and equipment. Here we present a low-cost, cloud-connected digital microscope for applications at the point-of-care. We evaluate the performance of the device in the digital assessment of estrogen receptor-alpha (ER) expression in breast cancer samples. Studies suggest computer-assisted analysis of tumor samples digitized with whole slide-scanners may be comparable to manual scoring, here we study whether similar results can be obtained with the device presented. Materials and Methods A total of 170 samples of human breast carcinoma, immunostained for ER expression, were digitized with a high-end slide-scanner and the point-of-care microscope. Corresponding regions from the samples were extracted, and ER status was determined visually and digitally. Samples were classified as ER negative (< 1% ER positivity) or positive, and further into weakly (1-10% positivity) and strongly positive. Interobserver agreement (Cohen's kappa) was measured and correlation coefficients (Pearson's product-momentum) were calculated for comparison of the methods. Results Correlation and interobserver agreement (r = 0.98, p < 0.001, kappa = 0.84, CI95% = 0.75-0.94) were strong in the results from both devices. Concordance of the point-of-care microscope and the manual scoring was good (r = 0.94, p < 0.001, kappa = 0.71, CI95% = 0.61-0.80), and comparable to the concordance between the slide scanner and manual scoring (r = 0.93, p < 0.001, kappa = 0.69, CI95% = 0.60-0.78). Fourteen (8%) discrepant cases between manual and device-based scoring were present with the slide scanner, and 16 (9%) with the point-of-care microscope, all representing samples of low ER expression. Conclusions Tumor ER status can be accurately quantified with a low-cost imaging device and digital image-analysis, with results comparable to conventional computer-assisted or manual scoring. This technology could potentially be expanded for other histopathological applications at the point-of-care.	[Holmstrom, Oscar; Linder, Nina; Lundin, Mikael; Suutala, Antti; Turkki, Riku; Joensuu, Heikki; Lundin, Johan] Inst Mol Med Finland, Helsinki, Finland; [Moilanen, Hannu] Univ Oulu, Ctr Microscopy & Nanotechnol, Oulu, Finland; [Isola, Jorma] Univ Tampere, BioMediTech, FIN-33101 Tampere, Finland; [Holmstrom, Oscar; Joensuu, Heikki] Helsinki Univ Hosp, Helsinki, Finland; [Holmstrom, Oscar; Joensuu, Heikki] Univ Helsinki, Helsinki, Finland; [Linder, Nina; Diwan, Vinod; Lundin, Johan] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	University of Oulu; Tampere University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Karolinska Institutet	Lundin, J (corresponding author), Inst Mol Med Finland, Helsinki, Finland.	johan.lundin@helsinki.fi	Lundin, Johan/I-1843-2018; Lundin, Johan/AAC-8510-2020	Lundin, Johan/0000-0002-2681-4139; Lundin, Johan/0000-0002-2681-4139; Turkki, Riku/0000-0002-8690-6983; Joensuu, Heikki/0000-0003-0281-2507; Linder, Nina/0000-0003-3930-0513	Swedish Research Council; Sigrid Juselius Foundation; Finska Lakaresallskapet; Medicinska Understodsforeningen Liv och Halsa rf; "European Advanced Translational Research Infra Structure in Medicine" (EATRIS)/Academy of Finland; Innovative Medicines Initiative (IMI)/Predect; Cancer Foundation Finland sr [120084, 130093, 150084, 110071] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finska Lakaresallskapet; Medicinska Understodsforeningen Liv och Halsa rf; "European Advanced Translational Research Infra Structure in Medicine" (EATRIS)/Academy of Finland; Innovative Medicines Initiative (IMI)/Predect; Cancer Foundation Finland sr	This work was supported by grants from the Swedish Research Council, Sigrid Juselius Foundation, Finska Lakaresallskapet and Medicinska Understodsforeningen Liv och Halsa rf. In addition, this study has received funding from the "European Advanced Translational Research Infra Structure in Medicine" (EATRIS)/Academy of Finland and the Innovative Medicines Initiative (IMI)/Predect. The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.; We thank Dr. Yinhai Wang for helpful discussions, constructive feedback and assistance with the image analysis. We also thank Panu Kovanen, MD, PhD, department of pathology and genetics, HUSLAB, Helsinki, Finland. This work was supported by grants from the Swedish Research Council, Sigrid Juselius Foundation, Finska Lakaresallskapet and Medicinska Understodsforeningen Liv och Halsa rf. In addition, this study has received funding from the "European Advanced Translational Research Infra Structure in Medicine" (EATRIS)/Academy of Finland and the Innovative Medicines Initiative (IMI)/Predect. The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Allred DC, 1998, MODERN PATHOL, V11, P155; Bolton KL, 2010, CANCER EPIDEM BIOMAR, V19, P992, DOI 10.1158/1055-9965.EPI-09-1023; Bray F, 2006, NAT REV CANCER, V6, P63, DOI 10.1038/nrc1781; Collins LC, 2005, AM J CLIN PATHOL, V123, P16, DOI 10.1309/HCF035N9WK40ETJ0; Diaz Leslie K, 2004, Ann Diagn Pathol, V8, P23, DOI 10.1016/j.anndiagpath.2003.11.004; Faratian D, 2009, HISTOPATHOLOGY, V55, P587, DOI 10.1111/j.1365-2559.2009.03419.x; Fitzgibbons PL, 2000, ARCH PATHOL LAB MED, V124, P966; HAHNEL R, 1979, CANCER, V44, P671, DOI 10.1002/1097-0142(197908)44:2<671::AID-CNCR2820440238>3.0.CO;2-V; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hede K, 2008, J NATL CANCER I, V100, P836, DOI 10.1093/jnci/djn200; Isaacs Mike, 2011, J Pathol Inform, V2, P39, DOI 10.4103/2153-3539.84232; Kemfang Ngowa J.D., 2015, ADV BREAST CANC RES, V4, P44, DOI [10.1007/BF01805718, DOI 10.1007/BF01805718, DOI 10.4236/ABCR.2015.42005]; Konsti J, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-29; Layfield Lester J., 2000, Breast J, V6, P189, DOI 10.1046/j.1524-4741.2000.99097.x; Lundin J, 2006, EUR J CANCER, V42, P3228, DOI 10.1016/j.ejca.2006.06.028; Makler MT, 1998, ANN TROP MED PARASIT, V92, P419, DOI 10.1080/00034989859401; Mann GB, 2005, J CLIN ONCOL, V23, P5148, DOI 10.1200/JCO.2005.02.076; Nadji M, 2005, AM J CLIN PATHOL, V123, P21, DOI 10.1309/4WV79N2GHJ3X1841; Parker RL, 2002, AM J CLIN PATHOL, V117, P723; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Qureshi A, 2010, J PAK MED ASSOC, V60, P350; Rhodes A, 2000, J CLIN PATHOL, V53, P125, DOI 10.1136/jcp.53.2.125; Rizzardi AE, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-42; Shea YR, 2009, J CLIN MICROBIOL, V47, P1553, DOI 10.1128/JCM.00348-09; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Turkki R, 2013, DIAGNOSTIC PATHOL S1, pS30, DOI [10.1186/1746-1596-8-S1-S30, DOI 10.1186/1746-S1-S30]; Wells CA, 2004, VIRCHOWS ARCH, V445, P119, DOI 10.1007/s00428-004-1063-8; Zhu HY, 2013, LAB CHIP, V13, P51, DOI [10.1039/c2lc40864c, 10.1039/c21c40864c]	29	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144688	10.1371/journal.pone.0144688	http://dx.doi.org/10.1371/journal.pone.0144688			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659386	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900087
J	Leipoldt, F; Zeyhle, P; Kulik, A; Kalinowski, J; Heide, L; Kaysser, L				Leipoldt, Franziska; Zeyhle, Philipp; Kulik, Andreas; Kalinowski, Joern; Heide, Lutz; Kaysser, Leonard			Diversity of ABBA Prenyltransferases in Marine Streptomyces sp CNQ-509: Promiscuous Enzymes for the Biosynthesis of Mixed Terpenoid Compounds	PLOS ONE			English	Article							MEVALONATE PATHWAY; GENE-CLUSTER; AROMATIC PRENYLTRANSFERASES; HETEROLOGOUS EXPRESSION; NATURAL-PRODUCT; PRENYLATION; BACTERIUM; IDENTIFICATION; PHENAZINES; MECHANISM	Terpenoids are arguably the largest and most diverse family of natural products, featuring prominently in e.g. signalling, self-defence, UV-protection and electron transfer. Prenyl-transferases are essential players in terpenoid and hybrid isoprenoid biosynthesis that install isoprene units on target molecules and thereby often modulate their bioactivity. In our search for new prenyltransferase biocatalysts we focused on the marine-derived Streptomyces sp. CNQ-509, a particularly rich source of meroterpenoid chemistry. Sequencing and analysis of the genome of Streptomyces sp. CNQ-509 revealed seven putative phenol/phenazine-specific ABBA prenyltransferases, and one putative indole-specific ABBA prenyltransferase. To elucidate the substrate specificity of the ABBA prenyltransferases and to learn about their role in secondary metabolism, CnqP1-CnqP8 were produced in Escherichia coli and incubated with various aromatic and isoprenoid substrates. Five of the eight prenyltransferases displayed enzymatic activity. The efficient conversion of dihydroxynaphthalene derivatives by CnqP3 (encoded by AA958_24325) and the co-location of AA958_24325 with genes characteristic for the biosynthesis of THN (tetrahydroxynaphthalene)-derived natural products indicates that the enzyme is involved in the formation of debromomarinone or other naphthoquinone-derived meroterpenoids. Moreover, CnqP3 showed high flexibility towards a range of aromatic and isoprenoid substrates and thus represents an interesting new tool for biocatalytic applications.	[Leipoldt, Franziska; Zeyhle, Philipp; Heide, Lutz; Kaysser, Leonard] Univ Tubingen, Inst Pharmaceut, Pharmaceut Biol, Tubingen, Germany; [Leipoldt, Franziska; Heide, Lutz; Kaysser, Leonard] Partner Site Tubingen, German Ctr Infect Res DZIF, Tubingen, Germany; [Kulik, Andreas] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Microbial Biotechnol, Tubingen, Germany; [Kalinowski, Joern] Univ Bielefeld, Microbial Genom & Biotechnol, Ctr Biotechnol, D-33615 Bielefeld, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; German Center for Infection Research; Eberhard Karls University of Tubingen; University of Bielefeld	Kaysser, L (corresponding author), Univ Tubingen, Inst Pharmaceut, Pharmaceut Biol, Tubingen, Germany.	leonard.kaysser@pharm.uni-tuebingen.de	Kaysser, Leonard/Q-2091-2019	Kaysser, Leonard/0000-0002-3943-993X; Kulik, Andreas/0000-0002-6914-7313; Heide, Lutz/0000-0001-7809-7453	GenBioCom German Federal Ministry of Education and Research; German Centre for Infection Research (DZIF) - German Federal Ministry of Education and Research; DFG [SFB 766]; German Centre for Infection Research; German Federal Ministry of Education and Research (GenBioCom)	GenBioCom German Federal Ministry of Education and Research; German Centre for Infection Research (DZIF) - German Federal Ministry of Education and Research; DFG(German Research Foundation (DFG)); German Centre for Infection Research; German Federal Ministry of Education and Research (GenBioCom)	This work was supported by GenBioCom German Federal Ministry of Education and Research to JK and LH, and German Centre for Infection Research (DZIF) - German Federal Ministry of Education and Research to LK. AK was supported by grants from the DFG (SFB 766). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank William Fenical and Paul R. Jensen ( University of California, San Diego, USA) for providing Streptomyces sp. CNQ-509. We are grateful to T. Bonitz, E. Haug-Schifferdecker, U. Metzger and K. Seeger for synthesis of DMAPP, GPP and FPP. Thanks to K. Seeger and Y. Haagen for generation of the nphB and fnq26 expression plasmids. The work was funded by the German Centre for Infection Research and the German Federal Ministry of Education and Research (GenBioCom). A. K. was supported by grants from the DFG (SFB 766).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Bonitz T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085707; Bonitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027336; Botta B, 2005, TRENDS PHARMACOL SCI, V26, P606, DOI 10.1016/j.tips.2005.09.012; Brandt W, 2009, PHYTOCHEMISTRY, V70, P1758, DOI 10.1016/j.phytochem.2009.09.001; Cho JY, 2006, ORG LETT, V8, P2471, DOI 10.1021/ol060630r; Edwards DJ, 2004, J AM CHEM SOC, V126, P11432, DOI 10.1021/ja047876g; Espindola APDdM, 2008, THESIS; Fenical W, 2006, NAT CHEM BIOL, V2, P666, DOI 10.1038/nchembio841; Gallagher KA, 2010, CURR OPIN BIOTECH, V21, P794, DOI 10.1016/j.copbio.2010.09.010; Gross F, 2006, ARCH MICROBIOL, V185, P28, DOI 10.1007/s00203-005-0059-3; Haagen Y, 2007, FEBS LETT, V581, P2889, DOI 10.1016/j.febslet.2007.05.031; Haug-Schifferdecker E, 2010, J BIOL CHEM, V285, P16487, DOI 10.1074/jbc.M110.113720; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Izumikawa M, 2010, J NAT PROD, V73, P208, DOI 10.1021/np900747t; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Kalaitzis JA, 2003, ORG LETT, V5, P4449, DOI 10.1021/ol035748b; Kawasaki T, 2003, J ANTIBIOT, V56, P957, DOI 10.7164/antibiotics.56.957; Kaysser L, 2012, J AM CHEM SOC, V134, P11988, DOI 10.1021/ja305665f; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kumano T, 2008, BIOORGAN MED CHEM, V16, P8117, DOI 10.1016/j.bmc.2008.07.052; Kumano T, 2010, J BIOL CHEM, V285, P39663, DOI 10.1074/jbc.M110.153957; Kuzuyama T, 2005, NATURE, V435, P983, DOI 10.1038/nature03668; Kuzuyama T, 2002, J ANTIBIOT, V55, P919, DOI 10.7164/antibiotics.55.919; Kwon HC, 2010, J NAT PROD, V73, P2047, DOI 10.1021/np1006229; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mavrodi DV, 1998, J BACTERIOL, V180, P2541, DOI 10.1128/JB.180.9.2541-2548.1998; Metzger U, 2009, P NATL ACAD SCI USA, V106, P14309, DOI 10.1073/pnas.0904897106; Park J, STRAIN CNQ 509 2010; PATHIRANA C, 1992, TETRAHEDRON LETT, V33, P7663, DOI 10.1016/0040-4039(93)88010-G; Pojer F, 2003, P NATL ACAD SCI USA, V100, P2316, DOI 10.1073/pnas.0337708100; Prieto-Davo A, 2008, AQUAT MICROB ECOL, V52, P1, DOI 10.3354/ame01211; Riclea R, 2011, CHEM-EUR J, V17, P11930, DOI 10.1002/chem.201101139; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Ruckert C, 2015, J BIOTECHNOL, V216, P140, DOI 10.1016/j.jbiotec.2015.08.009; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Saleh O, 2012, MEDCHEMCOMM, V3, P1009, DOI 10.1039/c2md20045g; Saleh O, 2009, PHYTOCHEMISTRY, V70, P1728, DOI 10.1016/j.phytochem.2009.05.009; Saleh O, 2009, J BIOL CHEM, V284, P14439, DOI 10.1074/jbc.M901312200; Sambrook J., 2001, MOL CLONING LAB MANU; Schmidt J, 2012, ORG LETT, V14, P4042, DOI 10.1021/ol300954s; Schultz AW, 2010, J NAT PROD, V73, P373, DOI 10.1021/np9006876; Seeger K, 2011, MICROB BIOTECHNOL, V4, P252, DOI 10.1111/j.1751-7915.2010.00234.x; Shindo K, 2011, BIOSCI BIOTECH BIOCH, V75, P505, DOI 10.1271/bbb.100731; SHINYA K, 1990, J ANTIBIOT, V43, P444, DOI 10.7164/antibiotics.43.444; Tello M, 2008, CELL MOL LIFE SCI, V65, P1459, DOI 10.1007/s00018-008-7579-3; Teufel R, 2014, ANGEW CHEM INT EDIT, V53, P11019, DOI 10.1002/anie.201405694; Winter JM, 2007, J BIOL CHEM, V282, P16362, DOI 10.1074/jbc.M611046200; WOODSIDE AB, 1988, ORG SYNTH, V66, P211; Zeyhle P, 2014, CHEMBIOCHEM, V15, P2385, DOI 10.1002/cbic.201402394	52	22	22	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143237	10.1371/journal.pone.0143237	http://dx.doi.org/10.1371/journal.pone.0143237			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659564	gold, Green Submitted, Green Published			2022-12-27	WOS:000366715900007
J	Lukowski, A; Maderek, E; Giertych, MJ; Karolewski, P				Lukowski, Adrian; Maderek, Ewa; Giertych, Marian J.; Karolewski, Piotr			Sex Ratio and Body Mass of Adult Herbivorous Beetles Depend on Time of Occurrence and Light Conditions	PLOS ONE			English	Article							HOST-PLANT QUALITY; PRUNUS-SEROTINA; LEAF BEETLE; BIRD CHERRY; GONIOCTENA-QUINQUEPUNCTATA; INSECT HERBIVORE; FOOD QUALITY; TRADE-OFF; GROWTH; PERFORMANCE	Body mass and sex ratio (F/M) of folivorous insects are easily measured parameters that are commonly used to assess the effect of food quality, living conditions, and preferences on the selection of favourable sites for offspring. A study was conducted on the polyphagous beetle, Gonioctena quinquepunctata (a pest of the native Prunus padus and alien P. serotina) and on the monophagous beetle, Altica brevicollis coryletorum (a pest of Corylus avellana). Both species have a similar life cycle with emergence of current-year adults in summer, and reproduction of 1-year-old insects in spring. A. brevicollis coryletorum feeds primarily on sunlit shrubs, while G. quinquepunctata prefers shaded leaves. The present study assessed the effect of time of occurrence (insect age) on body mass in both sexes and on the sex ratio F/M, taking into account the influence of light conditions associated with their favoured food source (sunlit vs. shaded leaves). We hypothesized that a change in body mass in current-year insects would be determined by the amount of consumed food, while the sex ratio would be stable, when in 1-year-old insects females would die shortly after oviposition, while males would be active for a prolonged time. Results confirmed the hypothesis that changes in mass of current-year beetles was determined by the amount of food intake. We also found that in spring, unfertilized females coexist with fertilized ones and that the latter females live for some time after oviposition; resulting in fluctuations of the mean mass for females. In both species, 1-year-old beetles were heavier than current-year. The preference of A. brevicollis coryletorum for sunlit leaves results in a higher body weight than in G. quinquepunctata in both seasons. The data are consistent and indicate seasonal fluctuations in body mass and changes in the sex ratio in 1-year-old beetles, due to the entrance into their reproductive period.	[Lukowski, Adrian; Maderek, Ewa; Giertych, Marian J.; Karolewski, Piotr] Polish Acad Sci, Inst Dendrol, PL-62035 Kornik, Poland; [Lukowski, Adrian] Poznan Univ Life Sci, Fac Forestry, Dept Forest Protect, Poznan, Poland; [Giertych, Marian J.] Univ ZielonaGora, Fac Biol Sci, Zielonagora, Poland	Polish Academy of Sciences; Poznan University of Life Sciences	Lukowski, A (corresponding author), Polish Acad Sci, Inst Dendrol, PL-62035 Kornik, Poland.	adrian.lukowski@gmail.com	Łukowski, Adrian/K-2923-2019; Giertych, Marian J/A-1618-2008	Łukowski, Adrian/0000-0002-4860-4984; Maderek, Ewa/0000-0003-3933-000X; Giertych, Marian/0000-0001-5578-9545; Karolewski, Piotr/0000-0003-3064-1274	National Science Centre, Poland [N N304 037640]; statutory activities of the Institute of Dendrology Polish Academy of Sciences in Kornik	National Science Centre, Poland(National Science Centre, Poland); statutory activities of the Institute of Dendrology Polish Academy of Sciences in Kornik	The research was financially supported by the National Science Centre, Poland (grant no. N N304 037640 for PK), the statutory activities of the Institute of Dendrology Polish Academy of Sciences in Kornik, and grant for young scientists (for AL; Poznan University of Life Sciences, Poland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS MD, 1992, TREE PHYSIOL, V10, P343, DOI 10.1093/treephys/10.4.343; Alonso C, 2000, ACTA OECOL, V21, P257, DOI 10.1016/S1146-609X(00)01082-1; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; BARTKOWSKA J, 1975, Polskie Pismo Entomologiczne, V45, P633; Bjorkman C, 1997, OIKOS, V79, P45, DOI 10.2307/3546088; Blanckenhorn WU, 2005, ETHOLOGY, V111, P977, DOI 10.1111/j.1439-0310.2005.01147.x; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; Closset-Kopp D, 2007, FOREST ECOL MANAG, V247, P120, DOI 10.1016/j.foreco.2007.04.023; Crawley MJ, 1997, PLANT ECOL; Crone EE, 1999, J CHEM ECOL, V25, P635, DOI 10.1023/A:1020966206840; DEACON J, 1974, NEW PHYTOL, V73, P1055, DOI 10.1111/j.1469-8137.1974.tb01331.x; Decocq G, 2004, J APPL ECOL, V41, P1065, DOI 10.1111/j.0021-8901.2004.00960.x; DIXON AFG, 1971, ANN APPL BIOL, V68, P135, DOI 10.1111/j.1744-7348.1971.tb06450.x; Dominy NJ, 2008, ANN BOT-LONDON, V101, P1363, DOI 10.1093/aob/mcn046; Gantner M., 2002, Acta Scientiarum Polonorum - Hortorum Cultus, V1, P55; Giertych MJ, 2005, ENTOMOL EXP APPL, V117, P59, DOI 10.1111/j.1570-7458.2005.00332.x; Gokirmak T, 2009, GENET RESOUR CROP EV, V56, P147, DOI 10.1007/s10722-008-9352-8; Gruev Blagoy, 1997, Scopolia, V37, P1; Halarewicz A., 2011, Lene Pr Badaw, V72, P267; Halarewicz A, 2011, POL J ECOL, V59, P589; Hardin JW, 1997, J TORREY BOT SOC, V124, P124, DOI 10.2307/2996580; Harvey JA, 2012, ENTOMOL EXP APPL, V144, P14, DOI 10.1111/j.1570-7458.2012.01252.x; Heleno RH, 2009, CONSERV BIOL, V23, P410, DOI 10.1111/j.1523-1739.2008.01129.x; Hemming JDC, 1999, J CHEM ECOL, V25, P1687, DOI 10.1023/A:1020805420160; Henriksson J, 2003, OIKOS, V103, P3, DOI 10.1034/j.1600-0706.2003.12306.x; Jansen MPT, 1997, ENTOMOL EXP APPL, V82, P319, DOI 10.1023/A:1002916325052; Jaworski Tomasz, 2013, Lesne Prace Badawcze, V74, P345; Kaplan I, 2007, ECOL LETT, V10, P977, DOI 10.1111/j.1461-0248.2007.01093.x; Kaplan I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093714; Karolewski P, 2014, EUR J ENTOMOL, V111, P227, DOI 10.14411/eje.2014.026; Karolewski P, 2013, ACTA OECOL, V53, P19, DOI 10.1016/j.actao.2013.08.004; Karolewski P, 2010, TREE PHYSIOL, V30, P969, DOI 10.1093/treephys/tpq060; Koricheva J, 2004, AM NAT, V163, pE64, DOI 10.1086/382601; Kral J., 1964, Entomologische Blaetter Krefeld, V60, P126; Kudo S, 1995, ECOL ENTOMOL, V20, P367, DOI 10.1111/j.1365-2311.1995.tb00469.x; LEATHER S R, 1986, Entomologist's Gazette, V37, P209; Leather SR, 1996, J ECOL, V84, P125, DOI 10.2307/2261707; Leather SR, 1995, EUR J ENTOMOL, V92, P623; Lee KP, 2010, ENTOMOL EXP APPL, V136, P151, DOI 10.1111/j.1570-7458.2010.01018.x; Lee M.R., 2004, BRUSH MANAGEMENT PRE; Levesque KR, 2002, B ENTOMOL RES, V92, P127, DOI 10.1079/BER2002153; Lukowski A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126072; Lukowski A, 2014, SYLWAN, V158, P595; Maderek E, 2015, ENTOMOL EXP APPL, V155, P193, DOI 10.1111/eea.12298; Mardulyn P, 1997, SYST BIOL, V46, P722, DOI 10.2307/2413502; Mathur V, 2011, ENTOMOL EXP APPL, V139, P215, DOI 10.1111/j.1570-7458.2011.01122.x; Molina-Montenegro MA, 2006, ACTA OECOL, V30, P147, DOI 10.1016/j.actao.2006.02.008; Mooney EH, 2012, ECOLOGY, V93, P2683, DOI 10.1890/11-1620.1; Moreau G, 2003, OECOLOGIA, V135, P391, DOI 10.1007/s00442-003-1213-8; Nowakowska K, 2006, ELECT J POLISH AGR, V9, P05; Osier TL, 2007, ENTOMOL EXP APPL, V123, P159, DOI 10.1111/j.1570-7458.2007.00534.x; Paquette A, 2007, FOREST ECOL MANAG, V241, P278, DOI 10.1016/j.foreco.2007.01.004; Perez-Contreras T, 2014, ACTA OECOL, V55, P15, DOI 10.1016/j.actao.2013.10.006; Rehounek Jiri, 2002, Acta Universitatis Palackianae Olomucensis Facultas Rerum Naturalium Biologica, V39-40, P123; Roberts MR, 2006, NEW PHYTOL, V170, P677, DOI 10.1111/j.1469-8137.2006.01707.x; SOUTHWOOD TRE, 1961, J ANIM ECOL, V30, P1, DOI 10.2307/2109; Tong Y. F., 2006, Wetlands Ecology and Management, V14, P39, DOI 10.1007/s11273-005-2565-0; Tremmel M, 2013, BEHAV ECOL, V24, P386, DOI 10.1093/beheco/ars175; Urban J., 1998, Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis, V46, P7; Uusitalo M, 2004, AGRIFOODRESEARCG REP; Vanhellemont M, 2009, THESIS; Wennstrom A, 2010, CHEMOECOLOGY, V20, P35, DOI 10.1007/s00049-010-0040-8	63	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144718	10.1371/journal.pone.0144718	http://dx.doi.org/10.1371/journal.pone.0144718			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657564	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900092
J	Nagappa, M; Liao, P; Wong, J; Auckley, D; Ramachandran, SK; Memtsoudis, S; Mokhlesi, B; Chung, F				Nagappa, Mahesh; Liao, Pu; Wong, Jean; Auckley, Dennis; Ramachandran, Satya Krishna; Memtsoudis, Stavros; Mokhlesi, Babak; Chung, Frances			Validation of the STOP-Bang Questionnaire as a Screening Tool for Obstructive Sleep Apnea among Different Populations: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							POSTOPERATIVE OUTCOMES; PROPOFOL SEDATION; SURGICAL-PATIENTS; SURGERY ANALYSIS; HIGH-RISK; PREVALENCE; MORTALITY; OSA; SPECIFICITY; ASSOCIATION	Background Diagnosing obstructive sleep apnea (OSA) is clinically relevant because untreated OSA has been associated with increased morbidity and mortality. The STOP-Bang questionnaire is a validated screening tool for OSA. We conducted a systematic review and meta-analysis to determine the effectiveness of STOP-Bang for screening patients suspected of having OSA and to predict its accuracy in determining the severity of OSA in the different populations. Methods A search of the literature databases was performed. Inclusion criteria were: 1) Studies that used STOP-Bang questionnaire as a screening tool for OSA in adult subjects (> 18 years); 2) The accuracy of the STOP-Bang questionnaire was validated by polysomnography-the gold standard for diagnosing OSA; 3) OSA was clearly defined as apnea/hypopnea index (AHI) or respiratory disturbance index (RDI) >= 5; 4) Publications in the English language. The quality of the studies were explicitly described and coded according to the Cochrane Methods group on the screening and diagnostic tests. Results Seventeen studies including 9,206 patients met criteria for the systematic review. In the sleep clinic population, the sensitivity was 90%, 94% and 96% to detect any OSA (AHI >= 5), moderate-to-severe OSA (AHI >= 15), and severe OSA (AHI >= 30) respectively. The corresponding NPV was 46%, 75% and 90%. A similar trend was found in the surgical population. In the sleep clinic population, the probability of severe OSA with a STOP-Bang score of 3 was 25%. With a stepwise increase of the STOP-Bang score to 4, 5, 6 and 7/8, the probability rose proportionally to 35%, 45%, 55% and 75%, respectively. In the surgical population, the probability of severe OSA with a STOP-Bang score of 3 was 15%. With a stepwise increase of the STOP-Bang score to 4, 5, 6 and 7/8, the probability increased to 25%, 35%, 45% and 65%, respectively. Conclusion This meta-analysis confirms the high performance of the STOP-Bang questionnaire in the sleep clinic and surgical population for screening of OSA. The higher the STOP-Bang score, the greater is the probability of moderate-to-severe OSA.	[Nagappa, Mahesh; Liao, Pu; Wong, Jean; Chung, Frances] Univ Toronto, Toronto Western Hosp, Dept Anesthesiol, Univ Hlth Network, Toronto, ON M5T 2S8, Canada; [Auckley, Dennis] Case Western Reserve Univ, Metrohlth Med Ctr, Div Pulm Crit Care & Sleep Med, Cleveland, OH USA; [Ramachandran, Satya Krishna] Univ Michigan Hlth Syst, Dept Anesthesiol, Ann Arbor, MI USA; [Memtsoudis, Stavros] Cornell Univ, Hosp Special Surg, Weill Med Coll, Dept Anesthesiol, New York, NY 10021 USA; [Mokhlesi, Babak] Univ Chicago, Dept Med, Sleep Disorders Ctr, Chicago, IL 60637 USA; [Mokhlesi, Babak] Univ Chicago, Sect Pulm & Crit Care, Chicago, IL 60637 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Case Western Reserve University; MetroHealth System; University of Michigan System; University of Michigan; Cornell University; University of Chicago; University of Chicago	Chung, F (corresponding author), Univ Toronto, Toronto Western Hosp, Dept Anesthesiol, Univ Hlth Network, Toronto, ON M5T 2S8, Canada.	frances.chung@uhn.ca	Ramachandran, Satya Krishna/P-6636-2016; Nagappa, Mahesh/AAA-7389-2022; Wong, Jean/B-7808-2015; Chung, Frances/F-5618-2015	Ramachandran, Satya Krishna/0000-0002-7176-6375; Nagappa, Mahesh/0000-0001-8036-3319; Wong, Jean/0000-0002-7213-4898; Chung, Frances/0000-0001-9576-3606	University Health Network Foundation; Department of Anesthesia, Toronto Western Hospital, University Health Network, University of Toronto	University Health Network Foundation; Department of Anesthesia, Toronto Western Hospital, University Health Network, University of Toronto(University of Toronto)	This work was supported by University Health Network Foundation and Department of Anesthesia, Toronto Western Hospital, University Health Network, University of Toronto. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsattar ZM, 2015, SLEEP; Abrishami A, 2010, CAN J ANAESTH, V57, P423, DOI 10.1007/s12630-010-9280-x; Acar HV, 2014, EUR REV MED PHARMACO, V18, P1869; Acar HV, 2013, TURK J ANAESTHESIOL, V41, P115; Agrawal Sanjay, 2013, Saudi J Anaesth, V7, P155, DOI 10.4103/1658-354X.114072; Alam A, 2012, GEN HOSP PSYCHIAT, V34, P660, DOI 10.1016/j.genhosppsych.2012.06.015; Boynton Grace, 2013, J Sleep Disord Treat Care, V2, DOI 10.4172/2325-9639.1000121; Chia P, 2013, ANAESTHESIA, V68, P950, DOI 10.1111/anae.12369; Chung F, 2012, BRIT J ANAESTH, V108, P768, DOI 10.1093/bja/aes022; Chung F, 2008, ANESTHESIOLOGY, V108, P812, DOI 10.1097/ALN.0b013e31816d83e4; Chung F, 2014, J CLIN SLEEP MED, V10, P951, DOI 10.5664/jcsm.4022; Chung F, 2014, ANESTH ANALG, V118, P251, DOI 10.1213/ANE.0000000000000067; Chung F, 2013, OBES SURG, V23, P2050, DOI 10.1007/s11695-013-1006-z; Chung F, 2013, CHEST, V143, P1284, DOI 10.1378/chest.12-1132; Coelho FM, 2012, SLEEP MED, V13, P450, DOI 10.1016/j.sleep.2012.01.008; Cote GA, 2010, CLIN GASTROENTEROL H, V8, P660, DOI 10.1016/j.cgh.2010.05.015; Cowan DC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004519; Devnani P, 2013, SLEEP MED, V14, pe20; DOUGLASS AB, 1994, SLEEP, V17, P160, DOI 10.1093/sleep/17.2.160; Drager LF, 2013, J AM COLL CARDIOL, V62, P569, DOI 10.1016/j.jacc.2013.05.045; El-Sayed IH, 2012, EGYPT J CHEST DIS TU, V61, P433, DOI 10.1016/j.ejcdt.2012.07.003; Farney RJ, 2011, J CLIN SLEEP MED, V7, P459, DOI 10.5664/JCSM.1306; Finkel KJ, 2009, SLEEP MED, V10, P753, DOI 10.1016/j.sleep.2008.08.007; Firat H, 2012, SLEEP BIOL RHYTHMS, V10, P231, DOI 10.1111/j.1479-8425.2012.00566.x; Frey WC, 2003, OBES SURG, V13, P676, DOI 10.1381/096089203322509228; Gross JB, 2014, ANESTHESIOLOGY, V120, P268, DOI 10.1097/ALN.0000000000000053; Guralnick AS, 2012, J CLIN SLEEP MED, V8, P501, DOI 10.5664/jcsm.2140; Ha SCN, 2014, SLEEP BREATH, V18, P715, DOI 10.1007/s11325-013-0889-1; Hallowell PT, 2007, SURGERY, V142, P608, DOI 10.1016/j.surg.2007.08.002; HARALDSSON PO, 1992, SLEEP, V15, P261, DOI 10.1093/sleep/15.3.261; Kaw R, 2012, BRIT J ANAESTH, V109, P897, DOI 10.1093/bja/aes308; Kim GH, 2012, ANAESTHESIA, V67, P755, DOI 10.1111/j.1365-2044.2012.07115.x; Kulkarni GV, 2014, AM J SURG, V207, P436, DOI 10.1016/j.amjsurg.2013.09.018; Kunisaki Ken M, 2014, Ann Am Thorac Soc, V11, P192, DOI 10.1513/AnnalsATS.201305-134OC; Lockhart EM, 2013, SLEEP MED, V14, P407, DOI 10.1016/j.sleep.2012.10.018; Luo JM, 2014, CHINESE MED J-PEKING, V127, P1843, DOI 10.3760/cma.j.issn.0366-6999.20133003; Marshall NS, 2008, SLEEP, V31, P1079; Mehta PP, 2014, GASTROINTEST ENDOSC, V79, P436, DOI 10.1016/j.gie.2013.09.022; Memtsoudis S, 2011, ANESTH ANALG, V112, P113, DOI 10.1213/ANE.0b013e3182009abf; Memtsoudis SG, 2014, ANESTH ANALG, V118, P407, DOI 10.1213/ANE.0000000000000051; Mokhlesi B, 2013, OBES SURG, V23, P1842, DOI 10.1007/s11695-013-0991-2; Mokhlesi B, 2013, CHEST, V144, P903, DOI 10.1378/chest.12-2905; Mutter TC, 2014, ANESTHESIOLOGY, V121, P707, DOI 10.1097/ALN.0000000000000407; Nagappa M, 2015, ANESTH ANALG, V120, P1013, DOI 10.1213/ANE.0000000000000634; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Nicholl DDM, 2013, J CLIN SLEEP MED, V9, P31, DOI 10.5664/jcsm.2334; Nunes FS, 2015, SLEEP BREATH, V19, P115, DOI 10.1007/s11325-014-0971-3; Ong TH, 2010, SLEEP BREATH, V14, P371, DOI 10.1007/s11325-010-0350-7; Ozoh Obianuju B, 2013, Niger Med J, V54, P224, DOI 10.4103/0300-1652.119607; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Pereira EJ, 2013, J CLIN SLEEP MED, V9, P1259, DOI 10.5664/jcsm.3264; Pereira H, 2013, REV PORT PNEUMOL, V19, P144, DOI 10.1016/j.rppneu.2013.01.003; Proczko MA, 2014, J ANESTH, V28, P891, DOI 10.1007/s00540-014-1848-0; Ramachandran SK, 2009, ANESTHESIOLOGY, V110, P928, DOI 10.1097/ALN.0b013e31819c47b6; Reis R, 2015, REV PORT PNEUMOL, V21, P61, DOI 10.1016/j.rppnen.2014.04.009; Sharma SK, 2006, CHEST, V130, P149, DOI 10.1378/chest.130.1.149; Silva GE, 2011, J CLIN SLEEP MED, V7, P468, DOI 10.5664/JCSM.1308; Singh M, 2013, BRIT J ANAESTH, V110, P629, DOI 10.1093/bja/aes465; Uchoa CHG, 2015, CHEST, P14; van Zeller M, 2013, RESP MED, V107, P2046, DOI 10.1016/j.rmed.2013.10.011; Vana KD, 2013, RES NURS HEALTH, V36, P84, DOI 10.1002/nur.21512; Vasu TS, 2010, ARCH OTOLARYNGOL, V136, P1020, DOI 10.1001/archoto.2010.1020; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705; Young T, 2008, SLEEP, V31, P1071; Yu Yang, 2012, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V26, P256	65	313	322	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143697	10.1371/journal.pone.0143697	http://dx.doi.org/10.1371/journal.pone.0143697			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658438	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900017
J	Rytioja, J; Hilden, K; Makinen, S; Vehmaanpera, J; Hatakka, A; Makela, MR				Rytioja, Johanna; Hilden, Kristiina; Makinen, Susanna; Vehmaanpera, Jari; Hatakka, Annele; Makela, Miia R.			Saccharification of Lignocelluloses by Carbohydrate Active Enzymes of the White Rot Fungus Dichomitus squalens	PLOS ONE			English	Article							CELLOBIOSE DEHYDROGENASE; TRICHODERMA-REESEI; PHANEROCHAETE-CHRYSOSPORIUM; SPRUCE WOOD; MANGANESE PEROXIDASES; DEGRADING ENZYMES; LIGNIN; PURIFICATION; XYLANASE; LACCASE	White rot fungus Dichomitus squalens is an efficient lignocellulose degrading basidiomycete and a promising source for new plant cell wall polysaccharides depolymerizing enzymes. In this work, we focused on cellobiohydrolases (CBHs) of D. squalens. The native CBHI fraction of the fungus, consisting three isoenzymes, was purified and it maintained the activity for 60 min at 50 degrees C, and was stable in acidic pH. Due to the lack of enzyme activity assay for detecting only CBHII activity, CBHII of D. squalens was produced recombinantly in an industrially important ascomycete host, Trichoderma reesei. CBH enzymes of D. squalens showed potential in hydrolysis of complex lignocellulose substrates sugar beet pulp and wheat bran, and microcrystalline cellulose, Avicel. Recombinant CBHII (rCel6A) of D. squalens hydrolysed all the studied plant biomasses. Compared to individual activities, synergistic effect between rCel6A and native CBHI fraction of D. squalens was significant in the hydrolysis of Avicel. Furthermore, the addition of laccase to the mixture of CBHI fraction and rCel6A significantly enhanced the amount of released reducing sugars from sugar beet pulp. Especially, synergy between individual enzymes is a crucial factor in the tailor-made enzyme mixtures needed for hydrolysis of different plant biomass feedstocks. Our data supports the importance of oxidoreductases in improved enzyme cocktails for lignocellulose saccharification.	[Rytioja, Johanna; Hilden, Kristiina; Hatakka, Annele; Makela, Miia R.] Univ Helsinki, Div Microbiol & Biotechnol, Dept Food & Environm Sci, Helsinki, Finland; [Makinen, Susanna; Vehmaanpera, Jari] Roal Oy, Rajamaki, Finland	University of Helsinki	Makela, MR (corresponding author), Univ Helsinki, Div Microbiol & Biotechnol, Dept Food & Environm Sci, Helsinki, Finland.	miia.r.makela@helsinki.fi	Mäkelä, Miia R./F-2181-2011; Hildén, Kristiina/B-7766-2009	Mäkelä, Miia R./0000-0003-0771-2329; Hildén, Kristiina/0000-0002-0126-8186; Hatakka, Annele/0000-0001-7056-3931; Karppi, Johanna/0000-0002-8393-6546	European Community's Seventh Framework Programme (FP7) under the project NEMO [222699]	European Community's Seventh Framework Programme (FP7) under the project NEMO	Funding for the research was received from the European Community's Seventh Framework Programme (FP7/2007-2013) under the project NEMO (grant agreement no. 222699). The Doctoral Programme of Biomass Biorefining (BIOREGS), the Doctoral Programme of Microbiology and Biotechnology (MBDP) and the Finnish Cultural Foundation are acknowledged for the personal grants to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY MJ, 1981, ENZYME MICROB TECH, V3, P153, DOI 10.1016/0141-0229(81)90076-4; BAILEY MJ, 1992, J BIOTECHNOL, V23, P257, DOI 10.1016/0168-1656(92)90074-J; Baminger U, 2001, APPL ENVIRON MICROB, V67, P1766, DOI 10.1128/AEM.67.4.1766-1774.2001; Baminger U, 1999, J MICROBIOL METH, V35, P253, DOI 10.1016/S0167-7012(99)00022-6; Bergmans MEF, 1996, J CEREAL SCI, V23, P235, DOI 10.1006/jcrs.1996.0024; Berlin A, 2006, J BIOTECHNOL, V125, P198, DOI 10.1016/j.jbiotec.2006.02.021; Boer H, 2000, BIOTECHNOL BIOENG, V69, P486, DOI 10.1002/1097-0290(20000905)69:5<486::AID-BIT3>3.0.CO;2-N; BRILLOUET JM, 1985, CARBOHYD RES, V144, P113, DOI 10.1016/0008-6215(85)85012-6; Budak SO, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-523; Energy research Centre of the Netherlands, 2012, PHYLLIS2 DAT BIOM WA; Fackler K, 2006, ENZYME MICROB TECH, V39, P1476, DOI 10.1016/j.enzmictec.2006.03.043; Fernandez-Fueyo E, 2012, P NATL ACAD SCI USA, V109, P5458, DOI 10.1073/pnas.1119912109; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Hakala TK, 2005, ENZYME MICROB TECH, V36, P461, DOI 10.1016/j.enzmictec.2004.10.004; Hakala TK, 2004, ENZYME MICROB TECH, V34, P255, DOI 10.1016/j.enzmictec.2003.10.014; Hemsworth GR, 2013, CURR OPIN STRUC BIOL, V23, P660, DOI 10.1016/j.sbi.2013.05.006; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hori C, 2013, MYCOLOGIA, V105, P1412, DOI 10.3852/13-072; Igarashi K, 1998, EUR J BIOCHEM, V253, P101, DOI 10.1046/j.1432-1327.1998.2530101.x; JOUTSJOKI VV, 1993, CURR GENET, V24, P223, DOI 10.1007/BF00351796; Jurado M, 2009, BIORESOURCE TECHNOL, V100, P6378, DOI 10.1016/j.biortech.2009.07.049; Kamal-Eldin Afaf, 2009, Food Nutr Res, V53, DOI 10.3402/fnr.v53i0.1912; KARHUNEN T, 1993, MOL GEN GENET, V241, P515, DOI 10.1007/BF00279893; Kudanga T, 2014, APPL MICROBIOL BIOT, V98, P6525, DOI 10.1007/s00253-014-5810-8; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Li DM, 1999, BBA-PROTEIN STRUCT M, V1434, P356, DOI 10.1016/S0167-4838(99)00191-0; Liu Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1432, DOI 10.1271/bbb.80888; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lucatero S, 2004, BIOTECHNOL LETT, V26, P41, DOI 10.1023/B:BILE.0000009458.58602.d9; Micard V, 1996, ENZYME MICROB TECH, V19, P162, DOI 10.1016/0141-0229(95)00224-3; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moilanen U, 2011, ENZYME MICROB TECH, V49, P492, DOI 10.1016/j.enzmictec.2011.09.012; Mukelu MR., 2014, FUNGAL GENOMICS, P175, DOI DOI 10.1007/978-3-642-45218-5_8; Paloheimo M, 2003, APPL ENVIRON MICROB, V69, P7073, DOI 10.1128/AEM.69.12.7073-7082.2003; Palonen H, 2004, BIOTECHNOL BIOENG, V86, P550, DOI 10.1002/bit.20135; PENTTILA M, 1987, GENE, V61, P155, DOI 10.1016/0378-1119(87)90110-7; Perie FH, 1996, BBA-PROTEIN STRUCT M, V1297, P139, DOI 10.1016/S0167-4838(96)00096-9; Perie FH, 1998, ARCH BIOCHEM BIOPHYS, V353, P349, DOI 10.1006/abbi.1998.0625; Rahikainen JL, 2013, BIORESOURCE TECHNOL, V146, P118, DOI 10.1016/j.biortech.2013.07.069; REESE ET, 1969, APPL MICROBIOL, V17, P242, DOI 10.1128/AEM.17.2.242-245.1969; Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111; ROUAU X, 1986, CARBOHYD RES, V145, P279, DOI 10.1016/S0008-6215(00)90435-X; Rytioja J, 2014, MICROBIOL MOL BIOL R, V78, P614, DOI 10.1128/MMBR.00035-14; Rytioja J, 2014, FUNGAL GENET BIOL, V72, P91, DOI 10.1016/j.fgb.2013.12.008; Susla M, 2007, BIORESOURCE TECHNOL, V98, P2109, DOI 10.1016/j.biortech.2006.08.007; Temp U, 1999, APPL ENVIRON MICROB, V65, P389; Toda H, 2008, BIOSCI BIOTECH BIOCH, V72, P3142, DOI 10.1271/bbb.80316; UZCATEGUI E, 1991, J BIOTECHNOL, V19, P271, DOI 10.1016/0168-1656(91)90064-3; VANTILBEURGH H, 1982, FEBS LETT, V149, P152, DOI 10.1016/0014-5793(82)81092-2; Varnai A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-30; Varnai A, 2011, BIORESOURCE TECHNOL, V102, P9096, DOI 10.1016/j.biortech.2011.06.059; Varnai A, 2011, BIORESOURCE TECHNOL, V102, P1220, DOI 10.1016/j.biortech.2010.07.120; VENKATADRI R, 1990, APPL ENVIRON MICROB, V56, P2684, DOI 10.1128/AEM.56.9.2684-2691.1990; WARIISHI H, 1992, J BIOL CHEM, V267, P23688; Yoshida M, 2009, BIOSCI BIOTECH BIOCH, V73, P67, DOI 10.1271/bbb.80477	55	12	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145166	10.1371/journal.pone.0145166	http://dx.doi.org/10.1371/journal.pone.0145166			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660105	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900189
J	Saleem, S; Azam, A; Maqsood, SI; Muslim, I; Bashir, S; Fazal, N; Riaz, M; Ali, SHB; Niazi, MK; Ishaq, M; Waheed, NK; Qamar, R; Azam, M				Saleem, Saba; Azam, Aisha; Maqsood, Sundus Ijaz; Muslim, Irfan; Bashir, Shaheena; Fazal, Nosheen; Riaz, Moeen; Ali, Syeda Hafiza Benish; Niazi, Muhammad Khizar; Ishaq, Mazhar; Waheed, Nadia Khalida; Qamar, Raheel; Azam, Maleeha			Role of ACE and PAI-1 Polymorphisms in the Development and Progression of Diabetic Retinopathy	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; ANGIOTENSIN-CONVERTING ENZYME; ENDOTHELIAL GROWTH-FACTOR; INSERTION/DELETION POLYMORPHISM; DELETION POLYMORPHISM; 4G/5G POLYMORPHISM; GENETIC-VARIATION; I/D POLYMORPHISM; PROMOTER 4G/5G; ASSOCIATION	In the present study we determined the association of angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms with diabetic retinopathy (DR) and its sub-clinical classes in Pakistani type 2 diabetic patients. A total of 353 diabetic subjects including 160 DR and 193 diabetic non retinopathy (DNR) as well as 198 healthy controls were genotyped by allele specific polymerase chain reaction (PCR) for ACE Insertion/Deletion (ID) polymorphism, rs4646994 in intron 16 and PAI-1 4G/5G (deletion/insertion) polymorphism, rs1799768 in promoter region of the gene. To statistically assess the genotype-phenotype association, multivariate logistic regression analysis was applied to the genotype data of DR, DNR and control individuals as well as the subtypes of DR. The ACE genotype ID was found to be significantly associated with DR (p = 0.009, odds ratio (OR) 1.870 [95% confidence interval (CI) = 1.04-3.36]) and its sub-clinical class non-proliferative DR (NPDR) (p = 0.006, OR 2.250 [95% CI = 1.098-4.620]), while PAI polymorphism did not show any association with DR in the current cohort. In conclusion in Pakistani population the ACE ID polymorphism was observed to be significantly associated with DR and NPDR, but not with the severe form of the disease i.e. proliferative DR (PDR).	[Saleem, Saba; Bashir, Shaheena; Fazal, Nosheen; Riaz, Moeen; Ali, Syeda Hafiza Benish; Qamar, Raheel; Azam, Maleeha] COMSATS Inst Informat Technol, Dept Biosci, Islamabad, Pakistan; [Azam, Aisha; Muslim, Irfan] Mayo Hosp, Inst Ophthalmol, Lahore, Pakistan; [Maqsood, Sundus Ijaz] Royal Coll Ophthalmologists, Mersey Deanery, England; [Niazi, Muhammad Khizar; Ishaq, Mazhar] Armed Forces Inst Ophthalmol, Rawalpindi, Pakistan; [Niazi, Muhammad Khizar; Ishaq, Mazhar] Army Med Coll, Rawalpindi, Pakistan; [Waheed, Nadia Khalida] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Qamar, Raheel] Isra Univ, Al Nafees Med Coll & Hosp, Islamabad, Pakistan; [Qamar, Raheel] Pakistan Acad Sci, Islamabad, Pakistan	COMSATS University Islamabad (CUI); National University of Sciences & Technology - Pakistan; Tufts University	Qamar, R (corresponding author), COMSATS Inst Informat Technol, Dept Biosci, Islamabad, Pakistan.	raheelqamar@hotmail.com; malihazam@gmail.com	Niazi, Muhammad Khizar/AAM-5459-2020; Azam, Maleeha/AAD-9924-2022; Azam, Maleeha/L-1721-2017	Niazi, Muhammad Khizar/0000-0003-3870-3599; Azam, Maleeha/0000-0003-0170-3325	Higher Education Commission (HEC) Pakistan [3738]; COMSATS Institute of Information Technology, Islamabad, Pakistan	Higher Education Commission (HEC) Pakistan(Higher Education Commission of Pakistan); COMSATS Institute of Information Technology, Islamabad, Pakistan	This work was funded by a grant from Higher Education Commission (HEC) Pakistan (3738) to MA and RQ and by a core grant to RQ from the COMSATS Institute of Information Technology, Islamabad, Pakistan.	Ahmed W, 2011, MOL BIOL REP, V38, P2541, DOI 10.1007/s11033-010-0392-8; Anderson JL, 1999, J AM COLL CARDIOL, V34, P1778, DOI 10.1016/S0735-1097(99)00424-6; Broch M, 1998, DIABETES CARE, V21, P463, DOI 10.2337/diacare.21.3.463a; Dobrovolsky AB, 2002, BIOCHEMISTRY-MOSCOW+, V67, P99, DOI 10.1023/A:1013960416302; Downie LE, 2009, NEUROSCIENCE, V161, P195, DOI 10.1016/j.neuroscience.2009.02.084; Ezzidi I, 2009, DIABETES METAB, V35, P214, DOI 10.1016/j.diabet.2008.12.002; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Globocnik-Petrovic M, 2003, OPHTHALMOLOGICA, V217, P219, DOI 10.1159/000068975; Gutierrez C, 1997, METABOLISM, V46, P976, DOI 10.1016/S0026-0495(97)90090-1; Ishizaki E, 2006, AM J OPHTHALMOL, V141, P129, DOI 10.1016/j.ajo.2005.08.066; Kathiresan S, 2005, CIRCULATION, V112, P1728, DOI 10.1161/CIRCULATIONAHA.105.547836; Kimura H, 1998, KIDNEY INT, V54, P1659, DOI 10.1046/j.1523-1755.1998.00139.x; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; Lu Y, 2012, J RENIN-ANGIO-ALDO S, V13, P289, DOI 10.1177/1470320311432187; MANSFIELD MW, 1994, THROMB HAEMOSTASIS, V71, P731; Garcia PJM, 2014, WORLD J CARDIOL, V6, P968, DOI 10.4330/wjc.v6.i9.968; Matsumoto A, 2000, DIABETES RES CLIN PR, V50, P195, DOI 10.1016/S0168-8227(00)00194-7; Matsushita K, 2010, INVEST OPHTH VIS SCI, V51, P5979, DOI 10.1167/iovs.10-5377; Mazaheri H, 2015, IRAN J PUBLIC HEALTH, V44, P369; Meigs JB, 2006, OBESITY, V14, P753, DOI 10.1038/oby.2006.85; MIGDALIS IN, 1990, SOUTHERN MED J, V83, P425; Nagi DK, 1996, DIABETIC MED, V13, P59, DOI 10.1002/(SICI)1096-9136(199601)13:1<59::AID-DIA2>3.0.CO;2-Z; Nagi DK, 1997, DIABETES CARE, V20, P1304, DOI 10.2337/diacare.20.8.1304; NAGI DK, 1995, DIABETIC MED, V12, P997, DOI 10.1111/j.1464-5491.1995.tb00412.x; NAKAI K, 1994, CIRCULATION, V90, P2199, DOI 10.1161/01.CIR.90.5.2199; Ng DPK, 2008, DIABETES, V57, P2541, DOI 10.2337/db08-0581; Nikzamir A, 2010, OPHTHALMIC GENET, V31, P108, DOI 10.3109/13816810.2010.482554; Olszowski T, 2015, CARIES RES, V49, P390, DOI 10.1159/000381962; Otani A, 1998, CIRC RES, V82, P619, DOI 10.1161/01.RES.82.5.619; Puavilai G, 1999, DIABETES RES CLIN PR, V44, P21, DOI 10.1016/S0168-8227(99)00008-X; Sambrook J., 2001, MOL CLONING LAB MANU, V3rd ed.; Santos KG, 2003, DIABETES RES CLIN PR, V61, P133, DOI 10.1016/S0168-8227(03)00112-8; Tariq K, 2013, MOL VIS, V19, P710; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Wang J, 2010, HUM HERED, V69, P212, DOI 10.1159/000289597; Wong TYH, 2000, KIDNEY INT, V57, P632; Zhang Wenbo, 2011, J Cardiovasc Dis Res, V2, P96, DOI 10.4103/0975-3583.83035	37	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144557	10.1371/journal.pone.0144557	http://dx.doi.org/10.1371/journal.pone.0144557			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658948	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900063
J	Salem, TZ; Seaborn, CP; Turney, CM; Xue, JL; Shang, H; Cheng, XW				Salem, Tamer Z.; Seaborn, Craig P.; Turney, Colin M.; Xue, Jianli; Shang, Hui; Cheng, Xiao-Wen			The Influence of SV40 polyA on Gene Expression of Baculovirus Expression Vector Systems	PLOS ONE			English	Article							MESSENGER-RNA; POLYADENYLATION; TRANSLATION; SEQUENCE; TRANSCRIPTION; RECOGNITION; POLYMERASE; CLEAVAGE; SUBUNIT; VACCINE	The simian virus 40 polyadenylation signal (SV40 polyA) has been routinely inserted downstream of the polyhedrin promoter in many baculovirus expression vector systems (BEVS). In the baculovirus prototype Autographa californica multiple nucleopolyhedrovirus (AcMNPV), the polyhedrin promoter (very late promoter) transcribes its gene by a viral RNA polymerase therefore there is no supporting evidence that SV40 polyA is required for the proper gene expression under the polyhedrin promoter. Moreover, the effect of the SV40 polyA sequence on the polyhedrin promoter activity has not been tested either at its natural polyhedrin locus or in other loci in the viral genome. In order to test the significance of adding the SV40 polyA sequence on gene expression, the expression of the enhanced green fluorescent protein (egfp) was evaluated with and without the presence of SV40 polyA under the control of the polyhedrin promoter at different genomic loci (polyherin, ecdysteroid UDP-glucosyltransferase (egt), and gp37). In this study, spectrofluorometry and western blot showed reduction of EGFP protein for all recombinant viruses with SV40 polyA, whereas qPCR showed an increase in the egfp mRNA levels. Therefore, we conclude that SV40 polyA increases mRNA levels but decreases protein production in the BEVS when the polyhedrin promoter is used at different loci. This work suggests that SV40 polyA in BEVSs should be replaced by an AcMNPV late gene polyA for optimal protein production or left untouched for optimal RNA production (RNA interference applications).	[Salem, Tamer Z.; Seaborn, Craig P.; Turney, Colin M.; Xue, Jianli; Shang, Hui; Cheng, Xiao-Wen] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA; [Salem, Tamer Z.] Univ Sci & Technol Zewail City, Biomed Sci, Giza, Egypt; [Salem, Tamer Z.] ARC, AGERI, Dept Microbial Mol Biol, Giza, Egypt	University System of Ohio; Miami University; Egyptian Knowledge Bank (EKB); Zewail City of Science & Technology; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt	Salem, TZ (corresponding author), Miami Univ, Dept Microbiol, 32 Pearson Hall, Oxford, OH 45056 USA.	tsalem@zewailcity.edu.eg; Chengx@MiamiOH.edu	CHENG, Xiao-Wen/AAA-6949-2020; Salem, Tamer/I-5778-2019	Salem, Tamer/0000-0002-6264-5037	US Department of Agriculture (US-Egypt Science and Technology Joint Fund) [58-3148-7-164]; National Natural Science Foundation of China [31228020]	US Department of Agriculture (US-Egypt Science and Technology Joint Fund); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the US Department of Agriculture (US-Egypt Science and Technology Joint Fund project no. 58-3148-7-164) and National Natural Science Foundation of China (contract no. 31228020); We thank Mike Hughes for help in statistical analyses and Dr. Fareed Aboul-Ela for proofreading of the manuscript. This research is partially supported by the US Department of Agriculture (US-Egypt Science and Technology Joint Fund project no. 58-3148-7-164) and the National Natural Science Foundation of China (31228020) to XWC.	Beilharz TH, 2007, RNA, V13, P982, DOI 10.1261/rna.569407; BLISSARD GW, 1990, ANNU REV ENTOMOL, V35, P127, DOI 10.1146/annurev.en.35.010190.001015; Canadillas JMP, 2003, EMBO J, V22, P2821, DOI 10.1093/emboj/cdg259; Cheng XW, 2001, J GEN VIROL, V82, P299, DOI 10.1099/0022-1317-82-2-299; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Deschuyteneer M, 2010, HUM VACCINES, V6, P407, DOI 10.4161/hv.6.5.11023; FITZGERALD M, 1981, CELL, V24, P251, DOI 10.1016/0092-8674(81)90521-3; Guarino LA, 1998, J VIROL, V72, P7985, DOI 10.1128/JVI.72.10.7985-7991.1998; Herniou E. A., 2012, VIRUS TAXONOMY, P163; Jarvis DL, 2009, METHOD ENZYMOL, V463, P191, DOI 10.1016/S0076-6879(09)63014-7; Jin JP, 2000, J VIROL, V74, P8930, DOI 10.1128/JVI.74.19.8930-8937.2000; Kato T, 2010, APPL MICROBIOL BIOT, V85, P459, DOI 10.1007/s00253-009-2267-2; KELLER W, 1991, EMBO J, V10, P4241, DOI 10.1002/j.1460-2075.1991.tb05002.x; KUZIO J, 1984, VIROLOGY, V139, P414, DOI 10.1016/0042-6822(84)90388-X; Luckow V. A, 1991, Recombinant DNA technology and applications., P97; MAEDA S, 1989, BIOCHEM BIOPH RES CO, V165, P1177, DOI 10.1016/0006-291X(89)92726-5; Martincic K, 1998, P NATL ACAD SCI USA, V95, P11095, DOI 10.1073/pnas.95.19.11095; MURTHY KGK, 1995, GENE DEV, V9, P2672, DOI 10.1101/gad.9.21.2672; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Passarelli A. Lorena, 2007, Virologica Sinica, V22, P94; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SMITH GE, 1983, MOL CELL BIOL, V3, P2156, DOI 10.1128/MCB.3.12.2156; Tani H, 2008, FUTURE VIROL, V3, P35, DOI 10.2217/17460794.3.1.35; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; van Oers MM, 1999, J GEN VIROL, V80, P2253, DOI 10.1099/0022-1317-80-8-2253; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; WESTWOOD JA, 1993, VIROLOGY, V195, P90, DOI 10.1006/viro.1993.1349; WU JG, 1989, J GEN VIROL, V70, P2449, DOI 10.1099/0022-1317-70-9-2449; Xue J-L, 2011, CURRENT PROTOCOLS MI; Xue JL, 2010, J VIROL METHODS, V163, P210, DOI 10.1016/j.jviromet.2009.09.019	30	4	4	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145019	10.1371/journal.pone.0145019	http://dx.doi.org/10.1371/journal.pone.0145019			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659470	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900170
J	Xu, JH; Peng, ZC				Xu, Jianhua; Peng, Zongchao			People at Risk of Influenza Pandemics: The Evolution of Perception and Behavior	PLOS ONE			English	Article							H1N1 INFLUENZA; INFECTION; CAMPAIGNS; MORTALITY; IMPACT	Influenza pandemics can severely impact human health and society. Understanding public perception and behavior toward influenza pandemics is important for minimizing the effects of such events. Public perception and behavior are expected to change over the course of an influenza pandemic, but this idea has received little attention in previous studies. Our study aimed to understand the dynamics of public perception and behavior over the course of the 2009 H1N1 influenza pandemic. Three consecutive cross-sectional surveys were administered among Beijing residents with random-digit dialing techniques in March 2008 and August and November 2009. Effective samples of 507, 508 and 1006 respondents were interviewed in each of the three surveys, respectively. The mean scores of risk perception were low to moderate across the three surveys. The perceived risk of infection of self was significantly lower than that of the community, revealing an optimistic bias. Longitudinally, the perceived risk of contracting H1N1 increased, whereas the perceived risk of being unable to obtain medicine and medical care once influenza permeated the community first increased and then decreased. Responsive actions toward influenza varied. Most respondents took actions that required little extra effort, such as ventilating rooms; these actions did not change over time. Comparatively, a smaller number of respondents took actions for coping with influenza, such as vaccination; however, these actions were taken by an increasing number of respondents over time. The association between risk perception and behavior was unstable. Positive, insignificant, and negative associations were obtained in the three surveys. In conclusion, the evolving patterns of risk perception and responsive behavior over the course of an influenza pandemic are sensitive to how risk and behavior are defined and scoped.	[Xu, Jianhua] Peking Univ, Coll Environm Sci & Engn, Beijing 100871, Peoples R China; [Xu, Jianhua; Peng, Zongchao] Tsinghua Univ, Sch Publ Policy & Management, Ctr Crisis Management Res, Beijing 100084, Peoples R China	Peking University; Tsinghua University	Peng, ZC (corresponding author), Tsinghua Univ, Sch Publ Policy & Management, Ctr Crisis Management Res, Beijing 100084, Peoples R China.	pengzch@mail.tsinghua.edu.cn			National Natural Science Foundation of China [91024031, 91124003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the National Natural Science Foundation of China under grant nos. 91024031 and 91124003, http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the National Natural Science Foundation of China under Grant No. 91024031 and 91124003. We are very grateful to Tian Tang and Beibei Zou, who were graduate students at Tsinghua University, for their contributions in data collection.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], 2010, LONGMAN DICTIONARY O, P1980; Bell D, 2006, EMERG INFECT DIS, V12, P88; Bults M, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-2, 10.1186/1471-2458-11-165]; Cao B, 2009, EMERG INFECT DIS, V15, P1418, DOI 10.3201/eid1509.090794; Collignon PJ, 2006, MED J AUSTRALIA, V185, pS54; Congressional Budget Office, 2005, POT INFL PAND POSS M; Eastwood K, 2010, EMERG INFECT DIS, V16, P1211, DOI 10.3201/eid1608.100132; Edwards W, 1954, PSYCHOL BULL, V51, P27; Gilles I, 2011, EUR J EPIDEMIOL, V26, P203, DOI 10.1007/s10654-011-9577-2; Gostin LO, 2004, J LAW MED ETHICS, V32, P565, DOI 10.1111/j.1748-720X.2004.tb01962.x; Ibuka Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-296; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Juckett G, 2006, AM FAM PHYSICIAN, V74, P783; Karademas EC, 2013, J HEALTH PSYCHOL, V18, P419, DOI 10.1177/1359105312436765; Karlsson M, 2014, J HEALTH ECON, V36, P1, DOI 10.1016/j.jhealeco.2014.03.005; Lau JTF, 2009, J INFECTION, V59, P122, DOI 10.1016/j.jinf.2009.06.004; Leung GM, 2005, CLIN INFECT DIS, V40, P1713, DOI 10.1086/429923; Liang HG, 2004, INT J MED INFORM, V73, P675, DOI 10.1016/j.ijmedinf.2004.05.010; Maurer J, 2010, PREV MED, V51, P185, DOI 10.1016/j.ypmed.2010.05.008; Ministry of Health, 2005, PREPAREDNESS AND CON; Ofri D, 2009, NEW ENGL J MED, V361, P2594, DOI 10.1056/NEJMp0911047; Oshitani Hitoshi, 2006, Journal of Infection and Chemotherapy, V12, P167, DOI 10.1007/s10156-006-0453-z; Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016460; Potter CW, 2001, J APPL MICROBIOL, V91, P572, DOI 10.1046/j.1365-2672.2001.01492.x; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; Slater MD, 1999, HEALTH COMMUN, V11, P335, DOI 10.1207/S15327027HC1104_2; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; SteelFisher GK, 2012, LANCET INFECT DIS, V12, P845, DOI 10.1016/S1473-3099(12)70206-2; SteelFisher Gillian K, 2010, N Engl J Med, V362, pe65, DOI 10.1056/NEJMp1005102; Tooher R, 2013, INFLUENZA OTHER RESP, V7, P1316, DOI 10.1111/irv.12103; van der Pligt J, 1996, EUR PSYCHOL, V1, P34, DOI 10.1027/1016-9040.1.1.34; WEINSTEIN ND, 1988, HEALTH PSYCHOL, V7, P355, DOI 10.1037/0278-6133.7.4.355; WEISS JA, 1994, J POLICY ANAL MANAG, V13, P82, DOI 10.2307/3325092; WHO, 2008, WHO OUTBREAK COMMUNI; WHO, 2009, SWINE INFLUENZA; WHO, 2008, WHO GUIDELINES FOR E; Wong LP, 2011, J BEHAV MED, V34, P23, DOI 10.1007/s10865-010-9283-7; World Health Organization, 2005, WHO GLOBAL INFLUENZA; Xue L, 2014, CHINAS CRISIS MANAGE, P57; Yang P, 2010, J INFECTION, V61, P277, DOI 10.1016/j.jinf.2010.07.010; Yates F.J., 1992, RISK TAKING BEHAV, P1	44	23	24	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144868	10.1371/journal.pone.0144868	http://dx.doi.org/10.1371/journal.pone.0144868			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26658371	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900126
J	Zhang, N; Wen, J; Zimmer, EA				Zhang, Ning; Wen, Jun; Zimmer, Elizabeth A.			Congruent Deep Relationships in the Grape Family (Vitaceae) Based on Sequences of Chloroplast Genomes and Mitochondrial Genes via Genome Skimming	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; BIOGEOGRAPHIC DIVERSIFICATION; INTERCONTINENTAL DISJUNCTIONS; AUSTRALIAN VITACEAE; MOLECULAR PHYLOGENY; SPECIES TREES; NORTH-AMERICA; MIXED MODELS; NUCLEAR; DNA	Vitaceae is well-known for having one of the most economically important fruits, i.e., the grape (Vitis vinifera). The deep phylogeny of the grape family was not resolved until a recent phylogenomic analysis of 417 nuclear genes from transcriptome data. However, it has been reported extensively that topologies based on nuclear and organellar genes may be incongruent due to differences in their evolutionary histories. Therefore, it is important to reconstruct a backbone phylogeny of the grape family using plastomes and mitochondrial genes. In this study, next-generation sequencing data sets of 27 species were obtained using genome skimming with total DNAs from silica-gel preserved tissue samples on an Illumina HiSeq 2500 instrument. Plastomes were assembled using the combination of de novo and reference genome (of V. vinifera) methods. Sixteen mitochondrial genes were also obtained via genome skimming using the reference genome of V. vinifera. Extensive phylogenetic analyses were performed using maximum likelihood and Bayesian methods. The topology based on either plastome data or mitochondrial genes is congruent with the one using hundreds of nuclear genes, indicating that the grape family did not exhibit significant reticulation at the deep level. The results showcase the power of genome skimming in capturing extensive phylogenetic data: especially from chloroplast and mitochondrial DNAs.	[Zhang, Ning; Wen, Jun; Zimmer, Elizabeth A.] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, MRC 166, Washington, DC 20013 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Wen, J (corresponding author), Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, MRC 166, Washington, DC 20013 USA.	wenj@si.edu; zimmerl@si.edu			National Museum of Natural History; Laboratories of Analytical Biology of the Smithsonian National Museum of Natural History (NMNH); National Science Foundation [DEB 0743474]; Smithsonian Institution	National Museum of Natural History(Smithsonian InstitutionSmithsonian National Museum of Natural History); Laboratories of Analytical Biology of the Smithsonian National Museum of Natural History (NMNH); National Science Foundation(National Science Foundation (NSF)); Smithsonian Institution(Smithsonian Institution)	This study was supported by a Peter Buck Postdoctoral Fellowship from the National Museum of Natural History, Smithsonian Institution, awarded to Ning Zhang, the Laboratories of Analytical Biology of the Smithsonian National Museum of Natural History (NMNH), a grant from the National Science Foundation (DEB 0743474 to S.R. Manchester and J. Wen), a Smithsonian Endowment Grant, and the Small Grants Program of the National Museum of Natural History.	Barrett CF, 2015, NEW PHYTOL; Blischak PD, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400044; Bock DG, 2014, NEW PHYTOL, V201, P1021, DOI 10.1111/nph.12560; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; DOYLE JJ, 1992, SYST BOT, V17, P144, DOI 10.2307/2419070; Fehrer J, 2007, MOL PHYLOGENET EVOL, V42, P347, DOI 10.1016/j.ympev.2006.07.004; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Govindarajulu R, 2015, AM J BOT, V102, P544, DOI 10.3732/ajb.1500026; Hillis DM, 2003, SYST BIOL, V52, P124, DOI 10.1080/10635150390132911; Ingrouille MJ, 2002, BOT J LINN SOC, V138, P421, DOI 10.1046/j.1095-8339.2002.00028.x; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jansen RK, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-32; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu XQ, 2013, MOL PHYLOGENET EVOL, V66, P43, DOI 10.1016/j.ympev.2012.09.003; Lu LM, 2013, MOL PHYLOGENET EVOL, V68, P502, DOI 10.1016/j.ympev.2013.04.023; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Male PJG, 2014, MOL ECOL RESOUR, V14, P966, DOI 10.1111/1755-0998.12246; Mandel JR, 2015, J SYST EVOL, V53, P391, DOI 10.1111/jse.12167; Mandel JR, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1300085; McPherson H, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-8; Nie ZL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-17; Nie ZL, 2010, AM J BOT, V97, P1342, DOI 10.3732/ajb.1000085; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Ren H, 2011, TAXON, V60, P629, DOI 10.1002/tax.603001; Richardson AO, 2007, J EXP BOT, V58, P1, DOI 10.1093/jxb/erl148; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rossetto M, 2002, SYST BOT, V27, P522; Rossetto M, 2001, GENET RESOUR CROP EV, V48, P307, DOI 10.1023/A:1011225319360; Rossetto M, 2007, CAN J BOT, V85, P722, DOI 10.1139/B07-022; Rothfels CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076957; Soejima A, 2006, AM J BOT, V93, P278, DOI 10.3732/ajb.93.2.278; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Straub SCK, 2012, AM J BOT, V99, P349, DOI 10.3732/ajb.1100335; Weitemier K, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400042; WEN J, 2013, PHILIPP J SCI, V142, P223; Wen J, 2015, BOTANY, V2015; Wen J., 2007, FAMILIES GENERA VASC, P466, DOI [10.1007/978-3-540-32219-1_54, DOI 10.1007/978-3-540-32219-1_54]; Wen J, 2007, CAN J BOT, V85, P731, DOI 10.1139/B07-071; Wen J, 2014, PHYTOKEYS, V42, P11, DOI 10.3897/phytokeys.42.7704; Wen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074394; Wolf PG, 2015, GENOME BIOL EVOL; Yi TS, 2015, MOL PHYLOGENET EVOL, V85, P10, DOI 10.1016/j.ympev.2014.09.028; Zeng LP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5956; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang N, 2012, NEW PHYTOL, V195, P923, DOI 10.1111/j.1469-8137.2012.04212.x; Zimmer EA, 2015, J SYST EVOL, V53, P371, DOI 10.1111/jse.12174; Zimmer EA, 2013, MOL PHYLOGENET EVOL, V66, P539, DOI 10.1016/j.ympev.2013.01.005	52	66	67	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144701	10.1371/journal.pone.0144701	http://dx.doi.org/10.1371/journal.pone.0144701			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656830	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900090
J	Cetkovska, K; Sustova, H; Kosztyu, P; Uldrijan, S				Cetkovska, Katerina; Sustova, Hana; Kosztyu, Pavlna; Uldrijan, Stjepan			A Novel Interaction between TFII-I and Mdm2 with a Negative Effect on TFII-I Transcriptional Activity	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; WILLIAMS-BEUREN-SYNDROME; P53 TUMOR-SUPPRESSOR; LONG TERMINAL REPEAT; HISTONE DEACETYLASE-3; HUMAN CYTOMEGALOVIRUS; P53-INDEPENDENT ROLE; HIV-1 TRANSCRIPTION; ACIDIC DOMAIN; CELL-CYCLE	Williams-Beuren syndrome-associated transcription factor TFII-I plays a critical regulatory role in bone and neural tissue development and in immunity, in part by regulating cell proliferation in response to mitogens. Mdm2, a cellular oncogene responsible for the loss of p53 tumor suppressor activity in a significant proportion of human cancers, was identified in this study as a new binding partner for TFII-I and a negative regulator of TFII-I-mediated transcription. These findings suggest a new p53-independent mechanism by which increased Mdm2 levels found in human tumors could influence cancer cells. In addition to that, we present data indicating that TFII-I is an important cellular regulator of transcription from the immediate-early promoter of human cytomegalovirus, a promoter sequence frequently used in mammalian expression vectors, including vectors for gene therapy. Our observation that Mdm2 over-expression can decrease the ability of TFII-I to activate the CMV promoter might have implications for the efficiency of experimental gene therapy based on CMV promoter-derived vectors in cancers with Mdm2 gene amplification.	[Cetkovska, Katerina; Uldrijan, Stjepan] St Annes Univ Hosp, Int Clin Res Ctr, Ctr Biomol & Cellular Engn, Brno, Czech Republic; [Cetkovska, Katerina; Sustova, Hana; Kosztyu, Pavlna; Uldrijan, Stjepan] Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic	St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno	Uldrijan, S (corresponding author), St Annes Univ Hosp, Int Clin Res Ctr, Ctr Biomol & Cellular Engn, Brno, Czech Republic.	uldrijan@med.muni.cz	Uldrijan, Stjepan/N-1664-2016	Uldrijan, Stjepan/0000-0001-8316-2539	European Regional Development Fund - Project FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]; Czech Science Foundation [301/09/1324]; Ministry of Education, Youth and Sports of the Czech Republic (Specific University Research Grant) [MUNI/A/1123/2014]	European Regional Development Fund - Project FNUSA-ICRC; Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic (Specific University Research Grant)	This work was supported by the European Regional Development Fund - Project FNUSA-ICRC (CZ.1.05/1.1.00/02.0123), the Czech Science Foundation (Project 301/09/1324), and by the Ministry of Education, Youth and Sports of the Czech Republic (Specific University Research Grant MUNI/A/1123/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende-Vega N, 2008, MOL CELL BIOCHEM, V316, P99, DOI 10.1007/s11010-008-9816-3; Ashworth T, 2009, CELL CYCLE, V8, P596, DOI 10.4161/cc.8.4.7728; Barami K, 2010, J CLIN NEUROSCI, V17, P819, DOI 10.1016/j.jocn.2009.10.040; Chang LJ, 1999, GENE THER, V6, P715, DOI 10.1038/sj.gt.3300895; Chen DL, 2003, J BIOL CHEM, V278, P13595, DOI 10.1074/jbc.C200694200; Chen JG, 2005, J VIROL, V79, P4396, DOI 10.1128/JVI.79.7.4396-4406.2005; Cheriyath V, 2002, J BIOL CHEM, V277, P22798, DOI 10.1074/jbc.M202956200; Cheriyath V, 1998, MOL CELL BIOL, V18, P4444, DOI 10.1128/MCB.18.8.4444; Cross B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.228981; Crusselle-Davis VJ, 2007, FEBS J, V274, P6065, DOI 10.1111/j.1742-4658.2007.06128.x; Dahabieh MS, 2011, VIROLOGY, V418, P57, DOI 10.1016/j.virol.2011.07.002; Desgranges ZP, 2005, MOL CELL BIOL, V25, P10940, DOI 10.1128/MCB.25.24.10940-10952.2005; Dimitriadi M, 2008, BRIT J CANCER, V99, P1144, DOI 10.1038/sj.bjc.6604643; Enkhmandakh B, 2009, P NATL ACAD SCI USA, V106, P181, DOI 10.1073/pnas.0811531106; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Gronroos E, 2004, P NATL ACAD SCI USA, V101, P12165, DOI 10.1073/pnas.0402283101; Grueneberg DA, 1997, GENE DEV, V11, P2482, DOI 10.1101/gad.11.19.2482; Gu LB, 2002, BLOOD, V99, P3367, DOI 10.1182/blood.V99.9.3367; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Hakre S, 2006, MOL CELL, V24, P301, DOI 10.1016/j.molcel.2006.09.005; Hinsley TA, 2004, PROTEIN SCI, V13, P2588, DOI 10.1110/ps.04747604; Isomura H, 2005, J VIROL, V79, P9597, DOI 10.1128/JVI.79.15.9597-9607.2005; Jin Y, 2008, MOL CELL BIOL, V28, P1218, DOI 10.1128/MCB.01198-07; Johnson-Pais T, 2001, P NATL ACAD SCI USA, V98, P2211, DOI 10.1073/pnas.051415898; Kim DW, 1998, MOL CELL BIOL, V18, P3310, DOI 10.1128/MCB.18.6.3310; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lazebnik MB, 2009, J BIOL CHEM, V284, P36234, DOI 10.1074/jbc.C109.063115; Li L, 2012, J BIOTECHNOL, V162, P171, DOI 10.1016/j.jbiotec.2012.08.012; Liu CYY, 2009, J VIROL, V83, P3604, DOI 10.1128/JVI.01778-08; Macias MP, 1996, J VIROL, V70, P3628, DOI 10.1128/JVI.70.6.3628-3635.1996; Maguire M, 2008, CANCER RES, V68, P3232, DOI 10.1158/0008-5472.CAN-07-5271; MAIO JJ, 1988, J VIROL, V62, P1398, DOI 10.1128/JVI.62.4.1398-1407.1988; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; Matlaf LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068176; Michaelis M, 2009, NEOPLASIA, V11, P1, DOI 10.1593/neo.81178; Mobley CM, 2000, J VIROL, V74, P6511, DOI 10.1128/JVI.74.14.6511-6519.2000; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Montano MA, 1996, P NATL ACAD SCI USA, V93, P12376, DOI 10.1073/pnas.93.22.12376; Papadakis ED, 2004, CURR GENE THER, V4, P89, DOI 10.2174/1566523044578077; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; REIFENBERGER G, 1993, CANCER RES, V53, P2736; Rodova M, 2013, PLASMID, V69, P223, DOI 10.1016/j.plasmid.2013.01.004; Roy AL, 2007, BBA-GENE STRUCT EXPR, V1769, P613, DOI 10.1016/j.bbaexp.2007.10.002; Roy AL, 2012, GENE, V492, P32, DOI 10.1016/j.gene.2011.10.030; Sacrist n C, 2004, J BIOL CHEM, V279, P7147, DOI 10.1074/jbc.M303724200; Sadowski I, 2005, EUR J CANCER, V41, P2528, DOI 10.1016/j.ejca.2005.08.011; Shen X, 2009, GENES CELLS, V14, P1133, DOI 10.1111/j.1365-2443.2009.01340.x; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Soroceanu L, 2011, VIRUS RES, V157, P193, DOI 10.1016/j.virusres.2010.10.026; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Sun PQ, 1998, SCIENCE, V282, P2270, DOI 10.1126/science.282.5397.2270; Taylor HE, 2011, J VIROL, V85, P7699, DOI 10.1128/JVI.00337-11; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tussie-Luna MI, 2002, P NATL ACAD SCI USA, V99, P12807, DOI 10.1073/pnas.192464499; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Wen YD, 2003, J BIOL CHEM, V278, P1841, DOI 10.1074/jbc.M206528200; Wright J, 2015, J VIROL, V89, P7053, DOI 10.1128/JVI.00683-15; Zhou S, 2011, MOL CELL BIOL, V31, P4928, DOI 10.1128/MCB.06085-11	60	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144753	10.1371/journal.pone.0144753	http://dx.doi.org/10.1371/journal.pone.0144753			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656605	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903600085
J	Solomon, BJ; Desai, J; Rosenthal, M; McArthur, GA; Pattison, ST; Pattison, SL; MacDiarmid, J; Brahmbhatt, H; Scott, AM				Solomon, Benjamin J.; Desai, Jayesh; Rosenthal, Mark; McArthur, Grant A.; Pattison, Scott T.; Pattison, Stacey L.; MacDiarmid, Jennifer; Brahmbhatt, Himanshu; Scott, Andrew M.			A First-Time-In-Human Phase I Clinical Trial of Bispecific Antibody-Targeted, Paclitaxel-Packaged Bacterial Minicells	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; CANCER-THERAPY; DRUG; MECHANISM	Background We have harnessed a novel biological system, the bacterial minicell, to deliver cancer therapeutics to cancer cells. Preclinical studies showed that epidermal growth factor receptor (EGFR)-targeted, paclitaxel-loaded minicells ((EGFR)minicells(Pac)) have antitumor effects in xenograft models. To examine the safety of the minicell delivery system, we initiated a first-time-in-human, open-label, phase I clinical study of (EGFR)minicells(Pac) in patients with advanced solid tumors. Methodology Patients received 5 weekly infusions followed by a treatment free week. Seven dose levels (1x10(8), 1x10(9), 3x10(9), 1x10(10), 1.5x10(10), 2x10(10), 5x10(10)) were evaluated using a 3+3 dose-escalation design. Primary objectives were safety, tolerability and determination of the maximum tolerated dose. Secondary objectives were assessment of immune/inflammatory responses and antitumor activity. Principal Findings Twenty eight patients were enrolled, 22 patients completed at least one cycle of (EGFR)minicells(Pac); 6 patients did not complete a cycle due to rapidly progressive disease. A total of 236 doses was delivered over 42 cycles, with a maximum of 45 doses administered to a single patient. Most common treatment-related adverse events were rigors and pyrexia. No deaths resulted from treatment-related adverse events and the maximum tolerated dose was defined as 1x10(10) (EGFR)minicells(Pac). Surprisingly, only a mild self-limiting elevation in the inflammatory cytokines IL-6, IL-8 and TNF alpha and anti-inflammatory IL-10 was observed. Anti-LPS antibody titers peaked by dose 3 and were maintained at that level despite repeat dosing with the bacterially derived minicells. Ten patients ( 45%; n = 22) achieved stable disease as their best response. Conclusions/Significance This is the first study in humans of a novel biological system that can provide targeted delivery of a range of chemotherapeutic drugs to solid tumor cells. Bispecific antibody-targeted minicells, packaged with the chemotherapeutic paclitaxel, were shown to be safe in patients with advanced solid tumors with modest clinical efficacy observed. Further study in Phase II trials is planned.	[Solomon, Benjamin J.; McArthur, Grant A.] Peter MacCallum Canc Ctr, Dept Hematol & Med Oncol, Melbourne, Vic, Australia; [Desai, Jayesh; Rosenthal, Mark] Royal Melbourne Hosp, Med Oncol, Melbourne, Vic, Australia; [Pattison, Scott T.; Pattison, Stacey L.; MacDiarmid, Jennifer; Brahmbhatt, Himanshu] EnGeneIC Ltd, Canc Therapeut, Sydney, NSW, Australia; [Scott, Andrew M.] Austin Hosp, Olivia Newton John Canc & Wellness Ctr, Heidelberg, Vic 3084, Australia; [Scott, Andrew M.] Austin Hosp, Ludwig Inst Canc Res, Heidelberg, Vic 3084, Australia	Peter Maccallum Cancer Center; Royal Melbourne Hospital; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; La Trobe University; Olivia Newton-John Cancer Research Institute; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Ludwig Institute for Cancer Research	Solomon, BJ (corresponding author), Peter MacCallum Canc Ctr, Dept Hematol & Med Oncol, Melbourne, Vic, Australia.	ben.solomon@petermac.org	Brahmbhatt, Himanshu/AAY-9997-2020; Desai, Jayesh/AAV-1237-2021	Scott, Andrew/0000-0002-6656-295X; Solomon, Benjamin/0000-0003-3059-5730; McArthur, Grant/0000-0001-8908-6071; Desai, Jayesh/0000-0003-4246-9344	EnGeneIC Ltd.	EnGeneIC Ltd.	This first-in-human Phase I, clinical trial was funded by EnGeneIC Ltd. The study was designed by BJS, JD, AMS, MR, GAM, JM and HB. The sponsor collected the data and analysed them in conjunction with all authors. BJS, AMS, JM and HB wrote the first draft of the manuscript. All authors reviewed the manuscript and approved the final version.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Andersen Anders, 2006, BMC Clin Pharmacol, V6, P2, DOI 10.1186/1472-6904-6-2; [Anonymous], 2002, CLIN CANC RES OFFICI, V8, P955; CASSATELLA MA, 1993, J EXP MED, V178, P2207, DOI 10.1084/jem.178.6.2207; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; de Waal Malefyt R., 1991, J EXP MED, V174, P1209, DOI DOI 10.1084/JEM.174.5.1209; Fiske MJ, 2001, J CHROMATOGR B, V753, P269, DOI 10.1016/S0378-4347(00)00561-2; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; KUMAR N, 1981, J BIOL CHEM, V256, P435; MacDiarmid JA, 2007, CANCER CELL, V11, P431, DOI 10.1016/j.ccr.2007.03.012; MacDiarmid JA, 2011, CURR OPIN BIOTECH, V22, P909, DOI 10.1016/j.copbio.2011.04.008; MacDiarmid JA, 2009, NAT BIOTECHNOL, V27, P643, DOI 10.1038/nbt.1547; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Monkemoller V, 2014, PHYS CHEM CHEM PHYS, V16, P12576, DOI 10.1039/c4cp01574f; Noble CO, 2004, EXPERT OPIN THER TAR, V8, P335, DOI 10.1517/14728222.8.4.335; Siwak D. R., 2002, CLIN CANCER RES, V8, P1172	19	41	44	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144559	10.1371/journal.pone.0144559	http://dx.doi.org/10.1371/journal.pone.0144559			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659127	gold, Green Submitted, Green Published			2022-12-27	WOS:000366903600058
J	Chan, RW; Ho, LC; Zhou, IY; Gao, PP; Chan, KC; Wu, EX				Chan, Russell W.; Ho, Leon C.; Zhou, Iris Y.; Gao, Patrick P.; Chan, Kevin C.; Wu, Ed X.			Structural and Functional Brain Remodeling during Pregnancy with Diffusion Tensor MRI and Resting-State Functional MRI	PLOS ONE			English	Article							MANGANESE-ENHANCED MRI; DENTATE GYRUS; RAT-BRAIN; MATERNAL-BEHAVIOR; HIPPOCAMPAL CONNECTIVITY; ESTROUS-CYCLE; FEMALE RAT; ADULT-RAT; PLASTICITY; NETWORKS	Although pregnancy-induced hormonal changes have been shown to alter the brain at the neuronal level, the exact effects of pregnancy on brain at the tissue level remain unclear. In this study, diffusion tensor imaging (DTI) and resting-state functional MRI (rsfMRI) were employed to investigate and document the effects of pregnancy on the structure and function of the brain tissues. Fifteen Sprague-Dawley female rats were longitudinally studied at three days before mating (baseline) and seventeen days after mating (G17). G17 is equivalent to the early stage of the third trimester in humans. Seven age-matched nulliparous female rats served as non-pregnant controls and were scanned at the same time-points. For DTI, diffusivity was found to generally increase in the whole brain during pregnancy, indicating structural changes at microscopic levels that facilitated water molecular movement. Regionally, mean diffusivity increased more pronouncedly in the dorsal hippocampus while fractional anisotropy in the dorsal dentate gyrus increased significantly during pregnancy. For rsfMRI, bilateral functional connectivity in the hippocampus increased significantly during pregnancy. Moreover, fractional anisotropy increase in the dentate gyrus appeared to correlate with the bilateral functional connectivity increase in the hippocampus. These findings revealed tissue structural modifications in the whole brain during pregnancy, and that the hippocampus was structurally and functionally remodeled in a more marked manner.	[Chan, Russell W.; Ho, Leon C.; Zhou, Iris Y.; Gao, Patrick P.; Wu, Ed X.] Univ Hong Kong, Lab Biomed Imaging & Signal Proc, Pokfulam, Hong Kong, Peoples R China; [Chan, Russell W.; Ho, Leon C.; Zhou, Iris Y.; Gao, Patrick P.; Wu, Ed X.] Univ Hong Kong, Dept Elect & Elect Engn, Pokfulam, Hong Kong, Peoples R China; [Chan, Kevin C.] Univ Pittsburgh, Dept Ophthalmol, UPMC Eye Ctr, Ophthalmol & Visual Sci Res Ctr, Pittsburgh, PA 15260 USA	University of Hong Kong; University of Hong Kong; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wu, EX (corresponding author), Univ Hong Kong, Lab Biomed Imaging & Signal Proc, Pokfulam, Hong Kong, Peoples R China.	ewu@eee.hku.hk	Zhou, Iris Yuwen/A-2089-2017; Chan, Kevin C/AAK-7665-2020; Wu, Ed Xuekui/C-1579-2009	Zhou, Iris Yuwen/0000-0002-4351-7398; Chan, Kevin C/0000-0003-4012-7084; Wu, Ed Xuekui/0000-0001-5581-1546; Chan, Russell/0000-0002-7680-9231	Hong Kong Research Grants Council [RGC GRF HKU7837/11M]; Croucher Foundation	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Croucher Foundation	This work was supported in part by the Hong Kong Research Grants Council (RGC GRF HKU7837/11M) and Croucher Foundation. EXW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Shujuan Fan and Dr. Adrian Tsang for their comments on the manuscript. This work was supported in part by the Hong Kong Research Grants Council (RGC GRF HKU7837/11M) and Croucher Foundation.	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; BAER SM, 1991, J NEUROPHYSIOL, V65, P874, DOI 10.1152/jn.1991.65.4.874; Baldassarre A, 2012, P NATL ACAD SCI USA, V109, P3516, DOI 10.1073/pnas.1113148109; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bathellier B, 2013, P NATL ACAD SCI USA, V110, P19950, DOI 10.1073/pnas.1312125110; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2012, NEUROIMAGE, V62, P938, DOI 10.1016/j.neuroimage.2012.01.090; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Brunton PJ, 2003, J NEUROENDOCRINOL, V15, P633, DOI 10.1046/j.1365-2826.2003.01045.x; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chan KC, 2014, NEUROIMAGE, V90, P235, DOI 10.1016/j.neuroimage.2013.12.056; Chan KC, 2012, NEUROIMAGE, V59, P2274, DOI 10.1016/j.neuroimage.2011.09.055; CHESLEY LC, 1985, OBSTET GYNECOL, V65, P423; Cheung MM, 2009, NEUROIMAGE, V45, P386, DOI 10.1016/j.neuroimage.2008.12.018; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Ding AY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051704; Ding AY, 2012, MAGN RESON IMAGING, V30, P993, DOI 10.1016/j.mri.2012.02.012; Dukart J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114227; Fan SJ, 2013, NMR BIOMED, V26, P1089, DOI 10.1002/nbm.2922; FLEMING AS, 1974, J COMP PHYSIOL PSYCH, V86, P957, DOI 10.1037/h0036414; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Galea LAM, 2000, HORM BEHAV, V37, P86, DOI 10.1006/hbeh.1999.1560; Gregg C, 2007, J NEUROSCI, V27, P1812, DOI 10.1523/JNEUROSCI.4441-06.2007; Gregg C, 2009, J NEUROL SCI, V285, P22, DOI 10.1016/j.jns.2009.06.040; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Hermundstad AM, 2013, P NATL ACAD SCI USA, V110, P6169, DOI 10.1073/pnas.1219562110; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hui ES, 2010, NEUROIMAGE, V49, P2366, DOI 10.1016/j.neuroimage.2009.10.022; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P955, DOI 10.1002/hipo.20455; Hutchison RM, 2010, J NEUROPHYSIOL, V103, P3398, DOI 10.1152/jn.00141.2010; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Jonckers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018876; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kim S., 2012, FUNCT NEURORADIOL, P293; Kinsley CH, 2006, SCI AM, V294, P72, DOI 10.1038/scientificamerican0106-72; Kinsley CH, 1999, NATURE, V402, P137, DOI 10.1038/45957; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; LAW RO, 1994, J EXP ZOOL, V268, P90, DOI 10.1002/jez.1402680204; Le Bihan D, 2012, NEUROIMAGE, V61, P324, DOI 10.1016/j.neuroimage.2011.11.006; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Liang ZF, 2013, NEUROIMAGE, V83, P237, DOI 10.1016/j.neuroimage.2013.06.029; Liang ZF, 2011, J NEUROSCI, V31, P3776, DOI 10.1523/JNEUROSCI.4557-10.2011; Lorberbaum JP, 1999, DEPRESS ANXIETY, V10, P99, DOI 10.1002/(SICI)1520-6394(1999)10:3<99::AID-DA2>3.0.CO;2-#; Maguire J, 2009, J NEUROSCI, V29, P9592, DOI 10.1523/JNEUROSCI.2162-09.2009; McEwen BS, 2001, J APPL PHYSIOL, V91, P2785, DOI 10.1152/jappl.2001.91.6.2785; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Moya J, 2014, J EXPO SCI ENV EPID, V24, P449, DOI 10.1038/jes.2013.92; MUHLETHALER M, 1984, BRAIN RES, V308, P97, DOI 10.1016/0006-8993(84)90921-1; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Oatridge A, 2002, AM J NEURORADIOL, V23, P19; Oja SS, 1996, METAB BRAIN DIS, V11, P153, DOI 10.1007/BF02069502; Ottowitz WE, 2008, PSYCHONEUROENDOCRINO, V33, P1419, DOI 10.1016/j.psyneuen.2008.09.013; Owen SF, 2013, NATURE, V500, P458, DOI 10.1038/nature12330; Parekh MB, 2010, EXP NEUROL, V224, P258, DOI 10.1016/j.expneurol.2010.03.031; Paris JJ, 2008, REPRODUCTION, V136, P105, DOI 10.1530/REP-07-0512; PasantesMorales H, 1997, AMINO ACIDS, V12, P281, DOI 10.1007/BF01373008; Pasco A, 2006, EUR RADIOL, V16, P1501, DOI 10.1007/s00330-005-0086-0; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Rombouts SARB, 2003, NEUROIMAGE, V20, P1236, DOI 10.1016/S1053-8119(03)00386-0; ROSENBLATT JS, 1967, SCIENCE, V156, P1512, DOI 10.1126/science.156.3781.1512; ROSENBLATT JS, 1988, PSYCHONEUROENDOCRINO, V13, P29, DOI 10.1016/0306-4530(88)90005-4; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Shah D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084241; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Stack EC, 2002, BEHAV BRAIN RES, V131, P17, DOI 10.1016/S0166-4328(01)00370-9; Strange BA, 2014, NAT REV NEUROSCI, V15, P655, DOI 10.1038/nrn3785; Taubert M, 2011, NEUROIMAGE, V57, P1492, DOI 10.1016/j.neuroimage.2011.05.078; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; TURNER O, 1994, EXP PHYSIOL, V79, P681, DOI 10.1113/expphysiol.1994.sp003800; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang L, 2010, HIPPOCAMPUS, V20, P345, DOI 10.1002/hipo.20771; Wartella J, 2003, PHYSIOL BEHAV, V79, P373, DOI 10.1016/S0031-9384(03)00150-1; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; Woolley CS, 1998, HORM BEHAV, V34, P140, DOI 10.1006/hbeh.1998.1466; Zhang NY, 2010, J NEUROSCI METH, V189, P186, DOI 10.1016/j.jneumeth.2010.04.001; Zhou IY, 2014, NEUROIMAGE, V84, P1, DOI 10.1016/j.neuroimage.2013.08.037; Zhou IY, 2013, NEUROSCI LETT, V553, P170, DOI 10.1016/j.neulet.2013.08.041	85	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144328	10.1371/journal.pone.0144328	http://dx.doi.org/10.1371/journal.pone.0144328			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658306	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000366903500020
J	Hunter, DJ; Torkelson, JL; Bodnar, J; Mortazavi, B; Laurent, T; Deason, J; Thephavongsa, K; Zhong, JM				Hunter, Daniel J.; Torkelson, Jessica L.; Bodnar, James; Mortazavi, Bobak; Laurent, Timothy; Deason, Jeff; Thephavongsa, Khanhkeo; Zhong, Jianmin			The Rickettsia Endosymbiont of Ixodes pacificus Contains All the Genes of De Novo Folate Biosynthesis	PLOS ONE			English	Article							OBLIGATE INTRACELLULAR BACTERIA; BLACK-LEGGED TICK; GENOME SEQUENCE; 6-PYRUVOYLTETRAHYDROPTERIN SYNTHASE; GTP CYCLOHYDROLASE; ESCHERICHIA-COLI; PROVIDES INSIGHT; SYMBIONTS; WOLBACHIA; MANIPULATORS	Ticks and other arthropods often are hosts to nutrient providing bacterial endosymbionts, which contribute to their host's fitness by supplying nutrients such as vitamins and amino acids. It has been detected, in our lab, that Ixodes pacificus is host to Rickettsia species phylotype G021. This endosymbiont is predominantly present, and 100% maternally transmitted in I. pacificus. To study roles of phylotype G021 in I. pacificus, bioinformatic and molecular approaches were carried out. MUMmer genome alignments of whole genome sequence of I. scapularis, a close relative to I. pacificus, against completely sequenced genomes of R. bellii OSU85-389, R. conorii, and R. felis, identified 8,190 unique sequences that are homologous to Rickettsia sequences in the NCBI Trace Archive. MetaCyc metabolic reconstructions revealed that all folate gene orthologues (folA, folC, folE, folKP, ptpS) required for de novo folate biosynthesis are present in the genome of Rickettsia buchneri in I. scapularis. To examine the metabolic capability of phylotype G021 in I. pacificus, genes of the folate biosynthesis pathway of the bacterium were PCR amplified using degenerate primers. BLAST searches identified that nucleotide sequences of the folA, folC, folE, folKP, and ptpS genes possess 98.6%, 98.8%, 98.9%, 98.5% and 99.0% identity respectively to the corresponding genes of Rickettsia buchneri. Phylogenetic tree constructions show that the folate genes of phylotype G021 and homologous genes from various Rickettsia species are monophyletic. This study has shown that all folate genes exist in the genome of Rickettsia species phylotype G021 and that this bacterium has the genetic capability for de novo folate synthesis.	[Hunter, Daniel J.; Torkelson, Jessica L.; Bodnar, James; Laurent, Timothy; Deason, Jeff; Thephavongsa, Khanhkeo; Zhong, Jianmin] Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA; [Mortazavi, Bobak] Yale Univ, Sch Med, Ctr Outcomes Res & Evaluat, New Haven, CT USA	California State University System; California State Polytechnic University, Humboldt; Yale University	Zhong, JM (corresponding author), Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA.	jz15@humboldt.edu	Zhong, Jianmin/AAO-9401-2020	Zhong, Jianmin/0000-0002-4746-8458	National Institute of Health AREA [1 R15 AI099902-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI099902] Funding Source: NIH RePORTER	National Institute of Health AREA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Health AREA grant 1 R15 AI099902-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NE, 2014, MBIO, V5, DOI 10.1128/mBio.01378-14; Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; Akman L, 2001, P NATL ACAD SCI USA, V98, P7546, DOI 10.1073/pnas.131057498; Azad AF, 1998, EMERG INFECT DIS, V4, P179, DOI 10.3201/eid0402.980205; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; BAUMANN P, 1995, ANNU REV MICROBIOL, V49, P55, DOI 10.1146/annurev.mi.49.100195.000415; Beard CB, 2001, INT J PARASITOL, V31, P621, DOI 10.1016/S0020-7519(01)00165-5; Bermingham A, 2002, BIOESSAYS, V24, P637, DOI 10.1002/bies.10114; Blatch SA, 2010, FLY, V4, P312, DOI 10.4161/fly.4.4.13258; Breeuwer JAJ, 1996, EXP APPL ACAROL, V20, P421, DOI 10.1007/BF00053306; BURGDORFER W, 1985, AM J TROP MED HYG, V34, P925, DOI 10.4269/ajtmh.1985.34.925; Cheng D, 2013, TICKS TICK-BORNE DIS, V4, P421, DOI 10.1016/j.ttbdis.2013.04.006; Cheng D, 2013, TICKS TICK-BORNE DIS, V4, P280, DOI 10.1016/j.ttbdis.2012.12.005; Currie CR, 2001, P ROY SOC B-BIOL SCI, V268, P1033, DOI 10.1098/rspb.2001.1605; Darnton-Hill I, 2015, NUTRIENTS, V7, P1744, DOI 10.3390/nu7031744; Defossez E, 2011, P ROY SOC B-BIOL SCI, V278, P1419, DOI 10.1098/rspb.2010.1884; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Dittrich S, 2008, MOL MICROBIOL, V67, P609, DOI 10.1111/j.1365-2958.2007.06073.x; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Douglas AE, 2014, J MOL BIOL, V426, P3830, DOI 10.1016/j.jmb.2014.04.005; Duron O, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-45; El Yacoubi B, 2006, J BIOL CHEM, V281, P37586, DOI 10.1074/jbc.M607114200; FAN HZ, 1992, J CLIN INVEST, V90, P1803, DOI 10.1172/JCI116055; Fenech M, 2012, MUTAT RES-FUND MOL M, V733, P21, DOI 10.1016/j.mrfmmm.2011.11.003; Fermer C, 1997, J BACTERIOL, V179, P831, DOI 10.1128/jb.179.3.831-837.1997; Furman DP, 1984, TICKS CALIFORNIA ACA, pviii; Gengenbacher M, 2008, FEMS MICROBIOL LETT, V287, P128, DOI 10.1111/j.1574-6968.2008.01302.x; Gerdes S, 2012, J EXP BOT, V63, P5379, DOI 10.1093/jxb/ers208; Gillespie JJ, 2015, GENOME BIOL EVOL, V7, P35, DOI 10.1093/gbe/evu262; Gillespie JJ, 2012, J BACTERIOL, V194, P376, DOI 10.1128/JB.06244-11; Ginkel SZ, 1997, FEMS MICROBIOL LETT, V156, P69, DOI 10.1016/S0378-1097(97)00402-3; Grochowski LL, 2007, BIOCHEMISTRY-US, V46, P6658, DOI 10.1021/bi700052a; Gross R, 2009, MOL MICROBIOL, V73, P751, DOI 10.1111/j.1365-2958.2009.06820.x; Hansen AK, 2011, P NATL ACAD SCI USA, V108, P2849, DOI 10.1073/pnas.1013465108; Hill CA, 2005, TRENDS PARASITOL, V21, P151, DOI 10.1016/j.pt.2005.02.004; Hossain T, 2004, P NATL ACAD SCI USA, V101, P5158, DOI 10.1073/pnas.0401342101; Kambhampati S, 2013, GENOMICS, V102, P479, DOI 10.1016/j.ygeno.2013.09.003; Kurlovs AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104815; Kurtti TJ, 2015, INT J SYST EVOL MICR, V65, P965, DOI 10.1099/ijs.0.000047; MARTIN MM, 1970, SCIENCE, V169, P16, DOI 10.1126/science.169.3940.16; McCutcheon JP, 2009, P NATL ACAD SCI USA, V106, P15394, DOI 10.1073/pnas.0906424106; Merhej V, 2014, INFECT GENET EVOL, V25, P122, DOI 10.1016/j.meegid.2014.03.014; Moran-Cadenas F, 2007, VECTOR-BORNE ZOONOT, V7, P555, DOI 10.1089/vbz.2006.0596; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Neef A, 2011, GENOME BIOL EVOL, V3, P1437, DOI 10.1093/gbe/evr118; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Phan JN, 2011, VECTOR-BORNE ZOONOT, V11, P957, DOI 10.1089/vbz.2010.0077; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Pribat A, 2009, J BACTERIOL, V191, P4158, DOI 10.1128/JB.00416-09; PYNE C, 1992, J BACTERIOL, V174, P1750, DOI 10.1128/jb.174.6.1750-1759.1992; Salzberg SL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r23; Sentausa E, 2012, J BACTERIOL, V194, P5130, DOI 10.1128/JB.01118-12; Sifakis S, 2000, ANN NY ACAD SCI, V900, P125, DOI 10.1111/j.1749-6632.2000.tb06223.x; Sybesma W, 2004, METAB ENG, V6, P109, DOI 10.1016/j.ymben.2003.11.002; Sybesma W, 2003, APPL ENVIRON MICROB, V69, P3069, DOI 10.1128/AEM.69.6.3069-3076.2003; Van Zee JP, 2007, INT J PARASITOL, V37, P1297, DOI 10.1016/j.ijpara.2007.05.011; Vigneron A, 2014, CURR BIOL, V24, P2267, DOI 10.1016/j.cub.2014.07.065; Wang P, 2010, MOL BIOCHEM PARASIT, V172, P41, DOI 10.1016/j.molbiopara.2010.03.012; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; WESTROM DR, 1985, J MED ENTOMOL, V22, P507, DOI 10.1093/jmedent/22.5.507; WHEELER PR, 1992, INT J LEPROSY, V60, P445; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004	64	68	70	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144552	10.1371/journal.pone.0144552	http://dx.doi.org/10.1371/journal.pone.0144552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650541	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903300057
J	Raiho, AM; Hooten, MB; Bates, S; Hobbs, NT				Raiho, Ann M.; Hooten, Mevin B.; Bates, Scott; Hobbs, N. Thompson			Forecasting the Effects of Fertility Control on Overabundant Ungulates: White-Tailed Deer in the National Capital Region	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; SURVIVAL RATES; IMMUNOCONTRACEPTION; POPULATIONS; EFFICACY; PATTERNS	Overabundant populations of ungulates have caused environmental degradation and loss of biological diversity in ecosystems throughout the world. Culling or regulated harvest is often used to control overabundant species. These methods are difficult to implement in national parks, other types of conservation reserves, or in residential areas where public hunting may be forbidden by policy. As a result, fertility control has been recommended as a non-lethal alternative for regulating ungulate populations. We evaluate this alternative using white-tailed deer in national parks in the vicinity of Washington, D.C., USA as a model system. Managers seek to reduce densities of white-tailed deer from the current average (50 deer per km(2)) to decrease harm to native plant communities caused by deer. We present a Bayesian hierarchical model using 13 years of population estimates from 8 national parks in the National Capital Region Network. We offer a novel way to evaluate management actions relative to goals using short term forecasts. Our approach confirms past analyses that fertility control is incapable of rapidly reducing deer abundance. Fertility control can be combined with culling to maintain a population below carrying capacity with a high probability of success. This gives managers confronted with problematic overabundance a framework for implementing management actions with a realistic assessment of uncertainty.	[Raiho, Ann M.; Hobbs, N. Thompson] Colorado State Univ, Dept Ecosyst Sci & Sustainabil, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Raiho, Ann M.; Hobbs, N. Thompson] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Hooten, Mevin B.] Colorado State Univ, Colorado Cooperat Fish & Wildlife Res Unit, US Geol Survey, Ft Collins, CO 80523 USA; [Hooten, Mevin B.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Hooten, Mevin B.] Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA; [Bates, Scott] Natl Pk Serv, Urban Ecol Ctr, Natl Capital Reg, Washington, DC 20240 USA	Colorado State University; Colorado State University; Colorado State University; United States Department of the Interior; United States Geological Survey; Colorado State University; Colorado State University; United States Department of the Interior	Raiho, AM (corresponding author), St Marys Coll, Dept Biol, Notre Dame, IN 46556 USA.	araiho@nd.edu	Hobbs, Tom/C-5263-2016		Rocky Mountains Cooperative Ecosystem Studies Unit (RM-CESU), RM-CESU [H2370094000, J2340110031]; NTH; National Parks Service, Biological Resources Management Division	Rocky Mountains Cooperative Ecosystem Studies Unit (RM-CESU), RM-CESU; NTH; National Parks Service, Biological Resources Management Division	This work was supported by Rocky Mountains Cooperative Ecosystem Studies Unit (RM-CESU), RM-CESU Cooperative Agreement Number: H2370094000 (WASO), J2340110031. The PI for this grant is NTH. The task agreement follows: A primary mission of the Natural Resource Ecology Laboratory at Colorado State University is to understand and quantify ecosystems, and effectively communicate this information to decision-makers, managers, students, and the public. This project will meet these mission goals by 1) summarizing the issues, data protocols, approaches, and future needs for ungulate management throughout the NPS; and 2) quantifying population sizes, trajectories, and effects of different management strategies. Products will be summarized in a report to NPS managers and leadership. In addition, results will be presented to a wide variety of audiences, including: academics and managers via peer-reviewed publications and at science conferences; students and faculty of Colorado State University during lectures and seminars (Dr. Hobbs teaches a modeling course "Systems Ecology", which incorporates real-world results and models); and the general public through NPS press releases, newspaper articles, and the NPS website. This agreement will provide employment and education opportunities for a research assistant and graduate student at Colorado State University. The research assistant will gain hands on experience and direct knowledge about ungulate management science and real world management implementation in the NPS. Additionally, the research assistant will learn how to create searchable databases, facilitate a science/management workshop, gain a variety of perspectives from parks and managers during interviews for data and the workshop, and develop their writing abilities. These collective experiences will increase the capability of the research assistant to find future work in a state or federal wildlife agency or private sector (e.g., one of the many private consultants that works on ungulate management plans). The graduate student will learn state-of-the-art modeling procedures, greatly increase their quantitative, writing, and presentation capabilities, and develop materials that will be presented at university classes and seminars and national science conferences. The knowledge gained during the process will also facilitate interactions within the academic and agency setting and give the student a set of quantitative skills that are very marketable (e.g., developing hierarchical models in a Bayesian framework). The review (task 1) developed in this agreement will benefit the scientific community at large by informing them of current trends in NPS management and the scientific basis for those decisions. The models (task 2) will further the wildlife scientific and management communities on the limitations and requirements of using fertility control technology and culling to control ungulate populations. It will also increase the ability of the NPS to obtain correct targets during reduction operations, which will facilitate cooperative management efforts with state agencies outside of NPS units. The funders provided the data and helped the PI determine which model experiments to conduct.; This study was funded by the National Parks Service, Biological Resources Management Division. Comments and suggestions from Barry Noon, Ryan Monello, and Jenny Powers improved the manuscript. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. government.	[Anonymous], 2013, TEXTS STAT SCI SERIE; Barlow ND, 1997, WILDLIFE RES, V24, P129, DOI 10.1071/WR95027; Bates S., 2006, WHITE TAILED DEER DE; Berliner LM, 1996, FUND THEOR, V79, P15; Bowman Jacob L., 2007, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V61, P76; Brinkman TJ, 2004, WILDLIFE SOC B, V32, P726, DOI 10.2193/0091-7648(2004)032[0726:SOWDIA]2.0.CO;2; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Buckland S.T., 2005, ENCY BIOSTATISTICS V, VWiley and Sons.; Campbell TA, 2005, WILDLIFE SOC B, V33, P212, DOI 10.2193/0091-7648(2005)33[212:PCOACA]2.0.CO;2; Caswell H., 2006, MATRIX POPULATION MO; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; DePerno CS, 2000, WILDLIFE SOC B, V28, P1030; DIAMOND J, 1992, NAT HIST, P2; DUSEK GL, 1992, J WILDLIFE MANAGE, V56, P645, DOI 10.2307/3809455; FULLER TK, 1990, WILDLIFE MONOGR, P1; GARROTT RA, 1993, CONSERV BIOL, V7, P946, DOI 10.1046/j.1523-1739.1993.740946.x; Gelman A., 2007, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Grovenburg TW, 2011, AM MIDL NAT, V165, P426, DOI 10.1674/0003-0031-165.2.426; HEIDELBERGER P, 1983, OPER RES, V31, P1109, DOI 10.1287/opre.31.6.1109; Hobbs N.T., 2015, BAYESIAN MODELS, DOI [DOI 10.1515/9781400866557, 10.1515/9781400866557]; Hobbs NT, 2000, J WILDLIFE MANAGE, V64, P473, DOI 10.2307/3803245; Hobbs NT, 2015, ECOLOGICAL IN PRESS; HONE J, 1992, J APPL ECOL, V29, P695, DOI 10.2307/2404478; Jewell PA, 1981, PROBLEMS MANAGEMENT; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kilpatrick HJ, 2001, CAN J ZOOL, V79, P949, DOI 10.1139/cjz-79-6-949; Kirkpatrick JF, 1997, REPROD FERT DEVELOP, V9, P105, DOI 10.1071/R96052; Knight TM, 2009, FOREST ECOL MANAG, V257, P1095, DOI 10.1016/j.foreco.2008.11.018; Knowlton FF, 1972, J WILDLIFE MANAGEMEN, V36; LESLIE PH, 1948, BIOMETRIKA, V35, P213, DOI 10.2307/2332342; Malcolm KD, 2010, ANIM REPROD SCI, V117, P261, DOI 10.1016/j.anireprosci.2009.05.003; McCabe Thomas R., 1997, P11; McCullough D.R., 1979, GEORGE RESERVE DEER; McShea WJ, 1997, J WILDLIFE MANAGE, V61, P560, DOI 10.2307/3802615; Noon BR, 2001, WILDLIFE 2001 POPULA, P441; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Plummer M, 2012, JAGS VERSION 3 3 0 U; Plummer M, 2013, R PACKAGE VERSION 3; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Burroughs JP, 2006, J WILDLIFE MANAGE, V70, P743, DOI 10.2193/0022-541X(2006)70[743:CMASOW]2.0.CO;2; R Core Team, 2021, R LANGUAGE ENV STAT; Ransom JI, 2014, J APPL ECOL, V51, P259, DOI 10.1111/1365-2664.12166; Russell FL, 2001, AM MIDL NAT, V146, P1, DOI 10.1674/0003-0031(2001)146[0001:EOWTDO]2.0.CO;2; Sinclair ARE, 2003, PHILOS T R SOC B, V358, P1729, DOI 10.1098/rstb.2003.1359; Stubben C, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i11; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Todd CR, 2008, J APPL ECOL, V45, P568, DOI 10.1111/j.1365-2664.2007.01434.x; Van Der Peet S, 2007, AUSTRAL ECOLOGY, V32, P720, DOI [10.1111/j.1442-9993.2007.01786.x, DOI 10.1111/J.1442-9993.2007.01786.X]; VanDeelen TR, 1997, J WILDLIFE MANAGE, V61, P903, DOI 10.2307/3802199; VerCauteren K.C., 2003, USDA STAFF PUBLICATI, V281; Vreeland JK, 2004, WILDLIFE SOC B, V32, P542, DOI 10.2193/0091-7648(2004)32[542:SRMCAH]2.0.CO;2; WESTERN D, 1979, AFR J ECOL, V17, P185, DOI 10.1111/j.1365-2028.1979.tb00256.x; Whitlaw HA, 1998, J WILDLIFE MANAGE, V62, P1335, DOI 10.2307/3801999; Wickham Brian M., 1993, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V47, P222; Wright R, 1993, RENEWABLE RESOURCES, V11, P18	57	19	19	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143122	10.1371/journal.pone.0143122	http://dx.doi.org/10.1371/journal.pone.0143122			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650739	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903300011
J	Orlhac, F; Soussan, M; Chouahnia, K; Martinod, E; Buvat, I				Orlhac, Fanny; Soussan, Michael; Chouahnia, Kader; Martinod, Emmanuel; Buvat, Irene			18F-FDG PET-Derived Textural Indices Reflect Tissue-Specific Uptake Pattern in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							PATHOLOGICAL RESPONSE; ESOPHAGEAL CANCER; FEATURES; HETEROGENEITY; IMAGES; RADIOTHERAPY; PARAMETERS; RADIOMICS; SURVIVAL; VOLUMES	Purpose Texture indices (TI) calculated from 18F-FDG PET tumor images show promise for predicting response to therapy and survival. Their calculation involves a resampling of standardized uptake values (SUV) within the tumor. This resampling can be performed differently and significantly impacts the TI values. Our aim was to investigate how the resampling approach affects the ability of TI to reflect tissue-specific pattern of metabolic activity. Methods 18F-FDG PET were acquired for 48 naive-treatment patients with non-small cell lung cancer and for a uniform phantom. We studied 7 TI, SUVmax and metabolic volume (MV) in the phantom, tumors and healthy tissue using the usual relative resampling (RR) method and an absolute resampling (AR) method. The differences in TI values between tissue types and cancer subtypes were investigated using Wilcoxon's tests. Results Most RR-based TI were highly correlated with MV for tumors less than 60 mL (Spearman correlation coefficient r between 0.74 and 1), while this correlation was reduced for ARbased TI (r between 0.06 and 0.27 except for RLNU where r = 0.91). Most AR-based TI were significantly different between tumor and healthy tissues (pvalues < 0.01 for all 7 TI) and between cancer subtypes (pvalues<0.05 for 6 TI). Healthy tissue and adenocarcinomas exhibited more homogeneous texture than tumor tissue and squamous cell carcinomas respectively. Conclusion TI computed using an AR method vary as a function of the tissue type and cancer subtype more than the TI involving the usual RR method. AR-based TI might be useful for tumor characterization.	[Orlhac, Fanny; Soussan, Michael; Buvat, Irene] Univ Paris Saclay, Univ Paris 11, Imagerie Mol Vivo, IMIV,CEA,Inserm,CNRS,CEA,SHFJ, Orsay, France; [Soussan, Michael] Avicenne Hosp, AP HP, Dept Nucl Med, Bobigny, France; [Chouahnia, Kader] Avicenne Hosp, AP HP, Dept Oncol, Bobigny, France; [Martinod, Emmanuel] Avicenne Hosp, AP HP, Dept Thorac Surg, Bobigny, France	CEA; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP	Orlhac, F (corresponding author), Univ Paris Saclay, Univ Paris 11, Imagerie Mol Vivo, IMIV,CEA,Inserm,CNRS,CEA,SHFJ, Orsay, France.	orlhacf@gmail.com	Buvat, Irene/U-8447-2018; Orlhac, Fanny/AAC-6428-2019	Buvat, Irene/0000-0002-7053-6471; Orlhac, Fanny/0000-0002-5588-1867; Soussan, Michael/0000-0002-0798-4749; Martinod, Emmanuel/0000-0001-8465-4498				Asamura H, 2008, J THORAC ONCOL, V3, P46, DOI 10.1097/JTO.0b013e31815e8577; Brooks FJ, 2014, J NUCL MED, V55, P37, DOI 10.2967/jnumed.112.116715; Brooks FJ, 2013, EUR J NUCL MED MOL I, V40, P1292, DOI 10.1007/s00259-013-2430-y; Buvat I, 2002, PHYS MED BIOL, V47, P1761, DOI 10.1088/0031-9155/47/10/311; Buvat I, 2015, J NUCL MED, V56, P1642, DOI 10.2967/jnumed.115.163469; Chalkidou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124165; Cheng NM, 2015, EUR J NUCL MED MOL I, V42, P419, DOI 10.1007/s00259-014-2933-1; Cheng NM, 2013, J NUCL MED, V54, P1703, DOI 10.2967/jnumed.112.119289; Cook GJR, 2013, J NUCL MED, V54, P19, DOI 10.2967/jnumed.112.107375; Dong XZ, 2013, NUCL MED COMMUN, V34, P40, DOI 10.1097/MNM.0b013e32835ae50c; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; Galavis PE, 2010, ACTA ONCOL, V49, P1012, DOI 10.3109/0284186X.2010.498437; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Leijenaar RTH, 2013, ACTA ONCOL, V52, P1391, DOI 10.3109/0284186X.2013.812798; Mangili E, 1998, EUR J HISTOCHEM, V42, P287; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Nestle U, 2005, J NUCL MED, V46, P1342; Orlhac F, 2014, J NUCL MED, V56, P430; Orlhac F, 2014, J NUCL MED, V55, P414, DOI 10.2967/jnumed.113.129858; Soussan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094017; Tan S, 2013, INT J RADIAT ONCOL, V85, P1375, DOI 10.1016/j.ijrobp.2012.10.017; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Vaidya M, 2012, RADIOTHER ONCOL, V102, P239, DOI 10.1016/j.radonc.2011.10.014; Willaime JMY, 2013, PHYS MED BIOL, V58, P187, DOI 10.1088/0031-9155/58/2/187; Xu R, 2014, ANN NUCL MED, V28, P926, DOI 10.1007/s12149-014-0895-9; Yang F, 2013, EUR J NUCL MED MOL I, V40, P716, DOI 10.1007/s00259-012-2332-4; Zhang H, 2014, INT J RADIAT ONCOL, V88, P195, DOI 10.1016/j.ijrobp.2013.09.037	27	99	99	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145063	10.1371/journal.pone.0145063	http://dx.doi.org/10.1371/journal.pone.0145063			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669541	gold, Green Published, Green Submitted			2022-12-27	WOS:000366719300043
J	Bernasconi, L; Ramenzoni, LL; Al-Majid, A; Tini, GM; Graber, SM; Schmidlin, PR; Irani, S				Bernasconi, Luca; Ramenzoni, Liza L.; Al-Majid, Ahmed; Tini, Gabrielo M.; Graber, Sereina M.; Schmidlin, Patrick R.; Irani, Sarosh			Elevated Matrix Metalloproteinase Levels in Bronchi Infected with Periodontopathogenic Bacteria	PLOS ONE			English	Article							TREPONEMA-DENTICOLA; LUNG; MICROBIOME; MMP-8; MATRIX-METALLOPROTEINASE-9; TISSUE; TNF	Objectives To determine whether bronchial colonisations/infections with periodontopathogenic bacteria are associated with elevated inflammatory markers such as MMPs, interleukins and Tumor necrosis factor alpha in the bronchial fluid. Methods Periodontal status was assessed in consecutive outpatients planned for elective bronchoscopies, and PCR for periodontopathogenic bacteria was performed from a protected specimen brush sample taken from the bronchial mucosa. Additionally, MMPs, interleukins and Tumor necrosis factor alpha were measured in the bronchial fluid. Results Out of the four species assessed, one species was found in 13 of 91 (14%) patients, and two in 12 (13%), three in 13 (14%) and all four in 1 (1%) patient, respectively. In multiple linear regression models the presence of Treponema denticola showed a consistent pattern of positive effects in bronchial fluid (Bonferroni adjusted p-values) on the levels of MMP9 (p adj.: 0.028) and MMP12 (p adj.: 0.029). Active smoking was independently associated with increased levels of aMMP8 (p adj.: 0.005) and MMP9 (p adj.: 0.009). Levels of IL-1 beta, IL-8 and Tumor necrosis factor alpha measured in the bronchial fluid were not affected by the presence of periodontopathogenic bacteria. Conclusions Bronchial colonisation/infection with Treponema denticola and smoking are independently associated with elevated MMPs (MMP9/MMP12 and MMP8/MMP9, respectively) in the bronchial fluid.	[Bernasconi, Luca] Cantonal Hosp Aarau, Ctr Lab Med, CH-5001 Aarau, Switzerland; [Ramenzoni, Liza L.; Al-Majid, Ahmed; Schmidlin, Patrick R.] Univ Zurich, Ctr Dent Med, Clin Prevent Dent Periodontol & Cariol, CH-8032 Zurich, Switzerland; [Tini, Gabrielo M.; Irani, Sarosh] Cantonal Hosp Aarau, Clin Pulm & Sleep Med, CH-5001 Aarau, Switzerland; [Graber, Sereina M.] Univ Zurich Irchel, Anthropol Inst & Museum, CH-8057 Zurich, Switzerland	Kantonsspital Aarau AG (KSA); University of Zurich; Kantonsspital Aarau AG (KSA); University of Zurich	Irani, S (corresponding author), Cantonal Hosp Aarau, Clin Pulm & Sleep Med, CH-5001 Aarau, Switzerland.	siran@gmx.ch	Irani, Sarosh/AAO-6911-2020	Irani, Sarosh/0000-0002-7667-9748; Ramenzoni, Liza L./0000-0002-7732-2118	Research Council of the Cantonal Hospital Aarau, Switzerland; Cantonal Hospital Aarau Endoscopy Team	Research Council of the Cantonal Hospital Aarau, Switzerland; Cantonal Hospital Aarau Endoscopy Team	This work was supported by the Research Fund from the Research Council of the Cantonal Hospital Aarau, Switzerland. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a Research Fund from the Research Council of the Cantonal Hospital Aarau, Switzerland. We also thank Constanze Spelters for her precise work as study nurse and the the Cantonal Hospital Aarau Endoscopy Team for its support.	Beklen A, 2007, J DENT RES, V86, P347, DOI 10.1177/154405910708600409; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Craig VJ, 2013, J IMMUNOL, V190, P4283, DOI 10.4049/jimmunol.1201043; Cutress T W, 1987, Int Dent J, V37, P222; CUTRESS TW, 1978, COMMUNITY DENT ORAL, V6, P245, DOI 10.1111/j.1600-0528.1978.tb01159.x; D'Armiento JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056352; Eick S, 2011, DIAGN MICR INFEC DIS, V69, P12, DOI 10.1016/j.diagmicrobio.2010.08.017; El-Solh AA, 2009, J INFECTION, V59, P49, DOI 10.1016/j.jinf.2009.05.004; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Fenno JC, 2012, J ORAL MICROBIOL, V4; Grenier D, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.21517; Haq I, 2011, THORAX, V66, P970, DOI 10.1136/thx.2011.159087; Hellyer TP, 2015, THORAX, V70, P41, DOI 10.1136/thoraxjnl-2014-205766; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Huang YJ, 2010, OMICS, V14, P9, DOI 10.1089/omi.2009.0100; Ilumets Helen, 2007, Int J Chron Obstruct Pulmon Dis, V2, P369; Irani Sarosh, 2011, Schweiz Monatsschr Zahnmed, V121, P1144; Kraft-Neumarker M, 2012, J PERIODONTAL RES, V47, P121, DOI 10.1111/j.1600-0765.2011.01416.x; Mocchegiani E, 2011, CURR OPIN PULM MED, V17, pS11, DOI 10.1097/01.mcp.0000410743.98087.12; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Noh MK, 2013, EXP THER MED, V6, P847, DOI 10.3892/etm.2013.1222; Page RC, 1997, PERIODONTOL 2000, V14, P9, DOI 10.1111/j.1600-0757.1997.tb00189.x; Ramseier CA, 2009, J PERIODONTOL, V80, P436, DOI [10.1902/jop.2009.080480, 10.1902/jop.2009.080480 ]; Schmidlin PR, 2015, J INFECTION, V70, P255, DOI 10.1016/j.jinf.2014.10.005; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sorsa T, 1999, ANN NY ACAD SCI, V878, P130, DOI 10.1111/j.1749-6632.1999.tb07679.x; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Victor Dayanand John, 2014, J Int Oral Health, V6, P67; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Villalta PC, 2014, AM J PHYSIOL-LUNG C, V307, pL652, DOI 10.1152/ajplung.00113.2014; Wilkinson TS, 2012, CHEST, V142, P1425, DOI 10.1378/chest.11-3273; Xie SS, 2014, J INT MED RES, V42, P1272, DOI 10.1177/0300060514548290; Yakob M, 2013, ORAL DIS, V19, P694, DOI 10.1111/odi.12057; Yakob M, 2012, J CLIN PERIODONTOL, V39, P256, DOI 10.1111/j.1600-051X.2011.01813.x; Zehnder M, 2011, J ENDODONT, V37, P17, DOI 10.1016/j.joen.2010.10.003	35	4	5	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144461	10.1371/journal.pone.0144461	http://dx.doi.org/10.1371/journal.pone.0144461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656474	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000366715900052
J	Butler, NM; Atkins, PA; Voytas, DF; Douches, DS				Butler, Nathaniel M.; Atkins, Paul A.; Voytas, Daniel F.; Douches, David S.			Generation and Inheritance of Targeted Mutations in Potato (Solanum tuberosum L.) Using the CRISPR/Cas System	PLOS ONE			English	Article							HOMING ENDONUCLEASES; GENOME; MUTAGENESIS; GENES; TOMATO; CROPS; MODEL	Genome editing using sequence-specific nucleases (SSNs) offers an alternative approach to conventional genetic engineering and an opportunity to extend the benefits of genetic engineering in agriculture. Currently available SSN platforms, such as zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and CRISPR/Cas (clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated systems (Cas)) have been used in a range of plant species for targeted mutagenesis via nonhomologous end joining (NHEJ) are just beginning to be explored in crops such as potato (Solanum tuberosum Group Tuberosum L.). In this study, CRISPR/Cas reagents expressing one of two single-guide RNA (sgRNA) targeting the potato ACETOLACTATE SYNTHASE1 (StALS1) gene were tested for inducing targeted mutations in callus and stable events of diploid and tetraploid potato using Agrobacterium-mediated transformation with either a conventional T-DNA or a modified geminivirus T-DNA. The percentage of primary events with targeted mutations ranged from 3-60% per transformation and from 0-29% above an expected threshold based on the number of ALS alleles. Primary events with targeted mutation frequencies above the expected threshold were used for mutation cloning and inheritance studies using clonal propagation and crosses or selfing. Four of the nine primary events used for mutation cloning had more than one mutation type, and eight primary events contained targeted mutations that were maintained across clonal generations. Somatic mutations were most evident in the diploid background with three of the four primary events having more than two mutation types at a single ALS locus. Conversely, in the tetraploid background, four of the five candidates carried only one mutation type. Single targeted mutations were inherited through the germline of both diploid and tetraploid primary events with transmission percentages ranging from 87-100%. This demonstration of CRISPR/Cas in potato extends the range of plant species modified using CRISPR/Cas and provides a framework for future studies.	[Butler, Nathaniel M.; Douches, David S.] Michigan State Univ, Dept Plant Soils & Microbial Sci, E Lansing, MI 48824 USA; [Atkins, Paul A.; Voytas, Daniel F.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	Michigan State University; University of Minnesota System; University of Minnesota Twin Cities	Douches, DS (corresponding author), Michigan State Univ, Dept Plant Soils & Microbial Sci, E Lansing, MI 48824 USA.	douchesd@msu.edu		Butler, Nathaniel/0000-0002-9235-7626; Voytas, Daniel/0000-0002-4944-1224; Atkins, Paul/0000-0002-4840-7825	Biotechnology Risk Assessment Grant Program from the USDA National Institute of Food and Agriculture [2013-33522-21090]; Agricultural Research Service; Direct For Biological Sciences [1339209] Funding Source: National Science Foundation	Biotechnology Risk Assessment Grant Program from the USDA National Institute of Food and Agriculture; Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Biotechnology Risk Assessment Grant Program competitive grant no. 2013-33522-21090 from the USDA National Institute of Food and Agriculture and the Agricultural Research Service (http://nifa.usda.gov/) to DFV and DSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Curtin SJ, 2012, PLANT GENOME-US, V5, P42, DOI 10.3835/plantgenome2012.06.0008; Curtin SJ, 2011, PLANT PHYSIOL, V156, P466, DOI 10.1104/pp.111.172981; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Endo M, 2013, J PESTIC SCI, V38, P49, DOI 10.1584/jpestics.D12-073; Farboud B, 2015, GENETICS, V199, P959, DOI 10.1534/genetics.115.175166; Felcher KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036347; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hunter P, 2014, EMBO REP, V15, P1; Jansky SH, 2014, J PLANT REGIST, V8, P195, DOI 10.3198/jpr2013.05.0024crg; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Klumper W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111629; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Lor VS, 2014, PLANT PHYSIOL, V166, P1288, DOI 10.1104/pp.114.247593; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Palmgren MG, 2014, TRENDS PLANT SCI, P1; Qi YP, 2013, GENOME RES, V23, P547, DOI 10.1101/gr.145557.112; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; SMITH JK, 1989, P NATL ACAD SCI USA, V86, P4179, DOI 10.1073/pnas.86.11.4179; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Takeuchi R, 2011, P NATL ACAD SCI USA, V108, P13077, DOI 10.1073/pnas.1107719108; Verhoeven HA, 1988, PLANT CELL REP, V7, P47, DOI [10.1007/BF00272976, DOI 10.1007/BF00272976]; Wendt T, 2013, PLANT MOL BIOL, V83, P279, DOI 10.1007/s11103-013-0078-4; Wu JC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093806, 10.1371/journal.pone.0090528]; Xu H, 2015, GENOME RES; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158	33	130	143	1	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144591	10.1371/journal.pone.0144591	http://dx.doi.org/10.1371/journal.pone.0144591			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657719	Green Published, gold			2022-12-27	WOS:000366715900067
J	Simpson, MR; Brede, G; Johansen, J; Johnsen, R; Storro, O; Saetrom, P; Oien, T				Simpson, Melanie Rae; Brede, Gaute; Johansen, Jostein; Johnsen, Roar; Storro, Ola; Saetrom, Pal; Oien, Torbjorn			Human Breast Milk miRNA, Maternal Probiotic Supplementation and Atopic Dermatitis in Offspring	PLOS ONE			English	Article							LARGE GENE LISTS; EXTRACELLULAR VESICLES; SMALL-INTESTINE; MICRORNAS; EXPRESSION; RNA; MOUSE; EXOSOMES; DISEASE; INJURY	Background Perinatal probiotic ingestion has been shown to prevent atopic dermatitis (AD) in infancy in a number of randomised trials. The Probiotics in the Prevention of Allergy among Children in Trondheim (ProPACT) trial involved a probiotic supplementation regime given solely to mothers in the perinatal period and demonstrated a similar to 40% relative risk reduction in the cumulative incidence of AD at 2 years of age. However, the mechanisms behind this effect are incompletely understood. Micro-RNAs (miRNA) are abundant in mammalian milk and may influence the developing gastrointestinal and immune systems of newborn infants. The objectives of this study were to describe the miRNA profile of human breast milk, and to investigate breast milk miRNAs as possible mediators of the observed preventative effect of probiotics. Methods Small RNA sequencing was conducted on samples collected 3 months postpartum from 54 women participating in the ProPACT trial. Differential expression of miRNA was assessed for the probiotic vs placebo and AD vs non-AD groups. The results were further analysed using functional prediction techniques. Results Human breast milk samples contain a relatively stable core group of highly expressed miRNAs, including miR-148a-3p, miR-22-3p, miR-30d-5p, let-7b-5p and miR-200a-3p. Functional analysis of these miRNAs revealed enrichment in a broad range of biological processes and molecular functions. Although several miRNAs were found to be differentially expressed on comparison of the probiotic vs placebo and AD vs non-AD groups, none had an acceptable false discovery rate and their biological significance in the development of AD is not immediately apparent from their predicted functional consequences. Conclusion Whilst breast milk miRNAs have the potential to be active in a diverse range of tissues and biological process, individual miRNAs in breast milk 3 months postpartum are unlikely to play a major role in the prevention of atopic dermatitis in infancy by probiotics ingestion in the perinatal period.	[Simpson, Melanie Rae; Johnsen, Roar; Storro, Ola; Oien, Torbjorn] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Brede, Gaute; Johansen, Jostein; Saetrom, Pal] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Saetrom, Pal] Norwegian Univ Sci & Technol, Dept Comp & Informat Sci, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Simpson, MR (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway.	melanie.simpson@ntnu.no	Sætrom, Pål/AAH-1216-2019; Simpson, Melanie Rae/H-6853-2019	Sætrom, Pål/0000-0001-8142-7441; Simpson, Melanie Rae/0000-0003-2763-6343	Norwegian University of Science and Technology; Norwegian Research Council; Nidarosfondet; Tine BA	Norwegian University of Science and Technology; Norwegian Research Council(Research Council of NorwayEuropean Commission); Nidarosfondet; Tine BA	This study was funded by the Norwegian University of Science and Technology, the Norwegian Research Council and Nidarosfondet. Tine BA sponsored the study through supply of study milk and logistics of its distribution. Siemens Medical Solutions Diagnostics AS provided reagents for the analysis of serum IgE. Employees from funding sources played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2011, J HUM LACT, V27, P171, DOI 10.1177/0890334410395761; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Anderson R. C., 2012, COLITIS; Argov-Argaman N, 2010, J AGR FOOD CHEM, V58, P11234, DOI 10.1021/jf102495s; Arroyo JD, 2011, PNAS, V108, P6; Baier SR, 2014, J NUTR, V144, P1495, DOI 10.3945/jn.114.196436; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Chapkin RS, 2010, AM J PHYSIOL-GASTR L, V298, pG582, DOI 10.1152/ajpgi.00004.2010; Chassin C, 2012, EMBO MOL MED, V4, P1308, DOI 10.1002/emmm.201201298; Chen T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-100; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Davis MK, 2001, PEDIATR CLIN N AM, V48, P125, DOI 10.1016/S0031-3955(05)70289-3; Dhahbi JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-298; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dotterud CK, 2010, BRIT J DERMATOL, V163, P616, DOI 10.1111/j.1365-2133.2010.09889.x; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043691; Hu CH, 2013, J ANIM SCI, V91, P1094, DOI 10.2527/jas.2012-5796; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Izumi H, 2012, J DAIRY SCI, V95, P4831, DOI 10.3168/jds.2012-5489; Izumi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088843; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lu TX, 2013, J ALLERGY CLIN IMMUN, V132, P3, DOI 10.1016/j.jaci.2013.04.039; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matheson MC, 2012, CLIN EXP ALLERGY, V42, P827, DOI 10.1111/j.1365-2222.2011.03925.x; Modepalli V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1012; Munch EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050564; Nata T, 2013, J GENE MED, V15, P249, DOI 10.1002/jgm.2717; Panduru M, 2015, J EUR ACAD DERMATOL, V29, P232, DOI 10.1111/jdv.12496; Patelarou E, 2012, NUTR REV, V70, P509, DOI 10.1111/j.1753-4887.2012.00513.x; Pelucchi C, 2012, EPIDEMIOLOGY, V23, P402, DOI 10.1097/EDE.0b013e31824d5da2; Power ML, 2013, APPL TRANSL GENOM, V2, P55, DOI 10.1016/j.atg.2013.06.001; R Core Team, 2018, R LANG ENV STAT COMP; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Van Deun J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24858; Walker WA, 2015, PEDIATR RES, V77, P220, DOI 10.1038/pr.2014.160; Wang JJ, 2008, J NUTR, V138, P1025, DOI 10.1093/jn/138.6.1025; Webber J, 2010, CLIN CHEM, V56, P9; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118; Zonneveld MI, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24215	50	40	41	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143496	10.1371/journal.pone.0143496	http://dx.doi.org/10.1371/journal.pone.0143496			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657066	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900011
J	Thompson, DR; Momplaisir, FM; Adams, JW; Yehia, BR; Anderson, EA; Alleyne, G; Brady, KA				Thompson, Dana R.; Momplaisir, Florence M.; Adams, Joella W.; Yehia, Baligh R.; Anderson, Emily A.; Alleyne, Gregg; Brady, Kathleen A.			Mode of Delivery among HIV-Infected Pregnant Women in Philadelphia, 2005-2013	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TO-CHILD-TRANSMISSION; CESAREAN-SECTION; ANTIRETROVIRAL THERAPY; PRETERM DELIVERY; VAGINAL DELIVERY; PREVENTION; METAANALYSIS; COHORT; RISK	Objective Current guidelines call for HIV-infected women to deliver via scheduled Caesarean when the maternal HIV viral load (VL) is > 1,000 copies/ml. We describe the mode of delivery among HIV-infected women and evaluate adherence to relevant recommendations. Study Design We performed a population-based surveillance analysis of HIV-infected pregnant women in Philadelphia from 2005 to 2013, comparing mode of delivery (vaginal, scheduled Caesarean, or emergent Caesarean) by VL during pregnancy, closest to the time of delivery (<= 1,000 copies/ml versus an unknown VL or VL > 1,000 copies/ml) and associated factors in multivariable analysis. Results Our cohort included 824 deliveries from 648 HIV-infected women, of whom 69.4% had a VL <= 1,000 copies/ml and 30.6% lacked a VL or had a VL > 1,000 copies/ml during pregnancy, closest to the time of delivery. Mode of delivery varied by VL: 56.6% of births were vaginal, 30.1% scheduled Caesarean, and 13.3% emergent Caesarean when the VL was <= 1,000 copies/ml; when the VL was unknown or > 1,000 copies/ml, 32.9% of births were vaginal, 49.9% scheduled Caesarean and 17.5% emergent Caesarean. In multivariable analyses, Hispanic women (adjusted odds ratio (AOR) 0.17, 95% Confidence Interval (CI) 0.04-0.76) and non-Hispanic black women (AOR 0.27, 95% CI 0.10-0.77) were less to likely to deliver via scheduled Caesarean compared to non-Hispanic white women. Women who delivered prior to 38 weeks' gestation (AOR 0.37, 95% CI 0.18-0.76) were also less likely to deliver via scheduled Caesarean compared to women who delivered after 38 weeks' gestation. An interaction term for race and gestational age at delivery was significant in multivariable analysis. Non-Hispanic black (AOR 0.06, 95% CI 0.01-0.36) and Hispanic women (AOR 0.03, 95% CI 0.00-0.59) were more likely to deliver prematurely and less likely to deliver via scheduled C-section compared to non-Hispanic white women. Having a previous Caesarean (AOR 27.77, 95% CI 8.94-86.18) increased the odds of scheduled Caesarean delivery. Conclusions Only half of deliveries for women with an unknown VL or VL > 1,000 copies/ml occurred via scheduled Caesarean. Delivery prior to 38 weeks, particularly among minority women, resulted in a missed opportunity to receive a scheduled Caesarean. However, even when delivering at or after 38 weeks' gestation, a significant proportion of women did not get a scheduled Caesarean when indicated, suggesting a need for focused public health interventions to increase the proportion of women achieving viral suppression during pregnancy and delivering via scheduled Caesarean when indicated.	[Thompson, Dana R.] Christiana Care Hlth Syst, Ctr Womens & Childrens Hlth Res, Newark, DE 19718 USA; [Momplaisir, Florence M.] Drexel Univ, Div Infect Dis & HIV Med, Coll Med, Philadelphia, PA 19104 USA; [Adams, Joella W.; Anderson, Emily A.; Brady, Kathleen A.] Philadelphia Dept Publ Hlth, AIDS Act & Coordinating Off, Philadelphia, PA USA; [Yehia, Baligh R.; Brady, Kathleen A.] Hosp Univ Penn, Div Infect Dis, Philadelphia, PA 19104 USA; [Yehia, Baligh R.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; Drexel Univ, Dept Obstet & Gynecol, Coll Med, Philadelphia, PA 19104 USA	Christiana Care Health System; Drexel University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Drexel University	Thompson, DR (corresponding author), Christiana Care Hlth Syst, Ctr Womens & Childrens Hlth Res, Newark, DE 19718 USA.	dana.thompson@christianacare.org		Adams, Joella/0000-0002-7703-5944				Aebi-Popp K, 2013, JAIDS-J ACQ IMM DEF, V64, P58, DOI 10.1097/QAI.0b013e3182a334e3; Andiman W, 1999, NEW ENGL J MED, V340, P977, DOI 10.1056/NEJM199904013401301; [Anonymous], 2008, MMWR; [Anonymous], HIV SURV REP; Behague DP, 2002, BMJ-BRIT MED J, V324, P942, DOI 10.1136/bmj.324.7343.942; Bradford JB, 2007, AIDS PATIENT CARE ST, V21, pS49, DOI 10.1089/apc.2007.9987; BURNS LR, 1995, MED CARE, V33, P365, DOI 10.1097/00005650-199504000-00004; Centers for Disease Control and Prevention, 2005, ENH PER SURV 15 AR; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Curtin S.C., 2013, NATL VITAL STAT REPO, V62; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Gardner LI, 2005, AIDS, V19, P423, DOI 10.1097/01.aids.0000161772.51900.eb; Goler NC, 2008, J PERINATOL, V28, P597, DOI 10.1038/jp.2008.70; KEELER EB, 1993, MILBANK Q, V71, P365, DOI 10.2307/3350407; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1414, DOI 10.2105/AJPH.84.9.1414; Kozhimannil KB, 2014, MED CARE, V52, P649, DOI 10.1097/MLR.0000000000000153; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Mitler LK, 2000, J CLIN EPIDEMIOL, V53, P1030, DOI 10.1016/S0895-4356(00)00221-3; Momplaisir FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132262; Myer L, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-94; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, 2015, REC US ANT DRUGS PRE; Parazzini F, 1999, LANCET, V353, P1035, DOI 10.1016/S0140-6736(98)08084-2; Practice CoO, 2001, INT J GYNECOL OBSTET, V73, P279; Short CES, 2014, HIV MED, V15, P233, DOI 10.1111/hiv.12083; Simhan HN, 2007, NEW ENGL J MED, V357, P477, DOI 10.1056/NEJMra050435; STAFFORD RS, 1991, JAMA-J AM MED ASSOC, V265, P59, DOI 10.1001/jama.265.1.59; Suy A, 2008, EUR J OBSTET GYN R B, V139, P127, DOI 10.1016/j.ejogrb.2007.12.007; Turan JM, 2013, AIDS BEHAV, V17, P2528, DOI 10.1007/s10461-013-0446-8; TUSSING AD, 1993, SOC SCI MED, V37, P1251; Villar J, 2007, BRIT MED J, V335, P1025, DOI 10.1136/bmj.39363.706956.55; Wettstein C, 2012, AIDS, V26, P2361, DOI 10.1097/QAD.0b013e328359ab0c	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144592	10.1371/journal.pone.0144592	http://dx.doi.org/10.1371/journal.pone.0144592			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26657902	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900068
J	Fujita, K; Kuge, K; Ozawa, N; Sahara, S; Zaiki, K; Nakaoji, K; Hamada, K; Takenaka, Y; Tanahashi, T; Tamai, K; Kaneda, Y; Maeda, A				Fujita, Kosuke; Kuge, Katsunori; Ozawa, Noriyasu; Sahara, Shunya; Zaiki, Kaori; Nakaoji, Koichi; Hamada, Kazuhiko; Takenaka, Yukiko; Tanahashi, Takao; Tamai, Katsuto; Kaneda, Yasufumi; Maeda, Akito			Cinnamtannin B-1 Promotes Migration of Mesenchymal Stem Cells and Accelerates Wound Healing in Mice	PLOS ONE			English	Article							BONE-MARROW; STROMAL CELLS; IN-VITRO; REPAIR; SKIN; TRANSDIFFERENTIATION; ANTIOXIDANT; MOUSE	Substances that enhance the migration of mesenchymal stem cells to damaged sites have the potential to improve the effectiveness of tissue repair. We previously found that ethanol extracts of Mallotus philippinensis bark promoted migration of mesenchymal stem cells and improved wound healing in a mouse model. We also demonstrated that bark extracts contain cinnamtannin B-1, a flavonoid with in vitro migratory activity against mesenchymal stem cells. However, the in vivo effects of cinnamtannin B-1 on the migration of mesenchymal stem cells and underlying mechanism of this action remain unknown. Therefore, we examined the effects of cinnamtannin B-1 on in vivo migration of mesenchymal stem cells and wound healing in mice. In addition, we characterized cinnamtannin B-1-induced migration of mesenchymal stem cells pharmacologically and structurally. The mobilization of endogenous mesenchymal stem cells into the blood circulation was enhanced in cinnamtannin B-1-treated mice as shown by flow cytometric analysis of peripheral blood cells. Whole animal imaging analysis using luciferase-expressing mesenchymal stem cells as a tracer revealed that cinnamtannin B-1 increased the homing of mesenchymal stem cells to wounds and accelerated healing in a diabetic mouse model. Additionally, the cinnamtannin B-1-induced migration of mesenchymal stem cells was pharmacologically susceptible to inhibitors of phosphatidylinositol 3-kinase, phospholipase C, lipoxygenase, and purines. Furthermore, biflavonoids with similar structural features to cinnamtannin B-1 also augmented the migration of mesenchymal stem cells by similar pharmacological mechanisms. These results demonstrate that cinnamtannin B-1 promoted mesenchymal stem cell migration in vivo and improved wound healing in mice. Furthermore, the results reveal that cinnamtannin B-1-induced migration of mesenchymal stem cells may be mediated by specific signaling pathways, and the flavonoid skeleton may be relevant to its effects on mesenchymal stem cell migration.	[Fujita, Kosuke; Kuge, Katsunori; Ozawa, Noriyasu; Sahara, Shunya; Zaiki, Kaori; Nakaoji, Koichi; Maeda, Akito] Osaka Univ, UIC, PIAS Collaborat Res, Skin Regenerat, Suita, Osaka 5650871, Japan; [Ozawa, Noriyasu; Sahara, Shunya; Zaiki, Kaori; Nakaoji, Koichi; Hamada, Kazuhiko] PIAS Corp, Div Res & Dev, Kobe, Hyogo 6512241, Japan; [Takenaka, Yukiko; Tanahashi, Takao] Kobe Pharmaceut Univ, Dept Organ Chem, Kobe, Hyogo 6588558, Japan; [Tamai, Katsuto] Osaka Univ, Grad Sch Med, Div Stem Cell Therapy Sci, Suita, Osaka 5650871, Japan; [Kaneda, Yasufumi] Osaka Univ, Grad Sch Med, Div Gene Therapy Sci, Suita, Osaka 5650871, Japan	Osaka University; Kobe Pharmaceutical University; Osaka University; Osaka University	Maeda, A (corresponding author), Osaka Univ, UIC, PIAS Collaborat Res, Skin Regenerat, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	amaeda@uic.osaka-u.ac.jp	Maeda, Akito/AAX-6252-2020	Maeda, Akito/0000-0001-8776-9135	Ministry of Education, Culture, Sports, Science and Technology [23618007]; Osaka University [J119801020]; PIAS Corporation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Osaka University; PIAS Corporation	This work was supported in part by Grants-in-Aid for Scientific Research (C,23618007) from the Ministry of Education, Culture, Sports, Science and Technology, and by Budget for Joint Research at the Osaka University (J119801020). The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. PIAS Corporation provided support in the form of salaries for authors NO, SS, KZ, KN, and KH, but did not have any additional role in the study design, data collection, and analysis, decision to publish, preparation of the manuscript. The specific roles of these authors are described in the author contributions section.	Battula VL, 2010, STEM CELLS, V28, P1435, DOI 10.1002/stem.467; Bicker J, 2009, FITOTERAPIA, V80, P483, DOI 10.1016/j.fitote.2009.08.015; Bouaziz A, 2007, ARCH BIOCHEM BIOPHYS, V457, P235, DOI 10.1016/j.abb.2006.10.020; Cho M, 2014, PHYTOMEDICINE, V21, P560, DOI 10.1016/j.phymed.2013.10.006; Fiorina P, 2011, ENDOCR REV, V32, P725, DOI 10.1210/er.2011-0008; Fiorina P, 2010, CELL TRANSPLANT, V19, P1369, DOI 10.3727/096368910X514288; Fiorina P, 2011, J IMMUNOL, V186, P121, DOI 10.4049/jimmunol.1000799; Fujita R, 2015, STEM CELLS, V33, P962, DOI 10.1002/stem.1900; Furumoto T, 2014, PHYTOMEDICINE, V21, P247, DOI 10.1016/j.phymed.2013.09.003; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; Hong S, 2014, BRIT J DERMATOL, V171, P30, DOI 10.1111/bjd.12899; Houghton PJ, 2005, J ETHNOPHARMACOL, V100, P100, DOI 10.1016/j.jep.2005.07.001; Idowu TO, 2010, PHYTOCHEMISTRY, V71, P2092, DOI 10.1016/j.phytochem.2010.08.018; Iinuma S, 2015, J IMMUNOL, V194, P1996, DOI 10.4049/jimmunol.1400914; Introna Martino, 2015, Curr Opin Organ Transplant, V20, P72, DOI 10.1097/MOT.0000000000000158; Ip CKM, 2011, ONCOGENE, V30, P2420, DOI 10.1038/onc.2010.615; KARANJGAOKAR CG, 1967, TETRAHEDRON LETT, P3195, DOI 10.1016/S0040-4039(01)89897-X; Kharaziha P, 2009, EUR J GASTROEN HEPAT, V21, P1199, DOI 10.1097/MEG.0b013e32832a1f6c; Kim YW, 2012, J GASTROEN HEPATOL, V27, P397, DOI 10.1111/j.1440-1746.2011.06873.x; Li XC, 2002, TETRAHEDRON, V58, P8709, DOI 10.1016/S0040-4020(02)01096-7; Lin MN, 2013, BRAIN RES, V1513, P1, DOI 10.1016/j.brainres.2013.03.035; Lopez JJ, 2008, LIFE SCI, V82, P977, DOI 10.1016/j.lfs.2008.03.009; Marquez-Curtis LA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/561098; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; MURTI VVS, 1967, TETRAHEDRON, V23, P397, DOI 10.1016/S0040-4020(01)83325-1; Bui NT, 2014, PHYTOMEDICINE, V21, P570, DOI 10.1016/j.phymed.2013.10.010; Nishikawa T, 2009, J CELL MOL MED, V13, P535, DOI 10.1111/j.1582-4934.2008.00341.x; Park JS, 2015, METHODS, V84, P3, DOI 10.1016/j.ymeth.2015.03.002; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Schneider N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120538; Sharma J, 2011, ARG PHRMACOLOGYONLIN, V3, P1256; Tamai K, 2011, P NATL ACAD SCI USA, V108, P6609, DOI 10.1073/pnas.1016753108; Tang JM, 2012, J CELL BIOCHEM, V113, P2704, DOI 10.1002/jcb.24148; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; UMEZAWA A, 1992, J CELL PHYSIOL, V151, P197, DOI 10.1002/jcp.1041510125; Wang H, 2008, EUR J PHARMACOL, V599, P24, DOI 10.1016/j.ejphar.2008.09.030; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420	39	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144166	10.1371/journal.pone.0144166	http://dx.doi.org/10.1371/journal.pone.0144166			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657737	gold, Green Published			2022-12-27	WOS:000366903600025
J	Hu, BR; Yue, YQ; Zhu, Y; Wen, W; Zhang, FM; Hardie, JW				Hu, Boran; Yue, Yaqing; Zhu, Yong; Wen, Wen; Zhang, Fengmin; Hardie, Jim W.			Proton Nuclear Magnetic Resonance-Spectroscopic Discrimination of Wines Reflects Genetic Homology of Several Different Grape (V. vinifera L.) Cultivars	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; RED WINES; H-1-NMR; NMR; VARIETIES; PARENTAGE; MERLOT; REGION	Background and Aims Proton nuclear magnetic resonance spectroscopy coupled multivariate analysis (H-1 NMR-PCA/ PLS-DA) is an important tool for the discrimination of wine products. Although H-1 NMR has been shown to discriminate wines of different cultivars, a grape genetic component of the discrimination has been inferred only from discrimination of cultivars of undefined genetic homology and in the presence of many confounding environmental factors. We aimed to confirm the influence of grape genotypes in the absence of those factors. Methods and Results We applied H-1 NMR-PCA/PLS-DA and hierarchical cluster analysis (HCA) to wines from five, variously genetically-related grapevine (V. vinifera) cultivars; all grown similarly on the same site and vinified similarly. We also compared the semi-quantitative profiles of the discriminant metabolites of each cultivar with previously reported chemical analyses. The cultivars were clearly distinguishable and there was a general correlation between their grouping and their genetic homology as revealed by recent genomic studies. Between cultivars, the relative amounts of several of the cultivar-related discriminant metabolites conformed closely with reported chemical analyses. Conclusions Differences in grape-derived metabolites associated with genetic differences alone are a major source of H-1 NMR-based discrimination of wines and H-1 NMR has the capacity to discriminate between very closely related cultivars. Significance of the Study The study confirms that genetic variation among grape cultivars alone can account for the discrimination of wine by H-1 NMR-PCA/PLS and indicates that H-1 NMR spectra of wine of single grape cultivars may in future be used in tandem with hierarchical cluster analysis to elucidate genetic lineages and metabolomic relations of grapevine cultivars. In the absence of genetic information, for example, where predecessor varieties are no longer extant, this may be a particularly useful approach.	[Hu, Boran; Yue, Yaqing] Yangzhou Univ, Coll Food Sci & Engn, Yangzhou 225009, Jiangsu, Peoples R China; [Zhu, Yong; Wen, Wen] Yangzhou Univ, Coll Tourism & Gastron, Yangzhou 225009, Jiangsu, Peoples R China; [Zhang, Fengmin] Yangzhou Univ, Testing Ctr, Yangzhou 225009, Jiangsu, Peoples R China; [Hardie, Jim W.] Northern Melbourne Inst TAFE, Epping, Vic, Australia	Yangzhou University; Yangzhou University; Yangzhou University	Hu, BR (corresponding author), Yangzhou Univ, Coll Food Sci & Engn, Yangzhou 225009, Jiangsu, Peoples R China.	huboran@yzu.edu.cn	Hardie, William J/J-5599-2017	Hardie, William J/0000-0001-9489-9157	National Natural Science Foundation of China 465 [31271857]; Ch teau Sun God, 466 Great Wall Wines, COFCO Group, P.R. China; National Natural Science Foundation of China; National Natural Science Foundation of China [31271857]; Chateau Sun God, Great Wall Wines, COFCO Group, P.R.China	National Natural Science Foundation of China 465; Ch teau Sun God, 466 Great Wall Wines, COFCO Group, P.R. China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chateau Sun God, Great Wall Wines, COFCO Group, P.R.China	The research was supported by the National Natural Science Foundation of China 465 (Project No. 31271857. The authors gratefully acknowledge the support of Ch teau Sun God, 466 Great Wall Wines, COFCO Group, P.R. China. The founding is supported by National Natural Science Foundation of China. Boran Hu received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research was supported by the National Natural Science Foundation of China (Project No.31271857). We gratefully acknowledge the support of Chateau Sun God, Great Wall Wines, COFCO Group, P.R.China, all the wine samples are provided by it. We also thank the comments and suggestions by our anonymous journal reviewers.	Ali K, 2011, J BIOMOL NMR, V49, P255, DOI 10.1007/s10858-011-9487-3; AMERINE M. A., 1958, Vitis, V1, P224; Anastasiadi M, 2009, J AGR FOOD CHEM, V57, P11067, DOI 10.1021/jf902137e; Arozarena I, 2000, J SCI FOOD AGR, V80, P1909, DOI 10.1002/1097-0010(200010)80:13<1909::AID-JSFA728>3.0.CO;2-U; Boursiquot JM, 2009, AUST J GRAPE WINE R, V15, P144, DOI 10.1111/j.1755-0238.2008.00041.x; Bourzeix M., 1983, Progres Agricole et Viticole, V100, P421; Bowers J. E., 2000, Acta Horticulturae, P129; Bowers JE, 1997, NAT GENET, V16, P84, DOI 10.1038/ng0597-84; Brescia MA, 2002, ANAL CHIM ACTA, V458, P177, DOI 10.1016/S0003-2670(01)01532-X; Cliff MA, 2007, FOOD RES INT, V40, P92, DOI 10.1016/j.foodres.2006.08.002; Coulter AD, 2004, AUSTR NZ WINE IND J, V19, P16; Du YY, 2007, CHINESE J CHEM, V25, P930, DOI 10.1002/cjoc.200790181; FRANKEL EN, 1995, J AGR FOOD CHEM, V43, P890, DOI 10.1021/jf00052a008; Hong YS, 2011, MAGN RESON CHEM, V49, pS13, DOI 10.1002/mrc.2832; Hotelling H, 1931, ANN MATH STAT, V2, P360, DOI 10.1214/aoms/1177732979; Imparato G, 2011, J AGR FOOD CHEM, V59, P4429, DOI 10.1021/jf200587n; Jackson R.S., 2000, WINE SCI; Jiang B, 2012, MOLECULES, V17, P8804, DOI 10.3390/molecules17088804; KLIEWER W. M., 1967, AMER J ENOL VITICULT, V18, P42; Kosir IJ, 2002, ANAL CHIM ACTA, V458, P77, DOI 10.1016/S0003-2670(01)01549-5; Lafon-Lafourcade S., 1959, VITIS, V2, P45; Landrault N, 2001, J AGR FOOD CHEM, V49, P3341, DOI 10.1021/jf010128f; Larsen FH, 2006, J CHEMOMETR, V20, P198, DOI 10.1002/cem.991; Lee JE, 2009, J AGR FOOD CHEM, V57, P4810, DOI 10.1021/jf900502a; Olmo H. P., 1948, CALIFORNIA AGRIC EXPT STA BULL, V704, P1; OUGH C S, 1968, Vitis, V7, P321; Papotti G, 2013, J AGR FOOD CHEM, V61, P1741, DOI 10.1021/jf302728b; Pereira GE, 2005, J AGR FOOD CHEM, V53, P6382, DOI 10.1021/jf058058q; Pereira GE, 2007, J INT SCI VIGNE VIN, V41, P103; Robinson J., 2012, WINE GRAPES COMPLETE, P426; Rochfort S, 2010, FOOD CHEM, V121, P1296, DOI 10.1016/j.foodchem.2010.01.067; Son HS, 2008, J AGR FOOD CHEM, V56, P8007, DOI 10.1021/jf801424u; Son HS, 2009, FOOD RES INT, V42, P1483, DOI 10.1016/j.foodres.2009.08.006; Son HS, 2009, J AGR FOOD CHEM, V57, P1481, DOI 10.1021/jf803388w; Viggiani L, 2008, J AGR FOOD CHEM, V56, P8273, DOI 10.1021/jf801513u; Woraratphoka J, 2007, FOOD CHEM, V104, P1485, DOI 10.1016/j.foodchem.2007.02.020	36	14	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0142840	10.1371/journal.pone.0142840	http://dx.doi.org/10.1371/journal.pone.0142840			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658757	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903600007
J	Huijgen, BCH; Leemhuis, S; Kok, NM; Verburgh, L; Oosterlaan, J; Elferink-Gemser, MT; Visscher, C				Huijgen, Barbara C. H.; Leemhuis, Sander; Kok, Niels M.; Verburgh, Lot; Oosterlaan, Jaap; Elferink-Gemser, Marije T.; Visscher, Chris			Cognitive Functions in Elite and Sub-Elite Youth Soccer Players Aged 13 to 17 Years	PLOS ONE			English	Article							EXECUTIVE FUNCTION; SKILL DEVELOPMENT; EXERCISE CHARACTERISTICS; INDIVIDUAL-DIFFERENCES; TALENT DEVELOPMENT; INTELLIGENCE; PERFORMANCE; CREATIVITY; ATTENTION; SPORTS	Soccer players are required to anticipate and react continuously in a changing, relatively unpredictable situation in the field. Cognitive functions might be important to be successful in soccer. The current study investigated the relationship between cognitive functions and performance level in elite and sub-elite youth soccer players aged 13-17 years. A total of 47 elite youth soccer players (mean age 15.5 years, SD = 0.9) and 41 sub-elite youth soccer players (mean age 15.2 years, SD = 1.2) performed tasks for "higher-level" cognitive functions measuring working memory (i.e., Visual Memory Span), inhibitory control (i.e., Stop-Signal Task), cognitive flexibility (i.e., Trail Making Test), and metacognition (i.e., Delis-Kaplan Executive Function System Design Fluency Test). "Lower-level" cognitive processes, i.e., reaction time and visuo-perceptual abilities, were also measured with the previous tasks. ANOVA's showed that elite players outscored sub-elite players at the "higherlevel" cognitive tasks only, especially on metacognition (p<.05). Using stepwise discriminant analysis, 62.5% of subjects was correctly assigned to one of the groups based on their metacognition, inhibitory control and cognitive flexibility performance. Controlling for training hours and academic level, MANCOVA's showed differences in favor of the elite youth soccer players on inhibitory control (p =.001), and cognitive flexibility (p =.042), but not on metacognition (p =.27). No differences were found concerning working memory nor the "lower-level" cognitive processes (p >.05). In conclusion, elite youth soccer players have better inhibitory control, cognitive flexibility, and especially metacognition than their subelite counterparts. However, when training hours are taken into account, differences between elite and sub-elite youth soccer players remain apparent on inhibitory control and cognitive flexibility in contrast to metacognition. This highlights the need for longitudinal studies to further investigate the importance of "higher-level" cognitive functions for talent identification, talent development and performance in soccer.	[Huijgen, Barbara C. H.; Leemhuis, Sander; Elferink-Gemser, Marije T.; Visscher, Chris] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Kok, Niels M.] AZ Alkmaar, Alkmaar, Netherlands; [Verburgh, Lot; Oosterlaan, Jaap] Vrije Univ Amsterdam, Sect Clin Neuropsychol, Amsterdam, Netherlands; [Elferink-Gemser, Marije T.] Univ Appl Sci Nijmegen, Inst Studies Sports & Exercise, HAN, Nijmegen, Netherlands	University of Groningen; Vrije Universiteit Amsterdam	Huijgen, BCH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	b.c.h.huijgen@umcg.nl						Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Alves H, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00036; Best JR, 2009, DEV REV, V29, P180, DOI 10.1016/j.dr.2009.05.002; Burgess DJ, 2010, INT J SPORT PHYSIOL, V5, P103, DOI 10.1123/ijspp.5.1.103; Silva MJCE, 2010, INT J SPORTS MED, V31, P790, DOI 10.1055/s-0030-1263139; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crone EA, 2012, NAT REV NEUROSCI, V13, P636, DOI 10.1038/nrn3313; Crowe SF, 1998, J CLIN PSYCHOL, V54, P585, DOI 10.1002/(SICI)1097-4679(199808)54:5<585::AID-JCLP4>3.3.CO;2-M; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Elferink-Gemser MT, 2011, BRIT J SPORT MED, V45, P683, DOI 10.1136/bjsports-2011-090254; Elferink-Gemser MT, 2010, J SPORT SCI, V28, P521, DOI 10.1080/02640410903582743; Elferink-Gemser MT, 2004, J SPORT SCI, V22, P1053, DOI 10.1080/02640410410001729991; Field A., 2009, DISCOVERING STAT USI, V3, DOI DOI 10.1080/1057610X.2016.1157408; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Furley P. A., 2010, INT REV SPORT EXER P, V3, P171, DOI [10.1080/1750984X.2010.526238, DOI 10.1080/1750984X.2010.526238]; Garon N, 2008, PSYCHOL BULL, V134, P31, DOI 10.1037/0033-2909.134.1.31; Homack S, 2005, J CLIN EXP NEUROPSYC, V27, P599, DOI 10.1080/13803390490918444; Hughes PK, 1993, CLIN EXP OPTOM, V76, P51, DOI DOI 10.1111/J.1444-0938.1993.TB05090.X; Huijgen BCH, 2013, INT J SPORTS MED, V34, P720, DOI 10.1055/s-0032-1323781; Huijgen BCH, 2009, INT J SPORTS MED, V30, P585, DOI 10.1055/s-0029-1202354; Kannekens R, 2011, SCAND J MED SCI SPOR, V21, P846, DOI 10.1111/j.1600-0838.2010.01104.x; Karbach J, 2009, DEVELOPMENTAL SCI, V12, P978, DOI 10.1111/j.1467-7687.2009.00846.x; Kessels RPC, 2008, ASSESSMENT, V15, P426, DOI 10.1177/1073191108315611; Kida N, 2005, COGNITIVE BRAIN RES, V22, P257, DOI 10.1016/j.cogbrainres.2004.09.003; Lehto JE, 2003, BRIT J DEV PSYCHOL, V21, P59, DOI 10.1348/026151003321164627; Logan Gordon D., 1994, P189; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Meinz EJ, 2010, PSYCHOL SCI, V21, P914, DOI 10.1177/0956797610373933; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Memmert D, 2007, J SPORT SCI, V25, P1423, DOI 10.1080/02640410601129755; Memmert D, 2011, J SPORT SCI, V29, P93, DOI 10.1080/02640414.2010.528014; Memmert D, 2010, HIGH ABIL STUD, V21, P3, DOI 10.1080/13598139.2010.488083; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Nakamoto H, 2012, BRAIN COGNITION, V80, P23, DOI 10.1016/j.bandc.2012.04.004; Nisbett RE, 2012, AM PSYCHOL, V67, P130, DOI 10.1037/a0026699; Nutley SB, 2011, DEVELOPMENTAL SCI, V14, P591, DOI 10.1111/j.1467-7687.2010.01022.x; Pesce C, 2001, J PSYCHOPHYSIOL, V15, P256, DOI 10.1027//0269-8803.15.4.256; Pesce C, 2007, J SPORT SCI, V25, P1259, DOI 10.1080/02640410601040085; Pesce C, 2012, J SPORT EXERCISE PSY, V34, P766, DOI 10.1123/jsep.34.6.766; Reilly T, 2000, J SPORT SCI, V18, P695, DOI 10.1080/02640410050120050; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Scheres A, 2004, ARCH CLIN NEUROPSYCH, V19, P569, DOI 10.1016/j.acn.2003.08.005; Sternberg R.J., 1999, HDB CREAT, V1, P3; Strauss E, 2006, COMPENDIUM NEUROPSYC, DOI DOI 10.1212/WNL.41.11.1856-A; Supinski J, 2014, ARCH BUDO, P10; Swanson J, 2005, CAN J SCH PSYCHOL, V20, P117, DOI 10.1177/0829573506295469; Taddei F, 2012, MED SCI SPORT EXER, V44, P1057, DOI 10.1249/MSS.0b013e31824529c2; Thorell LB, 2009, DEVELOPMENTAL SCI, V12, P106, DOI 10.1111/j.1467-7687.2008.00745.x; Tomporowski PD, 2015, J SPORT HEALTH SCI, V4, P47, DOI 10.1016/j.jshs.2014.09.003; Vaeyens R, 2006, BRIT J SPORT MED, V40, P928, DOI 10.1136/bjsm.2006.029652; Verburgh L, 2012, BRIT J SPORT MED, V48, P973; Verburgh L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091254; Vestberg T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034731; Wang CH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055773, 10.1371/journal.pone.0073985]; Ward P, 2003, J SPORT EXERCISE PSY, V25, P93, DOI 10.1123/jsep.25.1.93; Wechsler D, 1987, WMS R WECHSLER MEMOR; Williams AM, 2000, J SPORT SCI, V18, P657, DOI 10.1080/02640410050120041; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; Yuan K., 2006, ED RES REV, V1, P83, DOI [10.1016/j.edurev.2006.08.005, DOI 10.1016/j.edurev.2006.08.005, DOI 10.1016/J.EDUREV.2006.08.005]	59	122	123	6	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144580	10.1371/journal.pone.0144580	http://dx.doi.org/10.1371/journal.pone.0144580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1ZA	26657073	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903600060
J	Dahlui, M; Azahar, N; Bulgiba, A; Zaki, R; Oche, OM; Adekunjo, FO; Chinna, K				Dahlui, Maznah; Azahar, Nazar; Bulgiba, Awang; Zaki, Rafdzah; Oche, Oche Mansur; Adekunjo, Felix Oluyemi; Chinna, Karuthan			HIV/AIDS Related Stigma and Discrimination against PLWHA in Nigerian Population	PLOS ONE			English	Article							HIV-INFECTION; WOMEN; CARE; TRANSMISSION; EXPERIENCES; DISCLOSURE; PEOPLE	Background HIV/AIDS remain a major public health concern in Nigeria. People living with HIV/AIDS (PLWHA) face not only personal medical problems but also social problems associated with the disease such as stigma and discriminatory attitudes. This study provides an insight into HIV/AIDS related stigma and discrimination against PLWHA in Nigeria. Methods The data for this study was extracted from the 2013 Nigeria Demographic and Health Survey conducted by the National Population Commission. All men and women aged 15-49 years, permanent residents and visitors of the households were eligible for the interview. Several questionnaires were used in the survey, some covering questions on HIV/AIDS. Results A total of 56 307 men and women aged 15-49 years participated in this national survey. About half of the population in Nigeria have HIV stigma. Younger persons, men, those without formal education and those within poor wealth index are more likely to have stigma towards PLWHA. In addition, married people are more likely to have stigma on PLWHA and are more likely to blame PLWHA for bringing the disease to the community. Also about half of the population discriminates against PLWHA. However, those with higher levels of education and those from higher wealth index seem to be more compassionate towards PLWHA. About 70% in the population are willing to care for relative with AIDS, even more so among those with higher level of education. Conclusion There is a high level of HIV stigma and discrimination against PLWHA in the Nigerian population. Education seems to play a major role in the society with respect to HIV stigma and discrimination against PLWHA. Educating the population with factual information on HIV/AIDS is needed to reduce stigma and discrimination towards PLWHA in the community.	[Dahlui, Maznah] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Azahar, Nazar] Univ Teknol MARA, Fac Hlth Sci, Dept Med Lab Technol, George Town, Malaysia; [Bulgiba, Awang; Zaki, Rafdzah; Chinna, Karuthan] Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur, Malaysia; [Oche, Oche Mansur] Usmanu Danfodiyo Univ, Dept Community Hlth, Sokoto, Nigeria; [Adekunjo, Felix Oluyemi] Univ Malaya, Fac Econ & Adm, Dept Dev Studies, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Teknologi MARA; Universiti Malaya; Universiti Malaya	Dahlui, M (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia.	maznahd@ummc.edu.my	ZAKI, RAFDZAH AHMAD/B-9520-2010; DAHLUI, MAZNAH/B-8976-2010; Dahlui, Maznah/F-9665-2010; chinna, karuthan/E-4495-2014; Bulgiba, Awang/B-8271-2010; Azahar, Nazar/N-7476-2015; Oche, Oche Mansur/AAU-4935-2021	ZAKI, RAFDZAH AHMAD/0000-0003-2884-5198; DAHLUI, MAZNAH/0000-0003-4923-9410; chinna, karuthan/0000-0002-5449-2341; Bulgiba, Awang/0000-0002-5313-0445; Azahar, Nazar/0000-0002-0412-4268; 	University of Malaya Research Grant UMRG Africa-Asia Development University Network [RP026-2012C]; University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant [E000010-20001]	University of Malaya Research Grant UMRG Africa-Asia Development University Network; University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant	The authors value the collaboration with Usmanu Danfodiyo University, Sokoto, Nigeria in coming up with this manuscript. Obtaining the data and development of this manuscript were supported by the University of Malaya Research Grant UMRG Africa-Asia Development University Network (RP026-2012C) and University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant (E000010-20001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alubo O, 2002, AIDS CARE, V14, P117, DOI 10.1080/09540120220097991; Babalola S, 2007, AIDS BEHAV, V11, P759, DOI 10.1007/s10461-006-9189-0; Bharat S, 2011, SAHARA J-J SOC ASP H, V8, P138, DOI 10.1080/17290376.2011.9724996; Blackstock O, 2005, NEW ENGL J MED, V353, P752, DOI 10.1056/NEJMp058198; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Campbell C, 2007, J HEALTH PSYCHOL, V12, P403, DOI 10.1177/1359105307076229; Cock D, 2014, DAILY HIV AIDS REPOR; Ehiri John E, 2005, AIDS Public Policy J, V20, P25; Ekanem E E, 2004, Afr J Reprod Health, V8, P91, DOI 10.2307/3583183; Etiebet MA, 2004, AIDS CARE, V16, P37, DOI 10.1080/09540120310001633958; Greeff M, 2008, QUAL HEALTH RES, V18, P311, DOI 10.1177/1049732307311118; Holzemer WL, 2009, J ASSOC NURSE AIDS C, V20, P161, DOI 10.1016/j.jana.2009.02.002; Iwelunmor J, 2006, Int Q Community Health Educ, V27, P321, DOI 10.2190/IQ.27.4.d; Kalichman S., 2005, POSITIVE PREVENTION, P1; Lal Panna, 1998, Journal of Communicable Diseases, V30, P38; Link BG, 2006, LANCET, V367, P528, DOI 10.1016/S0140-6736(06)68184-1; Makoae LN, 2008, J ASSOC NURSE AIDS C, V19, P137, DOI 10.1016/j.jana.2007.11.004; Mbonu NC, 2009, J TROP MED-US, V2009, DOI 10.1155/2009/145891; Miller AN, 2007, QUAL HEALTH RES, V17, P586, DOI 10.1177/1049732307301498; Monjok Emmanuel, 2009, Afr J Reprod Health, V13, P21; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20; Nyblade L, 2006, CAN WE MEASURE HIV A; Nyblade L, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-15; Okoror TA, 2008, INT Q COMMUNITY HEAL, V28, P201, DOI 10.2190/IQ.28.3.c; Oyediran K, 2005, 25 INT POP C INT UN; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Parker R, 2007, AIDS RELATED STIGMA; Rankin WW, 2005, PLOS MED, V2, P702, DOI 10.1371/journal.pmed.0020247; Santos ML, 2014, BMC PUBLIC HLTH, V14; Shisana O, 2007, TECHNICAL REPORT; Simbayi LC, 2007, SOC SCI MED, V64, P1823, DOI 10.1016/j.socscimed.2007.01.006; Stangl AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18734; Stewart R, 2002, ADDRESSING HIV AIDS; Thorne C, 2003, CURR HIV RES, V1, P447, DOI 10.2174/1570162033485140; UNAIDS, 2014, FAST TRACT END AIDS; UNAIDS, 2000, HIV AIDS REL STIGM D; Valdiserri RO, 2002, AM J PUBLIC HEALTH, V92, P341, DOI 10.2105/AJPH.92.3.341; Wailoo K, 2006, LANCET, V367, P531, DOI 10.1016/S0140-6736(06)68186-5; Zierler S, 2000, AM J PUBLIC HEALTH, V90, P208, DOI 10.2105/AJPH.90.2.208	39	50	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0143749	10.1371/journal.pone.0143749	http://dx.doi.org/10.1371/journal.pone.0143749			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YZ	26658767	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903500004
J	Haider, S; Rahman, R; Ghosh, S; Pal, R				Haider, Saad; Rahman, Raziur; Ghosh, Souparno; Pal, Ranadip			A Copula Based Approach for Design of Multivariate Random Forests for Drug Sensitivity Prediction	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; CELL LUNG-CANCER; CHEMOSENSITIVITY	Modeling sensitivity to drugs based on genetic characterizations is a significant challenge in the area of systems medicine. Ensemble based approaches such as Random Forests have been shown to perform well in both individual sensitivity prediction studies and team science based prediction challenges. However, Random Forests generate a deterministic predictive model for each drug based on the genetic characterization of the cell lines and ignores the relationship between different drug sensitivities during model generation. This application motivates the need for generation of multivariate ensemble learning techniques that can increase prediction accuracy and improve variable importance ranking by incorporating the relationships between different output responses. In this article, we propose a novel cost criterion that captures the dissimilarity in the output response structure between the training data and node samples as the difference in the two empirical copulas. We illustrate that copulas are suitable for capturing the multivariate structure of output responses independent of the marginal distributions and the copula based multivariate random forest framework can provide higher accuracy prediction and improved variable selection. The proposed framework has been validated on genomics of drug sensitivity for cancer and cancer cell line encyclopedia database.	[Haider, Saad; Rahman, Raziur; Pal, Ranadip] Texas Tech Univ, Dept Elect & Comp Engn, Lubbock, TX 79409 USA; [Ghosh, Souparno] Texas Tech Univ, Dept Math & Stat, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University	Pal, R (corresponding author), Texas Tech Univ, Dept Elect & Comp Engn, Lubbock, TX 79409 USA.	ranadip.pal@ttu.edu	Pal, Ranadip/F-3905-2012	Pal, Ranadip/0000-0002-9311-5901	National Science Foundation [CCF 0953366]; Direct For Computer & Info Scie & Enginr [0953366] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by National Science Foundation Grant CCF 0953366. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer KJ, 2008, COMPUT STAT DATA AN, V52, P2249, DOI 10.1016/j.csda.2007.08.015; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Biau G, 2012, J MACH LEARN RES, V13, P1063; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Broad-Novartis Cancer Cell Line Encyclopedia, GEN PHARM CHAR LARG; Ciuffreda L, 2009, NEOPLASIA, V11, P720, DOI 10.1593/neo.09398; CLAYTON DG, 1978, BIOMETRIKA, V65, P141, DOI 10.2307/2335289; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; Demarta S, 2005, INT STAT REV, V73, P111, DOI 10.1111/j.1751-5823.2005.tb00254.x; Falchook GS, 2012, LANCET ONCOL, V13, P782, DOI 10.1016/S1470-2045(12)70269-3; Frank M.J., 1979, AEQUATIONES MATH, V19, P194, DOI DOI 10.1007/BF02189866; Gonen M, 2014, BIOINFORMATICS, V30, pI556, DOI 10.1093/bioinformatics/btu464; Gumbel EJ, 1960, PUBL I STAT U PARIS, V9, P171; Johnston SRD, 2006, DRUG TODAY, V42, P441, DOI 10.1358/dot.2006.42.7.985637; Kouros Owzar PKS, 2003, METRON, VLXI, P323; Larsen AB, 2010, CELL SIGNAL, V22, P636, DOI 10.1016/j.cellsig.2009.11.018; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; LEE LF, 1983, ECONOMETRICA, V51, P507, DOI 10.2307/1912003; Ling YH, 2007, MOL PHARMACOL, V72, P248, DOI 10.1124/mol.107.034827; Ma PC, 2005, CLIN CANCER RES, V11, P2312, DOI 10.1158/1078-0432.CCR-04-1708; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Meinshausen N, 2006, J MACH LEARN RES, V7, P983; Menden MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061318; Mitsos A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000591; Morabito A, 2009, ONCOLOGIST, V14, P378, DOI 10.1634/theoncologist.2008-0261; Riddick G, 2011, BIOINFORMATICS, V27, P220, DOI 10.1093/bioinformatics/btq628; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Segal M, 2011, WIRES DATA MIN KNOWL, V1, P80, DOI 10.1002/widm.12; Sim K. C., 2004, PRECISION MATRIX MOD; Sklar A., 1959, PUBL I STAT U PARIS, V8, P229, DOI DOI 10.1007/978-3-642-33590-7; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Tanizaki J, 2011, J THORAC ONCOL, V6, P1624, DOI 10.1097/JTO.0b013e31822591e9; Walther Z, 2011, CANCER J, V17, P71, DOI 10.1097/PPO.0b013e318212dd6d; Wan Q, 2013, IEEE INT WORK GENOM, P53, DOI 10.1109/GENSIPS.2013.6735929; Wan Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101183; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	38	27	27	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144490	10.1371/journal.pone.0144490	http://dx.doi.org/10.1371/journal.pone.0144490			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658256	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903500031
J	Mayati, A; Bruyere, A; Moreau, A; Jouan, E; Denizot, C; Parmentier, Y; Fardel, O				Mayati, Abdullah; Bruyere, Arnaud; Moreau, Amelie; Jouan, Elodie; Denizot, Claire; Parmentier, Yannick; Fardel, Olivier			Protein Kinase C-Independent Inhibition of Organic Cation Transporter 1 Activity by the Bisindolylmaleimide Ro 31-8220	PLOS ONE			English	Article							N-TERMINAL KINASE; GF 109203X; MULTIDRUG-RESISTANCE; SELECTIVE INHIBITORS; POTENT INHIBITORS; GLYCOGEN-SYNTHASE; DRUG-INTERACTIONS; RAT ADIPOCYTES; S6 KINASE; CELL-LINE	Ro 31-8220 is a potent protein kinase C (PKC) inhibitor belonging to the chemical class of bisindolylmaleimides (BIMs). Various PKC-independent effects of Ro 31-8220 have however been demonstrated, including inhibition of the ATP-binding cassette drug transporter breast cancer resistance protein. In the present study, we reported that the BIM also blocks activity of the solute carrier organic cation transporter (OCT) 1, involved in uptake of marketed drugs in the liver, in a PKC-independent manner. Ro 31-8220, in contrast to other pan-PKC inhibitors such as staurosporine and chelerythrine, was thus shown to cis-inhibit uptake of the reference OCT1 substrate tetraethylammonium in OCT1-transfected HEK293 cells in a concentration-dependent manner (IC50 = 0.18 mu M) and without altering membrane expression of OCT1. This blockage of OCT1 was also observed in human hepatic HepaRG cells that constitutionally express OCT1. It likely occurred through a mixed mechanism of inhibition. Ro 31-8220 additionally trans-inhibited TEA uptake in OCT1-transfected HEK293 cells, which likely discards a transport of Ro 31-8220 by OCT1. Besides Ro 318220, 7 additional BIMs, including the PKC inhibitor LY 333531, inhibited OCT1 activity, whereas 4 other BIMs were without effect. In silico analysis of structure-activity relationships next revealed that various molecular descriptors, especially 3D-WHIM descriptors related to total size, correspond to key physico-chemical parameters for inhibition of OCT1 activity by BIMs. In addition to activity of OCT1, Ro 31-8220 inhibited those of other organic cation transporters such as multidrug and toxin extrusion protein (MATE) 1 and MATE2-K, whereas, by contrast, it stimulated that of OCT2. Taken together, these data extend the nature of cellular off-targets of the BIM Ro 31-8220 to OCT1 and other organic cation transporters, which has likely to be kept in mind when using Ro 31-8220 and other BIMs as PKC inhibitors in experimental or clinical studies.	[Mayati, Abdullah; Bruyere, Arnaud; Jouan, Elodie; Fardel, Olivier] IRSET, UMR INSERM U1085, Fac Pharm, F-35043 Rennes, France; [Moreau, Amelie; Denizot, Claire; Parmentier, Yannick] Technol Servier, Ctr Pharmacocinet, F-45000 Orleans, France; [Fardel, Olivier] Ctr Hosp Univ, Pole Biol, F-35033 Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Servier; CHU Rennes	Fardel, O (corresponding author), IRSET, UMR INSERM U1085, Fac Pharm, 2 Ave Pr Leon Bernard, F-35043 Rennes, France.	olivier.fardel@univ-rennes1.fr	Bruyere, Arnaud/J-8577-2015; Fardel, Olivier/J-8560-2015; Sharma, Ashwani/AAK-3879-2020	Bruyere, Arnaud/0000-0003-1158-1413; Sharma, Ashwani/0000-0001-9835-1973; Moreau, Amelie/0000-0002-7485-2332				Alessi DR, 1997, FEBS LETT, V402, P121, DOI 10.1016/S0014-5793(96)01510-4; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bansal D, 2013, DIABETES METAB J, V37, P375, DOI 10.4093/dmj.2013.37.5.375; Bayer M, 2009, NUCL MED BIOL, V36, P287, DOI 10.1016/j.nucmedbio.2008.12.010; Begemann M, 1998, ANTICANCER RES, V18, P3139; Beltman J, 1996, J BIOL CHEM, V271, P27018, DOI 10.1074/jbc.271.43.27018; Bosco R, 2011, MINI-REV MED CHEM, V11, P185, DOI 10.2174/138955711795049899; Bucher S, 2014, J BIOCHEM MOL TOXIC, V28, P119, DOI 10.1002/jbt.21543; Camenisch G, 1998, EUR J PHARM SCI, V6, P313, DOI 10.1016/S0928-0987(97)10019-7; Chen LG, 2014, P NATL ACAD SCI USA, V111, P9983, DOI 10.1073/pnas.1314939111; Ciarimboli G, 2005, J AM SOC NEPHROL, V16, P1562, DOI 10.1681/ASN.2004040256; Ciarimboli G, 2004, J CELL PHYSIOL, V201, P420, DOI 10.1002/jcp.20081; Cuenda A, 2000, METH MOL B, V99, P161; DAVIS PD, 1989, FEBS LETT, V259, P61, DOI 10.1016/0014-5793(89)81494-2; DAVIS PD, 1992, J MED CHEM, V35, P994, DOI 10.1021/jm00084a004; Ezeamuzie CI, 2004, BRIT J PHARMACOL, V143, P725, DOI 10.1038/sj.bjp.0706028; GEKELER V, 1995, BIOCHEM BIOPH RES CO, V206, P119, DOI 10.1006/bbrc.1995.1017; Gekeler V, 1996, BRIT J CANCER, V74, P897, DOI 10.1038/bjc.1996.454; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Han Z, 2000, CELL DEATH DIFFER, V7, P521, DOI 10.1038/sj.cdd.4400681; Herbert TP, 2002, J BIOL CHEM, V277, P11591, DOI 10.1074/jbc.M110367200; Hers I, 1999, FEBS LETT, V460, P433, DOI 10.1016/S0014-5793(99)01389-7; Jouan E, 2014, FUND CLIN PHARMACOL, V28, P65, DOI 10.1111/j.1472-8206.2012.01071.x; Karlgren M, 2012, J MED CHEM, V55, P4740, DOI 10.1021/jm300212s; Koepsell H, 2011, BIOL CHEM, V392, P95, DOI 10.1515/BC.2011.009; Kotani N, 2012, MOL PHARMACEUT, V9, P3434, DOI 10.1021/mp300171p; Le Vee M, 2006, EUR J PHARM SCI, V28, P109, DOI 10.1016/j.ejps.2006.01.004; Le Vee M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121232; Lecureur V, 2005, FEBS LETT, V579, P1904, DOI 10.1016/j.febslet.2005.01.081; LIMATOLA C, 1994, BIOCHEM J, V304, P1001, DOI 10.1042/bj3041001; Lingameneni R, 2000, FEBS LETT, V473, P265, DOI 10.1016/S0014-5793(00)01532-5; Galvez MIL, 2009, CURR DIABETES REV, V5, P14, DOI 10.2174/157339909787314167; Loweth JA, 2009, NEUROSCI LETT, V455, P88, DOI 10.1016/j.neulet.2009.03.012; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Mwanjewe J, 2001, BIOCHEM J, V359, P211, DOI 10.1042/0264-6021:3590211; Nies AT, 2011, HANDB EXP PHARMACOL, V201, P105, DOI 10.1007/978-3-642-14541-4_3; Numazawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC334, DOI 10.1152/ajpcell.00043.2003; Pedersen JM, 2008, J MED CHEM, V51, P3275, DOI 10.1021/jm7015683; Pietig G, 2001, J BIOL CHEM, V276, P33741, DOI 10.1074/jbc.M104617200; Roberts NA, 2005, BRIT J PHARMACOL, V145, P477, DOI 10.1038/sj.bjp.0706210; Robey RW, 2007, MOL CANCER THER, V6, P1877, DOI 10.1158/1535-7163.MCT-06-0811; Roth M, 2011, J PHARMACOL EXP THER, V339, P624, DOI 10.1124/jpet.111.184564; Schonhoff CM, 2013, HEPATOLOGY, V58, P284, DOI 10.1002/hep.26333; Standaert ML, 1999, ENDOCRINOLOGY, V140, P2145, DOI 10.1210/en.140.5.2145; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Stross C, 2010, AM J PHYSIOL-GASTR L, V299, pG320, DOI 10.1152/ajpgi.00180.2010; Todeschini R, 1997, SAR QSAR Environ Res, V7, P173, DOI 10.1080/10629369708039130; Tomas-Zuber M, 2000, J BIOL CHEM, V275, P23549, DOI 10.1074/jbc.M002586200; Wang QD, 2006, INT J CANCER, V118, P326, DOI 10.1002/ijc.21373; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; Wittwer MB, 2013, J MED CHEM, V56, P781, DOI 10.1021/jm301302s; Yasujima T, 2011, J PHARM SCI-US, V100, P4006, DOI 10.1002/jps.22548; Yeo EJ, 1997, BBA-MOL CELL RES, V1356, P308, DOI 10.1016/S0167-4889(97)00006-2; Yuan JZ, 2002, BIOCHEM BIOPH RES CO, V291, P444, DOI 10.1006/bbrc.2002.6469; Zelcer N, 2003, J BIOL CHEM, V278, P23538, DOI 10.1074/jbc.M303504200; Zhang L, 1999, J PHARMACOL EXP THER, V288, P1192	57	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144667	10.1371/journal.pone.0144667	http://dx.doi.org/10.1371/journal.pone.0144667			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657401	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903500053
J	Guaraldi, G; Raggi, P; Gomes, A; Zona, S; Marchi, E; Santoro, A; Besutti, G; Scaglioni, R; Ligabue, G; Leipsic, J; Man, P; Sin, D				Guaraldi, Giovanni; Raggi, Paolo; Gomes, Andre; Zona, Stefano; Marchi, Enrico; Santoro, Antonella; Besutti, Giulia; Scaglioni, Riccardo; Ligabue, Guido; Leipsic, Jonathon; Man, Paul; Sin, Don			Lung and Heart Diseases Are Better Predicted by Pack-Years than by Smoking Status or Duration of Smoking Cessation in HIV Patients	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; CANCER; RISK; AGE	Background The objective of this study was to assess the relationship of pack-years smoking and time since smoking cessation with risk of lung and heart disease. Methods We investigated the history of lung and heart disease in 903 HIV-infected patients who had undergone thoracic computed tomography (CT) imaging stratified by smoking history. Multimorbidity lung and heart disease (MLHD) was defined as the presence of >= 2 clinical or subclinical lung abnormalities and at least one heart abnormality. Results Among 903 patients, 23.7% had never smoked, 28.7% were former smokers and 47.6% were current smokers. Spirometry indicated chronic obstructive pulmonary disease in 11.4% of patients and MLHD was present in 53.6%. Age, male sex, greater pack-years smoking history and smoking cessation less than 5 years earlier vs. more than 10 years earlier (OR 2.59, 95% CI 1.27-5.29, p = 0.009) were independently associated with CT detected subclinical lung and heart disease. Pack-years smoking history was more strongly associated with MLHD than smoking status (p<0.001). Conclusions MLHD is common even among HIV-infected patients who never smoked and pack-years smoking history is a stronger predictor than current smoking status of MLHD. A detailed pack-years smoking history should be routinely obtained and smoking cessation strategies implemented.	[Guaraldi, Giovanni; Zona, Stefano; Marchi, Enrico; Santoro, Antonella] UNIMORE, Modena HIV Metab Clin, Modena, Italy; [Raggi, Paolo] Univ Alberta, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada; [Gomes, Andre] Hosp Garcia de Orta, Dept Infect Dis, Almada, Portugal; [Besutti, Giulia; Scaglioni, Riccardo; Ligabue, Guido] UNIMORE, Radiol Unit, Modena, Italy; [Leipsic, Jonathon] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada; [Man, Paul; Sin, Don] Univ British Columbia, Dept Med, Div Resp, Vancouver, BC, Canada	University of Alberta; Hospital Garcia de Orta; University of British Columbia; University of British Columbia	Guaraldi, G (corresponding author), UNIMORE, Modena HIV Metab Clin, Modena, Italy.	giovanni.guaraldi@unimore.it	Sin, Don/AAC-2219-2021; Leipsic, Jonathon/ABE-6194-2020; Guaraldi, Giovanni/J-9467-2018; Besutti, Giulia/K-5453-2018	Besutti, Giulia/0000-0001-5319-5495; Guaraldi, Giovanni/0000-0002-5724-3914; Santoro, Antonella/0000-0002-2345-9135; Zona, Stefano/0000-0003-3451-2744	RICERCA FINALIZZATA, Ministry of Health [GR-2011-0230596]	RICERCA FINALIZZATA, Ministry of Health	The research was supported by RICERCA FINALIZZATA 2011-2012, Ministry of Health, project code: GR-2011-0230596. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Althoff KN, 2015, CLIN INFECT DIS, V60, P627, DOI 10.1093/cid/ciu869; [Anonymous], 1991, MMWR Recomm Rep, V40, P1; BEAGLEHOLE R, 1987, INT J EPIDEMIOL, V16, P373, DOI 10.1093/ije/16.3.373; Calvo M, 2015, AIDS REV, V17, P47; George MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006328; Gingo MR, 2010, AM J RESP CRIT CARE, V182, P790, DOI 10.1164/rccm.200912-1858OC; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guaraldi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109027; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hemkens LG, 2014, EUR HEART J, V35, P1373, DOI 10.1093/eurheartj/eht528; Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383; KAWACHI I, 1994, ARCH INTERN MED, V154, P169, DOI 10.1001/archinte.154.2.169; Kazerooni EA, 1997, AM J ROENTGENOL, V169, P977, DOI 10.2214/ajr.169.4.9308447; Leffondre K, 2002, AM J EPIDEMIOL, V156, P813, DOI 10.1093/aje/kwf122; Lichtenstein KA, 2001, AIDS, V15, P1389, DOI 10.1097/00002030-200107270-00008; Mdodo R, 2015, ANN INTERN MED, V162, P335, DOI 10.7326/M14-0954; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Petoumenos K, 2011, HIV MED, V12, P412, DOI 10.1111/j.1468-1293.2010.00901.x; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Tynan Michael A., 2012, Morbidity and Mortality Weekly Report, V61, P565; Winston TA, 2013, CHEST, V143, P305, DOI 10.1378/chest.12-1699	23	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143700	10.1371/journal.pone.0143700	http://dx.doi.org/10.1371/journal.pone.0143700			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650682	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903300022
J	Caz, V; Elvira, M; Tabernero, M; Grande, AG; Lopez-Plaza, B; de Miguel, E; Largo, C; Santamaria, M				Caz, Victor; Elvira, Marcos; Tabernero, Maria; Grande, Antonio G.; Lopez-Plaza, Bricia; de Miguel, Enrique; Largo, Carlota; Santamaria, Monica			Growth Hormone Protects the Intestine Preserving Radiotherapy Efficacy on Tumors: A Short-Term Study	PLOS ONE			English	Article							ADULT HYPOPITUITARY PATIENTS; HUMAN MAMMARY-CARCINOMA; IN-VITRO; GENE-EXPRESSION; PRIMARY CANCERS; TREFOIL FACTOR; NUDE-MICE; RADIATION; CELLS; RAT	The efficacy of radiotherapy on tumors is hampered by its devastating adverse effects on healthy tissue, particularly that of the gastrointestinal tract. These effects cause acute symptoms that are so disruptive to patients that they can lead to interruption of the radiotherapy program. These adverse effects could limit the intensity of radiation received by the patient, resulting in a sublethal dose to the tumor, thus increasing the risk of tumor resistance. The lack of an effective treatment to protect the bowel during radiation therapy to allow higher radiation doses that are lethal to the tumor has become a barrier to implementing effective therapy. In this study, we present a comparative analysis of both intestinal and tumor tissue in regard to the efficacy and the preventive impact of a short-term growth hormone (GH) treatment in tumor-bearing rats as a protective agent during radiotherapy. Our data show that the exogenous administration of GH improved intestinal recovery after radiation treatment while preserving the therapeutic effect against the tumor. GH significantly increased proliferation in the irradiated intestine but not in the irradiated tumors, as assessed by Positron Emission Tomography and the proliferative markers Ki67, cyclin D3, and Proliferating Cell Nuclear Antigen. This proliferative effect was consistent with a significant increase in irradiated intestinal villi and crypt length. Furthermore, GH significantly decreased caspase-3 activity in the intestine, whereas GH did not produce this effect in the irradiated tumors. In conclusion, short-term GH treatment protects the bowel, inducing proliferation while reducing apoptosis in healthy intestinal tissue and preserving radiotherapy efficacy on tumors.	[Caz, Victor; Elvira, Marcos; Tabernero, Maria; de Miguel, Enrique; Largo, Carlota; Santamaria, Monica] Hosp La Paz, Res Inst, Dept Expt Surg, Madrid, Spain; [Grande, Antonio G.] La Paz Univ Hosp, Dept Radiat Oncol, Madrid, Spain; [Lopez-Plaza, Bricia] Hosp La Paz, Res Inst, Dept Nutr, Madrid, Spain	Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz	Largo, C (corresponding author), Hosp La Paz, Res Inst, Dept Expt Surg, Madrid, Spain.	carlota.largo@salud.madrid.org; monica.santamaria@idipaz.es	Doadrio, Ignacio/F-8448-2016	Doadrio, Ignacio/0000-0003-4863-9711; Largo, Carlota/0000-0003-3306-7925	Instituto de Salud Carlos III-Fondos Feder [FIS PI13/01990]; Instituto de Salud Carlos III, I3SNS [CES10/011]	Instituto de Salud Carlos III-Fondos Feder; Instituto de Salud Carlos III, I3SNS	This work was supported by Instituto de Salud Carlos III-Fondos Feder grant FIS PI13/01990 to MS. This work was also supported by a contract (CES10/011) from the Instituto de Salud Carlos III, I3SNS to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck PL, 2004, GASTROENTEROLOGY, V126, P796, DOI 10.1053/j.gastro.2003.12.004; Bennett WL, 2007, MOL CELL ENDOCRINOL, V274, P53, DOI 10.1016/j.mce.2007.05.020; Booth D, 2001, J Natl Cancer Inst Monogr, P16; Carel JC, 2012, J CLIN ENDOCR METAB, V97, P416, DOI 10.1210/jc.2011-1995; Carlo-Stella C, 2004, EXP HEMATOL, V32, P171, DOI 10.1016/j.exphem.2003.11.007; Chen BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011056; Chen JY, 2004, WORLD J GASTROENTERO, V10, P1132; Child CJ, 2015, EUR J ENDOCRINOL, V172, P779, DOI 10.1530/EJE-14-1123; Child CJ, 2011, EUR J ENDOCRINOL, V165, P217, DOI 10.1530/EJE-11-0286; Clavijo J, 2004, EUR J GASTROEN HEPAT, V16, P75, DOI 10.1097/00042737-200401000-00012; Costoya Jose A., 2000, Molecular Cell Biology Research Communications, V4, P26, DOI 10.1006/mcbr.2000.0252; Liang DM, 2006, WORLD J GASTROENTERO, V12, P3810, DOI 10.3748/wjg.v12.i24.3810; de Segura IAG, 2004, EUR J GASTROEN HEPAT, V16, P479, DOI [10.1097/00042737-200405000-00008, 10.1097/01.meg.0000108302.52416.c4]; Denham JW, 2013, LANCET, V382, P2046, DOI 10.1016/S0140-6736(13)61946-7; DeSegura IAG, 1996, J SURG RES, V62, P5, DOI 10.1006/jsre.1996.0164; Devesa J, 2010, MED CLIN-BARCELONA, V135, P665, DOI 10.1016/j.medcli.2009.10.017; Devin JK, 2008, GROWTH HORM IGF RES, V18, P253, DOI 10.1016/j.ghir.2007.11.001; FDA Drug Safety Communication, 2011, ONG SAF REV REC HUM; Fiebig HH, 2000, ANTI-CANCER DRUG, V11, P659, DOI 10.1097/00001813-200009000-00011; Glynn N, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/972617; de Segura IAG, 2010, EXP BIOL MED, V235, P463, DOI 10.1258/ebm.2009.009247; Gomez-De-Segura IA, 1998, ACTA ONCOL, V37, P179, DOI 10.1080/028418698429748; Gonzalez-Rodriguez A, 2007, J CELL PHYSIOL, V212, P76, DOI 10.1002/jcp.21004; Harb Ali H, 2014, Curr Gastroenterol Rep, V16, P383, DOI 10.1007/s11894-014-0383-3; Ibrahim YH, 2004, GROWTH HORM IGF RES, V14, P261, DOI 10.1016/j.ghir.2004.01.005; ICHIYA Y, 1991, J NUCL MED, V32, P1655; Jeay S, 2002, MOL CELL ENDOCRINOL, V188, P1, DOI 10.1016/S0303-7207(02)00014-X; Jiang J, 2011, ENDOCRINOLOGY, V152, P4777, DOI 10.1210/en.2011-1336; Kawaguchi M, 2015, CANCER SCI, V106, P1130, DOI 10.1111/cas.12725; Lee CL, 2013, TRANSL CANCER RES, V2, P412, DOI 10.3978/j.issn.2218-676X.2013.09.01; Liang D, 2014, CHIN MED, V5, P259; Liang H, 2007, WORLD J GASTROENTERO, V13, P4365, DOI 10.3748/wjg.v13.i32.4365; LOBIE PE, 1990, ENDOCRINOLOGY, V126, P299, DOI 10.1210/endo-126-1-299; Louis E, 2007, J NUCL MED, V48, P1053, DOI 10.2967/jnumed.107.040436; Morante J, 2003, DIGEST DIS SCI, V48, P2159, DOI 10.1023/B:DDAS.0000004520.71462.c9; Ning SC, 1998, INT J RADIAT ONCOL, V40, P177, DOI 10.1016/S0360-3016(97)00561-0; Ortega M, 2001, ACTA ONCOL, V40, P615, DOI 10.1080/028418601750444169; Perry JK, 2006, GROWTH HORM IGF RES, V16, P277, DOI 10.1016/j.ghir.2006.09.006; Posadas SJ, 2011, EXP BIOL MED, V236, P205, DOI 10.1258/ebm.2010.009358; POTTEN CS, 1995, GUT, V36, P864, DOI 10.1136/gut.36.6.864; POTTEN CS, 1990, INT J RADIAT BIOL, V58, P925, DOI 10.1080/09553009014552281; POTTEN CS, 1990, INT J RADIAT BIOL, V57, P185, DOI 10.1080/09553009014550431; Potten CS, 1997, COMP BIOCHEM PHYS B, V118, P473, DOI 10.1016/S0305-0491(97)00219-8; Raguso CA, 2002, CLIN NUTR, V21, P487, DOI 10.1054/clnu.2002.0579; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Santamaria M, 2013, GASTROENTEROLOGY, V144, P818, DOI 10.1053/j.gastro.2012.12.029; Shadad AK, 2013, WORLD J GASTROENTERO, V19, P199, DOI 10.3748/wjg.v19.i2.199; Shen L, 2015, NEUROL SCI, V36, P1859, DOI 10.1007/s10072-015-2269-z; Sklar CA, 2002, J CLIN ENDOCR METAB, V87, P3136, DOI 10.1210/jc.87.7.3136; Stacey R, 2014, THER ADV CHRONIC DIS, V5, P15, DOI 10.1177/2040622313510730; Tekin SB, 2006, J EUR ACAD DERMATOL, V20, P293, DOI 10.1111/j.1468-3083.2006.01454.x; TOROSIAN MH, 1993, J PEDIATR ENDOCRINOL, V6, P93; Trobec K, 2011, J CACHEXIA SARCOPENI, V2, P191, DOI 10.1007/s13539-011-0043-5; Vazquez I, 1999, DIGEST DIS SCI, V44, P2350, DOI 10.1023/A:1026637611298; Wang ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118213; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Wilton P, 2010, J PEDIATR-US, V157, P265, DOI 10.1016/j.jpeds.2010.02.028; WOLF RF, 1994, ANN SURG ONCOL, V1, P314, DOI 10.1007/BF02303570; Xu XQ, 2005, J BIOL CHEM, V280, P23987, DOI 10.1074/jbc.M503869200; Yu J, 2013, TRANSL CANCER RES, V2, P384, DOI 10.3978/j.issn.2218-676X.2013.07.03; Zhu T, 2005, CANCER RES, V65, P317; Zhu Z, 2005, ONCOGENE, V24, P3774, DOI 10.1038/sj.onc.1208541	62	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144537	10.1371/journal.pone.0144537	http://dx.doi.org/10.1371/journal.pone.0144537			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670463	gold, Green Published, Green Submitted			2022-12-27	WOS:000366719300011
J	Kolyadko, VN; Lushchekina, SV; Vuimo, TA; Surov, SS; Ovsepyan, RA; Korneeva, VA; Vorobiev, II; Orlova, NA; Minakhin, L; Kuznedelov, K; Severinov, KV; Ataullakhanov, FI; Panteleev, MA				Kolyadko, Vladimir N.; Lushchekina, Sofya V.; Vuimo, Tatiana A.; Surov, Stepan S.; Ovsepyan, Ruzanna A.; Korneeva, Vera A.; Vorobiev, Ivan I.; Orlova, Nadezhda A.; Minakhin, Leonid; Kuznedelov, Konstantin; Severinov, Konstantin V.; Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.			New Infestin-4 Mutants with Increased Selectivity against Factor XIIa	PLOS ONE			English	Article							SERINE PROTEINASE-INHIBITORS; COAGULATION-FACTOR-XII; THROMBIN GENERATION; TRYPSIN-INHIBITOR; IN-VITRO; MOLECULAR-DYNAMICS; BLOOD-COAGULATION; ACTIVE-SITE; WEB SERVER; CORN	Factor XIIa (fXIIa) is a serine protease that triggers the coagulation contact pathway and plays a role in thrombosis. Because it interferes with coagulation testing, the need to inhibit fXIIa exists in many cases. Infestin-4 (Inf4) is a Kazal-type inhibitor of fXIIa. Its specificity for fXIIa can be enhanced by point mutations in the protease-binding loop. We attempted to adapt Inf4 for the selective repression of the contact pathway under various in vitro conditions, e.g., during blood collection and in 'global' assays of tissue factor (TF)-dependent coagulation. First, we designed a set of new Inf4 mutants that, in contrast to wt-Inf4, had stabilized canonical conformations during molecular dynamics simulation. Off-target activities against factor Xa (fXa), plasmin, and other coagulation proteases were either reduced or eliminated in these recombinant mutants, as demonstrated by chromogenic assays. Interactions with fXIIa and fXa were also analyzed using protein-protein docking. Next, Mutant B, one of the most potent mutants (its Ki for fXIIa is 0.7 nM) was tested in plasma. At concentrations 5-20 mu M, this mutant delayed the contact-activated generation of thrombin, as well as clotting in thromboelastography and thrombodynamics assays. In these assays, Mutant B did not affect coagulation initiated by TF, thus demonstrating sufficient selectivity and its potential practical significance as a reagent for coagulation diagnostics.	[Kolyadko, Vladimir N.; Surov, Stepan S.; Korneeva, Vera A.; Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] Russian Acad Sci, Ctr Theoret Problems Physicochem Pharmacol, Moscow, Russia; [Lushchekina, Sofya V.] Russian Acad Sci, Emanuel Inst Biochem Phys, Moscow, Russia; [Vuimo, Tatiana A.; Ovsepyan, Ruzanna A.; Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] Minist Hlth, Fed Res & Clin Ctr Pediat Hematol Oncol & Immunol, Moscow, Russia; [Vorobiev, Ivan I.; Orlova, Nadezhda A.] Russian Acad Sci, Ctr Bioengn, Moscow, Russia; [Minakhin, Leonid; Kuznedelov, Konstantin; Severinov, Konstantin V.] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ USA; [Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] Moscow MV Lomonosov State Univ, Dept Phys, Moscow, Russia; [Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] Moscow Inst Phys & Technol, Fac Biol & Med Phys, Dolgoprudnyi, Russia; [Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] HemaCore LLC, Moscow, Russia	Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences; Russian Academy of Sciences; Russian Academy of Sciences; Emanuel Institute of Biochemical Physics; Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology & Immunology; Ministry of Health of the Russian Federation; Research Center of Biotechnology RAS; Russian Academy of Sciences; Rutgers State University New Brunswick; Lomonosov Moscow State University; Moscow Institute of Physics & Technology	Panteleev, MA (corresponding author), Russian Acad Sci, Ctr Theoret Problems Physicochem Pharmacol, Moscow, Russia.	mapanteleev@yandex.ru	Severinov, Konstantin/C-8545-2016; Orlova, Nadezhda/AAE-8279-2020; Panteleev, Mikhail A/H-5491-2012; Lushchekina, Sofya/F-8469-2010; Ataullakhanov, Fazoil/J-8076-2012; Ataullakhanov, Fazoil/O-3458-2019; Vorobiev, Ivan/ABF-6809-2021; Zhivotova, Vera/E-4766-2014	Orlova, Nadezhda/0000-0001-9483-2892; Panteleev, Mikhail A/0000-0002-8128-7757; Lushchekina, Sofya/0000-0002-6922-020X; Vorobiev, Ivan/0000-0003-0064-4458; Zhivotova, Vera/0000-0003-2937-1190; Kolyadko, Vladimir/0000-0003-4008-2461	Russian Science Foundation [14-14-00195]; Dynasty Foundation Fellowship; HemaCore LLC	Russian Science Foundation(Russian Science Foundation (RSF)); Dynasty Foundation Fellowship; HemaCore LLC	The project was supported by Russian Science Foundation grant 14-14-00195 to MAP, with the exception of all molecular dynamics and docking studies that were supported by Dynasty Foundation Fellowship to SVL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HemaCore LLC provided support in the form of salaries for authors VNK, TAV, SSS, RAO, VAK, FIA, MAP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Apostoluk W, 1998, PROTEINS, V32, P459, DOI 10.1002/(SICI)1097-0134(19980901)32:4<459::AID-PROT5>3.0.CO;2-B; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Campos ITN, 2012, ACTA CRYSTALLOGR D, V68, P695, DOI 10.1107/S0907444912009067; Campos ITN, 2004, FEBS LETT, V577, P512, DOI 10.1016/j.febslet.2004.10.052; Campos ITN, 2002, INSECT BIOCHEM MOLEC, V32, P991, DOI 10.1016/S0965-1748(02)00035-8; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Colman RW, 1997, BLOOD, V90, P3819, DOI 10.1182/blood.V90.10.3819; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Dashkevich NM, 2012, BIOPHYS J, V103, P2233, DOI 10.1016/j.bpj.2012.10.011; Fadeeva OA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P734, DOI 10.1134/S0006297910060088; Grzesiak A, 2000, BBA-PROTEIN STRUCT M, V1478, P318, DOI 10.1016/S0167-4838(00)00034-0; Hagedorn I, 2010, CIRCULATION, V121, P1510, DOI 10.1161/CIRCULATIONAHA.109.924761; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOJIMA Y, 1980, THROMB RES, V20, P149, DOI 10.1016/0049-3848(80)90381-3; Holmes MB, 2000, CIRCULATION, V102, P2051, DOI 10.1161/01.CIR.102.17.2051; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jimenez-Garcia B, 2013, BIOINFORMATICS, V29, P1698, DOI 10.1093/bioinformatics/btt262; Kolyadko VN, 2014, BIOCHEM MOSC SUPPL S, V8, P279, DOI 10.1134/S1990747814040059; Korneeva VA, 2014, J BIOL CHEM, V289, P14109, DOI 10.1074/jbc.M114.553735; Leung PY, 2012, TRANSL STROKE RES, V3, P381, DOI 10.1007/s12975-012-0186-5; Lipets E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087692; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Luddington R, 2004, J THROMB HAEMOST, V2, P1954, DOI 10.1111/j.1538-7836.2004.00964.x; Panteleev MA, 2015, THROMB J, V13, DOI 10.1186/s12959-014-0032-y; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; Renne T, 2012, BLOOD, V120, P4296, DOI 10.1182/blood-2012-07-292094; Rimphanitchayakit V, 2010, DEV COMP IMMUNOL, V34, P377, DOI 10.1016/j.dci.2009.12.004; Sadovnichy V., 2013, LOMONOSOV SUPERCOMPU, P283; Salonen LM, 2009, ANGEW CHEM INT EDIT, V48, P811, DOI 10.1002/anie.200804695; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schmaier AH, 2008, J CLIN INVEST, V118, P3006, DOI 10.1172/JCI36617; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schousboe I, 2008, BIOCHEM PHARMACOL, V75, P1007, DOI 10.1016/j.bcp.2007.10.003; Schrodinger LLC., 2014, PYMOL MOL GRAPHICS S; Soshitova NP, 2012, BLOOD COAGUL FIBRIN, V23, P498, DOI 10.1097/MBC.0b013e328352e90e; Spronk HMH, 2009, THROMB HAEMOSTASIS, V101, P1156, DOI 10.1160/TH08-10-0670; Sugase K, 2008, PROTEIN EXPRES PURIF, V57, P108, DOI 10.1016/j.pep.2007.10.018; Tarandovskiy ID, 2013, THROMB RES, V131, pE274, DOI 10.1016/j.thromres.2013.04.004; Thaimattam R, 2002, ACTA CRYSTALLOGR D, V58, P1448, DOI 10.1107/S0907444902011769; WIECZOREK M, 1985, BIOCHEM BIOPH RES CO, V126, P646, DOI 10.1016/0006-291X(85)90233-5; Wu Y, 2007, P NATL ACAD SCI USA, V104, P19784, DOI 10.1073/pnas.0708251104; Xu YM, 2014, THROMB HAEMOSTASIS, V111, P694, DOI 10.1160/TH13-08-0668; Yau JW, 2012, ACTA BIOMATER, V8, P4092, DOI 10.1016/j.actbio.2012.07.019	45	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144940	10.1371/journal.pone.0144940	http://dx.doi.org/10.1371/journal.pone.0144940			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670620	Green Submitted, gold, Green Published			2022-12-27	WOS:000366719300032
J	You, XP; Zou, QL; Li, JL; Zhou, JY				You, Xiao-Ping; Zou, Qi-Lei; Li, Jian-Long; Zhou, Ji-Yuan			Likelihood Ratio Test for Excess Homozygosity at Marker Loci on X Chromosome	PLOS ONE			English	Article							ASSOCIATION ANALYSIS; MAXIMUM-LIKELIHOOD; FREQUENCIES; PARENT	The assumption of Hardy-Weinberg equilibrium (HWE) is generally required for association analysis using case-control design on autosomes; otherwise, the size may be inflated. There has been an increasing interest of exploring the association between diseases and markers on X chromosome and the effect of the departure from HWE on association analysis on X chromosome. Note that there are two hypotheses of interest regarding the X chromosome: (i) the frequencies of the same allele at a locus in males and females are equal and (ii) the inbreeding coefficient in females is zero (without excess homozygosity). Thus, excess homozygosity and significantly different minor allele frequencies between males and females are used to filter X-linked variants. There are two existing methods to test for (i) and (ii), respectively. However, their size and powers have not been studied yet. Further, there is no existing method to simultaneously detect both hypotheses till now. Therefore, in this article, we propose a novel likelihood ratio test for both (i) and (ii) on X chromosome. To further investigate the underlying reason why the null hypothesis is statistically rejected, we also develop two likelihood ratio tests for detecting (i) and (ii), respectively. Moreover, we explore the effect of population stratification on the proposed tests. From our simulation study, the size of the test for (i) is close to the nominal significance level. However, the size of the excess homozygosity test and the test for both (i) and (ii) is conservative. So, we propose parametric bootstrap techniques to evaluate their validity and performance. Simulation results show that the proposed methods with bootstrap techniques control the size well under the respective null hypothesis. Power comparison demonstrates that the methods with bootstrap techniques are more powerful than those without bootstrap procedure and the existing methods. The application of the proposed methods to a rheumatoid arthritis dataset indicates their utility.	[Zhou, Ji-Yuan] Southern Med Univ, Sch Publ Hlth & Trop Med, State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China; Southern Med Univ, Sch Publ Hlth & Trop Med, Guangdong Prov Key Lab Trop Res, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Zhou, JY (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China.	zhoujiyuan5460@hotmail.com	Zhou, Ji-Yuan/AAI-4623-2020	Zhou, Ji-Yuan/0000-0003-0866-4402	National Natural Science Foundation of China [81373098]; Science and Technology Planning Project of Guangdong Province, China [2013B021800038]; National Institutes of Health [R01 GM031575, NO1-AR-2-2263, RO1-AR-44422]; National Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [N01AR022263, R01AR044422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031575] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Natural Science Foundation of China (81373098), Science and Technology Planning Project of Guangdong Province, China (2013B021800038) to Professor Ji-Yuan Zhou. The Genetic Analysis Workshops are supported by the National Institutes of Health grant R01 GM031575. The RA data were gathered with the support of grants from the National Institutes of Health (NO1-AR-2-2263 and RO1-AR-44422), and the National Arthritis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos-Landgraf JM, 2006, AM J HUM GENET, V79, P493, DOI 10.1086/507565; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Chang D, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113684, 10.1371/journal.pone.0113596]; Chen ZX, 2017, STAT METHODS MED RES, V26, P567, DOI 10.1177/0962280214551815; Chung RH, 2007, AM J HUM GENET, V80, P59, DOI 10.1086/510630; Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; Clayton DG, 2009, GENOME MED, V1, DOI 10.1186/gm110; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Ding J, 2006, AM J HUM GENET, V79, P567, DOI 10.1086/507609; EMIGH TH, 1980, BIOMETRICS, V36, P627, DOI 10.2307/2556115; Gartler SM, 2014, J GENET, V93, P591, DOI 10.1007/s12041-014-0360-5; Gillespie J., 2010, BIOMETRICS, DOI DOI 10.2307/2533705; Hickey PF, 2011, GENET EPIDEMIOL, V35, P664, DOI 10.1002/gepi.20616; Horvath S, 2000, AM J HUM GENET, V66, P1161, DOI 10.1086/302823; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Konig IR, 2014, GENET EPIDEMIOL, V38, P97, DOI 10.1002/gepi.21782; Kuk AYC, 2009, BIOINFORMATICS, V25, P379, DOI 10.1093/bioinformatics/btn623; Lenart BA, 2009, OSTEOPOROSIS INT, V20, P1353, DOI 10.1007/s00198-008-0805-x; Li CC, 1976, 1 COURS POP GEN; Mao WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077399; Nei M., 1987, MOL EVOLUTIONARY GEN; Overall ADJ, 2001, MOL BIOL EVOL, V18, P2048, DOI 10.1093/oxfordjournals.molbev.a003746; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schaid DJ, 1999, AM J EPIDEMIOL, V149, P706; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang M, 2014, BIOINFORMATICS, V30, P2611, DOI 10.1093/bioinformatics/btu347; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weir BS, 1989, COMPLETE CHARACTERIZ; Wright S, 1921, GENETICS, V6, P111; Yang Z. H., 2005, STAT METHODS MOL EVO; Zhang DW, 2003, BIOSTATISTICS, V4, P57, DOI 10.1093/biostatistics/4.1.57; Zhang H, 2014, BIOINFORMATICS, V30, P2171, DOI 10.1093/bioinformatics/btu186; Zhang L, 2008, GENET EPIDEMIOL, V32, P370, DOI 10.1002/gepi.20311; Zheng G, 2007, GENET EPIDEMIOL, V31, P834, DOI 10.1002/gepi.20244	36	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145032	10.1371/journal.pone.0145032	http://dx.doi.org/10.1371/journal.pone.0145032			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671781	Green Submitted, Green Published, gold			2022-12-27	WOS:000366719300041
J	Bowles, KR; Brooks, SP; Dunnett, SB; Jones, L				Bowles, Kathryn R.; Brooks, Simon P.; Dunnett, Stephen B.; Jones, Lesley			Huntingtin Subcellular Localisation Is Regulated by Kinase Signalling Activity in the StHdh(Q111) Model of HD	PLOS ONE			English	Article							CREB-BINDING PROTEIN; MUTANT HUNTINGTIN; EGF RECEPTOR; POLYGLUTAMINE PROTEINS; NUCLEAR-LOCALIZATION; STRIATAL NEURONS; DISEASE PROTEIN; EXPRESSION; PHOSPHORYLATION; CELLS	Huntington's disease is a neurodegenerative disorder characterised primarily by motor abnormalities, and is caused by an expanded polyglutamine repeat in the huntingtin protein. Huntingtin dynamically shuttles between subcellular compartments, and the mutant huntingtin protein is mislocalised to cell nuclei, where it may interfere with nuclear functions, such as transcription. However, the mechanism by which mislocalisation of mutant huntingtin occurs is currently unknown. An immortalised embryonic striatal cell model of HD (StHdh(Q111)) was stimulated with epidermal growth factor in order to determine whether the subcellular localisation of huntingtin is dependent on kinase signalling pathway activation. Aberrant phosphorylation of AKT and MEK signalling pathways was identified in cells carrying mutant huntingtin. Activity within these pathways was found to contribute to the regulation of huntingtin and mutant huntingtin localisation, as well as to the expression of immediate-early genes. We propose that altered kinase signalling is a phenotype of Huntington's disease that occurs prior to cell death; specifically, that altered kinase signalling may influence huntingtin localisation, which in turn may impact upon nuclear processes such as transcriptional regulation. Aiming to restore the balance of activity between kinase signalling networks may therefore prove to be an effective approach to delaying Huntington's disease symptom development and progression.	[Bowles, Kathryn R.; Jones, Lesley] Cardiff Univ, Inst Psychol Med & Clin Neurosci, MRC Ctr Neuropsychiat Genet & Genom, Sch Med, Cardiff CF24 4HQ, S Glam, Wales; [Brooks, Simon P.; Dunnett, Stephen B.] Cardiff Univ, Sch Biosci, Brain Repair Grp, Cardiff CF10 3AX, S Glam, Wales	Cardiff University; Cardiff University	Bowles, KR (corresponding author), Mt Sinai Sch Med, Friedman Brain Inst, Ronald M Loeb Ctr Alzheimers Dis, 1425 Madison Ave,Icahn 10-52, New York, NY 10029 USA.	Kathryn.bowles@mssm.edu	Dunnett, Stephen B/A-5869-2010	Dunnett, Stephen B/0000-0003-1826-1578; Brooks, Simon/0000-0001-9853-6177	Wellcome Trust [089640/Z/09/Z]; CHDI; Medical Research Council [MR/L010305/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); CHDI; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was funded by a Wellcome Trust Scholarship awarded to KRB, grant number 089640/Z/09/Z (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Professor Marcy MacDonald for the kind gift of the StHdh<SUP>Q111</SUP> cells lines, and Dr. Sandrine Humbert for the generous gift of the S421 antibody. We also thank Yateen Patel for maintaining the Hdh<SUP>Q111</SUP> mouse colony and co-ordinating the staged pregnancies. KRB was supported by a Wellcome Trust studentship. The breeding colony is supported by CHDI.	Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; Apostol BL, 2006, HUM MOL GENET, V15, P273, DOI 10.1093/hmg/ddi443; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Aylward EH, 2004, NEUROLOGY, V63, P66, DOI 10.1212/01.WNL.0000132965.14653.D1; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Benn CL, 2008, J NEUROSCI, V28, P10720, DOI 10.1523/JNEUROSCI.2126-08.2008; Boutell JM, 1999, HUM MOL GENET, V8, P1647, DOI 10.1093/hmg/8.9.1647; Bowles KR, 2014, J HUNTINGTONS DIS, V3, P89, DOI 10.3233/JHD-140106; Brognard J, 2011, CURR OPIN GENET DEV, V21, P4, DOI 10.1016/j.gde.2010.10.012; Buckley NJ, 2010, NEUROBIOL DIS, V39, P28, DOI 10.1016/j.nbd.2010.02.003; Cabodi S, 2009, J CELL PHYSIOL, V218, P294, DOI 10.1002/jcp.21603; Carnemolla A, 2009, J BIOL CHEM, V284, P18167, DOI 10.1074/jbc.M109.018325; Carri AD, 2013, DEVELOPMENT, V140, P301, DOI 10.1242/dev.084608; Chong ZZ, 2005, HISTOL HISTOPATHOL, V20, P299, DOI 10.14670/HH-20.299; Ciarmiello A, 2006, J NUCL MED, V47, P215; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; del Toro D, 2009, MOL BIOL CELL, V20, P1478, DOI 10.1091/mbc.E08-07-0726; Desmond Carly R, 2013, Commun Integr Biol, V6, pe23318, DOI 10.4161/cib.23318; Desmond CR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412379; Dorsman JC, 1999, PHILOS T R SOC B, V354, P1061, DOI 10.1098/rstb.1999.0459; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Dunnett SB, 2000, NEUROMETH, V36, P3, DOI 10.1007/978-1-59259-690-4_1; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; Ferrigno P, 2000, NEURON, V26, P9, DOI 10.1016/S0896-6273(00)81132-0; Fossale E, 2002, HUM MOL GENET, V11, P2233, DOI 10.1093/hmg/11.19.2233; Gines S, 2003, J BIOL CHEM, V278, P50514, DOI 10.1074/jbc.M309348200; Gines S, 2010, J BIOL CHEM, V285, P21537, DOI 10.1074/jbc.M109.084202; GRAFTON ST, 1992, ARCH NEUROL-CHICAGO, V49, P1161, DOI 10.1001/archneur.1992.00530350075022; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Havel LS, 2011, HUM MOL GENET, V20, P1424, DOI 10.1093/hmg/ddr023; Hilditch-Maguire P, 2000, HUM MOL GENET, V9, P2789, DOI 10.1093/hmg/9.19.2789; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Humbert S, 2003, CLIN NEUROSCI RES, V3, P149, DOI 10.1016/S1566-2772(03)00057-4; Iijima-Andot K, 2005, P NATL ACAD SCI USA, V102, P10261, DOI 10.1073/pnas.0503937102; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Kim YJ, 2006, NEUROBIOL DIS, V22, P346, DOI 10.1016/j.nbd.2005.11.012; Kong PJ, 2009, NEUROL RES, V31, P77, DOI 10.1179/174313208X331572; KUWERT T, 1990, BRAIN, V113, P1405, DOI 10.1093/brain/113.5.1405; Lee JM, 2007, PLOS GENET, V3, P1397, DOI 10.1371/journal.pgen.0030135; Leng Y, 2004, DIABETES, V53, P1436, DOI 10.2337/diabetes.53.6.1436; Levine MS, 2004, TRENDS NEUROSCI, V27, P691, DOI 10.1016/j.tins.2004.08.008; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Lievens JC, 2005, HUM MOL GENET, V14, P713, DOI 10.1093/hmg/ddi067; Lievens JC, 2008, HUM MOL GENET, V17, P882, DOI 10.1093/hmg/ddm360; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Liu YF, 1997, J BIOL CHEM, V272, P8121, DOI 10.1074/jbc.272.13.8121; Maiuri T, 2013, HUM MOL GENET, V22, P1383, DOI 10.1093/hmg/dds554; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Melone MAB, 2013, BBA-MOL BASIS DIS, V1832, P105, DOI 10.1016/j.bbadis.2012.09.001; Novak MJU, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3109; Owada Y, 1997, J MOL NEUROSCI, V9, P27, DOI 10.1007/BF02789392; Pal A, 2006, J CELL BIOL, V172, P605, DOI 10.1083/jcb.200509091; Pennuto M, 2009, HUM MOL GENET, V18, pR40, DOI 10.1093/hmg/ddn412; Pineda JR, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-33; Rangone H, 2004, EUR J NEUROSCI, V19, P273, DOI 10.1111/j.0953-816X.2003.03131.x; Reddy PH, 1999, TRENDS NEUROSCI, V22, P248, DOI 10.1016/S0166-2236(99)01415-0; Ritch JJ, 2012, MOL CELL NEUROSCI, V50, P70, DOI 10.1016/j.mcn.2012.03.011; Ro YT, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-18; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Rosas HD, 2008, BRAIN, V131, P1057, DOI 10.1093/brain/awn025; Saavedra A, 2010, CELL DEATH DIFFER, V17, P324, DOI 10.1038/cdd.2009.127; Saavedra A, 2011, J NEUROSCI, V31, P8150, DOI 10.1523/JNEUROSCI.3446-10.2011; Sawa A, 2005, NEUROBIOL DIS, V20, P267, DOI 10.1016/j.nbd.2005.02.013; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Seong IS, 2010, HUM MOL GENET, V19, P573, DOI 10.1093/hmg/ddp524; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Song C, 2002, J BIOL CHEM, V277, P6703, DOI 10.1074/jbc.M110338200; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Sun J, 2007, J NEUROSCI RES, V85, P2306, DOI 10.1002/jnr.21369; Tao T, 2001, TRAFFIC, V2, P385, DOI 10.1034/j.1600-0854.2001.002006385.x; Taylor DM, 2013, J NEUROSCI, V33, P2313, DOI 10.1523/JNEUROSCI.4965-11.2013; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Truant R, 2003, CLIN NEUROSCI RES, V3, P157, DOI 10.1016/S1566-2772(03)00058-6; Truant R, 2007, PROG NEUROBIOL, V83, P211, DOI 10.1016/j.pneurobio.2006.11.004; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Warby SC, 2005, HUM MOL GENET, V14, P1569, DOI 10.1093/hmg/ddi165; Warby SC, 2009, MOL CELL NEUROSCI, V40, P121, DOI 10.1016/j.mcn.2008.09.007; Wexler NS, 2012, ANNU REV MED, V63, P1, DOI 10.1146/annurev-med-050710-134457; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Wheeler VC, 2002, HUM MOL GENET, V11, P633, DOI 10.1093/hmg/11.6.633; Xia JR, 2003, HUM MOL GENET, V12, P1393, DOI 10.1093/hmg/ddg156; Zala D, 2008, HUM MOL GENET, V17, P3837, DOI 10.1093/hmg/ddn281; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	91	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144864	10.1371/journal.pone.0144864	http://dx.doi.org/10.1371/journal.pone.0144864			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660732	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000366715900123
J	Guo, CH; Wei, MZ; Liu, H				Guo, Chaohua; Wei, Mingzhen; Liu, Hong			Modeling of Gas Production from Shale Reservoirs Considering Multiple Transport Mechanisms	PLOS ONE			English	Article							TANGENTIAL MOMENTUM ACCOMMODATION; NATURALLY FRACTURED RESERVOIRS; POROUS-MEDIA; FLOW; PERMEABILITY; SIMULATION; PRESSURES; CHANNELS; PIPES	Gas transport in unconventional shale strata is a multi-mechanism-coupling process that is different from the process observed in conventional reservoirs. In micro fractures which are inborn or induced by hydraulic stimulation, viscous flow dominates. And gas surface diffusion and gas desorption should be further considered in organic nano pores. Also, the Klin-kenberg effect should be considered when dealing with the gas transport problem. In addition, following two factors can play significant roles under certain circumstances but have not received enough attention in previous models. During pressure depletion, gas viscosity will change with Knudsen number; and pore radius will increase when the adsorption gas desorbs from the pore wall. In this paper, a comprehensive mathematical model that incorporates all known mechanisms for simulating gas flow in shale strata is presented. The objective of this study was to provide a more accurate reservoir model for simulation based on the flow mechanisms in the pore scale and formation geometry. Complex mechanisms, including viscous flow, Knudsen diffusion, slip flow, and desorption, are optionally integrated into different continua in the model. Sensitivity analysis was conducted to evaluate the effect of different mechanisms on the gas production. The results showed that adsorption and gas viscosity change will have a great impact on gas production. Ignoring one of following scenarios, such as adsorption, gas permeability change, gas viscosity change, or pore radius change, will underestimate gas production.	[Guo, Chaohua; Wei, Mingzhen] Missouri Univ Sci & Technol, Dept Petr Engn, Rolla, MO 65401 USA; [Liu, Hong] Chongqing Univ Sci & Technol, Dept Petr Engn, Chongqing 401331, Peoples R China	University of Missouri System; Missouri University of Science & Technology; Chongqing University of Science & Technology	Guo, CH (corresponding author), Missouri Univ Sci & Technol, Dept Petr Engn, Rolla, MO 65401 USA.	chaohua.guo@mst.edu			RPSEA through the "Ultra-Deepwater and Unconventional Natural Gas and Other Petroleum Resources"; Baker Hughes and Hess Company	RPSEA through the "Ultra-Deepwater and Unconventional Natural Gas and Other Petroleum Resources"; Baker Hughes and Hess Company	Funding for this project is provided by RPSEA through the "Ultra-Deepwater and Unconventional Natural Gas and Other Petroleum Resources". The authors also wish to acknowledge for the consultant support from Baker Hughes and Hess Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1941, DRILLING PRODUCTION; [Anonymous], 1954, J PET TECHNOL, DOI DOI 10.2118/271-G; Arkilic EB, 2001, J FLUID MECH, V437, P29, DOI 10.1017/S0022112001004128; Beskok A, 1999, MICROSCALE THERM ENG, V3, P43; BROWN GP, 1946, J APPL PHYS, V17, P802, DOI 10.1063/1.1707647; Bustin A., 2008, UNC RES C COL US 10; Cao BY, 2006, INT J ENG SCI, V44, P927, DOI 10.1016/j.ijengsci.2006.06.005; Cao BY, 2009, INT J MOL SCI, V10, P4638, DOI 10.3390/ijms10114638; Cao BY, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1871363; Civan F, 2011, TRANSPORT POROUS MED, V86, P925, DOI 10.1007/s11242-010-9665-x; Cui X, 2009, GEOFLUIDS, V9, P208, DOI 10.1111/j.1468-8123.2009.00244.x; Freeman C., 2012, LAT AM CAR PETR ENG; Guo C., 2015, SPE 176714; Guo CH, 2015, FUEL, V143, P107, DOI 10.1016/j.fuel.2014.11.032; Guo C, 2017, J INTELL MANUF, V28, P657, DOI 10.1007/s10845-014-1002-8; Hill D.G., 2000, GAS TIPS, V6, P4, DOI DOI 10.1016/J.FUEL.2005.05.002; Javadpour F, 2009, J CAN PETROL TECHNOL, V48, P16, DOI 10.2118/09-08-16-DA; Javadpour F., 2007, J CANADIAN PETROLEUM, V46; Kast W, 2000, INT J HEAT MASS TRAN, V43, P807, DOI 10.1016/S0017-9310(99)00158-1; KAZEMI H, 1976, SOC PETROL ENG J, V16, P317, DOI 10.2118/5719-PA; Michalis VK, 2010, MICROFLUID NANOFLUID, V9, P847, DOI 10.1007/s10404-010-0606-3; Moridis G., 2010, LAT AM CAR PETR ENG; Ozkan E., 2010, ANN TECHN C EXH LIM; PEACEMAN DW, 1983, SOC PETROL ENG J, V23, P531, DOI 10.2118/10528-PA; Pruess K., 1999, TOUGH2 USERS GUIDE V; Sakhaee-Pour A, 2012, SPE RESERV EVAL ENG, V15, P401, DOI 10.2118/146944-PA; Shabro V., 2011, N AM UNC GAS C EXH T; Shabro V, 2012, ANN TECHN C EXH TEX; Wang Z., 2013, RETROSPECTIVE REV SH; WARREN JE, 1963, SOC PETROL ENG J, V3, P245, DOI 10.2118/426-PA; Wu Y.S., 2011, EUROPEC EAGE ANN C E; Wu YS, 1998, TRANSPORT POROUS MED, V32, P117, DOI 10.1023/A:1006535211684; Xiong X., 2012, ANN TECHN C EXH TEX; Ziarani AS, 2012, TRANSPORT POROUS MED, V91, P239, DOI 10.1007/s11242-011-9842-6	34	16	16	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143649	10.1371/journal.pone.0143649	http://dx.doi.org/10.1371/journal.pone.0143649			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657698	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900013
J	Roubik, K; Sieger, L; Sykora, K				Roubik, Karel; Sieger, Ladislav; Sykora, Karel			Work of Breathing into Snow in the Presence versus Absence of an Artificial Air Pocket Affects Hypoxia and Hypercapnia of a Victim Covered with Avalanche Snow: A Randomized Double Blind Crossover Study	PLOS ONE			English	Article							PRESSURE-TIME PRODUCT; SURVIVAL; PATTERNS; DEATH	Presence of an air pocket and its size play an important role in survival of victims buried in the avalanche snow. Even small air pockets facilitate breathing. We hypothesize that the size of the air pocket significantly affects the airflow resistance and work of breathing. The aims of the study are (1) to investigate the effect of the presence of an air pocket on gas exchange and work of breathing in subjects breathing into the simulated avalanche snow and (2) to test whether it is possible to breathe with no air pocket. The prospective interventional double-blinded study involved 12 male volunteers, from which 10 completed the whole protocol. Each volunteer underwent two phases of the experiment in a random order: phase "AP"-breathing into the snow with a one-liter air pocket, and phase "NP"-breathing into the snow with no air pocket. Physiological parameters, fractions of oxygen and carbon dioxide in the airways and work of breathing expressed as pressure-time product were recorded continuously. The main finding of the study is that it is possible to breath in the avalanche snow even with no air pocket (0 L volume), but breathing under this condition is associated with significantly increased work of breathing. The significant differences were initially observed for end-tidal values of the respiratory gases (EtO2 and EtCO2) and peripheral oxygen saturation (SpO(2)) between AP and NP phases, whereas significant differences in inspiratory fractions occurred much later (for FIO2) or never (for FICO2). The limiting factor in no air pocket conditions is excessive increase in work of breathing that induces increase in metabolism accompanied by higher oxygen consumption and carbon dioxide production. The presence of even a small air pocket reduces significantly the work of breathing.	[Roubik, Karel] Czech Tech Univ, Fac Biomed Engn, Dept Biomed Technol, CR-16635 Prague, Czech Republic; [Sieger, Ladislav] Czech Tech Univ, Fac Elect Engn, Dept Phys, CR-16635 Prague, Czech Republic; [Sykora, Karel] Charles Univ Prague, Fac Phys Educ & Sport, Dept Physiol & Biochem, Prague, Czech Republic	Czech Technical University Prague; Czech Technical University Prague; Charles University Prague	Roubik, K (corresponding author), Czech Tech Univ, Fac Biomed Engn, Dept Biomed Technol, CR-16635 Prague, Czech Republic.	roubik@fbmi.cvut.cz	Sieger, Ladislav/AAM-2593-2020; Roubik, Karel/A-8801-2012; Sykora, Karel/AAM-6317-2021	Sykora, Karel/0000-0003-0212-1247; Sieger, Ladislav/0000-0002-6097-7062	Charles University [SVV 2015-260236]; Faculty of Physical Education and Sport; Czech Technical University in Prague [SGS14/216/OHK4/3T/17]	Charles University; Faculty of Physical Education and Sport; Czech Technical University in Prague	The experiment conducted as a part of this study was supported by research grant SVV 2015-260236 of Charles University, Faculty of Physical Education and Sport, and by a research grant SGS14/216/OHK4/3T/17 of Czech Technical University in Prague. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, 88352 EN ISO; Bellani G, 2007, ANESTHESIOLOGY, V106, P484, DOI 10.1097/00000542-200703000-00012; Boyd J, 2009, CAN MED ASSOC J, V180, P507, DOI 10.1503/cmaj.081327; Brugger H, 2003, RESUSCITATION, V58, P81, DOI 10.1016/S0300-9572(03)00113-8; Brugger H, 2001, RESUSCITATION, V51, P7, DOI 10.1016/S0300-9572(01)00383-5; Brugger H, 2011, HIGH ALT MED BIOL, V12, P199, DOI 10.1089/ham.2011.1025; COLLETT PW, 1985, J APPL PHYSIOL, V58, P1263, DOI 10.1152/jappl.1985.58.4.1263; FALK M, 1994, NATURE, V368, P21, DOI 10.1038/368021a0; FIELD S, 1984, J APPL PHYSIOL, V57, P44, DOI 10.1152/jappl.1984.57.1.44; Grissom CK, 2000, JAMA-J AM MED ASSOC, V283, P2261; Grissom CK, 2008, AVIAT SPACE ENVIR MD, V79, P735, DOI 10.3357/ASEM.2261.2008; Haegeli P, 2011, CAN MED ASSOC J, V183, P789, DOI 10.1503/cmaj.101435; Hohlrieder M, 2007, HIGH ALT MED BIOL, V8, P56, DOI 10.1089/ham.2006.0815; Lumb AB, 2012, NUNNS APPL RESP PHYS; McClung D.M., 1993, AVALANCHE HDB; McIntosh SE, 2007, WILD ENVIRON MED, V18, P293, DOI 10.1580/07-WEME-OR-092R1.1; OTIS AB, 1954, PHYSIOL REV, V34, P449, DOI 10.1152/physrev.1954.34.3.449; Paal P, 2013, RESUSCITATION, V84, P239, DOI 10.1016/j.resuscitation.2012.06.019; Radwin IM, 2001, WILDERNESS ENV MED, V12, P256; Sassoon C.S.H., 1998, WORK BREATHING MECH, P261; SECHZER PH, 1963, ANESTHESIOLOGY, V24, P779, DOI 10.1097/00000542-196311000-00005; Windsor JS, 2009, WILD ENVIRON MED, V20, P61, DOI 10.1580/08-WEME-BR-183.1	22	14	14	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144332	10.1371/journal.pone.0144332	http://dx.doi.org/10.1371/journal.pone.0144332			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26666523	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900039
J	Shen, ZF; Yu, XJ; Sheng, YW; Li, JL; Luo, JC				Shen, Zhanfeng; Yu, Xinju; Sheng, Yongwei; Li, Junli; Luo, Jiancheng			A Fast Algorithm to Estimate the Deepest Points of Lakes for Regional Lake Registration	PLOS ONE			English	Article							DIGITAL ELEVATION MODELS; MEDIAL AXIS; SKELETONIZATION; EXTRACTION; SURFACE; IMAGE	When conducting image registration in the U.S. state of Alaska, it is very difficult to locate satisfactory ground control points because ice, snow, and lakes cover much of the ground. However, GCPs can be located by seeking stable points from the extracted lake data. This paper defines a process to estimate the deepest points of lakes as the most stable ground control points for registration. We estimate the deepest point of a lake by computing the center point of the largest inner circle (LIC) of the polygon representing the lake. An LIC-seeking method based on Voronoi diagrams is proposed, and an algorithm based on medial axis simplification (MAS) is introduced. The proposed design also incorporates parallel data computing. A key issue of selecting a policy for partitioning vector data is carefully studied, the selected policy that equalize the algorithm complexity is proved the most optimized policy for vector parallel processing. Using several experimental applications, we conclude that the presented approach accurately estimates the deepest points in Alaskan lakes; furthermore, we gain perfect efficiency using MAS and a policy of algorithm complexity equalization.	[Shen, Zhanfeng; Yu, Xinju; Luo, Jiancheng] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Beijing 100101, Peoples R China; [Sheng, Yongwei] Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA; [Li, Junli] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi 830020, Peoples R China	Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; University of California System; University of California Los Angeles; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Yu, XJ (corresponding author), Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Beijing 100101, Peoples R China.	yuxj@radi.ac.cn	Li, Junli/C-8904-2014; Luo, jian/HGE-7331-2022		Chinese 863 project [2013AA12A401]; National Natural Science Foundation project of China [41101398, 41301438]; National Aeronautics and Space Administration through the Terrestrial Hydrology Program [NNX08AE51G]	Chinese 863 project(National High Technology Research and Development Program of China); National Natural Science Foundation project of China(National Natural Science Foundation of China (NSFC)); National Aeronautics and Space Administration through the Terrestrial Hydrology Program	This work was supported by the Chinese 863 project (No. 2013AA12A401), National Natural Science Foundation project of China (No. 41101398), the National Aeronautics and Space Administration through the Terrestrial Hydrology Program (No. NNX08AE51G).; This work was supported in part by the Chinese 863 project (No. 2013AA12A401), National Natural Science Foundation project of China (No. 41301438), and in part by the National Aeronautics and Space Administration through the Terrestrial Hydrology Program (No. NNX08AE51G).	Attali D, 2001, COMP GEOM-THEOR APPL, V19, P175, DOI 10.1016/S0925-7721(01)00019-0; Beristain A, 2012, J MATH IMAGING VIS, V42, P225, DOI 10.1007/s10851-011-0291-1; Blum H., 1967, MODELS PERCEPTION SP, P362, DOI DOI 10.1142/S0218654308001154; Borgefors G., 1991, P 7 SCAND C IM AN, V2, P974; Chaussard J, 2011, PATTERN RECOGN LETT, V32, P1384, DOI 10.1016/j.patrec.2010.09.002; Cheong O, 2011, COMP GEOM-THEOR APPL, V44, P234, DOI 10.1016/j.comgeo.2010.11.004; DAVIES ER, 1981, PATTERN RECOGN, V14, P53, DOI 10.1016/0031-3203(81)90045-5; Dey TK, 2004, COMPUT AIDED DESIGN, V36, P195, DOI 10.1016/S0010-4485(03)00061-7; Dorado R, 2009, COMPUT AIDED DESIGN, V41, P1050, DOI 10.1016/j.cad.2009.08.005; Drysdale R. L.  III, 1978, Proceedings of the Sixteenth Annual Allerton Conference on Communication, Control and Computing, P833; Hesselink WH, 2008, IEEE T PATTERN ANAL, V30, P2204, DOI 10.1109/TPAMI.2008.21; Hulin J, 2009, THESIS; KIMMEL R, 1995, COMPUT VIS IMAGE UND, V62, P382, DOI 10.1006/cviu.1995.1062; Kirkpatrick D. G., 1979, 20th Annual Symposium of Foundations of Computer Science, P18, DOI 10.1109/SFCS.1979.15; LEE DT, 1981, SIAM J COMPUT, V10, P73, DOI 10.1137/0210006; LEE DT, 1982, IEEE T PATTERN ANAL, V4, P363, DOI 10.1109/TPAMI.1982.4767267; Leymarie FF, 2007, IEEE T PATTERN ANAL, V29, P313, DOI 10.1109/TPAMI.2007.44; O'-Rourke, 2008, COMPUTATIONAL GEOMET; OGNIEWICZ RL, 1995, PATTERN RECOGN, V28, P343, DOI 10.1016/0031-3203(94)00105-U; OISHI Y, 1995, GRAPH MODEL IM PROC, V57, P303, DOI 10.1006/gmip.1995.1027; Preparata F. P., 1977, MATH FDN COMPUTER SC, P443; Quesada A., 2008, POLAR LAKES RIVERS L, P583; Ramamurthy R, 1999, J COMPUT APPL MATH, V102, P119, DOI 10.1016/S0377-0427(98)00211-8; Serra J, 1983, IMAGE ANAL MATH MORP; Shah CA, 2008, IEEE T GEOSCI REMOTE, V46, P3908, DOI 10.1109/TGRS.2008.2000636; Shen DY, 2012, IEEE GEOSCI REMOTE S, V9, P194, DOI 10.1109/LGRS.2011.2163812; Shen Zhan-feng, 2006, Journal of the Harbin Institute of Technology, V38, P1968; Shen ZF, 2012, J INDIAN SOC REMOTE, V40, P357, DOI 10.1007/s12524-011-0166-3; Siddiqi K., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P828, DOI 10.1109/ICCV.1999.790307; TALBOT H, 1992, P SOC PHOTO-OPT INS, V1818, P862, DOI 10.1117/12.131499; Wang JD, 2012, REMOTE SENS ENVIRON, V119, P325, DOI 10.1016/j.rse.2011.10.027; Zhu HS, 2015, ADV ENG SOFTW, V85, P96, DOI 10.1016/j.advengsoft.2015.03.004	32	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144700	10.1371/journal.pone.0144700	http://dx.doi.org/10.1371/journal.pone.0144700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656598	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900089
J	Miglietta, MP; Odegard, D; Faure, B; Faucci, A				Miglietta, Maria Pia; Odegard, Dean; Faure, Baptiste; Faucci, Anuschka			Barcoding Techniques Help Tracking the Evolutionary History of the Introduced Species Pennaria disticha (Hydrozoa, Cnidaria)	PLOS ONE			English	Article							BLACKFORDIA-VIRGINICA; MAEOTIAS-MARGINATA; GENETIC-ANALYSIS; MARINE HABITATS; SEA; HYDROMEDUSAE; HYDRACTINIIDAE	The Christmas tree hydroid Pennaria disticha is listed as one of the most common introduced species in Hawaii. Firstly reported in Kaneohe Bay (Oahu) in 1928, it is now established throughout the entire archipelago, including the Northwestern Hawaiian Islands, a U.S. National Monument and World Heritage site. The Hawaiian population of P. disticha has also been reported as being the source of further introductions to Palmyra Atoll in the U.S. Line Islands. Using a phylogenetic hypothesis based on a 611 base pair fragment of the mitochondrial 16S barcoding gene, we demonstrate that P. disticha is a complex of cryptic species, rather than one species with cosmopolitan distribution. We also show that in Hawaii there are three species of Pennaria, rather than one introduced species. Two of these species share haplotypes with specimens from distant locations such as Florida and Panama and may have been introduced, possibly from the Atlantic Ocean. A third species could either represent a lineage with nearly cosmopolitan distribution, or another introduced species. Our dataset refutes the widely accepted idea that only one lineage of P. disticha is present in Hawaii. On the contrary, P. disticha in Hawaii may be the outcome of multiple independent introductions of several morphologically undistinguishable cryptic lineages. Our results uncover an unsuspected complexity within the very common hydroid P. disticha, and highlight the need for routine use of molecular tools, such as DNA barcoding, to improve the identification and recognition of non-indigenous species.	[Miglietta, Maria Pia] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Odegard, Dean] Univ Notre Dame, Notre Dame, IN 46556 USA; [Faure, Baptiste] Univ La Reunion, Lab Ecol Marine, St Denis, Reunion, France; [Faucci, Anuschka] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA	Texas A&M University System; University of Notre Dame; University of La Reunion; University of Hawaii System; University of Hawaii Manoa	Miglietta, MP (corresponding author), Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA.	miglietm@tamug.edu		Odegard, Dean/0000-0002-7093-6889	University of Notre Dame; Texas AAMP;M University at Galveston; University of Notre Dame; Texas AAMP;M University at Galveston	University of Notre Dame; Texas AAMP;M University at Galveston; University of Notre Dame; Texas AAMP;M University at Galveston	Funding was provided by the University of Notre Dame and Texas A&M University at Galveston (start-up funds to MPM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bax N, 2003, MAR POLICY, V27, P313, DOI 10.1016/S0308-597X(03)00041-1; Blanchet S, 2012, FISHERIES MANAG ECOL, V19, P120, DOI 10.1111/j.1365-2400.2011.00832.x; Boero F, 2008, MAR ECOL PROG SER, V356, P299, DOI 10.3354/meps07368; Bouillon J, 2004, SCI MAR, V68, P5, DOI 10.3989/scimar.2004.68s25; Calder Dale R., 2010, Zootaxa, V2590, P1; Carlton J., 2009, MARINE BIOINVASIONS; Carlton James T., 1999, Population and Community Biology Series, V24, P195; Coles SL, 2006, PAC SCI, V60, P483, DOI 10.1353/psc.2006.0026; Concepcion GT, 2010, MAR ECOL PROG SER, V401, P113, DOI 10.3354/meps08364; Costello JH, 2002, LIMNOL OCEANOGR, V47, P934, DOI 10.4319/lo.2002.47.4.0934; CUNNINGHAM CW, 1993, BIOCHEM SYST ECOL, V21, P57, DOI 10.1016/0305-1978(93)90009-G; Darling JA, 2007, BIOL INVASIONS, V9, P751, DOI 10.1007/s10530-006-9079-4; Darling JA, 2009, MOL ECOL, V18, P4827, DOI 10.1111/j.1365-294X.2009.04405.x; Edmondson CH, 1933, REEF SHORE FAUNA HAW; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Folino-Rorem NC, 2009, BIOL INVASIONS, V11, P1869, DOI 10.1007/s10530-008-9365-4; Gili JM, 1998, TRENDS ECOL EVOL, V13, P316, DOI 10.1016/S0169-5347(98)01365-2; Godwin S, 2006, REDUCING POTENTIAL I; Haddad MA, 2014, ZOOTAXA, V3796, P494, DOI 10.11646/zootaxa.3796.3.5; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knapp I.S., 2011, Marine Biodiversity Records, V4; Mead A, 2011, BIOL INVASIONS, V13, P1991, DOI 10.1007/s10530-011-0016-9; Megina C, 2013, MAR BIOL, V160, P371, DOI 10.1007/s00227-012-2094-3; Miglietta MP, 2011, INTEGR COMP BIOL, V51, P449, DOI 10.1093/icb/icr024; Miglietta MP, 2008, J PLANKTON RES, V30, P783, DOI 10.1093/plankt/fbn038; Miglietta MP, 2009, ZOOL SCR, V38, P403, DOI 10.1111/j.1463-6409.2008.00376.x; Miglietta MP, 2009, BIOL INVASIONS, V11, P825, DOI 10.1007/s10530-008-9296-0; MILLS CE, 1995, MAR BIOL, V122, P279; Mills CE, 2000, SCI MAR, V64, P151, DOI 10.3989/scimar.2000.64s1151; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Moura CJ, 2011, ZOOL SCR, V40, P520, DOI 10.1111/j.1463-6409.2011.00489.x; Nawrocki AM, 2010, ZOOL SCR, V39, P290, DOI 10.1111/j.1463-6409.2009.00419.x; Phair N, 2015, CONSERV GENET, V16, P801, DOI 10.1007/s10592-015-0701-9; Rambaut A, 2014, FIGTREE 1 4; Ray GL, 2005, ANSRP056 ERDCTN; Rossi S, 2012, MAR ECOL PROG SER, V467, P97, DOI 10.3354/meps09848; Santini F, 2012, EVOL BIOL, V39, P141, DOI 10.1007/s11692-012-9177-4; Schuchert P, 2014, MOL PHYLOGENET EVOL, V76, P1, DOI 10.1016/j.ympev.2014.02.020; See K, 2009, MARINE BIOGEOGRAPHIC, P275; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tezcan OD, 2013, TOXICON, V61, P125, DOI 10.1016/j.toxicon.2012.10.019; Vainola R, 2001, SARSIA, V86, P401	43	18	19	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144762	10.1371/journal.pone.0144762	http://dx.doi.org/10.1371/journal.pone.0144762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657561	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903600089
J	Thaler, C; Faizy, T; Sedlacik, J; Holst, B; Stellmann, JP; Young, KL; Heesen, C; Fiehler, J; Siemonsen, S				Thaler, Christian; Faizy, Tobias; Sedlacik, Jan; Holst, Brigitte; Stellmann, Jan-Patrick; Young, Kim Lea; Heesen, Christoph; Fiehler, Jens; Siemonsen, Susanne			T1-Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients	PLOS ONE			English	Article							SPIN-ECHO MRI; HYPOINTENSE LESIONS; WHITE-MATTER; MAGNETIZATION-TRANSFER; COGNITIVE IMPAIRMENT; FUNCTIONAL COMPOSITE; POSTMORTEM MRI; T1-WEIGHTED MR; BRAIN; T1	Background Magnetic Resonance Imaging (MRI) is an established tool in diagnosing and evaluating disease activity in Multiple Sclerosis (MS). While clinical-radiological correlations are limited in general, hypointense T1 lesions (also known as Black Holes (BH)) have shown some promising results. The definition of BHs is very heterogeneous and depends on subjective visual evaluation. Objective We aimed to improve clinical-radiological correlations by defining BHs using T1 relaxation time (T1-RT) thresholds to achieve best possible correlation between BH lesion volume and clinical disability. Method 40 patients with mainly relapsing-remitting MS underwent MRI including 3-dimensional fluid attenuated inversion recovery (FLAIR), magnetization-prepared rapid gradient echo (MPRAGE) before and after Gadolinium (GD) injection and double inversion-contrast magnetization-prepared rapid gradient echo (MP2RAGE) sequences. BHs (BHvis) were marked by two raters on native T1-weighted (T1w)-MPRAGE, contrast-enhancing lesions (CE lesions) on T1w-MPRAGE after GD and FLAIR lesions (total-FLAIR lesions) were detected separately. BHvis and total-FLAIR lesion maps were registered to MP2RAGE images, and the mean T1-RT were calculated for all lesion ROIs. Mean T1 values of the cortex (CTX) were calculated for each patient. Subsequently, Spearman rank correlations between clinical scores (Expanded Disability Status Scale and Multiple Sclerosis Functional Composite) and lesion volume were determined for different T1-RT thresholds. Results Significant differences in T1-RT were obtained between all different lesion types with highest T1 values in visually marked BHs (BHvis: 1453.3 +/- 213.4 ms, total-FLAIR lesions: 1394.33 +/- 187.38 ms, CTX: 1305.6 +/- 35.8 ms; p<0.05). Significant correlations between BHvis/total-FLAIR lesion volume and clinical disability were obtained for a wide range of T1-RT thresholds. The highest correlation for BHvis and total-FLAIR lesion masks were found at T1-RT>1500 ms (Expanded Disability Status Scale vs. lesion volume: r(BHvis) = 0.442 and r(total-FLAIR) = 0.497, p<0.05; Multiple Sclerosis Functional Composite vs. lesion volume: r(BHvis) = -0.53 and r(total-FLAIR) = -0.627, p<0.05). Conclusion Clinical-radiological correlations in MS patients are increased by application of T1-RT thresholds. With the short acquisition time of the MP2RAGE sequences, quantitative T1 maps could be easily established in clinical studies.	[Thaler, Christian; Faizy, Tobias; Sedlacik, Jan; Holst, Brigitte; Fiehler, Jens; Siemonsen, Susanne] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Stellmann, Jan-Patrick; Young, Kim Lea; Heesen, Christoph] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Stellmann, Jan-Patrick; Young, Kim Lea; Heesen, Christoph; Siemonsen, Susanne] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Thaler, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany.	c.thaler@uke.de	Stellmann, Jan-Patrick/ABA-7132-2020	Stellmann, Jan-Patrick/0000-0003-2565-2833; Gellissen, Susanne/0000-0002-7444-7265	Biogen; Merck-Serono; Teva; Sanofi Aventis; Genzyme	Biogen(Biogen); Merck-Serono(Merck & Company); Teva(Teva Pharmaceutical Industries); Sanofi Aventis(Sanofi-Aventis); Genzyme(Sanofi-AventisGenzyme Corporation)	C. Heesen has received lecture honoraria and grants from Biogen, Merck-Serono, Teva, Sanofi Aventis, and Genzyme. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Barkhof F, 2003, ARCH NEUROL-CHICAGO, V60, P1073, DOI 10.1001/archneur.60.8.1073; Bitsch A, 2001, ANN NEUROL, V49, P793, DOI 10.1002/ana.1053; Caligiuri ME, 2015, NEUROINFORMATICS, V13, P261, DOI 10.1007/s12021-015-9260-y; Castriota-Scanderbeg A, 2004, MULT SCLER J, V10, P556, DOI 10.1191/1352458504ms1073oa; De Groot CJA, 2001, BRAIN, V124, P1635, DOI 10.1093/brain/124.8.1635; Enzinger C, 2004, ANN NEUROL, V55, P563, DOI 10.1002/ana.20027; Evangelou N, 2000, ANN NEUROL, V47, P391, DOI 10.1002/1531-8249(200003)47:3<391::AID-ANA20>3.0.CO;2-J; Fischer JS, 1999, MULT SCLER J, V5, P244, DOI 10.1177/135245859900500409; Giugni E, 1997, MULT SCLER, V3, P221, DOI 10.1177/135245859700300401; Griffin CM, 2002, MULT SCLER J, V8, P211, DOI 10.1191/1352458502ms807oa; Jain S, 2015, NEUROIMAGE-CLIN, V8, P367, DOI 10.1016/j.nicl.2015.05.003; Jonkman LE, 2015, J NEUROL, V262, P1074, DOI 10.1007/s00415-015-7689-4; Kappos L, 2002, NEUROSTATUS NEUROSTA; Kober T, 2012, INVEST RADIOL, V47, P346, DOI 10.1097/RLI.0b013e31824600e9; LARSSON HBW, 1989, MAGNET RESON MED, V11, P337, DOI 10.1002/mrm.1910110308; Laule C, 2006, MULT SCLER, V12, P747, DOI 10.1177/1352458506070928; LOEVNER LA, 1995, AM J NEURORADIOL, V16, P1473; MacKay A, 2006, MAGN RESON IMAGING, V24, P515, DOI 10.1016/j.mri.2005.12.037; Manfredonia F, 2007, ARCH NEUROL-CHICAGO, V64, P411, DOI 10.1001/archneur.64.3.411; Miller DM, 2000, ARCH NEUROL-CHICAGO, V57, P1319, DOI 10.1001/archneur.57.9.1319; Mitjana R, 2014, MULT SCLER J, V20, P1471, DOI 10.1177/1352458514526083; NOSEWORTHY JH, 1990, NEUROLOGY, V40, P971, DOI 10.1212/WNL.40.6.971; O'Riordan JI, 1998, MULT SCLER J, V4, P408, DOI 10.1191/135245898678919483; Parmenter BA, 2007, MULT SCLER J, V13, P52, DOI 10.1177/1352458506070750; Pichler A, 2013, MULT SCLER J, V19, P167, DOI 10.1177/1352458512448107; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Riva M, 2009, AM J NEURORADIOL, V30, P1394, DOI 10.3174/ajnr.A1573; Roosendaal SD, 2009, MULT SCLER, V15, P708, DOI 10.1177/1352458509102907; Sahraian MA, 2010, ACTA NEUROL SCAND, V122, P1, DOI 10.1111/j.1600-0404.2009.01221.x; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202; Simioni S, 2014, J NEUROL, V261, P1606, DOI 10.1007/s00415-014-7398-4; Simon JH, 2000, NEUROLOGY, V55, P185, DOI 10.1212/WNL.55.2.185; Tam RC, 2011, MULT SCLER J, V17, P949, DOI 10.1177/1352458511402113; Truyen L, 1996, NEUROLOGY, V47, P1469, DOI 10.1212/WNL.47.6.1469; van Walderveen MAA, 1998, NEUROLOGY, V50, P1282, DOI 10.1212/WNL.50.5.1282; Venkatesan R, 1998, MAGNET RESON MED, V40, P592, DOI 10.1002/mrm.1910400412	38	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144693	10.1371/journal.pone.0144693	http://dx.doi.org/10.1371/journal.pone.0144693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659852	gold, Green Submitted, Green Published			2022-12-27	WOS:000366903600079
J	Edge, J; Mundel, T; Pilegaard, H; Hawke, E; Leikis, M; Lopez-Villalobos, N; Oliveira, RSF; Bishop, DJ				Edge, Johann; Muendel, Toby; Pilegaard, Henriette; Hawke, Emma; Leikis, Murray; Lopez-Villalobos, Nicolas; Oliveira, Rodrigo S. F.; Bishop, David J.			Ammonium Chloride Ingestion Attenuates Exercise-Induced mRNA Levels in Human Muscle	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; METABOLIC-ACIDOSIS; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; MITOCHONDRIAL BIOGENESIS; SIGNALING PATHWAY; RENAL-FAILURE; L6 CELLS; PROTEIN; RATS	Minimizing the decrease in intracellular pH during high-intensity exercise training promotes greater improvements in mitochondrial respiration. This raises the intriguing hypothesis that pH may affect the exercise-induced transcription of genes that regulate mitochondrial biogenesis. Eight males performed 10x2-min cycle intervals at 80% (V)over dotO(2peak) intensity on two occasions separated by similar to 2 weeks. Participants ingested either ammonium chloride (ACID) or calcium carbonate (PLA) the day before and on the day of the exercise trial in a randomized, counterbalanced order, using a crossover design. Biopsies were taken from the vastus lateralis muscle before and after exercise. The mRNA level of peroxisome proliferator-activated receptor co-activator 1 alpha (PGC-1 alpha), citrate synthase, cytochome c and FOXO1 was elevated at rest following ACID (P<0.05). During the PLA condition, the mRNA content of mitochondrial-and glucose-regulating proteins was elevated immediately following exercise (P<0.05). In the early phase (0-2 h) of post-exercise recovery during ACID, PGC-1 alpha, citrate synthase, cytochome C, FOXO1, GLUT4, and HKII mRNA levels were not different from resting levels (P>0.05); the difference in PGC-1 alpha mRNA content 2 h post-exercise between ACID and PLA was not significant (P = 0.08). Thus, metabolic acidosis abolished the early post-exercise increase of PGC-1 alpha mRNA and the mRNA of downstream mitochondrial and glucose-regulating proteins. These findings indicate that metabolic acidosis may affect mitochondrial biogenesis, with divergent responses in resting and post-exercise skeletal muscle.	[Edge, Johann] Univ Auckland, Dept Sport & Exercise Sci, Auckland 1, New Zealand; [Edge, Johann; Muendel, Toby] Massey Univ, Sch Sport & Exercise, Palmerston North, New Zealand; [Pilegaard, Henriette; Hawke, Emma] Univ Copenhagen, Dept Biol, CIM, Copenhagen, Denmark; [Leikis, Murray] Wellington Hosp, Dept Renal Med, Newtown, New Zealand; [Lopez-Villalobos, Nicolas] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Oliveira, Rodrigo S. F.; Bishop, David J.] Victoria Univ, ISEAL, Melbourne, Vic 8001, Australia	University of Auckland; Massey University; University of Copenhagen; Massey University; Victoria University	Bishop, DJ (corresponding author), Victoria Univ, ISEAL, Melbourne, Vic 8001, Australia.	David.Bishop@vu.edu.au	Mündel, Toby/AAO-9426-2020; Bishop, David John/X-9826-2019; Pilegaard, Henriette/M-2315-2014	Mündel, Toby/0000-0002-4214-8543; Bishop, David John/0000-0002-6956-9188; Lopez-Villalobos, Nicolas/0000-0001-6611-907X; Pilegaard, Henriette/0000-0002-1071-0327	Massey University Research Fund; Danish National Research Foundation [02-512-55]	Massey University Research Fund; Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by a grant from the Massey University Research Fund. The Centre of Inflammation and Metabolism (CIM) is supported by a grant from the Danish National Research Foundation (# 02-512-55). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JL, 2006, J AM SOC NEPHROL, V17, P1388, DOI 10.1681/ASN.2004100842; BAILEY JL, 1995, AM J PHYSIOL-CELL PH, V269, pC706, DOI 10.1152/ajpcell.1995.269.3.C706; Bailey JL, 1996, J CLIN INVEST, V97, P1447, DOI 10.1172/JCI118566; Bentley DJ, 2007, SPORTS MED, V37, P575, DOI 10.2165/00007256-200737070-00002; Bento LMA, 2005, NEPHROL DIAL TRANSPL, V20, P2654, DOI 10.1093/ndt/gfi133; Bevington A, 2002, EUR J CLIN INVEST, V32, P590, DOI 10.1046/j.1365-2362.2002.01038.x; Bishop D, 2009, PFLUG ARCH EUR J PHY, V458, P929, DOI 10.1007/s00424-009-0673-z; Bishop DJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE225, DOI 10.1152/ajpendo.00738.2009; Caso G, 2004, AM J PHYSIOL-ENDOC M, V287, pE90, DOI 10.1152/ajpendo.00387.2003; Edge J, 2006, J APPL PHYSIOL, V101, P918, DOI 10.1152/japplphysiol.01534.2005; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Hashimoto T, 2007, FASEB J, V21, P2602, DOI 10.1096/fj.07-8174com; HAYASHI T, 1992, PFLUG ARCH EUR J PHY, V420, P297, DOI 10.1007/BF00374462; Hollidge-Horvat MG, 1999, AM J PHYSIOL-ENDOC M, V277, pE647, DOI 10.1152/ajpendo.1999.277.4.E647; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; JONES NL, 1977, J APPL PHYSIOL, V43, P959, DOI 10.1152/jappl.1977.43.6.959; KOWALCHUK JM, 1984, J APPL PHYSIOL, V57, P1558, DOI 10.1152/jappl.1984.57.5.1558; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7; Morton JP, 2009, J APPL PHYSIOL, V106, P1513, DOI 10.1152/japplphysiol.00003.2009; Mutsvangwa T, 2004, J NUTR, V134, P558, DOI 10.1093/jn/134.3.558; Niklas P, 2010, EUR J APPL PHYSIOL, V110, P597, DOI 10.1007/s00421-010-1544-1; Nowik M, 2008, PHYSIOL GENOMICS, V32, P322, DOI 10.1152/physiolgenomics.00160.2007; Perez-Schindler J, 2009, P PHYSL SOC, V14, pPC44; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; Pilegaard H, 2002, J PHYSIOL-LONDON, V541, P261, DOI 10.1113/jphysiol.2002.016832; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; Racinais S, 2010, CHRONOBIOL INT, V27, P855, DOI 10.3109/07420521003668412; Rao KVR, 2005, NEUROCHEM INT, V47, P31, DOI 10.1016/j.neuint.2005.04.004; REAICH D, 1992, AM J PHYSIOL, V263, pE735, DOI 10.1152/ajpendo.1992.263.4.E735; Regensteiner JG, 1998, J APPL PHYSIOL, V85, P310, DOI 10.1152/jappl.1998.85.1.310; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Shi Q, 2001, ONCOGENE, V20, P3751, DOI 10.1038/sj.onc.1204500; Stathopoulou K, 2006, J EXP BIOL, V209, P1344, DOI 10.1242/jeb.02134; Thomas C, 2007, AM J PHYSIOL-ENDOC M, V293, pE916, DOI 10.1152/ajpendo.00164.2007; Thomas C, 2012, AM J PHYSIOL-REG I, V302, pR1, DOI 10.1152/ajpregu.00250.2011; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	40	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0141317	10.1371/journal.pone.0141317	http://dx.doi.org/10.1371/journal.pone.0141317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26656911	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000366903500001
J	Maier, LJ; Liakoni, E; Schildmann, J; Schaub, MP; Liechti, ME				Maier, Larissa J.; Liakoni, Evangelia; Schildmann, Jan; Schaub, Michael P.; Liechti, Matthias E.			Swiss University Students' Attitudes toward Pharmacological Cognitive Enhancement	PLOS ONE			English	Article							NEUROENHANCEMENT; METHYLPHENIDATE	Pharmacological cognitive enhancement (PCE) refers to the nonmedical use of prescription or recreational drugs to enhance cognitive performance. Several concerns about PCE have been raised in the public. The aim of the present study was to investigate students' attitudes toward PCE. Students at three Swiss universities were invited by e-mail to participate in a web-based survey. Of the 29,282 students who were contacted, 3,056 participated. Of these students, 22% indicated that they had used prescription drugs (12%) or recreational substances including alcohol (14%) at least once for PCE. The use of prescription drugs or recreational substances including alcohol prior to the last exam was reported by 16%. Users of pharmacological cognitive enhancers were more likely to consider PCE fair (24%) compared with nonusers (11%). Only a minority of the participants agreed with the nonmedical use of prescription drugs by fellow students when assuming weak (7%) or hypothetically strong efficacy and availability to everyone (14%). Two-thirds (68%) considered performance that is obtained with PCE less worthy of recognition. Additionally, 80% disagreed that PCE is acceptable in a competitive environment. More than half (64%) agreed that PCE in academia is similar to doping in sports. Nearly half (48%) claimed that unregulated access to pharmacological cognitive enhancers increases the pressure to engage in PCE and educational inequality (55%). In conclusion, Swiss students' main concerns regarding PCE were related to coercion and fairness. As expected, these concerns were more prevalent among nonusers than among users of pharmacological cognitive enhancers. More balanced information on PCE should be shared with students, and future monitoring of PCE is recommended.	[Maier, Larissa J.; Schaub, Michael P.] Univ Zurich, Associated Inst, Swiss Res Inst Publ Hlth & Addict ISGF, Zurich, Switzerland; [Maier, Larissa J.; Schaub, Michael P.] WHO Collaborating Ctr, Zurich, Switzerland; [Liakoni, Evangelia; Liechti, Matthias E.] Univ Basel Hosp, Dept Clin Res, Div Clin Pharmacol & Toxicol, CH-4031 Basel, Switzerland; [Schildmann, Jan] Ruhr Univ Bochum, Inst Med Eth & Geschichte Med, Bochum, Germany	University of Zurich; World Health Organization; University of Basel; Ruhr University Bochum	Liechti, ME (corresponding author), Univ Basel Hosp, Dept Clin Res, Div Clin Pharmacol & Toxicol, CH-4031 Basel, Switzerland.	matthias.liechti@usb.ch	Schaub, Michael P./ABF-9468-2021; Maier, Larissa/P-8669-2014; Maier, Larissa J/C-2922-2017	Schaub, Michael P./0000-0002-8375-4005; Maier, Larissa/0000-0002-4302-0488; Maier, Larissa J/0000-0002-4302-0488; Schildmann, Jan/0000-0002-5755-7630	Division of Clinical Pharmacology & Toxicology, University Hospital Basel; Swiss Centre of Applied Human Toxicology (SCAHT); Swiss Research Institute for Public Health and Addiction (ISGF), Zurich	Division of Clinical Pharmacology & Toxicology, University Hospital Basel; Swiss Centre of Applied Human Toxicology (SCAHT); Swiss Research Institute for Public Health and Addiction (ISGF), Zurich	This study was supported by internal funds from the Division of Clinical Pharmacology & Toxicology, University Hospital Basel (ML), Swiss Centre of Applied Human Toxicology (SCAHT) (ML), and Swiss Research Institute for Public Health and Addiction (ISGF), Zurich (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagot KS, 2014, ADDICTION, V109, P547, DOI 10.1111/add.12460; Bell S, 2013, NEUROETHICS-NETH, V6, P197, DOI 10.1007/s12152-012-9153-9; de Jongh R, 2008, NEUROSCI BIOBEHAV R, V32, P760, DOI 10.1016/j.neubiorev.2007.12.001; Dodge T, 2012, PSYCHOL ADDICT BEHAV, V26, P678, DOI 10.1037/a0027872; Faulmuller N, 2013, AM J BIOETHICS, V13, P45, DOI 10.1080/15265161.2013.794880; Forlini C, 2014, NEUROETHICS; Forlini C, 2009, BMC MED ETHICS, V10, DOI 10.1186/1472-6939-10-9; Franke AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040047; Franke AndreasG., 2012, AJOB PRIMARY RES, V3, P48, DOI [DOI 10.1080/21507716.2011.608411, 10.1080/21507716.2011.608411]; Goold I, 2015, MED LAW REV, V23, P427, DOI 10.1093/medlaw/fwu028; Hall W., 2012, AJOB PRIMARY RES, V3, P81, DOI [DOI 10.1080/21507716.2012.720639, 10.1080/21507716.2012.720639]; Maier LJ, 2015, EUR PSYCHOL, V20, P155, DOI 10.1027/1016-9040/a000228; Maier LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077967; Maslen H, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00107; Ott R, 2014, PHARMACOPSYCHIATRY, V47, P22, DOI 10.1055/s-0033-1358682; Partridge B., 2014, PERMANCE ENHANCEM, V3, P20, DOI [https://doi.org/10.1016/j.peh.2014.03.001, DOI 10.1016/J.PEH.2014.03.001]; Partridge B, 2013, DRUG ALCOHOL REV, V32, P295, DOI 10.1111/dar.12005; Repantis D, 2010, PHARMACOL RES, V62, P187, DOI 10.1016/j.phrs.2010.04.002; Sattler S, 2014, SUBST ABUSE TREAT PR, V9, DOI 10.1186/1747-597X-9-8; Sattler S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068821; Schelle KJ, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00010; Schelle KJ, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00053; Shook JR, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00228	23	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144402	10.1371/journal.pone.0144402	http://dx.doi.org/10.1371/journal.pone.0144402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YZ	26657300	Green Accepted, Green Published, gold			2022-12-27	WOS:000366903500026
J	Li, DD; Wang, TS; Shen, S; Cheng, S; Yu, JX; Zhang, Y; Zhang, C; Tang, HL				Li, Dandan; Wang, Tiansheng; Shen, Su; Cheng, Sheng; Yu, Junxian; Zhang, Yang; Zhang, Chao; Tang, Huilin			Effects of Fluroquinolones in Newly Diagnosed, Sputum-Positive Tuberculosis Therapy: A Systematic Review and Network Meta-Analysis	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; RANDOMIZED CONTROLLED-TRIALS; EARLY BACTERICIDAL ACTIVITY; PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; STERILIZING ACTIVITIES; CULTURE CONVERSION; CONTAINING REGIMEN; PHASE-II; MOXIFLOXACIN	Background Tuberculosis is a major public health problem especially in developing countries, the comparative efficacy and safety of fluroquinolones (FQs) for adult patients with newly diagnosed, sputum-positive tuberculosis remains controversial. We aimed to investigate the benefits and risks of FQs-containing (addition/substitution) regimens in this population. Methods A network meta-analysis was performed to compare FQs (C: ciprofloxacin; O: ofloxacin; Lo: levofloxacin; M: moxifloxacin; G: gatifloxacin) addition/substitution regimen with standard HRZE regimen (ie isoniazid, rifampicin, pyrazinamide and ethambutol) in newly diagnosed, sputum-positive tuberculosis. Medline, Embase and Cochrane Central Register of Controlled Trials were systematically searched, randomized trials with duration longer than 8 weeks were included. The primary outcome was week-8 sputum negativity, and secondary outcomes included treatment failure, serious adverse events and death from all cause. Results Twelve studies comprising 6465 participants were included in the network meta-analysis. Lowenstein-Jensen culture method showed that HRZEM (OR 4.96, 95% CI 2.83-8.67), MRZE (OR 1.48, 95% CI 1.19-1.84) and HRZM (OR 1.32, 95% CI 1.08-1.62) had more sputum conversion than HRZE by the eighth week, whereas HRC (OR 0.39, 95% CI 0.19-0.77) and HRZO (OR 0.47, 95% CI 0.24-0.92) were worse than HRZE. Moxifloxacin-containing regimens showed more conversion than HRZE by liquid method at the end of two months. But by the end of treatment, FQs-containing regimens didn't show superiority than HRZE on treatment failure. There were no significant differences between any regimens on other outcomes like serious adverse events and all-cause death. Conclusion This comprehensive network meta-analysis showed that compared with HRZE, moxifloxacin-containing regimens could significantly increase sputum conversion by the eighth week for patients with newly diagnosed pulmonary tuberculosis while HRC and HRZO regimens were inferior. But all the FQs-containing regimens did not show superiority in other outcomes (such as treatment failure, serious adverse events and all-cause death). Thus, HRZE is still an effective regimen for this population. Although moxifloxacin-containing regimens have deomonstrated their potential, FQs-containing regimens should be used with great caution to avoid widespread FQs-resistance worldwide.	[Li, Dandan; Shen, Su; Cheng, Sheng; Yu, Junxian; Zhang, Yang; Zhang, Chao] Capital Med Univ, Beijing Friendship Hosp, Dept Pharm, Beijing, Peoples R China; [Wang, Tiansheng] Peking Univ, Dept Pharm Adm & Clin Pharm, Sch Pharmaceut Sci, Beijing 100871, Peoples R China; [Tang, Huilin] Peking Univ, Dept Pharm, Hosp 3, Beijing 100871, Peoples R China	Capital Medical University; Peking University; Peking University	Tang, HL (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Pharm, Beijing, Peoples R China.	hltang1985@bjmu.edu.cn		Tang, Huilin/0000-0002-5814-6657				Abraha I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2697; Almeida D, 2007, ANTIMICROB AGENTS CH, V51, P4261, DOI 10.1128/AAC.01123-07; Alvirez-Freites EJ, 2002, ANTIMICROB AGENTS CH, V46, P1022, DOI 10.1128/AAC.46.4.1022-1025.2002; [Anonymous], RAND CLIN TRIAL TRIA; Basu S, 2009, P NATL ACAD SCI USA, V106, P7672, DOI 10.1073/pnas.0812472106; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Burman WJ, 2006, AM J RESP CRIT CARE, V174, P331, DOI 10.1164/rccm.200603-360OC; Caldwell DM, 2010, J CLIN EPIDEMIOL, V63, P875, DOI 10.1016/j.jclinepi.2009.08.025; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Chan ED, 2004, AM J RESP CRIT CARE, V169, P1103, DOI 10.1164/rccm.200308-1159OC; Conde MB, 2009, LANCET, V373, P1183, DOI 10.1016/S0140-6736(09)60333-0; DerSimonian R, 2015, CONTROL CLIN TRIALS, VS1551-7144; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; El-Sadr WM, 1998, CLIN INFECT DIS, V26, P1148, DOI 10.1086/520275; Fraunfelder FW, 2006, EXPERT OPIN DRUG SAF, V5, P615, DOI 10.1517/14740338.5.5.615; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426; Ginsberg AM, 2010, TUBERCULOSIS, V90, P162, DOI 10.1016/j.tube.2010.03.003; Ginsburg AS, 2003, LANCET INFECT DIS, V3, P432, DOI 10.1016/S1473-3099(03)00671-6; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hooper DC, 1999, DRUG RESIST UPDATE, V2, P38, DOI 10.1054/drup.1998.0068; Jawahar MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067030; Jindani A, 2014, NEW ENGL J MED, V371, P1599, DOI 10.1056/NEJMoa1314210; Johnson JL, 2006, INT J TUBERC LUNG D, V10, P605; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Kadioglu EE, 2014, EURASIAN J MED, V46, P74, DOI 10.5152/eajm.2014.19; KENNEDY N, 1993, AM REV RESPIR DIS, V148, P1547, DOI 10.1164/ajrccm/148.6_Pt_1.1547; Kennedy N, 1996, CLIN INFECT DIS, V22, P827, DOI 10.1093/clinids/22.5.827; Keus F, 2009, AM J GASTROENTEROL, V104, P546, DOI 10.1038/ajg.2008.22; Li X, 2012, INT J TUBERC LUNG D, V16, P612, DOI 10.5588/ijtld.11.0507; Long R, 2013, CAN J PUBLIC HEALTH, V104, pE22, DOI 10.1007/BF03405649; Lounis N, 2001, ANTIMICROB AGENTS CH, V45, P3482, DOI 10.1128/AAC.45.12.3482-3486.2001; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817; MITCHISON DA, 1993, AM REV RESPIR DIS, V147, P1062, DOI 10.1164/ajrccm/147.4.1062; Moadebi S, 2007, DRUGS, V67, P2077, DOI 10.2165/00003495-200767140-00007; Moreno SG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-2; Mukamolova GV, 2002, MOL MICROBIOL, V46, P623, DOI 10.1046/j.1365-2958.2002.03184.x; Nuermberger EL, 2004, AM J RESP CRIT CARE, V169, P421, DOI 10.1164/rccm.200310-1380OC; Peloquin CA, 2008, ANTIMICROB AGENTS CH, V52, P852, DOI 10.1128/AAC.01036-07; Pietersen E, 2014, LANCET, V383, P1230, DOI 10.1016/S0140-6736(13)62675-6; Pletz MWR, 2004, ANTIMICROB AGENTS CH, V48, P780, DOI 10.1128/AAC.48.3.780-782.2004; Raviglione M, 2006, INT J TUBERC LUNG D, V10, P1185; Rustomjee R, 2008, INT J TUBERC LUNG D, V12, P128; Shean K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063057; Smythe W, 2013, ANTIMICROB AGENTS CH, V57, P4164, DOI 10.1128/AAC.00479-13; Stijnen T, 2010, STAT MED, V29, P3046, DOI 10.1002/sim.4040; Trinquart L, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-150; Velayutham BV, 2014, CLIN INFECT DIS, V59, pE142, DOI 10.1093/cid/ciu550; White IR, 2012, RES SYNTH METHODS, V3, P111, DOI 10.1002/jrsm.1045; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Ziganshina LE, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004795.pub3, 10.1002/14651858.CD004795.pub2]; Ziganshina LE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004795.pub4; Zumla A, 2013, LANCET, V382, P1765, DOI 10.1016/S0140-6736(13)62078-4	55	19	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145066	10.1371/journal.pone.0145066	http://dx.doi.org/10.1371/journal.pone.0145066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669635	Green Published, gold, Green Submitted			2022-12-27	WOS:000366719300044
J	Goldsmith, LP; Dunn, G; Bentall, RP; Lewis, SW; Wearden, AJ				Goldsmith, Lucy P.; Dunn, Graham; Bentall, Richard P.; Lewis, Shon W.; Wearden, Alison J.			Therapist Effects and the Impact of Early Therapeutic Alliance on Symptomatic Outcome in Chronic Fatigue Syndrome	PLOS ONE			English	Article							COGNITIVE-BEHAVIOR THERAPY; GRADED-EXERCISE; PSYCHOTHERAPY; INTERVENTIONS; WORKING; TRIALS	Few studies have examined therapist effects and therapeutic alliance (TA) in treatments for chronic fatigue syndrome (CFS). Therapist effects are the differences in outcomes achieved by different therapists. TA is the quality of the bond and level of agreement regarding the goals and tasks of therapy. Prior research suffers the methodological problem that the allocation of therapist was not randomized, meaning therapist effects may be confounded with selection effects. We used data from a randomized controlled treatment trial of 296 people with CFS. The trial compared pragmatic rehabilitation (PR), a nurse led, home based self-help treatment, a counselling-based treatment called supportive listening (SL), with general practitioner treatment as usual. Therapist allocation was randomized. Primary outcome measures, fatigue and physical functioning were assessed blind to treatment allocation. TA was measured in the PR and SL arms. Regression models allowing for interactions were used to examine relationships between (i) therapist and therapeutic alliance, and (ii) therapist and average treatment effect (the difference in mean outcomes between different treatment conditions). We found no therapist effects. We found no relationship between TA and the average treatment effect of a therapist. One therapist formed stronger alliances when delivering PR compared to when delivering SL (effect size 0.76, SE 0.33, 95% CI 0.11 to 1.41). In these therapies for CFS, TA does not influence symptomatic outcome. The lack of significant therapist effects on outcome may result from the trial's rigorous quality control, or random therapist allocation, eliminating selection effects. Further research is needed.	[Goldsmith, Lucy P.; Dunn, Graham] Univ Manchester, Inst Populat Hlth, Ctr Biostat, Manchester, Lancs, England; [Goldsmith, Lucy P.; Dunn, Graham; Lewis, Shon W.; Wearden, Alison J.] Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Goldsmith, Lucy P.] Univ Huddersfield, Sch Hlth & Human Sci, Huddersfield HD1 3DH, W Yorkshire, England; [Bentall, Richard P.] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England; [Lewis, Shon W.] Univ Manchester, Inst Brain Behav & Mental Hlth, Manchester, Lancs, England; [Wearden, Alison J.] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Wearden, Alison J.] Univ Manchester, Manchester Ctr Hlth Psychol, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Huddersfield; University of Liverpool; University of Manchester; University of Manchester; University of Manchester	Goldsmith, LP (corresponding author), Univ Manchester, Inst Populat Hlth, Ctr Biostat, Manchester, Lancs, England.	LPGoldsmith1@gmail.com	Goldsmith, Lucy/AFB-2121-2022	Goldsmith, Lucy/0000-0002-6934-1925; Lewis, Shon/0000-0003-1861-4652	Medical Research Council [G200212]; UK Department of Health; MRC [G0200212] Funding Source: UKRI; Medical Research Council [G0200212] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (Grant no G200212) (www.mrc.ac.uk) and the UK Department of Health (https://www.gov.uk/government/organisations/department-of-health).	[Anonymous], 2007, NICE GUIDELINE CG53; Barber JP, 2009, PSYCHOTHER RES, V19, P1, DOI 10.1080/10503300802609680; Bordin ES., 1979, PSYCHOTHERAPY THEORY, V16, DOI [10.1037/h0085885, DOI 10.1037/H0085885]; Castell BD, 2011, CLIN PSYCHOL-SCI PR, V18, P311, DOI 10.1111/j.1468-2850.2011.01262.x; Cella M, 2011, PSYCHOTHER RES, V21, P168, DOI 10.1080/10503307.2010.535571; Cella M, 2010, J PSYCHOSOM RES, V69, P17, DOI 10.1016/j.jpsychores.2009.10.007; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Chalder T, 2015, LANCET PSYCHIAT, V2, P141, DOI 10.1016/S2215-0366(14)00069-8; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crits-Christoph P., 1991, PSYCHOTHER RES, V1, P2, DOI [DOI 10.1080/10503309112331335511, 10.1080/10503309112331335511]; CRITSCHRISTOPH P, 1991, J CONSULT CLIN PSYCH, V59, P20, DOI 10.1037/0022-006X.59.1.20; Dunn G, 2007, STAT MED, V26, P4719, DOI 10.1002/sim.2891; Elkin I, 1999, CLIN PSYCHOL-SCI PR, V6, P10, DOI 10.1093/clipsy/6.1.10; Everitt B, 2004, WORLD SCI; Godfrey E, 2007, BRIT J CLIN PSYCHOL, V46, P253, DOI 10.1348/014466506X147420; Green J, 2008, BRIT J PSYCHIAT, V192, P323, DOI 10.1192/bjp.bp.107.046284; Heins MJ, 2013, J PSYCHOSOM RES, V75, P235, DOI 10.1016/j.jpsychores.2013.06.034; Heins MJ, 2013, BEHAV RES THER, V51, P368, DOI 10.1016/j.brat.2013.02.001; HEYTING A, 1992, STAT MED, V11, P2043, DOI 10.1002/sim.4780111603; HORVATH AO, 1991, J COUNS PSYCHOL, V38, P139, DOI 10.1037/0022-0167.38.2.139; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Luborsky L, 1999, CLIN PSYCHOL-SCI PR, V6, P95, DOI 10.1093/clipsy/6.1.95; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; McLeod BD, 2011, CLIN PSYCHOL REV, V31, P603, DOI 10.1016/j.cpr.2011.02.003; Morriss RK, 1998, J PSYCHOSOM RES, V45, P411, DOI 10.1016/S0022-3999(98)00022-1; Moss-Morris R, 2005, J HEALTH PSYCHOL, V10, P245, DOI 10.1177/1359105305049774; MURAN JC, 1995, J CONSULT CLIN PSYCH, V63, P651, DOI 10.1037/0022-006X.63.4.651; Powell P, 2001, BMJ-BRIT MED J, V322, P387, DOI 10.1136/bmj.322.7283.387; Rimes KA, 2014, BEHAV COGN PSYCHOTH, V42, P760, DOI 10.1017/S1352465814000290; Serlin RC, 2003, PSYCHOL METHODS, V8, P524, DOI 10.1037/1082-989X.8.4.524; SHARPE MC, 1991, J ROY SOC MED, V84, P118, DOI 10.1177/014107689108400224; Soldz S, 2006, PSYCHOTHER RES, V16, P173, DOI 10.1080/10503300500264937; Statacorp STATA, 2013, STAT SOFTW REL 13; Wampold B.E., 2012, COUNS PSYCHOL, V40, P601, DOI [10.1177/0011000011432709, DOI 10.1177/0011000011432709]; Wampold BE, 2013, GREAT PSYCHOTHERAPY, V9; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wearden AJ, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-9; Wearden AJ, 2013, J CONSULT CLIN PSYCH, V81, P831, DOI 10.1037/a0033561; Wearden AJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1777; Westcare, 1994, REP NAT TASK FORC CH; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; White IR, 2005, STAT MED, V24, P993, DOI 10.1002/sim.1981; White PD, 2011, LANCET, V377, P823, DOI 10.1016/S0140-6736(11)60096-2; Wiborg J, 2012, J PSYCHOSOM RES, V72, P509; Wiborg JF, 2011, J PSYCHOSOM RES, V70, P306, DOI 10.1016/j.jpsychores.2010.12.011; XLSTAT, 2014, XLSTAT STAT SOFTW	47	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144623	10.1371/journal.pone.0144623	http://dx.doi.org/10.1371/journal.pone.0144623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26657793	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900074
J	Jiang, X; Jiang, Y; Parasuraman, R				Jiang, Xiong; Jiang, Yang; Parasuraman, Raja			The Visual Priming of Motion-Defined 3D Objects	PLOS ONE			English	Article							STRUCTURE-FROM-MOTION; SHAPE; AREA; PERCEPTION; REPRESENTATION; CORTEX; MEMORY; FORM; STIMULATION; REPETITION	The perception of a stimulus can be influenced by previous perceptual experience, a phenomenon known as perceptual priming. However, there has been limited investigation on perceptual priming of shape perception of three-dimensional object structures defined by moving dots. Here we examined the perceptual priming of a 3D object shape defined purely by motion-in-depth cues (i.e., Shape-From-Motion, SFM) using a classic prime-target paradigm. The results from the first two experiments revealed a significant increase in accuracy when a "cloudy" SFM stimulus (whose object structure was difficult to recognize due to the presence of strong noise) was preceded by an unambiguous SFM that clearly defined the same transparent 3D shape. In contrast, results from Experiment 3 revealed no change in accuracy when a "cloudy" SFM stimulus was preceded by a static shape or a semantic word that defined the same object shape. Instead, there was a significant decrease in accuracy when preceded by a static shape or a semantic word that defined a different object shape. These results suggested that the perception of a noisy SFM stimulus can be facilitated by a preceding unambiguous SFM stimulus-but not a static image or a semantic stimulus-that defined the same shape. The potential neural and computational mechanisms underlying the difference in priming are discussed.	[Jiang, Xiong] Georgetown Univ, Dept Neurosci, Med Ctr, Washington, DC 20007 USA; [Jiang, Yang] Univ Kentucky, Coll Med, Dept Behav Sci, Lexington, KY 40506 USA; [Parasuraman, Raja] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA	Georgetown University; University of Kentucky; George Mason University	Jiang, X (corresponding author), Georgetown Univ, Dept Neurosci, Med Ctr, Washington, DC 20007 USA.	xj9@georgetown.edu		JIANG, Yang/0000-0003-4589-0097	NIH [AG19653, AG000986]; NATIONAL INSTITUTE ON AGING [U01AG019653, K01AG000986, R01AG019653] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants AG19653 to RP and AG000986 to YJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported by NIH grants AG19653 to RP and AG000986 to YJ. We thank C Olash for proof-reading the manuscript.	Beer AL, 2009, EUR J NEUROSCI, V30, P703, DOI 10.1111/j.1460-9568.2009.06857.x; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Brascamp JW, 2010, J NEUROSCI, V30, P760, DOI 10.1523/JNEUROSCI.4171-09.2010; Brouwer GJ, 2007, J NEUROSCI, V27, P1015, DOI 10.1523/JNEUROSCI.4593-06.2007; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Campana G, 2002, CEREB CORTEX, V12, P663, DOI 10.1093/cercor/12.6.663; Chen XC, 2004, CURR BIOL, V14, P1013, DOI 10.1016/j.cub.2004.05.042; de Jong MC, 2012, EUR J NEUROSCI, V36, P3718, DOI 10.1111/ejn.12005; de Jong MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030595; Glezer LS, 2009, NEURON, V62, P199, DOI 10.1016/j.neuron.2009.03.017; Gotts SJ, 2012, COGN NEUROSCI-UK, V3, P227, DOI 10.1080/17588928.2012.670617; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Jiang X, 2006, NEURON, V50, P159, DOI 10.1016/j.neuron.2006.03.012; Jiang X, 2007, NEURON, V53, P891, DOI 10.1016/j.neuron.2007.02.015; Jiang X, 2014, VISION RES, V105, P77, DOI 10.1016/j.visres.2014.08.023; Jiang Y, 2002, BRAIN RES BULL, V57, P211, DOI 10.1016/S0361-9230(01)00743-2; Jiang Y, 1998, PERCEPT PSYCHOPHYS, V60, P275, DOI 10.3758/BF03206036; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Klink PC, 2012, J NEUROPHYSIOL, V108, P2101, DOI 10.1152/jn.00252.2012; KOENDERINK JJ, 1991, J OPT SOC AM A, V8, P377, DOI 10.1364/JOSAA.8.000377; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Krekelberg B, 2006, TRENDS NEUROSCI, V29, P250, DOI 10.1016/j.tins.2006.02.008; Kriegeskorte N, 2003, J NEUROSCI, V23, P1451, DOI 10.1523/JNEUROSCI.23-04-01451.2003; Liu CL, 2015, NEUROIMAGE-CLIN, V8, P667, DOI 10.1016/j.nicl.2014.12.003; Maier A, 2003, CURR BIOL, V13, P1076, DOI 10.1016/S0960-9822(03)00414-7; Murd C, 2012, VISION RES, V68, P59, DOI 10.1016/j.visres.2012.07.009; Murray SO, 2003, CEREB CORTEX, V13, P508, DOI 10.1093/cercor/13.5.508; Mysore SG, 2010, J NEUROSCI, V30, P15491, DOI 10.1523/JNEUROSCI.0820-10.2010; Orban GA, 1999, NEURON, V24, P929, DOI 10.1016/S0896-6273(00)81040-5; Orban GA, 2011, ANNU REV NEUROSCI, V34, P361, DOI 10.1146/annurev-neuro-061010-113819; Paradis AL, 2000, CEREB CORTEX, V10, P772, DOI 10.1093/cercor/10.8.772; Pastukhov A, 2013, ATTEN PERCEPT PSYCHO, V75, P1215, DOI 10.3758/s13414-013-0471-8; Sarkheil P, 2008, NEUROIMAGE, V42, P1529, DOI 10.1016/j.neuroimage.2008.04.265; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Schacter DL, 2004, NAT REV NEUROSCI, V5, P853, DOI 10.1038/nrn1534; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Theoret H, 2002, NEUROPSYCHOLOGIA, V40, P2280, DOI 10.1016/S0028-3932(02)00112-4; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; van Turennout M, 2000, NAT NEUROSCI, V3, P1329, DOI 10.1038/81873; Vanduffel W, 2002, SCIENCE, V298, P413, DOI 10.1126/science.1073574; Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880; Weigelt S, 2007, J NEUROSCI, V27, P3864, DOI 10.1523/JNEUROSCI.0340-07.2007; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Zhang QF, 2012, P NATL ACAD SCI USA, V109, P20691, DOI 10.1073/pnas.1218654109	46	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144730	10.1371/journal.pone.0144730	http://dx.doi.org/10.1371/journal.pone.0144730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658496	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900097
J	Mendoza-Olazaran, S; Morfin-Otero, R; Villarreal-Trevino, L; Rodriguez-Noriega, E; Llaca-Diaz, J; Camacho-Ortiz, A; Gonzalez, GM; Casillas-Vega, N; Garza-Gonzalez, E				Mendoza-Olazaran, Soraya; Morfin-Otero, Rayo; Villarreal-Trevino, Licet; Rodriguez-Noriega, Eduardo; Llaca-Diaz, Jorge; Camacho-Ortiz, Adrian; Gonzalez, Gloria M.; Casillas-Vega, Nestor; Garza-Gonzalez, Elvira			Antibiotic Susceptibility of Biofilm Cells and Molecular Characterisation of Staphylococcus hominis Isolates from Blood	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; COAGULASE-NEGATIVE STAPHYLOCOCCI; FIELD GEL-ELECTROPHORESIS; 23S RIBOSOMAL-RNA; NOSOCOMIAL SPREAD; RESISTANCE; STRAINS; EPIDERMIDIS; AUREUS; IDENTIFICATION	Objectives We aimed to characterise the staphylococcal cassette chromosome mec (SCCmec) type, genetic relatedness, biofilm formation and composition, icaADBC genes detection, icaD expression, and antibiotic susceptibility of planktonic and biofilm cells of Staphylococcus hominis isolates from blood. Methods The study included 67 S. hominis blood isolates. Methicillin resistance was evaluated with the cefoxitin disk test. mecA gene and SCCmec were detected by multiplex PCR. Genetic relatedness was determined by pulsed-field gel electrophoresis. Biofilm formation and composition were evaluated by staining with crystal violet and by detachment assay, respectively; and the biofilm index (BI) was determined. Detection and expression of icaADBC genes were performed by multiplex PCR and real-time PCR, respectively. Antibiotic susceptibilities of planktonic cells (minimum inhibitory concentration, MIC) and biofilm cells (minimum biofilm eradication concentration, MBEC) were determined by the broth dilution method. Results Eighty-five percent (57/67) of isolates were methicillin resistant and mecA positive. Of the mecA-positive isolates, 66.7%(38/57) carried a new putative SCCmec type. Four clones were detected, with two to five isolates each. Among all isolates, 91% (61/67) were categorised as strong biofilm producers. Biofilm biomass composition was heterogeneous ( polysaccharides, proteins and DNA). All isolates presented the icaD gene, and 6.66%(1/15) isolates expressed icaD. This isolate presented the five genes of ica operon. Higher BI and MBEC values than the MIC values were observed for amikacin, vancomycin, linezolid, oxacillin, ciprofloxacin, and chloramphenicol. Conclusions S. hominis isolates were highly resistant to methicillin and other antimicrobials. Most of the detected SCCmec types were different than those described for S. aureus. Isolates indicated low clonality. The results indicate that S. hominis is a strong biofilm producer with an extracellular matrix with similar composition of proteins, DNA and N-acetylglucosamine; and presents high frequency and low expression of icaD gene. Biofilm production is associated with increased antibiotic resistance.	[Mendoza-Olazaran, Soraya; Casillas-Vega, Nestor; Garza-Gonzalez, Elvira] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Serv Gastroenterol, Monterrey, Nuevo Leon, Mexico; [Morfin-Otero, Rayo; Rodriguez-Noriega, Eduardo] Hosp Civil Guadalajara, Guadalajara, Jalisco, Mexico; [Morfin-Otero, Rayo; Rodriguez-Noriega, Eduardo] Univ Guadalajara, Inst Patol Infecciosa & Expt, Ctr Univ Ciencias Salud, Guadalajara 44430, Jalisco, Mexico; [Villarreal-Trevino, Licet] Univ Autonoma Nuevo Leon, Dept Microbiol & Inmunol, Fac Ciencias Biol, Monterrey, Nuevo Leon, Mexico; [Llaca-Diaz, Jorge; Garza-Gonzalez, Elvira] Univ Autonoma Nuevo Leon, Dept Patol Clin, Hosp Univ Dr Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico; [Camacho-Ortiz, Adrian] Univ Autonoma Nuevo Leon, Serv Infectol, Hosp Univ Dr Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico; [Gonzalez, Gloria M.] Univ Autonoma Nuevo Leon, Fac Med, Dept Microbiol, Monterrey, Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad de Guadalajara; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon	Garza-Gonzalez, E (corresponding author), Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Serv Gastroenterol, Monterrey, Nuevo Leon, Mexico.	elvira_garza_gzz@yahoo.com	Morfín-Otero, Rayo/AAR-8027-2021; Casillas-Vega, Nestor/A-8210-2019	Morfín-Otero, Rayo/0000-0001-9576-1950; Rodriguez-Noriega, Eduardo/0000-0002-1386-4815; Villarreal, Licet/0000-0002-4721-6162; Mendoza-Olazaran, Soraya/0000-0001-5649-4810; Llaca Diaz, Jorge Martin/0000-0001-6875-2530; Casillas-Vega, Nestor/0000-0003-2242-9126	CONACyT (Mexican Council for Science and Technology) [CB-2011-01-167802]	CONACyT (Mexican Council for Science and Technology)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grant CB-2011-01-167802 from CONACyT (Mexican Council for Science and Technology).	Arciola CR, 2005, J BIOMED MATER RES A, V75A, P408, DOI 10.1002/jbm.a.30445; Bouchami O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021940; Ceri H, 2001, METHOD ENZYMOL, V337, P377, DOI 10.1016/S0076-6879(01)37026-X; Chamon RC, 2014, DIAGN MICR INFEC DIS, V80, P307, DOI 10.1016/j.diagmicrobio.2014.09.011; Chaves F, 2005, J CLIN MICROBIOL, V43, P4877, DOI 10.1128/JCM.43.9.4877-4879.2005; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; CLSI, 2017, M100 CLSI, DOI DOI 10.1039/C4DT01694G; Cui BT, 2015, J MED MICROBIOL, V64, P591, DOI 10.1099/jmm.0.000059; Cunha BA, 2007, HEART LUNG, V36, P380, DOI 10.1016/j.hrtlng.2006.11.002; d'Azevedo PA, 2008, J MED MICROBIOL, V57, P256, DOI 10.1099/jmm.0.47345-0; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; de Almeida LM, 2013, ANTIMICROB AGENTS CH, V57, P4082, DOI 10.1128/AAC.00437-13; DEIGHTON M, 1993, INFECT IMMUN, V61, P4473, DOI 10.1128/IAI.61.10.4473-4479.1993; Fitzpatrick F, 2005, J CLIN MICROBIOL, V43, P1973, DOI 10.1128/JCM.43.4.1973-1976.2005; Frank KL, 2007, INFECT IMMUN, V75, P4728, DOI 10.1128/IAI.00640-07; Frank KL, 2007, ANTIMICROB AGENTS CH, V51, P888, DOI 10.1128/AAC.01052-06; Fredheim EGA, 2009, J CLIN MICROBIOL, V47, P1172, DOI 10.1128/JCM.01891-08; Garza-Gonzalez E, 2010, EPIDEMIOL INFECT, V138, P645, DOI 10.1017/S0950268809991361; Garza-Gonzalez E, 2011, SCAND J INFECT DIS, V43, P930, DOI 10.3109/00365548.2011.598873; de Allori MCG, 2006, BIOL PHARM BULL, V29, P1592, DOI 10.1248/bpb.29.1592; Heikens E, 2005, J CLIN MICROBIOL, V43, P2286, DOI 10.1128/JCM.43.5.2286-2290.2005; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Klingenberg C, 2005, PEDIATR INFECT DIS J, V24, P817, DOI 10.1097/01.inf.0000176735.20008.cd; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Larson EL, 1998, AM J INFECT CONTROL, V26, P513, DOI 10.1016/S0196-6553(98)70025-2; Mendoza-Olazaran S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061161; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Oliveira DC, 2006, ANTIMICROB AGENTS CH, V50, P3457, DOI 10.1128/AAC.00629-06; Qin ZQ, 2007, J MED MICROBIOL, V56, P83, DOI 10.1099/jmm.0.46799-0; Qu Y, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-16; de Gopegui ER, 2011, ENFERM INFEC MICR CL, V29, P339, DOI 10.1016/j.eimc.2011.02.001; STRUELENS MJ, 1992, J CLIN MICROBIOL, V30, P2599, DOI 10.1128/JCM.30.10.2599-2605.1992; Sunbul M, 2006, PACE, V29, P543, DOI 10.1111/j.1540-8159.2006.00391.x; Sychev YV, 2014, EYE, V28, P1517, DOI 10.1038/eye.2014.201; Szczuka E, 2015, FOLIA MICROBIOL, V60, P1, DOI 10.1007/s12223-014-0332-4; Szczuka E, 2014, POL J MICROBIOL, V63, P349; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Palazzo ICV, 2008, J ANTIMICROB CHEMOTH, V62, P1222, DOI 10.1093/jac/dkn375; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Wohoush A, 2011, CLIN MICROBIOL INFEC, V17, P569, DOI 10.1111/j.1469-0691.2010.03372.x; Won JY, 2013, CLIN OPHTHALMOL, V7, P1193, DOI 10.2147/OPTH.S46792; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005; Zhang L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058440, 10.1371/journal.pone.0066496]	44	15	15	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144684	10.1371/journal.pone.0144684	http://dx.doi.org/10.1371/journal.pone.0144684			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659110	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900086
J	Pinar, IP; Arthur, JF; Andrews, RK; Gardiner, EE; Ryan, K; Carberry, J				Pinar, Isaac P.; Arthur, Jane F.; Andrews, Robert K.; Gardiner, Elizabeth E.; Ryan, Kris; Carberry, Josie			Methods to Determine the Lagrangian Shear Experienced by Platelets during Thrombus Growth	PLOS ONE			English	Article							AGGREGATION; MECHANISM; FLOW	Platelets can become activated in response to changes in flow-induced shear; however, the underlying molecular mechanisms are not clearly understood. Here we present new techniques for experimentally measuring the flow-induced shear rate experienced by platelets prior to adhering to a thrombus. We examined the dynamics of blood flow around experimentally grown thrombus geometries using a novel combination of experimental (ex vivo) and numerical (in silico) methodologies. Using a microcapillary system, platelet aggregate formation was analysed at elevated shear rates in the presence of coagulation inhibitors, where thrombus formation is predominantly platelet-dependent. These approaches permit the resolution and quantification of thrombus parameters at the scale of individual platelets (2 mu m) in order to quantify real time thrombus development. Using our new techniques we can correlate the shear rate experienced by platelets with the extent of platelet adhesion and aggregation. The techniques presented offer the unique capacity to determine the flow properties for a temporally evolving thrombus field in real time.	[Pinar, Isaac P.; Ryan, Kris; Carberry, Josie] Monash Univ, Dept Mech & Aerosp Engn, Melbourne, Vic 3004, Australia; [Pinar, Isaac P.; Carberry, Josie] Monash Univ, Fac Engn, Div Biol Engn, Melbourne, Vic 3004, Australia; [Arthur, Jane F.; Andrews, Robert K.; Gardiner, Elizabeth E.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia	Monash University; Monash University; Monash University	Carberry, J (corresponding author), Monash Univ, Dept Mech & Aerosp Engn, Melbourne, Vic 3004, Australia.	Josie.Carberry@monash.edu	Gardiner, Elizabeth/P-8716-2019; ARTHUR, JANE/AAW-9983-2020	Gardiner, Elizabeth/0000-0001-9453-9688; Andrews, Robert Keith/0000-0001-9577-8082	National Health and Medical Research Council of Australia; National Heart Foundation of Australia; Victorian Life Sciences Computation Initiative (VLSCI) [VR0023]; Multi-modal Australian ScienceS Imaging and Visualisation Environment (MASSIVE) [MONASH024]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); Victorian Life Sciences Computation Initiative (VLSCI); Multi-modal Australian ScienceS Imaging and Visualisation Environment (MASSIVE)	This research was supported by the National Health and Medical Research Council of Australia, the National Heart Foundation of Australia, the Victorian Life Sciences Computation Initiative (VLSCI) (grant VR0023 using the Peak Computing Facility at the University of Melbourne, an initiative of the Victorian Government, Australia) and by the Multi-modal Australian ScienceS Imaging and Visualisation Environment (MASSIVE) (www.massive.org.au) (grant MONASH024).	Al-Tamimi M, 2012, BLOOD, V119, P4311, DOI 10.1182/blood-2011-10-386607; Bacabac RG, 2005, J BIOMECH, V38, P159, DOI 10.1016/j.jbiomech.2004.03.020; Branchford BR, 2015, THROMB RES, V136, P13, DOI 10.1016/j.thromres.2015.05.012; Casa LDC, 2015, J VASC SURG, V61, P1068, DOI 10.1016/j.jvs.2014.12.050; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Colace TV, 2013, ANNU REV BIOMED ENG, V15, P283, DOI 10.1146/annurev-bioeng-071812-152406; Cosemans JMEM, 2013, CARDIOVASC RES, V99, P342, DOI 10.1093/cvr/cvt110; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Li M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082493; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; OPENCFD, 2014, OPENFOAM OP SOURC CF; Pitts KL, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/10/105302; Pitts KL, 2014, PLOS ONE, V9; Press WH, 2007, NUMERICAL RECIPES AR, V3, P907; Tolouei E, 2011, ANN BIOMED ENG, V39, P1403, DOI 10.1007/s10439-010-0239-4; Visualization Sciences Group (VSG), 2014, AV STAND 3D AN SOFTW; Westein E, 2013, P NATL ACAD SCI USA, V110, P1357, DOI 10.1073/pnas.1209905110; Yuan YP, 1997, J BIOL CHEM, V272, P21847, DOI 10.1074/jbc.272.35.21847	18	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144860	10.1371/journal.pone.0144860	http://dx.doi.org/10.1371/journal.pone.0144860			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660525	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900122
J	Zhu, C; Li, F; Wong, MCM; Feng, XP; Lu, HX; Xu, W				Zhu, Ce; Li, Fei; Wong, May. Chun. Mei; Feng, Xi-Ping; Lu, Hai-Xia; Xu, Wei			Association between Herpesviruses and Chronic Periodontitis: A Meta-Analysis Based on Case-Control Studies	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HUMAN CYTOMEGALOVIRUS; PORPHYROMONAS-GINGIVALIS; PERIODONTOPATHIC BACTERIA; T-CELLS; INFECTIONS; PREVALENCE; PATHOGENS	Objective Numerous studies have investigated the associations between herpesviruses and chronic periodontitis; however, the results remain controversial. To derive a more precise estimation, a meta-analysis on all available studies was performed to identify the association between herpesviruses and chronic periodontitis. Methods A computerized literature search was conducted in December 2014 to identify eligible case-control studies from the PUBMED and EMBASE databases according to inclusion and exclusion criteria. Data were extracted and pooled odds ratios (OR) with 95% confidence intervals (CI) were used to assess the association between herpesviruses and risk of chronic periodontitis. A fixed or random effects model was determined based on a heterogeneity test. Sensitivity analysis was conducted to investigate stability and reliability. Publication bias was investigated using the Begg rank correlation test and Egger's funnel plot. Results Ten eligible studies were included to investigate the association between Epstein-Barr virus (EBV) and chronic periodontitis. The results showed that EBV has a significant association with chronic periodontitis compared with periodontally healthy group (OR = 5.74, 95% CI = 2.53-13.00, P<0.001). The association between human cytomegalovirus (HCMV) and chronic periodontitis was analyzed in 10 studies. The pooled result showed that HCMV also has a significant association with chronic periodontitis (OR = 3.59, 95% CI = 1.41-9.16, P = 0.007). Similar results were found in the sensitivity analyses. No significant publication bias was observed. Two eligible studies were included to investigate the association between herpes simplex virus (HSV) and chronic periodontitis risk. The association between HSV and chronic periodontitis was inconclusive (OR = 2.81 95% CI = 0.95-8.27, P = 0.06). Only one included study investigated the association between human herpesvirus 7 (HHV-7) and chronic periodontitis risk (OR = 1.00, 95% CI = 0.21-4.86). Conclusion The findings of this meta-analysis suggest that two members of the herpesvirus family, EBV and HCMV, are significantly associated with chronic periodontitis. There is insufficient evidence to support associations between HSV, HHV-7 and chronic periodontitis.	[Zhu, Ce; Li, Fei; Feng, Xi-Ping; Lu, Hai-Xia] Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Dept Prevent Dent, Peoples Hosp 9,Sch Med, Shanghai 200030, Peoples R China; [Wong, May. Chun. Mei] Univ Hong Kong, Dent Publ Hlth, Fac Dent, Hong Kong, Hong Kong, Peoples R China; [Xu, Wei] Shanghai Municipal Hosp Oral Hlth, Dept Prevent Dent, Shanghai, Peoples R China	Shanghai Jiao Tong University; University of Hong Kong	Lu, HX (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Dept Prevent Dent, Peoples Hosp 9,Sch Med, Shanghai 200030, Peoples R China.	ritalu0225@hotmail.com; rommelxu@gmail.com	xu, wei/HHD-2891-2022	Lu, Haixia/0000-0002-0013-6472; /0000-0002-7899-1460; Zhu, Ce/0000-0001-8148-0664	National Natural Science Foundation of China [81400496, 81470737]; Doctoral Fund of Ministry of Education of China [20130073120015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	Support was provided by the National Natural Science Foundation of China (Project No. 81400496) to Hai-Xia Lu (study design, data collection and analysis) and by a Doctoral Fund of Ministry of Education of China (Project No. 20130073120015) to Hai-Xia Lu (study design, data collection and analysis); and by the National Natural Science Foundation of China (Project No. 81470737) to Xi-Ping Feng (study design, data collection and analysis, decision to publish, or preparation of the manuscript).	Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174; Albandar Jasim M, 2005, Dent Clin North Am, V49, P517, DOI 10.1016/j.cden.2005.03.003; Botero JE, 2007, J PERIODONTOL, V78, P2303, DOI 10.1902/jop.2007.070252; Cardoso CR, 2008, J LEUKOCYTE BIOL, V84, P311, DOI 10.1189/jlb.0108014; Chalabi M, 2010, MOL ORAL MICROBIOL, V25, P236, DOI 10.1111/j.2041-1014.2010.00571.x; Chalabi M, 2008, ARCH VIROL, V153, P1917, DOI 10.1007/s00705-008-0186-7; Das Sushma, 2012, J Oral Maxillofac Pathol, V16, P203, DOI 10.4103/0973-029X.98502; Feldstein AE, 2003, PEDIATR TRANSPLANT, V7, P125, DOI 10.1034/j.1399-3046.2003.00028.x; Hanookai D, 2000, J PERIODONTOL, V71, P376, DOI 10.1902/jop.2000.71.3.376; Imai K, 2012, BIOCHIMIE, V94, P839, DOI 10.1016/j.biochi.2011.12.001; Ito A, 2010, J VET MED SCI, V72, P1145, DOI 10.1292/jvms.09-0201; Kato A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071990; Lmbronito AV, 2008, J PERIODONTOL, V79, P2313, DOI [10.1902/jop.2008.070388, 10.1902/jop.2008.070388 ]; Mendez JC, 2001, J INFECT DIS, V183, P179, DOI 10.1086/317929; Michalowicz BS, 2000, J PERIODONTOL, V71, P981, DOI 10.1902/jop.2000.71.6.981; Nibali L, 2009, J CLIN PERIODONTOL, V36, P928, DOI 10.1111/j.1600-051X.2009.01476.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Riep B, 2009, J CLIN MICROBIOL, V47, P1705, DOI 10.1128/JCM.01387-08; Rotola A, 2008, J CLIN PERIODONTOL, V35, P831, DOI 10.1111/j.1600-051X.2008.01301.x; Saygun I, 2008, J PERIODONTAL RES, V43, P352, DOI 10.1111/j.1600-0765.2007.01043.x; Saygun I, 2004, J PERIODONTAL RES, V39, P207, DOI 10.1111/j.1600-0765.2004.00728.x; Saygun I, 2002, J PERIODONTOL, V73, P1437, DOI 10.1902/jop.2002.73.12.1437; Sharma Rupali, 2012, Indian J Dent Res, V23, P454, DOI 10.4103/0970-9290.104948; Slots J, 2003, J PERIODONTAL RES, V38, P318, DOI 10.1034/j.1600-0765.2003.00659.x; Slots J, 2009, PERIODONTOL 2000, V49, P60, DOI 10.1111/j.1600-0757.2008.00279.x; Slots J, 2007, CURR OPIN INFECT DIS, V20, P278, DOI 10.1097/QCO.0b013e3280964da0; Slots Jorgen, 2011, J Calif Dent Assoc, V39, P393; Slots J, 2010, PERIODONTOL 2000, V53, P89, DOI 10.1111/j.1600-0757.2009.00325.x; Slots J, 2010, PERIODONTOL 2000, V52, P117, DOI 10.1111/j.1600-0757.2009.00308.x; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Sunde PT, 2008, J CLIN VIROL, V42, P176, DOI 10.1016/j.jcv.2008.01.007; Tabanella G, 2005, J PERIODONTOL, V76, P2306, DOI 10.1902/jop.2005.76.12.2306; Teughels W, 2007, J DENT RES, V86, P175, DOI 10.1177/154405910708600213; Thomasini RL, 2012, J PERIODONTAL RES, V47, P114, DOI 10.1111/j.1600-0765.2011.01413.x; Wakiguchi H, 1999, PEDIATR INT, V41, P484, DOI 10.1046/j.1442-200x.1999.01119.x; Wu YM, 2007, J CLIN MICROBIOL, V45, P3665, DOI 10.1128/JCM.00374-07; Wu Yan-min, 2006, J Zhejiang Univ Sci B, V7, P876, DOI 10.1631/jzus.2006.B0876; Yildirim S, 2006, ORAL MICROBIOL IMMUN, V21, P73, DOI 10.1111/j.1399-302X.2006.00250.x	38	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144319	10.1371/journal.pone.0144319	http://dx.doi.org/10.1371/journal.pone.0144319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26666412	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900038
J	Aboulnasr, F; Hazari, S; Nayak, S; Chandra, PK; Panigrahi, R; Ferraris, P; Chava, S; Kurt, R; Song, K; Dash, A; Balart, LA; Garry, RF; Wu, T; Dash, S				Aboulnasr, Fatma; Hazari, Sidhartha; Nayak, Satyam; Chandra, Partha K.; Panigrahi, Rajesh; Ferraris, Pauline; Chava, Srinivas; Kurt, Ramazan; Song, Kyongsub; Dash, Asha; Balart, Luis A.; Garry, Robert F.; Wu, Tong; Dash, Srikanta			IFN-lambda Inhibits MiR-122 Transcription through a Stat3-HNF4 alpha Inflammatory Feedback Loop in an IFN-alpha Resistant HCV Cell Culture System	PLOS ONE			English	Article							HEPATITIS-C VIRUS; JAK-STAT PATHWAY; GENOME-WIDE ASSOCIATION; GENETIC-VARIATION; HEPATOCELLULAR-CARCINOMA; ANTIVIRAL ACTIVITY; INTERFERON-LAMBDA; VIRAL CLEARANCE; IL28B; INFECTION	Background HCV replication in persistently infected cell culture remains resistant to IFN-alpha/RBV combination treatment, whereas IFN-lambda 1 induces viral clearance. The antiviral mechanisms by which IFN-lambda 1 induces sustained HCV clearance have not been determined. Aim To investigate the mechanisms by which IFN-lambda clears HCV replication in an HCV cell culture model. Methods IFN-alpha sensitive (S3-GFP) and resistant (R4-GFP) cells were treated with equivalent concentrations of either IFN-alpha or IFN-lambda. The relative antiviral effects of IFN-alpha and IFN-lambda 1 were compared by measuring the HCV replication, quantification of HCV-GFP expression by flow cytometry, and viral RNA levels by real time RT-PCR. Activation of Jak-Stat signaling, interferon stimulated gene (ISG) expression, and miRNA-122 transcription in S3-GFP and R4GFP cells were examined. Results We have shown that IFN-lambda 1 induces HCV clearance in IFN-alpha resistant and sensitive replicon cell lines in a dose dependent manner through Jak-Stat signaling, and induces STAT 1 and STAT 2 activation, ISRE-luciferase promoter activation and ISG expression. Stat 3 activation is also involved in IFN-lambda 1 induced antiviral activity in HCV cell culture. IFN-lambda 1 induced Stat 3 phosphorylation reduces the expression of hepatocyte nuclear factor 4 alpha (HNF4 alpha) through miR-24 in R4-GFP cells. Reduced expression of HNF4 alpha is associated with decreased expression of miR-122 resulting in an anti-HCV effect. Northern blot analysis confirms that IFN-lambda 1 reduces miR-122 levels in R4-GFP cells. Our results indicate that IFN-lambda 1 activates the Stat 3-HNF4 alpha feedback inflammatory loop to inhibit miR-122 transcription in HCV cell culture. Conclusions In addition to the classical Jak-Stat antiviral signaling pathway, IFN-lambda 1 inhibits HCV replication through the suppression of miRNA-122 transcription via an inflammatory Stat 3-HNF4 alpha feedback loop. Inflammatory feedback circuits activated by IFNs during chronic inflammation expose non-responders to the risk of hepatocellular carcinoma.	[Aboulnasr, Fatma; Hazari, Sidhartha; Nayak, Satyam; Chandra, Partha K.; Panigrahi, Rajesh; Ferraris, Pauline; Chava, Srinivas; Song, Kyongsub; Dash, Asha; Wu, Tong; Dash, Srikanta] Tulane Univ, Sch Med, Pathol & Lab Med, New Orleans, LA 70112 USA; [Kurt, Ramazan; Balart, Luis A.; Dash, Srikanta] Tulane Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, New Orleans, LA 70112 USA; [Garry, Robert F.] Tulane Univ, Sch Med, Microbiol & Immunol, New Orleans, LA 70112 USA	Tulane University; Tulane University; Tulane University	Dash, S (corresponding author), Tulane Univ, Sch Med, Pathol & Lab Med, 1430 Tulane Ave, New Orleans, LA 70112 USA.	sdash@tulane.edu	Ferraris, Pauline/F-9077-2017	Ferraris, Pauline/0000-0002-8796-3074; Panigrahi, Rajesh/0000-0002-6704-0029; Garry, Robert/0000-0002-5683-3250	National Institutes of Health [CA127481, CA089121, AI103106]; NATIONAL CANCER INSTITUTE [R01CA127481, R01CA089121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported but National Institutes of Health grants CA127481, CA089121, AI103106.	Asselah T, 2013, LIVER INT, V33, P93, DOI 10.1111/liv.12076; Chandra PK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108616; Chandra PK, 2014, AM J PATHOL, V184, P214, DOI 10.1016/j.ajpath.2013.10.005; Chu TW, 2012, GASTROENTEROLOGY, V142, P790, DOI 10.1053/j.gastro.2011.12.057; Datta S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-351; Dolganiuc A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044915; Donnelly RP, 2011, TRENDS IMMUNOL, V32, P443, DOI 10.1016/j.it.2011.07.002; Eslam M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7422; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Hazari S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-36; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lee HC, 2014, J BIOL CHEM, V289, P5310, DOI 10.1074/jbc.M113.536102; Lemon SM, 2010, J BIOL CHEM, V285, P22739, DOI 10.1074/jbc.R109.099556; Li ZY, 2011, J HEPATOL, V55, P602, DOI 10.1016/j.jhep.2010.12.023; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Maher SG, 2008, CANCER BIOL THER, V7, P1109, DOI 10.4161/cbt.7.7.6192; Makowska Z, 2011, HEPATOLOGY, V53, P1154, DOI 10.1002/hep.24189; Matsuura K, 2014, J GASTROEN HEPATOL, V29, P241, DOI 10.1111/jgh.12475; Meissner EG, 2014, J CLIN INVEST, V124, P3352, DOI 10.1172/JCI75938; Meissner EG, 2014, J INFECT DIS, V209, P1700, DOI 10.1093/infdis/jit827; Morgan TR, 2011, CLIN GASTROENTEROL H, V9, P293, DOI 10.1016/j.cgh.2010.12.014; Panigrahi R, 2015, J VIROL, V89, P626, DOI 10.1128/JVI.02492-14; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Redig AJ, 2009, J BIOL CHEM, V284, P10301, DOI 10.1074/jbc.M807254200; Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332; Song K, 2013, HEPATOLOGY, V58, P1681, DOI 10.1002/hep.26514; Su TH, 2013, P NATL ACAD SCI USA, V110, P7844, DOI 10.1073/pnas.1306138110; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Wang H, 2014, HEPATOLOGY, V60, P1466, DOI 10.1002/hep.27287; Webster DP, 2015, LANCET, V385, P1124, DOI [10.1016/S0140-6736(14)62401-6, 10.1016/S0140-6736(14)61932-2]; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Zeng CX, 2010, HEPATOLOGY, V52, P1702, DOI 10.1002/hep.23875; Zhang LL, 2011, J HEPATOL, V55, P289, DOI 10.1016/j.jhep.2010.11.019; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	44	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0141655	10.1371/journal.pone.0141655	http://dx.doi.org/10.1371/journal.pone.0141655			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657215	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903600002
J	Peyro, M; Soheilypour, M; Ghavami, A; Mofrad, MRK				Peyro, Mohaddeseh; Soheilypour, Mohammad; Ghavami, Ali; Mofrad, Mohammad R. K.			Nucleoporin's Like Charge Regions Are Major Regulators of FG Coverage and Dynamics Inside the Nuclear Pore Complex	PLOS ONE			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; MOLECULAR-DYNAMICS; TRANSLOCATION; PROTEINS; INSIGHTS; DISEASE; PERMEABILITY; ARCHITECTURE; SIMULATIONS; SNAPSHOTS	Nucleocytoplasmic transport has been the subject of a large body of research in the past few decades. Recently, the focus of investigations in this field has shifted from studies of the overall function of the nuclear pore complex (NPC) to the examination of the role of different domains of phenylalanine-glycine nucleoporin (FG Nup) sequences on the NPC function. In our recent bioinformatics study, we showed that FG Nups have some evolutionarily conserved sequence-based features that might govern their physical behavior inside the NPC. We proposed the 'like charge regions' (LCRs), sequences of charged residues with only one type of charge, as one of the features that play a significant role in the formation of FG network inside the central channel. In this study, we further explore the role of LCRs in the distribution of FG Nups, using a recently developed coarse-grained molecular dynamics model. Our results demonstrate how LCRs affect the formation of two transport pathways. While some FG Nups locate their FG network at the center of the NPC forming a homogeneous meshwork of FG repeats, other FG Nups cover the space adjacent to the NPC wall. LCRs in the former group, i.e. FG Nups that form an FG domain at the center, tend to regulate the size of the highly dense, doughnut-shaped FG meshwork and leave a small low FG density area at the center of the pore for passive diffusion. On the other hand, LCRs in the latter group of FG Nups enable them to maximize their interactions and cover a larger space inside the NPC to increase its capability to transport numerous cargos at the same time. Finally, a new viewpoint is proposed that reconciles different models for the nuclear pore selective barrier function.	[Mofrad, Mohammad R. K.] Univ Calif Berkeley, Mol Cell Biomech Lab, Dept Bioengn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mech Engn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Mofrad, MRK (corresponding author), Univ Calif Berkeley, Mol Cell Biomech Lab, Dept Bioengn, Berkeley, CA 94720 USA.	mofrad@berkeley.edu	/R-6010-2019	/0000-0001-7004-4859; Ghavami, Ali/0000-0002-8523-1515				Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Ando D, 2014, BIOPHYS J, V106, P1997, DOI 10.1016/j.bpj.2014.03.021; Ando D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073831; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Beckstein O, 2003, P NATL ACAD SCI USA, V100, P7063, DOI 10.1073/pnas.1136844100; Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014; Cook AG, 2010, CURR OPIN STRUC BIOL, V20, P247, DOI 10.1016/j.sbi.2010.01.012; Cronshaw JM, 2004, TRENDS ENDOCRIN MET, V15, P34, DOI 10.1016/j.tem.2003.11.005; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Duarte-Rey C, 2012, AUTOIMMUN REV, V11, P898, DOI 10.1016/j.autrev.2012.03.005; Fiserova J, 2010, BIOCHEM SOC T, V38, P273, DOI 10.1042/BST0380273; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Frey S, 2009, EMBO J, V28, P2554, DOI 10.1038/emboj.2009.199; Ghavami A, 2014, BIOPHYS J, V107, P1393, DOI [10.1016/j.bpj.2014.07.060, 10.1016/j.bpj.20014.07.060]; Ghavami A, 2013, J CHEM THEORY COMPUT, V9, P432, DOI 10.1021/ct300684j; Hetzer MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000539; Hetzer MW, 2009, DEV CELL, V17, P606, DOI 10.1016/j.devcel.2009.10.007; Hinshaw JE, 2003, J STRUCT BIOL, V141, P259, DOI 10.1016/S1047-8477(02)00626-3; Hulsmann BB, 2012, CELL, V150, P738, DOI 10.1016/j.cell.2012.07.019; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Izaguirre JA, 2001, J CHEM PHYS, V114, P2090, DOI 10.1063/1.1332996; Jamali T, 2011, INT REV CEL MOL BIO, V287, P233, DOI 10.1016/B978-0-12-386043-9.00006-2; Kapon R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036001; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Labokha AA, 2013, EMBO J, V32, P204, DOI 10.1038/emboj.2012.302; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; Ma J, 2012, P NATL ACAD SCI USA, V109, P7326, DOI 10.1073/pnas.1201724109; Ma J, 2010, P NATL ACAD SCI USA, V107, P7305, DOI 10.1073/pnas.0908269107; Mincer JS, 2011, P NATL ACAD SCI USA, V108, pE351, DOI 10.1073/pnas.1104521108; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Moussavi-Baygi R, 2011, BIOPHYS J, V100, P1410, DOI 10.1016/j.bpj.2011.01.061; Moussavi-Baygi R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002049; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; Peters R, 2009, BIOESSAYS, V31, P466, DOI 10.1002/bies.200800159; Peyro M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15795; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Sheffield LG, 2006, J NEUROPATH EXP NEUR, V65, P45, DOI 10.1097/01.jnen.0000195939.40410.08; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Tagliazucchi M, 2013, P NATL ACAD SCI USA, V110, P3363, DOI 10.1073/pnas.1212909110; Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09; Walde S, 2010, TRENDS CELL BIOL, V20, P461, DOI 10.1016/j.tcb.2010.05.001; Wolf C, 2008, BIOPHYS J, V95, P2073, DOI 10.1529/biophysj.108.130336; Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101	49	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0143745	10.1371/journal.pone.0143745	http://dx.doi.org/10.1371/journal.pone.0143745			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658558	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903600013
J	Bae, JS; Kim, SH; Shin, CI; Joo, I; Yoon, JH; Lee, HJ; Yang, HK; Baek, JH; Kim, TH; Han, JK; Choi, BI				Bae, Jae Seok; Kim, Se Hyung; Shin, Cheong-Il; Joo, Ijin; Yoon, Jeong Hee; Lee, Hyuk-Joon; Yang, Han-Kwang; Baek, Jee Hyun; Kim, Tae Han; Han, Joon Koo; Choi, Byung Ihn			Efficacy of Gastric Balloon Dilatation and/or Retrievable Stent Insertion for Pyloric Spasms after Pylorus-Preserving Gastrectomy: Retrospective Analysis	PLOS ONE			English	Article							CONVENTIONAL DISTAL GASTRECTOMY; BENIGN ESOPHAGEAL STRICTURES; POSTOPERATIVE EVALUATION; METAL STENT; CANCER; DILATION; PALLIATION; EXPERIENCE; PLACEMENT; CARCINOMA	Purpose We retrospectively investigated the feasibility and clinical efficacy of balloon dilatation and subsequent retrievable stent insertion, when necessitated, for pyloric spasms after pylorus-preserving gastrectomy (PPG). Materials and Methods Forty-five patients experiencing pyloric spasms after PPG underwent fluoroscopic balloon dilations to alleviate obstructive symptoms due to delayed gastric emptying. Patients showing poor response to balloon dilation underwent subsequent retrievable stent insertion. Safety of the procedures was analyzed, and subjective symptoms and objective signs of pyloric spasms were analyzed and compared before and after treatment. Results Thirty-three patients (73.3%, 33/45) showed good response to balloon dilatation requiring no further treatment (balloon group). Conversely, 12 patients (26.7%, 12/45) showed poor or no response after balloon dilation requiring subsequent stent insertion (stent group). Balloon dilations and/or stent insertions were safely performed in all patients except one patient who suffered a transmural tear after balloon dilatation. In both groups, mean subjective symptom score was significantly improved and mean pyloric canal-to-height of the adjacent vertebral body ratio was significantly increased after the procedures (P < .05). Conclusion Balloon dilation is a safe and effective treatment for patients with pyloric spasms after PPG. In patients refractory to balloon dilations, retrievable stent placement can be a safe alternative tool.	[Bae, Jae Seok; Kim, Se Hyung; Shin, Cheong-Il; Joo, Ijin; Yoon, Jeong Hee; Han, Joon Koo; Choi, Byung Ihn] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Shin, Cheong-Il; Han, Joon Koo; Choi, Byung Ihn] Seoul Natl Univ Hosp, Inst Radiat Med, Seoul 110744, South Korea; [Lee, Hyuk-Joon; Yang, Han-Kwang; Kim, Tae Han] Seoul Natl Univ Hosp, Dept Surg, Seoul 110744, South Korea; [Baek, Jee Hyun] New Korea Hosp, Dept Radiol, Gimpo, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Kim, SH (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea.	shkim7071@gmail.com	Bae, Jaeseok/T-9071-2019; Yoon, Jeong Hee/ABA-5127-2021	Bae, Jaeseok/0000-0003-2768-7917; Yoon, Jeong Hee/0000-0002-9925-9973	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2013R1A1A3005937]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This study by J.S.B. et al. was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2013R1A1A3005937) (http://www.nrf.re.kr/nrf_eng_cms/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron TH, 2006, GASTROINTEST ENDOSC, V64, P263, DOI 10.1016/j.gie.2006.03.936; Cheng YS, 2003, WORLD J GASTROENTERO, V9, P2359; De Luca L, 2004, DIGEST LIVER DIS, V36, P806, DOI 10.1016/j.dld.2004.07.010; DENYS A, 1994, J VASC INTERV RADIOL, V5, P781, DOI 10.1016/S1051-0443(94)71602-X; Hagiwara A, 2001, GASTROINTEST ENDOSC, V53, P504, DOI 10.1067/mge.2001.113281; Hotta T, 2001, SURG TODAY, V31, P774, DOI 10.1007/s005950170046; Ikeguchi M, 2010, INDIAN J SURG, V72, P453, DOI 10.1007/s12262-010-0167-4; Ikeguchi M, 2010, SURG TODAY, V40, P228, DOI 10.1007/s00595-009-4043-4; Imada T, 1998, SURG TODAY, V28, P135, DOI 10.1007/s005950050094; Isozaki H, 1996, BRIT J SURG, V83, P266, DOI 10.1046/j.1365-2168.1996.02093.x; Jeong JY, 2004, SURGERY, V135, P171, DOI 10.1016/S0039-6060(03)00346-5; Jiang XH, 2011, ANN SURG, V253, P928, DOI 10.1097/SLA.0b013e3182117b24; Kim HH, 2014, J CLIN ONCOL, V32, P627, DOI 10.1200/JCO.2013.48.8551; Kim JH, 2008, KOREAN J RADIOL, V9, P364, DOI 10.3348/kjr.2008.9.4.364; Kim JH, 2008, J VASC INTERV RADIOL, V19, P565, DOI 10.1016/j.jvir.2007.11.015; Kim JH, 2010, KOREAN J RADIOL, V11, P497, DOI 10.3348/kjr.2010.11.5.497; Ko HK, 2007, J VASC INTERV RADIOL, V18, P725, DOI 10.1016/j.jvir.2007.02.030; KODAMA M, 1995, WORLD J SURG, V19, P456, DOI 10.1007/BF00299190; MAKI T, 1967, SURGERY, V61, P838; Morita S, 2008, BRIT J SURG, V95, P1131, DOI 10.1002/bjs.6295; Nagano Hideki, 2004, Gastric Cancer, V7, P54, DOI 10.1007/s10120-004-0269-4; Nunobe S, 2007, GASTRIC CANCER, V10, P167, DOI 10.1007/s10120-007-0434-7; Nunobe S, 2007, WORLD J SURG, V31, P2335, DOI 10.1007/s00268-007-9262-5; Park DJ, 2008, WORLD J SURG, V32, P1029, DOI 10.1007/s00268-007-9441-4; Repici A, 2004, GASTROINTEST ENDOSC, V60, P513, DOI 10.1016/S0016-5107(04)01882-6; Song H, 2000, RADIOLOGY, V217, P551; Suh YS, 2014, ANN SURG, V259, P485, DOI 10.1097/SLA.0b013e318294d142; Tanaka N, 2011, SURG ENDOSC, V25, P114, DOI 10.1007/s00464-010-1142-7; Tomita R, 2003, WORLD J SURG, V27, P725, DOI 10.1007/s00268-003-6906-y; Zhang J, 2013, J PEDIATR SURG, V48, P2235, DOI 10.1016/j.jpedsurg.2013.06.005; Zhu YQ, 2010, NEUROGASTROENT MOTIL, V22, P1240, DOI 10.1111/j.1365-2982.2010.01573.x	31	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144470	10.1371/journal.pone.0144470	http://dx.doi.org/10.1371/journal.pone.0144470			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657405	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903500029
J	Brauman, A; Majeed, MZ; Buatois, B; Robert, A; Pablo, AL; Miambi, E				Brauman, Alain; Majeed, Muhammad Zeeshan; Buatois, Bruno; Robert, Alain; Pablo, Anne-Laure; Miambi, Edouard			Nitrous Oxide (N2O) Emissions by Termites: Does the Feeding Guild Matter?	PLOS ONE			English	Article							HUMIC MODEL COMPOUNDS; FIXATION GENES; PHYLOGENETIC DIVERSITY; XYLOPHAGOUS TERMITES; GUT; MINERALIZATION; DENITRIFICATION; CUBITERMES; COMMUNITY; TRANSFORMATION	In the tropics, termites are major players in the mineralization of organic matter leading to the production of greenhouse gases including nitrous oxide (N2O). Termites have a wide trophic diversity and their N-metabolism depends on the feeding guild. This study assessed the extent to which N2O emission levels were determined by termite feeding guild and tested the hypothesis that termite species feeding on a diet rich in N emit higher levels of N2O than those feeding on a diet low in N. An in-vitro incubation approach was used to determine the levels of N2O production in 14 termite species belonging to different feeding guilds, collected from a wide range of biomes. Fungus-growing and soil-feeding termites emit N2O. The N2O production levels varied considerably, ranging from 13.14 to 117.62 ng N2O-N d(-1) (g dry wt.)(-1) for soil-feeding species, with Cubitermes spp. having the highest production levels, and from 39.61 to 65.61 ng N2O-N d(-1) (g dry wt.)(-1) for fungus-growing species. Wood-feeding termites were net N2O consumers rather than N2O producers with a consumption ranging from 16.09 to 45.22 ng N2O-N d(-1) (g dry wt.)(-1). Incubating live termites together with their mound increased the levels of N2O production by between 6 and 13 fold for soil-feeders, with the highest increase in Capritermes capricornis, and between 14 and 34 fold for fungus-growers, with the highest increase in Macrotermes muelleri. Ammoniaoxidizing (amoA-AOB and amoA-AOA) and denitrifying (nirK, nirS, nosZ) gene markers were detected in the guts of all termite species studied. No correlation was found between the abundance of these marker genes and the levels of N2O production from different feeding guilds. Overall, these results support the hypothesis that N2O production rates were higher in termites feeding on substrates with higher N content, such as soil and fungi, compared to those feeding on N-poor wood.	[Brauman, Alain; Majeed, Muhammad Zeeshan; Pablo, Anne-Laure] IRD, UMR ECO&SOLS, Campus Supagro, Montpellier, France; [Brauman, Alain] IRD, UMR Eco&Sols, LMI LUSES, Land Dev Dept, Bangkok, Thailand; [Buatois, Bruno] CNRS, UMR CEFE 5175, Montpellier, France; [Robert, Alain] IRD, iEES, Bondy, France; [Miambi, Edouard] Univ Paris Est Creteil, iEES, Creteil, France	Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Majeed, MZ (corresponding author), Univ Sargodha, Univ Coll Agr, Dept Entomol, Sargodha, Punjab, Pakistan.	zeeshan.majeed@uos.edu.pk	Majeed, Muhammad Z/A-9791-2019; brauman, alain/X-8747-2019; brauman, alain/C-8400-2009	Majeed, Muhammad Z/0000-0002-3786-8589; brauman, alain/0000-0002-4865-2919	project BAMBI (ANR-Metagenome; France)	project BAMBI (ANR-Metagenome; France)(French National Research Agency (ANR))	This study was funded by the project BAMBI (ANR-Metagenome; France).	Attard E, 2011, GLOBAL CHANGE BIOL, V17, P1975, DOI 10.1111/j.1365-2486.2010.02340.x; Bignell DE, 2006, SOIL BIOL, P183; Bignell DE, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P363; Bru D, 2011, ISME J, V5, P532, DOI 10.1038/ismej.2010.130; Brummer C, 2009, GEOPHYS RES LETT, P36; BRUNE A, 1995, APPL ENVIRON MICROB, V61, P2681, DOI 10.1128/AEM.61.7.2681-2687.1995; Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182; Chapuis-Lardy L, 2010, APPL SOIL ECOL, V45, P201, DOI 10.1016/j.apsoil.2010.04.006; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; Desai MS, 2012, ISME J, V6, P1302, DOI 10.1038/ismej.2011.194; Eggleton P, 1996, PHILOS T R SOC B, V351, P51, DOI 10.1098/rstb.1996.0004; IPCC, 2007, IPPC 4 ASS REP CLIM; Ji R, 2000, SOIL BIOL BIOCHEM, V32, P1281, DOI 10.1016/S0038-0717(00)00046-8; Ji R, 2001, BIOL FERT SOILS, V33, P166, DOI 10.1007/s003740000310; Ji R, 2006, BIOGEOCHEMISTRY, V78, P267, DOI 10.1007/s10533-005-4279-z; Jouquet P, 2011, EUR J SOIL BIOL, V47, P215, DOI 10.1016/j.ejsobi.2011.05.005; Kappler A, 2000, SOIL BIOL BIOCHEM, V32, P1271, DOI 10.1016/S0038-0717(00)00047-X; Kohler T, 2012, APPL ENVIRON MICROB, V78, P4691, DOI 10.1128/AEM.00683-12; Levy-Booth DJ, 2014, SOIL BIOL BIOCHEM, V75, P11, DOI 10.1016/j.soilbio.2014.03.021; Majeed MZ, 2013, PEDOBIOLOGIA, V56, P49, DOI 10.1016/j.pedobi.2012.10.003; Majeed MZ, 2012, EUR J SOIL BIOL, V53, P121, DOI 10.1016/j.ejsobi.2012.10.002; Morales SE, 2010, ISME J, V4, P799, DOI 10.1038/ismej.2010.8; Ndiaye D, 2004, PLANT SOIL, V259, P277, DOI 10.1023/B:PLSO.0000020980.50095.e1; Ngugi DK, 2012, ENVIRON MICROBIOL, V14, P860, DOI 10.1111/j.1462-2920.2011.02648.x; Ngugi DK, 2011, BIOGEOCHEMISTRY, V103, P355, DOI 10.1007/s10533-010-9478-6; Ohkuma M, 1999, APPL ENVIRON MICROB, V65, P4926; Ohkuma M, 1996, APPL ENVIRON MICROB, V62, P2747, DOI 10.1128/AEM.62.8.2747-2752.1996; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Rouland-Lefevre C, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P289; Sanderson MG, 1996, GLOBAL BIOGEOCHEM CY, V10, P543, DOI 10.1029/96GB01893; TAYASU I, 1994, NATURWISSENSCHAFTEN, V81, P229, DOI 10.1007/s001140050063; Wood T.G., 1978, International Biological Programme, P245; Wuebbles DJ, 2009, SCIENCE, V326, P56, DOI 10.1126/science.1179571; Yamada A, 2007, MOL ECOL, V16, P3768, DOI 10.1111/j.1365-294X.2007.03326.x	34	17	18	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144340	10.1371/journal.pone.0144340	http://dx.doi.org/10.1371/journal.pone.0144340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658648	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903500021
J	Krishnan, S; Collett, M; Robinson, PJ				Krishnan, Sai; Collett, Michael; Robinson, Phillip J.			SH3 Domains Differentially Stimulate Distinct Dynamin I Assembly Modes and G Domain Activity	PLOS ONE			English	Article							GTPASE ACTIVITY; PHOSPHORYLATION; ACTIVATION; OLIGOMERIZATION; REQUIREMENT; MECHANISM; PROTEINS; BINDING	Dynamin I is a highly regulated GTPase enzyme enriched in nerve terminals which mediates vesicle fission during synaptic vesicle endocytosis. One regulatory mechanism involves its interactions with proteins containing Src homology 3 (SH3) domains. At least 30 SH3 domain-containing proteins bind dynamin at its proline-rich domain (PRD). Those that stimulate dynamin activity act by promoting its oligomerisation. We undertook a systematic parallel screening of 13 glutathione-S-transferase (GST)-tagged endocytosis-related SH3 domains on dynamin binding, GTPase activity and oligomerisation. No correlation was found between dynamin binding and their potency to stimulate GTPase activity. There was limited correlation between the extent of their ability to stimulate dynamin activity and the level of oligomerisation, indicating an as yet uncharacterised allosteric coupling of the PRD and G domain. We examined the two variants, dynamin Iab and Ibb, which differ in the alternately splice middle domain alpha 2 helix. They responded differently to the panel of SH3s, with the extent of stimulation between the splice variants varying greatly between the SH3s. This study reveals that SH3 binding can act as a heterotropic allosteric regulator of the G domain via the middle domain alpha 2 helix, suggesting an involvement of this helix in communicating the PRD-mediated allostery. This indicates that SH3 binding both stabilises multiple conformations of the tetrameric building block of dynamin, and promotes assembly of dynamin-SH3 complexes with distinct rates of GTP hydrolysis.	[Krishnan, Sai; Collett, Michael; Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Cell Signalling Unit, Westmead, NSW 2145, Australia	Children's Medical Research Institute - Australia; University of Sydney	Robinson, PJ (corresponding author), Univ Sydney, Childrens Med Res Inst, Cell Signalling Unit, Westmead, NSW 2145, Australia.	probinson@cmri.org.au	Robinson, Phillip J/G-4008-2011	Robinson, Phillip J/0000-0002-7878-0313	National Health & Medical Research Council Australia [GNT1069493, GNT1052494, GNT1047070]; Children's Medical Research Institute (CMRI); CMRI	National Health & Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Children's Medical Research Institute (CMRI); CMRI	The authors are grateful for financial support from the National Health & Medical Research Council Australia (GNT1069493, GNT1052494, and GNT1047070) and the Children's Medical Research Institute (CMRI), and for equipment from the Australian Cancer Research Foundation, the Ramaciotti Foundation and the Cancer Institute NSW. SK and MC gratefully acknowledge scholarship support from CMRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for financial support from the National Health & Medical Research Council Australia (GNT1047070 and GNT1069493) and the Children's Medical Research Institute (CMRI), and for equipment from the Australian Cancer Research Foundation, the Ramaciotti Foundation and the Cancer Institute NSW. SK and MC gratefully acknowledge scholarship support from CMRI. This research has been facilitated by access to Australian Proteome Analysis Facility and to the CSIRO Recombinant Protein Production Facility, which are funded by an initiative of the Australian Government as part of the National Collaborative Research Infrastructure Strategy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anggono V, 2007, J NEUROCHEM, V102, P931, DOI 10.1111/j.1471-4159.2007.04574.x; Barylko B, 1998, J BIOL CHEM, V273, P3791, DOI 10.1074/jbc.273.6.3791; Binns DD, 1999, J PROTEIN CHEM, V18, P277, DOI 10.1023/A:1021083211267; Brymora A, 2001, ANAL BIOCHEM, V295, P119, DOI 10.1006/abio.2001.5215; Carr JF, 1997, J BIOL CHEM, V272, P28030, DOI 10.1074/jbc.272.44.28030; Chan LS, 2010, J PROTEOME RES, V9, P4028, DOI 10.1021/pr100223n; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; CHENG Q, 1995, ANAL BIOCHEM, V226, P68, DOI 10.1006/abio.1995.1192; Daniel JA, 2015, TRAFFIC, V16, P635, DOI 10.1111/tra.12272; Faelber K, 2013, PROG MOL BIOL TRANSL, V117, P411, DOI 10.1016/B978-0-12-386931-9.00015-5; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Frohlich C, 2013, EMBO J, V32, P1280, DOI 10.1038/emboj.2013.74; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Kay BK, 2012, FEBS LETT, V586, P2606, DOI 10.1016/j.febslet.2012.05.025; Knezevic I, 2011, J CELL MOL MED, V15, P2364, DOI 10.1111/j.1582-4934.2010.01226.x; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Liu GY, 2013, NEUROMOL MED, V15, P384, DOI 10.1007/s12017-013-8225-2; MAEDA K, 1992, MOL BIOL CELL, V3, P1181, DOI 10.1091/mbc.3.10.1181; Mattila JP, 2015, NATURE; McPherson PS, 1999, CELL SIGNAL, V11, P229, DOI 10.1016/S0898-6568(98)00059-X; Okamoto PM, 1999, J BIOL CHEM, V274, P10277, DOI 10.1074/jbc.274.15.10277; Pawlowski N, 2010, BIOESSAYS, V32, P1033, DOI 10.1002/bies.201000086; POWELL KA, 1995, NEUROSCIENCE, V64, P821, DOI 10.1016/0306-4522(94)00337-5; Praefcke GJK, 2004, J MOL BIOL, V344, P257, DOI 10.1016/j.jmb.2004.09.026; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; ROBINSON PJ, 1983, J NEUROCHEM, V41, P909, DOI 10.1111/j.1471-4159.1983.tb09034.x; ROBINSON PJ, 1993, NATURE, V365, P163, DOI 10.1038/365163a0; Ross JA, 2011, BIOPHYS J, V100, P729, DOI 10.1016/j.bpj.2010.12.3717; Saksela K, 2012, FEBS LETT, V586, P2609, DOI 10.1016/j.febslet.2012.04.042; Selwood T, 2012, ARCH BIOCHEM BIOPHYS, V519, P131, DOI 10.1016/j.abb.2011.11.020; Song BD, 2004, MOL BIOL CELL, V15, P2243, DOI 10.1091/mbc.E04-01-0015; SONTAG JM, 1994, J BIOL CHEM, V269, P4547; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TUMA PL, 1994, J BIOL CHEM, V269, P30842; Verhelst J, 2013, MICROBIOL MOL BIOL R, V77, P551, DOI 10.1128/MMBR.00024-13; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Yamada H, 2013, J NEUROSCI, V33, P4514, DOI 10.1523/JNEUROSCI.2762-12.2013; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	46	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144609	10.1371/journal.pone.0144609	http://dx.doi.org/10.1371/journal.pone.0144609			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26659814	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903500048
J	Matsumoto, K				Matsumoto, Ken'ichi			Energy Structure and Energy Security under Climate Mitigation Scenarios in China	PLOS ONE			English	Article							CARBON; STABILIZATION; REDUCTION; SOCIETY; PATHWAY	This study investigates how energy structure and energy security in China will change in the future under climate mitigation policy scenarios using Representative Concentration Pathways in a computable general equilibrium model. The findings suggest that to reduce greenhouse gas emissions, China needs to shift its energy structure from fossil fuel dominance to renewables and nuclear. The lower the allowable emissions, the larger the shifts required. Among fossil fuels, coal use particularly must significantly decrease. Such structural shifts will improve energy self-sufficiency, thus enhancing energy security. Under the policy scenarios, energy-source diversity as measured by the Herfindahl Index improves until 2050, after which diversity declines because of high dependence on a specific energy source (nuclear and biomass). Overall, however, it is revealed that energy security improves along with progress in climate mitigation. These improvements will also contribute to the economy by reducing energy procurement risks.	[Matsumoto, Ken'ichi] Univ Shiga Prefecture, Sch Environm Sci, Hikone, Shiga, Japan	University Shiga Prefecture	Matsumoto, K (corresponding author), Univ Shiga Prefecture, Sch Environm Sci, Hikone, Shiga, Japan.	matsumoto.k@ses.usp.ac.jp		Matsumoto, Ken'ichi/0000-0002-9349-9765	Japan Society for the Promotion of Science (KAKENHI) [24710046, 25241030, 15K00669, 15K16161]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Program for Risk Information on Climate Change (Theme B); Grants-in-Aid for Scientific Research [25241030] Funding Source: KAKEN	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Risk Information on Climate Change (Theme B); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (KAKENHI 24710046, 25241030, 15K00669 and 15K16161; http://www.jsps.go.jp/english/index.html) to KM, Ministry of Education, Culture, Sports, Science and Technology, Japan; Program for Risk Information on Climate Change (Theme B); http://www.mext.go.jp/english/ to KM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A?el J.A., 2015, CONTEMP PHYS, V56, P2, DOI [10.1080/00107514.2015.1006251, DOI 10.1080/00107514.2015.1006251]; Ahn Hwi-joon, 2000, HANGUK HOEHWASA YONG; Ang BW, 2015, RENEW SUST ENERG REV, V42, P1077, DOI 10.1016/j.rser.2014.10.064; ARMINGTON PS, 1969, INT MONET FUND S PAP, V16, P159; Audient P., 2014, WEATHER MATTERS ENER, P17; British Petroleum (BP), 2014, STAT REV WORLD EN JU; Coppin P, 2014, WEATHER MATTERS ENER, P399; Dai HC, 2011, ENERG POLICY, V39, P2875, DOI 10.1016/j.enpol.2011.02.062; Dimaranan B.V., 2006, GLOBAL TRADE ASSISTA; European Commission Joint Research Centre Netherlands Environmental Assessment Agency, 2010, EM DAT GLOB ATM RES; Federation of Electric Power Companies of Japan, 2004, HARM NUCL EN DER; Frondel M., 2008, RUHR EC PAPER, P52, DOI [https://dx.doi.org/10.2139/ssrn.1161141, DOI 10.2139/SSRN.1161141]; Gunasekera D., 2014, WEATHER MATTERS ENER, P497; Hubler M, 2014, ENERG POLICY, V75, P57, DOI 10.1016/j.enpol.2014.02.019; Hubler M, 2012, ENERG POLICY, V50, P315, DOI 10.1016/j.enpol.2012.07.025; Hubler M, 2011, ENERG ECON, V33, P131, DOI 10.1016/j.eneco.2010.09.002; International Energy Agency, 2012, EN BAL OECD COUNTR 2; International Energy Agency, 2012, EN BAL NONOECD COUNT; International Energy Agency, 2008, WORLD EN OUTL 2008; International Energy Agency, 2013, WORLD EN OUTL 2013; IPCC, P AR6 SCOP M ADD AB; Lehl U, 2009, MORE BASKETS RENEWAB; Masui T., 2010, ANAL 4 5 W M2 STABIL; Masui T, 2011, CLIMATIC CHANGE, V109, P59, DOI 10.1007/s10584-011-0150-5; Matsumoto K, 2009, ENV SCI, V22, P391; Matsumoto K, 2014, USAEE IAEE WORKING P, P14; Matsumoto K., 2013, GLOBAL ENERGY POLICY, P45; Matsumoto K, 2011, MANAG ENVIRON QUAL, V22, P33, DOI 10.1108/14777831111098462; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Nautilus Institute, 2013, AS EN SEC; Neff T.L., 1997, PAC AS REG EN SEC PA; Okagawa A, 2012, ENERG ECON, V34, pS391, DOI 10.1016/j.eneco.2012.07.011; Paltsev S, 2005, 125 MIT; Paltsev S, 2012, ENERG ECON, V34, pS444, DOI 10.1016/j.eneco.2012.04.007; Peace J, 2008, INSIGHTS NOT NUMBERS; Renne D.S., 2014, WEATHER MATTERS ENER, P257; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Rogner HH, 1997, ANNU REV ENERG ENV, V22, P217, DOI 10.1146/annurev.energy.22.1.217; Ronalds B.F., 2014, WEATHER MATTERS ENER, P3; Saveyn B, 2012, ENERG ECON, V34, pS451, DOI 10.1016/j.eneco.2012.04.010; Saveyn B, 2011, ENERG ECON, V33, pS34, DOI 10.1016/j.eneco.2011.07.024; Shukla PR, 2008, CLIM POLICY, V8, pS156, DOI 10.3763/cpol.2007.0498; Sims R.E, 2014, WEATHER MATTERS ENER, P91; Stanislaw JA., 2007, CLIMATE CHANGE ENERG; Thomson AM, 2011, CLIMATIC CHANGE, V109, P77, DOI 10.1007/s10584-011-0151-4; U. S. Department of Justice and Federal Trade Commision, 2010, HORIZONTAL MERGER GU; *UN DEP EC SOC AFF, 2004, WORLD POP 2300; United Nations. Department of Economic and Social Affairs. Population Division, 2007, WORLD POP PROSP 2006; United Nations Environment Programme, 2007, GLOB ENV OUTL; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; van Vuuren DP, 2014, CLIMATIC CHANGE, V122, P373, DOI 10.1007/s10584-013-0906-1; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; von Hippel D, 2011, ENERG POLICY, V39, P6719, DOI 10.1016/j.enpol.2009.07.001; von Hippel D, 2011, ENERG POLICY, V39, P6712, DOI 10.1016/j.enpol.2008.01.010; Wang K, 2009, ENERG POLICY, V37, P2930, DOI 10.1016/j.enpol.2009.03.023; Wang YJ, 2011, ENERG POLICY, V39, P6745, DOI 10.1016/j.enpol.2010.07.002; Zhang ZX, 1998, J POLICY MODEL, V20, P213, DOI 10.1016/S0161-8938(97)00005-7; Zillman J.W., 2014, WEATHER MATTERS ENER, P201, DOI DOI 10.1007/978-1-4614-9221-4_9	59	11	12	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144884	10.1371/journal.pone.0144884	http://dx.doi.org/10.1371/journal.pone.0144884			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26660094	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903500064
J	Deng, S; Wang, CY; Zhang, X; Wang, Q; Lin, L				Deng, Sheng; Wang, Cai-yue; Zhang, Xin; Wang, Qing; Lin, Ling			VdNUC-2, the Key Regulator of Phosphate Responsive Signaling Pathway, Is Required for Verticillium dahliae Infection	PLOS ONE			English	Article							ANKYRIN-REPEAT; NEUROSPORA-CRASSA; FUNCTIONAL-ANALYSIS; PROTEIN; KINASE; PATHOGENICITY; TRANSDUCTION; EXPRESSION; VIRULENCE; INACTIVATION	In fungal cells, a phosphate (Pi) responsive signaling and metabolism (PHO) pathway regulates Pi-homeostasis. NUC-2/PHO81 and its homologs are one of the most important components in the regulation pathway. In soil-borne phytopathogenic fungus Verticillium dahliae, we identified a Neurospora crassa nuc-2 homolog gene VdNUC-2. VdNUC-2 is composed of 1,018 amino acids, and is highly conserved in tested filamentous fungi. Under conditions of Pi-starvation, compared with the wild-type strain and ectopic complementation strains, the VdNUC-2 knocked out mutants exhibited reduced radial growth, decreased production of conidia and microsclerotia, and were more sensitive to hydrogen peroxide stress. The virulence of VdNUC-2 defective mutants was significantly compromised, and that was unable to be restored by exogenous application of extra Pi. Additionally, the deletion mutants of VdNUC-1, a key transcription factor gene positively controlled by VdNUC-2 in the PHO pathway, showed the similar cultural phenotypes as VdNUC-2 mutants when both of them grew in Pi-limited conditions. However, the virulence of VdNUC-1 mutants was comparable to the wild-type strain. These evidences indicated that the virulence reduction in VdNUC-2 mutants is not due to the interruptions in the PHO pathway or the disturbance of Pi-homeostasis in V. dahliae cytoplasm. VdNUC-2 is not only a crucial gene in the PHO pathway in V. dahliae, but also is required for the full virulence during host-infection.	[Deng, Sheng; Wang, Cai-yue; Zhang, Xin; Wang, Qing; Lin, Ling] Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences	Lin, L (corresponding author), Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing, Jiangsu, Peoples R China.	linling@jaas.ac.cn		Deng, Sheng/0000-0002-9050-7221	National Science Foundation [31101400, 31201462, 31301625]; Special Fund for Agro-scientific Research in the Public Interest [201503109]; National Key Technology Research and Development Program [2012BAD19B05]; "333" Project of JiangSu Province [BRA2015447]	National Science Foundation(National Science Foundation (NSF)); Special Fund for Agro-scientific Research in the Public Interest; National Key Technology Research and Development Program(National Key Technology R&D Program); "333" Project of JiangSu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Science Foundation (31101400, 31201462 and 31301625), Special Fund for Agro-scientific Research in the Public Interest (201503109), the National Key Technology Research and Development Program during the Twelfth Five-year Plan Period (2012BAD19B05) and the "333" Project of JiangSu Province (BRA2015447).	Al-Khodor S, 2010, TRENDS MICROBIOL, V18, P132, DOI 10.1016/j.tim.2009.11.004; Becerra C, 2004, GENE, V340, P111, DOI 10.1016/j.gene.2004.06.006; Castillo-Lluva S, 2007, J CELL SCI, V120, P1584, DOI 10.1242/jcs.005314; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Jonge R, 2013, GENOME RES, V23, P1271, DOI 10.1101/gr.152660.112; de Jonge R, 2012, P NATL ACAD SCI USA, V109, P5110, DOI 10.1073/pnas.1119623109; Deng S, 2014, CAN J MICROBIOL, V60, P445, DOI 10.1139/cjm-2014-0081; Dick Claudia Fernanda, 2011, Enzyme Res, V2011, P103980, DOI 10.4061/2011/103980; Dub AM, 2013, EUKARYOT CELL, V12, P1609, DOI 10.1128/EC.00160-13; Fernandez J, 2014, PROTOPLASMA, V251, P37, DOI 10.1007/s00709-013-0541-8; Fradin EF, 2006, MOL PLANT PATHOL, V7, P71, DOI [10.1111/j.1364-3703.2006.00323.x, 10.1111/J.1364-3703.2006.00323.X]; Giraldo MC, 2013, NAT REV MICROBIOL, V11, P800, DOI 10.1038/nrmicro3119; Gras DE, 2007, FEMS MICROBIOL LETT, V269, P196, DOI 10.1111/j.1574-6968.2006.00613.x; Gras DE, 2013, FUNGAL GENET BIOL, V60, P140, DOI 10.1016/j.fgb.2013.05.007; Hamel LP, 2012, PLANT CELL, V24, P1327, DOI 10.1105/tpc.112.096156; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; Hoagland D.R., 1938, The Water Culture Methods for Growing Plants without Soil, V347, P1, DOI DOI 10.1017/CBO9781107415324.004; Hoppenau CE, 2014, ENVIRON EXP BOT, V108, P14, DOI 10.1016/j.envexpbot.2013.12.015; Huang JY, 2009, PLANT MOL BIOL, V71, P207, DOI 10.1007/s11103-009-9518-6; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; KANG SC, 1990, MOL CELL BIOL, V10, P5839, DOI 10.1128/MCB.10.11.5839; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Li L, 2007, ANNU REV MICROBIOL, V61, P423, DOI 10.1146/annurev.micro.61.080706.093432; Liu SY, 2013, GENE, V529, P307, DOI 10.1016/j.gene.2013.06.089; Liu TL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5686; Luo XM, 2014, APPL MICROBIOL BIOT, V98, P6921, DOI 10.1007/s00253-014-5863-8; METZENBERG RL, 1979, MICROBIOL REV, V43, P361, DOI 10.1128/MMBR.43.3.361-383.1979; Mou SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059699; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Paz Z, 2011, FUNGAL GENET BIOL, V48, P677, DOI 10.1016/j.fgb.2011.02.003; Peleg Y, 1996, MOL GEN GENET, V252, P709, DOI 10.1007/s004380050280; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santhanam P, 2013, MOL PLANT MICROBE IN, V26, P249, DOI 10.1094/MPMI-08-12-0198-R; SCHNEIDER KR, 1994, SCIENCE, V266, P122, DOI 10.1126/science.7939631; Secco D, 2012, FEBS LETT, V586, P289, DOI 10.1016/j.febslet.2012.01.036; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tian H, 2015, FUNGAL GENET BIOL, V74, P21, DOI 10.1016/j.fgb.2014.11.003; Timpner C, 2013, MOL PLANT MICROBE IN, V26, P1312, DOI 10.1094/MPMI-06-13-0181-R; Tomar P, 2014, J BIOSCIENCES, V39, P525, DOI 10.1007/s12038-014-9435-y; Turra D, 2014, ANNU REV PHYTOPATHOL, V52, P267, DOI 10.1146/annurev-phyto-102313-050143; Tzima AK, 2011, MOL PLANT MICROBE IN, V24, P129, DOI 10.1094/MPMI-09-09-0217; Tran VT, 2014, NEW PHYTOL, V202, P565, DOI 10.1111/nph.12671; Wolff B, 1999, ONCOGENE, V18, P2663, DOI 10.1038/sj.onc.1202617; Yang YA, 2012, PLANT PHYSIOL, V159, P1857, DOI 10.1104/pp.112.197152; Yun YZ, 2015, NEW PHYTOL, V207, P119, DOI 10.1111/nph.13374; Zhang CK, 2013, FUNGAL GENET BIOL, V61, P90, DOI 10.1016/j.fgb.2013.09.001; Zhang JR, 2015, BIOTECHNOL BIOENG, V112, P1033, DOI 10.1002/bit.25516; Zhang XC, 2010, MOL BIOL REP, V37, P653, DOI 10.1007/s11033-009-9507-5	53	9	12	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145190	10.1371/journal.pone.0145190	http://dx.doi.org/10.1371/journal.pone.0145190			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670613	Green Published, gold, Green Submitted			2022-12-27	WOS:000366719300052
J	Ballard, ME; Dean, AC; Mandelkern, MA; London, ED				Ballard, Michael E.; Dean, Andy C.; Mandelkern, Mark A.; London, Edythe D.			Striatal Dopamine D-2/D-3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine Users	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; REFERENCE TISSUE MODEL; PREFRONTAL CORTEX; COGNITIVE PERFORMANCE; DISTRIBUTION VOLUME; D-2 RECEPTORS; COCAINE; DEFICITS; ADDICTION; BINDING	Background Dopamine D-2/D-3 receptor availability in the striatum has been linked with executive function in healthy individuals, and is below control levels among drug addicts, possibly contributing to diminished executive function in the latter group. This study tested for an association of striatal D-2/D-3 receptor availability with a measure of executive function among research participants who met DSM-IV criteria for methamphetamine dependence. Methods Methamphetamine users and non-user controls (n = 18 per group) completed the Wisconsin Card Sorting Test and positron emission tomography with [F-18]fallypride. Results The methamphetamine users displayed significantly lower striatal D-2/D-3 receptor availability on average than controls after controlling for age and education (p = 0.008), but they did not register greater proportions of either perseverative or non-perseverative errors when controlling for education (both ps >= 0.622). The proportion of non-perseverative, but not perseverative, errors was negatively correlated with striatal D2/D3 receptor availability among controls (r = -0.588, p = 0.010), but not methamphetamine users (r = 0.281, p = 0.258), and the group-wise interaction was significant (p = 0.030). Conclusions These results suggest that cognitive flexibility, as measured by perseverative errors on the Wisconsin Card Sorting Test, is not determined by signaling through striatal D-2/D-3 receptors in healthy controls, and that in stimulant abusers, who have lower D-2/D-3 receptor availability, compensation can effectively maintain other executive functions, which are associated with D-2/D-3 receptor signaling in controls.	[Ballard, Michael E.; Dean, Andy C.; London, Edythe D.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Ballard, Michael E.; Mandelkern, Mark A.; London, Edythe D.] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Dean, Andy C.; London, Edythe D.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Mandelkern, Mark A.] Univ Calif Irvine, Dept Phys, Irvine, CA 92717 USA; [London, Edythe D.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA	University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California Irvine; University of California System; University of California Los Angeles	London, ED (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA.	elondon@mednet.ucla.edu	Ballard, Michael/F-9146-2013	Ballard, Michael/0000-0002-2651-6588	National Institutes of Health [R01 DA020726, P20 DA022539, K23 DA027734, M0I RR00865]; Marjorie M. Greene Trust; Thomas P. and Katherine K. Pike Chair in Addiction Studies;  [T32 DA024635]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA024635, K23DA027734, P20DA022539, R01DA020726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marjorie M. Greene Trust; Thomas P. and Katherine K. Pike Chair in Addiction Studies; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The research was supported by National Institutes of Health grants R01 DA020726 (EDL), P20 DA022539 (EDL), K23 DA027734 (ACD), M0I RR00865 (UCLA GCRC), by endowments from the Thomas P. and Katherine K. Pike Chair in Addiction Studies (EDL), and the Marjorie M. Greene Trust. MEB was supported by T32 DA024635. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDEKANI BA, 1995, J COMPUT ASSIST TOMO, V19, P615, DOI 10.1097/00004728-199507000-00022; Backman L, 2000, AM J PSYCHIAT, V157, P635; Ballard ME, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu119; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Bolla KI, 1999, J NEUROPSYCH CLIN N, V11, P361, DOI 10.1176/jnp.11.3.361; Brown AK, 2012, INT J NEUROPSYCHOPH, V15, P989, DOI 10.1017/S1461145711001957; Cervenka S, 2008, NEUROIMAGE, V40, P1287, DOI 10.1016/j.neuroimage.2007.12.063; Chen PS, 2005, PSYCHOL MED, V35, P197, DOI 10.1017/S0033291704003101; Chudasama Y, 2011, BEHAV NEUROSCI, V125, P327, DOI 10.1037/a0023766; Chung A, 2007, INT J NEUROPSYCHOPH, V10, P765, DOI 10.1017/Sl461145706007395; Cox SML, 2015, NEUROIMAGE, V109, P95, DOI 10.1016/j.neuroimage.2014.12.070; Cunha Paulo Jannuzzi, 2013, Front Psychiatry, V4, P126, DOI 10.3389/fpsyt.2013.00126; Dean AC, 2013, NEUROPSYCHOPHARMACOL, V38, P259, DOI 10.1038/npp.2012.179; Errico AL, 2002, ALCOHOL CLIN EXP RES, V26, P1198, DOI 10.1097/01.ALC.0000025885.23192.FF; Fereshteh A., 2012, ANN BIOL RES, V3, P415; First M. B, 1996, STRUCTURED CLINICAL; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Ghahremani DG, 2012, J NEUROSCI, V32, P7316, DOI 10.1523/JNEUROSCI.4284-11.2012; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Goldstein RZ, 2004, NEUROPSYCHOLOGIA, V42, P1447, DOI 10.1016/j.neuropsychologia.2004.04.002; Grant S, 2000, NEUROPSYCHOLOGIA, V38, P1180, DOI 10.1016/S0028-3932(99)00158-X; Groman SM, 2012, J NEUROSCI, V32, P5843, DOI 10.1523/JNEUROSCI.0029-12.2012; Groman SM, 2011, J NEUROSCI, V31, P7291, DOI 10.1523/JNEUROSCI.0363-11.2011; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Heaton RK, 1981, WISCONSIN CARD SORTI; Hoff AL, 1996, PSYCHIAT RES, V60, P167, DOI 10.1016/0165-1781(96)02758-8; Hosak L, 2012, PSYCHIAT DANUB, V24, P188; Ichise M, 2008, J CEREBR BLOOD F MET, V28, P420, DOI 10.1038/sj.jcbfm.9600530; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Izquierdo A, 2012, PSYCHOPHARMACOLOGY, V219, P607, DOI 10.1007/s00213-011-2579-7; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jocham G, 2009, J NEUROSCI, V29, P3695, DOI 10.1523/JNEUROSCI.5195-08.2009; Johanson CE, 2006, PSYCHOPHARMACOLOGY, V185, P327, DOI 10.1007/s00213-006-0330-6; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Kohno M, 2015, CEREB CORTEX, V25, P236, DOI 10.1093/cercor/bht218; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lawrence AD, 1998, BRAIN, V121, P1343, DOI 10.1093/brain/121.7.1343; Lee B, 2007, NEUROPSYCHOPHARMACOL, V32, P2125, DOI 10.1038/sj.npp.1301337; Lee B, 2009, J NEUROSCI, V29, P14734, DOI 10.1523/JNEUROSCI.3765-09.2009; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; London ED, 2015, BRAIN RES, V1628, P174, DOI 10.1016/j.brainres.2014.10.044; Lumme V, 2007, PSYCHIAT RES-NEUROIM, V156, P69, DOI 10.1016/j.pscychresns.2006.12.012; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; Mawlawi O, 2001, J CEREBR BLOOD F MET, V21, P1034, DOI 10.1097/00004647-200109000-00002; McCann UD, 2008, SYNAPSE, V62, P91, DOI 10.1002/syn.20471; Miller BT, 2005, NEURON, V48, P535, DOI 10.1016/j.neuron.2005.11.002; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MINTUN MA, 1984, ANN NEUROL, V15, P217, DOI 10.1002/ana.410150302; Moeller SJ, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.110; MUKHERJEE J, 1995, NUCL MED BIOL, V22, P283, DOI 10.1016/0969-8051(94)00117-3; Nowakowska K, 2007, PSYCHIATR POL, V41, P693; Pau CWH, 2002, ARCH CLIN NEUROPSYCH, V17, P663, DOI 10.1016/S0887-6177(01)00169-X; Reeves SJ, 2005, NEUROIMAGE, V28, P216, DOI 10.1016/j.neuroimage.2005.05.034; Simon SL, 2010, J STUD ALCOHOL DRUGS, V71, P335, DOI 10.15288/jsad.2010.71.335; Slagter HA, 2012, J COGNITIVE NEUROSCI, V24, P1932, DOI 10.1162/jocn_a_00255; Sofuoglu M, 2013, NEUROPHARMACOLOGY, V64, P452, DOI 10.1016/j.neuropharm.2012.06.021; Takahashi H, 2008, J NEUROSCI, V28, P12032, DOI 10.1523/JNEUROSCI.3446-08.2008; Takahashi H, 2007, NEUROIMAGE, V34, P1643, DOI 10.1016/j.neuroimage.2006.11.008; Trifilieff P, 2014, NEUROPHARMACOLOGY, V76, P498, DOI 10.1016/j.neuropharm.2013.06.031; Vandehey NT, 2010, J CEREBR BLOOD F MET, V30, P994, DOI 10.1038/jcbfm.2009.270; Verdejo-Garcia A, 2007, PSYCHOPHARMACOLOGY, V190, P517, DOI 10.1007/s00213-006-0632-8; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; Volkow ND, 1998, AM J PSYCHIAT, V155, P344; Volkow ND, 2001, AM J PSYCHIAT, V158, P2015, DOI 10.1176/appi.ajp.158.12.2015; Wang GJ, 2012, MOL PSYCHIATR, V17, P918, DOI 10.1038/mp.2011.86; Woicik PA, 2011, NEUROPSYCHOLOGIA, V49, P1660, DOI 10.1016/j.neuropsychologia.2011.02.037; Woicik PA, 2009, NEUROPSYCHOPHARMACOL, V34, P1112, DOI 10.1038/npp.2008.60; Wu YJ, 2002, J CEREBR BLOOD F MET, V22, P1440, DOI 10.1097/01.WCB.0000033967.83623.34; Zorick T, 2012, MOL PSYCHIATR, V17, P569, DOI 10.1038/mp.2011.137	70	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143510	10.1371/journal.pone.0143510	http://dx.doi.org/10.1371/journal.pone.0143510			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657223	Green Submitted, gold, Green Published			2022-12-27	WOS:000366715900012
J	Padmanabha, H; Correa, F; Rubio, C; Baeza, A; Osorio, S; Mendez, J; Jones, JH; Diuk-Wasser, MA				Padmanabha, Harish; Correa, Fabio; Rubio, Camilo; Baeza, Andres; Osorio, Salua; Mendez, Jairo; Jones, James Holland; Diuk-Wasser, Maria A.			Human Social Behavior and Demography Drive Patterns of Fine-Scale Dengue Transmission in Endemic Areas of Colombia	PLOS ONE			English	Article							RIO-DE-JANEIRO; AEDES-AEGYPTI; HUMAN MOVEMENT; VIRUS TRANSMISSION; POPULATIONS; VILLAGES; HETEROGENEITY; NICARAGUA; DISPERSAL; CULICIDAE	Dengue is known to transmit between humans and A. aegypti mosquitoes living in neighboring houses. Although transmission is thought to be highly heterogeneous in both space and time, little is known about the patterns and drivers of transmission in groups of houses in endemic settings. We carried out surveys of PCR positivity in children residing in 2-block patches of highly endemic cities of Colombia. We found high levels of heterogeneity in PCR positivity, varying from less than 30% in 8 of the 10 patches to 56 and 96%, with the latter patch containing 22 children simultaneously PCR positive (PCR22) for DEN2. We then used an agent-based model to assess the likely eco-epidemiological context of this observation. Our model, simulating daily dengue dynamics over a 20 year period in a single two block patch, suggests that the observed heterogeneity most likely derived from variation in the density of susceptible people. Two aspects of human adaptive behavior were critical to determining this density: external social relationships favoring viral introduction (by susceptible residents or infectious visitors) and immigration of households from non-endemic areas. External social relationships generating frequent viral introduction constituted a particularly strong constraint on susceptible densities, thereby limiting the potential for explosive outbreaks and dampening the impact of heightened vectorial capacity. Dengue transmission can be highly explosive locally, even in neighborhoods with significant immunity in the human population. Variation among neighborhoods in the density of local social networks and rural-to-urban migration is likely to produce significant fine-scale heterogeneity in dengue dynamics, constraining or amplifying the impacts of changes in mosquito populations and cross immunity between serotypes.	[Padmanabha, Harish] Univ Norte, Ctr Invest Desarrollo Humano CIDHUM, Puerto Colombia, Colombia; [Padmanabha, Harish; Baeza, Andres] Univ Maryland, Natl Socioenvironm Synth Ctr SESYNC, Annapolis, MD 21401 USA; [Correa, Fabio; Rubio, Camilo; Osorio, Salua; Mendez, Jairo] Inst Nacl Salud Colombia, Bogota, Dc, Colombia; [Jones, James Holland] Stanford Univ, Woods Inst Environm, Dept Anthropol, Stanford, CA 94305 USA; [Diuk-Wasser, Maria A.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Diuk-Wasser, Maria A.] Yale Univ, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA	Universidad del Norte; Instituto Nacional de Salud (Colombia); Stanford University; Columbia University; Yale University	Padmanabha, H (corresponding author), Univ Norte, Ctr Invest Desarrollo Humano CIDHUM, Km 5 Via Puerto Colombia, Puerto Colombia, Colombia.	harishpadmanabha@gmail.com		Correa, Fabio/0000-0002-4562-7419; Jones, James/0000-0003-1680-6757	Global Environmental Facility/World Bank through the Integrated National Adaptation Pilot, a project executed in the Instituto Nacional de Salud de Colombia; National Virology Laboratory of the Instituto Nacional de Salud de Colombia; Yale Climate and Energy Institute; National Socio-Environmental Synthesis Center; Direct For Biological Sciences [1052875] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1639145] Funding Source: National Science Foundation	Global Environmental Facility/World Bank through the Integrated National Adaptation Pilot, a project executed in the Instituto Nacional de Salud de Colombia; National Virology Laboratory of the Instituto Nacional de Salud de Colombia; Yale Climate and Energy Institute; National Socio-Environmental Synthesis Center; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by the Global Environmental Facility/World Bank through the Integrated National Adaptation Pilot, a project executed in the Instituto Nacional de Salud de Colombia. It also received funding from the National Virology Laboratory of the Instituto Nacional de Salud de Colombia, the Yale Climate and Energy Institute (grant awarded to MAD) and the National Socio-Environmental Synthesis Center (postdoctoral fellowships of HP, AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders KL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003528; Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bhoomiboonchoo P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003138; Boyd R, 1985, CULTURE EVOLUTIONARY, pviii; Breunlin R, 2006, AM ANTHROPOL, V108, P744, DOI 10.1525/aa.2006.108.4.744; Chao DL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001876; Christophers R., 1960, AEDES AEGYPTI L YELL; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cross PC, 2005, ECOL LETT, V8, P587, DOI 10.1111/j.1461-0248.2005.00760.x; Medeiros LCD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000942; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Domingo C., 2004, Dengue Bulletin, V28, P87; Dwiartama A, 2014, ECOL SOC, V19, DOI 10.5751/ES-06805-190328; Favier C, 2005, P ROY SOC B-BIOL SCI, V272, P1171, DOI 10.1098/rspb.2004.3020; Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159; GWADZ RW, 1968, MOSQ NEWS, V28, P586; Jetten TH, 1997, AM J TROP MED HYG, V57, P285, DOI 10.4269/ajtmh.1997.57.285; Li T, 2011, INT J TUBERC LUNG D, V15, P163; Liebman KA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002702; Luz PM, 2003, MEM I OSWALDO CRUZ, V98, P871, DOI 10.1590/S0074-02762003000700002; Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; Mendez JA, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-64; Mesch GS, 1998, ENVIRON BEHAV, V30, P504, DOI 10.1177/001391659803000405; Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123; Nathan MB, 2006, ANN TROP MED PARASIT, V100, pS1, DOI 10.1179/136485906X105462; Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110; Otero M, 2010, MATH BIOSCI, V223, P32, DOI 10.1016/j.mbs.2009.10.005; Padmanabha H, 2010, ECOHEALTH, V7, P78, DOI 10.1007/s10393-010-0301-6; Padmanabha H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001799; Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327; Pianka ER, 1988, EVOLUTIONARY ECOLOGY, pix; Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414; Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111; Reiner RC, 2014, EPIDEMICS-NETH, V6, P30, DOI 10.1016/j.epidem.2013.12.003; Reyes M, 2010, AM J TROP MED HYG, V83, P683, DOI 10.4269/ajtmh.2010.10-0023; Rodriguez-Barraquer I, 2014, AM J EPIDEMIOL, V179, P353, DOI 10.1093/aje/kwt256; Roy M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03710; Salje H, 2012, P NATL ACAD SCI USA, V109, P9535, DOI 10.1073/pnas.1120621109; Sterelny K, 2007, PHILOS T R SOC B, V362, P719, DOI 10.1098/rstb.2006.2006; Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; SUBRA R, 1983, ANN TROP MED PARASIT, V77, P195, DOI 10.1080/00034983.1983.11811697; Thai KTD, 2010, EPIDEMIOL INFECT, V138, P585, DOI 10.1017/S095026880999046X; Vanwambeke Sophie O, 2006, Int J Health Geogr, V5, P5, DOI 10.1186/1476-072X-5-5; Vazquez-Prokopec GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058802; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103; Winterhalder B, 2000, EVOL ANTHROPOL, V9, P51; Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730; Yoon IK, 2012, J INFECT DIS, V206, P389, DOI 10.1093/infdis/jis357	52	11	11	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144451	10.1371/journal.pone.0144451	http://dx.doi.org/10.1371/journal.pone.0144451			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656072	gold, Green Submitted, Green Published			2022-12-27	WOS:000366715900050
J	Vagne, Q; Turner, MS; Sens, P				Vagne, Quentin; Turner, Matthew S.; Sens, Pierre			Sensing Size through Clustering in Non-Equilibrium Membranes and the Control of Membrane-Bound Enzymatic Reactions	PLOS ONE			English	Article							CELL-SURFACE; DOMAINS; ORGANIZATION; VESICLES; FLUID; ENDOCYTOSIS; MATURATION; MIXTURES; BEHAVIOR; RAFTS	The formation of dynamical clusters of proteins is ubiquitous in cellular membranes and is in part regulated by the recycling of membrane components. We show, using stochastic simulations and analytic modeling, that the out-of-equilibrium cluster size distribution of membrane components undergoing continuous recycling is strongly influenced by lateral confinement. This result has significant implications for the clustering of plasma membrane proteins whose mobility is hindered by cytoskeletal "corrals" and for protein clustering in cellular organelles of limited size that generically support material fluxes. We show how the confinement size can be sensed through its effect on the size distribution of clusters of membrane heterogeneities and propose that this could be regulated to control the efficiency of membrane-bound reactions. To illustrate this, we study a chain of enzymatic reactions sensitive to membrane protein clustering. The reaction efficiency is found to be a non-monotonic function of the system size, and can be optimal for sizes comparable to those of cellular organelles.	[Vagne, Quentin; Sens, Pierre] PSL Res Univ, CNRS, Inst Curie, UMR 168, F-75005 Paris, France; [Turner, Matthew S.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Turner, Matthew S.] Univ Warwick, Complex Ctr, Coventry CV4 7AL, W Midlands, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; University of Warwick; University of Warwick	Sens, P (corresponding author), PSL Res Univ, CNRS, Inst Curie, UMR 168, 26 Rue Ulm, F-75005 Paris, France.	pierre.sens@curie.fr	sens, pierre/C-3537-2011; Turner, Matthew/D-1121-2011	sens, pierre/0000-0003-4523-3791; Turner, Matthew/0000-0002-3441-678X	Engineering and Physical Sciences Research Council	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Engineering and Physical Sciences Research Council (MST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagatolli LA, 2000, BIOPHYS J, V78, P290, DOI 10.1016/S0006-3495(00)76592-1; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Quang BAT, 2013, CURR BIOL, V23, P2197, DOI 10.1016/j.cub.2013.09.015; BRAY AJ, 1994, ADV PHYS, V43, P357, DOI 10.1080/00018739400101505; Buchner A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.208104; Camacho J, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.046112; Castellana M, 2014, NAT BIOTECHNOL, V32, P1011, DOI 10.1038/nbt.3018; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chan YHM, 2012, SCIENCE, V337, P1186, DOI 10.1126/science.1223539; Cicuta P, 2007, J PHYS CHEM B, V111, P3328, DOI 10.1021/jp0702088; Connaughton C, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061114; Davies SC, 1999, J ENG MATH, V36, P57, DOI 10.1023/A:1004589822425; Dmitrieff S, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062704; EDIDIN M, 1991, SCIENCE, V254, P1379, DOI 10.1126/science.1835798; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Foret L, 2005, EUROPHYS LETT, V71, P508, DOI 10.1209/epl/i2005-10098-x; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GLOTZER SC, 1995, PHYS REV LETT, V74, P2034, DOI 10.1103/PhysRevLett.74.2034; Goehring NW, 2012, CURR BIOL, V22, pR330, DOI 10.1016/j.cub.2012.03.046; Gowrishankar K, 2012, CELL, V149, P1353, DOI 10.1016/j.cell.2012.05.008; Johnson SA, 2010, BBA-BIOMEMBRANES, V1798, P1427, DOI 10.1016/j.bbamem.2010.03.009; Lavi Y, 2007, BIOPHYS J, V93, pL35, DOI 10.1529/biophysj.107.111567; Levental I, 2011, P NATL ACAD SCI USA, V108, P11411, DOI 10.1073/pnas.1105996108; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; Mugler A, 2013, P NATL ACAD SCI USA, V110, P5927, DOI 10.1073/pnas.1218301110; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Nair PM, 2011, NAT PROTOC, V6, P523, DOI 10.1038/nprot.2011.302; OVADI J, 1991, J THEOR BIOL, V152, P1, DOI 10.1016/S0022-5193(05)80500-4; Pfeffer SR, 2010, P NATL ACAD SCI USA, V107, P19614, DOI 10.1073/pnas.1011016107; Rivera-Molina FE, 2009, P NATL ACAD SCI USA, V106, P14408, DOI 10.1073/pnas.0906536106; Sengupta D, 2011, ANNU REV CELL DEV BI, V27, P57, DOI 10.1146/annurev-cellbio-100109-104003; Sens P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.238101; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; Sikder MKU, 2014, J CHEM PHYS, V141, DOI [10.1063/1.4890655, DOI 10.1063/1.4890655]; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Smoluchowski MV., 1916, Z PHYS, V17, P557; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Tang Q, 2001, BIOPHYS J, V81, P196, DOI 10.1016/S0006-3495(01)75691-3; Treanor B, 2010, IMMUNITY, V32, P187, DOI 10.1016/j.immuni.2009.12.005; Turner MS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.168301; Veatch SL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.268101; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8	44	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143470	10.1371/journal.pone.0143470	http://dx.doi.org/10.1371/journal.pone.0143470			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656912	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900010
J	de Souza, VA; Scott, DJ; Nettleship, JE; Rahman, N; Charlton, MH; Walsh, MA; Owens, RJ				de Souza, Victoria Arena; Scott, David J.; Nettleship, Joanne E.; Rahman, Nahid; Charlton, Michael H.; Walsh, Martin A.; Owens, Raymond J.			Comparison of the Structure and Activity of Glycosylated and Aglycosylated Human Carboxylesterase 1	PLOS ONE			English	Article							RABBIT LIVER CARBOXYLESTERASE; SITE-DIRECTED MUTAGENESIS; MAMMALIAN CARBOXYLESTERASES; SPODOPTERA-FRUGIPERDA; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CELL LINES; INHIBITION; CPT-11; EXPRESSION	Human Carboxylesterase 1 (hCES1) is the key liver microsomal enzyme responsible for detoxification and metabolism of a variety of clinical drugs. To analyse the role of the single N-linked glycan on the structure and activity of the enzyme, authentically glycosylated and aglycosylated hCES1, generated by mutating asparagine 79 to glutamine, were produced in human embryonic kidney cells. Purified enzymes were shown to be predominantly trimeric in solution by analytical ultracentrifugation. The purified aglycosylated enzyme was found to be more active than glycosylated hCES1 and analysis of enzyme kinetics revealed that both enzymes exhibit positive cooperativity. Crystal structures of hCES1 a catalytically inactive mutant (S221A) and the aglycosylated enzyme were determined in the absence of any ligand or substrate to high resolutions (1.86 angstrom, 1.48 angstrom and 2.01 angstrom, respectively). Superposition of all three structures showed only minor conformational differences with a root mean square deviations of around 0.5 angstrom over all C alpha positions. Comparison of the active sites of these un-liganded enzymes with the structures of hCES1-ligand complexes showed that side-chains of the catalytic triad were pre-disposed for substrate binding. Overall the results indicate that preventing N-glycosylation of hCES1 does not significantly affect the structure or activity of the enzyme.	[de Souza, Victoria Arena; Nettleship, Joanne E.; Rahman, Nahid; Owens, Raymond J.] Rutherford Appleton Lab Harwell Oxford, UK OPPF UK, Didcot, Oxon, England; [de Souza, Victoria Arena; Nettleship, Joanne E.; Rahman, Nahid] Univ Oxford, Div Struct Biol, Oxford, England; [Scott, David J.; Walsh, Martin A.] Rutherford Appleton Lab Harwell Oxford, Didcot, Oxon, England; [Scott, David J.] Univ Nottingham, Sch Biosci, Loughborough, Leics, England; [Charlton, Michael H.] Chroma Therapeut Ltd, Abingdon, Oxon, England; [de Souza, Victoria Arena; Walsh, Martin A.] Diamond Light Source, Didcot, Oxon, England	University of Oxford; University of Nottingham; Diamond Light Source	Walsh, MA (corresponding author), Rutherford Appleton Lab Harwell Oxford, Res Complex Harwell, Didcot, Oxon, England.	martin.walsh@diamond.ac.uk; ray@strubi.ox.ac.uk	Walsh, Martin A/I-1566-2013	Walsh, Martin A/0000-0001-5683-1151; Nettleship, Joanne/0000-0002-1258-1733	Medical Research Council UK [MR/K018779/1]; Nuffield Department of Medicine, University of Oxford; Diamond Light Source Ltd.; Chroma Therapeutics Ltd.; Wellcome Trust [075491/Z/04]; Chroma Therapeutics; MRC [MR/K018779/1] Funding Source: UKRI; Medical Research Council [MR/K018779/1] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Nuffield Department of Medicine, University of Oxford; Diamond Light Source Ltd.; Chroma Therapeutics Ltd.; Wellcome Trust(Wellcome TrustEuropean Commission); Chroma Therapeutics; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work described was supported by the following: Medical Research Council UK Grant no. MR/K018779/1 (RJO). Nuffield Department of Medicine, University of Oxford (VAS). Diamond Light Source Ltd. (VAS). Chroma Therapeutics Ltd. (VAS). Wellcome Trust Grant no. 075491/Z/04 (VAS, RJO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Chroma Therapeutics provided support in the form of part of the stipend for the lead author, VAS and author (MHC) formerly employed by Chroma Therapeutics was involved in the conception of the study and contributed to the writing of the paper. Chroma Therapeutics did not play any role in the decision to publish the paper.	Alam M, 2002, BIOCHEMISTRY-US, V41, P6679, DOI 10.1021/bi0255625; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Bencharit S, 2003, NAT STRUCT BIOL, V10, P349, DOI 10.1038/nsb919; Bencharit S, 2002, NAT STRUCT BIOL, V9, P337, DOI 10.1038/nsb790; Bencharit S, 2003, CHEM BIOL, V10, P341, DOI 10.1016/S1074-5521(03)00071-1; Bencharit S, 2006, J MOL BIOL, V363, P201, DOI 10.1016/j.jmb.2006.08.025; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Boonyuen U, 2015, PROTEIN EXPRES PURIF, V107, P68, DOI 10.1016/j.pep.2014.11.006; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Crow JA, 2012, TOXICOL APPL PHARM, V258, P145, DOI 10.1016/j.taap.2011.10.017; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fleming CD, 2005, J MOL BIOL, V352, P165, DOI 10.1016/j.jmb.2005.07.016; Fleming CD, 2007, BIOCHEMISTRY-US, V46, P5063, DOI 10.1021/bi700246n; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; Greenblatt HM, 2012, ACTA CRYSTALLOGR F, V68, P269, DOI 10.1107/S1744309112003326; Hatfield MJ, 2011, BIOCHEM PHARMACOL, V81, P24, DOI 10.1016/j.bcp.2010.09.001; Hemmert AC, 2010, MOL PHARMACOL, V77, P508, DOI 10.1124/mol.109.062356; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Holmes RS, 2010, MAMM GENOME, V21, P427, DOI 10.1007/s00335-010-9284-4; Hosokawa M, 2008, MOLECULES, V13, P412, DOI 10.3390/molecules13020412; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; KROETZ DL, 1993, BIOCHEMISTRY-US, V32, P11606, DOI 10.1021/bi00094a018; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Morton CL, 2000, MOL BIOTECHNOL, V16, P193, DOI 10.1385/MB:16:3:193; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Needham LA, 2011, J PHARMACOL EXP THER, V339, P132, DOI 10.1124/jpet.111.183640; Neffleship Joanne E., 2009, V498, P245, DOI 10.1007/978-1-59745-196-3_16; Nettleship JE, 2015, METHODS MOL BIOL, V1258, P209, DOI 10.1007/978-1-4939-2205-5_11; Newman J, 2005, ACTA CRYSTALLOGR D, V61, P1426, DOI [10.1107/S0907444905024984, 10.1107/S090744905024984]; Nishi K, 2006, ARCH BIOCHEM BIOPHYS, V445, P115, DOI 10.1016/j.abb.2005.11.005; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Parkinson EI, 2011, BIOORGAN MED CHEM, V19, P4635, DOI 10.1016/j.bmc.2011.06.012; Potter PM, 2006, CURR MED CHEM, V13, P1045, DOI 10.2174/092986706776360969; Potter PM, 1998, CANCER RES, V58, P2646; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; SATOH T, 1994, BIOL PHARM BULL, V17, P662; Satoh T, 1998, ANNU REV PHARMACOL, V38, P257, DOI 10.1146/annurev.pharmtox.38.1.257; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; SuzukiKurasaki M, 1997, BIOCHEM J, V325, P155, DOI 10.1042/bj3250155; Takahashi S, 2008, J PHARM SCI-US, V97, P5434, DOI 10.1002/jps.21376; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Wadkins RM, 2007, MOL PHARMACOL, V71, P713, DOI 10.1124/mol.105.021683; Wadkins RM, 2001, MOL PHARMACOL, V60, P355, DOI 10.1124/mol.60.2.355; Walter TS, 2005, ACTA CRYSTALLOGR D, V61, P651, DOI 10.1107/S0907444905007808	46	7	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0143919	10.1371/journal.pone.0143919	http://dx.doi.org/10.1371/journal.pone.0143919			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657071	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903600016
J	Ma, YJ; Sun, XH; Xu, XY; Zhao, Y; Pan, YJ; Hwang, CA; Wu, VCH				Ma, Yue-jiao; Sun, Xiao-hong; Xu, Xiao-yan; Zhao, Yong; Pan, Ying-jie; Hwang, Cheng-An; Wu, Vivian C. H.			Investigation of Reference Genes in Vibrio parahaemolyticus for Gene Expression Analysis Using Quantitative RT-PCR	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; REAL-TIME PCR; HOUSEKEEPING GENES; TEMPERATURE REGULATION; VIRULENCE; QUANTIFICATION; NORMALIZATION; SELECTION; CONTRIBUTES; INTEGRITY	Vibrio parahaemolyticus is a significant human pathogen capable of causing foodborne gastroenteritis associated with the consumption of contaminated raw or undercooked seafood. Quantitative RT-PCR (qRT-PCR) is a useful tool for studying gene expression in V. parahaemolyticus to characterize its virulence factors and understand the effect of environmental conditions on its pathogenicity. However, there is not a stable gene in V. parahaemolyticus that has been identified for use as a reference gene for qRT-PCR. This study evaluated the stability of 6 reference genes (16S rRNA, recA, rpoS, pvsA, pvuA, and gapdh) in 5 V. parahaemolyticus strains (O3:K6-clinical strain-tdh(+), ATCC33846-tdh(+), ATCC33847-tdh(+), ATCC17802-trh(+), and F13-environmental strain-tdh(+)) cultured at 4 different temperatures (15, 25, 37 and 42 degrees C). Stability values were calculated using GeNorm, NormFinder, BestKeeper, and Delta CT algorithms. The results indicated that recA was the most stably expressed gene in the V. parahaemolyticus strains cultured at different temperatures. This study examined multiple V. parahaemolyticus strains and growth temperatures, hence the finding provided stronger evidence that recA can be used as a reference gene for gene expression studies in V. parahaemolyticus.	[Ma, Yue-jiao; Sun, Xiao-hong; Zhao, Yong; Pan, Ying-jie] Shanghai Ocean Univ, Coll Food Sci & Technol, Shanghai, Peoples R China; [Ma, Yue-jiao; Sun, Xiao-hong; Zhao, Yong; Pan, Ying-jie] Shanghai Engn Res Ctr Aquat Prod Proc & Preservat, Shanghai 201306, Peoples R China; [Xu, Xiao-yan] Shanghai Ocean Univ, Key Lab Explorat & Utilizat Aquat Genet Resources, Minist Educ, Shanghai, Peoples R China; [Hwang, Cheng-An] ARS, Residue Chem & Predict Microbiol Res Unit, Eastern Reg Res Ctr, USDA, Wyndmoor, PA 19038 USA; [Wu, Vivian C. H.] Univ Maine, Pathogen Microbiol Lab, Sch Food & Agr, Orono, ME 04469 USA; [Wu, Vivian C. H.] ARS, Produce Safety & Microbiol Res Unit, Western Reg Res Ctr, USDA, Albany, CA 94710 USA	Shanghai Ocean University; Shanghai Ocean University; United States Department of Agriculture (USDA); University of Maine System; University of Maine Orono; United States Department of Agriculture (USDA)	Sun, XH (corresponding author), Shanghai Ocean Univ, Coll Food Sci & Technol, Shanghai, Peoples R China.	xhsun@shou.edu.cn; Vivian.Wu@ARS.USDA.GOV		Wu, Vivian C.H./0000-0002-1525-1078	Shanghai Ocean University Doctoral Research Foundation; Key Project of Shanghai Agriculture Prosperity through Science and Technology [4-5]; Hatch Grant from the USDA National Institute of Food and Agriculture [ME08562-10]	Shanghai Ocean University Doctoral Research Foundation; Key Project of Shanghai Agriculture Prosperity through Science and Technology; Hatch Grant from the USDA National Institute of Food and Agriculture	This work was supported by grants from Shanghai Ocean University Doctoral Research Foundation, Key Project of Shanghai Agriculture Prosperity through Science and Technology (2015, 4-5). This work is based upon research supported in part by Hatch Grant number ME08562-10 from the USDA National Institute of Food and Agriculture.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Boonyawantang A, 2012, FOOD CONTROL, V26, P479, DOI 10.1016/j.foodcont.2012.02.009; Broberg CA, 2011, MICROBES INFECT, V13, P992, DOI 10.1016/j.micinf.2011.06.013; Bustin SA, 2005, CLIN SCI, V109, P365, DOI 10.1042/CS20050086; Coutard F, 2007, APPL ENVIRON MICROB, V73, P5183, DOI 10.1128/AEM.02776-06; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Florindo C, 2012, J MICROBIOL METH, V90, P220, DOI 10.1016/j.mimet.2012.05.011; Hansen MC, 2001, J BACTERIOL, V183, P4747, DOI 10.1128/JB.183.16.4747-4751.2001; Hufnagel M, 2004, J INFECT DIS, V189, P420, DOI 10.1086/381150; Kallman O, 2009, MICROB DRUG RESIST, V15, P91, DOI 10.1089/mdr.2009.0883; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Li Qin, 2013, Weishengwu Xuebao, V53, P306; Mahoney JC, 2010, APPL ENVIRON MICROB, V76, P7459, DOI 10.1128/AEM.01450-10; Marco ML, 2008, J APPL MICROBIOL, V104, P587, DOI 10.1111/j.1365-2672.2007.03578.x; MAURELLI AT, 1989, MICROB PATHOGENESIS, V7, P1, DOI 10.1016/0882-4010(89)90106-X; McLaughlin JB, 2005, NEW ENGL J MED, V353, P1463, DOI 10.1056/NEJMoa051594; McMillan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098162; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Sengupta P, 2013, CURR BIOL, V23, pR304, DOI 10.1016/j.cub.2013.03.009; Shivaji S, 2010, ARCH MICROBIOL, V192, P85, DOI 10.1007/s00203-009-0539-y; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Stevenson DM, 2005, APPL ENVIRON MICROB, V71, P4672, DOI 10.1128/AEM.71.8.4672-4678.2005; Su YC, 2007, FOOD MICROBIOL, V24, P549, DOI 10.1016/j.fm.2007.01.005; Takle GW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-50; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Trevors JT, 2012, EXTREMOPHILES, V16, P167, DOI 10.1007/s00792-011-0423-y; Vandecasteele SJ, 2001, J BACTERIOL, V183, P7094, DOI 10.1128/JB.183.24.7094-7101.2001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Whitaker WB, 2010, APPL ENVIRON MICROB, V76, P4720, DOI 10.1128/AEM.00474-10; Yeung P S Marie, 2004, Foodborne Pathog Dis, V1, P74, DOI 10.1089/153531404323143594	35	21	22	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144362	10.1371/journal.pone.0144362	http://dx.doi.org/10.1371/journal.pone.0144362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659406	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903600038
J	Shitiz, K; Sharma, N; Pal, T; Sood, H; Chauhan, RS				Shitiz, Kirti; Sharma, Neha; Pal, Tarun; Sood, Hemant; Chauhan, Rajinder S.			NGS Transcriptomes and Enzyme Inhibitors Unravel Complexity of Picrosides Biosynthesis in Picrorhiza kurroa Royle ex. Benth	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; SUSPENSION-CULTURES; 5-ENOLPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE; UROPORPHYRINOGEN DECARBOXYLASE; ISOPRENOID BIOSYNTHESIS; GLYPHOSATE TOLERANCE; SHIKIMATE PATHWAY; MEDICINAL HERB; FERULIC ACID; EXPRESSION	Picrorhiza kurroa is an important medicinal herb valued for iridoid glycosides, Picroside-I (P-I) and Picroside-II (P-II), which have several pharmacological activities. Genetic interventions for developing a picroside production platform would require knowledge on biosynthetic pathway and key control points, which does not exist as of today. The current study reports that geranyl pyrophosphate (GPP) moiety is mainly contributed by the non-mevalonate (MEP) route, which is further modified to P-I and P-II through phenylpropanoid and iridoid pathways, in total consisting of 41 and 35 enzymatic steps, respectively. The role of the MEP pathway was ascertained through enzyme inhibitors fosmidomycin and mevinolin along with importance of other integrating pathways using glyphosate, aminooxy acetic acid (AOA) and actinomycin D, which overall resulted in 17%-92% inhibition of P-I accumulation. Retrieval of gene sequences for enzymatic steps from NGS transcriptomes and their expression analysis vis-a-vis picrosides content in different tissues/organs showed elevated transcripts for twenty genes, which were further shortlisted to seven key genes, ISPD, DXPS, ISPE, PMK, 2HFD, EPSPS and SK, on the basis of expression analysis between high versus low picrosides content strains of P. kurroa so as to eliminate tissue type/developmental variations in picrosides contents. The higher expression of the majority of the MEP pathway genes (ISPD, DXPS and ISPE), coupled with higher inhibition of DXPR enzyme by fosmidomycin, suggested that the MEP route contributed to the biosynthesis of P-I in P. kurroa. The outcome of the study is expected to be useful in designing a suitable genetic intervention strategy towards enhanced production of picrosides. Possible key genes contributing to picroside biosynthesis have been identified with potential implications in molecular breeding and metabolic engineering of P. kurroa.	[Shitiz, Kirti; Sharma, Neha; Pal, Tarun; Sood, Hemant; Chauhan, Rajinder S.] Jaypee Univ, Dept Biotechnol & Bioinformat, Solan 73234, Himachal Prades, India	Jaypee University of Information Technology	Chauhan, RS (corresponding author), Jaypee Univ, Dept Biotechnol & Bioinformat, Solan 73234, Himachal Prades, India.	rajinder.chauhan@juit.ac.in	Chauhan, Rajinder Singh/HGB-5642-2022; Pal, Tarun/V-4301-2019; Sood, Hemant/AAL-3516-2021	Pal, Tarun/0000-0002-4344-0351; 	Department of Biotechnology, Ministry of Science and Technology, Government of India; Department of Biotechnology, Govt. of India	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	The research work has been funded by Department of Biotechnology, Ministry of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are thankful to the Department of Biotechnology, Govt. of India for providing financial support to RSC in the form of a programme support on high value medicinal plants. The authors are also thankful to Dr. Jagdish Singh, Himalayan Forest Research Institute (HFRI), Shimla, India for providing Picrorhiza kurroa plant material.	ALBERTS AW, 1980, P NATL ACAD SCI-BIOL, V77, P3957, DOI 10.1073/pnas.77.7.3957; Ali MB, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-84; Bauer N, 2011, FOOD TECHNOL BIOTECH, V49, P24; Bhandari P, 2009, CHROMATOGRAPHIA, V69, P221, DOI 10.1365/s10337-008-0889-7; Bhat WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073804; BRECKE BJ, 1980, PLANT PHYSIOL, V66, P656, DOI 10.1104/pp.66.4.656; Cabe MC, 2014, SACNAS NAT C LOS ANG; Cao GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038718; Chakraborty D, 2008, J PLANT PHYSIOL, V165, P1033, DOI 10.1016/j.jplph.2007.09.002; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Cui LJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08227; DOTZLAF JE, 1987, J BACTERIOL, V169, P1611, DOI 10.1128/jb.169.4.1611-1618.1987; Dutt S., 2004, DIFFERENTIAL ACCUMUL; Eisenreich W, 1997, TETRAHEDRON LETT, V38, P3889, DOI 10.1016/S0040-4039(97)00761-2; Estevez JM, 2001, J BIOL CHEM, V276, P22901, DOI 10.1074/jbc.M100854200; Flores-Sanchez IJ, 2002, PLANT CELL PHYSIOL, V43, P1502, DOI 10.1093/pcp/pcf181; FUNK C, 1992, PLANT PHYSIOL, V99, P256, DOI 10.1104/pp.99.1.256; Gahlan P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-126; Garg Bharti, 2014, BMC Res Notes, V7, P58, DOI 10.1186/1756-0500-7-58; Guo YL, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-43; Gupta N, 2011, J PLANT PHYSIOL, V168, P2117, DOI 10.1016/j.jplph.2011.06.018; Hampel D, 2006, J AGR FOOD CHEM, V54, P1473, DOI 10.1021/jf0523972; Han JY, 2010, PHYTOCHEMISTRY, V71, P36, DOI 10.1016/j.phytochem.2009.09.031; Healy-Fried ML, 2007, J BIOL CHEM, V282, P32949, DOI 10.1074/jbc.M705624200; Hemmerlin A, 2003, J BIOL CHEM, V278, P26666, DOI 10.1074/jbc.M302526200; HERRMANN KM, 1995, PLANT CELL, V7, P907; HOAGLAND RE, 1980, WEED SCI, V28, P393, DOI 10.1017/S0043174500055545; HOLLANDER H, 1980, PLANT PHYSIOL, V66, P823, DOI 10.1104/pp.66.5.823; Kamo T, 2000, BIOSCI BIOTECH BIOCH, V64, P2089, DOI 10.1271/bbb.64.2089; Kawoosa T, 2010, FUNCT INTEGR GENOMIC, V10, P393, DOI 10.1007/s10142-009-0152-9; KLEE HJ, 1987, MOL GEN GENET, V210, P437, DOI 10.1007/BF00327194; Kumar V, 2013, PHYTOCHEM ANALYSIS, V24, P598, DOI 10.1002/pca.2437; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Lois LM, 2000, PLANT J, V22, P503, DOI 10.1046/j.1365-313x.2000.00764.x; Mahmoud SS, 2001, P NATL ACAD SCI USA, V98, P8915, DOI 10.1073/pnas.141237298; MEHROTRA R, 1990, INDIAN J MED RES-B, V92, P133; Miettinen K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4606; Mock HP, 1998, PLANT PHYSIOL, V116, P107, DOI 10.1104/pp.116.1.107; Mock HP, 1997, PLANT PHYSIOL, V113, P1101, DOI 10.1104/pp.113.4.1101; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nagatoshi M, 2011, J BIOL CHEM, V286, P32866, DOI 10.1074/jbc.M111.242586; Nair RB, 2004, PLANT CELL, V16, P544, DOI 10.1105/tpc.017509; Nakayama T, 2003, J MOL CATAL B-ENZYM, V23, P117, DOI 10.1016/S1381-1177(03)00078-X; Narbad A, 1998, MICROBIOL-SGM, V144, P1397, DOI 10.1099/00221287-144-5-1397; Olofsson L, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-45; Palazon J, 2003, J BIOTECHNOL, V101, P157, DOI 10.1016/S0168-1656(02)00318-8; Pandit S, 2013, J PLANT BIOCHEM BIOT, V22, P335, DOI 10.1007/s13562-012-0136-z; Pandit S, 2013, MOL BIOL REP, V40, P1053, DOI 10.1007/s11033-012-2147-1; Peebles CAM, 2011, METAB ENG, V13, P234, DOI 10.1016/j.ymben.2010.11.005; Peiser G, 1998, POSTHARVEST BIOL TEC, V14, P171, DOI 10.1016/S0925-5214(98)00048-9; Rathee D, 2013, ARAB J CHEM, V6, P49, DOI 10.1016/j.arabjc.2011.01.011; Schwender J, 1999, FEBS LETT, V455, P140, DOI 10.1016/S0014-5793(99)00849-2; Shahzad A., 2013, RECENT TRENDS BIOTEC, P263, DOI [10.1007/978-94-007-6603-7_12, DOI 10.1007/978-94-007-6603-7_12]; Shen GA, 2006, BIOSCIENCE REP, V26, P19, DOI 10.1007/s10540-006-9007-y; Shimamura M, 2007, PLANT CELL PHYSIOL, V48, P1652, DOI 10.1093/pcp/pcm125; Simkin AJ, 2013, PHYTOCHEMISTRY, V85, P36, DOI 10.1016/j.phytochem.2012.09.014; Singh H, 2012, GENE, P320; Singh K, 2008, TREE PHYSIOL, V28; Singh RS, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-88; Sood H, 2010, PLANT CELL TISS ORG, V100, P113, DOI 10.1007/s11240-009-9618-7; Vashisht I, 2015, PLANTA, V241, P1255, DOI 10.1007/s00425-015-2255-y; Wang JF, 2010, BIOSCI BIOTECH BIOCH, V74, P1583, DOI 10.1271/bbb.100175; Wang L, 2015, EXP THER MED, V9, P817, DOI 10.3892/etm.2015.2192; Wu N, 2014, DRUG DES DEV THER, V8, P545, DOI 10.2147/DDDT.S62355; Ye GN, 2001, PLANT J, V25, P261, DOI 10.1046/j.1365-313x.2001.00958.x; Yendo ACA, 2010, MOL BIOTECHNOL, V46, P94, DOI 10.1007/s12033-010-9257-6; Zhang M, 2013, J NANOMATER, V2013, DOI 10.1155/2013/648346; Zhao L, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-25	69	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144546	10.1371/journal.pone.0144546	http://dx.doi.org/10.1371/journal.pone.0144546			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658062	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903600055
J	Taha, MR; Mobasser, S				Taha, Mohd Raihan; Mobasser, Shariat			Adsorption of DDT and PCB by Nanomaterials from Residual Soil	PLOS ONE			English	Article							SOLID-PHASE EXTRACTION; MULTIWALLED CARBON NANOTUBES; GAS-CHROMATOGRAPHY; PACKED CARTRIDGE; WATER SAMPLES; ADSORBENT; SORPTION; REMOVAL; ALUMINA	This paper presents the findings of a study on adsorption of dichlorodiphenythreechloroethen (DDT) and polychlorinated biphenyls (PCBs) on three nanomaterials including Multi walled Carbon Nanotube (MWNT), nano-clay and nano-alumina. DDT and PCBs are of significant concern due their high toxicity and long environmental half-lives. Experiments were conducted using batch adsorption procedures at different DDT and PCBs concentrations, from 10 to 60 mg/L. The amounts of MWNT, nano-clay and Nano-alumina used were 0.25%, 0.50%, 0.75%, 1%, 2% and 10%. The adsorption of PCBs solution onto the MWNT, nano-clay and nano-alumina was characterized by an initial rapid adsorption which eventually became constant within 22, 20, and 17 hours, respectively. The adsorption of DDT solution onto the MWNT, nano-clay and nano-alumina was also characterized by an initial rapid adsorption which gradually became constant within 22, 22 and 16 hours, respectively. Results of this study indicated that MWNT was a better adsorbent material compared to nano-clay and nano-alumina for both contaminants in this study. While at 10% of MWNT 88.9% and 77% of DDT and PCB were removed by MWNT, respectively. The effect of pH and temperature were also investigated.	[Taha, Mohd Raihan; Mobasser, Shariat] Univ Kebangsaan Malaysia, Dept Civil & Struct Engn, Bangi 43600, Selangor, Malaysia; [Taha, Mohd Raihan] Univ Kebangsaan Malaysia, Inst Environm & Dev LESTARI, Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Mobasser, S (corresponding author), Univ Kebangsaan Malaysia, Dept Civil & Struct Engn, Bangi 43600, Selangor, Malaysia.	shariat_m741@yahoo.com	Mobasser, Shariat/AFT-9643-2022	Taha, Mohd Raihan/0000-0001-6719-9147				Agnihotri S, 2005, CARBON, V43, P2379, DOI 10.1016/j.carbon.2005.04.020; Alyamani A., 2010, JORNAL ELECT TESTING, V3, P513; Anand D., 2010, THESIS SO ILLINOIS U; Anbia M, 2009, APPL SURF SCI, V255, P9487, DOI 10.1016/j.apsusc.2009.07.070; Bhatnagar A, 2010, CHEM ENG J, V163, P317, DOI 10.1016/j.cej.2010.08.008; Bhattacharya AK, 2008, CHEM ENG J, V137, P529, DOI 10.1016/j.cej.2007.05.021; Boehm F., 2006, NAN039A; Cai YQ, 2003, ANAL CHEM, V75, P2517, DOI 10.1021/ac0263566; Cai YQ, 2005, J CHROMATOGR A, V1081, P245, DOI 10.1016/j.chroma.2005.05.080; Cai YQ, 2003, ANAL CHIM ACTA, V494, P149, DOI 10.1016/j.aca.2003.08.006; Chen W, 2008, ENVIRON SCI TECHNOL, V42, P6862, DOI 10.1021/es8013612; Chen WQ, 2002, MAR POLLUT BULL, V45, P385, DOI 10.1016/S0025-326X(02)00092-9; Colborn T., 1996, OUR STOLEN FUTURE ED; Cornelissen G, 2006, ENVIRON POLLUT, V141, P526, DOI 10.1016/j.envpol.2005.08.053; Gotovac S, 2006, J PHYS CHEM B, V110, P16219, DOI 10.1021/jp0611830; HANCE RJ, 1967, WEED RES, V7, P29, DOI 10.1111/j.1365-3180.1967.tb01345.x; HIRAIDE M, 1995, ANAL SCI, V11, P611, DOI 10.2116/analsci.11.611; [胡建信 Hu Jiaxin], 2006, [环境污染与防治, Environmental Pollution & Control], V28, P222; Li YH, 2002, CHEM PHYS LETT, V357, P263, DOI 10.1016/S0009-2614(02)00502-X; Liao Q, 2008, COLLOID SURFACE A, V312, P160, DOI 10.1016/j.colsurfa.2007.06.045; Lu CY, 2007, SEP PURIF TECHNOL, V58, P113, DOI 10.1016/j.seppur.2007.07.036; Lu CS, 2005, WATER RES, V39, P1183, DOI 10.1016/j.watres.2004.12.033; NICHOLLS PH, 1991, PESTIC SCI, V33, P319, DOI 10.1002/ps.2780330306; Niu JJ, 2008, SOLID STATE SCI, V10, P1189, DOI 10.1016/j.solidstatesciences.2007.12.016; Nollet H, 2003, CHEMOSPHERE, V53, P655, DOI 10.1016/S0045-6535(03)00517-4; Pan B, 2008, ENVIRON SCI TECHNOL, V42, P9005, DOI 10.1021/es801777n; Pan C. S., 2005, J AM SOC MASS SPECTR; Peng XJ, 2003, CHEM PHYS LETT, V376, P154, DOI 10.1016/S0009-2614(03)00960-6; Pyrzynska K, 2007, MICROCHIM ACTA, V159, P293, DOI 10.1007/s00604-007-0739-6; Salam M., 2008, APPL SURFECE SCI, P1975; Semple KT, 2003, EUR J SOIL SCI, V54, P809, DOI 10.1046/j.1351-0754.2003.0564.x; Shao D., 2010, J PHYS CHEM, P860; Sun XL, 2008, ENVIRON TOXICOL CHEM, V27, P2287, DOI 10.1897/08-020.1; Tchomgui-Kamga E, 2010, CARBON, V48, P333, DOI 10.1016/j.carbon.2009.09.034; Wang JX, 2006, J CHROMATOGR A, V1137, P8, DOI 10.1016/j.chroma.2006.10.003; Wang LP, 2006, J CHROMATOGR A, V1136, P99, DOI 10.1016/j.chroma.2006.09.088; Wang S. G., 2008, J CHEM TECHNOL BIOT, V82, P698; Wang XH, 2005, ENVIRON POLLUT, V136, P453, DOI 10.1016/j.envpol.2005.01.004; Wodarg D, 2004, MAR CHEM, V87, P23, DOI 10.1016/j.marchem.2003.12.002; Yang K, 2006, ENVIRON SCI TECHNOL, V40, P1855, DOI 10.1021/es052208w; Zhou QX, 2007, MICROCHIM ACTA, V157, P93, DOI 10.1007/s00604-006-0674-y	41	14	14	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144071	10.1371/journal.pone.0144071	http://dx.doi.org/10.1371/journal.pone.0144071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659225	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903600020
J	Wang, SY; Jiang, BL; Zhou, X; Chen, JH; Li, WJ; Liu, J; Hu, W; Xiao, GQ; Dong, MY; Wang, YC				Wang, Shu-Yang; Jiang, Bo-Ling; Zhou, Xiang; Chen, Ji-Hong; Li, Wen-Jian; Liu, Jing; Hu, Wei; Xiao, Guo-Qing; Dong, Miao-Yin; Wang, Yu-Chen			Study of a High-Yield Cellulase System Created by Heavy-Ion Irradiation-Induced Mutagenesis of Aspergillus niger and Mixed Fermentation with Trichoderma reesei	PLOS ONE			English	Article							EXPLODED CORN STOVER; ENZYMATIC-HYDROLYSIS; NEUROSPORA-CRASSA; BETA-GLUCOSIDASE; BIO-ETHANOL; RUT-C30; OPTIMIZATION; ACID; SACCHARIFICATION; PRETREATMENT	The aim of this study was to evaluate and validate the efficiency of C-12(6+) irradiation of Aspergillus niger (A. niger) or mutagenesis via mixed Trichoderma viride (T. viride) culturing as well as a liquid cultivation method for cellulase production via mixed Trichoderma reesei (T. reesei) and A. niger culture fermentation. The first mutagenesis approach was employed to optimize yield from a cellulase-producing strain via heavy-ion mutagenesis and high-throughput screening, and the second was to effectively achieve enzymatic hydrolysis of cellulase from a mixed culture of mutant T. viride and A. niger. We found that C-12(6+)-ion irradiation induced changes in cellulase biosynthesis in A. niger but had no effect on the time course of the synthesis. It is notable that the exoglucanases (CBH) activities of A. niger strains H11-1 and H differed (6.71 U/mL vs. 6.01 U/mL) and were significantly higher than that of A. niger mutant H3-1. Compared with strain H, the filter paper assay (FPA), endoglucanase (EG) and beta-glucosidase (BGL) activities of mutant strain H11-1 were increased by 250.26%, 30.26% and 34.91%, respectively. A mixed culture system was successfully optimized, and the best ratio of T. reesei to A. niger was 5: 1 for 96 h with simultaneous inoculation. The BGL activity of the mixed culture increased after 72 h. At 96 h, the FPA and BGL activities of the mixed culture were 689.00 and 797.15 U/mL, respectively, significantly higher than those of monocultures, which were 408.70 and 646.98 U/mL for T. reesei and 447.29 and 658.89 U/mL for A. niger, respectively. The EG activity of the mixed culture was 2342.81 U/mL, a value that was significantly higher than that of monocultures at 2206.57 U/mL for T. reesei and 1727.62 U/mL for A. niger. In summary, cellulose production and hydrolysis yields were significantly enhanced by the proposed combination scheme.	[Wang, Shu-Yang; Jiang, Bo-Ling; Zhou, Xiang; Chen, Ji-Hong; Li, Wen-Jian; Liu, Jing; Hu, Wei; Xiao, Guo-Qing; Dong, Miao-Yin; Wang, Yu-Chen] Chinese Acad Sci, Inst Modern Phys, Lanzhou 730000, Gansu, Peoples R China; [Wang, Shu-Yang] Lanzhou Univ, Lanzhou 730000, Gansu, Peoples R China; [Jiang, Bo-Ling; Dong, Miao-Yin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Modern Physics, CAS; Lanzhou University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, SY (corresponding author), Chinese Acad Sci, Inst Modern Phys, 509 Nanchang Rd, Lanzhou 730000, Gansu, Peoples R China.	wangsy@impcas.ac.cn			National Natural Science Foundation of China [11305225, 11105193]; Science and Technology Service Network Initiative [KFJ-EW-STS-086]; Western Action Plan of CCAS [kzcxz-xb3-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Service Network Initiative; Western Action Plan of CCAS	This work was supported by grants from the National Natural Science Foundation of China (11305225 and 11105193), the Science and Technology Service Network Initiative (KFJ-EW-STS-086) and the Western Action Plan of CCAS (kzcxz-xb3-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed A, 2008, BIOCHEM ENG J, V42, P41, DOI 10.1016/j.bej.2008.05.007; Ahamed A, 2008, BIOCHEM ENG J, V40, P399, DOI 10.1016/j.bej.2007.11.030; Avci A, 2013, BIORESOURCE TECHNOL, V130, P603, DOI 10.1016/j.biortech.2012.12.104; Chen M, 2008, CARBOHYD POLYM, V71, P411, DOI 10.1016/j.carbpol.2007.06.011; Fang H, 2010, BIORESOURCE TECHNOL, V101, P4111, DOI 10.1016/j.biortech.2010.01.078; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Gutierrez-Correa M, 1999, BIORESOURCE TECHNOL, V68, P173, DOI 10.1016/S0960-8524(98)00139-4; Hahn-Hagerdal B, 2006, TRENDS BIOTECHNOL, V24, P549, DOI 10.1016/j.tibtech.2006.10.004; Hu W, 2014, NUCL SCI TECH, V25; Lee SY, 2005, TRENDS BIOTECHNOL, V23, P349, DOI 10.1016/j.tibtech.2005.05.003; Lei Y, 2013, OPT MATER, V35, P1179, DOI 10.1016/j.optmat.2013.01.010; Li ZZ, 2011, JOURNAL NAME; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Naveena B, 2012, BIORESOURCE TECHNOL, V111, P417, DOI 10.1016/j.biortech.2012.02.056; Ortega N, 2001, INT BIODETER BIODEGR, V47, P7, DOI 10.1016/S0964-8305(00)00101-3; Rana V, 2014, BIORESOURCE TECHNOL, V154, P282, DOI 10.1016/j.biortech.2013.12.059; Romero MD, 1999, ENZYME MICROB TECH, V25, P244, DOI 10.1016/S0141-0229(99)00035-6; Seyis I, 2003, MICROBIOLOGICA, V26, P75; Singh A, 2012, BIORESOURCE TECHNOL, V108, P94, DOI 10.1016/j.biortech.2011.12.084; STOCKTON BC, 1991, BIOTECHNOL LETT, V13, P57, DOI 10.1007/BF01033518; Sukumaran RK, 2009, RENEW ENERG, V34, P421, DOI 10.1016/j.renene.2008.05.008; Sun WC, 2008, PROCESS BIOCHEM, V43, P1083, DOI 10.1016/j.procbio.2008.05.015; Wang LY, 2010, J APPL MICROBIOL, V108, P851, DOI 10.1111/j.1365-2672.2009.04483.x; Wang SY, 2012, CHINESE PHYS C, V36, P1140, DOI 10.1088/1674-1137/36/11/019; Wooley R, 1999, BIOTECHNOL PROGR, V15, P794, DOI 10.1021/bp990107u; Wu WH, 2013, ARCH MICROBIOL, V195, P823, DOI 10.1007/s00203-013-0931-5; Wu WH, 2013, ENZYME MICROB TECH, V52, P184, DOI 10.1016/j.enzmictec.2012.12.010; Wyman CE, 2007, TRENDS BIOTECHNOL, V25, P153, DOI 10.1016/j.tibtech.2007.02.009; Yang B, 2008, BIOFUEL BIOPROD BIOR, V2, P26, DOI 10.1002/bbb.49; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003; Zhou X, 2014, BIORESOURCE TECHNOL, V161, P221, DOI 10.1016/j.biortech.2014.03.039	31	6	9	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144233	10.1371/journal.pone.0144233	http://dx.doi.org/10.1371/journal.pone.0144233			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656155	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903600031
J	Levesque, S; Dufresne, PJ; Soualhine, H; Domingo, MC; Bekal, S; Lefebvre, B; Tremblay, C				Levesque, Simon; Dufresne, Philippe J.; Soualhine, Hafid; Domingo, Marc-Christian; Bekal, Sadjia; Lefebvre, Brigitte; Tremblay, Cecile			A Side by Side Comparison of Bruker Biotyper and VITEK MS: Utility of MALDI-TOF MS Technology for Microorganism Identification in a Public Health Reference Laboratory	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; ROUTINE IDENTIFICATION; YEAST IDENTIFICATION; MICROFLEX LT; SP NOV.; BACTERIA; SYSTEMS; MYCOBACTERIA	Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has emerged as a rapid, highly accurate, and cost-effective method for routine identification of a wide range of microorganisms. We carried out a side by side comparative evaluation of the performance of Bruker Biotyper versus VITEK MS for identification of a large and diverse collection of microorganisms. Most difficult and/or unusual microorganisms, as well as commonly encountered microorganisms were selected, including Gram-positive and negative bacteria, mycobacteria, actinomycetes, yeasts and filamentous fungi. Six hundred forty two strains representing 159 genera and 441 species from clinical specimens previously identified at the Laboratoire de sante publique du Quebec (LSPQ) by reference methods were retrospectively chosen for the study. They included 254 Gram-positive bacteria, 167 Gram-negative bacteria, 109 mycobacteria and aerobic actinomycetes and 112 yeasts and moulds. MALDI-TOF MS analyses were performed on both systems according to the manufacturer's instructions. Of the 642 strains tested, the name of the genus and / or species of 572 strains were referenced in the Bruker database while 406 were present in the VITEK MS IVD database. The Biotyper correctly identified 494 (86.4%) of the strains, while the VITEK MS correctly identified 362 (92.3%) of the strains (excluding 14 mycobacteria that were not tested). Of the 70 strains not present in the Bruker database at the species level, the Biotyper correctly identified 10 (14.3%) to the genus level and 2 (2.9%) to the complex/group level. For 52 (74.2%) strains, we obtained no identification, and an incorrect identification was given for 6 (8.6%) strains. Of the 178 strains not present in the VITEK MS IVD database at the species level (excluding 71 untested mycobacteria and actinomycetes), the VITEK MS correctly identified 12 (6.8%) of the strains each to the genus and to the complex/group level. For 97 (54.5%) strains, no identification was given and for 69 (38.7%) strains, an incorrect identification was obtained. Our study demonstrates that both systems gave a high level (above 85%) of correct identification for a wide range of microorganisms. However, VITEK MS gave more misidentification when the microorganism analysed was not present in the database, compared to Bruker Biotyper. This should be taken into account when this technology is used alone for microorganism identification in a public health laboratory, where isolates received are often difficult to identify and/or unusual microorganisms.	[Levesque, Simon; Dufresne, Philippe J.; Soualhine, Hafid; Domingo, Marc-Christian; Bekal, Sadjia; Lefebvre, Brigitte; Tremblay, Cecile] Inst Natl Sante Publ Quebec, Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada; [Bekal, Sadjia] Univ Montreal, Dept Microbiol Immunol & Infectiol, Montreal, PQ, Canada; [Tremblay, Cecile] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada	Institut national de sante publique du Quebec (INSPQ); Universite de Montreal; Universite de Montreal	Levesque, S (corresponding author), Inst Natl Sante Publ Quebec, Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada.	simon.levesque@inspq.qc.ca	Soualhine, Hafid/AAH-3735-2019	Soualhine, Hafid/0000-0002-5526-6741; Levesque, Simon/0000-0002-4356-9702; Dufresne, Philippe J/0000-0001-5871-3933; Bekal, Sadjia/0000-0001-9840-0114	LSPQ internal funding; i2A Canada (Bruker Daltonics); bioMErieux Canada	LSPQ internal funding; i2A Canada (Bruker Daltonics); bioMErieux Canada	This work was supported by LSPQ internal funding, and partly supported by i2A Canada (Bruker Daltonics) and bioMErieux Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatoom AA, 2011, J CLIN MICROBIOL, V49, P2868, DOI 10.1128/JCM.00506-11; Balada-Llasat JM, 2013, J CLIN MICROBIOL, V51, P2875, DOI 10.1128/JCM.00819-13; Bekal S, 2006, J CLIN MICROBIOL, V44, P2584, DOI 10.1128/JCM.02707-05; BHAPKAR VP, 1966, J AM STAT ASSOC, V61, P228, DOI 10.2307/2283057; Bizzini A, 2010, J CLIN MICROBIOL, V48, P1549, DOI 10.1128/JCM.01794-09; Brown BA, 1999, INT J SYST BACTERIOL, V49, P1493, DOI 10.1099/00207713-49-4-1493; Chao QT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109376; Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09; Deak E, 2015, DIAGN MICR INFEC DIS, V81, P27, DOI 10.1016/j.diagmicrobio.2014.09.018; Dingle TC, 2013, CLIN LAB MED, V33, P589, DOI 10.1016/j.cll.2013.03.001; Dubois D, 2012, J CLIN MICROBIOL, V50, P2568, DOI 10.1128/JCM.00343-12; FARMER JJ, 1985, J CLIN MICROBIOL, V21, P46, DOI 10.1128/JCM.21.1.46-76.1985; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Haigh J, 2011, J CLIN MICROBIOL, V49, P3441, DOI 10.1128/JCM.00576-11; Hill JE, 2006, J MED MICROBIOL, V55, P393, DOI 10.1099/jmm.0.46282-0; Kim H, 2005, INT J SYST EVOL MICR, V55, P1649, DOI 10.1099/ijs.0.63553-0; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Lohmann C, 2013, J CLIN MICROBIOL, V51, P1231, DOI 10.1128/JCM.03268-12; Mancini N, 2013, J CLIN MICROBIOL, V51, P2453, DOI 10.1128/JCM.00841-13; Martiny D, 2012, J CLIN MICROBIOL, V50, P1313, DOI 10.1128/JCM.05971-11; Mather CA, 2014, J CLIN MICROBIOL, V52, P130, DOI 10.1128/JCM.01996-13; Neville SA, 2011, J CLIN MICROBIOL, V49, P2980, DOI 10.1128/JCM.00431-11; Packeu A, 2013, MED MYCOL, V51, P580, DOI 10.3109/13693786.2013.770605; Patel R, 2015, CLIN CHEM, V61, P100, DOI 10.1373/clinchem.2014.221770; Petti C, 2011, MANUAL CLIN MICROBIO, V10th, P15; Samson RA, 2014, STUD MYCOL, P141, DOI 10.1016/j.simyco.2014.07.004; Tayeb LA, 2008, RES MICROBIOL, V159, P169, DOI 10.1016/j.resmic.2007.12.005; TeKippe EM, 2014, EUR J CLIN MICROBIOL, V33, P2163, DOI 10.1007/s10096-014-2183-y; Theel ES, 2011, J CLIN MICROBIOL, V49, P4067, DOI 10.1128/JCM.01280-11; van Veen SQ, 2010, J CLIN MICROBIOL, V48, P900, DOI 10.1128/JCM.02071-09; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	31	89	93	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144878	10.1371/journal.pone.0144878	http://dx.doi.org/10.1371/journal.pone.0144878			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658918	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903500063
J	Boersma, AT; Pyenson, ND				Boersma, Alexandra T.; Pyenson, Nicholas D.			Albicetus oxymycterus, a New Generic Name and Redescription of a Basal Physeteroid (Mammalia, Cetacea) from the Miocene of California, and the Evolution of Body Size in Sperm Whales	PLOS ONE			English	Article							CEPHALOPODS; FALL	Living sperm whales are represented by only three species (Physeter macrocephalus, Kogia breviceps and Kogia sima), but their fossil record provides evidence of an ecologically diverse array of different forms, including morphologies and body sizes without analog among living physeteroids. Here we provide a redescription of Ontocetus oxymycterus, a large but incomplete fossil sperm whale specimen from the middle Miocene Monterey Formation of California, described by Remington Kellogg in 1925. The type specimen consists of a partial rostrum, both mandibles, an isolated upper rostrum fragment, and incomplete tooth fragments. Although incomplete, these remains exhibit characteristics that, when combined, set it apart morphologically from all other known physeteroids (e.g., a closed mesorostral groove, and the retention of enameled tooth crowns). Kellogg originally placed this species in the genus Ontocetus, a enigmatic tooth taxon reported from the 19th century, based on similarities between the type specimen Ontocetus emmonsi and the conspicuously large lower dentition of Ontocetus oxymycterus. However, the type of the genus Ontocetus is now known to represent a walrus tusk (belonging to fossil Odobenidae) instead of a cetacean tooth. Thus, we assign this species to the new genus Albicetus, creating the new combination of Albicetus oxymycterus, gen. nov. We provide new morphological observations of the type specimen, including a 3D model. We also calculate a total length of approximately 6 m in life, using cranial proxies of body size for physeteroids. Lastly, a phylogenetic analysis of Albicetus oxymycterus with other fossil and living Physeteroidea resolves its position as a stem physeteroid, implying that large body size and robust dentition in physeteroids evolved multiple times and in distantly related lineages.	[Boersma, Alexandra T.] Vassar Coll, Dept Earth Sci & Geog, Poughkeepsie, NY 12604 USA; [Boersma, Alexandra T.; Pyenson, Nicholas D.] Smithsonian Inst, Dept Paleobiol, Natl Museum Nat Hist, Washington, DC 20013 USA; [Pyenson, Nicholas D.] Burke Museum Nat Hist & Culture, Dept Mammal, Seattle, WA 98195 USA; [Pyenson, Nicholas D.] Burke Museum Nat Hist & Culture, Dept Paleontol, Seattle, WA 98195 USA	Vassar College; Smithsonian Institution; Smithsonian National Museum of Natural History	Boersma, AT (corresponding author), Vassar Coll, Dept Earth Sci & Geog, Poughkeepsie, NY 12604 USA.	boersma.alex@gmail.com		Pyenson, Nicholas/0000-0003-4678-5782	Vassar College; NMNH Remington Kellogg Fund; Basis Foundation	Vassar College; NMNH Remington Kellogg Fund; Basis Foundation	This work was supported by Vassar College (AB), and the NMNH Remington Kellogg Fund and Basis Foundation (NDP) (http://www.mnh.si.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameghino F., 1894, BOLET ACAD NAC CCIAS, V13, P259, DOI DOI 10.5962/BHL.TITLE.77348; [Anonymous], 1999, WALKERS MAMMALS WORL; BARNES LG, 1985, MAR MAMMAL SCI, V1, P15, DOI 10.1111/j.1748-7692.1985.tb00530.x; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Bianucci G, 2006, ZOOL J LINN SOC-LOND, V148, P103, DOI 10.1111/j.1096-3642.2006.00228.x; Blainville H. M. de., 1838, ANN FRANCAISES ETRAN, V2, P335; Blake Z, 1972, THE SPERM WHALE; Boessenecker RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054311; Brandt J.-F., 1873, MEMOIRES LACADEMIE I, V20, P1, DOI DOI 10.5962/BHL.TITLE.39524; Brisson AD., 1762, LUGDUM BATARORUM APU; Churchill M, 2015, EVOLUTION, V69, P201, DOI 10.1111/evo.12560; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1053, DOI 10.1098/rstb.1996.0093; Cope E. D., 1895, Proceedings of the American Philosophical Society, Vxxxiv, P135; Cope E. D., 1867, P ACAD NAT SCI PHILA, V19, P138; du Bus BAL., 1867, B ACAD ROYALE SCI LE, V24, P562; Emmons E, 1860, MANUAL GEOLOGY DESIG; Fitzgerald EMG, 2011, J VERTEBR PALEONTOL, V31, P929, DOI 10.1080/02724634.2011.579670; Flower W. H., 1867, T ZOOLOGICAL SOC LON, V6, P87, DOI DOI 10.1111/J.1096-3642.1867.TB00572.X; Flower WH., 1868, T ZOOLOGICAL SOC LON, V6, P309; Fordyce R.E., 2009, THERIAN SKULL LEXICO; FORDYCE RE, 2001, SECONDARY ADAPTATION; Fujiwara Y, 2007, MAR ECOL-EVOL PERSP, V28, P219, DOI 10.1111/j.1439-0485.2007.00150.x; Gatesy J, 2013, MOL PHYLOGENET EVOL, V66, P479, DOI 10.1016/j.ympev.2012.10.012; Geisler Jonathan H., 2003, Journal of Mammalian Evolution, V10, P23, DOI 10.1023/A:1025552007291; Geisler JH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-112; Gibbs NJ, 2011, NEW ZEAL J MAR FRESH, V35, P325; Gondar D, 1974, AC PRIM C ARG PAL BI, V2, P349; Gray JE., 1868, SYNOPSIS SPECIES WHA; Hampe Oliver, 2006, Fossil Record, V9, P61, DOI 10.1002/mmng.200600002; Heyning JE, 1997, MAR MAMMAL SCI, V13, P596, DOI 10.1111/j.1748-7692.1997.tb00086.x; Hirota Kiyoharu, 1994, Island Arc, V3, P453, DOI 10.1111/j.1440-1738.1994.tb00125.x; Hope Ranch Home Owners Association, 2015, HISTORY; Kazar Emese, 2002, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V72, P151; Kelley NP, 2015, SCIENCE, V348, DOI 10.1126/science.aaa3716; Kellogg AR, 1925, CONTRIBUTIONS PALAEO, V348, P1; Kellogg R, 1927, ADDITIONS PALEONTOLO, V346, P3; Kellogg R, 1925, P US NATL MUSEUM, V66; Kellogg R, 1965, FOSSIL MARINE MAMMAL, P47; Kimura Toshiyuki, 2006, Bulletin of Gunma Museum of Natural History, V10, P1; Kleinpell RM, 1980, AM ASS PETROLEUM GEO, V11; KLEINPELL RM, 1938, MIOCENE STRATIGRAPHY; Kohno N, 2008, VIRGINIA MUSEUM NATU, V14, P39; Lambert O, 2008, CR PALEVOL, V7, P361, DOI 10.1016/j.crpv.2008.06.002; Lambert O, 2014, NATURWISSENSCHAFTEN, V101, P517, DOI 10.1007/s00114-014-1182-2; Lambert O, 2010, NATURE, V466, P105, DOI 10.1038/nature09067; Lambert O, 2008, BULL INST R SC N B-S, V78, P277; Leidy J, 1869, J ACAD NATURAL SCI P, P440; Leidy J, 1860, P ACAD NAT SCI PHILA, V11, P162; Lindberg DR, 2007, LETHAIA, V40, P335, DOI 10.1111/j.1502-3931.2007.00032.x; Linnaeus C, 1766, SYSTEMA NATURAE REGN; Maddison WP., 2021, MESQUITE MODULAR SYS; MATSUMOTO HIKOSHIHIRO, 1926, SCI REPT TOHOKU IMP UNIV GEOL 2ND SER, V10, P17; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; Mchedlidze G. A., 1970, NEKOTORYE OBSHCHIE C; Melnikov VV, 1997, J MORPHOL, V234, P37; Melville H, 1981, THE WHALE; Messenger SL, 1998, SYST BIOL, V47, P90, DOI 10.1080/106351598261058; Mirceta S, 2013, SCIENCE, V340, DOI 10.1126/science.1234192; Muizon C, 1988, VERTEBRES FOSSILES F; Okazaki, 1976, B MIZUNAMI FOSSIL MU, V3, P25; Owen R., 1866, T ZOOLOGICAL SOC LON, V6, P17, DOI DOI 10.1111/J.1096-3642.1866.TB00570.X; Perez LM, 2011, ENV TAPHONOMY AMEGHI, P648; Pyenson ND, 2007, BIOLOGY LETT, V3, P709, DOI 10.1098/rsbl.2007.0342; Pyenson ND, 2011, J MAMM EVOL, V18, P269, DOI 10.1007/s10914-011-9170-1; RAY C E, 1975, Proceedings of the Biological Society of Washington, V88, P281; Rowlett R, 2005, LIGHTHOUSE DIRECTORY, P25; Santa Barbara County Genealogical Society, 2015, CEM REC; Shikama T, 1973, MEMOIRS GEOLOGICAL S, V8, P137; Smith CR, 2015, ANNU REV MAR SCI, V7, P571, DOI 10.1146/annurev-marine-010213-135144; SPAMER EE, 1995, ACAD NATURAL SCI PHI, V16, P1; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tsai CH, 2016, J MAMM EVOL, V23, P33, DOI 10.1007/s10914-015-9292-y; Uhen MD, 2007, PALAEONTOL ELECTRON, V10; United States Coast Guard, 2015, LIGHT LIST, VVI; Van Beneden PJ, 1877, B ACAD ROYAL SCI LET, V64, P851; Van Beneden PJ, 1869, MEMOIRES ACAD ROYALE, V28, P2; Velez-Juarbe J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123909; Velez-Juarbe J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031294; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Whitehead H., 2003, SPERM WHALES SOCIAL; Williams TM, 2000, SCIENCE, V288, P133, DOI 10.1126/science.288.5463.133	81	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0135551	10.1371/journal.pone.0135551	http://dx.doi.org/10.1371/journal.pone.0135551			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26651027	gold, Green Submitted, Green Published			2022-12-27	WOS:000366903300001
J	Matheson, AMM; Sakata, JT				Matheson, Andrew M. M.; Sakata, Jon T.			Relationship between the Sequencing and Timing of Vocal Motor Elements in Birdsong	PLOS ONE			English	Article							CONTEXT-DEPENDENT CHANGES; AUDITORY-FEEDBACK; BASAL GANGLIA; SONG MOTOR; TEMPORAL STRUCTURE; MUSIC PERFORMANCE; NEURAL MECHANISMS; FINCH SONG; BRAIN; GENERATION	Accurate coordination of the sequencing and timing of motor gestures is important for the performance of complex and evolutionarily relevant behaviors. However, the degree to which motor sequencing and timing are related remains largely unknown. Birdsong is a communicative behavior that consists of discrete vocal motor elements ('syllables') that are sequenced and timed in a precise manner. To reveal the relationship between syllable sequencing and timing, we analyzed how variation in the probability of syllable transitions at branch points, nodes in song with variable sequencing across renditions, correlated with variation in the duration of silent gaps between syllable transitions ('gap durations') for adult Bengalese finch song. We observed a significant negative relationship between transition probability and gap duration: more prevalent transitions were produced with shorter gap durations. We then assessed the degree to which long-term age-dependent changes and acute context-dependent changes to syllable sequencing and timing followed this inverse relationship. Age-but not context-dependent changes to syllable sequencing and timing were inversely related. On average, gap durations at branch points decreased with age, and the magnitude of this decrease was greater for transitions that increased in prevalence than for transitions that decreased in prevalence. In contrast, there was no systematic relationship between acute context-dependent changes to syllable sequencing and timing. Gap durations at branch points decreased when birds produced female-directed courtship song compared to when they produced undirected song, and the magnitude of this decrease was not related to the direction and magnitude of changes to transition probabilities. These analyses suggest that neural mechanisms that regulate syllable sequencing could similarly control syllable timing but also highlight mechanisms that can independently regulate syllable sequencing and timing.	[Matheson, Andrew M. M.; Sakata, Jon T.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Sakata, JT (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	jon.sakata@mcgill.ca		Matheson, Andrew/0000-0001-9062-2521	Natural Sciences and Engineering Research Council [402417-2011]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by the Natural Sciences and Engineering Research Council (JTS; 402417-2011); http://www.nserc-crsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abutalebi J, 2008, ACTA PSYCHOL, V128, P466, DOI 10.1016/j.actpsy.2008.03.014; Ashmore RC, 2005, J NEUROSCI, V25, P8543, DOI 10.1523/JNEUROSCI.1668-05.2005; Ashmore RC, 2008, J NEUROPHYSIOL, V99, P373, DOI 10.1152/jn.00830.2007; Bertram R, 2014, NEUROSCIENCE, V277, P806, DOI 10.1016/j.neuroscience.2014.07.061; Bohland JW, 2010, J COGNITIVE NEUROSCI, V22, P1504, DOI 10.1162/jocn.2009.21306; Brainard MS, 2013, ANNU REV NEUROSCI, V36, P489, DOI 10.1146/annurev-neuro-060909-152826; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Chambers F., 1997, SYSTEM, V25, P535, DOI [10.1016/S0346-251X(97)00046-8, DOI 10.1016/S0346-251X(97)00046-8]; Clay Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018786; Clay Z, 2009, ANIM BEHAV, V77, P1387, DOI 10.1016/j.anbehav.2009.02.016; Cooper BG, 2006, J NEUROPHYSIOL, V95, P3798, DOI 10.1152/jn.01123.2005; Cooper BG, 2012, NEUROBIOL AGING, V33, P564, DOI 10.1016/j.neurobiolaging.2010.04.014; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Doyon J, 2002, P NATL ACAD SCI USA, V99, P1017, DOI 10.1073/pnas.022615199; Drake C, 2000, COGNITION, V74, P1, DOI 10.1016/S0010-0277(99)00061-X; Fee MS, 2010, ILAR J, V51, P362, DOI 10.1093/ilar.51.4.362; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Fujimoto H, 2011, J NEUROSCI, V31, P10023, DOI 10.1523/JNEUROSCI.1606-11.2011; Glaze CM, 2007, J NEUROSCI, V27, P7631, DOI 10.1523/JNEUROSCI.1065-07.2007; Glaze CM, 2013, J NEUROPHYSIOL, V109, P1025, DOI 10.1152/jn.00578.2012; Glaze CM, 2006, J NEUROSCI, V26, P991, DOI 10.1523/JNEUROSCI.3387-05.2006; Golfinopoulos E, 2010, NEUROIMAGE, V52, P862, DOI 10.1016/j.neuroimage.2009.10.023; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hamaguchi K, 2014, ELIFE, V3, DOI 10.7554/eLife.01833; Hampton CM, 2009, J NEUROPHYSIOL, V101, P3235, DOI 10.1152/jn.91089.2008; Heinig A, 2014, ANIM BEHAV, V97, P1, DOI 10.1016/j.anbehav.2014.08.016; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; Housen A, 2009, APPL LINGUIST, V30, P461, DOI 10.1093/applin/amp048; Iwashita N, 2008, APPL LINGUIST, V29, P24, DOI 10.1093/applin/amm017; James LS, 2014, J NEUROPHYSIOL, V112, P2040, DOI 10.1152/jn.00217.2014; James LS, J NEUROPHYS IN PRESS; Janata P, 2003, NAT NEUROSCI, V6, P682, DOI 10.1038/nn1081; Jin DZ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051902; Jungers M. K., 2002, COGN PROCESS, V1-2, P21; Kakishita Y, 2009, DATA MIN KNOWL DISC, V18, P446, DOI 10.1007/s10618-008-0122-1; Kao MH, 2006, J NEUROPHYSIOL, V96, P1441, DOI 10.1152/jn.01138.2005; Katahira K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024516; Kershenbaum A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1370; Kormos J., 2004, SYSTEM, V32, P145, DOI [10.1016/j.system.2004.01.001, DOI 10.1016/J.SYSTEM.2004.01.001]; Kosche G, 2015, J NEUROSCI, V35, P1217, DOI 10.1523/JNEUROSCI.4346-14.2015; Kuhl PK, 2010, NEURON, V67, P713, DOI 10.1016/j.neuron.2010.08.038; Lashley K., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Matheson LE, 2016, DEV NEUROBIOL, V76, P47, DOI 10.1002/dneu.22298; Matheson LE, 2015, EUR J NEUROSCI, V41, P1180, DOI 10.1111/ejn.12885; Mooney R, 2005, J NEUROSCI, V25, P1952, DOI 10.1523/JNEUROSCI.3726-04.2005; Mooney R, 2009, CURR OPIN NEUROBIOL, V19, P654, DOI 10.1016/j.conb.2009.10.004; MORRIS D, 1954, BEHAVIOUR, V6, P271, DOI 10.1163/156853954X00130; Okanoya K, 1997, J NEUROBIOL, V33, P343; Palmer C, 1997, CAN J EXP PSYCHOL, V51, P369, DOI 10.1037/1196-1961.51.4.369; Penhune VB, 2012, BEHAV BRAIN RES, V226, P579, DOI 10.1016/j.bbr.2011.09.044; Pfenning AR, 2014, SCIENCE, V346, P1333, DOI 10.1126/science.1256846; Sakata JT, 2008, J NEUROSCI, V28, P11378, DOI 10.1523/JNEUROSCI.3254-08.2008; Sakata JT, 2008, J NEUROPHYSIOL, V99, P1700, DOI 10.1152/jn.01296.2007; Sakata JT, 2006, J NEUROSCI, V26, P9619, DOI 10.1523/JNEUROSCI.2027-06.2006; Sakata JT, 2012, J EXP BIOL, V215, P201, DOI 10.1242/jeb.056911; Sakata JT, 2009, J NEUROPHYSIOL, V102, P2485, DOI 10.1152/jn.00340.2009; SCHMIDT RA, 1998, MOTOR CONTROL LEARNI; Takahasi M, 2010, ETHOLOGY, V116, P481, DOI 10.1111/j.1439-0310.2010.01772.x; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; VU ET, 1994, J NEUROSCI, V14, P6924; Wang CZH, 2008, PLOS BIOL, V6, P2154, DOI 10.1371/journal.pbio.0060250; Warren TL, 2012, J NEUROSCI, V32, P15414, DOI 10.1523/JNEUROSCI.1254-12.2012; Wild JM, 2004, ANN NY ACAD SCI, V1016, P438, DOI 10.1196/annals.1298.016; Woolley SMN, 1997, J NEUROSCI, V17, P6380; Zann RA., 1996, ZEBRA FINCH SYNTHESI; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	71	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143203	10.1371/journal.pone.0143203	http://dx.doi.org/10.1371/journal.pone.0143203			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650933	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903300013
J	Xia, XL; Shao, YF; Jiang, JF; Du, XP; Sheng, LP; Chen, FD; Fang, WM; Guan, ZY; Chen, SM				Xia, Xiaolong; Shao, Yafeng; Jiang, Jiafu; Du, Xinping; Sheng, Liping; Chen, Fadi; Fang, Weimin; Guan, Zhiyong; Chen, Sumei			MicroRNA Expression Profile during Aphid Feeding in Chrysanthemum (Chrysanthemum morifolium)	PLOS ONE			English	Article							GREEN PEACH APHID; NICOTIANA-ATTENUATA; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; MIRNA; RNA; RESPONSES; TARGETS; IDENTIFICATION; TRANSCRIPTOME	MicroRNAs (miRNAs) are important regulators of gene expression, affecting many biological processes. As yet, their roles in the response of chrysanthemum to aphid feeding have not been explored. Here, the identity and abundance of miRNAs induced by aphid infestation have been obtained using high-throughput Illumina sequencing platform. Three leaf small RNA libraries were generated, one from plants infested with the aphid Macrosiphoniella sanbourni (library A), one from plants with mock puncture treatment (library M), and the third from untreated control plants (library CK). A total of 7,944,797, 7,605,251 and 9,244,002 clean unique reads, ranging from 18 to 30 nucleotides (nt) in length, were obtained from library CK, A and M, respectively. As a result, 303 conserved miRNAs belonging to 276 miRNAs families and 234 potential novel miRNAs were detected in chrysanthemum leaf, out of which 80, 100 and 79 significantly differentially expressed miRNAs were identified in the comparison of CK-VS-A, CK-VS-M and M-VS-A, respectively. Several of the differentially abundant miRNAs (in particular miR159a, miR160a, miR393a) may be associated with the plant's response to aphid infestation.	[Xia, Xiaolong; Shao, Yafeng; Jiang, Jiafu; Du, Xinping; Sheng, Liping; Chen, Fadi; Fang, Weimin; Guan, Zhiyong; Chen, Sumei] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Chen, SM (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.	chensm@njau.edu.cn			National Nature Science Foundation of China (NSFC) [31471900, 31471913]; Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province [CX(12)2020]; Program for Science and Technology Support, Jiangsu, China [BE2011325, BE2012350]	National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province; Program for Science and Technology Support, Jiangsu, China	This work was supported by National Nature Science Foundation of China (NSFC, 31471900, 31471913), Fund for Independent Innovation of Agricultural Sciences in Jiangsu Province (CX(12)2020) and the Program for Science and Technology Support, Jiangsu, China (grant no. BE2011325, BE2012350). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Alonso-Peral MM, 2010, PLANT PHYSIOL, V154, P757, DOI 10.1104/pp.110.160630; Barah P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058987; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazzini AA, 2007, P NATL ACAD SCI USA, V104, P12157, DOI 10.1073/pnas.0705114104; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Bozorov TA, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-209; Bozorov TA, 2012, J INTEGR PLANT BIOL, V54, P189, DOI 10.1111/j.1744-7909.2012.01104.x; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; da Silva JAT, 2013, CRIT REV PLANT SCI, V32, P21, DOI 10.1080/07352689.2012.696461; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Girousse C, 2005, PLANT PHYSIOL, V137, P1474, DOI 10.1104/pp.104.057430; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He XF, 2008, FEBS LETT, V582, P2445, DOI 10.1016/j.febslet.2008.06.011; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Katiyar-Agarwal S, 2010, ANNU REV PHYTOPATHOL, V48, P225, DOI 10.1146/annurev-phyto-073009-114457; Kettles GJ, 2011, ANAL ARABIDOPSIS THA; Kettles GJ, 2013, NEW PHYTOL, V198, P1178, DOI 10.1111/nph.12218; Kusnierczyk A, 2007, J EXP BOT, V58, P2537, DOI 10.1093/jxb/erm043; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Lindow M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-119; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu SF, 2007, PLANT J, V51, P1077, DOI 10.1111/j.1365-313X.2007.03208.x; Miles PW, 1999, BIOL REV, V74, P41, DOI 10.1017/S0006323198005271; Moran PJ, 2001, PLANT PHYSIOL, V125, P1074, DOI 10.1104/pp.125.2.1074; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Pandey SP, 2008, P NATL ACAD SCI USA, V105, P4559, DOI 10.1073/pnas.0711363105; Pandey SP, 2007, PLANT J, V50, P40, DOI 10.1111/j.1365-313X.2007.03030.x; Pegadaraju V, 2005, PLANT PHYSIOL, V139, P1927, DOI 10.1104/pp.105.070433; Sattar S, 2012, MOL PLANT MICROBE IN, V25, P839, DOI 10.1094/MPMI-09-11-0252; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shinoyama H, 2012, PLANT BIOTECHNOL-NAR, V29, P323, DOI 10.5511/plantbiotechnology.12.0521a; Song AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057229; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Sunkar R, 2010, SEMIN CELL DEV BIOL, V21, P805, DOI 10.1016/j.semcdb.2010.04.001; Woodger FJ, 2003, J PLANT GROWTH REGUL, V22, P176, DOI 10.1007/s00344-003-0025-8; Xia XL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1050; Xie FL, 2014, PLANT BIOTECHNOL J, V12, P354, DOI 10.1111/pbi.12142; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yamasaki H, 2007, J BIOL CHEM, V282, P16369, DOI 10.1074/jbc.M700138200	46	15	17	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143720	10.1371/journal.pone.0143720	http://dx.doi.org/10.1371/journal.pone.0143720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650759	gold, Green Published			2022-12-27	WOS:000366903300023
J	Hajam, IA; Dar, PA; Appavoo, E; Kishore, S; Bhanuprakash, V; Ganesh, K				Hajam, Irshad Ahmed; Dar, Pervaiz Ahmad; Appavoo, Elamurugan; Kishore, Subodh; Bhanuprakash, Veerakyathappa; Ganesh, Kondabattula			Bacterial Ghosts of Escherichia coli Drive Efficient Maturation of Bovine Monocyte-Derived Dendritic Cells	PLOS ONE			English	Article							IMMUNE-RESPONSE; GENE-E; EXPRESSION; LYSIS; ACTIVATION; CYTOKINE; BLOOD; ANTIGEN; DIFFERENTIATION; INDUCTION	Bacterial ghosts (BGs) are empty cell envelopes derived from Gram-negative bacteria. They not only represent a potential platform for development of novel vaccines but also provide a tool for efficient adjuvant and antigen delivery system. In the present study, we investigated the interaction between BGs of Escherichia coli (E. coli) and bovine monocyte-derived dendritic cells (MoDCs). MoDCs are highly potent antigen-presenting cells and have the potential to act as a powerful tool for manipulating the immune system. We generated bovine MoDCs in vitro from blood monocytes using E. coli expressed bovine GM-CSF and IL-4 cytokines. These MoDCs displayed typical morphology and functions similar to DCs. We further investigated the E. coli BGs to induce maturation of bovine MoDCs in comparison to E. coli lipopolysaccharide (LPS). We observed the maturation marker molecules such as MHC-II, CD80 and CD86 were induced early and at higher levels in BG stimulated MoDCs as compared to the LPS stimulated MoDCs. BG mediated stimulation induced significantly higher levels of cytokine expression in bovine MoDCs than LPS. Both pro-inflammatory (IL-12 and TNF-alpha) and anti-inflammatory (IL-10) cytokines were induced in MoDCs after BGs stimulation. We further analysed the effects of BGs on the bovine MoDCs in an allogenic mixed lymphocyte reaction (MLR). We found the BG-treated bovine MoDCs had significantly (p<0.05) higher capacity to stimulate allogenic T cell proliferation in MLR as compared to the LPS. Taken together, these findings demonstrate the E. coli BGs induce a strong activation and maturation of bovine MoDCs.	[Hajam, Irshad Ahmed; Appavoo, Elamurugan; Kishore, Subodh; Bhanuprakash, Veerakyathappa; Ganesh, Kondabattula] Indian Vet Res Inst, FMD Res Ctr, Bangalore, Karnataka, India; [Dar, Pervaiz Ahmad] SKUAST Kashmir, Fac Vet Sci & Anim Husb, Div Vet Microbiol & Immunol, Srinagar, Jammu & Kashmir, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Sher-e-Kashmir University of Agricultural Sciences & Technology of Kashmir (SKUAST Kashmir)	Dar, PA (corresponding author), SKUAST Kashmir, Fac Vet Sci & Anim Husb, Div Vet Microbiol & Immunol, Srinagar, Jammu & Kashmir, India.	dar.pervaiz@gmail.com; kondabattula@gmail.com	Kondabattula, Ganesh/AAT-7377-2021; Dar, Pervaiz/F-3596-2016; V, BHANUPRAKASH/AAG-6804-2019	Dar, Pervaiz/0000-0001-6718-7293; 				Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Amara AA, 2013, SCI WORLD J, DOI 10.1155/2013/545741; Bajer AA, 2003, J LEUKOCYTE BIOL, V73, P100, DOI 10.1189/jlb.0302128; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BAYER ME, 1968, J GEN MICROBIOL, V53, P395, DOI 10.1099/00221287-53-3-395; Benko S, 2008, BIOL CHEM, V389, P469, DOI 10.1515/BC.2008.054; BLASI U, 1989, J BIOL CHEM, V264, P4552; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaudhari AA, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-44; Dar P, 2013, VACCINE, V31, P3327, DOI 10.1016/j.vaccine.2013.05.078; Dar PA, 2015, CYTOKINE, V72, P58, DOI 10.1016/j.cyto.2014.12.011; Datta SK, 2003, J IMMUNOL, V170, P4102, DOI 10.4049/jimmunol.170.8.4102; DENHARDT DT, 1965, J MOL BIOL, V12, P641, DOI 10.1016/S0022-2836(65)80318-7; Dubois B, 2001, J LEUKOCYTE BIOL, V70, P633; Ebensen T, 2004, J IMMUNOL, V172, P6858, DOI 10.4049/jimmunol.172.11.6858; Estes DM, 1998, IMMUNOLOGY, V95, P604; Gonzalez-Cano P, 2014, DEV COMP IMMUNOL, V44, P378, DOI 10.1016/j.dci.2014.01.014; Granucci F, 2003, J INFECT DIS, V187, pS346, DOI 10.1086/374748; Haidinger W, 2003, APPL ENVIRON MICROB, V69, P6106, DOI 10.1128/AEM.69.10.6106-6113.2003; Hajam IA, 2013, VET ITAL, V49, P181, DOI 10.12834/VetIt.2013.492.187.192; HALFMANN G, 1986, J BACTERIOL, V166, P683, DOI 10.1128/jb.166.2.683-685.1986; Hamza T, 2010, INT J MOL SCI, V11, P789, DOI 10.3390/ijms11030789; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; Hope JC, 2003, VET IMMUNOL IMMUNOP, V95, P21, DOI 10.1016/S0165-2427(03)00104-1; Huter V, 1999, J CONTROL RELEASE, V61, P51, DOI 10.1016/S0168-3659(99)00099-1; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Kaka AS, 2008, J IMMUNOTHER, V31, P359, DOI 10.1097/CJI.0b013e318165f5d2; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; Kudela P, 2010, VACCINE, V28, P5760, DOI 10.1016/j.vaccine.2010.06.087; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Mauel S, 2014, IMMUNOLOGY, V177, P463; Mayr UB, 2005, ADV DRUG DELIVER REV, V57, P1381, DOI 10.1016/j.addr.2005.01.027; Menzies M, 2006, VET IMMUNOL IMMUNOP, V109, P23, DOI 10.1016/j.vetimm.2005.06.014; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Pickl WF, 1996, J IMMUNOL, V157, P3850; Pinchuk LM, 2003, COMP IMMUNOL MICROB, V26, P233, DOI 10.1016/S0147-9571(02)00061-9; Price JC, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110965; Saenz R, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-211; Sanders CJ, 2006, J IMMUNOL, V177, P2810, DOI 10.4049/jimmunol.177.5.2810; Sei JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109273; Steinbach F, 1998, RES IMMUNOL, V149, P627, DOI 10.1016/S0923-2494(99)80028-5; Werling D, 1999, J LEUKOCYTE BIOL, V66, P50, DOI 10.1002/jlb.66.1.50; WITTE A, 1990, J BACTERIOL, V172, P4109, DOI 10.1128/jb.172.7.4109-4114.1990; WITTE A, 1989, EUR J BIOCHEM, V180, P393, DOI 10.1111/j.1432-1033.1989.tb14661.x; YOUNG KD, 1982, J VIROL, V44, P993, DOI 10.1128/JVI.44.3.993-1002.1982; Zaros LG, 2007, GENET MOL BIOL, V30, P575, DOI 10.1590/S1415-47572007000400012	49	35	40	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144397	10.1371/journal.pone.0144397	http://dx.doi.org/10.1371/journal.pone.0144397			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669936	Green Submitted, Green Published, gold			2022-12-27	WOS:000366719300007
J	Balzer, J; Heuer, K; Demir, E; Hoffmanns, MA; Baldus, S; Fuchs, PC; Awakowicz, P; Suschek, CV; Oplander, C				Balzer, Julian; Heuer, Kiara; Demir, Erhan; Hoffmanns, Martin A.; Baldus, Sabrina; Fuchs, Paul C.; Awakowicz, Peter; Suschek, Christoph V.; Oplaender, Christian			Non-Thermal Dielectric Barrier Discharge (DBD) Effects on Proliferation and Differentiation of Human Fibroblasts Are Primary Mediated by Hydrogen Peroxide	PLOS ONE			English	Article							ATMOSPHERIC-PRESSURE PLASMA; NITRIC-OXIDE; MYOFIBROBLAST DIFFERENTIATION; OXIDATIVE STRESS; HUMAN SKIN; KERATINOCYTES; TEMPERATURE; IRRADIATION; MEDICINE; ARREST	The proliferation of fibroblasts and myofibroblast differentiation are crucial in wound healing and wound closure. Impaired wound healing is often correlated with chronic bacterial contamination of the wound area. A new promising approach to overcome wound contamination, particularly infection with antibiotic-resistant pathogens, is the topical treatment with non-thermal "cold" atmospheric plasma (CAP). Dielectric barrier discharge (DBD) devices generate CAP containing active and reactive species, which have antibacterial effects but also may affect treated tissue/cells. Moreover, DBD treatment acidifies wound fluids and leads to an accumulation of hydrogen peroxide (H2O2) and nitric oxide products, such as nitrite and nitrate, in the wound. Thus, in this paper, we addressed the question of whether DBD-induced chemical changes may interfere with wound healing-relevant cell parameters such as viability, proliferation and myofibroblast differentiation of primary human fibroblasts. DBD treatment of 250 mu l buffered saline (PBS) led to a treatment time-dependent acidification (pH 6.7; 300 s) and coincidently accumulation of nitrite (similar to 300 mu M), nitrate (similar to 1 mM) and H2O2 (similar to 200 mu M). Fibroblast viability was reduced by single DBD treatments (60-300 s; similar to 77-66%) or exposure to freshly DBD-treated PBS (60-300 s; similar to 75-55%), accompanied by prolonged proliferation inhibition of the remaining cells. In addition, the total number of myofibroblasts was reduced, whereas in contrast, the myofibroblast frequency was significantly increased 12 days after DBD treatment or exposure to DBD-treated PBS. Control experiments mimicking DBD treatment indicate that plasma-generated H2O2 was mainly responsible for the decreased proliferation and differentiation, but not for DBD-induced toxicity. In conclusion, apart from antibacterial effects, DBD/CAP may mediate biological processes, for example, wound healing by accumulation of H2O2. Therefore, a clinical DBD treatment must be well-balanced in order to avoid possible unwanted side effects such as a delayed healing process.	[Balzer, Julian; Heuer, Kiara; Hoffmanns, Martin A.; Suschek, Christoph V.; Oplaender, Christian] Univ Dusseldorf, Fac Med, Dept Trauma & Hand Surg, Dusseldorf, Germany; [Demir, Erhan; Fuchs, Paul C.] Univ Witten Herdecke, Merheim Hosp Cologne, Dept Plast Surg, Hand Surg,Burn Ctr, Cologne, Germany; [Baldus, Sabrina; Awakowicz, Peter] Ruhr Univ Bochum, Inst Elect Engn & Plasma Technol, Bochum, Germany	Heinrich Heine University Dusseldorf; Witten Herdecke University; Ruhr University Bochum	Oplander, C (corresponding author), Univ Dusseldorf, Fac Med, Dept Trauma & Hand Surg, Dusseldorf, Germany.	christian.oplaender@hhu.de			German Research Foundation, Deutsche Forschungsgemeinschaft [OP 207/6-1, SU 631/4-1, AW 7/4-1]; Bundesministerium fur Wirtschaft und Energie [ZIM KF2790102]	German Research Foundation, Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Wirtschaft und Energie	This work was supported by the German Research Foundation, Deutsche Forschungsgemeinschaft, http://www.dfg.de/: OP 207/6-1 was received by CO, SU 631/4-1 was received by CVS, and AW 7/4-1 was received by PA. It also received support from Bundesministerium fur Wirtschaft und Energie, http://www.bmwi.de/. ZIM KF2790102 was received by CVS.	Baum CL, 2005, DERMATOL SURG, V31, P674; Bekeschus S, 2014, FREE RADICAL RES, V48, P542, DOI 10.3109/10715762.2014.892937; Bibinov N, 2011, J PHYS D, P44; Blackert S, 2013, J DERMATOL SCI, V70, P173, DOI 10.1016/j.jdermsci.2013.01.012; Brehmer F, 2015, J EUR ACAD DERMATOL, V29, P148, DOI 10.1111/jdv.12490; Chen LC, 2009, CHEM LETT, V38, P520, DOI 10.1246/cl.2009.520; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X; Davis SC, 2008, WOUND REPAIR REGEN, V16, P23, DOI 10.1111/j.1524-475X.2007.00303.x; DEBONO DP, 1995, ATHEROSCLEROSIS, V114, P235, DOI 10.1016/0021-9150(94)05488-5; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; DESMOULIERE A, 1995, CELL BIOL INT, V19, P471, DOI 10.1006/cbir.1995.1090; Dimitrijevic-Bussod M, 1999, CANCER RES, V59, P4843; Driessens N, 2009, ENDOCR-RELAT CANCER, V16, P845, DOI 10.1677/ERC-09-0020; Edwards R, 2004, CURR OPIN INFECT DIS, V17, P91, DOI 10.1097/00001432-200404000-00004; Feelisch M, 2002, FASEB J, V16, P1775, DOI 10.1096/fj.02-0363com; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Haertel B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/761451; Haertel B, 2012, CELL BIOL INT, V36, P1217, DOI 10.1042/CBI20120139; Haertel B, 2012, IMMUNOBIOLOGY, V217, P628, DOI 10.1016/j.imbio.2011.10.017; Heinlin J, 2013, J EUR ACAD DERMATOL, V27, P324, DOI 10.1111/j.1468-3083.2011.04395.x; Heinlin J, 2011, J EUR ACAD DERMATOL, V25, P1, DOI 10.1111/j.1468-3083.2010.03702.x; Heinlin J, 2010, J DTSCH DERMATOL GES, V8, P968, DOI 10.1111/j.1610-0387.2010.07495.x; Heuer K, 2015, NITRIC OXIDE-BIOL CH, V44, P52, DOI 10.1016/j.niox.2014.11.015; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Isbary G, 2013, EXPERT REV MED DEVIC, V10, P367, DOI [10.1586/erd.13.4, 10.1586/ERD.13.4]; Jones Stuart G, 2004, Int J Low Extrem Wounds, V3, P201, DOI 10.1177/1534734604271810; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kalghatgi S, 2010, ANN BIOMED ENG, V38, P748, DOI 10.1007/s10439-009-9868-x; Kaushik NK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103349; KONG MG, 2009, NEW J PHYS, V11, DOI DOI 10.1088/1367-2630/11/11/115012; Kuo LJ, 2008, IN VIVO, V22, P305; Liebmann J, 2011, NITRIC OXIDE-BIOL CH, V24, P8, DOI 10.1016/j.niox.2010.09.005; Liebmann J, 2010, J INVEST DERMATOL, V130, P259, DOI 10.1038/jid.2009.194; Maisch T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034610; Oplander C, 2011, J PHOTOCH PHOTOBIO B, V103, P118, DOI 10.1016/j.jphotobiol.2011.02.018; PIERAGGI MT, 1985, ANN PATHOL, V5, P65; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SELLERS RM, 1980, ANALYST, V105, P950, DOI 10.1039/an9800500950; Shi XM, 2008, PLASMA PROCESS POLYM, V5, P482, DOI 10.1002/ppap.200700174; Shin DM, 2004, PLAST RECONSTR SURG, V113, P633, DOI 10.1097/01.PRS.0000101530.33096.5B; Stoffels E, 2002, PLASMA SOURCES SCI T, V11, P383, DOI 10.1088/0963-0252/11/4/304; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Suschek CV, 2006, BIOL CHEM, V387, P499, DOI 10.1515/BC.2006.065; Suschek CV, 2005, METHOD ENZYMOL, V396, P568, DOI 10.1016/S0076-6879(05)96048-5; Toullec A, 2010, EMBO MOL MED, V2, P211, DOI 10.1002/emmm.201000073; Weltmann KD, 2009, CONTRIB PLASM PHYS, V49, P631, DOI 10.1002/ctpp.200910067; Winter J, 2014, J PHYS D, V47; Xu DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128205; Yang F, 1997, CLIN CHEM, V43, P657	50	43	44	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144968	10.1371/journal.pone.0144968	http://dx.doi.org/10.1371/journal.pone.0144968			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26661594	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900159
J	Hunter, RK; Nevitt, CD; Gaskins, JT; Keller, BB; Bohler, HCL; LeBlanc, AJ				Hunter, Robert K., II; Nevitt, Chris D.; Gaskins, Jeremy T.; Keller, Bradley B.; Bohler, Henry C. L., Jr.; LeBlanc, Amanda J.			Adipose-Derived Stromal Vascular Fraction Cell Effects on a Rodent Model of Thin Endometrium	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VITRO FERTILIZATION; STEM-CELLS; LOCAL INJURY; EMBRYO IMPLANTATION; VAGINAL SILDENAFIL; THICKNESS; PERFUSION; CYCLES; VEGF	Endometrial dysfunction affects approximately 1% of infertile women, and there is currently no standard therapy for improving fertility treatment outcomes in these patients. In our study, we utilized a rodent model of thin endometrium to test whether intrauterine application of adipose-derived stromal vascular fraction cells (SVF) could improve morphological and physiological markers of endometrial receptivity. Using anhydrous ethanol, endometrial area and gland density were significantly reduced in our model of thin endometrium. Application of SVF was associated with a 29% reduction in endometrial vascular endothelial growth factor (VEGF) expression and significant increases in uterine artery systolic/diastolic velocity ratios and resistance index values, suggesting reduced diastolic microvascular tone. However, no significant improvements in endometrial area or gland density were observed following SVF treatment. 3D confocal imaging demonstrated poor engraftment of SVF cells into recipient tissue, which likely contributed to the negative results of this study. We suspect modified treatment protocols utilizing adjuvant estrogen and/or tail vein cell delivery may improve SVF retention and therapeutic response in subsequent studies. SVF is an easily-obtainable cell product with regenerative capability that may have a future role in the treatment of infertile women with endometrial dysfunction.	[Hunter, Robert K., II; Bohler, Henry C. L., Jr.] Univ Louisville, Sch Med, Dept Obstet Gynecol & Womens Hlth, Div Reprod Endocrinol & Infertil, Louisville, KY 40292 USA; [Nevitt, Chris D.] Univ Louisville, Sch Med, Dept Biochem & Mol Genet, Louisville, KY 40292 USA; [Gaskins, Jeremy T.] Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Bioinformat & Biostat, Louisville, KY 40292 USA; [Keller, Bradley B.; LeBlanc, Amanda J.] Cardiovasc Innovat Inst, Louisville, KY 40202 USA; [LeBlanc, Amanda J.] Univ Louisville, Sch Med, Dept Physiol, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	LeBlanc, AJ (corresponding author), Cardiovasc Innovat Inst, Louisville, KY 40202 USA.	amanda.leblanc@louisville.edu		LeBlanc, Amanda/0000-0003-2507-1203	American Heart Association [12BGIA9310043]; Gheens Foundation; National Institutes of Health [P30 GM103507]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103507] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Gheens Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was generously supported by the American Heart Association (12BGIA9310043 to AJL), the Gheens Foundation (to AJL), and the National Institutes of Health (P30 GM103507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird AL, 2015, EXP GERONTOL, V63, P18, DOI 10.1016/j.exger.2015.01.044; Barash A, 2003, FERTIL STERIL, V79, P1317, DOI 10.1016/S0015-0282(03)00345-5; Bicknell R, 1996, ENDOTHELIAL CELL CUL; Binder NK, 2014, HUM REPROD, V29, P2278, DOI 10.1093/humrep/deu211; Bodombossou-Djobo MMA, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-122; Casper RF, 2011, FERTIL STERIL, V96, P519, DOI 10.1016/j.fertnstert.2011.07.1096; Casteilla Louis, 2011, World J Stem Cells, V3, P25, DOI 10.4252/wjsc.v3.i4.25; Chen MJ, 2006, J ASSIST REPROD GEN, V23, P337, DOI 10.1007/s10815-006-9053-1; Cocuzza MA, 2011, FERTIL STERIL, V95, P2418, DOI 10.1016/j.fertnstert.2011.03.064; Fan XJ, 2008, FASEB J, V22, P3571, DOI 10.1096/fj.08-111401; Fanchin R, 2001, FERTIL STERIL, V76, P994, DOI 10.1016/S0015-0282(01)02841-2; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Gargett CE, 2007, HUM REPROD UPDATE, V13, P87, DOI 10.1093/humupd/dml045; Gargett CE, 2012, REV ENDOCR METAB DIS, V13, P235, DOI 10.1007/s11154-012-9221-9; Gargett CE, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.05.004; Gargett CE, 2010, MOL HUM REPROD, V16, P818, DOI 10.1093/molehr/gaq061; Gir P, 2012, PLAST RECONSTR SURG, V129, P1277, DOI 10.1097/PRS.0b013e31824ecae6; Gleicher N, 2013, HUM REPROD, V28, P172, DOI 10.1093/humrep/des370; Gleicher N, 2011, FERTIL STERIL, V95, DOI 10.1016/j.fertnstert.2011.01.143; Gnainsky Y, 2010, FERTIL STERIL, V94, P2030, DOI 10.1016/j.fertnstert.2010.02.022; Gonzalez-Rey E, 2010, ANN RHEUM DIS, V69, P241, DOI 10.1136/ard.2008.101881; Hannan NJ, 2011, ENDOCRINOLOGY, V152, P4948, DOI 10.1210/en.2011-1248; Kellar RS, 2011, TISSUE ENG PT A, V17, P2177, DOI [10.1089/ten.tea.2010.0680, 10.1089/ten.TEA.2010.0680]; Kilic S, 2014, J ASSIST REPROD GEN, V31, P975, DOI 10.1007/s10815-014-0268-2; Koh YJ, 2011, ARTERIOSCL THROM VAS, V31, P1141, DOI 10.1161/ATVBAHA.110.218206; LeBlanc AJ, 2013, STEM CELL TRANSL MED, V2, P896, DOI 10.5966/sctm.2013-0046; LeBlanc AJ, 2012, AM J PHYSIOL-HEART C, V302, pH973, DOI 10.1152/ajpheart.00735.2011; Ledee-Bataille N, 2002, HUM REPROD, V17, P1249, DOI 10.1093/humrep/17.5.1249; Locke M, 2009, ANZ J SURG, V79, P235, DOI 10.1111/j.1445-2197.2009.04852.x; Masuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010387; Miwa I, 2009, FERTIL STERIL, V91, P998, DOI 10.1016/j.fertnstert.2008.01.029; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Morris ME, 2015, STEM CELL TRANSL MED, V4, P369, DOI 10.5966/sctm.2014-0252; Nagori Chaitanya B, 2011, J Hum Reprod Sci, V4, P43, DOI 10.4103/0974-1208.82360; NOYES N, 1995, HUM REPROD, V10, P919, DOI 10.1093/oxfordjournals.humrep.a136061; Nunes SS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02141; Qublan H, 2008, Hum Fertil (Camb), V11, P43, DOI 10.1080/14647270701704768; R Core Team. R, R LANG ENV STAT COMP; Revel A, 2012, FERTIL STERIL, V97, P1028, DOI 10.1016/j.fertnstert.2012.03.039; Richter KS, 2007, FERTIL STERIL, V87, P53, DOI 10.1016/j.fertnstert.2006.05.064; RUPNICK MA, 1989, J VASC SURG, V9, P788, DOI 10.1067/mva.1989.vs0090788; Schwab KE, 2007, HUM REPROD, V22, P2903, DOI 10.1093/humrep/dem265; Sher G, 2002, FERTIL STERIL, V78, P1073, DOI 10.1016/S0015-0282(02)03375-7; Shufaro Y, 2008, J ASSIST REPROD GEN, V25, P421, DOI 10.1007/s10815-008-9245-y; Singh Neeta, 2014, J Hum Reprod Sci, V7, P93, DOI 10.4103/0974-1208.138864; Singh Neeta, 2011, J Hum Reprod Sci, V4, P29, DOI 10.4103/0974-1208.82357; Tesarik Jan, 2003, Reprod Biomed Online, V7, P59; Weckstein LN, 1997, FERTIL STERIL, V68, P927, DOI 10.1016/S0015-0282(97)00330-0; Williams S K, 1989, Ann Vasc Surg, V3, P146, DOI 10.1016/S0890-5096(06)62008-6; Zhao J, 2012, J FERT IN VITRO, V2, P109, DOI [10.4172/2165-7491.1000109, DOI 10.4172/2165-7491.1000109]; Zhao J, 2015, REPROD SCI, V22, P181, DOI 10.1177/1933719114537715; Zhao J, 2014, FERTIL STERIL, V101, P587, DOI 10.1016/j.fertnstert.2013.10.053; Zhou L, 2008, FERTIL STERIL, V89, P1166, DOI 10.1016/j.fertnstert.2007.05.064; Zinger M, 2006, J WOMENS HEALTH, V15, P442, DOI 10.1089/jwh.2006.15.442	54	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144823	10.1371/journal.pone.0144823	http://dx.doi.org/10.1371/journal.pone.0144823			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657744	gold, Green Submitted, Green Published			2022-12-27	WOS:000366715900112
J	Kumar, V; Sobhia, ME				Kumar, Vivek; Sobhia, M. Elizabeth			Molecular Dynamics Assisted Mechanistic Study of Isoniazid-Resistance against Mycobacterium tuberculosis InhA	PLOS ONE			English	Article							FREE-ENERGY CALCULATIONS; WILD-TYPE; FORCE-FIELD; DIVERSE SET; PROTEIN; BINDING; SIMULATIONS; PREDICTION; REDUCTASE; PEPTIDE	Examination of InhA mutants I16T, I21V, I47T, S94A, and I95P showed that direct and water mediated H-bond interactions between NADH and binding site residues reduced drastically. It allowed conformational flexibility to NADH, particularly at the pyrophosphate region, leading to weakening of its binding at dinucleotide binding site. The highly scattered distribution of pyrophosphate dihedral angles and chi1 side chain dihedral angles of corresponding active site residues therein confirmed weak bonding between InhA and NADH. The average direct and water mediated bridged H-bond interactions between NADH and mutants were observed weaker as compared to wild type. Further, estimated NADH binding free energy in mutants supported the observed weakening of InhA-NADH interactions. Similarly, per residue contribution to NADH binding was also found little less as compared to corresponding residues in wild type. This investigation clearly depicted and supported the effect of mutations on NADH binding and can be accounted for isoniazid resistance as suggested by previous biochemical and mutagenic studies. Further, structural analysis of InhA provided the crucial points to enhance the NADH binding affinity towards InhA mutants in the presence of direct InhA inhibitors to combat isoniazid drug resistance. This combination could be a potential alternative for treatment of drug resistant tuberculosis.	[Kumar, Vivek; Sobhia, M. Elizabeth] Natl Inst Pharmaceut Educ & Res, Dept Pharmacoinformat, Sect 67, Sas Nagar 160062, Punjab, India	National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali)	Sobhia, ME (corresponding author), Natl Inst Pharmaceut Educ & Res, Dept Pharmacoinformat, Sect 67, Sas Nagar 160062, Punjab, India.	mesophia@niper.ac.in			NIPER SAS Nagar; Ministry of chemicals and fertilizers, Govt. of India [PI/2010/VIII/278/P]	NIPER SAS Nagar; Ministry of chemicals and fertilizers, Govt. of India	This work is supported by the NIPER SAS Nagar and Ministry of chemicals and fertilizers, Govt. of India, Grant No. PI/2010/VIII/278/P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the NIPER SAS Nagar and Ministry of chemicals and fertilizers, Govt. of India, Grant No.: PI/2010/VIII/278/P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, 1010 SHERB ST W SUIT; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Basso LA, 1998, J INFECT DIS, V178, P769, DOI 10.1086/515362; Bello M, 2015, IMMUNOL RES, V62, P3, DOI 10.1007/s12026-015-8629-1; Bello M, 2014, BIOPOLYMERS, V101, P1010, DOI 10.1002/bip.22483; Bello M, 2014, BIOCHEM PHARMACOL, V90, P145, DOI 10.1016/j.bcp.2014.04.016; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DESSEN A, 1995, SCIENCE, V267, P1638, DOI 10.1126/science.7886450; Dias MVB, 2007, J STRUCT BIOL, V159, P369, DOI 10.1016/j.jsb.2007.04.009; Dobner P, 1997, INT J TUBERC LUNG D, V1, P365; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Ho YM, 2009, ANTIMICROB AGENTS CH, V53, P4010, DOI 10.1128/AAC.00433-09; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hou TJ, 2012, J PROTEOME RES, V11, P2982, DOI 10.1021/pr3000688; Hou TJ, 2011, J COMPUT CHEM, V32, P866, DOI 10.1002/jcc.21666; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kuhn B, 2000, J MED CHEM, V43, P3786, DOI 10.1021/jm000241h; Oliveira JS, 2006, J MOL BIOL, V359, P646, DOI 10.1016/j.jmb.2006.03.055; Pavelites JJ, 1997, J COMPUT CHEM, V18, P221, DOI 10.1002/(SICI)1096-987X(19970130)18:2<221::AID-JCC7>3.0.CO;2-X; Reva BA, 1998, FOLD DES, V3, P141, DOI 10.1016/S1359-0278(98)00019-4; Robertson MJ, 2015, J CHEM THEORY COMPUT, V11, P3499, DOI 10.1021/acs.jctc.5b00356; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Schroeder EK, 2005, BIOPHYS J, V89, P876, DOI 10.1529/biophysj.104.053512; Shafreen RMB, 2013, J MOL RECOGNIT, V26, P276, DOI 10.1002/jmr.2270; VANGUNSTEREN WF, 1977, MOL PHYS, V34, P1311, DOI 10.1080/00268977700102571; Verkhivker GM, 1999, J MOL RECOGNIT, V12, P371, DOI 10.1002/(SICI)1099-1352(199911/12)12:6<371::AID-JMR479>3.0.CO;2-O; Vilcheze C, 2006, NAT MED, V12, P1027, DOI 10.1038/nm1466; Walker RC, 2002, J PHYS CHEM B, V106, P11658, DOI 10.1021/jp0261814; Wang B, 2013, J CHEM INF MODEL, V53, P2659, DOI 10.1021/ci400312v; Wang JY, 2006, BIOPHYS J, V91, P2798, DOI 10.1529/biophysj.106.084301; Wichapong K, 2010, J MOL RECOGNIT, V23, P283, DOI 10.1002/jmr.977; Yang L, 2009, PROTEINS, V76, P164, DOI 10.1002/prot.22328; Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001	38	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144635	10.1371/journal.pone.0144635	http://dx.doi.org/10.1371/journal.pone.0144635			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658674	gold, Green Published			2022-12-27	WOS:000366715900077
J	Lopez-Dupla, M; Maymo-Masip, E; Martinez, E; Domingo, P; Leal, M; Peraire, J; Vilades, C; Veloso, S; Arnedo, M; Ferrando-Martinez, S; Beltran-Debon, R; Alba, V; Gatell, JM; Vendrell, J; Vidal, F; Chacon, MR				Lopez-Dupla, Miguel; Maymo-Masip, Elsa; Martinez, Esteban; Domingo, Pere; Leal, Manuel; Peraire, Joaquim; Vilades, Consuelo; Veloso, Sergi; Arnedo, Mireia; Ferrando-Martinez, Sara; Beltran-Debon, Raul; Alba, Veronica; Gatell, Josep Ma; Vendrell, Joan; Vidal, Francesc; Chacon, Matilde R.			HIV-1/HAART-Related Lipodystrophy Syndrome (HALS) Is Associated with Decreased Circulating sTWEAK Levels	PLOS ONE			English	Article							WEAK INDUCER; HIV-1-INFECTED PATIENTS; SOLUBLE CD163; UP-REGULATION; TWEAK; APOPTOSIS; OBESITY; INFLAMMATION; CYTOKINE; IDENTIFICATION	Background and Objectives Obesity and HIV-1/HAART-associated lipodystrophy syndrome (HALS) share clinical, pathological and mechanistic features. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) is a multifunctional cytokine that plays an important role in obesity and related diseases. We sought to explore the relationship between HALS and circulating levels of soluble (s) TWEAK and its scavenger receptor sCD163. Methods This was a cross-sectional multicenter study of 120 HIV-1-infected patients treated with a stable HAART regimen; 56 with overt HALS and 64 without HALS. Epidemiological and clinical variables were determined. Serum levels of sTWEAK and sCD163 levels were measured by ELISA. Results were analyzed with Student's t-test, Mann-Whitney U and chi(2) test. Pearson and Spearman correlation were used to estimate the strength of association between variables. Results Circulating sTWEAK was significantly decreased in HALS patients compared with non-HALS patients (2.81 +/- 0.2 vs. 2.94 +/- 0.28 pg/mL, p = 0.018). No changes were observed in sCD163 levels in the studied cohorts. On multivariate analysis, a lower log sTWEAK concentration was independently associated with the presence of HALS (OR 0.027, 95% CI 0.001-0.521, p = 0.027). Conclusions HALS is associated with decreased sTWEAK levels.	[Lopez-Dupla, Miguel; Maymo-Masip, Elsa; Peraire, Joaquim; Vilades, Consuelo; Veloso, Sergi; Beltran-Debon, Raul; Alba, Veronica; Vendrell, Joan; Vidal, Francesc; Chacon, Matilde R.] Univ Rovira & Virgili, IISPV, Hosp Univ Joan 23, E-43007 Tarragona, Spain; [Maymo-Masip, Elsa; Vendrell, Joan; Chacon, Matilde R.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Tarragona, Spain; [Martinez, Esteban; Arnedo, Mireia; Gatell, Josep Ma] Univ Barcelona, Hosp Clin, Barcelona, Spain; [Domingo, Pere] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain; [Leal, Manuel; Ferrando-Martinez, Sara] Univ Seville, IBIS, Hosp Univ Virgen del Rocio, Seville, Spain	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Hospital Clinic de Barcelona; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Vidal, F (corresponding author), Univ Rovira & Virgili, IISPV, Hosp Univ Joan 23, E-43007 Tarragona, Spain.	fvidalmarsal.hj23.ics@gencat.cat; mrodriguez.hj23.ics@gencat.cat	Chacón, Matilde R./E-5574-2019; Vendrell, Joan j/V-4034-2018; Domingo, Pere/CAF-3577-2022; Domingo, Pere/AAP-7571-2021; Maymó Masip, Elsa/T-1828-2017; Beltrán-Debón, Raúl/A-9287-2014	Chacón, Matilde R./0000-0003-1531-2165; Vendrell, Joan j/0000-0002-6994-6115; Domingo, Pere/0000-0003-1138-5770; Maymó Masip, Elsa/0000-0002-9133-3120; Beltrán-Debón, Raúl/0000-0001-9691-1906; Lopez Dupla, Jesus Miguel/0000-0002-9141-2523; ALBA ELVIRA, VERONICA/0000-0002-5925-9573; Vidal, Francesc/0000-0002-6692-6186; Veloso Esteban, Sergio/0000-0001-7943-1169; Vilades, Consuelo/0000-0002-2991-9593; /0000-0001-7808-5479	Fondo de Investigacion Sanitaria [PI10/2635, PI11/02512, PI11/0376, PI13/0796, 14/0465]; Instituto de Salud Carlos III, Ministerio de Sanidad, Politica Social e Igualdad [EC11-293]; Fundacion para la Investigacion y Prevencion del Sida en Espana [FIPSE 06/36572, 06/36610]; Gilead Fellowship Program [GD14-293]; Programa de Suport als Grups de Recerca AGAUR [2014SGR250]; Red de Investigacion en Sida (RIS) [RIS-EST29, RD12/0017/0001, RD12/0017/0005, RD17/0017/0022, RD17/0017/0029]; Accion Estrategica en Salud, Plan Nacional de Investigacion Cientifica, Desarrollo en Innovacion Tecnologica; Instituto de Salud Carlos III, Fondos Europeos para el Desarrollo Regional (FEDER); Programa de Intensificacion de Investigadores, Instituto de Salud Carlos III [INT11/240, INT12/282, INT12/383]; Departament de Salut de la Generalitat de Catalunya; Research Stabilization Programme of the Instituto de Salud Carlos III (ISCIII) - Institut Catala de Salut (ICS) in Catalonia; Instituto de Salud Carlos III	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Instituto de Salud Carlos III, Ministerio de Sanidad, Politica Social e Igualdad; Fundacion para la Investigacion y Prevencion del Sida en Espana; Gilead Fellowship Program(Gilead Sciences); Programa de Suport als Grups de Recerca AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Red de Investigacion en Sida (RIS); Accion Estrategica en Salud, Plan Nacional de Investigacion Cientifica, Desarrollo en Innovacion Tecnologica; Instituto de Salud Carlos III, Fondos Europeos para el Desarrollo Regional (FEDER); Programa de Intensificacion de Investigadores, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Departament de Salut de la Generalitat de Catalunya(Generalitat de Catalunya); Research Stabilization Programme of the Instituto de Salud Carlos III (ISCIII) - Institut Catala de Salut (ICS) in Catalonia; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work has been partially financed by grants from: Fondo de Investigacion Sanitaria (PI10/2635, PI11/02512, PI11/0376, PI13/0796 and 14/0465); Instituto de Salud Carlos III. Ministerio de Sanidad, Politica Social e Igualdad (EC11-293); Fundacion para la Investigacion y Prevencion del Sida en Espana (FIPSE 06/36572 and 06/36610); Gilead Fellowship Program (GD14-293); Programa de Suport als Grups de Recerca AGAUR (2014SGR250); Red de Investigacion en Sida (RIS): RIS-EST29 and RD12/0017/0001, RD12/0017/0005, RD17/0017/0022 and RD17/0017/0029; Accion Estrategica en Salud, Plan Nacional de Investigacion Cientifica, Desarrollo en Innovacion Tecnologica 2008-2001; Instituto de Salud Carlos III, Fondos Europeos para el Desarrollo Regional (FEDER). FV and PD are supported by a grant from the Programa de Intensificacion de Investigadores, Instituto de Salud Carlos III (INT11/240, INT12/282 and INT12/383). MA is supported by the Instituto de Salud Carlos III and the Departament de Salut de la Generalitat de Catalunya. MRC is supported by the Research Stabilization Programme of the Instituto de Salud Carlos III (ISCIII) co-financed by Institut Catala de Salut (ICS) in Catalonia.	Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Banerjee A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076850; Beltran LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090541; Blanco-Colio LM, 2007, ARTERIOSCL THROM VAS, V27, P916, DOI 10.1161/01.ATV.0000258972.10109.ff; Bover LC, 2007, J IMMUNOL, V178, P8183, DOI 10.4049/jimmunol.178.12.8183; Brown SAN, 2010, J BIOL CHEM, V285, P17432, DOI 10.1074/jbc.M110.131979; Burdo TH, 2011, J INFECT DIS, V204, P1227, DOI 10.1093/infdis/jir520; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Ceperuelo-Mallafre V, 2012, HIV MED, V13, P297, DOI 10.1111/j.1468-1293.2011.00976.x; Connoy A, 2011, AIDS RES HUM RETROV, V27, P719, DOI [10.1089/aid.2010.0224, 10.1089/AID.2010.0224]; Diaz-Lopez A, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-51; Domingo P, 2001, J INFECT DIS, V184, P1197, DOI 10.1086/323805; Echeverry R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-45; Escote X, 2011, HIV MED, V12, P428, DOI 10.1111/j.1468-1293.2010.00903.x; Escote X, 2011, JAIDS-J ACQ IMM DEF, V57, P16, DOI 10.1097/QAI.0b013e318213312c; Etzerodt A, 2013, ANTIOXID REDOX SIGN, V18, P2352, DOI 10.1089/ars.2012.4834; Fabriek BO, 2009, BLOOD, V113, P887, DOI 10.1182/blood-2008-07-167064; Fjeldborg K, 2013, OBESITY, V21, P2437, DOI 10.1002/oby.20376; Frings W, 2002, FEBS LETT, V526, P93, DOI 10.1016/S0014-5793(02)03142-3; Hintz KA, 2002, J LEUKOCYTE BIOL, V72, P711; Kim MJ, 2007, ANTIVIR THER, V12, P1273; Kowal K, 2011, FOLIA HISTOCHEM CYTO, V49, P365, DOI 10.5603/FHC.2011.0052; Kralisch S, 2008, ATHEROSCLEROSIS, V199, P440, DOI 10.1016/j.atherosclerosis.2007.10.022; Llaurado G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043919; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; Maymo-Masip E, 2013, J CLIN ENDOCR METAB, V98, pE1323, DOI 10.1210/jc.2012-4177; McKibben RA, 2015, J INFECT DIS, V211, P1219, DOI 10.1093/infdis/jiu594; Moller HJ, 2011, CLIN CHEM, V57, P291, DOI 10.1373/clinchem.2010.154724; Moreno JA, 2009, ATHEROSCLEROSIS, V207, P103, DOI 10.1016/j.atherosclerosis.2009.04.033; Nakayama M, 2003, J IMMUNOL, V170, P341, DOI 10.4049/jimmunol.170.1.341; Peraire J, 2015, Clin Microbiol Infect, V21, DOI 10.1016/j.cmi.2015.04.002; Urbonaviciene G, 2011, ATHEROSCLEROSIS, V219, P892, DOI 10.1016/j.atherosclerosis.2011.09.016; Vazquez-Carballo A, 2013, AM J PHYSIOL-ENDOC M, V305, pE101, DOI 10.1152/ajpendo.00589.2012; Veloso S, 2012, CYTOKINE, V58, P253, DOI 10.1016/j.cyto.2012.01.013; Vendrell J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00488; Vendrell J, 2010, J CLIN ENDOCR METAB, V95, P2983, DOI 10.1210/jc.2009-2481; Villarroya F, 2007, INT J OBESITY, V31, P1763, DOI 10.1038/sj.ijo.0803698; Weaver LK, 2007, J LEUKOCYTE BIOL, V81, P663, DOI 10.1189/jlb.0706428; Wicovsky A, 2009, CELL DEATH DIFFER, V16, P1445, DOI 10.1038/cdd.2009.80; Wilson NL, 2014, J ASSOC NURSE AIDS C, V25, P483, DOI 10.1016/j.jana.2014.07.004; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Yamana J, 2012, CELL IMMUNOL, V272, P293, DOI 10.1016/j.cellimm.2011.09.004; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004; Zhong X, 2012, BIOCHEM BIOPH RES CO, V425, P401, DOI 10.1016/j.bbrc.2012.07.110	44	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144789	10.1371/journal.pone.0144789	http://dx.doi.org/10.1371/journal.pone.0144789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658801	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900105
J	Moriwaki, Y; Terada, T; Tsumoto, K; Shimizu, K				Moriwaki, Yoshitaka; Terada, Tohru; Tsumoto, Kouhei; Shimizu, Kentaro			Rapid Heme Transfer Reactions between NEAr Transporter Domains of Staphylococcus aureus: A Theoretical Study Using QM/MM and MD Simulations	PLOS ONE			English	Article							REGULATED SURFACE DETERMINANT; ESCHERICHIA-COLI; NEAT DOMAIN; LISTERIA-MONOCYTOGENES; MOLECULAR-DYNAMICS; OUTER-MEMBRANE; ACQUISITION-SYSTEM; BINDING PROPERTIES; CELL-WALL; PROTEIN	In vertebrates, most iron is present as heme or is chelated by proteins. Thus, Gram-positive pathogens such as Staphylococcus aureus have evolved an iron-regulated surface determinant (Isd) system that transports heme across thick cell walls into the cytoplasm. Recent studies have demonstrated that heme is rapidly transferred between the NEAr Transporter (NEAT) domains of the Isd system, despite its high affinity toward each domain, suggesting the presence of an intermediate NEAT center dot heme center dot NEAT complex. In the present study, we performed short restrained molecular dynamics (MD) simulations to dock the acceptor NEAT domain to the donor NEAT center dot heme complex and obtained models where the two NEAT domains were arranged with two-fold pseudo symmetry around the heme molecule. After turning off the restraints, complex structures were stably maintained during subsequent unrestrained MD simulations, except for the hydrogen bond between the propionate group of the heme molecule and the donor NEAT domain, potentially facilitating the transition of heme from the donor to the acceptor. Subsequent structural optimization using the quantum mechanics/molecular mechanics (QM/MM) method showed that two tyrosine residues, one from each NEAT domain, were simultaneously coordinated to the ferric heme iron in the intermediate complex only if they were deprotonated. Based on these results, we propose a reaction scheme for heme transfer between NEAT domains.	[Moriwaki, Yoshitaka; Shimizu, Kentaro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Tokyo, Japan; [Terada, Tohru] Univ Tokyo, Grad Sch Agr & Life Sci, Agr Bioinformat Res Unit, Tokyo, Japan; [Tsumoto, Kouhei] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Moriwaki, Y (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Tokyo, Japan.	virgospica93@bi.a.u-tokyo.ac.jp	Terada, Tohru/W-2956-2019	Terada, Tohru/0000-0002-7091-0646; Moriwaki, Yoshitaka/0000-0003-0448-9790	 [25-6526]		The work was supported by Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows 25-6526, https://www.jsps.go.jp/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bussi G, 2008, COMPUT PHYS COMMUN, V179, P26, DOI 10.1016/j.cpc.2008.01.006; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Bussi G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3073889; Case DA, 2012, AMBER 12; Dickson CF, 2014, J BIOL CHEM, V289, P6728, DOI 10.1074/jbc.M113.545566; FISCHER E, 1989, J BACTERIOL, V171, P5127, DOI 10.1128/jb.171.9.5127-5134.1989; Frisch G. W., 2013, GAUSSIAN 09; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Ghigo JM, 1997, J BACTERIOL, V179, P3572, DOI 10.1128/jb.179.11.3572-3579.1997; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; Grigg JC, 2011, J MOL BIOL, V413, P684, DOI 10.1016/j.jmb.2011.08.047; Grubmueller H, 1996, SOLVATE V 1 0; Gupta RS, 1998, MICROBIOL MOL BIOL R, V62, P1435, DOI 10.1128/MMBR.62.4.1435-1491.1998; HAY PJ, 1985, J CHEM PHYS, V82, P299, DOI [10.1063/1.448975, 10.1063/1.448800, 10.1063/1.448799]; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kanamori D, 2005, INORG CHIM ACTA, V358, P331, DOI 10.1016/j.ica.2004.09.014; Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LETOFFE S, 1994, J BACTERIOL, V176, P5372; LETOFFE S, 1994, P NATL ACAD SCI USA, V91, P9876, DOI 10.1073/pnas.91.21.9876; Letoffe S, 2001, MOL MICROBIOL, V41, P439, DOI 10.1046/j.1365-2958.2001.02530.x; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Malmirchegini GR, 2014, J BIOL CHEM, V289, P34886, DOI 10.1074/jbc.M114.583013; Matias VRF, 2003, J BACTERIOL, V185, P6112, DOI 10.1128/JB.185.20.6112-6118.2003; Mobley DL, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2221683; Moriwaki Y, 2013, BIOCHEMISTRY-US, V52, P8866, DOI 10.1021/bi4008325; MURRAY RGE, 1965, CAN J MICROBIOL, V11, P547, DOI 10.1139/m65-072; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nee MW, 1999, J CHEM SOC DALTON, P3373, DOI 10.1039/a902636c; Newton SMC, 2005, MOL MICROBIOL, V55, P927, DOI 10.1111/j.1365-2958.2004.04436.x; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pluym M, 2008, J INORG BIOCHEM, V102, P480, DOI 10.1016/j.jinorgbio.2007.11.011; Pluym M, 2007, J PORPHYR PHTHALOCYA, V11, P165, DOI 10.1142/S1088424607000217; Ran YC, 2013, BIOCHEMISTRY-US, V52, P6537, DOI 10.1021/bi400965u; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Spirig T, 2013, J BIOL CHEM, V288, P1065, DOI 10.1074/jbc.M112.419119; Tao P, 2009, BIOCHEMISTRY-US, V48, P9839, DOI 10.1021/bi901118r; Tiedemann MT, 2012, J AM CHEM SOC, V134, P16578, DOI 10.1021/ja305115y; Tiedemann MT, 2009, J PORPHYR PHTHALOCYA, V13, P1006, DOI 10.1142/S1088424609001352; Uberuaga BP, 2004, J CHEM PHYS, V120, P6363, DOI 10.1063/1.1667473; UNO T, 1990, INORG CHEM, V29, P2803, DOI 10.1021/ic00340a018; Vermeiren CL, 2006, BIOCHEMISTRY-US, V45, P12867, DOI 10.1021/bi0607711; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; Villareal VA, 2011, J AM CHEM SOC, V133, P14176, DOI 10.1021/ja203805b; Vu NT, 2013, PROTEIN SCI, V22, P942, DOI 10.1002/pro.2276; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Xiao QB, 2011, MOL MICROBIOL, V80, P1581, DOI 10.1111/j.1365-2958.2011.07667.x; Yao X, 1999, J BACTERIOL, V181, P6865, DOI 10.1128/JB.181.22.6865-6875.1999; Zapotoczna M, 2012, J BACTERIOL, V194, P6453, DOI 10.1128/JB.01195-12; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200; Zhu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100744	57	7	7	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145125	10.1371/journal.pone.0145125	http://dx.doi.org/10.1371/journal.pone.0145125			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658942	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900186
J	Takaoka, K; Yamamura, M; Nishioka, T; Abe, T; Tamaoka, J; Segawa, E; Shinohara, M; Ueda, H; Kishimoto, H; Urade, M				Takaoka, Kazuki; Yamamura, Michiyo; Nishioka, Toshihiro; Abe, Tetsuya; Tamaoka, Joji; Segawa, Emi; Shinohara, Masami; Ueda, Haruyasu; Kishimoto, Hiromitsu; Urade, Masahiro			Establishment of an Animal Model of Bisphosphonate-Related Osteonecrosis of the Jaws in Spontaneously Diabetic Torii Rats	PLOS ONE			English	Article							FRACTURE RISK; BONE; TYPE-1; CANCER; OSTEOMYELITIS; PREVENTION; MELLITUS; INSULIN	Background We evaluated the side effects of bisphosphonate (BP) on tooth extraction socket healing in spontaneously diabetic Torii (SDT) rats, an established model of non-obese type 2 diabetes mellitus, to develop an animal model of BP-related osteonecrosis of the jaws (BRONJ). Materials and Methods Male Sprague-Dawley (SD) rats and SDT rats were randomly assigned to the zoledronic acid (ZOL)-treated groups (SD/ZOL or SDT/ZOL) or to the control groups (SD/control or SDT/control). Rats in the SD/ZOL or SDT/ZOL groups received an intravenous bolus injection of ZOL (35 mu g/kg) every 2 weeks. Each group consisted of 6 rats each. Twenty-one weeks after ZOL treatment began, the left maxillary molars were extracted. The rats were euthanized at 2, 4, or 8 weeks after tooth extraction, and the total maxillae were harvested for histological and histochemical studies. Results In the oral cavity, bone exposure persisted at the tooth extraction site in all rats of the SDT/ZOL group until 8 weeks after tooth extraction. In contrast, there was no bone exposure in SD/control or SDT/control groups, and only 1 of 6 rats in the SD/ZOL group showed bone exposure. Histologically, necrotic bone areas with empty lacunae, microbial colonies, and less invasion by inflammatory cells were observed. The number of tartrate-resistant acid phosphatase-positive osteoclasts was lower in the SDT/ZOL group than in the SD/control group. The mineral apposition rate was significantly lower in the SDT/ZOL group compared with the SD/control group. Conclusions This study demonstrated the development of BRONJ-like lesions in rats and suggested that low bone turnover with less inflammatory cell infiltration plays an important role in the development of BRONJ.	[Takaoka, Kazuki; Yamamura, Michiyo; Nishioka, Toshihiro; Abe, Tetsuya; Tamaoka, Joji; Segawa, Emi; Kishimoto, Hiromitsu; Urade, Masahiro] Hyogo Coll Med, Dept Oral & Maxillofacial Surg, Nishinomiya, Hyogo 6638501, Japan; [Shinohara, Masami] CLEA Japan Inc, Planning & Dev Sect, Meguro Ku, Tokyo, Japan; [Ueda, Haruyasu] Hyogo Univ Hlth Sci, Immunobiol Lab, Sch Pharm, Kobe, Hyogo, Japan	Hyogo College of Medicine; Immuno-Biological Laboratories Co. Ltd.	Takaoka, K (corresponding author), Hyogo Coll Med, Dept Oral & Maxillofacial Surg, Nishinomiya, Hyogo 6638501, Japan.	ktaka@hyo-med.ac.jp			JSPS KAKENHI Grant [24593069, 15K11332]; Hyogo College of Medicine	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hyogo College of Medicine	This study was supported by JSPS KAKENHI Grant Number 24593069, 15K11332 (to K.T.) and by Grant-in-Aid for Researchers, Hyogo College of Medicine, 2013 (to M.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAOMS, 2007, J ORAL MAXIL SURG, V65, P369, DOI 10.1016/j.joms.2006.11.003; Bamias A, 2005, J CLIN ONCOL, V23, P8580, DOI 10.1200/JCO.2005.02.8670; Bertoldo F, 2007, NAT CLIN PRACT ONCOL, V4, P711, DOI 10.1038/ncponc1000; Bonds DE, 2006, J CLIN ENDOCR METAB, V91, P3404, DOI 10.1210/jc.2006-0614; Boonyapakorn T, 2008, ORAL ONCOL, V44, P857, DOI 10.1016/j.oraloncology.2007.11.012; BURSELL SE, 1989, CURR EYE RES, V8, P821, DOI 10.3109/02713688909000872; Carnevale V, 2004, DIABETES-METAB RES, V20, P196, DOI 10.1002/dmrr.449; Cheng A, 2005, AUST DENT J, V50, pS4, DOI 10.1111/j.1834-7819.2005.tb00384.x; Cremers S, 2011, BONE, V49, P42, DOI 10.1016/j.bone.2011.01.014; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Fiore F, 2007, BLOOD, V110, P921, DOI 10.1182/blood-2006-09-044321; Fujii H, 2008, BONE, V42, P372, DOI 10.1016/j.bone.2007.10.007; Green JR, 2001, SEMIN ONCOL, V28, P4, DOI 10.1053/sonc.2001.24154; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Hill SL, 1999, AM J SURG, V177, P282, DOI 10.1016/S0002-9610(99)00050-1; Hokugo A, 2010, J BONE MINER RES, V25, P1337, DOI 10.1002/jbmr.23; Jaiprakash A, 2012, INT J BIOL SCI, V8, P406, DOI 10.7150/ijbs.4221; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Kobayashi Y, 2010, J BONE MINER METAB, V28, P165, DOI 10.1007/s00774-009-0128-9; Kumeda Yasuro, 2006, Clin Calcium, V16, P1277; Kyrgidis A, 2008, J CLIN ONCOL, V26, P4634, DOI 10.1200/JCO.2008.16.2768; Licata AA, 2005, ANN PHARMACOTHER, V39, P668, DOI 10.1345/aph.1E357; Maahs MP, 2011, HEAD NECK-J SCI SPEC, V33, P199, DOI 10.1002/hed.21422; Marx RE, 2005, J ORAL MAXIL SURG, V63, P1567, DOI 10.1016/j.joms.2005.07.010; Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1; Melani C, 2007, CANCER RES, V67, P11438, DOI 10.1158/0008-5472.CAN-07-1882; Michaelson MD, 2005, J CLIN ONCOL, V23, P8219, DOI 10.1200/JCO.2005.02.9579; Migliorati CA, 2005, J AM DENT ASSOC, V136, P1658, DOI 10.14219/jada.archive.2005.0108; Mortensen M, 2007, LARYNGOSCOPE, V117, P30, DOI 10.1097/01.mlg.0000240885.64568.9e; O'Ryan FS, 2009, J ORAL MAXIL SURG, V67, P1363, DOI 10.1016/j.joms.2009.03.005; Ohta T, 2015, J VET MED S IN PRESS; Purcell PM, 2005, MED J AUSTRALIA, V182, P417, DOI 10.5694/j.1326-5377.2005.tb06762.x; Ravosa MJ, 2011, ARCH ORAL BIOL, V56, P491, DOI 10.1016/j.archoralbio.2010.11.003; Ruggiero SL, 2009, J ORAL MAXIL SURG, V67, P2, DOI 10.1016/j.joms.2009.01.009; Ruggiero SL, 2004, J ORAL MAXIL SURG, V62, P527, DOI 10.1016/j.joms.2004.02.004; Santini D, 2003, ANN ONCOL, V14, P1468, DOI 10.1093/annonc/mdg401; Sonis ST, 2009, ORAL ONCOL, V45, P164, DOI 10.1016/j.oraloncology.2008.04.013; Sorensen VR, 2005, DIABETIC MED, V22, P871, DOI 10.1111/j.1464-5491.2005.01543.x; Stegeman Cynthia A, 2005, Home Healthc Nurse, V23, P233, DOI 10.1097/00004045-200504000-00009; Tao F, 2014, ANN BIOMED ENG, V42, P1238, DOI 10.1007/s10439-014-0998-4; Thrailkill KM, 2005, AM J PHYSIOL-ENDOC M, V289, pE735, DOI 10.1152/ajpendo.00159.2005; Urade M, 2011, J ORAL MAXIL SURG, V69, pE364, DOI 10.1016/j.joms.2011.03.051; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Vestergaard P, 2005, DIABETOLOGIA, V48, P1292, DOI 10.1007/s00125-005-1786-3; Wang J, 2003, J ORAL MAXIL SURG, V61, P1104, DOI 10.1016/S0278-2391(03)00328-8; Wilkinson GS, 2007, JNCI-J NATL CANCER I, V99, P1016, DOI 10.1093/jnci/djm025; Wolf AM, 2006, HAEMATOLOGICA, V91, P1165; Woo SB, 2006, ANN INTERN MED, V144, P753, DOI 10.7326/0003-4819-144-10-200605160-00009; Yoshii Taishi, 2015, J Clin Med Res, V7, P762, DOI 10.14740/jocmr2278w	50	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144355	10.1371/journal.pone.0144355	http://dx.doi.org/10.1371/journal.pone.0144355			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659123	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900041
J	Ahmad, Z; Rafeeq, M; Collombat, P; Mansouri, A				Ahmad, Zeeshan; Rafeeq, Maria; Collombat, Patrick; Mansouri, Ahmed			Pax6 Inactivation in the Adult Pancreas Reveals Ghrelin as Endocrine Cell Maturation Marker	PLOS ONE			English	Article							BETA-CELLS; INSULIN-SECRETION; MOUSE PANCREAS; ENZYMATIC-ACTIVITY; ALPHA-CELLS; DIFFERENTIATION; EXPRESSION; MICE; 7B2; IDENTITY	The transcription factor Pax6 is an important regulator of development and cell differentiation in various organs. Thus, Pax6 was shown to promote neural development in the cerebral cortex and spinal cord, and to control pancreatic endocrine cell genesis. However, the role of Pax6 in distinct endocrine cells of the adult pancreas has not been addressed. We report the conditional inactivation of Pax6 in insulin and glucagon producing cells of the adult mouse pancreas. In the absence of Pax6, beta- and alpha-cells lose their molecular maturation characteristics. Our findings provide strong evidence that Pax6 is responsible for the maturation of beta-, and alpha-cells, but not of delta-, and PP-cells. Moreover, lineage-tracing experiments demonstrate that Pax6-deficient beta- and alpha-cells are shunted towards ghrelin marked cells, sustaining the idea that ghrelin may represent a marker for endocrine cell maturation.	[Ahmad, Zeeshan; Rafeeq, Maria; Mansouri, Ahmed] Max Planck Inst Biophys Chem, Dept Mol Dev Biol, RG Mol Cell Differentiat, D-37077 Gottingen, Germany; [Collombat, Patrick] Univ Nice Sophia Antipolis, F-06189 Nice, France; [Collombat, Patrick] Fac Med Nice, INSERM, U1091, IBV,Diabet Genet Team, F-06034 Nice, France; [Collombat, Patrick; Mansouri, Ahmed] JDRF, New York, NY USA; [Collombat, Patrick] Erciyes Univ, Genome & Stem Cell Ctr, GENKOK, Kayseri, Turkey; [Mansouri, Ahmed] Univ Gottingen, Dept Clin Neurophysiol, D-37073 Gottingen, Germany	Max Planck Society; UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Erciyes University; University of Gottingen	Ahmad, Z (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Dev Biol, RG Mol Cell Differentiat, D-37077 Gottingen, Germany.	zahmad@gwdg.de; amanou@gwdg.de	collombat, patrick/F-4495-2015; collombat, patrick/P-3741-2019	collombat, patrick/0000-0001-8232-1438; collombat, patrick/0000-0001-8232-1438	Max-Planck Society; Juvenile Diabetes Research foundation [17-2011-16, 2-2010-567, 26-2008-639, 17-2013-426]; INSERM AVENIR program; INSERM; European Research Council [StG-2011-281265]; FMR [DRC20091217179]; ANR/BMBF [GENO 105 01/01KU0906]; "Investments for the Future'' LABEX SIGNALIFE [ANR-11-LABX-0028-01]; Club Isatis; Mr. and Mrs. Dorato; Fondation Generale de Sante; Foundation Schlumberger pour l'Education et la Recherche	Max-Planck Society(Max Planck SocietyFoundation CELLEX); Juvenile Diabetes Research foundation(Juvenile Diabetes Research Foundation); INSERM AVENIR program(Institut National de la Sante et de la Recherche Medicale (Inserm)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); European Research Council(European Research Council (ERC)European Commission); FMR; ANR/BMBF(French National Research Agency (ANR)); "Investments for the Future'' LABEX SIGNALIFE; Club Isatis; Mr. and Mrs. Dorato; Fondation Generale de Sante; Foundation Schlumberger pour l'Education et la Recherche	This work was supported by the Max-Planck Society, the Juvenile Diabetes Research foundation (17-2011-16, 2-2010-567, 26-2008-639, 17-2013-426), the INSERM AVENIR program, the INSERM, the European Research Council (StG-2011-281265) the FMR (DRC20091217179), the ANR/BMBF (2009 GENO 105 01/01KU0906), the "Investments for the Future'' LABEX SIGNALIFE (ANR-11-LABX-0028-01), Club Isatis, Mr. and Mrs. Dorato, the Fondation Generale de Sante, and the Foundation Schlumberger pour l'Education et la Recherche.	Al-Hasani K, 2013, DEV CELL, V26, P86, DOI 10.1016/j.devcel.2013.05.018; Artner I, 2006, DIABETES, V55, P297, DOI 10.2337/diabetes.55.02.06.db05-0946; Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Ashery-Padan R, 2004, DEV BIOL, V269, P479, DOI 10.1016/j.ydbio.2004.01.040; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Bel-Vialar S, 2007, DEV BIOL, V305, P659, DOI 10.1016/j.ydbio.2007.02.012; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124; Chandra V, 2014, CELL REP, V9, P2206, DOI 10.1016/j.celrep.2014.11.010; Collombat P, 2009, CELL CYCLE, V8, P3450, DOI 10.4161/cc.8.21.9791; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Collombat P, 2006, MECH DEVELOP, V123, P501, DOI 10.1016/j.mod.2006.05.006; Courtney M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003934; Delporte FM, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-53; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Farber CR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-34; Fortenberry Y, 2002, J BIOL CHEM, V277, P5175, DOI 10.1074/jbc.M104531200; Furuta M, 1997, P NATL ACAD SCI USA, V94, P6646, DOI 10.1073/pnas.94.13.6646; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Gosmain Y, 2012, MOL ENDOCRINOL, V26, P696, DOI 10.1210/me.2011-1256; Gosmain Y, 2010, J BIOL CHEM, V285, P33381, DOI 10.1074/jbc.M110.147215; Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390; Hart AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054173; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Heller RS, 2004, DEV BIOL, V268, P123, DOI 10.1016/j.ydbio.2003.12.008; Helwig M, 2013, J BIOL CHEM, V288, P1114, DOI 10.1074/jbc.M112.417071; Helwig M, 2011, J BIOL CHEM, V286, P42504, DOI 10.1074/jbc.M111.281980; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hoshino A, 2014, J NEUROCHEM, V128, P419, DOI 10.1111/jnc.12454; Katz LS, 2009, MOL CELL BIOL, V29, P2322, DOI 10.1128/MCB.01543-08; Liu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046934; MacDonald PE, 2002, DIABETES, V51, pS434, DOI 10.2337/diabetes.51.2007.S434; Nishimura W, 2008, DEV BIOL, V314, P443, DOI 10.1016/j.ydbio.2007.12.009; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Pfeifer A, 2013, CELL CYCLE, V12, P3243, DOI 10.4161/cc.26357; Piccand J, 2014, CELL REP, V9, P2219, DOI 10.1016/j.celrep.2014.11.033; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Spijker HS, 2015, DIABETES, V64, P2928, DOI 10.2337/db14-1752; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; THORENS B, 1992, J CLIN INVEST, V90, P77, DOI 10.1172/JCI115858; Wang JF, 2004, DEV BIOL, V266, P178, DOI 10.1016/j.ydbio.2003.10.018; Wang Q, 2004, DIABETOLOGIA, V47, P478, DOI 10.1007/s00125-004-1327-5; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhang X, 2006, DEV BIOL, V300, P748, DOI 10.1016/j.ydbio.2006.06.030; ZHU XR, 1995, J CELL BIOL, V129, P1641, DOI 10.1083/jcb.129.6.1641	48	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144597	10.1371/journal.pone.0144597	http://dx.doi.org/10.1371/journal.pone.0144597			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658466	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903600062
J	Cascao, R; Vidal, B; Lopes, IP; Paisana, E; Rino, J; Moita, LF; Fonseca, JE				Cascao, Rita; Vidal, Bruno; Lopes, Ines P.; Paisana, Eunice; Rino, Jose; Moita, Luis F.; Fonseca, Joao E.			Decrease of CD68 Synovial Macrophages in Celastrol Treated Arthritic Rats	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; TUMOR-NECROSIS-FACTOR; KAPPA-B-KINASE; INTERLEUKIN-1 RECEPTOR ANTAGONIST; EARLY RHEUMATOID-ARTHRITIS; AUTOIMMUNE ARTHRITIS; OSTEOCLAST DIFFERENTIATION; CLINICAL IMPROVEMENT; BONE DESTRUCTION; ALPHA BLOCKADE	Background Rheumatoid arthritis (RA) is a chronic immune-mediated inflammatory disease characterized by cellular infiltration into the joints, hyperproliferation of synovial cells and bone damage. Available treatments for RA only induce remission in around 30% of the patients, have important adverse effects and its use is limited by their high cost. Therefore, compounds that can control arthritis, with an acceptable safety profile and low production costs are still an unmet need. We have shown, in vitro, that celastrol inhibits both IL-1 beta and TNF, which play an important role in RA, and, in vivo, that celastrol has significant anti-inflammatory properties. Our main goal in this work was to test the effect of celastrol in the number of sublining CD68 macrophages (a biomarker of therapeutic response for novel RA treatments) and on the overall synovial tissue cellularity and joint structure in the adjuvant-induced rat model of arthritis (AIA). Methods Celastrol was administered to AIA rats both in the early (4 days after disease induction) and late (11 days after disease induction) phases of arthritis development. The inflammatory score, ankle perimeter and body weight were evaluated during treatment period. Rats were sacrificed after 22 days of disease progression and blood, internal organs and paw samples were collected for toxicological blood parameters and serum proinflammatory cytokine quantification, as well as histopathological and immunohistochemical evaluation, respectively. Results Here we report that celastrol significantly decreases the number of sublining CD68 macrophages and the overall synovial inflammatory cellularity, and halted joint destruction without side effects. Conclusions Our results validate celastrol as a promising compound for the treatment of arthritis.	[Cascao, Rita; Vidal, Bruno; Lopes, Ines P.; Paisana, Eunice; Rino, Jose; Fonseca, Joao E.] Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal; [Moita, Luis F.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Fonseca, Joao E.] Lisbon Acad Med Ctr, Hosp Santa Maria, Ctr Hosp Lisboa Norte, Dept Rheumatol,EPE, Lisbon, Portugal	Universidade de Lisboa; Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Hospital Santa Maria	Cascao, R (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal.	ritacascao@medicina.ulisboa.pt	Moita, Luis/HCI-2793-2022; Moita, Luis F./L-1296-2013; Rino, Jose/I-2990-2013; Cascao, Rita/N-6675-2013	Moita, Luis/0000-0003-0707-315X; Moita, Luis F./0000-0003-0707-315X; Lopes, Ines/0000-0002-2109-6203; Rino, Jose/0000-0002-0637-4527; Paisana, Eunice/0000-0001-5915-8556; Cascao, Rita/0000-0001-5533-9413	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BPD/92860/2013]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	RC was supported with a fellowship from Fundacao para a Ciencia e a Tecnologia (FCT, SFRH/BPD/92860/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astry B, 2015, CLIN IMMUNOL, V157, P228, DOI 10.1016/j.clim.2015.01.011; Astry B, 2011, J INTERF CYTOK RES, V31, P927, DOI 10.1089/jir.2011.0094; Bendele AM, 2000, ARTHRITIS RHEUM-US, V43, P2648, DOI 10.1002/1529-0131(200012)43:12<2648::AID-ANR4>3.0.CO;2-M; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; BRAUER R, 1994, EXP TOXICOL PATHOL, V46, P383; Bresnihan B, 2009, J RHEUMATOL, V36, P1800, DOI 10.3899/jrheum.090348; Cascao R, 2012, AUTOIMMUN REV, V11, P856, DOI 10.1016/j.autrev.2012.02.022; Cascao R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3168; Chen SY, 2011, HUM GENE THER, V22, P145, DOI 10.1089/hum.2009.217; Cunnane G, 2001, RHEUMATOLOGY, V40, P62, DOI 10.1093/rheumatology/40.1.62; DaSilva JAP, 1996, CLIN EXP RHEUMATOL, V14, P43; Dolhain RJEM, 1998, BRIT J RHEUMATOL, V37, P502; Fonseca JE, 2002, ARTHRITIS RHEUM-US, V46, P1210, DOI 10.1002/art.10207; Fonseca JE, 2009, CLIN RHEUMATOL, V28, P1213, DOI 10.1007/s10067-009-1207-y; Gan K, 2015, INT IMMUNOPHARMACOL, V24, P239, DOI 10.1016/j.intimp.2014.12.012; Gerlag DM, 2004, ARTHRITIS RHEUM, V50, P3783, DOI 10.1002/art.20664; Gorman CL, 2008, BEST PRACT RES CL RH, V22, P221, DOI 10.1016/j.berh.2008.01.003; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; Hahn B, 2004, JCR-J CLIN RHEUMATOL, V10, pS3, DOI 10.1097/01.rhu.0000130683.61892.b2; Haringman JJ, 2006, ARTHRITIS RHEUM, V54, P2387, DOI 10.1002/art.21975; Haringman JJ, 2005, ANN RHEUM DIS, V64, P834, DOI 10.1136/ard.2004.029751; Idris AI, 2010, FASEB J, V24, P4545, DOI 10.1096/fj.10-164095; Joosten LAB, 1999, J IMMUNOL, V163, P5049; Karmakar S, 2010, RHEUM DIS CLIN N AM, V36, P385, DOI 10.1016/j.rdc.2010.03.003; Kim HY, 2012, LIFE SCI, V91, P250, DOI 10.1016/j.lfs.2012.07.003; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Kraan MC, 2000, ARTHRITIS RHEUM, V43, P1820, DOI 10.1002/1529-0131(200008)43:8<1820::AID-ANR18>3.0.CO;2-D; Kusy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035733; LaBranche TP, 2012, ARTHRITIS RHEUM-US, V64, P3531, DOI 10.1002/art.34649; Le Goff B, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2877; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; Li GQ, 2012, INT IMMUNOPHARMACOL, V14, P422, DOI 10.1016/j.intimp.2012.08.016; Li GQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068905; Li H, 2008, J ETHNOPHARMACOL, V118, P479, DOI 10.1016/j.jep.2008.05.028; Ma YH, 2010, INT IMMUNOPHARMACOL, V10, P1456, DOI 10.1016/j.intimp.2010.08.022; MIHARA M, 1995, BRIT J RHEUMATOL, V34, P321; Nanjundaiah SM, 2012, J BIOL CHEM, V287, P22216, DOI 10.1074/jbc.M112.356816; NAWROTH PP, 1986, J EXP MED, V163, P1363, DOI 10.1084/jem.163.6.1363; Plasqui G, 2008, PHYSIOL BEHAV, V94, P270, DOI 10.1016/j.physbeh.2007.12.012; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Schett G, 2006, WIEN MED WOCHENSCHR, V156, P34, DOI 10.1007/s10354-005-0244-7; Sims NA, 2004, ARTHRITIS RHEUM-US, V50, P2338, DOI 10.1002/art.20382; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Smeets TJM, 2003, ARTHRITIS RHEUM-US, V48, P2155, DOI 10.1002/art.11098; Smith MD, 2001, RHEUMATOLOGY, V40, P367, DOI 10.1093/rheumatology/40.4.367; Smolen JS, 2005, ARTHRITIS RHEUM, V52, P1020, DOI 10.1002/art.20982; Steiner G, 1999, RHEUMATOLOGY, V38, P202, DOI 10.1093/rheumatology/38.3.202; Stolina M, 2009, J CLIN IMMUNOL, V29, P158, DOI 10.1007/s10875-008-9238-8; Suzuki M, 2010, CYTOKINE, V51, P178, DOI 10.1016/j.cyto.2010.03.017; Tas SW, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1958; Taylor PC, 2000, ARTHRITIS RHEUM-US, V43, P38, DOI 10.1002/1529-0131(200001)43:1<38::AID-ANR6>3.0.CO;2-L; Thurlings RM, 2008, ANN RHEUM DIS, V67, P917, DOI 10.1136/ard.2007.080960; Tsubaki T, 2005, ARTHRITIS RES THER, V7, pR825, DOI 10.1186/ar1751; Venkatesha SH, 2012, BIOORGAN MED CHEM, V20, P5229, DOI 10.1016/j.bmc.2012.06.050; Venkatesha SH, 2011, J BIOL CHEM, V286, P15138, DOI 10.1074/jbc.M111.226365; Vidal B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117100; Vieira-Sousa Elsa, 2011, Open Rheumatol J, V5, P115, DOI 10.2174/1874312901105010115; Vincenti MP, 1998, ARTHRITIS RHEUM, V41, P1987, DOI 10.1002/1529-0131(199811)41:11<1987::AID-ART14>3.3.CO;2-#; Vivar Nancy, 2014, F1000Prime Rep, V6, P31, DOI 10.12703/P6-31; Wijbrandts CA, 2007, ARTHRITIS RHEUM, V56, P3869, DOI 10.1002/art.22964; Xu SQ, 2012, RHEUMATOL INT, V32, P3397, DOI 10.1007/s00296-011-2175-5; YANNI G, 1994, ANN RHEUM DIS, V53, P315, DOI 10.1136/ard.53.5.315; Yu H, 2012, INT IMMUNOPHARMACOL, V13, P499, DOI 10.1016/j.intimp.2012.05.015; Zhang J, 2012, J ETHNOPHARMACOL, V144, P195, DOI 10.1016/j.jep.2012.09.005; Zhu XJ, 2014, J ETHNOPHARMACOL, V158, P283, DOI 10.1016/j.jep.2014.10.021	65	20	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0142448	10.1371/journal.pone.0142448	http://dx.doi.org/10.1371/journal.pone.0142448			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658436	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903600005
J	Merema, MR; Speelman, CP				Merema, Matt R.; Speelman, Craig P.			The Interdependence of Long- and Short-Term Components in Unmasked Repetition Priming: An Indication of Shared Resources	PLOS ONE			English	Article							IMPLICIT MEMORY; WORD-FREQUENCY; LEXICAL DECISION; EXPLICIT MEMORY; RECOGNITION; ASSOCIATIONS; ACQUISITION; NONWORDS; DECAY; SPAN	It has been suggested that unmasked repetition priming is composed of distinct long-and short-term priming components. The current study sought to clarify the relationship between these components by examining the relationship between them. A total of 60 people (45 females, 15 males) participated in a computer-based lexical decision task designed to measure levels of short-term priming across different levels of long-term priming. The results revealed an interdependent relationship between the two components, whereby an increase in long-term priming prompted a decrease in short-term priming. Both long-term and short-term priming were accurately captured by a single power function over seven minutes post repetition, suggesting the two components may draw on the same resources. This interdependence between long-and short-term priming may serve to improve fluency in reading.	[Merema, Matt R.; Speelman, Craig P.] Edith Cowan Univ, Sch Psychol & Social Sci, Joondalup, WA, Australia	Edith Cowan University	Speelman, CP (corresponding author), Edith Cowan Univ, Sch Psychol & Social Sci, Joondalup, WA, Australia.	c.speelman@ecu.edu.au	Speelman, Craig/P-8866-2019	Speelman, Craig/0000-0001-8629-174X				Balota DA, 1999, J EXP PSYCHOL GEN, V128, P32, DOI 10.1037/0096-3445.128.1.32; Bowers JS, 2000, PSYCHON B REV, V7, P83, DOI 10.3758/BF03210726; Bowers JS, 2000, MEM COGNITION, V28, P406, DOI 10.3758/BF03198556; COFER CN, 1967, PSYCHOL BULL, V68, P1, DOI 10.1037/h0024713; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P501, DOI 10.1037/0278-7393.11.3.501; GRANT SC, 1993, MEM COGNITION, V21, P611, DOI 10.3758/BF03197193; HULME C, 1991, J MEM LANG, V30, P685, DOI 10.1016/0749-596X(91)90032-F; KINOSHITA S, 1995, MEM COGNITION, V23, P569, DOI 10.3758/BF03197259; Kucera H., 1967, COMPUTATIONAL ANAL P; McKone E, 1999, MEM COGNITION, V27, P619, DOI 10.3758/BF03211556; MCKONE E, 1995, J EXP PSYCHOL LEARN, V21, P1108, DOI 10.1037/0278-7393.21.5.1108; McKone E, 1998, MEM COGNITION, V26, P1173, DOI 10.3758/BF03201193; McKone E, 2000, PSYCHON B REV, V7, P341, DOI 10.3758/BF03212991; MORRISON CM, 1995, J EXP PSYCHOL LEARN, V21, P116, DOI 10.1037/0278-7393.21.1.116; RATCLIFF R, 1985, J EXP PSYCHOL GEN, V114, P435, DOI 10.1037/0096-3445.114.4.435; ROODENRYS S, 1993, J EXP CHILD PSYCHOL, V56, P431, DOI 10.1006/jecp.1993.1043; RUBIN GS, 1992, VISION RES, V32, P895, DOI 10.1016/0042-6989(92)90032-E; Schnyer DM, 1997, NEUROPSYCHOLOGY, V11, P243, DOI 10.1037/0894-4105.11.2.243; Schott B, 2002, J COGNITIVE NEUROSCI, V14, P578, DOI 10.1162/08989290260045828; Tunney RJ, 2003, EXP PSYCHOL, V50, P124, DOI 10.1026//1618-3169.50.2.124	20	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144747	10.1371/journal.pone.0144747	http://dx.doi.org/10.1371/journal.pone.0144747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1ZA	26660083	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903600083
J	Tapsas, D; Hollen, E; Stenhammar, L; Falth-Magnusson, K				Tapsas, Dimitrios; Hollen, Elisabet; Stenhammar, Lars; Falth-Magnusson, Karin			Unusually High Incidence of Paediatric Coeliac Disease in Sweden during the Period 1973-2013	PLOS ONE			English	Article							ANTIGLIADIN ANTIBODIES; BIRTH COHORTS; DIAGNOSIS; CHILDREN; IGA; HISTOPATHOLOGY; SENSITIVITY; CRITERIA; GLUTEN; IMPACT	Objective The prevalence of coeliac disease in Sweden during the "epidemic period" (1984-1996) was one of the highest in the world. The aim of this study was to assess the coeliac disease incidence in our region over the 41-year period, and how diagnostic activity and diagnostic accuracy were affected by the introduction of antibody testing. We also looked into how patients with mild enteropathy were evaluated. Methods In the county of Ostergotland in Sweden, 2790 paediatric patients were investigated for suspected coeliac disease between 1973 and 2013. Notes were scrutinised for data on sex, age, histopathological reports and final diagnosis. For comparative purposes this period was divided into three sub-periods (1973-1983, 1984-1996 and 1997-2013) named pre-epidemic, epidemic and post-epidemic. Results Coeliac disease diagnosis was received by 1,030 patients. The peak incidence rate, 301 cases/100,000 in 1994 for the age group 0-1.9 years is the highest figure ever reported. The other age groups, 2-4.9, 5-14.9, and 15-17.9 years, also had high incidence rates. After the 1984-1996 "epidemic period" the incidence decreased for the youngest group but continued to increase for the other groups. The cumulative incidence at 18 years-of-age for children born during the epidemic reached 14 cases/1000 births, the highest figure hitherto reported. Diagnostic activity differed significantly between the three sub-periods (p<0.001) increasing gradually from 1984 and reaching a peak value of 0.87 in 2012. Cases of mild enteropathy were more frequently regarded as non-coeliac disease cases, decreasing significantly in the "post-epidemic" period (p<0.001). Conclusions The incidence rate and cumulative incidence of coeliac disease were possibly the highest ever reported. Changes in diagnostic activity and accuracy could not be attributed to the introduction of new antibody tests, possibly because of other changes e.g. variations in the symptoms at presentation and improved knowledge of the disease among parents and health professionals.	[Tapsas, Dimitrios; Stenhammar, Lars; Falth-Magnusson, Karin] Linkoping Univ, Dept Clin & Expt Med, Div Paediat, Linkoping, Sweden; [Hollen, Elisabet] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Hollen, Elisabet] Linkoping Univ, Div Microbiol & Mol Med, Linkoping, Sweden; [Stenhammar, Lars] Linkoping Univ, Dept Paediat, Norrkoping, Sweden; [Stenhammar, Lars] Linkoping Univ, Dept Clin & Expt Med, Norrkoping, Sweden; [Falth-Magnusson, Karin] Linkoping Univ, Dept Paediat, Linkoping, Sweden; [Falth-Magnusson, Karin] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University; Linkoping University; Linkoping University; Linkoping University; Linkoping University	Tapsas, D (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Paediat, Linkoping, Sweden.	dimta624@student.liu.se	Tapsas, Dimitrios/H-7738-2019		Medical Research Council of Southeast Sweden; County Council of Ostergotland; Swedish Research Council	Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); County Council of Ostergotland; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding was received from the Medical Research Council of Southeast Sweden, the County Council of Ostergotland and the Swedish Research Council (KFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh D, 2015, PEDIATRICS, V135, P627, DOI 10.1542/peds.2014-3675; Arguelles-Grande C, 2012, J CLIN PATHOL, V65, P242, DOI 10.1136/jclinpath-2011-200372; CHORZELSKI TP, 1983, ANN NY ACAD SCI, V420, P325, DOI 10.1111/j.1749-6632.1983.tb22220.x; Cook Bramwell, 2004, N Z Med J, V117, pU772; Corrao G, 1996, J EPIDEMIOL COMMUN H, V50, P299, DOI 10.1136/jech.50.3.299; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Fortunato F, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-38; GRODZINSKY E, 1994, ALLERGY, V49, P593, DOI 10.1111/j.1398-9995.1994.tb00124.x; GRODZINSKY E, 1990, INT ARCH ALLER A IMM, V92, P119, DOI 10.1159/000235201; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Kakar S, 2003, AM J GASTROENTEROL, V98, P2027, DOI 10.1016/S0002-9270(03)00542-2; Kelly CP, 2015, GASTROENTEROLOGY, V148, P1175, DOI 10.1053/j.gastro.2015.01.044; Ludvigsson JF, 2004, J PEDIATR GASTR NUTR, V38, P181, DOI 10.1097/00005176-200402000-00015; Ludvigsson JF, 2013, AM J GASTROENTEROL, V108, P818, DOI 10.1038/ajg.2013.60; Ludvigsson JF, 2013, GUT, V62, P43, DOI 10.1136/gutjnl-2011-301346; Ludvigsson JF, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-19; Cilleruelo ML, 2014, J PEDIATR GASTR NUTR, V59, P522, DOI 10.1097/MPG.0000000000000446; Mahadeva S, 2002, J CLIN PATHOL, V55, P424, DOI 10.1136/jcp.55.6.424; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; McGowan KE, 2009, PEDIATRICS, V124, P1572, DOI 10.1542/peds.2008-2373; Mubarak A, 2011, SCAND J GASTROENTERO, V46, P1065, DOI 10.3109/00365521.2011.589471; Myleus A, 2009, J PEDIATR GASTR NUTR, V49, P170, DOI 10.1097/MPG.0b013e31818c52cc; Namatovu F, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-59; Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019; Olsson C, 2008, PEDIATRICS, V122, P528, DOI 10.1542/peds.2007-2989; Ress K, 2012, EUR J PEDIATR, V171, P1823, DOI 10.1007/s00431-012-1835-0; Roma E, 2009, DIGESTION, V80, P185, DOI 10.1159/000227275; SAKULA J, 1957, LANCET, V2, P876; Savilahti E, 2010, ACTA PAEDIATR, V99, P1026, DOI 10.1111/j.1651-2227.2010.01740.x; Tanpowpong P, 2012, CLIN TRANSL GASTROEN, V3, DOI 10.1038/ctg.2012.4; UNSWORTH DJ, 1981, CLIN EXP IMMUNOL, V46, P286; Volta U, 2011, CELL MOL IMMUNOL, V8, P96, DOI 10.1038/cmi.2010.64; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909; Weile B, 2000, APMIS, V108, P380, DOI 10.1034/j.1600-0463.2000.d01-72.x; White LE, 2013, ARCH DIS CHILD, V98, P52, DOI 10.1136/archdischild-2012-302056; Whyte LA, 2013, ARCH DIS CHILD, V98, P405, DOI 10.1136/archdischild-2012-303113; Zingone F, 2015, UNITED EUR GASTROENT, V3, P182, DOI 10.1177/2050640615571021	37	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144346	10.1371/journal.pone.0144346	http://dx.doi.org/10.1371/journal.pone.0144346			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658809	Green Submitted, gold, Green Published			2022-12-27	WOS:000366903600037
J	Breit, C; Bange, T; Petrovic, A; Weir, JR; Muller, F; Vogt, D; Musacchio, A				Breit, Claudia; Bange, Tanja; Petrovic, Arsen; Weir, John R.; Mueller, Franziska; Vogt, Doro; Musacchio, Andrea			Role of Intrinsic and Extrinsic Factors in the Regulation of the Mitotic Checkpoint Kinase Bub1	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; SPINDLE CHECKPOINT; KINETOCHORE LOCALIZATION; CENP-E; CHROMOSOME SEGREGATION; PROTEIN; PHOSPHORYLATION; BINDING; CDC20; AUTOPHOSPHORYLATION	The spindle assembly checkpoint (SAC) monitors microtubule attachment to kinetochores to ensure accurate sister chromatid segregation during mitosis. The SAC members Bub1 and BubR1 are paralogs that underwent significant functional specializations during evolution. We report an in-depth characterization of the kinase domains of Bub1 and BubR1. BubR1 kinase domain binds nucleotides but is unable to deliver catalytic activity in vitro. Conversely, Bub1 is an active kinase regulated by intra-molecular phosphorylation at the P+1 loop. The crystal structure of the phosphorylated Bub1 kinase domain illustrates a hitherto unknown conformation of the P+1 loop docked into the active site of the Bub1 kinase. Both Bub1 and BubR1 bind Bub3 constitutively. A hydrodynamic characterization of Bub1: Bub3 and BubR1: Bub3 demonstrates both complexes to have 1: 1 stoichiometry, with no additional oligomerization. Conversely, Bub1: Bub3 and BubR1: Bub3 combine to form a heterotetramer. Neither BubR1: Bub3 nor Knl1, the kinetochore receptor of Bub1: Bub3, modulate the kinase activity of Bub1 in vitro, suggesting autonomous regulation of the Bub1 kinase domain. We complement our study with an analysis of the Bub1 substrates. Our results contribute to the mechanistic characterization of a crucial cell cycle checkpoint.	[Breit, Claudia; Bange, Tanja; Petrovic, Arsen; Weir, John R.; Mueller, Franziska; Vogt, Doro; Musacchio, Andrea] Max Planck Inst Mol Physiol, Dept Mechanist Cell Biol, D-44227 Dortmund, Germany; [Musacchio, Andrea] Univ Duisburg Essen, Fac Biol, Ctr Med Biotechnol, D-45141 Essen, Germany	Max Planck Society; University of Duisburg Essen	Musacchio, A (corresponding author), Max Planck Inst Mol Physiol, Dept Mechanist Cell Biol, Otto Hahn Str 11, D-44227 Dortmund, Germany.	andrea.musacchio@mpi-dortmund.mpg.de	Weir, John R./AAF-5435-2020	Weir, John R./0000-0002-6904-0284; Muller, Franziska/0000-0002-4880-9269; Musacchio, Andrea/0000-0003-2362-8784; Petrovic, Arsen/0000-0003-4448-4230	European Research Council (ERC) Advanced Investigator Grant RECEPIANCE [669686]	European Research Council (ERC) Advanced Investigator Grant RECEPIANCE(European Research Council (ERC))	A.M. gratefully acknowledges funding by the European Research Council (ERC) Advanced Investigator Grant RECEPIANCE (proposal number no 669686).; We are grateful to Charlotte Smith and Marion Pesenti for providing the Borealin: Survivin complex as Bub1 substrate, Ivana Primorac for providing the MBP-Knl1 fragment, Stefano Maffini and the Dortmund Protein Facility for Mps1 kinase, Doro Vogt and Federica Basilico for the H3 and CENP-A nucleosome preparations, Sascha Gentz for help with peptide chemistry, and Alex Faesen for critical reading of the manuscript. We would like to thank Arthur Porfetye, David Bier, Andre Richters and Juliane John for collecting the crystallographic data as well as the SLS X10SA beam line staff for their outstanding support. A.M. gratefully acknowledges funding by the European Research Council (ERC) Advanced Investigator award RECEPIANCE (proposal number no 669686). The authors declare no competing financial interests.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Asghar A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9364; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bolanos-Garcia VM, 2011, STRUCTURE, V19, P1691, DOI 10.1016/j.str.2011.09.017; Bourhis E, 2009, BIOCHEMISTRY-US, V48, P6783, DOI 10.1021/bi900530v; Boyarchuk Y, 2007, J CELL BIOL, V176, P919, DOI 10.1083/jcb.200609044; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Chen RH, 2002, J CELL BIOL, V158, P487, DOI 10.1083/jcb.200204048; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Creixell P, 2015, CELL, V163, P187, DOI 10.1016/j.cell.2015.08.057; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernius J, 2007, PLOS GENET, V3, P2312, DOI 10.1371/journal.pgen.0030213; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Fraschini R, 2001, EMBO J, V20, P6648, DOI 10.1093/emboj/20.23.6648; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Guo YG, 2012, J CELL BIOL, V198, P205, DOI 10.1083/jcb.201202152; Haase J, 2012, CURR BIOL, V22, P471, DOI 10.1016/j.cub.2012.02.006; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; Harris L, 2005, EXP CELL RES, V308, P85, DOI 10.1016/j.yexcr.2005.03.036; Hashimoto Y, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-12; Huang HM, 2007, J CELL BIOL, V177, P413, DOI 10.1083/jcb.200701122; Huang HM, 2008, J CELL BIOL, V183, P667, DOI 10.1083/jcb.200805163; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kang JS, 2008, MOL CELL, V32, P394, DOI 10.1016/j.molcel.2008.09.017; KARASAKI Y, 1984, ARCH BIOCHEM BIOPHYS, V233, P796, DOI 10.1016/0003-9861(84)90508-3; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Klebig C, 2009, J CELL BIOL, V185, P841, DOI 10.1083/jcb.200902128; KNIGHTON DR, 1993, ACTA CRYSTALLOGR D, V49, P357, DOI 10.1107/S0907444993000502; Krenn V, 2014, CURR BIOL, V24, P29, DOI 10.1016/j.cub.2013.11.046; Krenn V, 2012, J CELL BIOL, V196, P451, DOI 10.1083/jcb.201110013; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lin ZH, 2014, STRUCTURE, V22, P1616, DOI 10.1016/j.str.2014.08.020; Liu H, 2015, MOL CELL, V59, P426, DOI 10.1016/j.molcel.2015.06.018; Liu H, 2013, CURR BIOL, V23, P1927, DOI 10.1016/j.cub.2013.07.078; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Logarinho E, 2008, MOL BIOL CELL, V19, P1798, DOI 10.1091/mbc.E07-07-0633; London N, 2014, NAT REV MOL CELL BIO, V15, P735, DOI 10.1038/nrm3888; London N, 2012, CURR BIOL, V22, P900, DOI 10.1016/j.cub.2012.03.052; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Mao YH, 2003, CELL, V114, P87, DOI 10.1016/S0092-8674(03)00475-6; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Meraldi P, 2005, EMBO J, V24, P1621, DOI 10.1038/sj.emboj.7600641; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Murphy JM, 2014, BIOCHEM J, V457, P369, DOI 10.1042/BJ20131270; Murphy JM, 2014, BIOCHEM J, V457, P323, DOI 10.1042/BJ20131174; Ni DQ, 2000, PROTEIN SCI, V9, P1818, DOI 10.1110/ps.9.9.1818; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Overlack K, 2015, ELIFE, V4, DOI 10.7554/eLife.05269; Perera D, 2010, J CELL SCI, V123, P653, DOI 10.1242/jcs.059501; Primorac I, 2013, ELIFE, V2, DOI 10.7554/eLife.01030; Qi W, 2007, J BIOL CHEM, V282, P3672, DOI 10.1074/jbc.M609376200; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ricke RM, 2012, J CELL BIOL, V199, P931, DOI 10.1083/jcb.201205115; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; ROBERTS BT, 1994, MOL CELL BIOL, V14, P8282, DOI 10.1128/MCB.14.12.8282; Seeley TW, 1999, BIOCHEM BIOPH RES CO, V257, P589, DOI 10.1006/bbrc.1999.0514; Sharp-Baker H, 2001, J CELL BIOL, V153, P1239, DOI 10.1083/jcb.153.6.1239; Shepperd LA, 2012, CURR BIOL, V22, P891, DOI 10.1016/j.cub.2012.03.051; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Suijkerbuijk SJE, 2012, DEV CELL, V22, P1321, DOI 10.1016/j.devcel.2012.03.009; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Taylor SS, 2001, J CELL SCI, V114, P4385; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Trowitzsch S, 2010, J STRUCT BIOL, V172, P45, DOI 10.1016/j.jsb.2010.02.010; van der Waal MS, 2012, EMBO REP, V13, P847, DOI 10.1038/embor.2012.93; Vleugel M, 2015, J CELL SCI, V128, P2975, DOI 10.1242/jcs.169821; Vleugel M, 2012, DEV CELL, V23, P239, DOI 10.1016/j.devcel.2012.06.013; Warren CD, 2002, MOL BIOL CELL, V13, P3029, DOI 10.1091/mbc.E02-04-0203; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yamagishi Y, 2012, NAT CELL BIOL, V14, P746, DOI 10.1038/ncb2515; Yamaguchi S, 2003, EMBO J, V22, P1075, DOI 10.1093/emboj/cdg100; Zhang G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8162; Zhang JY, 2007, J CELL BIOL, V178, P773, DOI 10.1083/jcb.200702138	86	13	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144673	10.1371/journal.pone.0144673	http://dx.doi.org/10.1371/journal.pone.0144673			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658523	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903500055
J	Gondos, AS; Al-Moyed, KA; Al-Robasi, ABA; Al-Shamahy, HA; Alyousefi, NA				Gondos, Adnan S.; Al-Moyed, Khaled A.; Al-Robasi, Abdul Baki A.; Al-Shamahy, Hassan A.; Alyousefi, Naelah A.			Urinary Tract Infection among Renal Transplant Recipients in Yemen	PLOS ONE			English	Article							ASYMPTOMATIC BACTERIURIA; KIDNEY-TRANSPLANTATION; GRAFT FUNCTION; UNITED-STATES; COMPLICATIONS; PREVALENCE	Urinary tract infection (UTI) is the most common complication following kidney transplantation (KT), which could result in losing the graft. This study aims to identify the prevalence of bacterial UTI among KT recipients in Yemen and to determine the predisposing factors associated with post renal transplantation UTI. A cross sectional study included of 150 patients, who underwent KT was conducted between June 2010 and January 2011. A Morning mid-stream urine specimen was collected for culture and antibiotic susceptibility test from each recipient. Bacterial UTI was found in 50 patients (33.3%). The prevalence among females 40.3% was higher than males 29%. The UTI was higher in the age group between 41-50 years with a percentage of 28% and this result was statistically significant. Predisposing factors as diabetes mellitus, vesicoureteral reflux, neurogenic bladder and polycystic kidney showed significant association. High relative risks were found for polycystic kidney = 13.5 and neurogenic bladder = 13.5. The most prevalent bacteria to cause UTI was Escherichia coli represent 44%, followed by Staphylococcus saprophyticus 34%. Amikacin was the most effective antibiotic against gram-negative isolates while Ciprofloxacin was the most effective antibiotic against Staphylococcus saprophyticus. In conclusion, there is high prevalence of bacterial UTI among KT recipients in Yemen. Diabetes mellitus, vesicoureteral reflux, neurogenic bladder, polycystic kidney and calculi were the main predisposing factors.	[Gondos, Adnan S.; Al-Moyed, Khaled A.; Al-Robasi, Abdul Baki A.; Al-Shamahy, Hassan A.] Sanaa Univ, Fac Med & Hlth Sci, Dept Med Microbiol, Sanaa, Yemen; [Alyousefi, Naelah A.] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Alyousefi, NA (corresponding author), Univ Malaya, Fac Med, Dept Med, Kuala Lumpur 50603, Malaysia.	naelaalyousfi@gmail.com	Al-Shamahy, Hassan Abdulwahab/AAZ-5266-2021; Alyousefi, Naelah/D-2006-2010	Al-Shamahy, Hassan Abdulwahab/0000-0001-6958-7012; Alyousefi, Naelah/0000-0001-8871-1824	University of Malaya [GC002A-14HTM]	University of Malaya(Universiti Malaya)	This project was supported by University of Malaya grant number GC002A-14HTM but this financial support had no interference on the manuscript content.	Abbott KC, 2004, AM J KIDNEY DIS, V44, P353, DOI 10.1053/j.ajkd.2004.04.040; Al-Awadi MAA, 2005, THESIS; Al-Rohani M, 2000, Saudi J Kidney Dis Transpl, V11, P82; Al-Rohani Muhamed, 2003, Saudi J Kidney Dis Transpl, V14, P80; Alangaden GJ, 2006, CLIN TRANSPLANT, V20, P401, DOI 10.1111/j.1399-0012.2006.00519.x; Alkatheri AM, 2013, AGE, V30, P3; Alkhyat S. H., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P876; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Camargo L, 2014, TRANSPLANTATION P; Charfeddine K, 2005, TRANSPLANTATION P; Chuang P, 2005, CLIN TRANSPLANT, V19, P230, DOI 10.1111/j.1399-0012.2005.00327.x; de Souza RM, 2008, NAT CLIN PRACT NEPHR, V4, P252, DOI 10.1038/ncpneph0781; Elkehili I., 2010, AJNT, V3, P53; Ersoy A, 2015, NEPHROLOGY DIALYS S3, V30; Golebiewska J, 2011, TRANSPLANTATION P; Iqbal T, 2010, J PAK MED ASSOC, V60, P826; John U, 2006, NEPHROL DIAL TRANSPL, V21, P3269, DOI 10.1093/ndt/gfl464; Khanna P, 2010, SAUDI J KIDNEY DIS T, V21, P876; Khosroshahi H, 2006, TRANSPLANTATION P; Maraha B, 2001, CLIN MICROBIOL INFEC, V7, P619, DOI 10.1046/j.1198-743x.2001.00329.x; Munoz P, 2001, CLIN INFECT DIS, V33, pS53, DOI 10.1086/320905; Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507; Nicolle LE, 2003, INFECT DIS CLIN N AM, V17, P367, DOI 10.1016/S0891-5520(03)00008-4; Oguz Y, 2002, Cent Eur J Public Health, V10, P153; Pelle G, 2007, AM J TRANSPLANT, V7, P899, DOI 10.1111/j.1600-6143.2006.01700.x; Procopio F, 2014, TRANSPLANTATION P; Rivera-Sanchez R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-245; Said R, 1998, Saudi J Kidney Dis Transpl, V9, P301; Samhan M, 2005, TRANSPLANTATION P; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Schmaldienst Sabine, 2002, Curr Opin Urol, V12, P125, DOI 10.1097/00042307-200203000-00007; Senger S., 2007, TRANSPLANTATION P; Shaheen F A, 1995, Saudi J Kidney Dis Transpl, V6, P41; Sheiban A, 1999, Saudi J Kidney Dis Transpl, V10, P183; Shirazi M, 2005, IRAN J PUBLIC HEALTH, V34, P62; Singh R, 2015, CURR OPIN INFECT DIS, V28, P112, DOI 10.1097/QCO.0000000000000120; Sorto R, 2010, TRANSPLANTATION P; Valera B., 2006, TRANSPLANTATION P; Veroux M, 2008, TRANSPLANTATION P	39	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144266	10.1371/journal.pone.0144266	http://dx.doi.org/10.1371/journal.pone.0144266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657128	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903500018
J	Wang, SAH; Zhang, ZB; Liu, ML; Li, SQ; Jiang, CQ				Wang, Shuanhu; Zhang, Zongbing; Liu, Mulin; Li, Shiqing; Jiang, Congqiao			Endoscopic Resection Compared with Gastrectomy to Treat Early Gastric Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							LYMPH-NODE-METASTASIS; LONG-TERM OUTCOMES; SUBMUCOSAL DISSECTION; PREDICTIVE FACTORS; EMR; SURVIVAL; COMPLICATIONS; FREQUENCY; EFFICACY; SURGERY	Background Endoscopic resection and gastrectomy are treatment modalities for early gastric cancer, but their relative benefits and risks are unclear. We conducted a systematic review and meta-analysis to compare endoscopic resection and gastrectomy for treating early gastric cancer. Methods We searched PubMed, Embase, and the Cochrane Library until April 2015 for studies comparing endoscopic resection with gastrectomy for treatment of early gastric cancer. Outcome measures were five-year overall survival (OS), length of hospital stay and postoperative morbidity. We calculated pooled hazard ratio (HR), weighted mean difference (WMD) and odds ratio (OR) using random effects models. Results Six studies comprising 1,466 patients (618 endoscopic resection and 848 gastrectomy) met inclusion criteria. Five-year OS was similar between endoscopic resection and gastrectomy (HR, 1.06; 95%CI: 0.61 to 1.83). Endoscopic resection was associated with shorter hospital stays (WMD, -6.94; 95%CI: -7.59 to -6.29) and reduced overall postoperative morbidity (OR, 0.36; 95%CI: 0.17 to 0.74). Conclusions While five-year OS is similar between endoscopic resection and gastrectomy, endoscopic resection offers a shorter hospital stay and fewer complications than gastrectomy for treating early gastric cancer. Endoscopic resection is a reasonable treatment for early gastric cancer with a negligible risk of lymph node metastasis.	[Wang, Shuanhu; Zhang, Zongbing; Liu, Mulin; Li, Shiqing; Jiang, Congqiao] Bengbu Med Coll, Affiliated Hosp 1, Dept Gastrointestinal Surg, Bengbu, Anhui, Peoples R China	Bengbu Medical College	Wang, SAH (corresponding author), Bengbu Med Coll, Affiliated Hosp 1, Dept Gastrointestinal Surg, Bengbu, Anhui, Peoples R China.	knight01030103@126.com	Wang, Shuanhu/AAV-4931-2020					An JY, 2007, ANN SURG, V246, P749, DOI 10.1097/SLA.0b013e31811f3fb7; Bennett C, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004276.pub3; Bok GH, 2012, GASTROENTEROLOGICAL, V54, P1110; Chiu PWY, 2012, SURG ENDOSC, V26, P3584, DOI 10.1007/s00464-012-2371-8; Chiu PW, 2011, GASTROINTEST ENDOSC, V73, pAB234; Cho JH, 2012, J GASTROEN HEPATOL, V27, P425; Choi IJ, 2015, GASTROINTEST ENDOSC, V81, P333, DOI 10.1016/j.gie.2014.07.047; Choi KS, 2011, GASTROINTEST ENDOSC, V73, P942, DOI 10.1016/j.gie.2010.12.032; Chung IK, 2009, GASTROINTEST ENDOSC, V69, P1228, DOI 10.1016/j.gie.2008.09.027; Etoh T, 2005, GASTROINTEST ENDOSC, V62, P868, DOI 10.1016/j.gie.2005.09.012; Fang WL, 2015, PATHOL ONCOL RES, V21, P941, DOI 10.1007/s12253-015-9920-0; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gotoda Takuji, 2000, Gastric Cancer, V3, P219, DOI 10.1007/PL00011720; HAMANAKA H, 2005, DIGEST ENDOSC, V17, P275; Holscher AH, 2009, ANN SURG, V250, P791, DOI 10.1097/SLA.0b013e3181bdd3e4; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Jang JS, 2009, SCAND J GASTROENTERO, V44, P1315, DOI 10.3109/00365520903254304; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Kim DY, 2014, GUT LIVER, V8, P519, DOI 10.5009/gnl13061; Kim HS, 2000, YONSEI MED J, V41, P577, DOI 10.3349/ymj.2000.41.5.577; Kim Sang Gyun, 2009, Korean J Gastroenterol, V54, P77; Kim YI, 2015, ENDOSCOPY, V47, P293, DOI 10.1055/s-0034-1391284; Kosaka T, 2014, DIGEST ENDOSC, V26, P183, DOI 10.1111/den.12099; Lee SR, 2014, SURG LAPARO ENDO PER, V24, P277, DOI 10.1097/SLE.0b013e3182901290; Lian JJ, 2012, GASTROINTEST ENDOSC, V76, P763, DOI 10.1016/j.gie.2012.06.014; Lo CKL, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-45; Memon MA, 2008, SURG ENDOSC, V22, P1781, DOI 10.1007/s00464-008-9925-9; Memon MA, 2011, ANN SURG, V253, P900, DOI 10.1097/SLA.0b013e318212bff6; Milhomem LM, 2012, ABCD-ARQ BRAS CIR DI, V25, P235, DOI 10.1590/S0102-67202012000400005; Murakami T, 1979, World J Surg, V3, P685; Najmeh S, 2014, GASTROENTEROLOGY, V146, pS1096; Nam MJ, 2010, J GASTRIC CANCER, V10, P162, DOI 10.5230/jgc.2010.10.4.162; Neuhaus H, 2009, DIGEST ENDOSC, V21, pS4, DOI 10.1111/j.1443-1661.2009.00864.x; Oda I, 2013, DIGEST ENDOSC, V25, P71, DOI 10.1111/j.1443-1661.2012.01376.x; Oka S, 2006, GASTROINTEST ENDOSC, V64, P877, DOI 10.1016/j.gie.2006.03.932; Ortiz J, 2015, ANN GASTROENTEROL, V28, P1; Palma Perez Silvia, 2006, Gac Sanit, V20 Suppl 3, P10; Park S. H., 2014, IMMUNE NETW, V14, P14, DOI [10.4110/in.2014.14.1.14, DOI 10.4110/in.2014.14.1.14, DOI 10.4110/IN.2014.14.1.14]; Saito I, 2014, CLIN ENDOSC, V47, P398, DOI 10.5946/ce.2014.47.5.398; Sedgwick P, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4028; SHIMIZU S, 1995, ENDOSCOPY, V27, P27, DOI 10.1055/s-2007-1005628; Sim EH, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.3_suppl.120; Sung CM, 2010, WORLD J GASTROENTERO, V16, P5252, DOI 10.3748/wjg.v16.i41.5252; Suzuki H, 2016, GASTRIC CANCER, V19, P198, DOI 10.1007/s10120-015-0469-0; Tanaka N, 2010, GASTRIC CANCER, V13, P74, DOI 10.1007/s10120-009-0536-5; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Uedo Noriya, 2006, Gastric Cancer, V9, P88, DOI 10.1007/s10120-005-0357-0; Wang Z, 2014, ASIAN PAC J CANCER P, V15, P7219, DOI 10.7314/APJCP.2014.15.17.7219; Yokota T, 2004, SCAND J GASTROENTERO, V39, P380, DOI 10.1080/00365520310008629; Zhang HY, 2014, WORLD CHINESE J DIGE, V22, P5330; Zheng ZX, 2014, CHINESE J CANCER RES, V26, P192, DOI 10.3978/j.issn.1000-9604.2014.04.06	51	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144774	10.1371/journal.pone.0144774	http://dx.doi.org/10.1371/journal.pone.0144774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658344	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903500061
J	Friedmann, MP; Torbeev, V; Zelenay, V; Sobol, A; Greenwald, J; Riek, R				Friedmann, Michael P.; Torbeev, Vladimir; Zelenay, Viviane; Sobol, Alexander; Greenwald, Jason; Riek, Roland			Towards Prebiotic Catalytic Amyloids Using High Throughput Screening	PLOS ONE			English	Article							AMINO-ACIDS; PEPTIDES; FIBRILS; LIFE; STABILITY; ORIGIN; PROTEINS; POLYPEPTIDES; CONFORMATION; HYDROLYSIS	Enzymes are capable of directing complex stereospecific transformations and of accelerating reaction rates many orders of magnitude. As even the simplest known enzymes comprise thousands of atoms, the question arises as to how such exquisite catalysts evolved. A logical predecessor would be shorter peptides, but they lack the defined structure and size that are apparently necessary for enzyme functions. However, some very short peptides are able to assemble into amyloids, thereby forming a well-defined tertiary structure called the cross-a-sheet, which bestows unique properties upon the peptides. We have hypothesized that amyloids could have been the catalytically active precursor to modern enzymes. To test this hypothesis, we designed an amyloid peptide library that could be screened for catalytic activity. Our approach, amenable to high-throughput methodologies, allowed us to find several peptides and peptide mixtures that form amyloids with esterase activity. These results indicate that amyloids, with their stability in a wide range of conditions and their potential as catalysts with low sequence specificity, would indeed be fitting precursors to modern enzymes. Furthermore, our approach can be efficiently expanded upon in library size, screening conditions, and target activity to yield novel amyloid catalysts with potential applications in aqueous-organic mixtures, at high temperature and in other extreme conditions that could be advantageous for industrial applications.	[Friedmann, Michael P.; Zelenay, Viviane; Sobol, Alexander; Greenwald, Jason; Riek, Roland] Swiss Fed Inst Technol, Dept Chem, Phys Chem Lab, Zurich, Switzerland; [Torbeev, Vladimir] Swiss Fed Inst Technol, Dept Chem, Organ Chem Lab, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Greenwald, J (corresponding author), Swiss Fed Inst Technol, Dept Chem, Phys Chem Lab, Zurich, Switzerland.	jason.greenwald@phys.chem.ethz.ch; roland.riek@phys.chem.ethz.ch	Torbeev, Vladimir/M-8813-2015	Torbeev, Vladimir/0000-0002-7865-1044				Altermann W, 2003, RES MICROBIOL, V154, P611, DOI 10.1016/j.resmic.2003.08.006; BARBIER B, 1992, J AM CHEM SOC, V114, P3511, DOI 10.1021/ja00035a053; Bourbo V, 2011, ORIGINS LIFE EVOL B, V41, P563, DOI 10.1007/s11084-011-9257-y; BRACK A, 1978, INT J PEPT PROT RES, V11, P128; BRACK A, 1975, NATURE, V256, P383, DOI 10.1038/256383a0; Carny O, 2005, FASEB J, V19, P1051, DOI 10.1096/fj.04-3256hyp; Greenwald J, 2012, J MOL BIOL, V421, P417, DOI 10.1016/j.jmb.2012.04.015; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Higgs PG, 2015, NAT REV GENET, V16, P7, DOI 10.1038/nrg3841; Higgs PG, 2009, ASTROBIOLOGY, V9, P483, DOI 10.1089/ast.2008.0280; Huber C, 1998, SCIENCE, V281, P670, DOI 10.1126/science.281.5377.670; Huber C, 2003, SCIENCE, V301, P938; Ikehara K, 2005, CHEM REC, V5, P107, DOI 10.1002/tcr.20037; KIRSCH JF, 1964, J AM CHEM SOC, V86, P833, DOI 10.1021/ja01059a018; Kuipers BJH, 2007, J AGR FOOD CHEM, V55, P5445, DOI 10.1021/jf070337l; LAM KS, 1991, NATURE, V354, P82, DOI 10.1038/354082a0; Leman L, 2004, SCIENCE, V306, P283, DOI 10.1126/science.1102722; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Maury CPJ, 2009, ORIGINS LIFE EVOL B, V39, P141, DOI 10.1007/s11084-009-9165-6; Meersman F, 2006, BBA-PROTEINS PROTEOM, V1764, P452, DOI 10.1016/j.bbapap.2005.10.021; Mesquida P, 2007, J MATER SCI-MATER M, V18, P1325, DOI 10.1007/s10856-006-0075-0; PerezPaya E, 1996, J MOL RECOGNIT, V9, P488, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<488::AID-JMR289>3.0.CO;2-F; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Rode BM, 1999, PEPTIDES, V20, P773, DOI 10.1016/S0196-9781(99)00062-5; Rufo CM, 2014, NAT CHEM, V6, P303, DOI [10.1038/NCHEM.1894, 10.1038/nchem.1894]; SAFAR J, 1993, PROTEIN SCI, V2, P2206, DOI 10.1002/pro.5560021220; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; SCHWENDINGER MG, 1992, ORIGINS LIFE EVOL B, V22, P349, DOI 10.1007/BF01809371; Shammas SL, 2011, BIOPHYS J, V100, P2783, DOI 10.1016/j.bpj.2011.04.039; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Stathopoulos P, 2006, J PEPT SCI, V12, P227, DOI 10.1002/psc.706; Takahashi Y, 2004, BIOORGAN MED CHEM, V12, P693, DOI 10.1016/j.bmc.2003.11.022; Takahashi Y, 2002, CHEMBIOCHEM, V3, P637, DOI 10.1002/1439-7633(20020703)3:7<637::AID-CBIC637>3.0.CO;2-9; Trifonov EN, 2000, GENE, V261, P139, DOI 10.1016/S0378-1119(00)00476-5; West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211	35	47	46	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143948	10.1371/journal.pone.0143948	http://dx.doi.org/10.1371/journal.pone.0143948			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650386	gold, Green Submitted, Green Published			2022-12-27	WOS:000366903300032
J	Shi, CC; Yan, W; Wang, G; Wang, F; Li, QY; Lin, NM				Shi, Changcheng; Yan, Wei; Wang, Gang; Wang, Fei; Li, Qingyu; Lin, Nengming			Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							REDUCTASE COMPLEX SUBUNIT-1; CYP2C9 GENOTYPE; PILOT TRIAL; ANTICOAGULATION; INITIATION; ALGORITHM; STANDARD; VKORC1; IMPACT; MANAGEMENT	Background Recently, using the patient's genotype to guide warfarin dosing has gained interest; however, whether pharmacogenetics-based dosing (PD) improves clinical outcomes compared to conventional dosing (CD) remains unclear. Thus, we performed a meta-analysis to evaluate these two strategies. Methods The PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), Chinese VIP and ChineseWan-fang databases were searched. The Cochrane Collaboration's tool was used to assess the risk of bias in randomized controlled trials (RCTs). The primary outcome was time within the therapeutic range (TTR); the secondary end points were the time to maintenance dose and time to first therapeutic international normalized ratio (INR), an INR greater than 4, adverse events, major bleeding, thromboembolism and death from any cause. Results A total of 11 trials involving 2,678 patients were included in our meta-analysis. The results showed that PD did not improve the TTR compared to CD, although PD significantly shortened the time to maintenance dose (MD = -8.80; 95% CI: -11.99 to -5.60; P<0.00001) and the time to first therapeutic INR (MD = -2.80; 95% CI: -3.45 to -2.15; P<0.00001). Additionally, PD significantly reduced the risk of adverse events (RR = 0.86; 95% CI: 0.75 to 0.99; P = 0.03) and major bleeding (RR = 0.36; 95% CI: 0.15 to 0.89, P = 0.03), although it did not reduce the percentage of INR greater than 4, the risk of thromboembolic events and death from any cause. Subgroup analysis showed that PD resulted in a better improvement in the endpoints of TTR and over-anticoagulation at a fixed initial dosage rather than a non-fixed initial dosage. Conclusions The use of genotype testing in the management of warfarin anticoagulation was associated with significant improvements in INR-related and clinical outcomes. Thus, genotype-based regimens can be considered a reliable and accurate method to determine warfarin dosing and may be preferred over fixed-dose regimens.	[Shi, Changcheng; Yan, Wei; Wang, Gang; Wang, Fei; Li, Qingyu; Lin, Nengming] Hangzhou First Peoples Hosp, Dept Clin Pharm, Hangzhou, Zhejiang, Peoples R China; [Shi, Changcheng; Wang, Fei; Lin, Nengming] Hangzhou Translat Med Res Ctr, Dept Clin Pharmacol, Hangzhou, Zhejiang, Peoples R China; [Lin, Nengming] Nanjing Med Univ, Affiliated Hangzhou Hosp, Hangzhou, Zhejiang, Peoples R China; [Lin, Nengming] Zhejiang Chinese Med Univ, Affiliated Hangzhou Hosp 1, Hangzhou, Zhejiang, Peoples R China	Nanjing Medical University; Zhejiang Chinese Medical University	Lin, NM (corresponding author), Hangzhou First Peoples Hosp, Dept Clin Pharm, Hangzhou, Zhejiang, Peoples R China.	lnm1013@163.com		Shi, Changcheng/0000-0003-1616-3958	Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents [2010-190-4]	Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	The authors gratefully acknowledge financial support from Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents (2010-190-4, Nengming Lin). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageno W, 2000, THROMB HAEMOSTASIS, V83, P849; Ageno W, 2012, CHEST, V141, pE44S, DOI 10.1378/chest.11-2292; Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Aquilante CL, 2006, CLIN PHARMACOL THER, V79, P291, DOI 10.1016/j.clpt.2005.11.011; Avery PJ, 2011, CLIN PHARMACOL THER, V90, P701, DOI 10.1038/clpt.2011.186; Borgman MP, 2012, THROMB HAEMOSTASIS, V108, P561, DOI 10.1160/TH12-03-0159; Burmester JK, 2011, GENET MED, V13, P509, DOI 10.1097/GIM.0b013e31820ad77d; Burns M, 1999, J THROMB THROMBOLYS, V7, P137, DOI 10.1023/A:1008829403320; Caraco Y, 2008, CLIN PHARMACOL THER, V83, P460, DOI 10.1038/sj.clpt.6100316; Carlquist JF, 2006, J THROMB THROMBOLYS, V22, P191, DOI 10.1007/s11239-006-9030-7; Donohue MM, 2011, CURR NEUROL NEUROSCI, V11, P52, DOI 10.1007/s11910-010-0157-8; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Franchini M, 2014, J THROMB HAEMOST, V12, P1480, DOI 10.1111/jth.12647; Furie B, 2013, NEW ENGL J MED, V369, P2345, DOI 10.1056/NEJMe1313682; Gage BF, 2008, CLIN PHARMACOL THER, V84, P326, DOI 10.1038/clpt.2008.10; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hillman MA, 2004, PHARMACOGENETICS, V14, P539, DOI 10.1097/01.fpc.0000114760.08559.dc; Hillman MA, 2005, CLIN MED RES, V3, P137, DOI 10.3121/cmr.3.3.137; Hirsh J, 2001, CHEST, V119, p8S, DOI 10.1378/chest.119.1_suppl.8S; Holbrook AM, 2005, ARCH INTERN MED, V165, P1095, DOI 10.1001/archinte.165.10.1095; Holbrook A, 2012, CHEST, V141, pE152S, DOI 10.1378/chest.11-2295; Huang SW, 2009, PHARMACOGENET GENOM, V19, P226, DOI 10.1097/FPC.0b013e328326e0c7; Hylek Elaine M, 2003, Semin Vasc Med, V3, P271; Jonas DE, 2013, PHARMACOGENOMICS, V14, P1593, DOI 10.2217/pgs.13.145; Kangelaris KN, 2009, J GEN INTERN MED, V24, P656, DOI 10.1007/s11606-009-0949-1; Kimmel SE, 2013, NEW ENGL J MED, V369, P2283, DOI 10.1056/NEJMoa1310669; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Kovacs MJ, 2003, ANN INTERN MED, V138, P714, DOI 10.7326/0003-4819-138-9-200305060-00007; Lenzini P, 2010, CLIN PHARMACOL THER, V87, P572, DOI 10.1038/clpt.2010.13; Lenzini PA, 2008, J THROMB HAEMOST, V6, P1655, DOI 10.1111/j.1538-7836.2008.03095.x; Li Jie, 2013, Zhonghua Jie He He Hu Xi Za Zhi, V36, P950; Li XQ, 2015, THROMB RES, V135, P621, DOI 10.1016/j.thromres.2015.01.018; Linder MW, 2009, CLIN CHEM, V55, P1861, DOI 10.1373/clinchem.2009.125898; McMillin GA, 2010, THER DRUG MONIT, V32, P338, DOI 10.1097/FTD.0b013e3181d925bb; Meckley LM, 2010, HEALTH POLICY, V94, P91, DOI 10.1016/j.healthpol.2009.09.006; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Pirmohamed M, 2006, BRIT J CLIN PHARMACO, V62, P509, DOI 10.1111/j.1365-2125.2006.02806.x; Pirmohamed M, 2013, NEW ENGL J MED, V369, P2294, DOI 10.1056/NEJMoa1311386; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Sconce EA, 2005, BLOOD, V106, P2329, DOI 10.1182/blood-2005-03-1108; Stergiopoulos K, 2014, JAMA INTERN MED, V174, P1330, DOI 10.1001/jamainternmed.2014.2368; Tang QH, 2014, INT J CARDIOL, V175, P587, DOI 10.1016/j.ijcard.2014.06.031; Voora D, 2005, THROMB HAEMOSTASIS, V93, P700, DOI 10.1160/TH04-08-0542; Wadelius M, 2007, PHARMACOGENOMICS J, V7, P99, DOI 10.1038/sj.tpj.6500417; Wadelius M, 2007, HUM GENET, V121, P23, DOI 10.1007/s00439-006-0260-8; Wang MS, 2012, INT J MED SCI, V9, P472, DOI 10.7150/ijms.4637	48	38	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144511	10.1371/journal.pone.0144511	http://dx.doi.org/10.1371/journal.pone.0144511			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672604	Green Published, gold, Green Submitted			2022-12-27	WOS:000366722700042
J	Ostrow, KL; Donaldson, K; Blakeley, J; Belzberg, A; Hoke, A				Ostrow, Kimberly Laskie; Donaldson, Katelyn; Blakeley, Jaishri; Belzberg, Allan; Hoke, Ahmet			Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients	PLOS ONE			English	Article							FAMILIAL SCHWANNOMATOSIS; GENE; INI1/SMARCB1; EXPRESSION; HEREGULIN; FORSKOLIN	Schwannomatosis, a rare form of neurofibromatosis, is characterized predominantly by multiple, often painful, schwannomas throughout the peripheral nervous system. The current standard of care for schwannomatosis is surgical resection. A major obstacle to schwannomatosis research is the lack of robust tumor cell lines. There is a great need for mechanistic and drug discovery studies of schwannomatosis, yet appropriate tools are not currently available. Schwannomatosis tumors are difficult to grow in culture as they survive only a few passages before senescence. Our lab has extensive experience in establishing primary and immortalized human Schwann cell cultures from normal tissue that retain their phenotypes after immortalization. Therefore we took on the challenge of creating immortalized human Schwann cell lines derived from tumors from schwannomatosis patients. We have established and fully characterized 2 schwannomatosis cell lines from 2 separate patients using SV40 virus large T antigen. One patient reported pain and the other did not. The schwannomatosis cell lines were stained with S100B antibodies to confirm Schwann cell identity. The schwannomatosis cells also expressed the Schwann cell markers, p75NTR, S100B, and NGF after multiple passages. Cell morphology was retained following multiple passaging and freeze/thaw cycles. Gene expression microarray analysis was used to compare the cell lines with their respective parent tumors. No differences in key genes were detected, with the exception that several cell cycle regulators were upregulated in the schwannomatosis cell lines when compared to their parent tumors. This upregulation was apparently a product of cell culturing, as the schwannomatosis cells exhibited the same expression pattern of cell cycle regulatory genes as normal primary human Schwann cells. Cell growth was also similar between normal primary and immortalized tumor cells in culture. Accurate cell lines derived directly from human tumors will serve as invaluable tools for advancing schwannomatosis research, including drug screening.	[Ostrow, Kimberly Laskie; Donaldson, Katelyn; Blakeley, Jaishri; Hoke, Ahmet] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Blakeley, Jaishri] Johns Hopkins Sch Med, Deparment Oncol, Baltimore, MD 21205 USA; [Blakeley, Jaishri; Belzberg, Allan] Johns Hopkins Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Hoke, Ahmet] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Ostrow, KL (corresponding author), Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	Kostrow3@jhmi.edu			Johns Hopkins Neurosurgery Pain Research Institute; Ohrstrom Foundation; Dr. Miriam and Sheldon Adelson Medical Foundation	Johns Hopkins Neurosurgery Pain Research Institute; Ohrstrom Foundation; Dr. Miriam and Sheldon Adelson Medical Foundation	Funded by The Johns Hopkins Neurosurgery Pain Research Institute (KLO AB), The Ohrstrom Foundation (KLO AB), and The Dr. Miriam and Sheldon Adelson Medical Foundation (AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the by Dr. Miriam and Sheldon Adelson Medical Foundation, Ohrstrom Foundation and The Johns Hopkins Neurosurgery Pain Research Institute. Technical assistance was provided by Adrian Bumbut.	Hulsebos TJM, 2007, AM J HUM GENET, V80, P805, DOI 10.1086/513207; Jacoby LB, 1997, AM J HUM GENET, V61, P1293, DOI 10.1086/301633; Kaufman DL, 2003, ARCH NEUROL-CHICAGO, V60, P1317, DOI 10.1001/archneur.60.9.1317; Lehmann HC, 2012, STEM CELLS DEV, V21, P423, DOI 10.1089/scd.2010.0513; MacCollin M, 2005, NEUROLOGY, V64, P1838, DOI 10.1212/01.WNL.0000163982.78900.AD; MacCollin M, 2003, NEUROLOGY, V60, P1968, DOI 10.1212/01.WNL.0000070184.08740.E0; May T, 2004, NUCLEIC ACIDS RES, V32, P5529, DOI 10.1093/nar/gkh887; Muir D, 2001, AM J PATHOL, V158, P501, DOI 10.1016/S0002-9440(10)63992-2; Patil S, 2008, BRAIN PATHOL, V18, P517, DOI 10.1111/j.1750-3639.2008.00155.x; Piotrowski A, 2014, NAT GENET, V46, P182, DOI 10.1038/ng.2855; Rahmatullah M, 1998, MOL CELL BIOL, V18, P6245, DOI 10.1128/MCB.18.11.6245; Schularick NM, 2014, JOVE-J VIS EXP, DOI 10.3791/51093; Schworer CM, 2003, J NEUROSCI RES, V73, P456, DOI 10.1002/jnr.10679	13	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144620	10.1371/journal.pone.0144620	http://dx.doi.org/10.1371/journal.pone.0144620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657314	Green Submitted, gold, Green Published			2022-12-27	WOS:000366715900073
J	Polotsky, VY; Bevans-Fonti, S; Grigoryev, DN; Punjabi, NM				Polotsky, Vsevolod Y.; Bevans-Fonti, Shannon; Grigoryev, Dmitry N.; Punjabi, Naresh M.			Intermittent Hypoxia Alters Gene Expression in Peripheral Blood Mononuclear Cells of Healthy Volunteers	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; FACTOR-KAPPA-B; EARLY SIGNS; ATHEROSCLEROSIS; INTERLEUKIN-8; CHEMOKINES; RECEPTORS; MORTALITY; OBESITY	Obstructive sleep apnea is associated with high cardiovascular morbidity and mortality. Intermittent hypoxia of obstructive sleep apnea is implicated in the development and progression of insulin resistance and atherosclerosis, which have been attributed to systemic inflammation. Intermittent hypoxia leads to pro-inflammatory gene up-regulation in cell culture, but the effects of intermittent hypoxia on gene expression in humans have not been elucidated. A cross-over study was performed exposing eight healthy men to intermittent hypoxia or control conditions for five hours with peripheral blood mononuclear cell isolation before and after exposures. Total RNA was isolated followed by gene microarrays and confirmatory real time reverse transcriptase PCR. Intermittent hypoxia led to greater than two fold up-regulation of the pro-inflammatory gene toll receptor 2 (TLR2), which was not increased in the control exposure. We hypothesize that up-regulation of TLR2 by intermittent hypoxia may lead to systemic inflammation, insulin resistance and atherosclerosis in patients with obstructive sleep apnea.	[Polotsky, Vsevolod Y.; Bevans-Fonti, Shannon; Punjabi, Naresh M.] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA; [Grigoryev, Dmitry N.] Johns Hopkins Univ, Sch Med, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD 21205 USA; [Punjabi, Naresh M.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Polotsky, VY (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA.	vpolots1@jhmi.edu	Punjabi, Naresh/EMH-1007-2022		National Institutes of Health [HL075078, HL080105]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080105, R01HL075078] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work has been supported by the National Institutes of Health grants HL075078 and HL080105.	[Anonymous], 1998, CLIN GUID ID EV TREA; Apostolakis S, 2009, CARDIOVASC RES, V84, P353, DOI 10.1093/cvr/cvp241; Arnardottir ES, 2009, SLEEP, V32, P447, DOI 10.1093/sleep/32.4.447; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Bijani FM, 2012, INT REV IMMUNOL, V31, P379, DOI 10.3109/08830185.2012.706761; Caricilli AM, 2008, J ENDOCRINOL, V199, P399, DOI 10.1677/JOE-08-0354; Davis JE, 2009, HORM METAB RES; Drager LF, 2005, AM J RESP CRIT CARE, V172, P613, DOI 10.1164/rccm.200503-340OC; Drager LF, 2007, AM J RESP CRIT CARE, V176, P706, DOI 10.1164/rccm.200703-500OC; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Erridge C, 2011, ATHEROSCLEROSIS, V216, P1, DOI 10.1016/j.atherosclerosis.2011.02.043; Fan CH, 2005, PHYSIOL GENOMICS, V22, P292, DOI 10.1152/physiolgenomics.00217.2004; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; GASTAUT H., 1966, BRAIN RES, V1, P167, DOI 10.1016/0006-8993(66)90117-X; Greenberg H, 2006, BIOCHEM BIOPH RES CO, V343, P591, DOI 10.1016/j.bbrc.2006.03.015; Grigoryev DN, 2008, TRANSL RES, V151, P197, DOI 10.1016/j.trsl.2007.12.010; HILL DB, 1993, HEPATOLOGY, V18, P576, DOI 10.1016/0270-9139(93)90358-T; Hoffmann MS, 2007, ANTIOXID REDOX SIGN, V9, P661, DOI 10.1089/ars.2007.1589; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Khalyfa A, 2009, SLEEP MED, V10, P75, DOI 10.1016/j.sleep.2007.11.006; Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364; Li JG, 2005, J APPL PHYSIOL, V99, P1643, DOI 10.1152/japplphysiol.00522.2005; Louis M, 2009, J APPL PHYSIOL, V106, P1538, DOI 10.1152/japplphysiol.91523.2008; Madan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003204; Marshall NS, 2008, SLEEP, V31, P1079; Minoguchi K, 2005, AM J RESP CRIT CARE, V172, P625, DOI 10.1164/rccm.200412-1652OC; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Polotsky VY, 2010, PHYSIOL GENOMICS, V41, P306, DOI 10.1152/physiolgenomics.00091.2009; Poulain L, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/620258; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Rahman SA, 2015, BRAIN BEHAV IMMUN, V47, P4, DOI 10.1016/j.bbi.2014.11.003; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; Ryan S, 2007, BIOCHEM BIOPH RES CO, V355, P728, DOI 10.1016/j.bbrc.2007.02.015; Ryan S, 2006, AM J RESP CRIT CARE, V174, P824, DOI 10.1164/rccm.200601-066OC; Savransky V, 2008, CIRC RES, V103, P1173, DOI 10.1161/CIRCRESAHA.108.178533; Savransky V, 2007, AM J PHYSIOL-GASTR L, V293, pG871, DOI 10.1152/ajpgi.00145.2007; Savransky V, 2007, AM J RESP CRIT CARE, V175, P1290, DOI 10.1164/rccm.200612-1771OC; Savransky V, 2007, HEPATOLOGY, V45, P1007, DOI 10.1002/hep.21593; Schober A, 2008, ARTERIOSCL THROM VAS, V28, P1950, DOI 10.1161/ATVBAHA.107.161224; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P4409, DOI 10.1210/jc.2003-031929; Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151; Young T, 2008, SLEEP, V31, P1071	43	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144725	10.1371/journal.pone.0144725	http://dx.doi.org/10.1371/journal.pone.0144725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657991	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900094
J	Wong, SB; Cheng, SJ; Hung, WC; Lee, WT; Min, MY				Wong, Shi-Bing; Cheng, Sin-Jhong; Hung, Wei-Chen; Lee, Wang-Tso; Min, Ming-Yuan			Rosiglitazone Suppresses In Vitro Seizures in Hippocampal Slice by Inhibiting Presynaptic Glutamate Release in a Model of Temporal Lobe Epilepsy	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; PPAR-GAMMA; EPILEPTIFORM ACTIVITY; NITRIC-OXIDE; BRAIN; EXPRESSION; CORTEX; MECHANISMS; BUMETANIDE; AGONIST	Peroxisomal proliferator-activated receptor gamma (PPAR.) is a nuclear hormone receptor whose agonist, rosiglitazone has a neuroprotective effect to hippocampal neurons in pilocarpine-induced seizures. Hippocampal slice preparations treated in Mg2+ free medium can induce ictal and interictal-like epileptiform discharges, which is regarded as an in vitro model of N-methyl-D-aspartate (NMDA) receptor-mediated temporal lobe epilepsy (TLE). We applied rosiglitazone in hippocampal slices treated in Mg2+ free medium. The effects of rosiglitazone on hippocampal CA1-Schaffer collateral synaptic transmission were tested. We also examined the neuroprotective effect of rosiglitazone toward NMDA excitotoxicity on cultured hippocampal slices. Application of 10 mu M rosiglitazone significantly suppressed amplitude and frequency of epileptiform discharges in CA1 neurons. Pretreatment with the PPAR. antagonist GW9662 did not block the effect of rosiglitazone on suppressing discharge frequency, but reverse the effect on suppressing discharge amplitude. Application of rosiglitazone suppressed synaptic transmission in the CA1-Schaffer collateral pathway. By miniature excitatory-potential synaptic current (mEPSC) analysis, rosiglitazone significantly suppressed presynaptic neurotransmitter release. This phenomenon can be reversed by pretreating PPAR. antagonist GW9662. Also, rosiglitazone protected cultured hippocampal slices from NMDA-induced excitotoxicity. The protective effect of 10 mu M rosiglitazone was partially antagonized by concomitant high dose GW9662 treatment, indicating that this effect is partially mediated by PPAR. receptors. In conclusion, rosiglitazone suppressed NMDA receptor-mediated epileptiform discharges by inhibition of presynaptic neurotransmitter release. Rosiglitazone protected hippocampal slice from NMDA excitotoxicity partially by PPAR. activation. We suggest that rosiglitazone could be a potential agent to treat patients with TLE.	[Wong, Shi-Bing; Hung, Wei-Chen] Taipei Tzu Chi Gen Hosp, Dept Pediat, Buddhist Tzu Chi Med Fdn, Taipei, Taiwan; [Wong, Shi-Bing; Min, Ming-Yuan] Natl Taiwan Univ, Inst Zool, Coll Life Sci, Taipei 10764, Taiwan; [Cheng, Sin-Jhong] Acad Sinica, Neurosci Program, Taipei 115, Taiwan; [Cheng, Sin-Jhong] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Lee, Wang-Tso] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan	Buddhist Tzu Chi General Hospital; Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital	Lee, WT (corresponding author), Natl Taiwan Univ Hosp, Dept Pediat, 1 Chang Te St, Taipei 10016, Taiwan.	leeped@hotmail.com; mymin@ntu.edu.tw	Chang, Sin-Jhong/AAL-4118-2020	Lee, Wang-Tso/0000-0003-3231-9764	Taipei Tzu Chi General Hospital [TCRD-TPE-101-04, TCRD-TPE-102-23, TCRD-TPE-NSC-102-11]; National Science Council, Taiwan [NSC101-2314-B-303-101]	Taipei Tzu Chi General Hospital; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The paper is supported by Taipei Tzu Chi General Hospital (TCRD-TPE-101-04; TCRD-TPE-102-23; TCRD-TPE-NSC-102-11) and National Science Council, Taiwan (NSC101-2314-B-303-101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah DM, 2010, BRAIN RES, V1351, P246, DOI 10.1016/j.brainres.2010.06.034; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Avoli M, 2002, PROG NEUROBIOL, V68, P167, DOI 10.1016/S0301-0082(02)00077-1; Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; Berretta N, 2012, EPILEPSIA, V53, pe80, DOI 10.1111/j.1528-1167.2012.03420.x; Carta AR, 2013, CURR DRUG TARGETS, V14, P743, DOI 10.2174/1389450111314070004; Cavus I, 2005, ANN NEUROL, V57, P226, DOI 10.1002/ana.20380; Crino PB, 2002, EPILEPSIA, V43, P211, DOI 10.1046/j.1528-1157.2002.35001.x; de Moura JC, 2012, HIPPOCAMPUS, V22, P92, DOI 10.1002/hipo.20863; DURING MJ, 1993, LANCET, V341, P1607; Dzhala VI, 2008, ANN NEUROL, V63, P222, DOI 10.1002/ana.21229; Eid T, 2013, EPILEPSIA, V54, P228, DOI 10.1111/epi.12008; Eid T, 2008, BRAIN, V131, P2061, DOI 10.1093/brain/awn133; Ermolyuk YS, 2013, NAT NEUROSCI, V16, P1754, DOI 10.1038/nn.3563; Gao HM, 2002, J NEUROCHEM, V81, P1285, DOI 10.1046/j.1471-4159.2002.00928.x; Jiang QG, 2008, CNS DRUGS, V22, P1, DOI 10.2165/00023210-200822010-00001; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Kilb W, 2007, NEUROPHARMACOLOGY, V53, P524, DOI 10.1016/j.neuropharm.2007.06.015; Kovacs R, 2009, J NEUROSCI, V29, P8565, DOI 10.1523/JNEUROSCI.5698-08.2009; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; MODY I, 1987, J NEUROPHYSIOL, V57, P869, DOI 10.1152/jn.1987.57.3.869; Mohazab RA, 2012, EPILEPSY RES, V101, P28, DOI 10.1016/j.eplepsyres.2012.02.015; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; Moser J, 2006, BRAIN RES, V1077, P170, DOI 10.1016/j.brainres.2006.01.024; Mrak RE, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-5; Nenov MN, 2014, J NEUROSCI, V34, P1028, DOI 10.1523/JNEUROSCI.3413-13.2014; NEUMAN RS, 1989, NEUROSCIENCE, V28, P393, DOI 10.1016/0306-4522(89)90186-3; Nicolas CS, 2012, NEURON, V73, P374, DOI 10.1016/j.neuron.2011.11.024; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Ou ZS, 2006, BRAIN RES, V1096, P196, DOI 10.1016/j.brainres.2006.04.062; Pancani T, 2009, J NEUROCHEM, V109, P1800, DOI 10.1111/j.1471-4159.2009.06107.x; Park EJ, 2003, J BIOL CHEM, V278, P14747, DOI 10.1074/jbc.M210819200; Park EY, 2004, CANCER RES, V64, P3701, DOI 10.1158/0008-5472.CAN-03-3924; Petroff OAC, 1996, ANN NEUROL, V40, P908, DOI 10.1002/ana.410400613; Quilichini PP, 2002, EUR J NEUROSCI, V16, P850, DOI 10.1046/j.1460-9568.2002.02143.x; Satriotomo I, 2006, J NEUROCHEM, V98, P1353, DOI 10.1111/j.1471-4159.2006.04051.x; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sun H, 2008, INT J DEV NEUROSCI, V26, P505, DOI 10.1016/j.ijdevneu.2008.01.009; Tellez-Zenteno Jose F, 2012, Epilepsy Res Treat, V2012, P630853, DOI 10.1155/2012/630853; TRAUB RD, 1993, J PHYSIOL-LONDON, V461, P525, DOI 10.1113/jphysiol.1993.sp019527; Upreti C, 2012, BRAIN, V135, P869, DOI 10.1093/brain/awr341; Yu X, 2008, BRAIN RES, V1200, P146, DOI 10.1016/j.brainres.2008.01.047; Zhao XR, 2009, J NEUROSCI, V29, P6186, DOI 10.1523/JNEUROSCI.5857-08.2009	43	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144806	10.1371/journal.pone.0144806	http://dx.doi.org/10.1371/journal.pone.0144806			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659605	gold, Green Submitted, Green Published			2022-12-27	WOS:000366715900107
J	Abdel-Moneim, AM; Al-Kahtani, MA; El-Kersh, MA; Al-Omair, MA				Abdel-Moneim, Ashraf M.; Al-Kahtani, Mohammed A.; El-Kersh, Mohamed A.; Al-Omair, Mohammed A.			Free Radical-Scavenging, Anti-Inflammatory/Anti-Fibrotic and Hepatoprotective Actions of Taurine and Silymarin against CCl4 Induced Rat Liver Damage	PLOS ONE			English	Article							TETRACHLORIDE-INDUCED HEPATOTOXICITY; INDUCED OXIDATIVE STRESS; INDUCED HEPATIC DAMAGE; CCL4-INDUCED HEPATOTOXICITY; SPECTROPHOTOMETRIC ASSAY; EXTRACT; ANTIOXIDANT; INJURY; FIBROSIS; ADIPONECTIN	The present study aims to investigate the hepatoprotective effect of taurine (TAU) alone or in combination with silymarin (SIL) on CCl4-induced liver damage. Twenty five male rats were randomized into 5 groups: normal control (vehicle treated), toxin control (CCl4 treated), CCl4+TAU, CCl4+SIL and CCl4+TAU+SIL. CCl4 provoked significant increases in the levels of hepatic TBARS, NO and NOS compared to control group, but the levels of endogenous antioxidants such as SOD, GPx, GR, GST and GSH were significantly decreased. Serum pro-inflammatory and fibrogenic cytokines including TNF-alpha, TGF-beta 1, IL-6, leptin and resistin were increased while the anti-inflammatory (adiponectin) cytokine was decreased in all treated rats. Our results also showed that CCl4 induced an increase in liver injury parameters like serum ALT, AST, ALP, GGT and bilirubin. In addition, a significant increase in liver tissue hydroxyproline (a major component of collagen) was detected in rats exposed to CCl4. Moreover, the concentrations of serum TG, TC, HDL-C, LDL-C, VLDL-C and FFA were significantly increased by CCl4. Both TAU and SIL (i.e., antioxidants) post-treatments were effectively able to relieve most of the above mentioned imbalances. However, the combination therapy was more effective than single applications in reducing TBARS levels, NO production, hydroxyproline content in fibrotic liver and the activity of serum GGT. Combined treatment (but not TAU-or SIL-alone) was also able to effectively prevent CCl4-induced decrease in adiponectin serum levels. Of note, the combined post-treatment with TAU+ SIL (but not monotherapy) normalized serum FFA in CCl4-treated rats. The biochemical results were confirmed by histological and ultrastructural changes as compared to CCl4-poisoned rats. Therefore, on the basis of our work, TAU may be used in combination with SIL as an additional adjunct therapy to cure liver diseases such as fibrosis, cirrhosis and viral hepatitis.	[Abdel-Moneim, Ashraf M.; Al-Kahtani, Mohammed A.] King Faisal Univ, Fac Sci, Dept Biol Sci, Al Hasa, Saudi Arabia; [Abdel-Moneim, Ashraf M.] Univ Alexandria, Fac Sci, Dept Zool, Alexandria, Egypt; [El-Kersh, Mohamed A.; Al-Omair, Mohammed A.] King Faisal Univ, Fac Sci, Dept Chem, Al Hasa, Saudi Arabia; [El-Kersh, Mohamed A.] Univ Alexandria, Fac Sci, Dept Biochem, Alexandria, Egypt	King Faisal University; Egyptian Knowledge Bank (EKB); Alexandria University; King Faisal University; Egyptian Knowledge Bank (EKB); Alexandria University	Abdel-Moneim, AM (corresponding author), King Faisal Univ, Fac Sci, Dept Biol Sci, Al Hasa, Saudi Arabia.	aabdelmoneim@kfu.edu.sa	Abdel-Moneim, Ashraf/A-4601-2009; Al-Omair, Mohammed/P-4396-2016; Abdel-Moneim, Ashraf/GQH-0206-2022	Abdel-Moneim, Ashraf/0000-0002-0270-703X; Al-Omair, Mohammed/0000-0003-4358-6665; 	Deanship of Scientific Research, King Faisal University [120041]	Deanship of Scientific Research, King Faisal University	This research work is financially supported by Deanship of Scientific Research, King Faisal University (project no. 120041).	Abdelaziz DHA, 2014, J ETHNOPHARMACOL, V155, P736, DOI 10.1016/j.jep.2014.06.026; Ahmed AF, 2011, ANN HEPATOL, V10, P207; Arulmozhi V, 2010, PHARMACOGN MAG, V6, P42, DOI 10.4103/0973-1296.59965; Bektur NE, 2016, TOXICOL IND HEALTH, V32, P589, DOI 10.1177/0748233713502841; Bertolani Cristiana, 2008, Pathophysiology, V15, P91, DOI 10.1016/j.pathophys.2008.05.001; Bhondave PD, 2014, J ETHNOPHARMACOL, V151, P183, DOI 10.1016/j.jep.2013.10.025; Buechler C, 2011, WORLD J GASTROENTERO, V17, P2801, DOI 10.3748/wjg.v17.i23.2801; Bulau P, 2007, AM J PHYSIOL-LUNG C, V292, pL18, DOI 10.1152/ajplung.00076.2006; Cao W, 2015, TOXICOL LETT, V232, P233, DOI 10.1016/j.toxlet.2014.11.009; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Chen XC, 2009, HEPATOLOGY, V49, P1554, DOI 10.1002/hep.22811; Das J, 2010, FREE RADICAL RES, V44, P340, DOI 10.3109/10715760903513017; Debnath S, 2013, FOOD CHEM TOXICOL, V59, P485, DOI 10.1016/j.fct.2013.06.036; DELEVE LD, 1991, PHARMACOL THERAPEUT, V52, P287, DOI 10.1016/0163-7258(91)90029-L; Devi SL, 2010, EUR J PHARMACOL, V647, P161, DOI 10.1016/j.ejphar.2010.08.011; Dincer S, 2002, AMINO ACIDS, V22, P417, DOI 10.1007/s007260200025; Domitrovic R, 2011, FOOD CHEM TOXICOL, V49, P848, DOI 10.1016/j.fct.2010.12.006; El Ashry FEZ, 2012, FOOD CHEM TOXICOL, V50, P1159, DOI 10.1016/j.fct.2011.12.020; El-Sayed WM, 2011, J HAZARD MATER, V192, P880, DOI 10.1016/j.jhazmat.2011.05.100; Essawy A. E., 2012, Journal of Applied Pharmaceutical Science, V2, P21; Flora SJS, 2008, OXID MED CELL LONGEV, V1, P39, DOI 10.4161/oxim.1.1.6481; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fujii T, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-79; Ghigo D, 2006, NITRIC OXIDE-BIOL CH, V15, P148, DOI 10.1016/j.niox.2006.01.002; Girish C, 2012, J PHARMACOL PHARMACO, V3, P149, DOI 10.4103/0976-500X.95515; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hagar HH, 2004, TOXICOL LETT, V151, P335, DOI 10.1016/j.toxlet.2004.03.002; Hamdy N, 2012, TOXICOL APPL PHARM, V261, P292, DOI 10.1016/j.taap.2012.04.012; Haretskaya MV, 2014, BIOCHEM MOSC-SUPPL S, V8, P286, DOI 10.1134/S1990750814040039; Hsu YW, 2008, FOOD CHEM TOXICOL, V46, P3311, DOI 10.1016/j.fct.2008.07.027; Huo HZ, 2011, INT J MOL SCI, V12, P6529, DOI 10.3390/ijms12106529; JACOBSON B, 1988, CLIN CHEM, V34, P2164; Jelinek D, 2012, J NUTR, V142, P1935, DOI 10.3945/jn.112.162818; Kabil NN, 2014, PEPTIDES, V52, P90, DOI 10.1016/j.peptides.2013.11.022; Kamata K, 1996, EUR J PHARMACOL, V303, P47, DOI 10.1016/0014-2999(96)00094-5; Li Hong-Shan, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P546, DOI 10.3736/jcim20090610; Lindenmaier H, 2005, DRUG METAB DISPOS, V33, P1576, DOI 10.1124/dmd.105.005314; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mansour HH, 2006, J BIOCHEM MOL BIOL, V39, P656; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; Militante JD, 2004, NUTR RES, V24, P787, DOI 10.1016/S0271-5317(04)00109-5; Miyazaki T, 2005, J HEPATOL, V43, P117, DOI 10.1016/j.jhep.2005.01.033; Moschen AR, 2012, CURR MED CHEM, V19, P5467; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Parveen R, 2011, ARCH PHARM RES, V34, P767, DOI 10.1007/s12272-011-0510-8; Peng XD, 2009, BIOCHEM BIOPH RES CO, V388, P31, DOI 10.1016/j.bbrc.2009.07.099; Polyak SJ, 2010, P NATL ACAD SCI USA, V107, P5995, DOI 10.1073/pnas.0914009107; Raj S, 2014, FOOD CHEM TOXICOL, V67, P105, DOI 10.1016/j.fct.2014.02.028; Ramasamy P, 2014, INT J BIOL MACROMOL, V65, P559, DOI 10.1016/j.ijbiomac.2014.02.009; Ranawat L, 2010, J ETHNOPHARMACOL, V127, P777, DOI 10.1016/j.jep.2009.10.019; Reiter RJ, 2000, J BIOMED SCI, V7, P444, DOI 10.1007/BF02253360; Saller R, 2008, FORSCH KOMPLEMENTMED, V15, P9, DOI 10.1159/000113648; Shafik Amani N, 2011, Arab J Gastroenterol, V12, P143, DOI 10.1016/j.ajg.2011.07.001; Shaker ME, 2011, TOXICOL APPL PHARM, V252, P165, DOI 10.1016/j.taap.2011.02.004; Sreelatha S, 2009, FOOD CHEM TOXICOL, V47, P702, DOI 10.1016/j.fct.2008.12.022; Tabassum H, 2006, CLIN CHIM ACTA, V370, P129, DOI 10.1016/j.cca.2006.02.006; Tasci I, 2008, WORLD J GASTROENTERO, V14, P4897, DOI 10.3748/wjg.14.4897; Tipoe GL, 2010, TOXICOLOGY, V273, P45, DOI 10.1016/j.tox.2010.04.014; Turgut O, 2011, J ATHEROSCLER THROMB, V18, P177, DOI 10.5551/jat.6189; Ukeda H, 1997, ANAL BIOCHEM, V251, P206, DOI 10.1006/abio.1997.2273; Vargas-Mendoza N, 2014, WORLD J HEPATOL, V6, P144, DOI 10.4254/wjh.v6.i3.144; Vuda M, 2012, EXP TOXICOL PATHOL, V64, P855, DOI 10.1016/j.etp.2011.03.006; Wang BJ, 2004, FOOD CHEM TOXICOL, V42, P609, DOI 10.1016/j.fct.2003.11.011; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227; WILLIAMS AT, 1990, SEMIN LIVER DIS, V10, P279, DOI 10.1055/s-2008-1040483; Willianson FJ, 1996, SELECTION PREPARATIO; Wills PJ, 2012, ASIAN PAC J TROP MED, V5, P421, DOI 10.1016/S1995-7645(12)60072-8; Yadav NP, 2008, PHYTOMEDICINE, V15, P1053, DOI 10.1016/j.phymed.2008.08.002; Yang JY, 2010, J AGR FOOD CHEM, V58, P6525, DOI 10.1021/jf903070a	69	101	106	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144509	10.1371/journal.pone.0144509	http://dx.doi.org/10.1371/journal.pone.0144509			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659465	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903600049
J	Qiao, MN; Wu, D; Carey, M; Zhou, XB; Zhang, L				Qiao, Minna; Wu, Dan; Carey, Michelle; Zhou, Xiaobo; Zhang, Le			Multi-Scale Agent-Based Multiple Myeloma Cancer Modeling and the Related Study of the Balance between Osteoclasts and Osteoblasts	PLOS ONE			English	Article							BONE-MARROW; STEM-CELL; GLUCOCORTICOIDS; PATHOGENESIS; MECHANISMS; CYTOKINES; PROTEIN; RNA	Research Background Currently, multiple myeloma is the second most common hematological malignancy in the U.S., constituting 1% of all cancers. With conventional treatment, the median survival time is typically 3-4 years, although it can be extended to 5-7 years or longer with advanced treatments. Recent research indicated that an increase in osteoclast (OC) activity is often associated withmultiple myeloma (MM) and that a decrease inosteoblast (OB) activity contributesto the osteolytic lesions in MM. Normally, the populations of OCs and OBs are inequilibrium, and an imbalance in this statecontributes to the development of lesions. Research procedures A multi-scale agent-based multiple myeloma model was developed to simulate the proliferation, migration and death of OBs and OCs. Subsequently, this model was employed to investigate the efficacy of thethree most commonly used drugs for MM treatment under the following two premises: the reduction in the progression of MM and the re-establishment of the equilibrium between OCs and OBs. Research purposes The simulated results not only demonstrated the capacity of the model to choose optimal combinations of the drugs but also showed that the optimal use of the three drugs can restore the balance between OCs and OBs as well as kill MMs. Furthermore, the drug synergism analysis function of the model revealed that restoring the balance between OBs and OCs can significantly increase the efficacy of drugs against tumor cells.	[Qiao, Minna; Zhang, Le] Southwest Univ, Coll Comp & Informat Sci, Chongqing, Peoples R China; [Wu, Dan; Zhou, Xiaobo] Wake Forest Univ, Sch Med, Dept Radiol, Winston Salem, NC 27109 USA; [Carey, Michelle] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY 14627 USA	Southwest University - China; Wake Forest University; University of Rochester	Zhou, XB (corresponding author), Wake Forest Univ, Sch Med, Dept Radiol, Winston Salem, NC 27109 USA.	xizhou@wakehealth.edu; zhanglcq@swu.edu.cn	Zhang, Le/AAD-9104-2019	Zhang, Le/0000-0002-3708-1727; Carey, Michelle/0000-0002-5603-4264	 [U01 CA166886-01];  [P30AI078498];  [HHSN272201000055C];  [61372138]; NATIONAL CANCER INSTITUTE [U01CA166886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI078498] Funding Source: NIH RePORTER	; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by http://grants.nih.gov/grants/oer.htm: U01 CA166886-01, P30AI078498, HHSN272201000055C; and www.nsfc.gov.cn: No. 61372138.	ALEXANIAN R, 1969, J AMER MED ASSOC, V208, P1680, DOI 10.1001/jama.208.9.1680; BATAILLE R, 1991, J CLIN INVEST, V88, P62, DOI 10.1172/JCI115305; Filella X, 1996, CANCER DETECT PREV, V20, P52; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Fulciniti M, 2009, BLOOD, V114, pS151; GERHART J, 1984, J CELL BIOL, V98, P1247, DOI 10.1083/jcb.98.4.1247; Guo J, 2004, CLIN CANCER RES, V10, P3333, DOI 10.1158/1078-0432.CCR-03-0366; Hideshima T, 2002, NAT REV CANCER, V2, P927, DOI 10.1038/nrc952; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hiroshi T, 2003, NATURE, V423, P337; ISHIKAWA H, 1990, BLOOD, V75, P715; Jian-Ming Hou, 2012, Acta Pharmacologica Sinica, V33, P1277; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Maria-Victoria M, 2006, BLOOD, V108, P2165; Meletios D, 2007, NEW ENGL J MED, V357, P2123; MOALLI PA, 1993, CANCER RES, V53, P3877; MOALLI PA, 1992, BLOOD, V79, P213; Nicola G, 2006, BLOOD, V108, P3992; Oftedal S, 1921, J AMER MED ASSOC, V77, P1547; Politou MC, 2006, INT J CANCER, V119, P1728, DOI 10.1002/ijc.22033; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Rongrong Z, 2013, BONE, V52, P145, DOI [10.1016/j.bone.2012.09.029, DOI 10.1016/J.BONE.2012.09.029]; Roodman GD, 2010, J BONE MINER METAB, V28, P244, DOI 10.1007/s00774-009-0154-7; Straetemans R, 2005, BIOMETRICAL J, V47, P299, DOI 10.1002/bimj.200410124; Sun XQ, 2012, BIOMATERIALS, V33, P8265, DOI 10.1016/j.biomaterials.2012.07.041; Sundar J, 2005, BRIT J HAEMATOL, V129, P776; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Yaccoby S, 2002, BRIT J HAEMATOL, V116, P278, DOI 10.1046/j.1365-2141.2002.03257.x; Yong-Zhan Z, 2009, ACTA PHARMACOL SIN, V7, P1025; ZAR JH, 1972, J AM STAT ASSOC, V67, P578, DOI 10.2307/2284441; ZHANG XG, 1994, BLOOD, V83, P3654; Zhen YZ, 2009, INT J HEMATOL, V90, P44, DOI 10.1007/s12185-009-0340-3	32	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0143206	10.1371/journal.pone.0143206	http://dx.doi.org/10.1371/journal.pone.0143206			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659358	gold, Green Submitted, Green Published			2022-12-27	WOS:000366903600009
J	Jarvinen, KM; Westfall, J; De Jesus, M; Mantis, NJ; Carroll, JA; Metzger, DW; Sampson, HA; Berin, MC				Jaervinen, Kirsi M.; Westfall, Jennifer; De Jesus, Magdia; Mantis, Nicholas J.; Carroll, Jessica A.; Metzger, Dennis W.; Sampson, Hugh A.; Berin, M. Cecilia			Role of Maternal Dietary Peanut Exposure in Development of Food Allergy and Oral Tolerance	PLOS ONE			English	Article							BREAST-MILK; INDUCED ANAPHYLAXIS; ATOPIC-DERMATITIS; MURINE MODEL; TREE NUTS; SENSITIZATION; CHILDREN; RISK; CONSUMPTION; INFANTS	Background The impact of maternal ingestion of peanut during pregnancy and lactation on an offspring's risk for peanut allergy is under debate. Objective To investigate the influence of maternal dietary peanut exposure and breast milk on an offspring's allergy risk. Methods Preconceptionally peanut-exposed C3H/HeJ females were either fed or not fed peanut during pregnancy and lactation. The offsprings' responses to peanut sensitization or oral tolerance induction by feeding antigen prior to immunization were assessed. We also assessed the impact of immune murine milk on tolerance induction pre- or post-weaning. For antigen uptake studies, mice were gavaged with fluorescent peanut in the presence or absence of immune murine milk; Peyer's patches were harvested for immunostaining. Results Preconceptional peanut exposure resulted in the production of varying levels of maternal antibodies in serum (and breast milk), which were transferred to the offspring. Despite this, maternal peanut exposure either preconceptionally or during pregnancy and lactation, when compared to no maternal exposure, had no impact on peanut allergy. When offspring were fed peanut directly, dose-dependent tolerance induction, unaltered by maternal feeding of peanut, was seen. Although peanut uptake into the gut-associated lymphoid tissues was enhanced by immune milk as compared to naive milk, tolerance induction was not affected by the co-administration of immune milk either pre- or post-weaning. Conclusion Maternal peanut exposure during pregnancy and lactation has no impact on the development of peanut allergy in the offspring. Tolerance to peanut can be induced early, even pre-weaning, by giving moderate amounts of peanut directly to the infant, and this is neither enhanced nor impaired by concurrent exposure to immune milk.	[Jaervinen, Kirsi M.; Westfall, Jennifer; Carroll, Jessica A.] Albany Med Coll, Div Allergy & Immunol, Albany, NY 12208 USA; [De Jesus, Magdia; Mantis, Nicholas J.] New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY USA; [Mantis, Nicholas J.] SUNY Albany, Dept Biomed Sci, Albany, NY USA; [Metzger, Dennis W.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Sampson, Hugh A.; Berin, M. Cecilia] Icahn Sch Med Mt Sinai, Div Pediat Allergy & Immunol, New York, NY 10029 USA; [Sampson, Hugh A.; Berin, M. Cecilia] Icahn Sch Med Mt Sinai, Jaffe Food Allergy Inst, New York, NY 10029 USA	Albany Medical College; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Albany Medical College; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Jarvinen, KM (corresponding author), Univ Rochester, Sch Med & Dent, Div Pediat Allergy & Immunol, Rochester, NY 14627 USA.	kirsi_jarvinen-seppo@URMC.Rochester.edu	Metzger, Dennis W/I-2771-2019	Metzger, Dennis W/0000-0002-8000-9907; Mantis, Nicholas/0000-0002-5083-8640; berin, cecilia/0000-0002-9051-9249; Doering, Jennifer/0000-0001-8749-774X	NIH [AI44236, AI066738, AI093577, HD061916]; Life Sciences Research Foundation; Howard Hughes Medical Institute (HHMI);  [AI091655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093577, K08AI091655, U19AI066738] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Sciences Research Foundation; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by Grant Number AI091655 (K.M. Jarvinen), H.A. Sampson is supported in part by grants from the NIH, AI44236 and AI066738. M. Cecilia Berin is supported in part by NIH grant AI093577. N.J. Mantis was supported in part by NIH HD061916. M. De Jesus was supported by the Life Sciences Research Foundation, postdoctoral fellowship sponsored by the Howard Hughes Medical Institute (HHMI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health.	Baker SS, 2000, PEDIATRICS, V106, P346; Ben-Shoshan M, 2010, J ALLERGY CLIN IMMUN, V125, P1327, DOI 10.1016/j.jaci.2010.03.015; Berin MC, 2013, MUCOSAL IMMUNOL, V6, P114, DOI 10.1038/mi.2012.55; Bernard H, 2014, ALLERGY, V69, P888, DOI 10.1111/all.12411; Bock SA, 2007, J ALLERGY CLIN IMMUN, V119, P1016, DOI 10.1016/j.jaci.2006.12.622; Brough HA, 2015, J ALLERGY CLIN IMMUN, V135, P164, DOI 10.1016/j.jaci.2014.10.007; Chan SMH, 2012, ALLERGY, V67, P336, DOI 10.1111/j.1398-9995.2011.02765.x; De Jesus M, 2013, JOVE-J VIS EXP, DOI 10.3791/50167; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Fleischer DM, 2015, ALLERGY, V70, P1193, DOI 10.1111/all.12687; Flohr C, 2014, J INVEST DERMATOL, V134, P345, DOI 10.1038/jid.2013.298; Frank L, 1999, PEDIATR ALLERGY IMMU, V10, P27, DOI 10.1034/j.1399-3038.1999.101010.x; Frazier AL, 2014, JAMA PEDIATR, V168, P156, DOI 10.1001/jamapediatrics.2013.4139; Fusaro AE, 2009, IMMUNOLOGY, V128, pe541, DOI 10.1111/j.1365-2567.2008.03028.x; Greer FR, 2008, PEDIATRICS, V121, P183, DOI 10.1542/peds.2007-3022; Grundy J, 2002, J ALLERGY CLIN IMMUN, V110, P784, DOI 10.1067/mai.2002.128802; Jarvinen KM, 1999, J PEDIATR-US, V135, P506, DOI 10.1016/S0022-3476(99)70175-7; Khodoun M, 2009, J ALLERGY CLIN IMMUN, V123, P342, DOI 10.1016/j.jaci.2008.11.004; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Li XM, 2000, J ALLERGY CLIN IMMUN, V106, P150, DOI 10.1067/mai.2000.107395; Li XM, 2001, J ALLERGY CLIN IMMUN, V108, P639, DOI 10.1067/mai.2001.118787; Lopez-Exposito I, 2011, FOOD RES INT, V44, P1649, DOI 10.1016/j.foodres.2011.04.047; Lopez-Exposito I, 2009, J ALLERGY CLIN IMMUN, V124, P1039, DOI 10.1016/j.jaci.2009.08.024; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Matson AP, 2007, J IMMUNOL, V179, P1282, DOI 10.4049/jimmunol.179.2.1282; Mosconi E, 2010, MUCOSAL IMMUNOL, V3, P461, DOI 10.1038/mi.2010.23; Mullins RJ, 2009, J ALLERGY CLIN IMMUN, V123, P689, DOI 10.1016/j.jaci.2008.12.1116; Palmer DJ, 2005, CLIN EXP ALLERGY, V35, P173, DOI 10.1111/j.1365-2222.2005.02170.x; Pumphrey RSH, 2007, J ALLERGY CLIN IMMUN, V119, P1018, DOI 10.1016/j.jaci.2007.01.021; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V126, P1191, DOI 10.1016/j.jaci.2010.08.036; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1322, DOI 10.1016/j.jaci.2010.03.029; Sicherer SH, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e6; Tordesillas L, 2014, J CLIN INVEST, V124, P4965, DOI 10.1172/JCI75660; Vadas P, 2001, JAMA-J AM MED ASSOC, V285, P1746, DOI 10.1001/jama.285.13.1746; Verhasselt V, 2008, NAT MED, V14, P170, DOI 10.1038/nm1718; ZEIGER RS, 1995, J ALLERGY CLIN IMMUN, V95, P1179, DOI 10.1016/S0091-6749(95)70074-9	39	18	18	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0143855	10.1371/journal.pone.0143855	http://dx.doi.org/10.1371/journal.pone.0143855			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26656505	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903500008
J	Mandrich, L; Cerreta, M; Manco, G				Mandrich, Luigi; Cerreta, Mariangela; Manco, Giuseppe			An Engineered Version of Human PON2 Opens the Way to Understand the Role of Its Post-Translational Modifications in Modulating Catalytic Activity	PLOS ONE			English	Article							SIGNAL N-(3-OXODODECANOYL)-L-HOMOSERINE LACTONE; PSEUDOMONAS-AERUGINOSA; OXIDATIVE STRESS; SULFOLOBUS-SOLFATARICUS; ENDOPLASMIC-RETICULUM; PARAOXONASE 2; PHOSPHOTRIESTERASE; EXPRESSION; STABILITY; INFECTION	The human paraoxonase 2 (PON2) has been described as a highly specific lactonase hydrolysing the quorum sensing molecule N-(3-oxododecanoyl)-L-homoserine lactone (3OC12-HSL) and having secondary esterase but not phosphotriesterase activity, in contrast with the related enzymes PON1 and PON3. It has been suggested that PON2 enzyme activity is dependent on glycosylation and its N-terminal region has been recently demonstrated to be a transmembrane domain mediating association to membranes. In the present study we describe a mutated form of PON2, lacking the above N-terminal region, which has been further stabilized by the insertion of six amino acidic substitutions. The engineered version, hence forth called rPON2, has been over-expressed in E.coli, refolded from inclusion bodies and purified, yielding an enzyme with the same characteristics as the full length enzyme. Therefore the first conclusion of this work was that the catalytic activity is independent from the N-terminus and protein glycosylation. The kinetic characterization confirmed the primary activity on 3OC12-HSL; accordingly, in vitro experiments of inhibition of the bio-film formed by Pseudomonas aeruginosa (PAO1) have demonstrated that rPON2 is more effective than PON1. In addition, we observed small but significant activity against organo-phosphorothiotes pesticides, m-parathion, coumaphos and malathion. The availability of fair amount of active protein allowed to pinpoint, by mass-spectrometry, ubiquitination of Lys 168 induced in rPON2 by HeLa extract and to correlate such post-translational modification to the modulation of catalytic activity. A mutational analysis of the modified residue confirmed the result.	[Mandrich, Luigi; Cerreta, Mariangela; Manco, Giuseppe] CNR, Inst Prot Biochem, I-80131 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Mandrich, L (corresponding author), CNR, Inst Prot Biochem, Via Pietro Castellino 111, I-80131 Naples, Italy.	l.mandrich@ibp.cnr.it	Manco, Giuseppe/AAL-3777-2020; MANDRICH, Luigi/L-7198-2019; Mandrich, Luigi/AAH-9328-2020	Manco, Giuseppe/0000-0001-6191-3952; MANDRICH, Luigi/0000-0002-0025-9544; Mandrich, Luigi/0000-0002-0025-9544	Italian Cystic Fibrosis Research Foundation [FFC10/2010]; Italian Ministry of Education, University and Research [PON01_01585]; CNR Flagship Project "Interomics"	Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); CNR Flagship Project "Interomics"	This work was supported by The Italian Cystic Fibrosis Research Foundation (FFC10/2010); The "Programma Operativo Nazionale Ricerca e Competitivita 2007-2013" (PON), PON01_01585 from Italian Ministry of Education, University and Research; and The CNR Flagship Project "Interomics". The funders had no role in study design, data collection and analysis, decision to publish, or preparating of the manuscript.	Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Altenhofer S, 2010, J BIOL CHEM, V285, P24398, DOI 10.1074/jbc.M110.118604; Bar-Rogovsky H, 2013, J BIOL CHEM, V288, P23914, DOI 10.1074/jbc.M112.427922; Beckham GT, 2012, CURR OPIN BIOTECH, V23, P338, DOI 10.1016/j.copbio.2011.11.030; Bourquard N, 2008, PROTEINS CELL REGUL, V6, P103, DOI 10.1007/978-1-4020-6561-3_7; BROWN WC, 1993, GENE, V127, P99, DOI 10.1016/0378-1119(93)90622-A; Cleland JL, 2001, J PHARM SCI, V90, P310, DOI 10.1002/1520-6017(200103)90:3<310::AID-JPS6>3.3.CO;2-I; Costa LG, 2013, TOXICOLOGY, V307, P115, DOI 10.1016/j.tox.2012.07.011; DIEPGEN TL, 1986, ARCH TOXICOL, P154; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Dorn J, 2014, J BIOL CHEM, V289, P7049, DOI 10.1074/jbc.M113.536094; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Estin ML, 2010, ADV EXP MED BIOL, V660, P183, DOI 10.1007/978-1-60761-350-3_17; Farinha CM, 2013, FEBS J, V280, P4396, DOI 10.1111/febs.12392; Gao Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3656; Hagmann H, 2014, FASEB J, V28, P1769, DOI 10.1096/fj.13-240309; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Horke S, 2007, CIRCULATION, V115, P2055, DOI 10.1161/CIRCULATIONAHA.106.681700; Horke S, 2010, BIOCHEM J, V426, P73, DOI 10.1042/BJ20091414; Jaouad L, 2006, ATHEROSCLEROSIS, V185, P191, DOI 10.1016/j.atherosclerosis.2005.06.012; Josse D, 1999, BIOCHEMISTRY-US, V38, P2816, DOI 10.1021/bi982281h; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; La Du BN, 1992, PHARMACOGENETICS DRU, P51; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Leviev I, 1997, ARTERIOSCL THROM VAS, V17, P2935, DOI 10.1161/01.ATV.17.11.2935; Li HG, 2013, TRENDS PHARMACOL SCI, V34, P313, DOI 10.1016/j.tips.2013.03.007; Merone L, 2005, EXTREMOPHILES, V9, P297, DOI 10.1007/s00792-005-0445-4; Nagant C, 2011, J APPL MICROBIOL, V111, P763, DOI 10.1111/j.1365-2672.2011.05085.x; Ng CJ, 2005, FREE RADICAL BIO MED, V38, P153, DOI 10.1016/j.freeradbiomed.2004.09.035; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; Ozer EA, 2005, FEMS MICROBIOL LETT, V253, P29, DOI 10.1016/j.femsle.2005.09.023; Parsek MR, 2000, P NATL ACAD SCI USA, V97, P8789, DOI 10.1073/pnas.97.16.8789; Pezzullo M, 2013, PROTEIN ENG DES SEL, V26, P47, DOI 10.1093/protein/gzs066; Porzio E, 2007, BIOCHIMIE, V89, P625, DOI 10.1016/j.biochi.2007.01.007; PrimoParmo SL, 1996, GENOMICS, V33, P498, DOI 10.1006/geno.1996.0225; Sierksma A, 2002, ALCOHOL CLIN EXP RES, V26, P1430, DOI 10.1097/01.ALC.0000030639.57507.60; Sola RJ, 2009, J PHARM SCI-US, V98, P1223, DOI 10.1002/jps.21504; Sorenson RC, 1995, GENOMICS, V30, P431, DOI 10.1006/geno.1995.1261; Stoltz DA, 2007, AM J PHYSIOL-LUNG C, V292, pL852, DOI 10.1152/ajplung.00370.2006; Stoltz DA, 2009, J BIOL CHEM, V284, P35564, DOI 10.1074/jbc.M109.051706; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Suzuki SM, 2010, ADV EXP MED BIOL, V660, P37, DOI 10.1007/978-1-60761-350-3_5; Teiber JF, 2008, INFECT IMMUN, V76, P2512, DOI 10.1128/IAI.01606-07; Wagner VE, 2008, CLIN REV ALLERG IMMU, V35, P124, DOI 10.1007/s12016-008-8079-9	45	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144579	10.1371/journal.pone.0144579	http://dx.doi.org/10.1371/journal.pone.0144579			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26656916	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903500043
J	Markiewicz, I; Strupczewski, WG; Bogdanowicz, E; Kochanek, K				Markiewicz, Iwona; Strupczewski, Witold G.; Bogdanowicz, Ewa; Kochanek, Krzysztof			Generalized Exponential Distribution in Flood Frequency Analysis for Polish Rivers	PLOS ONE			English	Article							LOGISTIC PROBABILITY-DISTRIBUTIONS; HYDROLOGICAL ANALYSES; LOG-GUMBEL; APPLICABILITY; GAMMA; MODEL	Many distributions have been used in flood frequency analysis (FFA) for fitting the flood extremes data. However, as shown in the paper, the scatter of Polish data plotted on the moment ratio diagram shows that there is still room for a new model. In the paper, we study the usefulness of the generalized exponential (GE) distribution in flood frequency analysis for Polish Rivers. We investigate the fit of GE distribution to the Polish data of the maximum flows in comparison with the inverse Gaussian (IG) distribution, which in our previous studies showed the best fitting among several models commonly used in FFA. Since the use of a discrimination procedure without the knowledge of its performance for the considered probability density functions may lead to erroneous conclusions, we compare the probability of correct selection for the GE and IG distributions along with the analysis of the asymptotic model error in respect to the upper quantile values. As an application, both GE and IG distributions are alternatively assumed for describing the annual peak flows for several gauging stations of Polish Rivers. To find the best fitting model, four discrimination procedures are used. In turn, they are based on the maximized logarithm of the likelihood function (K procedure), on the density function of the scale transformation maximal invariant (QK procedure), on the Kolmogorov-Smirnov statistics (KS procedure) and the fourth procedure based on the differences between the ML estimate of 1% quantile and its value assessed by the method of moments and linear moments, in sequence (R procedure). Due to the uncertainty of choosing the best model, the method of aggregation is applied to estimate of the maximum flow quantiles.	[Markiewicz, Iwona; Strupczewski, Witold G.; Kochanek, Krzysztof] Polish Acad Sci, Inst Geophys, Dept Hydrol & Hydrodynam, Warsaw 42, Poland; [Bogdanowicz, Ewa] Polish Acad Sci, Inst Geophys, CHIHE Norway Grants, Warsaw 42, Poland	Polish Academy of Sciences; Institute of Geophysics of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Geophysics of the Polish Academy of Sciences	Markiewicz, I (corresponding author), Polish Acad Sci, Inst Geophys, Dept Hydrol & Hydrodynam, Warsaw 42, Poland.	iwonamar@igf.edu.pl	Bogdanowicz, Ewa/Q-6947-2018; Kochanek, Krzysztof/I-2824-2016		Polish National Science Centre titled "Modern statistical models for analysis of flood frequency and features of flood waves" [DEC-2012/05/B/ST10/00482]; Polish Ministry of Science and Higher Education under the Grant Iuventus Plus [IP 2010 024570]; Ministry of Science and Higher Education of Poland [3841/E-41/S/2015]	Polish National Science Centre titled "Modern statistical models for analysis of flood frequency and features of flood waves"; Polish Ministry of Science and Higher Education under the Grant Iuventus Plus; Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland)	This work was partly financed by the grant of the Polish National Science Centre titled "Modern statistical models for analysis of flood frequency and features of flood waves", decision nr DEC-2012/05/B/ST10/00482 and by the Polish Ministry of Science and Higher Education under the Grant Iuventus Plus IP 2010 024570 titled "Analysis of the efficiency of estimation methods in flood frequency modelling". This work was partially supported within statutory activities No 3841/E-41/S/2015 of the Ministry of Science and Higher Education of Poland.	Abramowitz M, 1972, HDB MATH FUNCTIONS; Adler RJ, 1998, PRACTICAL GUIDE TO HEAVY TAILS, P133; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2012, REV APPL EUR FLOOD F; [Anonymous], 1969, GUID DET ANN MAX FLO; [Anonymous], [No title captured]; Beard L.R., 1974, FLOOD FLOW FREQUENCY; BENSON MA, 1968, WATER RESOUR RES, V4, P891, DOI 10.1029/WR004i005p00891; BERNARDO JM, 1976, ROY STAT SOC C-APP, V25, P315, DOI 10.2307/2347257; Bogdanowicz E, 2010, MG KOM INZ SR PAN, P57; BOUGHTON WC, 1980, WATER RESOUR RES, V16, P347, DOI 10.1029/WR016i002p00347; Brzezinski J, 2010, MONOGRAPHS COMMITTEE, V68, P71; Chakravarty IM, 1967, HDB METHODS APPL STA, VI, P392; Cox D. R., 1965, THEORY STOCHASTIC PR; Cunnane C, 1989, 33 WORLD MET ORG; Dey AK, 2009, IEEE T RELIAB, V58, P416, DOI 10.1109/TR.2009.2019494; Dooge J. C. I., 1973, TECHNICAL B AGR RES, V1468; DYER AR, 1973, J AM STAT ASSOC, V68, P970, DOI 10.2307/2284533; El Adlouni S, 2008, J HYDROL, V355, P16, DOI 10.1016/j.jhydrol.2008.02.011; Foss S, 2013, SPRINGER SERIES OPER, DOI [10.1007/978-1-4614-7101-1, DOI 10.1007/978-1-4614-7101-1]; Griffis VW, 2007, J HYDROL ENG, V12, P283, DOI 10.1061/(ASCE)1084-0699(2007)12:3(283); Gumbel EJ, 1941, ANN MATH STAT, V12, P163, DOI 10.1214/aoms/1177731747; Gupta R, 2004, J STAT COMPUT SIM, V74, P107, DOI 10.1080/0094965031000114359; Gupta RD, 2007, J STAT PLAN INFER, V137, P3537, DOI 10.1016/j.jspi.2007.03.030; Gupta RD, 2003, COMPUT STAT DATA AN, V43, P179, DOI 10.1016/S0167-9473(02)00206-2; Gupta RD, 2003, COMMUN STAT-THEOR M, V32, P705, DOI 10.1081/STA-120018824; Gupta RD, 2001, J STAT COMPUT SIM, V69, P315, DOI 10.1080/00949650108812098; Gupta RD, 1999, AUST NZ J STAT, V41, P173, DOI 10.1111/1467-842X.00072; Hayami S., 1951, B DISASTER PREV RES, V1, P1; Hosking J.R.M., 1997, REGIONAL FREQUENCY A, DOI DOI 10.1017/CBO9780511529443; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Institute of Hydrology, 1999, FLOOD ESTIMATION HDB; Jenkinson AF, 1969, 233 WMO, P183; Kaczmarek Z., 1977, STAT METHODS HYDROLO; KAPPENMAN RF, 1988, STAT PROBABIL LETT, V7, P123, DOI 10.1016/0167-7152(88)90036-3; KAPPENMAN RF, 1982, COMMUN STAT A-THEOR, V11, P663, DOI 10.1080/03610928208828260; Katz RW, 2002, ADV WATER RESOUR, V25, P1287, DOI 10.1016/S0309-1708(02)00056-8; Kendall Atkinson E., 1989, INTRO NUMERICAL ANAL; Kendall M.G., 1973, ADV THEORY STAT, V2; Kendall M.G., 1969, ADV THEORY STAT, V1; Kolmogorov, 1933, GIORNALE DELLISTITUT, V4, P83; Kundu D, 2005, J STAT PLAN INFER, V127, P213, DOI 10.1016/j.jspi.2003.08.017; Markiewicz I, 2010, HYDROL EARTH SYST SC, V14, P2167, DOI 10.5194/hess-14-2167-2010; Mitosek HT, 2006, J HYDROL, V323, P57, DOI 10.1016/j.jhydrol.2005.08.016; Moran PAP, 1957, T AM GEOPHYS UNION, V38, P519, DOI [10.1029/tr038i004p00519.4., DOI 10.1029/TR038I004P00519]; NERC (Natural Environment Research Council), 1975, FLOOD STUD REP, V1; QUESENBERRY CP, 1982, TECHNOMETRICS, V24, P59, DOI 10.2307/1267579; Rao AR., 2000, NEW D CIV E, V1, P376; Rowinski PM, 2002, HYDROLOG SCI J, V47, P107, DOI 10.1080/02626660209492911; Strupczewski W. G., 2002, Acta Geophysica Polonica, V50, P433; Strupczewski W. G., 2003, Acta Geophysica Polonica, V51, P85; Strupczewski W. G., 2006, STOCH ENV RES RISK A, V18, P1, DOI [10.1007/s00477-004-0210-8, DOI 10.1007/S00477-004-0210-8]; Strupczewski WG, 2002, J HYDROL, V258, P122, DOI 10.1016/S0022-1694(01)00563-7; Strupczewski WG, 2001, HYDROLOG SCI J, V46, P761, DOI 10.1080/02626660109492869; Strupczewski WG, 2011, HYDROL RES, V42, P171, DOI 10.2166/nh.2011.062; Weglarczyk S, 2002, HYDROLOG SCI J, V47, P123, DOI 10.1080/02626660209492912	57	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0143965	10.1371/journal.pone.0143965	http://dx.doi.org/10.1371/journal.pone.0143965			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657239	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903500009
J	Martelli, N; Devaux, C; van den Brink, H; Pineau, J; Prognon, P; Borget, I				Martelli, Nicolas; Devaux, Capucine; van den Brink, Helene; Pineau, Judith; Prognon, Patrice; Borget, Isabelle			A Systematic Review of the Level of Evidence in Economic Evaluations of Medical Devices: The Example of Vertebroplasty and Kyphoplasty	PLOS ONE			English	Review							VERTEBRAL COMPRESSION FRACTURES; COST-EFFECTIVENESS ANALYSIS; PERCUTANEOUS VERTEBROPLASTY; BALLOON KYPHOPLASTY; QUALITY; PHARMACEUTICALS; SURGERY	Context Economic evaluations are far less frequently reported for medical devices than for drugs. In addition, little is known about the quality of existing economic evaluations, particularly for innovative devices, such as those used in vertebroplasty and kyphoplasty. Objective To assess the level of evidence provided by the available economic evaluations for vertebroplasty and kyphoplasty. Data Sources A systematic review of articles in English or French listed in the MEDLINE, PASCAL, COCHRANE and National Health Service Economic Evaluation databases, with limits on publication date (up to the date of the review, March 2014). Study Selection We included only economic evaluations of vertebroplasty or kyphoplasty. Editorial and methodological articles were excluded. Data Extraction Data were extracted from articles by two authors working independently and using two analysis grids to measure the quality of economic evaluations. Data Synthesis Twenty-one studies met our inclusion criteria. All were published between 2008 and 2014. Eighteen (86%) were full economic evaluations. Cost-effectiveness analysis (CEA) was the most frequent type of economic evaluation, and was present in 11 (52%) studies. Only three CEAs complied fully with the British Medical Journal checklist. The quality of the data sources used in the 21 studies was high, but the CEAs conforming to methodological guidelines did not use high-quality data sources for all components of the analysis. Conclusions This systematic review shows that the level of evidence in economic evaluations of vertebroplasty and kyphoplasty is low, despite the recent publication of a large number of studies. This finding highlights the challenges to be faced to improve the quality of economic evaluations of medical devices.	[Martelli, Nicolas; Devaux, Capucine; Pineau, Judith; Prognon, Patrice] Georges Pompidou European Hosp, AP HP, Dept Pharm, F-75015 Paris, France; [Martelli, Nicolas; van den Brink, Helene; Borget, Isabelle] Univ Paris Saclay, Univ Paris 11, GRADES, Chatenay Malabry, France; [Borget, Isabelle] Inst Gustave Roussy, Dept Hlth Econ, F-94805 Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Martelli, N (corresponding author), Georges Pompidou European Hosp, AP HP, Dept Pharm, 20 Rue Leblanc, F-75015 Paris, France.	nicolas.martelli@aphp.fr	Martelli, Nicolas/ABB-2722-2021	Martelli, Nicolas/0000-0001-5959-231X; Borget, Isabelle/0000-0002-6295-6361				Azimi NA, 1998, J GEN INTERN MED, V13, P664, DOI 10.1046/j.1525-1497.1998.00201.x; Barbieri M, 2001, Curr Oncol Rep, V3, P410, DOI 10.1007/s11912-001-0027-2; Becker S, 2011, EUR SPINE J, V20, P1259, DOI 10.1007/s00586-011-1692-y; Boudard A, 2013, J EVAL CLIN PRACT, V19, P697, DOI 10.1111/jep.12024; Chew C, 2013, CLIN RADIOL, V68, P776, DOI 10.1016/j.crad.2013.02.009; Cookson R, 2003, HEALTH POLICY, V63, P167, DOI 10.1016/S0168-8510(02)00063-5; Cooper Nicola, 2005, J Health Serv Res Policy, V10, P245, DOI 10.1258/135581905774414187; Drummond M, 2005, MED CARE, V43, P5; Drummond M, 2009, VALUE HEALTH, V12, P402, DOI 10.1111/j.1524-4733.2008.00476_1.x; Drummond MF, 2008, INT J TECHNOL ASSESS, V24, P244, DOI 10.1017/S0266462308080343; Edidin AA, 2012, APPL HEALTH ECON HEA, V10, P273, DOI 10.2165/11633220-000000000-00000; Flug J, 2013, PAIN PHYSICIAN, V16, P441; Fritzell P, 2011, SPINE, V36, P2243, DOI 10.1097/BRS.0b013e3182322d0f; Gan MF, 2014, ACTA RADIOL, V55, P985, DOI 10.1177/0284185113511603; Gerkens S, 2008, INT J TECHNOL ASSESS, V24, P318, DOI 10.1017/S0266462308080422; Goz V, 2013, SPINE J; Gray DT, 2008, SPINE, V33, P1905, DOI 10.1097/BRS.0b013e31817bb0a4; Hart RA, 2008, SPINE J, V8, P875, DOI 10.1016/j.spinee.2008.01.015; Holroyd C, 2008, BEST PRACT RES CL EN, V22, P671, DOI 10.1016/j.beem.2008.06.001; Hoomans T, 2012, PHARMACOECONOMICS, V30, P219, DOI 10.2165/11539850-000000000-00000; Iglesias CP, 2015, EXPERT REV PHARM OUT, V15, P21, DOI 10.1586/14737167.2015.982098; Itagaki MW, 2012, J VASC INTERV RADIOL, V23, P1423, DOI 10.1016/j.jvir.2012.08.010; Jefferson T, 2002, JAMA-J AM MED ASSOC, V287, P2809, DOI 10.1001/jama.287.21.2809; Kamdem AF, 2015, J PEDIATR SURG, V50, P659, DOI 10.1016/j.jpedsurg.2015.01.012; Kirisits A, 2013, APPL HEALTH ECON HEA, V11, P15, DOI 10.1007/s40258-012-0006-9; Krimsky S, 1999, JAMA-J AM MED ASSOC, V282, P1474, DOI 10.1001/jama.282.15.1474; Lad SP, 2009, SURG NEUROL, V71, P580, DOI 10.1016/j.surneu.2008.02.043; Lange A, 2014, SPINE, V39, P318, DOI 10.1097/BRS.0000000000000135; Liljas B, 1998, PHARMACOECONOMICS, V13, P1, DOI 10.2165/00019053-199813010-00001; Masala S, 2008, EUR SPINE J, V17, P1242, DOI 10.1007/s00586-008-0708-8; Mehio AK, 2011, AM J NEURORADIOL, V32, P1290, DOI 10.3174/ajnr.A2502; Mohandas Anita, 2010, Biotechnol Healthc, V7, P25; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Ong KL, 2013, OSTEOPOROSIS INT, V24, P1437, DOI 10.1007/s00198-012-2100-0; Sedrakyan A, 2010, MED CARE, V48, pS121, DOI 10.1097/MLR.0b013e3181d991c4; Shemilt I, 2008, COCHRANE HDB SYSTEMA, P449, DOI DOI 10.1002/14651858.CD004741.PUB2; SILVERMAN SL, 1992, BONE, V13, pS27, DOI 10.1016/8756-3282(92)90193-Z; Sorenson C, 2013, CLINICOECONOMICS OUT, P223, DOI [10.2147/CEOR.S39634, DOI 10.2147/CEOR.S39634]; Stevenson M, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18170; Strom O, 2010, OSTEOPOROSIS INT, V21, P1599, DOI 10.1007/s00198-009-1096-6; Svedbom A, 2013, OSTEOPOROSIS INT, V24, P355, DOI 10.1007/s00198-012-2102-y; Takura T, 2013, J SPINAL DISORDERS T; Tang H, 2011, J INT MED RES, V39, P1438, DOI 10.1177/147323001103900432; Teerawattananon DY, 2012, PHARMACOECONOMICS, V25, P467, DOI [10.2165/00019053-200725060-00003, DOI 10.2165/00019053-200725060-00003]; Torrance GW, 2005, METHODS EC EVALUATIO; Voidey A, 2014, PHARMACIEN HOSP CLIN, V49, P77, DOI [10.1016/j.phclin.2013.05.008, DOI 10.1016/J.PHCLIN.2013.05.008]; Voormolen MHJ, 2007, AM J NEURORADIOL, V28, P555; Walker DG, 2012, BEST PRACTICES CONDU; Wardlaw D, 2009, LANCET, V373, P1016, DOI 10.1016/S0140-6736(09)60010-6; Zampini JM, 2010, CLIN ORTHOP RELAT R, V468, P1773, DOI 10.1007/s11999-010-1279-7; Zoarski GH, 2002, J VASC INTERV RADIOL, V13, P139, DOI 10.1016/S1051-0443(07)61930-7	51	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144892	10.1371/journal.pone.0144892	http://dx.doi.org/10.1371/journal.pone.0144892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26661078	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903500065
J	Cho, KS; Do Jung, H; Ham, WS; Chung, DY; Kang, YJ; Jang, WS; Kwon, JK; Choi, YD; Lee, JY				Cho, Kang Su; Do Jung, Hae; Ham, Won Sik; Chung, Doo Yong; Kang, Yong Jin; Jang, Won Sik; Kwon, Jong Kyou; Choi, Young Deuk; Lee, Joo Yong			Optimal Skin-to-Stone Distance Is a Positive Predictor for Successful Outcomes in Upper Ureter Calculi following Extracorporeal Shock Wave Lithotripsy: A Bayesian Model Averaging Approach	PLOS ONE			English	Article							NONCONTRAST COMPUTED-TOMOGRAPHY; FREE RATES; PARAMETERS; MANAGEMENT; SELECTION; DENSITY	Objectives To investigate whether skin-to-stone distance (SSD), which remains controversial in patients with ureter stones, can be a predicting factor for one session success following extracorporeal shock wave lithotripsy (ESWL) in patients with upper ureter stones. Patients and Methods We retrospectively reviewed the medical records of 1,519 patients who underwent their first ESWL between January 2005 and December 2013. Among these patients, 492 had upper ureter stones that measured 4-20 mm and were eligible for our analyses. Maximal stone length, mean stone density (HU), and SSD were determined on pretreatment non-contrast computed tomography (NCCT). For subgroup analyses, patients were divided into four groups. Group 1 consisted of patients with SSD<25th percentile, group 2 consisted of patients with SSD in the 25th to 50th percentile, group 3 patients had SSD in the 50th to 75th percentile, and group 4 patients had SSD >= 75th percentile. Results In analyses of group 2 patients versus others, there were no statistical differences in mean age, stone length and density. However, the one session success rate in group 2 was higher than other groups (77.9% vs. 67.0%; P = 0.032). The multivariate logistic regression model revealed that shorter stone length, lower stone density, and the group 2 SSD were positive predictors for successful outcomes in ESWL. Using the Bayesian model-averaging approach, longer stone length, lower stone density, and group 2 SSD can be also positive predictors for successful outcomes following ESWL. Conclusions Our data indicate that a group 2 SSD of approximately 10 cm is a positive predictor for success following ESWL.	[Cho, Kang Su] Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol,Gangnam Severance Hosp, Seoul, South Korea; [Do Jung, Hae] Incheon Red Cross Hosp, Dept Urol, Incheon, South Korea; [Ham, Won Sik; Chung, Doo Yong; Kang, Yong Jin; Jang, Won Sik; Choi, Young Deuk; Lee, Joo Yong] Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol,Severance Hosp, Seoul, South Korea; [Kwon, Jong Kyou] Yonsei Univ Hlth Syst, Dept Urol, Severance Check Up, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, JY (corresponding author), Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol,Severance Hosp, Seoul, South Korea.	joouro@yuhs.ac	Lee, Joo Yong/C-3851-2013	Lee, Joo Yong/0000-0002-3470-1767; Ham, Won Sik/0000-0003-2246-8838; Choi, Young Deuk/0000-0002-8545-5797; Jang, Won Sik/0000-0002-9082-0381; Cho, Kang Su/0000-0002-3500-8833	Yonsei University College of Medicine [6-2014-0156]	Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant from the Yonsei University College of Medicine for 2014 (6-2014-0156).	Bandi G, 2009, BJU INT, V103, P524, DOI 10.1111/j.1464-410X.2008.08069.x; Berry DA, 2006, NAT REV DRUG DISCOV, V5, P27, DOI 10.1038/nrd1927; Bhojani N, 2013, UROL CLIN N AM, V40, P59, DOI 10.1016/j.ucl.2012.09.001; Choi JW, 2012, KOREAN J UROL, V53, P424, DOI 10.4111/kju.2012.53.6.424; Cleveland RO, 1998, ULTRASOUND MED BIOL, V24, P293, DOI 10.1016/S0301-5629(97)00270-6; El-Nahas AR, 2007, EUR UROL, V51, P1688, DOI 10.1016/j.eururo.2006.11.048; ERTURK E, 1993, J UROLOGY, V149, P1425, DOI 10.1016/S0022-5347(17)36405-4; Galvin DJ, 2006, BJU INT, V98, P1283, DOI 10.1111/j.1464-410X.2006.06514.x; Geng JH, 2015, KAOHSIUNG J MED SCI, V31, P34, DOI 10.1016/j.kjms.2014.10.001; Gonulalan U, 2014, UROL INT, V92, P444, DOI 10.1159/000356562; Jacobs BL, 2008, J ENDOUROL, V22, P1623, DOI 10.1089/end.2008.0169; Kacker R, 2008, J UROLOGY, V179, P1866, DOI 10.1016/j.juro.2008.01.038; Kim IK, 2014, KOREAN J UROL, V55, P574, DOI 10.4111/kju.2014.55.9.574; Kwon SY, 2013, J ENDOUROL, V27, P1209, DOI 10.1089/end.2013.0347; Lee AS, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0834-y; Neisius A, 2015, WORLD J UROL, V33, P213, DOI 10.1007/s00345-014-1369-3; Ng CF, 2009, J UROLOGY, V181, P1151, DOI 10.1016/j.juro.2008.10.161; Pareek G, 2005, UROLOGY, V66, P941, DOI 10.1016/j.urology.2005.05.011; Pareek G, 2003, J UROLOGY, V169, P1679, DOI 10.1097/01.ju.0000055608.92069.3a; Pearle MS, 2012, NEW ENGL J MED, V367, P50, DOI 10.1056/NEJMct1103074; Perks AE, 2007, J UROLOGY, V178, P912, DOI 10.1016/j.juro.2007.05.043; Rush Elaine, 2004, N Z Med J, V117, pU1203; Seitz C, 2007, EUR UROL, V52, P1223, DOI 10.1016/j.eururo.2007.02.001; Tanaka M, 2013, KOREAN J UROL, V54, P454, DOI 10.4111/kju.2013.54.7.454; Tran TY, 2015, J ENDOUROL, V29, P226, DOI 10.1089/end.2014.0212; Wang DL, 2004, STAT MED, V23, P3451, DOI 10.1002/sim.1930; Weld KJ, 2007, UROLOGY, V70, P1043, DOI 10.1016/j.urology.2007.07.074; Wiesenthal JD, 2011, J UROLOGY, V186, P556, DOI 10.1016/j.juro.2011.03.109; Wiesenthal JD, 2010, UROL RES, V38, P307, DOI 10.1007/s00240-010-0295-0; Yeung KY, 2005, BIOINFORMATICS, V21, P2394, DOI 10.1093/bioinformatics/bti319	30	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144912	10.1371/journal.pone.0144912	http://dx.doi.org/10.1371/journal.pone.0144912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659086	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900147
J	Huisman, M; Staruch, RM; Ladouceur-Wodzak, M; van den Bosch, MA; Burns, DK; Chhabra, A; Chopra, R				Huisman, Merel; Staruch, Robert M.; Ladouceur-Wodzak, Michelle; van den Bosch, Maurice A.; Burns, Dennis K.; Chhabra, Avneesh; Chopra, Rajiv			Non-Invasive Targeted Peripheral Nerve Ablation Using 3D MR Neurography and MRI-Guided High-Intensity Focused Ultrasound (MR-HIFU): Pilot Study in a Swine Model	PLOS ONE			English	Article							CHRONIC PELVIC PAIN; PUDENDAL NEURALGIA; SCIATIC-NERVE; CANCER PAIN; FEASIBILITY; BLOCK; NEUROLYSIS; MANAGEMENT; DIAGNOSIS	Purpose Ultrasound (US)-guided high intensity focused ultrasound (HIFU) has been proposed for noninvasive treatment of neuropathic pain and has been investigated in in-vivo studies. However, ultrasound has important limitations regarding treatment guidance and temperature monitoring. Magnetic resonance (MR)-imaging guidance may overcome these limitations and MR-guided HIFU (MR-HIFU) has been used successfully for other clinical indications. The primary purpose of this study was to evaluate the feasibility of utilizing 3D MR neurography to identify and guide ablation of peripheral nerves using a clinical MR-HIFU system. Methods Volumetric MR-HIFU was used to induce lesions in the peripheral nerves of the lower limbs in three pigs. Diffusion-prep MR neurography and T1-weighted images were utilized to identify the target, plan treatment and immediate post-treatment evaluation. For each treatment, one 8 or 12 mm diameter treatment cell was used (sonication duration 20 s and 36 s, power 160-300 W). Peripheral nerves were extracted <3 hours after treatment. Ablation dimensions were calculated from thermal maps, post-contrast MRI and macroscopy. Histological analysis included standard H&E staining, Masson's trichrome and toluidine blue staining. Results All targeted peripheral nerves were identifiable on MR neurography and T1-weighted images and could be accurately ablated with a single exposure of focused ultrasound, with peak temperatures of 60.3 to 85.7 degrees C. The lesion dimensions as measured on MR neurography were similar to the lesion dimensions as measured on CE-T1, thermal dose maps, and macroscopy. Histology indicated major hyperacute peripheral nerve damage, mostly confined to the location targeted for ablation. Conclusion Our preliminary results indicate that targeted peripheral nerve ablation is feasible with MR-HIFU. Diffusion-prep 3D MR neurography has potential for guiding therapy procedures where either nerve targeting or avoidance is desired, and may also have potential for post-treatment verification of thermal lesions without contrast injection.	[Huisman, Merel; Staruch, Robert M.; Ladouceur-Wodzak, Michelle; Chhabra, Avneesh; Chopra, Rajiv] UT Southwestern Med Ctr, Dept Radiol, Dallas, TX 75390 USA; [Huisman, Merel; van den Bosch, Maurice A.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Burns, Dennis K.] UT Southwestern Med Ctr, Dept Pathol, Dallas, TX USA; [Staruch, Robert M.] Philips Res North Amer, Clin Sites Res Program, Briarcliff Manor, NY USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Utrecht University; Utrecht University Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Philips; Philips Research	Chopra, R (corresponding author), UT Southwestern Med Ctr, Dept Radiol, Dallas, TX 75390 USA.	Rajiv.chopra@utsouthwestern.edu	Chopra, Rajiv/A-8367-2013	Chopra, Rajiv/0000-0003-3605-6076	Cancer Prevention and Research Institute of Texas [R1308]; MR and Evelyn Hudson Foundation; Philips; NATIONAL CANCER INSTITUTE [R01CA199937] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; MR and Evelyn Hudson Foundation; Philips; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was generously provided by the Cancer Prevention and Research Institute of Texas (R1308, http://www.cprit.state.tx.us/) and the MR and Evelyn Hudson Foundation. The MR-HIFU system used in this study is a product of Philips Healthcare. Philips also provided support in the form of salaries for authors [RS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Chhabra A, 2011, AM J ROENTGENOL, V197, P583, DOI 10.2214/AJR.10.6012; Chopra R, 2012, RADIOLOGY, V265, P303, DOI 10.1148/radiol.12112263; Chopra R, 2009, MED PHYS, V36, P1867, DOI 10.1118/1.3115680; Colucci V, 2009, ULTRASOUND MED BIOL, V35, P1737, DOI 10.1016/j.ultrasmedbio.2009.05.002; Elias WJ, 2013, NEW ENGL J MED, V369, P640, DOI 10.1056/NEJMoa1300962; Ellens NPK, 2015, MED PHYS, V42, P430, DOI 10.1118/1.4903950; Fanucci E, 2009, RADIOL MED, V114, P425, DOI 10.1007/s11547-009-0371-0; Fite BZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035509; Foley JL, 2008, MUSCLE NERVE, V37, P241, DOI 10.1002/mus.20932; Foley JL, 2007, ANN BIOMED ENG, V35, P109, DOI 10.1007/s10439-006-9162-0; Fritz J, 2014, NEUROIMAG CLIN N AM, V24, P211, DOI 10.1016/j.nic.2013.03.028; Fritz J, 2013, SKELETAL RADIOL, V42, P579, DOI 10.1007/s00256-012-1553-8; Gulati A, 2012, PAIN MANAG, V2, P569, DOI [10.2217/pmt.12.61, 10.2217/PMT.12.61]; Gulati A, 2014, REGION ANESTH PAIN M, V39, P26, DOI 10.1097/AAP.0000000000000028; Harnof S, 2014, J THER ULTRASOUND, V2, DOI 10.1186/2050-5736-2-9; Hurwitz MD, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju082; HYNYNEN K, 1993, MED PHYS, V20, P107, DOI 10.1118/1.597093; Izumi M, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-267; Kasper JM, 2015, EUR RADIOL, V25, P1672, DOI 10.1007/s00330-014-3552-8; Kasper JM, 2014, CLIN IMAG, V38, P540, DOI 10.1016/j.clinimag.2014.02.017; Kastler A, 2012, RADIOLOGY, V262, P701, DOI 10.1148/radiol.11110727; Kaye EA, 2015, CARDIOVASC INTER RAD, V38, P985, DOI 10.1007/s00270-015-1141-0; Kohler MO, 2009, MED PHYS, V36, P3521, DOI 10.1118/1.3152112; Lee YF, 2015, ULTRASOUND MED BIOL, V41, P132, DOI 10.1016/j.ultrasmedbio.2014.08.014; Mamlouk MD, 2014, AM J ROENTGENOL, V203, P196, DOI 10.2214/AJR.13.11346; McDannold N, 2006, RADIOLOGY, V240, P263, DOI 10.1148/radiol.2401050717; Monteith SJ, 2013, J NEUROSURG, V118, P319, DOI 10.3171/2012.10.JNS12186; Morrissey D, 2014, CURR OPIN UROL, V24, P336, DOI 10.1097/MOU.0000000000000062; Peng PWH, 2008, PAIN PHYSICIAN, V11, P215; Raslan AM, 2011, J NEUROSURG, V114, P155, DOI 10.3171/2010.6.JNS10119; Robert R, 2005, EUR UROL, V47, P403, DOI 10.1016/j.eururo.2004.09.003; Rofaeel A, 2008, REGION ANESTH PAIN M, V33, P139, DOI 10.1016/j.rapm.2007.10.004; Schroder JM, 2012, PATHOLOGY PERIPHERAL; ter Haar G, 2012, INTERVENTIONAL ONCOLOGY: A PRACTICAL GUIDE FOR THE INTERVENTIONAL RADIOLOGIST, P51, DOI 10.1007/978-1-4419-1469-9_5; Voogt MJ, 2011, EUR RADIOL; VUJASKOVIC Z, 1994, INT J HYPERTHER, V10, P845, DOI 10.3109/02656739409012377; Weeks EM, 2012, EUR RADIOL, V22, P2822, DOI 10.1007/s00330-012-2628-6; Yoneyama M, 2013, MAGN RESON MED SCI, V12, P111, DOI 10.2463/mrms.2012-0063	38	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144742	10.1371/journal.pone.0144742	http://dx.doi.org/10.1371/journal.pone.0144742			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659073	gold, Green Published			2022-12-27	WOS:000366715900099
J	Zaychikova, MV; Zakharevich, NV; Sagaidak, MO; Bogolubova, NA; Smirnova, TG; Andreevskaya, SN; Larionova, EE; Alekseeva, MG; Chernousova, LN; Danilenko, VN				Zaychikova, Marina V.; Zakharevich, Natalia V.; Sagaidak, Maria O.; Bogolubova, Nadezhda A.; Smirnova, Tatiana G.; Andreevskaya, Sofya N.; Larionova, Elena E.; Alekseeva, Maria G.; Chernousova, Larisa N.; Danilenko, Valery N.			Mycobacterium tuberculosis Type II Toxin-Antitoxin Systems: Genetic Polymorphisms and Functional Properties and the Possibility of Their Use for Genotyping	PLOS ONE			English	Article							BEIJING GENOTYPE; STRAINS; VIRULENCE; BACTERIA; IDENTIFICATION; RIBONUCLEASES; RESISTANCE; TOLERANCE; CLEAVAGE; LINEAGE	Various genetic markers such as IS-elements, DR-elements, variable number tandem repeats (VNTR), single nucleotide polymorphisms (SNPs) in housekeeping genes and other groups of genes are being used for genotyping. We propose a different approach. We suggest the type II toxin-antitoxin (TA) systems, which play a significant role in the formation of pathogenicity, tolerance and persistence phenotypes, and thus in the survival of Mycobacterium tuberculosis in the host organism at various developmental stages (colonization, infection of macrophages, etc.), as the marker genes. Most genes of TA systems function together, forming a single network: an antitoxin from one pair may interact with toxins from other pairs and even from other families. In this work a bioinformatics analysis of genes of the type II TA systems from 173 sequenced genomes of M. tuberculosis was performed. A number of genes of type II TA systems were found to carry SNPs that correlate with specific genotypes. We propose a minimally sufficient set of genes of TA systems for separation of M. tuberculosis strains at nine basic genotype and for further division into subtypes. Using this set of genes, we genotyped a collection consisting of 62 clinical isolates of M. tuberculosis. The possibility of using our set of genes for genotyping using PCR is also demonstrated.	[Zaychikova, Marina V.; Zakharevich, Natalia V.; Sagaidak, Maria O.; Bogolubova, Nadezhda A.; Alekseeva, Maria G.; Danilenko, Valery N.] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Smirnova, Tatiana G.; Andreevskaya, Sofya N.; Larionova, Elena E.; Chernousova, Larisa N.] Cent Res Inst TB, Moscow, Russia; [Zaychikova, Marina V.; Danilenko, Valery N.] Sci Res Ctr Biotechnol Antibiot BIOAN, Moscow, Russia; [Sagaidak, Maria O.] State Univ, Moscow Inst Phys & Technol, Moscow, Russia	Russian Academy of Sciences; Vavilov Institute of General Genetics; Moscow Institute of Physics & Technology	Danilenko, VN (corresponding author), Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia.	valeridanilenko@yandex.ru	Smirnova, Tatiana G/H-4613-2014; Zakharevich, Natalia/L-3746-2016; Danilenko, Valery/K-2751-2015; Zaychikova, Marina V/F-3491-2017; Alekseeva, Maria/ABG-4819-2021	Zakharevich, Natalia/0000-0001-9336-2884; Alekseeva, Maria/0000-0002-0358-7017; Danilenko, Valery/0000-0001-5780-0621; Larionova, Elena/0000-0002-6032-175X				Arcus VL, 2011, PROTEIN ENG DES SEL, V24, P33, DOI 10.1093/protein/gzq081; Averina O, 2015, ANAEROBE, V35, P59, DOI 10.1016/j.anaerobe.2015.07.007; Beste DJV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005349; Chuang PC, 2010, J CLIN MICROBIOL, V48, P4245, DOI 10.1128/JCM.00970-10; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; De la Cruz MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003827; Demidenok OI, 2014, FEMS MICROBIOL LETT, V352, P69, DOI 10.1111/1574-6968.12380; Faksri K, 2014, ASIAN PAC J ALLERGY, V32, P124, DOI 10.12932/AP0361.32.2.2013; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Georgiades K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017962; Homolka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039855; Hurley JM, 2009, J BIOL CHEM, V284, P18605, DOI 10.1074/jbc.M109.008763; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; Jagielski T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/645802; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Klimina KM, 2013, ANAEROBE, V22, P82, DOI 10.1016/j.anaerobe.2013.05.007; Komi KK, 2015, MICROBES INFECT, V17, P34, DOI 10.1016/j.micinf.2014.10.010; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lasunskaia E, 2010, MICROBES INFECT, V12, P467, DOI 10.1016/j.micinf.2010.02.008; Leung V, 2012, J BACTERIOL, V194, P2265, DOI 10.1128/JB.06707-11; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Maslov DA, 2015, TUBERCULOSIS, V95, P608, DOI 10.1016/j.tube.2015.05.013; Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195; Mokrousov I, 2013, CLIN MICROBIOL REV, V26, P342, DOI 10.1128/CMR.00087-12; Mokrousov I, 2012, J CLIN MICROBIOL, V50, P3757, DOI 10.1128/JCM.02001-12; Mokrousov I, 2012, INFECT GENET EVOL, V12, P619, DOI 10.1016/j.meegid.2011.09.026; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Prozorov AA, 2014, RUSS J GENET+, V50, P775, DOI 10.1134/S1022795414080055; Prozorov AA, 2010, MICROBIOLOGY+, V79, P129, DOI 10.1134/S0026261710020013; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Reiling N, 2013, MBIO, V4, DOI 10.1128/mBio.00250-13; Ribeiro SCM, 2014, J CLIN MICROBIOL, V52, P2615, DOI 10.1128/JCM.00498-14; Rindi L, 2012, INFECT GENET EVOL, V12, P1551, DOI 10.1016/j.meegid.2012.06.008; Sala A, 2014, TOXINS, V6, P1002, DOI 10.3390/toxins6031002; Sandegren L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016647; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Shur KV, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00403-15; Simic M, 2009, J BIOL CHEM, V284, P20002, DOI 10.1074/jbc.M109.014035; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tiwari P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7059; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Wang YN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135696; Winther KS, 2012, NUCLEIC ACIDS RES, V40, P4347, DOI 10.1093/nar/gks029; Xu YH, 2015, CRIT REV MICROBIOL, V41, P399, DOI 10.3109/1040841X.2013.860948; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Yuan J, 2010, J BIOL CHEM, V285, P40397, DOI 10.1074/jbc.M110.138776; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	50	22	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143682	10.1371/journal.pone.0143682	http://dx.doi.org/10.1371/journal.pone.0143682			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658274	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900016
J	Ahnaou, A; Lavreysen, H; Tresadern, G; Cid, JM; Drinkenburg, WH				Ahnaou, Abdallah; Lavreysen, Hilde; Tresadern, Gary; Cid, Jose M.; Drinkenburg, Wilhelmus H.			mGlu2 Receptor Agonism, but Not Positive Allosteric Modulation, Elicits Rapid Tolerance towards Their Primary Efficacy on Sleep Measures in Rats	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; CENTRAL-NERVOUS-SYSTEM; GROUP-II; REM-SLEEP; SUPRACHIASMATIC NUCLEUS; PHARMACOLOGICAL CHARACTERIZATION; ACETYLCHOLINE-RELEASE; PREFRONTAL CORTEX; MOOD DISORDERS; AMYGDALA	G-protein-coupled receptor (GPCR) agonists are known to induce both cellular adaptations resulting in tolerance to therapeutic effects and withdrawal symptoms upon treatment discontinuation. Glutamate neurotransmission is an integral part of sleep-wake mechanisms, which processes have translational relevance for central activity and target engagement. Here, we investigated the efficacy and tolerance potential of the metabotropic glutamate receptors (mGluR2/3) agonist LY354740 versus mGluR2 positive allosteric modulator (PAM) JNJ-42153605 on sleep-wake organisation in rats. In vitro, the selectivity and potency of JNJ-42153605 were characterized. In vivo, effects on sleep measures were investigated in rats after once daily oral repeated treatment for 7 days, withdrawal and consecutive re-administration of LY354740 (1-10 mg/kg) and JNJ-42153605 (3-30 mg/kg). JNJ-42153605 showed high affinity, potency and selectivity at mGluR2. Binding site analyses and knowledge-based docking confirmed the specificity of JNJ-42153605 at the mGluR2 allosteric binding site. Acute LY354740 and JNJ-42153605 dose-dependently decreased rapid eye movement (REM) sleep time and prolonged its onset latency. Sub chronic effects of LY354740 on REM sleep measures disappeared from day 3 onwards, whereas those of JNJ-42153605 were maintained after repeated exposure. LY354740 attenuated REM sleep homeostatic recovery, while this was preserved after JNJ-42153605 administration. JNJ-42153605 enhanced sleep continuity and efficiency, suggesting its potential as an add-on medication for impaired sleep quality during early stages of treatment. Abrupt cessation of JNJ-42153605 did not induce withdrawal phenomena and sleep disturbances, while the initial drug effect was fully reinstated after re-administration. Collectively, long-term treatment with JNJ-42153605 did not induce tolerance phenomena to its primary functional effects on sleep measures, nor adverse effects at withdrawal, while it promoted homeostatic recovery sleep. From the translational perspective, the present rodent findings suggest that mGluR2 positive allosteric modulation has therapeutic potential based on its superior long term efficacy over agonists in psychiatric disorders, particularly of those commonly occurring with REM sleep overdrive.	[Ahnaou, Abdallah; Lavreysen, Hilde; Drinkenburg, Wilhelmus H.] Janssen Res & Dev, Dept Neurosci, B-2340 Beerse, Belgium; [Tresadern, Gary; Cid, Jose M.] Janssen Cilag SA, Janssen Res & Dev, Neurosci Med Chem, Toledo 45007, Spain	Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson	Ahnaou, A (corresponding author), Janssen Res & Dev, Dept Neurosci, Turnhoutseweg 30, B-2340 Beerse, Belgium.	aahnaou@its.jnj.com		Drinkenburg, Wilhelmus/0000-0002-1095-7995; Tresadern, Gary/0000-0002-4801-1644	Janssen Research Development	Janssen Research Development	All authors are employed by Janssen Research & Development. Janssen Research & Development provided support in the form of salaries for authors [AA, HL, GT, CJ and WD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahnaou A, 2014, BEHAV BRAIN RES, V270, P56, DOI 10.1016/j.bbr.2014.05.003; Ahnaou A, 2009, EUR J PHARMACOL, V603, P62, DOI 10.1016/j.ejphar.2008.11.018; American Psychiatric Association, 2000, TASK FORC DSM 4 DIAG; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; BORBELY AA, 1992, J SLEEP RES, V1, P63, DOI 10.1111/j.1365-2869.1992.tb00013.x; Campbell IG, 1996, J NEUROPHYSIOL, V76, P3714, DOI 10.1152/jn.1996.76.6.3714; Cartmell J, 2000, N-S ARCH PHARMACOL, V361, P39, DOI 10.1007/s002109900151; Chaki S, 2011, CURR PHARM DESIGN, V17, P94, DOI 10.2174/138161211795049570; Cohrs S, 2008, CNS DRUGS, V22, P939, DOI 10.2165/00023210-200822110-00004; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P25, DOI 10.1016/j.tips.2008.10.006; Cui LN, 2001, AM J PHYSIOL-REG I, V281, pR1283, DOI 10.1152/ajpregu.2001.281.4.R1283; Datta S, 2001, AM J PHYSIOL-REG I, V280, pR752, DOI 10.1152/ajpregu.2001.280.3.R752; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Dong EH, 2012, BRAIN RES, V1452, P85, DOI 10.1016/j.brainres.2012.03.003; Doornbos MLJ, 2015, MOL MECH POSIT UNPUB; Dore AS, 2014, NATURE, V511, P557, DOI 10.1038/nature13396; El Moustaine D, 2012, P NATL ACAD SCI USA, V109, P16342, DOI 10.1073/pnas.1205838109; Farinha A, 2015, BRIT J PHARMACOL, V172, P2383, DOI 10.1111/bph.13065; Feinberg I, 2005, J PHARMACOL EXP THER, V312, P826, DOI 10.1124/jpet.104.076547; Fell MJ, 2011, J PHARMACOL EXP THER, V336, P165, DOI 10.1124/jpet.110.172957; Fell MJ, 2010, NEUROPHARMACOLOGY, V58, P632, DOI 10.1016/j.neuropharm.2009.11.014; FEUILLADE P, 1992, J AFFECT DISORDERS, V24, P135, DOI 10.1016/0165-0327(92)90061-A; Fraley ME, 2009, EXPERT OPIN THER PAT, V19, P1259, DOI 10.1517/13543770903045009; Gewirtz JC, 2000, NEUROPSYCHOPHARMACOL, V23, P569, DOI 10.1016/S0893-133X(00)00136-6; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Gu GB, 2008, BRAIN RES, V1197, P47, DOI 10.1016/j.brainres.2007.12.057; Guthrie CR, 2005, J PHARMACOL EXP THER, V313, P1003, DOI 10.1124/jpet.104.081919; Helton DR, 1998, J PHARMACOL EXP THER, V284, P651; Hemstapat K, 2007, J PHARMACOL EXP THER, V322, P254, DOI 10.1124/jpet.106.117093; Hermes MLHJ, 1996, J PHYSIOL-LONDON, V496, P749, DOI 10.1113/jphysiol.1996.sp021724; Hikichi H, 2013, J PHARMACOL SCI, V122, P10, DOI 10.1254/jphs.13036FP; Imre G, 2006, EUR J PHARMACOL, V544, P77, DOI 10.1016/j.ejphar.2006.06.037; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Ivarsson M, 2005, EUR J PHARMACOL, V522, P63, DOI 10.1016/j.ejphar.2005.08.050; Jha SK, 2005, PHYSIOL BEHAV, V86, P415, DOI 10.1016/j.physbeh.2005.06.033; JONES BE, 1991, NEUROSCIENCE, V40, P637, DOI 10.1016/0306-4522(91)90002-6; Jones CK, 2005, NEUROPHARMACOLOGY, V49, P206, DOI 10.1016/j.neuropharm.2005.05.008; Kahn M, 2013, INT J PSYCHOPHYSIOL, V89, P218, DOI 10.1016/j.ijpsycho.2013.05.010; Kalinchuk AV, 2008, NEUROSCIENCE, V157, P238, DOI 10.1016/j.neuroscience.2008.08.040; Kaur S, 2008, J NEUROSCI, V28, P491, DOI 10.1523/JNEUROSCI.1585-07.2008; Kerkhof GA, 2010, PROG BRAIN RES, V185, P49, DOI 10.1016/B978-0-444-53702-7.00004-X; Kingston AE, 1998, NEUROPHARMACOLOGY, V37, P1, DOI 10.1016/S0028-3908(97)00191-3; Kodama T, 1998, BRAIN RES, V780, P178, DOI 10.1016/S0006-8993(97)01308-5; Landolt HP, 2009, EUR J NEUROSCI, V29, P1795, DOI 10.1111/j.1460-9568.2009.06718.x; Landolt HP, 2001, ARCH GEN PSYCHIAT, V58, P268, DOI 10.1001/archpsyc.58.3.268; Lavreysen H, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.96; Lavreysen H, 2013, J PHARMACOL EXP THER, V346, P514, DOI 10.1124/jpet.113.204990; Leonard TO, 1997, J NEUROSCI, V17, P774; Linden A.M., 2006, DRUG DISCOV TODAY, V3, P507; Linden AM, 2006, NEUROPHARMACOLOGY, V51, P213, DOI 10.1016/j.neuropharm.2006.03.014; Lopez-Rodriguez F, 2007, ARCH MED RES, V38, P52, DOI 10.1016/j.arcmed.2006.07.004; Lorrain DS, 2003, NEUROSCIENCE, V117, P697, DOI 10.1016/S0306-4522(02)00652-8; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Lundstrom L, 2011, BRIT J PHARMACOL, V164, P521, DOI 10.1111/j.1476-5381.2011.01409.x; Marek GJ, 2000, J PHARMACOL EXP THER, V292, P76; Marek GJ, 2001, NEUROSCIENCE, V105, P379, DOI 10.1016/S0306-4522(01)00199-3; Cid JM, 2012, J MED CHEM, V55, P8770, DOI 10.1021/jm3010724; Marti M, 2003, J NEUROCHEM, V84, P792, DOI 10.1046/j.1471-4159.2003.01569.x; Mayers AG, 2005, HUM PSYCHOPHARM CLIN, V20, P533, DOI 10.1002/hup.726; Mela F, 2006, MOL CELL NEUROSCI, V31, P284, DOI 10.1016/j.mcn.2005.09.016; Naylor E, 2011, J ELECTROANAL CHEM, V656, P106, DOI 10.1016/j.jelechem.2010.12.031; Neckelmann D, 1996, BEHAV BRAIN RES, V79, P183, DOI 10.1016/0166-4328(96)00013-7; OHISHI H, 1993, NEUROSCIENCE, V53, P1009, DOI 10.1016/0306-4522(93)90485-X; Palucha A, 2007, PHARMACOL THERAPEUT, V115, P116, DOI 10.1016/j.pharmthera.2007.04.007; Parmentier-Batteur S, 2012, NEUROPHARMACOLOGY, V62, P1453, DOI 10.1016/j.neuropharm.2010.11.013; Perreau-Lenz S, 2004, EUR J NEUROSCI, V19, P318, DOI 10.1111/j.0953-816X.2003.03132.x; Peterson MJ, 2006, PSYCHIAT CLIN N AM, V29, P1009, DOI 10.1016/j.psc.2006.09.003; Pisani A, 2002, J NEUROSCI, V22, P6176; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Riegel AC, 2003, NEUROPSYCHOPHARMACOL, V28, P1440, DOI 10.1038/sj.npp.1300193; Rowe BA, 2008, J PHARMACOL EXP THER, V326, P240, DOI 10.1124/jpet.108.138271; Saletu-Zyhlarz GM, 2002, METHOD FIND EXP CLIN, V24, P37; Sanford LD, 2002, BRAIN RES, V956, P276, DOI 10.1016/S0006-8993(02)03552-7; Schaffhauser H, 2003, MOL PHARMACOL, V64, P798, DOI 10.1124/mol.64.4.798; Schoepp Darryle D., 2002, Current Drug Targets - CNS and Neurological Disorders, V1, P215, DOI 10.2174/1568007024606177; Shea JL, 2008, BRAIN RES, V1213, P48, DOI 10.1016/j.brainres.2008.03.062; Silvestri R, 2001, J CLIN PSYCHIAT, V62, P642, DOI 10.4088/JCP.v62n0812; Smialowska M, 2002, FOLIA HISTOCHEM CYTO, V40, P153; Smolders I, 2004, J NEUROCHEM, V88, P1068, DOI 10.1046/j.1471-4159.2003.02251.x; Sodhi Monsheel, 2008, Expert Rev Neurother, V8, P1389, DOI 10.1586/14737175.8.9.1389; Steiger A, 2010, J PSYCHIATR RES, V44, P242, DOI 10.1016/j.jpsychires.2009.08.013; Sun X, 2001, EUR J NEUROSCI, V14, P1257, DOI 10.1046/j.0953-816x.2001.0001755.x; Swanson CJ, 2005, NAT REV DRUG DISCOV, V4, P131, DOI 10.1038/nrd1630; Tamaru Y, 2001, NEUROSCIENCE, V106, P481, DOI 10.1016/S0306-4522(01)00305-0; Tang XD, 2005, SLEEP, V28, P923, DOI 10.1093/sleep/28.8.923; Thase Michael E, 2006, Dialogues Clin Neurosci, V8, P217; Tsuno N, 2005, J CLIN PSYCHIAT, V66, P1254, DOI 10.4088/JCP.v66n1008; Turner JP, 2003, NEUROSCIENCE, V122, P459, DOI 10.1016/j.neuroscience.2003.08.014; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; Wilson S, 2005, DRUGS, V65, P927, DOI 10.2165/00003495-200565070-00003; Witkin Jeffrey M., 2007, CNS & Neurological Disorders-Drug Targets, V6, P87, DOI 10.2174/187152707780363302; Wright RA, 2001, J PHARMACOL EXP THER, V298, P453; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489	93	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144017	10.1371/journal.pone.0144017	http://dx.doi.org/10.1371/journal.pone.0144017			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658273	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903600018
J	Henley, RY; Vazquez-Pagan, AG; Johnson, M; Kanavarioti, A; Wanunu, M				Henley, Robert Y.; Vazquez-Pagan, Ana G.; Johnson, Michael; Kanavarioti, Anastassia; Wanunu, Meni			Osmium-Based Pyrimidine Contrast Tags for Enhanced Nanopore-Based DNA Base Discrimination	PLOS ONE			English	Article							MEMBRANE CHANNEL; SEQUENCING DNA; RESOLUTION; TRANSPORT	Nanopores are a promising platform in next generation DNA sequencing. In this platform, an individual DNA strand is threaded into nanopore using an electric field, and enzyme-based ratcheting is used to move the strand through the detector. During this process the residual ion current through the pore is measured, which exhibits unique levels for different base combinations inside the pore. While this approach has shown great promise, accuracy is not optimal because the four bases are chemically comparable to one another, leading to small differences in current obstruction. Nucleobase-specific chemical tagging can be a viable approach to enhancing the contrast between different bases in the sequence. Herein we show that covalent modification of one or both of the pyrimidine bases by an osmium bipyridine complex leads to measureable differences in the blockade amplitudes of DNA molecules. We qualitatively determine the degree of osmylation of a DNA strand by passing it through a solid-state nanopore, and are thus able to gauge T and C base content. In addition, we show that osmium bipyridine reacts with dsDNA, leading to substantially different current blockade levels than exhibited for bare dsDNA. This work serves as a proof of principle for nanopore sequencing and mapping via base-specific DNA osmylation.	[Henley, Robert Y.; Wanunu, Meni] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Vazquez-Pagan, Ana G.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Johnson, Michael; Wanunu, Meni] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Kanavarioti, Anastassia] Yenos Analyt LLC, El Dorado Hills, CA USA	Northeastern University; Northeastern University; Northeastern University	Wanunu, M (corresponding author), Northeastern Univ, Dept Phys, Boston, MA 02115 USA.	wanunu@neu.edu		Vazquez-Pagan, Ana/0000-0001-9984-7129	National Institutes of Health [NHGRI HG006321]; Yenos Analytical LLC; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yenos Analytical LLC; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The study was funded by National Institutes of Health, NHGRI HG006321. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Yenos Analytical LLC provided support in the form of salary for author AK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Carson S, 2014, BIOPHYS J, V107, P2381, DOI 10.1016/j.bpj.2014.10.017; CHANG CH, 1977, BIOCHEMISTRY-US, V16, P33, DOI 10.1021/bi00620a006; Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Connelly LS, 2014, ACS APPL MATER INTER, V6, P5290, DOI 10.1021/am500639q; Faller M, 2004, SCIENCE, V303, P1189, DOI 10.1126/science.1094114; Feng J, 2015, NANO LETT, V15, P3431, DOI 10.1021/acs.nanolett.5b00768; Goodwin S., 2015, BIORXIV; Kanavarioti A, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/13/134003; Kanavarioti A, 2012, ELECTROPHORESIS, V33, P3529, DOI 10.1002/elps.201200214; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Larkin J, 2013, ACS NANO, V7, P10121, DOI 10.1021/nn404326f; Laszlo AH, 2014, NAT BIOTECHNOL, V32, P829, DOI 10.1038/nbt.2950; Liu K, 2014, ACS NANO, V8, P2504, DOI 10.1021/nn406102h; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Merchant CA, 2010, NANO LETT, V10, P2915, DOI 10.1021/nl101046t; Pendleton M, 2015, NAT METHODS, V12, P780, DOI [10.1038/nmeth.3454, 10.1038/NMETH.3454]; Schneider GF, 2010, NANO LETT, V10, P3163, DOI [10.1021/nl102069z, 10.1021/nl101046t]; Thompson JF, 2012, ELECTROPHORESIS, V33, P3429, DOI 10.1002/elps.201200136; Venta K, 2013, ACS NANO, V7, P4629, DOI 10.1021/nn4014388; Waduge P, 2015, ACS NANO, V9, P7352, DOI 10.1021/acsnano.5b02369; Wanunu M, 2010, NAT NANOTECHNOL, V5, P807, DOI [10.1038/nnano.2010.202, 10.1038/NNANO.2010.202]	23	7	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0142155	10.1371/journal.pone.0142155	http://dx.doi.org/10.1371/journal.pone.0142155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657869	Green Published, gold			2022-12-27	WOS:000366903600003
J	Kao, CY; Yang, JC; Lin, CH				Kao, Chung-Yao; Yang, Jhen-Ci; Lin, Chih-Hao			The Impact of Ambulance and Patient Diversion on Crowdedness of Multiple Emergency Departments in a Region	PLOS ONE			English	Article							SYSTEM	Emergency department (ED) overcrowding threatens healthcare quality. Ambulance diversion (AD) may relieve ED overcrowding; however, diverting patients from an overcrowded ED will load neighboring EDs with more patients and may result in regional overcrowding. The purpose of this study was to evaluate the impact of different diversion strategies on the crowdedness of multiple EDs in a region. The importance of regional coordination was also explored. A queuing model for patient flow was utilized to develop a computer program for simulating AD among EDs in a region. Key parameters, including patient arrival rates, percentages of patients of different acuity levels, percentage of patients transported by ambulance, and total resources of EDs, were assigned based on real data. The crowdedness indices of each ED and the regional crowdedness index were assessed to evaluate the effectiveness of various AD strategies. Diverting patients equally to all other EDs in a region is better than diverting patients only to EDs with more resources. The effect of diverting all ambulance-transported patients is similar to that of diverting only low-acuity patients. To minimize regional crowdedness, ambulatory patients should be sent to proper EDs when AD is initiated. Based on a queuing model with parameters calibrated by real data, patient flows of EDs in a region were simulated by a computer program. From a regional point of view, randomly diverting ambulatory patients provides almost no benefit. With regards to minimizing the crowdedness of the whole region, the most promising strategy is to divert all patients equally to all other EDs that are not already crowded. This result implies that communication and coordination among regional hospitals are crucial to relieve overall crowdedness. A regional coordination center may prioritize AD strategies to optimize ED utility.	[Kao, Chung-Yao; Yang, Jhen-Ci] Natl Sun Yat Sen Univ, Dept Elect Engn, Kaohsiung, Taiwan; [Lin, Chih-Hao] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Emergency Med, Tainan 70101, Taiwan	National Sun Yat Sen University; National Cheng Kung University; National Cheng Kung University Hospital	Lin, CH (corresponding author), Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Emergency Med, Tainan 70101, Taiwan.	emergency.lin@gmail.com						Anantharaman V, 2008, INT J EMERG MED, V1, P11, DOI 10.1007/s12245-008-0004-8; Asplin BR, 2003, ANN EMERG MED, V42, P173, DOI 10.1067/mem.2003.302; Bair AE, 2010, J MED SYST, V34, P919, DOI 10.1007/s10916-009-9307-4; Banks J, 2009, DISCRETE EVENT SYSTE, V5th; Brenner S, 2010, J EMERG NURS, V36, P303, DOI 10.1016/j.jen.2009.07.018; Burt CW, 2006, ANN EMERG MED, V47, P317, DOI 10.1016/j.annemergmed.2005.12.001; Castillo EM, 2011, J EMERG MED, V40, P300, DOI 10.1016/j.jemermed.2010.02.023; Channouf Nabil, 2007, Health Care Manag Sci, V10, P25, DOI 10.1007/s10729-006-9006-3; Cooney DR, 2011, PREHOSP EMERG CARE, V15, P555, DOI 10.3109/10903127.2011.608871; de Bruin Arnoud M, 2007, Health Care Manag Sci, V10, P125; Epstein SK, 2006, ACAD EMERG MED, V13, P421, DOI 10.1197/j.aem.2005.11.081; Espinosa G, 2002, ANN EMERG MED, V39, P693, DOI 10.1067/mem.2002.124447; Gross D, 2008, FUNDAMENTALS QUEUEIN; HALLSTROM A, 1981, SOC SCI MED-MED ECON, V15, P13, DOI 10.1016/0160-7995(81)90004-6; Hoot NR, 2008, ANN EMERG MED, V52, P126, DOI 10.1016/j.annemergmed.2008.03.014; Hoot NR, 2008, ANN EMERG MED, V52, P116, DOI 10.1016/j.annemergmed.2007.12.011; Hoot NR, 2009, J AM MED INFORM ASSN, V16, P338, DOI 10.1197/jamia.M2772; Leegon Jeffrey, 2007, AMIA Annu Symp Proc, P1026; Lin CH, 2015, J FORMOS MED ASSOC, V114, P64, DOI 10.1016/j.jfma.2012.09.007; Nafarrate AR, 2010, WINT SIMUL C PROC, P2315, DOI 10.1109/WSC.2010.5678929; Nash K, 2009, J EMERG NURS, V35, P109, DOI 10.1016/j.jen.2008.02.016; Nawar EW, 2005, ADV DATA, V2007, P1; Ng CJ, 2010, J FORMOS MED ASSOC, V109, P828, DOI 10.1016/S0929-6646(10)60128-3; Richardson Sandra K, 2005, Accid Emerg Nurs, V13, P18, DOI 10.1016/j.aaen.2004.10.010; SAUNDERS CE, 1989, ANN EMERG MED, V18, P134, DOI 10.1016/S0196-0644(89)80101-5; Scheulen JJ, 2001, ACAD EMERG MED, V8, P36, DOI 10.1111/j.1553-2712.2001.tb00546.x; Siegel Bruce, 2003, Mod Healthc, V33, P24; Su S, 2003, INT J MED INFORM, V72, P57, DOI 10.1016/j.ijmedinf.2003.08.003; VALENZUELA TD, 1990, ANN EMERG MED, V19, P898, DOI 10.1016/S0196-0644(05)81565-3; Weiss SJ, 2004, ACAD EMERG MED, V11, P38, DOI 10.1197/S1069-6563(03)00583-9	30	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144227	10.1371/journal.pone.0144227	http://dx.doi.org/10.1371/journal.pone.0144227			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659589	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903600030
J	Reynisson, PJ; Scali, M; Smistad, E; Hofstad, EF; Leira, HO; Lindseth, F; Hernes, TAN; Amundsen, T; Sorger, H; Lango, T				Reynisson, Pall Jens; Scali, Marta; Smistad, Erik; Hofstad, Erlend Fagertun; Leira, Hakon Olav; Lindseth, Frank; Hernes, Toril Anita Nagelhus; Amundsen, Tore; Sorger, Hanne; Lango, Thomas			Airway Segmentation and Centerline Extraction from Thoracic CT - Comparison of a New Method to State of the Art Commercialized Methods	PLOS ONE			English	Article							IMAGES; SOFTWARE; TREES	Introduction Our motivation is increased bronchoscopic diagnostic yield and optimized preparation, for navigated bronchoscopy. In navigated bronchoscopy, virtual 3D airway visualization is often used to guide a bronchoscopic tool to peripheral lesions, synchronized with the real time video bronchoscopy. Visualization during navigated bronchoscopy, the segmentation time and methods, differs. Time consumption and logistics are two essential aspects that need to be optimized when integrating such technologies in the interventional room. We compared three different approaches to obtain airway centerlines and surface. Method CT lung dataset of 17 patients were processed in Mimics (Materialize, Leuven, Belgium), which provides a Basic module and a Pulmonology module (beta version) (MPM), OsiriX (Pixmeo, Geneva, Switzerland) and our Tube Segmentation Framework (TSF) method. Both MPM and TSF were evaluated with reference segmentation. Automatic and manual settings allowed us to segment the airways and obtain 3D models as well as the centrelines in all datasets. We compared the different procedures by user interactions such as number of clicks needed to process the data and quantitative measures concerning the quality of the segmentation and centrelines such as total length of the branches, number of branches, number of generations, and volume of the 3D model. Results The TSF method was the most automatic, while the Mimics Pulmonology Module (MPM) and the Mimics Basic Module (MBM) resulted in the highest number of branches. MPM is the software which demands the least number of clicks to process the data. We found that the freely available OsiriX was less accurate compared to the other methods regarding segmentation results. However, the TSF method provided results fastest regarding number of clicks. The MPM was able to find the highest number of branches and generations. On the other hand, the TSF is fully automatic and it provides the user with both segmentation of the airways and the centerlines. Reference segmentation comparison averages and standard deviations for MPM and TSF correspond to literature. Conclusion The TSF is able to segment the airways and extract the centerlines in one single step. The number of branches found is lower for the TSF method than in Mimics. OsiriX demands the highest number of clicks to process the data, the segmentation is often sparse and extracting the centerline requires the use of another software system. Two of the software systems performed satisfactory with respect to be used in preprocessing CT images for navigated bronchoscopy, i.e. the TSF method and the MPM. According to reference segmentation both TSF and MPM are comparable with other segmentation methods. The level of automaticity and the resulting high number of branches plus the fact that both centerline and the surface of the airways were extracted, are requirements we considered particularly important. The in house method has the advantage of being an integrated part of a navigation platform for bronchoscopy, whilst the other methods can be considered preprocessing tools to a navigation system.	[Reynisson, Pall Jens; Leira, Hakon Olav; Hernes, Toril Anita Nagelhus; Amundsen, Tore; Sorger, Hanne] Norwegian Univ Sci & Technol NTNU, Dept Circulat & Med Imaging, Trondheim, Norway; [Scali, Marta] Delft Univ Technol, Fac Mech Engn, Biomech Engn, Delft, Netherlands; [Smistad, Erik; Lindseth, Frank] NTNU, Dept Comp & Informat Sci, Trondheim, Norway; [Hofstad, Erlend Fagertun; Lindseth, Frank; Lango, Thomas] SINTEF, Dept Med Technol, N-7034 Trondheim, Norway; [Leira, Hakon Olav; Amundsen, Tore; Sorger, Hanne] St Olavs Hosp, Dept Thorac Med, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Delft University of Technology; Norwegian University of Science & Technology (NTNU); SINTEF; Norwegian University of Science & Technology (NTNU)	Reynisson, PJ (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Circulat & Med Imaging, Trondheim, Norway.	jens.p.reynisson@ntnu.no	Scali, Marta/AAI-2194-2020	Lango, Thomas/0000-0002-2824-6120	Liaison Committee; local Cancer Fund at St. Olavs University hospital, SINTEF Department of Medical Technology; Ministry of Health and Social Affairs of Norway through the Norwegian National Advisory Unit for Ultrasound and Image-Guided Therapy (Trondheim, Norway); eMIT (enhanced Minimally Invasive Therapy) in the FRIMED program of the Research Council of Norway [196726/V50]; EEA Financial Mechanism under Navigation System For Confocal Laser Endomicroscopy To Improve Optical Biopsy Of Peripheral Lesions In The Lungs (NAVICAD) [EEA-JRP-RO-NO-2013-1-0123, 3SEE/30.06.2014]; Marie Curie Initial Training Network for the Integrated Interventional Imaging Operating System [DT-sak 267-11]; Norwegian Research School in Medical Imaging and Interventional Center (OUS/UiO)	Liaison Committee; local Cancer Fund at St. Olavs University hospital, SINTEF Department of Medical Technology; Ministry of Health and Social Affairs of Norway through the Norwegian National Advisory Unit for Ultrasound and Image-Guided Therapy (Trondheim, Norway); eMIT (enhanced Minimally Invasive Therapy) in the FRIMED program of the Research Council of Norway; EEA Financial Mechanism under Navigation System For Confocal Laser Endomicroscopy To Improve Optical Biopsy Of Peripheral Lesions In The Lungs (NAVICAD); Marie Curie Initial Training Network for the Integrated Interventional Imaging Operating System; Norwegian Research School in Medical Imaging and Interventional Center (OUS/UiO)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding for MS EFH HOL ES FL TANH TA HS TL is from: This work was supported by the Liaison Committee between the Central Norway Regional Health Authority (RHA), the local Cancer Fund at St. Olavs University hospital, SINTEF Department of Medical Technology, the Ministry of Health and Social Affairs of Norway through the Norwegian National Advisory Unit for Ultrasound and Image-Guided Therapy (Trondheim, Norway), and the project 196726/V50 eMIT (enhanced Minimally Invasive Therapy) in the FRIMED program of the Research Council of Norway. The research leading to these results has also received funding from EEA Financial Mechanism 2009-2014 under the project EEA-JRP-RO-NO-2013-1-0123 - Navigation System For Confocal Laser Endomicroscopy To Improve Optical Biopsy Of Peripheral Lesions In The Lungs (NAVICAD), contract no. 3SEE/30.06.2014. PhD position of PJR is funded by following: The work is also a part of a Marie Curie Initial Training Network for the Integrated Interventional Imaging Operating System (IIIOS project) funded specially by the Dean Office of Norges teknisk-naturvitenskapelige universitet (NTNU) (DT-sak 267-11 Temporary position as PhD Candidate, Department of Circulation and Medical Imaging, Faculty of Medicine). The work is also granted from Norwegian Research School in Medical Imaging and the Interventional Center (OUS/UiO).	Askeland C, 2015, THESIS NORWEGIAN U S; Aykac D, 2003, IEEE T MED IMAGING, V22, P940, DOI 10.1109/TMI.2003.815905; Bauer C, 2009, P 2 INT WORKSH PULM, P203; Detterbeck FC, 2013, CHEST, V143, pE78, DOI 10.1378/chest.12-2350; Hasegawa M, 2006, AM J RESP CRIT CARE, V173, P1309, DOI 10.1164/rccm.200601-037OC; Hofstad EF, 2014, MED PHYS, V41, DOI 10.1118/1.4866884; Hu SY, 2001, IEEE T MED IMAGING, V20, P490, DOI 10.1109/42.929615; Kazerooni EA, 2001, AM J ROENTGENOL, V177, P501, DOI 10.2214/ajr.177.3.1770501; Kiraly AP, 2002, ACAD RADIOL, V9, P1153, DOI 10.1016/S1076-6332(03)80517-2; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Lo P, 2012, IEEE T MED IMAGING, V31, P2093, DOI 10.1109/TMI.2012.2209674; Palomo JM, 2010, AM J ORHOD DENTOFACI, V137, pS50, DOI [10.1016/ ajodo. 2010.01.014, DOI 10.1016/AJ0D0.2010.01.014]; Park W, 1998, IEEE T MED IMAGING, V17, P489, DOI 10.1109/42.730394; Pu JT, 2012, MED PHYS, V39, P2603, DOI 10.1118/1.4703901; Reynisson PJ, 2014, J BRONCHOL INTERN PU, V21, P242, DOI 10.1097/LBR.0000000000000064; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Singh H, 2004, LECT NOTES COMPUT SC, V3217, P975; Smistad E, 2012, THESIS; Smistad E, 2015, MED IMAGE ANAL, V20, P1, DOI 10.1016/j.media.2014.10.012; Smistad E, 2014, INT J COMPUT ASS RAD, V9, P561, DOI 10.1007/s11548-013-0956-x; Tschirren J, 2005, IEEE T MED IMAGING, V24, P1529, DOI 10.1109/TMI.2005.857654; Weissheimer A, 2012, AM J ORTHOD DENTOFAC, V142, P801, DOI 10.1016/j.ajodo.2012.07.015	22	28	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144282	10.1371/journal.pone.0144282	http://dx.doi.org/10.1371/journal.pone.0144282			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657513	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903600034
J	Khoury, EDT; Souza, GD; da Costa, CA; de Araujo, AAK; de Oliveira, CSB; Silveira, LCD; Pinheiro, MDN				Torres Khoury, Eliana Dirce; Souza, Givago da Silva; da Costa, Carlos Araujo; Kamogari de Araujo, Amelia Ayako; Baltazar de Oliveira, Claudia Simone; Silveira, Luiz Carlos de Lima; Pinheiro, Maria da Conceicao Nascimento			Somatosensory Psychophysical Losses in Inhabitants of Riverside Communities of the Tapajos River Basin, Amazon, Brazil: Exposure to Methylmercury Is Possibly Involved	PLOS ONE			English	Article							TACTILE SPATIAL-RESOLUTION; MINAMATA DISEASE; MERCURY POLLUTION; CONTRAST SENSITIVITY; FISH CONSUMPTION; COLOR-VISION; PARA STATE; POPULATIONS; HAIR; DISCRIMINATION	The purpose of this work was to evaluate the somatosensory system of methylmercury-exposed inhabitants living in the communities of the Tapajos river basin by using psychophysical tests and to compare with measurements performed in inhabitants of the Tocantins river basin. We studied 108 subjects from Barreiras and Sao Luiz do Tapajos, two communities of the Tapajos river basin, State of Para, Amazon, Brazil, aged 13-53 years old. Mercury analysis was performed in head hair samples weighting 0.1-0.2 g by using atomic absorption spectrometry. Three somatosensory psychophysical tests were performed: tactile sensation threshold, vibration sensation duration, and two-point discrimination. Semmes-Weinstein 20 monofilaments with different diameters were used to test the tactile sensation in the lower lip, right and left breasts, right and left index fingers, and right and left hallux. The threshold was the thinner monofilament perceived by the subject. Vibration sensation was investigated using a 128 Hz diapason applied to the sternum, right and left radial sides of the wrist, and right and left outer malleoli. Two trials were performed at each place. A stopwatch recorded the vibration sensation duration. The two-point discrimination test was performed using a two-point discriminator. Head hair mercury concentration was significantly higher in mercury-exposed inhabitants of Tapajos than in non-exposed inhabitants of Tocantins (p < 0.01). When all subjects were divided in two groups independently of age-mercury-exposed and non-exposed-the following results were found: tactile sensation thresholds in mercury-exposed subjects were higher than in non-exposed subjects at all body parts, except at the left chest; vibration sensation durations were shorter in mercury-exposed than in non-exposed subjects, at all locations except in the upper sternum; two-point discrimination thresholds were higher in mercury exposed than in non-exposed subjects at all body parts. There was a weak linear correlation between tactile sensation threshold and mercury concentration in the head hair samples. No correlation was found for the other two measurements. Mercury-exposed subjects had impaired somatosensory function compared with non-exposed control subjects. Long-term mercury exposure of riverside communities in the Tapajos river basin is a possible but not a definitely proven cause for psychophysical somatosensory losses observed in their population. Additionally, the relatively simple psychophysical measures used in this work should be followed by more rigorous measures of the same population.	[Torres Khoury, Eliana Dirce; Souza, Givago da Silva; da Costa, Carlos Araujo; Baltazar de Oliveira, Claudia Simone; Silveira, Luiz Carlos de Lima; Pinheiro, Maria da Conceicao Nascimento] Fed Univ Para, Nucleo Med Trop, BR-66059 Belem, PA, Brazil; [Souza, Givago da Silva; Silveira, Luiz Carlos de Lima] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, PA, Brazil; [Kamogari de Araujo, Amelia Ayako] Secretaria Saude, Itaituba, PA, Brazil; [Silveira, Luiz Carlos de Lima] Univ Ceuma, Sao Luis, MA, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Ceuma	Pinheiro, MDN (corresponding author), Fed Univ Para, Nucleo Med Trop, BR-66059 Belem, PA, Brazil.	mconci@ufpa.br	Souza, Givago/W-6393-2019	Souza, Givago/0000-0002-4525-3971	CAPES Pro-Amazonia; CNPq [486545/2012-1, 479624/2012-7, 442191/2014-6]; FAPESPA [003/2012]; FINEP IBN Net [1723]	CAPES Pro-Amazonia(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); FINEP IBN Net(Financiadora de Inovacao e Pesquisa (Finep))	The work was supported by the following: CAPES Pro-Amazonia to MCNP; CNPq #486545/ 2012-1 to GSS, #479624/2012-7 to MCNP, #442191/2014-6 to LCLS; FAPESPA #003/2012 to MCNP; and FINEP IBN Net #1723 to LCLS. LCLS and MCNP are CNPq research fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi H, 2000, J HEALTH SCI, V46, P323; Akagi H, 1995, MERCURY GLOBAL POLLU, P85; BAKIR F, 1980, POSTGRAD MED J, V56, P1, DOI 10.1136/pgmj.56.651.1; Barbieri FL, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-71; Barregard L, 2006, SCI TOTAL ENVIRON, V368, P326, DOI 10.1016/j.scitotenv.2005.08.048; Nevado JJB, 2010, ENVIRON INT, V36, P593, DOI 10.1016/j.envint.2010.03.011; Bidone ED, 1997, B ENVIRON CONTAM TOX, V59, P194, DOI 10.1007/s001289900464; Castilhos ZC, 1998, B ENVIRON CONTAM TOX, V61, P202, DOI 10.1007/s001289900749; Craig JC, 2000, CURR DIR PSYCHOL SCI, V9, P29, DOI 10.1111/1467-8721.00054; Dolbec J, 2000, INT ARCH OCC ENV HEA, V73, P195, DOI 10.1007/s004200050027; dos Santos LDN, 2000, SCI TOTAL ENVIRON, V261, P1, DOI 10.1016/S0048-9697(00)00590-8; Ekino S, 2007, J NEUROL SCI, V262, P131, DOI 10.1016/j.jns.2007.06.036; ETO K, 1978, ACTA PATHOL JAPON, V28, P565; ETO K, 1977, VIRCHOWS ARCH B, V23, P109; Eto K, 1997, TOXICOL PATHOL, V25, P614, DOI 10.1177/019262339702500612; Fillion M, 2011, ECOHEALTH, V8, P210, DOI 10.1007/s10393-011-0710-1; Fillion M, 2011, PUBLIC HEALTH NUTR, V14, P2236, DOI 10.1017/S1368980011001765; Freitas JD, 2015, INV OPHTHALMOL VIS S, V56; Grandjean P, 1999, ENVIRON HEALTH PERSP, V107, P587, DOI 10.2307/3434402; Harada M, 2005, B ENVIRON CONTAM TOX, V74, P689, DOI 10.1007/s00128-005-0638-7; Harada M, 2001, ENVIRON INT, V27, P285, DOI 10.1016/S0160-4120(01)00059-9; Harada M., 1997, MINERAL METAL NEUROT, P177; Harada Masazumi, 2004, MINAMATA DIS; Hunter D, 1940, Q J MED, V9, P193; HUNTER D, 1954, J NEUROL NEUROSUR PS, V17, P235, DOI 10.1136/jnnp.17.4.235; Kingdom F. A. A., 2010, PSYCHOPHYSICS PRACTI; Lebel J, 1996, NEUROTOXICOLOGY, V17, P157; Lebel J, 1998, ENVIRON RES, V79, P20, DOI 10.1006/enrs.1998.3846; Malm O, 1995, SCI TOTAL ENVIRON, V175, P141, DOI 10.1016/0048-9697(95)04910-X; MAURISSEN JPJ, 1988, TOXICOL LETT, V43, P321, DOI 10.1016/0378-4274(88)90036-7; Mergler D, 2000, ENVIRON TOXICOL PHAR, V12, P93; Ninomiya T, 2005, NEUROTOXICOL TERATOL, V27, P643, DOI 10.1016/j.ntt.2005.03.008; Nomura S, 1998, J OCCUP HEALTH, V40, P1, DOI 10.1539/joh.40.1; PassosD CJS, 2008, J EXPO SCI ENV EPID, V18, P76, DOI 10.1038/sj.jes.7500599; Pinheiro MCN, 2008, ENVIRON RES, V107, P53, DOI 10.1016/j.envres.2007.08.007; Pinheiro MCN, 2007, ENVIRON INT, V33, P56, DOI 10.1016/j.envint.2006.06.024; Pinheiro MCN, 2012, B ENVIRON CONTAM TOX, V89, P119, DOI 10.1007/s00128-012-0652-5; Pinheiro M d, 2000, Rev Soc Bras Med Trop, V33, P265; Pinheiro MCN, 2006, BRAZ J MED BIOL RES, V39, P411, DOI 10.1590/S0100-879X2006000300012; Pinheiro MCN, 2005, SCI TOTAL ENVIRON, V349, P284, DOI 10.1016/j.scitotenv.2005.06.026; Pinheiro MCN, 2003, ENVIRON SCI-TOKYO, V10, P99; Rodrigues AR, 2007, BRAZ J MED BIOL RES, V40, P415, DOI 10.1590/S0100-879X2007000300018; Santos ECD, 2000, ENVIRON RES, V84, P100, DOI 10.1006/enrs.2000.4088; Silveira LCL, 2003, NORMAL DEFECTIVE COL, P407; Soong TR, 1994, ENV SCI, V3, P41; Suzuki T., 2004, MERCURY ANAL MANUAL; Takaoka S, 2004, ENVIRON RES, V95, P126, DOI 10.1016/j.envres.2003.08.002; Takaoka S, 2008, ENVIRON RES, V107, P6, DOI 10.1016/j.envres.2007.05.012; Tavares Lydia Maria Bocayuva, 2005, Cad. Saúde Pública, V21, P1160, DOI 10.1590/S0102-311X2005000400018; Tong J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00579; Khoury EDT, 2013, CAD SAUDE PUBLICA, V29, P2307, DOI [10.1590/0102-311x00158012, 10.1590/0102-311X00158012]; Uchino M, 2001, TOHOKU J EXP MED, V195, P181, DOI 10.1620/tjem.195.181; UCHINO M, 1995, INTERNAL MED, V34, P744, DOI 10.2169/internalmedicine.34.744; VANBOVEN RW, 1994, BRAIN, V117, P149, DOI 10.1093/brain/117.1.149; VANBOVEN RW, 1994, NEUROLOGY, V44, P2361, DOI 10.1212/WNL.44.12.2361; Ventura DF, 2005, ENVIRON TOXICOL PHAR, V19, P523, DOI 10.1016/j.etap.2004.12.016; Ventura DF, 2004, VISUAL NEUROSCI, V21, P421, DOI 10.1017/S0952523804213372; WHEATLEY B, 1994, ENV SCI, V3, P33; WHO-IPCS, 1990, ENV HLTH CRIT 101 ME; [No title captured]	60	11	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144625	10.1371/journal.pone.0144625	http://dx.doi.org/10.1371/journal.pone.0144625			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658153	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903600071
J	Oliva-Olivera, W; Coin-Araguez, L; Salas, J; Lhamyani, S; Gentile, AM; Garcia, ES; Hmadcha, A; Zayed, H; Vega-Rioja, A; Tinahones, FJ; El Bekay, R				Oliva-Olivera, Wilfredo; Coin-Aragueez, Leticia; Salas, Julian; Lhamyani, Said; Gentile, Adriana-Mariel; Garcia, Esteban Sarria; Hmadcha, Abdelkrim; Zayed, Hatem; Vega-Rioja, Antonio; Tinahones, Francisco J.; El Bekay, Rajaa			Myocardial Ischemic Subject's Thymus Fat: A Novel Source of Multipotent Stromal Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HUMAN ADIPOSE-TISSUE; ENDOTHELIAL PROGENITOR CELLS; BONE-MARROW; CORD BLOOD; DIFFERENTIATION; MECHANISMS; EXPRESSION; GENE; AGE	Objective Adipose Tissue Stromal Cells (ASCs) have important clinical applications in the regenerative medicine, cell replacement and gene therapies. Subcutaneous Adipose Tissue (SAT) is the most common source of these cells. The adult human thymus degenerates into adipose tissue (TAT). However, it has never been studied before as a source of stem cells. Material and Methods We performed a comparative characterization of TAT-ASCs and SAT-ASCs from myocardial ischemic subjects (n = 32) according to the age of the subjects. Results TAT-ASCs and SAT-ASCs showed similar features regarding their adherence, morphology and in their capacity to form CFU-F. Moreover, they have the capacity to differentiate into osteocyte and adipocyte lineages; and they present a surface marker profile corresponding with stem cells derived from AT; CD73(+)CD90(+)CD105(+)CD14(-)CD19(-)CD45(-)HLA-DR. Interestingly, and in opposition to SAT-ASCs, TAT-ASCs have CD14(+)CD34(+)CD133(+)CD45(-) cells. Moreover, TAT-ASCs from elderly subjects showed higher adipogenic and osteogenic capacities compared to middle aged subjects, indicating that, rather than impairing; aging seems to increase adipogenic and osteogenic capacities of TAT-ASCs. Conclusions This study describes the human TAT as a source of mesenchymal stem cells, which may have an enormous potential for regenerative medicine.	[Oliva-Olivera, Wilfredo; Coin-Aragueez, Leticia; Tinahones, Francisco J.; El Bekay, Rajaa] Carlos III Hlth Inst, CIBER Pathophysiol Obes & Nutr CB06 03, Malaga 29010, Spain; [Oliva-Olivera, Wilfredo; Coin-Aragueez, Leticia; Tinahones, Francisco J.; El Bekay, Rajaa] Virgen Victoria Clin Univ Hosp, Biomed Res Lab, Malaga 29010, Spain; [Salas, Julian; Garcia, Esteban Sarria] Univ Hosp Carlos Haya, Dept Cardiovasc Surg, Malaga, Spain; [Lhamyani, Said; Gentile, Adriana-Mariel] Univ Malaga, Sch Sci, Res Lab, E-29071 Malaga, Spain; [Hmadcha, Abdelkrim] Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Dept Stem Cells, Seville, Spain; [Hmadcha, Abdelkrim] Inst Salud Carlos III, CIBERDEM, Madrid, Spain; [Zayed, Hatem] Qatar Univ, Coll Arts & Sci, Dept Hlth Sci, Program Biomed Sci, Doha, Qatar; [Vega-Rioja, Antonio] Hosp Univ Virgen Macarena, Serv Reg Inmunol & Alergia, Seville, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Hospital Carlos Haya; Universidad de Malaga; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Qatar University; Hospital Universitario Virgen Macarena	Vega-Rioja, A (corresponding author), Hosp Univ Virgen Macarena, Serv Reg Inmunol & Alergia, Seville, Spain.	macrofago@us.es; fjtinahones@hotmail.com; elbekay@gmail.com	LHAMYANI, said/AAQ-1973-2020; Hmadcha, Abdelkrim/T-1173-2019; Bekay, Rajaa El/AAZ-3959-2020; Zayed, Hatem/R-1800-2019; El Bekay, RAJAA/AGN-6069-2022; Tinahones, Francisco José/AAB-2882-2020; GENTILE, Adriana Mariel/AAB-3350-2020	LHAMYANI, said/0000-0002-9830-9772; Hmadcha, Abdelkrim/0000-0002-4105-3702; Zayed, Hatem/0000-0001-8838-6638; El Bekay, RAJAA/0000-0003-3332-3431; GENTILE, Adriana Mariel/0000-0002-2296-9117; Oliva Olivera, Wilfredo/0000-0003-3473-7898; Vega Rioja, Antonio/0000-0003-4698-9697; Tinahones, Francisco J/0000-0001-6871-4403	Instituto de Salud Carlos III/FEDER; EU [PI10/01947, PI13/02628]; Consejeria de Economia e Innovacion [CTS-7895]; Ciencia y Empleo; Junta de Andalucia/FEDER; ISCIII/FEDER, EU "Miguel Servet II" [CPII13/00041]; Ministerio de Economia y Competitividad [SAF2014-60649-JIN]; Fondo Europeo de Desarrollo Regional-FEDER	Instituto de Salud Carlos III/FEDER(Instituto de Salud Carlos IIIEuropean Commission); EU(European Commission); Consejeria de Economia e Innovacion; Ciencia y Empleo; Junta de Andalucia/FEDER(Junta de AndaluciaEuropean Commission); ISCIII/FEDER, EU "Miguel Servet II"; Ministerio de Economia y Competitividad(Spanish Government); Fondo Europeo de Desarrollo Regional-FEDER(European CommissionSpanish Government)	This work was supported in part by grants from the Instituto de Salud Carlos III/FEDER, EU (PI10/01947, PI13/02628), CTS-7895 from the Consejeria de Economia e Innovacion, Ciencia y Empleo, Junta de Andalucia/FEDER, EU. R. El Bekay is supported by fellowships from the ISCIII/FEDER, EU "Miguel Servet II" (CPII13/00041). AV-R is under a contract Proyectos de I+D+i para jovenes investigadores from the Ministerio de Economia y Competitividad (SAF2014-60649-JIN) and co-funded by Fondo Europeo de Desarrollo Regional-FEDER.	Alvarez DF, 2008, AM J PHYSIOL-LUNG C, V294, pL419, DOI 10.1152/ajplung.00314.2007; Beane OS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115963; Cao YH, 2005, NAT REV CANCER, V5, P735, DOI 10.1038/nrc1693; Cartwright MJ, 2007, EXP GERONTOL, V42, P463, DOI 10.1016/j.exger.2007.03.003; Casteilla L, 2005, ARCH MAL COEUR VAISS, V98, P922; Choudhery MS, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-8; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; FINA L, 1990, BLOOD, V75, P2417; Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010; Gimble JM, 2011, STEM CELLS, V29, P749, DOI 10.1002/stem.629; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Habib HS, 2011, MED SCI MONITOR, V17, pRA233, DOI 10.12659/MSM.882036; Hale Laura P, 2004, Ann Diagn Pathol, V8, P50, DOI 10.1016/j.anndiagpath.2003.11.006; Hilbe W, 2004, J CLIN PATHOL, V57, P965, DOI 10.1136/jcp.2004.016444; Huang SC, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-18; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kawai M, 2012, J INTERN MED, V272, P317, DOI 10.1111/j.1365-2796.2012.02564.x; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Khan WS, 2012, CELL PROLIFERAT, V45, P111, DOI 10.1111/j.1365-2184.2011.00804.x; Khan WS, 2009, INJURY, V40, P150, DOI 10.1016/j.injury.2008.05.029; Krampera M, 2007, BONE, V40, P382, DOI 10.1016/j.bone.2006.09.006; Krenning G, 2009, J CELL MOL MED, V13, P2521, DOI 10.1111/j.1582-4934.2008.00479.x; Krenning G, 2007, BIOMATERIALS, V28, P1470, DOI 10.1016/j.biomaterials.2006.11.017; Liu ZJ, 2009, J CELL BIOCHEM, V106, P984, DOI 10.1002/jcb.22091; Ma N, 2005, CARDIOVASC RES, V66, P45, DOI 10.1016/j.cardiores.2004.12.013; Madonna R, 2011, EUR J CLIN INVEST, V41, P126, DOI 10.1111/j.1365-2362.2010.02384.x; Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234; Mitterberger MC, 2014, J GERONTOL A-BIOL, V69, P13, DOI 10.1093/gerona/glt043; Mouiseddine M, 2008, STEM CELLS DEV, V17, P1165, DOI 10.1089/scd.2007.0252; Ogata K, 2005, STEM CELLS, V23, P619, DOI 10.1634/stemcells.2004-0280; Onate B, 2012, FASEB J, V26, P4327, DOI 10.1096/fj.12-207217; Perez LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123397; Popa ER, 2006, J MOL CELL CARDIOL, V41, P86, DOI 10.1016/j.yjmcc.2006.04.021; Pujol BF, 2000, DIFFERENTIATION, V65, P287, DOI 10.1046/j.1432-0436.2000.6550287.x; Rider DA, 2008, STEM CELLS, V26, P1598, DOI 10.1634/stemcells.2007-0480; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Russo V, 2014, STEM CELL TRANSL MED, V3, P206, DOI 10.5966/sctm.2013-0125; Shi YY, 2005, PLAST RECONSTR SURG, V116, P1686, DOI 10.1097/01.prs.0000185606.03222.a9; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Tchkonia T, 2006, DIABETES, V55, P2571, DOI 10.2337/db06-0540; Tinahones F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008213; Toyoda M, 2009, CELL BIOCHEM FUNCT, V27, P440, DOI 10.1002/cbf.1591; Varma MJO, 2007, STEM CELLS DEV, V16, P91, DOI 10.1089/scd.2006.0026; Zhu M, 2009, J TISSUE ENG REGEN M, V3, P290, DOI 10.1002/term.165; Zhu XS, 2012, CLIN LAB, V58, P897, DOI 10.7754/Clin.Lab.2012.120312; Zimmerlin L, 2013, CYTOM PART A, V83A, P134, DOI 10.1002/cyto.a.22227; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	51	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144401	10.1371/journal.pone.0144401	http://dx.doi.org/10.1371/journal.pone.0144401			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657132	gold, Green Submitted, Green Published			2022-12-27	WOS:000366903500025
J	Sianipar, A; Middelburg, R; Dijkstra, T				Sianipar, Agnes; Middelburg, Renee; Dijkstra, Ton			When Feelings Arise with Meanings: How Emotion and Meaning of a Native Language Affect Second Language Processing in Adult Learners	PLOS ONE			English	Article							TIME-COURSE; WORDS; AUTOMATICITY; TRANSLATION; INTEGRATION; ACTIVATION; RESPONSES; TASK; 1ST; ERP	To determine when and how L2 learners start to process L2 words affectively and semantically, we conducted a longitudinal study on their interaction in adult L2 learners. In four test sessions, spanning half a year of L2 learning, we monitored behavioral and ERP learning-related changes for one and the same set of words by means of a primed lexical-decision paradigm with L1 primes and L2 targets. Sensitivity rates, accuracy rates, RTs, and N400 amplitude to L2 words and pseudowords improved significantly across sessions. A semantic priming effect (e.g, prime "driver" facilitating response to target "street") was found in accuracy rates and RTs when collapsing Sessions 1 to 4, while this effect modulated ERP amplitudes within the first 300 ms of L2 target processing. An overall affective priming effect (e.g., "sweet" facilitating"taste") was also found in RTs and ERPs (posterior P1). Importantly, the ERPs showed an L2 valence effect across sessions (e.g., positive words were easier to process than neutral words), indicating that L2 learners were sensitive to L2 affective meaning. Semantic and affective priming interacted in the N400 time-window only in Session 4, implying that they affected meaning integration during L2 immersion together. The results suggest that L1 and L2 are initially processed semantically and affectively via relatively separate channels that are more and more linked contingent on L2 exposure.	[Sianipar, Agnes; Middelburg, Renee; Dijkstra, Ton] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Cognit, NL-6525 HR Nijmegen, Netherlands; [Sianipar, Agnes] Univ Indonesia, Fac Psychol, Depok, Jawa Barat, Indonesia	Radboud University Nijmegen; University of Indonesia	Sianipar, A (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Cognit, Montessorilaan 3, NL-6525 HR Nijmegen, Netherlands.	a.wulandari@donders.ru.nl	Dijkstra, Ton/A-7042-2010	Sianipar, Agnes/0000-0002-2828-5197; Sianipar, Agnes/0000-0002-7989-6350	Indonesian Ministry of Education and Culture [2566.12/E4.4/2011]	Indonesian Ministry of Education and Culture(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	This work was supported by Indonesian Ministry of Education and Culture, no: 2566.12/E4.4/2011 (http://dikti.go.id/) to Agnes Sianipar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abutalebi J, 2007, J NEUROLINGUIST, V20, P242, DOI 10.1016/j.jneuroling.2006.10.003; Altarriba Jeanette., 2004, J MULTILING MULTICUL, V25, P248, DOI [10.1080/01434630408666531, DOI 10.1080/01434630408666531]; Bartholow BD, 2009, J EXP SOC PSYCHOL, V45, P655, DOI 10.1016/j.jesp.2009.02.015; Bradley M., 1999, TECHNICAL REPORT, DOI DOI 10.1109/MIC.2008.114; Brysbaert M, 2011, EXP PSYCHOL, V58, P412, DOI 10.1027/1618-3169/a000123; Castner JE, 2007, BRAIN, V130, P1395, DOI 10.1093/brain/awm059; De Houwer J, 2002, COGNITION EMOTION, V16, P643, DOI 10.1080/02699930143000419; Degner J, 2012, BILING-LANG COGN, V15, P181, DOI 10.1017/S1366728911000095; DEHOUWER J, 1994, COGNITION EMOTION, V8, P1, DOI 10.1080/02699939408408925; Dijkstra T, 1998, SCI PSYCH S, P189; Dijkstra T, 2002, BILING-LANG COGN, V5, P175, DOI 10.1017/S1366728902003012; Eder AB, 2012, SOC COGN AFFECT NEUR, V7, P436, DOI 10.1093/scan/nsr033; FAZIO RH, 1986, J PERS SOC PSYCHOL, V50, P229, DOI 10.1037/0022-3514.50.2.229; Ferre P, 2014, PSICOLOGICA, V35, P117; Ferre P, 2013, BILING-LANG COGN, V16, P495, DOI 10.1017/S1366728912000314; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Green D., 1998, BILING-LANG COGN, V1, P67, DOI [DOI 10.1017/S1366728998000133, 10.1017/S1366728998000133]; Harris CL, 2003, APPL PSYCHOLINGUIST, V24, P561, DOI 10.1017/S0142716403000286; Harris CL, 2006, BILINGUAL MINDS EMOT, P257, DOI DOI 10.21832/9781853598746-012; Herring DR, 2013, PSYCHOL BULL, V139, P1062, DOI 10.1037/a0031309; Herring DR, 2011, EMOTION, V11, P794, DOI 10.1037/a0022804; Jasmin K, 2012, PSYCHON B REV, V19, P499, DOI 10.3758/s13423-012-0229-7; Kanske P, 2011, NEUROPSYCHOLOGIA, V49, P3121, DOI 10.1016/j.neuropsychologia.2011.07.022; Keuleers E, 2010, BEHAV RES METHODS, V42, P643, DOI 10.3758/BRM.42.3.643; Keuper K, 2014, HUM BRAIN MAPP, V35, P875, DOI 10.1002/hbm.22220; Kim A, 2012, J COGNITIVE NEUROSCI, V24, P1104, DOI 10.1162/jocn_a_00148; Kissler J, 2006, PROG BRAIN RES, V156, P147, DOI 10.1016/S0079-6123(06)56008-X; Kissler J, 2011, BIOL PSYCHOL, V86, P254, DOI 10.1016/j.biopsycho.2010.12.006; Klauer K.C., 1998, EUR REV SOC PSYCHOL, V8, P67, DOI [10.1080/14792779643000083, DOI 10.1080/14792779643000083]; Klimesch W, 2007, J NEUROPHYSIOL, V97, P1311, DOI 10.1152/jn.00876.2006; KROLL JF, 1994, J MEM LANG, V33, P149, DOI 10.1006/jmla.1994.1008; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Li W, 2008, J COGNITIVE NEUROSCI, V20, P95; Liu HY, 2010, BRAIN LANG, V112, P121, DOI 10.1016/j.bandl.2009.11.001; McCandliss BD, 1997, COGNITIVE PSYCHOL, V33, P88, DOI 10.1006/cogp.1997.0661; McLaughlin J, 2004, NAT NEUROSCI, V7, P703, DOI 10.1038/nn1264; Midgley KJ, 2009, PSYCHOPHYSIOLOGY, V46, P551, DOI 10.1111/j.1469-8986.2009.00784.x; Ordonez CL, 2002, J EDUC PSYCHOL, V94, P719, DOI 10.1037//0022-0663.94.4.719; Palazova M, 2011, NEUROPSYCHOLOGIA, V49, P2766, DOI 10.1016/j.neuropsychologia.2011.06.005; Pavlenko A, 2007, EMOTIONS MULTILINGUA; Penolazzi B, 2007, BIOL PSYCHOL, V74, P374, DOI 10.1016/j.biopsycho.2006.09.008; Rellecke J, 2011, BRAIN COGNITION, V77, P23, DOI 10.1016/j.bandc.2011.07.001; Rienties B, 2013, INT J INTERCULT REL, V37, P188, DOI 10.1016/j.ijintrel.2012.11.004; Rossell SL, 2004, EMOTION, V4, P354, DOI 10.1037/1528-3542.4.4.354; Sass K, 2012, HUM BRAIN MAPP, V33, P676, DOI 10.1002/hbm.21241; Schacht A, 2009, COGN AFFECT BEHAV NE, V9, P28, DOI 10.3758/CABN.9.1.28; Schepens J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063006; Scott GG, 2008, BIOL PSYCHOL; Segalowitz SJ, 2009, BIOL PSYCHOL, V80, P122, DOI 10.1016/j.biopsycho.2008.04.009; Skrandies W, 1998, BRAIN RES; Storbeck J, 2004, PERS SOC PSYCHOL B, V30, P81, DOI 10.1177/0146167203258855; Storbeck J, 2007, COGNITION EMOTION, V21, P1212, DOI 10.1080/02699930701438020; Vo MLH, 2009, BEHAV RES METHODS, V41, P534, DOI 10.3758/BRM.41.2.534; Wu YJ, 2012, J NEUROSCI, V32, P6485, DOI 10.1523/JNEUROSCI.6119-11.2012; Zhang Q, 2012, BRAIN RES, V1474, P60, DOI 10.1016/j.brainres.2012.07.023; Zhang Q, 2010, BRAIN RES, V1329, P142, DOI 10.1016/j.brainres.2010.03.021	56	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144576	10.1371/journal.pone.0144576	http://dx.doi.org/10.1371/journal.pone.0144576			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YZ	26656502	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903500042
J	Wijmenga-Monsuur, AJ; van Westen, E; Knol, MJ; Jongerius, RMC; Zancolli, M; Goldblatt, D; van Gageldonk, PGM; Tcherniaeva, I; Berbers, GAM; Rots, NY				Wijmenga-Monsuur, Alienke J.; van Westen, Els; Knol, Mirjam J.; Jongerius, Riet M. C.; Zancolli, Marta; Goldblatt, David; van Gageldonk, Pieter G. M.; Tcherniaeva, Irina; Berbers, Guy A. M.; Rots, Nynke Y.			Direct Comparison of Immunogenicity Induced by 10-or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants	PLOS ONE			English	Article							MULTIPLEX IMMUNOASSAY; BORDETELLA-PERTUSSIS; PHID-CV; DISEASE; CHILDREN; IMMUNIZATION; ANTIBODIES; SAFETY; PROTECTION; CARRIAGE	Background & Aims Since 2009/10, a 10- and a 13-valent pneumococcal conjugate vaccine (PCV) are available, but only the 10-valent vaccine is now being used for the children in the Netherlands. As the vaccines differ in number of serotypes, antigen concentration, and carrier proteins this study was designed to directly compare quantity and quality of the antibody responses induced by PCV10 and PCV13 before and after the 11-month booster. Methods Dutch infants (n = 132) were immunized with either PCV10 or PCV13 and DTaP-IPV-Hib-HepB at the age of 2, 3, 4 and 11 months. Blood samples were collected pre-booster and post-booster at one week and one month post-booster for quantitative and qualitative immunogenicity against 13 pneumococcal serotypes, as well as quantitative immunogenicity against diphtheria, tetanus, pertussis and Haemophilus influenzae type b. We compared immunogenicity induced by PCV13 and PCV10 for their ten shared serotypes. Results One month post-booster, pneumococcal serotype-specific IgG geometric mean concentrations (GMCs) for the PCV13 group were higher compared with the PCV10 group for six serotypes, although avidity was lower. Serotype 19F showed the most distinct difference in IgG and, in contrast to other serotypes, its avidity was higher in the PCV13 group. One week post-booster, opsonophagocytosis for serotype 19F did not differ significantly between the PCV10- and the PCV13 group. Conclusion Both PCV10 and PCV13 were immunogenic and induced a booster response. Compared to the PCV10 group, the PCV13 group showed higher levels for serotype 19F GMCs and avidity, pre-as well as post-booster, although opsonophagocytosis did not differ significantly between groups. In our study, avidity is not correlated to opsonophagocytotic activity (OPA) and correlations between IgG and OPA differ per serotype. Therefore, besides assays to determine IgG GMCs, assays to detect opsonophagocytotic activity, i.e., the actual killing of the pneumococcus, are important for PCV evaluation. How differences between the two vaccines relate to long-term protection requires further investigation.	[Wijmenga-Monsuur, Alienke J.; van Westen, Els; Knol, Mirjam J.; Jongerius, Riet M. C.; van Gageldonk, Pieter G. M.; Tcherniaeva, Irina; Berbers, Guy A. M.; Rots, Nynke Y.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Zancolli, Marta; Goldblatt, David] UCL, Inst Child Hlth, London, England	Netherlands National Institute for Public Health & the Environment; University of London; University College London	Wijmenga-Monsuur, AJ (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	alienke.wijmenga@rivm.nl	Goldblatt, David/C-5972-2008	Goldblatt, David/0000-0002-0769-5242; van Gageldonk, Pieter/0000-0003-2753-9674				Adderson EE, 2001, SPRINGER SEMIN IMMUN, V23, P387, DOI 10.1007/s281-001-8166-x; Andrews NJ, 2014, LANCET INFECT DIS, V14, P839, DOI 10.1016/S1473-3099(14)70822-9; Azzari C, 2014, PEDIATR INFECT DIS J, V33, P858, DOI 10.1097/INF.0000000000000328; Bergh van den MR., 2013, THESIS; Blanchard-Rohner G, 2011, EXPERT REV VACCINES, V10, P673, DOI 10.1586/erv.11.14; Bosch AATM, EMERGING INFEC UNPUB; Burton RL, 2006, CLIN VACCINE IMMUNOL, V13, P1004, DOI 10.1128/CVI.00112-06; Dagan R, 2013, CLIN INFECT DIS, V57, P952, DOI 10.1093/cid/cit428; de Voer RM, 2009, CLIN VACCINE IMMUNOL, V16, P433, DOI 10.1128/CVI.00364-08; Demczuk WHB, 2013, CAN J MICROBIOL, V59, P778, DOI 10.1139/cjm-2013-0614; Domingues CMAS, 2014, LANCET RESP MED, V2, P464, DOI 10.1016/S2213-2600(14)70060-8; Elberse KEM, 2010, CLIN VACCINE IMMUNOL, V17, P674, DOI 10.1128/CVI.00408-09; Goldblatt D, 2006, PEDIATR INFECT DIS J, V25, P312, DOI 10.1097/01.inf.0000207483.60267.e7; Grant LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074906; Harboe ZB, 2014, CLIN INFECT DIS, V59, P1066, DOI 10.1093/cid/ciu524; Hausdorff WP, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-4; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Kaplan SL, 2013, PEDIATR INFECT DIS J, V32, P203, DOI 10.1097/INF.0b013e318275614b; Kelly DF, 2004, IMMUNOLOGY, V113, P163, DOI 10.1111/j.1365-2567.2004.01971.x; Knol MJ, EMERGIN INFECT UNPUB; Knuf M, 2012, PEDIATR INFECT DIS J, V31, pE31, DOI 10.1097/INF.0b013e3182323ac2; Knuf M, 2009, PEDIATR INFECT DIS J, V28, pS97, DOI 10.1097/INF.0b013e318199f61b; Kubler-Kielb J, 2011, P NATL ACAD SCI USA, V108, P4087, DOI 10.1073/pnas.1100782108; McHeyzer-Williams LJ, 2006, IMMUNOL REV, V211, P255, DOI 10.1111/j.0105-2896.2006.00397.x; Millar EV, 2010, CLIN INFECT DIS, V51, P1258, DOI 10.1086/657070; Myint TTH, 2013, ADV THER, V30, P127, DOI 10.1007/s12325-013-0007-6; Omenaca F, 2011, PEDIATRICS, V128, pE290, DOI 10.1542/peds.2010-1184; Oosterhuis-Kafeja F, 2007, VACCINE, V25, P2194, DOI 10.1016/j.vaccine.2006.11.032; Palmu AA, 2013, LANCET, V381, P214, DOI 10.1016/S0140-6736(12)61854-6; Park IH, 2008, J INFECT DIS, V198, P1818, DOI 10.1086/593339; Plosker GL, 2013, PEDIATR DRUGS, V15, P403, DOI 10.1007/s40272-013-0047-z; Poolman J, 2011, CLIN VACCINE IMMUNOL, V18, P327, DOI 10.1128/CVI.00402-10; Prymula R, 2009, EXPERT REV VACCINES, V8, P1479, DOI 10.1586/ERV.09.113; Rijkers G, 1998, VACCINE, V16, P1396, DOI 10.1016/S0264-410X(98)00098-X; Rodenburg GD, 2010, EMERG INFECT DIS, V16, P816, DOI 10.3201/eid1605.091223; Siber GR, 2007, VACCINE, V25, P3816, DOI 10.1016/j.vaccine.2007.01.119; Silfverdal Sven Arne, 2009, Pediatr Infect Dis J, V28, pe276, DOI 10.1097/INF.0b013e3181b48ca3; Simell B, 2012, CLIN VACCINE IMMUNOL, V19, P1618, DOI 10.1128/CVI.00248-12; Spijkerman J, 2013, JAMA-J AM MED ASSOC, V310, P930, DOI 10.1001/jama.2013.228052; Spijkerman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039730; Spijkerman J, 2011, EMERG INFECT DIS, V17, P584, DOI 10.3201/eid1704.101115; van den Bergh MR, 2011, PEDIATR INFECT DIS J, V30, pE170, DOI 10.1097/INF.0b013e31821a0614; van der Linden M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-70; van Deursen AMM, 2012, EMERG INFECT DIS, V18, P1729, DOI 10.3201/eid1811.120329; van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018; van Gageldonk PGM, 2011, CLIN VACCINE IMMUNOL, V18, P1183, DOI 10.1128/CVI.05081-11; van Hoek AJ, 2014, VACCINE, V32, P4349, DOI 10.1016/j.vaccine.2014.03.017; van Westen E, 2015, CLIN INFECT DIS, V61, P342, DOI 10.1093/cid/civ274; van't Schurink-van't Klooster TM, 2014, 1511030012014 RIVM; Vesikari T, 2010, PEDIATR INFECT DIS J, V29, pE47, DOI 10.1097/INF.0b013e3181dffabf; Vesikari T, 2009, PEDIATR INFECT DIS J, V28, pS66, DOI 10.1097/INF.0b013e318199f8ef; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; Wysocki J, 2009, PEDIATR INFECT DIS J, V28, pS77, DOI 10.1097/INF.0b013e318199f609; Yeh SH, 2010, PEDIATRICS, V126, pE493, DOI 10.1542/peds.2009-3027	54	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144739	10.1371/journal.pone.0144739	http://dx.doi.org/10.1371/journal.pone.0144739			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658902	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903500058
J	Cho, SW; Bae, JH; Noh, GW; Kim, YA; Moon, MK; Park, KU; Song, J; Yi, KH; Park, DJ; Chung, JK; Cho, BY; Park, YJ				Cho, Sun Wook; Bae, Jae Hyun; Noh, Gyeong Woon; Kim, Ye An; Moon, Min Kyong; Park, Kyoung Un; Song, Junghan; Yi, Ka Hee; Park, Do Joon; Chung, June-Key; Cho, Bo Youn; Park, Young Joo			The Presence of Thyroid-Stimulation Blocking Antibody Prevents High Bone Turnover in Untreated Premenopausal Patients with Graves' Disease	PLOS ONE			English	Article							THYROTROPIN-RECEPTOR ANTIBODIES; MINERAL DENSITY; NEGATIVE CORRELATION; ANTITHYROID DRUGS; FRACTURE RISK; TSH; HYPERTHYROIDISM; HORMONES; HYPOTHYROIDISM; METAANALYSIS	Osteoporosis-related fractures are one of the complications of Graves' disease. This study hypothesized that the different actions of thyroid-stimulating hormone receptor (TSHR) antibodies, both stimulating and blocking activities in Graves' disease patients might oppositely impact bone turnover. Newly diagnosed premenopausal Graves' disease patients were enrolled (n = 93) and divided into two groups: patients with TSHR antibodies with thyroid-stimulating activity (stimulating activity group, n = 83) and patients with TSHR antibodies with thyroid-stimulating activity combined with blocking activity (blocking activity group, n = 10). From the stimulating activity group, patients who had matched values for free T4 and TSH binding inhibitor immunoglobulin (TBII) to the blocking activity group were further classified as stimulating activity-matched control (n = 11). Bone turnover markers BS-ALP, Osteocalcin, and C-telopeptide were significantly lower in the blocking activity group than in the stimulating activity or stimulating activity-matched control groups. The TBII level showed positive correlations with BS-ALP and osteocalcin levels in the stimulating activity group, while it had a negative correlation with the osteocalcin level in the blocking activity group. In conclusion, the activation of TSHR antibody-activated TSH signaling contributes to high bone turnover, independent of the actions of thyroid hormone, and thyroid-stimulation blocking antibody has protective effects against bone metabolism in Graves' disease.	[Cho, Sun Wook; Bae, Jae Hyun; Kim, Ye An; Moon, Min Kyong; Yi, Ka Hee; Park, Do Joon; Cho, Bo Youn; Park, Young Joo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Noh, Gyeong Woon; Moon, Min Kyong; Yi, Ka Hee; Chung, June-Key] Seoul Natl Univ Hosp, Dept Nucl Med, Seoul 110744, South Korea; [Song, Junghan] Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Park, Kyoung Un] Seoul Natl Univ, Bundang Hosp, Dept Lab Med, Songnam, South Korea; [Cho, Bo Youn] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul 156756, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Chung Ang University; Chung Ang University Hospital	Park, YJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	yjparkmd@snu.ac.kr	Park, Young Joo/J-4161-2012; Moon, Min Kyong/AAE-7663-2020; Bae, Jae Hyun/D-6500-2012; Park, Kyoung Un/J-5473-2012	Park, Young Joo/0000-0002-3671-6364; Moon, Min Kyong/0000-0002-5460-2846; Bae, Jae Hyun/0000-0002-1384-6123; Park, Kyoung Un/0000-0002-2402-7633	Seoul National University Hospital [04-2015-0900]	Seoul National University Hospital	This work was funded by Seoul National University Hospital (Grant No. 04-2015-0900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2; Amashukeli M, 2013, J INVEST MED, V61, P842, DOI [10.231/JIM.0b013e31828fcafb, 10.2310/JIM.0b013e31828fcafb]; AMINO N, 1987, CLIN ENDOCRINOL, V27, P615, DOI 10.1111/j.1365-2265.1987.tb01192.x; Ando T, 2005, BEST PRACT RES CL EN, V19, P33, DOI 10.1016/j.beem.2004.11.005; Baliram R, 2012, J CLIN INVEST, V122, P3737, DOI 10.1172/JCI63948; Bassett JHD, 2008, MOL ENDOCRINOL, V22, P501, DOI 10.1210/me.2007-0221; Bassett JHD, 2003, TRENDS ENDOCRIN MET, V14, P356, DOI 10.1016/S1043-2760(03)00144-90; Bauer DC, 2001, ANN INTERN MED, V134, P561, DOI 10.7326/0003-4819-134-7-200104030-00009; BRITTO JM, 1994, ENDOCRINOLOGY, V134, P169, DOI 10.1210/en.134.1.169; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; CHO BY, 1992, CLIN ENDOCRINOL, V36, P585, DOI 10.1111/j.1365-2265.1992.tb02269.x; Gupta MK, 2000, CLIN CHIM ACTA, V293, P1, DOI 10.1016/S0009-8981(99)00235-1; Kim BJ, 2010, CLIN ENDOCRINOL, V73, P396, DOI 10.1111/j.1365-2265.2010.03818.x; Kim MK, 2015, BONE, V71, P101, DOI 10.1016/j.bone.2014.10.009; Kim TY, 2003, J CLIN ENDOCR METAB, V88, P117, DOI 10.1210/jc.2002-020389; KLAUSHOFER K, 1995, J NUTR, V125, pS1996, DOI 10.1093/jn/125.suppl_7.1996S; Kumeda Y, 2000, J CLIN ENDOCR METAB, V85, P4157, DOI 10.1210/jc.85.11.4157; LEE MS, 1990, J CLIN ENDOCR METAB, V70, P766, DOI 10.1210/jcem-70-3-766; Miura M, 2002, BIOCHEM BIOPH RES CO, V291, P987, DOI 10.1006/bbrc.2002.6561; Moon JH, 2013, ENDOCRINOL METAB, V28, P275, DOI 10.3803/EnM.2013.28.4.275; Sampath TK, 2007, J BONE MINER RES, V22, P849, DOI 10.1359/JBMR.070302; Siddiqi A, 1997, J CLIN ENDOCR METAB, V82, P753, DOI 10.1210/jc.82.3.753; Sun L, 2008, P NATL ACAD SCI USA, V105, P4289, DOI 10.1073/pnas.0712395105; Tada H, 2003, CLIN ENDOCRINOL, V58, P403, DOI 10.1046/j.1365-2265.2003.01726.x; Taylor PN, 2013, J CLIN ENDOCR METAB, V98, P3562, DOI 10.1210/jc.2013-1315; Tsourdi E, 2015, OSTEOP IN PRESS 0812; Uzzan B, 1996, J CLIN ENDOCR METAB, V81, P4278, DOI 10.1210/jc.81.12.4278; van Rijn LE, 2014, EUR J ENDOCRINOL, V170, P461, DOI 10.1530/EJE-13-0769; Vestergaard P, 2005, CALCIFIED TISSUE INT, V77, P139, DOI 10.1007/s00223-005-0068-x; Vestergaard P, 2003, THYROID, V13, P585, DOI 10.1089/105072503322238854; Wang LY, 2015, THYROID, V25, P300, DOI 10.1089/thy.2014.0287; Yoshida K, 1996, J ENDOCRINOL INVEST, V19, P682, DOI 10.1007/BF03349039	32	7	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144599	10.1371/journal.pone.0144599	http://dx.doi.org/10.1371/journal.pone.0144599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650844	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903300060
J	Andrews, CS; Miyata, M; Susuki-Miyata, S; Lee, BC; Komatsu, K; Li, JD				Andrews, Carla S.; Miyata, Masanori; Susuki-Miyata, Seiko; Lee, Byung-Cheol; Komatsu, Kensei; Li, Jian-Dong			nil Nontypeable Haemophilus influenzae-Induced MyD88 Short Expression Is Regulated by Positive IKK beta and CREB Pathways and Negative ERK1/2 Pathway	PLOS ONE			English	Article							NF-KAPPA-B; OBSTRUCTIVE PULMONARY-DISEASE; DEPENDENT UP-REGULATION; STREPTOCOCCUS-PNEUMONIAE; EPITHELIAL-CELLS; INFLAMMATION; ACTIVATION; INNATE; CYLD; INTERLEUKIN-8	Airway diseases such as asthma and chronic obstructive pulmonary disease (COPD) are characterized by excessive inflammation and are exacerbated by nontypeable Haemophilus influenzae (NTHi). Airway epithelial cells mount the initial innate immune responses to invading pathogens and thus modulate inflammation. While inflammation is necessary to eliminate a pathogen, excessive inflammation can cause damage to the host tissue. Therefore, the inflammatory response must be tightly regulated and deciphering the signaling pathways involved in this response will enhance our understanding of the regulation of the host inflammatory response. NTHi binds to TLR2 and signal propagation requires the adaptor molecule myeloid differentiation factor 88 (MyD88). An alternative spliced form of MyD88 is called MyD88 short (MyD88s) and has been identified in macrophages and embryonic cell lines as a negative regulator of inflammation. However, the role of MyD88s in NTHi-induced inflammation in airway epithelial cells remains unknown. Here we show that NTHi induces MyD88s expression and MyD88s is a negative regulator of inflammation in airway epithelial cells. We further demonstrate that MyD88s is positively regulated by IKK beta and CREB and negatively regulated by ERK1/2 signaling pathways. Taken together these data indicate that airway inflammation is controlled in a negative feedback manner involving MyD88s and suggest that airway epithelial cells are essential to maintain immune homeostasis.	[Andrews, Carla S.; Miyata, Masanori; Susuki-Miyata, Seiko; Lee, Byung-Cheol; Komatsu, Kensei; Li, Jian-Dong] Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Li, JD (corresponding author), Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA.	jdli@gsu.edu	Komatsu, Kensei/AAO-6492-2021	Komatsu, Kensei/0000-0001-7418-3805; Li, Jian-Dong/0000-0002-5593-050X	National Institutes of Health [DC005843, DC004562, DC013833, GM107529]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005843, R01DC004562, R01DC013833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from National Institutes of Health (http://www.nih.gov) DC005843, DC004562, DC013833 and GM107529 to JDL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2006, CRIT CARE MED, V34, P2377, DOI 10.1097/01.CCM.0000233875.93866.88; Alikhan MM, 2014, CURR OPIN PULM MED, V20, P159, DOI 10.1097/MCP.0000000000000023; Barbu C, 2011, ROM J MORPHOL EMBRYO, V52, P21; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Cohen P, 2014, J CELL SCI, V127, P2383, DOI 10.1242/jcs.149831; Foxwell AR, 1998, MICROBIOL MOL BIOL R, V62, P294, DOI 10.1128/MMBR.62.2.294-308.1998; Ha U, 2007, J IMMUNOL, V178, P1736, DOI 10.4049/jimmunol.178.3.1736; Hallstrand TS, 2014, CLIN IMMUNOL, V151, P1, DOI 10.1016/j.clim.2013.12.003; Ito M, 2010, INT J PEDIATR OTORHI, V74, P901, DOI 10.1016/j.ijporl.2010.05.008; Janssens S, 2003, FEBS LETT, V548, P103, DOI 10.1016/S0014-5793(03)00747-6; Janssens S, 2002, CURR BIOL, V12, P467, DOI 10.1016/S0960-9822(02)00712-1; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Jono H, 2004, J BIOL CHEM, V279, P36171, DOI 10.1074/jbc.M406638200; Jundi K, 2015, BIOMOLECULES, V5, P1386, DOI 10.3390/biom5031386; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Knight DA, 2012, RESPIROLOGY, V17, P563, DOI 10.1111/j.1440-1843.2012.02126.x; Komatsu K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2674; Lee J, 2012, J BIOL CHEM, V287, P22799, DOI 10.1074/jbc.M111.337378; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lim JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001032; Lugade AA, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00010; Miyata M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7062; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Proud D, 2011, IMMUNOL REV, V242, P186, DOI 10.1111/j.1600-065X.2011.01033.x; Rubinstein AL, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-34; Sanin DE, 2015, J IMMUNOL, V195, P1218, DOI 10.4049/jimmunol.1500146; Schumacher SK, 2012, PEDIATR INFECT DIS J, V31, P145, DOI 10.1097/INF.0b013e31823aaeb3; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Susuki-Miyata S, 2015, P NATL ACAD SCI USA, V112, pE1800, DOI 10.1073/pnas.1418716112; Wang BN, 2003, INFECT IMMUN, V71, P5523, DOI 10.1128/IAI.71.10.5523-5530.2003; Wang WJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0083908, 10.1371/journal.pone.0084654]	34	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144840	10.1371/journal.pone.0144840	http://dx.doi.org/10.1371/journal.pone.0144840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669856	Green Published, gold, Green Submitted			2022-12-27	WOS:000366719300026
J	Lu, ZY; Zeng, YQ; Lu, FH; Liu, XS; Zou, CA				Lu, Zhaoyu; Zeng, Yuqun; Lu, Fuhua; Liu, Xusheng; Zou, Chuan			Rhubarb Enema Attenuates Renal Tubulointerstitial Fibrosis in 5/6 Nephrectomized Rats by Alleviating Indoxyl Sulfate Overload	PLOS ONE			English	Article							BOUND UREMIC SOLUTES; TOXINS; KIDNEY	Aim To investigate the effects of rhubarb enema treatment using a 5/6 nephrectomized rat model and study its mechanisms. Methods Twenty-eight Sprague Dawley rats were divided into three groups: sham operation group (n = 8), 5/6 nephrectomized (5/6Nx) (n = 10), and 5/6Nx with rhubarb enema treatment (n = 10). The rhubarb enema was continuous for 1.0month. Serum creatinine, serum indoxyl sulfate (IS) level, renal pathology, tubulointerstitial fibrosis, and renal oxidative stress were assessed. Results 5/6Nx rats showed increasing levels of serum creatinine and severe pathological lesions. Their serum creatinine levels obviously decreased after rhubarb enema treatment (P < 0.05 vs 5/6Nx group). The administration of rhubarb enema attenuated the histopathological changes in 5/6Nx rats. In addition, 5/6Nx rats showed an enhanced extent of tubulointerstitial fibrosis compared with sham rats, and administration of rhubarb enema to 5/6Nx rats ameliorated tubulointerstitial fibrosis. 5/6Nx rats showed increased serum levels of IS, renal oxidative stress, and NF-kappa B compared with sham rats, whereas administration of rhubarb enema to 5/6Nx rats decreased serum levels of IS, renal oxidative stress, and NF-kappa B levels. Conclusion Rhubarb enema treatment ameliorates tubulointerstitial fibrosis in the kidneys of 5/6Nx rats, most likely by alleviating IS overload and reducing kidney oxidative stress and inflammatory injury.	[Lu, Zhaoyu; Zeng, Yuqun; Lu, Fuhua; Liu, Xusheng; Zou, Chuan] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Natl Key Unit Clin Res TCM Chron Kidney Dis, Key Unit Kidney Dis,Guangdong Prov Hosp TCM, Guangzhou 510120, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine	Zou, CA (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 2, Natl Key Unit Clin Res TCM Chron Kidney Dis, Key Unit Kidney Dis,Guangdong Prov Hosp TCM, Guangzhou 510120, Guangdong, Peoples R China.	doctorzc541888@126.com			National Natural Science Foundation of China [81202819]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81202819).	Aronov PA, 2011, J AM SOC NEPHROL, V22, P1769, DOI 10.1681/ASN.2010121220; Chiu Cheng-An, 2010, Rev Diabet Stud, V7, P275, DOI 10.1900/RDS.2010.7.275; Evenepoel P, 2009, KIDNEY INT, V76, pS12, DOI 10.1038/ki.2009.402; Fagugli RM, 2002, AM J KIDNEY DIS, V40, P339, DOI 10.1053/ajkd.2002.34518; Friedman EA, 2009, CURR MED RES OPIN, V25, P1913, DOI 10.1185/03007990903069173; Guo Jun, 2011, Clinical Focus, V26, P1595; He PX, 2014, ACTA PHARMACOL SIN, V35, P1546, DOI 10.1038/aps.2014.105; Jiang J, 2011, J MED RES CHIN, V40, P20; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Li A, 2013, MICROCIRCULATION, V20, P617, DOI 10.1111/micc.12061; Liabeuf S, 2011, TOXINS, V3, P911, DOI 10.3390/toxins3070911; Lin B., 2011, J NEW CHIN MED CHIN, V43, P38; Lin CJ, 2010, NEPHROL DIAL TRANSPL, V25, P3693, DOI 10.1093/ndt/gfq251; McCullough PA, 2010, AM J KIDNEY DIS, V55, pS1, DOI 10.1053/j.ajkd.2009.12.017; Meert N, 2009, NEPHROL DIAL TRANSPL, V24, P562, DOI 10.1093/ndt/gfn522; Meijers BKI, 2009, CLIN J AM SOC NEPHRO, V4, P1932, DOI 10.2215/CJN.02940509; Meijers BKI, 2011, NEPHROL DIAL TRANSPL, V26, P759, DOI 10.1093/ndt/gfq818; Shu ZJ, 2011, EXPERT OPIN THER TAR, V15, P1147, DOI 10.1517/14728222.2011.614234; Torres-Gonzalez M, 2014, AM J PHYSIOL-CELL PH, V306, pC221, DOI 10.1152/ajpcell.00140.2013; Tumur Z, 2009, AM J NEPHROL, V29, P551, DOI 10.1159/000191468; Vanholder R, 2008, BLOOD PURIFICAT, V26, P77, DOI 10.1159/000110570; Vanholder R, 2008, J AM SOC NEPHROL, V19, P863, DOI 10.1681/ASN.2007121377; Wang GF, 2009, RAPID COMMUN MASS SP, V23, P2061, DOI 10.1002/rcm.4111; Watanabe H, 2011, J PHARM SCI-US, V100, P3682, DOI 10.1002/jps.22592; Zhang BD, 2009, CHIN J TRADIT CHIN M, V50, P261; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhao C, 2011, CLIN FOCUS CHIN, V26, P1310; Zheng H., 2008, LIAONING J TRADITION, V35, P1650; Zhou QG, 2009, ACTA PHARMACOL SIN, V30, P98, DOI 10.1038/aps.2008.11; Zhu Wei, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P471	30	19	24	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144726	10.1371/journal.pone.0144726	http://dx.doi.org/10.1371/journal.pone.0144726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671452	Green Submitted, Green Published, gold			2022-12-27	WOS:000366719300018
J	De Grande, H; Vandenheede, H; Deboosere, P				De Grande, Hannelore; Vandenheede, Hadewijch; Deboosere, Patrick			Educational Inequalities in the Transition to Adulthood in Belgium: The Impact of Intergenerational Mobility on Young-Adult Mortality in 2001-2009	PLOS ONE			English	Article							SOCIOECONOMIC POSITION; LIFE-COURSE; SOCIAL DETERMINANTS; POPULATION HEALTH; NORWEGIAN MEN; CHILDHOOD; BEHAVIORS; COHORT; DEATH; CIRCUMSTANCES	Several studies have focused on the association between parental and personal socioeconomic position (SEP) and health, with mixed results depending on the specific health outcome, research methodology and population under study. In the last decades, a growing interest is given to the influence of intergenerational mobility on several health outcomes at young ages. This study addresses the following research question: Is educational intergenerational mobility associated with all-cause and cause-specific mortality in young adulthood? To this end, the Belgian 1991 and 2001 censuses are used, providing characteristics of young persons at two time points (T1 = 01/03/91; T2 = 01/10/01) and follow-up information on mortality and emigration between T2 and 31/12/09 (T3). The study population consists of all official inhabitants of Flanders and the Brussels-Capital Region at T2, born between 1972 and 1982 and alive at T2. Parental and personal education are divided into primary (PE), lower secondary (LSE), higher secondary (HSE) and higher education (HE). We analyse mortality between T2 and T3 calculating age-standardised mortality rates (ASMRs) and using Cox regression (hazard ratios = HR). Personal rather than parental education determines the observed mortality rates, with high all-cause mortality rates among those with PE, irrespective of parental education (e.g., among men ASMR(PE-PE) = 200.0 [95% CI 158.0-241.9]; ASMR(HE-PE) = 319.7 [183.2-456.3]) and low all-cause mortality among those in higher education, regardless of parental education (ASMR(PE-HE) = 41.7 [30.8-52.6]; ASMR(HE-HE) = 38.0 [33.2-42.8]). There is some variation by gender and according to cause of death. This study shows the strong association between personal education and young-adult mortality.	[De Grande, Hannelore] Vrije Univ Brussel, Fac Econ & Social Sci, Dept Sociol, Interface Demog, B-1050 Brussels, Elsene, Belgium; Vrije Univ Brussel, Business Solvay Sch, B-1050 Brussels, Elsene, Belgium	Vrije Universiteit Brussel; Vrije Universiteit Brussel	De Grande, H (corresponding author), Vrije Univ Brussel, Fac Econ & Social Sci, Dept Sociol, Interface Demog, Pl Laan 5, B-1050 Brussels, Elsene, Belgium.	hannelore.de.grande@vub.ac.be	Deboosere, Patrick/C-1113-2014	Vandenheede, Hadewijch/0000-0002-1134-8155; Deboosere, Patrick/0000-0002-8148-3694	Innoviris Belgium; Prospective Research for Brussels by Innoviris	Innoviris Belgium(Innoviris); Prospective Research for Brussels by Innoviris(Innoviris)	This Prospective Research for Brussels Project was funded by Innoviris Belgium. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by Prospective Research for Brussels by Innoviris. Many thanks goes to our data manager, Didier Willaert, who prepared the main database, and to the Agency for Care and Health and the Brussels-Capital Health and Social Observatory, from whom we received the death certificate data.	Baker DP, 2011, POPUL DEV REV, V37, P307, DOI 10.1111/j.1728-4457.2011.00412.x; Bartley M, 2007, J R STAT SOC A STAT, V170, P469, DOI 10.1111/j.1467-985X.2006.00464.x; Bauldry S, 2014, SOC SCI MED, V111, P94, DOI 10.1016/j.socscimed.2014.04.005; Becker B, 2013, CHILD INDIC RES, V6, P737, DOI 10.1007/s12187-013-9190-x; Berg L, 2014, PEDIATRICS, V133, P682, DOI 10.1542/peds.2013-2771; Blackwell DL, 2001, SOC SCI MED, V52, P1269, DOI 10.1016/S0277-9536(00)00230-6; BLANE D, 1993, SOCIOL HEALTH ILL, V15, P2; Boudon R, 1973, EDUCATION OPPORTUNIT; Boyle PJ, 2009, SOC SCI MED, V68, P1835, DOI 10.1016/j.socscimed.2009.02.051; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; Bukodi E, 2013, EUR SOCIOL REV, V29, P1024, DOI 10.1093/esr/jcs079; Claussen B, 2003, J EPIDEMIOL COMMUN H, V57, P40, DOI 10.1136/jech.57.1.40; Danhier J, 2012, NAAR KWALITEITSSCHOL; De Grande H, 2014, HEALTH PLACE, V30, P61, DOI 10.1016/j.healthplace.2014.08.003; Deboosere P, 2011, SOCIALE ONGELIJKHEDE, P127; Deboosere P, 2010, DE GEZONDE LEVENSLOO, P15; Elo IT, 2014, SOC SCI MED, V119, P198, DOI 10.1016/j.socscimed.2013.11.037; Gall SL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-55; Galobardes B, 2008, J EPIDEMIOL COMMUN H, V62, P387, DOI 10.1136/jech.2007.065508; Galobardes B, 2004, EPIDEMIOL REV, V26, P7, DOI 10.1093/epirev/mxh008; Galobardes B, 2007, BRIT MED BULL, V81-82, P21, DOI 10.1093/bmb/ldm001; Gauffin K, 2013, J EPIDEMIOL COMMUN H, V67, P932, DOI 10.1136/jech-2013-202624; Gravseth HM, 2010, J EPIDEMIOL COMMUN H, V64, P407, DOI 10.1136/jech.2008.083485; Groenez S., 2010, TIJDSCHRIFT SOCIOLOG, V31, P199; Halfon N, 2014, MATERN CHILD HLTH J, V18, P344, DOI 10.1007/s10995-013-1346-2; Hannum E, 2005, WORLD DEV, V33, P333, DOI 10.1016/j.worlddev.2004.10.001; Hayward MD, 2004, DEMOGRAPHY, V41, P87, DOI 10.1353/dem.2004.0005; House JS, 2005, J GERONTOL B-PSYCHOL, V60, P15; Karvonen S, 1999, J EPIDEMIOL COMMUN H, V53, P211, DOI 10.1136/jech.53.4.211; Kestila L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-164; Kuh D, 2002, BRIT MED J, V325, P1076, DOI 10.1136/bmj.325.7372.1076; Kulhanova I, 2014, SOC SCI MED, V117, P142, DOI 10.1016/j.socscimed.2014.07.027; Kuntz B, 2013, J PUBLIC HEALTH-HEID, V21, P49, DOI 10.1007/s10389-012-0523-x; Leveque A, 2002, REV EPIDEMIOL SANTE, V50, P371; Lynch SM, 2003, DEMOGRAPHY, V40, P309, DOI 10.2307/3180803; Manor O, 2003, SOC SCI MED, V57, P2217, DOI 10.1016/S0277-9536(03)00097-2; Marmot M, 2009, INT J PUBLIC HEALTH, V54, P125, DOI 10.1007/s00038-009-5402-z; Naess O, 2007, J EPIDEMIOL COMMUN H, V61, P1004, DOI 10.1136/jech.2006.052811; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Poulton R, 2002, LANCET, V360, P1640, DOI 10.1016/S0140-6736(02)11602-3; Power C, 1998, LANCET, V351, P1009, DOI 10.1016/S0140-6736(97)11082-0; Remes H, 2012, ADV LIFE COURSE RES, V17, P199, DOI 10.1016/j.alcr.2012.09.001; Ross CE, 2006, SOC SCI MED, V63, P1400, DOI 10.1016/j.socscimed.2006.03.013; Ross CE, 2011, SOC SCI MED, V72, P591, DOI 10.1016/j.socscimed.2010.11.028; ROSS CE, 1995, AM SOCIOL REV, V60, P719, DOI 10.2307/2096319; Rostila M, 2011, J MARRIAGE FAM, V73, P236, DOI 10.1111/j.1741-3737.2010.00801.x; Schafer MH, 2013, SOC FORCES, V91, P1007, DOI 10.1093/sf/sos192; Sen A, 1998, ECON J, V108, P1, DOI 10.1111/1468-0297.00270; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P153; Strand BH, 2006, SOC SCI MED, V63, P2825, DOI 10.1016/j.socscimed.2006.07.020; van de Mheen HD, 1998, SOCIOL HEALTH ILL, V20, P754, DOI 10.1111/1467-9566.00128; Viner RM, 2011, LANCET, V377, P1162, DOI 10.1016/S0140-6736(11)60106-2; Wickrama KAS, 2003, J HEALTH SOC BEHAV, V44, P61, DOI 10.2307/1519816; Willson AE, 2007, AM J SOCIOL, V112, P1886, DOI 10.1086/512712	54	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0142104	10.1371/journal.pone.0142104	http://dx.doi.org/10.1371/journal.pone.0142104			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26657691	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900005
J	Garcia-Diaz, C; van Witteloostuijn, A; Peli, G				Garcia-Diaz, Cesar; van Witteloostuijn, Arjen; Peli, Gabor			Micro-Level Adaptation, Macro-Level Selection, and the Dynamics of Market Partitioning	PLOS ONE			English	Article							INDUSTRIAL-ORGANIZATION; RESOURCE; COMPETITION; INTERDEPENDENCY; PRODUCT; FIRMS	This paper provides a micro-foundation for dual market structure formation through partitioning processes in marketplaces by developing a computational model of interacting economic agents. We propose an agent-based modeling approach, where firms are adaptive and profit-seeking agents entering into and exiting from the market according to their (lack of) profitability. Our firms are characterized by large and small sunk costs, respectively. They locate their offerings along a unimodal demand distribution over a one-dimensional product variety, with the distribution peak constituting the center and the tails standing for the peripheries. We found that large firms may first advance toward the most abundant demand spot, the market center, and release peripheral positions as predicted by extant dual market explanations. However, we also observed that large firms may then move back toward the market fringes to reduce competitive niche overlap in the center, triggering nonlinear resource occupation behavior. Novel results indicate that resource release dynamics depend on firm-level adaptive capabilities, and that a minimum scale of production for low sunk cost firms is key to the formation of the dual structure.	[Garcia-Diaz, Cesar] Univ Los Andes, Dept Ind Engn, Bogota, Colombia; [van Witteloostuijn, Arjen] Tilburg Univ, Tilburg Sch Econ & Management, NL-5000 LE Tilburg, Netherlands; [van Witteloostuijn, Arjen] Univ Antwerp, Fac Appl Econ, B-2020 Antwerp, Belgium; [van Witteloostuijn, Arjen] Univ Antwerp, Antwerp Management Sch, B-2020 Antwerp, Belgium; [van Witteloostuijn, Arjen] Cardiff Univ, Cardiff Business Sch, Cardiff CF10 3AX, S Glam, Wales; [Peli, Gabor] Univ Utrecht, Utrecht Sch Econ, Utrecht, Netherlands	Universidad de los Andes (Colombia); Tilburg University; University of Antwerp; University of Antwerp; Cardiff University; Utrecht University	Garcia-Diaz, C (corresponding author), Univ Los Andes, Dept Ind Engn, Bogota, Colombia.	ce.garcia392@uniandes.edu.co	García-Díaz, César/R-1559-2017	García-Díaz, César/0000-0002-5395-5324; van Witteloostuijn, A./0000-0002-0287-5965	Fonds Wetenschappelijk Onderzoek (FWO); Odysseus program	Fonds Wetenschappelijk Onderzoek (FWO)(FWO); Odysseus program	This work was supported by Fonds Wetenschappelijk Onderzoek (FWO, http://www.fwo.be/), Odysseus program (http://www.fwo.be/en/fellowships-funding/research-projects/odysseusprogramme/), and P.I. AvW.	Adner R, 2001, MANAGE SCI, V47, P611, DOI 10.1287/mnsc.47.5.611.10482; Barron DN, 2001, DYNAMICS OF ORGANIZATIONS, P209; Barron DN, 1999, AM SOCIOL REV, V64, P421, DOI 10.2307/2657494; Bernardino JPR, 2013, J EVOL ECON, V23, P1047, DOI 10.1007/s00191-013-0317-5; Boone C, 2004, IND CORP CHANGE, V13, P117, DOI 10.1093/icc/13.1.117; Boone C, 2004, IND CORP CHANGE, V13, P701, DOI 10.1093/icc/dth028; BOONE C, 1995, ORGAN STUD, V16, P265, DOI 10.1177/017084069501600204; Boone C, 2002, AM SOCIOL REV, V67, P408, DOI 10.2307/3088964; Boone C, 2000, ORGAN STUD, V21, P355, DOI 10.1177/0170840600212003; Burton RM., 1995, COMPUT MATH ORGAN TH, V1, P57, DOI [10.1007/BF01307828, DOI 10.1007/BF01307828]; CARROLL GR, 1985, AM J SOCIOL, V90, P1262, DOI 10.1086/228210; Carroll GR, 2002, RES ORGAN BEHAV, V24, P1, DOI 10.1016/S0191-3085(02)24002-2; Carroll GR, 2000, AM J SOCIOL, V106, P715, DOI 10.1086/318962; Chang MH, 2015, OXFORD HDB COMPUTATI; Chang MH, 2015, COMPUTATIONAL MODEL; Chang MH, 2011, EAST ECON J, V37, P28, DOI 10.1057/eej.2010.30; Colombo L, 2014, J ECON DYN CONTROL, V48, P288, DOI 10.1016/j.jedc.2014.05.018; Cyert R. M., 1963, BEHAV THEORY FIRM; Dobrev SD, 2000, ORGAN STUD, V21, P383, DOI 10.1177/0170840600212004; Garcia-Diaz C. E., 2011, LECT NOTES ECON MATH, V652, P153; Hannan MT, 2005, J ECON PERSPECT, V19, P51, DOI 10.1257/0895330053147985; Hotelling H, 1929, ECON J, V39, P41, DOI 10.2307/2224214; Kleijnen JPC, 2007, DESIGN ANAL SIMULATI; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Le Mens G, 2011, ADMIN SCI QUART, V56, P95, DOI 10.2189/asqu.2011.56.1.095; Lee K, 2013, JASSS-J ARTIF SOC S, V16, DOI 10.18564/jasss.2080; Lenox MJ, 2007, MANAGE SCI, V53, P599, DOI 10.1287/mnsc.1060.0679; Lenox MJ, 2006, MANAGE SCI, V52, P757, DOI 10.1287/mnsc.1050.0495; Liu M, 2011, THESIS; McPherson M, 2004, IND CORP CHANGE, V13, P263, DOI 10.1093/icc/13.1.263; Reis S, 2013, IND CORP CHANGE, V22, P459, DOI 10.1093/icc/dts020; SALOP SC, 1979, BELL J ECON, V10, P141, DOI 10.2307/3003323; Simon H, 1957, MODELS MAN SOCIAL RA; Solomon S, 2015, J ECON INTERACT COOR, V10, P5, DOI 10.1007/s11403-014-0135-3; Sutton J., 1991, SUNK COSTS MARKET ST; Tirole J., 1988, THEORY IND ORG; Van Witteloostuijn A, 2006, ACAD MANAGE REV, V31, P409; WHITE HC, 1981, AM J SOCIOL, V87, P517, DOI 10.1086/227495	38	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144574	10.1371/journal.pone.0144574	http://dx.doi.org/10.1371/journal.pone.0144574			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26656107	Green Published, gold			2022-12-27	WOS:000366715900064
J	Hajek, A; Brettschneider, C; Lange, C; Posselt, T; Wiese, B; Steinmann, S; Weyerer, S; Werle, J; Pentzek, M; Fuchs, A; Stein, J; Luck, T; Bickel, H; Mosch, E; Wagner, M; Jessen, F; Maier, W; Scherer, M; Riedel-Heller, SG; Konig, HH				Hajek, Andre; Brettschneider, Christian; Lange, Carolin; Posselt, Tina; Wiese, Birgitt; Steinmann, Susanne; Weyerer, Siegfried; Werle, Jochen; Pentzek, Michael; Fuchs, Angela; Stein, Janine; Luck, Tobias; Bickel, Horst; Moesch, Edelgard; Wagner, Michael; Jessen, Frank; Maier, Wolfgang; Scherer, Martin; Riedel-Heller, Steffi G.; Koenig, Hans-Helmut		AgeCoDe Study Grp	Longitudinal Predictors of Institutionalization in Old Age	PLOS ONE			English	Article							NURSING-HOME PLACEMENT; RISK-FACTORS; DEMENTIA; IMPAIRMENT; ADMISSION; HEALTH; LONELINESS; COMMUNITY; DISEASES; FRAILTY	Objective To investigate time-dependent predictors of institutionalization in old age using a longitudinal approach. Methods In a representative survey of the German general population aged 75 years and older predictors of institutionalization were observed every 1.5 years over six waves. Conditional fixed-effects logistic regressions (with 201 individuals and 960 observations) were performed to estimate the effects of marital status, depression, dementia, and physical impairments (mobility, hearing and visual impairments) on the risk of admission to old-age home or nursing home. By exploiting the longitudinal data structure using panel econometric models, we were able to control for unobserved heterogeneity such as genetic predisposition and personality traits. Results The probability of institutionalization increased significantly with occurrence of widowhood, depression, dementia, as well as walking and hearing impairments. In particular, the occurrence of widowhood (OR = 78.3), dementia (OR = 154.1) and substantial mobility impairment (OR = 36.7) were strongly associated with institutionalization. Conclusion Findings underline the strong influence of loss of spouse as well as dementia on institutionalization. This is relevant as the number of old people (a) living alone and (b) suffering from dementia is expected to increase rapidly in the next decades. Consequently, it is supposed that the demand for institutionalization among the elderly will increase considerably. Practitioners as well as policy makers should be aware of these upcoming challenges.	[Hajek, Andre; Brettschneider, Christian; Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Dept Hlth Econ & Hlth Serv Res, Hamburg Ctr Hlth Econ, Hamburg, Germany; [Lange, Carolin; Posselt, Tina; Scherer, Martin] Univ Med Ctr Hamburg Eppendorf, Dept Primary Med Care, Ctr Psychosocial Med, Hamburg, Germany; [Wiese, Birgitt; Steinmann, Susanne] Hannover Med Sch, WG Med Stat & IT Infrastruct, Inst Gen Practice, Hannover, Germany; [Weyerer, Siegfried; Werle, Jochen] Heidelberg Univ, Cent Inst Mental Hlth, Med Fac Mannheim, Mannheim, Germany; [Pentzek, Michael; Fuchs, Angela] Univ Dusseldorf, Inst Gen Practice, Fac Med, Dusseldorf, Germany; [Stein, Janine; Luck, Tobias; Riedel-Heller, Steffi G.] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, D-04109 Leipzig, Germany; [Bickel, Horst; Moesch, Edelgard] Tech Univ Munich, Dept Psychiat, D-80290 Munich, Germany; [Wagner, Michael; Jessen, Frank; Maier, Wolfgang] Univ Bonn, Dept Psychiat, Bonn, Germany; [Wagner, Michael; Maier, Wolfgang] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Jessen, Frank] Univ Cologne, Dept Psychiat & Psychotherapy, D-50931 Cologne, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Heinrich Heine University Dusseldorf; Leipzig University; Technical University of Munich; University of Munich; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Cologne	Hajek, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Hlth Econ & Hlth Serv Res, Hamburg Ctr Hlth Econ, Hamburg, Germany.	a.hajek@uke.de	Wagner, Michael/E-2325-2011; Jessen, Frank/AAK-6170-2020; König, Hans-Helmut/P-1211-2018; Riedel-Heller, Steffi/ABG-1537-2021; Brettschneider, Christian/H-5920-2019	Wagner, Michael/0000-0003-2589-6440; König, Hans-Helmut/0000-0001-5711-6862; Brettschneider, Christian/0000-0002-5280-1075; Luck, Tobias/0000-0001-7551-4397; Pentzek, Michael/0000-0001-6538-0241; Hajek, Andre/0000-0002-6886-2745	German Federal Ministry of Education and Research [KND 01GI0102, 01GI0420, 01GI0422, 01GI0423, 01GI0429, 01GI0431, 01GI0433, 01GI0434, KNDD 01GI0710, 01GI0711, 01GI0712, 01GI0713, 01GI0714, 01GI0715, 01GI0716, AgeQualiDe 01GY1322A, 01GY1322B, 01GY1322C, 01GY1322D, 01GY1322E, 01GY1322F, 01GY1322G]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This publication is part of the German Research Network on Dementia (KND), the German Research Network on Degenerative Dementia (KNDD), and the Study on Needs, Health Service Use, Costs and Health-related Quality of Life in a large Sample of Oldest-old Primary Care Patients (85 +) (AgeQualiDe) and was funded by the German Federal Ministry of Education and Research (grants KND 01GI0102, 01GI0420, 01GI0422, 01GI0423, 01GI0429, 01GI0431, 01GI0433 and 01GI0434; grants KNDD 01GI0710, 01GI0711, 01GI0712, 01GI0713, 01GI0714, 01GI0715 and 01GI0716; and grants AgeQualiDe 01GY1322A, 01GY1322B, 01GY1322C, 01GY1322D, 01GY1322E, 01GY1322F, 01GY1322G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero-Torres H, 2001, J CLIN EPIDEMIOL, V54, P795, DOI 10.1016/S0895-4356(00)00371-1; Andel R, 2007, J AGING HEALTH, V19, P213, DOI 10.1177/0898264307299359; Banaszak-Holl J, 2004, ALZ DIS ASSOC DIS, V18, P83, DOI 10.1097/01.wad.0000126619.80941.91; Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Bharucha AJ, 2004, J AM GERIATR SOC, V52, P434, DOI 10.1111/j.1532-5415.2004.52118.x; Bickel H., 2012, DEMENZEN, V2, P18; Brauns H, 1999, ZUMA NACHRICHTEN, V23, P7; Eaker ED, 2002, J CLIN EPIDEMIOL, V55, P462, DOI 10.1016/S0895-4356(01)00498-X; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fydrich T., 2009, Z MED PSYCHOL, V18, P43, DOI DOI 10.1026//0012-1924.45.4.212; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; Grenade L, 2008, AUST HEALTH REV, V32, P468, DOI 10.1071/AH080468; GURALNIK JM, 1989, J GERONTOL, V44, pM141, DOI 10.1093/geronj/44.5.M141; Jee J, 2005, OPHTHAL EPIDEMIOL, V12, P199, DOI 10.1080/09286580590969707; Kinsella K, 2009, INT POPULATION REPOR; Lachs M, 2006, GERONTOLOGIST, V46, P583, DOI 10.1093/geront/46.5.583; Lachs MS, 2002, GERONTOLOGIST, V42, P734, DOI 10.1093/geront/42.6.734; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Luck T, 2010, ACTA PSYCHIAT SCAND, V121, P260, DOI 10.1111/j.1600-0447.2009.01481.x; Luck T, 2008, NEUROEPIDEMIOLOGY, V31, P100, DOI 10.1159/000146251; Ludwig V., 2015, SAGE HDB REGRESSION, P327, DOI DOI 10.4135/9781446288146.N15; Luppa M, 2008, DEMENT GERIATR COGN, V26, P65, DOI 10.1159/000144027; Luppa M, 2012, SOC PSYCH PSYCH EPID, V47, P263, DOI 10.1007/s00127-010-0333-9; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Luppa M, 2009, INT PSYCHOGERIATR, V21, P1015, DOI 10.1017/S1041610209990238; MAHONEY F I, 1965, Md State Med J, V14, P61; Matthews Z, 2006, NOTES WORKFORCE IMPL; McCallum J, 2005, AUSTRALAS J AGEING, V24, P169, DOI 10.1111/j.1741-6612.2005.00116.x; Miller DK, 2008, J GERONTOL A-BIOL, V63, P487, DOI 10.1093/gerona/63.5.487; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Pollak C P, 1990, J Community Health, V15, P123, DOI 10.1007/BF01321316; Prieto-Flores ME, 2011, J AGING HEALTH, V23, P177, DOI 10.1177/0898264310382658; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Sarma S, 2009, SOC SCI MED, V68, P1106, DOI 10.1016/j.socscimed.2008.12.046; Shapiro E., 1985, CAN J AGING, V4, P11, DOI [10.1017/S0714980800015798, DOI 10.1017/S0714980800015798]; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; STATISTISCHES BUNDESAMT, 2009, BEV DTSCH 2060 12 KO; Tomiak M, 2000, J GERONTOL A-BIOL, V55, pM279, DOI 10.1093/gerona/55.5.M279; Tsai HJ, 2013, GERIATR GERONTOL INT, V13, P597, DOI 10.1111/j.1447-0594.2012.00944.x; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; Victor, 2012, AGING HLTH, V8, P637, DOI [DOI 10.2217/AHE.12.65, 10.2217/ahe.12.65]; von Bonsdorff M, 2006, GERONTOLOGY, V52, P359, DOI 10.1159/000094985; Wang JJ, 2003, OPHTHALMIC EPIDEMIOL, V10, P3, DOI 10.1076/opep.10.1.3.13773; Wang SY, 2013, ARCH GERONTOL GERIAT, V57, P16, DOI 10.1016/j.archger.2013.03.007; WOLINSKY FD, 1993, J GERONTOL, V48, pS93	47	106	110	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144203	10.1371/journal.pone.0144203	http://dx.doi.org/10.1371/journal.pone.0144203			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26658776	gold, Green Submitted, Green Published			2022-12-27	WOS:000366715900031
J	Lu, J; Chang, C; Zhang, HP; Wang, SX; Sun, GL; Xiao, SH; Ma, CX				Lu, Jie; Chang, Cheng; Zhang, Hai-Ping; Wang, Sheng-Xing; Sun, Genlou; Xiao, Shi-He; Ma, Chuan-Xi			Identification of a Novel Allele of TaCKX6a02 Associated with Grain Size, Filling Rate and Weight of Common Wheat	PLOS ONE			English	Article							BACKCROSS QTL ANALYSIS; TRITICUM-AESTIVUM L.; CYTOKININ; GENE; YIELD; RICE; CROSS; ACCUMULATION; TRAITS; BARLEY	Cytokinin oxidase (CKX) plays a crucial role in plant growth and development by reversibly inactivating cytokinin (CTK). Twenty-four primer pairs, designed from ESTs of the TaCKX genes family of common wheat, were used to identify their allelic variations associated with grain size, weight, and filling rate in 169 recombinant inbred lines (RIL) derived from Jing 411 x Hongmangchun 21. TaCKX6a02, a member of TaCKX gene family, amplified by primer pair T31-32, showed a close association with grain traits in this RIL population. Statistical analysis indicated that allelic variation of TaCKX6a02 had significant correlation with grain size, weight, and filling rate (GFR; P < 0.001) under varied environments. The TaCKX6a02-D1a allele from Jing411 significantly increased grain size, weight and grain filling rate, compared with TaCKX6a02-D1b from Hongmangchun 21. TaCKX6a02 was located on chromosome 3DS in the interval of Xbarc1119 and Xbarc1162, with a genetic distance of 1.4 cM. The location was further confirmed using Chinese Spring nulli-tetrasomic lines. A major QTL (quantitative trait locus) tightly linked to TaCKX6a02 was detected in the RIL population, explaining 17.1 similar to 38.2% of phenotype variations for grain size, weight, GFRmax and GFRmean in different environments. In addition, significant effects of variations of TaCKX6a02 on grain weight and GFR were further validated by association analysis among 102 wheat varieties in two cropping seasons. 12.8 similar to 35.1% of phenotypic variations were estimated for these genotypes. A novel 29-bp InDel behind the stop codon was detected by DNA sequence analysis between the two alleles of TaCKX6a02-D1. The gene-specific marker, TKX3D, was designed according to the novel variation, and can be used in marker-assisted selection (MAS) for grain size, weight, and GFR in common wheat.	[Lu, Jie; Chang, Cheng; Zhang, Hai-Ping; Wang, Sheng-Xing; Sun, Genlou; Ma, Chuan-Xi] Anhui Agr Univ, Coll Agron, Key Lab Wheat Biol & Genet Improvement Southern Y, Minist Agr, Hefei 230036, Peoples R China; [Xiao, Shi-He] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Natl Wheat Improvement Ctr, Inst Crop Sci, Beijing 100081, Peoples R China; [Sun, Genlou] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada	Anhui Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Saint Marys University - Canada	Sun, GL (corresponding author), Anhui Agr Univ, Coll Agron, Key Lab Wheat Biol & Genet Improvement Southern Y, Minist Agr, Hefei 230036, Peoples R China.	genlou.sun@smu.ca; machuanxi@ahau.edu.cn			National Natural Science Foundation of China [31000705]; China Agriculture Research System [CARS-03]; Scientific Research Special Program of Agricultural Commonwealth [201203033-04]; Anhui province natural science foundation of China [1508085MC57]; Agriculture Research System of Anhui Province [AHCYTX-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Scientific Research Special Program of Agricultural Commonwealth; Anhui province natural science foundation of China; Agriculture Research System of Anhui Province	This work was supported by grants from the National Natural Science Foundation of China (31000705), the China Agriculture Research System (CARS-03), the Scientific Research Special Program of Agricultural Commonwealth (201203033-04), Anhui province natural science foundation of China (1508085MC57), the Agriculture Research System of Anhui Province (AHCYTX-02) and the introduced leading talent research team for Universities in Anhui Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Bednarek J, 2012, J EXP BOT, V63, P5945, DOI 10.1093/jxb/ers249; Chang C, 2010, MOL BREEDING, V25, P481, DOI 10.1007/s11032-009-9346-z; Chang C, 2011, EUPHYTICA, V179, P343, DOI 10.1007/s10681-011-0348-7; Criado MV, 2009, J PLANT PHYSIOL, V166, P1775, DOI 10.1016/j.jplph.2009.05.007; Dholakia BB, 2003, PLANT BREEDING, V122, P392, DOI 10.1046/j.1439-0523.2003.00896.x; Dong MingHui, 2008, Scientia Agricultura Sinica, V41, P370; [樊高琼 FAN Gaoqiong], 2007, [麦类作物学报, Journal of triticeae crops], V27, P327; Feng DS, 2008, PLANT MOL BIOL REP, V26, P143, DOI 10.1007/s11105-008-0033-8; Galuszka P, 2004, EUR J BIOCHEM, V271, P3990, DOI 10.1111/j.1432-1033.2004.04334.x; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gupta NK, 2003, PLANT GROWTH REGUL, V40, P201, DOI 10.1023/A:1025023822806; [洪彦彬 Hong Yanbin], 2009, [分子植物育种, Molecular Plant Breeding], V7, P360; Huang XQ, 2004, THEOR APPL GENET, V109, P933, DOI 10.1007/s00122-004-1708-7; Javid MG, 2011, PLANT GROWTH REGUL, V65, P305, DOI 10.1007/s10725-011-9602-1; Jeffrey CS, 1998, PHYSIOL PLANTARUM, V103, P59; Jia J, 2013, CURR OPIN GENET DEV, V23, P29, DOI 10.1016/j.gde.2012.12.004; Kamo K, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-79; Kang HW, 1998, PLANT MOL BIOL REP, V16, P90, DOI 10.1023/A:1007418606098; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kumar N, 2007, MOL BREEDING, V19, P163, DOI 10.1007/s11032-006-9056-8; Lazova G, 2010, INT J PLANT SCI, V171, P809, DOI 10.1086/655857; Lee Eung Gwan, 2002, Journal of Plant Biology, V45, P71; [李文阳 LI Wenyang], 2007, [华北农学报, Acta Agriculturae Boreali-Sinica], V22, P5; [李秀菊 Li Xiuju], 2005, [麦类作物学报, Journal of triticeae crops], V25, P42; Liang ZhenXing, 1998, Acta Agronomica Sinica, V24, P788; Ma X, 2011, PLANT MOL BIOL REP, V29, P98, DOI 10.1007/s11105-010-0209-x; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; McCartney CA, 2005, GENOME, V48, P870, DOI 10.1139/g05-055; MCGAW BA, 1983, PHYTOCHEMISTRY, V22, P1103, DOI 10.1016/0031-9422(83)80200-3; Monde RA, 2000, PLANT MOL BIOL, V44, P529, DOI 10.1023/A:1026540310934; Narasimhamoorthy B, 2006, THEOR APPL GENET, V112, P787, DOI 10.1007/s00122-005-0159-0; Paradkar MR, 2001, J PLANT PHYSIOL, V158, P929, DOI 10.1078/0176-1617-00369; Quarrie SA, 2005, THEOR APPL GENET, V110, P865, DOI 10.1007/s00122-004-1902-7; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Riou-Khamlichi C, 1999, SCIENCE, V283, P1541, DOI 10.1126/science.283.5407.1541; Sivakumar T, 2001, J AGRON CROP SCI, V186, P43, DOI 10.1046/j.1439-037x.2001.00450.x; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Su ZQ, 2011, THEOR APPL GENET, V122, P211, DOI 10.1007/s00122-010-1437-z; Subbaraj AK, 2010, J PLANT GROWTH REGUL, V29, P487, DOI 10.1007/s00344-010-9160-1; Sun XY, 2009, EUPHYTICA, V165, P615, DOI 10.1007/s10681-008-9794-2; Swartzberg D, 2008, EUR J PLANT PATHOL, V120, P289, DOI 10.1007/s10658-007-9217-6; Vignesh M, 2013, J PLANT BIOCHEM BIOT, V22, P401, DOI 10.1007/s13562-012-0168-4; Wang RX, 2009, THEOR APPL GENET, V118, P313, DOI 10.1007/s00122-008-0901-5; Wang ZL, 2001, ACTA AGRONOMICA SINI, V27, P447; Wei YM, 2000, J TRITICEAE CROPS, V20, P35; [徐丽娜 Xu Lina], 2010, [作物学报, Acta Agronomica Sinica], V36, P1596; Yang JC, 2003, PLANT GROWTH REGUL, V41, P185, DOI 10.1023/B:GROW.0000007503.95391.38; Yang JC, 2000, PLANT GROWTH REGUL, V30, P261, DOI 10.1023/A:1006356125418; Yang JC, 2002, ANN BOT-LONDON, V90, P369, DOI 10.1093/aob/mcf198; Yue AQ, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0266-9; Zalewski W, 2010, J EXP BOT, V61, P1839, DOI 10.1093/jxb/erq052; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; Zhang HaiPing, 2010, Acta Agronomica Sinica, V36, P1649, DOI 10.1016/S1875-2780(09)60077-8; Zhang H, 2009, PLANT PHYSIOL BIOCH, V47, P195, DOI 10.1016/j.plaphy.2008.11.012; Zhang JP, 2011, MOL BIOL REP, V38, P2337, DOI 10.1007/s11033-010-0367-9; Zhang Lei, 2007, Acta Agronomica Sinica, V33, P1419; Zhang L, 2012, NEW PHYTOL, V195, P574, DOI 10.1111/j.1469-8137.2012.04194.x; Zhang XY, 2013, EUPHYTICA, V192, P347, DOI 10.1007/s10681-012-0858-y; Zhang YJ, 2014, MOL BREEDING, V34, P1097, DOI 10.1007/s11032-014-0102-7; Zhao BuHong, 2006, Scientia Agricultura Sinica, V39, P477; Zubo YO, 2008, PLANT PHYSIOL, V148, P1082, DOI 10.1104/pp.108.122275	62	24	29	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144765	10.1371/journal.pone.0144765	http://dx.doi.org/10.1371/journal.pone.0144765			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657796	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900103
J	Lu, YJ; Chang, SH; Ye, JT; Ye, YS; Yu, YS				Lu, Ying-juan; Chang, Shao-hai; Ye, Jian-tao; Ye, Yu-shan; Yu, Yan-song			Finite Element Analysis of Bone Stress around Micro-Implants of Different Diameters and Lengths with Application of a Single or Composite Torque Force	PLOS ONE			English	Article							ROOT RESORPTION; MINI-IMPLANTS; CORTICAL BONE; STABILITY; ANCHORAGE; MAXILLARY; DESIGN	Background Stress on the bone surrounding dental micro-implants affects implant success. Purpose To compare the stress on the bone surrounding a micro-implant after application of a single force (SF) of 200 g or a composite force (CF) of 200 g and 6 N. mm torque. Materials and Methods Finite element models were developed for micro-implant diameters of 1.2, 1.6, and 2.0 mm, and lengths of 6, 8, 10, and 12 mm and either a SF or CF was applied. The maximum equivalent stress (Max EQS) of the bone surrounding the micro-implant was determined, and the relationships among type of force, diameter, and length were evaluated. Results The Max EQS of the CF exceeded that of the SF (P< 0.05). The effect of force on stress was related to implant diameter, but not to implant length. The larger CF led to greater instability of the micro-implant and the effect was most pronounced at an implant diameter of 1.2 mm. The use of implant diameters of 1.6 mm and 2.0 mm produced no significant difference in implant stability when either a CF or SF was applied. Conclusion When considering the use of an implant to perform three-dimensional control on the teeth, the implant diameter chosen should be > 1.2 mm.	[Lu, Ying-juan; Chang, Shao-hai; Ye, Jian-tao; Ye, Yu-shan; Yu, Yan-song] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Stomatol, Guangzhou 510120, Guangdong, Peoples R China	Sun Yat Sen University	Chang, SH (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Stomatol, Guangzhou 510120, Guangdong, Peoples R China.	changshaoh@gmail.com			Guangdong Science and Technology Program Project [A002014004]	Guangdong Science and Technology Program Project	This work was supported by Guangdong Science and Technology Program Project (A002014004). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the support of the Guangdong Science and Technology Program Project (A002014004).	Ao JH, 2010, COMPUT BIOL MED, V40, P681, DOI 10.1016/j.compbiomed.2009.10.007; Bahat O, 1993, Int J Oral Maxillofac Implants, V8, P151; Chan E, 2005, AM J ORTHOD DENTOFAC, V127, P186, DOI 10.1016/j.ajodo.2003.11.026; Chang JZC, 2012, AM J ORTHOD DENTOFAC, V141, P279, DOI 10.1016/j.ajodo.2011.09.008; Cheng SJ, 2004, INT J ORAL MAX IMPL, V19, P100; Coelho Goiato M, 2014, J CLIN DIAGN RES, V8, P86; De Clerck H, 2004, Ned Tijdschr Tandheelkd, V111, P10; Duaibis R, 2012, ANGLE ORTHOD, V82, P875, DOI 10.2319/111011-696.1; Eraslan O, 2010, CLIN ORAL INVEST, V14, P411, DOI 10.1007/s00784-009-0305-1; Garfinkle JS, 2008, AM J ORTHOD DENTOFAC, V133, P642, DOI 10.1016/j.ajodo.2006.04.053; Gracco A, 2009, EUR J ORTHODONT, V31, P12, DOI 10.1093/ejo/cjn066; Guo D., 2012, CHINESE J ORTHODONTI, V19, P86; Hohmann A, 2007, ANGLE ORTHOD, V77, P653, DOI 10.2319/060806-234; Holm L, 2012, ANGLE ORTHOD, V82, P1022, DOI 10.2319/011912-47.1; Jasmine MIF, 2012, AM J ORTHOD DENTOFAC, V141, P71, DOI 10.1016/j.ajodo.2011.06.031; Kang N, 2014, OR SURG OR MED OR PA, V118, P519, DOI 10.1016/j.oooo.2014.05.021; Lee JS, 2013, COMPUT METHOD BIOMEC, V16, P1143, DOI 10.1080/10255842.2012.654780; Lin CL, 2010, J BIOMECH, V43, P2174, DOI 10.1016/j.jbiomech.2010.03.043; Liu TC, 2012, AM J ORTHOD DENTOFAC, V141, P468, DOI 10.1016/j.ajodo.2011.11.012; Motoyoshi M, 2009, INT J ORAL MAX SURG, V38, P13, DOI 10.1016/j.ijom.2008.09.006; Singh S, 2012, AM J ORTHOD DENTOFAC, V141, P327, DOI 10.1016/j.ajodo.2011.07.022; T A, 1985, TISSUE INTEGRATED PR, P199, DOI DOI 10.1111/J.1708-8208.2002.TB00174.X; Verri FR, 2014, MAT SCI ENG C-MATER, V45, P234, DOI 10.1016/j.msec.2014.09.005; Woodall N, 2011, AM J ORTHOD DENTOFAC, V139, DOI 10.1016/j.ajodo.2010.08.017	24	11	11	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144744	10.1371/journal.pone.0144744	http://dx.doi.org/10.1371/journal.pone.0144744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659581	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900101
J	Sueoka, H; Aoki, M; Tsukimura, T; Togawa, T; Sakuraba, H				Sueoka, Hideaki; Aoki, Mikio; Tsukimura, Takahiro; Togawa, Tadayasu; Sakuraba, Hitoshi			Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an alpha-Galactosidase A Knockout Mouse, a Model of Fabry Disease	PLOS ONE			English	Article							MASS-SPECTROMETRY; ENDOTHELIAL DYSFUNCTION; MICE; NEPHROPATHY; K(CA)3.1; PLASMA	Fabry disease is caused by deficient activity of alpha-galactosidase A (GLA) and characterized by systemic accumulation of glycosphingolipids, substrates of the enzyme. To gain insight into the pathogenesis of Fabry disease based on accumulated substrates, we examined the tissue and plasma distributions of globotriaosylceramide (Gb3) isoforms, and globotriao-sylsphingosine (lyso-Gb3) and its analogues in a GLA knockout mouse, a model of Fabry disease, by means of liquid chromatography-mass spectrometry and nano-liquid chromatography-tandem mass spectrometry, respectively. The results revealed that the contents of these substrates in the liver, kidneys, heart, and plasma of GLA knockout mice were apparently higher than in those of wild-type ones, and organ specificity in the accumulation of Gb3 isoforms was found. Especially in the kidneys, accumulation of a large amount of Gb3 isoforms including hydroxylated residues was found. In the GLA knockout mice, the proportion of hydrophobic Gb3 isoforms was apparently higher than that in the wild-type mice. On the other hand, hydrophilic residues were abundant in plasma. Unlike that of Gb3, the concentration of lyso-Gb3 was high in the liver, and the lyso-Gb3/Gb3 ratio in plasma was significantly higher than those in the organs. The concentration of lyso-Gb3 was apparently higher than those of its analogues in the organs and plasma from both the GLA knockout and wild-type mice. This information will be useful for elucidating the basis of Fabry disease.	[Sueoka, Hideaki; Aoki, Mikio] Sumitomo Dainippon Pharma Co Ltd, Genom Sci Labs, Konohana Ku, Osaka, Japan; [Tsukimura, Takahiro; Togawa, Tadayasu] Meiji Pharmaceut Univ, Dept Funct Bioanal, Tokyo, Japan; [Sakuraba, Hitoshi] Meiji Pharmaceut Univ, Dept Clin Genet, Tokyo, Japan	Dainippon Sumitomo Pharmaceutical Company; Meiji Pharmaceutical University; Meiji Pharmaceutical University	Sakuraba, H (corresponding author), Meiji Pharmaceut Univ, Dept Clin Genet, Tokyo, Japan.	sakuraba@my-pharm.ac.jp			Japan Society for Promotion of Science [15K0960]; Sumitomo Dainippon Pharma Co., Ltd.; Sumitomo Dainippon Pharma Co., Ltd	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sumitomo Dainippon Pharma Co., Ltd.; Sumitomo Dainippon Pharma Co., Ltd	This work was supported by the Japan Society for Promotion of Science (ID: 15K0960, HSa), and Sumitomo Dainippon Pharma Co., Ltd. Sumitomo Dainippon Pharma Co., Ltd provided research tools and support in the form of salaries for two authors [H. Sueoka and M. Aoki], but did not play any additional role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are given in the 'author contributions' section.; We wish to thank A.B Kulkarni and T. Oshima (National Institutes of Health) for the GLA knockout mice. This work was supported by the Japan Society for Promotion of Science (ID: 15K0960, H Sa). We also wish to thank the members of Sumitomo Dainippon Pharma Co., Ltd., especially Tetsuya Nishide, for the experimental assistance.	Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105; [Anonymous], 2014, METABOLIC MOL BASES; Auray-Blais C, 2012, ANAL CHEM, V84, P2745, DOI 10.1021/ac203433e; Bangari DS, 2015, AM J PATHOL, V185, P651, DOI 10.1016/j.ajpath.2014.11.004; Choi L, 2015, NEUROSCI LETT, V594, P163, DOI 10.1016/j.neulet.2015.01.084; Choi S, 2014, ARTERIOSCL THROM VAS, V34, P81, DOI 10.1161/ATVBAHA.113.302200; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; Gold H, 2013, CLIN CHEM, V59, P547, DOI 10.1373/clinchem.2012.192138; Ikeda K, 2010, RAPID COMMUN MASS SP, V24, P2957, DOI 10.1002/rcm.4716; Khanna R, 2010, MOL THER, V18, P23, DOI 10.1038/mt.2009.220; Kuchar L, 2015, ANAL BIOANAL CHEM, V407, P2283, DOI 10.1007/s00216-014-8402-7; Lee MH, 2012, INT J MOL MED, V30, P1275, DOI 10.3892/ijmm.2012.1139; Marshall J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015033; Ohshima T, 1999, P NATL ACAD SCI USA, V96, P6423, DOI 10.1073/pnas.96.11.6423; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; Park S, 2011, CARDIOVASC RES, V89, P290, DOI 10.1093/cvr/cvq333; Rodrigues LG, 2009, NEUROBIOL DIS, V33, P48, DOI 10.1016/j.nbd.2008.09.001; Rombach SM, 2010, BBA-MOL BASIS DIS, V1802, P741, DOI 10.1016/j.bbadis.2010.05.003; Sanchez-Nino MD, 2011, NEPHROL DIAL TRANSPL, V26, P1797, DOI 10.1093/ndt/gfq306; Satoh K, 2014, ARTERIOSCL THROM VAS, V34, P2, DOI 10.1161/ATVBAHA.113.302744; Sueoka H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127048; Tajima Y, 2009, AM J HUM GENET, V85, P569, DOI 10.1016/j.ajhg.2009.09.016; Takenaka T, 2000, P NATL ACAD SCI USA, V97, P7515, DOI 10.1073/pnas.120177997; Togawa T, 2010, MOL GENET METAB, V100, P257, DOI 10.1016/j.ymgme.2010.03.020; van Breemen MJ, 2011, BBA-MOL BASIS DIS, V1812, P70, DOI 10.1016/j.bbadis.2010.09.007; Wang A. M., 1996, American Journal of Human Genetics, V59, pA208; Yamada T, 2013, J CHROMATOGR A, V1292, P211, DOI 10.1016/j.chroma.2013.01.078	27	16	16	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144958	10.1371/journal.pone.0144958	http://dx.doi.org/10.1371/journal.pone.0144958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26661087	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900156
J	Taioli, E; Wolf, AS; Camacho-Rivera, M; Kaufman, A; Lee, DS; Nicastri, D; Rosenzweig, K; Flores, RM				Taioli, Emanuela; Wolf, Andrea S.; Camacho-Rivera, Marlene; Kaufman, Andrew; Lee, Dong-Seok; Nicastri, Daniel; Rosenzweig, Kenneth; Flores, Raja M.			Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients	PLOS ONE			English	Article							SURGERY; PNEUMONECTOMY; FEASIBILITY; THERAPY	Introduction Left untreated, malignant pleural mesothelioma (MPM) is associated with uniformly poor prognosis. Better survival has been reported with surgery-based multimodality therapy, but to date, no trial has demonstrated survival benefit of surgery over other therapies. We evaluated whether cancer-directed surgery influenced survival independently from other predictors in a large population-based dataset. Methods The SEER database was explored from 1973 to 2009 to identify all cases of pathologically-Proven MPM. Age, sex, race, year of diagnosis, histology stage, cancer-directed surgery, radiation, and vital status were analyzed. The association between prognostic factors and survival was estimated using Cox regression and propensity matched analysis. Results There were 14,228 patients with pathologic diagnosis of MPM. On multivariable analysis, female gender, younger age, early stage, and treatment with surgery were independent predictors of longer survival. In comparison to no treatment, surgery alone was associated with significant improvement in survival [adjusted hazard ratio (adj HR) 0.64 (0.61-0.67)], but not radiation [adj HR 1.15 (1.08-1.23)]. Surgery and radiation combined had similar survival as surgery alone [adj HR 0.69 (0.64-0.76)]. Results were similar when cases diagnosed between 1973 and 1999 were compared to cases diagnosed between 2000 and 2009. Conclusions Despite developments in surgical and radiation techniques, the prognosis for MPM patients has not improved over the past 4 decades. Cancer-directed surgery is independently associated with better survival, suggesting that multimodal surgery-based therapy can benefit these patients. Further research in adjuvant treatment is necessary to improve prognosis in this challenging disease.	[Taioli, Emanuela; Wolf, Andrea S.; Kaufman, Andrew; Lee, Dong-Seok; Nicastri, Daniel; Flores, Raja M.] Mt Sinai Med Ctr, Dept Thorac Surg, New York, NY 10029 USA; [Taioli, Emanuela] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; [Taioli, Emanuela] Icahn Sch Med Mt Sinai, Inst Translat Epidemiol, New York, NY 10029 USA; [Camacho-Rivera, Marlene] CUNY City Coll, Dept Community Hlth & Social Med, Sophie Davis Sch Biomed Educ, New York, NY 10031 USA; [Rosenzweig, Kenneth] Mt Sinai Med Ctr, Dept Oncol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; City College of New York (CUNY); Sophie Davis School of Biomedical Education; Icahn School of Medicine at Mount Sinai	Flores, RM (corresponding author), Mt Sinai Med Ctr, Dept Thorac Surg, One Gustave L Levy Pl,Box 1023, New York, NY 10029 USA.	raja.flores@mountsinai.org		Camacho-Rivera, Marlene/0000-0003-2343-2941				Baldini EH, 2015, J THORAC CARDIOV SUR, V149, P1374, DOI 10.1016/j.jtcvs.2014.10.128; Baumann F, 2015, CARCINOGENESIS, V36, P76, DOI 10.1093/carcin/bgu227; Blomberg C, 2015, ANTICANCER RES, V35, P2493; Bovolato P, 2014, J THORAC ONCOL, V9, P390, DOI 10.1097/JTO.0000000000000064; Cho BCJ, 2014, J THORAC ONCOL, V9, P397, DOI 10.1097/JTO.0000000000000078; Flores RM, 2010, J THORAC ONCOL, V5, P1649, DOI 10.1097/JTO.0b013e3181f1903e; Kapeles M, 2015, AM J CLIN ONCOL; Kotova S, 2015, CANCER MANAG RES, V7, P51, DOI 10.2147/CMAR.S72814; Price B, 2009, CRIT REV TOXICOL, V39, P576, DOI 10.1080/10408440903044928; Taioli E, 2015, ANN THORAC SURG, V99, P472, DOI 10.1016/j.athoracsur.2014.09.056; Treasure T, 2011, LANCET ONCOL, V12, P763, DOI 10.1016/S1470-2045(11)70149-8	11	67	71	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145039	10.1371/journal.pone.0145039	http://dx.doi.org/10.1371/journal.pone.0145039			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660351	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900174
J	Yeh, JH; Hung, CH; Wang, JH; Chen, CH; Kee, KM; Kuo, CM; Yen, YH; Cheng, YF; Chen, YY; Hsu, HC; Lu, SN				Yeh, Jen-Hao; Hung, Chao-Hung; Wang, Jing-Houng; Chen, Chien-Hung; Kee, Kwong-Ming; Kuo, Chung-Mou; Yen, Yi-Hao; Cheng, Yu-Fan; Chen, Yen-Yang; Hsu, Hsuan-Chi; Lu, Sheng-Nan			Modifiable Prognostic Factors of Hepatocellular Carcinoma in Patients with Non-Surgical Treatment	PLOS ONE			English	Article							HEPATITIS-C VIRUS; RADIOFREQUENCY ABLATION; LIVER RESECTION; SURGICAL RESECTION; ANTIVIRAL THERAPY; TUMOR ABLATION; SURVIVAL; RECURRENCE; CIRRHOSIS; TRANSPLANTATION	Background & aims Current hepatocellular carcinoma (HCC) staging systems only use baseline characteristics to predict outcome. We aimed to explore modifiable factors of the prognosis in HCC cases had undergone non-surgical treatment. Methods All HCC cases in Kaohsiung Chang Gung Memorial hospital in southern Taiwan from 2002 to 2012 must met all below criteria: (1) met international diagnostic guidelines, (2) underwent the initial treatments in our hospital (3) treated by non-surgical treatment modalities and (4) survived more than two years, with follow-up time longer than five years. Results A total 698 patients were enrolled: 451 (24.6%, group A) survivied between 2 to 5 years, and 247 (13.5%, group B) had survived > 5 years. Aside from liver function reserve and BCLC stages, four interventional factors: initial treatment modality, outcomes of 1st or 2nd treatment, and anti-viral therapy to chronic viral hepatitis were associated with prognosis. After propensity score matching, multiple logistic regression of 223 well-matched pairs showed that recurrence within one year after 1st treatment (OR: 2.17, 95% CI: 1.35-3.48), incomplete 2nd treatment (2.01, 1.27-3.17) and absence of anti-viral agents (1.68, 1.09-2.59) were independent poor prognostic factors. Conclusion Complete treatment and anti-viral agents to chronic hepatitis were both independent modifiable prognostic factors of HCC patients had undergone non-surgical treatment. Based on these findings, timely treatment to achieve maximal locoregional control and anti-viral treatment should be provided as possible.	[Yeh, Jen-Hao; Hung, Chao-Hung; Wang, Jing-Houng; Chen, Chien-Hung; Kee, Kwong-Ming; Kuo, Chung-Mou; Yen, Yi-Hao; Lu, Sheng-Nan] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Yeh, Jen-Hao; Hung, Chao-Hung; Wang, Jing-Houng; Chen, Chien-Hung; Kee, Kwong-Ming; Kuo, Chung-Mou; Yen, Yi-Hao; Lu, Sheng-Nan] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Cheng, Yu-Fan] Kaohsiung Chang Gung Mem Hosp, Dept Diagnost Radiol, Kaohsiung, Taiwan; [Chen, Yen-Yang] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Kaohsiung, Taiwan; [Hsu, Hsuan-Chi] Kaohsiung Chang Gung Mem Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Lu, SN (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan.	juten@ms17.hinet.net			Kaohsiung Chang-Gung Memorial hospital [CMRPG8B1413]	Kaohsiung Chang-Gung Memorial hospital(Chang Gung Memorial Hospital)	This study was supported by the CMRPG8B1413 project of Kaohsiung Chang-Gung Memorial hospital to Dr. Sheng-Nan Lu. The funder had no role in this study design, data collection and analysis, decision to publish or preparation of the manuscript. https://www.cgmh.org.tw/eng2002/index.asp.	Bharat A, 2006, J AM COLL SURGEONS, V203, P411, DOI 10.1016/j.jamcollsurg.2006.06.016; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chan KM, 2011, ANN SURG ONCOL, V18, P2638, DOI 10.1245/s10434-011-1779-z; Changchien CS, 2008, J GASTROENTEROL, V43, P159, DOI 10.1007/s00535-007-2134-9; Cho YK, 2011, J GASTROEN HEPATOL, V26, P1354, DOI 10.1111/j.1440-1746.2011.06812.x; Clavien PA, 2012, LANCET ONCOL, V13, pE11, DOI 10.1016/S1470-2045(11)70175-9; European Association for the study of the liver and European Organisation for Research and Treatment of Cancer, 2012, EUR J CANCER, V48, P599, DOI DOI 10.1016/J.EJCA.2011.12.021; Goldberg SN, 2005, RADIOLOGY, V235, P728, DOI 10.1148/radiol.2353042205; Huang YJ, 2009, INT J RADIAT ONCOL, V73, P1155, DOI 10.1016/j.ijrobp.2008.06.1486; Hung CH, 2005, J GASTROEN HEPATOL, V20, P1553, DOI 10.1111/j.1440-1746.2005.03925.x; Ishikawa T, 2012, HEPATO-GASTROENTEROL, V59, P529, DOI 10.5754/hge10867; Johnson PJ, 2015, J CLIN ONCOL, V33, P550, DOI 10.1200/JCO.2014.57.9151; Kuo YH, 2010, EUR J CANCER, V46, P744, DOI 10.1016/j.ejca.2009.12.018; Lee DH, 2014, RADIOLOGY, V270, P900, DOI 10.1148/radiol.13130940; Lencioni RA, 2003, RADIOLOGY, V228, P235, DOI 10.1148/radiol.2281020718; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Lok ASF, 2012, JAMA-J AM MED ASSOC, V308, P1922, DOI 10.1001/jama.2012.12971; Mazzaferro V, 2006, HEPATOLOGY, V44, P1543, DOI 10.1002/hep.21415; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; Park JW, 2012, J HEPATOL, V56, P1336, DOI 10.1016/j.jhep.2012.01.006; Portolani N, 2006, ANN SURG, V243, P229, DOI 10.1097/01.sla.0000197706.21803.a1; Shah SA, 2006, J AM COLL SURGEONS, V202, P275, DOI 10.1016/j.jamcollsurg.2005.10.005; Su CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066457; The Cancer of the Liver Italian Program (CLIP), 1998, HEPATOLOGY, V28, P751, DOI DOI 10.1002/HEP.510280322; Tiong L, 2011, BRIT J SURG, V98, P1210, DOI 10.1002/bjs.7669; Tseng PL, 2010, J GASTROEN HEPATOL, V25, P1426, DOI 10.1111/j.1440-1746.2010.06285.x; Vauthey JN, 2007, J AM COLL SURGEONS, V204, P1016, DOI 10.1016/j.jamcollsurg.2006.12.043; Vauthey JN, 2010, HPB, V12, P289, DOI 10.1111/j.1477-2574.2010.00181.x; Wang JH, 2008, EUR J CANCER, V44, P1000, DOI 10.1016/j.ejca.2008.02.018; Wang JH, 2015, J GASTROEN HEPATOL, V30, P358, DOI 10.1111/jgh.12686; Wang JH, 2013, AM J GASTROENTEROL, V108, P416, DOI 10.1038/ajg.2012.445; Wang JH, 2012, J HEPATOL, V56, P412, DOI 10.1016/j.jhep.2011.05.020; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975	34	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144893	10.1371/journal.pone.0144893	http://dx.doi.org/10.1371/journal.pone.0144893			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26661388	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900138
J	Ebbensgaard, A; Mordhorst, H; Overgaard, MT; Nielsen, CG; Aarestrup, FM; Hansen, EB				Ebbensgaard, Anna; Mordhorst, Hanne; Overgaard, Michael Toft; Nielsen, Claus Gyrup; Aarestrup, Frank Moller; Hansen, Egon Bech			Comparative Evaluation of the Antimicrobial Activity of Different Antimicrobial Peptides against a Range of Pathogenic Bacteria	PLOS ONE			English	Article							ANTIBACTERIAL PEPTIDES; ESCHERICHIA-COLI; OUTER-MEMBRANE; ALPHA; STRATEGIES; RESISTANCE; BINDING; PROTEIN; GENES; CAP18	Analysis of a Selected Set of Antimicrobial Peptides The rapid emergence of resistance to classical antibiotics has increased the interest in novel antimicrobial compounds. Antimicrobial peptides (AMPs) represent an attractive alternative to classical antibiotics and a number of different studies have reported antimicrobial activity data of various AMPs, but there is only limited comparative data available. The mode of action for many AMPs is largely unknown even though several models have suggested that the lipopolysaccharides (LPS) play a crucial role in the attraction and attachment of the AMP to the bacterial membrane in Gram-negative bacteria. We compared the potency of Cap18, Cap11, Cap11-1-18m(2), Cecropin P1, Cecropin B, Bac2A, Bac2A-NH2, Sub5-NH2, Indolicidin, Melittin, Myxinidin, Myxinidin-NH2, Pyrrhocoricin, Apidaecin and Metalnikowin I towards Staphylococcus aureus, Enterococcus faecalis, Pseudomonas aeruginosa, Escherichia coli, Aeromonas salmonicida, Listeria monocytogenes, Campylobacter jejuni, Flavobacterium psychrophilum, Salmonella typhimurium and Yersinia ruckeri by minimal inhibitory concentration (MIC) determinations. Additional characteristics such as cytotoxicity, thermo and protease stability were measured and compared among the different peptides. Further, the antimicrobial activity of a selection of cationic AMPs was investigated in various E. coli LPS mutants. Cap18 Shows a High Broad Spectrum Antimicrobial Activity Of all the tested AMPs, Cap18 showed the most efficient antimicrobial activity, in particular against Gram-negative bacteria. In addition, Cap18 is highly thermostable and showed no cytotoxic effect in a hemolytic assay, measured at the concentration used. However, Cap18 is, as most of the tested AMPs, sensitive to proteolytic digestion in vitro. Thus, Cap18 is an excellent candidate for further development into practical use; however, modifications that should reduce the protease sensitivity would be needed. In addition, our findings from analyzing LPS mutant strains suggest that the core oligosaccharide of the LPS molecule is not essential for the antimicrobial activity of cationic AMPs, but in fact has a protective role against AMPs.	[Ebbensgaard, Anna; Mordhorst, Hanne; Aarestrup, Frank Moller] Tech Univ Denmark, Natl Food Inst, DK-2800 Lyngby, Denmark; [Hansen, Egon Bech] Tech Univ Denmark, Natl Food Inst, DK-2860 Soborg, Denmark; [Overgaard, Michael Toft; Nielsen, Claus Gyrup] Aalborg Univ, Dept Chem & Biosci, DK-9220 Aalborg, Denmark	Technical University of Denmark; Technical University of Denmark; Aalborg University	Hansen, EB (corresponding author), Tech Univ Denmark, Natl Food Inst, Morkhoj Bygade 19, DK-2860 Soborg, Denmark.	egbh@food.dtu.dk	Ebbensgaard, Anna/AAH-2582-2019; Overgaard, Michael Toft/E-1354-2011; Hansen, Egon Bech/AGQ-4772-2022	Overgaard, Michael Toft/0000-0002-1423-2481; Hansen, Egon Bech/0000-0002-3795-6706; Ebbensgaard, Anna Elisabeth/0000-0003-2557-4679; Aarestrup, Frank/0000-0002-7116-2723	Danish Ministery of Food, Agriculture and Fisheries programme supporting Green Development and Demonstration (GUDP grant) [3405-10-0124]	Danish Ministery of Food, Agriculture and Fisheries programme supporting Green Development and Demonstration (GUDP grant)	Financial support for the project was obtained from the the Danish Ministery of Food, Agriculture and Fisheries programme supporting Green Development and Demonstration (GUDP grant nr.: 3405-10-0124) (http://naturerhverv.dk/tvaergaaende/gudp/).	Aarestrup FM, 2008, EXPERT REV ANTI-INFE, V6, P733, DOI 10.1586/14787210.6.5.733; Amerah AM, 2011, WORLD POULTRY SCI J, V67, P29, DOI 10.1017/S0043933911000031; [Anonymous], 2008, EFSA J, V720, P1, DOI DOI 10.2903/J.EFSA.2010.1543; [Anonymous], 2009, METHODS DILUTION ANT; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bhunia A, 2007, BBA-BIOMEMBRANES, V1768, P3282, DOI 10.1016/j.bbamem.2007.07.017; BOMAN HG, 1993, INFECT IMMUN, V61, P2978, DOI 10.1128/IAI.61.7.2978-2984.1993; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; CASTEELS P, 1989, EMBO J, V8, P2387, DOI 10.1002/j.1460-2075.1989.tb08368.x; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Chernysh S, 1996, J INSECT PHYSIOL, V42, P81, DOI 10.1016/0022-1910(95)00085-2; COCIANCICH S, 1994, BIOCHEM J, V300, P567, DOI 10.1042/bj3000567; Collignon P, 2009, CLIN INFECT DIS, V49, P132, DOI 10.1086/599374; Cudic M, 2002, PEPTIDES, V23, P2071, DOI 10.1016/S0196-9781(02)00244-9; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DelvesBroughton J, 1996, ANTON LEEUW INT J G, V69, P193, DOI 10.1007/BF00399424; Falla TJ, 1996, J BIOL CHEM, V271, P19298, DOI 10.1074/jbc.271.32.19298; Fouz B, 2006, J FISH DIS, V29, P339, DOI 10.1111/j.1365-2761.2006.00723.x; Giuliani A, 2011, CELL MOL LIFE SCI, V68, P2255, DOI 10.1007/s00018-011-0717-3; Gronow S, 2000, EUR J BIOCHEM, V267, P6602, DOI 10.1046/j.1432-1327.2000.01754.x; Guilhelmelli F, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00353; Gutsmann T, 2001, BIOPHYS J, V80, P2935, DOI 10.1016/S0006-3495(01)76259-5; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; Hagiwara A, 2010, FOOD CHEM TOXICOL, V48, P2421, DOI 10.1016/j.fct.2010.06.002; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hancock REW, 2006, IMMUNOBIOLOGY, V211, P315, DOI 10.1016/j.imbio.2005.10.017; Hilpert K, 2005, NAT BIOTECHNOL, V23, P1008, DOI 10.1038/nbt1113; Huang JF, 2010, PURE APPL CHEM, V82, P243, DOI 10.1351/PAC-CON-09-01-12; Huang Y, 2014, PROTEIN CELL, V5, P194, DOI 10.1007/s13238-014-0028-1; Jiang ZQ, 2008, BIOPOLYMERS, V90, P369, DOI 10.1002/bip.20911; Kjuul AK, 1999, J FISH DIS, V22, P387, DOI 10.1046/j.1365-2761.1999.00191.x; Knappe D, 2010, ANTIMICROB AGENTS CH, V54, P4003, DOI 10.1128/AAC.00300-10; LARRICK JW, 1995, INFECT IMMUN, V63, P1291, DOI 10.1128/IAI.63.4.1291-1297.1995; LARRICK JW, 1993, ANTIMICROB AGENTS CH, V37, P2534, DOI 10.1128/AAC.37.12.2534; LEE JY, 1989, P NATL ACAD SCI USA, V86, P9159, DOI 10.1073/pnas.86.23.9159; Lee MT, 2013, P NATL ACAD SCI USA, V110, P14243, DOI 10.1073/pnas.1307010110; Lohner K, 2009, GEN PHYSIOL BIOPHYS, V28, P105, DOI 10.4149/gpb_2009_02_105; Malmsten M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016400; Maroti G, 2011, RES MICROBIOL, V162, P363, DOI 10.1016/j.resmic.2011.02.005; Mason DJ, 1997, ANTIMICROB AGENTS CH, V41, P624, DOI 10.1128/AAC.41.3.624; McArthur F, 2005, J BACTERIOL, V187, P5292, DOI 10.1128/JB.187.15.5292-5300.2005; Michel C, 1999, RES MICROBIOL, V150, P351, DOI 10.1016/S0923-2508(99)80061-8; Moore AJ, 1996, J ANTIMICROB CHEMOTH, V37, P1077, DOI 10.1093/jac/37.6.1077; Muller-Loennies S, 2003, J BIOL CHEM, V278, P34090, DOI 10.1074/jbc.M303985200; Nagaoka I, 2000, INFLAMM RES, V49, P73, DOI 10.1007/s000110050561; Nagaoka I, 2001, J IMMUNOL, V167, P3329, DOI 10.4049/jimmunol.167.6.3329; Okelo PO, 2006, ANIM FEED SCI TECH, V129, P116, DOI 10.1016/j.anifeedsci.2005.12.011; Okuda D, 2009, INT J MOL MED, V23, P501, DOI 10.3892/ijmm_00000157; PARKER CT, 1992, J BACTERIOL, V174, P2525, DOI 10.1128/jb.174.8.2525-2538.1992; SELSTED ME, 1992, J BIOL CHEM, V267, P4292; SHLAES DM, 1989, ANTIMICROB AGENTS CH, V33, P192, DOI 10.1128/AAC.33.2.192; Stromstedt AA, 2009, ANTIMICROB AGENTS CH, V53, P593, DOI 10.1128/AAC.00477-08; Subramanian S, 2009, MAR BIOTECHNOL, V11, P748, DOI 10.1007/s10126-009-9189-y; Tiwari BK, 2009, J AGR FOOD CHEM, V57, P5987, DOI 10.1021/jf900668n; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; VAARA M, 1993, ANTIMICROB AGENTS CH, V37, P354, DOI 10.1128/AAC.37.2.354; Vaara M, 1999, ANTIMICROB AGENTS CH, V43, P1459, DOI 10.1128/AAC.43.6.1459; Valvano MA, 2000, J BACTERIOL, V182, P488, DOI 10.1128/JB.182.2.488-497.2000; Weinberg ED, 2007, CURR PHARM DESIGN, V13, P801, DOI 10.2174/138161207780363095; Wu MH, 1999, ANTIMICROB AGENTS CH, V43, P1274, DOI 10.1128/AAC.43.5.1274; Wulff G, 2006, APPL ENVIRON MICROB, V72, P4313, DOI 10.1128/AEM.02288-05; Yethon JA, 2000, J BACTERIOL, V182, P5620, DOI 10.1128/JB.182.19.5620-5623.2000; Yomogida S, 1996, ARCH BIOCHEM BIOPHYS, V328, P219, DOI 10.1006/abbi.1996.0166; Zamyatina A, 2003, CARBOHYD RES, V338, P2571, DOI 10.1016/S0008-6215(03)00319-7; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	65	109	109	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144611	10.1371/journal.pone.0144611	http://dx.doi.org/10.1371/journal.pone.0144611			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656394	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903600067
J	Giannakopoulos, T				Giannakopoulos, Theodoros			pyAudioAnalysis: An Open-Source Python Library for Audio Signal Analysis	PLOS ONE			English	Article								Audio information plays a rather important role in the increasing digital content that is available today, resulting in a need for methodologies that automatically analyze such content: audio event recognition for home automations and surveillance systems, speech recognition, music information retrieval, multimodal analysis (e.g. audio-visual analysis of online videos for content-based recommendation), etc. This paper presents pyAudioAnalysis, an open-source Python library that provides a wide range of audio analysis procedures including: feature extraction, classification of audio signals, supervised and unsupervised segmentation and content visualization. pyAudioAnalysis is licensed under the Apache License and is available at GitHub (https://github.com/tyiannak/pyAudioAnalysis/). Here we present the theoretical background behind the wide range of the implemented methodologies, along with evaluation metrics for some of the methods. pyAudioAnalysis has been already used in several audio analysis research applications: smart-home functionalities through audio event detection, speech emotion recognition, depression classification based on audiovisual features, music segmentation, multimodal content-based movie recommendation and health applications (e.g. monitoring eating habits). The feedback provided from all these particular audio applications has led to practical enhancement of the library.	[Giannakopoulos, Theodoros] NCSR Demokritos, Computat Intelligence Lab, Inst Informat & Telecommun, Athens 15310, Greece	National Centre of Scientific Research "Demokritos"	Giannakopoulos, T (corresponding author), NCSR Demokritos, Computat Intelligence Lab, Inst Informat & Telecommun, Patriarchou Grigoriou & Neapoleos St, Athens 15310, Greece.	tyiannak@gmail.com			European Union's Horizon research and innovation programme [643892]; RADIO EU Project (Robots in assisted living environments: Unobtrusive, efficient, reliable and modular solutions for independent ageing)	European Union's Horizon research and innovation programme; RADIO EU Project (Robots in assisted living environments: Unobtrusive, efficient, reliable and modular solutions for independent ageing)	This paper has been funded in the context of the RADIO EU Project (Robots in assisted living environments: Unobtrusive, efficient, reliable and modular solutions for independent ageing). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 643892.	Miro XA, 2012, IEEE T AUDIO SPEECH, V20, P356, DOI 10.1109/TASL.2011.2125954; Bartsch MA, 2005, IEEE T MULTIMEDIA, V7, P96, DOI 10.1109/TMM.2004.840597; Giannakopoulos T, 2014, INT WORKSH ART INT A; Giannakopoulos T, 2015, AUTOMATIC SOUNDSCAPE; Giannakopoulos T, 2014, INTRO AUD ANAL MATLA; Giannakopoulos T, 2012, SYSTEMS MAN CYBERN A, V20, P1913, DOI [10.1109/TASL.2012.2191285, DOI 10.1109/TASL.2012.2191285]; Gouyon F, 2006, IEEE T AUDIO SPEECH, V14, P1832, DOI 10.1109/TSA.2005.858509; Hyoung-Gook K., 2005, MPEG 7 AUDIO AUDIO C; Lehinevych T, 2014, 2014 10 INT C SIGN I; Pikrakis A, 2004, P INT C MUS INF RETR; Pikrakis A, 2008, IEEE T MULTIMEDIA, V10, P846, DOI 10.1109/TMM.2008.922870; Plumpe M., 1998, P INT C SPOK LANG PR, P2751; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1; Tranter SE, 2006, SYSTEMS MAN CYBERN A, V14, P1557, DOI [10.1109/TASL.2006.878256, DOI 10.1109/TASL.2006.878256]; Tsiakas K, 8 PERVASIVE TECHNOLO; Vendramin L., 2009, P 2009 SIAM INT C DA, P733, DOI 10.1137/1.9781611972795.63.; Vinciarelli A., 2009, P 3 INT C AFF COMP I, P1	17	201	202	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144610	10.1371/journal.pone.0144610	http://dx.doi.org/10.1371/journal.pone.0144610			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656189	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903600066
J	McKnight, LL; Root-McCaig, J; Wright, D; Davenport, GM; France, J; Shoveller, AK				McKnight, Leslie L.; Root-McCaig, Jared; Wright, David; Davenport, Gary M.; France, James; Shoveller, Anna Kate			Dietary Mannoheptulose Does Not Significantly Alter Daily Energy Expenditure in Adult Labrador Retrievers	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BODY-COMPOSITION; ADIPOSE-TISSUE; LEPTIN; DOGS; AGE; PHOTOPERIOD; GLUCOSE; CELLS; FAT	Mannoheptulose (MH), a sugar found in avocados that inhibits glycolysis in vitro, has been preliminarily investigated as a novel food ingredient for dogs. This study aimed to determine the effects of dietary MH, delivered as an extract of un-ripened avocado, on energy expenditure (EE) in healthy adult Labrador Retriever dogs (total of 12 dogs, 26.99 +/- 0.634 kg, 4.9 +/- 0.2 y). The study was a double-blind, cross-over with each dog receiving both dietary treatments, control (CON) and MH (400 mg/kg of diet; 6 mg/kg BW), in random order. Resting and post-prandial (10 h) EE and respiratory quotient (RQ) were determined by indirect calorimetry (d 42). The following day, body composition was assessed using dual X-ray absorptiometry. Continuous activity monitoring was conducted using an Atical (R) accelerometer (d 43-47). A vastus lateralis muscle biopsy was obtained prior to the morning meal (d 49) and 4 h after consumption of their meal (d 56) to determine the protein content and phosphorylation of 5' adenosine monophosphate-activated protein kinase (AMPK). Diet did not affect body weight, resting EE or skeletal muscle AMPK phosphorylation. Dogs fed MH had significantly lower post-prandial RQ (p = 0.02) and ratio of fat to lean body mass (p = 0.02). Physical activity during light time periods (but not dark) was lower in dogs fed MH (p < 0.05) during weekends, but not on weekdays. These results suggest that MH affects energy balance of adult dogs, but that these effects are not dose dependent and not due to physical activity.	[McKnight, Leslie L.; France, James; Shoveller, Anna Kate] Univ Guelph, Dept Anim Biosci, Ctr Nutr Modelling, Guelph, ON N1G 2W1, Canada; [Root-McCaig, Jared; Wright, David] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Davenport, Gary M.; Shoveller, Anna Kate] Procter & Gamble Pet Care, Lewisburg, OH 45338 USA	University of Guelph; University of Guelph; Procter & Gamble	Shoveller, AK (corresponding author), Univ Guelph, Dept Anim Biosci, Ctr Nutr Modelling, Guelph, ON N1G 2W1, Canada.	ashovell@uoguelph.ca		Wright, David/0000-0003-3867-8901	Procter and Gamble Pet Care	Procter and Gamble Pet Care	This study was funded by Procter and Gamble Pet Care. The funder provided support in the form of salaries for authors (GMD and AKS) and provided all the materials and animals for the study, excluding the AMPK work. The funder did not have any additional role in the study design, data collection and analyses, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	American Veterinary Medical Association (AVMA), 2012, US PET OWN DEM SOURC, P25; Bernabucci U, 2006, J DAIRY SCI, V89, P4678, DOI 10.3168/jds.S0022-0302(06)72518-8; Bocquier F, 1998, REPROD NUTR DEV, V38, P489, DOI 10.1051/rnd:19980501; COORE HG, 1964, BIOCHEM J, V91, P56, DOI 10.1042/bj0910056; Crane RK, 1954, J BIOL CHEM, P606; Davenport G, 2010, FASEB J, V24, P725; Fleischer S, 2008, AAPS J, V10, P110, DOI 10.1208/s12248-008-9011-1; Fontana L, 2007, JAMA-J AM MED ASSOC, V297, P986, DOI 10.1001/jama.297.9.986; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Jiang WQ, 2008, MOL CARCINOGEN, V47, P616, DOI 10.1002/mc.20425; Johnstone AM, 2005, AM J CLIN NUTR, V82, P941, DOI 10.1093/ajcn/82.5.941; Kealy RD, 2002, J AM VET MED ASSOC, V220, P1315, DOI 10.2460/javma.2002.220.1315; Laflamme D, 1997, CANINE PRACT, V22, P10; Massimino SP, 2005, Patent No. [EPO1773133B1, 1773133]; McKnight LL, 2015, J APPL ANIM RES, V43, P357, DOI 10.1080/09712119.2014.978775; McKnight LL, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2014.17; Mori A, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-146; Piper MDW, 2008, CELL METAB, V8, P99, DOI 10.1016/j.cmet.2008.06.012; Pouteau EB, 2002, AM J VET RES, V63, P111, DOI 10.2460/AJVR.2002.63.111; REIMERS E, 1982, CAN J ZOOL, V60, P1812, DOI 10.1139/z82-235; Roth GS, 2004, SCIENCE, V305, P1423, DOI 10.1126/science.1102541; Roudebush P, 2008, JAVMA-J AM VET MED A, V233, P717, DOI 10.2460/javma.233.5.717; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; SCOTT MD, 1973, J WILDLIFE MANAGE, V37, P253, DOI 10.2307/3800116; Siwak CT, 2003, BEHAV NEUROSCI, V117, P813, DOI 10.1037/0735-7044.117.4.813; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Yoo S, 2006, J ANIM PHYSIOL AN N, V90, P185, DOI 10.1111/j.1439-0396.2005.00588.x	28	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0143324	10.1371/journal.pone.0143324	http://dx.doi.org/10.1371/journal.pone.0143324			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656105	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903600010
J	Moreira, AJ; Ordonez, R; Cerski, CT; Picada, JN; Garcia-Palomo, A; Marroni, NP; Mauriz, JL; Gonzalez-Gallego, J				Moreira, Andrea Janz; Ordonez, Raquel; Cerski, Carlos Thadeu; Picada, Jaqueline Nascimento; Garcia-Palomo, Andres; Marroni, Norma Possa; Mauriz, Jose L.; Gonzalez-Gallego, Javier			Melatonin Activates Endoplasmic Reticulum Stress and Apoptosis in Rats with Diethylnitrosamine-Induced Hepatocarcinogenesis	PLOS ONE			English	Article							INDUCED HEPATOCELLULAR-CARCINOMA; CELL-CYCLE ARREST; ER STRESS; SIGNALING PATHWAYS; HEPATOMA-CELLS; ANIMAL-MODEL; CANCER; LIVER; PREVENTION; INHIBITION	Hepatocellular carcinoma (HCC) is one of the most lethal human cancers worldwide because of its high incidence, its metastatic potential and the low efficacy of conventional treatment. Inactivation of apoptosis is implicated in tumour progression and chemotherapy resistance, and has been linked to the presence of endoplasmic reticulum stress. Melatonin, the main product of the pineal gland, exerts anti-proliferative, pro-apoptotic and anti-angiogenic effects in HCC cells, but these effects still need to be confirmed in animal models. Male Wistar rats in treatment groups received diethylnitrosamine (DEN) 50 mg/kg intraperitoneally twice/once a week for 18 weeks. Melatonin was given in drinking water at 1 mg/kg/d, beginning 5 or 12 weeks after the start of DEN administration. Melatonin improved survival rates and successfully attenuated liver injury, as shown by histopathology, decreased levels of serum transaminases and reduced expression of placental glutathione S-transferase. Furthermore, melatonin treatment resulted in a significant increase of caspase 3, 8 and 9 activities, polyadenosine diphosphate (ADP) ribose polymerase (PARP) cleavage, and Bcl-associated X protein (Bax)/Bcl-2 ratio. Cytochrome c, p53 and Fas-L protein concentration were also significantly enhanced by melatonin. Melatonin induced an increased expression of activating transcription factor 6 (ATF6), C/EBP-homologous protein (CHOP) and immunoglobulin heavy chain-binding protein (BiP), while cyclooxygenase (COX)-2 expression decreased. Data obtained suggest that induction of apoptosis and ER stress contribute to the beneficial effects of melatonin in rats with DEN-induced HCC.	[Moreira, Andrea Janz; Cerski, Carlos Thadeu; Marroni, Norma Possa] Hosp Clin Porto Alegre, Ctr Expt Res, Porto Alegre, RS, Brazil; [Moreira, Andrea Janz; Cerski, Carlos Thadeu; Marroni, Norma Possa] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil; [Picada, Jaqueline Nascimento; Marroni, Norma Possa] Univ Luterana Brasil, Grad Program Cell & Mol Biol Appl Hlth, Canoas, Brazil; [Ordonez, Raquel; Mauriz, Jose L.; Gonzalez-Gallego, Javier] Univ Leon, Inst Biomed IBIOMED, E-24071 Leon, Spain; [Ordonez, Raquel; Mauriz, Jose L.; Gonzalez-Gallego, Javier] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Leon, Spain; [Garcia-Palomo, Andres] Complejo Asistencial Univ Leon, Serv Oncol, Leon, Spain	Universidade Federal do Rio Grande do Sul; Universidade Luterana do Brasil; Universidad de Leon; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Universidad de Leon	Gonzalez-Gallego, J (corresponding author), Univ Leon, Inst Biomed IBIOMED, E-24071 Leon, Spain.	jgonga@unileon.es	Gonzalez-Gallego, Javier/D-8219-2012; Picada, Jaqueline Nascimento/B-2480-2014; Ordóñez, Raquel/H-6367-2015; Mauriz, Jose L/G-9970-2014	Gonzalez-Gallego, Javier/0000-0002-4386-9342; Picada, Jaqueline Nascimento/0000-0003-2360-1557; Mauriz, Jose L/0000-0003-3160-8599; Possa Marroni, Norma/0000-0001-7856-7953; Garcia Palomo, Andres/0000-0002-9159-9025	Instituto de la Salud Carlos III, Spain; program "Formacion del Profesorado Universitario" (Becas FPU) from the Ministry of Education (Spain) [FPU12/01433]; Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Brazilian agency: Coordenacao de Aperfeicoamento de Pessoal de Novel Superior (CAPES); Brazilian agency: Fundo de Incentivo a Pesquisa e Eventos (FIPE) of the Hospital de Clinicas of Porto Alegre (HCPA); Brazilian agency: Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Brazilian agency: Laboratorio Experimental de Hepatologia e Gastroenterologia (HCPA/UFRGS)	Instituto de la Salud Carlos III, Spain(Instituto de Salud Carlos III); program "Formacion del Profesorado Universitario" (Becas FPU) from the Ministry of Education (Spain); Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian agency: Coordenacao de Aperfeicoamento de Pessoal de Novel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian agency: Fundo de Incentivo a Pesquisa e Eventos (FIPE) of the Hospital de Clinicas of Porto Alegre (HCPA); Brazilian agency: Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Brazilian agency: Laboratorio Experimental de Hepatologia e Gastroenterologia (HCPA/UFRGS)	CIBERehd is granted by Instituto de la Salud Carlos III, Spain. Raquel Ordonez is supported by the program "Formacion del Profesorado Universitario" (Becas FPU, reference FPU12/01433) from the Ministry of Education (Spain). This study was supported by grants from the Brazilian agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Novel Superior (CAPES), Fundo de Incentivo a Pesquisa e Eventos (FIPE) of the Hospital de Clinicas of Porto Alegre (HCPA), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) and Laboratorio Experimental de Hepatologia e Gastroenterologia (HCPA/UFRGS).	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Amin A, 2011, HEPATOLOGY, V54, P857, DOI 10.1002/hep.24433; Anisimov VN, 2006, BBA-BIOENERGETICS, V1757, P573, DOI 10.1016/j.bbabio.2006.03.012; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Balamurugan K, 2012, INDIAN J CLIN BIOCHE, V27, P157, DOI 10.1007/s12291-011-0166-7; Bejarano I, 2011, MOL CELL BIOCHEM, V353, P167, DOI 10.1007/s11010-011-0783-8; Blask DE, 2005, ENDOCRINE, V27, P179, DOI 10.1385/ENDO:27:2:179; Carbajo-Pescador S, 2013, BRIT J CANCER, V109, P83, DOI 10.1038/bjc.2013.285; Carbajo-Pescador S, 2013, BRIT J CANCER, V108, P442, DOI 10.1038/bjc.2012.563; Carbajo-Pescador S, 2011, J PINEAL RES, V51, P463, DOI 10.1111/j.1600-079X.2011.00910.x; Cosentino K, 2014, CHEM PHYS LIPIDS, V181, P62, DOI 10.1016/j.chemphyslip.2014.04.001; Cutando A, 2012, ANTICANCER RES, V32, P2747; Dakshayani KB, 2005, J PHARM PHARM SCI, V8, P316; Delbridge ARD, 2015, CELL DEATH DIFFER, V22, P1071, DOI 10.1038/cdd.2015.50; Fan LL, 2010, WORLD J GASTROENTERO, V16, P1473, DOI 10.3748/wjg.v16.i12.1473; Fan LL, 2013, J PINEAL RES, V55, P184, DOI 10.1111/jpi.12061; Fan LL, 2013, J PINEAL RES, V55, P174, DOI 10.1111/jpi.12060; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferrin G, 2015, HEPATIC MED-EVID RES, V7, P1, DOI 10.2147/HMER.S50161; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Fulda S, 2015, SEMIN CANCER BIOL, V31, P84, DOI 10.1016/j.semcancer.2014.05.002; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Gao Y, 2012, MOL BIOL REP, V39, P1683, DOI 10.1007/s11033-011-0908-x; Garcia-Mediavilla MV, 2005, J HEPATOL, V43, P606, DOI 10.1016/j.jhep.2005.04.019; Ghosh D, 2012, CHEM-BIOL INTERACT, V195, P206, DOI 10.1016/j.cbi.2011.12.004; Hadem Khetbadei Lysinia Hynniewta, 2014, J Carcinog, V13, P7, DOI 10.4103/1477-3163.133520; Hickman ES, 2002, CURR OPIN GENET DEV, V12, P60, DOI 10.1016/S0959-437X(01)00265-9; Imamoto R, 2014, EXP THER MED, V7, P31, DOI 10.3892/etm.2013.1391; Jayakumar S, 2012, MOL CELL BIOCHEM, V360, P51, DOI 10.1007/s11010-011-1043-7; Kowsalya R, 2015, SOUTH ASIAN J CANCER, V4, P83, DOI 10.4103/2278-330X.155691; Liu R, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-1; Lu WL, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/192749; Martin-Renedo J, 2008, J PINEAL RES, V45, P532, DOI 10.1111/j.1600-079X.2008.00641.x; Mauriz JL, 2008, MINI-REV MED CHEM, V8, P1485, DOI 10.2174/138955708786786499; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Molpeceres V, 2007, J GERONTOL A-BIOL, V62, P687, DOI 10.1093/gerona/62.7.687; Moon DO, 2011, BIOCHEM PHARMACOL, V82, P1641, DOI 10.1016/j.bcp.2011.08.019; Moreira A RG, 2015, TOXICOLOGY REPORTS, V2, P8; Muchowicz A, 2015, BIOCHEM PHARMACOL, V93, P418, DOI 10.1016/j.bcp.2014.12.019; Nagelkerke A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3373; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ordonez R, 2014, J PINEAL RES, V56, P20, DOI 10.1111/jpi.12092; Perdomo J, 2013, J PINEAL RES, V55, P195, DOI 10.1111/jpi.12062; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Rahman KW, 2003, NUTR CANCER, V47, P148, DOI 10.1207/s15327914nc4702_7; Rajasekaran D, 2011, MOL MED REP, V4, P1211, DOI 10.3892/mmr.2011.555; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Sakai M, 2007, BIOCHEM BIOPH RES CO, V357, P575, DOI 10.1016/j.bbrc.2007.03.174; San-Miguel B, 2006, APOPTOSIS, V11, P1945, DOI 10.1007/s10495-006-0090-0; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Sivaramakrishnan V, 2010, CHEM-BIOL INTERACT, V183, P284, DOI 10.1016/j.cbi.2009.11.011; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Su RJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-20; Subramanian P, 2007, J PINEAL RES, V43, P305, DOI 10.1111/j.1600-079X.2007.00478.x; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Tomas-Zapico C, 2005, J PINEAL RES, V39, P99, DOI 10.1111/j.1600-079X.2005.00248.x; Tomov B, 2013, ANTICANCER RES, V33, P4531; Tunon MJ, 2011, J PINEAL RES, V50, P38, DOI 10.1111/j.1600-079X.2010.00807.x; Varghese L, 2005, CLIN CANCER RES, V11, P8441, DOI 10.1158/1078-0432.CCR-05-1646; Wang ZX, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/732516; Wurstle ML, 2012, EXP CELL RES, V318, P1213, DOI 10.1016/j.yexcr.2012.02.013; Yadav Raj Kumar, 2014, J Cancer Prev, V19, P75, DOI 10.15430/JCP.2014.19.2.75; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yi X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093599; Yoon JS, 2013, PHYTOMEDICINE, V20, P1013, DOI 10.1016/j.phymed.2013.03.024; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zha LX, 2012, J PINEAL RES, V52, P322, DOI 10.1111/j.1600-079X.2011.00946.x	67	53	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144517	10.1371/journal.pone.0144517	http://dx.doi.org/10.1371/journal.pone.0144517			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656265	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903600051
J	Nanya, M; Sato, M; Tanimoto, K; Tozuka, M; Mizutani, S; Takagi, M				Nanya, Mai; Sato, Masaki; Tanimoto, Kousuke; Tozuka, Minoru; Mizutani, Shuki; Takagi, Masatoshi			Dysregulation of the DNA Damage Response and KMT2A Rearrangement in Fetal Liver Hematopoietic Cells	PLOS ONE			English	Article							MLL GENE; INFANT-LEUKEMIA; ATAXIA-TELANGIECTASIA; IN-VITRO; ETOPOSIDE; ATM; THERAPY; EXPRESSION; MECHANISM; CLEAVAGE	Etoposide, a topoisomerase 2 (TOP2) inhibitor, is associated with the development of KMT2A (MLL)-rearranged infant leukemia. An epidemiological study suggested that in utero exposure to TOP2 inhibitors may be involved in generation of KMT2A (MLL) rearrangement. The present study examined the mechanism underlying the development of KMT2A (MLL)-rearranged infant leukemia in response to in utero exposure to etoposide in a mouse model. Fetal liver hematopoietic stem cells were more susceptible to etoposide than maternal bone marrow mononuclear cells. Etoposide-induced Kmt2a breakage was detected in fetal liver hematopoietic stem cells using a newly developed chromatin immuno-precipitation (ChIP) assay. Assessment of etoposide-induced chromosomal translocation by next-generation RNA sequencing (RNA-seq) identified several chimeric fusion messenger RNAs that were generated by etoposide treatment. However, Kmt2a (MII)-rearranged fusion mRNA was detected in Atm-knockout mice, which are defective in the DNA damage response, but not in wild-type mice. The present findings suggest that in utero exposure to TOP2 inhibitors induces Kmt2a rearrangement when the DNA damage response is defective.	[Nanya, Mai; Sato, Masaki; Mizutani, Shuki; Takagi, Masatoshi] Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Tokyo, Japan; [Nanya, Mai; Tozuka, Minoru] Tokyo Med & Dent Univ, Analyt Chem Lab, Grad Sch Hlth Care Sci, Tokyo, Japan; [Tanimoto, Kousuke] Tokyo Med & Dent Univ, Dept Genom, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Mizutani, S (corresponding author), Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Tokyo, Japan.	skkmiz@gmail.com; m.takagi.ped@tmd.ac.jp	Sato, Masaki/L-2169-2017	Sato, Masaki/0000-0003-1277-7645	Ministry of education, culture, sport, science and technology, Japan [25461580]; Project for Development of innovative research on cancer therapeutics	Ministry of education, culture, sport, science and technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Project for Development of innovative research on cancer therapeutics	This research was supported by grant aid from Project for Development of innovative research on cancer therapeutics, Grants-in-aid for Scientific Research 25461580, Ministry of education, culture, sport, science and technology, Japan.	Alexander FE, 2001, CANCER RES, V61, P2542; Andersson AK, 2015, NAT GENET, V47, P330, DOI 10.1038/ng.3230; BLANCO JG, 2004, FASEB J, V18, P173, DOI 10.1096/fj.03-0638fje; Bueno C, 2011, LEUKEMIA, V25, P400, DOI 10.1038/leu.2010.284; Bueno C, 2009, CARCINOGENESIS, V30, P1628, DOI 10.1093/carcin/bgp169; Chen WL, 2006, BLOOD, V108, P669, DOI 10.1182/blood-2005-08-3498; Cowell IG, 2012, INT J ENV RES PUB HE, V9, P2075, DOI 10.3390/ijerph9062075; EASTON DF, 1994, INT J RADIAT BIOL, V66, pS177, DOI 10.1080/09553009414552011; FELIX CA, 1995, BLOOD, V85, P3250, DOI 10.1182/blood.V85.11.3250.bloodjournal85113250; FORD AM, 1993, NATURE, V363, P358, DOI 10.1038/363358a0; Gale KB, 1997, P NATL ACAD SCI USA, V94, P13950, DOI 10.1073/pnas.94.25.13950; Greaves MF, 1997, LANCET, V349, P344, DOI 10.1016/S0140-6736(96)09412-3; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishii E, 2002, INT J HEMATOL, V76, P74, DOI 10.1007/BF02982722; Isoda T, 2012, BLOOD, V120, P789, DOI 10.1182/blood-2012-02-413195; Kobayashi M, 2014, STEM CELLS, V32, P1956, DOI 10.1002/stem.1672; Libura J, 2005, BLOOD, V105, P2124, DOI 10.1182/blood-2004-07-2683; Libura J, 2008, EUR J HAEMATOL, V81, P185, DOI 10.1111/j.1600-0609.2008.01103.x; Moneypenny CG, 2006, CARCINOGENESIS, V27, P874, DOI 10.1093/carcin/bgi322; Nakada S, 2006, J CLIN INVEST, V116, P80, DOI 10.1172/JCI25716; Nam C, 2013, EXP ANIM TOKYO, V62, P93, DOI 10.1538/expanim.62.93; Oguchi K, 2003, BLOOD, V101, P3622, DOI 10.1182/blood-2002-02-0570; ROSS JA, 1994, J NATL CANCER I, V86, P1678, DOI 10.1093/jnci/86.22.1678; Ross JA, 2000, P NATL ACAD SCI USA, V97, P4411, DOI 10.1073/pnas.97.9.4411; Sanjuan-Pla A, 2015, BLOOD, V126, P2676, DOI 10.1182/blood-2015-09-667378; Shiloh Y, 1996, J CLIN IMMUNOL, V16, P254, DOI 10.1007/BF01541389; Strick R, 2000, P NATL ACAD SCI USA, V97, P4790, DOI 10.1073/pnas.070061297; Takagi M, 2013, DNA REPAIR, V12, P500, DOI 10.1016/j.dnarep.2013.04.022; Tamaichi H, 2013, CANCER SCI, V104, P178, DOI 10.1111/cas.12067; Tomizawa D, 2007, LEUKEMIA, V21, P2258, DOI 10.1038/sj.leu.2404903; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120	32	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144540	10.1371/journal.pone.0144540	http://dx.doi.org/10.1371/journal.pone.0144540			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657054	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903600052
J	Rubio, M; Ballester, AR; Olivares, PM; de Moura, MC; Dicenta, F; Martinez-Gomez, P				Rubio, Manuel; Rosa Ballester, Ana; Manuel Olivares, Pedro; Castro de Moura, Manuel; Dicenta, Federico; Martinez-Gomez, Pedro			Gene Expression Analysis of Plum pox virus (Sharka) Susceptibility/Resistance in Apricot (Prunus armeniaca L.)	PLOS ONE			English	Article							RNA-SEQ; PEACH LEAVES; LINKAGE MAP; RESISTANCE; IDENTIFICATION; MARKERS; MODEL; PPV; INFECTION; ANALOGS	RNA-Seq has proven to be a very powerful tool in the analysis of the Plum pox virus (PPV, sharka disease)/Prunus interaction. This technique is an important complementary tool to other means of studying genomics. In this work an analysis of gene expression of resistance/ susceptibility to PPV in apricot is performed. RNA-Seq has been applied to analyse the gene expression changes induced by PPV infection in leaves from two full-sib apricot genotypes, "Rojo Pasion" and "Z506-7", resistant and susceptible to PPV, respectively. Transcriptomic analyses revealed the existence of more than 2,000 genes related to the pathogen response and resistance to PPV in apricot. These results showed that the response to infection by the virus in the susceptible genotype is associated with an induction of genes involved in pathogen resistance such as the allene oxide synthase, S-adenosylmethionine synthetase 2 and the major MLP-like protein 423. Over-expression of the Dicer protein 2a may indicate the suppression of a gene silencing mechanism of the plant by PPV HCPro and P1 PPV proteins. On the other hand, there were 164 genes involved in resistance mechanisms that have been identified in apricot, 49 of which are located in the PPVres region (scaffold 1 positions from 8,050,804 to 8,244,925), which is responsible for PPV resistance in apricot. Among these genes in apricot there are several MATH domain-containing genes, although other genes inside (Pleiotropic drug resistance 9 gene) or outside (CAP, Cysteine-rich secretory proteins, Antigen 5 and Pathogenesis-related 1 protein; and LEA, Late embryogenesis abundant protein) PPVres region could also be involved in the resistance.	[Rubio, Manuel; Manuel Olivares, Pedro; Dicenta, Federico; Martinez-Gomez, Pedro] Ctr Edafol & Biol Aplicada Segura CEBAS CSIC, Dept Plant Breeding, E-30100 Espinardo, Murcia, Spain; [Rosa Ballester, Ana] Inst Agroquim & Tecnol Alimentos IATA CSIC, Dept Food Sci, Paterna 46980, Valencia, Spain; [Castro de Moura, Manuel] AScidea Computat Biol Solut, Barcelona 08193, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); Consejo Superior de Investigaciones Cientificas (CSIC)	Martinez-Gomez, P (corresponding author), Ctr Edafol & Biol Aplicada Segura CEBAS CSIC, Dept Plant Breeding, POB 164, E-30100 Espinardo, Murcia, Spain.	pmartinez@cebas.csic.es	Castro, Manuel/AAF-5985-2019; Rubio, Manuel/E-8607-2010; Dicenta, Federico/L-1777-2017; Ballester, Ana-Rosa/D-9677-2011; Martinez-Gomez, Pedro/G-4217-2011; de Moura, Manuel Castro/L-4259-2017	Castro, Manuel/0000-0002-8488-5306; Rubio, Manuel/0000-0003-4605-8227; Ballester, Ana-Rosa/0000-0002-7688-7838; Martinez-Gomez, Pedro/0000-0003-1054-8814; de Moura, Manuel Castro/0000-0002-8488-5306; Dicenta, Federico/0000-0002-9593-7351	Spanish Ministry of Economy and Competitiveness [AGL2010-16335, AGL2013-43550-R]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This study was supported by the projects "Gene expression analysis of the resistance to Plum pox virus, PPV (sharka) in apricot by transcriptome deep sequencing (RNA-Seq)" (AGL2010-16335) and "Regulation of gene expression in the resistance to Plum pox virus (Sharka) induced in peach by 'Garrigues' almond grafting" (AGL2013-43550-R) of the Spanish Ministry of Economy and Competitiveness. A.R. Ballester and M. Rubio are grateful to CSIC and the European Social Fund for their postdoctoral contracts. Author Manuel Castro de Moura is employed by aScidea Computational Biology Solutions, S.L. aScidea Computational Biology Solutions, S.L. provided support in the form of salary for author MCdM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Salazar JA, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0845-2; Garcia JA, 2014, MOL PLANT PATHOL, V15, P226, DOI 10.1111/mpp.12083; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babu M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-325; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Clemente-Moreno MJ, 2015, J EXP BOT, V66, P25, DOI 10.1093/jxb/eru428; Cosson P, 2010, PLANT PHYSIOL, V154, P222, DOI 10.1104/pp.110.155754; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; Decroocq S, 2014, TREE GENET GENOMES, V10, P1161, DOI 10.1007/s11295-014-0750-0; Decroocq V, 2006, MOL PLANT MICROBE IN, V19, P541, DOI 10.1094/MPMI-19-0541; Dondini L, 2004, J HORTIC SCI BIOTECH, V79, P729, DOI 10.1080/14620316.2004.11511834; Dondini L, 2011, MOL BREEDING, V27, P289, DOI 10.1007/s11032-010-9431-3; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Egea J, 2004, HORTSCIENCE, V39, P1490, DOI 10.21273/HORTSCI.39.6.1490; Gardiner DM, 2013, FEMS MICROBIOL LETT, V348, P36, DOI 10.1111/1574-6968.12240; Gonzalez-Ibeas D, 2012, MOL PLANT MICROBE IN, V25, P107, DOI 10.1094/MPMI-07-11-0193; Hurtado MA, 2002, THEOR APPL GENET, V105, P182, DOI 10.1007/s00122-002-0936-y; Jaouannet M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004918; Jung S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-76; Karayiannis I, 2008, TREE GENET GENOMES, V4, P143, DOI 10.1007/s11295-007-0095-z; Labaj PP, 2011, BIOINFORMATICS, V27, pI383, DOI 10.1093/bioinformatics/btr247; Lalli DA, 2008, TREE GENET GENOMES, V4, P481, DOI 10.1007/s11295-007-0125-x; Lalli DA, 2005, THEOR APPL GENET, V111, P1504, DOI 10.1007/s00122-005-0079-z; Lambert P, 2007, TREE GENET GENOMES, V3, P299, DOI 10.1007/s11295-006-0069-6; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindner R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052403; Liu Y, 2013, PLANT CELL PHYSIOL, V54, P944, DOI 10.1093/pcp/pct047; Llacer G, 2008, ACTA HORTIC, P263, DOI 10.17660/ActaHortic.2008.781.39; Marandel G, 2009, MOL PLANT PATHOL, V10, P347, DOI [10.1111/j.1364-3703.2009.00535.x, 10.1111/J.1364-3703.2009.00535.X]; Mariette S, 2016, NEW PHYTOL, V209, P773, DOI 10.1111/nph.13627; Martinez-Gomez P, 2000, AGRONOMIE, V20, P407, DOI 10.1051/agro:2000137; Martinez-Gomez P, 2012, OMICS, V16, P268, DOI 10.1089/omi.2011.0133; Martinez-Gomez P, 2011, GENETICA, V139, P755, DOI 10.1007/s10709-011-9580-2; Soriano JM, 2012, MOL BREEDING, V30, P1017, DOI 10.1007/s11032-011-9685-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pilarova P, 2010, TREE GENET GENOMES, V6, P467, DOI 10.1007/s11295-009-0264-3; Rasori A, 2002, J EXP BOT, V53, P2333, DOI [10.1093/jxb/\\, 10.1093/jxb/\\|[ast ]\\|, 10.1093/jxb/erf097]; Rau A, 2013, BIOINFORMATICS, V29, P2146, DOI 10.1093/bioinformatics/btt350; Rodamilans B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100477; Rubio M, 2007, SCI HORTIC-AMSTERDAM, V112, P361, DOI 10.1016/j.scienta.2006.12.049; Rubio M, 2015, MOL PLANT PATHOL, V16, P164, DOI 10.1111/mpp.12169; Rubio M, 2014, TREE GENET GENOMES, V10, P513, DOI 10.1007/s11295-014-0700-x; Rubio M, 2010, TREE GENET GENOMES, V6, P291, DOI 10.1007/s11295-009-0249-2; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schurdi-Levraud Escalettes V, 2006, GENE, V374, P96, DOI 10.1016/j.gene.2006.01.021; Sicard O, 2008, MOL PLANT MICROBE IN, V21, P198, DOI 10.1094/MPMI-21-2-0198; Simon AS, 2014, ANNU REV MICROBIOL, V67, P21; Soriano JM, 2008, TREE GENET GENOMES, V4, P391, DOI 10.1007/s11295-007-0118-9; Soriano JM, 2005, THEOR APPL GENET, V110, P980, DOI 10.1007/s00122-005-1920-0; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Valli A, 2006, J VIROL, V80, P10055, DOI 10.1128/JVI.00985-06; Ruiz EMV, 2011, MOL PLANT PATHOL, V12, P535, DOI [10.1111/J.1364-3703.2010.00691.X, 10.1111/j.1364-3703.2010.00691.x]; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Vilanova S, 2003, THEOR APPL GENET, V107, P239, DOI 10.1007/s00122-003-1243-y; Wagner GP, 2013, THEOR BIOSCI, V132, P159, DOI 10.1007/s12064-013-0178-3; Wang A, 2005, CAN J PLANT PATHOL, V27, P410; Wang L, 2013, PLANT MOL BIOL, V83, P365, DOI 10.1007/s11103-013-0093-5; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zhebentyayeva TN, 2008, TREE GENET GENOMES, V4, P403, DOI 10.1007/s11295-007-0119-8; Zhong WJ, 2013, PLANT MOL BIOL, V83, P247, DOI 10.1007/s11103-013-0086-4; Zuriaga E, 2013, MOL PLANT PATHOL, V14, P663, DOI 10.1111/mpp.12037	65	20	20	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144670	10.1371/journal.pone.0144670	http://dx.doi.org/10.1371/journal.pone.0144670			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658051	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903600074
J	Shirmanova, M; Yuzhakova, D; Snopova, L; Perelman, G; Serebrovskaya, E; Lukyanov, K; Turchin, I; Subochev, P; Lukyanov, S; Kamensky, V; Zagaynova, E				Shirmanova, Marina; Yuzhakova, Diana; Snopova, Ludmila; Perelman, Gregory; Serebrovskaya, Ekaterina; Lukyanov, Konstantin; Turchin, Ilya; Subochev, Pavel; Lukyanov, Sergey; Kamensky, Vladislav; Zagaynova, Elena			Towards PDT with Genetically Encoded Photosensitizer KillerRed: A Comparison of Continuous and Pulsed Laser Regimens in an Animal Tumor Model	PLOS ONE			English	Article							CONTINUOUS-WAVE LIGHT; PHOTODYNAMIC THERAPY; IN-VIVO; FLUORESCENT PROTEINS; CELL CARCINOMAS; CANCER-CELLS; DYE-LASER; ACTIVATION; MECHANISMS; DELIVERY	The strong phototoxicity of the red fluorescent protein KillerRed allows it to be considered as a potential genetically encoded photosensitizer for the photodynamic therapy (PDT) of cancer. The advantages of KillerRed over chemical photosensitizers are its expression in tumor cells transduced with the appropriate gene and direct killing of cells through precise damage to any desired cell compartment. The ability of KillerRed to affect cell division and to induce cell death has already been demonstrated in cancer cell lines in vitro and HeLa tumor xenografts in vivo. However, the further development of this approach for PDT requires optimization of the method of treatment. In this study we tested the continuous wave (593 nm) and pulsed laser (584 nm, 10 Hz, 18 ns) modes to achieve an antitumor effect. The research was implemented on CT26 subcutaneous mouse tumors expressing KillerRed in fusion with histone H2B. The results showed that the pulsed mode provided a higher rate of photobleaching of KillerRed without any temperature increase on the tumor surface. PDT with the continuous wave laser was ineffective against CT26 tumors in mice, whereas the pulsed laser induced pronounced histopathological changes and inhibition of tumor growth. Therefore, we selected an effective regimen for PDT when using the genetically encoded photosensitizer KillerRed and pulsed laser irradiation.	[Shirmanova, Marina; Yuzhakova, Diana; Snopova, Ludmila; Serebrovskaya, Ekaterina; Lukyanov, Konstantin; Lukyanov, Sergey; Zagaynova, Elena] Nizhny Novgorod State Med Acad, Nizhnii Novgorod, Russia; [Yuzhakova, Diana; Perelman, Gregory] Lobachevsky State Univ Nizhny Novgorod, Nizhnii Novgorod, Russia; [Serebrovskaya, Ekaterina; Lukyanov, Konstantin; Lukyanov, Sergey] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Turchin, Ilya; Subochev, Pavel; Kamensky, Vladislav] Russian Acad Sci, Inst Appl Phys, Nizhnii Novgorod, Russia; [Lukyanov, Sergey] Pirogov Russian Natl Res Med Univ, Moscow, Russia	Privolzhsky Research Medical University; Lobachevsky State University of Nizhni Novgorod; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Sciences; Institute of Applied Physics of the Russian Academy of Sciences; Pirogov Russian National Research Medical University	Shirmanova, M (corresponding author), Nizhny Novgorod State Med Acad, Nizhnii Novgorod, Russia.	Shirmanovam@mail.ru	Lukyanov, Konstantin A/D-4030-2013; Yuzhakova, Diana V/F-8990-2017; Subochev, Pavel/E-4918-2014; Serebrovskaya, Ekaterina/AAN-8121-2020; Turchin, Ilya/E-3863-2014; Shirmanova, Marina V./M-7635-2016	Lukyanov, Konstantin A/0000-0001-9845-2088; Subochev, Pavel/0000-0001-5803-5773; Turchin, Ilya/0000-0002-8471-7361; Shirmanova, Marina/0000-0002-3207-7227; Perelman, Grigory/0000-0003-2512-247X	Russian Scientific Foundation [14-25-00129]; Russian Foundation for Basic Research [14-02-00860]; Russian Science Foundation [14-25-00129] Funding Source: Russian Science Foundation	Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Scientific Foundation (#14-25-00129) to KL, and the Russian Foundation for Basic Research (#14-02-00860) to VK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RD, 2004, BBA-REV CANCER, V1704, P59, DOI 10.1016/j.bbcan.2004.05.003; Anbil S, 2013, PROC SPIE, V8568, DOI 10.1117/12.2010840; BARR H, 1989, Lasers in Medical Science, V4, P7, DOI 10.1007/BF02032503; Bulina ME, 2006, NAT PROTOC, V1, P947, DOI 10.1038/nprot.2006.89; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Chen B, 2008, INT J CANCER, V123, P695, DOI 10.1002/ijc.23538; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; FERRARIO A, 1991, LASER SURG MED, V11, P404, DOI 10.1002/lsm.1900110504; Grecco C, 2013, LASER MED SCI, V28, P1177, DOI 10.1007/s10103-012-1216-y; Henderson BW, 2000, CANCER RES, V60, P525; Jarvi MT, 2012, BIOPHYS J, V102, P661, DOI 10.1016/j.bpj.2011.12.043; Jimenez-Banzo A, 2008, BIOPHYS J, V94, P168, DOI 10.1529/biophysj.107.107128; Kawauchi S, 2004, LASER MED SCI, V18, P179, DOI 10.1007/s10103-004-0288-8; Kimura H, 2010, J CELL BIOCHEM, V110, P1439, DOI 10.1002/jcb.22693; Klimenko VV, 2014, J PHYS CONF SER, V541, DOI 10.1088/1742-6596/541/1/012040; Kuznetsova DS, 2015, J BIOPHOTONICS, V8, P952, DOI 10.1002/jbio.201400130; Lan L, 2014, NUCLEIC ACIDS RES, V42, P2330, DOI 10.1093/nar/gkt1233; LAPLANT M, 1987, LASER SURG MED, V7, P336, DOI 10.1002/lsm.1900070407; Liao ZX, 2014, J CONTROL RELEASE, V193, P304, DOI 10.1016/j.jconrel.2014.04.024; MIMURA S, 1995, P SOC PHOTO-OPT INS, V2371, P522; Mitra S, 2011, LASER SURG MED, V43, P632, DOI 10.1002/lsm.21108; Miyamoto Y, 1999, J PHOTOCH PHOTOBIO B, V53, P53, DOI 10.1016/S1011-1344(99)00125-6; Momiyama M, 2012, ANTICANCER RES, V32, P4327; Muthiah M, 2014, COLLOID SURFACE B, V116, P284, DOI 10.1016/j.colsurfb.2014.01.001; OKUNAKA T, 1992, JPN J CANCER RES, V83, P226, DOI 10.1111/j.1349-7006.1992.tb00090.x; Pletnev S, 2009, J BIOL CHEM, V284, P32028, DOI 10.1074/jbc.M109.054973; Pogue BW, 1999, BRIT J CANCER, V80, P344, DOI 10.1038/sj.bjc.6690361; Pogue BW, 1997, APPL OPTICS, V36, P7257, DOI 10.1364/AO.36.007257; RAUSCH PC, 1993, EUR ARCH OTO-RHINO-L, V250, P82; Roy A, 2010, PHOTOCH PHOTOBIO SCI, V9, P1342, DOI 10.1039/c0pp00141d; Sato K, 2015, THERANOSTICS, V5, P698, DOI 10.7150/thno.11559; Serebrovskaya EO, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.7.071403; Serebrovskaya EO, 2011, BIOCHEM J, V435, P65, DOI 10.1042/BJ20101217; Serebrovskaya EO, 2009, P NATL ACAD SCI USA, V106, P9221, DOI 10.1073/pnas.0904140106; Sheng C, 2007, PHOTOCHEM PHOTOBIOL, V83, P738, DOI 10.1562/2006-09-07-RA-1033; Shirmanova MV, 2013, J BIOPHOTONICS, V6, P283, DOI 10.1002/jbio.201200056; Sterenborg HJCM, 1996, PHYS MED BIOL, V41, P835, DOI 10.1088/0031-9155/41/5/002; Takehara K, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-706; Teh C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-110; Tseng SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7456; Vegh RB, 2014, J PHYS CHEM B, V118, P4527, DOI 10.1021/jp500919a; Vegh RB, 2011, CHEM COMMUN, V47, P4887, DOI 10.1039/c0cc05713d; Waldeck W, 2011, INT J MED SCI, V8, P97, DOI 10.7150/ijms.8.97	43	14	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144617	10.1371/journal.pone.0144617	http://dx.doi.org/10.1371/journal.pone.0144617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657001	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903600069
J	Sun, L; Lu, JJ; Niu, ZH; Ding, KJ; Bi, DB; Liu, S; Li, JM; Wu, F; Zhang, H; Zhao, ZH; Ding, ST				Sun, Liang; Lu, Jiaju; Niu, Zhihong; Ding, Kejia; Bi, Dongbin; Liu, Shuai; Li, Jiamei; Wu, Fei; Zhang, Hui; Zhao, Zuohui; Ding, Sentai			A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer	PLOS ONE			English	Article							MITOTIC KINESIN EG5; TRITYL-L-CYSTEINE; RIBONUCLEOTIDE REDUCTASE M1; HUMAN PANCREATIC-CANCER; CELL LUNG-CANCER; OVARIAN-CANCER; SPINDLE PROTEIN; CARCINOMA; SUBUNIT; EXPRESSION	Development of resistance to gemcitabine is a major concern in bladder cancer therapy, and the mechanism remains unclear. Eg5 has been recently identified as an attractive target in cancer chemotherapy, so novel targeted chemotherapy with Eg5 inhibitor is expected to improve the anticancer effect in gemcitabine-resistant bladder cancer. In this research, RT112-Gr cells were 350-fold less sensitive to gemcitabine than the parental cell lines, while KU7-Gr cells were 15-fold less sensitive to gemcitabine than the parental cell lines. Human OneArray Microarray analysis was performed to obtain broad spectrum information about the genes differentially expressed in RT112 and RT112-Gr cells. The anti-proliferative activity of S(MeO) TLC, an Eg5 inhibitor, was analyzed in RT112-Gr cell lines using a cell viability assay. Furthermore, the inhibitory effect was evaluated in vivo using subcutaneous xenograft tumor model. According to the result of Human OneArray1GeneChip, RRM1 and RRM2 were up-regulated, while there was no significant change in Eg5. Trypan blue staining confirmed that in S(MeO) TLC and Gemcitabine combining S(MeO) TLC group cell viability were significantly decreased in RT112-Gr cells as compared with other groups. S (MeO) TLC and S(MeO) TLC+gemcitabine groups prominently suppressed tumor growth in comparison with other groups' in vivo. There were no significant differences in S(MeO) TLC and gemcitabine+S(MeO) TLC group in the effect of inhibition of bladder cancer in vivo and in vitro. Our data collectively demonstrated that S(MeO) TLC represents a novel strategy for the treatment of gemcitabine resistant bladder cancer.	[Sun, Liang; Lu, Jiaju; Niu, Zhihong; Ding, Kejia; Bi, Dongbin; Liu, Shuai; Wu, Fei; Zhang, Hui; Zhao, Zuohui; Ding, Sentai] Shandong Univ, Shandong Prov Hosp, Dept Urol, Jinan 250100, Shandong, Peoples R China; [Li, Jiamei] Shandong Univ, Shandong Prov Hosp, Dept Pathol, Jinan 250100, Shandong, Peoples R China; [Sun, Liang] Shandong Univ Tradit Chinese Med, Dept Cardiac Surg, Affiliated Hosp 2, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University of Traditional Chinese Medicine	Ding, ST (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Urol, Jinan 250100, Shandong, Peoples R China.	dingsentai@126.com	Wu, Fei/GWV-4224-2022	Wu, Fei/0000-0002-3601-9593	National Natural Science Foundation of China [81202017]; Natural Science Foundation of Shandong Province [ZR2011HQ027, ZR2014HQ041]; Science and Technology Research Foundation of Shandong Province [2012YD18049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Science and Technology Research Foundation of Shandong Province	This work was supported by the grants from the National Natural Science Foundation of China (No. 81202017) (http://www.nsfc.gov.cn), the Natural Science Foundation of Shandong Province (No. ZR2011HQ027 and No. ZR2014HQ041) (http://www.sdnsf.gov.cn), and the Science and Technology Research Foundation of Shandong Province (No. 2012YD18049) (http://www.sdnsf.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abualhasan MN, 2012, EUR J MED CHEM, V54, P483, DOI 10.1016/j.ejmech.2012.05.034; Allory Y, 2014, EUR UROL, V65, P360, DOI 10.1016/j.eururo.2013.08.052; Amit D, 2012, INT J CLIN EXP MED, V5, P296; Angelova AL, 2009, CLIN CANCER RES, V15, P511, DOI 10.1158/1078-0432.CCR-08-1088; Barsanti PA, 2010, BIOORG MED CHEM LETT, V20, P157, DOI 10.1016/j.bmcl.2009.11.012; Bepler G, 2004, J CLIN ONCOL, V22, P1878, DOI 10.1200/JCO.2004.12.002; Bhutia YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053436; Chung WG, 2012, J CONTROL RELEASE, V157, P132, DOI 10.1016/j.jconrel.2011.08.004; Ding ST, 2010, J UROLOGY, V184, P1175, DOI 10.1016/j.juro.2010.04.073; Droller MJ, 2002, UROL CLIN N AM, V29, P229, DOI 10.1016/S0094-0143(02)00008-3; Gandaglia G, 2014, EUR UROL, V66, P561, DOI 10.1016/j.eururo.2014.01.014; Good JAD, 2013, J MED CHEM, V56, P1878, DOI 10.1021/jm3014597; Hodge LS, 2011, BIOCHEM PHARMACOL, V81, P950, DOI 10.1016/j.bcp.2011.01.016; Itoi T, 2007, J GASTROENTEROL, V42, P389, DOI 10.1007/s00535-007-2017-0; Kang HW, 2012, KOREAN J UROL, V53, P598, DOI 10.4111/kju.2012.53.9.598; Knight SD, 2008, CURR TOP MED CHEM, V8, P888, DOI 10.2174/156802608784911626; Leijen S, 2013, GYNECOL ONCOL, V130, P511, DOI 10.1016/j.ygyno.2013.05.001; Marcus AI, 2005, J BIOL CHEM, V280, P11569, DOI 10.1074/jbc.M413471200; Matsui Y, 2010, BJU INT, V105, P558, DOI 10.1111/j.1464-410X.2009.08732.x; Motoyama T, 2012, CHEM BIOL, V19, P1611, DOI 10.1016/j.chembiol.2012.10.010; Muramaki M, 2009, BJU INT, V103, P384, DOI 10.1111/j.1464-410X.2008.08098.x; Nakahira S, 2007, INT J CANCER, V120, P1355, DOI 10.1002/ijc.22390; Nakai R, 2009, CANCER RES, V69, P3901, DOI 10.1158/0008-5472.CAN-08-4373; Nakano Y, 2007, BRIT J CANCER, V96, P457, DOI 10.1038/sj.bjc.6603559; Ohtaka K, 2008, ONCOL REP, V20, P279, DOI 10.3892/or_00000004; Peters T, 2006, N-S ARCH PHARMACOL, V372, P291, DOI 10.1007/s00210-005-0022-5; Rosenberg JE, 2007, EXPERT REV ANTICANC, V7, P1729, DOI 10.1586/14737140.7.12.1729; Saijo T, 2006, LUNG CANCER, V54, P217, DOI 10.1016/j.lungcan.2006.06.018; Sarli V, 2008, CLIN CANCER RES, V14, P7583, DOI 10.1158/1078-0432.CCR-08-0120; Sun DQ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0476-0; Tcherniuk S, 2010, BIOCHEM PHARMACOL, V79, P864, DOI 10.1016/j.bcp.2009.11.001; Wiltshire C, 2010, MOL CANCER THER, V9, P1730, DOI 10.1158/1535-7163.MCT-09-1103; Xie H, 2013, CANCER-AM CANCER SOC, V119, P173, DOI 10.1002/cncr.27715; Xing ND, 2011, ASIAN J ANDROL, V13, P236, DOI 10.1038/aja.2010.171; Yu HJ, 2013, HISTOPATHOLOGY, V62, P788, DOI 10.1111/his.12087; Zhang M, 2013, INT J GYNECOL CANCER, V23, P659, DOI 10.1097/IGC.0b013e318287e2b3	36	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144484	10.1371/journal.pone.0144484	http://dx.doi.org/10.1371/journal.pone.0144484			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658059	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903500030
J	Fetterman, AK; Sassenberg, K				Fetterman, Adam K.; Sassenberg, Kai			The Reputational Consequences of Failed Replications and Wrongness Admission among Scientists	PLOS ONE			English	Article							SELF; JUDGMENT; BIAS	Scientists are dedicating more attention to replication efforts. While the scientific utility of replications is unquestionable, the impact of failed replication efforts and the discussions surrounding them deserve more attention. Specifically, the debates about failed replications on social media have led to worry, in some scientists, regarding reputation. In order to gain data-informed insights into these issues, we collected data from 281 published scientists. We assessed whether scientists overestimate the negative reputational effects of a failed replication in a scenario-based study. Second, we assessed the reputational consequences of admitting wrongness (versus not) as an original scientist of an effect that has failed to replicate. Our data suggests that scientists overestimate the negative reputational impact of a hypothetical failed replication effort. We also show that admitting wrongness about a non-replicated finding is less harmful to one's reputation than not admitting. Finally, we discovered a hint of evidence that feelings about the replication movement can be affected by whether replication efforts are aimed one's own work versus the work of another. Given these findings, we then present potential ways forward in these discussions.	[Fetterman, Adam K.; Sassenberg, Kai] Leibniz Inst Wissensmedien, Tubingen, Germany; [Fetterman, Adam K.] Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England; [Sassenberg, Kai] Univ Tubingen, Dept Psychol, Tubingen, Germany	Leibniz Institut fur Wissensmedien; University of Essex; Eberhard Karls University of Tubingen	Fetterman, AK (corresponding author), Leibniz Inst Wissensmedien, Tubingen, Germany.	akfett@essex.ac.uk	Fetterman, Adam/ABG-1483-2020; Sassenberg, Kai/D-3048-2011	Fetterman, Adam/0000-0001-5957-7670; Sassenberg, Kai/0000-0001-6579-8250				Bohannon J, 2014, SCIENCE, V344, P788, DOI 10.1126/science.344.6186.788; BRAVER SL, 1977, J EXP SOC PSYCHOL, V13, P565, DOI 10.1016/0022-1031(77)90055-5; Brooks AW, 2015, MANAGE SCI, V61, P1421, DOI 10.1287/mnsc.2014.2054; Canevello A, 2011, EUR J SOC PSYCHOL, V41, P422, DOI 10.1002/ejsp.808; Chancellor J, 2013, SOC PERSONAL PSYCHOL, V7, P819, DOI 10.1111/spc3.12069; CIALDINI RB, 1976, J PERS SOC PSYCHOL, V33, P395, DOI 10.1037/0022-3514.33.4.395; CIALDINI RB, 1974, J PERS SOC PSYCHOL, V30, P631, DOI 10.1037/h0037448; Crommelinck M, 2013, MED EDUC, V47, P232, DOI 10.1111/medu.12075; Gilovich T, 2000, J PERS SOC PSYCHOL, V78, P211, DOI 10.1037/0022-3514.78.2.211; Gilovich T, 2002, J EXP SOC PSYCHOL, V38, P93, DOI 10.1006/jesp.2001.1490; Greitemeyer T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126316; John LK, 2012, PSYCHOL SCI, V23, P524, DOI 10.1177/0956797611430953; Kahneman D, 2014, SOC PSYCHOL-GERMANY, V45, P310; Leary MR, 2011, EUR J SOC PSYCHOL, V41, P411, DOI 10.1002/ejsp.813; LEARY MR, 1990, PSYCHOL BULL, V107, P34, DOI 10.1037/0033-2909.107.1.34; LEARY MR, 1983, PERS SOC PSYCHOL B, V9, P371, DOI 10.1177/0146167283093007; ROSS LD, 1977, J PERS SOC PSYCHOL, V35, P485, DOI 10.1037/0022-3514.35.7.485; Savitsky K, 2001, J PERS SOC PSYCHOL, V81, P44, DOI 10.1037//0022-3514.81.1.44; SCHWARZ N, 1991, J PERS SOC PSYCHOL, V61, P195, DOI 10.1037/0022-3514.61.2.195; Shelton JN, 2005, J PERS SOC PSYCHOL, V88, P91, DOI 10.1037/0022-3514.88.1.91; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Uziel L, 2012, PERS SOC PSYCHOL B, V38, P384, DOI 10.1177/0146167211427310; Van Noorden R, 2014, NATURE, V512, P126, DOI 10.1038/512126a; WINK P, 1991, J PERS SOC PSYCHOL, V61, P590	25	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143723	10.1371/journal.pone.0143723	http://dx.doi.org/10.1371/journal.pone.0143723			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YX	26650842	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000366903300024
J	Gao, Y; Zhang, XJ; Wei, JK; Sun, XQ; Yuan, JB; Li, FH; Xiang, JH				Gao, Yi; Zhang, Xiaojun; Wei, Jiankai; Sun, Xiaoqing; Yuan, Jianbo; Li, Fuhua; Xiang, Jianhai			Whole Transcriptome Analysis Provides Insights into Molecular Mechanisms for Molting in Litopenaeus vannamei	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; DE-NOVO TRANSCRIPTOME; INHIBITING HORMONE; ANTILIPOPOLYSACCHARIDE FACTOR; RNA-SEQ; PORTUNUS-TRITUBERCULATUS; CHERAX-QUADRICARINATUS; SWIMMING CRAB; WHITE SHRIMP; CYCLE	Molting is one of the most important biological processes in shrimp growth and development. All shrimp undergo cyclic molting periodically to shed and replace their exoskeletons. This process is essential for growth, metamorphosis, and reproduction in shrimp. However, the molecular mechanisms underlying shrimp molting remain poorly understood. In this study, we investigated global expression changes in the transcriptomes of the Pacific white shrimp, Litopenaeus vannamei, the most commonly cultured shrimp species worldwide. The transcriptome of whole L. vannamei was investigated by RNA-sequencing (RNA-seq) throughout the molting cycle, including the inter-molt (C), pre-molt (D0, D1, D2, D3, D4), and post-molt (P1 and P2) stages, and 93,756 unigenes were identified. Among these genes, we identified 5,117 genes differentially expressed (log(2)ratio >= 1 and FDR <= 0.001) in adjacent molt stages. The results were compared against the National Center for Biotechnology Information (NCBI) non-redundant protein/nucleotide sequence database, SwissProt, PFAM database, the Gene Ontology database, and the Kyoto Encyclopedia of Genes and Genomes database in order to annotate gene descriptions, associate them with gene ontology terms, and assign them to pathways. The expression patterns for genes involved in several molecular events critical for molting, such as hormone regulation, triggering events, implementation phases, skelemin, immune responses were characterized and considered as mechanisms underlying molting in L. vannamei. Comparisons with transcriptomic analyses in other arthropods were also performed. The characterization of major transcriptional changes in genes involved in the molting cycle provides candidates for future investigation of the molecular mechanisms. The data generated in this study will serve as an important transcriptomic resource for the shrimp research community to facilitate gene and genome annotation and to characterize key molecular processes underlying shrimp development.	[Gao, Yi; Zhang, Xiaojun; Wei, Jiankai; Sun, Xiaoqing; Yuan, Jianbo; Li, Fuhua; Xiang, Jianhai] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Wei, Jiankai; Sun, Xiaoqing] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xiang, JH (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	jhxiang@qdio.ac.cn	zhang, jin/GXV-9154-2022		Major State Basic Research Development Program of China (973 program) [2012CB114403]; National Natural Science Foundation of China [31172396, 41376165]	Major State Basic Research Development Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Major State Basic Research Development Program of China (973 program) (2012CB114403) and National Natural Science Foundation of China (31172396, 41376165).	Abehsera S, 2015, PLOS ONE, V10; Aiken D.E., 1980, P91; Bliss DE, 2012, INTEGUMENT PIGMENTS, V9, P44; BORST DW, 1987, INSECT BIOCHEM, V17, P1123, DOI 10.1016/0020-1790(87)90133-8; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; BURTIS KC, 1990, CELL, V61, P85, DOI 10.1016/0092-8674(90)90217-3; Ceccaldi H.J., 1990, IFREMER Actes de Colloques, P243; CHANG ES, 1993, ANNU REV ENTOMOL, V38, P161, DOI 10.1146/annurev.en.38.010193.001113; Chen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131503; Cheng WT, 2002, AQUACULTURE, V211, P325, DOI 10.1016/S0044-8486(01)00768-2; Christie AE, 2014, GEN COMP ENDOCR, V206, P96, DOI 10.1016/j.ygcen.2014.07.010; Chung JS, 2003, EUR J BIOCHEM, V270, P3280, DOI 10.1046/j.1432-1033.2003.03720.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corteel M, 2012, AQUACULT INT, V20, P13, DOI 10.1007/s10499-011-9437-9; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Devisetty UK, 2014, G3 GENES GENOMICS GE, V4; Diwan A. D., 2005, Indian Journal of Experimental Biology, V43, P209; Durica DS, 2014, GEN COMP ENDOCR, V206, P80, DOI 10.1016/j.ygcen.2014.05.034; Durica DS, 2002, MOL CELL ENDOCRINOL, V189, P59, DOI 10.1016/S0303-7207(01)00740-7; Feng CM, 2008, AQUAC RES, V39, P1639, DOI 10.1111/j.1365-2109.2008.02037.x; Fischbarg J, 1997, SCIENCE, V275, P1491; Ghaffari N, 2014, SCI REP-UK, V4, DOI 10.1038/srep07081; GOECKELER ZM, 1995, J CELL BIOL, V130, P613, DOI 10.1083/jcb.130.3.613; Guo B, 2011, AQUACULTURE, V314, P210, DOI 10.1016/j.aquaculture.2011.02.023; Hancock REW, 2006, IMMUNOBIOLOGY, V211, P315, DOI 10.1016/j.imbio.2005.10.017; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Hooper SL, 2005, PHYSIOL REV, V85, P1001, DOI 10.1152/physrev.00019.2004; Hou CQ, 2011, AQUAC RES, V42, P1453, DOI 10.1111/j.1365-2109.2010.02737.x; Hudson NJ, 2002, J EXP BIOL, V205, P2297; Jiang HS, 2014, DEV COMP IMMUNOL, V48, P33; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kiran RBP, 2002, J FISH DIS, V25, P201, DOI 10.1046/j.1365-2761.2002.00357.x; Klein B, 1996, INT J BIOCHEM CELL B, V28, P551, DOI 10.1016/1357-2725(95)00169-7; Koenders A, 2002, J EXP ZOOL, V292, P618, DOI 10.1002/jez.10081; Kuballa AV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-147; Kuballa AV, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-575; LACHAISE F, 1993, J CRUSTACEAN BIOL, V13, P198, DOI 10.2307/1548970; Lee KJ, 1998, BIOCHEM BIOPH RES CO, V249, P624, DOI 10.1006/bbrc.1998.9215; Lehman W, 2000, J MOL BIOL, V302, P593, DOI 10.1006/jmbi.2000.4080; Leslie T, 2014, G3 GENS GENOMICS GEN, V4; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li FH, 2013, FISH SHELLFISH IMMUN, V34, P973, DOI 10.1016/j.fsi.2012.08.023; Li FH, 2013, DEV COMP IMMUNOL, V39, P11, DOI 10.1016/j.dci.2012.03.016; Li SH, 2014, DEV COMP IMMUNOL, V46, P349, DOI 10.1016/j.dci.2014.05.013; Li ZX, 2013, J WORLD AQUACULT SOC, V44, P826, DOI 10.1111/jwas.12083; Liang JB, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-173; Liao IC, 2011, INVAD NAT SPRING SER, V6, P489, DOI 10.1007/978-94-007-0591-3_17; Liu CH, 2004, FISH SHELLFISH IMMUN, V16, P151, DOI 10.1016/S1050-4648(03)00058-5; Liu N, 2015, DEV COMP IMMUNOL, V49, P313, DOI 10.1016/j.dci.2014.11.021; Liu Y, 2013, FISH SHELLFISH IMMUN, V34, P463, DOI 10.1016/j.fsi.2012.11.050; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margam VM, 2006, J INSECT PHYSIOL, V52, P558, DOI 10.1016/j.jinsphys.2006.02.003; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Mindnich R, 2004, MOL CELL ENDOCRINOL, V218, P7, DOI 10.1016/j.mce.2003.12.006; Soares MPM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-576; Mohd-Shamsudin MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060839; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muhlia-Almazan A, 2003, DIGESTION PHYSL PROT, P77; Nagaraju GPC, 2007, AQUACULTURE, V272, P39, DOI 10.1016/j.aquaculture.2007.05.014; Nakatsuji T, 2000, ZOOL SCI, V17, P1129, DOI 10.2108/zsj.17.1129; NAYA Y, 1989, P NATL ACAD SCI USA, V86, P6826, DOI 10.1073/pnas.86.17.6826; Naylor E, 1957, BIOL CRUSTACEA; Ohira T, 1997, ZOOL SCI, V14, P785, DOI 10.2108/zsj.14.785; Ote M, 2005, COMP BIOCHEM PHYS B, V141, P314, DOI 10.1016/j.cbpc.2005.04.005; Pamuru RR, 2012, GEN COMP ENDOCR, V178, P227, DOI 10.1016/j.ygcen.2012.05.007; Powell D, 2015, MAR GENOM, V22, P71, DOI 10.1016/j.margen.2015.04.006; Priya TAJ, 2010, COMP BIOCHEM PHYS B, V156, P149, DOI 10.1016/j.cbpb.2010.02.004; Priya TAJ, 2009, COMP BIOCHEM PHYS B, V153, P121, DOI 10.1016/j.cbpb.2009.02.009; Qian ZY, 2014, COMP BIOCHEM PHYS A, V172, P10, DOI 10.1016/j.cbpa.2014.02.011; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Reynolds SE, 1996, ADV INSECT PHYSIOL, V26, P157, DOI 10.1016/S0065-2806(08)60031-4; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sangsuriya P, 2014, FISH SHELLFISH IMMUN, V37, P46, DOI 10.1016/j.fsi.2014.01.007; Santos CA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00298; Sathapondecha P, 2014, COMP BIOCHEM PHYS A, V175, P124, DOI 10.1016/j.cbpa.2014.06.001; SCHAFER DA, 1994, J CELL BIOL, V126, P403, DOI 10.1083/jcb.126.2.403; Seear PJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-582; Shechter A, 2005, BIOL REPROD, V73, P72, DOI 10.1095/biolreprod.104.038554; Shen WY, 2015, GENES GENOM, V37, P441, DOI 10.1007/s13258-015-0273-6; Skinner DM, 1985, MOLTING REGENERATION, P43; Uddowla MH, 2013, ANIM CELLS SYST, V17, P203, DOI 10.1080/19768354.2013.799100; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2003, J GENET GENOMICS, V30; Wang Z, 2001, OCEANOLOGIA LIMNOLOG, V33, P432; Wang Z, 2001, J FISHERIES CHINA, V26, P487; Wei JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106201; Wu WJ, 2008, EXP PARASITOL, V119, P313, DOI 10.1016/j.exppara.2008.03.001; Yang WJ, 1996, PEPTIDES, V17, P197, DOI 10.1016/0196-9781(95)02122-1; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yudkovski Y, 2007, INSECT MOL BIOL, V16, P661, DOI 10.1111/j.1365-2583.2007.00762.x; Zhang Peidong, 2006, Yingyong Shengtai Xuebao, V17, P340; Zhang Y, 2010, DEV COMP IMMUNOL, V34, P945, DOI 10.1016/j.dci.2010.04.002; Zhang YJ, 2014, G3-GENES GENOM GENET, V4, P851, DOI 10.1534/g3.113.009779	93	56	61	7	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144350	10.1371/journal.pone.0144350	http://dx.doi.org/10.1371/journal.pone.0144350			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650402	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903300044
J	Liu, L; Yang, YL; Wang, ZY; Wu, H; Wang, Y; Wang, L				Liu, Li; Yang, Yi-Long; Wang, Zi-Yue; Wu, Hui; Wang, Yang; Wang, Lie			Prevalence and Positive Correlates of Posttraumatic Stress Disorder Symptoms among Chinese Patients with Hematological Malignancies: A Cross-Sectional Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; BONE-MARROW-TRANSPLANTATION; BREAST-CANCER PATIENTS; NON-HODGKINS-LYMPHOMA; SOCIAL SUPPORT; GENDER-DIFFERENCES; CIVILIAN VERSION; PTSD CHECKLIST; SELF-EFFICACY; SURVIVORS	Purpose Positive psychological constructs have been given increasing attention in research on the coping resources of cancer-related distresses. However, little research is available on post-traumatic stress disorder (PTSD) in patients with hematological malignancies. The purposes of this study were to assess the prevalence of PTSD symptoms and to explore the associations of perceived social support (PSS), hope, optimism and resilience with PTSD symptoms among Chinese patients with hematological malignancies. Methods A cross-sectional study was conducted during the period from July 2013 through April 2014. A total of 225 inpatients with hematological malignancies, which were eligible for the study, completed the Post-traumatic Stress Checklist-Civilian Version, Multidimensional Scale of Perceived Social Support, Adult Hope Scale, Life Orientation Scale-Revised, and Resilience Scale. Hierarchical regression analysis was performed to explore the correlates of PTSD symptoms. Results Overall, the prevalence of PTSD symptoms was 10.7%. Initially, PSS was negatively associated with PTSD symptoms (beta = -0.248, P < 0.01). However, when positive psychological variables were added, optimism was negatively associated with PTSD symptoms (beta = -0.452, P < 0.01), and gender had a significant effect on PTSD symptoms. Women were more vulnerable to these symptoms than men (beta = 0.123, P < 0.05). When the analysis was performed separately by gender, only optimism showed a significantly negative association with PTSD symptoms in both men (beta = -0.389, P < 0.01) and women (beta = -0.493, P < 0.01). Conclusions Some patients with hematological malignancies suffer from PTSD symptoms. The positive effects of PSS and optimism on PTSD symptoms suggest that an integrated approach to psychosocial intervention from both external and internal perspectives could have practical significance. Gender difference should be considered in developing potential interventions in reducing cancer-related PTSD symptoms.	[Liu, Li; Yang, Yi-Long; Wang, Zi-Yue; Wu, Hui; Wang, Yang; Wang, Lie] China Med Univ, Dept Social Med, Sch Publ Hlth, Shenyang 110001, Liaoning, Peoples R China	China Medical University	Wang, L (corresponding author), China Med Univ, Dept Social Med, Sch Publ Hlth, Shenyang 110001, Liaoning, Peoples R China.	liewang@mail.cmu.edu.cn						Abbey G, 2015, PSYCHO-ONCOLOGY, V24, P371, DOI 10.1002/pon.3654; American Psychiatric Association, 1994, DIAGNOSTIC AND STATI; Andreasen Nancy C, 2011, Dialogues Clin Neurosci, V13, P240; Andrykowski MA, 2000, PSYCHO-ONCOLOGY, V9, P69; Andrykowski MA, 1998, J CONSULT CLIN PSYCH, V66, P586, DOI 10.1037/0022-006X.66.3.586; Bendall LJ, 2010, CURR DRUG TARGETS, V11, P767; Black EK, 2005, PSYCHO-ONCOL, V14, P510, DOI 10.1002/pon.894; Bonanno GA, 2007, J CONSULT CLIN PSYCH, V75, P671, DOI 10.1037/0022-006X.75.5.671; Carver CS, 2014, TRENDS COGN SCI, V18, P293, DOI 10.1016/j.tics.2014.02.003; Casellas-Grau A, 2014, PSYCHO-ONCOLOGY, V23, P9, DOI 10.1002/pon.3353; Charuvastra A, 2008, ANNU REV PSYCHOL, V59, P301, DOI 10.1146/annurev.psych.58.110405.085650; [陈露露 Chen Lulu], 2012, [第三军医大学学报, Journal of Third Military Medical University], V34, P1097; Clarke SA, 2006, CANCER NURS, V29, P66, DOI 10.1097/00002820-200601000-00012; Cordova MJ, 2007, J CLIN PSYCHOL MED S, V14, P308, DOI 10.1007/s10880-007-9083-6; CORDOVA MJ, 1995, J CONSULT CLIN PSYCH, V63, P981, DOI 10.1037/0022-006X.63.6.981; Cordova MJ, 2000, J TRAUMA STRESS, V13, P301, DOI 10.1023/A:1007762812848; Else-Quest NM, 2012, PSYCHOL BULL, V138, P947, DOI 10.1037/a0027930; Freedman SA, 2002, J TRAUMA STRESS, V15, P407, DOI 10.1023/A:1020189425935; Geffen DB, 2003, LEUKEMIA LYMPHOMA, V44, P1925, DOI 10.1080/1042819031000123573; Gottlieb BH, 2010, J PSYCHOSOM RES, V69, P511, DOI 10.1016/j.jpsychores.2009.10.001; Hahn EE, 2015, PSYCHO-ONCOLOGY, V24, P643, DOI 10.1002/pon.3623; Hirsch JK, 2006, SUICIDE LIFE-THREAT, V36, P661, DOI 10.1521/suli.2006.36.6.661; Ho S, 2011, ORAL ONCOL, V47, P121, DOI 10.1016/j.oraloncology.2010.11.015; Hou WL, 2014, AIDS CARE, V26, P996, DOI 10.1080/09540121.2013.873764; Jacobsen PB, 1998, PSYCHOSOM MED, V60, P366, DOI 10.1097/00006842-199805000-00026; Jacobsen PB, 2002, J CONSULT CLIN PSYCH, V70, P235, DOI 10.1037//0022-006X.70.1.235; Kornblith AB, 2003, CANCER-AM CANCER SOC, V98, P679, DOI 10.1002/cncr.11531; Kornblith AB, 2007, PSYCHO-ONCOLOGY, V16, P895, DOI 10.1002/pon.1146; Lai JCL, 1998, INT J PSYCHOL, V33, P45, DOI 10.1080/002075998400600; Lee V, 2006, SOC SCI MED, V62, P3133, DOI 10.1016/j.socscimed.2005.11.041; Magaletta PR, 1999, J CLIN PSYCHOL, V55, P539, DOI 10.1002/(SICI)1097-4679(199905)55:5<539::AID-JCLP2>3.3.CO;2-7; Mehnert A, 2007, PSYCHO-ONCOLOGY, V16, P181, DOI 10.1002/pon.1057; Morrill EF, 2008, PSYCHO-ONCOLOGY, V17, P948, DOI 10.1002/pon.1313; Norberg AL, 2006, PSYCHO-ONCOLOGY, V15, P335, DOI 10.1002/pon.960; Ong AD, 2006, PERS INDIV DIFFER, V41, P1263, DOI 10.1016/j.paid.2006.03.028; Oniszczenko W, 2014, ARCH MED SCI, V10, P110, DOI 10.5114/aoms.2013.33069; Perez S, 2014, J TRAUMA STRESS, V27, P224, DOI 10.1002/jts.21901; Pratchett LC, 2010, PSYCHIAT CLIN N AM, V33, P465, DOI 10.1016/j.psc.2010.01.010; Rajandram Rama K, 2011, BMC Res Notes, V4, P519, DOI 10.1186/1756-0500-4-519; Rodin G, 2013, PSYCHO-ONCOLOGY, V22, P299, DOI 10.1002/pon.2092; Rourke MT, 2007, PEDIATR BLOOD CANCER, V49, P177, DOI 10.1002/pbc.20942; Rustad JK, 2012, PALLIAT SUPPORT CARE, V10, P213, DOI 10.1017/S1478951511000897; Santos FRM, 2006, J PSYCHOSOM RES, V60, P505, DOI 10.1016/j.jpsychores.2005.08.017; SCHEIER MF, 1985, HEALTH PSYCHOL, V4, P219, DOI 10.1037/0278-6133.4.3.219; Sharpley CF, 2014, EUR J CANCER CARE, V23, P545, DOI 10.1111/ecc.12170; Shelby RA, 2005, J TRAUMA STRESS, V18, P347, DOI 10.1002/jts.20033; Shu XL, 2012, SOC SCI RES, V41, P1100, DOI 10.1016/j.ssresearch.2012.05.004; Smith SK, 2008, J CLIN ONCOL, V26, P934, DOI 10.1200/JCO.2007.12.3414; SNYDER CR, 1991, J PERS SOC PSYCHOL, V60, P570, DOI 10.1037/0022-3514.60.4.570; Snyder CR, 2002, PSYCHOL INQ, V13, P249, DOI 10.1207/S15327965PLI1304_01; Tian J, 2013, SUPPORT CARE CANCER, V21, P1497, DOI 10.1007/s00520-012-1699-x; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; Trunzo JJ, 2003, J CONSULT CLIN PSYCH, V71, P805, DOI 10.1037/0022-006X.71.4.805; Varela VS, 2013, PSYCHO-ONCOLOGY, V22, P434, DOI 10.1002/pon.2109; Wagnild G., 2009, RESILIENCE SCALE USE; Wang Q., 2013, MED INFORM, V26, P62; Wang YP, 2015, PSYCHO-ONCOLOGY, V24, P533, DOI 10.1002/pon.3685; Weathers F. W., 1993, ANN M INT SOC TRAUM, DOI [10.1037/t02622-000, DOI 10.1037/T02622-000]; Widows MR, 2000, PSYCHOSOM MED, V62, P873, DOI 10.1097/00006842-200011000-00018; Wu G, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00010; Xiao YC, 2012, ASIA PAC J HUM RESOU, V50, P6, DOI 10.1111/j.1744-7941.2011.00005.x; Yang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094804; Zenger M, 2010, PSYCHO-ONCOLOGY, V19, P879, DOI 10.1002/pon.1635; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	64	24	27	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145103	10.1371/journal.pone.0145103	http://dx.doi.org/10.1371/journal.pone.0145103			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9HZ	26669841	Green Published, gold, Green Submitted			2022-12-27	WOS:000366719300046
J	Baeta, M; Nunez, C; Cardoso, S; Palencia-Madrid, L; Pineiro-Hermida, S; Arriba-Barredo, M; Villanueva-Millan, MJ; de Pancorbo, MM				Baeta, Miriam; Nunez, Carolina; Cardoso, Sergio; Palencia-Madrid, Leire; Pineiro-Hermida, Sergio; Arriba-Barredo, Miren; Jesus Villanueva-Millan, Maria; de Pancorbo, Marian M.			Different Evolutionary History for Basque Diaspora Populations in USA and Argentina Unveiled by Mitochondrial DNA Analysis	PLOS ONE			English	Article							CONTROL REGION; MTDNA; DIVERSITY; ADMIXTURE	The Basque Diaspora in Western USA and Argentina represents two populations which have maintained strong Basque cultural and social roots in a completely different geographic context. Hence, they provide an exceptional opportunity to study the maternal genetic legacy from the ancestral Basque population and assess the degree of genetic introgression from the host populations in two of the largest Basque communities outside the Basque Country. For this purpose, we analyzed the complete mitochondrial DNA control region of Basque descendants living in Western USA (n = 175) and in Argentina (n = 194). The Diaspora populations studied here displayed a genetic diversity in their European maternal input which was similar to that of the Basque source populations, indicating that not important founder effects would have occurred. Actually, the genetic legacy of the Basque population still prevailed in their present-day maternal pools, by means of a haplogroup distribution similar to the source population characterized by the presence of autochthonous Basque lineages, such as U5b1f1a and J1c5c1. However, introgression of non-Basque lineages, mostly Native American, has been observed in the Diaspora populations, particularly in Argentina, where the quick assimilation of the newcomers would have favored a wider admixture with host populations. In contrast, a longer isolation of the Diaspora groups in USA, because of language and cultural differences, would have limited the introgression of local lineages. This study reveals important differences in the maternal evolutionary histories of these Basque Diaspora populations, which have to be taken into consideration in forensic and medical genetic studies.	[Baeta, Miriam; Nunez, Carolina; Cardoso, Sergio; Palencia-Madrid, Leire; Pineiro-Hermida, Sergio; Arriba-Barredo, Miren; Jesus Villanueva-Millan, Maria; de Pancorbo, Marian M.] Univ Pais Vasco UPV EHU, BIOMICs Res Grp, Ctr Invest Lascaray Ikergunea, Vitoria, Spain	University of Basque Country	de Pancorbo, MM (corresponding author), Univ Pais Vasco UPV EHU, BIOMICs Res Grp, Ctr Invest Lascaray Ikergunea, Vitoria, Spain.	marian.mdepancorbo@ehu.es	Palencia-Madrid, Leire/AAW-8145-2020; Bafalluy, Miriam Baeta/L-6686-2014	Palencia-Madrid, Leire/0000-0002-4351-3450; Bafalluy, Miriam Baeta/0000-0002-6869-1413; Nunez, Carolina/0000-0001-5643-3970; Pineiro Hermida, Sergio/0000-0002-8915-5687; MARTINEZ DE PANCORBO, MARIA DE LOS ANGELES/0000-0002-7408-6068; M. de Pancorbo, Marian/0000-0002-8081-0702	Basque Government [IT833-13]; Basque Government (Dpto. de Educacion, Universidades e Investigacion)	Basque Government(Basque Government); Basque Government (Dpto. de Educacion, Universidades e Investigacion)(Basque Government)	Funds were provided by the Basque Government (Grupo Consolidado IT833-13). Leire Palencia-Madrid is a Ph.D. student granted by the Basque Government (Dpto. de Educacion, Universidades e Investigacion).	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Alfonso-Sanchez MA, 2008, AM J HUM BIOL, V20, P154, DOI 10.1002/ajhb.20706; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Behar DM, 2012, AM J HUM GENET, V90, P486, DOI 10.1016/j.ajhg.2012.01.002; Cardoso S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067835; Cardoso S, 2013, FORENSIC SCI INT-GEN, V7, pE52, DOI 10.1016/j.fsigen.2013.01.007; Cardoso S, 2012, FORENSIC SCI INT-GEN, V6, pE106, DOI 10.1016/j.fsigen.2011.12.007; Cardoso S, 2011, AM J PHYS ANTHROPOL, V145, P480, DOI 10.1002/ajpa.21532; Cardoso S, 2010, J FORENSIC SCI, V55, P1196, DOI 10.1111/j.1556-4029.2010.01440.x; Catelli ML, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-77; Chiang CWK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000866; Davis MC, 2011, AM J PHYS ANTHROPOL, V144, P516, DOI 10.1002/ajpa.21432; de Pancorbo MM, 2001, HUM GENET, V109, P224, DOI 10.1007/s004390100544; Diegoli TM, 2009, FORENSIC SCI INT-GEN, V4, pE45, DOI 10.1016/j.fsigen.2009.04.010; Douglass W., 2007, BASQUE CULTURE ANTHR; Douglass WA, 2013, BOGA BASQUE STUDIES, V1, DOI DOI 10.18122/B2D13T; Dubut V, 2004, EUR J HUM GENET, V12, P293, DOI 10.1038/sj.ejhg.5201145; Echeverria Jeromina, 1999, HOME AWAY HOME HIST; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gomez-Carballa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032851; Gonzalez AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-124; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Illescas MJ, 2011, FORENS SCI INT-GEN S, V3, pE441, DOI 10.1016/j.fsigss.2011.09.082; Just RS, 2008, FORENSIC SCI INT-GEN, V2, pE45, DOI [10.1016/j.fsigen.2007.12.001, 10.1016/j.fsigen.2007.11.004]; Kaestle FA, 2006, AM CRIM LAW REV, V43, P53; Kivisild T, 2015, INVESTIG GENET, V6, DOI 10.1186/s13323-015-0022-2; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lasagabaster D, 2008, J MULTILING MULTICUL, V29, P66, DOI 10.2167/jmmd567.0; Martinez-Cruz B, 2012, MOL BIOL EVOL, V29, P2211, DOI 10.1093/molbev/mss091; Nunez C, 2010, AM J PHYS ANTHROPOL, V143, P591, DOI 10.1002/ajpa.21355; Pereira L, 2005, GENOME RES, V15, P19, DOI 10.1101/gr.3182305; Perez-Miranda AM, 2005, J HUM GENET, V50, P403, DOI 10.1007/s10038-005-0268-2; Richard C, 2007, ANN HUM BIOL, V34, P68, DOI 10.1080/03014460601076098; Rodas C, 2003, HUM BIOL, V75, P13, DOI 10.1353/hub.2003.0026; Sans M, 2011, HUM BIOL, V83, P55, DOI 10.3378/027.083.0104; Silva M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12526; Soares P, 2012, MOL BIOL EVOL, V29, P915, DOI 10.1093/molbev/msr245; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Totoricaguena G, 2005, BASQUE TEXTB SER, P1; Valverde L, 2012, INT J LEGAL MED, V126, P293, DOI 10.1007/s00414-011-0644-8; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Yoldi P, 2011, EUSKARA, P24; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551	44	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144919	10.1371/journal.pone.0144919	http://dx.doi.org/10.1371/journal.pone.0144919			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659590	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900149
J	Curtis, LT; Wu, M; Lowengrub, J; Decuzzi, P; Frieboes, HB				Curtis, Louis T.; Wu, Min; Lowengrub, John; Decuzzi, Paolo; Frieboes, Hermann B.			Computational Modeling of Tumor Response to Drug Release from Vasculature-Bound Nanoparticles	PLOS ONE			English	Article							MACROMOLECULAR THERAPEUTICS; INTERSTITIAL PRESSURE; PLGA NANOPARTICLES; CANCER-THERAPY; SOLID TUMORS; DELIVERY; ADHESION; SYSTEMS; NANOMEDICINE; ANGIOGENESIS	Systemically injected nanoparticle (NPs) targeting tumor vasculature offer a venue for anti-angiogenic therapies as well as cancer detection and imaging. Clinical application has been limited, however, due to the challenge of elucidating the complex interplay of nanotechnology, drug, and tumor parameters. A critical factor representing the likelihood of endothelial adhesion is the NP vascular affinity, a function of vascular receptor expression and NP size and surface-bound ligand density. We propose a theoretical framework to simulate the tumor response to vasculature-bound drug-loaded NPs and examine the interplay between NP distribution and accumulation as a function of NP vascular affinity, size, and drug loading and release characteristics. The results show that uniform spatial distribution coupled with high vascular affinity is achievable for smaller NPs but not for larger sizes. Consequently, small (100 nm) NPs with high vascular affinity are predicted to be more effective than larger (1000 nm) NPs with similar affinity, even though small NPs have lower drug loading and local drug release compared to the larger NPs. Medium vascular affinity coupled with medium or larger sized NPs is also effective due to a more uniform distribution with higher drug loading and release. Low vascular affinity hampered treatment efficacy regardless of NP size, with larger NPs additionally impeded by heterogeneous distribution and drug release. The results further show that increased drug diffusivity mainly benefits heterogeneously distributed NPs, and would negatively affect efficacy otherwise due to increased wash-out. This model system enables evaluation of efficacy for vascular-targeted drug-loaded NPs as a function of critical NP, drug, and tumor parameters.	[Curtis, Louis T.; Frieboes, Hermann B.] Univ Louisville, Dept Bioengn, Louisville, KY 40292 USA; [Wu, Min] Northwestern Univ, Dept Engn Sci & Appl Math, Chicago, IL 60611 USA; [Lowengrub, John] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA; [Lowengrub, John] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Lowengrub, John] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA USA; [Decuzzi, Paolo] Houston Methodist Res Inst, Dept Translat Imaging, Houston, TX USA; [Decuzzi, Paolo] Houston Methodist Res Inst, Dept Nanomed, Houston, TX USA; [Frieboes, Hermann B.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA	University of Louisville; Northwestern University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; University of Louisville	Frieboes, HB (corresponding author), Univ Louisville, Dept Bioengn, Louisville, KY 40292 USA.	hbfrie01@louisville.edu	Decuzzi, Paolo/F-1899-2016	Decuzzi, Paolo/0000-0001-6050-4188; Wu, Min/0000-0003-4728-6475	NIH/NCI [U54CA143907, U54CA143837]; NIH-ICBP [U54CA151668]; NIH [P50-GM76516, P30-CA062203]; National Science Foundation, Division of Mathematics; NATIONAL CANCER INSTITUTE [U54CA143837, P30CA062203, U54CA151668, U54CA143907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH-ICBP; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation, Division of Mathematics(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HF acknowledges funding by NIH/NCI U54CA143907. PD acknowledges funding by NIH/NCI U54CA143837 and NIH-ICBP U54CA151668. JL acknowledges NIH P50-GM76516 for a Center of Excellence in Systems Biology at the University of California, Irvine, and P30-CA062203 for the Chao Comprehensive Cancer Center at the University of California, Irvine. JL also acknowledges partial support from the National Science Foundation, Division of Mathematics.	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; AUERBACH R, 1991, INT J RADIAT BIOL, V60, P1, DOI 10.1080/09553009114551401; Boso DP, 2011, INT J NANOMED, V6, P1517, DOI 10.2147/IJN.S20283; Caputo KE, 2005, BIOPHYS J, V89, P187, DOI 10.1529/biophysj.104.054171; Curtis LT, 2015, NANOMEDICINE UK IN P; Decuzzi P, 2006, BIOMATERIALS, V27, P5307, DOI 10.1016/j.biomaterials.2006.05.024; Decuzzi P, 2010, J CONTROL RELEASE, V141, P320, DOI 10.1016/j.jconrel.2009.10.014; Decuzzi P, 2009, PHARM RES-DORD, V26, P235, DOI 10.1007/s11095-008-9697-x; Drummond DC, 1999, PHARMACOL REV, V51, P691; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Frieboes HB, 2006, BIOMEMS BIOMEDICAL N, P435, DOI DOI 10.1007/978-0-387-25842-3_15; Frieboes HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056876; Gao Y, 2013, AAPS J, V15, P816, DOI 10.1208/s12248-013-9478-2; Godin B, 2010, ADV GENET, V69, P31, DOI 10.1016/S0065-2660(10)69009-8; Haun JB, 2008, LANGMUIR, V24, P8821, DOI 10.1021/la8005844; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; JAIN RK, 1990, CANCER RES, V50, pS814; Kaddi CD, 2013, NANOMEDICINE-UK, V8, P1323, DOI [10.2217/NNM.13.117, 10.2217/nnm.13.117]; Lee SY, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/49/495101; Li MG, 2013, DRUG DELIV TRANSL RE, V3, P551, DOI 10.1007/s13346-013-0162-y; Li MG, 2012, INT J NANOMED, V7, P1345, DOI 10.2147/IJN.S23758; Lu MG, 2010, ACS NANO, V4, P6303, DOI 10.1021/nn1018818; Macklin P, 2009, J MATH BIOL, V58, P765, DOI 10.1007/s00285-008-0216-9; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; MATSUMURA Y, 1986, CANCER RES, V46, P6387; McDougall SR, 2006, J THEOR BIOL, V241, P564, DOI 10.1016/j.jtbi.2005.12.022; Mingguang Li, 2011, International Journal of Nano and Biomaterials, V3, P222, DOI 10.1504/IJNBM.2011.042131; Murphy EA, 2008, P NATL ACAD SCI USA, V105, P9343, DOI 10.1073/pnas.0803728105; Patil VRS, 2001, BIOPHYS J, V80, P1733, DOI 10.1016/S0006-3495(01)76144-9; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Reddy GR, 2006, CLIN CANCER RES, V12, P6677, DOI 10.1158/1078-0432.CCR-06-0946; Sergeeva A, 2006, ADV DRUG DELIVER REV, V58, P1622, DOI 10.1016/j.addr.2006.09.018; Tan JF, 2013, MICROFLUID NANOFLUID, V14, P77, DOI 10.1007/s10404-012-1024-5; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; van de Ven AL, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/5/055004; van de Ven AL, 2012, AIP ADV, V2, DOI 10.1063/1.3699060; Wu M, 2014, J THEOR BIOL, V355, P194, DOI 10.1016/j.jtbi.2014.04.012; Wu M, 2013, J THEOR BIOL, V320, P131, DOI 10.1016/j.jtbi.2012.11.031; Zern BJ, 2013, ACS NANO, V7, P2461, DOI 10.1021/nn305773f	40	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144888	10.1371/journal.pone.0144888	http://dx.doi.org/10.1371/journal.pone.0144888			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660469	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900135
J	Dietz, PM; Van Handel, M; Wang, HS; Peters, PJ; Zhang, J; Viall, A; Branson, BM				Dietz, Patricia M.; Van Handel, Michelle; Wang, Huisheng; Peters, Philip J.; Zhang, Jun; Viall, Abigail; Branson, Bernard M.			HIV Testing among Outpatients with Medicaid and Commercial Insurance	PLOS ONE			English	Article							SELF-REPORT	Objective To assess HIV testing and factors associated with receipt of testing among persons with Medicaid and commercial insurance during 2012. Methods Outpatient and laboratory claims were analyzed from two databases: all Medicaid claims from six states and all claims from Medicaid health plans from four other states and a large national convenience sample of patients with commercial insurance in the United States. We excluded those aged < 13 years and > 64 years, enrolled < 9 of the 12 months, pregnant females, and previously diagnosed with HIV. We identified patients with new HIV diagnoses that followed (did not precede) the HIV test, using HIV ICD-9 codes. HIV testing percentages were assessed by patient demographics and other tests or diagnoses that occurred during the same visit. Results During 2012, 89,242 of 2,069,536 patients (4.3%) with Medicaid had at least one HIV test, and 850 (1.0%) of those tested received a new HIV diagnosis. Among 27,206,804 patients with commercial insurance, 757,646 (2.8%) had at least one HIV test, and 5,884 (0.8%) of those tested received a new HIV diagnosis. During visits that included an HIV test, 80.2% of Medicaid and 83.0% of commercial insurance claims also included a test or diagnosis for a sexually transmitted infection (STI), and/or Hepatitis B or C virus at the same visit. Conclusions HIV testing primarily took place concurrently with screening or diagnoses for STIs or Hepatitis B or C. We found little evidence to suggest routine screening for HIV infection was widespread.	[Dietz, Patricia M.; Van Handel, Michelle; Wang, Huisheng; Peters, Philip J.; Zhang, Jun; Viall, Abigail; Branson, Bernard M.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Dietz, PM (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA.	pad8@cdc.gov						[Anonymous], 2006, MMWR MORB MORTAL WKL; [Anonymous], 2015, FIN UPD SUMM HUM IMM; Arya Monisha, 2014, J Int Assoc Provid AIDS Care, V13, P296, DOI 10.1177/2325957413517140; Centers for Disease Control and Prevention, 2013, HIV SURV REP, V25; Centers for Disease Control and Prevention, 2013, HIV TEST TRENDS US 2, P2000; Centers for Disease Control and Prevention, 2015, HIV SURV REP, V20; Chandra A, 2012, NATL HLTH STAT REPOR; Czamogorski M, 2009, AM J PUBLIC HEALTH, V103, pe40, DOI 10.; Huang YLA, 2015, HEALTH AFFAIR, V34, P1657, DOI 10.1377/hlthaff.2015.0249; Lin X, 2014, MMWR-MORBID MORTAL W, V63, P537; Meyers D, 2008, AM FAM PHYSICIAN, V77, P819; Mohajer Mayar Al, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P101, DOI 10.1177/1545109711430165; OCampo P, 1997, J CLIN EPIDEMIOL, V50, P57, DOI 10.1016/S0895-4356(96)00301-0; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; SAS Institute Inc, 2012, SAS VERS 9 3 WIND; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; The Kaiser Family Foundation, QUICK TAK UPD ACA HI; Yudin MH, 2006, J OBSTET GYNAECOL CA, V28, P867, DOI 10.1016/S1701-2163(16)32286-1	18	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144965	10.1371/journal.pone.0144965	http://dx.doi.org/10.1371/journal.pone.0144965			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26661399	Green Published, gold			2022-12-27	WOS:000366715900157
J	Kenmogne, LC; Ayan, D; Roy, J; Maltais, R; Poirier, D				Kenmogne, Lucie Carolle; Ayan, Diana; Roy, Jenny; Maltais, Rene; Poirier, Donald			The Aminosteroid Derivative RM-133 Shows In Vitro and In Vivo Antitumor Activity in Human Ovarian and Pancreatic Cancers	PLOS ONE			English	Article							DRUG-DELIVERY; CHEMICAL-SYNTHESIS; GROWTH; CARBOPLATIN; PACLITAXEL; INHIBITOR; CELLS; DIHYDROARTEMISININ; APOPTOSIS; ANDROGEN	Ovarian and pancreatic cancers are two of the most aggressive and lethal cancers, whose management faces only limited therapeutic options. Typically, these tumors spread insidiously accompanied first with atypical symptoms, and usually shift to a drug resistance phenotype with the current pharmaceutical armamentarium. Thus, the development of new drugs acting via a different mechanism of action represents a clear priority. Herein, we are reporting for the first time that the aminosteroid derivative RM-133, developed in our laboratory, displays promising activity on two models of aggressive cancers, namely ovarian (OVCAR-3) and pancreatic (PANC-1) cancers. The IC50 value of RM-133 was 0.8 mu M and 0.3 mu M for OVCAR-3 and PANC-1 cell lines in culture, respectively. Based on pharmacokinetic studies on RM-133 using 11 different vehicles, we selected two main vehicles: aqueous 0.4% methylcellulose: ethanol (92: 8) and sunflower oil: ethanol (92: 8) for in vivo studies. Using subcutaneous injection of RM-133 with the methylcellulose-based vehicle, growth of PANC-1 tumors xenografted to nude mice was inhibited by 63%. Quite interestingly, RM-133 injected subcutaneously with the methylcellulose-based or sunflower-based vehicles reduced OVCAR-3 xenograft growth by 122% and 100%, respectively. After the end of RM-133 treatment using the methylcellulose-based vehicle, OVCAR-3 tumor growth inhibition was maintained for >= 1 week. RM-133 was also well tolerated in the whole animal, no apparent sign of toxicity having been detected in the xenograft studies.	[Kenmogne, Lucie Carolle; Ayan, Diana; Roy, Jenny; Maltais, Rene; Poirier, Donald] CHU Quebec, Res Ctr, Endocrinol & Nephrol Unit, Med Chem Lab, Quebec City, PQ, Canada; [Kenmogne, Lucie Carolle; Poirier, Donald] Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Poirier, D (corresponding author), CHU Quebec, Res Ctr, Endocrinol & Nephrol Unit, Med Chem Lab, Quebec City, PQ, Canada.	donald.poirier@crchul.ulaval.ca			Canadian Institutes of Health Research (CIHR, POP-I); Quebec Breast Cancer Foundation (QBCF); Societe de valorisation de la recherche at Quebec City (SOVAR); Faculty of Medicine of Universite Laval; Centre de Recherche en Endocrinologie Moleculaire et Oncologique et Genomique Humaine (CREMOGH)	Canadian Institutes of Health Research (CIHR, POP-I)(Canadian Institutes of Health Research (CIHR)); Quebec Breast Cancer Foundation (QBCF); Societe de valorisation de la recherche at Quebec City (SOVAR); Faculty of Medicine of Universite Laval; Centre de Recherche en Endocrinologie Moleculaire et Oncologique et Genomique Humaine (CREMOGH)	This work was funded by Canadian Institutes of Health Research (CIHR, POP-I), Quebec Breast Cancer Foundation (QBCF), Societe de valorisation de la recherche at Quebec City (SOVAR), Faculty of Medicine of Universite Laval, and Centre de Recherche en Endocrinologie Moleculaire et Oncologique et Genomique Humaine (CREMOGH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayan D, 2014, BIOORGAN MED CHEM, V22, P5847, DOI 10.1016/j.bmc.2014.09.026; Banzato A, 2008, CLIN CANCER RES, V14, P3598, DOI 10.1158/1078-0432.CCR-07-2019; Bruell D, 2005, INT J MOL MED, V15, P305; CASTRO CA, 1995, PHARMACOL BIOCHEM BE, V50, P521, DOI 10.1016/0091-3057(94)00331-9; Challa R, 2005, AAPS PHARMSCITECH, V6, DOI 10.1208/pt060243; Chen Huaping, 2011, Frontiers in Genetics, V2, P67, DOI 10.3389/fgene.2011.00067; Chen T, 2009, J CELL MOL MED, V13, P1358, DOI 10.1111/j.1582-4934.2008.00360.x; Colombo PE, 2014, CRIT REV ONCOL HEMAT, V89, P207, DOI 10.1016/j.critrevonc.2013.08.017; Desai KGH, 2008, EUR J PHARM BIOPHARM, V70, P187, DOI 10.1016/j.ejpb.2008.03.007; Du JH, 2010, CANCER CHEMOTH PHARM, V65, P895, DOI 10.1007/s00280-009-1095-5; Gould S, 2005, FOOD CHEM TOXICOL, V43, P1451, DOI 10.1016/j.fct.2005.03.007; HAMILTON TC, 1983, CANCER RES, V43, P5379; Herzog TJ, 2014, GYNECOL ONCOL, V132, P8, DOI 10.1016/j.ygyno.2013.11.008; Huang YH, 2009, P NATL ACAD SCI USA, V106, P3426, DOI 10.1073/pnas.0813348106; Jegham H, 2012, INVEST NEW DRUG, V30, P176, DOI 10.1007/s10637-010-9548-6; Jiao Y, 2007, ACTA PHARMACOL SIN, V28, P1045, DOI 10.1111/j.1745-7254.2007.00612.x; KRAMER CY, 1956, BIOMETRICS, V12, P307, DOI 10.2307/3001469; Kwon Y., 2001, HDB ESSENTIAL PHARMA; Li J, 2009, MOL PHARMACOL, V76, P81, DOI 10.1124/mol.109.054551; MacDonald C, 2010, DRUG DELIV, V17, P434, DOI 10.3109/10717541003777548; Maltais R, 2014, STEROIDS, V82, P68, DOI 10.1016/j.steroids.2014.01.008; Masters GR, 2006, GYNECOL ONCOL, V102, P462, DOI 10.1016/j.ygyno.2005.12.004; Patrick-Iwuanyanwu KC, 2010, EXCLI J, V9, P187; Poveda A, 2014, CANCER TREAT REV, V40, P366, DOI 10.1016/j.ctrv.2013.08.001; Roy J, 2013, MOL CELL ENDOCRINOL, V376, P148, DOI 10.1016/j.mce.2013.06.022; Schmid BC, 2014, MATURITAS, V77, P128, DOI 10.1016/j.maturitas.2013.11.009; Schott, 1965, PHARMACOTOXIC EVALUA; Shaw AY, 2009, J PHARMACOL EXP THER, V331, P636, DOI 10.1124/jpet.109.156406; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Skarda J, 2001, PHYSIOL RES, V50, P275; Statistics CC, 2014, CAN CANC STAT 2014 E; van Zuylen L, 2001, INVEST NEW DRUG, V19, P125, DOI 10.1023/A:1010618632738; Wang Q, 2008, CANCER LETT, V272, P277, DOI 10.1016/j.canlet.2008.07.017; Weinberg BD, 2008, J PHARM SCI-US, V97, P1681, DOI 10.1002/jps.21038; Wistuba J, 2005, J MED PRIMATOL, V34, P178, DOI 10.1111/j.1600-0684.2005.00115.x; Xin B, 2007, CANCER, V110, P791, DOI 10.1002/cncr.22854; Yan C, 2009, MOL PHARMACOL, V76, P163, DOI 10.1124/mol.109.055855; Yu Jun, 2013, Curr Ther Res Clin Exp, V75, P8, DOI 10.1016/j.curtheres.2013.04.001; Zemskov V, 2002, LANGENBECK ARCH SURG, V387, P84, DOI 10.1007/s00423-002-0293-y	39	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144890	10.1371/journal.pone.0144890	http://dx.doi.org/10.1371/journal.pone.0144890			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660672	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900136
J	Osiecki, MJ; Michl, TD; Babur, BK; Kabiri, M; Atkinson, K; Lott, WB; Griesser, HJ; Doran, MR				Osiecki, Michael J.; Michl, Thomas D.; Babur, Betul Kul; Kabiri, Mahboubeh; Atkinson, Kerry; Lott, William B.; Griesser, Hans J.; Doran, Michael R.			Packed Bed Bioreactor for the Isolation and Expansion of Placental-Derived Mesenchymal Stromal Cells	PLOS ONE			English	Article							HUMAN BONE-MARROW; STEM-CELLS; SHEAR-STRESS; PERFUSION BIOREACTOR; OXYGEN-TRANSPORT; CLINICAL-TRIALS; IN-VITRO; CULTURE; SYSTEM; DIFFERENTIATION	Large numbers of Mesenchymal stem/stromal cells (MSCs) are required for clinical relevant doses to treat a number of diseases. To economically manufacture these MSCs, an automated bioreactor system will be required. Herein we describe the development of a scalable closed-system, packed bed bioreactor suitable for large-scale MSCs expansion. The packed bed was formed from fused polystyrene pellets that were air plasma treated to endow them with a surface chemistry similar to traditional tissue culture plastic. The packed bed was encased within a gas permeable shell to decouple the medium nutrient supply and gas exchange. This enabled a significant reduction in medium flow rates, thus reducing shear and even facilitating single pass medium exchange. The system was optimised in a small-scale bioreactor format (160 cm(2)) with murine-derived green fluorescent protein-expressing MSCs, and then scaled-up to a 2800 cm(2) format. We demonstrated that placental derived MSCs could be isolated directly within the bioreactor and subsequently expanded. Our results demonstrate that the closed system large-scale packed bed bioreactor is an effective and scalable tool for large-scale isolation and expansion of MSCs.	[Osiecki, Michael J.; Babur, Betul Kul; Atkinson, Kerry; Lott, William B.; Doran, Michael R.] Queensland Univ Technol, Translat Res Inst, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Osiecki, Michael J.; Lott, William B.] Queensland Univ Technol, Fac Sci & Engn, Sch Chem Phys & Mech Engn, Brisbane, Qld 4001, Australia; [Michl, Thomas D.] Univ S Australia, Ian Wark Res Inst, Adelaide, SA 5001, Australia; [Michl, Thomas D.; Griesser, Hans J.] Univ S Australia, Mawson Inst, Adelaide, SA 5001, Australia; [Kabiri, Mahboubeh] Univ Tehran, Coll Sci, Dept Biotechnol, Tehran, Iran; [Atkinson, Kerry] Univ Queensland, Univ Queensland Ctr Clin Res, Brisbane, Qld, Australia; [Doran, Michael R.] Univ Queensland, Mater Med Res Inst, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of South Australia; University of South Australia; University of Tehran; University of Queensland; Mater Research; University of Queensland	Osiecki, MJ (corresponding author), Queensland Univ Technol, Translat Res Inst, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	m.osiecki@hdr.qut.edu.au	Doran, Michael R/F-6059-2014; Kabiri, Mahboubeh/ABE-1182-2021; Griesser, Hans J/E-5628-2011	Griesser, Hans J/0000-0003-1072-7863; Doran, Michael/0000-0001-5876-4757	Inner Wheel Australia; Wound Management Innovation CRC [1.06]	Inner Wheel Australia; Wound Management Innovation CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This study was funded by Inner Wheel Australia (http://www.innerwheelaustralia.org.au/) and Wound Management Innovation CRC (project 1.06, http://www.woundcrc.com/) awarded to MRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Josie Tarren and the Mater Hospital Pathology Unit for their assistance in performing the glucose and lactic acid quantification. We like to also thank Paul Reynolds of Styron, PA, USA for donating the polystyrene pellets. This research was supported by Wound Management Innovation CRC and Inner Wheel Australia.	Akhavan B, 2013, POWDER TECHNOL, V249, P403, DOI 10.1016/j.powtec.2013.09.018; Allen CB, 2001, LIMITATIONS OXYGEN D; Bacabac RG, 2005, J BIOMECH, V38, P159, DOI 10.1016/j.jbiomech.2004.03.020; BALTZ JM, 1991, MOL REPROD DEV, V28, P351, DOI 10.1002/mrd.1080280407; Barlow S, 2008, STEM CELLS DEV, V17, P1095, DOI 10.1089/scd.2007.0154; Bock A, 2009, BIOTECHNOL PROGR, V25, P1717, DOI 10.1002/btpr.262; Brooke G, 2009, BRIT J HAEMATOL, V144, P571, DOI 10.1111/j.1365-2141.2008.07492.x; Charbord P, 2010, HUM GENE THER, V21, P1045, DOI 10.1089/hum.2010.115; Chen JP, 2006, J BIOSCI BIOENG, V102, P41, DOI 10.1263/jbb.102.41; Christensen ME, 2010, HAEMATOL-HEMATOL J, V95, P2102, DOI 10.3324/haematol.2010.028910; Cierpka K, 2013, CHEM-ING-TECH, V85, P67, DOI 10.1002/cite.201200151; Daculsi R, 2008, J BIOMECH, V41, P2781, DOI 10.1016/j.jbiomech.2008.06.003; De Napoli IE, 2011, J MEMBRANE SCI, V379, P341, DOI 10.1016/j.memsci.2011.06.001; dos Santos F, 2011, TISSUE ENG PART C-ME, V17, P1201, DOI 10.1089/ten.tec.2011.0255; Fujita H, 2014, CELL BIOCHEM FUNCT, V32, P77, DOI 10.1002/cbf.2974; Jager M, 2009, STEM CELL REV REP, V5, P266, DOI 10.1007/s12015-009-9083-z; Kim SS, 2000, TISSUE ENG, V6, P39, DOI 10.1089/107632700320874; Lanfrey PY, 2010, CHEM ENG SCI, V65, P1891, DOI 10.1016/j.ces.2009.11.011; Leijten J, 2014, P NATL ACAD SCI USA, V111, P13954, DOI 10.1073/pnas.1410977111; Li DQ, 2009, TISSUE ENG PT A, V15, P2773, DOI [10.1089/ten.tea.2008.0540, 10.1089/ten.TEA.2008.0540]; Markway BD, 2010, CELL TRANSPLANT, V19, P29, DOI 10.3727/096368909X478560; Mizukami A, 2013, BIOTECHNOL PROGR, V29, P568, DOI 10.1002/btpr.1707; Mosna F, 2010, STEM CELLS DEV, V19, P1449, DOI 10.1089/scd.2010.0140; Mundra V, 2013, MOL PHARMACEUT, V10, P77, DOI 10.1021/mp3005148; Muscari C, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-63; Nold P, 2013, BIOCHEM BIOPH RES CO, V430, P325, DOI 10.1016/j.bbrc.2012.11.001; Regehr KJ, 2009, LAB CHIP, V9, P2132, DOI 10.1039/b903043c; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Timmins NE, 2012, BIOTECHNOL BIOENG, V109, P1817, DOI 10.1002/bit.24425; van Kooten TG, 2004, BIOMATERIALS, V25, P1735, DOI 10.1016/j.biomaterials.2003.08.071; von Heimburg D, 2005, RESP PHYSIOL NEUROBI, V146, P107, DOI 10.1016/j.resp.2004.12.013; Wang J, 2011, EXPERT OPIN BIOL TH, V11, P893, DOI 10.1517/14712598.2011.574119; Weber C, 2010, ADV BIOCHEM ENG BIOT, V123, P143, DOI 10.1007/10_2009_25; Weber C, 2010, INT J ARTIF ORGANS, V33, P512, DOI 10.1177/039139881003300802; Yeatts AB, 2013, BBA-GEN SUBJECTS, V1830, P2470, DOI 10.1016/j.bbagen.2012.06.007; Zhao F, 2005, BIOTECHNOL PROGR, V21, P1269, DOI 10.1021/bp0500664; Zhao F, 2007, BIOTECHNOL BIOENG, V96, P584, DOI 10.1002/bit.21184; Zhu XH, 2010, CHEM ENG SCI, V65, P2108, DOI 10.1016/j.ces.2009.12.006	38	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144941	10.1371/journal.pone.0144941	http://dx.doi.org/10.1371/journal.pone.0144941			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660475	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900153
J	Sabesan, R; Hofer, H; Roorda, A				Sabesan, Ramkumar; Hofer, Heidi; Roorda, Austin			Characterizing the Human Cone Photoreceptor Mosaic via Dynamic Photopigment Densitometry	PLOS ONE			English	Article							SCANNING LASER OPHTHALMOSCOPE; WAVELENGTH-SENSITIVE CONES; LIVING HUMAN EYE; ADAPTIVE OPTICS; RETINAL DENSITOMETRY; COLOR-BLINDNESS; GENE-THERAPY; DENSITY; FOVEA; ARRANGEMENT	Densitometry is a powerful tool for the biophysical assessment of the retina. Until recently, this was restricted to bulk spatial scales in living humans. The application of adaptive optics (AO) to the conventional fundus camera and scanning laser ophthalmoscope (SLO) has begun to translate these studies to cellular scales. Here, we employ an AOSLO to perform dynamic photopigment densitometry in order to characterize the optical properties and spectral types of the human cone photoreceptor mosaic. Cone-resolved estimates of optical density and photosensitivity agree well with bulk estimates, although show smaller variability than previously reported. Photopigment kinetics of individual cones derived from their selective bleaching allowed efficient mapping of cone sub-types in human retina. Estimated uncertainty in identifying a cone as long vs middle wavelength was less than 5%, and the total time taken per subject ranged from 3-9 hours. Short wavelength cones were delineated in every subject with high fidelity. The lack of a third cone-type was confirmed in a protanopic subject. In one color normal subject, cone assignments showed 91% correspondence against a previously reported cone-typing method from more than a decade ago. Combined with cone-targeted stimulation, this brings us closer in studying the visual percept arising from a specific cone type and its implication for color vision circuitry.	[Sabesan, Ramkumar; Roorda, Austin] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Hofer, Heidi] Univ Houston, Coll Optometry, Houston, TX USA	University of California System; University of California Berkeley; University of Houston System; University of Houston	Sabesan, R (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	rsabesan@uw.edu			National Eye Institute Bioengineering Research [R01EY023591]; National Eye Insitute grant [R21EY021642]; Fight for Sight Postdoctoral award; Burroughs Wellcome Fund; NATIONAL EYE INSTITUTE [R21EY021642, R01EY023591] Funding Source: NIH RePORTER	National Eye Institute Bioengineering Research; National Eye Insitute grant; Fight for Sight Postdoctoral award; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute Bioengineering Research Partnership grant R01EY023591, National Eye Insitute grant R21EY021642 and a Fight for Sight Postdoctoral award (https://www.fightforsight.org/Grants/ResearchAward-Types/). Ramkumar Sabesan holds a Career Award at the Scientific Interfaces from the Burroughs Wellcome Fund (http://www.bwfund.org/grantprograms/interfaces-science/career-awards-scientificinterface).	Arathorn DW, 2007, OPT EXPRESS, V15, P13731, DOI 10.1364/OE.15.013731; Atchison DA, 2005, J OPT SOC AM A, V22, P29, DOI 10.1364/JOSAA.22.000029; Bedggood P, 2012, INVEST OPHTH VIS SCI, V53, P3673, DOI 10.1167/iovs.11-8796; Berendschot TTJM, 1996, J PHYSIOL-LONDON, V492, P307, DOI 10.1113/jphysiol.1996.sp021310; Boye SE, 2013, MOL THER, V21, P509, DOI 10.1038/mt.2012.280; Bruce KS, 2015, INVEST OPHTH VIS SCI, V56, P4431, DOI 10.1167/iovs.15-16547; Carroll J, 2004, P NATL ACAD SCI USA, V101, P8461, DOI 10.1073/pnas.0401440101; Carroll Joseph, 2002, J Vis, V2, P531, DOI 10.1167/2.8.1; Christou JC, 2004, J OPT SOC AM A, V21, P1393, DOI 10.1364/JOSAA.21.001393; CICERONE CM, 1989, VISION RES, V29, P115, DOI 10.1016/0042-6989(89)90178-8; Cooper RF, 2011, BIOMED OPT EXPRESS, V2, P2577, DOI 10.1364/BOE.2.002577; CURCIO CA, 1991, J COMP NEUROL, V312, P610, DOI 10.1002/cne.903120411; Delori F. o. C., 2007, J OPT SOC AM A, V24, P1250; Dubra A, 2011, BIOMED OPT EXPRESS, V2, P1757, DOI 10.1364/BOE.2.001757; ELSNER AE, 1993, J OPT SOC AM A, V10, P52, DOI 10.1364/JOSAA.10.000052; Field GD, 2010, NATURE, V467, P673, DOI 10.1038/nature09424; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Grieve K, 2008, INVEST OPHTH VIS SCI, V49, P713, DOI 10.1167/iovs.07-0837; Harmening WM, 2014, J NEUROSCI, V34, P5667, DOI 10.1523/JNEUROSCI.5191-13.2014; Hofer H, 2005, J NEUROSCI, V25, P9669, DOI 10.1523/JNEUROSCI.2414-05.2005; Jonnal RS, 2007, OPT EXPRESS, V15, P16141, DOI 10.1364/OE.15.016141; Kremers J, 2000, J OPT SOC AM A, V17, P517, DOI 10.1364/JOSAA.17.000517; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; Masella BD, 2014, INVEST OPHTH VIS SCI, V55, P7525, DOI 10.1167/iovs.13-13795; MOLLON JD, 1992, NATURE, V360, P677, DOI 10.1038/360677a0; Packer OS, 1996, J NEUROSCI, V16, P2251; Pallikaris A, 2003, INVEST OPHTH VIS SCI, V44, P4580, DOI 10.1167/iovs.03-0094; Renner AB, 2004, VISUAL NEUROSCI, V21, P827, DOI 10.1017/S0952523804216030; Roorda A, 2002, OPT EXPRESS, V10, P405, DOI 10.1364/OE.10.000405; Roorda A, 2001, VISION RES, V41, P1291, DOI 10.1016/S0042-6989(01)00043-8; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; Roorda A, 2010, OPTOMETRY VISION SCI, V87, P260, DOI 10.1097/OPX.0b013e3181d39479; RUSHTON WAH, 1968, VISION RES, V8, P617, DOI 10.1016/0042-6989(68)90040-0; Sincich LC, 2009, NAT NEUROSCI, V12, P967, DOI 10.1038/nn.2352; SMITH VC, 1973, VISION RES, V13, P1199, DOI 10.1016/0042-6989(73)90156-9; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; Tuten WS, 2012, OPTOMETRY VISION SCI, V89, P563, DOI 10.1097/OPX.0b013e3182512b98; VANNORREN D, 1989, VISION RES, V29, P369, DOI 10.1016/0042-6989(89)90085-0; WALD G, 1967, J OPT SOC AM, V57, P1289, DOI 10.1364/JOSA.57.001289; WEBB RH, 1987, APPL OPTICS, V26, P1492, DOI 10.1364/AO.26.001492; Williams DR, 2011, VISION RES, V51, P1379, DOI 10.1016/j.visres.2011.05.002; WILLIAMS DR, 1981, VISION RES, V21, P1341, DOI 10.1016/0042-6989(81)90241-8; WILLIAMS DR, 1981, VISION RES, V21, P1357, DOI 10.1016/0042-6989(81)90242-X	44	34	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144891	10.1371/journal.pone.0144891	http://dx.doi.org/10.1371/journal.pone.0144891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660894	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900137
J	Stausberg, J; Hagn, S				Stausberg, Juergen; Hagn, Stefan			New Morbidity and Comorbidity Scores based on the Structure of the ICD-10	PLOS ONE			English	Article							ADMINISTRATIVE DATA; PREDICTING MORTALITY; CO-MORBIDITY; ICD-9-CM; HOSPITALIZATION; CLASSIFICATION; DISEASE; QUALITY; HEALTH; INDEX	Measures of morbidity and comorbidity are frequently used for the control of confounding, particularly in health services research. Several proposals for those measures are defined with ICD-coded diagnoses available in hospital routine data. However, a measure that makes use of the ICD structure is missing. Objective of this work was to elaborate the power of the ICD structure for defining morbidity and comorbidity measures. Routine data from three German hospitals with inpatients discharged 2008 were used for model development; routine data from 36 German hospitals with inpatients admitted and discharged 2010 were used for model evaluation. Two different risk models were developed, one based on ICD-10 chapters, the other based on ICD-10 groups. The models were transformed into sum scores using whole-number weights. Models and scores were compared with the Charlson Index and the Elixhauser Comorbidities using the receiver operating characteristic. Dependent variable was hospital death. Logistic regression was used to derive the new models. Charlson Index and Elixhauser Comorbidities were mapped to the German ICD-10. According to the receiver operating characteristic, the quality of the measures based on the structure of the ICD-10 was superior compared with the Charlson Index and the Elixhauser Comorbidities. The best result was achieved with the measure based on ICD-10-groups with an area under curve of 0.910 (95% confidence interval = 0.907-0.913). The sum scores showed a comparable performance. The developed new measures may be used to control for confounding.	[Stausberg, Juergen] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Fac Med, Essen, Germany	University of Duisburg Essen	Stausberg, J (corresponding author), Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Fac Med, Essen, Germany.	stausberg@ekmed.de			ID Information und Dokumentation im Gesundheitswesen GmbH & Co. KGaA, Berlin, Germany	ID Information und Dokumentation im Gesundheitswesen GmbH & Co. KGaA, Berlin, Germany	The development of the models was supported by ID Information und Dokumentation im Gesundheitswesen GmbH & Co. KGaA, Berlin, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chu YT, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-140; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Drosler S, 2009, OECD HLTH WORKING PA; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; FEINSTEIN AR, 1970, J CHRON DIS, V23, P455, DOI 10.1016/0021-9681(70)90054-8; Gaertner T, 2015, GESUNDHEITSWESEN; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Halfon P, 2002, J CLIN EPIDEMIOL, V55, P573, DOI 10.1016/S0895-4356(01)00521-2; Huber H, 2012, GESUNDHEITSWESEN, V74, P645, DOI 10.1055/s-0031-1301269; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Luft HS, 1997, HEALTH SERV RES, V32, P239; Mansour TAS, 2012, MED CARE, V50, P1109, DOI [10.1097/MLR.0b013e31825f64d0, DOI 10.1097/MLR.0B013E31825F64D0]; Ou HT, 2010, THESIS; Perneger TV, 2002, J CLIN EPIDEMIOL, V55, P498, DOI 10.1016/S0895-4356(01)00514-5; POMPEI P, 1991, J CLIN EPIDEMIOL, V44, P1063, DOI 10.1016/0895-4356(91)90008-W; Porta M, 2008, DICT EPIDEMIOLOGY; Pouw ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059160; Quail JM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-146; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Roos LL, 1997, HEALTH SERV RES, V32, P229; Schneeweiss S, 2003, HEALTH SERV RES, V38, P1103, DOI 10.1111/1475-6773.00165; SIMBORG DW, 1981, NEW ENGL J MED, V304, P1602, DOI 10.1056/NEJM198106253042611; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; Stausberg J, 2007, BUNDESGESUNDHEITSBLA, V50, P1039, DOI 10.1007/s00103-007-0296-5; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Yurkovich M, 2015, J CLIN EPIDEMIOL, V68, P3, DOI 10.1016/j.jclinepi.2014.09.010	32	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143365	10.1371/journal.pone.0143365	http://dx.doi.org/10.1371/journal.pone.0143365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656501	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900009
J	van Bruggen, R; Gualtieri, C; Iliescu, A; Cheepsunthorn, CL; Mungkalasut, P; Trape, JF; Modiano, D; Sirima, BS; Singhasivanon, P; Lathrop, M; Sakuntabhai, A; Bureau, JF; Gros, P				van Bruggen, Rebekah; Gualtieri, Christian; Iliescu, Alexandra; Cheepsunthorn, Chalisa Louicharoen; Mungkalasut, Punchalee; Trape, Jean-Francois; Modiano, David; Sirima, Bienvenu Sodiomon; Singhasivanon, Pratap; Lathrop, Mark; Sakuntabhai, Anavaj; Bureau, Jean-Francois; Gros, Philippe			Modulation of Malaria Phenotypes by Pyruvate Kinase (PKLR) Variants in a Thai Population	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; RED-BLOOD-CELL; HUMAN-ERYTHROCYTES; HOLOENDEMIC AREA; MOLECULAR-BASIS; DEFICIENCY; RESISTANCE; IDENTIFICATION; ENZYME; VIVAX	Pyruvate kinase (PKLR) is a critical erythrocyte enzyme that is required for glycolysis and production of ATP. We have shown that Pklr deficiency in mice reduces the severity (reduced parasitemia, increased survival) of blood stage malaria induced by infection with Plasmodium chabaudi AS. Likewise, studies in human erythrocytes infected ex vivo with P. falciparum show that presence of host PK-deficiency alleles reduces infection phenotypes. We have characterized the genetic diversity of the PKLR gene, including haplotype structure and presence of rare coding variants in two populations from malaria endemic areas of Thailand and Senegal. We investigated the effect of PKLR genotypes on rich longitudinal datasets including haematological and malaria-associated phenotypes. A coding and possibly damaging variant (R41Q) was identified in the Thai population with a minor allele frequency of similar to 4.7%. Arginine 41 (R41) is highly conserved in the pyruvate kinase family and its substitution to Glutamine (R41Q) affects protein stability. Heterozygosity for R41Q is shown to be associated with a significant reduction in the number of attacks with Plasmodium falciparum, while correlating with an increased number of Plasmodium vivax infections. These results strongly suggest that PKLR protein variants may affect the frequency, and the intensity of malaria episodes induced by different Plasmodium parasites in humans living in areas of endemic malaria.	[van Bruggen, Rebekah; Lathrop, Mark; Gros, Philippe] McGill Univ, Fac Med, Dept Human Genet, Montreal, PQ, Canada; [Gualtieri, Christian; Iliescu, Alexandra; Gros, Philippe] McGill Univ, Dept Biochem, Fac Med, Montreal, PQ, Canada; [Cheepsunthorn, Chalisa Louicharoen; Mungkalasut, Punchalee] Chulalongkorn Univ, Dept Biochem, Fac Med, Bangkok 10330, Thailand; [Trape, Jean-Francois] Inst Rech Dev, Lab Paludol & Zool Med, Dakar, Senegal; [Modiano, David] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Inst Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Sirima, Bienvenu Sodiomon] Minist Hlth, Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Singhasivanon, Pratap] Mahidol Univ, Fac Trop Med, Dept Trop Hyg Biomed & Hlth Informat, Bangkok, Thailand; [Sakuntabhai, Anavaj; Bureau, Jean-Francois] Inst Pasteur, Unite Genet Fonct Malad Infect, Paris, France; [Sakuntabhai, Anavaj; Bureau, Jean-Francois] Ctr Natl Rech Sci, URA3012, F-75015 Paris, France	McGill University; McGill University; Chulalongkorn University; Institut de Recherche pour le Developpement (IRD); Fondazione Cenci Bolognetti; Sapienza University Rome; Mahidol University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Gros, P (corresponding author), McGill Univ, Fac Med, Dept Human Genet, Montreal, PQ, Canada.	philippe.gros@mcgill.ca		Singhasivanon, Pratap/0000-0002-9759-1702; Bureau, Jean-Francois/0000-0003-1945-1883	Canadian Institutes for Health Research [MOP-119342]; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR))	This work was supported by research grants to PG from the Canadian Institutes for Health Research (MOP-119342) and funding to AS from the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant No. ANR-10-LABX-62-IBEID).	Alves J, 2010, BLOOD CELL MOL DIS, V44, P62, DOI 10.1016/j.bcmd.2009.09.008; Ayi K, 2004, BLOOD, V104, P3364, DOI 10.1182/blood-2003-11-3820; Ayi K, 2008, NEW ENGL J MED, V358, P1805, DOI 10.1056/NEJMoa072464; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berghout J, 2012, GENES IMMUN, V13, P98, DOI 10.1038/gene.2011.54; Beutler E, 1997, HUM MUTAT, V9, P282, DOI 10.1002/(SICI)1098-1004(1997)9:3<282::AID-HUMU13>3.0.CO;2-Z; Bongfen SE, 2009, TRENDS PARASITOL, V25, P417, DOI 10.1016/j.pt.2009.05.012; CARDENAS JM, 1978, J CELL PHYSIOL, V96, P189, DOI 10.1002/jcp.1040960207; CARDENAS JM, 1978, J EXP ZOOL, V204, P361, DOI 10.1002/jez.1402040307; Durand PM, 2008, HAEMATOLOGICA, V93, P939, DOI 10.3324/haematol.12450; FANJUL AN, 1993, J BIOL CHEM, V268, P175; Fermo E, 2005, BRIT J HAEMATOL, V129, P839, DOI 10.1111/j.1365-2141.2005.05520.x; Fortin A, 2001, P NATL ACAD SCI USA, V98, P10793, DOI 10.1073/pnas.191288998; FRIEDMAN MJ, 1978, P NATL ACAD SCI USA, V75, P1994, DOI 10.1073/pnas.75.4.1994; Fry AE, 2008, HUM MOL GENET, V17, P567, DOI 10.1093/hmg/ddm331; GENTON B, 1995, NATURE, V378, P564, DOI 10.1038/378564a0; GUPTA RK, 1976, BIOCHEMISTRY-US, V15, P2881, DOI 10.1021/bi00658a028; Gupta V, 2010, PROTEIN SCI, V19, P2031, DOI 10.1002/pro.505; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16; Hedrick PW, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-349; Hirono A, 2001, METABOLIC MOL BASES, V2, P4637; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; KAHN A, 1982, METHOD ENZYMOL, V90, P131; KANNO H, 1992, BIOCHEM BIOPH RES CO, V188, P516, DOI 10.1016/0006-291X(92)91086-6; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lawaly YR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011358; Louicharoen C, 2009, SCIENCE, V326, P1546, DOI 10.1126/science.1178849; Machado P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047071; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; MARIE J, 1979, BIOCHEM BIOPH RES CO, V91, P123, DOI 10.1016/0006-291X(79)90592-8; MARIE J, 1980, EUR J BIOCHEM, V108, P251, DOI 10.1111/j.1432-1033.1980.tb04718.x; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Min-Oo G, 2005, CELL MICROBIOL, V7, P753, DOI 10.1111/j.1462-5822.2005.00524.x; Min-Oo G, 2004, GENES IMMUN, V5, P168, DOI 10.1038/sj.gene.6364069; Min-Oo G, 2003, NAT GENET, V35, P357, DOI 10.1038/ng1260; Mockenhaupt FP, 2004, BLOOD, V104, P2003, DOI 10.1182/blood-2003-11-4090; Modiano D, 2001, T ROY SOC TROP MED H, V95, P149, DOI 10.1016/S0035-9203(01)90141-5; Modiano D., 1995, Parassitologia (Rome), V37, P255; MORIMOTO M, 1995, BLOOD, V86, P4323, DOI 10.1182/blood.V86.11.4323.bloodjournal86114323; MUEGGLER PA, 1983, BIOCHEM GENET, V21, P691, DOI 10.1007/BF00498916; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Olivieri NF, 2008, BRIT J HAEMATOL, V141, P388, DOI 10.1111/j.1365-2141.2008.07126.x; Phimpraphi W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-99; Phimpraphi W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003887; Rihet P, 1998, AM J HUM GENET, V63, P498, DOI 10.1086/301967; Rogier C, 1999, AM J TROP MED HYG, V60, P410, DOI 10.4269/ajtmh.1999.60.410; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; Rogier C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P255; Rowe JA, 2009, CURR OPIN HEMATOL, V16, P480, DOI 10.1097/MOH.0b013e3283313de0; Sakuntabhai A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002000; Smith T, 2001, AM J TROP MED HYG, V64, P262, DOI 10.4269/ajtmh.2001.64.262; STRANDHOLM JJ, 1976, ARCH BIOCHEM BIOPHYS, V173, P125, DOI 10.1016/0003-9861(76)90242-3; Summerer M, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-17; Timmann C, 2007, PLOS GENET, V3, P393, DOI 10.1371/journal.pgen.0030048; Tiono AB, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-163; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; VALENTINE W, 1961, T ASSOC AM PHYSICIAN, V74, P100; Valentini G, 2002, J BIOL CHEM, V277, P23807, DOI 10.1074/jbc.M202107200; van Wijk R, 2005, BLOOD, V106, P4034, DOI 10.1182/blood-2005-04-1622; van Wijk R, 2009, HUM MUTAT, V30, P446, DOI 10.1002/humu.20915; Wang CQ, 2001, BLOOD, V98, P3113, DOI 10.1182/blood.V98.10.3113; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Williams TN, 2005, BLOOD, V106, P368, DOI 10.1182/blood-2005-01-0313; Zanella A, 2005, BRIT J HAEMATOL, V130, P11, DOI 10.1111/j.1365-2141.2005.05527.x; Zanella A, 2000, BEST PRACT RES CL HA, V13, P57, DOI 10.1053/beha.1999.0057; Zimmerman PA, 1999, P NATL ACAD SCI USA, V96, P13973, DOI 10.1073/pnas.96.24.13973; Zurcher C, 1965, Folia Haematol Int Mag Klin Morphol Blutforsch, V83, P366	68	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144555	10.1371/journal.pone.0144555	http://dx.doi.org/10.1371/journal.pone.0144555			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658699	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900062
J	Grangl, G; Zohrer, E; Kostenberger, M; Jud, A; Fauler, G; Scharnagl, H; Stojakovic, T; Marterer, R; Gamillscheg, A; Jahnel, J				Grangl, Gernot; Zoehrer, Evelyn; Koestenberger, Martin; Jud, Alexandra; Fauler, Goenter; Scharnagl, Hubert; Stojakovic, Tatjana; Marterer, Robert; Gamillscheg, Andreas; Jahnel, Joerg			Serum Bile Acids in Repaired Tetralogy of Fallot: A Marker for Liver and Heart?	PLOS ONE			English	Article							FUNCTION ABNORMALITIES; FAILURE; PERFORMANCE; REGURGITATION; DYSFUNCTION; PREVALENCE; PHYSIOLOGY; MOTION; ADULTS	Background and Aims Patients with repaired tetralogy of Fallot may develop chronic right ventricular dysfunction and hepatic congestion over time. We hypothesized that bile acid metabolism is altered in repaired tetralogy of Fallot patients and therefore sought to correlate right ventricular indices with serum bile acid levels. Methods Indexed right ventricular end diastolic volume, as assessed by cardiac magnetic-resonance imaging, was classified as <100ml/m(2) (Group 1, n = 5), 100-150ml/m(2) (Group 2, n = 18), and >150ml/m(2) (Group 3, n = 6) in 29 patients with repaired tetralogy of Fallot. Pulmonary regurgitation fraction and right ventricular ejection fraction were calculated. The serum bile acid profile, including 15 species, in these patients was determined by liquid chromatography coupled with mass spectrometry. Results Serum bile acid levels increased from Group 1 to Group 3 (2.5 +/- 0.7; 4.1 +/- 2.5; 6.0 +/- 2.8 mu mol/l, respectively) with significantly increased bile acid values in Group 3 compared to Group 1 (p <= 0.05). In Group 3, but not in Group 1 and 2, a significant increase in glycine-conjugated bile acids was observed. Pulmonary regurgitation fraction increased (12 +/- 1; 28 +/- 16; 43 +/- 3%, Groups 1-3, respectively) and right ventricular ejection fraction decreased (48.4 +/- 6.4; 48.5 +/- 6.5; 42.1 +/- 5.3%, Groups 1-3, respectively) with rising indexed right ventricular end diastolic volume. Conclusions These preliminary results suggest that serum bile acid levels are positively correlated with indexed right ventricular end-diastolic volume in patients with repaired tetralogy of Fallot; however, this needs to be confirmed in a larger patient cohort.	[Grangl, Gernot; Zoehrer, Evelyn; Koestenberger, Martin; Jud, Alexandra; Gamillscheg, Andreas; Jahnel, Joerg] Med Univ Graz, Div Pediat Cardiol, Dept Pediat & Adolescent Med, Graz, Austria; [Scharnagl, Hubert; Stojakovic, Tatjana] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Marterer, Robert] Med Univ Graz, Div Pediat Radiol, Dept Radiol, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz	Jahnel, J (corresponding author), Med Univ Graz, Div Pediat Cardiol, Dept Pediat & Adolescent Med, Graz, Austria.	joerg.jahnel@medunigraz.at	Marterer, Robert/Y-5278-2019	Marterer, Robert/0000-0001-6806-122X				Allen LA, 2009, EUR J HEART FAIL, V11, P170, DOI 10.1093/eurjhf/hfn031; Bouzas B, 2005, CARDIOL YOUNG, V15, P51, DOI 10.1017/S1047951105001034; Burchill Luke J, 2011, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V14, P92, DOI 10.1053/j.pcsu.2011.01.016; Davlouros PA, 2004, INT J CARDIOL, V97, P91, DOI 10.1016/j.ijcard.2004.08.013; Eindhoven JA, 2014, INT J CARDIOL, V174, P550, DOI 10.1016/j.ijcard.2014.04.137; Ford RM, 2015, TRANSPLANT REV-ORLAN, V29, P33, DOI 10.1016/j.trre.2014.11.003; GALATOLA G, 1991, GASTROENTEROLOGY, V100, P1100, DOI 10.1016/0016-5085(91)90288-V; GATZOULIS MA, 1995, CIRCULATION, V91, P1775, DOI 10.1161/01.CIR.91.6.1775; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Knauth AL, 2008, HEART, V94, P211, DOI 10.1136/hrt.2006.104745; Koestenberger M, 2012, CONGENIT HEART DIS, V7, P250, DOI 10.1111/j.1747-0803.2012.00655.x; Koestenberger M, 2011, J AM SOC ECHOCARDIOG, V24, P45, DOI 10.1016/j.echo.2010.10.001; Lau GT, 2002, AM J CARDIOL, V90, P1405, DOI 10.1016/S0002-9149(02)02886-2; Lotz J, 2009, ROFO-FORTSCHR RONTG, V181, P800, DOI 10.1055/s-0028-1109542; Marterer R, 2015, EUR RADIOL, V25, P3528, DOI 10.1007/s00330-015-3788-y; Meluzin J, 2001, EUR HEART J, V22, P340, DOI 10.1053/euhj.2000.2296; Miller D, 2004, J AM SOC ECHOCARDIOG, V17, P443, DOI 10.1016/j.echo.2004.01.010; Monte MJ, 2009, WORLD J GASTROENTERO, V15, P804, DOI 10.3748/wjg.15.804; Nikolaou M, 2013, EUR HEART J, V34, P742, DOI 10.1093/eurheartj/ehs332; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Poelzl G, 2012, EUR J CLIN INVEST, V42, P153, DOI 10.1111/j.1365-2362.2011.02573.x; Shinebourne EA, 2006, HEART, V92, P1353, DOI 10.1136/hrt.2005.061143; Tagliacozzi D, 2003, CLIN CHEM LAB MED, V41, P1633, DOI 10.1515/CCLM.2003.247; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Van Deursen VM, 2010, J CARD FAIL, V16, P84, DOI 10.1016/j.cardfail.2009.08.002; Vliegen HW, 2002, CIRCULATION, V106, P1703, DOI 10.1161/01.CIR.0000030995.59403.F8	26	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144745	10.1371/journal.pone.0144745	http://dx.doi.org/10.1371/journal.pone.0144745			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659834	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903600082
J	Hassoun, N				Hassoun, Nicole			The Global Health Impact Index: Promoting Global Health	PLOS ONE			English	Article							FIXED-DOSE COMBINATION; TREATMENT-NAIVE; TENOFOVIR DF; EFAVIRENZ; SAFETY; LAMIVUDINE; EFFICACY; NEVIRAPINE; STAVUDINE; THERAPY	Millions of people cannot access essential medicines they need for deadly diseases like malaria, tuberculosis (TB) and HIV/AIDS. There is good information on the need for drugs for these diseases but until now, no global estimate of the impact drugs are having on this burden. This paper presents a model measuring companies' key malaria, TB and HIV/AIDS drugs' consequences for global health (global-health-impact.org). It aggregates drugs' impacts in several ways-by disease, country and originator-company. The methodology can be extended across diseases as well as drugs to provide a more extensive picture of the impact companies' drugs are having on the global burden of disease. The study suggests that key malaria, TB and HIV/AIDS drugs are, together, ameliorating about 37% of the global burden of these diseases and Sanofi, Novartis, and Pfizer's drugs are having the largest effect on this burden. Moreover, drug impacts vary widely across countries. This index provides important information for policy makers, pharmaceutical companies, countries, and other stake-holders that can help increase access to essential medicines.	[Hassoun, Nicole] SUNY Binghamton, Dept Philosophy, Binghamton, NY 13902 USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Hassoun, N (corresponding author), SUNY Binghamton, Dept Philosophy, Binghamton, NY 13902 USA.	nhassoun@binghamton.edu			Binghamton University; Carnegie Mellon University; Academics Stand Against Poverty; Stanford University's Center for Ethics in Society; Justitia Amplificata, Germany; Center for Advanced Studies in Frankfurt, Germany; Binghamton University's Citizenship, Rights, and Belonging Transdisciplinary Area of Excellence; Swedish-Franco Program in Philosophy and Economics in Paris, France; Center for Poverty Research in Salzburg, Austria; World Institute for Development Economics Research in Helsinki, Finland; Berkman Foundation at Carnegie Mellon University; Falk Foundation at Carnegie Mellon University	Binghamton University; Carnegie Mellon University; Academics Stand Against Poverty; Stanford University's Center for Ethics in Society; Justitia Amplificata, Germany; Center for Advanced Studies in Frankfurt, Germany; Binghamton University's Citizenship, Rights, and Belonging Transdisciplinary Area of Excellence; Swedish-Franco Program in Philosophy and Economics in Paris, France; Center for Poverty Research in Salzburg, Austria; World Institute for Development Economics Research in Helsinki, Finland; Berkman Foundation at Carnegie Mellon University; Falk Foundation at Carnegie Mellon University	Binghamton University and Carnegie Mellon University seed grants were provided. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author would like to thank Public Affairs Quarterly for allowing her to reprint some of the material from the HIV appendix in her article "Globalization, Global Justice, and Global Health Impact" in their July 2014 issue. The author would also like to thank all of the people and organizations that have contributed to the project-especially the Global Health Impact team. She is thankful for recent discussions about the project at the World Health Organization, The Global Fund; the Edmund J. Safra Center for Ethics at Harvard University; the University of Manchester; the American Philosophical Association; Yale University; Binghamton University; the University of Delaware; London School of Economics; William and Lee College; Goethe University; California University; University College London; Santa Clara University; the Universidad De Antioquia; Carnegie Mellon University; the American Society for Bioethics and Humanities; Stanford University; Dickinson College; Newcastle on the Tyne; and researchers at UNAIDS, the World Health Organization, and Medecins Sans Frontieres along with countless others. She is also especially grateful for support from Academics Stand Against Poverty; Stanford University's Center for Ethics in Society; Justitia Amplificata and the Center for Advanced Studies in Frankfurt, Germany; Binghamton University's Citizenship, Rights, and Belonging Transdisciplinary Area of Excellence collaborative grant program; the Swedish-Franco Program in Philosophy and Economics in Paris, France; the Center for Poverty Research in Salzburg, Austria; the World Institute for Development Economics Research in Helsinki, Finland; and the Berkman and Falk Foundations at Carnegie Mellon University.	Annan NT, 2009, JAIDS-J ACQ IMM DEF, V51, P140, DOI 10.1097/QAI.0b013e3181a56e81; [Anonymous], 2018, GLOBAL BURDEN DIS ST, DOI DOI 10.2147/DDDT.S164565; [Anonymous], WE CLASS COUNTRIES; [Anonymous], 2007 2008 XDR MDR TU; [Anonymous], 18 C RETR OPP INF BO; [Anonymous], AB THE FDN; [Anonymous], 2009, MAN MDR TB FIELD GUI; [Anonymous], 6 IAS C HIV PATH TRE; [Anonymous], 2010, GLOB REP ANT EFF DRU; [Anonymous], **NON-TRADITIONAL**; [Anonymous], J INT ASS PHYS AIDS; [Anonymous], J ACQUIR IMMUNE DEFI; [Anonymous], MONITORING FINANCIAL; [Anonymous], 2014, PUBLIC AFFAIRS Q; [Anonymous], HLTH INEQUALITIES GL; [Anonymous], GLOB HIV AIDS RESP; [Anonymous], JOINT UN PROGR HIV A; [Anonymous], N ENGL J MED; [Anonymous], J ACQUIR IMMUNE DEFI; [Anonymous], KEY FACTS GLOB HIV E; [Anonymous], ANT MED LOW MIDDL IN; [Anonymous], TB HIV FACTS 2011; [Anonymous], TUB TB DAT GLOB TUB; [Anonymous], 2013, ANT MED LOW MIDDL IN; [Anonymous], 2011 12 TUB GLOB FAC; [Anonymous], DAT HIV AIDS RESP AN; [Anonymous], CHILDR 5 FEV BEING T; [Anonymous], EST ANT THER COV CHI; [Anonymous], TUBERCULOSIS MULTIDR; Bao L, 2012, SEX TRANSM INFECT, V88, pI58, DOI 10.1136/sextrans-2012-050689; Bunupuradah T, 2012, ANTIVIR THER, V17, P1351, DOI 10.3851/IMP2443; Cohen C, 2011, AIDS, V25, pF7, DOI 10.1097/QAD.0b013e328345766f; Cohen CJ, 2012, JAIDS-J ACQ IMM DEF, V60, P33, DOI 10.1097/QAI.0b013e31824d006e; Daar ES, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00316; DeJesus E, 2011, INT J CLIN PRACT, V65, P1240, DOI 10.1111/j.1742-1241.2011.02807.x; DeJesus E, 2012, HIV CLIN TRIALS, V13, P228, DOI 10.1310/hct1304-228; Echeverria P, 2010, ANTIVIR RES, V85, P403, DOI 10.1016/j.antiviral.2009.11.008; Frange P, 2011, PEDIATR INFECT DIS J, V30, P684, DOI 10.1097/INF.0b013e31821752d6; Galactionova K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127818; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gay CL, 2011, AIDS, V25, P941, DOI 10.1097/QAD.0b013e3283463c07; Hassoun N, 2012, DEV WORLD BIOETH, V12, P121, DOI 10.1111/j.1471-8847.2011.00314.x; Kebba A, 2002, AIDS RES HUM RETROV, V18, P1181, DOI 10.1089/08892220260387922; Komatsu R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-109; Laurent C, 2004, LANCET, V364, P29, DOI 10.1016/S0140-6736(04)16586-0; Lee BY, 2010, VACCINE, V28, P2806, DOI 10.1016/j.vaccine.2009.09.047; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Manosuthi W, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-136; Molina JM, 2011, LANCET, V378, P238, DOI 10.1016/S0140-6736(11)60936-7; Munderi P, 2010, HIV MED, V11, P334, DOI 10.1111/j.1468-1293.2009.00786.x; Murphy RL, 2008, HIV CLIN TRIALS, V9, P1, DOI 10.1310/hct0901-1; Pensi T, 2007, INDIAN PEDIATR, V44, P519; Post FA, 2010, JAIDS-J ACQ IMM DEF, V55, P49, DOI 10.1097/QAI.0b013e3181dd911e; Puls RL, 2010, CLIN INFECT DIS, V51, P855, DOI 10.1086/656363; Puthanakit T, 2009, J ANTIMICROB CHEMOTH, V64, P1080, DOI 10.1093/jac/dkp322; Rey D, 2009, J ANTIMICROB CHEMOTH, V63, P380, DOI 10.1093/jac/dkn471; Saez-Llorens X, 2008, PEDIATRICS, V121, pE827, DOI 10.1542/peds.2006-3078; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Sierra-Madero J, 2010, HIV CLIN TRIALS, V11, P127, DOI 10.1310/hct1103-125; Smith KY, 2009, AIDS, V23, P1547, DOI 10.1097/QAD.0b013e32832cbcc2; Soriano V, 2011, ANTIVIR THER, V16, P339, DOI 10.3851/IMP1745; Udwadia ZF, 2012, THORAX, V67, P286, DOI 10.1136/thoraxjnl-2012-201663; Vallecillo G, 2012, AIDS RES HUM RETROV, V28, P165, DOI 10.1089/aid.2011.0092; Waning B, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-35; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2008, IMPL WHO STOP TB STR	70	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0141374	10.1371/journal.pone.0141374	http://dx.doi.org/10.1371/journal.pone.0141374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657064	Green Published, gold			2022-12-27	WOS:000366903600001
J	Herraiz, C; Olivares, C; Castejon-Grinan, M; Abrisqueta, M; Jimenez-Cervantes, C; Garcia-Borron, JC				Herraiz, Cecilia; Olivares, Conchi; Castejon-Grinan, Maria; Abrisqueta, Marta; Jimenez-Cervantes, Celia; Carlos Garcia-Borron, Jose			Functional Characterization of MC1R-TUBB3 Intergenic Splice Variants of the Human Melanocortin 1 Receptor	PLOS ONE			English	Article							RED HAIR; EXPRESSION; MELANOMA; PROTEIN; MC1R; GENE; PIGMENTATION; MELANOCYTES; DIMERIZATION; TRAFFICKING	The melanocortin 1 receptor gene (MC1R) expressed in melanocytes is a major determinant of skin pigmentation. It encodes a Gs protein-coupled receptor activated by alpha-melanocyte stimulating hormone (alpha MSH). Human MC1R has an inefficient poly(A) site allowing intergenic splicing with its downstream neighbour Tubulin-beta-III (TUBB3). Intergenic splicing produces two MC1R isoforms, designated Iso1 and Iso2, bearing the complete seven transmembrane helices from MC1R fused to TUBB3-derived C-terminal extensions, in-frame for Iso1 and out-of-frame for Iso2. It has been reported that exposure to ultraviolet radiation (UVR) might promote an isoform switch from canonical MC1R (MC1R-001) to the MC1R-TUBB3 chimeras, which might lead to novel phenotypes required for tanning. We expressed the Flag epitope-tagged intergenic isoforms in heterologous HEK293T cells and human melanoma cells, for functional characterization. Iso1 was expressed with the expected size. Iso2 yielded a doublet of Mr significantly lower than predicted, and impaired intracellular stability. Although Iso1- and Iso2 bound radiolabelled agonist with the same affinity as MC1R-001, their plasma membrane expression was strongly reduced. Decreased surface expression mostly resulted from aberrant forward trafficking, rather than high rates of endocytosis. Functional coupling of both isoforms to cAMP was lower than wild-type, but ERK activation upon binding of alpha MSH was unimpaired, suggesting imbalanced signaling from the splice variants. Heterodimerization of differentially labelled MC1R-001 with the splicing isoforms analyzed by co-immunoprecipitation was efficient and caused decreased surface expression of binding sites. Thus, UVR-induced MC1R isoforms might contribute to fine-tune the tanning response by modulating MC1R-001 availability and functional parameters.	[Herraiz, Cecilia] Univ Murcia, Sch Med, Dept Biochem Mol Biol & Immunol, Murcia, Spain; IMIB Arrixaca, Murcia, Spain	University of Murcia; Hospital Clinico Universitario Virgen de la Arrixaca	Herraiz, C (corresponding author), Univ Murcia, Sch Med, Dept Biochem Mol Biol & Immunol, Campus Espinardo, Murcia, Spain.	ceciliahs@um.es	Jimenez-Cervantes, Celia/H-1953-2015; Garcia-Borron, Jose Carlos/H-2247-2015; Olivares, Conchi/H-2794-2015; Castejón Griñán, María/AAC-8557-2022; Serrano, Cecilia Herraiz/H-2550-2015; Abrisqueta Gonzalez, Marta/H-8998-2015	Jimenez-Cervantes, Celia/0000-0002-5821-9510; Garcia-Borron, Jose Carlos/0000-0002-9192-588X; Olivares, Conchi/0000-0001-7518-3858; Castejón Griñán, María/0000-0003-4494-3986; Serrano, Cecilia Herraiz/0000-0001-6912-0738; Abrisqueta Gonzalez, Marta/0000-0001-9464-3135	Comision Interministerial de Ciencia y Tecnologia, Spain [SAF2012-32134]; FEDER funds (European Community); University of Murcia	Comision Interministerial de Ciencia y Tecnologia, Spain(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); FEDER funds (European Community)(European Commission); University of Murcia	This work was supported by grant SAF2012-32134 (to JCGB) from the Comision Interministerial de Ciencia y Tecnologia, Spain, FEDER funds (European Community). CH holds a post-doctoral fellowship from the University of Murcia. MC is a fellow of the Fundacion Seneca (Agencia de Ciencia y Tecnologia de la Region de Murcia, Spain).	Abrisqueta M, 2013, J CELL SCI, V126, P3724, DOI 10.1242/jcs.128322; Beaumont KA, 2007, HUM MOL GENET, V16, P2249, DOI 10.1093/hmg/ddm177; Communi D, 2001, J BIOL CHEM, V276, P16561, DOI 10.1074/jbc.M009609200; Corre S, 2004, J BIOL CHEM, V279, P51226, DOI 10.1074/jbc.M409768200; Corre S, 2006, J INVEST DERMATOL, V126, P916, DOI 10.1038/sj.jid.5700190; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; Dalziel M, 2007, MOL CELL BIOL, V27, P1568, DOI 10.1128/MCB.01821-06; Dalziel M, 2011, NUCLEIC ACIDS RES, V39, P2378, DOI 10.1093/nar/gkq1125; Davies JR, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12193; Funasaka Y, 1998, BRIT J DERMATOL, V139, P216; Garcia-Borron JC, 2014, PIGM CELL MELANOMA R, V27, P699, DOI 10.1111/pcmr.12257; Herraiz C, 2012, INT J BIOCHEM CELL B, V44, P2244, DOI 10.1016/j.biocel.2012.09.008; Herraiz C, 2011, MOL ENDOCRINOL, V25, P138, DOI 10.1210/me.2010-0217; Herraiz C, 2009, FEBS LETT, V583, P3269, DOI 10.1016/j.febslet.2009.09.023; Hoek KS, 2007, PIGM CELL RES, V20, P466, DOI 10.1111/j.1600-0749.2007.00412.x; Hsiao JJ, 2014, ARCH BIOCHEM BIOPHYS, V563, P28, DOI 10.1016/j.abb.2014.07.019; Jividen K, 2014, GENE CHROMOSOME CANC, V53, P963, DOI 10.1002/gcc.22207; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Maresca V, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12365; Markovic D, 2009, CELL MOL LIFE SCI, V66, P3337, DOI 10.1007/s00018-009-0093-4; Minneman K P, 2001, Mol Interv, V1, P108; Mort RL, 2015, DEVELOPMENT, V142, P620, DOI 10.1242/dev.106567; Needham PG, 2013, BBA-MOL CELL RES, V1833, P2447, DOI 10.1016/j.bbamcr.2013.03.018; Oliva ABP, 2009, HUM MUTAT, V30, P811, DOI 10.1002/humu.20971; Rousseau K, 2007, FASEB J, V21, P1844, DOI 10.1096/fj.06-7398com; Rouzaud F, 2003, FASEB J, V17, P2154, DOI 10.1096/fj.03-0206fje; Rouzaud F, 2006, FASEB J, V20, P1927, DOI 10.1096/fj.06-5922fje; Sanchez-Laorden BL, 2007, J BIOL CHEM, V282, P3241, DOI 10.1074/jbc.M606865200; Sanchez-Laorden BL, 2006, J INVEST DERMATOL, V126, P172, DOI 10.1038/sj.jid.5700036; Sanchez-Laorden BL, 2009, J CELL PHYSIOL, V220, P640, DOI 10.1002/jcp.21804; Sanchez-Laorden L, 2006, CELL MOL BIOL, V52, P39, DOI 10.1170/T706; Sanchez-Mas A, 2005, PEPTIDES, V26, P1848, DOI 10.1016/j.peptides.2004.11.030; Sarangarajan R, 2006, MELANOMA RES, V16, P3, DOI 10.1097/01.cmr.0000195699.35143.df; Scott MC, 2002, PIGM CELL RES, V15, P433, DOI 10.1034/j.1600-0749.2002.02051.x; Smith AG, 2001, GENE, V281, P81, DOI 10.1016/S0378-1119(01)00791-0; Tan CP, 1999, FEBS LETT, V451, P137, DOI 10.1016/S0014-5793(99)00525-6; Taylor NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119920; Taylor NJ, 2015, INT J CANCER, V136, P2659, DOI 10.1002/ijc.29317; URABE K, 1994, BBA-MOL CELL RES, V1221, P272, DOI 10.1016/0167-4889(94)90250-X; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Zanna PT, 2008, BIOCHEM BIOPH RES CO, V368, P211, DOI 10.1016/j.bbrc.2008.01.060	41	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144757	10.1371/journal.pone.0144757	http://dx.doi.org/10.1371/journal.pone.0144757			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657157	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903600087
J	Phan, K; Mitchell, P; Liew, G; Plant, AJ; Wang, SB; Au, C; Chiha, J; Kovoor, P; Thiagalingam, A; Burlutsky, G; Gopinath, B				Phan, Kevin; Mitchell, Paul; Liew, Gerald; Plant, Adam J.; Wang, Sarah B.; Au, Cheryl; Chiha, Joseph; Kovoor, Pramesh; Thiagalingam, Aravinda; Burlutsky, George; Gopinath, Bamini			Association between Retinal Arteriolar and Venule Calibre with Prevalent Heart Failure: A Cross-Sectional Study	PLOS ONE			English	Article							VASCULAR CALIBER; CARDIOVASCULAR-DISEASE; MICROVASCULAR ABNORMALITIES; ATHEROSCLEROSIS RISK; PROGNOSTIC IMPACT; RETINOPATHY; MORTALITY; COMMUNITIES; MESA	Background There is evidence to suggest that microvascular disease, particularly diabetic retinopathy, plays a role in the pathogenesis of HF. However, whether changes in retinal vessel calibre predicts HF is unclear. The purpose of this study was to examine the association of retinal microvascular structure with prevalent heart failure (HF). Methods The Australian Heart Eye Study (AHES) is a cross-sectional study that surveyed 1680 participants who presented to a tertiary referral hospital for the evaluation of potential coronary artery disease by coronary angiography. Retinal vessel calibre was graded using retinal photography and participants' self-reported echocardiography-confirmed HF was obtained via an extensive medical questionnaire. Results There were 107 participants (8.1%) with prevalent self-reported HF. Persons with wider retinal arteriolar calibre (comparing highest versus lowest tertile or reference) were more likely to have prevalent HF (OR 3.5; 95% CI, 1.7-7.2) when adjusted for age and sex. After further adjustment for body mass index, hypertension, diabetes, smoking status, triglycerides and estimated glomerular filtration rate, this association remained significant (OR 4.5; 95% CI, 2.0-9.8). After further stratification, this association remained significant among participants with diabetes (OR 10.3; 95% CI, 2.7-39.3) but not in those without diabetes (OR 2.7; 95% CI, 0.9-7.5). The strength of this association was not dependent on the length of history of diabetes, or retinopathy status. There was no significant association between retinal venular calibre and prevalence of HF. Conclusions Wider retinal arteriolar diameter was significantly and independently associated with prevalent HF in participants of a cross-sectional study. This association was significant stronger among participants with diabetes compared to without diabetes. No association was found between retinal venule calibre with prevalent HF.	[Phan, Kevin; Mitchell, Paul; Liew, Gerald; Plant, Adam J.; Wang, Sarah B.; Au, Cheryl; Burlutsky, George; Gopinath, Bamini] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW 2006, Australia; [Phan, Kevin; Mitchell, Paul; Liew, Gerald; Plant, Adam J.; Wang, Sarah B.; Au, Cheryl; Burlutsky, George; Gopinath, Bamini] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Chiha, Joseph; Kovoor, Pramesh; Thiagalingam, Aravinda] Univ Sydney, Westmead Millennium Inst, Ctr Heart Res, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Westmead Institute for Medical Research	Gopinath, B (corresponding author), Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW 2006, Australia.	bamini.gopinath@sydney.edu.au	Liew, Gerald/AAB-6870-2022; Mitchell, Paul/P-1498-2014; Gopinath, Bamini/K-4286-2019	Gopinath, Bamini/0000-0003-3573-359X; Thiagalingam, Aravinda/0000-0002-7763-7806; Phan, Kevin/0000-0002-5940-3555	National Health and Medical Research Council (NHMRC) [571012]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (NHMRC) Project Grant 571012. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibrahim E, 2006, OPHTHALMOLOGY, V113, P1499, DOI 10.1016/j.ophtha.2006.05.009; Brinchmann-Hansen O., 1986, ACTA OPHTHALMOL, V64, P20, DOI DOI 10.1111/J.1755-3768.1986.TB00699; Cheung N, 2008, J AM COLL CARDIOL, V51, P1573, DOI 10.1016/j.jacc.2007.11.076; Ciulla TA, 2002, ACTA OPHTHALMOL SCAN, V80, P468, DOI 10.1034/j.1600-0420.2002.800503.x; Dries DL, 2001, J AM COLL CARDIOL, V38, P421, DOI 10.1016/S0735-1097(01)01408-5; Gheorghiade M, 2006, CIRCULATION, V114, P1202, DOI 10.1161/CIRCULATIONAHA.106.623199; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Ingelsson E, 2007, DIABETES, V56, P1718, DOI 10.2337/db07-0078; Kannel WB, 2011, CLIN CHEM, V57, P338, DOI 10.1373/clinchem.2010.149740; KEITH NM, 1974, AM J MED SCI, V268, P336, DOI 10.1097/00000441-197412000-00004; Kifley A, 2007, AM J OPHTHALMOL, V143, P1024, DOI 10.1016/j.ajo.2007.01.034; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; KULLER LH, 1995, CIRCULATION, V92, P720, DOI 10.1161/01.CIR.92.4.720; McGeechan K, 2009, ANN INTERN MED, V151, P404, DOI 10.7326/0003-4819-151-6-200909150-00005; Nguyen TT, 2008, DIABETES CARE, V31, P544, DOI 10.2337/dc07-1528; Phan K, 2015, INT J CARDIOL, V182, P213, DOI 10.1016/j.ijcard.2014.12.146; Phan K, 2015, INT J CARDIOL, V178, P96, DOI 10.1016/j.ijcard.2014.10.102; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Tikellis G, 2007, DIABETOLOGIA, V50, P2263, DOI 10.1007/s00125-007-0822-x; VASAN RS, 1995, J AM COLL CARDIOL, V26, P1565, DOI 10.1016/0735-1097(95)00381-9; Wang JJ, 2006, HEART, V92, P1583, DOI 10.1136/hrt.2006.090522; Wang JJ, 2007, EUR HEART J, V28, P1984, DOI 10.1093/eurheartj/ehm221; Witt N, 2006, HYPERTENSION, V47, P975, DOI 10.1161/01.HYP.0000216717.72048.6c; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; Wong TY, 2005, JAMA-J AM MED ASSOC, V293, P63, DOI 10.1001/jama.293.1.63; Wong TY, 2003, OPHTHALMOLOGY, V110, P933, DOI 10.1016/S0161-6420(03)00084-8; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P1153, DOI 10.1001/jama.287.9.1153; Yau JWY, 2012, DIABETES RES CLIN PR, V95, P265, DOI 10.1016/j.diabres.2011.10.027	29	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144850	10.1371/journal.pone.0144850	http://dx.doi.org/10.1371/journal.pone.0144850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659133	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903600096
J	Wei, J; Wang, XL; Yang, HB; Yang, TB				Wei, Jie; Wang, Xin-liang; Yang, Hao-bin; Yang, Tu-bao			Development of an In-Patient Satisfaction Questionnaire for the Chinese Population	PLOS ONE			English	Article							PATIENT SATISFACTION; HOSPITAL-CARE; VALIDATION; QUALITY; INSTRUMENT; COMPONENTS; VALIDITY	Background Patients' satisfaction has been considered as a crucial measurement of health care quality. Our objective was to develop a reliable and practical questionnaire for the assessment of inpatients' satisfaction in Chinese people, and report the current situation of in-patients' satisfaction in the central south area of China through a large-scale cross-sectional study. Design In order to generate the questionnaire, we reviewed previous studies, interviewed related people, held discussions, refined questionnaire items after the pilot study, and finally conducted a large cross-sectional survey to test the questionnaire. Setting This study was conducted in three A-level hospitals in the Hunan province, China. Results There were 6640 patients in this large-scale survey (another 695 patients in the pilot study). A factor analysis on the data from the pilot study generated four dimensions, namely, doctors' care quality, nurses' care quality, quality of the environment and facilities, and comprehensive quality. The Cronbach's alpha coefficients for each dimension were above 0.7 and the inter-subscale correlation was between 0.72 and 0.83. The overall in-patient satisfaction rate was 89.6%. Conclusion The in-patient satisfaction questionnaire was proved to have optimal internal consistency, reliability, and validity.	[Wei, Jie; Wang, Xin-liang; Yang, Hao-bin; Yang, Tu-bao] Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China	Central South University	Wang, XL (corresponding author), Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China.	wxl680924@163.com; 1064960669@qq.com	Wei, Jie/ACR-8087-2022	Wei, Jie/0000-0003-3510-8241	Hunan Provincial Innovation Foundation for Postgraduate [CX2014B096]; Fundamental Research Funds for the Central Universities of Central South University [2014zzts070]	Hunan Provincial Innovation Foundation for Postgraduate; Fundamental Research Funds for the Central Universities of Central South University	This work was supported by Hunan Provincial Innovation Foundation for Postgraduate (CX2014B096), and the Fundamental Research Funds for the Central Universities of Central South University (2014zzts070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharony L, 1993, Med Care Rev, V50, P49, DOI 10.1177/002570879305000104; Aletras VH, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-66; Baker R, 1997, QUAL HEALTH CARE, V6, P201, DOI 10.1136/qshc.6.4.201; CAREY RG, 1993, MED CARE, V31, P834, DOI 10.1097/00005650-199309000-00008; Chan SKK, 2010, QUAL SAF HEALTH CARE, V19, P173, DOI 10.1136/qshc.2007.026013; CLEARY PD, 1991, HEALTH AFFAIR, V10, P254, DOI 10.1377/hlthaff.10.4.254; CLEARY PD, 1988, INQUIRY-J HEALTH CAR, V25, P25; Coban GI, 2010, J CLIN NURS, V19, P1929, DOI 10.1111/j.1365-2702.2009.03125.x; Crow R, 2002, Health Technol Assess, V6, P1; DELGRECO L, 1987, CAN MED ASSOC J, V136, P699; Drain M, 2001, J Ambul Care Manage, V24, P30; Fayers PM, 1997, QUAL LIFE RES, V6, P139; FERRIS LE, 1992, CAN MED ASSOC J, V146, P1727; Fung D, 1998, ANESTH ANALG, V87, P1089, DOI 10.1097/00000539-199811000-00020; Gonzalez N, 2005, INT J QUAL HEALTH C, V17, P465, DOI 10.1093/intqhc/mzi067; Halcomb EJ, 2011, J NURS SCHOLARSHIP, V43, P318, DOI 10.1111/j.1547-5069.2011.01408.x; HALL JA, 1988, SOC SCI MED, V27, P935, DOI 10.1016/0277-9536(88)90284-5; Hardy GE, 1996, BRIT J HEALTH PSYCH, V1, P65, DOI 10.1111/j.2044-8287.1996.tb00492.x; Horne R, 2001, QUAL HEALTH CARE, V10, P135, DOI 10.1136/qhc.0100135..; Katz MH, 1997, J ACQ IMMUN DEF SYND, V14, P35, DOI 10.1097/00042560-199701010-00007; KIRSHNER B, 1985, J CHRON DIS, V38, P27, DOI 10.1016/0021-9681(85)90005-0; Labarere J, 2001, INT J QUAL HEALTH C, V13, P99, DOI 10.1093/intqhc/13.2.99; LINDERPELZ S, 1982, SOC SCI MED, V16, P577, DOI 10.1016/0277-9536(82)90311-2; Mohd Athar, 2014, Med J Armed Forces India, V70, P237, DOI 10.1016/j.mjafi.2013.06.010; Moores KL, 2012, INT J QUAL HEALTH C, V24, P517, DOI 10.1093/intqhc/mzs051; National Health Service, 2013, AD INP SURV 2013; Nunnally JC., 1994, PSYCHOMETRIC THEORY; Quispe SYO, 2011, INT J CLIN PHARM-NET, V33, P949, DOI 10.1007/s11096-011-9566-2; Pinto Sharrel L, 2010, J Pharm Pract, V23, P128, DOI 10.1177/0897190009334329; Singh J, 1989, ADV CONSUMER RES; Sitzia J, 1999, INT J QUAL HEALTH C, V11, P319, DOI 10.1093/intqhc/11.4.319; Vuori H, 1987, QRB Qual Rev Bull, V13, P106; Wei J, 2015, PUBLIC HEALTH, V129, P1523, DOI 10.1016/j.puhe.2015.03.004; Weston RL, 2010, INT J STD AIDS, V21, P584, DOI 10.1258/ijsa.2010.010159; Williams B, 1998, SOC SCI MED, V47, P1351, DOI 10.1016/S0277-9536(98)00213-5; Wong ELY, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-265; Wong ELY, 2013, INT J QUAL HEALTH C, V25, P443, DOI 10.1093/intqhc/mzt034; Wong ELY, 2011, INT J QUAL HEALTH C, V23, P390, DOI 10.1093/intqhc/mzr037; Ygge BM, 2001, INT J QUAL HEALTH C, V13, P33, DOI 10.1093/intqhc/13.1.33	39	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144785	10.1371/journal.pone.0144785	http://dx.doi.org/10.1371/journal.pone.0144785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1ZA	26658579	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903600090
J	Cao, SJ; Yu, L; Mao, JY; Wang, Q; Ruan, JS				Cao, Shujuan; Yu, Liang; Mao, Jingyuan; Wang, Quan; Ruan, Jishou			Uncovering the Molecular Mechanism of Actions between Pharmaceuticals and Proteins on the AD Network	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ACE; TAU; ACTIVATION; HYPOTHESIS; INHIBITORS; AFFINITY; RECEPTOR; PROGRESS; BINDING	This study begins with constructing the mini metabolic networks (MMNs) of beta amyloid (A beta) and acetylcholine (ACh) which stimulate the Alzheimer's Disease (AD). Then we generate the AD network by incorporating MMNs of A beta and ACh, and other MMNs of stimuli of AD. The panel of proteins contains 49 enzymes/receptors on the AD network which have the 3D-structure in PDB. The panel of drugs is formed by 5 AD drugs and 5 AD nutraceutical drugs, and 20 non-AD drugs. All of these complexes formed by these 30 drugs and 49 proteins are transformed into dyadic arrays. Utilizing the prior knowledge learned from the drug panel, we propose a statistical classification (dry-lab). According to the wet-lab for the complex of amiloride and insulin degrading enzyme, and the complex of amiloride and neutral endopeptidase, we are confident that this dry-lab is reliable. As the consequences of the dry-lab, we discover many interesting implications. Especially, we show that possible causes of Tacrine, donepezil, galantamine and huperzine A cannot improve the level of ACh which is against to their original design purpose but they still prevent AD to be worse as A beta deposition appeared. On the other hand, we recommend Miglitol and Atenolol as the safe and potent drugs to improve the level of ACh before A beta deposition appearing. Moreover, some nutrients such as NADH and Vitamin E should be controlled because they may harm health if being used in wrong way and wrong time. Anyway, the insights shown in this study are valuable to be developed further.	[Cao, Shujuan; Yu, Liang; Ruan, Jishou] Nankai Univ, Coll Math Sci, Tianjin 300071, Peoples R China; [Cao, Shujuan; Yu, Liang; Ruan, Jishou] Nankai Univ, LPMC, Tianjin 300071, Peoples R China; [Mao, Jingyuan] Tianjin Univ Tradit Chinese Med, Internal Med Heart, Tianjin, Peoples R China; [Wang, Quan] Chinese Acad Sci, Inst Biophys, Natl Lab Macromol, Beijing 100080, Peoples R China; [Wang, Quan] TEDA, Tianjin Int Joint Acad Biomed, High Throughput Mol Drug Discovery Ctr, Tianjin, Peoples R China; [Ruan, Jishou] Nankai Univ, State Key Lab Med Chem & Biol, Tianjin 300071, Peoples R China	Nankai University; Nankai University; Tianjin University of Traditional Chinese Medicine; Chinese Academy of Sciences; Institute of Biophysics, CAS; Tianjin International Joint Academy of Biomedicine; Nankai University	Ruan, JS (corresponding author), Nankai Univ, Coll Math Sci, Tianjin 300071, Peoples R China.	jsruan@nankai.edu.cn			Natural Science Funding of China [10671100, 11101226, 31050110432, 31150110577]; International Development Research Center in Ottawa, Canada [104519010]	Natural Science Funding of China; International Development Research Center in Ottawa, Canada	J.R. and his research group are thankful for the financial support from the Natural Science Funding of China (grants 10671100, 11101226, 31050110432, and 31150110577). J.R. also expresses gratitude to the International Development Research Center in Ottawa, Canada (grant 104519010).	Amtul Z, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.014; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bartzokis G, 2011, NEUROBIOL AGING, V32, P1341, DOI 10.1016/j.neurobiolaging.2009.08.007; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Birks J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005593; Bourne KZ, 2007, J NEUROSCI RES, V85, P1194, DOI 10.1002/jnr.21252; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; BUXBAUM JD, 1992, P NATL ACAD SCI USA, V89, P10075, DOI 10.1073/pnas.89.21.10075; Chen CH, 2012, INT J NEUROPSYCHOPH, V15, P77, DOI 10.1017/S1461145711000149; Cui W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037790; Glenn ND, 1981, BRIT J CLIN PHARMACO, V11, P549; Gohlke P, 2001, J PHARMACOL EXP THER, V298, P62; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Grommes C, 2013, CANCER CHEMOTH PHARM, V71, P929, DOI 10.1007/s00280-013-2084-2; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heneka MT, 2010, P NATL ACAD SCI USA, V107, P6058, DOI 10.1073/pnas.0909586107; Hu G, 2012, STRUCTURE, V20, P1815, DOI 10.1016/j.str.2012.09.011; HUNG AY, 1993, J BIOL CHEM, V268, P22959; Itzhaki RF, 2008, J ALZHEIMERS DIS, V13, P393; Jandeleit-Dahm KAM, 2006, J HUM HYPERTENS, V20, P478, DOI 10.1038/sj.jhh.1002018; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jouquey S, 1995, NEUROPHARMACOLOGY, V34, P1689, DOI 10.1016/0028-3908(95)00146-8; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Kuhn W, 1996, J NEURAL TRANSM, V103, P1187, DOI 10.1007/BF01271203; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Mellin V, 2005, J CARDIOVASC PHARM, V46, P390, DOI 10.1097/01.fjc.0000175457.48031.8b; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; Rosendoff C, 2007, AM J GERIATR CARDIOL, V16, P143, DOI 10.1111/j.1076-7460.2007.06696.x; Rossi GP, 2003, CARDIOVASC DRUG REV, V21, P51; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Szekely Christine A, 2007, Subcell Biochem, V42, P229; Thathiah A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.293re8; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Wang HY, 2000, J NEUROCHEM, V75, P1155, DOI 10.1046/j.1471-4159.2000.0751155.x; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033709; Wang R, 2006, ACTA PHARMACOL SIN, V27, P1, DOI 10.1111/j.1745-7254.2006.00255.x; Yorulmaz H, 2011, NEUROPHYSIOLOGY+, V42, P349, DOI 10.1007/s11062-011-9168-6	42	4	4	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144387	10.1371/journal.pone.0144387	http://dx.doi.org/10.1371/journal.pone.0144387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650760	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903300047
J	Gren, ST; Rasmussen, TB; Janciauskiene, S; Hakansson, K; Gerwien, JG; Grip, O				Gren, Susanne T.; Rasmussen, Thomas B.; Janciauskiene, Sabina; Hakansson, Katarina; Gerwien, Jens G.; Grip, Olof			A Single-Cell Gene-Expression Profile Reveals Inter-Cellular Heterogeneity within Human Monocyte Subsets	PLOS ONE			English	Article							BLOOD MONOCYTES; DENDRITIC CELLS; T-CELLS; CD16(+); MACROPHAGES; MIGRATION	Human monocytes are a heterogeneous cell population classified into three different subsets: Classical CD14(++)CD16(-), intermediate CD14(++)CD16(+), and non-classical CD14(+)CD16(++) monocytes. These subsets are distinguished by their differential expression of CD14 and CD16, and unique gene expression profile. So far, the variation in inter-cellular gene expression within the monocyte subsets is largely unknown. In this study, the cellular variation within each human monocyte subset from a single healthy donor was described by using a novel single- cell PCR gene-expression analysis tool. We investigated 86 different genes mainly encoding cell surface markers, and proteins involved in immune regulation. Within the three human monocyte subsets, our descriptive findings show multimodal expression of key immune response genes, such as CD40, NFkB1, RELA, TLR4, TLR8 and TLR9. Furthermore, we discovered one subgroup of cells within the classical monocytes, which showed alterations of 22 genes e.g. IRF8, CD40, CSF1R, NFkB1, RELA and TNF. Additionally one subgroup within the intermediate and non-classical monocytes also displayed distinct gene signatures by altered expression of 8 and 6 genes, respectively. Hence the three monocyte subsets can be further subdivided according to activation status and differentiation, independently of the traditional classification based on cell surface markers. Demonstrating the use and the ability to discover cell heterogeneity within defined populations of human monocytes is of great importance, and can be useful in unravelling inter-cellular variation in leukocyte populations, identifying subpopulations involved in disease pathogenesis and help tailor new therapies.	[Gren, Susanne T.; Hakansson, Katarina] Novo Nordisk AS, Cellular Pharmacol, Malov, Denmark; [Gren, Susanne T.; Grip, Olof] Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden; [Rasmussen, Thomas B.] Copenhagen Univ Hosp, Clin Immunol, Copenhagen, Denmark; [Janciauskiene, Sabina] Hannover Med Sch, Dept Resp Med, Hannover, Germany; [Gerwien, Jens G.] Novo Nordisk AS, Global Biobanking Management, Malov, Denmark	Novo Nordisk; Lund University; University of Copenhagen; Hannover Medical School; Novo Nordisk	Grip, O (corresponding author), Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden.	olof.grip@med.lu.se		Gren, Susanne Thiesen/0000-0003-4162-8083	Novo Nordisk A/S; Danish Agency for Science, Technology and Innovation	Novo Nordisk A/S(Novo Nordisk); Danish Agency for Science, Technology and Innovation	This work was supported by grants from Novo Nordisk A/S and the Danish Agency for Science, Technology and Innovation (http://en.fi.dk/funding/funding-opportunities/industrial-phdprogramme). The funder provided support in the form of salaries for authors [STG, TBR, KH, JGG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Ancuta P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-403; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Castano D, 2011, TUBERCULOSIS, V91, P348, DOI 10.1016/j.tube.2011.04.002; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; FINGERLE G, 1993, BLOOD, V82, P3170; Grip O, 2007, INFLAMM BOWEL DIS, V13, P566, DOI 10.1002/ibd.20025; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Holmkvist P, 2015, MUCOSAL IMMUNOL, V8, P545, DOI 10.1038/mi.2014.87; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Kawanaka N, 2002, ARTHRITIS RHEUM, V46, P2578, DOI 10.1002/art.10545; Kippner LE, 2014, PEERJ, V2, DOI 10.7717/peerj.452; Papadakis KA, 2004, J IMMUNOL, V172, P7002, DOI 10.4049/jimmunol.172.11.7002; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Randolph GJ, 2002, J EXP MED, V196, P517, DOI 10.1084/jem.20011608; Rogacev KS, 2011, EUR HEART J, V32, P84, DOI 10.1093/eurheartj/ehq371; Rossol M, 2012, ARTHRITIS RHEUM-US, V64, P671, DOI 10.1002/art.33418; Sattler A, 2009, BLOOD, V113, P1948, DOI 10.1182/blood-2008-02-139147; Schmidl C, 2014, BLOOD, V123, pE90, DOI 10.1182/blood-2013-02-484188; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Thiesen S, 2014, J LEUKOCYTE BIOL, V95, P531, DOI 10.1189/jlb.0113021; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025812; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Ziegler-Heitbrock L, 2014, CELL IMMUNOL, V291, P11, DOI 10.1016/j.cellimm.2014.06.008; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	29	70	71	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144351	10.1371/journal.pone.0144351	http://dx.doi.org/10.1371/journal.pone.0144351			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650546	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903300045
J	Howell, AM; Burns, EM; Bouras, G; Donaldson, LJ; Athanasiou, T; Darzi, A				Howell, Ann-Marie; Burns, Elaine M.; Bouras, George; Donaldson, Liam J.; Athanasiou, Thanos; Darzi, Ara			Can Patient Safety Incident Reports Be Used to Compare Hospital Safety? Results from a Quantitative Analysis of the English National Reporting and Learning System Data	PLOS ONE			English	Article							QUALITY-OF-CARE; OUTCOMES; NHS; ASSOCIATION; ANESTHESIA; ATTITUDES; ENGLAND; RATIOS	Background The National Reporting and Learning System (NRLS) collects reports about patient safety incidents in England. Government regulators use NRLS data to assess the safety of hospitals. This study aims to examine whether annual hospital incident reporting rates can be used as a surrogate indicator of individual hospital safety. Secondly assesses which hospital characteristics are correlated with high incident reporting rates and whether a high reporting hospital is safer than those lower reporting hospitals. Finally, it assesses which health-care professionals report more incidents of patient harm, which report more near miss incidents and what hospital factors encourage reporting. These findings may suggest methods for increasing the utility of reporting systems. Methods This study used a mix methods approach for assessing NRLS data. The data were investigated using Pareto analysis and regression models to establish which patients are most vulnerable to reported harm. Hospital factors were correlated with institutional reporting rates over one year to examine what factors influenced reporting. Staff survey findings regarding hospital safety culture were correlated with reported rates of incidents causing harm; no harm and death to understand what barriers influence error disclosure. Findings 5,879,954 incident reports were collected from acute hospitals over the decade. 70.3% of incidents produced no harm to the patient and 0.9% were judged by the reporter to have caused severe harm or death. Obstetrics and Gynaecology reported the most no harm events [OR 1.61(95% CI: 1.12 to 2.27), p<0.01] and pharmacy was the hospital location where most near-misses were captured [OR 3.03(95% CI: 2.04 to 4.55), p<0.01]. Clinicians were significantly more likely to report death than other staff [OR 3.04(95% CI: 2.43 to 3.80) p<0.01]. A higher ratio of clinicians to beds correlated with reduced rate of harm reported [RR = -1.78(95% Cl: -3.33 to -0.23), p = 0.03]. Litigation claims per bed were significantly negatively associated with incident reports. Patient satisfaction and mortality outcomes were not significantly associated with reporting rates. Staff survey responses revealed that keeping reports confidential, keeping staff informed about incidents and giving feedback on safety initiatives increased reporting rates [r = 0.26 (p<0.01), r = 0.17 (p = 0.04), r = 0.23 (p = 0.01), r = 0.20 (p = 0.02)]. Conclusion The NRLS is the largest patient safety reporting system in the world. This study did not demonstrate many hospital characteristics to significantly influence overall reporting rate. There were no association between size of hospital, number of staff, mortality outcomes or patient satisfaction outcomes and incident reporting rate. The study did show that hospitals where staff reported more incidents had reduced litigation claims and when clinician staffing is increased fewer incidents reporting patient harm are reported, whilst near misses remain the same. Certain specialties report more near misses than others, and doctors report more harm incidents than near misses. Staff survey results showed that open environments and reduced fear of punitive response increases incident reporting. We suggest that reporting rates should not be used to assess hospital safety. Different healthcare professionals focus on different types of safety incidents and focusing on these areas whilst creating a responsive, confidential learning environment will increase staff engagement with error disclosure.	[Howell, Ann-Marie; Burns, Elaine M.; Bouras, George; Athanasiou, Thanos; Darzi, Ara] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, St Marys Hosp, London, England; [Donaldson, Liam J.; Darzi, Ara] Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth Innovat, St Marys Hosp, London, England	Imperial College London; Imperial College London	Howell, AM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, St Marys Hosp, London, England.	a.howell@imperial.ac.uk	Burns, Elaine/V-5416-2019		NHS England; Cancer Research-UK Clinical Lectureship [C42671/A13720]; National Institute for Health Research [NF-SI-0510-10186] Funding Source: researchfish	NHS England; Cancer Research-UK Clinical Lectureship; National Institute for Health Research(National Institute for Health Research (NIHR))	All authors (AMH, EB, GB, LJD, TA, AD) have been commissioned by and receive funding from NHS England to implement an independent research and development program for the NRLS. NHS England had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. EB is supported by a Cancer Research-UK Clinical Lectureship (C42671/A13720). Cancer Research UK had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arabi Y, 2012, J PATIENT SAF, V8, P81, DOI 10.1097/PTS.0b013e31824badb7; Arabi YM, 2010, AM J RESP CRITICAL C, V181; Benn J, 2009, QUAL SAF HEALTH CARE, V18, P11, DOI 10.1136/qshc.2007.024166; Birkmeyer NJO, 2013, ANN SURG, V257, P260, DOI 10.1097/SLA.0b013e31826c0085; Bruce J, 2001, Health Technol Assess, V5, P1; Campbell MJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1001; Catchpole K, 2008, ANAESTHESIA, V63, P340, DOI 10.1111/j.1365-2044.2007.05427.x; Choy CY, 2008, CURR OPIN ANESTHESIO, V21, P183, DOI 10.1097/ACO.0b013e3282f33592; Darzi A, 2008, LANCET, V371, P1563, DOI 10.1016/S0140-6736(08)60672-8; de Feijter JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031125; [Department of Health National Audit Office H.o.C.C.o.P. Accounts.], 2006, SAF PLAC PAT LEARN I; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Donaldson L, 2002, CLIN MED, V2, P452, DOI 10.7861/clinmedicine.2-5-452; Evans SM, 2006, QUAL SAF HEALTH CARE, V15, P39, DOI 10.1136/qshc.2004.012559; Ferroli P, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12252; Ghaferi AA, 2010, J SURG RES, V158, P310; Harless DW, 2010, MED CARE, V48, P659, DOI 10.1097/MLR.0b013e3181dbe200; Hogan H, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3239; HSCIC, 2012, SUMM HOSP LEV MORT I; Hutchinson A, 2009, QUAL SAF HEALTH CARE, V18, P5, DOI 10.1136/qshc.2007.022400; Imison C, 2012, OLDER PEOPLE EM BED; Itri JN, 2012, J AM COLL RADIOL, V9, P329, DOI 10.1016/j.jacr.2011.11.015; Kane Robert L, 2007, Evid Rep Technol Assess (Full Rep), P1; Kane RL, 2007, MED CARE, V45, P1195, DOI 10.1097/MLR.0b013e3181468ca3; Keogh B, 2013, REV QUALITY CARE TRE; Kingston MJ, 2004, MED J AUSTRALIA, V181, P36, DOI 10.5694/j.1326-5377.2004.tb06158.x; Leguelinel-Blache G, 2014, EUR J INTERN MED; National Advisory Group on the Safety of Patients in England, 2013, PROM LEARN A COMM AC; NHS, 2010, NHS LIT AUTH FACTSH; NHS, 2012, BEDS OP OV 2010 2011; NHS, 2010, NAT NHS STAFF SURV; NHS, 2012, NHS WORKF 2010; NRLS, NRLS Q DAT SUMM 2012; Penoyer DA, 2010, CRIT CARE MED, V38, P1521, DOI 10.1097/CCM.0b013e3181e47888; Pinder RJ, 2013, BMJ QUAL SAF, V22, P563, DOI 10.1136/bmjqs-2012-001540; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Roehr B, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e386; Runciman W, 2009, INT J QUAL HEALTH C, V21, P18, DOI 10.1093/intqhc/mzn057; Sari ABA, 2007, BMJ-BRIT MED J, V334, P79, DOI 10.1136/bmj.39031.507153.AE; Shaw KN, 2012, EMERG MED J; Shekelle PG, 2013, ANN INTERN MED, V158, P404, DOI 10.7326/0003-4819-158-5-201303051-00007; Singer S, 2009, HEALTH SERV RES, V44, P399, DOI 10.1111/j.1475-6773.2008.00918.x; Spigelman AD, 2005, ANZ J SURG, V75, P657, DOI 10.1111/j.1445-2197.2005.03482.x; Thomas L, 2012, BMJ QUAL SAF; Vincent C, 1999, J EVAL CLIN PRACT, V5, P13, DOI 10.1046/j.1365-2753.1999.00147.x; Ward JK, 2012, BMJ QUAL SAF, V21, P685, DOI 10.1136/bmjqs-2011-000213; Weingart SN, 2007, JT COMM J QUAL PATIE, V33, P83, DOI 10.1016/S1553-7250(07)33010-9; Williams SK, 2006, MED J AUSTRALIA, V184, pS65	48	60	63	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144107	10.1371/journal.pone.0144107	http://dx.doi.org/10.1371/journal.pone.0144107			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650823	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000366903300036
J	Luo, P; Dong, GT; Liu, L; Zhou, H				Luo, Pei; Dong, Gengting; Liu, Liang; Zhou, Hua			The Long-Term Consumption of Ginseng Extract Reduces the Susceptibility of Intermediate-Aged Hearts to Acute Ischemia Reperfusion Injury	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; CARDIAC-HYPERTROPHY; PANAX-GINSENG; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; RATS; FAILURE; ANGIOGENESIS; DISEASE; YOUNG	Background A large number of experimental studies using young adult subjects have shown that ginseng (Panax ginseng C.A. Meyer) protects against ischemia heart disease. However, ginseng has not been explored for its anti-I/R effect and mechanism of action in the aged myocardium. The present study was designed to evaluate the effects of the long-term consumption of ginseng extract on myocardial I/R in an in vivo rat model and explore the potential underlying mechanism. Methods and Results Young (6-mo-old) and intermediate-aged (18-mo-old) rats were gavaged with either standardized ginseng extract (RSE) at 80 mg/kg or vehicle for 90 days. The rats were sacrificed after LAD coronary artery ligation was performed to induce 30 min of ischemia, followed by 90 min of reperfusion. The myocardial infarct size was measured. Left ventricular function was evaluated using pressure-volume loops. The levels of survival, apoptotic and longevity protein expression were assessed through Western blot analysis. Myocardial pathology was detected through H&E or Masson's trichrome staining. We observed higher infarct expansion with impairment in the LV functional parameters, such as LVSP and LVEDP, in aged rats compared with young rats. Enhanced Akt phosphorylation and eNOS expression in RSE-treated aged hearts were accompanied with reduced infarct size, improved cardiac performance, and inducted survival signals. In contrast, p-Erk and caspase 7 were significantly downregulated in aged rats, suggesting that cardiomyocyte apoptosis was suppressed after RSE treatment. RSE also inhibited caspase-3/7 activation and decreased Bax/Bcl-2 ratio. Consistent with the results of apoptosis, Sirt1 and Sirt3 were significantly increased in the RSE-treated aged heart compared with vehicle-treated I/R, suggesting that the anti-aging effect was correlated with the anti-apoptotic activity of RSE. Conclusion These findings suggest that the long-term consumption of ginseng extract reduced the susceptibility of intermediate-aged hearts to acute ischemia reperfusion injury in rats. These effects might be mediated through the activation of Akt/eNOS, suppression of Erk/caspase 7 and upregulation of Sirt1 and Sirt3 in intermediate-aged rats.	[Luo, Pei; Dong, Gengting; Liu, Liang; Zhou, Hua] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China; [Luo, Pei; Liu, Liang; Zhou, Hua] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon, Hong Kong, Peoples R China	Macau University of Science & Technology; Hong Kong Baptist University	Liu, L (corresponding author), Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Ave Wai Long, Taipa, Macau, Peoples R China.	lliu@must.edu.mo; hzhou@must.edu.mo			Macao Science and Technology Development Fund [071/2011/A3, 073/2011/A3, 052/2013/A2]; Faculty Research Grant of Hong Kong Baptist University [FRG 08-09 II-18]	Macao Science and Technology Development Fund; Faculty Research Grant of Hong Kong Baptist University	This research was supported by the Macao Science and Technology Development Fund (Grant numbers: 071/2011/A3, 073/2011/A3, www.fdct.gov.mo) and the Faculty Research Grant of Hong Kong Baptist University (Grant numbers: FRG 08-09 II-18; URL: www.hkbu.edu.hk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Macao Science and Technology Development Fund (Grant numbers: 071/2011/A3, 073/2011/A3, 052/2013/A2; URL: www.fdct.gov.mo) and the Faculty Research Grant of Hong Kong Baptist University (Grant numbers: FRG 08-09 II-18; URL: www.hkbu.edu.hk).	Arbab-Zadeh A, 2004, CIRCULATION, V110, P1799, DOI 10.1161/01.CIR.0000142863.71285.74; Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194; Choi KT, 2008, ACTA PHARMACOL SIN, V29, P1109, DOI 10.1111/j.1745-7254.2008.00869.x; Dai DF, 2012, ANTIOXID REDOX SIGN, V16, P1492, DOI 10.1089/ars.2011.4179; de Souza RR, 2002, BIOGERONTOLOGY, V3, P325, DOI 10.1023/A:1021312027486; Forman DE, 1997, J AM COLL CARDIOL, V30, P1872, DOI 10.1016/S0735-1097(97)00411-7; Fromm Annette, 2014, BMC Res Notes, V7, P176, DOI 10.1186/1756-0500-7-176; Fu Y, 2003, J NUTR, V133, P3603, DOI 10.1093/jn/133.11.3603; Gould KE, 2002, AM J PHYSIOL-HEART C, V282, pH615, DOI 10.1152/ajpheart.00206.2001; Hacker TA, 2006, AM J PHYSIOL-HEART C, V290, pH304, DOI 10.1152/ajpheart.00290.2005; HOIT BD, 1986, CIRCULATION, V74, P712, DOI 10.1161/01.CIR.74.4.712; Im DS, 2013, ACTA PHARMACOL SIN, V34, P1367, DOI 10.1038/aps.2013.100; Joukar S, 2010, CARDIOVASC TOXICOL, V10, P66, DOI 10.1007/s12012-010-9063-1; Karmazyn M, 2011, DRUGS, V71, P1989, DOI 10.2165/11594300-000000000-00000; Kim JH, 2012, J GINSENG RES, V36, P16, DOI 10.5142/jgr.2012.36.1.16; Kris-Etherton PM, 2004, CIRCULATION, V110, P637, DOI 10.1161/01.CIR.0000137822.39831.F1; Lindsey ML, 2006, AM J PHYSIOL-HEART C, V290, pH232, DOI 10.1152/ajpheart.00457.2005; Lindsey ML, 2005, CARDIOVASC RES, V66, P410, DOI 10.1016/j.cardiores.2004.11.029; Nadal-Ginard B, 2003, CIRC RES, V92, P139, DOI 10.1161/01.RES.0000053618.86362.DF; Phaneuf S, 2002, AM J PHYSIOL-REG I, V282, pR423, DOI 10.1152/ajpregu.00296.2001; Pillai VB, 2014, CIRC RES, V114, P368, DOI 10.1161/CIRCRESAHA.113.300536; Ramesh T, 2012, EXP GERONTOL, V47, P77, DOI 10.1016/j.exger.2011.10.007; Rich MW, 2006, AM J GERIATR CARDIOL, V15, P7, DOI 10.1111/j.1076-7460.2006.05273.x; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Song JQ, 2009, APOPTOSIS, V14, P1299, DOI 10.1007/s10495-009-0398-7; Sulaiman M, 2010, AM J PHYSIOL-HEART C, V298, pH833, DOI 10.1152/ajpheart.00418.2009; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Turer AT, 2010, AM J CARDIOL, V106, P360, DOI 10.1016/j.amjcard.2010.03.032; Weiss RG, 2005, P NATL ACAD SCI USA, V102, P808, DOI 10.1073/pnas.0408962102; Xiang YZ, 2008, PHYTOTHER RES, V22, P851, DOI 10.1002/ptr.2384; Yang B, 1999, AM J PHYSIOL-HEART C, V277, pH1906, DOI 10.1152/ajpheart.1999.277.5.H1906; Yang YN, 2008, AM J PHYSIOL-HEART C, V294, pH1815, DOI 10.1152/ajpheart.00831.2007; Zhou H, 2011, J ETHNOPHARMACOL, V135, P287, DOI 10.1016/j.jep.2011.03.015	33	22	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144733	10.1371/journal.pone.0144733	http://dx.doi.org/10.1371/journal.pone.0144733			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650753	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903300071
J	Alocci, D; Mariethoz, J; Horlacher, O; Bolleman, JT; Campbell, MP; Lisacek, F				Alocci, Davide; Mariethoz, Julien; Horlacher, Oliver; Bolleman, Jerven T.; Campbell, Matthew P.; Lisacek, Frederique			Property Graph vs RDF Triple Store: A Comparison on Glycan Substructure Search	PLOS ONE			English	Article							GLYCOMICS DATA; NOMENCLATURE; REPRESENTATION; PLATFORM	Resource description framework (RDF) and Property Graph databases are emerging technologies that are used for storing graph-structured data. We compare these technologies through a molecular biology use case: glycan substructure search. Glycans are branched tree-like molecules composed of building blocks linked together by chemical bonds. The molecular structure of a glycan can be encoded into a direct acyclic graph where each node represents a building block and each edge serves as a chemical linkage between two building blocks. In this context, Graph databases are possible software solutions for storing glycan structures and Graph query languages, such as SPARQL and Cypher, can be used to perform a substructure search. Glycan substructure searching is an important feature for querying structure and experimental glycan databases and retrieving biologically meaningful data. This applies for example to identifying a region of the glycan recognised by a glycan binding protein (GBP). In this study, 19,404 glycan structures were selected from Glycome-DB (www.glycome-db.org) and modelled for being stored into a RDF triple store and a Property Graph. We then performed two different sets of searches and compared the query response times and the results from both technologies to assess performance and accuracy. The two implementations produced the same results, but interestingly we noted a difference in the query response times. Qualitative measures such as portability were also used to define further criteria for choosing the technology adapted to solving glycan substructure search and other comparable issues.	[Alocci, Davide; Mariethoz, Julien; Horlacher, Oliver; Lisacek, Frederique] SIB Swiss Inst Bioinformat, Proteome Informat Grp, CH-1211 Geneva, Switzerland; [Alocci, Davide; Horlacher, Oliver; Lisacek, Frederique] Univ Geneva, Dept Comp Sci, CH-1227 Geneva, Switzerland; [Bolleman, Jerven T.] SIB Swiss Inst Bioinformat, Swiss Prot Grp, CH-1211 Geneva, Switzerland; [Campbell, Matthew P.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia	Swiss Institute of Bioinformatics; University of Geneva; Swiss Institute of Bioinformatics; University of Geneva; Macquarie University	Lisacek, F (corresponding author), SIB Swiss Inst Bioinformat, Proteome Informat Grp, CH-1211 Geneva, Switzerland.	Frederique.lisacek@isb-sib.ch	; Campbell, Matthew/D-8874-2015	Mariethoz, Julien/0000-0001-8974-4417; LISACEK, Frederique/0000-0002-0948-4537; Campbell, Matthew/0000-0002-9525-792X; Bolleman, Jerven/0000-0002-7449-1266	Seventh Framework Programme - Initial Training Network [316929]; Swiss Federal Government through the State Secretariat for Education, Research and Innovation SERI; EU-ITN (FP7-PEOPLE-ITN) [316929]; Australian National eResearch Collaboration Tools and Resources project (NeCTAR)	Seventh Framework Programme - Initial Training Network; Swiss Federal Government through the State Secretariat for Education, Research and Innovation SERI; EU-ITN (FP7-PEOPLE-ITN); Australian National eResearch Collaboration Tools and Resources project (NeCTAR)	This work is supported by the Seventh Framework Programme - Initial Training Network No 316929 (http://ec.europa.eu/research/fp7/index_en.cfm). The grant recipient is FL. This activity at SIB is supported by the Swiss Federal Government through the State Secretariat for Education, Research and Innovation SERI. DA is supported by EU-ITN (FP7-PEOPLE-2012-ITN # 316929). MPC acknowledges funding support from the Australian National eResearch Collaboration Tools and Resources project (NeCTAR).	Angles R, 2013, 1 INT WORKSH GRAPH D, DOI 10.1145/2484425.2484440; [Anonymous], RESOURCE DESCRIPTION; [Anonymous], BLAZ ULTR HIGH PERF; Aoki KF, 2004, NUCLEIC ACIDS RES, V32, pW267, DOI 10.1093/nar/gkh473; Aoki-Kinoshita KF, 2013, J BIOMED SEMANT, V4, DOI 10.1186/2041-1480-4-39; Aoki-Kinoshita Kiyoko F, 2008, Seikagaku, V80, P1038; Auer S, 2007, LECT NOTES COMPUT SC, V4825, P722, DOI 10.1007/978-3-540-76298-0_52; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Broekstra J., 2002, ISWC, V2002, P54, DOI DOI 10.1007/3-540-48005-6_; Campbell MP, 2014, NUCLEIC ACIDS RES, V42, pD215, DOI 10.1093/nar/gkt1128; Campbell MP, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S1-S9; Cummings RD, 2009, MOL BIOSYST, V5, P1087, DOI 10.1039/b907931a; DOUBET S, 1992, GLYCOBIOLOGY, V2, P505, DOI 10.1093/glycob/2.6.505; Erling O., 2009, NETWORKED KNOWLEDGE, P7; Herget S, 2008, CARBOHYD RES, V343, P2162, DOI 10.1016/j.carres.2008.03.011; Holzschuher F., 2013, P GRAPHQ EDBT ICDT 1, P195, DOI DOI 10.1145/2457317.2457351; Horlacher O, 2015, J PROTEOMICS, V129, P63, DOI 10.1016/j.jprot.2015.06.013; Kawasaki T., 2008, EXPT GLYCOSCIENCE, P429, DOI [10.1007/978-4-431-77922-3_104, DOI 10.1007/978-4-431-77922-3_104]; Kotera M, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S6-S2; McNaught AD, 1997, CARBOHYD RES, V297, P1, DOI 10.1016/S0008-6215(97)83449-0; Ranzinger R, 2015, BIOINFORMATICS, V31, P919, DOI 10.1093/bioinformatics/btu732; Ranzinger R, 2011, NUCLEIC ACIDS RES, V39, pD373, DOI 10.1093/nar/gkq1014; Sahoo SS, 2005, CARBOHYD RES, V340, P2802, DOI 10.1016/j.carres.2005.09.019; SHARON N, 1986, GLYCOCONJUGATE J, V3, P123, DOI 10.1007/BF01049370; Tanaka K, 2014, J CHEM INF MODEL, V54, P1558, DOI 10.1021/ci400571e; Toukach PV, 2016, NUCLEIC ACIDS RES, V44, pD1229, DOI 10.1093/nar/gkv840; Varki A., 1999, ESSENTIALS GLYCOBIOL; Varki A, 2009, PROTEOMICS, V9, P5398, DOI 10.1002/pmic.200900708; von der Lieth CW, 2011, GLYCOBIOLOGY, V21, P493, DOI 10.1093/glycob/cwq188; York William S., GLYDE 2 GLYCAN STRUC	30	31	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144578	10.1371/journal.pone.0144578	http://dx.doi.org/10.1371/journal.pone.0144578			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656740	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900066
J	Mateescu, M; Baixe, S; Garnier, T; Jierry, L; Ball, V; Haikel, Y; Metz-Boutigue, MH; Nardin, M; Schaaf, P; Etienne, O; Lavalle, P				Mateescu, Mihaela; Baixe, Sebastien; Garnier, Tony; Jierry, Loic; Ball, Vincent; Haikel, Youssef; Metz-Boutigue, Marie Helene; Nardin, Michel; Schaaf, Pierre; Etienne, Olivier; Lavalle, Philippe			Antibacterial Peptide-Based Gel for Prevention of Medical Implanted-Device Infection	PLOS ONE			English	Article							RELEASE-INHIBITORY PEPTIDE; IN-VITRO; CHROMOGRANIN-A; DENTAL IMPLANTS; SOL-GEL; CATESTATIN; HYDROGELS; SURFACES; VIVO; ANTIBIOTICS	Implanted medical devices are prone to infection. Designing new strategies to reduce infection and implant rejection are an important challenge for modern medicine. To this end, in the last few years many hydrogels have been designed as matrices for antimicrobial molecules destined to fight frequent infection found in moist environments like the oral cavity. In this study, two types of original hydrogels containing the antimicrobial peptide Cateslytin have been designed. The first hydrogel is based on alginate modified with catechol moieties (AC gel). The choice of these catechol functional groups which derive from mussel's catechol originates from their strong adhesion properties on various surfaces. The second type of gel we tested is a mixture of alginate catechol and thiol-terminated Pluronic (AC/PlubisSH), a polymer derived from Pluronic, a well-known biocompatible polymer. This PlubisSH polymer has been chosen for its capacity to enhance the cohesion of the composition. These two gels offer new clinical uses, as they can be injected and jellify in a few minutes. Moreover, we show these gels strongly adhere to implant surfaces and gingiva. Once gelled, they demonstrate a high level of rheological properties and stability. In particular, the dissipative energy of the (AC/PlubisSH) gel detachment reaches a high value on gingiva (10 J.m(-2)) and on titanium alloys (4 J.m(-2)), conferring a strong mechanical barrier. Moreover, the Cateslytin peptide in hydrogels exhibited potent antimicrobial activities against P. gingivalis, where a strong inhibition of bacterial metabolic activity and viability was observed, indicating reduced virulence. Gel biocompatibility tests indicate no signs of toxicity. In conclusion, these new hydrogels could be ideal candidates in the prevention and/or management of periimplant diseases.	[Mateescu, Mihaela; Baixe, Sebastien; Ball, Vincent; Haikel, Youssef; Metz-Boutigue, Marie Helene; Schaaf, Pierre; Etienne, Olivier; Lavalle, Philippe] INSERM, UMR S 1121, Biomat & Bioingn, Strasbourg, France; [Mateescu, Mihaela; Baixe, Sebastien; Ball, Vincent; Haikel, Youssef; Metz-Boutigue, Marie Helene; Schaaf, Pierre; Etienne, Olivier; Lavalle, Philippe] Univ Strasbourg, Fac Chirurg Dent, Strasbourg, France; [Garnier, Tony; Jierry, Loic; Schaaf, Pierre] Univ Strasbourg, CNRS, Inst Charles Sadron, Strasbourg, France; [Nardin, Michel] CNRS, LRC 7228, Inst Sci Mat Mulhouse, Mulhouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Universites de Strasbourg Etablissements Associes; Universite de Haute-Alsace (UHA)	Etienne, O (corresponding author), INSERM, UMR S 1121, Biomat & Bioingn, Strasbourg, France.	olivier.etienne@unistra.fr	ETIENNE, olivier/D-1601-2013; SCHAAF, Pierre/J-2751-2016; etienne, olivier/D-9542-2011; Lavalle, Philippe/E-6328-2016; BALL, Vincent VB/E-8500-2016	ETIENNE, olivier/0000-0001-8870-4659; SCHAAF, Pierre/0000-0001-7423-5492; etienne, olivier/0000-0001-8870-4659; Lavalle, Philippe/0000-0001-8798-912X; JIERRY, Loic/0000-0002-7541-1360	Projet MICA Dopaglue	Projet MICA Dopaglue	This work was supported by Projet MICA Dopaglue (http://www.instituts-carnot.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah Al N, 2011, MACROMOLECULAR BIOSC, V11, P1264, DOI [10.1002/mabi.201100083, DOI 10.1002/MABI.201100083]; Akaddar A, 2010, CELL MOL LIFE SCI, V67, P1005, DOI 10.1007/s00018-009-0235-8; Bahar AA, 2013, PHARMACEUTICALS-BASE, V6, P1543, DOI 10.3390/ph6121543; Ben-Nissan B, 2006, NANOMEDICINE-UK, V1, P311, DOI 10.2217/17435889.1.3.311; Besimo CE, 1999, INT J ORAL MAX IMPL, V14, P654; Brandl F, 2010, J CONTROL RELEASE, V142, P221, DOI 10.1016/j.jconrel.2009.10.030; Briolat J, 2005, CELL MOL LIFE SCI, V62, P377, DOI 10.1007/s00018-004-4461-9; Cado G, 2012, LANGMUIR, V28, P8470, DOI 10.1021/la300563s; Chae JJ, 2014, MIL MED, V179, P686, DOI 10.7205/MILMED-D-13-00360; D'Ercole S, 2009, INT J IMMUNOPATH PH, V22, P1019, DOI 10.1177/039463200902200417; Ding FY, 2013, CARBOHYD POLYM, V98, P1547, DOI 10.1016/j.carbpol.2013.07.042; Etienne O, 2006, J DENT RES, V85, P44, DOI 10.1177/154405910608500107; Glinel K, 2012, ACTA BIOMATER, V8, P1670, DOI 10.1016/j.actbio.2012.01.011; Gupta H, 2015, J PHARM BIOALLIED SC, V7, P9, DOI 10.4103/0975-7406.149810; Johnson DW, 2009, PERITON DIALYSIS INT, V29, P303; Kastrup CJ, 2012, P NATL ACAD SCI USA, V109, P21444, DOI 10.1073/pnas.1217972110; Kennedy BP, 1998, PEPTIDES, V19, P1241, DOI 10.1016/S0196-9781(98)00086-2; Lee C, 2013, BIOMACROMOLECULES, V14, P2004, DOI 10.1021/bm400352d; Lee Y, 2010, SOFT MATTER, V6, P977, DOI 10.1039/b919944f; Lin HR, 2004, BIOMACROMOLECULES, V5, P2358, DOI 10.1021/bm0496965; Mahata SK, 2000, MOL ENDOCRINOL, V14, P1525, DOI 10.1210/me.14.10.1525; Matsuno H, 2006, J ORTHOP SCI, V11, P497, DOI 10.1007/s00776-006-1059-0; Nayak AG, 2014, J ORAL IMPLANTOL, V40, P11, DOI 10.1563/AAID-JOI-D-10-00167; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; O'Connor DT, 2002, J HYPERTENS, V20, P1335, DOI 10.1097/00004872-200207000-00020; Paolantonio M, 2008, J PERIODONTOL, V79, P1419, DOI [10.1902/jop.2008.070660, 10.1902/jop.2008.070660 ]; Pingel LC, 2008, IMMUNOL CELL BIOL, V86, P643, DOI 10.1038/icb.2008.56; Radin S, 2001, J BIOMED MATER RES, V57, P313, DOI 10.1002/1097-4636(200111)57:2<313::AID-JBM1173>3.0.CO;2-E; Risbud MV, 2000, J CONTROL RELEASE, V68, P23, DOI 10.1016/S0168-3659(00)00208-X; Ryu JH, 2011, BIOMACROMOLECULES, V12, P2653, DOI 10.1021/bm200464x; van Winkelhoff AJ, 2012, EUR J ORAL IMPLANTOL, V5, pS43; Wang GS, 2015, PHARMACEUTICALS-BASE, V8, P123, DOI 10.3390/ph8010123; Wang GS, 2014, PHARMACEUTICALS-BASE, V7, P545, DOI 10.3390/ph7050545; Xu JK, 2012, LANGMUIR, V28, P14010, DOI 10.1021/la3025414; Zitzmann NU, 2008, J CLIN PERIODONTOL, V35, P286, DOI 10.1111/j.1600-051X.2008.01274.x	35	46	47	2	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145143	10.1371/journal.pone.0145143	http://dx.doi.org/10.1371/journal.pone.0145143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659616	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900187
J	Ogata, N; Kozaki, T; Yokoyama, T; Hata, T; Iwabuchi, K				Ogata, Norichika; Kozaki, Toshinori; Yokoyama, Takeshi; Hata, Tamako; Iwabuchi, Kikuo			Comparison between the Amount of Environmental Change and the Amount of Transcriptome Change	PLOS ONE			English	Article							CELL-LINE; HETEROGENEITY; NETWORK	Cells must coordinate adjustments in genome expression to accommodate changes in their environment. We hypothesized that the amount of transcriptome change is proportional to the amount of environmental change. To capture the effects of environmental changes on the transcriptome, we compared transcriptome diversities (defined as the Shannon entropy of frequency distribution) of silkworm fat-body tissues cultured with several concentrations of phenobarbital. Although there was no proportional relationship, we did identify a drug concentration "tipping point" between 0.25 and 1.0 mM. Cells cultured in media containing lower drug concentrations than the tipping point showed uniformly high transcriptome diversities, while those cultured at higher drug concentrations than the tipping point showed uniformly low transcriptome diversities. The plasticity of transcriptome diversity was corroborated by cultivations of fat bodies in MGM-450 insect medium without phenobarbital and in 0.25 mM phenobarbital-supplemented MGM-450 insect medium after previous cultivation (cultivation for 80 hours in MGM-450 insect medium without phenobarbital, followed by cultivation for 10 hours in 1.0 mM phenobarbital-supplemented MGM-450 insect medium). Interestingly, the transcriptome diversities of cells cultured in media containing 0.25 mM phenobarbital after previous cultivation (cultivation for 80 hours in MGM-450 insect medium without phenobarbital, followed by cultivation for 10 hours in 1.0 mM phenobarbital-supplemented MGM-450 insect medium) were different from cells cultured in media containing 0.25 mM phenobarbital after previous cultivation (cultivation for 80 hours in MGM-450 insect medium without phenobarbital). This hysteretic phenomenon of transcriptome diversities indicates multi-stability of the genome expression system. Cellular memories were recorded in genome expression networks as in DNA/histone modifications.	[Ogata, Norichika] Nihon BioData Corp, Takatsu Ku, Kawasaki, Kanagawa 2130012, Japan; [Kozaki, Toshinori] Tokyo Univ Agr & Technol, Human Resource Dev Program Agr Genome Sci, Fuchu, Tokyo 1838501, Japan; [Yokoyama, Takeshi] Tokyo Univ Agr & Technol, Fac Agr, Sericultural Sci Lab, Fuchu, Tokyo 1838501, Japan; [Hata, Tamako] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan; [Iwabuchi, Kikuo] Tokyo Univ Agr & Technol, Fac Agr, Appl Entomol Lab, Fuchu, Tokyo 1838501, Japan	Tokyo University of Agriculture & Technology; Tokyo University of Agriculture & Technology; National Institute of Agrobiological Sciences - Japan; Tokyo University of Agriculture & Technology	Ogata, N (corresponding author), Nihon BioData Corp, Takatsu Ku, 3-2-1 Sakado, Kawasaki, Kanagawa 2130012, Japan.	norichik@nbiodata.com	Yokoyama, Takeshi/C-3854-2013; Iwabuchi, Kikuo/I-7530-2012	Ogata, Norichika/0000-0002-6856-6655	Nihon BioData Corporation; Grants-in-Aid for Scientific Research [15H02483] Funding Source: KAKEN	Nihon BioData Corporation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Ogata is a member of a commercial company: Nihon BioData Corporation (NBD). NBD is Ogata's company, and Ogata bought some materials using the company's money. The funder, Nihon BioData Corporation, provided support in the form of materials for author NO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section."	ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Heckel DG, 2012, SCIENCE, V337, P1613, DOI 10.1126/science.1226994; Heil M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030537; Huang Sui, 2006, Breast Dis, V26, P27; Kramer BP, 2005, P NATL ACAD SCI USA, V102, P9517, DOI 10.1073/pnas.0500345102; Le Vee M, 2009, DRUG METAB DISPOS, V37, P2228, DOI 10.1124/dmd.109.028035; Loscher W, 2009, EPILEPSIA, V50, P1, DOI 10.1111/j.1528-1167.2008.01716.x; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martinez O, 2008, P NATL ACAD SCI USA, V105, P9709, DOI 10.1073/pnas.0803479105; Martinez O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010398; MITSUHASHI J, 1988, APPL ENTOMOL ZOOL, V23, P488, DOI 10.1303/aez.23.488; Noori HR, 2014, SPRINGERBR APPL SCI, P1, DOI 10.1007/978-3-642-38218-5; Ogata N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034940; Ohno M, 2009, BIOL PHARM BULL, V32, P813, DOI 10.1248/bpb.32.813; Saadatpour A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0525-9; Wei P., 2002, Pharmacogenomics Journal, V2, P117, DOI 10.1038/sj.tpj.6500087	19	5	5	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144822	10.1371/journal.pone.0144822	http://dx.doi.org/10.1371/journal.pone.0144822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657512	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900111
J	Arcanjo, DDR; Vasconcelos, AG; Comerma-Steffensen, SG; Jesus, JR; Silva, LP; Pires, OR; Costa-Neto, CM; Oliveira, EB; Migliolo, L; Franco, OL; Restini, CBA; Paulo, M; Bendhack, LM; Bemquerer, MP; Oliveira, AP; Simonsen, U; Leite, JRDD				Rufino Arcanjo, Daniel Dias; Vasconcelos, Andreanne Gomes; Comerma-Steffensen, Simon Gabriel; Jesus, Joilson Ramos; Silva, Luciano Paulino; Pires Junior, Osmindo Rodrigues; Costa-Neto, Claudio Miguel; Oliveira, Eduardo Brandt; Migliolo, Ludovico; Franco, Octavio Luiz; Araujo Restini, Carolina Baraldi; Paulo, Michele; Bendhack, Lusiane Maria; Bemquerer, Marcelo Porto; Oliveira, Aldeidia Pereira; Simonsen, Ulf; de Souza de Almeida Leite, Jose Roberto			A Novel Vasoactive Proline-Rich Oligopeptide from the Skin Secretion of the Frog Brachycephalus ephippium	PLOS ONE			English	Article							BRADYKININ-POTENTIATING PEPTIDES; ANGIOTENSIN-CONVERTING-ENZYME; ATLANTIC RAIN-FOREST; NITRIC-OXIDE; BOTHROPS-JARARACA; NATRIURETIC PEPTIDE; MASS-SPECTROMETRY; RELAXING FACTOR; SCORPION-VENOM; SMOOTH-MUSCLE	Proline-rich oligopeptides (PROs) are a large family which comprises the bradykinin-potentiating peptides (BPPs). They inhibit the activity of the angiotensin I-converting enzyme (ACE) and have a typical pyroglutamyl (Pyr)/proline-rich structure at the N- and C-terminus, respectively. Furthermore, PROs decrease blood pressure in animals. In the present study, the isolation and biological characterization of a novel vasoactive BPP isolated from the skin secretion of the frog Brachycephalus ephippium is described. This new PRO, termed BPP-Brachy, has the primary structure WPPPKVSP and the amidated form termed BPP-BrachyNH(2) inhibits efficiently ACE in rat serum. In silico molecular modeling and docking studies suggest that BPP-BrachyNH(2) is capable of forming a hydrogen bond network as well as multiple van der Waals interactions with the rat ACE, which blocks the access of the substrate to the C-domain active site. Moreover, in rat thoracic aorta BPP-BrachyNH(2) induces potent endothelium-dependent vasodilatation with similar magnitude as captopril. In DAF-FM DA-loaded aortic cross sections examined by confocal microscopy, BPP-BrachyNH(2) was found to increase the release of nitric oxide (NO). Moreover, BPP-BrachyNH(2) was devoid of toxicity in endothelial and smooth muscle cell cultures. In conclusion, the peptide BPP-BrachyNH(2) has a novel sequence being the first BPP isolated from the skin secretion of the Brachycephalidae family. This opens for exploring amphibians as a source of new biomolecules. The BPP-BrachyNH(2) is devoid of cytotoxicity and elicits endothelium-dependent vasodilatation mediated by NO. These findings open for the possibility of potential application of these peptides in the treatment of endothelial dysfunction and cardiovascular diseases.	[Rufino Arcanjo, Daniel Dias; Vasconcelos, Andreanne Gomes; Jesus, Joilson Ramos; de Souza de Almeida Leite, Jose Roberto] Univ Fed Piaui UFPI, Nucleo Pesquisa Biodiversidade & Biotecnol BIOTEC, Parnaiba, PI, Brazil; [Rufino Arcanjo, Daniel Dias; Oliveira, Aldeidia Pereira] Univ Fed Piaui UFPI, NPPM, LFC, Teresina, PI, Brazil; [Comerma-Steffensen, Simon Gabriel; Simonsen, Ulf] Aarhus Univ, Dept Biomed, Pulm & Cardiovasc Pharmacol, Aarhus, Denmark; [Silva, Luciano Paulino; Bemquerer, Marcelo Porto] EMBRAPA Recursos Genet & Biotecnol, Lab Espectrometria Massa, Brasilia, DF, Brazil; [Pires Junior, Osmindo Rodrigues] Univ Brasilia UnB, ICB, Lab Toxinol, Brasilia, DF, Brazil; [Costa-Neto, Claudio Miguel; Oliveira, Eduardo Brandt] Univ Sao Paulo, FMRP, Dept Bioquim & Imunol, BR-14049 Ribeirao Preto, SP, Brazil; [Migliolo, Ludovico; Franco, Octavio Luiz] Univ Catolica Brasilia, CAPB, Brasilia, DF, Brazil; [Araujo Restini, Carolina Baraldi] Univ Ribeirao Preto UNAERP, Curso Med, Ribeirao Preto, SP, Brazil; [Paulo, Michele; Bendhack, Lusiane Maria] Univ Sao Paulo, FCFRP, Dept Fis & Quim, BR-14049 Ribeirao Preto, SP, Brazil	Universidade Federal do Piaui; Universidade Federal do Piaui; Aarhus University; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia; Universidade de Sao Paulo; Universidade Catolica de Brasilia; Universidade de Ribeirao Preto; Universidade de Sao Paulo	Leite, JRDD (corresponding author), Univ Fed Piaui UFPI, Nucleo Pesquisa Biodiversidade & Biotecnol BIOTEC, Campus Minist Reis Velloso CMRV, Parnaiba, PI, Brazil.	jrsaleite@gmail.com	Franco, Octavio L/T-3020-2017; Comerma-Steffensen, Simon Gabriel/H-9631-2019; MIGLIOLO, LUDOVICO/AAV-6913-2021; Bemquerer, Marcelo Porto/A-9688-2013; Arcanjo, Daniel Dias Rufino/D-8851-2012; Silva, Luciano Paulino/G-4915-2012; Pires, O.r./ABC-8410-2020; Costa-Neto, Claudio/K-7291-2015; Rodrigues Pires Junior, Osmindo/Q-8384-2016	Comerma-Steffensen, Simon Gabriel/0000-0001-6516-694X; MIGLIOLO, LUDOVICO/0000-0002-6606-2189; Bemquerer, Marcelo Porto/0000-0002-9740-5818; Arcanjo, Daniel Dias Rufino/0000-0001-7021-2744; Silva, Luciano Paulino/0000-0001-9075-7725; Franco, Octavio/0000-0001-9546-0525; Oliveira, Aldeidia/0000-0003-3286-4295; Costa-Neto, Claudio/0000-0002-7256-6412; Gomes Vasconcelos, Andreanne/0000-0002-9651-1598; Rodrigues Pires Junior, Osmindo/0000-0002-9875-9407	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [552676/2011-0]; Fundacao de Amparo a Pesquisa do Piaui (FAPEPI); CAPES Foundation (Bolsista CAPES-PDSE) [BEX 2883/15-5]; CDCH-UCV; Aarhus University	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Piaui (FAPEPI); CAPES Foundation (Bolsista CAPES-PDSE)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CDCH-UCV; Aarhus University	The authors would like to thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, 552676/2011-0 process number), Fundacao de Amparo a Pesquisa do Piaui (FAPEPI, payment of scholarships to students) for the financial support and Genetic Resources and Biotechnology (EMBRAPA) for the facilities, structure mass spectrometry and peptide synthesis. Daniel D. R. Arcanjo acknowledges the CAPES Foundation (Bolsista CAPES-PDSE - Processo no BEX 2883/15-5) for the financial support. S. Comerma-Steffensen acknowledges the CDCH-UCV and the Aarhus University for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to FMRP-USP (Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Brazil) for the facility of laser confocal microscopy, and to LEM (Laboratorio de Espectrometria de Massa) at EMBRAPA Genetic Resources and Biotechnology for the facilities, structure mass spectrometry and peptide synthesis. Daniel D. R. Arcanjo acknowledges the CAPES Foundation (Bolsista CAPES-PDSE-Processo no BEX 2883/15-5) for the financial support. S. Comerma-Steffensen acknowledges the CDCH-UCV and the Aarhus University for their support. There is no conflict of interest.	Akif M, 2011, FEBS J, V278, P3644, DOI 10.1111/j.1742-4658.2011.08276.x; ARAUJO RL, 1976, GEN PHARMACOL, V7, P123, DOI 10.1016/0306-3623(76)90047-1; BAGNARA JT, 1979, SCIENCE, V203, P410, DOI 10.1126/science.760198; Biedermannova L, 2008, PHYS CHEM CHEM PHYS, V10, P6350, DOI 10.1039/b805087b; Camargo ACM, 2012, TOXICON, V59, P516, DOI 10.1016/j.toxicon.2011.07.013; Capellini VK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062887; Conceicao K, 2007, PEPTIDES, V28, P515, DOI 10.1016/j.peptides.2006.10.002; Conlon JM, 1999, REGUL PEPTIDES, V79, P71, DOI 10.1016/S0167-0115(98)00160-8; Coutinho-Neto A, 2013, TOXINS, V5, P327, DOI 10.3390/toxins5020327; Cushman DW, 1999, NAT MED, V5, P1110, DOI 10.1038/13423; Dourado FS, 2007, TOXICON, V50, P572, DOI 10.1016/j.toxicon.2007.04.027; Ferreira LAF, 1996, TOXICON, V34, P599, DOI 10.1016/0041-0101(96)00010-4; Ferreira LAF, 1998, J PROTEIN CHEM, V17, P285, DOI 10.1023/A:1022545020764; FERREIRA SH, 1970, BIOCHEMISTRY-US, V9, P2583, DOI 10.1021/bi00815a005; FERREIRA SH, 1965, BRIT J PHARM CHEMOTH, V24, P163, DOI 10.1111/j.1476-5381.1965.tb02091.x; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; GAVRAS H, 1974, NEW ENGL J MED, V291, P817, DOI 10.1056/NEJM197410172911603; GAVRAS H, 1978, NEW ENGL J MED, V298, P991, DOI 10.1056/NEJM197805042981803; Gomes CL, 2007, BIOCHEM PHARMACOL, V74, P1350, DOI 10.1016/j.bcp.2007.07.014; Guerreiro JR, 2009, J BIOL CHEM, V284, P20022, DOI 10.1074/jbc.M109.021089; Hayashi MAF, 2003, J NEUROCHEM, V85, P969, DOI 10.1046/j.1471-4159.2003.01743.x; Ianzer D, 2004, PEPTIDES, V25, P1085, DOI 10.1016/j.peptides.2004.04.006; Ianzer D, 2007, J PHARMACOL EXP THER, V322, P795, DOI 10.1124/jpet.107.120873; Ianzer Danielle, 2011, Ther Adv Cardiovasc Dis, V5, P281, DOI 10.1177/1753944711427318; IGNARRO LJ, 1988, J PHARMACOL EXP THER, V244, P181; Jitonnom J, 2012, J MOL GRAPH MODEL, V38, P298, DOI 10.1016/j.jmgm.2012.09.002; KATO H, 1971, BIOCHEMISTRY-US, V10, P972, DOI 10.1021/bi00782a007; Kojima H, 1998, CHEM PHARM BULL, V46, P373; Lameu C, 2013, INTEGRATED VIEW MOL, P119, DOI [10.5772/3429, DOI 10.5772/3429]; Leite JRSA, 2005, PEPTIDES, V26, P565, DOI 10.1016/j.peptides.2004.11.002; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Machado RJA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063571; Masuyer G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00717; MEKI ARMA, 1995, PEPTIDES, V16, P1359, DOI 10.1016/0196-9781(95)02036-5; Menin L, 2008, TOXICON, V51, P1288, DOI 10.1016/j.toxicon.2008.02.019; Morais KLP, 2011, BIOCHEM PHARMACOL, V81, P736, DOI 10.1016/j.bcp.2010.12.016; Morais KLP, 2013, PEPTIDES, V48, P124, DOI 10.1016/j.peptides.2013.07.016; Murayama N, 1997, P NATL ACAD SCI USA, V94, P1189, DOI 10.1073/pnas.94.4.1189; Nagano T, 2002, CHEM REV, V102, P1235, DOI 10.1021/cr010152s; ONDETTI MA, 1971, BIOCHEMISTRY-US, V10, P4033, DOI 10.1021/bi00798a004; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Paulo M, 2012, EUR J PHARM SCI, V45, P344, DOI 10.1016/j.ejps.2011.12.002; Petriz BD, 2013, CURR PROTEIN PEPT SC, V14, P459, DOI 10.2174/13892037113149990063; Pie MR, 2013, ECOL MODEL, V250, P165, DOI 10.1016/j.ecolmodel.2012.10.019; Pires OR, 2005, TOXICON, V45, P73, DOI 10.1016/j.toxicon.2004.09.016; Pires OR, 2003, TOXICON, V42, P563, DOI 10.1016/S0041-0101(03)00235-6; Pires OR, 2002, TOXICON, V40, P761, DOI 10.1016/S0041-0101(01)00279-3; Pombal JP, 1998, J HERPETOL, V32, P70, DOI 10.2307/1565481; REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x; Rioli V, 2008, FEBS J, V275, P2442, DOI 10.1111/j.1742-4658.2008.06389.x; SANTOS RAS, 1985, HYPERTENSION, V7, P244, DOI 10.1161/01.HYP.7.2.244; Schmaier AH, 2002, J CLIN INVEST, V109, P1007, DOI 10.1172/JCI200215490; Schonbrunn E, 2013, J MED CHEM, V56, P3768, DOI 10.1021/jm301234k; Silva-Filho JC, 2012, BASIC CLIN PHARMACOL, V110, P171, DOI 10.1111/j.1742-7843.2011.00784.x; Soares MR, 2005, TOXICON, V46, P31, DOI 10.1016/j.toxicon.2005.03.006; Verano-Braga T, 2008, BIOCHEM BIOPH RES CO, V371, P515, DOI 10.1016/j.bbrc.2008.04.104; Verano-Braga T, 2010, TOXICON, V56, P1162, DOI 10.1016/j.toxicon.2010.04.006; YANG HYT, 1972, J NEUROCHEM, V19, P2443, DOI 10.1111/j.1471-4159.1972.tb01298.x; [No title captured]	59	14	15	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145071	10.1371/journal.pone.0145071	http://dx.doi.org/10.1371/journal.pone.0145071			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26661890	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900180
J	Sharma, S; Kim, BN; Stansfeld, PJ; Sansom, MSP; Lindau, M				Sharma, Satyan; Kim, Brian N.; Stansfeld, Phillip J.; Sansom, Mark S. P.; Lindau, Manfred			A Coarse Grained Model for a Lipid Membrane with Physiological Composition and Leaflet Asymmetry	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; STRATUM-CORNEUM; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PLASMA-MEMBRANE; CHOLESTEROL; BILAYERS; VESICLE; PERMEATION; EXTENSION; MOVEMENT	The resemblance of lipid membrane models to physiological membranes determines how well molecular dynamics (MD) simulations imitate the dynamic behavior of cell membranes and membrane proteins. Physiological lipid membranes are composed of multiple types of phospholipids, and the leaflet compositions are generally asymmetric. Here we describe an approach for self-assembly of a Coarse-Grained (CG) membrane model with physiological composition and leaflet asymmetry using the MARTINI force field. An initial set-up of two boxes with different types of lipids according to the leaflet asymmetry of mammalian cell membranes stacked with 0.5 nm overlap, reliably resulted in the self-assembly of bilayer membranes with leaflet asymmetry resembling that of physiological mammalian cell membranes. Self-assembly in the presence of a fragment of the plasma membrane protein syntaxin 1A led to spontaneous specific positioning of phosphatidylionositol(4,5)bisphosphate at a positively charged stretch of syntaxin consistent with experimental data. An analogous approach choosing an initial set-up with two concentric shells filled with different lipid types results in successful assembly of a spherical vesicle with asymmetric leaflet composition. Self-assembly of the vesicle in the presence of the synaptic vesicle protein synaptobrevin 2 revealed the correct position of the synaptobrevin transmembrane domain. This is the first CG MD method to form a membrane with physiological lipid composition as well as leaflet asymmetry by self-assembly and will enable unbiased studies of the incorporation and dynamics of membrane proteins in more realistic CG membrane models.	[Sharma, Satyan; Lindau, Manfred] Max Planck Inst Biophys Chem, Lab Nanoscale Cell Biol, D-37077 Gottingen, Germany; [Kim, Brian N.; Lindau, Manfred] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Stansfeld, Phillip J.; Sansom, Mark S. P.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Max Planck Society; Cornell University; University of Oxford	Sharma, S (corresponding author), Max Planck Inst Biophys Chem, Lab Nanoscale Cell Biol, D-37077 Gottingen, Germany.	satyan.sharma@mpibpc.mpg.de	Stansfeld, Phillip James/AAA-9228-2020; Sansom, Mark S.P./C-5157-2009; Lindau, Manfred/ABD-3449-2021; Stansfeld, Phill/C-6213-2011	Stansfeld, Phillip James/0000-0001-8800-7669; Sansom, Mark S.P./0000-0001-6360-7959; Lindau, Manfred/0000-0002-5722-9557; Stansfeld, Phill/0000-0001-8800-7669; Kim, Brian/0000-0002-5523-6091	European Research Council [ADG 322699]; National Institutes of Health (NIH) [R01MH095046]; NIH Molecular Biophysics Training Grant at Cornell University [T32GM008267]; Biotechnology and Biological Sciences Research Council [BB/I019855/1] Funding Source: researchfish; BBSRC [BB/I019855/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095046] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Molecular Biophysics Training Grant at Cornell University; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the European Research Council (Grant ADG 322699), National Institutes of Health (NIH) grant R01MH095046, and NIH Molecular Biophysics Training Grant T32GM008267 at Cornell University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the European Research Council (Grant ADG 322699), National Institutes of Health (NIH) grant R01MH095046, and NIH Molecular Biophysics Training Grant T32GM008267 at Cornell University.	Bennett WFD, 2009, J AM CHEM SOC, V131, P12714, DOI 10.1021/ja903529f; BRETSCHER MS, 1973, SCIENCE, V181, P622, DOI 10.1126/science.181.4100.622; Calderon RO, 1997, J NEUROSCI RES, V49, P372; Clarke S, 1981, J CHEM EDUC, V58, pA246, DOI DOI 10.1021/ED058PA246.1; CRONAN JE, 1975, BACTERIOL REV, V39, P232, DOI 10.1128/MMBR.39.3.232-256.1975; Das C, 2009, BIOPHYS J, V97, P1941, DOI 10.1016/j.bpj.2009.06.054; de Vries AH, 2004, J AM CHEM SOC, V126, P4488, DOI 10.1021/ja0398417; Flinner N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133999; Gurtovenko AA, 2008, J PHYS CHEM B, V112, P4629, DOI 10.1021/jp8001993; Holtje M, 2001, BBA-BIOMEMBRANES, V1511, P156, DOI 10.1016/S0005-2736(01)00270-X; Ingolfsson HI, 2014, J AM CHEM SOC, V136, P14554, DOI 10.1021/ja507832e; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; Kasson PM, 2007, PLOS COMPUT BIOL, V3, P2228, DOI 10.1371/journal.pcbi.0030220; Khelashvili G, 2012, BIOCHEMISTRY-US, V51, P7685, DOI 10.1021/bi300833z; Knight CJ, 2015, BIOINFORMATICS; Koldso H, 2014, LIPID CLUSTERING COR; Kucerka N, 2009, LANGMUIR, V25, P13522, DOI 10.1021/la9020299; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lindau M, 2012, BIOPHYS J, V103, P959, DOI 10.1016/j.bpj.2012.08.007; Marrink SJ, 2008, J AM CHEM SOC, V130, P10, DOI 10.1021/ja076641c; Marrink SJ, 2003, J AM CHEM SOC, V125, P15233, DOI 10.1021/ja0352092; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; Mondal M, 2009, MOL BIOL CELL, V20, P581, DOI 10.1091/mbc.E08-07-0785; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Morozova D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002067; Murray DH, 2011, BIOCHEMISTRY-US, V50, P9014, DOI 10.1021/bi201307u; Murray DH, 2009, BIOCHEMISTRY-US, V48, P4617, DOI 10.1021/bi9003217; Paloncyova M, 2015, J PHYS CHEM B, V119, P9811, DOI 10.1021/acs.jpcb.5b05522; Perlmutter JD, 2011, J AM CHEM SOC, V133, P6563, DOI 10.1021/ja106626r; Polley A, 2012, J PHYS CHEM B, V116, P13403, DOI 10.1021/jp3032868; Qu L, 2009, J COMP NEUROL, V514, P343, DOI 10.1002/cne.22007; Risselada HJ, 2008, P NATL ACAD SCI USA, V105, P17367, DOI 10.1073/pnas.0807527105; Rog T, 2003, ACTA BIOCHIM POL, V50, P789; ROTHMAN JE, 1977, SCIENCE, V195, P743, DOI 10.1126/science.402030; ROTHMAN JE, 1977, P NATL ACAD SCI USA, V74, P1821, DOI 10.1073/pnas.74.5.1821; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SAMBRANO GR, 1995, P NATL ACAD SCI USA, V92, P1396, DOI 10.1073/pnas.92.5.1396; Schmidt MR, 2013, BIOCHEMISTRY-US, V52, P279, DOI 10.1021/bi301350s; SCHROEDER F, 1984, NEUROBIOL AGING, V5, P323, DOI 10.1016/0197-4580(84)90010-1; Scott KA, 2008, STRUCTURE, V16, P621, DOI 10.1016/j.str.2008.01.014; Shinoda W, 1998, J CHEM PHYS, V109, P1517, DOI 10.1063/1.476702; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stansfeld PJ, 2009, BIOCHEMISTRY-US, V48, P10926, DOI 10.1021/bi9013193; Stansfeld PJ, 2015, STRUCTURE; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Vacha R, 2009, BIOPHYS J, V96, P4493, DOI 10.1016/j.bpj.2009.03.010; van Eerden FJ, 2015, BBA-BIOMEMBRANES, V1848, P1319, DOI 10.1016/j.bbamem.2015.02.025; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wan G, 2015, J MOL GRAPH MODEL, V60, P98, DOI 10.1016/j.jmgm.2015.06.005; Wassenaar TA, 2015, J CHEM THEORY COMPUT, V11, P2144, DOI 10.1021/acs.jctc.5b00209; Wassenaar TA, 2014, J CHEM THEORY COMPUT, V10, P676, DOI 10.1021/ct400617g; Wood WG, 2011, J NEUROCHEM, V116, P684, DOI 10.1111/j.1471-4159.2010.07017.x; Yesylevskyy SO, 2015, METHODS MOL BIOL, V1232, P291, DOI 10.1007/978-1-4939-1752-5_20; ZWAAL RFA, 1977, NATURE, V268, P358, DOI 10.1038/268358a0	57	34	34	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144814	10.1371/journal.pone.0144814	http://dx.doi.org/10.1371/journal.pone.0144814			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659855	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900108
J	Seo, JB; Jung, SR; Huang, WG; Zhang, QS; Koh, DS				Seo, Jong Bae; Jung, Seung-Ryoung; Huang, Weigang; Zhang, Qisheng; Koh, Duk-Su			Charge Shielding of PIP2 by Cations Regulates Enzyme Activity of Phospholipase C	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE PIP2; MOLECULAR-DYNAMICS SIMULATIONS; ROSEUS TRANSFORMED ROOTS; ELECTROSTATIC INTERACTIONS; KINASE SUBSTRATE; BOVINE BRAIN; K+ CHANNELS; DELTA 1; MG2+; INHIBITION	Hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) of the plasma membrane by phospholipase C (PLC) generates two critical second messengers, inositol-1,4,5-trisphosphate and diacylglycerol. For the enzymatic reaction, PIP2 binds to positively charged amino acids in the pleckstrin homology domain of PLC. Here we tested the hypothesis that positively charged divalent and multivalent cations accumulate around the negatively charged PIP2, a process called electrostatic charge shielding, and therefore inhibit electrostatic PIP2-PLC interaction. This charge shielding of PIP2 was measured quantitatively with an in vitro enzyme assay using WH-15, a PIP2 analog, and various recombinant PLC proteins (beta 1,beta 1, and delta 1). Reduction of PLC activity by divalent cations, polyamines, and neomycin was well described by a theoretical model considering accumulation of cations around PIP2 via their electrostatic interaction and chemical binding. Finally, the charge shielding of PIP2 was also observed in live cells. Perfusion of the cations into cells via patch clamp pipette reduced PIP2 hydrolysis by PLC as triggered by M-1 muscarinic receptors with a potency order of Mg2+ < spermine(4+) < neomycin(6+). Accumulation of divalent cations into cells through divalent-permeable TRPM7 channel had the same effect. Altogether our results suggest that Mg2+ and polyamines modulate the activity of PLCs by controlling the amount of free PIP2 available for the enzymes and that highly charged biomolecules can be inactivated by counterions electrostatically.	[Seo, Jong Bae; Jung, Seung-Ryoung; Koh, Duk-Su] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Huang, Weigang; Zhang, Qisheng] Univ N Carolina, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA	University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill	Koh, DS (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	koh@uw.edu		Zhang, Qisheng/0000-0001-9808-5038	National Institute of Diabetes and Digestive and Kidney Diseases [R01-080840]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R01-080840 (http://www.niddk.nih.gov/about-niddk/Pages/default.aspx), National Institute of Diabetes and Digestive and Kidney Diseases to DSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballester LY, 2007, CHANNELS, V1, P209, DOI 10.4161/chan.4770; Baumann MK, 2011, ANAL CHEM, V83, P6267, DOI 10.1021/ac2009178; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BRISTOL A, 1988, COLD SPRING HARB SYM, V53, P915, DOI 10.1101/SQB.1988.053.01.105; CARNEY DH, 1985, CELL, V42, P479, DOI 10.1016/0092-8674(85)90105-9; Charpentier TH, 2014, J BIOL CHEM, V289, P29545, DOI 10.1074/jbc.M114.586784; Chen SJ, 2008, ANNU REV BIOPHYS, V37, P197, DOI 10.1146/annurev.biophys.37.032807.125957; Chubanov V, 2005, PFLUG ARCH EUR J PHY, V451, P228, DOI 10.1007/s00424-005-1470-y; Coburn RF, 2009, J CELL PHYSIOL, V221, P544, DOI 10.1002/jcp.21899; Echevarria-Machado I, 2002, J PLANT PHYSIOL, V159, P1179, DOI 10.1078/0176-1617-00893; EISENMAN G, 1962, Biophys J, V2, P259; Ellenbroek WG, 2011, BIOPHYS J, V101, P2178, DOI 10.1016/j.bpj.2011.09.039; GABEV E, 1989, BIOCHIM BIOPHYS ACTA, V979, P105, DOI 10.1016/0005-2736(89)90529-4; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; Glaser M, 1996, J BIOL CHEM, V271, P26187, DOI 10.1074/jbc.271.42.26187; HEINONEN E, 1986, NEUROSCI LETT, V72, P105, DOI 10.1016/0304-3940(86)90627-0; Helmholtz H. v., 1853, ANN PHYS-BERLIN, V165, P353, DOI 10.1002/andp.18531650702; Hoenderop JGJ, 2005, J AM SOC NEPHROL, V16, P15, DOI 10.1681/ASN.2004070523; Huang WG, 2013, J BIOL CHEM, V288, P5840, DOI 10.1074/jbc.M112.422501; Huang WG, 2011, ACS CHEM BIOL, V6, P223, DOI 10.1021/cb100308n; Jensen JB, 2009, J GEN PHYSIOL, V133, P347, DOI 10.1085/jgp.200810075; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kopka J, 1998, PLANT PHYSIOL, V116, P239, DOI 10.1104/pp.116.1.239; Kozak JA, 2005, J GEN PHYSIOL, V126, P499, DOI 10.1085/jgp.200509324; KUFFLER SW, 1975, J PHYSIOL-LONDON, V251, P465, DOI 10.1113/jphysiol.1975.sp011103; Lee J, 2005, J GEN PHYSIOL, V126, P439, DOI 10.1085/jgp.200509314; Li Z, 2009, BIOPHYS J, V97, P155, DOI 10.1016/j.bpj.2009.04.037; Lo Vasco VR, 2013, J CELL COMMUN SIGNAL, V7, P141, DOI 10.1007/s12079-013-0194-6; Matecki A, 1997, INT J BIOCHEM CELL B, V29, P815, DOI 10.1016/S1357-2725(97)00014-9; MCLAUGHLIN S, 1981, J GEN PHYSIOL, V77, P445, DOI 10.1085/jgp.77.4.445; Minois N, 2011, AGING-US, V3, P716, DOI 10.18632/aging.100361; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Neves-Petersen MT, 2003, BIOTECHNOL ANN REV, V9, P315, DOI 10.1016/S1387-2656(03)09010-0; Oldham KB, 2008, J ELECTROANAL CHEM, V613, P131, DOI 10.1016/j.jelechem.2007.10.017; Park Y, 2015, NAT STRUCT MOL BIOL, V22, P815, DOI 10.1038/nsmb.3097; Park Y, 2012, NAT STRUCT MOL BIOL, V19, P991, DOI 10.1038/nsmb.2375; Pawelczyk T, 1997, EUR J BIOCHEM, V248, P459, DOI 10.1111/j.1432-1033.1997.00459.x; PICAL C, 1992, PLANT PHYSIOL, V100, P1296, DOI 10.1104/pp.100.3.1296; Pina-Chable ML, 1998, PROSTAG OTH LIPID M, V56, P19, DOI 10.1016/S0090-6980(98)00037-9; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; RYU SH, 1987, P NATL ACAD SCI USA, V84, P6649, DOI 10.1073/pnas.84.19.6649; RYU SH, 1987, J BIOL CHEM, V262, P12511; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Slochower DR, 2013, J PHYS CHEM B, V117, P8322, DOI 10.1021/jp401414y; Subirana JA, 2003, ANNU REV BIOPH BIOM, V32, P27, DOI 10.1146/annurev.biophys.32.110601.141726; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suh BC, 2007, J GEN PHYSIOL, V130, P241, DOI 10.1085/jgp.200709821; TONER M, 1988, BIOCHEMISTRY-US, V27, P7435, DOI 10.1021/bi00419a039; Usachev YM, 1995, J PHYSIOL-LONDON, V489, P309, DOI 10.1113/jphysiol.1995.sp021052; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Wang JY, 2002, J BIOL CHEM, V277, P34401, DOI 10.1074/jbc.M203954200; Wang YH, 2012, J AM CHEM SOC, V134, P3387, DOI 10.1021/ja208640t; WOJCIKIEWICZ RJH, 1988, BIOCHEM J, V255, P1015, DOI 10.1042/bj2551015; Yang Yong Ryoul, 2013, Advances in Biological Regulation, V53, P232, DOI 10.1016/j.jbior.2013.08.003	55	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144432	10.1371/journal.pone.0144432	http://dx.doi.org/10.1371/journal.pone.0144432			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658739	gold, Green Published			2022-12-27	WOS:000366903600043
J	Watkins, D; Jiang, LW; Nahar, S; Maiti, S; Arya, DP				Watkins, Derrick; Jiang, Liuwei; Nahar, Smita; Maiti, Souvik; Arya, Dev P.			A pH Sensitive High-Throughput Assay for miRNA Binding of a Peptide-Aminoglycoside (PA) Library	PLOS ONE			English	Article							TELOMERIC G-QUADRUPLEX; DUAL RECOGNITION; MAJOR GROOVE; B-DNA; FLUORESCEIN; MICRORNAS; BIOGENESIS; SEQUENCES; HYBRID; PROBES	MicroRNAs (miRNA) are small RNAs that have a regulatory role in gene expression. Because of this regulatory role, miRNAs have become a new target for therapeutic compounds. Here, we outline an approach to target specific miRNAs using a high throughput capable assay and a 215 compound peptidic-aminosugar (PA) library. Aminosugars have been shown in a number of recent reports as important lead compounds that bind miRNA. In order to screen for compounds that bind miRNA, we have developed a high throughput displacement assay using a fluorescein-neomycin conjugated molecule (F-neo) as a probe for competitive miRNA binding compounds. We have applied the F-neo assay to four different miRNA constructs and the assay is applicable to most miRNAs, at various stages of processing. The results of the screen were validated by the determination of the IC50 for a select group of compounds from the library. For example, we identified eight compounds that bind to hsa-miR 504 with higher affinity than the parent neomycin. From the F-neo displacement assay we found that the number of binding sites differs for each miRNA, and the binding sites appear to differ both physically and chemically, with different affinity of the compounds resulting from the size of the molecule as well as the chemical structure. Additionally, the affinity of the compounds was dependent on the identity and position of the amino acid position of conjugation and the affinity of the compounds relative to other compounds in the library was miRNA dependent with the introduction of a second amino acid.	[Jiang, Liuwei; Arya, Dev P.] Clemson Univ, Dept Chem, Med Chem Lab, Clemson, SC 29634 USA; [Watkins, Derrick; Arya, Dev P.] NUBAD LLC, Greenville, SC USA; [Nahar, Smita; Maiti, Souvik] Acad Sci & Innovat Res AcSIR, New Delhi, India; [Nahar, Smita; Maiti, Souvik] CSIR Inst Genom & Integrat Biol, Delhi, India	Clemson University; Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Arya, DP (corresponding author), Clemson Univ, Dept Chem, Med Chem Lab, Clemson, SC 29634 USA.	dparya@clemson.edu	Jiang, Liuwei/D-5406-2017	Jiang, Liuwei/0000-0001-6178-4505; Maiti, Souvik/0000-0001-9897-1419	NUBAD, LLC	NUBAD, LLC	NUBAD, LLC provided support in the form of salaries for author J.D.W., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of J.D.W. are articulated in the 'author contributions' section.	Alvarez-Pez JM, 2001, J PHYS CHEM A, V105, P6320, DOI 10.1021/jp010372+; Arya DP, 2011, ACCOUNTS CHEM RES, V44, P134, DOI 10.1021/ar100113q; Arya DP, 2003, J AM CHEM SOC, V125, P12398, DOI 10.1021/ja036742k; Arya DP, 2003, J AM CHEM SOC, V125, P3733, DOI 10.1021/ja027765m; Arya DP, 2001, J AM CHEM SOC, V123, P5385, DOI 10.1021/ja003052x; Arya DP, 2001, J AM CHEM SOC, V123, P11093, DOI 10.1021/ja016481j; Arya DP, 2003, J AM CHEM S IN PRESS; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; FRIEDRICH K, 1988, EUR J BIOCHEM, V173, P227, DOI 10.1111/j.1432-1033.1988.tb13988.x; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hamilton PL, 2012, NAT PROD REP, V29, P134, DOI 10.1039/c1np00054c; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Im HI, 2012, TRENDS NEUROSCI, V35, P325, DOI 10.1016/j.tins.2012.01.004; Jiang LW, 2015, ACS CHEM BIOL, V10, P1278, DOI 10.1021/cb5010367; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; King A, 2013, ANTIMICROB AGENTS CH; Knemeyer JP, 2000, ANAL CHEM, V72, P3717, DOI 10.1021/ac000024o; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kumar S, 2012, BIOCHEMISTRY-US, V51, P2331, DOI 10.1021/bi201657k; Kumar S, 2011, J AM CHEM SOC, V133, P7361, DOI 10.1021/ja108118v; Lavis LD, 2007, ANAL CHEM, V79, P6775, DOI 10.1021/ac070907g; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Lynch SR, 2001, J MOL BIOL, V306, P1037, DOI 10.1006/jmbi.2000.4420; Maiti M, 2012, BIOORG MED CHEM LETT, V22, P1709, DOI 10.1016/j.bmcl.2011.12.103; Marras SAE, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf121; Ranasinghe RT, 2005, CHEM COMMUN, P5487, DOI 10.1039/b509522k; Ranjan N, 2013, MOLECULES, V18, P14228, DOI 10.3390/molecules181114228; Ranjan N, 2013, BIOORG MED CHEM LETT, V23, P5689, DOI 10.1016/j.bmcl.2013.08.014; Ranjan N, 2013, CHEM COMMUN, V49, P5796, DOI 10.1039/c3cc42721h; Ranjan N, 2010, BIOCHEMISTRY-US, V49, P9891, DOI 10.1021/bi101517e; Recht MI, 1996, J MOL BIOL, V262, P421, DOI 10.1006/jmbi.1996.0526; Shaw NN, 2008, BIOORG MED CHEM LETT, V18, P4142, DOI 10.1016/j.bmcl.2008.05.090; Shaw NN, 2008, BIOCHIMIE, V90, P1026, DOI 10.1016/j.biochi.2008.04.011; Sjoback R, 1998, BIOPOLYMERS, V46, P445; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Velagapudi SP, 2014, NAT CHEM BIOL, V10, P291, DOI [10.1038/NCHEMBIO.1452, 10.1038/nchembio.1452]; Velagapudi SP, 2011, J AM CHEM SOC, V133, P10111, DOI 10.1021/ja200212b; Watkins D, 2013, BIOORG MED CHEM LETT, V23, P6695, DOI 10.1016/j.bmcl.2013.10.030; Watkins D, 2013, ANAL BIOCHEM, V434, P300, DOI 10.1016/j.ab.2012.12.003; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Willis B, 2006, BIOCHEMISTRY-US, V45, P10217, DOI 10.1021/bi0609265; Willis B, 2006, ADV CARBOHYD CHEM BI, V60, P251, DOI 10.1016/S0065-2318(06)60006-1; Willis B, 2009, BIOORG MED CHEM LETT, V19, P4974, DOI 10.1016/j.bmcl.2009.07.079; Xi HJ, 2011, BIOCHEMISTRY-US, V50, P9088, DOI 10.1021/bi201077h; Xi HJ, 2010, BIOCHIMIE, V92, P514, DOI 10.1016/j.biochi.2010.02.004; Xue LA, 2011, BIOCHEMISTRY-US, V50, P2838, DOI 10.1021/bi1017304; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	60	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144251	10.1371/journal.pone.0144251	http://dx.doi.org/10.1371/journal.pone.0144251			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656788	Green Submitted, gold, Green Published			2022-12-27	WOS:000366903600032
J	Kuo, HC; Lo, MH; Hsieh, KS; Guo, MMH; Huang, YH				Kuo, Ho-Chang; Lo, Mao-Hung; Hsieh, Kai-Sheng; Guo, Mindy Ming-Huey; Huang, Ying-Hsien			High-Dose Aspirin Is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease	PLOS ONE			English	Article							CORONARY-ARTERY LESIONS; IMMUNOGLOBULIN TREATMENT FAILURE; LONG-TERM MANAGEMENT; INTRAVENOUS IMMUNOGLOBULIN; CARDIOVASCULAR-DISEASE; HEALTH-PROFESSIONALS; RHEUMATIC-FEVER; DIAGNOSIS; ENDOCARDITIS; RESISTANCE	Background Kawasaki disease (KD) is also known as multiple mucocutaneous lymph node syndrome of systemic vasculitis and is a leading cause of coronary artery lesions (CAL) in childhood. Intravenous immunoglobulin (IVIG) has been proven to effectively reduce the incidence of CAL, but the role and effect dose of aspirin in KD is still unclear. Moreover, overt bleeding and anemia are associated with the use of aspirin, and anemia is common in patients with KD. Thus, the aim of this study was conducted to compare the treatment efficacy, degree of anemia and inflammation, and changes in serum hepcidin in children who received a combination of high-dose aspirin and IVIG in the acute stage of KD, and those who received IVIG alone. Materials and Methods KD patients from two medical centers were retrospectively analyzed from 1999-2009. All patients were initially treated with a single dose of IVIG (2 g/kg) as the standard care of treatment. In group 1, high-dose aspirin was prescribed (> 30 mg/kg/day) until the fever subsided, and then low- dose aspirin (3-5 mg/kg/day) was prescribed until all the inflammation signs had resolved. In group 2, low- dose aspirin was prescribed without high-dose aspirin. Laboratory data were collected for analysis in both groups. Results A total of 851 KD patients (group 1, N = 305, group 2, N = 546) were enrolled in this study. There were no significant differences between group 1 and group 2 in terms of gender (p = 0.51), IVIG resistance rate (31/305 vs. 38/546, p = 0.07), CAL formation (52/305 vs. 84/546, p = 0.67), and duration of hospitalization (6.3 +/- 0.2 vs. 6.7 +/- 0.2 days, p = 0.13). There were also initially no significant differences in total white blood cell count, hemoglobin level, platelet count, and CRP before IVIG treatment between groups (all p>0.1). After IVIG treatment, group 1 had significantly lower levels of hemoglobin (p = 0.006) and higher CRP (p<0.001) as well as a smaller decrease in CRP level (p = 0.012). Furthermore, there was also a higher serum level of hepcidin and a delayed decrease in hepcidin level after receiving IVIG in group 1 (p = 0.04 and 0.02, respectively). Conclusions These results provide evidence demonstrating that high-dose aspirin in the acute phase of KD does not confer any benefit with regards to inflammation and it does not appear to improve treatment outcomes. Therefore, high-dose aspirin is unnecessary in acute phase KD.	[Kuo, Ho-Chang; Lo, Mao-Hung; Hsieh, Kai-Sheng; Guo, Mindy Ming-Huey; Huang, Ying-Hsien] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung 83301, Taiwan; [Kuo, Ho-Chang; Lo, Mao-Hung; Hsieh, Kai-Sheng; Guo, Mindy Ming-Huey; Huang, Ying-Hsien] Chang Gung Univ, Coll Med, Kaohsiung 83301, Taiwan; [Kuo, Ho-Chang; Lo, Mao-Hung; Hsieh, Kai-Sheng; Guo, Mindy Ming-Huey; Huang, Ying-Hsien] Kaohsiung Chang Gung Mem Hosp, Kawasaki Dis Ctr, Kaohsiung 83301, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Huang, YH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung 83301, Taiwan.	yhhuang123@yahoo.com.tw	Kuo, Ho-Chang/AAQ-6644-2020	Kuo, Ho-Chang/0000-0002-3295-2984; Hsieh, Kai-Sheng/0000-0002-0294-9872	Ministry of Science and Technology of Taiwan [102-2314-B-182A-022, 102-2314-B-182-053MY3]; Chang Gung Memorial Hospital [CMRPG8E0021, CMRPG8E0031, CMRPF6E0041, CMRPG8E0051, CMRPG8E0061, CMRPG8C1081, CMRPG8D0521]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by grants from the Ministry of Science and Technology of Taiwan (102-2314-B-182A-022 and 102-2314-B-182-053MY3) and grants from Chang Gung Memorial Hospital (CMRPG8E0021, CMRPG8E0031, CMRPF6E0041, CMRPG8E0051, CMRPG8E0061, CMRPG8C1081 and CMRPG8D0521). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali N A, 1999, East Mediterr Health J, V5, P457; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Chen CH, 2014, J MICROBIOL IMMUNOL, V47, P261, DOI 10.1016/j.jmii.2012.05.002; Chen CJ, 2012, SCI WORLD J, DOI 10.1100/2012/485758; Chen GD, 2010, HEARING RES, V265, P63, DOI 10.1016/j.heares.2010.02.010; Cho KH, 2014, KOREAN CIRC J, V44, P328, DOI 10.4070/kcj.2014.44.5.328; DAJANI AS, 1993, CIRCULATION, V87, P1776, DOI 10.1161/01.CIR.87.5.1776; DURONGPISITKUL K, 1995, PEDIATRICS, V96, P1057; Gaskell H, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-71; Hamdan J A, 1983, Ann Trop Paediatr, V3, P89; Hsieh KS, 2004, PEDIATRICS, V114, pE689, DOI 10.1542/peds.2004-1037; Huang YH, 2014, J PEDIATR-US, V165, P295, DOI 10.1016/j.jpeds.2014.04.031; KATO H, 1979, PEDIATRICS, V63, P175; KAWASAKI T, 1974, PEDIATRICS, V54, P271; Kim HK, 2011, KOREAN CIRC J, V41, P379, DOI 10.4070/kcj.2011.41.7.379; Kuo HC, 2007, PEDIAT ALLERG IMM-UK, V18, P354, DOI 10.1111/j.1399-3038.2007.00516.x; Kuo HC, 2012, J CLIN IMMUNOL, V32, P746, DOI 10.1007/s10875-012-9668-1; Kuo HC, 2011, J HUM GENET, V56, P161, DOI 10.1038/jhg.2010.154; Kuo HC, 2010, ACTA PAEDIATR, V99, P1578, DOI 10.1111/j.1651-2227.2010.01875.x; Kuo HC, 2009, PEDIAT ALLERG IMM-UK, V20, P266, DOI 10.1111/j.1399-3038.2008.00779.x; Kusakawa S, 1987, Prog Clin Biol Res, V250, P401; Lau AC, 2009, ARTHRITIS RHEUM-US, V60, P2131, DOI 10.1002/art.24660; Lee G, 2013, KOREAN CIRC J, V43, P182, DOI 10.4070/kcj.2013.43.3.182; Lee SM, 2014, KOREAN CIRC J, V44, P415, DOI 10.4070/kcj.2014.44.6.415; Liang CD, 2009, AM HEART J, V157, P584, DOI 10.1016/j.ahj.2008.11.020; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182; NEWBURGER JW, 1986, NEW ENGL J MED, V315, P341, DOI 10.1056/NEJM198608073150601; Saulsbury FT, 2002, CLIN PEDIATR, V41, P597, DOI 10.1177/000992280204100807; Shibata T, 2011, J VISION, V11, DOI 10.1167/11.8.11; SUDDLESON EA, 1987, J PEDIATR SURG, V22, P956, DOI 10.1016/S0022-3468(87)80600-0; Wang CL, 2005, PEDIATR INFECT DIS J, V24, P998, DOI 10.1097/01.inf.0000183786.70519.fa; Wei CM, 2005, J PAEDIATR CHILD H, V41, P303, DOI 10.1111/j.1440-1754.2005.00617.x	34	49	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144603	10.1371/journal.pone.0144603	http://dx.doi.org/10.1371/journal.pone.0144603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658843	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903500046
J	Porcu, G; Serone, E; De Nardis, V; Di Giandomenico, D; Lucisano, G; Scardapane, M; Poma, A; Ragnini-Wilson, A				Porcu, Giampiero; Serone, Eliseo; De Nardis, Velia; Di Giandomenico, Daniele; Lucisano, Giuseppe; Scardapane, Marco; Poma, Anna; Ragnini-Wilson, Antonella			Clobetasol and Halcinonide Act as Smoothened Agonists to Promote Myelin Gene Expression and RxR gamma Receptor Activation	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EARLY POSTNATAL DEXAMETHASONE; SONIC-HEDGEHOG; OLIGODENDROCYTE DIFFERENTIATION; REGULATORY FACTOR; IN-VITRO; REMYELINATION; PROLIFERATION; CELLS; CNS	One of the causes of permanent disability in chronic multiple sclerosis patients is the inability of oligodendrocyte progenitor cells (OPCs) to terminate their maturation program at lesions. To identify key regulators of myelin gene expression acting at the last stages of OPC maturation we developed a drug repositioning strategy based on the mouse immortalized oligodendrocyte (OL) cell line Oli-neu brought to the premyelination stage by stably expressing a key factor regulating the last stages of OL maturation. The Prestwick Chemical Library1 of 1,200 FDA-approved compound(s) was repositioned at three dosages based on the induction of Myelin Basic Protein (MBP) expression. Drug hits were further validated using dosage-dependent reproducibility tests and biochemical assays. The glucocorticoid class of compounds was the most highly represented and we found that they can be divided in three groups according to their efficacy on MBP up-regulation. Since target identification is crucial before bringing compounds to the clinic, we searched for common targets of the primary screen hits based on their known chemical-target interactomes, and the pathways predicted by top ranking compounds were validated using specific inhibitors. Two of the top ranking compounds, Halcinonide and Clobetasol, act as Smoothened (Smo) agonists to up-regulate myelin gene expression in the Oli-neuM cell line. Further, RxR. activation is required for MBP expression upon Halcinonide and Clobetasol treatment. These data indicate Clobetasol and Halcinonide as potential promyelinating drugs and also provide a mechanistic understanding of their mode of action in the pathway leading to myelination in OPCs. Furthermore, our classification of glucocorticoids with respect to MBP expression provides important novel insights into their effects in the CNS and a rational criteria for their choice in combinatorial therapies in de-myelinating diseases.	[Porcu, Giampiero; Ragnini-Wilson, Antonella] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Porcu, Giampiero; Serone, Eliseo; De Nardis, Velia; Di Giandomenico, Daniele; Lucisano, Giuseppe; Scardapane, Marco; Ragnini-Wilson, Antonella] Fdn Mario Negri Sud, Dept Translat Pharmacol, Santa Maria Imbaro, CH, Italy; [Serone, Eliseo; Poma, Anna] Univ Aquila, Dept Life Hlth & Environm Sci, I-67100 Laquila, Italy; [Lucisano, Giuseppe; Scardapane, Marco] Ctr Outcomes Res & Clin Epidemiol, Pescara, Italy; [Lucisano, Giuseppe] Univ Bari Aldo Moro, Dipartimento Sci Med Base Neurosci & Organi Senso, Bari, Italy	University of Rome Tor Vergata; University of L'Aquila; Universita degli Studi di Bari Aldo Moro	Ragnini-Wilson, A (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.	antonella.ragnini@uniroma2.it	Poma, Anna/AAH-5751-2019; Ragnini, Antonella/A-8089-2014	Ragnini, Antonella/0000-0001-7963-7554	Modello innovativo per l'identificazione di composti capaci di promuovere la rimielinazione in modelli cellulari di Sclerosi Multipla Fondazione Carichieti; Fondazione Mario Negri Sud	Modello innovativo per l'identificazione di composti capaci di promuovere la rimielinazione in modelli cellulari di Sclerosi Multipla Fondazione Carichieti; Fondazione Mario Negri Sud	This work was supported by Modello innovativo per l'identificazione di composti capaci di promuovere la rimielinazione in modelli cellulari di Sclerosi Multipla Fondazione Carichieti http://www.fondazionecarichieti.it/it/, and Fondazione Mario Negri Sud https://it-it.facebook.com/pages/Fondazione-Negri-Sud-ONLUS/221488934531828. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angot E, 2008, STEM CELLS, V26, P2311, DOI 10.1634/stemcells.2008-0297; Asai J, 2006, CIRCULATION, V113, P2413, DOI 10.1161/CIRCULATIONAHA.105.603167; Ayers KL, 2010, TRENDS CELL BIOL, V20, P287, DOI 10.1016/j.tcb.2010.02.002; Bambakidis NC, 2009, J NEUROSURG-SPINE, V10, P171, DOI 10.3171/2008.10.SPI08231; Baud O, 1999, ARCH DIS CHILD-FETAL, V80, pF159; Bergmann TK, 2012, CLIN PHARMACOKINET, V51, P711, DOI 10.1007/s40262-012-0007-8; Bhuta T, 1998, ARCH DIS CHILD-FETAL, V79, pF26, DOI 10.1136/fn.79.1.F26; Buckley CE, 2010, NEUROPHARMACOLOGY, V59, P149, DOI 10.1016/j.neuropharm.2010.04.014; Budni J, 2011, NEUROSCIENCE, V190, P346, DOI 10.1016/j.neuroscience.2011.05.053; Charytoniuk D, 2002, J PHYSIOLOGY-PARIS, V96, P9, DOI 10.1016/S0928-4257(01)00075-4; Clemente D, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00268; Comabella M, 2011, CURR NEUROL NEUROSCI, V11, P484, DOI 10.1007/s11910-011-0211-1; Ortega MC, 2012, GLIA, V60, P851, DOI 10.1002/glia.22316; De Vries GH, 2010, NEUROCHEM RES, V35, P1978, DOI 10.1007/s11064-010-0318-9; Deshmukh VA, 2013, NATURE, V502, P327, DOI 10.1038/nature12647; Donia M, 2010, SCAND J IMMUNOL, V72, P396, DOI 10.1111/j.1365-3083.2010.02451.x; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Feldmann A, 2011, J NEUROSCI, V31, P5659, DOI 10.1523/JNEUROSCI.6638-10.2011; Ferent J, 2014, STEM CELL REP, V3, P312, DOI 10.1016/j.stemcr.2014.05.016; Ferent J, 2013, J NEUROSCI, V33, P1759, DOI 10.1523/JNEUROSCI.3334-12.2013; Franklin RJM, 2008, J NEUROL, V255, P19, DOI 10.1007/s00415-008-1004-6; Fulton DL, 2011, NUCLEIC ACIDS RES, V39, P7974, DOI 10.1093/nar/gkr326; Gallo V, 2014, NEURON, V83, P283, DOI 10.1016/j.neuron.2014.06.010; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Gobert RP, 2009, MOL CELL BIOL, V29, P1538, DOI 10.1128/MCB.01375-08; Goudarzvand M, 2010, CELL MOL NEUROBIOL, V30, P289, DOI 10.1007/s10571-009-9451-x; Gruenenfelder FI, 2011, J ANAT, V219, P33, DOI 10.1111/j.1469-7580.2011.01363.x; Hanafy KA, 2011, FEBS LETT, V585, P3821, DOI 10.1016/j.febslet.2011.03.048; Heine VM, 2009, J CLIN INVEST, V119, P267, DOI 10.1172/JCI36376; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Inglese Melissa Dodd, 2009, J Pediatr Nurs, V24, P49, DOI 10.1016/j.pedn.2008.06.005; Jadasz JJ, 2012, CELL TISSUE RES, V349, P331, DOI 10.1007/s00441-012-1331-x; Jenkins D, 2009, CELL SIGNAL, V21, P1023, DOI 10.1016/j.cellsig.2009.01.033; Jenkins SI, 2014, ACS CHEM NEUROSCI, V5, P51, DOI 10.1021/cn400167n; Joubert L, 2010, J NEUROSCI RES, V88, P2546, DOI 10.1002/jnr.22434; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Keough MB, 2013, NEUROTHERAPEUTICS, V10, P44, DOI 10.1007/s13311-012-0152-7; Kim J, 2013, CANCER CELL, V23, P23, DOI 10.1016/j.ccr.2012.11.017; Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027; Koenning M, 2012, J NEUROSCI, V32, P12528, DOI 10.1523/JNEUROSCI.1069-12.2012; Kotter MR, 2011, BRAIN, V134, P1882, DOI 10.1093/brain/awr014; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lavine KJ, 2008, J CLIN INVEST, V118, P2404, DOI 10.1172/JCI34561; Le PP, 2005, PLOS GENET, V1, P159, DOI 10.1371/journal.pgen.0010016; Lee JM, 2008, J NEUROSCI, V28, P3141, DOI 10.1523/JNEUROSCI.5547-07.2008; Lou KJ, 2010, SCIBX, V3; Loulier K, 2006, J NEUROCHEM, V98, P530, DOI 10.1111/j.1471-4159.2006.03896.x; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Mastronardi FG, 2004, J IMMUNOL, V172, P6418, DOI 10.4049/jimmunol.172.10.6418; Mekhail M, 2012, PROG NEUROBIOL, V96, P322, DOI 10.1016/j.pneurobio.2012.01.008; Merchan P, 2007, MOL CELL NEUROSCI, V36, P355, DOI 10.1016/j.mcn.2007.07.012; Miron VE, 2011, BBA-MOL BASIS DIS, V1812, P184, DOI 10.1016/j.bbadis.2010.09.010; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Munzel EJ, 2013, DRUGS, V73, P2017, DOI 10.1007/s40265-013-0146-8; Najm FJ, 2015, NATURE, V522, P216, DOI 10.1038/nature14335; Noguchi KK, 2008, CELL DEATH DIFFER, V15, P1582, DOI 10.1038/cdd.2008.97; Pascussi JM, 2003, BBA-GEN SUBJECTS, V1619, P243, DOI 10.1016/S0304-4165(02)00483-X; Porcu G, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-88; Porcu G, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-197; Rezen T, 2010, BIOCHIM BIOPHYS ACTA, V1, P146; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Roberg-Larsen H, 2014, BIOCHEM BIOPH RES CO, V446, P669, DOI 10.1016/j.bbrc.2014.01.087; Rosenberg SS, 2007, CELL MOL LIFE SCI, V64, P3059, DOI 10.1007/s00018-007-7265-x; Saher G, 2012, NAT MED, V18, P1130, DOI 10.1038/nm.2833; Shanks EJ, 2013, EUROPEAN PHARM REV, V18, P11; Simons M, 2007, CURR OPIN NEUROBIOL, V17, P533, DOI 10.1016/j.conb.2007.08.003; Simons M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020479; Tobinick EL, 2009, DRUG NEWS PERSPECT, V22, P119, DOI 10.1358/dnp.2009.22.2.1303818; Wang JB, 2010, P NATL ACAD SCI USA, V107, P9323, DOI 10.1073/pnas.0910712107; White R, 2014, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00284; Wicking C, 1999, ONCOGENE, V18, P7844, DOI 10.1038/sj.onc.1203282; Winterstein C, 2008, J CELL SCI, V121, P834, DOI 10.1242/jcs.022731; Yeh TF, 1998, PEDIATRICS, V101, part. no., DOI 10.1542/peds.101.5.e7; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zuccaro E, 2013, NAT CELL BIOL, V15, P572, DOI 10.1038/ncb2750	75	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144550	10.1371/journal.pone.0144550	http://dx.doi.org/10.1371/journal.pone.0144550			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658258	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903500039
J	Singam, A; Ytterberg, C; Tham, K; von Koch, L				Singam, Avvai; Ytterberg, Charlotte; Tham, Kerstin; von Koch, Lena			Participation in Complex and Social Everyday Activities Six Years after Stroke: Predictors for Return to Pre-Stroke Level	PLOS ONE			English	Article							FRENCHAY ACTIVITIES INDEX; FUNCTIONAL STATUS; REHABILITATION; DETERMINANTS; DISCHARGE; RECOVERY; IMPACT; LIFE	Background Long-term disability following stroke can lead to participation restrictions in complex and social everyday activities, yet information is lacking on to what extent stroke survivors return to their pre-stroke levels of participation. Objectives The objectives of this study were to investigate the level of participation in complex and social everyday activities 6 years after stroke, to compare this with pre-stroke participation and to identify predictors of returning to pre-stroke levels of participation. Method All patients admitted to Karolinska University Hospital's stroke units during a 1-year period were eligible to participate and 349 patients were recruited. Assessments were made at base-line, 3 months and 6 years using self-reported outcome measures. Participation was assessed using the Frenchay Activities Index (FAI). The 6-year score for each participant was compared to the pre-stroke score, both for the total score and for each domain (domestic chores, leisure/work and outdoor activities). Predictors of having the same or better level of participation at 6 years were identified using logistic regression. Results At 6 years, 121 participants were followed up, 166 were deceased, 44 declined to take part and 18 could not be traced. At 6 years 84% could be described as active (FAI >= 15). The same level of participation or better than pre-stroke was found in 35% of participants, in 65% the level was lower. Similar predictors were identified for achieving the same or better level of participation at 6 years for FAI total and the three domains; ability to walk without aids and a lower age at stroke onset, and perceived mobility, participation and recovery at 3 months. Conclusion Six years after stroke, 35% of participants had the same or better level of participation as pre-stroke. Rehabilitation after stroke to improve walking ability and participation might improve long-term participation in complex and social everyday activities.	[Singam, Avvai] Nykopings Hosp, Nykoping, Sweden; [Singam, Avvai; Ytterberg, Charlotte; Tham, Kerstin; von Koch, Lena] Karolinska Inst, Stockholm, Sweden; [Ytterberg, Charlotte; Tham, Kerstin; von Koch, Lena] Karolinska Univ Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Ytterberg, C (corresponding author), Karolinska Inst, Stockholm, Sweden.	charlotte.ytterberg@ki.se	von Koch, Lena/P-2310-2018; Tham, Kerstin/T-3964-2018	von Koch, Lena/0000-0002-8560-3016; Tham, Kerstin/0000-0001-7025-5226; Ytterberg, Charlotte/0000-0003-3704-8887	Swedish Research Council [2007-3087, 2013-2806]; Stockholms Lans Landsting [2006-0700]; Swedish Stroke Association	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholms Lans Landsting; Swedish Stroke Association	Swedish Research Council 2007-3087 and 2013-2806 http://www.vr.se/, Stockholms Lans Landsting 2006-0700 https://www.sll.se/, Swedish Stroke Association www.strokeforbundet.se/AS CY KT LvK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, ANN REPORT; ASPLUND K, 1985, STROKE, V16, P885; BOND MJ, 1995, DISABIL REHABIL, V17, P63, DOI 10.3109/09638289509166629; De Wit L, 2007, STROKE, V38, P2101, DOI 10.1161/STROKEAHA.107.482869; Desrosiers J, 2006, DISABIL REHABIL, V28, P221, DOI 10.1080/09638280500158372; Desrosiers Johanne, 2005, Can J Occup Ther, V72, P195; Dijkerman HC, 1996, J ROY COLL PHYS LOND, V30, P538; Dobkin BH, 2004, LANCET NEUROL, V3, P528, DOI 10.1016/S1474-4422(04)00851-8; Duncan PW, 1999, STROKE, V30, P2131, DOI 10.1161/01.STR.30.10.2131; Ellwardt L, 2014, EUR SOCIOL REV, V30, P413, DOI 10.1093/esr/jcu046; Feigin VL, 2010, NEUROLOGY, V75, P1597, DOI 10.1212/WNL.0b013e3181fb44b3; Gadidi V, 2011, ARCH PHYS MED REHAB, V92, P1802, DOI 10.1016/j.apmr.2011.06.014; Gall SL, 2009, CEREBROVASC DIS, V27, P123, DOI 10.1159/000177919; Govan L, 2009, STROKE, V40, P3396, DOI 10.1161/STROKEAHA.109.557645; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jonsson AC, 2014, STROKE, V45, P1784, DOI 10.1161/STROKEAHA.114.005164; Kumlien S, 1999, DISABIL REHABIL, V21, P31, DOI 10.1080/096382899298070; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Liman TG, 2012, J NEUROL, V259, P1125, DOI 10.1007/s00415-011-6312-6; Lu WS, 2012, ARCH PHYS MED REHAB, V93, P1097, DOI 10.1016/j.apmr.2012.01.015; Norrving B., 2010, FOREKOMST BEFOLKNING; Patel MD, 2002, J AM GERIATR SOC, V50, P700, DOI 10.1046/j.1532-5415.2002.50165.x; Piercy W, 2000, CLIN REHABIL, V14, P433, DOI 10.1191/0269215500cr327oa; SCHULING J, 1993, STROKE, V24, P1173, DOI 10.1161/01.STR.24.8.1173; Spitzer J, 2011, OTJR THOROFARE N J, V31, P8; Tse T, 2013, ARCH PHYS MED REHAB, V94, P177, DOI 10.1016/j.apmr.2012.09.002; Turnbull JC, 2000, ARCH PHYS MED REHAB, V81, P1034, DOI 10.1053/apmr.2000.7162; von Koch L, 2000, CLIN REHABIL, V14, P574, DOI 10.1191/0269215500cr364oa; Wade D T, 1985, Int Rehabil Med, V7, P176; WADE DT, 1987, SCAND J REHABIL MED, V19, P25; WHO, 2001, WHO INT CLASS FUNCT; Wilkinson PR, 1997, QUAL HEALTH CARE, V6, P125, DOI 10.1136/qshc.6.3.125; Wolfe C, 2011, PLOS MED, V8, P1; Young J, 2001, CEREBROVASC DIS, V12, P114, DOI 10.1159/000047690	34	58	59	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144344	10.1371/journal.pone.0144344	http://dx.doi.org/10.1371/journal.pone.0144344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658735	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903500022
J	da Silva, RCS; Milet-Pinheiro, P; da Silva, PCB; da Silva, AG; da Silva, MV; Navarro, DMDF; da Silva, NH				Santos da Silva, Rayane Cristine; Milet-Pinheiro, Paulo; Bezerra da Silva, Patricia Cristina; da Silva, Alexandre Gomes; da Silva, Marcia Vanusa; do Amaral Ferraz Navarro, Daniela Maria; da Silva, Nicacio Henrique			(E)-Caryophyllene and alpha-Humulene: Aedes aegypti Oviposition Deterrents Elucidated by Gas Chromatography-Electrophysiological Assay of Commiphora leptophloeos Leaf Oil	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; INSECTICIDE RESISTANCE; PYRETHROID RESISTANCE; ACARICIDAL ACTIVITY; MEDICINAL-PLANTS; AROMATIC PLANTS; DENGUE VECTOR; OLEOGUM RESIN; MOSQUITO; CARYOPHYLLENE	Aedes aegypti is responsible for the transmission of dengue, a disease that infects millions of people each year. Although essential oils are well recognized as sources of compounds with repellent and larvicidal activities against the dengue mosquito, much less is known about their oviposition deterrent effects. Commiphora leptophloeos, a tree native to South America, has important pharmacological properties, but the chemical profile and applicability of its essential oil in controlling the spread of the dengue mosquito have not been investigated. The aim of this study was to determine the composition of C. leptophloeos leaf oil and to evaluate its larvicidal and oviposition deterrent effects against A. aegypti. Fifty-five components of the essential oil were detected by gas chromatography (GC)-mass spectrometry, with a-phellandrene (26.3%), (E)-caryophyllene (18.0%) and beta-phellandrene (12.9%) identified as the major constituents. Bioassays showed that the oil exhibited strong oviposition deterrent effects against A. aegypti at concentrations between 25 and 100 ppm, and possessed good larvicidal activity (LC50 = 99.4 ppm). Analysis of the oil by GC coupled with electroantennographic detection established that seven constituents could trigger antennal depolarization in A. aegypti gravid females. Two of these components, namely (E)-caryophyllene and a-humulene, were present in substantial proportions in the oil, and oviposition deterrence assays confirmed that both were significantly active at concentrations equivalent to those present in the oil. It is concluded that these sesquiterpenes are responsible, at least in part, for the deterrent effect of the oil. The oviposition deterrent activity of the leaf oil of C. leptophloeos is one of the most potent reported so far, suggesting that it could represent an interesting alternative to synthetic insecticides. The results of this study highlight the importance of integrating chemical and electrophysiological methods for screening natural compounds for their potential in combating vectors of insect-borne diseases.	[Santos da Silva, Rayane Cristine; Milet-Pinheiro, Paulo; Bezerra da Silva, Patricia Cristina; do Amaral Ferraz Navarro, Daniela Maria] Fed Univ Pernambuco UFPE, Dept Fundamental Chem, Lab Chem Ecol, Recife, PE, Brazil; [Santos da Silva, Rayane Cristine; da Silva, Alexandre Gomes; da Silva, Marcia Vanusa; da Silva, Nicacio Henrique] Fed Univ Pernambuco UFPE, Dept Biochem, Lab Nat Prod, Recife, PE, Brazil; [Milet-Pinheiro, Paulo] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Ulm University	Navarro, DMDF (corresponding author), Fed Univ Pernambuco UFPE, Dept Fundamental Chem, Lab Chem Ecol, Recife, PE, Brazil.	dmafn@ufpe.br	Navarro, Daniela Maria do Amaral Ferraz/C-4975-2013; Bezerra-Silva, Patricia C/E-8746-2016; Pinheiro, Paulo Milet/P-7035-2015; Navarro, Daniela Maria do Amaral Ferraz/GXM-4019-2022	Navarro, Daniela Maria do Amaral Ferraz/0000-0003-0158-7221; Bezerra-Silva, Patricia C/0000-0002-3774-8528; Pinheiro, Paulo Milet/0000-0002-4929-2177; Silva, Rayane Cristine Santos da/0000-0002-4765-7283	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco (FACEPE)/Programa de Apoio a Nucleos de Excelencia (PRONEX); FACEPE/PRONEX [APQ-0981-1.06/08]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) CNPq/Universal [482866/2011-0]; CNPq/INCT-Dengue [15204]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco (FACEPE)/Programa de Apoio a Nucleos de Excelencia (PRONEX); FACEPE/PRONEX(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) CNPq/Universal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); CNPq/INCT-Dengue	The study was supported financially by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco (FACEPE)/Programa de Apoio a Nucleos de Excelencia (PRONEX) and the following funding sources were not involved in the study design, in the collection, analysis, and interpretation of data: FACEPE/PRONEX (APQ-0981-1.06/08); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) CNPq/Universal (Processo: 482866/2011-0); CNPq/INCT-Dengue (15204).	Abdel-Aziz S. E., 2000, Annals of Agricultural Science (Cairo), V45, P717; Adams R. P, 2009, IDENTIFICATION ESSEN; Agra MF, 2007, J ETHNOPHARMACOL, V111, P383, DOI 10.1016/j.jep.2006.12.007; Ali NAA, 2008, REC NAT PROD, V2, P70; Ali NAA, 2009, J ESSENT OIL BEAR PL, V12, P244, DOI 10.1080/0972060X.2009.10643717; Amiel E, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/872394; ARN H, 1975, Z NATURFORSCH C, V30, P722; Arnason JT, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511542664.002; Asres K, 1998, PLANTA MED, V64, P473, DOI 10.1055/s-2006-957489; Autran ES, 2009, BIORESOURCE TECHNOL, V100, P2284, DOI 10.1016/j.biortech.2008.10.055; Avlessi F, 2005, J ESSENT OIL RES, V17, P569, DOI 10.1080/10412905.2005.9698998; Ayedoun M. A., 1998, Journal of Essential Oil Research, V10, P105; Baser KHC, 2003, FLAVOUR FRAG J, V18, P153, DOI 10.1002/ffj.1166; BENTLEY MD, 1989, ANNU REV ENTOMOL, V34, P401, DOI 10.1146/annurev.en.34.010189.002153; BRIESKORN CH, 1982, PLANTA MED, V44, P87, DOI 10.1055/s-2007-971408; Burger H, 2012, OECOLOGIA, V168, P727, DOI 10.1007/s00442-011-2136-4; Campbell C, 2011, ENTOMOL EXP APPL, V138, P21, DOI 10.1111/j.1570-7458.2010.01072.x; CARROLL JF, 1989, ENTOMOL EXP APPL, V53, P111, DOI 10.1007/BF00187991; Cartaxo SL, 2010, J ETHNOPHARMACOL, V131, P326, DOI 10.1016/j.jep.2010.07.003; Chantraine JM, 1998, PHYTOTHER RES, V12, P350, DOI 10.1002/(SICI)1099-1573(199808)12:5&lt;350::AID-PTR311&gt;3.0.CO;2-7; Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P452, DOI 10.1016/j.biortech.2008.02.038; Cheng SS, 2009, PEST MANAG SCI, V65, P339, DOI 10.1002/ps.1693; DAVIS EE, 1976, J INSECT PHYSIOL, V22, P1371, DOI 10.1016/0022-1910(76)90160-8; De Albuquerque UP, 2007, J ETHNOPHARMACOL, V114, P325, DOI 10.1016/j.jep.2007.08.017; Ferreira WS, 2011, J ETHNOPHARMACOL, V138, P238, DOI 10.1016/j.jep.2011.09.018; FLINT HM, 1979, ENVIRON ENTOMOL, V8, P1123, DOI 10.1093/ee/8.6.1123; Forattini OP, 2003, REV SAUDE PUBL, V37, P676, DOI 10.1590/S0034-89102003000500021; Gillij YG, 2008, BIORESOURCE TECHNOL, V99, P2507, DOI 10.1016/j.biortech.2007.04.066; de Lima GPG, 2013, PARASITOL RES, V112, P1953, DOI 10.1007/s00436-013-3351-1; Grisales N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002438; Habeeb S. M., 2009, American-Eurasian Journal of Agricultural and Environmental Science, V5, P196; Hanus Lumir O., 2005, Biomedical Papers (Olomouc), V149, P3; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Jantan I., 1998, ARBEC, P1; Junor GAO, 2008, J ESSENT OIL RES, V20, P560, DOI 10.1080/10412905.2008.9700088; Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948; Khandagle AJ, 2011, PARASITOL RES, V109, P339, DOI 10.1007/s00436-011-2261-3; Kim EH, 2003, APPL ENTOMOL ZOOL, V38, P261, DOI 10.1303/aez.2003.261; Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5; Liu Yu-Qing, 2010, Acta Entomologica Sinica, V53, P396; MAHARAJ R, 2011, OPEN ACCESS INSECT P, V3, P27, DOI DOI 10.2147/OAIP.S8620; Meshram P. B., 2000, Indian Forester, V126, P961; Milet-Pinheiro P, 2013, J CHEM ECOL, V39, P1347, DOI 10.1007/s10886-013-0363-3; Mothana RA, 2010, MOLECULES, V15, P689, DOI 10.3390/molecules15020689; Navarro DMDF, 2013, NAT PROD J, V3, P268, DOI 10.2174/221031550304140328113732; Noge K, 2009, MOLECULES, V14, P5289, DOI 10.3390/molecules14125289; Phasomkusolsil S, 2011, SE ASIAN J TROP MED, V42, P1083; Pierson TC, 2014, ANNU REV VIROL, V1, P191; Pontes WJT, 2010, J ESSENT OIL RES, V22, P279, DOI 10.1080/10412905.2010.9700324; Pooter H. L. de, 1989, Journal of Essential Oil Research, V1, P9; Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395; Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007; Ranaweera S. S., 1996, Journal of the National Science Council of Sri Lanka, V24, P63; Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103; Rozendaal J.A., 1997, VECTOR CONTROL METHO; Sant'Ana J, 2001, P WORKSH CHEM COUPL, P47; Santos GKN, 2014, MOLECULES, V19, P16573, DOI 10.3390/molecules191016573; Santos GKN, 2012, IND CROP PROD, V40, P254, DOI 10.1016/j.indcrop.2012.03.020; Schiestl FP, 2002, MOLEC METH PLAN ANAL, V21, P173; Shen T, 2012, J ETHNOPHARMACOL, V142, P319, DOI 10.1016/j.jep.2012.05.025; Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064; Simoes C.M.O., 1999, FARMACOGN PLANTA AO, V1th, P467; Vera SS, 2014, PARASITOL RES, V113, P2647, DOI 10.1007/s00436-014-3917-6; SOUZA V. C., 2008, BOT SISTEMATICA GUIA; Tauil P L, 2001, Cad Saude Publica, V17 Suppl, P99, DOI 10.1590/S0102-311X2001000700018; Pontes Wendel José Teles, 2007, Acta Amaz., V37, P103, DOI 10.1590/S0044-59672007000100012; Trentin DD, 2011, J ETHNOPHARMACOL, V137, P327, DOI 10.1016/j.jep.2011.05.030; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; Waliwitiya R, 2009, PEST MANAG SCI, V65, P241, DOI 10.1002/ps.1675; Warikoo R, 2011, PARASITOL RES, V109, P1125, DOI 10.1007/s00436-011-2355-y; World Health Organization, 2019, DENG SEV DENG; World Health Organization, 2005, GUID LAB FIELD TEST, P7; Yang DP, 1999, MYCOPATHOLOGIA, V148, P79, DOI 10.1023/A:1007178924408	74	42	42	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144586	10.1371/journal.pone.0144586	http://dx.doi.org/10.1371/journal.pone.0144586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650757	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903300059
J	Tang, WZ; Zhou, HF; Li, W				Tang, Weizhong; Zhou, Huafu; Li, Wei			Silver and Cyanine Staining of Oligonucleotides in Polyacrylamide Gel	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; ETHIDIUM-BROMIDE; DNA; PROTEINS; RNA	To explore why some oligonucleotides in denaturing polyacrylamide gel could not be silver-stained, 134 different oligonucleotides were analyzed using denaturing polyacrylamide gel electrophoresis stained with silver and asymmetric cyanine. As a result, we found that the sensitivity of oligos (dA), (dC), (dG) and (dT) to silver staining could be ranged as (dA) > (dG) > (dC) > (dT) from high to low. It was unexpected that oligo (dT) was hard to be silver-stained. Moreover, the silver staining of an oligonucleotide containing base T could be partially or completely inhibited by base T. The inhibition of silver staining by base T was a competitive inhibition which could be affected by the amounts of the argyrophil nucleobase and base T, the cis-distance between the argyrophil nucleobase and base T, and the gel concentration. The changes of the intensity of an oligonucleotide band caused by the changes of DNA base composition were diverse and interesting. The intensity of some oligonucleotide bands would significantly change when the changes of DNA base composition accumulated to a certain extent (usually >= 4 nt). The sensitivity of cyanine staining of <= 11-nt long oligonucleotides could be enhanced about 250-fold by fixing the gels with methanol fixing solution.	[Tang, Weizhong] Guangxi Med Univ, Affiliated Hosp 1, Dept Colorectal Surg, Nanning 530021, Guangxi, Peoples R China; [Zhou, Huafu] Guangxi Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Nanning 530021, Guangxi, Peoples R China; [Li, Wei] Guangxi Med Univ, Med Sci Res Ctr, Nanning 530021, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Li, W (corresponding author), Guangxi Med Univ, Med Sci Res Ctr, 22 Shuangyong Rd, Nanning 530021, Guangxi, Peoples R China.	liwei60@yahoo.com			National Natural Science Foundation of China [31360218]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is funded by National Natural Science Foundation of China, Grant No. 31360218. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSAM BJ, 1993, APPL BIOCHEM BIOTECH, V42, P181, DOI 10.1007/BF02788051; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bassam BJ, 2007, NAT PROTOC, V2, P2649, DOI 10.1038/nprot.2007.330; BEIDLER JL, 1982, ANAL BIOCHEM, V126, P374, DOI 10.1016/0003-2697(82)90530-9; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BOULIKAS T, 1981, J BIOCHEM BIOPH METH, V5, P219, DOI 10.1016/0165-022X(81)90046-4; FERRES MD, 1984, MUTAT RES, V126, P245, DOI 10.1016/0027-5107(84)90003-4; Gao F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039251; GOLDMAN D, 1982, ELECTROPHORESIS, V3, P24, DOI 10.1002/elps.1150030105; GUILLEMETTE JG, 1983, ELECTROPHORESIS, V4, P92, DOI 10.1002/elps.1150040112; KOLODNY GM, 1984, ANAL BIOCHEM, V138, P66, DOI 10.1016/0003-2697(84)90769-3; Li W, 2006, CLIN BIOCHEM, V39, P833, DOI 10.1016/j.clinbiochem.2006.05.004; MARCOS R, 1981, EXPERIENTIA, V37, P559, DOI 10.1007/BF01990047; McKee DR, 2004, BIOTECHNIQUES, V37, P46, DOI 10.2144/04371BM04; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; MERRIL CR, 1979, P NATL ACAD SCI USA, V76, P4335, DOI 10.1073/pnas.76.9.4335; MERRIL CR, 1984, ELECTROPHORESIS, V5, P289, DOI 10.1002/elps.1150050509; Shukla S, 2009, NANOSCALE, V1, P122, DOI 10.1039/b9nr00004f; Singer VL, 1999, MUTAT RES-GEN TOX EN, V439, P37, DOI 10.1016/S1383-5718(98)00172-7; SOMERVILLE LL, 1981, BIOCHEM BIOPH RES CO, V102, P53, DOI 10.1016/0006-291X(81)91487-X; Tuma RS, 1999, ANAL BIOCHEM, V268, P278, DOI 10.1006/abio.1998.3067	21	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144422	10.1371/journal.pone.0144422	http://dx.doi.org/10.1371/journal.pone.0144422			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650843	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903300048
J	Petersen, JE; Frantz, CM; Shammin, MR; Yanisch, TM; Tincknell, E; Myers, N				Petersen, John E.; Frantz, Cynthia M.; Shammin, Md. Rumi; Yanisch, Tess M.; Tincknell, Evan; Myers, Noel			Electricity and Water Conservation on College and University Campuses in Response to National Competitions among Dormitories: Quantifying Relationships between Behavior, Conservation Strategies and Psychological Metrics	PLOS ONE			English	Article							ENERGY; CONSUMPTION; FEEDBACK; IMPACT; INFORMATION	"Campus Conservation Nationals" (CCN) is a recurring, nation-wide electricity and wateruse reduction competition among dormitories on college campuses. We conducted a two year empirical study of the competition's effects on resource consumption and the relationship between conservation, use of web technology and various psychological measures. Significant reductions in electricity and water use occurred during the two CCN competitions examined (n = 105,000 and 197,000 participating dorm residents respectively). In 2010, overall reductions during the competition were 4% for electricity and 6% for water. The top 10% of dorms achieved 28% and 36% reductions in electricity and water respectively. Participation was larger in 2012 and reductions were slightly smaller (i.e. 3% electricity). The fact that no seasonal pattern in electricity use was evident during non-competition periods suggests that results are attributable to the competition. Post competition resource use data collected in 2012 indicates that conservation behavior was sustained beyond the competition. Surveys were used to assess psychological and behavioral responses (n = 2,900 and 2,600 in 2010 and 2012 respectively). Electricity reductions were significantly correlated with: web visitation, specific conservation behaviors, awareness of the competition, motivation and sense of empowerment. However, participants were significantly more motivated than empowered. Perceived benefits of conservation were skewed towards global and future concerns while perceived barriers tended to be local. Results also suggest that competitionsmay be useful for "preaching beyond the choir"-engaging those who might lack prior intrinsic or political motivation. Although college life is distinct, certain conclusions related to competitions, self-efficacy, and motivation and social norms likely extend to other residential settings.	[Petersen, John E.; Shammin, Md. Rumi; Myers, Noel] Oberlin Coll, Environm Studies Program, Oberlin, OH 44074 USA; [Frantz, Cynthia M.; Tincknell, Evan] Oberlin Coll, Dept Psychol, Oberlin, OH 44074 USA; [Yanisch, Tess M.] New York Univ Steinhardt, Dept Appl Psychol, New York, NY USA	Oberlin College; Oberlin College; New York University	Petersen, JE (corresponding author), Oberlin Coll, Environm Studies Program, Oberlin, OH 44074 USA.	john.petersen@oberlin.edu			Great Lakes Protection Fund [901]; U.S. Environmental Protection Agency P3 Program [SU832466]	Great Lakes Protection Fund; U.S. Environmental Protection Agency P3 Program	Funding was provided by Great Lakes Protection Fund (www.glpf.org/), Grant #901, to JEP, CMF, and MRS. Funding was also provided by U.S. Environmental Protection Agency P3 Program (http://www.epa.gov/p3/), Grant #SU832466, to JEP and CMF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse W, 2005, J ENVIRON PSYCHOL, V25, P273, DOI 10.1016/j.jenvp.2005.08.002; Abrahamse W, 2007, J ENVIRON PSYCHOL, V27, P265, DOI 10.1016/j.jenvp.2007.08.002; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ardoin N., 2013, INFLUENCING CONSERVA; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; BECKER LJ, 1978, J APPL PSYCHOL, V63, P428, DOI 10.1037/0021-9010.63.4.428; Carrico AR, 2011, J ENVIRON PSYCHOL, V31, P1, DOI 10.1016/j.jenvp.2010.11.004; Cialdini R.B., 2009, INFLUENCE SCI PRACTI, V5th ed.; Delmas MA, 2013, ENERG POLICY, V61, P729, DOI 10.1016/j.enpol.2013.05.109; Diamond R, 1987, ENERGY EFFICIENCY PE; Dietz T, 2009, P NATL ACAD SCI USA, V106, P18452, DOI 10.1073/pnas.0908738106; DOE, 2012, BUILD EN DAT BOOK; Ehrhardt-Martinez K., 2010, ADV METERING INITIAT; Evans GW, 1998, J ENVIRON PSYCHOL, V18, P85, DOI 10.1006/jevp.1998.0089; Froehlich J, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1999; Gardner G.T., 1996, ENV PROBLEMS HUMAN B; Goldstein NJ, 2008, J CONSUM RES, V35, P472, DOI 10.1086/586910; Haas R, 1998, ENERG BUILDINGS, V27, P195, DOI 10.1016/S0378-7788(97)00034-0; Hagan C, 2008, ORG RESIDENCE HALL C, P32; HARKINS SG, 1989, J PERS SOC PSYCHOL, V56, P934, DOI 10.1037/0022-3514.56.6.934; Heede R, 2002, OBERLIN CLIMATE NEUT; Hodge C, 2011, DORM ENERGY COMPETIT; Jain RK, 2012, ENERG BUILDINGS, V48, P8, DOI 10.1016/j.enbuild.2011.12.033; Jones CM, 2015, REV ENERGY REDUCTION; KATZEV RD, 1983, J ECON PSYCHOL, V3, P267, DOI 10.1016/0167-4870(83)90006-5; Maniates M.F., 2001, GLOBAL ENVIRON POLIT, V1, P31, DOI [10.1162/152638001316881395, DOI 10.1162/152638001316881395, https://doi.org/10.1162/152638001316881395]; Markowitz E, 2014, CONNECTING CLIMATE C; Mayer FS, 2004, J ENVIRON PSYCHOL, V24, P503, DOI 10.1016/j.jenvp.2004.10.001; McKenzie-Mohr D., 1999, FOSTERING SUSTAINABL; Nolan JM, 2008, PERS SOC PSYCHOL B, V34, P913, DOI 10.1177/0146167208316691; O'Connor RE, 1999, RISK ANAL, V19, P461, DOI 10.1111/j.1539-6924.1999.tb00421.x; PALLAK MS, 1976, PERS SOC PSYCHOL B, V2, P27, DOI 10.1177/014616727600200105; Peschiera G, 2012, ENERG BUILDINGS, V49, P584, DOI 10.1016/j.enbuild.2012.03.011; Peschiera G, 2010, ENERG BUILDINGS, V42, P1329, DOI 10.1016/j.enbuild.2010.03.001; Peters J., 2009, P INT S ROB RES ISRR, P1; Petersen J.E., 2007, INT J SUSTAINABILITY, V8, P16, DOI DOI 10.1108/14676370710717562; Petersen JE, 2014, SOLUTIONS, V5, P79; Raudenbush S., 2000, HLM 6 HIERARCHICAL L; Siero FW, 1996, J ENVIRON PSYCHOL, V16, P235, DOI 10.1006/jevp.1996.0019; Steg L, 2009, J ENVIRON PSYCHOL, V29, P309, DOI 10.1016/j.jenvp.2008.10.004; Wilson A, 2001, ENV BUILDING NEWS, V10	41	20	20	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144070	10.1371/journal.pone.0144070	http://dx.doi.org/10.1371/journal.pone.0144070			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9JH	26672599	gold, Green Submitted, Green Published			2022-12-27	WOS:000366722700024
J	Birlie, A; Tesfaw, G; Dejene, T; Woldemichael, K				Birlie, Abayneh; Tesfaw, Getnet; Dejene, Tariku; Woldemichael, Kifle			Time to Death and Associated Factors among Tuberculosis Patients in Dangila Woreda, Northwest Ethiopia	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; MORTALITY	Background Tuberculosis (TB) is among the leading causes of morbidity and mortality worldwide. More than 70% of the deaths of TB patients occur during the first two months of TB treatment. The major risk factors that increase early death of TB patients are being positive for human immunodeficiency virus (HIV), being of old age, being underweight or undergoing re-treatment. Objective To assess the time of reported deaths and associated factors in a cohort of patients with TB during TB treatment. Methods An institution-based retrospective cohort study was analyzed in Dangila Woreda, Northwest Ethiopia from March 1st through March 30, 2014. All TB patients registered in the direct observed treatment (DOTs) clinic from 2008-2012 were included in the study. Data were entered into EpiData and exported to SPSS for analysis. The survival probability was analyzed by the Kaplan Meier method and Cox regression analysis was applied to investigate factors associated with death during TB treatment. Results From a total of 872 cases registered in TB registry log book, 810 were used for the analysis of which 60 (7.4%) died during the treatment. The overall mortality rate was 12.8/1000 person months of observation. A majority of TB deaths 34 (56.7%) occurred during the intensive phase of the treatment, and the median time of death was at two months of the treatment. Age, HIV status and baseline body weight were independent predictors of death during TB treatment. Conclusions Most deaths occurred in the first two months of TB treatment. Old age, TB/HIV co-infection and a baseline body weight of <35 kg increased the mortality during TB treatment. Therefore, a special follow up of TB patients during the intensive phase, of older patients and of TB/HIV co-infected cases, as well as nutritionally supplementing for underweight patients may be important to consider as interventions to reduce deaths during TB treatment.	[Birlie, Abayneh] Addis Ababa City Adm Hlth Bur, Dept Monitoring & Evaluat, Addis Ababa, Ethiopia; [Tesfaw, Getnet] Jimma Univ, Dept Med Lab Sci & Pathol, Coll Hlth Sci, Jimma, Ethiopia; [Dejene, Tariku] Univ Addis Ababa, Dept Stat, Coll Nat Sci, Addis Ababa, Ethiopia; [Woldemichael, Kifle] Jimma Univ, Dept Epidemiol, Coll Hlth Sci, Jimma, Ethiopia	Jimma University; Addis Ababa University; Jimma University	Birlie, A (corresponding author), Addis Ababa City Adm Hlth Bur, Dept Monitoring & Evaluat, Addis Ababa, Ethiopia.	abaybrl@gmail.com			Jimma University Postgraduate Coordination Office	Jimma University Postgraduate Coordination Office	This work was funded by Jimma University Postgraduate Coordination Office, www.ju.edu.et. The funding was received by AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis Z, 2013, IJBAR, V4, P7; Alavi SM, 2008, PAK J MED SCI, V24, P4; Albuquerque Maria de Fátima Pessoa Militão de, 2009, Rev. bras. epidemiol., V12, P513, DOI 10.1590/S1415-790X2009000400001; Babatunde OA, 2013, J MED MED SCI, V4, P10; Bao QS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-344; Berhe G, 2012, BMC PUBLIC HEALTH, P12; Beza M.G., 2013, J INFECT DIS THER, V1, P101, DOI [10.4172/2332-0877.1000101, DOI 10.4172/2332-0877.1000101]; Biadglegne F., 2013, INT J MED MED SCI, V5, P85, DOI DOI 10.5897/IJMMS12.142; Cayla JA, 2004, INT J TUBERC LUNG D, V8, P458; Farah MG, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-14; Federal Ministry of Health, 2011, ETH NAT TB PREV SURV; Federal Ministry of Health, 2013, GUID CLIN PROGR MAN; Federal Ministry of Health, 2008, TUB LEPR TB HIV PREV, V4th; Getahun B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-127; Harries AD, 2001, INT J TUBERC LUNG D, V5, P1000; Jonnalagada S, 2011, BMC PUBLIC HEALTH, V11, P7; Moolphate S, 2011, INT J GEN MED, V4, P181, DOI 10.2147/IJGM.S16486; Mugusi FM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-409; Naing NN, 2001, SE ASIAN J TROP MED, V32, P14; Pardeshi Geeta, 2009, Indian J Med Sci, V63, P180, DOI 10.4103/0019-5359.53163; Shaweno D, 2012, BMC RES NOTES, P5; Shen X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-95; Sileshi B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-297; Tessema B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-371; Vasantha M, 2008, Indian J Tuberc, V55, P64; World Health Organization, 2004, TB HIV CLIN MAN, V2nd; World Health Organization, 2021, 10 THREATS GLOB HLTH; World Health Organization, 2013, TUB FACT SHEET	28	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144244	10.1371/journal.pone.0144244	http://dx.doi.org/10.1371/journal.pone.0144244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669737	Green Published, Green Submitted, gold			2022-12-27	WOS:000366719300005
J	Kim, K; Kim, T; Yoon, T; Lee, C				Kim, Kayeon; Kim, Taekjun; Yoon, Taehwan; Lee, Choongkil			Covariation between Spike and LFP Modulations Revealed with Focal and Asynchronous Stimulation of Receptive Field Surround in Monkey Primary Visual Cortex	PLOS ONE			English	Article							MACAQUE V1 NEURONS; AREA MT; FUNCTIONAL CONNECTIVITY; EXPRESS-SACCADES; TRAVELING-WAVES; STRIATE CORTEX; CAT CORTEX; TIME; SUPPRESSION; RESPONSES	A focal visual stimulus outside the classical receptive field (RF) of a V1 neuron does not evoke a spike response by itself, and yet evokes robust changes in the local field potential (LFP). This subthreshold LFP provides a unique opportunity to investigate how changes induced by surround stimulation leads to modulation of spike activity. In the current study, two identical Gabor stimuli were sequentially presented with a variable stimulus onset asynchrony (SOA) ranging from 0 to 100 ms: the first (S1) outside the RF and the second (S2) over the RF of primary visual cortex neurons, while trained monkeys performed a fixation task. This focal and asynchronous stimulation of the RF surround enabled us to analyze the modulation of S2-evoked spike activity and covariation between spike and LFP modulation across SOA. In this condition, the modulation of S2-evoked spike response was dominantly facilitative and was correlated with the change in LFP amplitude, which was pronounced for the cells recorded in the upper cortical layers. The time course of covariation between the SOA-dependent spike modulation and LFP amplitude suggested that the subthreshold LFP evoked by the S1 can predict the magnitude of upcoming spike modulation.	[Kim, Kayeon; Kim, Taekjun; Lee, Choongkil] Seoul Natl Univ, Dept Psychol, Seoul, South Korea; [Yoon, Taehwan; Lee, Choongkil] Seoul Natl Univ, Program Cognit Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Lee, C (corresponding author), Seoul Natl Univ, Dept Psychol, Seoul, South Korea.	cklee@snu.ac.kr		Kim, Taekjun/0000-0002-8376-8861; Kim, Kayeon/0000-0002-4565-9429	Cognitive Neuroscience Research Program Grant of the National Research Foundation of Korea [NRF-20062005108]; Next Generation Grant of the Seoul National University	Cognitive Neuroscience Research Program Grant of the National Research Foundation of Korea(National Research Foundation of Korea); Next Generation Grant of the Seoul National University	This work was supported by the Cognitive Neuroscience Research Program Grant of the National Research Foundation of Korea (NRF-20062005108, http://nrf.re.kr) to CL, and by the Next Generation Grant of the Seoul National University to KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; Angelucci A, 2002, J NEUROSCI, V22, P8633; Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Bair W, 2002, J NEUROSCI, V22, P3189, DOI 10.1523/JNEUROSCI.22-08-03189.2002; Bair W, 2003, J NEUROSCI, V23, P7690; Benucci A, 2007, NEURON, V55, P103, DOI 10.1016/j.neuron.2007.06.017; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; BURT P, 1981, PSYCHOL REV, V88, P171, DOI 10.1037/0033-295X.88.2.171; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; FISCHER B, 1984, EXP BRAIN RES, V55, P232; Fitzpatrick D, 2000, CURR OPIN NEUROBIOL, V10, P438, DOI 10.1016/S0959-4388(00)00113-6; Freeman RD, 2001, PROG BRAIN RES, V134, P157; Fregnac Y, 2009, B ACAD NAT MED PARIS, V193, P851, DOI 10.1016/S0001-4079(19)32526-9; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRINVALD A, 1994, J NEUROSCI, V14, P2545; Guo K, 2007, EUR J NEUROSCI, V26, P1045, DOI 10.1111/j.1460-9568.2007.05712.x; Hafed ZM, 2011, J NEUROSCI, V31, P15219, DOI 10.1523/JNEUROSCI.3106-11.2011; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Haider B, 2010, NEURON, V65, P107, DOI 10.1016/j.neuron.2009.12.005; Haslinger R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039699; Henry CA, 2013, J NEUROSCI, V33, P6230, DOI 10.1523/JNEUROSCI.4155-12.2013; HORTON JC, 1991, ARCH OPHTHALMOL-CHIC, V109, P816, DOI 10.1001/archopht.1991.01080060080030; Ichida JM, 2007, J NEUROPHYSIOL, V98, P2168, DOI 10.1152/jn.00298.2007; Jancke D, 2004, NATURE, V428, P423, DOI 10.1038/nature02396; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kajikawa Y, 2011, NEURON, V72, P847, DOI 10.1016/j.neuron.2011.09.029; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Kim T, 2014, NEUROSCIENCE, V274, P170, DOI 10.1016/j.neuroscience.2014.05.041; Kim T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047543; KRAUT MA, 1985, ELECTROEN CLIN NEURO, V62, P300, DOI 10.1016/0168-5597(85)90007-3; Lee J, 2010, J NEUROPHYSIOL, V104, P2556, DOI 10.1152/jn.01040.2009; Levitt JB, 2002, VISUAL NEUROSCI, V19, P439, DOI 10.1017/S0952523802194065; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Liu YJ, 2011, J NEUROPHYSIOL, V105, P1306, DOI 10.1152/jn.00692.2010; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Maier A, 2011, J NEUROSCI, V31, P1971, DOI 10.1523/JNEUROSCI.5300-09.2011; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MITZDORF U, 1987, INT J NEUROSCI, V33, P33, DOI 10.3109/00207458708985928; Nauhaus I, 2012, J NEUROSCI, V32, P3088, DOI 10.1523/JNEUROSCI.5827-11.2012; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Okun M, 2010, J NEUROSCI, V30, P4440, DOI 10.1523/JNEUROSCI.5062-09.2010; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Rasch MJ, 2008, J NEUROPHYSIOL, V99, P1461, DOI 10.1152/jn.00919.2007; Ray S, 2011, J NEUROSCI, V31, P12674, DOI 10.1523/JNEUROSCI.1856-11.2011; RODMAN HR, 1987, VISION RES, V27, P2035, DOI 10.1016/0042-6989(87)90118-0; ROHRER WH, 1993, VISION RES, V33, P2447, DOI 10.1016/0042-6989(93)90125-G; Rudolph M, 2007, J NEUROSCI, V27, P5280, DOI 10.1523/JNEUROSCI.4652-06.2007; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; SCHROEDER CE, 1991, VISION RES, V31, P1143, DOI 10.1016/0042-6989(91)90040-C; Series P, 2003, J PHYSIOL-PARIS, V97, P453, DOI 10.1016/j.jphysparis.2004.01.023; Smith FW, 2010, P NATL ACAD SCI USA, V107, P20099, DOI 10.1073/pnas.1000233107; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Vinje WE, 2002, J NEUROSCI, V22, P2904, DOI 10.1523/JNEUROSCI.22-07-02904.2002; Walker GA, 1999, J NEUROSCI, V19, P10536; Walker GA, 2000, VISUAL NEUROSCI, V17, P369, DOI 10.1017/S0952523800173055; Xing DJ, 2012, P NATL ACAD SCI USA, V109, P13871, DOI 10.1073/pnas.1201478109; Xing DJ, 2009, J NEUROSCI, V29, P11540, DOI 10.1523/JNEUROSCI.2573-09.2009	67	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144929	10.1371/journal.pone.0144929	http://dx.doi.org/10.1371/journal.pone.0144929			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670337	Green Published, gold, Green Submitted			2022-12-27	WOS:000366719300030
J	Tribelli, PM; Venero, ECS; Ricardi, MM; Gomez-Lozano, M; Iustman, LJR; Molin, S; Lopez, NI				Tribelli, Paula M.; Solar Venero, Esmeralda C.; Ricardi, Martiniano M.; Gomez-Lozano, Maria; Raiger Iustman, Laura J.; Molin, Soren; Lopez, Nancy I.			Novel Essential Role of Ethanol Oxidation Genes at Low Temperature Revealed by Transcriptome Analysis in the Antarctic Bacterium Pseudomonas extremaustralis	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEM; ALCOHOL-DEHYDROGENASE; IRON ACQUISITION; GLOBAL REGULATOR; REDOX STATE; SMALL RNAS; STRESS; AERUGINOSA; GENOME; COLD	Temperature is one of the most important factors for bacterial growth and development. Cold environments are widely distributed on earth, and psychrotolerant and psychrophilic microorganisms have developed different adaptation strategies to cope with the stress derived from low temperatures. Pseudomonas extremaustralis is an Antarctic bacterium able to grow under low temperatures and to produce high amounts of polyhydroxyalkanoates (PHAs). In this work, we analyzed the genome-wide transcriptome by RNA deep-sequencing technology of early exponential cultures of P. extremaustralis growing in LB (Luria Broth) supplemented with sodium octanoate to favor PHA accumulation at 8 degrees C and 30 degrees C. We found that genes involved in primary metabolism, including tricarboxylic acid cycle (TCA) related genes, as well as cytochromes and amino acid metabolism coding genes, were repressed at low temperature. Among up-regulated genes, those coding for transcriptional regulatory and signal transduction proteins were over-represented at cold conditions. Remarkably, we found that genes involved in ethanol oxidation, exaA, exaB and exaC, encoding a pyrroloquinoline quinone (PQQ)-dependent ethanol dehydrogenase, the cytochrome c550 and an aldehyde dehydrogenase respectively, were up-regulated. Along with RNA-seq experiments, analysis of mutant strains for pqqB (PQQ biosynthesis protein B) and exaA were carried out. We found that the exaA and pqqB genes are essential for growth under low temperature in LB supplemented with sodium octanoate. Additionally, prosaniline assay measurements showed the presence of alcohol dehydrogenase activity at both 8 degrees C and 30 degrees C, while the activity was abolished in a pqqB mutant strain. These results together with the detection of ethanol by gas chromatography in P. extremaustralis cultures grown at 8 degrees C support the conclusion that this pathway is important under cold conditions. The obtained results have led to the identification of novel components involved in cold adaptation mechanisms in this bacterium, suggesting for the first time a role of the ethanol oxidation pathway for bacterial growth at low temperatures.	[Tribelli, Paula M.; Raiger Iustman, Laura J.; Lopez, Nancy I.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Tribelli, Paula M.; Solar Venero, Esmeralda C.; Raiger Iustman, Laura J.; Lopez, Nancy I.] Consejo Nacl Invest Cient & Tecn, IQUIBICEN, RA-1033 Buenos Aires, DF, Argentina; [Ricardi, Martiniano M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET, Inst Fisiol Biol Mol & Neurociencias IFIBYNE, Buenos Aires, DF, Argentina; [Gomez-Lozano, Maria; Molin, Soren] Tech Univ Denmark, Novo Nordisk Fdn, Ctr Biosustainabil, Horsholm, Denmark	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Novo Nordisk Foundation; Technical University of Denmark	Lopez, NI (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Intendente Guiraldes 2160,C1428EGA, Buenos Aires, DF, Argentina.	nan@qb.fcen.uba.ar	Gomez-Lozano, PhD, Maria/ABA-2244-2021	Gomez-Lozano, PhD, Maria/0000-0002-7078-4141; Ricardi, Martiniano/0000-0002-7904-6305; Molin, Soren/0000-0002-7973-2639; Solar Venero, Esmeralda/0000-0003-3516-8535; Raiger Iustman, Laura J./0000-0002-8541-3204; Tribelli, Paula Maria/0000-0001-9558-6275	Universidad de Buenos Aires [20020130100451BA]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [0338]; Agencia Nacional de Promocion Cientifica (ANPCyT), Argentina [2259]; CONICET; short term EMBO fellowship	Universidad de Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica (ANPCyT), Argentina(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); short term EMBO fellowship	This work was supported by grants from Universidad de Buenos Aires 2014-2017, Proyecto No 20020130100451BA, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PIP 2011, No 0338), and Agencia Nacional de Promocion Cientifica (ANPCyT: PICT 2013, No 2259), Argentina. PMT, LJRI, and NIL are career investigators from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina). ESV has a graduate student fellowship from CONICET. MMR has a postdoctoral fellowship from CONICET. RNA-seq experiments were performed by PMTat Dr. Molin's Lab supported by a short term EMBO fellowship.	Ayub ND, 2009, EXTREMOPHILES, V13, P59, DOI 10.1007/s00792-008-0197-z; Balasubramanian D, 2014, NUCLEIC ACIDS RES, V42, P979, DOI 10.1093/nar/gkt942; Barbier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089941; Barria C, 2013, MICROBIOL-SGM, V159, P2437, DOI 10.1099/mic.0.052209-0; Bignucolo A, 2013, J BIOTECHNOL, V167, P309, DOI 10.1016/j.jbiotec.2013.07.002; Casey A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00068; Catone MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098873; Chattopadhyay MK, 2011, CURR MICROBIOL, V62, P544, DOI 10.1007/s00284-010-9742-y; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CONWAY T, 1987, J BACTERIOL, V169, P2591, DOI 10.1128/jb.169.6.2591-2597.1987; Conway T, 2014, MBIO, V5, DOI 10.1128/mBio.01442-14; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Filipiak W, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-113; Fonseca P, 2011, ENV MICROBIOL REP, V3, P329, DOI 10.1111/j.1758-2229.2010.00229.x; Gomez-Lozano M, 2015, ENV MICROBIOL REP, V7, P227, DOI 10.1111/1758-2229.12233; Gomez-Lozano M, 2014, METHODS MOL BIOL, V1149, P433, DOI 10.1007/978-1-4939-0473-0_34; Gomez-Lozano M, 2012, ENVIRON MICROBIOL, V14, P2006, DOI 10.1111/j.1462-2920.2012.02759.x; Hempel N, 2013, J BACTERIOL, V195, P3925, DOI 10.1128/JB.00531-13; Jung IL, 2003, ARCH BIOCHEM BIOPHYS, V418, P125, DOI 10.1016/j.abb.2003.08.003; Karpinets TV, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-30; LAGEVEEN RG, 1988, APPL ENVIRON MICROB, V54, P2924, DOI 10.1128/AEM.54.12.2924-2932.1988; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lee SH, 2005, APPL ENVIRON MICROB, V71, P8581, DOI 10.1128/AEM.71.12.8581-8586.2005; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Lopez NI, 2009, CURR MICROBIOL, V59, P514, DOI 10.1007/s00284-009-9469-9; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; McClure R, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt444; McPhee JB, 2003, MOL MICROBIOL, V50, P205, DOI 10.1046/j.1365-2958.2003.03673.x; Mern DS, 2010, MICROBIOL-SGM, V156, P1505, DOI 10.1099/mic.0.032847-0; Miller SH, 2010, ENV MICROBIOL REP, V2, P403, DOI 10.1111/j.1758-2229.2009.00105.x; Mykytczuk NCS, 2013, ISME J, V7, P1211, DOI 10.1038/ismej.2013.8; Nikel PI, 2014, NEW BIOTECHNOL, V31, P562, DOI 10.1016/j.nbt.2014.02.006; Nikel PI, 2006, APPL ENVIRON MICROB, V72, P2614, DOI 10.1128/AEM.72.4.2614-2620.2006; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Piette F, 2011, APPL ENVIRON MICROB, V77, P3881, DOI 10.1128/AEM.02757-10; Iustman LJR, 2015, EXTREMOPHILES, V19, P207, DOI 10.1007/s00792-014-0700-7; Rodrigues DF, 2008, APPL ENVIRON MICROB, V74, P1677, DOI 10.1128/AEM.02000-07; Sabra W, 2002, MICROBIOL-SGM, V148, P3195, DOI 10.1099/00221287-148-10-3195; Schmidtke C, 2012, NUCLEIC ACIDS RES, V40, P2020, DOI 10.1093/nar/gkr904; Schobert M, 2001, MICROBIOL-SGM, V147, P363, DOI 10.1099/00221287-147-2-363; Schreiber K, 2006, J BACTERIOL, V188, P659, DOI 10.1128/JB.188.2.659-668.2006; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Subashchandrabose S, 2014, P NATL ACAD SCI USA, V111, P18327, DOI 10.1073/pnas.1415959112; Toyama H, 2004, ARCH BIOCHEM BIOPHYS, V428, P10, DOI 10.1016/j.abb.2004.03.037; Tribelli PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076685; Tribelli PM, 2013, MICROBIOL-SGM, V159, P259, DOI 10.1099/mic.0.061085-0; Tribelli PM, 2011, EXTREMOPHILES, V15, P541, DOI 10.1007/s00792-011-0384-1; Tribelli PM, 2010, J MOL MICROB BIOTECH, V19, P180, DOI 10.1159/000320261; Vasil ML, 2007, BIOMETALS, V20, P587, DOI 10.1007/s10534-006-9067-2; Vrionis HA, 2002, APPL MICROBIOL BIOT, V58, P469, DOI 10.1007/s00253-001-0912-5; Wang DP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-618; WOZNIAK DJ, 1994, J BACTERIOL, V176, P6007, DOI 10.1128/jb.176.19.6007-6014.1994	52	24	25	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145353	10.1371/journal.pone.0145353	http://dx.doi.org/10.1371/journal.pone.0145353			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671564	gold, Green Published, Green Submitted			2022-12-27	WOS:000366719300059
J	Chang, EM; Lim, E; Yoon, S; Jeong, K; Bae, S; Lee, DR; Yoon, TK; Choi, Y; Lee, WS				Chang, Eun Mi; Lim, Eunjin; Yoon, Sookyoung; Jeong, Kyungah; Bae, Sijeong; Lee, Dong Ryul; Yoon, Tae Ki; Choi, Youngsok; Lee, Woo Sik			Cisplatin Induces Overactivation of the Dormant Primordial Follicle through PTEN/AKT/FOXO3a Pathway which Leads to Loss of Ovarian Reserve in Mice	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; TUMOR-SUPPRESSOR GENE; SUBCELLULAR TARGETS; CANCER CELLS; PTEN; CHEMOTHERAPY; ACTIVATION; OOCYTES; MECHANISMS; RESISTANCE	Cisplatin is a first-line chemotherapeutic agent for ovarian cancer that acts by promoting DNA cross links and adduct. However drug resistance and considerable side effects including reproductive toxicity remain a significant challenge. PTEN is well known as a tumor suppressor function which plays a fundamental role in the regulation of the cell cycle, apoptosis and development of cancer. At the same time PTEN has been revealed to be critically important for the maintenance of the primordial follicle pool. In this study, we investigated the role of PTEN/Akt/FOXO3 pathway in cisplatin-induced primordial follicle depletion. Cisplatin induced ovarian failure mouse model was used to evaluate how this pathway involves. In vitro maturation was used for oocyte rescue after cisplatin damage. We found that cisplatin treatment decreased PTEN levels, leading to a subsequent increase in the phosphorylation of key molecules in the pathway. The activation of the PTEN/Akt/FOXO3 pathway cascade increased cytoplasmic translocation of FOXO3a in cisplatin-treated follicles, which in turn increased the pool size of growing follicles, and rapidly depleted the number of dormant follicles. Once activated, the follicles were more prone to apoptosis, and their cumulus cells showed a loss of luteinizing hormone (LH) receptor expression, which leads to failure during final maturation and ovulation. In vitro maturation to rescue oocytes in a cisplatin-treated mouse model resulted in successful maturation and fertilization. This study is the first to show the involvement of the PTEN/Akt/FOXO3 pathway in premature ovarian failure after cisplatin treatment and the possibility of rescue through in vitro maturation.	[Chang, Eun Mi; Yoon, Sookyoung; Lee, Dong Ryul; Yoon, Tae Ki; Lee, Woo Sik] CHA Univ, Dept Obstet & Gynecol, CHA Gangnam Med Ctr, Fertil Ctr, Seoul, South Korea; [Lim, Eunjin; Yoon, Sookyoung; Bae, Sijeong; Lee, Dong Ryul; Choi, Youngsok] CHA Univ, Dept Biomed Sci, Songnam, South Korea; [Jeong, Kyungah] Ewha Womans Univ, Dept Obstet & Gynecol, Sch Med, Seoul, South Korea	Pochon Cha University; Pochon Cha University; Ewha Womans University	Choi, Y (corresponding author), CHA Univ, Dept Biomed Sci, Songnam, South Korea.	youngsokchoi@cha.ac.kr; wooslee@cha.ac.kr		Choi, Youngsok/0000-0002-3862-4105	Korean Healthcare Technology R&D project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [A120080]; National Research foundation of Korea, Ministry of Science, ICT and Future planning [2014R1A1A1002702]	Korean Healthcare Technology R&D project, Ministry for Health, Welfare and Family Affairs, Republic of Korea; National Research foundation of Korea, Ministry of Science, ICT and Future planning	This study was supported by a grant (A120080) from the Korean Healthcare Technology R&D project, Ministry for Health, Welfare and Family Affairs, Republic of Korea and a grant (2014R1A1A1002702) from the National Research foundation of Korea, Ministry of Science, ICT and Future planning.; This study was supported by a grant (A120080) from the Korean Healthcare Technology R&D project, Ministry for Health, Welfare and Family Affairs, Republic of Korea and a grant (2014R1A1A1002702) from the National Research foundation of Korea, Ministry of Science, ICT and Future planning.	Adhikari D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039034; Blumenfeld Z, 2012, BEST PRACT RES CL OB, V26, P379, DOI 10.1016/j.bpobgyn.2011.11.008; Boosani CS, 2013, EXPERT OPIN THER PAT, V23, P569, DOI 10.1517/13543776.2013.768985; Carlsson IB, 2006, HUM REPROD, V21, P2223, DOI 10.1093/humrep/del165; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Choi Y, 2008, BIOL REPROD, V79, P442, DOI 10.1095/biolreprod.108.069393; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; FitzGerald MG, 1998, ONCOGENE, V17, P727, DOI 10.1038/sj.onc.1201984; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Jagarlamudi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006186; Kalich-Philosoph L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005402; Lan ZJ, 2004, BIOL REPROD, V71, P1469, DOI 10.1095/biolreprod.104.031757; LEIBBRANDT MEI, 1995, KIDNEY INT, V48, P761, DOI 10.1038/ki.1995.348; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li J, 2010, P NATL ACAD SCI USA, V107, P10280, DOI 10.1073/pnas.1001198107; Maccio A, 2013, EXPERT OPIN PHARMACO, V14, P1839, DOI 10.1517/14656566.2013.813934; Meirow D, 2007, HUM REPROD, V22, P1626, DOI 10.1093/humrep/dem027; Meirow D, 2000, MOL CELL ENDOCRINOL, V169, P123, DOI 10.1016/S0303-7207(00)00365-8; Meirow D, 2001, HUM REPROD UPDATE, V7, P535, DOI 10.1093/humupd/7.6.535; Meirow D, 2010, CLIN OBSTET GYNECOL, V53, P727, DOI 10.1097/GRF.0b013e3181f96b54; Morgan S, 2012, HUM REPROD UPDATE, V18, P525, DOI 10.1093/humupd/dms022; Morgan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070117; Myers M, 2004, REPRODUCTION, V127, P569, DOI 10.1530/rep.1.00095; Oktem O, 2007, CANCER RES, V67, P10159, DOI 10.1158/0008-5472.CAN-07-2042; Pelosi E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2861; Reddy P, 2009, HUM MOL GENET, V18, P2813, DOI 10.1093/hmg/ddp217; Sancho-Martinez SM, 2012, PHARMACOL THERAPEUT, V136, P35, DOI 10.1016/j.pharmthera.2012.07.003; Schondorf T, 2001, ANTI-CANCER DRUG, V12, P797, DOI 10.1097/00001813-200111000-00002; Singh M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-233; Sobinoff AP, 2012, TOXICOL SCI, V128, P258, DOI 10.1093/toxsci/kfs137; Sobinoff AP, 2011, TOXICOL SCI, V123, P563, DOI 10.1093/toxsci/kfr195; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Suzuki H, 1998, CANCER RES, V58, P204; Tilly J L, 1996, Rev Reprod, V1, P162, DOI 10.1530/revreprod/1.3.162; Tilly Jonathan L, 2003, Reprod Biol Endocrinol, V1, P11, DOI 10.1186/1477-7827-1-11; Winther JF, 2004, AM J HUM GENET, V74, P1282, DOI 10.1086/421473; Wu H, 2008, CANCER LETT, V271, P260, DOI 10.1016/j.canlet.2008.06.012; Wu HJ, 2014, BIOCHEM BIOPH RES CO, V444, P141, DOI 10.1016/j.bbrc.2014.01.014	39	72	76	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144245	10.1371/journal.pone.0144245	http://dx.doi.org/10.1371/journal.pone.0144245			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656301	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900034
J	Dong, J; Chen, Y; Tang, YC; Xu, F; Yu, CH; Li, YM; Pankaj, P; Dai, N				Dong, Jie; Chen, Yi; Tang, Yuchen; Xu, Fei; Yu, Chaohui; Li, Youming; Pankaj, Prasoon; Dai, Ning			Body Mass Index Is Associated with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							COMPREHENSIVE NUTRITIONAL-STATUS; CROHNS-DISEASE; METABOLIC FEATURES; ULCERATIVE-COLITIS; ADIPOSE-TISSUE; OBESITY; RISK; POPULATION; CANCER; OSTEOPOROSIS	Background Prior work suggested that patients with inflammatory bowel diseases (IBD) have lower body mass index (BMI) than controls and patients with lower BMI have more serious complications. Goal The study was aimed to find relationship between BMI in patients with and without IBD, investigate effects of medicine therapy and disease stages on patients' BMI. Methods Potentially eligible studies were identified through searching PubMed, Cochrane and Embase databases. Outcome measurements of mean BMI and the number of patients from each study were pooled by a random-effect model. Publication bias test, sensitivity analysis and subgroup analysis were conducted. Results A total of 24 studies containing 1442 patients and 2059 controls were included. Main results were as follows: (1) BMI in Crohn's disease (CD) patients was lower than that in health controls (-1.88, 95% CI -2.77 to -1.00, P<0.001); (2) Medical therapy significantly improved BMI of CD patients (with therapy: -1.58, -3.33 to 0.16; without: -2.09, 95% CI -3.21 to -0.98) while on the contrary not significantly improving BMI of UC patients (with therapy: -0.24, 95% CI -3.68 to 3.20; without: -1.34, 95% CI -2.87 to 0.20, P = 0.57); (3) Both CD and UC patients in active phase showed significantly greater BMI difference compared with controls than those in remission (CD patients: remission: -2.25, 95% CI -3.38 to -1.11; active phase: -4.25, 95% CI -5.58 to -2.92, P = 0.03; UC patients: remission: 0.4, 95% CI -2.05 to 2.84; active phase: -5.38, -6.78 to -3.97, P = 0.001). Conclusions BMI is lower in CD patients; medical therapy couldn't improve BMI of IBD patients; the state of disease affects BMI of CD patients and UC patients.	[Dong, Jie; Xu, Fei; Dai, Ning] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Yi; Yu, Chaohui; Li, Youming] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Tang, Yuchen] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Endocrinol, Hangzhou 310003, Zhejiang, Peoples R China; [Pankaj, Prasoon] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Dai, N (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.	ningdai2008@126.com		Ma, Han/0000-0001-9985-3035				Ali T, 2009, AM J MED, V122, P599, DOI 10.1016/j.amjmed.2009.01.022; Anandam A, 2013, SLEEP BREATH, V17, P227, DOI 10.1007/s11325-012-0677-3; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bryant RV, 2013, ALIMENT PHARM THER, V38, P213, DOI 10.1111/apt.12372; Burnham JM, 2005, AM J CLIN NUTR, V82, P413, DOI 10.1093/ajcn/82.2.413; Capristo E, 1998, J INTERN MED, V243, P339; Capristo E, 1999, ALIMENT PHARM THERAP, V13, P209; Capristo E, 1998, AM J GASTROENTEROL, V93, P2411, DOI 10.1016/S0002-9270(98)00577-2; Chan SSM, 2013, AM J GASTROENTEROL, V108, P575, DOI 10.1038/ajg.2012.453; Chen Y, 2013, CANCER EPIDEM BIOMAR, V22, P1395, DOI 10.1158/1055-9965.EPI-13-0042; Choi Y, 2013, INT J CANCER, V132, P625, DOI 10.1002/ijc.27639; Cravo M, 2010, INFLAMM BOWEL DIS, V16, P2117, DOI 10.1002/ibd.21297; Cuoco L, 2008, INT J CARDIOL, V127, P219, DOI 10.1016/j.ijcard.2007.06.006; Dai Z, 2007, WORLD J GASTROENTERO, V13, P4199, DOI 10.3748/wjg.v13.i31.4199; Discacciati A, 2012, ANN ONCOL, V23, P1665, DOI 10.1093/annonc/mdr603; Filippi J, 2006, INFLAMM BOWEL DIS, V12, P185, DOI 10.1097/01.MIB.0000206541.15963.c3; Flores A, 2015, DIGEST DIS SCI, V60, P2436, DOI 10.1007/s10620-015-3629-5; Geerling BJ, 1998, AM J CLIN NUTR, V67, P919, DOI 10.1093/ajcn/67.5.919; Geerling BJ, 1999, EUR J CLIN NUTR, V53, P479, DOI 10.1038/sj.ejcn.1600780; Geerling BJ, 2000, EUR J CLIN NUTR, V54, P514, DOI 10.1038/sj.ejcn.1601049; Ghoshal Uday C, 2008, Trop Gastroenterol, V29, P95; Greenfield JR, 2004, CIRCULATION, V109, P3022, DOI 10.1161/01.CIR.0000130640.77501.79; Gustafson B, 2007, ARTERIOSCL THROM VAS, V27, P2276, DOI 10.1161/ATVBAHA.107.147835; Harper JW, 2013, INFLAMM BOWEL DIS, V19, P2118, DOI 10.1097/MIB.0b013e31829cf401; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Jahnsen J, 1997, GUT, V40, P313, DOI 10.1136/gut.40.3.313; James SL, 2015, GUT, V64, P562, DOI 10.1136/gutjnl-2014-307198; Jeong Seung Uk, 2012, Korean J Gastroenterol, V59, P27; Jiang LY, 2012, JOINT BONE SPINE, V79, P291, DOI 10.1016/j.jbspin.2011.05.015; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; Kessler H, 2011, WORLD J GASTROENTERO, V17, P1116, DOI 10.3748/wjg.v17.i9.1116; Lanham-New SA, 2008, P NUTR SOC, V67, P163, DOI 10.1017/S0029665108007003; Lankarani KB, 2013, WORLD J GASTROENTERO, V19, P8571, DOI 10.3748/wjg.v19.i46.8571; Long MD, 2011, INFLAMM BOWEL DIS, V17, P2162, DOI 10.1002/ibd.21585; Mijac DD, 2010, EUR J INTERN MED, V21, P315, DOI 10.1016/j.ejim.2010.04.012; Mingrone G, 1999, AM J CLIN NUTR, V69, P325; Mingrone G, 1996, DIGEST DIS SCI, V41, P72, DOI 10.1007/BF02208586; Mingrone G, 1998, AM J CLIN NUTR, V67, P118, DOI 10.1093/ajcn/67.1.118; Mohamed-Hussein AAR, 2007, RESP MED, V101, P977, DOI 10.1016/j.rmed.2006.09.005; Peng LJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003619.pub3; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rui R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044522; Sajjadi M, 2015, DIGEST DIS SCI, V60, P1755, DOI 10.1007/s10620-014-3510-y; Sakellariou GT, 2006, JOINT BONE SPINE, V73, P725, DOI 10.1016/j.jbspin.2006.01.017; Schneider SM, 2008, INFLAMM BOWEL DIS, V14, P1562, DOI 10.1002/ibd.20504; Stabroth-Akil D, 2015, INT J COLORECTAL DIS, V30, P237, DOI 10.1007/s00384-014-2051-3; Suibhne TN, 2012, J CROHNS COLITIS; Wells GA., 2015, NEWCASTLE OTTAWA SCA; Wiroth JB, 2005, INFLAMM BOWEL DIS, V11, P296, DOI 10.1097/01.MIB.0000160810.76729.9c; Ye LN, 2013, SCI WORLD J, DOI 10.1155/2013/296470; Zoli G, 1996, DIGEST DIS SCI, V41, P1754, DOI 10.1007/BF02088741	52	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144872	10.1371/journal.pone.0144872	http://dx.doi.org/10.1371/journal.pone.0144872			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658675	Green Submitted, gold, Green Published			2022-12-27	WOS:000366715900128
J	Gushchin, A; Tang, A				Gushchin, Andrey; Tang, Ao			Total Wiring Length Minimization of C-elegans Neural Network: A Constrained Optimization Approach	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; NERVOUS-SYSTEM; ORGANIZATION; ECONOMY; BRAIN	Using the most recent data on the connectivity of the C. elegans neural network, we find optimal two-dimensional positions of interneurons that minimize the total wiring length provided that the positions of motor and sensory neurons are fixed. The rationale behind fixing motor and sensory neurons is the following: while positions of motor and sensory neurons can be influenced by the locations of muscles and sensory organs they are attached to, the main function of interneurons is to connect other neurons, and their placement could try to minimize the wiring length. Solutions for l(1), l(2) and squared l(2)-norm were obtained. For the Euclidean norm l2, the relative and absolute difference between the real and optimal total wiring lengths is minimal among these functions of distance. Additional network constraints were discussed such as assignment of different weights to electrical or chemical connections, fixation of "tail" interneurons, minimal interneural distance limitation, and others. These constraints were compared by their influence on the optimal positions of interneurons.	[Gushchin, Andrey] Cornell Univ, Ctr Appl Math, Ithaca, NY 14853 USA; [Tang, Ao] Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY USA	Cornell University; Cornell University	Gushchin, A (corresponding author), Cornell Univ, Ctr Appl Math, Ithaca, NY 14853 USA.	avg36@cornell.edu						Ahn YY, 2006, PHYSICA A, V367, P531, DOI 10.1016/j.physa.2005.12.013; [Anonymous], 1999, TEXTURE NERVOUS SYST; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; CHERNIAK C, 1994, J NEUROSCI, V14, P2418; Choe Y., 2004, SOC NEUR ABSTR, V30; HALL DH, 1991, J NEUROSCI, V11, P1; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kotter R, 2004, NEUROINFORMATICS, V2, P127; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Varshney LR, 2013, IEEE J SEL AREA COMM, V31, P1095, DOI 10.1109/JSAC.2013.130611; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	13	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145029	10.1371/journal.pone.0145029	http://dx.doi.org/10.1371/journal.pone.0145029			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659722	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900171
J	Krug, AZ; Patzkowsky, ME				Krug, Andrew Z.; Patzkowsky, Mark E.			Phylogenetic Clustering of Origination and Extinction across the Late Ordovician Mass Extinction	PLOS ONE			English	Article							SELECTIVITY; RECOVERIES; GENERA; SIGNAL	Mass extinctions can have dramatic effects on the trajectory of life, but in some cases the effects can be relatively small even when extinction rates are high. For example, the Late Ordovician mass extinction is the second most severe in terms of the proportion of genera eliminated, yet is noted for the lack of ecological consequences and shifts in clade dominance. By comparison, the end-Cretaceous mass extinction was less severe but eliminated several major clades while some rare surviving clades diversified in the Paleogene. This disconnect may be better understood by incorporating the phylogenetic relatedness of taxa into studies of mass extinctions, as the factors driving extinction and recovery are thought to be phylogenetically conserved and should therefore promote both origination and extinction of closely related taxa. Here, we test whether there was phylogenetic selectivity in extinction and origination using brachiopod genera from the Middle Ordovician through the Devonian. Using an index of taxonomic clustering (RCL) as a proxy for phylogenetic clustering, we find that A) both extinctions and originations shift from taxonomically random or weakly clustered within families in the Ordovician to strongly clustered in the Silurian and Devonian, beginning with the recovery following the Late Ordovician mass extinction, and B) the Late Ordovician mass extinction was itself only weakly clustered. Both results stand in stark contrast to Cretaceous-Cenozoic bivalves, which showed significant levels of taxonomic clustering of extinctions in the Cretaceous, including strong clustering in the mass extinction, but taxonomically random extinctions in the Cenozoic. The contrasting patterns between the Late Ordovician and end-Cretaceous events suggest a complex relationship between the phylogenetic selectivity of mass extinctions and the long-term phylogenetic signal in origination and extinction patterns.	[Krug, Andrew Z.; Patzkowsky, Mark E.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Krug, AZ (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	azk102@psu.edu			NASA Astrobiology [11-EXO11-0070]	NASA Astrobiology	This work was funded by NASA Astrobiology grant number 11-EXO11-0070.; This work was funded by NASA Astrobiology grant number 11-EXO11-0070. We thank Judi Sclafani for producing S1 Fig, and Dr. Friedman, Dr. Renbin and 2 anonymous reviewers for their helpful suggestions.	Bapst DW, 2014, PALEOBIOLOGY, V40, P331, DOI 10.1666/13033; Bennett PM, 2005, CONSERV BIOL SER, V8, P317; Carlson SJ, 2008, EARTH ENV SCI T R SO, V98, P311, DOI 10.1017/S1755691007078437; Congreve CR, 2015, PALAEONTOLOGY, V58, P743, DOI 10.1111/pala.12177; Davies TJ, 2008, P NATL ACAD SCI USA, V105, P11556, DOI 10.1073/pnas.0801917105; de Weerd DRU, 2004, MOL PHYLOGENET EVOL, V33, P533, DOI 10.1016/j.ympev.2004.07.010; Erwin DH, 2001, P NATL ACAD SCI USA, V98, P5399, DOI 10.1073/pnas.091092698; Erwin DH, 1998, TRENDS ECOL EVOL, V13, P344, DOI 10.1016/S0169-5347(98)01436-0; Erwin DH, 2008, P NATL ACAD SCI USA, V105, P11520, DOI 10.1073/pnas.0801913105; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Finnegan S, 2012, P NATL ACAD SCI USA, V109, P6829, DOI 10.1073/pnas.1117039109; Finnegan S, 2011, SCIENCE, V331, P903, DOI 10.1126/science.1200803; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Hardy C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037977; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Harnik PG, 2014, PALEOBIOLOGY, V40, P675, DOI 10.1666/14006; JABLONSKI D, 1991, SCIENCE, V253, P754, DOI 10.1126/science.253.5021.754; JABLONSKI D, 1989, PHILOS T ROY SOC B, V325, P357, DOI 10.1098/rstb.1989.0093; Jablonski D, 2009, P NATL ACAD SCI USA, V106, P8262, DOI 10.1073/pnas.0902973106; Krug AZ, 2007, PALEOBIOLOGY, V33, P435, DOI 10.1666/06039.1; Krug AZ, 2004, P NATL ACAD SCI USA, V101, P17605, DOI 10.1073/pnas.0405199102; McGhee GR, 2013, PALAEOGEOGR PALAEOCL, V370, P260, DOI 10.1016/j.palaeo.2012.12.019; McGhee GR, 2004, PALAEOGEOGR PALAEOCL, V211, P289, DOI 10.1016/j.palaeo.2004.05.010; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; Miller AI, 1996, PALEOBIOLOGY, V22, P304, DOI 10.1017/S0094837300016237; Mooers AO, 2005, CONSERV BIOL SER, V8, P120; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Rodrigues ASL, 2005, CONSERV BIOL SER, V8, P101; Roy K, 2009, SCIENCE, V325, P733, DOI 10.1126/science.1173073; Schreiber HA, 2013, J PALEONTOL, V87, P550, DOI 10.1666/12-115; Sepkoski J.J., 1996, GLOBAL EVENT STRATIG, P35, DOI [10.1007/978-3-642-79634-0_4, DOI 10.1007/978-3-642-79634-0_4]; Sepkoski J.J., 2002, B AM PALEONTOL, V363, P1; Sheehan PM, 2001, ANNU REV EARTH PL SC, V29, P331, DOI 10.1146/annurev.earth.29.1.331; Soul LC, 2015, SYST BIOL, V64, P608, DOI 10.1093/sysbio/syv015; Stanley S.M., 1990, P103; Willams A, 2000, TREATISE INVERTEBR H, V3; Willams A, 2002, TREATISE INVERTEBR H, V4; Willams A, 2006, TREATISE INVERTEBR H, V5; Willams A, 2000, TREATISE INVERTEBR H, V2	42	10	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144354	10.1371/journal.pone.0144354	http://dx.doi.org/10.1371/journal.pone.0144354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658946	gold, Green Published			2022-12-27	WOS:000366715900040
J	Laboissiere, R; Letievant, JC; Ionescu, E; Barraud, PA; Mazzuca, M; Cian, C				Laboissiere, Rafael; Letievant, Jean-Charles; Ionescu, Eugen; Barraud, Pierre-Alain; Mazzuca, Michel; Cian, Corinne			Relationship between Spectral Characteristics of Spontaneous Postural Sway and Motion Sickness Susceptibility	PLOS ONE			English	Article							VERTICAL AXIS ROTATION; HEALTHY-SUBJECTS; VISUAL-FIELD; INSTABILITY; FREQUENCY; SIMULATOR; CUES; EQUILIBRIUM; OSCILLATION; ORIENTATION	Motion sickness (MS) usually occurs for a narrow band of frequencies of the imposed oscillation. It happens that this frequency band is close to that which are spontaneously produced by postural sway during natural stance. This study examined the relationship between reported susceptibility to motion sickness and postural control. The hypothesis is that the level of MS can be inferred from the shape of the Power Spectral Density (PSD) profile of spontaneous sway, as measured by the displacement of the center of mass during stationary, upright stance. In Experiment 1, postural fluctuations while standing quietly were related to MS history for inertial motion. In Experiment 2, postural stability measures registered before the onset of a visual roll movement were related to MS symptoms following the visual stimulation. Study of spectral characteristics in postural control showed differences in the distribution of energy along the power spectrum of the antero-posterior sway signal. Participants with MS history provoked by exposure to inertial motion showed a stronger contribution of the high frequency components of the sway signal. When MS was visually triggered, sick participants showed more postural sway in the low frequency range. The results suggest that subject-specific PSD details may be a predictor of the MS level. Furthermore, the analysis of the sway frequency spectrum provided insight into the intersubject differences in the use of postural control subsystems. The relationship observed between MS susceptibility and spontaneous posture is discussed in terms of postural sensory weighting and in relation to the nature of the provocative stimulus.	[Laboissiere, Rafael; Cian, Corinne] CNRS, LPNC, F-38000 Grenoble, France; [Laboissiere, Rafael; Cian, Corinne] Univ Grenoble Alpes, LPNC, F-38000 Grenoble, France; [Laboissiere, Rafael; Mazzuca, Michel] CNRS, CRNL, INSERM, F-69675 Bron, France; [Letievant, Jean-Charles; Ionescu, Eugen; Mazzuca, Michel] HCL, Serv Explorat Audiovestibulaires, F-69003 Lyon, France; [Barraud, Pierre-Alain] CNRS, TIMC IMAG, F-38000 Grenoble, France; [Cian, Corinne] Inst Rech Biomed Armees, F-91223 Bretigny Sur Orge, France	Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Laboissiere, R (corresponding author), CNRS, LPNC, F-38000 Grenoble, France.	rafael.laboissiere@upmf-grenoble.fr	Laboissière, Rafael/E-9814-2013	Laboissière, Rafael/0000-0002-2180-9250; Ionescu, Eugen Constant/0000-0003-3773-9848	Ministere de la Defense (France) [07co805]	Ministere de la Defense (France)	This work was supported by grant #07co805 from Ministere de la Defense (France), awarded to CC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLARD B, 1985, EXP BRAIN RES, V61, P21; Barbour AJ, 2014, COMPUT GEOSCI-UK, V63, P1, DOI 10.1016/j.cageo.2013.09.015; BENSEL CK, 1968, PERCEPT PSYCHOPHYS, V4, P285, DOI 10.3758/BF03210516; Bles W, 1998, BRAIN RES BULL, V47, P481, DOI 10.1016/S0361-9230(98)00115-4; Bonnet CT, 2006, HUM MOVEMENT SCI, V25, P800, DOI 10.1016/j.humov.2006.03.001; Bos JE, 1998, BRAIN RES BULL, V47, P537, DOI 10.1016/S0361-9230(98)00088-4; Bos JE, 2005, AVIAT SPACE ENVIR MD, V76, P1111; Bos JE, 2011, DISPLAYS, V32, P189, DOI 10.1016/j.displa.2010.09.005; Bos JE, 2010, APPL ERGON, V41, P516, DOI 10.1016/j.apergo.2009.11.007; Catanzariti JF, 2016, EUR SPINE J, V25, P438, DOI 10.1007/s00586-015-4060-5; Cobb SVG, 1999, APPL ERGON, V30, P47, DOI 10.1016/S0003-6870(98)00038-6; Diels C, 2013, HUM FACTORS, V55, P595, DOI 10.1177/0018720812469046; Duarte M, 2001, PHYS LETT A, V283, P124, DOI 10.1016/S0375-9601(01)00188-8; Duh HBL, 2004, HUM FACTORS, V46, P142, DOI 10.1518/hfes.46.1.142.30384; Faugloire E, 2007, EXP BRAIN RES, V177, P520, DOI 10.1007/s00221-006-0700-7; FUKUDA T, 1975, ACTA OTO-LARYNGOL, P9; Golding JF, 2001, AVIAT SPACE ENVIR MD, V72, P188; Golding JF, 2006, AUTON NEUROSCI-BASIC, V129, P67, DOI 10.1016/j.autneu.2006.07.019; Golding JF, 2006, PERS INDIV DIFFER, V41, P237, DOI 10.1016/j.paid.2006.01.012; Golding JF, 2009, AVIAT SPACE ENVIR MD, V80, P516, DOI 10.3357/ASEM.2433.2009; Golomer E, 2000, INT J NEUROSCI, V105, P15, DOI 10.3109/00207450009003262; GRAYBIEL A, 1970, AEROSPACE MED, V41, P650; Guignard JC, 1990, MOTION SPACE SICKNES, P123; Hettinger L J, 1990, Mil Psychol, V2, P171, DOI 10.1207/s15327876mp0203_4; Horak F, 1996, HDB PHYSIOL 12, V12, P255; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Isableu B, 1997, EXP BRAIN RES, V114, P584, DOI 10.1007/PL00005667; Isableu B, 1998, HUM MOVEMENT SCI, V17, P367, DOI 10.1016/S0167-9457(98)00005-0; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kennedy R. S., 1993, INT J AVIAT PSYCHOL, V3, P203; Kennedy RS, 1997, AVIAT SPACE ENVIR MD, V68, P13; KENNEDY RS, 1993, AVIAT SPACE ENVIR MD, V64, P912; Kennedy RS, 1996, INT J HUM-COMPUT INT, V8, P25, DOI 10.1080/10447319609526139; Kennedy RS, 1997, P DRIV SIM C DSC97 E, P115; Kennedy RS, 1990, MOTION SPACE SICKNES, P179; Koslucher FC, 2014, GAIT POSTURE, V39, P606, DOI 10.1016/j.gaitpost.2013.09.016; Lane N., 1988, 887 EOTR ESS CORP; LAWTHER A, 1986, ERGONOMICS, V29, P535, DOI 10.1080/00140138608968289; LAWTHER A, 1987, J ACOUST SOC AM, V82, P957, DOI 10.1121/1.395295; LAWTHER A, 1988, ERGONOMICS, V31, P1373, DOI 10.1080/00140138808966783; MONEY KE, 1970, PHYSIOL REV, V50, P1, DOI 10.1152/physrev.1970.50.1.1; Nachum Z, 2004, LARYNGOSCOPE, V114, P581, DOI 10.1097/00005537-200403000-00036; Nashner L, 1970, REPORT NO MVT 70 3; Nishiike S, 2013, J MED INVESTIG, V60, P236; OHANLON JF, 1974, AEROSPACE MED, V45, P366; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; Oman C M, 1982, Acta Otolaryngol Suppl, V392, P1; Oppenheim U, 1999, DIABETES CARE, V22, P328, DOI 10.2337/diacare.22.2.328; Owen N, 1998, BRAIN RES BULL, V47, P471, DOI 10.1016/S0361-9230(98)00101-4; Pavol MJ, 2005, J NEUROPHYSIOL, V93, P20, DOI 10.1152/jn.00864.2004; R Development Core Team, 2012, R A LANGUAGE AND ENV; REASON JT, 1969, INT J MAN MACH STUD, V1, P21, DOI 10.1016/S0020-7373(69)80009-X; REASON JT, 1978, J ROY SOC MED, V71, P819, DOI 10.1177/014107687807101109; Reason JT., 1975, MOTION SICKNESS; RICCIO G E, 1991, Ecological Psychology, V3, P195, DOI 10.1207/s15326969eco0303_2; Schubert P., 2012, J BIOMED SCI ENG, V5, P508, DOI [10.4236/jbise.2012.59063, DOI 10.4236/JBISE.2012.59063]; Smart LJ, 2002, HUM FACTORS, V44, P451, DOI 10.1518/0018720024497745; STOFFREGEN T A, 1991, Ecological Psychology, V3, P159, DOI 10.1207/s15326969eco0303_1; Stoffregen TA, 2000, HUM FACTORS, V42, P458, DOI 10.1518/001872000779698097; Stoffregen TA, 1998, BRAIN RES BULL, V47, P437, DOI 10.1016/S0361-9230(98)00102-6; Stoffregen TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066949; Stoffregen TA, 2010, ECOL PSYCHOL, V22, P169, DOI 10.1080/10407413.2010.496645; TAKAHASHI M, 1992, AVIAT SPACE ENVIR MD, V63, P486; Tal D, 2010, NEUROSCI LETT, V479, P134, DOI 10.1016/j.neulet.2010.05.044; Venables WN., 2002, MODERN APPL STAT S 4; Villard SJ, 2008, HUM FACTORS, V50, P332, DOI 10.1518/001872008X250728; Wood SJ, 2002, NEUROSCI LETT, V323, P41, DOI 10.1016/S0304-3940(02)00118-0; Yokota Y, 2005, ACTA OTO-LARYNGOL, V125, P280, DOI 10.1080/00016480510003192	68	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144466	10.1371/journal.pone.0144466	http://dx.doi.org/10.1371/journal.pone.0144466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26657203	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900054
J	Mastroianni, P; Monechi, B; Liberto, C; Valenti, G; Servedio, VDP; Loreto, V				Mastroianni, Pierpaolo; Monechi, Bernardo; Liberto, Carlo; Valenti, Gaetano; Servedio, Vito D. P.; Loreto, Vittorio			Local Optimization Strategies in Urban Vehicular Mobility	PLOS ONE			English	Article							SPATIAL STRUCTURE; SCALING LAWS	The comprehension of vehicular traffic in urban environments is crucial to achieve a good management of the complex processes arising from people collective motion. Even allowing for the great complexity of human beings, human behavior turns out to be subject to strong constraints-physical, environmental, social, economic-that induce the emergence of common patterns. The observation and understanding of those patterns is key to setup effective strategies to optimize the quality of life in cities while not frustrating the natural need for mobility. In this paper we focus on vehicular mobility with the aim to reveal the underlying patterns and uncover the human strategies determining them. To this end we analyze a large dataset of GPS vehicles tracks collected in the Rome (Italy) district during a month. We demonstrate the existence of a local optimization of travel times that vehicle drivers perform while choosing their journey. This finding is mirrored by two additional important facts, i.e., the observation that the average vehicle velocity increases by increasing the travel length and the emergence of a universal scaling law for the distribution of travel times at fixed traveled length. A simple modeling scheme confirms this scenario opening the way to further predictions.	[Mastroianni, Pierpaolo; Liberto, Carlo; Valenti, Gaetano] ENEA, Casaccia Res Ctr, I-00123 Rome, Italy; [Mastroianni, Pierpaolo; Monechi, Bernardo; Servedio, Vito D. P.; Loreto, Vittorio] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy; [Servedio, Vito D. P.] Inst Complex Syst ISC CNR, I-00185 Rome, Italy; [Loreto, Vittorio] Inst Sci Interchange Fdn, I-10126 Turin, Italy; [Loreto, Vittorio] SONY CSL, F-75005 Paris, France	Italian National Agency New Technical Energy & Sustainable Economics Development; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR)	Monechi, B (corresponding author), Univ Roma La Sapienza, Dept Phys, Ple Aldo Moro 2, I-00185 Rome, Italy.	mone.berna@gmail.com	Liberto, Carlo/AAC-6182-2022	Liberto, Carlo/0000-0003-2792-7722	EU [611272, 265432]; CNR PNR Project CRISIS Lab; KREYON project - Templeton Foundation [51663]; CNR PNR Project "CRISIS Lab"; Templeton Foundation [51663]	EU(European Commission); CNR PNR Project CRISIS Lab(Consiglio Nazionale delle Ricerche (CNR)); KREYON project - Templeton Foundation; CNR PNR Project "CRISIS Lab"(Consiglio Nazionale delle Ricerche (CNR)); Templeton Foundation	This work was supported by EU-STREP project EveryAware (Grant Agreement 265432), EU FP7 Grant 611272 (project GROWTHCOM), CNR PNR Project CRISIS Lab, KREYON project funded by the Templeton Foundation under contract n. 51663. SONY-CSL provided support in the form of research materials for author VL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section.; The authors acknowledge support from the EU-STREP project EveryAware (Grant Agreement 265432), the EU FP7 Grant 611272 (project GROWTHCOM), the CNR PNR Project "CRISIS Lab" for financial support and the KREYON project funded by the Templeton Foundation under contract n. 51663. We acknowledge interesting discussions with P. Butta. We are grateful to A. Sirbu for providing us the OpenStreetMap and Google Directions data of the city of Rome and London. We thank M. Mancini for his valuable work on OctoTelematics data preprocessing. SONY-CSL provided support in the form of research material for author VL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author contribution statement.	[Anonymous], 2004, HDB STOCHASTIC METHO; Asgari F, 2013, ARXIV13070814; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Batty M., 2013, NEW SCI CITIES; Belmonte A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05301; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Brown B, 2011, MCKINSEY Q; Chowdhury D, 2000, PHYS REP, V329, P199, DOI 10.1016/S0370-1573(99)00117-9; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Eubank H, 2004, NATURE, V429; Gallotti R, 2013, STAT PHYS MODELLING; Garske T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016364; Gastner MT, 2006, EUR PHYS J B, V49, P247, DOI 10.1140/epjb/e2006-00046-8; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Gonzalez-Bailon S, 2013, SOCIAL SCI RES NETWO; Helbing D, 2001, REV MOD PHYS, V73, P1067, DOI 10.1103/RevModPhys.73.1067; Jenelius E, 2013, TRANSPORT RES B-METH, V53, P64, DOI 10.1016/j.trb.2013.03.008; Kolbl R, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/348; Lammer S, 2006, PHYSICA A, V363, P89, DOI 10.1016/j.physa.2006.01.051; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Mayer-Sch?nber V., 2013, BIG DATA REVOLUTION; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Rahmani M., 2010, 2010 13th International IEEE Conference on Intelligent Transportation Systems (ITSC 2010), P730, DOI 10.1109/ITSC.2010.5625177; Rambaldi S, 2007, P EUR C COMPL SYST D; Riccardo G, 2012, INT J MOD PHYS C, V23, DOI 10.1142/S0129183112500611; Rubinstein IS, 2013, 1256 NYU SCH LAW; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Sirbu A, 2014, CCS14 P HUM COMP; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Tene O, 2012, NW J TECHNOLOGY INTE; United Nations Secretariat, 2014, WORLD URB PROSP 2014; Wang XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084954; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	35	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143799	10.1371/journal.pone.0143799	http://dx.doi.org/10.1371/journal.pone.0143799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656106	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900019
J	Vaughn, NR; Asner, GP; Smit, IPJ; Riddel, ES				Vaughn, Nicholas R.; Asner, Gregory P.; Smit, Izak P. J.; Riddel, Edward S.			Multiple Scales of Control on the Structure and Spatial Distribution of Woody Vegetation in African Savanna Watersheds	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; FIRE; RAINFALL; BIOMASS; TREES; LANDSCAPE; MECHANISMS; HERBIVORES; DYNAMICS; PATTERNS	Factors controlling savanna woody vegetation structure vary at multiple spatial and temporal scales, and as a consequence, unraveling their combined effects has proven to be a classic challenge in savanna ecology. We used airborne LiDAR (light detection and ranging) to map three-dimensional woody vegetation structure throughout four savanna watersheds, each contrasting in geologic substrate and climate, in Kruger National Park, South Africa. By comparison of the four watersheds, we found that geologic substrate had a stronger effect than climate in determining watershed-scale differences in vegetation structural properties, including cover, height and crown density. Generalized Linear Models were used to assess the spatial distribution of woody vegetation structural properties, including cover, height and crown density, in relation to mapped hydrologic, topographic and fire history traits. For each substrate and climate combination, models incorporating topography, hydrology and fire history explained up to 30% of the remaining variation in woody canopy structure, but inclusion of a spatial autocovariate term further improved model performance. Both crown density and the cover of shorter woody canopies were determined more by unknown factors likely to be changing on smaller spatial scales, such as soil texture, herbivore abundance or fire behavior, than by our mapped regional-scale changes in topography and hydrology. We also detected patterns in spatial covariance at distances up to 50-450 m, depending on watershed and structural metric. Our results suggest that large-scale environmental factors play a smaller role than is often attributed to them in determining woody vegetation structure in southern African savannas. This highlights the need for more spatially-explicit, wide-area analyses using high resolution remote sensing techniques.	[Vaughn, Nicholas R.; Asner, Gregory P.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Smit, Izak P. J.] South African Natl Pk, Sci Serv, Skukuza, South Africa; [Smit, Izak P. J.] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Ctr African Ecol, ZA-2050 Johannesburg, South Africa; [Riddel, Edward S.] South African Natl Pk, Conservat Management, Skukuza, South Africa; [Riddel, Edward S.] Univ KwaZulu Natal, Ctr Water Resources Res, Pietermaritzburg, South Africa	Carnegie Institution for Science; University of Witwatersrand; University of Kwazulu Natal	Vaughn, NR (corresponding author), Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA.	nvaughn@carrnegiescience.edu	Asner, Gregory/G-9268-2013	Asner, Gregory/0000-0001-7893-6421; Vaughn, Nicholas/0000-0003-0428-2909	Andrew Mellon Foundation	Andrew Mellon Foundation	This work was supported by Andrew Mellon Foundation, mellon.org.; This study was funded by the Andrew Mellon Foundation. The Carnegie Airborne Observatory is made possible by the Avatar Alliance Foundation, John D. and Catherine T. MacArthur Foundation, Mary Anne Nyburg Baker and G. Leonard Baker, Jr., and William R. Hearst III.	Asner GP, 2016, ECOGRAPHY, V39, P240, DOI 10.1111/ecog.01640; Asner GP, 2012, ECOL LETT, V15, P1211, DOI 10.1111/j.1461-0248.2012.01842.x; Asner GP, 2012, REMOTE SENS ENVIRON, V124, P454, DOI 10.1016/j.rse.2012.06.012; Asner GP, 2009, P NATL ACAD SCI USA, V106, P4947, DOI 10.1073/pnas.0810637106; Augustin NH, 1996, J APPL ECOL, V33, P339, DOI 10.2307/2404755; Ball MC, 2002, OECOLOGIA, V133, P120, DOI 10.1007/s00442-002-1044-z; Beven K.J., 1979, HYDROL SCI B, V24, P43, DOI [10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Bivand R., 2017, SPDEP SPATIAL DEPEND; Bucini G., 2010, ECOSYSTEM FUNCTION S, P219, DOI DOI 10.1201/B10275; Bucini G, 2009, INT GEOSCI REMOTE SE, P2714, DOI 10.1109/IGARSS.2009.5417381; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Chadwick OA, 2013, GEOLOGY, V41, P1171, DOI 10.1130/G34721.1; Codron J, 2011, OECOLOGIA, V165, P89, DOI 10.1007/s00442-010-1835-6; COE MJ, 1976, OECOLOGIA, V22, P341, DOI 10.1007/BF00345312; COLE MM, 1982, ECOL STUD, V42, P145; COLE MM, 1987, PROG PHYS GEOG, V11, P334, DOI 10.1177/030913338701100302; Colgan MS, 2012, BIOGEOSCIENCES, V9, P1809, DOI 10.5194/bg-9-1809-2012; COUGHENOUR MB, 1993, J BIOGEOGR, V20, P383, DOI 10.2307/2845587; Dahlin KM, 2012, ECOL APPL, V22, P104, DOI 10.1890/11-1401.1; EAST R, 1984, AFR J ECOL, V22, P245, DOI 10.1111/j.1365-2028.1984.tb00700.x; Fisher J, 2009, INT GEOSCI REMOTE SE, P449, DOI 10.1109/IGARSS.2009.5418040; Gertenbach W. P. D., 1980, Koedoe, V23, P35; Gillson L, 2009, VEG HIST ARCHAEOBOT, V18, P171, DOI 10.1007/s00334-008-0202-6; GOODRICH DC, 1995, J HYDROL, V173, P283, DOI 10.1016/0022-1694(95)02703-R; Govender N, 2012, AFR J RANGE FOR SCI, V29, P63, DOI 10.2989/10220119.2012.697918; Groen TA, 2008, J TROP ECOL, V24, P269, DOI 10.1017/S0266467408004872; Hanan N.P., 2011, ECOSYSTEM FUNCTION S, P39, DOI DOI 10.1201/B10275; Higgins SI, 2007, ECOLOGY, V88, P1119, DOI 10.1890/06-1664; Hoffmann WA, 2003, FOREST ECOL MANAG, V180, P273, DOI 10.1016/S0378-1127(02)00566-2; House JI, 2003, J BIOGEOGR, V30, P1763, DOI 10.1046/j.1365-2699.2003.00873.x; Kaartinen H, 2012, REMOTE SENS-BASEL, V4, P950, DOI 10.3390/rs4040950; Khomo L, 2011, CATENA, V87, P119, DOI 10.1016/j.catena.2011.05.017; KNOOP WT, 1985, J ECOL, V73, P235, DOI 10.2307/2259780; Lambers H, 2008, PLANT PHYSL ECOLOGY, P154, DOI DOI 10.1007/978-0-387-78341-3; Levick SR, 2015, FUNCT ECOL, V29, P131, DOI 10.1111/1365-2435.12306; Levick SR, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1066; Levick SR, 2009, BIOL CONSERV, V142, P1693, DOI 10.1016/j.biocon.2009.03.004; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Luoga EJ, 2004, FOREST ECOL MANAG, V189, P23, DOI 10.1016/j.foreco.2003.02.001; Meek CS, 2013, KOEDOE, V55, DOI 10.4102/koedoe.v55i1.1099; Milne G.G., 1935, SOIL RES, V4, P183; PASSIOURA JB, 1991, AUST J SOIL RES, V29, P717, DOI 10.1071/SR9910717; Pivello VR, 2010, PLANT SOIL, V337, P111, DOI 10.1007/s11104-010-0508-x; R Core Development Team, 2012, 2142 R COR DEV TEAM; Riddell ES, 2012, KOEDOE, V54, DOI 10.4102/koedoe.v54i1.1070; Ryan MG, 1997, BIOSCIENCE, V47, P235, DOI 10.2307/1313077; Sankaran M, 2004, ECOL LETT, V7, P480, DOI 10.1111/j.1461-0248.2004.00596.x; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Scholes RJ, 2002, J VEG SCI, V13, P419, DOI 10.1111/j.1654-1103.2002.tb02066.x; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Scholes RJ, 1993, AFRICAN SAVANNA SYNT, P2, DOI [10.1017/CBO9780511565472.002, DOI 10.1017/CBO9780511565472.002]; Scholes RJ, 2003, KRUGER EXPERIENCE EC, P243; Scholtz R, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00034.1; Schutte I. C., 1986, KOEDOE, V29, P13, DOI DOI 10.4102/K0ED0E.V29I1.517; Shackleton C. M., 2000, Koedoe, V43, P75; Shannon G, 2011, ECOSYSTEMS, V14, P1372, DOI 10.1007/s10021-011-9485-z; SKARPE C, 1991, J VEG SCI, V2, P565, DOI 10.2307/3236039; SKARPE C, 1992, J VEG SCI, V3, P293, DOI 10.2307/3235754; Smit IPJ, 2013, ECOGRAPHY, V36, P447, DOI 10.1111/j.1600-0587.2012.07555.x; Smit IPJ, 2010, ECOL APPL, V20, P1865, DOI 10.1890/09-0929.1; SMITH TM, 1986, BIOTROPICA, V18, P219, DOI 10.2307/2388488; Trollope W. S. W., 1998, Koedoe, V41, P103; Trollope W.S.W., 1986, J GRASSLAND SOC SO A, V3, P37, DOI [https://doi.org/10.1080/02566702.1986.9648030, DOI 10.1080/02566702.1986.9648030]; van Langevelde F, 2003, ECOLOGY, V84, P337, DOI 10.1890/0012-9658(2003)084[0337:EOFAHO]2.0.CO;2; van Zijl G, 2014, WATER SA, V40, P331, DOI 10.4314/wsa.v40i2.15; Vanak AT, 2012, ECOGRAPHY, V35, P315, DOI 10.1111/j.1600-0587.2011.07213.x; Venter F. J., 1986, Koedoe, V29, P125; Venter F.J., 2003, KRUGER EXPERIENCE EC, P83, DOI DOI 10.2989/10220110409485835; VETAAS OR, 1992, J VEG SCI, V3, P337, DOI 10.2307/3235758	69	16	16	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145192	10.1371/journal.pone.0145192	http://dx.doi.org/10.1371/journal.pone.0145192			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660502	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900191
J	Zoega, H; Kieler, H; Norgaard, M; Furu, K; Valdimarsdottir, U; Brandt, L; Haglund, B				Zoega, Helga; Kieler, Helle; Norgaard, Mette; Furu, Kari; Valdimarsdottir, Unnur; Brandt, Lena; Haglund, Bengt			Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden	PLOS ONE			English	Article							SEROTONIN-REUPTAKE INHIBITORS; PERSISTENT PULMONARY-HYPERTENSION; NORDIC COUNTRIES; DRUG-USE; RISK; COHORT; DEPRESSION; PREVALENCE; PATTERNS; WOMEN	Background The purpose was to describe utilization of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), including trends in prevalence, characteristics of users, drug switching and changes in prescribed doses in a large group of pregnant women across four Nordic countries. Methods A drug utilization study based on linked individual-level data from the nationwide prescription- and medical birth registers in Denmark, Iceland, Norway and Sweden. The study population comprised all pregnancies in these countries, resulting in a live birth or stillbirth after gestational week 22 from January 1st 2008 to December 31st 2012 (N = 1 162 470). In addition to the main study drugs SSRIs and SNRIs, we included (concurrent) use of other antidepressants, antipsychotics, anxiolytics and hypnotics. Results A total of 38 219 (3.3%) pregnancies were exposed to SSRIs and 5 634 (0.5%) to SNRIs. Prevalence of SSRI and SNRI use varied by country (1.8% in Norway to 7.0% in Iceland). Use and prescribed dosages decreased with each passing trimester of pregnancy; prevalence was 2.7% at conception, and 2.1%, 1.7% and 1.3% respectively in 1st, 2nd and 3rd trimester. In 0.6% of pregnancies women filled a prescription before pregnancy and in every trimester. In one third of exposed pregnancies, women were also dispensed anxiolytics, hypnotics or sedatives. Conclusion Use of SSRI and SNRI use during pregnancy varied between the Nordic countries, but the overall prevalence remained low and relatively stable from 2008 to 2012. The low prevalence of use and high proportion of women who discontinue treatment in pregnancy raise questions about adequate treatment of depression in pregnant women.	[Zoega, Helga; Valdimarsdottir, Unnur] Univ Iceland, Fac Med, Ctr Publ Hlth Sci, Reykjavik, Iceland; [Kieler, Helle; Brandt, Lena; Haglund, Bengt] Solna Karolinska Inst, Ctr Pharmacoepidemiol, Dept Med, Stockholm, Sweden; [Norgaard, Mette] Aarhus Univ Hosp, Inst Clin Med, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Furu, Kari] Norwegian Inst Publ Hlth, Dept Pharmacoepidemiol, Oslo, Norway; [Valdimarsdottir, Unnur] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	University of Iceland; Karolinska Institutet; Aarhus University; Norwegian Institute of Public Health (NIPH); Harvard University; Harvard T.H. Chan School of Public Health	Zoega, H (corresponding author), Univ Iceland, Fac Med, Ctr Publ Hlth Sci, Reykjavik, Iceland.	helgaz@hi.is		Norgaard, Mette/0000-0001-6110-5891; Valdimarsdottir, Unnur/0000-0001-5382-946X; Zoega, Helga/0000-0003-0761-9028; Kieler, Helle/0000-0001-9338-7133	Icelandic Centre for Research, START-Reintegration Fellowship, FP7 Marie Curie Award [130814-051]; University of Iceland, Karolinska Institutet; Norwegian Institute of Public Health; Aarhus University Hospital	Icelandic Centre for Research, START-Reintegration Fellowship, FP7 Marie Curie Award; University of Iceland, Karolinska Institutet; Norwegian Institute of Public Health; Aarhus University Hospital	Helga Zoega received financial support from the Icelandic Centre for Research, START-Reintegration Fellowship, FP7 Marie Curie Award, (#130814-051), http://www.rannis.is/, http://ec.europa.eu/rea/index_en.htm. The study was otherwise funded by the authors' affiliations: the University of Iceland, Karolinska Institutet, the Norwegian Institute of Public Health and Aarhus University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alwan S, 2007, NEW ENGL J MED, V356, P2684, DOI 10.1056/NEJMoa066584; Alwan S, 2011, J CLIN PHARMACOL, V51, P264, DOI 10.1177/0091270010373928; Andrade SE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.07.036; Bakker MK, 2008, BRIT J CLIN PHARMACO, V65, P600, DOI 10.1111/j.1365-2125.2007.03048.x; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Chambers CD, 2006, NEW ENGL J MED, V354, P579, DOI 10.1056/NEJMoa052744; Charlton RA, 2015, BJOG-INT J OBSTET GY, V122, P1010, DOI 10.1111/1471-0528.13143; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Connolly KR, 2011, DRUGS, V71, P43, DOI 10.2165/11587620-000000000-00000; Cooper WO, 2007, AM J OBSTET GYNECOL, V196, P544, DOI 10.1016/j.ajog.2007.01.033; Deligiannidis KM, 2014, J CLIN PSYCHOPHARM, V34, P244, DOI 10.1097/JCP.0000000000000087; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Furu K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1798; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Gentile S, 2017, NEUROSCIENCE, V342, P154, DOI 10.1016/j.neuroscience.2015.09.001; Hayes RM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.04.028; Huybrechts KF, 2015, JAMA-J AM MED ASSOC, V313, P2142, DOI 10.1001/jama.2015.5605; Huybrechts KF, 2014, NEW ENGL J MED, V370, P2397, DOI 10.1056/NEJMoa1312828; Huybrechts KF, 2013, GEN HOSP PSYCHIAT, V35, P265, DOI 10.1016/j.genhosppsych.2012.12.010; Jimenez-Solem E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063034; Kieler H, 2015, BJOG-INT J OBSTET GY, V122, P1618, DOI 10.1111/1471-0528.13164; Kieler H, 2012, BMJ-BRIT MED J, V344, pd8012, DOI DOI 10.1136/BMJ.D8012; Laugesen K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003024; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; Lupattelli A, 2015, DEPRESS ANXIETY, V32, P426, DOI 10.1002/da.22352; Mitchell AA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.029; Organization for Economic Cooperation Development (OECD), 2013, HEALTH AT A GLANCE 2; Petersen I, 2011, J CLIN PSYCHIAT, V72, P979, DOI 10.4088/JCP.10m06090blu; Ramos E, 2007, BJOG-INT J OBSTET GY, V114, P1055, DOI 10.1111/j.1471-0528.2007.01387.x; Reefhuis J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3190; Rosen M, 2002, SCAND J PUBLIC HEALT, V30, P81, DOI 10.1080/140349401753683444; Stephansson O, 2013, JAMA-J AM MED ASSOC, V309, P48, DOI 10.1001/jama.2012.153812; van Gelder MMHJ, 2014, HUM REPROD, V29, P161, DOI 10.1093/humrep/det369; Ververs T, 2006, EUR J CLIN PHARMACOL, V62, P863, DOI 10.1007/s00228-006-0177-0; Warburton W, 2010, ACTA PSYCHIAT SCAND, V121, P471, DOI 10.1111/j.1600-0447.2009.01490.x; WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health, 2012, GUIDELINES FOR ATC C; Yamamoto A, 2015, J PERINATOL, V35, P246, DOI 10.1038/jp.2014.197; Yonkers KA, 2011, EPIDEMIOLOGY, V22, P848, DOI 10.1097/EDE.0b013e3182306847; Yonkers KA, 2009, GEN HOSP PSYCHIAT, V31, P403, DOI [10.1097/AOG.0b013e3181ba0632, 10.1016/j.genhosppsych.2009.04.003]; Zoega H, 2011, ACTA PSYCHIAT SCAND, V123, P360, DOI 10.1111/j.1600-0447.2010.01607.x; Zoega H, 2009, J CHILD ADOL PSYCHOP, V19, P757, DOI 10.1089/cap.2009.0003	42	67	67	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144474	10.1371/journal.pone.0144474	http://dx.doi.org/10.1371/journal.pone.0144474			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26657647	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900055
J	Ejsing, CS; Bilgin, M; Fabregat, A				Ejsing, Christer S.; Bilgin, Mesut; Fabregat, Andreu			Quantitative Profiling of Long-Chain Bases by Mass Tagging and Parallel Reaction Monitoring	PLOS ONE			English	Article							SHOTGUN LIPIDOMICS; SPHINGOLIPIDS; QUADRUPOLE; SPECTROMETER; QUANTIFICATION; METABOLISM	Long-chain bases (LCBs) are both intermediates in sphingolipid metabolism and potent signaling molecules that control cellular processes. To understand how regulation of sphingolipid metabolism and levels of individual LCB species impinge upon physiological and pathophysiological processes requires sensitive and specific assays for monitoring these molecules. Here we describe a shotgun lipidomics method for quantitative profiling of LCB molecules. The method employs a "mass-tag" strategy where LCBs are chemically derivatized with deuterated methyliodide (CD3I) to produce trimethylated derivatives having a positively charged quaternary amine group. This chemical derivatization minimizes unwanted in-source fragmentation of LCB analytes and prompts a characteristic trimethylaminium fragment ion that enables sensitive and quantitative profiling of LCB molecules by parallel reaction monitoring on a hybrid quadrupole time-of-flight mass spectrometer. Notably, the strategy provides, for the first time, a routine for monitoring endogenous 3-ketosphinganine molecules and distinguishing them from more abundant isomeric sphingosine molecules. To demonstrate the efficacy of the methodology we report an in-depth characterization of the LCB composition of yeast mutants with defective sphingolipid metabolism and the absolute levels of LCBs in mammalian cells. The strategy is generic, applicable to other types of mass spectrometers and can readily be applied as an additional routine in workflows for global lipidome quantification and for functional studies of sphingolipid metabolism.	[Ejsing, Christer S.; Bilgin, Mesut; Fabregat, Andreu] Univ Southern Denmark, Dept Biochem & Mol Biol, VILLUM Ctr Bioanalyt Sci, Odense, Denmark	University of Southern Denmark	Ejsing, CS (corresponding author), Univ Southern Denmark, Dept Biochem & Mol Biol, VILLUM Ctr Bioanalyt Sci, Odense, Denmark.	cse@bmb.sdu.dk	Ejsing, Christer S/R-5922-2016	Ejsing, Christer S./0000-0003-4963-0276	VILLUM FONDEN [VKR023439]; Lundbeck Foundation [R44-A4342, R54-A5858]; Danish Council for Independent Research | Natural Sciences [09-072484, 09-076199]; Villum Fonden [00007363] Funding Source: researchfish	VILLUM FONDEN(Villum Fonden); Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research | Natural Sciences(Det Frie Forskningsrad (DFF)); Villum Fonden(Villum Fonden)	This work was supported by the VILLUM FONDEN (VKR023439; CSE; http://villumfonden.dk), Lundbeck Foundation (R44-A4342, R54-A5858; CSE; www.lundbeckfoundation.com) and the Danish Council for Independent Research | Natural Sciences (09-072484, 09-076199; CSE; www.ufm.dk).	Almeida R, 2015, J AM SOC MASS SPECTR, V26, P133, DOI 10.1007/s13361-014-1013-x; Bilgin M, 2011, BBA-MOL CELL BIOL L, V1811, P1081, DOI 10.1016/j.bbalip.2011.09.018; Blanksby SJ, 2010, ANNU REV ANAL CHEM, V3, P433, DOI 10.1146/annurev.anchem.111808.073705; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Chernushevich IV, 2001, J MASS SPECTROM, V36, P849, DOI 10.1002/jms.207; Ejsing CS, 2006, ANAL CHEM, V78, P6202, DOI 10.1021/ac060545x; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Ekroos K, 2002, ANAL CHEM, V74, P941, DOI 10.1021/ac015655c; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Gallien S, 2012, MOL CELL PROTEOMICS, V11, P1709, DOI 10.1074/mcp.O112.019802; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Husen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079736; Kalvodova L, 2009, J VIROL, V83, P7996, DOI 10.1128/JVI.00635-09; Klose C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035063; LESTER RL, 1993, ADV LIPID RES, V26, P253; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; Peterson AC, 2012, MOL CELL PROTEOMICS, V11, P1475, DOI 10.1074/mcp.O112.020131; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Scherer M, 2010, J LIPID RES, V51, P2001, DOI 10.1194/jlr.D005322; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	24	10	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144817	10.1371/journal.pone.0144817	http://dx.doi.org/10.1371/journal.pone.0144817			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26660097	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903600093
J	Larstad, M; Almstrand, AC; Larsson, P; Bake, B; Larsson, S; Ljungstrom, E; Mirgorodskaya, E; Olin, AC				Larstad, Mona; Almstrand, Ann-Charlotte; Larsson, Per; Bake, Bjorn; Larsson, Sven; Ljungstrom, Evert; Mirgorodskaya, Ekaterina; Olin, Anna-Carin			Surfactant Protein A in Exhaled Endogenous Particles Is Decreased in Chronic Obstructive Pulmonary Disease (COPD) Patients: A Pilot Study	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE; AIRWAY-OBSTRUCTION; OXIDATIVE STRESS; HEALTHY SMOKERS; LUNG-DISEASE; BREATH; BIOMARKERS; ASTHMA; PROGRESSION; EXPRESSION	Background Exhaled, endogenous particles are formed from the epithelial lining fluid in small airways, where surfactant protein A (SP-A) plays an important role in pulmonary host defense. Based on the knowledge that chronic obstructive pulmonary disease (COPD) starts in the small airway epithelium, we hypothesized that chronic inflammation modulates peripheral exhaled particle SP-A and albumin levels. The main objective of this explorative study was to compare the SP-A and albumin contents in exhaled particles from patients with COPD and healthy subjects and to determine exhaled particle number concentrations. Methods Patients with stable COPD ranging from moderate to very severe (n = 13), and healthy nonsmoking subjects (n = 12) were studied. Subjects performed repeated breath maneuvers allowing for airway closure and re-opening, and exhaled particles were optically counted and collected on a membrane using the novel PExA1 instrument setup. Immunoassays were used to quantify SP-A and albumin. Results COPD patients exhibited significantly lower SP-A mass content of the exhaled particles (2.7 vs. 3.9 weight percent, p = 0.036) and lower particle number concentration (p<0.0001) than healthy subjects. Albumin mass contents were similar for both groups. Conclusions Decreased levels of SP-A may lead to impaired host defense functions of surfactant in the airways, contributing to increased susceptibility to COPD exacerbations. SP-A in exhaled particles from small airways may represent a promising non-invasive biomarker of disease in COPD patients.	[Larstad, Mona; Almstrand, Ann-Charlotte; Larsson, Per; Mirgorodskaya, Ekaterina; Olin, Anna-Carin] Univ Gothenburg, Dept Occupat & Environm Med, Sahlgrenska Acad, Gothenburg, Sweden; [Bake, Bjorn; Larsson, Sven] Univ Gothenburg, Dept Resp Med & Allergol, Sahlgrenska Acad, Gothenburg, Sweden; [Ljungstrom, Evert] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg	Larstad, M (corresponding author), Univ Gothenburg, Dept Occupat & Environm Med, Sahlgrenska Acad, Gothenburg, Sweden.	mona.larstad@amm.gu.se	Olin, Anna-Carin/ABH-2627-2021		Swedish Heart-Lung foundation [20130279]; LUA-ALF (lokalt utvecklingsavtal avtal om lakarutbildning och forskning), Sahlgrenska University Hospital	Swedish Heart-Lung foundation(Swedish Heart-Lung Foundation); LUA-ALF (lokalt utvecklingsavtal avtal om lakarutbildning och forskning), Sahlgrenska University Hospital	Grants from the Swedish Heart-Lung foundation (ACO; grant number 20130279) and from LUA-ALF (lokalt utvecklingsavtal avtal om lakarutbildning och forskning), Sahlgrenska University Hospital (ML), funded the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstrand AC, 2010, J APPL PHYSIOL, V108, P584, DOI 10.1152/japplphysiol.00873.2009; Almstrand AC, 2009, ANAL CHEM, V81, P662, DOI 10.1021/ac802055k; Antczak A, 2012, ARCH MED SCI, V8, P277, DOI 10.5114/aoms.2012.28555; BERNARD A, 1992, EUR RESPIR J, V5, P1231; Betsuyaku T, 2004, EUR RESPIR J, V24, P964, DOI 10.1183/09031936.04.00064004; Borrill ZL, 2008, EUR RESPIR J, V32, P472, DOI 10.1183/09031936.00116107; Burgel PR, 2011, EUR RESPIR REV, V20, P7, DOI 10.1183/09059180.10010610; Casaburi R, 2013, COPD, V10, P367, DOI 10.3109/15412555.2012.752807; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Effros RM, 2005, CURR OPIN PULM MED, V11, P135, DOI 10.1097/00063198-200503000-00006; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; FAIRCHILD CI, 1987, AM IND HYG ASSOC J, V48, P948, DOI 10.1080/15298668791385868; Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC; Galban CJ, 2012, NAT MED, V18, P1711, DOI 10.1038/nm.2971; HENRIKSEN JH, 1984, SCAND J CLIN LAB INV, V44, P119, DOI 10.3109/00365518409161392; Hill AT, 1999, AM J RESP CRIT CARE, V160, P893, DOI 10.1164/ajrccm.160.3.9901091; HOGG JC, 1968, NEW ENGL J MED, V278, P1355, DOI 10.1056/NEJM196806202782501; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Holmgren H, 2011, J AEROSOL MED PULM D, V24, P253, DOI 10.1089/jamp.2011.0880; Honda Y, 1996, CHEST, V109, P1006, DOI 10.1378/chest.109.4.1006; Huynh KN, 2008, CLIN INFECT DIS, V46, P93, DOI 10.1086/523000; Ishikawa N, 2011, RESPIRATION, V82, P10, DOI 10.1159/000324539; Khor YH, 2009, CLIN EXP ALLERGY, V39, P1659, DOI 10.1111/j.1365-2222.2009.03349.x; Kingma PS, 2006, CURR OPIN PHARMACOL, V6, P277, DOI 10.1016/j.coph.2006.02.003; Koczulla AR, 2012, RESP MED, V106, P120, DOI 10.1016/j.rmed.2011.06.015; KOULOURIS NG, 1995, EUR RESPIR J, V8, P306, DOI 10.1183/09031936.95.08020306; Larsson P, 2012, RESP MED, V106, P197, DOI 10.1016/j.rmed.2011.10.008; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Madsen J, 2003, AM J RESP CELL MOL, V29, P591, DOI 10.1165/rcmb.2002-0274OC; Mazur W, 2011, EUR RESPIR J, V38, P277, DOI 10.1183/09031936.00110510; Miller MR, 2005, EUR RESPIR J, V26, P153, DOI 10.1183/09031936.05.00034505; Minakata Y, 2005, THORAX, V60, P882, DOI 10.1136/thx.2005.045765; Montuschi P, 2005, CLIN CHIM ACTA, V356, P22, DOI 10.1016/j.cccn.2005.01.012; Nicola ML, 2014, CHEST, V145, P998, DOI 10.1378/chest.13-1355; Ohlmeler S, 2008, J PROTEOME RES, V7, P5125, DOI 10.1021/pr800423x; Papineni R S, 1997, J Aerosol Med, V10, P105, DOI 10.1089/jam.1997.10.105; Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW; Persson C, 2009, CLIN EXP ALLERGY, V39, P1626, DOI 10.1111/j.1365-2222.2009.03373.x; Postma DS, 2015, LANCET, V385, P899, DOI 10.1016/S0140-6736(14)60446-3; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Ropcke S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046207; Schwarz K, 2015, J AEROSOL MED PULM D, V28, P52, DOI 10.1089/jamp.2013.1104; Shaw JG, 2014, J THORAC DIS, V6, P1532, DOI 10.3978/j.issn.2072-1439.2014.11.33; Siddiqui S, 2012, NAT MED, V18, P1619, DOI 10.1038/nm.2981; Sundblad BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084110; van den Berge M, 2011, CHEST, V139, P412, DOI 10.1378/chest.10-1210; Vlachaki EM, 2010, CHEST, V137, P37, DOI 10.1378/chest.09-1029; Yigla M, 2007, ARCH ORAL BIOL, V52, P36, DOI 10.1016/j.archoralbio.2006.08.002	48	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144463	10.1371/journal.pone.0144463	http://dx.doi.org/10.1371/journal.pone.0144463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656890	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903600048
J	Ohol, YM; Wang, ZT; Kemble, G; Duke, G				Ohol, Yamini M.; Wang, Zhaoti; Kemble, George; Duke, Gregory			Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses	PLOS ONE			English	Article							F-PROTEIN; LIPID RAFTS; INFECTED CELLS; IN-VIVO; FUSION; MEMBRANE; MICRODOMAINS; CAVEOLIN-1; CANCER; ASSAY	Fatty acid synthase (FASN) catalyzes the de novo synthesis of palmitate, a fatty acid utilized for synthesis of more complex fatty acids, plasma membrane structure, and post-translational palmitoylation of host and viral proteins. We have developed a potent inhibitor of FASN (TVB-3166) that reduces the production of respiratory syncytial virus (RSV) progeny in vitro from infected human lung epithelial cells (A549) and in vivo from mice challenged intranasally with RSV. Addition of TVB-3166 to the culture medium of RSV-infected A549 cells reduces viral spread without inducing cytopathic effects. The antiviral effect of the FASN inhibitor is a direct consequence of reducing de novo palmitate synthesis; similar doses are required for both antiviral activity and inhibition of palmitate production, and the addition of exogenous palmitate to TVB-3166-treated cells restores RSV production. TVB3166 has minimal effect on RSV entry but significantly reduces viral RNA replication, protein levels, viral particle formation and infectivity of released viral particles. TVB-3166 substantially impacts viral replication, reducing production of infectious progeny 250-fold. In vivo, oral administration of TVB-3166 to RSV-A (Long)-infected BALB/c mice on normal chow, starting either on the day of infection or one day post-infection, reduces RSV lung titers 21-fold and 9-fold respectively. Further, TVB-3166 also inhibits the production of RSV B, human parainfluenza 3 (PIV3), and human rhinovirus 16 (HRV16) progeny from A549, HEp2 and HeLa cells respectively. Thus, inhibition of FASN and palmitate synthesis by TVB-3166 significantly reduces RSV progeny both in vitro and in vivo and has broad-spectrum activity against other respiratory viruses. FASN inhibition may alter the composition of regions of the host cell membrane where RSV assembly or replication occurs, or change the membrane composition of RSV progeny particles, decreasing their infectivity.	[Ohol, Yamini M.; Wang, Zhaoti; Kemble, George; Duke, Gregory] 3V Biosci, Menlo Pk, CA 94025 USA		Duke, G (corresponding author), 3V Biosci, Menlo Pk, CA 94025 USA.	greg.duke@3vbio.com			3-V Biosciences, Inc.	3-V Biosciences, Inc.	The study was funded by 3-V Biosciences, Inc. Employees of the company were involved in study design, data collection and analysis, decision to publish, and writing the manuscript. Although the therapeutics characterized in this study are products of 3-V Biosciences, studies were designed, executed, and objectively interpreted with the goal of advancing basic research on RSV and other respiratory viruses.	Adachi S, 2007, CANCER RES, V67, P6493, DOI 10.1158/0008-5472.CAN-07-0411; ARUMUGHAM RG, 1989, J BIOL CHEM, V264, P10339; Boukhvalova MS, 2007, J VIROL, V81, P9443, DOI 10.1128/JVI.00102-07; Branigan PJ, 2006, J GEN VIROL, V87, P395, DOI 10.1099/vir.0.81481-0; Brown G, 2002, J GEN VIROL, V83, P1841, DOI 10.1099/0022-1317-83-8-1841; Brown G, 2002, J GEN VIROL, V83, P611, DOI 10.1099/0022-1317-83-3-611; Centers for Disease Control and Prevention, 2013, RESP SYNC VIR INF RS; Chang TH, 2012, VIROLOGY, V422, P205, DOI 10.1016/j.virol.2011.10.029; Chapman J, 2007, ANTIMICROB AGENTS CH, V51, P3346, DOI 10.1128/AAC.00211-07; Cheng X, 2002, J VIROL METHODS, V105, P287, DOI 10.1016/S0166-0934(02)00122-2; Chirala SS, 2003, P NATL ACAD SCI USA, V100, P6358, DOI 10.1073/pnas.0931394100; Coleman DT, 2009, MOL CANCER THER, V8, P214, DOI 10.1158/1535-7163.MCT-08-0722; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; Daniels VW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106913; De Almeida IT, 2002, CLIN NUTR, V21, P219, DOI 10.1054/clnu.2001.0529; De Serres G, 2009, J CLIN VIROL, V46, P129, DOI 10.1016/j.jcv.2009.07.010; Di Vizio D, 2008, CELL CYCLE, V7, P2257, DOI 10.4161/cc.7.14.6475; Douglas JL, 2005, ANTIMICROB AGENTS CH, V49, P2460, DOI 10.1128/AAC.49.6.2460-2466.2005; Evanchik M, 2012, HEPATOLOGY, V56, p1066A; Fleming EH, 2006, J VIROL, V80, P12160, DOI 10.1128/JVI.00643-06; Geller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056762; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; HEMINWAY BR, 1994, VIROLOGY, V200, P801, DOI 10.1006/viro.1994.1245; Huang JT, 2013, J VIROL, V87, P4994, DOI 10.1128/JVI.02526-12; Jeffree CE, 2003, VIROLOGY, V306, P254, DOI 10.1016/S0042-6822(02)00016-8; Jensen-Urstad APL, 2013, J LIPID RES, V54, P1848, DOI 10.1194/jlr.M036103; Khan N, 2006, CANCER RES, V66, P2500, DOI 10.1158/0008-5472.CAN-05-3636; Knowles LM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-168; Matsumoto K, 2014, RESPIR INVESTIG, V52, P92, DOI 10.1016/j.resinv.2013.08.005; McCurdy LH, 2003, J VIROL, V77, P1747, DOI 10.1128/JVI.77.3.1747-1756.2003; McDonald TP, 2004, VIROLOGY, V330, P147, DOI 10.1016/j.virol.2004.09.034; Morton CJ, 2003, VIROLOGY, V311, P275, DOI 10.1016/S0042-6822(03)00115-6; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; NORRBY E, 1970, J VIROL, V6, P237, DOI 10.1128/JVI.6.2.237-242.1970; Oomens AGP, 2006, J VIROL, V80, P10465, DOI 10.1128/JVI.01439-06; Oslob JD, 2013, ACS MED CHEM LETT, V4, P113, DOI 10.1021/ml300335r; Perkins SM, 2005, J CLIN MICROBIOL, V43, P2356, DOI 10.1128/JCM.43.5.2356-2362.2005; Plummer E, 2015, J VIROL, V89, P5592, DOI 10.1128/JVI.00028-15; Puig T, 2008, ANTICANCER RES, V28, P3671; Puig T, 2009, CLIN CANCER RES, V15, P7608, DOI 10.1158/1078-0432.CCR-09-0856; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; San-Juan-Vergara H, 2012, J VIROL, V86, P1832, DOI 10.1128/JVI.06274-11; Smans KA, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-801; Swinnen JV, 2003, BIOCHEM BIOPH RES CO, V302, P898, DOI 10.1016/S0006-291X(03)00265-1; Tayyari F, 2011, NAT MED, V17, P1132, DOI 10.1038/nm.2444; Tomek K, 2011, MOL CANCER RES, V9, P1767, DOI 10.1158/1541-7786.MCR-10-0467; Turner TL, 2014, CLINICOECONOMIC OUTC, V6, P217, DOI 10.2147/CEOR.S60710; Veit M, 2012, BIOL CELL, V104, P493, DOI 10.1111/boc.201200006; WALSH EE, 1985, J GEN VIROL, V66, P409, DOI 10.1099/0022-1317-66-3-409; Yeo DSY, 2009, VIROLOGY, V386, P168, DOI 10.1016/j.virol.2008.12.017; Zhang HM, 2013, J PROTEOME RES, V12, P2967, DOI 10.1021/pr400247f	51	42	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144648	10.1371/journal.pone.0144648	http://dx.doi.org/10.1371/journal.pone.0144648			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659560	Green Submitted, gold, Green Published			2022-12-27	WOS:000366903600072
J	Yang, JH; Chen, CD; Chen, SU; Yang, YS; Chen, MJ				Yang, Jehn-Hsiahn; Chen, Chin-Der; Chen, Shee-Uan; Yang, Yu-Shih; Chen, Mei-Jou			Factors Influencing the Recurrence Potential of Benign Endometrial Polyps after Hysteroscopic Polypectomy	PLOS ONE			English	Article							PREGNANCY RATES; RESECTION	Background An endometrial polyp is a frequently encountered gynecologic disease with abnormal uterine bleeding and infertility being the two common presenting problems, and hysteroscopic polypectomy is an effective method to remove them. The postoperative polyp recurrence might result in reappearance of abnormal uterine bleeding or infertility, whereas factors influencing the postoperative recurrence potential have limited data. Methods This case-series report included 168 premenopausal women who suffered from endometrial polyps and underwent hysteroscopic polypectomy. All of them were awaiting a future pregnancy. Office hysteroscopy was done before and after hysteroscopic polypectomy, in which preoperative hysteroscopy examined the number, type, and location of endometrial polyps, and postoperative hysteroscopy checked the polyp recurrence. Surgical indications, either infertility or the presentation of abnormal uterine bleeding, and follow-up duration were recorded. Results Seventy-three out of 168 (43%) women had polyp recurrence after hysteroscopic polypectomy. Multivariate logistic regression analysis revealed that more endometrial polyps (P = 0.015) and longer duration of follow-up (P = 0.004) were significantly associated with an increased risk of postoperative polyp recurrence. The type of endometrial polyps was not correlated with polyp recurrence potential, whereas pedunculated type endometrial polyps were closely related to the presentation of abnormal uterine bleeding (P = 0.001). Conclusions A higher number of endometrial polyps and longer follow-up duration are associated with a greater potential of polyp recurrence after hysteroscopic polypectomy.	[Chen, Mei-Jou] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chen, MJ (corresponding author), Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan.	mjchen04@ntu.edu.tw	Chen, Mei-Jou/AAS-7698-2020	YANG, YU-SHIH/0000-0002-8633-0873; YANG, JEHN-HSIAHN/0000-0001-8648-0882; CHEN, CHIN-DER/0000-0002-6330-7742; CHEN, SHEE-UAN/0000-0001-7592-3238; CHEN, MEI-JOU/0000-0002-2305-1105				AAGL Advancing Minimally Invasive, 2012, J MINIM INVAS GYN, V19, P3, DOI 10.1016/j.jmig.2011.09.003; AlHilli MM, 2013, J MINIM INVAS GYN, V20, P215, DOI 10.1016/j.jmig.2012.10.013; Ayas S, 2011, SAJOG-S AFR J OBSTET, V17, P10; Brown SE, 2000, FERTIL STERIL, V74, P1029, DOI 10.1016/S0015-0282(00)01541-7; Guo SW, 2009, HUM REPROD UPDATE, V15, P441, DOI 10.1093/humupd/dmp007; Paradisi R, 2014, GYNECOL OBSTET INVES, V78, P26, DOI 10.1159/000362646; Perez-Medina T, 2005, HUM REPROD, V20, P1632, DOI 10.1093/humrep/deh822; PETERSON WF, 1956, OBSTET GYNECOL, V8, P40; Preutthipan S, 2005, FERTIL STERIL, V83, P705, DOI 10.1016/j.fertnstert.2004.08.031; Shokeir TA, 2004, J OBSTET GYNAECOL RE, V30, P84, DOI 10.1111/j.1447-0756.2003.00163.x; Stamatellos I, 2008, ARCH GYNECOL OBSTET, V277, P395, DOI 10.1007/s00404-007-0460-z; Tallini G, 2000, LAB INVEST, V80, P359, DOI 10.1038/labinvest.3780040; Varasteh NN, 1999, OBSTET GYNECOL, V94, P168, DOI 10.1016/S0029-7844(99)00278-1; Yang JH, 2008, FERTIL STERIL, V89, P1254, DOI 10.1016/j.fertnstert.2007.05.027; Yang JH, 2013, FERTIL STERIL, V99, P2092, DOI 10.1016/j.fertnstert.2013.01.137; Yang JH, 2011, FERTIL STERIL, V95, P1769, DOI 10.1016/j.fertnstert.2011.01.142; Yang JH, 2007, FERTIL STERIL, V88, DOI 10.1016/j.fertnstert.2007.01.033; Yang JH, 2015, BJOG IN PRESS	18	28	37	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144857	10.1371/journal.pone.0144857	http://dx.doi.org/10.1371/journal.pone.0144857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26660149	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903600098
J	Shiferaw, MB; Mengistu, AD				Shiferaw, Melashu Balew; Mengistu, Agmas Dessalegn			Helminthiasis: Hookworm Infection Remains a Public Health Problem in Dera District, South Gondar, Ethiopia	PLOS ONE			English	Article								Background Intestinal parasitic infections are significant cause of morbidity and mortality in endemic countries. In Ethiopia, helminthiasis was the third leading cause of outpatient visits. Despite the health extension program was launched to address this problem, there is limited information on the burden of intestinal parasites after implementation of the program in our setting. Therefore, the aim of this study was to assess the intestinal helminthic infections among clients attending at Anbesame health center, South Gondar, Ethiopia. Methods A cross sectional study was conducted at Anbesame health center from March to June 2015. A structured questionnaire was used to collect data from 464 study participants selected consecutively. Stool specimen collection, processing through formol-ether concentration technique and microscopic examination for presence of parasites were carried out. Data were entered, cleaned and analyzed using SPSS Version 20. Results Among the total 464 study participants with median (+/- IQR) age of 25.0 (+/- 21.75) years, 262 (56.5%) were females. Helminthic infection was found in 97 (20.9%) participants. Hookworm (68 [14.7%]) was the predominant parasite followed by S. mansoni (11 [2.4%]), E. vermicularis (9 [1.9%]) and S. stercoralis (5 [1.1%]). Patients with age group >= 15 years (AOR: 5.26; 95% CI: 2.05-13.46; P: 0.001) and walking barefoot (AOR: 2.20; 95% CI: 1.08-4.48; P: 0.031) were more vulnerable from the hookworm infections. Conclusions There was a high burden of hookworm infections in our setting. Hence, regular shoes wearing, considering all age groups in the albendazole deworming as mass treatment and environmental hygiene are important interventions to reduce the burden of such neglected tropical disease.	[Shiferaw, Melashu Balew] Bahir Dar Reg Hlth Res Lab Ctr, Bahir Dar, Ethiopia; [Mengistu, Agmas Dessalegn] Felege Hiwot Referral Hosp, Bahir Dar, Ethiopia		Shiferaw, MB (corresponding author), Bahir Dar Reg Hlth Res Lab Ctr, Bahir Dar, Ethiopia.	bmelashu@gmail.com	Shiferaw, Melashu/GPT-3320-2022	Shiferaw, Melashu Balew/0000-0002-5066-0758				Abate Abraraw, 2013, ISRN Parasitol, V2013, P757451, DOI 10.5402/2013/757451; Alemu A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-189; [Anonymous], 2014, DER WOR OFF AGR ANN; [Anonymous], 2015, ANBESAME HLTH CTR SE; Ayalew A., 2011, J PARASITOL VECTOR B, V3, P75; Cheesbrough M, 2006, DISTRICT LAB PRACT 1, V18, P126; Debalke S, 2013, ETHIOP J HEALTH SCI, V23, P237, DOI 10.4314/ejhs.v23i3.6; Demissie F, 2008, ETHIOP J HLTH SCI, V18, P53; Girum Tadesse, 2005, Ethiopian Journal of Health Development, V19, P140; Guyatt H, 2000, PARASITOL TODAY, V16, P153, DOI 10.1016/S0169-4758(99)01634-8; Haque R, 2007, J HEALTH POPUL NUTR, V25, P387; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Lopiso Erosie, 2002, Ethiopian Journal of Health Development, V16, P113; Mathewos Biniam, 2014, BMC Res Notes, V7, P88, DOI 10.1186/1756-0500-7-88; Ministry of Health (MOH), 2011, HLTH HLTH REL IND; Sebhatu A., 2008, ADDIS ABABA; Siddiqui AA, 2001, CLIN INFECT DIS, V33, P1040, DOI 10.1086/322707; Skolnik R., 2010, ENDING NEGLECT NEGLE, P1; USAID/ Pathfinder International, 2008, ETH HLTH EXT PROGR; Wegayehu T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-151; WHO, 1998, CONTR TROP DIS; World Health Organization, 2002, PREV CONTR SCHIST SO; Ziegelbauer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001162	23	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144588	10.1371/journal.pone.0144588	http://dx.doi.org/10.1371/journal.pone.0144588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657490	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903500045
J	Paco, S; Casserras, T; Rodriguez, MA; Jou, C; Puigdelloses, M; Ortez, CI; Diaz-Manera, J; Gallardo, E; Colomer, J; Nascimento, A; Kalko, SG; Jimenez-Mallebrera, C				Paco, Sonia; Casserras, Teresa; Angels Rodriguez, Maria; Jou, Cristina; Puigdelloses, Montserrat; Ortez, Carlos I.; Diaz-Manera, Jordi; Gallardo, Eduardo; Colomer, Jaume; Nascimento, Andres; Kalko, Susana G.; Jimenez-Mallebrera, Cecilia			Transcriptome Analysis of Ullrich Congenital Muscular Dystrophy Fibroblasts Reveals a Disease Extracellular Matrix Signature and Key Molecular Regulators	PLOS ONE			English	Article							ASCORBIC-ACID TREATMENT; COLLAGEN-VI DEFICIENCY; TENASCIN-X; VITAMIN-C; EXPRESSION; MUSCLE; SKIN; INTEGRIN; MYOPATHIES; GENES	Background Collagen VI related myopathies encompass a range of phenotypes with involvement of skeletal muscle, skin and other connective tissues. They represent a severe and relatively common form of congenital disease for which there is no treatment. Collagen VI in skeletal muscle and skin is produced by fibroblasts. Aims & Methods In order to gain insight into the consequences of collagen VI mutations and identify key disease pathways we performed global gene expression analysis of dermal fibroblasts from patients with Ullrich Congenital Muscular Dystrophy with and without vitamin C treatment. The expression data were integrated using a range of systems biology tools. Results were validated by real-time PCR, western blotting and functional assays. Findings We found significant changes in the expression levels of almost 600 genes between collagen VI deficient and control fibroblasts. Highly regulated genes included extracellular matrix components and surface receptors, including integrins, indicating a shift in the interaction between the cell and its environment. This was accompanied by a significant increase in fibroblasts adhesion to laminin. The observed changes in gene expression profiling may be under the control of two miRNAs, miR-30c and miR-181a, which we found elevated in tissue and serum from patients and which could represent novel biomarkers for muscular dystrophy. Finally, the response to vitamin C of collagen VI mutated fibroblasts significantly differed from healthy fibroblasts. Vitamin C treatment was able to revert the expression of some key genes to levels found in control cells raising the possibility of a beneficial effect of vitamin C as a modulator of some of the pathological aspects of collagen VI related diseases.	[Paco, Sonia; Angels Rodriguez, Maria; Puigdelloses, Montserrat; Ortez, Carlos I.; Colomer, Jaume; Nascimento, Andres; Jimenez-Mallebrera, Cecilia] Fdn St Joan de Deu, Hosp St Joan de Deu, Neuropaediat Dept, Neuromuscular Unit, Barcelona, Spain; [Casserras, Teresa; Kalko, Susana G.] Hosp Clin Barcelona, Bioinformat Core Facil, IDIBAPS, Barcelona, Spain; [Jou, Cristina] Hosp St Joan de Deu, Dept Pathol, Barcelona, Spain; [Diaz-Manera, Jordi; Gallardo, Eduardo] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Neurol, Neuromuscular Dis Unit, E-08193 Barcelona, Spain; [Nascimento, Andres; Jimenez-Mallebrera, Cecilia] Inst Salud Carlos III, Ctr Biomed Res Rare Dis CIBERER, Madrid, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Jimenez-Mallebrera, C (corresponding author), Fdn St Joan de Deu, Hosp St Joan de Deu, Neuropaediat Dept, Neuromuscular Unit, Barcelona, Spain.	cjimenezm@hsjdbcn.org	Jiménez-Mallebrera, Cecilia/F-5030-2016	Jiménez-Mallebrera, Cecilia/0000-0001-8203-7103; Gallardo, Eduard/0000-0002-3942-3436; Diaz-Manera, Jordi/0000-0003-2941-7988; Kalko, Susana/0000-0002-6701-0233; Ortez Gonzalez, Carlos Ignacio/0000-0001-8187-8103; Puigdelloses, Montserrat/0000-0001-6011-1755	Plan Nacional de I+D+I and Instituto de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la Investigacion Sanitaria [PI10/00177, PI13/00837, PI15/01822]; European Regional Development Fund (FEDER); Hospital Sant Joan de Deu Reserch Grants; Instituto de Salud Carlos III grant [CP09/00011]	Plan Nacional de I+D+I and Instituto de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la Investigacion Sanitaria; European Regional Development Fund (FEDER)(European Commission); Hospital Sant Joan de Deu Reserch Grants; Instituto de Salud Carlos III grant(Instituto de Salud Carlos III)	This work was funded by the "Plan Nacional de I+D+I and Instituto de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la Investigacion Sanitaria, http://www.isciii.es/", projects PI10/00177 (CJM), and PI13/00837 (CJM) and PI15/01822 (JDM), and the European Regional Development Fund (FEDER) (CJM). MAR is sponsored by the Hospital Sant Joan de Deu Reserch Grants. CJM is funded by the Instituto de Salud Carlos III grant CP09/00011.	Abonnenc M, 2013, CIRC RES, V113, P1138, DOI 10.1161/CIRCRESAHA.113.302400; Accorsi Anthony, 2015, J Neuromuscul Dis, V2, P51; Alexander Matthew S, 2015, J Neuromuscul Dis, V2, P1; Allamand V, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-30; Atkinson JC, 1996, EXP CELL RES, V228, P283, DOI 10.1006/excr.1996.0328; Bonnemann CG, 2011, NAT REV NEUROL, V7, P379, DOI 10.1038/nrneurol.2011.81; Borza CM, 2006, J BIOL CHEM, V281, P20932, DOI 10.1074/jbc.M601147200; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Burg MA, 1996, J BIOL CHEM, V271, P26110, DOI 10.1074/jbc.271.42.26110; Collins J, 2010, CURR NEUROL NEUROSCI, V10, P83, DOI 10.1007/s11910-010-0092-8; Duarte TL, 2009, FREE RADICAL BIO MED, V46, P78, DOI 10.1016/j.freeradbiomed.2008.09.028; Eisenberg I, 2009, J CELL MOL MED, V13, P2, DOI 10.1111/j.1582-4934.2008.00524.x; Ferreira LM, 2009, AN ACAD BRAS CIENC, V81, P623, DOI 10.1590/S0001-37652009000300024; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Higashi K, 2006, MUSCLE NERVE, V33, P120, DOI 10.1002/mus.20449; Hodges BL, 1997, J CELL SCI, V110, P2873; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jimenez-Mallebrera C, 2006, NEUROMUSCULAR DISORD, V16, P571, DOI 10.1016/j.nmd.2006.07.015; Juneja SC, 2013, ARTHRITIS, DOI 10.1155/2013/154812; Kawahara G, 2007, NEUROLOGY, V69, P1043, DOI 10.1212/01.wnl.0000271386.89878.22; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kirschner J, 2005, AM J MED GENET A, V132A, P296, DOI 10.1002/ajmg.a.30443; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; Lettmann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105686; Lewis RA, 2013, JAMA NEUROL, V70, P981, DOI 10.1001/jamaneurol.2013.3178; Lowell CA, 2011, METHODS MOL BIOL, V757, P369, DOI 10.1007/978-1-61779-166-6_22; MacDonald EM, 2012, CURR OPIN RHEUMATOL, V24, P628, DOI 10.1097/BOR.0b013e328358df34; Minamitani T, 2004, EXP CELL RES, V298, P305, DOI 10.1016/j.yexcr.2004.04.030; Minamitani T, 2004, EXP CELL RES, V297, P49, DOI 10.1016/j.yexcr.2004.03.002; OONO T, 1993, J INVEST DERMATOL, V100, P329, DOI 10.1111/1523-1747.ep12470022; Paco S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077430; Paco S, 2012, J NEUROPATH EXP NEUR, V71, P894, DOI 10.1097/NEN.0b013e31826c6f7b; Pan TC, 2013, J BIOL CHEM, V288, P14320, DOI 10.1074/jbc.M112.433078; Park HJ, 2010, EXP DERMATOL, V19, pE258, DOI 10.1111/j.1600-0625.2010.01070.x; Park NY, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-80; Passage E, 2004, NAT MED, V10, P396, DOI 10.1038/nm1023; PELTONEN J, 1990, ARTHRITIS RHEUM-US, V33, P1829, DOI 10.1002/art.1780331211; PFAFF M, 1993, EXP CELL RES, V206, P167, DOI 10.1006/excr.1993.1134; Ruhl M, 1999, J BIOL CHEM, V274, P34361, DOI 10.1074/jbc.274.48.34361; Sabatelli P, 2001, MATRIX BIOL, V20, P475, DOI 10.1016/S0945-053X(01)00160-3; Sarkar P, 2012, MOL CELL PROTEOMICS, V11, P1829, DOI 10.1074/mcp.M112.020503; Schmidt S, 2010, CELL TISSUE RES, V339, P83, DOI 10.1007/s00441-009-0892-9; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sinno Hani, 2013, Plast Surg Int, V2013, P146764, DOI 10.1155/2013/146764; Smith AN, 2010, EXP CELL RES, V316, P48, DOI 10.1016/j.yexcr.2009.08.001; Taylor CJ, 2012, EXP DIABETES RES, DOI 10.1155/2012/168368; Valero T, 2014, CURR PHARM DESIGN, V20, P5507, DOI 10.2174/138161282035140911142118; Villoslada P, 2009, ANN NEUROL, V65, P124, DOI 10.1002/ana.21634; Zaharieva IT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080263	50	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145107	10.1371/journal.pone.0145107	http://dx.doi.org/10.1371/journal.pone.0145107			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670220	gold, Green Submitted, Green Published			2022-12-27	WOS:000366719300049
J	Rikiishi, K; Matsuura, T; Ikeda, Y; Maekawa, M				Rikiishi, Kazuhide; Matsuura, Takakazu; Ikeda, Yoko; Maekawa, Masahiko			Light Inhibition of Shoot Regeneration Is Regulated by Endogenous Abscisic Acid Level in Calli Derived from Immature Barley Embryos	PLOS ONE			English	Article							TISSUE-CULTURE TRAITS; SOMATIC EMBRYOGENESIS; PLANT-REGENERATION; GENETIC-TRANSFORMATION; ANTHER CULTURE; HORMONE-LEVELS; LEAF EXPLANTS; SATIVA L.; ARABIDOPSIS; RICE	Shoot regeneration in calli derived from immature barley embryos is regulated by light conditions during the callus-induction period. Barley cultivars Kanto Nijo-5 (KN5) and K-3 (K3) showed lower efficiency of shoot regeneration in a 16-h photoperiod during callus-induction than those in continuous darkness, whereas shoot regeneration was enhanced in cultures under a 16-h photoperiod in Golden Promise (GP) and Lenins (LN). These cultivars were classified as photo-inhibition type (KN5 and K3) or photo-induction type (GP and LN) according to their response to light. Contents of endogenous plant hormones were determined in calli cultured under a 16-h photoperiod and continuous darkness. In photo-inhibition type, higher accumulation of abscisic acid (ABA) was detected in calli cultured under a 16-h photoperiod, whereas calli showed lower levels of endogenous ABA in continuous darkness. However, cultivars of photo-induction type showed lower levels of ABA in calli cultured under both light conditions, similarly to photo-inhibition type in continuous darkness. Exogenous ABA inhibited the callus growth and shoot regeneration independent of light conditions in all cultivars. In photo-inhibition type, lower levels of endogenous ABA induced by ABA biosynthesis inhibitor, fluridone, reduced the photo-inhibition of shoot regeneration. Expression of ABA biosynthesis gene, HvNCED1, in calli was regulated by the light conditions. Higher expression was observed in calli cultured under a 16-h photoperiod. These results indicate that ABA biosynthesis could be activated through the higher expression of HvNCED1 in a 16-h photoperiod and that the higher accumulations of ABA inhibit shoot regeneration in the photo-inhibition type cultivars.	[Rikiishi, Kazuhide; Matsuura, Takakazu; Ikeda, Yoko; Maekawa, Masahiko] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan	Okayama University	Rikiishi, K (corresponding author), Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan.	riki@rib.okayama-u.ac.jp		Ikeda, Yoko/0000-0002-3150-8902	Ohara Foundation for Agricultural Research	Ohara Foundation for Agricultural Research	This work was supported by a grant from the Ohara Foundation for Agricultural Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARCELO P, 1994, PLANT J, V5, P583, DOI 10.1046/j.1365-313X.1994.5040583.x; Ben AIM, 1997, THEOR APPL GENET, V94, P1047; Berrios EF, 2000, THEOR APPL GENET, V101, P1299, DOI 10.1007/s001220051610; BROWN C, 1989, J PLANT PHYSIOL, V133, P727, DOI 10.1016/S0176-1617(89)80080-X; CARMAN JG, 1988, PLANTA, V175, P417, DOI 10.1007/BF00396349; Cary AJ, 2002, PLANT J, V32, P867, DOI 10.1046/j.1365-313X.2002.01479.x; Charriere F, 1998, PLANT SCI, V137, P63, DOI 10.1016/S0168-9452(98)00128-9; Che P, 2002, PLANT CELL, V14, P2771, DOI 10.1105/tpc.006668; Che P, 2007, PLANTA, V226, P1183, DOI 10.1007/s00425-007-0565-4; Che P, 2006, PLANT PHYSIOL, V141, P620, DOI 10.1104/pp.106.081240; ETIENNE H, 1993, PLANT SCI, V88, P91, DOI 10.1016/0168-9452(93)90113-E; Fernando SC, 2000, PLANT SCI, V151, P193, DOI 10.1016/S0168-9452(99)00218-6; Finkelstein Ruth R., 2002, Plant Cell, V14, pS15; Goggin DE, 2015, ANN BOT-LONDON, V115, P293, DOI 10.1093/aob/mcu231; Guzman M, 2000, PLANT SCI, V151, P107, DOI 10.1016/S0168-9452(99)00204-6; Han SY, 2004, BIOORG MED CHEM LETT, V14, P3033, DOI 10.1016/j.bmcl.2004.04.035; Hiei Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00628; Himmelbach A, 2003, CURR OPIN PLANT BIOL, V6, P470, DOI 10.1016/S1369-5266(03)00090-6; Hoang TG, 2012, RUSS J PLANT PHYSL+, V59, P406, DOI 10.1134/S1021443712030089; Hoekstra S, 1997, PLANT SCI, V126, P211, DOI 10.1016/S0168-9452(97)00096-4; Holme IB, 2004, THEOR APPL GENET, V108, P1513, DOI 10.1007/s00122-003-1570-z; Huang WL, 2012, PLANT CELL TISS ORG, V108, P257, DOI 10.1007/s11240-011-0038-0; INOUE M, 1981, JPN J CROP SCI, V50, P318, DOI 10.1626/jcs.50.318; IVANOVA A, 1994, PHYSIOL PLANTARUM, V92, P85, DOI 10.1111/j.1399-3054.1994.tb06658.x; Jimenez VM, 2001, PHYSIOL PLANTARUM, V111, P389, DOI 10.1034/j.1399-3054.2001.1110317.x; Jimenez VM, 2001, PLANT SCI, V160, P247, DOI 10.1016/S0168-9452(00)00382-4; Kamal GB, 2007, AFR J BIOTECHNOL, V6, P861; KOORNEEF M, 1993, PLANT J, V3, P131, DOI 10.1111/j.1365-313X.1993.tb00016.x; KRAEPIEL Y, 1995, PLANTA, V197, P142, DOI 10.1007/BF00239950; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Kwon YS, 2001, MOL CELLS, V11, P64; Lema-Ruminska J, 2013, SCI WORLD J, DOI 10.1155/2013/513985; MAGGON R, 1995, SCI HORTIC-AMSTERDAM, V63, P123, DOI 10.1016/0304-4238(95)00780-W; Mano Y, 2002, THEOR APPL GENET, V105, P708, DOI 10.1007/s00122-002-0992-3; Mano Y, 1996, BREEDING SCI, V46, P137; Millar AA, 2006, PLANT J, V45, P942, DOI 10.1111/j.1365-313X.2006.02659.x; Motte H, 2014, P NATL ACAD SCI USA, V111, P8305, DOI 10.1073/pnas.1404978111; Nakagawa H, 2001, SCI HORTIC-AMSTERDAM, V90, P85, DOI 10.1016/S0304-4238(00)00259-4; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Nambara E, 2003, TRENDS PLANT SCI, V8, P213, DOI 10.1016/S1360-1385(03)00060-8; Nishimura A, 2005, P NATL ACAD SCI USA, V102, P11940, DOI 10.1073/pnas.0504220102; Obert B, 2008, BIOTECHNOL LETT, V30, P945, DOI 10.1007/s10529-007-9618-9; Oritani T, 2003, NAT PROD REP, V20, P414, DOI 10.1039/b109859b; Perez-Jimenez M, 2014, J PLANT PHYSIOL, V171, P619, DOI 10.1016/j.jplph.2014.01.006; Popova LP, 1998, PLANT PHYSIOL BIOCH, V36, P313, DOI 10.1016/S0981-9428(98)80045-4; QURESHI JA, 1989, PLANT CELL TISS ORG, V18, P55, DOI 10.1007/BF00033465; RAJASEKARAN K, 1987, PLANT PHYSIOL, V84, P47, DOI 10.1104/pp.84.1.47; Rikiishi K, 2003, PLANT BREEDING, V122, P99, DOI 10.1046/j.1439-0523.2003.00822.x; Rikiishi K, 2003, PLANT BREEDING, V122, P105, DOI 10.1046/j.1439-0523.2003.00823.x; Rikiishi K, 2008, BREEDING SCI, V58, P129, DOI 10.1270/jsbbs.58.129; Rikiishi K, 2010, J CEREAL SCI, V51, P292, DOI 10.1016/j.jcs.2010.01.003; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; TaguchiShiobara F, 1997, THEOR APPL GENET, V95, P828, DOI 10.1007/s001220050632; Takeuchi Y, 2000, CROP SCI, V40, P245, DOI 10.2135/cropsci2000.401245x; Thompson AJ, 2000, PLANT MOL BIOL, V42, P833, DOI 10.1023/A:1006448428401; Tingay S, 1997, PLANT J, V11, P1369, DOI 10.1046/j.1365-313X.1997.11061369.x; TORRIZO LB, 1986, PLANT CELL REP, V5, P136, DOI 10.1007/BF00269253; Trujillo-Moya C, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-140; Tsukahara K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123308; Tuan PA, 2013, FOOD CHEM, V141, P3803, DOI 10.1016/j.foodchem.2013.06.085; Tyagi N, 2010, CROP SCI, V50, P1697, DOI 10.2135/cropsci2009.10.0624; van Bergen S, 1999, J PLANT GROWTH REGUL, V18, P135, DOI 10.1007/PL00007061; WAN YC, 1994, PLANT PHYSIOL, V104, P37, DOI 10.1104/pp.104.1.37; Wu SH, 2014, ANNU REV PLANT BIOL, V65, P311, DOI 10.1146/annurev-arplant-050213-040337; Zhang S, 1999, PLANT CELL REP, V18, P959, DOI 10.1007/s002990050691; Zhang SG, 2010, BIOCHEM BIOPH RES CO, V398, P355, DOI 10.1016/j.bbrc.2010.06.056	66	5	5	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145242	10.1371/journal.pone.0145242	http://dx.doi.org/10.1371/journal.pone.0145242			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670930	Green Submitted, gold, Green Published			2022-12-27	WOS:000366719300055
J	Sistrom, M; Park, D; O'Brien, HE; Wang, Z; Guttman, DS; Townsend, JP; Turner, PE				Sistrom, Mark; Park, Derek; O'Brien, Heath E.; Wang, Zheng; Guttman, David S.; Townsend, Jeffrey P.; Turner, Paul E.			Genomic and Gene-Expression Comparisons among Phage-Resistant Type-IV Pilus Mutants of Pseudomonas syringae pathovar phaseolicola	PLOS ONE			English	Article							PV. TABACI 6605; VIRULENCE; SEQUENCE; BACTERIOPHAGE-PHI-6; PATHOGENICITY; REASSORTMENT; EVOLUTION; MOTILITY; REVEALS; 1448A	Pseudomonas syringae pv. phaseolicola (Pph) is a significant bacterial pathogen of agricultural crops, and phage Phi 6 and other members of the dsRNA virus family Cystoviridae undergo lytic (virulent) infection of Pph, using the type IV pilus as the initial site of cellular attachment. Despite the popularity of Pph/phage Phi 6 as a model system in evolutionary biology, Pph resistance to phage Phi 6 remains poorly characterized. To investigate differences between phage Phi 6 resistant Pph strains, we examined genomic and gene expression variation among three bacterial genotypes that differ in the number of type IV pili expressed per cell: ordinary (wild-type), non-piliated, and super-piliated. Genome sequencing of non-piliated and super-piliated Pph identified few mutations that separate these genotypes from wild type Pph- and none present in genes known to be directly involved in type IV pilus expression. Expression analysis revealed that 81.1% of gene ontology (GO) terms up-regulated in the non-piliated strain were down-regulated in the super-piliated strain. This differential expression is particularly prevalent in genes associated with respiration-specifically genes in the tricarboxylic acid cycle (TCA) cycle, aerobic respiration, and acetyl-CoA metabolism. The expression patterns of the TCA pathway appear to be generally up and down-regulated, in non-piliated and super-piliated Pph respectively. As pilus retraction is mediated by an ATP motor, loss of retraction ability might lead to a lower energy draw on the bacterial cell, leading to a different energy balance than wild type. The lower metabolic rate of the super-piliated strain is potentially a result of its loss of ability to retract.	[Sistrom, Mark] Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA; [Park, Derek; Wang, Zheng; Townsend, Jeffrey P.; Turner, Paul E.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [O'Brien, Heath E.; Guttman, David S.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3B2, Canada; [Guttman, David S.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON M5S 3B2, Canada; [Townsend, Jeffrey P.] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT 06520 USA; [Townsend, Jeffrey P.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Townsend, Jeffrey P.; Turner, Paul E.] Yale Univ, Program Microbiol, New Haven, CT 06520 USA	University of California System; University of California Merced; Yale University; University of Toronto; University of Toronto; Yale University; Yale University; Yale University	Sistrom, M (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA.	msistrom@ucmerced.edu	Townsend, Jeffrey/H-2747-2019; Guttman, David S/A-7839-2011	Townsend, Jeffrey/0000-0002-9890-3907; Guttman, David S/0000-0001-8479-3869	U.S. National Science Foundation [1021243]; Beckman Scholars Program from the Arnold and Mabel Beckman Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Beckman Scholars Program from the Arnold and Mabel Beckman Foundation	Grant #1021243 was awarded to P.E.T. from the U.S. National Science Foundation and the Beckman Scholars Program was awarded to D.S.P. from the Arnold and Mabel Beckman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomas AB, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-477; Arnold DL, 2011, MOL PLANT PATHOL, V12, P617, DOI [10.1111/j.1364-3703.2010.00697.x, 10.1111/J.1364-3703.2010.00697.X]; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; BAMFORD DH, 1987, EMBO J, V6, P1467, DOI 10.1002/j.1460-2075.1987.tb02388.x; BAMFORD DH, 1976, J GEN VIROL, V32, P249, DOI 10.1099/0022-1317-32-2-249; Burdman S, 2011, GENES-BASEL, V2, P706, DOI 10.3390/genes2040706; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Culley AI, 2006, SCIENCE, V312, P1795, DOI 10.1126/science.1127404; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Davidsen T, 2010, NUCLEIC ACIDS RES, V38, pD340, DOI 10.1093/nar/gkp912; Dennehy JJ, 2007, EVOLUTION, V61, P2516, DOI 10.1111/j.1558-5646.2007.00205.x; Dennehy JJ, 2007, ECOL LETT, V10, P230, DOI 10.1111/j.1461-0248.2006.01013.x; Dennehy JJ, 2009, TRENDS MICROBIOL, V17, P450, DOI 10.1016/j.tim.2009.07.006; Dessau M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003102; Diaz-Munoz SL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-206; Duffy S, 2006, GENETICS, V172, P751, DOI 10.1534/genetics.105.051136; Goldhill DH, 2014, CURR OPIN VIROL, V8, P79, DOI 10.1016/j.coviro.2014.07.005; GOTTLIEB P, 1988, VIROLOGY, V163, P183, DOI 10.1016/0042-6822(88)90245-0; Helaine S, 2007, P NATL ACAD SCI USA, V104, P15888, DOI 10.1073/pnas.0707581104; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; Huerta AM, 1998, NUCLEIC ACIDS RES, V26, P55, DOI 10.1093/nar/26.1.55; Jackson RW, 1999, P NATL ACAD SCI USA, V96, P10875, DOI 10.1073/pnas.96.19.10875; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; JOHNSON K, 1987, J BACTERIOL, V169, P5663, DOI 10.1128/jb.169.12.5663-5667.1987; Lee CC, 2004, STRUCTURE, V12, P487, DOI 10.1016/j.str.2004.02.013; Nguyen LC, 2012, MOL PLANT PATHOL, V13, P764, DOI 10.1111/j.1364-3703.2012.00789.x; Lythgoe KA, 2003, ECOL LETT, V6, P326, DOI 10.1046/j.1461-0248.2003.00433.x; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Mindich L, 1999, J BACTERIOL, V181, P4505, DOI 10.1128/JB.181.15.4505-4508.1999; Mindich L., 2006, BACTERIOPHAGES; Montville R, 2005, PLOS BIOL, V3, P1939, DOI 10.1371/journal.pbio.0030381; O'Brien HE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027199; O'Keefe KJ, 2010, EVOLUTION, V64, P3010, DOI 10.1111/j.1558-5646.2010.01040.x; PICKEN RN, 1977, J GEN MICROBIOL, V102, P305, DOI 10.1099/00221287-102-2-305; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Roine E, 1998, MOL PLANT MICROBE IN, V11, P1048, DOI 10.1094/MPMI.1998.11.11.1048; Roine E, 1996, J BACTERIOL, V178, P410, DOI 10.1128/jb.178.2.410-417.1996; ROMANTSCHUK M, 1993, J GEN MICROBIOL, V139, P2251, DOI 10.1099/00221287-139-9-2251; ROMANTSCHUK M, 1986, MICROB PATHOGENESIS, V1, P139, DOI 10.1016/0882-4010(86)90016-1; ROMANTSCHUK M, 1985, J GEN VIROL, V66, P2461, DOI 10.1099/0022-1317-66-11-2461; Silander OK, 2005, P NATL ACAD SCI USA, V102, P19009, DOI 10.1073/pnas.0503074102; Sundin GW, 2000, APPL ENVIRON MICROB, V66, P5167, DOI 10.1128/AEM.66.12.5167-5173.2000; Taguchi F, 2011, MOL PLANT MICROBE IN, V24, P1001, DOI 10.1094/MPMI-02-11-0026; Townsend JP, 2002, GENOME BIOL, V3; Townsend JP, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-54; Turner PE, 1999, NATURE, V398, P441, DOI 10.1038/18913; Wasik BR, 2013, ANNU REV MICROBIOL, V67, P519, DOI 10.1146/annurev-micro-090110-102833; Zumaquero A, 2010, J BACTERIOL, V192, P4474, DOI 10.1128/JB.00260-10	48	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144514	10.1371/journal.pone.0144514	http://dx.doi.org/10.1371/journal.pone.0144514			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670219	Green Submitted, gold, Green Published			2022-12-27	WOS:000366719300009
J	Aguirre, P; Mena, NP; Carrasco, CM; Munoz, Y; Perez-Henriquez, P; Morales, RA; Cassels, BK; Mendez-Galvez, C; Garcia-Beltran, O; Gonzalez-Billault, C; Nunez, MT				Aguirre, Pabla; Mena, Natalia P.; Carrasco, Carlos M.; Munoz, Yorka; Perez-Henriquez, Patricio; Morales, Rodrigo A.; Cassels, Bruce K.; Mendez-Galvez, Carolina; Garcia-Beltran, Olimpo; Gonzalez-Billault, Christian; Nunez, Marco T.			Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP plus /MPTP-Lesioned Dopaminergic Neurons	PLOS ONE			English	Article							SUBSTANTIA-NIGRA; INDUCED APOPTOSIS; DENDRITIC TREE; NEURODEGENERATION; EXPRESSION; DEGENERATION; DISEASE; PROTEIN; MODELS; RESTORATION	Neuronal death in Parkinson's disease (PD) is often preceded by axodendritic tree retraction and loss of neuronal functionality. The presence of non-functional but live neurons opens therapeutic possibilities to recover functionality before clinical symptoms develop. Considering that iron accumulation and oxidative damage are conditions commonly found in PD, we tested the possible neuritogenic effects of iron chelators and antioxidant agents. We used three commercial chelators: DFO, deferiprone and 2.2'-dypyridyl, and three 8-hydroxyquinoline-based iron chelators: M30, 7MH and 7DH, and we evaluated their effects in vitro using a mesencephalic cell culture treated with the Parkinsonian toxin MPP+ and in vivo using the MPTP mouse model. All chelators tested promoted the emergence of new tyrosine hydroxylase (TH)-positive processes, increased axodendritic tree length and protected cells against lipoperoxidation. Chelator treatment resulted in the generation of processes containing the presynaptic marker synaptophysin. The antioxidants N-acetylcysteine and dymetylthiourea also enhanced axodendritic tree recovery in vitro, an indication that reducing oxidative tone fosters neuritogenesis in MPP+-damaged neurons. Oral administration to mice of the M30 chelator for 14 days after MPTP treatment resulted in increased TH- and GIRK2-positive nigra cells and nigrostriatal fibers. Our results support a role for oral iron chelators as good candidates for the early treatment of PD, at stages of the disease where there is axodendritic tree retraction without neuronal death.	[Aguirre, Pabla; Mena, Natalia P.; Carrasco, Carlos M.; Munoz, Yorka; Perez-Henriquez, Patricio; Morales, Rodrigo A.; Nunez, Marco T.] Univ Chile, Fac Sci, Dept Biol, Iron & Biol Aging Lab, Santiago, Chile; [Aguirre, Pabla; Carrasco, Carlos M.; Munoz, Yorka; Gonzalez-Billault, Christian; Nunez, Marco T.] Res Ring Oxidat Stress Nervous Syst, Santiago, Chile; [Cassels, Bruce K.; Mendez-Galvez, Carolina; Garcia-Beltran, Olimpo] Univ Chile, Fac Sci, Dept Chem, Chemobiodynam Lab, Santiago, Chile; [Garcia-Beltran, Olimpo] Univ Ibague, Fac Ciencias Nat & Matemat, Ibague, Colombia; [Gonzalez-Billault, Christian] Univ Chile, Fac Sci, Dept Biol, Neuronal & Cellular Dynam Lab, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile	Nunez, MT (corresponding author), Univ Chile, Fac Sci, Dept Biol, Iron & Biol Aging Lab, Santiago, Chile.	mnunez@uchile.cl	García-Beltrán, Olimpo/O-1846-2017; Morales, Rodrigo A/H-2096-2017	García-Beltrán, Olimpo/0000-0003-3312-1776; Morales, Rodrigo A/0000-0003-4382-5777; Mendez-Galvez, Carolina/0000-0001-7977-9595	National Fund for Scientific and Technological Research of Chile, FONDECYT grant [1030068]; Program of Associative Research [ACT1114]	National Fund for Scientific and Technological Research of Chile, FONDECYT grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Program of Associative Research	This work was financed with funds from the National Fund for Scientific and Technological Research of Chile, FONDECYT grant 1030068 (http://www.conicyt.cl/fondecyt) and grant ACT1114 from the Program of Associative Research (http://www.conicyt.cl/pia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen HH, 2014, CELL MOL LIFE SCI, V71, P1607, DOI 10.1007/s00018-013-1509-8; Baloyannis SJ, 2006, J NEUROL SCI, V248, P35, DOI 10.1016/j.jns.2006.05.006; Beurrier C, 2006, NEUROSCIENCE, V140, P77, DOI 10.1016/j.neuroscience.2006.02.029; Bowenkamp KE, 1996, EXP BRAIN RES, V111, P1; BROUARD A, 1992, J NEUROSCI, V12, P1409; Bush AI, 2008, NEUROTHERAPEUTICS, V5, P421, DOI 10.1016/j.nurt.2008.05.001; Capetillo-Zarate E, 2006, BRAIN, V129, P2992, DOI 10.1093/brain/awl176; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chen T, 2013, CELL SIGNAL, V25, P2863, DOI 10.1016/j.cellsig.2013.09.004; Cobb CA, 2015, NEUROBIOL DIS, V84, P4, DOI 10.1016/j.nbd.2015.04.020; Crichton RR, 2011, J NEURAL TRANSM, V118, P301, DOI 10.1007/s00702-010-0470-z; Devos D, 2014, ANTIOXID REDOX SIGN, V21, P195, DOI 10.1089/ars.2013.5593; Fall CP, 1999, J NEUROSCI RES, V55, P620, DOI 10.1002/(SICI)1097-4547(19990301)55:5<620::AID-JNR9>3.0.CO;2-S; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Gal S, 2010, NEUROTOX RES, V17, P15, DOI 10.1007/s12640-009-9070-9; GERLACH M, 1994, J NEUROCHEM, V63, P793, DOI 10.1046/j.1471-4159.1994.63030793.x; Gomez FJ, 2011, J NEURAL TRANSM, V118, P421, DOI 10.1007/s00702-010-0489-1; Gulledge AT, 2005, J NEUROBIOL, V64, P75, DOI 10.1002/neu.20144; Hamrick SEG, 2005, NEUROSCI LETT, V379, P96, DOI 10.1016/j.neulet.2004.12.080; Hung HC, 1996, MOL BRAIN RES, V41, P16, DOI 10.1016/0169-328X(96)00062-9; HURN PD, 1995, STROKE, V26, P688, DOI 10.1161/01.STR.26.4.688; Kruer MC, 2013, INT REV NEUROBIOL, V110, P165, DOI 10.1016/B978-0-12-410502-7.00009-0; Kulkarni VA, 2012, MOL CELL NEUROSCI, V50, P10, DOI 10.1016/j.mcn.2012.03.005; Kupershmidt L, 2011, NEUROSCIENCE, V189, P345, DOI 10.1016/j.neuroscience.2011.03.040; Kupershmidt L, 2009, FASEB J, V23, P3766, DOI 10.1096/fj.09-130047; Kurian MA, 2013, INT REV NEUROBIOL, V110, P49, DOI 10.1016/B978-0-12-410502-7.00003-X; Levites Y, 2001, J NEUROCHEM, V78, P1073, DOI 10.1046/j.1471-4159.2001.00490.x; MCNEILL TH, 1988, BRAIN RES, V455, P148, DOI 10.1016/0006-8993(88)90124-2; Munoz P, 2011, J BIOL CHEM, V286, P13382, DOI 10.1074/jbc.M110.213785; OESTREICHER E, 1994, BRAIN RES, V660, P8, DOI 10.1016/0006-8993(94)90833-8; Oshiro S, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/378278; Polanski W, 2010, J NEUROCHEM, V113, P1659, DOI 10.1111/j.1471-4159.2010.06725.x; Reyes S, 2012, J COMP NEUROL, V520, P2591, DOI 10.1002/cne.23051; Rothblat DS, 2001, J NEUROSCI RES, V65, P254, DOI 10.1002/jnr.1149; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; SanMartin CD, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00013; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Solis O, 2007, SYNAPSE, V61, P450, DOI 10.1002/syn.20381; Stephens B, 2005, NEUROSCIENCE, V132, P741, DOI 10.1016/j.neuroscience.2005.01.007; Tardiff DF, 2012, J BIOL CHEM, V287, P4107, DOI 10.1074/jbc.M111.308668; TEMLETT JA, 1994, J NEUROCHEM, V62, P134; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; Vetter P, 2001, J NEUROPHYSIOL, V85, P926, DOI 10.1152/jn.2001.85.2.926; Ward RJ, 2012, CURR MED CHEM, V19, P2760; Weinreb O, 2013, FREE RADICAL BIO MED, V62, P52, DOI 10.1016/j.freeradbiomed.2013.01.017; Xu Z, 2005, SYNAPSE, V55, P45, DOI 10.1002/syn.20089; Zaja-Milatovic S, 2006, NEUROLOGY, V66, P1591, DOI 10.1212/01.wnl.0000216137.09685.c1; Zaman K, 1999, J NEUROSCI, V19, P9821; Zhang CY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-15-j0002.2001; Zhu W, 2007, FASEB J, V21, P3835, DOI 10.1096/fj.07-8386com	50	16	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144848	10.1371/journal.pone.0144848	http://dx.doi.org/10.1371/journal.pone.0144848			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658949	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900118
J	Bennett, MR; Farnell, L; Gibson, WG; Lagopoulos, J				Bennett, Maxwell R.; Farnell, Les; Gibson, William G.; Lagopoulos, Jim			Cortical Network Models of Firing Rates in the Resting and Active States Predict BOLD Responses	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; PROPOFOL-INDUCED LOSS; EYE-MOVEMENT SLEEP; FUNCTIONAL CONNECTIVITY; VISUAL-CORTEX; PYRAMIDAL NEURONS; BRAIN ACTIVITY; BALLOON MODEL; BLOOD-FLOW; FMRI	Measurements of blood oxygenation level dependent (BOLD) signals have produced some surprising observations. One is that their amplitude is proportional to the entire activity in a region of interest and not just the fluctuations in this activity. Another is that during sleep and anesthesia the average BOLD correlations between regions of interest decline as the activity declines. Mechanistic explanations of these phenomena are described here using a cortical network model consisting of modules with excitatory and inhibitory neurons, taken as regions of cortical interest, each receiving excitatory inputs from outside the network, taken as subcortical driving inputs in addition to extrinsic (intermodular) connections, such as provided by associational fibers. The model shows that the standard deviation of the firing rate is proportional to the mean frequency of the firing when the extrinsic connections are decreased, so that the mean BOLD signal is proportional to both as is observed experimentally. The model also shows that if these extrinsic connections are decreased or the frequency of firing reaching the network from the subcortical driving inputs is decreased, or both decline, there is a decrease in the mean firing rate in the modules accompanied by decreases in the mean BOLD correlations between the modules, consistent with the observed changes during NREM sleep and under anesthesia. Finally, the model explains why a transient increase in the BOLD signal in a cortical area, due to a transient subcortical input, gives rises to responses throughout the cortex as observed, with these responses mediated by the extrinsic (intermodular) connections.	[Bennett, Maxwell R.; Lagopoulos, Jim] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Bennett, Maxwell R.; Farnell, Les; Gibson, William G.] Univ Sydney, Ctr Math Biol, Sydney, NSW 2006, Australia; [Farnell, Les; Gibson, William G.] Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Bennett, MR (corresponding author), Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia.	maxb@medsci.usyd.edu.au						Bennett MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060518; Bennett MR, 2015, P NATL ACAD SCI USA, V112, P4134, DOI 10.1073/pnas.1411513112; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Boly M, 2012, P NATL ACAD SCI USA, V109, P5856, DOI 10.1073/pnas.1111133109; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Bowman FD, 2012, NEUROIMAGE, V62, P1769, DOI 10.1016/j.neuroimage.2012.05.032; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Cabral J, 2011, NEUROIMAGE, V57, P130, DOI 10.1016/j.neuroimage.2011.04.010; Chawla D, 1999, NEURAL COMPUT, V11, P1389, DOI 10.1162/089976699300016287; Colonnese MT, 2008, NAT NEUROSCI, V11, P72, DOI 10.1038/nn2017; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Deco G, 2014, CEREB CORTEX, V24, P3180, DOI 10.1093/cercor/bht176; Deco G, 2012, J NEUROSCI, V32, P3366, DOI 10.1523/JNEUROSCI.2523-11.2012; Eldaief MC, 2011, P NATL ACAD SCI USA, V108, P21229, DOI 10.1073/pnas.1113103109; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; Fiset P, 1999, J NEUROSCI, V19, P5506; FITZPATRICK D, 1987, J COMP NEUROL, V264, P73, DOI 10.1002/cne.902640107; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 2000, NEUROIMAGE, V12, P466, DOI 10.1006/nimg.2000.0630; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gonzalez-Castillo J, 2012, P NATL ACAD SCI USA, V109, P5487, DOI 10.1073/pnas.1121049109; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; Guldenmund P, 2013, BRAIN CONNECT, V3, P273, DOI 10.1089/brain.2012.0117; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Hyder F, 2013, P NATL ACAD SCI USA, V110, P3549, DOI 10.1073/pnas.1214912110; Hyder F, 2012, NEUROIMAGE, V62, P985, DOI 10.1016/j.neuroimage.2012.04.027; Litwin-Kumar A, 2012, NAT NEUROSCI, V15, P1498, DOI 10.1038/nn.3220; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Maandag NJG, 2007, P NATL ACAD SCI USA, V104, P20546, DOI 10.1073/pnas.0709515104; Mandeville JB, 1999, J CEREBR BLOOD F MET, V19, P679, DOI 10.1097/00004647-199906000-00012; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Massimini M, 2007, P NATL ACAD SCI USA, V104, P8496, DOI 10.1073/pnas.0702495104; McDonnell MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088254; Pan WJ, 2013, NEUROIMAGE, V74, P288, DOI 10.1016/j.neuroimage.2013.02.035; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Schlunzen L, 2012, ACTA ANAESTH SCAND, V56, P248, DOI 10.1111/j.1399-6576.2011.02561.x; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Spoormaker Victor I, 2012, Front Neurol, V3, P80, DOI 10.3389/fneur.2012.00080; Spoormaker VI, 2010, J NEUROSCI, V30, P11379, DOI 10.1523/JNEUROSCI.2015-10.2010; Tao L, 2004, P NATL ACAD SCI USA, V101, P366, DOI 10.1073/pnas.2036460100; Tao L, 2006, P NATL ACAD SCI USA, V103, P12911, DOI 10.1073/pnas.0605415103; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Tomasi D, 2013, P NATL ACAD SCI USA, V110, P13642, DOI 10.1073/pnas.1303346110; Wu CWW, 2012, BRAIN CONNECT, V2, P177, DOI 10.1089/brain.2012.0075; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	50	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144796	10.1371/journal.pone.0144796	http://dx.doi.org/10.1371/journal.pone.0144796			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659399	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900106
J	Charreton, M; Decourtye, A; Henry, M; Rodet, G; Sandoz, JC; Charnet, P; Collet, C				Charreton, Mercedes; Decourtye, Axel; Henry, Mickael; Rodet, Guy; Sandoz, Jean-Christophe; Charnet, Pierre; Collet, Claude			A Locomotor Deficit Induced by Sublethal Doses of Pyrethroid and Neonicotinoid Insecticides in the Honeybee Apis mellifera	PLOS ONE			English	Article							COLONY COLLAPSE DISORDER; SKELETAL-MUSCLE FIBERS; ANTENNAL LOBE NEURONS; BEE; ACETYLCHOLINE; PESTICIDES; RECEPTOR; TOXICITY; FIPRONIL; BEHAVIOR	The toxicity of pesticides used in agriculture towards non-targeted organisms and especially pollinators has recently drawn the attention from a broad scientific community. Increased honeybee mortality observed worldwide certainly contributes to this interest. The potential role of several neurotoxic insecticides in triggering or potentiating honeybee mortality was considered, in particular phenylpyrazoles and neonicotinoids, given that they are widely used and highly toxic for insects. Along with their ability to kill insects at lethal doses, they can compromise survival at sublethal doses by producing subtle deleterious effects. In this study, we compared the bee's locomotor ability, which is crucial for many tasks within the hive (e.g. cleaning brood cells, feeding larvae...), before and after an acute sublethal exposure to one insecticide belonging to the two insecticide classes, fipronil and thiamethoxam. Additionally, we examined the locomotor ability after exposure to pyrethroids, an older chemical insecticide class still widely used and known to be highly toxic to bees as well. Our study focused on young bees (day 1 after emergence) since (i) few studies are available on locomotion at this stage and (ii) in recent years, pesticides have been reported to accumulate in different hive matrices, where young bees undergo their early development. At sublethal doses (SLD48h, i.e. causing nomortality at 48h), three pyrethroids, namely cypermethrin (2.5 ng/bee), tetramethrin (70 ng/bee), tau-fluvalinate (33 ng/bee) and the neonicotinoid thiamethoxam (3.8 ng/bee) caused a locomotor deficit in honeybees. While the SLD48h of fipronil (a phenylpyrazole, 0.5 ng/bee) had no measurable effect on locomotion, we observed high mortality several days after exposure, an effect that was not observed with the other insecticides. Although locomotor deficits observed in the sublethal range of pyrethroids and thiamethoxam would suggest deleterious effects in the field, the case of fipronil demonstrates that toxicity evaluation requires information on multiple endpoints (e.g. long term survival) to fully address pesticides risks for honeybees. Pyrethroid-induced locomotor deficits are discussed in light of recent advances regarding their mode of action on honeybee ion channels and current structure-function studies.	[Charreton, Mercedes; Henry, Mickael; Rodet, Guy; Collet, Claude] INRA, UR Abeilles & Environm 406, F-84914 Avignon, France; [Charreton, Mercedes; Decourtye, Axel; Henry, Mickael; Rodet, Guy; Collet, Claude] UMT, Protect Abeilles Environm, F-84914 Avignon, France; [Decourtye, Axel] ITSAP Inst Abeille, F-84914 Avignon, France; [Decourtye, Axel] ACTA, F-84914 Avignon, France; [Sandoz, Jean-Christophe] Univ Paris 11, CNRS, IRD, UMR Evolut Genomes Behav & Ecol 9191, F-91198 Gif Sur Yvette, France; [Charnet, Pierre] Univ Montpellier 2, CNRS, UMR 5237, Ctr Rech Biochim Macromol, F-34293 Montpellier, France	INRAE; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Collet, C (corresponding author), INRA, UR Abeilles & Environm 406, F-84914 Avignon, France.	claude.collet@avignon.inra.fr	SANDOZ, Jean-Christophe/A-6085-2012	SANDOZ, Jean-Christophe/0000-0002-5423-9645; Charnet, Pierre/0000-0003-4692-528X	Agence Nationale de la Recherche [ANR-13- BSV7-0010]; European Agricultural Guarantee Fund	Agence Nationale de la Recherche(French National Research Agency (ANR)); European Agricultural Guarantee Fund	Financial support from the Agence Nationale de la Recherche (ANR Bee-channels ANR-13- BSV7-0010) was received by MC, JCS, PC, CC; and from the European Agricultural Guarantee Fund to MC, AD, CC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbara GS, 2005, J COMP PHYSIOL A, V191, P823, DOI 10.1007/s00359-005-0007-3; Barbara Guillaume Stephane, 2008, Invertebrate Neuroscience, V8, P19, DOI 10.1007/s10158-007-0062-2; Carlson F.D., 1974, MUSCLE PHYSL, VVolume 53; Cens T, 2015, INSECT BIOCHEM MOLEC, V58, P12, DOI 10.1016/j.ibmb.2015.01.005; Cens T, 2013, PFLUG ARCH EUR J PHY, V465, P985, DOI 10.1007/s00424-013-1223-2; Chauzat MP, 2007, PEST MANAG SCI, V63, P1100, DOI 10.1002/ps.1451; Chauzat MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079018; Collet C, 2007, J EXP BIOL, V210, P454, DOI 10.1242/jeb.02667; Collet C, 2009, PFLUG ARCH EUR J PHY, V458, P601, DOI 10.1007/s00424-009-0642-6; Dahlgren L, 2012, J ECON ENTOMOL, V105, P1895, DOI 10.1603/EC12175; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2011, ECOTOXICOLOGY, V20, P429, DOI 10.1007/s10646-011-0594-4; Decourtye A, 2010, ADV EXP MED BIOL, V683, P85; Deglise P, 2002, NEUROSCI LETT, V321, P13, DOI 10.1016/S0304-3940(01)02400-4; DELABIE J, 1985, PESTIC SCI, V16, P409, DOI 10.1002/ps.2780160417; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110; Eiri DM, 2012, J EXP BIOL, V215, P2022, DOI 10.1242/jeb.068718; Eisenstein M, 2015, NATURE, V521, pS52, DOI 10.1038/521S52a; El Hassani AK, 2008, ARCH ENVIRON CON TOX, V54, P653, DOI 10.1007/s00244-007-9071-8; El Hassani AK, 2005, PHARMACOL BIOCHEM BE, V82, P30, DOI 10.1016/j.pbb.2005.07.008; Gauthier M, 2010, ADV EXP MED BIOL, V683, P97; Gosselin-Badaroudine P, 2015, SCIENTIFIC REPORTS I; GU GG, 1995, J NEUROBIOL, V28, P269, DOI 10.1002/neu.480280302; Hardstone MC, 2010, PEST MANAG SCI, V66, P1171, DOI 10.1002/ps.2001; Henry M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5359; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Kadala A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112194; Kadala A, 2011, NEUROTOXICOLOGY, V32, P320, DOI 10.1016/j.neuro.2011.02.007; Kaneko H, 2011, J AGR FOOD CHEM, V59, P2786, DOI 10.1021/jf102567z; Khambay B.P., 2005, COMPREHENSIVE MOL IN, V6, P1, DOI [10.1016/B0-44-451924-6/00075-2, DOI 10.1016/B0-44-451924-6/00075-2]; Lambin M, 2001, ARCH INSECT BIOCHEM, V48, P129, DOI 10.1002/arch.1065; Maze IS, 2006, J INSECT PHYSIOL, V52, P1243, DOI 10.1016/j.jinsphys.2006.09.006; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925; OECD, 1998, OECD GUID TEST CHEM, V1, P7; OEPP/EPPO, 2010, B OEPP EPPO B, V40, P323; PAIN JANINE, 1966, ANN ABEILLE [PARIS], V9, P71, DOI 10.1051/apido:19660106; Palmer MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2648; Papaefthimiou C, 2001, PESTIC BIOCHEM PHYS, V69, P77, DOI 10.1006/pest.2000.2519; Pisa LW, 2015, ENVIRON SCI POLLUT R, V22, P68, DOI 10.1007/s11356-014-3471-x; Poquet Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113728; R Development Core Team, 2014, R LANG ENV STAT COMP; Shafer TJ, 2004, TOXICOL APPL PHARM, V196, P303, DOI 10.1016/j.taap.2003.12.013; Simon-Delso N, 2015, ENVIRON SCI POLLUT R, V22, P5, DOI 10.1007/s11356-014-3470-y; Soderlund DM, 2002, TOXICOLOGY, V171, P3, DOI 10.1016/S0300-483X(01)00569-8; Sokolowski MBC, 2012, J NEUROSCI METH, V207, P211, DOI 10.1016/j.jneumeth.2012.03.006; Teeters BS, 2012, ENVIRON TOXICOL CHEM, V31, P1349, DOI 10.1002/etc.1830; U.S. Environmental Protection Agency, 2015, ECOTOXICOLOGY DAT SY; VANDAME R, 1995, ENVIRON TOXICOL CHEM, V14, P855, DOI 10.1002/etc.5620140517; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williamson SM, 2014, ECOTOXICOLOGY, V23, P1409, DOI 10.1007/s10646-014-1283-x; Winston M.L., 1991, BIOL HONEY BEE; Zuur Alain F., 2009, P1	59	47	51	4	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144879	10.1371/journal.pone.0144879	http://dx.doi.org/10.1371/journal.pone.0144879			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659095	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900130
J	Chen, RB; Liu, JH; Xiao, Y; Zhang, F; Chen, JF; Ji, Q; Tan, HX; Huang, X; Feng, H; Huang, BK; Chen, WS; Zhang, L				Chen, Rui-Bing; Liu, Jiang-Hua; Xiao, Ying; Zhang, Feng; Chen, Jun-feng; Ji, Qian; Tan, He-Xin; Huang, Xin; Feng, Hao; Huang, Bao-Kang; Chen, Wan-Sheng; Zhang, Lei			Deep Sequencing Reveals the Effect of MeJA on Scutellarin Biosynthesis in Erigeron breviscapus	PLOS ONE			English	Article							EXPRESSION; TRANSCRIPTOME; ACCUMULATION; GENE	Background Erigeron breviscapus, a well-known traditional Chinese medicinal herb, is broadly used in the treatment of cerebrovascular disease. Scutellarin, a kind of flavonoids, is considered as the material base of the pharmaceutical activities in E. breviscapus. The stable and high content of scutellarin is critical for the quality and efficiency of E. breviscapus in the clinical use. Therefore, understanding the molecular mechanism of scutellarin biosynthesis is crucial for metabolic engineering to increase the content of the active compound. However, there is virtually no study available yet concerning the genetic research of scutellarin biosynthesis in E. breviscapus. Results Using Illumina sequencing technology, we obtained over three billion bases of high-quality sequence data and conducted de novo assembly and annotation without prior genome information. A total of 182,527 unigenes (mean length = 738 bp) were found. 63,059 unigenes were functionally annotated with a cut-off E-value of 10(-5). Next, a total of 238 (200 up-regulated and 38 down-regulated genes) and 513 (375 up-regulated and 138 down-regulated genes) differentially expressed genes were identified at different time points after methyl jasmonate (MeJA) treatment, which fell into categories of 'metabolic process' and 'cellular process' using GO database, suggesting that MeJA-induced activities of signal pathway in plant mainly led to re-programming of metabolism and cell activity. In addition, 13 predicted genes that might participate in the metabolism of flavonoids were found by two co-expression analyses in E. breviscapus. Conclusions Our study is the first to provide a transcriptome sequence resource for E. breviscapus plants after MeJA treatment and it reveals transcriptome re-programming upon elicitation. As the result, several putative unknown genes involved in the metabolism of flavonoids were predicted. These data provide a valuable resource for the genetic and genomic studies of special flavonoids metabolism and further metabolic engineering in E. breviscapus.	[Chen, Rui-Bing; Ji, Qian; Tan, He-Xin; Huang, Xin; Zhang, Lei] Second Mil Med Univ, Sch Pharm, Dept Pharmaceut Bot, Shanghai 200433, Peoples R China; [Liu, Jiang-Hua] Southwest Forestry Univ, Sch Forestry, Kunming 650224, Yunnan, Peoples R China; [Xiao, Ying; Zhang, Feng; Chen, Jun-feng; Chen, Wan-Sheng] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Pharm, Shanghai 200003, Peoples R China; [Feng, Hao] Shanghai Pharmaceut Holding Co Ltd, Business Dev & Strateg Planning Cent Res Inst, Shanghai 200021, Peoples R China; [Huang, Bao-Kang] Second Mil Med Univ, Sch Pharm, Dept Pharmacognosy, Shanghai 200433, Peoples R China	Naval Medical University; Southwest Forestry University - China; Naval Medical University; Naval Medical University	Zhang, L (corresponding author), Second Mil Med Univ, Sch Pharm, Dept Pharmaceut Bot, Shanghai 200433, Peoples R China.	zhanglei@smmu.edu.cn	Yu, Yaru/AAU-3372-2020	chen, wansheng/0000-0002-0025-1315	National Natural Science Foundation of China [31160059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (Grant No. 31160059), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzellotti D, 2000, ARCH BIOCHEM BIOPHYS, V382, P161, DOI 10.1006/abbi.2000.2002; Baloglu MC, 2014, GENE, V550, P117, DOI 10.1016/j.gene.2014.08.025; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Chen JF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-857; Deluc L, 2008, PLANT PHYSIOL, V147, P2041, DOI 10.1104/pp.108.118919; Dixon RA, 1999, TRENDS PLANT SCI, V4, P394, DOI 10.1016/S1360-1385(99)01471-5; Guo H, 2011, CHINESE J PHYSIOL, V54, P399, DOI 10.4077/CJP.2011.AMM059; HELLER W, 1986, FLAVONOIDS ADV RES S, P499; Jiang NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100357; Latunde-Dada AO, 2001, J BIOL CHEM, V276, P1688, DOI 10.1074/jbc.M006277200; Li HE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0111054; Li T, 2014, BIOCHEM BIOPH RES CO, V454, P78, DOI 10.1016/j.bbrc.2014.10.059; Ling Y, 2011, PLANT TRANSCRIPTION; Liu Chun-Xia, 2010, Wuhan Zhiwuxue Yanjiu, V28, P682, DOI 10.3724/SP.J.1142,2010.60682; Liu Tao, 2013, Zhongguo Zhong Yao Za Zhi, V38, P2241; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; National Pharmacopoeia Committee, 2010, PHARM PEOPL REP CH 1, p[138, 379, 848]; Qiu DY, 2008, MOL PLANT, V1, P538, DOI 10.1093/mp/ssn012; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Srinivasasainagendra V, 2008, PLANT PHYSIOL, V147, P1004, DOI 10.1104/pp.107.115535; Torales SL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-705; Mai VC, 2014, PLANT SCI, V221, P1, DOI 10.1016/j.plantsci.2014.01.011; Xiao Y, 2009, PHYSIOL PLANTARUM, V137, P1, DOI 10.1111/j.1399-3054.2009.01257.x; Xu YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-662; Zhang Guang-Hui, 2013, Zhongguo Zhong Yao Za Zhi, V38, P2231; [张盼盼 Zhang Panpan], 2014, [沈阳药科大学学报, Journal of Shenyang Pharmaceutical University], V31, P191	27	13	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143881	10.1371/journal.pone.0143881	http://dx.doi.org/10.1371/journal.pone.0143881			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656917	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900021
J	Desmet, CM; Lafosse, A; Veriter, S; Porporato, PE; Sonveaux, P; Dufrane, D; Leveque, P; Gallez, B				Desmet, Celine M.; Lafosse, Aurore; Veriter, Sophie; Porporato, Paolo E.; Sonveaux, Pierre; Dufrane, Denis; Leveque, Philippe; Gallez, Bernard			Application of Electron Paramagnetic Resonance (EPR) Oximetry to Monitor Oxygen in Wounds in Diabetic Models	PLOS ONE			English	Article							IN-VIVO EPR; RESPIRATORY GAS TENSIONS; LITHIUM PHTHALOCYANINE; TISSUE OXYGENATION; MURINE MODEL; BLOOD-FLOW; BENZYL NICOTINATE; SKIN OXYGENATION; NITRIC-OXIDE; RAT-BRAIN	A lack of oxygen is classically described as a major cause of impaired wound healing in diabetic patients. Even if the role of oxygen in the wound healing process is well recognized, measurement of oxygen levels in a wound remains challenging. The purpose of the present study was to assess the value of electron paramagnetic resonance (EPR) oximetry to monitor pO(2) in wounds during the healing process in diabetic mouse models. Kinetics of wound closure were carried out in streptozotocin (STZ)-treated and db/db mice. The pO(2) was followed repeatedly during the healing process by 1 GHz EPR spectroscopy with lithium phthalocyanine (LiPc) crystals used as oxygen sensor in two different wound models: a full-thickness excisional skin wound and a pedicled skin flap. Wound closure kinetics were dramatically slower in 12-week-old db/db compared to control (db/+) mice, whereas kinetics were not statistically different in STZ-treated compared to control mice. At the center of excisional wounds, measurements were highly influenced by atmospheric oxygen early in the healing process. In pedicled flaps, hypoxia was observed early after wounding. While reoxygenation occurred over time in db/+ mice, hypoxia was prolonged in the diabetic db/db model. This observation was consistent with impaired healing and microangiopathies observed using intravital microscopy. In conclusion, EPR oximetry using LiPc crystals as the oxygen sensor is an appropriate technique to follow wound oxygenation in acute and chronic wounds, in normal and diabetic animals. Nevertheless, the technique is limited for measurements in pedicled skin flaps and cannot be applied to excisional wounds in which diffusion of atmospheric oxygen significantly affects the measurements.	[Desmet, Celine M.; Leveque, Philippe; Gallez, Bernard] Catholic Univ Louvain, Louvain Drug Res Inst, Biomed Magnet Resonance Res Grp, B-1200 Brussels, Belgium; [Lafosse, Aurore; Veriter, Sophie; Dufrane, Denis] Catholic Univ Louvain, Clin Univ St Luc, Endocrine Cell Therapy Unit, Ctr Tissue Cell Therapy,Inst Rech Expt & Clin, B-1200 Brussels, Belgium; [Lafosse, Aurore] Catholic Univ Louvain, Clin Univ St Luc, Plast & Reconstruct Surg Unit, B-1200 Brussels, Belgium; [Porporato, Paolo E.; Sonveaux, Pierre] Catholic Univ Louvain, Inst Rech Expt & Clin, Pole Pharmacol, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain	Gallez, B (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Biomed Magnet Resonance Res Grp, B-1200 Brussels, Belgium.	bernard.gallez@uclouvain.be	Porporato, Paolo E./A-9932-2018	Porporato, Paolo E./0000-0001-8519-1552	European Research Council (ERC) [243188 TUMETABO]; Action de Recherche Concertee from the Communaute Francaise de Belgique [ARC14/19058]	European Research Council (ERC)(European Research Council (ERC)); Action de Recherche Concertee from the Communaute Francaise de Belgique	This work was supported by a Starting Grant from the European Research Council (ERC No. 243188 TUMETABO to Pierre Sonveaux) and an Action de Recherche Concertee from the Communaute Francaise de Belgique (ARC14/19058). P.S. is a Research Associate and P.E.P. a Postdoctoral Fellow of the Fonds National de la Recherche Scientifique (F.R.S.-FNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovic Z, 2007, SKIN PHARMACOL PHYS, V20, P77, DOI 10.1159/000097654; Abramovic Z, 2008, INT J PHARMACEUT, V359, P220, DOI 10.1016/j.ijpharm.2008.03.014; Ahmad R, 2010, CHEM REV, V110, P3212, DOI 10.1021/cr900396q; Allen DB, 1997, ARCH SURG-CHICAGO, V132, P991; Baudelet C, 2004, MAGN RESON IMAGING, V22, P905, DOI 10.1016/j.mri.2004.02.005; BENSEBAA F, 1992, J PHYS CHEM-US, V96, P5739, DOI 10.1021/j100193a016; BENSEBAA F, 1992, SYNTHETIC MET, V52, P57, DOI 10.1016/0379-6779(92)90020-J; Biswas S, 2010, P NATL ACAD SCI USA, V107, P6976, DOI 10.1073/pnas.1001653107; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Dunn JF, 2003, METHODS, V30, P159, DOI 10.1016/S1046-2023(03)00077-X; Dunn JF, 2002, J MAGN RESON IMAGING, V16, P511, DOI 10.1002/jmri.10192; Friedman BJ, 1996, MAGN RESON MED, V35, P214, DOI 10.1002/mrm.1910350213; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Gallez B, 1999, MAGN RESON MED, V42, P627, DOI 10.1002/(SICI)1522-2594(199910)42:4<627::AID-MRM2>3.0.CO;2-M; Gallez B, 2004, NMR BIOMED, V17, P240, DOI 10.1002/nbm.900; Gallez B, 1998, MAGN RESON MED, V40, P152, DOI 10.1002/mrm.1910400120; Gordillo GM, 2003, AM J SURG, V186, P259, DOI 10.1016/S0002-9610(03)00211-3; Greenhalgh DG, 2003, METH MOLEC MED, V78, P181; Grinberg OY, 1997, ADV EXP MED BIOL, V428, P261; Grinberg OY, 2004, PHYSIOL MEAS, V25, P659, DOI 10.1088/0967-3334/25/3/006; Grinberg OY, 1997, ADV EXP MED BIOL, V411, P171; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; He GL, 1999, P NATL ACAD SCI USA, V96, P4586, DOI 10.1073/pnas.96.8.4586; Helisch A, 2006, ARTERIOSCL THROM VAS, V26, P520, DOI 10.1161/01.ATV.0000202677.55012.a0; Hopf HW, 2003, WOUND REPAIR REGEN, V11, P424, DOI 10.1046/j.1524-475X.2003.11606.x; Hou HA, 2003, ANESTH ANALG, V96, P1467, DOI 10.1213/01.ANE.0000055648.41152.63; Hou HG, 2010, RADIAT RES, V173, P651, DOI 10.1667/RR1947.1; HUNT TK, 1967, AM J SURG, V114, P302, DOI 10.1016/0002-9610(67)90388-1; Isenberg JS, 2007, BLOOD, V109, P1945, DOI 10.1182/blood-2006-08-041368; James PE, 2002, NITRIC OXIDE-BIOL CH, V6, P18, DOI 10.1006/niox.2001.0383; James PE, 1999, NITRIC OXIDE-BIOL CH, V3, P292, DOI 10.1006/niox.1999.0238; James PE, 1996, FREE RADICAL BIO MED, V21, P25, DOI 10.1016/0891-5849(95)02221-X; Jiang JJ, 1996, J APPL PHYSIOL, V80, P552, DOI 10.1152/jappl.1996.80.2.552; Khan M, 2010, LIFE SCI, V87, P269, DOI 10.1016/j.lfs.2010.06.013; Khan N, 2007, ANTIOXID REDOX SIGN, V9, P1169, DOI 10.1089/ars.2007.1635; Krzic M, 2001, J CONTROL RELEASE, V70, P203, DOI 10.1016/S0168-3659(00)00351-5; KUPPUSAMY P, 1994, P NATL ACAD SCI USA, V91, P3388, DOI 10.1073/pnas.91.8.3388; Lazarus Gerald S., 1994, Wound Repair and Regeneration, V2, P165, DOI 10.1046/j.1524-475X.1994.20305.x; Lei H, 2001, BRAIN RES, V913, P174, DOI 10.1016/S0006-8993(01)02786-X; Li ZX, 2014, BIOMED OPT EXPRESS, V5, P3748, DOI 10.1364/BOE.5.003748; LIU KJ, 1993, P NATL ACAD SCI USA, V90, P5438, DOI 10.1073/pnas.90.12.5438; Liu SM, 2004, NMR BIOMED, V17, P327, DOI 10.1002/nbm.899; Lu CY, 2013, BONE, V52, P220, DOI 10.1016/j.bone.2012.09.037; Lu CY, 2011, J ORTHOP TRAUMA, V25, P494, DOI 10.1097/BOT.0b013e31822511e0; Lu Chuanyong, 2008, Iowa Orthop J, V28, P14; Madhani M, 2002, BBA-MOL BASIS DIS, V1588, P232, DOI 10.1016/S0925-4439(02)00170-9; Matsumoto A, 2005, MAGN RESON MED, V54, P1530, DOI 10.1002/mrm.20714; Michaels J, 2007, WOUND REPAIR REGEN, V15, P665, DOI 10.1111/j.1524-475X.2007.00273.x; Mustoe TA, 2006, PLAST RECONSTR SURG, V117, p35S, DOI 10.1097/01.prs.0000225431.63010.1b; NAKASHIMA T, 1995, MAGNET RESON MED, V34, P888, DOI 10.1002/mrm.1910340614; NIINIKOSKI J, 1972, ANN SURG, V175, P588, DOI 10.1097/00000658-197204000-00020; O'Hara JA, 2004, PHYSIOL MEAS, V25, P1413, DOI 10.1088/0967-3334/25/6/007; Parinandi NL, 2006, ANTIOXID REDOX SIGN, V8, P1385, DOI 10.1089/ars.2006.8.1385; Porporato PE, 2012, ANGIOGENESIS, V15, P581, DOI 10.1007/s10456-012-9282-0; PROCKOP DJ, 1979, NEW ENGL J MED, V301, P13, DOI 10.1056/NEJM197907053010104; Rebalka IA, 2015, DIABETES; Rolett EL, 2000, AM J PHYSIOL-REG I, V279, pR9, DOI 10.1152/ajpregu.2000.279.1.R9; Ruzehaji N, 2014, DIABETOLOGIA, V57, P402, DOI 10.1007/s00125-013-3107-6; Schreml S, 2010, BRIT J DERMATOL, V163, P257, DOI 10.1111/j.1365-2133.2010.09804.x; Schreml S, 2014, THERANOSTICS, V4, P721, DOI 10.7150/thno.9052; Schreml S, 2011, EXP DERMATOL, V20, P550, DOI 10.1111/j.1600-0625.2011.01263.x; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Swartz HM, 2014, ACAD RADIOL, V21, P197, DOI 10.1016/j.acra.2013.10.011; Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2; Towner RA, 2002, CHEM-BIOL INTERACT, V139, P231, DOI 10.1016/S0009-2797(02)00002-9; Trousdale RK, 2009, J SURG RES, V151, P100, DOI 10.1016/j.jss.2008.01.023; Van Eyck AS, 2009, FERTIL STERIL, V92, P374, DOI 10.1016/j.fertnstert.2008.05.012; Weaver J, 2014, J CEREBR BLOOD F MET, V34, P890, DOI 10.1038/jcbfm.2014.35; Weaver J, 2014, TOXICOL APPL PHARM, V275, P73, DOI 10.1016/j.taap.2013.12.023; Wong V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/969618; ZWEIER JL, 1991, J BIOENERG BIOMEMBR, V23, P855, DOI 10.1007/BF00786005	72	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144914	10.1371/journal.pone.0144914	http://dx.doi.org/10.1371/journal.pone.0144914			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659378	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900148
J	Horie, M; Warabi, E; Komine, S; Oh, S; Shoda, J				Horie, Masaki; Warabi, Eiji; Komine, Shoichi; Oh, Sechang; Shoda, Junichi			Cytoprotective Role of Nrf2 in Electrical Pulse Stimulated C2C12 Myotube	PLOS ONE			English	Article							SKELETAL-MUSCLE; OXIDATIVE STRESS; INDUCED APOPTOSIS; EXERCISE; ANTIOXIDANTS; ADAPTATION; MECHANISMS; MYOBLASTS; KEAP1	Regular physical exercise is central to a healthy lifestyle. However, exercise-related muscle contraction can induce reactive oxygen species and reactive nitrogen species (ROS/RNS) production in skeletal muscle. The nuclear factor-E2-related factor-2 (Nrf2) transcription factor is a cellular sensor for oxidative stress. Regulation of nuclear Nrf2 signaling regulates antioxidant responses and protects organ structure and function. However, the role of Nrf2 in exercise-or contraction-induced ROS/RNS production in skeletal muscle is not clear. In this study, using differentiated C2C12 cells and electrical pulse stimulation (EPS) of muscle contraction, we explored whether Nrf2 plays a role in the skeletal muscle response to muscle contraction-induced ROS/RNS. We found that EPS (40 V, 1 Hz, 2 ms) stimulated ROS/ RNS accumulation and Nrf2 activation. We also showed that expression of NQO1, HO-1 and GCLM increased after EPS-induced muscle contraction and was remarkably suppressed in cells with Nrf2 knockdown. We also found that the antioxidant N-acetylcysteine (NAC) significantly attenuated Nrf2 activation after EPS, whereas the nitric oxide synthetase inhibitor N omega-nitro-L-arginine methyl ester (L-NAME) did not. Furthermore, Nrf2 knockdown after EPS markedly decreased ROS/RNS redox potential and cell viability and increased expression of the apoptosis marker Annexin V in C2C12 myotubes. These results indicate that Nrf2 activation and expression of Nrf2 regulated-genes protected muscle against the increased ROS caused by EPS-induced muscle contraction. Thus, our findings suggest that Nrf2 may be a key factor for preservation of muscle function during muscle contraction.	[Horie, Masaki; Oh, Sechang; Shoda, Junichi] Univ Tsukuba, Fac Med, Div Med Sci, Tsukuba, Ibaraki, Japan; [Horie, Masaki; Oh, Sechang] Japan Soc Promot Sci, Tokyo, Japan; [Warabi, Eiji] Univ Tsukuba, Fac Med, Div Biomed Sci, Tsukuba, Ibaraki, Japan; [Komine, Shoichi] Univ Tsukuba, Grad Sch Comprehens Human Sci Majors Med Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba; Japan Society for the Promotion of Science; University of Tsukuba; University of Tsukuba	Shoda, J (corresponding author), Univ Tsukuba, Fac Med, Div Med Sci, Tsukuba, Ibaraki, Japan.	shodaj@md.tsukuba.ac.jp			Japan Health Science Foundation; Ministry of Education, Science and culture, Japan [13J00516]; Grants-in-Aid for Scientific Research [26670109] Funding Source: KAKEN	Japan Health Science Foundation; Ministry of Education, Science and culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was, in part, supported by the Japan Health Science Foundation and a Grant-in-Aid for Scientific Research on Priority Areas, Ministry of Education, Science and culture, Japan (Research project number: 13J00516), MH.; This work was, in part, supported by the Japan Health Science Foundation and a Grant-in-Aid for Scientific Research on Priority Areas, Ministry of Education, Science and culture, Japan (Research project number: 13J00516).	Aldred S, 2007, ATHEROSCLEROSIS, V192, P1, DOI 10.1016/j.atherosclerosis.2007.02.001; Andrade FH, 2001, FASEB J, V15, P309; Aoi Wataru, 2011, Curr Aging Sci, V4, P101; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; Crespo CJ, 2002, ANN EPIDEMIOL, V12, P543, DOI 10.1016/S1047-2797(01)00296-4; Gianni P, 2004, EXP GERONTOL, V39, P1391, DOI 10.1016/j.exger.2004.06.002; Gomez-Cabrera MC, 2008, AM J CLIN NUTR, V87, P142, DOI 10.1093/ajcn/87.1.142; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2010, ANTIOXID REDOX SIGN, V13, P1665, DOI 10.1089/ars.2010.3222; Jackson MJ, 2008, IUBMB LIFE, V60, P497, DOI 10.1002/iub.72; Jackson MJ, 2008, FREE RADICAL BIO MED, V44, P132, DOI 10.1016/j.freeradbiomed.2007.06.003; Jackson MJ, 2011, ANTIOXID REDOX SIGN, V15, P2477, DOI 10.1089/ars.2011.3976; Ji LL, 2007, EXP GERONTOL, V42, P582, DOI 10.1016/j.exger.2007.03.002; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Lee YH, 2013, BIOSCI BIOTECH BIOCH, V77, P375, DOI 10.1271/bbb.120465; McArdle A, 2001, AM J PHYSIOL-CELL PH, V280, pC621, DOI 10.1152/ajpcell.2001.280.3.C621; Miller CJ, 2012, BBA-MOL BASIS DIS, V1822, P1038, DOI 10.1016/j.bbadis.2012.02.007; Niess AM, 2007, FRONT BIOSCI-LANDMRK, V12, P4826, DOI 10.2741/2431; Pan HY, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/145418; Patwell DM, 2004, FREE RADICAL BIO MED, V37, P1064, DOI 10.1016/j.freeradbiomed.2004.06.026; Peleli M, 2015, BIOORGAN MED CHEM, V23, P390, DOI 10.1016/j.bmc.2014.12.046; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Powers SK, 2007, J APPL PHYSIOL, V102, P2389, DOI 10.1152/japplphysiol.01202.2006; Powers SK, 2010, EXP PHYSIOL, V95, P1, DOI 10.1113/expphysiol.2009.050526; Powers SK, 1999, CLIN SPORT MED, V18, P525, DOI 10.1016/S0278-5919(05)70166-6; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Vasilaki A, 2013, FREE RADICAL BIO MED, V65, P317, DOI 10.1016/j.freeradbiomed.2013.07.008	27	29	34	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144835	10.1371/journal.pone.0144835	http://dx.doi.org/10.1371/journal.pone.0144835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658309	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900115
J	Kibira, SPS; Makumbi, F; Daniel, M; Atuyambe, LM; Sandoy, IF				Kibira, Simon P. S.; Makumbi, Fredrick; Daniel, Marguerite; Atuyambe, Lynn Muhimbuura; Sandoy, Ingvild Fossgard			Sexual Risk Behaviours and Willingness to Be Circumcised among Uncircumcised Adult Men in Uganda	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HIV PREVENTION; HUMAN-PAPILLOMAVIRUS; YOUNG MEN; WOMEN; COMPENSATION; PREVALENCE; INFECTION; KISUMU; TRIAL	Background There has been substantial demand for safe male circumcision (SMC) in Uganda in the early programme scale-up phase. Research indicates that early adopters of new interventions often differ from later adopters in relation to a range of behaviours. However, there is limited knowledge about the risk profile of men who were willing to be circumcised at the time of launching the SMC programme, i.e., potential early adopters, compared to those who were reluctant. The aim of this study was to address this gap to provide indications on whether it is likely that potential early adopters of male circumcision were more in need of this new prevention measure than others. Methods Data were from the 2011 Uganda AIDS Indictor Survey (UAIS), with a nationally representative sample of men 15 to 59 years. The analysis was based on generalized linear models, obtaining prevalence risk ratios (PRR) with 95% confidence intervals (CI) as measures of association between willingness to be circumcised and multiple sexual partners, transactional sex, non-marital sex and non-use of condoms at last non-marital sex. Results Of the 5,776 men in the survey, 44% expressed willingness to be circumcised. Willingness to be circumcised was higher among the younger, urban and educated men. In the unadjusted analyses, all the sexual risk behaviours were associated with willingness to be circumcised, while in the adjusted analysis, non-marital sex (Adj PRR 1.27; CI: 1.16-1.40) and non-use of condoms at last such sex (Adj PRR 1.18; CI: 1.07-1.29) were associated with higher willingness to be circumcised. Conclusion Willingness to be circumcised was relatively high at the launch of the SMC programme and was more common among uncircumcised men reporting sexual risk behaviours. This indicates that the early adopters of SMC were likely to be in particular need of such additional HIV protective measures.	[Kibira, Simon P. S.; Sandoy, Ingvild Fossgard] Univ Bergen, Dept Global Publ Hlth & Primary Care, Ctr Int Hlth, Bergen, Norway; [Kibira, Simon P. S.; Atuyambe, Lynn Muhimbuura] Makerere Univ, Dept Community Hlth & Behav Sci, Sch Publ Hlth, Kampala, Uganda; [Makumbi, Fredrick] Makerere Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Kampala, Uganda; [Daniel, Marguerite] Univ Bergen, Dept Hlth Promot & Dev, Bergen, Norway	University of Bergen; Makerere University; Makerere University; University of Bergen	Kibira, SPS (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Ctr Int Hlth, Bergen, Norway.	pskibira@gmail.com	Sandøy, Ingvild Fossgard/ABD-3557-2020	Kibira, Simon Peter Sebina/0000-0002-7385-423X; Sandoy, Ingvild/0000-0001-5567-4588	Norwegian State Education Loan Fund (Lanekassen); University of Bergen, Norway	Norwegian State Education Loan Fund (Lanekassen); University of Bergen, Norway	This work was supported by a scholarship to the first author from the Norwegian State Education Loan Fund (Lanekassen), and the University of Bergen, Norway. The funders had no role in conducting the study.	[Anonymous], 2014, GLOB UPD HLTH SECT R; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2001, AIDS, V15, pS15, DOI 10.1097/00002030-200108004-00003; Auvert B, 2009, J INFECT DIS, V199, P14, DOI 10.1086/595566; AXELSON O, 1994, OCCUP ENVIRON MED, V51, P574, DOI 10.1136/oem.51.8.574; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Brawley E. M., 2006, RELATIONSHIP GENDER; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Center for Communication Programs, 2012, HLTH COMM PARTN UG; Chikutsa A, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0001-3; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Health Communication Partnerships, 2010, HCP 2010 SURV HIGHL; Keetile M, 2014, AFR POPUL STUD, V28, P1345, DOI DOI 10.11564/0-0-630; Kelly CA, 2014, STUD FAMILY PLANN, V45, P43, DOI 10.1111/j.1728-4465.2014.00375.x; Kelly CA, 2013, INT PERSPECT SEX R H, V39, P14, DOI 10.1363/3901413; Kitara DL, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.100.2338; Mnyika KS, 1997, INT J STD AIDS, V8, P176, DOI 10.1258/0956462971919840; MOH, 2010, SAF MAL CIRC HIV PRE; MOH and ICF International, 2012, UG AIDS IND SURV 201; Muhangi D., 2010, FACTORS INFLUENCE DE; MUSPH School of Public Health Makerere University College of Health Sciences, 2010, MUSPH ANN REP; Rogers EM, 1983, DIFFUSION INNOVATION; Schroder KEE, 2003, ANN BEHAV MED, V26, P76, DOI 10.1207/S15324796ABM2602_02; Siegfried N., 2003, COCHRANE DATABASE SY; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Uganda AIDS Commission, 2014, HIV AIDS UG COUNTR P; Uganda Bureau of Statistics - UBOS ICF International, 2012, UG DEM HLTH SURV 201; UNAIDS, 2000, NAT AIDS PROGR GUID; UNAIDS, 2014, UND FAST TRACK ACC A; Wabwire-Mangen F., 2009, UGANDA HIV PREVENTIO; Wawer MJ, 2011, LANCET, V377, P209, DOI 10.1016/S0140-6736(10)61967-8; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Westercamp M, 2012, AIDS CARE, V24, P157, DOI 10.1080/09540121.2011.597944; Westercamp N, 2014, AIDS BEHAV, V18, P1764, DOI 10.1007/s10461-014-0846-4; WHO/UNAIDS, 2011, JOINT STRAT ACT FRAM; WHO UNICEF & UNAIDS., 2011, UN ACC, P1; World Health Organization, 2007, NEW DAT MAL CIRC HIV	38	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144843	10.1371/journal.pone.0144843	http://dx.doi.org/10.1371/journal.pone.0144843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26658740	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900117
J	Liu, BM; Li, M; Yin, BS; Zou, JY; Zhang, WG; Wang, SY				Liu, Bo-Ming; Li, Ming; Yin, Bao-Sheng; Zou, Ji-Yang; Zhang, Wei-Guo; Wang, Shou-Yu			Effects of Incorporating Carboxymethyl Chitosan into PMMA Bone Cement Containing Methotrexate	PLOS ONE			English	Article							ACRYLIC CEMENT; GROWTH; ENHANCEMENT	Treatment of bone metastases usually includes surgical resection with local filling of methotrexate (MTX) in polymethyl methacrylate (PMMA) cement. We investigated whether incorporating carboxymethyl chitosan (CMCS) in MTX-PMMA cement might overcome disadvantages associated with MTX. To determine the optimal CMCS+MTX concentration to suppress the viability of cancer cells, an integrated microfluidic chip culturing highly metastatic lung cancer cells (H460) was employed. The mechanical properties, microstructure, and MTX release of (CMCS+MTX)-PMMA cement were evaluated respectively by universal mechanical testing machine, scanning electron microscopy (SEM), and incubation in simulated body fluid with subsequent HPLC-MS. Implants of MTX-PMMA and (CMCS+MTX)PMMA cement were evaluated in vivo in guinea pig femurs over time using spiral computed tomography with three-dimensional image reconstruction, and SEM at 6 months. Viability of H460 cells was significantly lowest after treatment with 57 mu g/mL CMCS + 21 mu g/mL MTX, which was thus used in subsequent experiments. Incorporation of 1.6% (w/w) CMCS to MTX-PMMA significantly increased the bending modulus, bending strength, and compressive strength by 5, 2.8, and 5.2%, respectively, confirmed by improved microstructural homogeneity. Incorporation of CMCS delayed the time-to-plateau of MTX release by 2 days, but increased the fraction released at the plateau from 3.24% (MTX-PMMA) to 5.34%. Relative to the controls, the (CMCS+MTX)-PMMA implants integrated better with the host bone. SEM revealed pores in the cement of the (CMCS+MTX)-PMMA implants that were not obvious in the controls. In conclusion, incorporation of CMCS in MTX-PMMA appears a feasible and effective modification for improving the anti-tumor properties of MTX-PMMA cement.	[Liu, Bo-Ming; Li, Ming; Yin, Bao-Sheng; Zou, Ji-Yang; Zhang, Wei-Guo; Wang, Shou-Yu] Dalian Med Univ, Dept Orthoped, Affiliated Hosp 1, Dalian 116044, Liaoning, Peoples R China; [Liu, Bo-Ming; Li, Ming; Yin, Bao-Sheng; Zou, Ji-Yang; Zhang, Wei-Guo; Wang, Shou-Yu] Dalian Med Univ, Dalian 116044, Liaoning, Peoples R China	Dalian Medical University; Dalian Medical University	Zhang, WG (corresponding author), Dalian Med Univ, Dept Orthoped, Affiliated Hosp 1, Dalian 116044, Liaoning, Peoples R China.	weiguozhang2014@hotmail.com; shmily_lbm@hotmail.com		Yin, Baosheng/0000-0002-1696-9110	National Natural Science Foundation of China [81171464, 81270052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the National Natural Science Foundation of China (No. 81171464 and No. 81270052). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amidi M, 2010, ADV DRUG DELIVER REV, V62, P59, DOI 10.1016/j.addr.2009.11.009; Barralet JE, 2002, J BIOMED MATER RES, V63, P1, DOI 10.1002/jbm.1074; Chen C, 2013, MOLECULES, V18, P7239, DOI 10.3390/molecules18067239; Dadas B, 2007, EUR ARCH OTO-RHINO-L, V264, P539, DOI 10.1007/s00405-006-0227-3; Damien E, 2003, J BIOMED MATER RES A, V66A, P241, DOI 10.1002/jbm.a.10564; Decker S, 1999, J BONE JOINT SURG BR, V81B, P545, DOI 10.1302/0301-620X.81B3.9167; Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016; Guminska M., 1996, J PHARM, V48, P495; Handal JA, 2007, CLIN ORTHOP RELAT R, P105, DOI 10.1097/BLO.0b013e31804f5446; Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z; HERNIGOU P, 1989, J BONE JOINT SURG BR, V71, P804, DOI 10.1302/0301-620X.71B5.2584251; Isikli C, 2012, J TISSUE ENG REGEN M, V6, P135, DOI 10.1002/term.406; Jaeblon T, 2010, J AM ACAD ORTHOP SUR, V18, P297, DOI 10.5435/00124635-201005000-00006; Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b; Kim SB, 2004, BIOMATERIALS, V25, P5715, DOI 10.1016/j.biomaterials.2004.01.022; Kim TH, 2006, MOL CANCER THER, V5, P1723, DOI 10.1158/1535-7163.MCT-05-0540; KISSIN I, 1989, ANESTHESIOLOGY, V70, P689, DOI 10.1097/00000542-198904000-00025; Koev ST, 2010, LAB CHIP, V10, P3026, DOI [10.1039/c0lc00047g, 10.1039/c01c00047g]; LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81; Li YC, 2010, TISSUE ENG PART C-ME, V16, P1267, DOI [10.1089/ten.tec.2009.0682, 10.1089/ten.TEC.2009.0682]; Lin LC, 2005, J MATER SCI-MATER M, V16, P567, DOI 10.1007/s10856-005-0533-0; Maccauro G, 2007, J MATER SCI-MATER M, V18, P839, DOI 10.1007/s10856-006-0036-7; Mun S, 2006, J COLLOID INTERF SCI, V296, P581, DOI 10.1016/j.jcis.2005.09.023; Oliveira AL, 1999, J MATER SCI-MATER M, V10, P827, DOI 10.1023/A:1008900428325; Oonishi H, 1999, J BIOMED MATER RES, V44, P31, DOI 10.1002/(SICI)1097-4636(199901)44:1<31::AID-JBM4>3.0.CO;2-9; Orr TE, 2001, BIOMATERIALS, V22, P1953, DOI 10.1016/S0142-9612(00)00370-7; Prochazka E, 2010, INT ORTHOP, V34, P137, DOI 10.1007/s00264-008-0717-6; Seo SH, 2009, CLIN EXP METASTAS, V26, P179, DOI 10.1007/s10585-008-9228-5; Shahidi F, 2005, ADV FOOD NUTR RES, V49, P93, DOI 10.1016/S1043-4526(05)49003-8; Wang XH, 2001, BIOMATERIALS, V22, P2247, DOI 10.1016/S0142-9612(00)00413-0; Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0	31	10	11	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144407	10.1371/journal.pone.0144407	http://dx.doi.org/10.1371/journal.pone.0144407			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657526	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900043
J	Olifiers, N; Jansen, AM; Herrera, HM; Bianchi, RD; D'Andrea, PS; Mourao, GD; Gompper, ME				Olifiers, Natalie; Jansen, Ana Maria; Herrera, Heitor Miraglia; Bianchi, Rita de Cassia; D'Andrea, Paulo Sergio; Mourao, Guilherme de Miranda; Gompper, Matthew Edzart			Co-Infection and Wild Animal Health: Effects of Trypanosomatids and Gastrointestinal Parasites on Coatis of the Brazilian Pantanal	PLOS ONE			English	Article							NASUA-NASUA; EXPERIMENTAL-INFECTION; BODY CONDITION; DIROFILARIA-IMMITIS; SEX-DIFFERENCES; CRUZI; EVANSI; HOST; POPULATIONS; EOSINOPHILS	Wild animals are infected by diverse parasites, but how they influence host health is poorly understood. We examined the relationship of trypanosomatids and gastrointestinal parasites with health of wild brown-nosed coatis (Nasua nasua) from the Brazilian Pantanal. We used coati body condition and hematological parameters as response variables in linear models that were compared using an information theoretic approach. Predictors were high/low parasitemias by Trypanosoma cruzi and T. evansi, and indices representing the abundance of distinct groups of gastrointestinal parasites. We also analyzed how host health changed with host sex and reproductive seasonality. Hemoparasites was best related to coati body condition and hematological indices, whereas abundance of gastrointestinal parasites was relatively less associated with coati health. Additionally, some associations were best predicted by models that incorporated reproductive seasonality and host sex. Overall, we observed a lower health condition during the breeding season, when coatis are under reproductive stress and may be less able to handle infection. In addition, females seem to handle infection better than males. Body condition was lower in coatis with high parasitemias of T. evansi, especially during the reproductive season. Total red blood cell counts, packed cell volume, platelets and eosinophils were also lower in animals with high T. evansi parasitemias. Total white blood cell counts and mature neutrophils were lower in animals with high parasitemias for both Trypanosoma species, with neutrophils decreasing mainly during the reproductive season. Overall, decreases in hematological parameters of females with T. evansi high parasitemias were less evident. For T. cruzi, monocytes decreased in individuals with high parasitemias. High abundances of microfilariae in the bloodstream, and cestode eggs and coccidian oocysts in feces were also associated with coati blood parameters. This study shows the potential value of examining hematological parameters as an approach to better understand the ecological relevance of parasite-host interactions.	[Olifiers, Natalie; D'Andrea, Paulo Sergio] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol & Parasitol Mamiferos Reservatorios, Rio De Janeiro, RJ, Brazil; [Jansen, Ana Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Tripanosomatideos, Rio De Janeiro, RJ, Brazil; [Herrera, Heitor Miraglia] Univ Catolica Dom Bosco, Lab Parasitol Anim, Campo Grande, MS, Brazil; [Bianchi, Rita de Cassia] Univ Estadual Paulista, Dept Biol Aplicada Agr, Sao Paulo, Brazil; [Mourao, Guilherme de Miranda] Empresa Brasileira Pesquisa Agr, Lab Vida Selvagem, Ctr Pesquisa Agr Pantanal, Corumba, MS, Brazil; [Gompper, Matthew Edzart] Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO USA	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Catolica Dom Bosco (UCDB); Universidade Estadual Paulista; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Missouri System; University of Missouri Columbia	Olifiers, N (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol & Parasitol Mamiferos Reservatorios, Rio De Janeiro, RJ, Brazil.	natolifiers@gmail.com	Mourão, Guilherme M/C-3319-2013; de Cassia Bianchi, Rita/E-5504-2012; Herrera, Heitor Miraglia/K-3759-2012; Olifiers, Natalie/N-5478-2019; D'Andrea, Paulo S./G-6820-2011	Mourão, Guilherme M/0000-0002-8300-4191; de Cassia Bianchi, Rita/0000-0001-8027-755X; Herrera, Heitor Miraglia/0000-0003-2404-8765; Olifiers, Natalie/0000-0002-3024-2049; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [484501/2006-2]; Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul [6654.235.476.06032007]; Empresa Brasileira de Estudos Agropecuarios (Macroprograma 3); Fundacao Oswaldo Cruz; University of Missouri; Earthwatch Institute; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Empresa Brasileira de Estudos Agropecuarios (Macroprograma 3); Fundacao Oswaldo Cruz; University of Missouri; Earthwatch Institute; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funds were provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (process number 484501/2006-2) to GMM, NO, AMJ, HMH, RCB, PSD; Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (process number 6654.235.476.06032007) to GMM, NO, AMJ, HMH, RCB, PSD; Empresa Brasileira de Estudos Agropecuarios (Macroprograma 3) to GMM, NO, AMJ, HMH, RCB, PSD; Fundacao Oswaldo Cruz to AMJ e PSD; University of Missouri to MEG; and Earthwatch Institute to NO, AMJ, HMH and PSD. Doctoral grants were provided by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to RCB and by the University of Missouri to NO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Alves FM, 2011, VECTOR-BORNE ZOONOT, V11, P835, DOI 10.1089/vbz.2010.0096; ANDERSON RM, 1985, T ROY SOC TROP MED H, V79, P812, DOI 10.1016/0035-9203(85)90128-2; Aquino LPCT, 2002, ARQ BRAS MED VET ZOO, V54, P8, DOI 10.1590/S0102-09352002000100002; Arias JF, 1997, J WILDLIFE DIS, V33, P359, DOI 10.7589/0090-3558-33.2.359; ATWELL RB, 1983, RES VET SCI, V35, P364, DOI 10.1016/S0034-5288(18)32034-4; Beldomenico PM, 2008, J ANIM ECOL, V77, P984, DOI 10.1111/j.1365-2656.2008.01413.x; Beldomenico PM, 2008, P ROY SOC B-BIOL SCI, V275, P1753, DOI 10.1098/rspb.2008.0147; Bianchi R.C., 2009, THESIS; Booth-Binczik S. D., 2001, THESIS; Bordes F, 2009, OIKOS, V118, P801, DOI 10.1111/j.1600-0706.2008.17169.x; Bordes Frederic, 2011, Infect Ecol Epidemiol, V1, DOI 10.3402/iee.v1i0.7346; Bott NJ, 2009, INT J PARASITOL, V39, P1277, DOI 10.1016/j.ijpara.2009.03.002; Budischak Sarah A., 2012, International Journal for Parasitology Parasites and Wildlife, V1, P2, DOI 10.1016/j.ijppaw.2012.10.001; Burnham KP, 2001, MODEL SELECTION MULT; Cadioli FA, 2006, ARQ BRAS MED VET ZOO, V58, P749, DOI 10.1590/S0102-09352006000500008; Campos Z, 1987, CIENC INTERAM, V26, P30; Cizauskas CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120800; Cordoba-Aguilar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076246; Costa FJV, 2005, ANIM BEHAV, V70, P1401, DOI 10.1016/j.anbehav.2005.03.024; Cox FEG, 2001, PARASITOLOGY, V122, pS23, DOI 10.1017/S003118200001698X; Ebert D, 2000, AM NAT, V156, P459, DOI 10.1086/303404; Elias D, 2006, PARASITE IMMUNOL, V28, P507, DOI 10.1111/j.1365-3024.2006.00854.x; Foreyt W.J, 2001, VET PARASITOLOGY REF, V5th; Fowler M E, 2001, BIOL MED SURG S AM W, V54; Franciscato Carina, 2007, Cienc. Rural, V37, P288, DOI 10.1590/S0103-84782007000100049; Fulkerson PC, 2013, NAT REV DRUG DISCOV, V12, P117, DOI 10.1038/nrd3838; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gompper Matthew E., 1998, Mammalian Species, V580, P1; Hakkarainen H, 2007, PARASITOLOGY, V134, P23, DOI 10.1017/S0031182006001120; Harrison P, 2005, BLOOD REV, V19, P111, DOI 10.1016/j.blre.2004.05.002; Harvey J W, 1982, Vet Clin Pathol, V11, P5, DOI 10.1111/j.1939-165X.1982.tb00811.x; Herrera HM, 2008, T ROY SOC TROP MED H, V102, P1133, DOI 10.1016/j.trstmh.2008.04.041; Herrera HM, 2011, T ROY SOC TROP MED H, V105, P380, DOI 10.1016/j.trstmh.2011.04.008; Herrera HM, 2004, VET PARASITOL, V125, P263, DOI 10.1016/j.vetpar.2004.07.013; Herrera HM, 2002, ACTA TROP, V81, P203, DOI 10.1016/S0001-706X(01)00204-2; Herrera HM, 2001, VET PARASITOL, V102, P209, DOI 10.1016/S0304-4017(01)00532-5; Hudson PJ, 1997, J PARASITOL, V83, P194, DOI 10.2307/3284438; Hughes VL, 2001, PARASITOLOGY, V123, P365, DOI 10.1017/S0031182001008599; Jacobsen EA, 2012, BLOOD, V120, P3882, DOI 10.1182/blood-2012-06-330845; Jain NC, 1993, ESSENTIALS VET HEMAT; Jolles AE, 2008, ECOLOGY, V89, P2239, DOI 10.1890/07-0995.1; Kassai T, 1999, VET HELMINTHOLOGY; Kipper M, 2011, RES VET SCI, V91, P240, DOI 10.1016/j.rvsc.2010.11.018; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; LAINSON R, 1989, ANN PARASIT HUM COMP, V64, P200, DOI 10.1051/parasite/1989643200; Lello J, 2005, INT J PARASITOL, V35, P1509, DOI 10.1016/j.ijpara.2005.06.002; Marcondes MCG, 2000, MICROBES INFECT, V2, P347, DOI 10.1016/S1286-4579(00)00333-6; Martin LB, 2008, PHILOS T R SOC B, V363, P321, DOI 10.1098/rstb.2007.2142; Meagher S, 2002, J PARASITOL, V88, P833, DOI 10.1645/0022-3395(2002)088[0833:EOTSOS]2.0.CO;2; Melo RCN, 2001, EXP PARASITOL, V97, P15, DOI 10.1006/expr.2000.4576; MILES MA, 1983, AM J TROP MED HYG, V32, P1251, DOI 10.4269/ajtmh.1983.32.1251; Monteiro RV, 2007, PARASITOL RES, V101, P1689, DOI 10.1007/s00436-007-0652-2; Newey S, 2004, WILDLIFE BIOL, V10, P171, DOI 10.2981/wlb.2004.023; Nunes V. L. B., 1993, Revista Brasileira de Parasitologia Veterinaria, V2, P41; OLIFIERS N, 2010, THESIS; Olifiers N, 2010, WILDLIFE BIOL, V16, P389, DOI 10.2981/09-104; Onah DN, 1996, PARASITOL RES, V82, P659, DOI 10.1007/s004360050181; ORIHEL TC, 1964, J PARASITOL, V50, P115, DOI 10.2307/3276043; OSHIRO E T, 1990, Memorias do Instituto Oswaldo Cruz, V85, P139; Ovington KS, 1997, MEM I OSWALDO CRUZ, V92, P93, DOI 10.1590/S0074-02761997000800013; Padilla AM, 2009, CURR OPIN IMMUNOL, V21, P385, DOI 10.1016/j.coi.2009.07.006; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Pioz M, 2008, OECOLOGIA, V155, P691, DOI 10.1007/s00442-007-0942-5; POLACK B, 1991, NOUV REV FR HEMATOL, V33, P317; Poulin R, 1996, AM NAT, V147, P287, DOI 10.1086/285851; Poulin R., 2004, PARASITE BIODIVERSIT; Prado Jose Clovis Do Jr., 1998, Parasitology Research, V84, P100; PUNG OJ, 1988, INT J PARASITOL, V18, P115, DOI 10.1016/0020-7519(88)90045-8; Rauw Wendy M., 2012, Frontiers in Genetics, V3, P267, DOI 10.3389/fgene.2012.00267; REPKA D, 1985, Revista Brasileira de Biologia, V45, P309; Rocha FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067463; da Paz RCR, 2012, THERIOGENOLOGY, V77, P1275, DOI 10.1016/j.theriogenology.2011.10.032; Rodriguez A, 1998, ACTA PARASITOL, V43, P128; Rodriguez M, 1999, PARASITE IMMUNOL, V21, P177, DOI 10.1046/j.1365-3024.1999.00218.x; ROSE ME, 1979, IMMUNOLOGY, V36, P71; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Santana VL, 2012, PESQUISA VET BRASIL, V32, P536, DOI 10.1590/S0100-736X2012000600011; Santos CD, 2007, VET PARASITOL, V143, P222, DOI 10.1016/j.vetpar.2006.08.038; Schalk G, 1997, OIKOS, V78, P67, DOI 10.2307/3545801; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; SCHUURS AHWM, 1990, J STEROID BIOCHEM, V35, P157, DOI 10.1016/0022-4731(90)90270-3; Seidl AF, 2001, ECOL ECON, V36, P413, DOI 10.1016/S0921-8009(00)00238-X; Sevimli FK, 2007, PARASITOL RES, V101, P1487, DOI 10.1007/s00436-007-0665-x; Silva A. S. da, 2010, Comparative Clinical Pathology, V19, P207, DOI 10.1007/s00580-009-0855-2; Silva AS, 2010, SEMIN-CIENC AGRAR, P699; Silva R.A.M.S., 1999, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V52, P119; Silva R.A.M.S., 1995, REV ELEV MED VET PAY, V48, P315; Stien A, 2002, J ANIM ECOL, V71, P937, DOI 10.1046/j.1365-2656.2002.00659.x; Telfer S, 2008, PARASITOLOGY, V135, P767, DOI 10.1017/S0031182008000395; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Tompkins DM, 2011, J ANIM ECOL, V80, P19, DOI 10.1111/j.1365-2656.2010.01742.x; Vandegrift KJ, 2008, ECOLOGY, V89, P2251, DOI 10.1890/07-1935.1; Varela-Stokes AS, 2008, J PARASITOL, V94, P564, DOI 10.1645/GE-1346.1; Vezzani D, 2006, VET PARASITOL, V136, P259, DOI 10.1016/j.vetpar.2005.10.026; Vieira FM, 2008, ZOOTAXA, P1; Voigt G.L, 2000, HEMATOLOGY TECHNIQUE; Wimmer B, 2004, INT J PARASITOL, V34, P625, DOI 10.1016/j.ijpara.2003.11.022; Woo P. T. K., 1970, Acta trop., V27, P384; Worliczek HL, 2010, PARASITE IMMUNOL, V32, P232, DOI 10.1111/j.1365-3024.2009.01184.x; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]; Zuk M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000267	104	17	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143997	10.1371/journal.pone.0143997	http://dx.doi.org/10.1371/journal.pone.0143997			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657699	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900022
J	Dashivets, T; Thomann, M; Rueger, P; Knaupp, A; Buchner, J; Schlothauer, T				Dashivets, Tetyana; Thomann, Marco; Rueger, Petra; Knaupp, Alexander; Buchner, Johannes; Schlothauer, Tilman			Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants	PLOS ONE			English	Article							FC-GAMMA RECEPTORS; ANTIINFLAMMATORY ACTIVITY; CONFORMATIONAL-CHANGES; GLYCOSYLATION PATTERN; ANTIBODY THERAPEUTICS; THERMAL-STABILITY; N-GLYCOSYLATION; SIALIC-ACID; BINDING; IMPACT	Therapeutic performance of recombinant antibodies relies on two independent mechanisms: antigen recognition and Fc-mediated antibody effector functions. Interaction of Fc-fragment with different FcR triggers antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity and determines longevity of the antibody in serum. In context of therapeutic antibodies Fc gamma Rs play the most important role. It has been demonstrated that the Fc-attached sugar moiety is essential for IgG effector functionality, dictates its affinity to individual Fc gamma Rs and determines binding to different receptor classes: activating or inhibitory. In this study, we systematically analyze effector functions of monoclonal IgG1 and its eight enzymatically engineered glycosylation variants. The analysis of interaction of glycovariants with FcRs was performed for single, as well as for antigen-bound antibodies and IgGs in a form of immune complex. In addition to functional properties we addressed impact of glycosylation on the structural properties of the tested glycovariants. We demonstrate a clear impact of glycosylation pattern on antibody stability and interaction with different Fc gamma Rs. Consistent with previous reports, deglycosylated antibodies failed to bind all Fc gamma-receptors, with the exception of high affinity Fc gamma RI. The Fc gamma RII and Fc gamma RIIIa binding activity of IgG1 was observed to depend on the galactosylation level, and hypergalactosylated antibodies demonstrated increased receptor interaction. Sialylation did not decrease the Fc gamma R binding of the tested IgGs; in contrast, sialylation of antibodies improved binding to Fc gamma RIIa and IIb. We demonstrate that glycosylation influences to some extent IgG1 interaction with FcRn. However, independent of glycosylation pattern the interaction of IgG1 with a soluble monomeric target surprisingly resulted in an impaired receptor binding. Here, we demonstrate, that immune complexes (IC), induced by multimeric ligand, compensated for the decreased affinity of target bound antibody towards FcRs, showing the importance of the IC-formation for the FcR-mediated effector functions.	[Dashivets, Tetyana; Rueger, Petra; Knaupp, Alexander; Schlothauer, Tilman] Roche Innovat Ctr, Biochem & Analyt Res, Large Mol Res, Roche Pharma Res & Early Dev PRED, Penzberg, Germany; [Thomann, Marco] Roche Diagnost GmbH, Pharma Biotech Dev Penzberg, Penzberg, Germany; [Dashivets, Tetyana; Buchner, Johannes] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich, D-85748 Garching, Germany	Roche Holding; Technical University of Munich	Schlothauer, T (corresponding author), Roche Innovat Ctr, Biochem & Analyt Res, Large Mol Res, Roche Pharma Res & Early Dev PRED, Penzberg, Germany.	tilman.schlothauer@roche.com	Buchner, Johannes/A-2651-2010	Buchner, Johannes/0000-0003-1282-7737	Roche Pharma Research and Early Development (pRED) Roche Innovation Center Penzberg; Pharma Technical Development Penzberg, Roche Diagnostics GmbH	Roche Pharma Research and Early Development (pRED) Roche Innovation Center Penzberg; Pharma Technical Development Penzberg, Roche Diagnostics GmbH	The author(s) received no specific funding for this work. Roche Pharma Research and Early Development (pRED) Roche Innovation Center Penzberg and Pharma Technical Development Penzberg, Roche Diagnostics GmbH provided support in the form of salaries for authors TD, MT, PR, AK, and TS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anthony RM, 2012, ANN NY ACAD SCI, V1253, P170, DOI 10.1111/j.1749-6632.2011.06305.x; Anthony RM, 2011, CURR OPIN ORGAN TRAN, V16, P7, DOI 10.1097/MOT.0b013e328342538f; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Arnold JN, 2006, IMMUNOL LETT, V106, P103, DOI 10.1016/j.imlet.2006.05.007; Baker K, 2014, FRONT IMMUNOL, V5, DOI [10.3389/fimmu.2014.00664, 10.3389/fimmu.2014.00408]; Baker K, 2011, P NATL ACAD SCI USA, V108, P9927, DOI 10.1073/pnas.1019037108; Bohm S, 2012, SEMIN IMMUNOPATHOL, V34, P443, DOI 10.1007/s00281-012-0308-x; Boyd PN, 1995, MOL IMMUNOL, V32, P1311, DOI 10.1016/0161-5890(95)00118-2; Brorson K, 2014, CURR OPIN BIOTECH, V30, P140, DOI 10.1016/j.copbio.2014.06.012; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Buck PM, 2013, MABS-AUSTIN, V5, P904, DOI 10.4161/mabs.26453; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Ferrara C, 2006, J BIOL CHEM, V281, P5032, DOI 10.1074/jbc.M510171200; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Hayes JM, 2014, J PROTEOME RES, V13, P5471, DOI 10.1021/pr500414q; Hogarth PM, 2012, NAT REV DRUG DISCOV, V11, P311, DOI 10.1038/nrd2909; HOGARTH PM, 1992, IMMUNOL RES, V11, P217, DOI 10.1007/BF02919128; Houde D, 2010, MOL CELL PROTEOMICS, V9, P1716, DOI 10.1074/mcp.M900540-MCP200; Hristodorov D, 2013, MOL BIOTECHNOL, V53, P326, DOI 10.1007/s12033-012-9531-x; Huang W, 2012, J AM CHEM SOC, V134, P12308, DOI 10.1021/ja3051266; Ito K, 2014, J IMMUNOL, V192, P581, DOI 10.4049/jimmunol.1302488; Jefferis R, 2002, IMMUNOL LETT, V82, P57, DOI 10.1016/S0165-2478(02)00019-6; JEFFERIS R, 1995, IMMUNOL LETT, V44, P111, DOI 10.1016/0165-2478(94)00201-2; JEFFERIS R, 1993, GLYCOCONJUGATE J, V10, P358; Jefferis R, 2012, ARCH BIOCHEM BIOPHYS, V526, P159, DOI 10.1016/j.abb.2012.03.021; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Jefferis Roy, 2009, V483, P223, DOI 10.1007/978-1-59745-407-0_13; Jiang XR, 2011, NAT REV DRUG DISCOV, V10, P101, DOI 10.1038/nrd3365; Jung ST, 2011, CURR OPIN BIOTECH, V22, P858, DOI 10.1016/j.copbio.2011.03.002; Kanda Y, 2007, GLYCOBIOLOGY, V17, P104, DOI 10.1093/glycob/cwl057; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kapur R, 2014, IMMUNOL LETT; Karsten CM, 2012, NAT MED, V18, P1401, DOI 10.1038/nm.2862; Kayser V, 2011, BIOTECHNOL J, V6, P38, DOI 10.1002/biot.201000091; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Kumpel Belinda M., 1995, Human Antibodies and Hybridomas, V6, P82; Leabman MK, 2013, MABS-AUSTIN, V5, P896, DOI 10.4161/mabs.26436; Lux A, 2013, J IMMUNOL, V190, P4315, DOI 10.4049/jimmunol.1200501; Mimura Y, 2000, MOL IMMUNOL, V37, P697, DOI 10.1016/S0161-5890(00)00105-X; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Nimmerjahn F, 2011, CURR TOP MICROBIOL, V350, P105, DOI 10.1007/82_2010_86; Nimmerjahn F, 2010, IMMUNOL REV, V236, P265, DOI 10.1111/j.1600-065X.2010.00910.x; Nimmerjahn Falk, 2008, V415, P151, DOI 10.1007/978-1-59745-570-1_9; Oda M, 2003, INT IMMUNOL, V15, P417, DOI 10.1093/intimm/dxg036; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Park-Min KH, 2007, IMMUNITY, V26, P67, DOI 10.1016/j.immuni.2006.11.010; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; Rath T, 2013, J CLIN IMMUNOL, V33, pS9, DOI 10.1007/s10875-012-9768-y; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Scallon BJ, 2007, MOL IMMUNOL, V44, P1524, DOI 10.1016/j.molimm.2006.09.005; Schlothauer T, 2013, MABS-AUSTIN, V5, P576, DOI 10.4161/mabs.24981; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Sela-Culang I, 2012, J IMMUNOL, V189, P4890, DOI 10.4049/jimmunol.1201493; Shibata-Koyama M, 2009, EXP HEMATOL, V37, P309, DOI 10.1016/j.exphem.2008.11.006; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Stracke J, 2014, MABS, V6; Thomann M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134949; Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1; Wang WR, 2011, DRUG METAB DISPOS, V39, P1469, DOI 10.1124/dmd.111.039453; Xue J, 2013, GLYCOCONJUGATE J, V30, P735, DOI 10.1007/s10719-013-9481-y; Yamada K, 2013, J AUTOIMMUN, V47, P104, DOI 10.1016/j.jaut.2013.09.001; Yamaguchi Y, 2006, BBA-GEN SUBJECTS, V1760, P693, DOI 10.1016/j.bbagen.2005.10.002; Zeck A, 2011, J PROTEOME RES, V10, P3031, DOI 10.1021/pr1012653; Zhang AM, 2014, ANAL CHEM, V86, P3468, DOI 10.1021/ac404130a; Zheng K, 2014, MABS-AUSTIN, V6, P649, DOI 10.4161/mabs.28588; Zheng K, 2011, MABS-AUSTIN, V3, P568, DOI 10.4161/mabs.3.6.17922	68	55	57	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0143520	10.1371/journal.pone.0143520	http://dx.doi.org/10.1371/journal.pone.0143520			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657484	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903600012
J	Fondo, EN; Chaloupka, M; Heymans, JJ; Skilleter, GA				Fondo, Esther N.; Chaloupka, Milani; Heymans, Johanna J.; Skilleter, Greg A.			Banning Fisheries Discards Abruptly Has a Negative Impact on the Population Dynamics of Charismatic Marine Megafauna	PLOS ONE			English	Article							GREAT-BARRIER-REEF; PRAWN TRAWLERS; MORETON-BAY; BY-CATCH; SEABIRD COMMUNITIES; FOOD WEBS; ECOSYSTEM; AUSTRALIA; SUBSIDIES; ECOPATH	Food subsidies have the potential to modify ecosystems and affect the provision of goods and services. Predictable Anthropogenic Food Subsidies (PAFS) modify ecosystems by altering ecological processes and food webs. The global concern over the effects of PAFS in ecosystems has led to development of environmental policies aimed at curbing the production or ultimately banning of PAFS. However, the effects of reducing or banning PAFS are not known. We explore the consequences of PAFS removal in a marine ecosystem under two scenarios: 1) gradual reduction, or 2) an abrupt ban, using a mass balance model to test these hypotheses-The reduction or loss of PAFS will: i) modify trophic levels and food webs through effects on foraging by opportunistic species, ii) increase the resilience of opportunistic species to food shortages, and iii) modify predator-prey interactions through shifts in prey consumption. We found that PAFS lower the trophic levels of opportunistic scavengers and increase their food pathways. Scavengers are able to switch prey when PAFS are reduced gradually but they decline when PAFS are abruptly banned. PAFS reduction to a certain minimal level causes a drop in the ecosystem's stability. We recommend gradual reduction of PAFS to a minimal level that would maintain the ecosystem's stability and allow species exploiting PAFS to habituate to the food subsidy reduction.	[Fondo, Esther N.; Chaloupka, Milani; Skilleter, Greg A.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Fondo, Esther N.] Kenya Marine & Fisheries Res Inst, Mombasa, Kenya; [Heymans, Johanna J.] Scottish Assoc Marine Sci, Oban, Argyll, Scotland	University of Queensland; UHI Millennium Institute	Fondo, EN (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	sther.fondo@uqconnect.edu.au; g.skilleter@uq.edu.au	Heymans, Johanna J/H-4848-2012; Skilleter, Greg Alan/F-9250-2010; Fondo, Esther/A-9295-2016	Heymans, Johanna J/0000-0002-7290-8988; Skilleter, Greg Alan/0000-0002-4719-0409; Fondo, Esther/0000-0002-5529-1867	University of Queensland (UQ); Natural Environment Research Council [NE/L003058/1] Funding Source: researchfish; NERC [NE/L003058/1] Funding Source: UKRI	University of Queensland (UQ)(University of Queensland); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work forms part of a PhD dissertation of ENF at the University of Queensland. We wish to thank the following: The University of Queensland (UQ) for the PhD Scholarship, Queensland Department of Agriculture and Fisheries for the Queensland Fishing data, Scottish Association for Marine Science for the Ecopath with Ecosim (EwE) training undertaken by ENF, Kenya Marine and Fisheries Research Institute for approval to ENF to do the PhD, Moggill-Mt. Crosby Anglican Parish for travel support for ENF to attend the EwE training and the Ecopath Consortium for the EwE software. We also thank Russell Richard (UQ), Dylan Moffitt (UQ) and the Editor and reviewers from PLOS ONE for comments and improvements of earlier versions of this paper.	Alverson DLF M.H., 1994, FAO PUBLICATION; [Anonymous], 2005, DISCARDS WORLDS MARI; Bartels P, 2012, OECOLOGIA, V168, P807, DOI 10.1007/s00442-011-2141-7; Bartumeus F, 2010, CURR BIOL, V20, P215, DOI 10.1016/j.cub.2009.11.073; Bicknell AWJ, 2013, J APPL ECOL, V50, P649, DOI 10.1111/1365-2664.12072; Bozzano A, 2002, ICES J MAR SCI, V59, P15, DOI 10.1006/jmsc.2001.1142; Carrete M, 2006, ECOL APPL, V16, P1674, DOI 10.1890/1051-0761(2006)016[1674:DPDIPB]2.0.CO;2; Chaloupka M, 2004, CORAL REEFS, V23, P325, DOI 10.1007/s00338-004-0387-9; Chilvers BL, 2001, P ROY SOC B-BIOL SCI, V268, P1901, DOI 10.1098/rspb.2001.1732; CHRISTENSEN V, 1995, ECOL MODEL, V77, P3, DOI 10.1016/0304-3800(93)E0073-C; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; CHRISTENSEN V, 1992, ECOL MODEL, V61, P169, DOI 10.1016/0304-3800(92)90016-8; Cortes-Avizanda A, 2012, ECOLOGY, V93, P2570, DOI 10.1890/12-0221.1; COURTNEY AJ, 1995, ESTUAR COAST SHELF S, V41, P377, DOI 10.1016/0272-7714(95)90000-4; Day JC, 2002, OCEAN COAST MANAGE, V45, P139, DOI 10.1016/S0964-5691(02)00052-2; Donazar JA, 2009, SCIENCE, V326, P664, DOI 10.1126/science.326_664a; FINN JT, 1976, J THEOR BIOL, V56, P363, DOI 10.1016/S0022-5193(76)80080-X; Furness RW, 2007, MAR ECOL PROG SER, V350, P235, DOI 10.3354/meps07191; HILL BJ, 1990, AUST J MAR FRESH RES, V41, P53; Hill BJ, 2000, FISH RES, V48, P277, DOI 10.1016/S0165-7836(00)00185-5; Hunsicker ME, 2011, ECOL LETT, V14, P1288, DOI 10.1111/j.1461-0248.2011.01696.x; Margalida A, 2014, ECOL APPL, V24, P436, DOI 10.1890/13-0414.1; Margalida A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065857; Margalida A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00753; Margalida A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020248; Martinez-Abrain A, 2012, J APPL ECOL, V49, P109, DOI 10.1111/j.1365-2664.2011.02080.x; Mateo-Tomas P, 2015, DIVERS DISTRIB, P1; Matthew, 1994, BOOK MATTHEW, V13, P47; Monaco ME, 1997, MAR ECOL PROG SER, V161, P239, DOI 10.3354/meps161239; Morris DW, 2005, ECOLOGY, V86, P2568, DOI 10.1890/04-0909; Newsome TM, 2015, GLOBAL ECOL BIOGEOGR, V24, P1, DOI 10.1111/geb.12236; Newsome TM, 2014, OECOLOGIA, V175, P139, DOI 10.1007/s00442-014-2889-7; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Oro D, 2013, ECOL LETT, V16, P1501, DOI 10.1111/ele.12187; Oro D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004084; Pichegru L, 2007, MAR ECOL PROG SER, V350, P127, DOI 10.3354/meps07128; Pitt K.A., 2009, JELLYFISH BLOOMS CAU, V206; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; POLOVINA JJ, 1984, CORAL REEFS, V3, P1, DOI 10.1007/BF00306135; Ramsay K, 1996, MAR ECOL PROG SER, V144, P63, DOI 10.3354/meps144063; Robertson AI, 1994, HAMMOND LS SYNNOT RN, P297; Ruffino L, 2013, OECOLOGIA, V172, P737, DOI 10.1007/s00442-012-2545-z; Saila SB, 1983, FAO PUBLICATION, P1; Sarda F, 2015, FISH FISH, V16, P175, DOI 10.1111/faf.12060; Skilleter GA, 2007, MAR ECOL PROG SER, V351, P287, DOI 10.3354/meps07174; Svane I, 2008, FISH RES, V90, P158, DOI 10.1016/j.fishres.2007.10.008; Tamsett D, 1999, FISH RES, V42, P117, DOI 10.1016/S0165-7836(99)00030-2; Ulanowicz R. E., 1986, GROWTH DEV ECOSYSTEM; Vasconcellos M, 1997, ECOL MODEL, V100, P125, DOI 10.1016/S0304-3800(97)00150-6; Votier SC, 2004, NATURE, V427, P727, DOI 10.1038/nature02315; Votier SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057376; Walters C, 1997, REV FISH BIOL FISHER, V7, P139, DOI 10.1023/A:1018479526149; WASSENBERG TJ, 1990, AUST J MAR FRESH RES, V41, P27, DOI 10.1071/MF9900027; WASSENBERG TJ, 1989, FISH RES, V7, P99, DOI 10.1016/0165-7836(89)90010-6; Zhou SJ, 2008, FISH FISH, V9, P308, DOI 10.1111/j.1467-2979.2008.00291.x	55	22	22	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144543	10.1371/journal.pone.0144543	http://dx.doi.org/10.1371/journal.pone.0144543			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657412	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903600054
J	Lind, TK; Wacklin, H; Schiller, J; Moulin, M; Haertlein, M; Pomorski, TG; Cardenas, M				Lind, Tania Kjellerup; Wacklin, Hanna; Schiller, Juergen; Moulin, Martine; Haertlein, Michael; Pomorski, Thomas Gunther; Cardenas, Marite			Formation and Characterization of Supported Lipid Bilayers Composed of Hydrogenated and Deuterated Escherichia coli Lipids	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; QUARTZ-CRYSTAL MICROBALANCE; QCM-D; VESICLE ADSORPTION; NEUTRON REFLECTION; PLANAR BILAYERS; MODEL MEMBRANES; SOLID-SURFACES; CELL; CARDIOLIPIN	Supported lipid bilayers are widely used for sensing and deciphering biomolecular interactions with model cell membranes. In this paper, we present a method to form supported lipid bilayers from total lipid extracts of Escherichia coli by vesicle fusion. We show the validity of this method for different types of extracts including those from deuterated biomass using a combination of complementary surface sensitive techniques; quartz crystal microbalance, neutron reflection and atomic force microscopy. We find that the head group composition of the deuterated and the hydrogenated lipid extracts is similar (approximately 75% phosphatidylethanolamine, 13% phosphatidylglycerol and 12% cardiolipin) and that both samples can be used to reconstitute high-coverage supported lipid bilayers with a total thickness of 41 +/- 3 angstrom, common for fluid membranes. The formation of supported lipid bilayers composed of natural extracts of Escherichia coli allow for following biomolecular interactions, thus advancing the field towards bacterial-specific membrane biomimics.	[Lind, Tania Kjellerup; Wacklin, Hanna; Cardenas, Marite] Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark; [Lind, Tania Kjellerup; Wacklin, Hanna; Cardenas, Marite] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Lind, Tania Kjellerup; Wacklin, Hanna] European Spallat Source ESS AB, Lund, Sweden; [Schiller, Juergen] Univ Leipzig, Fac Med, Inst Med Phys & Biophys, D-04109 Leipzig, Germany; [Moulin, Martine; Haertlein, Michael] Inst Laue Langevin, Life Sci Grp, Grenoble, France; [Pomorski, Thomas Gunther] Univ Copenhagen, Ctr Membrane Pumps Cells & Disease PUMPKIN, Dept Plant & Environm Sci, Copenhagen, Denmark; [Cardenas, Marite] Malmoe Univ, Dept Biomed Sci Hlth & Soc, S-20500 Malmo, Sweden	University of Copenhagen; University of Copenhagen; European Spallation Source (ESS); Leipzig University; Institut Laue-Langevin (ILL); University of Copenhagen; Malmo University	Cardenas, M (corresponding author), Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark.	cardenas@nano.ku.dk	Pomorski, Thomas Günther/G-4804-2014; Cardenas, Marite/AAG-1793-2019; Lind, Tania/AAF-5003-2021; Cárdenas, Marité/O-4669-2014; Lind, Tania Kjellerup/A-1412-2012	Pomorski, Thomas Günther/0000-0002-4889-0829; Cardenas, Marite/0000-0003-0392-3540; Cárdenas, Marité/0000-0003-0392-3540; Lind, Tania Kjellerup/0000-0003-0800-5650	European Spallation Source ESS AB in Lund, Sweden; Danscatt Centre - Danish government; Research Centre 'bioSYNergy' at University of Copenhagen - UCPH Excellence Program for Interdisciplinary Research; Swedish Research Council; Engineering and Physical Sciences Research Council [GR/R99393/01, EP/C015452/1]; EU [RII3-CT-2003-505925, NMP4-CT-2006-033256]; European Spallation Source; EPSRC [GR/R99393/01, EP/C015452/1]	European Spallation Source ESS AB in Lund, Sweden; Danscatt Centre - Danish government; Research Centre 'bioSYNergy' at University of Copenhagen - UCPH Excellence Program for Interdisciplinary Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EU(European Commission); European Spallation Source; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work was supported by the following: European Spallation Source ESS AB in Lund, Sweden (TKL); Danscatt Centre funded by the Danish government (MC); The Research Centre 'bioSYNergy' at University of Copenhagen funded by the UCPH Excellence Program for Interdisciplinary Research (TGP and MC); The Swedish Research Council (MC); and The Engineering and Physical Sciences Research Council (grants GR/R99393/01 and EP/C015452/1), EU contracts RII3-CT-2003-505925 and NMP4-CT-2006-033256 (MH). The European Spallation Source provided support in the form of salaries for author Tania K. Lind, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.; The authors wish to thank the ILL for allocation of beam time and Robert Barker for local support. We thank Volker Wirth and Karen Martinez for providing the hydrogenated E. coli biomass and Vivien Jagalski for help with DLS measurements. We acknowledge funding from the European Spallation Source in the form of salaries for author Tania K. Lind. This work was supported by the Danscatt Centre funded by the Danish government, the Research Centre 'bioSYNergy' at University of Copenhagen funded by the UCPH Excellence Program for Interdisciplinary Research (to TGP and MC) and the Swedish Research Council (to MC). MH would like to acknowledge the EPSRC for support (grants GR/R99393/01 and EP/C015452/1) for the creation of the Deuteration Laboratory in ILL's Life Sciences Group and for EU contracts RII3-CT-2003-505925 and NMP4-CT-2006-033256 that have supported associated developments.	Akesson A, 2012, SOFT MATTER, V8, P5658, DOI 10.1039/c2sm00013j; Armen RS, 1998, BIOPHYS J, V75, P734, DOI 10.1016/S0006-3495(98)77563-0; Arouri A, 2009, BBA-BIOMEMBRANES, V1788, P650, DOI 10.1016/j.bbamem.2008.11.022; Artero JB, 2005, ACTA CRYSTALLOGR D, V61, P1541, DOI 10.1107/S0907444905028532; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blodgett KB, 1935, J AM CHEM SOC, V57, P1007, DOI 10.1021/ja01309a011; Briand E, 2010, ANALYST, V135, P343, DOI 10.1039/b918288h; Campbell RA, 2011, EUR PHYS J PLUS, V126, DOI 10.1140/epjp/i2011-11107-8; Chan YHM, 2007, CURR OPIN CHEM BIOL, V11, P581, DOI 10.1016/j.cbpa.2007.09.020; Cho NJ, 2010, NAT PROTOC, V5, P1096, DOI 10.1038/nprot.2010.65; Clifton LA, 2015, ANGEW CHEM INT EDIT, V54, P11952, DOI 10.1002/anie.201504287; Clifton LA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0810; Cubitt R, 2002, APPL PHYS A-MATER, V74, pS329, DOI 10.1007/s003390201611; de Ghellinck A, 2015, BBA-BIOMEMBRANES, V1848, P2317, DOI 10.1016/j.bbamem.2015.06.006; Dodd CE, 2008, BIOINTERPHASES, V3, pFA59, DOI 10.1116/1.2896113; Domenech O, 2006, COLLOID SURFACE B, V47, P102, DOI 10.1016/j.colsurfb.2005.11.025; Fuchs B, 2009, ANAL BIOANAL CHEM, V395, P2479, DOI 10.1007/s00216-009-3032-1; Garcia-Manyes S, 2005, BIOPHYS J, V89, P1812, DOI 10.1529/biophysj.105.064030; Gidden J, 2009, INT J MASS SPECTROM, V283, P178, DOI 10.1016/j.ijms.2009.03.005; Greenwood AI, 2006, CHEM PHYS LIPIDS, V143, P1, DOI 10.1016/j.chemphyslip.2006.04.002; Hung WC, 2006, CHINESE J PHYS, V44, P137; ISHINAGA M, 1979, J BIOCHEM-TOKYO, V86, P161; Jing YJ, 2014, SOFT MATTER, V10, P187, DOI 10.1039/c3sm50947h; Kim YR, 2012, SENSORS-BASEL, V12, P9530, DOI 10.3390/s120709530; Lam KLH, 2012, BBA-BIOMEMBRANES, V1818, P194, DOI 10.1016/j.bbamem.2011.11.002; Lewis RNAH, 2009, BBA-BIOMEMBRANES, V1788, P2069, DOI 10.1016/j.bbamem.2009.03.014; Lind TK, 2015, BBA-BIOMEMBRANES, V1848, P2075, DOI 10.1016/j.bbamem.2015.05.015; Lind TK, 2014, LANGMUIR, V30, P7259, DOI 10.1021/la500897x; Lopes S, 2010, ANAL BIOANAL CHEM, V398, P1357, DOI 10.1007/s00216-010-4028-6; Lopes SC, 2012, MOL MEMBR BIOL, V29, P207, DOI 10.3109/09687688.2012.700491; LUGTENBERG EJJ, 1976, BIOCHIM BIOPHYS ACTA, V441, P38, DOI 10.1016/0005-2760(76)90279-4; Mecke A, 2005, BIOPHYS J, V89, P4043, DOI 10.1529/biophysj.105.062596; Merino S, 2003, LANGMUIR, V19, P6922, DOI 10.1021/la034232y; Merz C, 2008, BIOINTERPHASES, V3, pFA41, DOI 10.1116/1.2896119; Nelson A, 2006, J APPL CRYSTALLOGR, V39, P273, DOI 10.1107/S0021889806005073; NOLLERT P, 1995, BIOPHYS J, V69, P1447, DOI 10.1016/S0006-3495(95)80014-7; Ollivon M, 2000, BBA-BIOMEMBRANES, V1508, P34, DOI 10.1016/S0304-4157(00)00006-X; Pandit KR, 2012, BBA-BIOMEMBRANES, V1818, P1205, DOI 10.1016/j.bbamem.2012.01.009; Peetla C, 2009, MOL PHARMACEUT, V6, P1264, DOI 10.1021/mp9000662; Piantavigna S, 2011, BBA-BIOMEMBRANES, V1808, P1811, DOI 10.1016/j.bbamem.2011.03.002; Pomorski TG, 2014, ADV COLLOID INTERFAC, V205, P207, DOI 10.1016/j.cis.2013.10.028; RAETZ CRH, 1978, MICROBIOL REV, V42, P614, DOI 10.1128/MMBR.42.3.614-659.1978; Rakowska PD, 2013, P NATL ACAD SCI USA, V110, P8918, DOI 10.1073/pnas.1222824110; Reimhult E, 2003, LANGMUIR, V19, P1681, DOI 10.1021/la0263920; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; RICE PA, 1988, REV INFECT DIS, V10, pS277; Richter R, 2003, BIOPHYS J, V85, P3035, DOI 10.1016/S0006-3495(03)74722-5; Richter RP, 2005, BIOPHYS J, V88, P3422, DOI 10.1529/biophysj.104.053728; RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Ruiz N, 2004, BIOPHYS CHEM, V111, P1, DOI 10.1016/j.bpc.2004.03.006; Sani MA, 2012, BBA-BIOMEMBRANES, V1818, P205, DOI 10.1016/j.bbamem.2011.07.015; Separovic F, 1996, BIOPHYS J, V71, P274, DOI 10.1016/S0006-3495(96)79223-8; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Suarez-Germa C, 2011, J PHYS CHEM B, V115, P12778, DOI 10.1021/jp206369k; Vacklin HP, 2005, LANGMUIR, V21, P2827, DOI 10.1021/la047389e; Vacklin HP, 2005, BBA-BIOMEMBRANES, V1668, P17, DOI 10.1016/j.bbamem.2004.11.001; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233; Wacklin HP, 2010, CURR OPIN COLLOID IN, V15, P445, DOI 10.1016/j.cocis.2010.05.008; Wang KF, 2014, COLLOID SURFACE B, V116, P472, DOI 10.1016/j.colsurfb.2014.01.036; White Da Fau-Lennarz WJ, DISTRIBUTION LIPIDS; Yang LH, 2007, J AM CHEM SOC, V129, P12141, DOI 10.1021/ja072310o	64	34	34	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144671	10.1371/journal.pone.0144671	http://dx.doi.org/10.1371/journal.pone.0144671			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658241	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903600075
J	Zhang, ZQ; Han, YZ; Nian, Q; Chen, G; Cui, SQ; Wang, XY				Zhang, Zhi-Qiang; Han, Yu-Zhen; Nian, Qing; Chen, Gang; Cui, Shu-Qing; Wang, Xing-Yong			Tumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis and Unfavorable Prognosis in Young Breast Cancer Patients (<= 35 Years)	PLOS ONE			English	Article							VEGF-C; EXPRESSION; WOMEN; RECURRENCE; MMP-9; AGE; PATTERNS; FEATURES; SUBTYPES; VESSELS	The morbidity rate of breast cancer is on the rise, and the age of onset appears to be trending toward a young age. Breast cancer in young women (BCYW) has a number of distinctive features that differ from breast cancer in middle-aged or elderly women (BCMEW). Lymphatic metastasis plays an important role in the spread of BCYW; however, the mechanisms of lymph node metastasis (LNM) in BCYW are not clear. This study aimed to investigate the mechanism of lymphatic metastasis in BCYW and to evaluate the relationships between lymphangiogenesis, the expression of matrix metalloproteinase 9 (MMP-9) and vascular endothelial growth factor C (VEGF-C) expression, clinicopathological characteristics, and prognosis. Using immunohistochemistry, MMP-9, VEGF-C and the level of lymphatic microvessel density (LMVD) were analyzed in 106 cases of breast invasive ductal carcinoma and 20 cases of breast proliferative lesions. Compared with BCMEW, BCYW had higher MMP-9 expression, higher LNM, and more adverse prognoses. In BCYW, high MMP-9 expression was positively correlated with LNM and impaired survival time. However, in BCMEW, MMP-9 expression was not correlated with LNM or survival time. In addition, high VEGF-C expression was positively correlated with a high level of LMVD in both BCYW and BCMEW. Nevertheless, a high level of LMVD was not correlated with LNM or survival time in the two groups. More importantly, univariate and multivariate survival analysis showed that MMP-9 expression and LNM were independent prognostic factors in BCYW. Our present study indicates that lymphangiogenesis induced by VEGF-C is augmented in breast cancer; however, a higher level of lymphangiogenesis has no significant impact on LNM or survival time. We suggest that tumor invasiveness, rather than lymphangiogenesis, plays an important role in LNM among BCYW. Moreover, MMP-9 and LNM were independent prognostic factors for BCYW.	[Zhang, Zhi-Qiang; Nian, Qing; Wang, Xing-Yong] Key Lab Child Dev & Disorders, Minist Educ, Chongqing, Peoples R China; [Zhang, Zhi-Qiang; Nian, Qing; Wang, Xing-Yong] Key Lab Pediat Chongqing, Chongqing, Peoples R China; [Zhang, Zhi-Qiang; Nian, Qing; Wang, Xing-Yong] Chongqing Int Sci & Technol Cooperat Ctr Child De, Chongqing, Peoples R China; [Zhang, Zhi-Qiang; Nian, Qing; Wang, Xing-Yong] Chongqing Med Univ, Childrens Hosp, Dept Crit Care Med, Chongqing, Peoples R China; [Han, Yu-Zhen] Binzhou Med Univ, Affiliated Hosp, Dept Pathol, Binzhou, Peoples R China; [Chen, Gang] Binzhou Med Univ, Affiliated Hosp, Dept Vasc & Endovasc Surg, Binzhou, Peoples R China; [Cui, Shu-Qing] Community Hlth Serv Ctr North Binzhou, Dept Nursing Care & Intervent, Binzhou, Peoples R China	Chongqing Medical University; Binzhou Medical University; Binzhou Medical University	Zhang, ZQ (corresponding author), Key Lab Child Dev & Disorders, Minist Educ, Chongqing, Peoples R China.	ZhangZQ678@gmail.com; golden678@foxmail.com	Han, Yu/GZA-9220-2022					Aebi S, 2000, LANCET, V355, P1869, DOI 10.1016/S0140-6736(00)02292-3; Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; Brinton LA, 2008, JNCI-J NATL CANCER I, V100, P1643, DOI 10.1093/jnci/djn344; Colleoni M, 2002, ANN ONCOL, V13, P273, DOI 10.1093/annonc/mdf039; Fredholm H, 2009, PLOS ONE, V4, pA38, DOI 10.1371/journal.pone.0007695; Gnerlich JL, 2009, J AM COLL SURGEONS, V208, P341, DOI 10.1016/j.jamcollsurg.2008.12.001; Gou HF, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-14; Gu Y, 2008, CLIN EXP METASTAS, V25, P717, DOI 10.1007/s10585-008-9180-4; Han W, 2010, BREAST CANCER RES TR, V119, P193, DOI 10.1007/s10549-009-0388-z; Hao L, 2007, CANCER LETT, V253, P34, DOI 10.1016/j.canlet.2007.01.005; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hillen F, 2007, CANCER METAST REV, V26, P489, DOI 10.1007/s10555-007-9094-7; HUTTER RVP, 1990, CANCER-AM CANCER SOC, V66, P1363, DOI 10.1002/1097-0142(19900915)66:14+<1363::AID-CNCR2820661411>3.0.CO;2-4; Jackson DG, 2001, TRENDS IMMUNOL, V22, P317, DOI 10.1016/S1471-4906(01)01936-6; Karaman S, 2014, J CLIN INVEST, V124, P922, DOI 10.1172/JCI71606; Karpanen T, 2001, J EXP MED, V194, pF37, DOI 10.1084/jem.194.6.F37; Kroman N, 2000, BRIT MED J, V320, P474, DOI 10.1136/bmj.320.7233.474; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Livi L, 2010, EJSO-EUR J SURG ONC, V36, P639, DOI 10.1016/j.ejso.2010.05.016; Lowery AJ, 2012, BREAST CANCER RES TR, V133, P831, DOI 10.1007/s10549-011-1891-6; McGowan PM, 2008, ANN ONCOL, V19, P1566, DOI 10.1093/annonc/mdn180; Metzger O, 2013, J CLIN ONCOL, V31, P3083, DOI 10.1200/JCO.2012.46.1574; Miles RC, 2012, ANN SURG ONCOL, V19, P1153, DOI 10.1245/s10434-011-2084-6; Nakamura Y, 2005, BREAST CANCER RES TR, V91, P125, DOI 10.1007/s10549-004-5783-x; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Su JL, 2008, CANCER CELL, V13, P557, DOI 10.1016/j.ccr.2008.04.021; Timoshenko AV, 2007, BRIT J CANCER, V97, P1090, DOI 10.1038/sj.bjc.6603993; van der Schaft DWJ, 2007, CANCER LETT, V254, P128, DOI 10.1016/j.canlet.2007.03.001; Wei JT, 2014, SCI REP-UK, V4, DOI 10.1038/srep05360; Williams CSM, 2003, J PATHOL, V200, P195, DOI 10.1002/path.1343; Wu QW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097804; Wu QW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-47; Wu ZS, 2008, INT J CANCER, V122, P2050, DOI 10.1002/ijc.23337; Yousef EM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-609; Zhang XH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-4; Zhuo W, 2012, CLIN CANCER RES, V18, P5387, DOI 10.1158/1078-0432.CCR-12-0708	37	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144376	10.1371/journal.pone.0144376	http://dx.doi.org/10.1371/journal.pone.0144376			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656588	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903600040
J	Almeida, F; Sardinha-Silva, A; da Silva, TA; Pessoni, AM; Pinzan, CF; Alegre-Maller, ACP; Ceclio, NT; Moretti, NS; Damsio, ARL; Pedersoli, WR; Mineo, JR; Silva, RN; Roque-Barreira, MC				Almeida, Fausto; Sardinha-Silva, Aline; da Silva, Thiago Aparecido; Pessoni, Andre Moreira; Pinzan, Camila Figueiredo; Paiva Alegre-Maller, Ana Claudia; Ceclio, Nerry Tatiana; Moretti, Nilmar Silvio; Lima Damsio, Andre Ricardo; Pedersoli, Wellington Ramos; Mineo, Jose Roberto; Silva, Roberto Nascimento; Roque-Barreira, Maria Cristina			Toxoplasma gondii Chitinase Induces Macrophage Activation	PLOS ONE			English	Article							BETA-N-ACETYLGLUCOSAMINIDASE; PARACOCCIDIOIDES-BRASILIENSIS; STRUCTURAL COMPONENT; STATISTICAL-MODEL; PURIFICATION; IDENTIFICATION; PROTEINS; TISSUE; TRANSMISSION; ENCEPHALITIS	Toxoplasma gondii is an obligate intracellular protozoan parasite found worldwide that is able to chronically infect almost all vertebrate species, especially birds and mammalians. Chitinases are essential to various biological processes, and some pathogens rely on chitinases for successful parasitization. Here, we purified and characterized a chitinase from T. gondii. The enzyme, provisionally named Tg_chitinase, has a molecular mass of 13.7 kDa and exhibits a Km of 0.34 mM and a Vmax of 2.64. The optimal environmental conditions for enzymatic function were at pH 4.0 and 50 degrees C. Tg_chitinase was immunolocalized in the cytoplasm of highly virulent T. gondii RH strain tachyzoites, mainly at the apical extremity. Tg_chitinase induced macrophage activation as manifested by the production of high levels of pro-inflammatory cytokines, a pathogenic hallmark of T. gondii infection. In conclusion, to our knowledge, we describe for the first time a chitinase of T. gondii tachyzoites and provide evidence that this enzyme might influence the pathogenesis of T. gondii infection.	[Almeida, Fausto; Sardinha-Silva, Aline; da Silva, Thiago Aparecido; Pessoni, Andre Moreira; Pinzan, Camila Figueiredo; Paiva Alegre-Maller, Ana Claudia; Ceclio, Nerry Tatiana; Roque-Barreira, Maria Cristina] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, BR-14049900 Ribeirao Preto, SP, Brazil; [Moretti, Nilmar Silvio] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, SP, Brazil; [Lima Damsio, Andre Ricardo] Univ Estadual Campinas, Dept Bioquim & Biol Tecidual, Inst Biol, Campinas, SP, Brazil; [Pedersoli, Wellington Ramos; Silva, Roberto Nascimento] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, BR-14049900 Ribeirao Preto, SP, Brazil; [Mineo, Jose Roberto] Univ Fed Uberlandia, Lab Imunoparasitol, Dept Imunol Microbiol & Parasitol, BR-38400902 Uberlandia, MG, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Federal de Uberlandia	Roque-Barreira, MC (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.	mcrbarre@fmrp.usp.br	Silva, Roberto/F-3897-2012; da Silva, Thiago Aparecido/I-2315-2015; Moretti, Nilmar/G-1952-2015; Roque-Barreira, Maria-Cristina/A-4552-2008; Cecilio, Nerry/L-2378-2016; Almeida, Fausto/N-6540-2013; Mineo, Jose R/B-4151-2009; Cecilio, Nerry/L-9927-2017; Moretti, Nilmar Silvio/J-4459-2013; Damasio, André RL/H-1162-2016; Pessoni, André/A-3791-2014	Silva, Roberto/0000-0002-8992-7130; da Silva, Thiago Aparecido/0000-0001-5017-6539; Moretti, Nilmar/0000-0003-0455-2497; Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; Almeida, Fausto/0000-0002-3782-3698; Mineo, Jose R/0000-0002-9010-7228; Moretti, Nilmar Silvio/0000-0003-0455-2497; Damasio, André RL/0000-0001-9304-3998; Cecilio, Nerry Tatiana/0000-0001-5465-5238; Ramos Pedersoli, Wellington/0000-0002-3982-0626; Pessoni, Andre/0000-0003-4549-1387	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/10741-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto	This study was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Grant number 2013/10741-8). Additional financial help was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto.; This study was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Grant number 2013/10741-8). Additional financial help was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto. We are grateful to Dr Maria Aparecida Souza for fruitful discussions of our results. We also thank Patricia Vendruscolo and Sandra Thomaz for technical support.	Almeida F, 2015, EUKARYOT CELL, V14, P1173, DOI 10.1128/EC.00103-15; Arantes TEF, 2015, AM J OPHTHALMOL, V159, P1002, DOI 10.1016/j.ajo.2015.02.015; ARROYOBEGOVICH A, 1980, J PARASITOL, V66, P735, DOI 10.2307/3280662; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Boothroyd JC, 1997, PHILOS T ROY SOC B, V352, P1347, DOI 10.1098/rstb.1997.0119; CAMARGO ME, 1978, INFECT IMMUN, V21, P55, DOI 10.1128/IAI.21.1.55-58.1978; Castro LDS, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-41; Coppin A, 2003, BIOCHIMIE, V85, P353, DOI 10.1016/S0300-9084(03)00076-2; De Marco JL, 2004, APPL MICROBIOL BIOT, V64, P70, DOI 10.1007/s00253-003-1490-5; Almeida FBD, 2014, YEAST, V31, P1, DOI 10.1002/yea.2983; Almeida FBD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029216; Almeida FBD, 2010, YEAST, V27, P67, DOI 10.1002/yea.1731; Duo-Chuan L, 2006, MYCOPATHOLOGIA, V161, P345, DOI 10.1007/s11046-006-0024-y; ElMoudni B, 1996, EXP PARASITOL, V83, P167, DOI 10.1006/expr.1996.0063; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; HUNTER CA, 1994, INFECT IMMUN, V62, P2818, DOI 10.1128/IAI.62.7.2818-2824.1994; Jensen KDC, 2015, MBIO, V6, DOI 10.1128/mBio.02280-14; Jung C, 2004, INT J PARASITOL, V34, P285, DOI 10.1016/j.ijpara.2003.12.004; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Koch BEV, 2015, GLYCOBIOLOGY, V25, P469, DOI 10.1093/glycob/cwv005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Li H, 2002, APPL MICROBIOL BIOT, V60, P420, DOI 10.1007/s00253-002-1129-y; Lourenco EV, 2001, GLYCOBIOLOGY, V11, P541, DOI 10.1093/glycob/11.7.541; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; Lyons RE, 2002, TRENDS PARASITOL, V18, P198, DOI 10.1016/S1471-4922(02)02248-1; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; Marshall ES, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-80; Montoya JG, 2005, CLIN PERINATOL, V32, P705, DOI 10.1016/j.clp.2005.04.011; Nance JP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002990; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Park JK, 2011, J APPL MICROBIOL, V110, P277, DOI 10.1111/j.1365-2672.2010.04879.x; Pinzan CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143087; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; ROSE NR, 1975, IMMUNOL COMMUN, V4, P1, DOI 10.3109/08820137509055757; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SchartonKersten TM, 1996, J IMMUNOL, V157, P4045; SCHLEIN Y, 1992, P NATL ACAD SCI USA, V89, P9944, DOI 10.1073/pnas.89.20.9944; SHAHABUDDIN M, 1993, P NATL ACAD SCI USA, V90, P4266, DOI 10.1073/pnas.90.9.4266; Shahabuddin M, 1999, EXS, V87, P223; Sobrinho IDJ, 2005, BIOTECHNOL LETT, V27, P1273, DOI 10.1007/s10529-005-0218-2; SUZUKI Y, 1989, J INFECT DIS, V159, P790, DOI 10.1093/infdis/159.4.790; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; WARD HD, 1985, INFECT IMMUN, V49, P629, DOI 10.1128/IAI.49.3.629-634.1985; Wasmuth JD, 2012, MBIO, V3, DOI 10.1128/mBio.00321-12; YABUKI M, 1986, J GEN APPL MICROBIOL, V32, P25, DOI 10.2323/jgam.32.25; Zeng XM, 2000, J BACTERIOL, V182, P1916, DOI 10.1128/JB.182.7.1916-1922.2000	48	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144507	10.1371/journal.pone.0144507	http://dx.doi.org/10.1371/journal.pone.0144507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26659253	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903500034
J	Spencer, JD; Jackson, AR; Li, BR; Ching, CB; Vonau, M; Easterling, RS; Schwaderer, AL; McHugh, KM; Becknell, B				Spencer, John David; Jackson, Ashley R.; Li, Birong; Ching, Christina B.; Vonau, Martin; Easterling, Robert S.; Schwaderer, Andrew L.; McHugh, Kirk M.; Becknell, Brian			Expression and Significance of the HIP/PAP and RegIII gamma Antimicrobial Peptides during Mammalian Urinary Tract Infection	PLOS ONE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; PANCREAS/PANCREATITIS-ASSOCIATED PROTEIN; HOST-DEFENSE; BACTERICIDAL LECTIN; MOUSE STRAINS; BLADDER; MICE; INTESTINE; CYSTITIS; CELLS	Recent evidence indicates that antimicrobial peptides (AMPs) serve key roles in defending the urinary tract against invading uropathogens. To date, the individual contribution of AMPs to urinary tract host defense is not well defined. In this study, we identified Regenerating islet-derived 3 gamma (RegIII gamma) as the most transcriptionally up-regulated AMP in murine bladder transcriptomes following uropathogenic Escherichia coli (UPEC) infection. We confirmed induction of RegIII gamma mRNA during cystitis and pyelonephritis by quantitative RT-PCR. Immunoblotting demonstrates increased bladder and urinary RegIII gamma protein levels following UPEC infection. Immunostaining localizes RegIII gamma protein to urothelial cells of infected bladders and kidneys. Human patients with UTI have increased urine concentrations of the orthologous Hepatocarcinoma-Intestine-Pancreas /Pancreatitis Associated Protein (HIP/PAP) compared to healthy controls. Recombinant RegIII gamma protein does not demonstrate bactericidal activity toward UPEC in vitro, but does kill Staphylococcus saprophyticus in a dose-dependent manner. Kidney and bladder tissue from RegIII gamma knockout mice and wild-type mice contain comparable bacterial burden following UPEC and Gram-positive UTI. Our results demonstrate that RegIII gamma and HIP/PAP expression is induced during human and murine UTI. However, their specific function in the urinary tract remains uncertain.	[Spencer, John David; Schwaderer, Andrew L.; Becknell, Brian] Ohio State Univ, Coll Med, Dept Pediat, Div Nephrol, Columbus, OH 43210 USA; [Spencer, John David; Li, Birong; Schwaderer, Andrew L.; Becknell, Brian] Res Inst Nationwide Childrens, Ctr Clin & Translat Res, Columbus, OH USA; [Jackson, Ashley R.] Ohio State Univ, Coll Med, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Ching, Christina B.] Ohio State Univ, Coll Med, Dept Surg, Div Urol, Columbus, OH 43210 USA; [Vonau, Martin] Ohio State Univ, Coll Med, Dept Pediat & Internal Med, Columbus, OH 43210 USA; [Easterling, Robert S.] Med Coll Ohio, Toledo, OH 43699 USA; [McHugh, Kirk M.] Ohio State Univ, Coll Med, Dept Anat, Columbus, OH 43210 USA; [McHugh, Kirk M.] Res Inst Nationwide Childrens, Ctr Mol & Human Genet, Columbus, OH USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Becknell, B (corresponding author), Ohio State Univ, Coll Med, Dept Pediat, Div Nephrol, Columbus, OH 43210 USA.	Brian.Becknell2@nationwidechildrens.org		Jackson, Ashley R./0000-0002-1571-3906	National Institute of Diabetes and Digestive and Kidney Diseases; NIDDK [K08-DK094970-02, RO1-DK106286-01];  [K08-DK102594]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106286, K08DK102594, K08DK094970] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Three authors are supported by the National Institute of Diabetes and Digestive and Kidney Diseases (http://www.niddk.nih.gov). JDS is supported by NIDDK K08-DK094970-02. ALS is supported by NIDDK RO1-DK106286-01. BB is supported by K08-DK102594. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali ASM, 2009, J UROLOGY, V182, P21, DOI 10.1016/j.juro.2009.02.124; [Anonymous], 2012, HEALTHCARE COST UTIL; Becknell B, 2015, NAT REV NEPHROL; Becknell B, 2015, KIDNEY INT, V87, P151, DOI 10.1038/ki.2014.268; Becknell B, 2015, EXPERT REV ANTI-INFE, V13, P81, DOI 10.1586/14787210.2015.986097; Becknell B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077714; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Cash HL, 2006, PROTEIN EXPRES PURIF, V48, P151, DOI 10.1016/j.pep.2006.01.014; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Choi SM, 2014, INFECT IMMUN, V82, P1402, DOI 10.1128/IAI.00974-13; Choi SM, 2013, J EXP MED, V210, P551, DOI 10.1084/jem.20120260; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Dessing MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013394; Duell BL, 2012, J IMMUNOL, V188, P781, DOI 10.4049/jimmunol.1101231; Folch-Puy E, 2006, J IMMUNOL, V176, P3774, DOI 10.4049/jimmunol.176.6.3774; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Frantz AL, 2012, MUCOSAL IMMUNOL, V5, P501, DOI 10.1038/mi.2012.23; Gatermann S, 1988, FEMS Microbiol Immunol, V1, P179; Griebling TL, 2005, J UROLOGY, V173, P1281, DOI 10.1097/01.ju.0000155596.98780.82; Guha A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088848; Gupta K, 2014, INFECT DIS CLIN N AM, V28, P49, DOI 10.1016/j.idc.2013.10.002; Hannan TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001042; Haversen LA, 2000, INFECT IMMUN, V68, P5816, DOI 10.1128/IAI.68.10.5816-5823.2000; Hopkins WJ, 1996, INFECT IMMUN, V64, P1369, DOI 10.1128/IAI.64.4.1369-1372.1996; Hopkins WJ, 1998, INFECT IMMUN, V66, P2798, DOI 10.1128/IAI.66.6.2798-2802.1998; Kao JS, 1997, INFECT IMMUN, V65, P2812, DOI 10.1128/IAI.65.7.2812-2820.1997; Kau AL, 2005, INFECT IMMUN, V73, P2461, DOI 10.1128/IAI.73.4.2461-2468.2005; Kinnebrew MA, 2010, J INFECT DIS, V201, P534, DOI 10.1086/650203; Kline KA, 2010, INFECT IMMUN, V78, P1943, DOI 10.1128/IAI.01235-09; Lai YP, 2012, IMMUNITY, V37, P74, DOI 10.1016/j.immuni.2012.04.010; Lee KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030786; Loonen LMP, 2014, MUCOSAL IMMUNOL, V7, P939, DOI 10.1038/mi.2013.109; Makino T, 2010, UROLOGY, V75, P933, DOI 10.1016/j.urology.2009.05.044; Matsumoto S, 2012, J COMP NEUROL, V520, P479, DOI 10.1002/cne.22705; Mukherjee S, 2014, NATURE, V505, P103, DOI 10.1038/nature12729; Mukherjee S, 2009, J BIOL CHEM, V284, P4881, DOI 10.1074/jbc.M808077200; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mysorekar IU, 2009, CELL HOST MICROBE, V5, P463, DOI 10.1016/j.chom.2009.04.005; Mysorekar IU, 2002, J BIOL CHEM, V277, P7412, DOI 10.1074/jbc.M110560200; Nienhouse V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114185; Nitta Y, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-24; Paragas N, 2014, J CLIN INVEST, V124, P2963, DOI 10.1172/JCI71630; Roberts KB, 2011, PEDIATRICS, V128, P595, DOI 10.1542/peds.2011-1330; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwartz DJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004599; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Spencer JD, 2014, PEDIATR NEPHROL, V29, P1139, DOI 10.1007/s00467-013-2513-9; Spencer JD, 2013, KIDNEY INT, V83, P615, DOI 10.1038/ki.2012.410; Stange J, 2012, J IMMUNOL, V188, P2410, DOI 10.4049/jimmunol.1102062; Steigedal M, 2014, J IMMUNOL, V193, P6081, DOI 10.4049/jimmunol.1401528; Stockinger S, 2014, J IMMUNOL, V193, P4223, DOI 10.4049/jimmunol.1302708; Takahara Y, 2008, J UROLOGY, V179, P1603, DOI 10.1016/j.juro.2007.11.034; Tan CK, 2012, INFECT IMMUN, V80, P3145, DOI 10.1128/IAI.00023-12; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Zasloff M, 2007, J AM SOC NEPHROL, V18, P2810, DOI 10.1681/ASN.2007050611; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhou G, 2001, J CELL SCI, V114, P4095	59	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144024	10.1371/journal.pone.0144024	http://dx.doi.org/10.1371/journal.pone.0144024			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658437	gold, Green Submitted, Green Published			2022-12-27	WOS:000366903500012
J	Spriewald, S; Glaser, J; Beutler, M; Koeppel, MB; Stecher, B				Spriewald, Stefanie; Glaser, Jana; Beutler, Markus; Koeppel, Martin B.; Stecher, Baerbel			Reporters for Single-Cell Analysis of Colicin Ib Expression in Salmonella enterica Serovar Typhimurium	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; K ACTIVITY GENE; ESCHERICHIA-COLI; CHROMOSOMAL GENES; CONSTRUCTION; INDUCTION; K-12; CKA; INFLAMMATION; PROMOTER	Colicins are toxins that mediate interference competition in microbial ecosystems. They serve as a "common good" for the entire producer population but are synthesized by only few members which pay the costs of colicin production. We have previously shown that production of colicin Ib (cib), a group B colicin, confers a competitive advantage to Salmonella enterica serovar Typhimurium (S. Tm) over commensal E. coli strains. Here, we studied regulation of S. Tm cib expression at the single cell level. Comparative analysis of a single-and a multicopy gfp-reporter for the colicin Ib promoter (Pcib) revealed that the latter yielded optimal signal intensity for a diverse range of applications. We further validated this reporter and showed that gfp expression correlated well with colicin Ib (ColIb) protein levels in individual cells. Pcib is negatively controlled by two repressors, LexA and Fur. Only a small fraction of S. Tm expressed cib under non-inducing conditions. We studied Pcib activity in response to mitomycin C mediated DNA damage and iron limitation. Both conditions, if applied individually, lead to an increase in the fraction of GFP(+) S. Tm, albeit an overall low fluorescence intensity. When both conditions were applied simultaneously, the majority of S. Tm turned GFP(+) and displayed high fluorescence intensity. Thus, both repressors individually confine cib expression to a subset of the population. Taken together, we provide the first thorough characterization of a conventional gfp-reporter to study regulation of a group B colicin at the single cell level. This reporter will be useful to further investigate the costs and benefits of ColIb production in human pathogenic S. Tm and analyze cib expression under environmental conditions encountered in the mammalian gut.	[Spriewald, Stefanie; Glaser, Jana; Beutler, Markus; Koeppel, Martin B.; Stecher, Baerbel] Ludwig Maximilians Univ Munchen, Max Von Pettenkofer Inst, D-80336 Munich, Germany; [Glaser, Jana; Koeppel, Martin B.; Stecher, Baerbel] German Ctr Infect Res DZIF, Munich, Germany	University of Munich; German Center for Infection Research	Stecher, B (corresponding author), Ludwig Maximilians Univ Munchen, Max Von Pettenkofer Inst, Pettenkoferstr 9a, D-80336 Munich, Germany.	stecher@mvp.uni-muenchen.de	Stecher, Barbel/B-9940-2019; Stecher, Bärbel/A-2911-2015	Stecher, Bärbel/0000-0002-7445-5193	DFG [DFG STE 1971/2-1, DFG STE 1971/61]	DFG(German Research Foundation (DFG))	The work was supported by grants from the DFG (DFG STE 1971/2-1 and DFG STE 1971/61) to BS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; Butala M, 2012, MOL MICROBIOL, V86, P129, DOI 10.1111/j.1365-2958.2012.08179.x; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIES JK, 1975, J BACTERIOL, V123, P96, DOI 10.1128/JB.123.1.96-101.1975; Ghazaryan L, 2014, ARCH MICROBIOL, V196, P753, DOI 10.1007/s00203-014-1017-8; Gillor O, 2008, MICROBIOL-SGM, V154, P1783, DOI 10.1099/mic.0.2007/016139-0; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hebisch E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075991; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hol FJH, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0068-2; Husseiny MI, 2005, INFECT IMMUN, V73, P1598, DOI 10.1128/IAI.73.3.1598-1605.2005; Kamensek S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-283; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Kuhar I, 1999, J BACTERIOL, V181, P7373, DOI 10.1128/JB.181.23.7373-7380.1999; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Majeed H, 2015, J ANTIBIOT, V68, P52, DOI 10.1038/ja.2014.84; Majeed H, 2011, ISME J, V5, P71, DOI 10.1038/ismej.2010.90; MANKOVICH JA, 1986, J BACTERIOL, V168, P228, DOI 10.1128/jb.168.1.228-236.1986; Moller AK, 2003, INFECT IMMUN, V71, P2142, DOI 10.1128/IAI.71.4.2142-2152.2003; Mrak P, 2007, MOL GENET GENOMICS, V277, P391, DOI 10.1007/s00438-006-0185-x; Mulec J, 2003, J BACTERIOL, V185, P654, DOI 10.1128/JB.185.2.654-659.2003; Nanda AM, 2014, J BACTERIOL, V196, P180, DOI 10.1128/JB.01018-13; Nedialkova LP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003844; OZEKI H, 1959, NATURE, V184, P337, DOI 10.1038/184337a0; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Riley MA, 2002, BIOCHIMIE, V84, P357, DOI 10.1016/S0300-9084(02)01421-9; Schlumberger MC, 2005, P NATL ACAD SCI USA, V102, P12548, DOI 10.1073/pnas.0503407102; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stecher B, 2013, NAT REV MICROBIOL, V11, P277, DOI 10.1038/nrmicro2989; Stecher B, 2012, P NATL ACAD SCI USA, V109, P1269, DOI 10.1073/pnas.1113246109; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; WEAVER CA, 1981, BIOCHIM BIOPHYS ACTA, V645, P137, DOI 10.1016/0005-2736(81)90521-6; Yang TY, 2010, NUCLEIC ACIDS RES, V38, P3936, DOI 10.1093/nar/gkq177	40	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144647	10.1371/journal.pone.0144647	http://dx.doi.org/10.1371/journal.pone.0144647			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26659346	gold, Green Submitted, Green Published			2022-12-27	WOS:000366903500052
J	Correa, ARV; Berbel, ACER; Papa, MP; de Morais, ATS; Pecanha, LMT; de Arruda, LB				Vargas Correa, Arturo Ramon; Egypto Rosa Berbel, Ana Carolina; Papa, Michelle Premazzi; de Morais, Ana Theresa Silveira; Torres Pecanha, Ligia Maria; de Arruda, Luciana Barros			Dengue Virus Directly Stimulates Polyclonal B Cell Activation	PLOS ONE			English	Article							CROSS-REACTIVE ANTIBODIES; ORIGINAL ANTIGENIC SIN; PRINCIPAL TARGET-CELLS; SIGNAL-TRANSDUCTION; MONOCLONAL-ANTIBODIES; HEMORRHAGIC-FEVER; IMMUNE-RESPONSE; T-CELLS; INFECTION; PATHOGENESIS	Dengue infection is associated to vigorous inflammatory response, to a high frequency of activated B cells, and to increased levels of circulating cross-reactive antibodies. We investigated whether direct infection of B cells would promote activation by culturing primary human B lymphocytes from healthy donors with DENV in vitro. B cells were susceptible, but poorly permissive to infection. Even though, primary B cells cultured with DENV induced substantial IgM secretion, which is a hallmark of polyclonal B cell activation. Notably, DENV induced the activation of B cells obtained from either DENV immune or DENV naive donors, suggesting that it was not dependent on DENV-specific secondary/memory response. B cell stimulation was dependent on activation of MAPK and CD81. B cells cultured with DENV also secreted IL-6 and presented increased expression of CD86 and HLA-DR, which might contribute to B lymphocyte co-stimulatory function. Indeed, PBMCs, but not isolated B cells, secreted high amounts of IgG upon DENV culture, suggesting that interaction with other cell types in vivo might promote Ig isotype switching and IgG secretion from different B cell clones. These findings suggest that activation signaling pathways triggered by DENV interaction with non-specific receptors on B cells might contribute to the exacerbated response observed in dengue patients.	[Vargas Correa, Arturo Ramon; Egypto Rosa Berbel, Ana Carolina; Papa, Michelle Premazzi; de Morais, Ana Theresa Silveira; de Arruda, Luciana Barros] Univ Fed Rio de Janeiro, Dept Virol, Inst Microbiol Paulo Goes, Rio De Janeiro, RJ, Brazil; [Torres Pecanha, Ligia Maria] Univ Fed Rio de Janeiro, Dept Imunol, Inst Microbiol Paulo Goes, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	de Arruda, LB (corresponding author), Univ Fed Rio de Janeiro, Dept Virol, Inst Microbiol Paulo Goes, Rio De Janeiro, RJ, Brazil.	arruda@micro.ufrj.br	Arruda, Luciana B/N-9086-2013	Vargas Correa, Arturo Ramon/0000-0002-9326-3074; Premazzi Papa, Michelle/0000-0003-1957-666X	Brazilian Ministry of Health; CAPES; CNPq; FAPERJ; program INCT-Dengue; program Pronex-Rede Dengue; CAPES fellowship; CNPq fellowship	Brazilian Ministry of Health; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); program INCT-Dengue; program Pronex-Rede Dengue; CAPES fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Brazilian Ministry of Health, CAPES, CNPq, FAPERJ, and by the programs INCT-Dengue and Pronex-Rede Dengue. A. C. E. R. Berbel was the recipient of a CAPES fellowship, A. R. V. Correa was the recipient of a FAPERJ and CAPES fellowship. A. T. S. Morais and M. P. Papa were the recipients of a CNPq fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029430; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Blackley S, 2007, J VIROL, V81, P13325, DOI 10.1128/JVI.01568-07; BOONPUCKNAVIG S, 1976, AM J PATHOL, V85, P37; Campbell KS, 1999, CURR OPIN IMMUNOL, V11, P256, DOI 10.1016/S0952-7915(99)80042-9; CHUNGUE E, 1994, J INFECT DIS, V170, P1304, DOI 10.1093/infdis/170.5.1304; Conceicao TM, 2010, J VIROL METHODS, V163, P1, DOI 10.1016/j.jviromet.2009.10.001; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188; De Vita S, 2008, AUTOIMMUN REV, V8, P95, DOI 10.1016/j.autrev.2008.05.005; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; DEUBEL V, 1988, VIROLOGY, V165, P234, DOI 10.1016/0042-6822(88)90677-0; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Efremov DG, 2007, AUTOIMMUN REV, V7, P102, DOI 10.1016/j.autrev.2007.02.021; Farquhar MJ, 2011, BIOCHEM SOC T, V39, P532, DOI 10.1042/BST0390532; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; FEARON DT, 1995, ANNU REV IMMUNOL, V13, P127, DOI 10.1146/annurev.immunol.13.1.127; Friberg H, 2012, VIRAL IMMUNOL, V25, P348, DOI 10.1089/vim.2012.0010; Garcia-Bates TM, 2013, J IMMUNOL, V190, P80, DOI 10.4049/jimmunol.1103350; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P350; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kou Z, 2008, J MED VIROL, V80, P134, DOI 10.1002/jmv.21051; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001; Li XL, 2000, EUR J IMMUNOL, V30, P1576, DOI 10.1002/1521-4141(200006)30:6<1576::AID-IMMU1576>3.0.CO;2-0; Lin CF, 2003, J MED VIROL, V69, P82, DOI 10.1002/jmv.10261; Lin CF, 2001, J MED VIROL, V63, P143, DOI 10.1002/1096-9071(20000201)63:2&lt;143::AID-JMV1009&gt;3.0.CO;2-L; Lin YS, 2004, CURR PHARM DESIGN, V10, P213, DOI 10.2174/1381612043453469; Lin YW, 2002, J VIROL, V76, P12242, DOI 10.1128/JVI.76.23.12242-12249.2002; Machida K, 2005, J VIROL, V79, P8079, DOI 10.1128/JVI.79.13.8079-8089.2005; Machida K, 2008, J VIROL, V82, P6711, DOI 10.1128/JVI.02582-07; Maddaly R, 2010, FEBS LETT, V584, P4883, DOI 10.1016/j.febslet.2010.08.022; MARKOFF LJ, 1991, J INFECT DIS, V164, P294, DOI 10.1093/infdis/164.2.294; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; MATSUMOTO AK, 1993, J EXP MED, V178, P1407, DOI 10.1084/jem.178.4.1407; Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Rosa D, 2005, P NATL ACAD SCI USA, V102, P18544, DOI 10.1073/pnas.0509402102; Rossbacher J, 2003, J EXP MED, V198, P591, DOI 10.1084/jem.20022042; Rothman AL, 1999, VIROLOGY, V257, P1, DOI 10.1006/viro.1999.9656; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Schieffelin JS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-28; Thai KTD, 2011, CLIN MICROBIOL INFEC, V17, P1823, DOI 10.1111/j.1469-0691.2010.03434.x; THEOFILOPOULOS AN, 1976, J IMMUNOL, V117, P953; Woods A, 2007, J VIROL, V81, P12525, DOI 10.1128/JVI.00839-07; Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11	58	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0143391	10.1371/journal.pone.0143391	http://dx.doi.org/10.1371/journal.pone.0143391			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26656738	Green Submitted, gold, Green Published			2022-12-27	WOS:000366903500003
J	Yabuno, K; Morise, J; Kizuka, Y; Hashii, N; Kawasaki, N; Takahashi, S; Miyata, S; Izumikawa, T; Kitagawa, H; Takematsu, H; Oka, S				Yabuno, Keiko; Morise, Jyoji; Kizuka, Yasuhiko; Hashii, Noritaka; Kawasaki, Nana; Takahashi, Satoru; Miyata, Shinji; Izumikawa, Tomomi; Kitagawa, Hiroshi; Takematsu, Hiromu; Oka, Shogo			A Sulfated Glycosaminoglycan Linkage Region Is a Novel Type of Human Natural Killer-1 (HNK-1) Epitope Expressed on Aggrecan in Perineuronal Nets	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; CARBOHYDRATE EPITOPE; POSTNATAL-DEVELOPMENT; SYNAPTIC PLASTICITY; CORTICAL PLASTICITY; MOLECULAR-CLONING; GLUCURONIC-ACID; NERVOUS-SYSTEM; UP-REGULATION; TENASCIN-R	Human natural killer-1 (HNK-1) carbohydrate (HSO3-3GlcA beta 1-3Gal beta 1-4GlcNAc-R) is highly expressed in the brain and required for learning and neural plasticity. We previously demonstrated that expression of the HNK-1 epitope is mostly abolished in knockout mice for GlcAT-P (B3gat1), a major glucuronyltransferase required for HNK-1 biosynthesis, but remained in specific regions such as perineuronal nets (PNNs) in these mutant mice. Considering PNNs are mainly composed of chondroitin sulfate proteoglycans (CSPGs) and regulate neural plasticity, GlcAT-P-independent expression of HNK-1 in PNNs is suggested to play a role in neural plasticity. However, the function, structure, carrier glycoprotein and biosynthetic pathway for GlcAT-P-irrelevant HNK-1 epitope remain unclear. In this study, we identified a unique HNK-1 structure on aggrecan in PNNs. To determine the biosynthetic pathway for the novel HNK-1, we generated knockout mice for GlcAT-S (B3gat2), the other glucuronyltransferase required for HNK-1 biosynthesis. However, GlcAT-P and GlcAT-S double-knockout mice did not exhibit reduced HNK-1 expression compared with single GlcAT-P-knockout mice, indicating an unusual biosynthetic pathway for the HNK-1 epitope in PNNs. Aggrecan was purified from cultured cells in which GlcAT-P and -S are not expressed and we determined the structure of the novel HNK-1 epitope using liquid chromatography/mass spectrometry (LC/MS) as a sulfated linkage region of glycosaminoglycans (GAGs), HSO3-GlcA-Gal-Gal-Xyl-R. Taken together, we propose a hypothetical model where GlcAT-I, the sole glucuronyltransferase required for synthesis of the GAG linkage, is also responsible for biosynthesis of the novel HNK-1 on aggrecan. These results could lead to discovery of new roles of the HNK-1 epitope in neural plasticity.	[Yabuno, Keiko; Morise, Jyoji; Takematsu, Hiromu; Oka, Shogo] Kyoto Univ, Grad Sch Med, Dept Biol Chem, Human Hlth Sci, Kyoto 6068507, Japan; [Kizuka, Yasuhiko] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto 6068501, Japan; [Hashii, Noritaka; Kawasaki, Nana] Natl Inst Hlth Sci, Div Biol Chem & Biol, Tokyo 1588501, Japan; [Takahashi, Satoru] Univ Tsukuba, Fac Med, Dept Anat & Embryol, Tsukuba, Ibaraki 3058575, Japan; [Miyata, Shinji; Izumikawa, Tomomi; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Kobe, Hyogo 6588558, Japan	Kyoto University; Kyoto University; National Institute of Health Sciences - Japan; University of Tsukuba; Kobe Pharmaceutical University	Oka, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Biol Chem, Human Hlth Sci, Kyoto 6068507, Japan.	shogo@hs.med.kyoto-u.ac.jp	Miyata, Shinji/S-6000-2019; Kitagawa, Hiroshi/AAJ-1344-2020	Miyata, Shinji/0000-0001-6635-1645; Kitagawa, Hiroshi/0000-0002-9307-7079; Takematsu, Hiromu/0000-0003-1689-9500; Kizuka, Yasuhiko/0000-0002-3181-9743	MEXT of Japan [23110006]; Japan Society for the Promotion of Science [26291021, 24590078]	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (No. 23110006 to S.O.) from MEXT of Japan, and Grantsin-Aid for Scientific Research (B) (No. 26291021 to S.O.) and Scientific Research (C) (No. 24590078 to H.T.) from the Japan Society for the Promotion of Science.	Alpar A, 2006, BRAIN RES, V1120, P13, DOI 10.1016/j.brainres.2006.08.069; Bakker H, 1997, J BIOL CHEM, V272, P29942, DOI 10.1074/jbc.272.47.29942; Bartolini G, 2013, NEURON, V79, P849, DOI 10.1016/j.neuron.2013.08.014; Berardi N, 2004, NEURON, V44, P905, DOI 10.1016/S0896-6273(04)00796-2; BLUE ME, 1983, J NEUROCYTOL, V12, P599, DOI 10.1007/BF01181526; Bruckner G, 2000, J COMP NEUROL, V428, P616, DOI 10.1002/1096-9861(20001225)428:4<616::AID-CNE3>3.0.CO;2-K; Carulli D, 2006, J COMP NEUROL, V494, P559, DOI 10.1002/cne.20822; Carulli D, 2007, J COMP NEUROL, V501, P83, DOI 10.1002/cne.21231; CELIO MR, 1994, BRAIN RES REV, V19, P128, DOI 10.1016/0165-0173(94)90006-X; Dino MR, 2006, NEUROSCIENCE, V142, P1055, DOI 10.1016/j.neuroscience.2006.07.054; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; Dwyer CA, 2012, NEUROSCIENCE, V220, P47, DOI 10.1016/j.neuroscience.2012.06.026; Dwyer CA, 2015, J BIOL CHEM, V290, P10256, DOI 10.1074/jbc.M114.614099; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Frischknecht R, 2012, ADV EXP MED BIOL, V970, P153, DOI 10.1007/978-3-7091-0932-8_7; Frischknecht R, 2008, NEURON GLIA BIOL, V4, P249, DOI 10.1017/S1740925X09990226; Galtrey CM, 2008, EUR J NEUROSCI, V27, P1373, DOI 10.1111/j.1460-9568.2008.06108.x; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Hamada Y, 2015, NEUROSCI RES, V91, P63, DOI 10.1016/j.neures.2014.09.010; Hashiguchi T, 2011, J BIOL CHEM, V286, P33003, DOI 10.1074/jbc.M111.279174; HOCKFIELD S, 1990, COLD SPRING HARB SYM, V55, P505; Imiya K, 2002, GENE, V296, P29, DOI 10.1016/S0378-1119(02)00840-5; Izumikawa T, 2015, J BIOL CHEM, V290, P5438, DOI 10.1074/jbc.M114.603266; Izumikawa T, 2010, J BIOL CHEM, V285, P12190, DOI 10.1074/jbc.M110.100941; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; KITAGAWA H, 1995, ANAL BIOCHEM, V232, P114, DOI 10.1006/abio.1995.9952; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; KOSAKA T, 1989, BRAIN RES, V483, P158, DOI 10.1016/0006-8993(89)90048-6; Lander C, 1997, J NEUROSCI, V17, P1928; MAEDA N, 1992, DEV BIOL, V151, P564, DOI 10.1016/0012-1606(92)90194-L; Matsui F, 1998, BRAIN RES, V790, P45, DOI 10.1016/S0006-8993(98)00009-2; Matthews RT, 2002, J NEUROSCI, V22, P7536; McRae PA, 2007, J NEUROSCI, V27, P5405, DOI 10.1523/JNEUROSCI.5425-06.2007; Miyata S, 2015, J BIOCHEM, V157, P13, DOI 10.1093/jb/mvu067; Miyata S, 2012, NAT NEUROSCI, V15, P414, DOI 10.1038/nn.3023; Morise J, 2014, GLYCOBIOLOGY, V24, P314, DOI 10.1093/glycob/cwt116; Morita I, 2009, J BIOL CHEM, V284, P30209, DOI 10.1074/jbc.M109.024208; Morris NP, 2000, EUR J NEUROSCI, V12, P828, DOI 10.1046/j.1460-9568.2000.00970.x; Myers AK, 2012, BRAIN RES, V1465, P34, DOI 10.1016/j.brainres.2012.05.024; Nakagawa N, 2013, GLYCOBIOLOGY, V23, P1066, DOI 10.1093/glycob/cwt043; Nakagawa N, 2011, BIOCHEM BIOPH RES CO, V415, P109, DOI 10.1016/j.bbrc.2011.10.023; Nakamura M, 2009, BRAIN RES, V1252, P117, DOI 10.1016/j.brainres.2008.11.022; Ohyama J, 1997, J COMP NEUROL, V389, P453; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Saghatelyan AK, 2000, EUR J NEUROSCI, V12, P3331, DOI 10.1046/j.1460-9568.2000.00216.x; Saitoh Y, 2008, J NEUROSCI RES, V86, P1316, DOI 10.1002/jnr.21582; Seiki T, 1999, BIOCHEM BIOPH RES CO, V255, P182, DOI 10.1006/bbrc.1999.0151; Soleman S, 2013, NEUROSCIENCE, V253, P194, DOI 10.1016/j.neuroscience.2013.08.050; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Suzuki-Anekoji M, 2013, J BIOL CHEM, V288, P5007, DOI 10.1074/jbc.M112.433474; Tagawa H, 2005, J BIOL CHEM, V280, P23876, DOI 10.1074/jbc.M501728200; Terayama K, 1997, P NATL ACAD SCI USA, V94, P6093, DOI 10.1073/pnas.94.12.6093; Tone Y, 1999, FEBS LETT, V459, P415, DOI 10.1016/S0014-5793(99)01287-9; Tone Y, 2008, J BIOL CHEM, V283, P16801, DOI 10.1074/jbc.M709556200; Voshol H, 1996, J BIOL CHEM, V271, P22957, DOI 10.1074/jbc.271.38.22957; Wakabayashi H, 1999, J BIOL CHEM, V274, P5436, DOI 10.1074/jbc.274.9.5436; Wang DF, 2012, CELL TISSUE RES, V349, P147, DOI 10.1007/s00441-012-1375-y; Wintergerst ES, 1996, INT J DEV NEUROSCI, V14, P249, DOI 10.1016/0736-5748(96)00011-1; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; YAMAMOTO M, 1988, NEUROSCI RES, V5, P273, DOI 10.1016/0168-0102(88)90031-4; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yuen CT, 1997, J BIOL CHEM, V272, P8924	63	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144560	10.1371/journal.pone.0144560	http://dx.doi.org/10.1371/journal.pone.0144560			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26659409	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903500041
J	Bai, L; Lan, RT; Zhang, XL; Cui, SH; Xu, J; Guo, YC; Li, FQ; Zhang, D				Bai, Li; Lan, Ruiting; Zhang, Xiuli; Cui, Shenghui; Xu, Jin; Guo, Yunchang; Li, Fengqin; Zhang, Ding			Prevalence of Salmonella Isolates from Chicken and Pig Slaughterhouses and Emergence of Ciprofloxacin and Cefotaxime Co-Resistant S. enterica Serovar Indiana in Henan, China	PLOS ONE			English	Article							NON-TYPHOIDAL SALMONELLA; ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; RETAIL CHICKEN; MULTIDRUG-RESISTANCE; NONTYPHOID SALMONELLA; QUINOLONE RESISTANCE; UNITED-STATES; SUSCEPTIBILITY; SEROTYPES	The prevalence of Salmonella from chicken and pig slaughterhouses in Henan, China and antimicrobial susceptibility of these isolates to antibiotics was determined. From 283 chicken samples and 240 pig samples collected, 128 and 70 Salmonella isolates were recovered with an isolation rate of 45.2 and 29.2% respectively. The predominant serovars in chicken samples were S. enterica serovar Enteritidis, S. enterica serovar Hadar and S. enterica serovar Indiana, while those in pig samples were S. enterica serovar Typhimurium, S. enterica serovar Derby and S. enterica serovar Enteritidis. Resistance to ciprofloxacin was 8.6 and 10.0% for isolates from chickens and pigs respectively, whereas resistance to cefotaxime was 5.5 and 8.6%, respectively. Multidrug resistance (resistance to three or more classes of antimicrobial agent) was markedly higher in pig isolates (57.1%) than in chicken isolates (39.8%). Of particular concern was the detection of ciprofloxacin and cefotaxime co-resistant S. enterica serovar Indiana isolates, which pose risk to public health. All 16 S. enterica serovar Indiana isolates detected were resistant to ciprofloxacin, among which 11 were co-resistant to cefotaxime. The S. enterica serovar Indiana isolates accumulated point mutations in quinolone resistance determination regions of gyrA (S83F/D87G or S83F/D87N) and parC (T57S/S80R). Two plasmid mediated quinolone resistant determinants were found with aac (6')-Ib-cr and oqxAB in 16 and 12 S. enterica serovar Indiana isolates respectively. Cefotaxime-resistance of S. enterica serovar Indiana was associated with the acquisition of a bla(CTX-M-65) gene. The potential risk of ciprofloxacin and cefotaxime co-resistant S. enterica serovar Indiana infection is a significant concern due to limited alternative treatment options. Reduction of Salmonella in chicken and pig slaughterhouses, in particular, ciprofloxacin and cefotaxime co-resistant S. enterica serovar Indiana will be an important measure to reduce the public health burden of Salmonella infections.	[Bai, Li; Xu, Jin; Guo, Yunchang; Li, Fengqin] China Natl Ctr Food Safety Risk Assessment, Key Lab Food Safety Risk Assessment, Minist Hlth, Beijing, Peoples R China; [Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Zhang, Xiuli; Zhang, Ding] Henan Ctr Dis Control & Prevent, Zhengzhou, Henan, Peoples R China; [Cui, Shenghui] Natl Inst Food & Drug Control, Dept Food Sci, Beijing, Peoples R China	University of New South Wales Sydney; National Institute of Food & Drug Control - China	Li, FQ (corresponding author), China Natl Ctr Food Safety Risk Assessment, Key Lab Food Safety Risk Assessment, Minist Hlth, Beijing, Peoples R China.	lifengqin@cfsa.net.cn; zhangd222@hncdc.com.cn		Lan, Ruiting/0000-0001-9834-5258				Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Chen S, 2007, ANTIMICROB AGENTS CH, V51, P535, DOI 10.1128/AAC.00600-06; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLSI S; Cui SH, 2009, J ANTIMICROB CHEMOTH, V63, P87, DOI 10.1093/jac/dkn452; de Jong A, 2014, VET MICROBIOL, V171, P298, DOI 10.1016/j.vetmic.2014.01.030; EFSA, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.135r; Hansen LH, 2007, J ANTIMICROB CHEMOTH, V60, P145, DOI 10.1093/jac/dkm167; Hernandez A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00022; Hue O, 2011, FOOD CONTROL, V22, P1158, DOI 10.1016/j.foodcont.2011.01.009; Jacoby GA, 2003, ANTIMICROB AGENTS CH, V47, P559, DOI 10.1128/AAC.47.2.559-562.2003; Jiang HX, 2014, INT J ANTIMICROB AG, V43, P242, DOI 10.1016/j.ijantimicag.2013.12.005; Lai J, 2013, FOODBORNE PATHOG DIS, V10, P581, DOI 10.1089/fpd.2012.1455; Li JY, 2010, FOODBORNE PATHOG DIS, V7, P1387, DOI 10.1089/fpd.2010.0581; Li RC, 2013, INT J FOOD MICROBIOL, V163, P14, DOI 10.1016/j.ijfoodmicro.2013.01.020; Li YF, 2014, FOODBORNE PATHOG DIS, V11, P200, DOI 10.1089/fpd.2013.1629; Liang ZM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0784-4; Liu JH, 2008, ANTIMICROB AGENTS CH, V52, P2992, DOI 10.1128/AAC.01686-07; Lu Y, 2011, FOODBORNE PATHOG DIS, V8, P45, DOI 10.1089/fpd.2010.0605; Lunguya O, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002103; M'ikanatha NM, 2010, FOODBORNE PATHOG DIS, V7, P929, DOI 10.1089/fpd.2009.0499; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Malorny B, 2003, INT J FOOD MICROBIOL, V89, P241, DOI 10.1016/S0168-1605(03)00154-5; Medalla F, 2013, FOODBORNE PATHOG DIS, V10, P302, DOI 10.1089/fpd.2012.1336; Munday CJ, 2004, INT J ANTIMICROB AG, V23, P175, DOI 10.1016/j.ijantimicag.2003.07.004; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Sandt CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077836; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Su LH, 2004, CLIN INFECT DIS, V39, P546, DOI 10.1086/422726; Vlieghe ER, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001933; Wang HH, 2013, FOOD CONTROL, V33, P378, DOI 10.1016/j.foodcont.2013.03.030; Wang YR, 2014, FOODBORNE PATHOG DIS, V11, P126, DOI 10.1089/fpd.2013.1586; White DG, 2001, NEW ENGL J MED, V345, P1147, DOI 10.1056/NEJMoa010315; Wong MHY, 2014, ANTIMICROB AGENTS CH, V58, P3752, DOI 10.1128/AAC.02770-13; Wu HY, 2013, J FOOD PROTECT, V76, P2040, DOI 10.4315/0362-028X.JFP-13-224; Xia SL, 2009, J CLIN MICROBIOL, V47, P401, DOI 10.1128/JCM.01099-08; Xu L, 2005, J MED MICROBIOL, V54, P1183, DOI 10.1099/jmm.0.46160-0; Xu X, 2014, MICROB DRUG RESIST, V20, P73, DOI 10.1089/mdr.2012.0224; Yang BW, 2013, FOOD CONTROL, V32, P228, DOI 10.1016/j.foodcont.2012.11.022; Yang BW, 2011, J FOOD PROTECT, V74, P1724, DOI 10.4315/0362-028X.JFP-11-215; Yang BW, 2010, INT J FOOD MICROBIOL, V141, P63, DOI 10.1016/j.ijfoodmicro.2010.04.015	41	63	67	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144532	10.1371/journal.pone.0144532	http://dx.doi.org/10.1371/journal.pone.0144532			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650239	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903300055
J	Duong, M; Moles, RJ; Chaar, B; Chen, TF				Duong, Mai; Moles, Rebekah J.; Chaar, Betty; Chen, Timothy F.		World Hosp Pharm Res Consortium	Essential Medicines in a High Income Country: Essential to Whom?	PLOS ONE			English	Article								Objective To explore the perspectives of a diverse group of stakeholders engaged in medicines decision making around what constitutes an "essential" medicine, and how the Essential Medicines List (EML) concept functions in a high income country context. Methods In-depth qualitative semi-structured interviews were conducted with 32 Australian stakeholders, recognised as decision makers, leaders or advisors in the area of medicines reimbursement or supply chain management. Participants were recruited from government, pharmaceutical industry, pharmaceutical wholesale/distribution companies, medicines non-profit organisations, academic health disciplines, hospitals, and consumer groups. Perspectives on the definition and application of the EML concept in a high income country context were thematically analysed using grounded theory approach. Findings Stakeholders found it challenging to describe the EML concept in the Australian context because many perceived it was generally used in resource scarce settings. Stakeholders were unable to distinguish whether nationally reimbursed medicines were essential medicines in Australia. Despite frequent generic drug shortages and high prices paid by consumers, many struggled to describe how the EML concept applied to Australia. Instead, broad inclusion of consumer needs, such as rare and high cost medicines, and consumer involvement in the decision making process, has led to expansive lists of nationally subsidised medicines. Therefore, improved communication and coordination is needed around shared interests between stakeholders regarding how medicines are prioritised and guaranteed in the supply chain. Conclusions This study showed that decision-making in Australia around reimbursement of medicines has strayed from the fundamental utilitarian concept of essential medicines. Many stakeholders involved in medicine reimbursement decisions and management of the supply chain did not consider the EML concept in their approach. The wide range of views of what stakeholders considered were essential medicines, challenges whether the EML concept is out-dated or underutilised in high income countries.	[Duong, Mai; Moles, Rebekah J.; Chaar, Betty; Chen, Timothy F.; World Hosp Pharm Res Consortium] Univ Sydney, Discipline Pharm Practice, Fac Pharm, Sydney, NSW 2006, Australia	University of Sydney	Duong, M (corresponding author), Univ Sydney, Discipline Pharm Practice, Fac Pharm, Sydney, NSW 2006, Australia.	mai.duong@sydney.edu.au	Chen, Timothy/X-3684-2019	Chen, Timothy/0000-0003-4189-8403					0	15	15	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143654	10.1371/journal.pone.0143654	http://dx.doi.org/10.1371/journal.pone.0143654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650544	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903300021
J	Wang, LG; Wu, XX; Liu, YF; Qiu, QS				Wang, Liguang; Wu, Xuexia; Liu, Yafen; Qiu, Quan-Sheng			AtNHX5 and AtNHX6 Control Cellular K+ and pH Homeostasis in Arabidopsis: Three Conserved Acidic Residues Are Essential for K+ Transport	PLOS ONE			English	Article							NA+/H+ EXCHANGER; SALT TOLERANCE; PLASMA-MEMBRANE; CATION/H+ ANTIPORTERS; PLANT-GROWTH; V-ATPASE; ROLES; YEAST; SOS1; OVEREXPRESSION	AtNHX5 and AtNHX6, the endosomal Na+, K+/H+ antiporters in Arabidopsis, play an important role in plant growth and development. However, their function in K+ and pH homeostasis remains unclear. In this report, we characterized the function of AtNHX5 and AtNHX6 in K+ and H+ homeostasis in Arabidopsis. Using a yeast expression system, we found that AtNHX5 and AtNHX6 recovered tolerance to high K+ or salt. We further found that AtNHX5 and AtNHX6 functioned at high K+ at acidic pH while AtCHXs at low K+ under alkaline conditions. In addition, we showed that the nhx5 nhx6 double mutant contained less K+ and was sensitive to low K+ treatment. Overexpression of AtNHX5 or AtNHX6 gene in nhx5 nhx6 recovered root growth to the wild-type level. Three conserved acidic residues, D164, E188, and D193 in AtNHX5 and D165, E189, and D194 in AtNHX6, were essential for K+ homeostasis and plant growth. nhx5 nhx6 had a reduced vacuolar and cellular pH as measured with the fluorescent pH indicator BCECF or semimicroelectrode. We further show that AtNHX5 and AtNHX6 are localized to Golgi and TGN. Taken together, AtNHX5 and AtNHX6 play an important role in K+ and pH homeostasis in Arabidopsis. Three conserved acidic residues are essential for K+ transport.	[Wang, Liguang; Wu, Xuexia; Liu, Yafen; Qiu, Quan-Sheng] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Activ & Stress Adaptat, Lanzhou 73000, Gansu, Peoples R China	Lanzhou University	Qiu, QS (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Activ & Stress Adaptat, Lanzhou 73000, Gansu, Peoples R China.	qiuqsh@lzu.edu.cn			National Basic Research Program of China (973 project) [2013CB429904]; National Natural Science Foundation of China (NSFC) [31070222, 31371438, 31571464]; Doctoral Fund of Ministry of Education of China (RFDP) [20130211110001]; Fundamental Research Funds for the Central Universities [lzujbky-2013-k10]	National Basic Research Program of China (973 project)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China (RFDP); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Basic Research Program of China (973 project, 2013CB429904 to Quan-Sheng Qiu), National Natural Science Foundation of China (NSFC, 31070222 to Quan-Sheng Qiu), National Natural Science Foundation of China (NSFC, 31371438 to Quan-Sheng Qiu), National Natural Science Foundation of China (NSFC, 31571464 to Quan-Sheng Qiu), Doctoral Fund of Ministry of Education of China (RFDP, 20130211110001 to Quan-Sheng Qiu), Fundamental Research Funds for the Central Universities (lzujbky-2013-k10). All of the funders above had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Barragan V, 2012, PLANT CELL, V24, P1127, DOI 10.1105/tpc.111.095273; Bassil E, 2012, J EXP BOT, V63, P5727, DOI 10.1093/jxb/ers250; Bassil E, 2011, PLANT CELL, V23, P3482, DOI 10.1105/tpc.111.089581; Bassil E, 2011, PLANT CELL, V23, P224, DOI 10.1105/tpc.110.079426; Blumwald E, 2000, CURR OPIN CELL BIOL, V12, P431, DOI 10.1016/S0955-0674(00)00112-5; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Chang AB, 2004, MOL MEMBR BIOL, V21, P171, DOI 10.1080/09687680410001720830; Chanroj S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00025; Chanroj S, 2011, J BIOL CHEM, V286, P33931, DOI 10.1074/jbc.M111.252650; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dibrov P, 1998, BIOCHEMISTRY-US, V37, P8282, DOI 10.1021/bi9801457; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; Guo Q, 2004, ENDOCRINOLOGY, V145, P1640, DOI 10.1210/en.2003-1270; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Jiang XY, 2010, PLANT SIGNAL BEHAV, V5, P792, DOI 10.4161/psb.5.7.11767; Krebs M, 2010, P NATL ACAD SCI USA, V107, P3251, DOI 10.1073/pnas.0913035107; Li MR, 2011, TREE PHYSIOL, V31, P349, DOI 10.1093/treephys/tpr003; Li XY, 2008, PLANT PHYSIOL, V147, P1675, DOI 10.1104/pp.108.119909; Maresova L, 2005, MOL MICROBIOL, V55, P588, DOI 10.1111/j.1365-2958.2004.04410.x; MARRE E, 1988, BOT ACTA, V101, P24, DOI 10.1111/j.1438-8677.1988.tb00006.x; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; Mei Y, 2012, CELL RES, V22, P581, DOI 10.1038/cr.2011.150; MENEGUS F, 1989, PLANT PHYSIOL, V90, P29, DOI 10.1104/pp.90.1.29; Mitsui K, 2011, J BIOL CHEM, V286, P37625, DOI 10.1074/jbc.M111.260612; Oh DH, 2010, J EXP BOT, V61, P1205, DOI 10.1093/jxb/erp391; Pandey GK, 2007, CELL RES, V17, P411, DOI 10.1038/cr.2007.39; Pardo JM, 2006, J EXP BOT, V57, P1181, DOI 10.1093/jxb/erj114; Rodriguez-Rosales M, 2009, PLANT SIGNAL BEHAV, V4, P265, DOI 10.4161/psb.4.4.7919; Rodriguez-Rosales MP, 2008, NEW PHYTOL, V179, P366, DOI 10.1111/j.1469-8137.2008.02461.x; Qi Z, 2004, PLANT PHYSIOL, V136, P2548, DOI 10.1104/pp.104.049213; Qiu QS, 2003, PLANT PHYSIOL, V132, P1041, DOI 10.1104/pp.102.010421; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Qiu QS, 2012, J GENET GENOMICS, V39, P167, DOI 10.1016/j.jgg.2012.02.001; Qiu QS, 2012, J INTEGR PLANT BIOL, V54, P66, DOI 10.1111/j.1744-7909.2012.01097.x; Quintero FJ, 2000, FEBS LETT, V471, P224, DOI 10.1016/S0014-5793(00)01412-5; Reguera M, 2014, MOL PLANT, V7, P261, DOI 10.1093/mp/sst091; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Shi LY, 2008, FUNCT PLANT BIOL, V35, P185, DOI 10.1071/FP07269; Swanson SJ, 1996, PLANT CELL, V8, P2211, DOI 10.1105/tpc.8.12.2211; Sze H, 2004, PLANT PHYSIOL, V136, P2532, DOI 10.1104/pp.104.046003; Venema K, 2002, J BIOL CHEM, V277, P2413, DOI 10.1074/jbc.M105043200; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Wu SJ, 1996, PLANT CELL, V8, P617, DOI 10.1105/tpc.8.4.617; Yokoi S, 2002, PLANT J, V30, P529, DOI 10.1046/j.1365-313X.2002.01309.x; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; YOSHIDA S, 1994, PLANT PHYSIOL, V104, P1131, DOI 10.1104/pp.104.4.1131; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Zhang HX, 2001, P NATL ACAD SCI USA, V98, P12832, DOI 10.1073/pnas.231476498; Zheng S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081463	52	20	26	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144716	10.1371/journal.pone.0144716	http://dx.doi.org/10.1371/journal.pone.0144716			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650539	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903300069
J	Dong, XL; Liu, TH; Wang, W; Pan, CX; Wu, YF; Du, GY; Chen, P; Lu, C; Pan, MH				Dong, Xiao-long; Liu, Tai-hang; Wang, Wei; Pan, Cai-xia; Wu, Yun-fei; Du, Guo-yu; Chen, Peng; Lu, Cheng; Pan, Min-hui			BmREEPa Is a Novel Gene that Facilitates BmNPV Entry into Silkworm Cells	PLOS ONE			English	Article							HEREDITARY SPASTIC PARAPLEGIA; BOMBYX-MORI; NUCLEOPOLYHEDROVIRUS GP64; EXPRESSION PROFILE; MAMMALIAN-CELLS; MEMBRANE-FUSION; BACULOVIRUS; RESISTANCE; PROTEINS; REEP2	We previously established two silkworm cell lines, BmN-SWU1 and BmN-SWU2, from Bombyx mori ovaries. BmN-SWU1 cells are susceptible while BmN-SWU2 cells are highly resistant to BmNPV infection. Interestingly, we found that the entry of BmNPV into BmN-SWU2 cells was largely inhibited. To explore the mechanism of this inhibition, in this study we used isobaric tags for relative and absolute quantitation (iTRAQ)-based quantitative protein expression profiling and identified 629 differentially expressed proteins between the two cell lines. Among them, we identified a new membrane protein termed BmREEPa. The gene encoding BmREEPa transcribes two splice variants; a 573 bp long BmREEPa-L encoding a protein with 190 amino acids and a 501 bp long BmREEPa-S encoding a protein with 166 amino acids. BmREEPa contains a conserved TB2/DP, HVA22 domain and three transmembrane domains. It is localized in the plasma membrane with a cytoplasmic C-terminus and an extracellular N-terminus. We found that limiting the expression of BmREEPa in BmN-SWU1 cells inhibited BmNPV entry, whereas over-expression of BmREEPa in BmN-SWU2 cells promoted BmNPV entry. Our results also indicated that BmREEPa can interact with GP64, which is the key envelope fusion protein for BmNPV entry. Taken together, the findings of our study revealed that BmREEPa is required for BmNPV to gain entry into silkworm cells, and may provide insights for the identification of BmNPV receptors.	[Dong, Xiao-long; Liu, Tai-hang; Wang, Wei; Pan, Cai-xia; Wu, Yun-fei; Du, Guo-yu; Chen, Peng; Lu, Cheng; Pan, Min-hui] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Dong, Xiao-long; Lu, Cheng; Pan, Min-hui] Southwest Univ, Minist Agr, Key Lab Sericulture Funct Genom & Biotechnol, Chongqing, Peoples R China	Southwest University - China; Ministry of Agriculture & Rural Affairs; Southwest University - China	Lu, C (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	lucheng@swu.edu.cn; pmh047@126.com			Hi-Tech Research and Development 863 Program of China [2013AA 102507]; National Natural Science Foundation of China [30972146, 31272505, 31472152]; Based and Advanced Research Projects of Chongqing, China [cstc2013jcyjA80019]; China Agriculture Research System [CARS-22]	Hi-Tech Research and Development 863 Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Based and Advanced Research Projects of Chongqing, China; China Agriculture Research System	This work was supported by grants from the Hi-Tech Research and Development 863 Program of China (No. 2013AA 102507), the National Natural Science Foundation of China (Grant No. 30972146, 31272505 and 31472152), the Based and Advanced Research Projects of Chongqing, China (Grant No: cstc2013jcyjA80019) and China Agriculture Research System (CARS-22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argasinska J, 2009, INT J DEV BIOL, V53, P37, DOI 10.1387/ijdb.072542ja; Beetz C, 2008, BRAIN, V131, P1078, DOI 10.1093/brain/awn026; Bjork S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076366; Castermans D, 2007, EUR J HUM GENET, V15, P422, DOI 10.1038/sj.ejhg.5201785; de Jong J, 2011, J VIROL, V85, P9696, DOI 10.1128/JVI.00833-11; Dong SC, 2012, J VIROL, V86, P9617, DOI 10.1128/JVI.00813-12; Du J, 2009, CHINESE MED J, P122; Esteves T, 2014, AM J HUM GENET, V94, P268, DOI 10.1016/j.ajhg.2013.12.005; Hurt CM, 2014, BRAIN RES, V1545, P12, DOI 10.1016/j.brainres.2013.12.008; Ilegems E, 2010, J NEUROSCI, V30, P13774, DOI 10.1523/JNEUROSCI.0091-10.2010; Kataoka C, 2012, J VIROL, V86, P2610, DOI 10.1128/JVI.06704-11; Li ZF, 2011, J VIROL, V85, P12492, DOI 10.1128/JVI.05153-11; Li ZF, 2010, J VIROL, V84, P8584, DOI 10.1128/JVI.00264-10; Lin YT, 2013, INT J MOL MED, V31, P459, DOI 10.3892/ijmm.2012.1225; Luz-Madrigal A, 2013, J VIROL, V87, P11894, DOI 10.1128/JVI.01356-13; Mainland J, 2012, ADV EXP MED BIOL, V744, P75, DOI 10.1007/978-1-4614-2364-5_7; Pan MH, 2010, TISSUE CELL, V42, P42, DOI 10.1016/j.tice.2009.07.002; Qin LG, 2012, J PROTEOMICS, V75, P3630, DOI 10.1016/j.jprot.2012.04.015; Sagisaka A, 2010, VIRUS RES, V147, P166, DOI 10.1016/j.virusres.2009.10.015; Salem TZ, 2011, VIROLOGY, V412, P167, DOI 10.1016/j.virol.2011.01.006; Selot R, 2010, ARCH INSECT BIOCHEM, V73, P163, DOI 10.1002/arch.20348; Shen HX, 2012, FEBS LETT, V586, P990, DOI 10.1016/j.febslet.2011.12.040; Tavares J, 2011, GENET MOL RES, V10, P471, DOI 10.4238/vol10-1gmr978; Wang WQ, 2014, ADV INTEL SYS RES, V59, P9; Yang ZX, 2012, GEN HOSP PSYCHIAT, V34, P571, DOI 10.1016/j.genhosppsych.2012.05.015; Yao HP, 2010, BIOSCIENCE REP, V30, P209, DOI 10.1042/BSR20090045; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105986; Zhang J, 2014, ANTIVIR RES, V104, P143, DOI 10.1016/j.antiviral.2014.01.017; Zhou Y, 2013, GENOMICS, V101, P256, DOI 10.1016/j.ygeno.2013.02.004	29	21	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144575	10.1371/journal.pone.0144575	http://dx.doi.org/10.1371/journal.pone.0144575			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656276	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900065
J	Liang, J; Meng, F; Sun, S; Wu, CX; Wu, HY; Zhang, MR; Zhang, HF; Zheng, XB; Song, XY; Zhang, ZG				Liang, Jingang; Meng, Fang; Sun, Shi; Wu, Cunxiang; Wu, Haiying; Zhang, Mingrong; Zhang, Haifeng; Zheng, Xiaobo; Song, Xinyuan; Zhang, Zhengguang			Community Structure of Arbuscular Mycorrhizal Fungi in Rhizospheric Soil of a Transgenic High-Methionine Soybean and a Near Isogenic Variety	PLOS ONE			English	Article							MAIZE ZEA-MAYS; PHOSPHORUS CONCENTRATION; GENETIC MODIFICATIONS; RIBOSOMAL-RNA; BT-MAIZE; COLONIZATION; PLANTS; DYNAMICS; IMPACT; ROOTS	The use of transgenic plants in agriculture provides many economic benefits, but it also raises concerns over the potential impact of transgenic plants on the environment. We here examined the impact of transgenic high-methionine soybean ZD91 on the arbuscular mycorrhizal (AM) fungal community structure in rhizosphere soil. Our investigations based on clone libraries were conducted in field trials at four growth stages of the crops each year from 2012 to 2013. A total of 155 operational taxonomic units (OTUs) of AM fungi were identified based on the sequences of small subunit ribosomal RNA (SSU rRNA) genes. There were no significant differences found in AM fungal diversity in rhizosphere soil during the same growth stage between transgenic soybean ZD91 and its non-transgenic parental soybean ZD. In addition, plant growth stage and year had the strongest effect on the AM fungal community structure while the genetically modified (GM) trait studied was the least explanatory factor. In conclusion, we found no indication that transgenic soybean ZD91 cultivation poses a risk for AM fungal communities in agricultural soils.	[Liang, Jingang; Meng, Fang; Zhang, Haifeng; Zheng, Xiaobo; Zhang, Zhengguang] Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China; [Liang, Jingang; Meng, Fang; Zhang, Haifeng; Zheng, Xiaobo; Zhang, Zhengguang] Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China; [Liang, Jingang] Minist Agr, Dev Ctr Sci & Technol, Beijing, Peoples R China; [Sun, Shi; Wu, Cunxiang] Chinese Acad Agr Sci, Inst Crop Sci, MOA Key Lab Soybean Biol Beijing, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Wu, Haiying; Zhang, Mingrong] Nanchong Acad Agr Sci, Nanchong, Peoples R China; [Song, Xinyuan] Jilin Acad Agr Sci, Agrobiotechnol Res Inst, Changchun, Peoples R China	Nanjing Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Jilin Academy of Agricultural Sciences	Song, XY (corresponding author), Jilin Acad Agr Sci, Agrobiotechnol Res Inst, Changchun, Peoples R China.	songxinyuan1980@163.com; zhgzhang@njau.edu.cn			Genetically Modified Organisms Breeding Major Projects of China [2016ZX08011-003, 2014ZX08011-003]; Jiangsu Provincial Coordination Panel for Recruitment and Selection of Specially-Appointed Professors	Genetically Modified Organisms Breeding Major Projects of China; Jiangsu Provincial Coordination Panel for Recruitment and Selection of Specially-Appointed Professors	This research was supported by Genetically Modified Organisms Breeding Major Projects of China (Grant No. 2016ZX08011-003 and 2014ZX08011-003) and Jiangsu Provincial Coordination Panel for Recruitment and Selection of Specially-Appointed Professors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andow DA, 2004, BIOSCIENCE, V54, P637, DOI 10.1641/0006-3568(2004)054[0637:SRAFNE]2.0.CO;2; Asghari HR, 2005, PLANT SOIL, V273, P245, DOI 10.1007/s11104-004-7942-6; de Azevedo LCB, 2014, BRAZ J MICROBIOL, V45, P995, DOI 10.1590/S1517-83822014000300032; Begum H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119873; Bever JD, 2001, BIOSCIENCE, V51, P923, DOI 10.1641/0006-3568(2001)051[0923:AMFMDT]2.0.CO;2; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Burke DJ, 2008, AM J BOT, V95, P1416, DOI 10.3732/ajb.0800184; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castaldini M, 2005, APPL ENVIRON MICROB, V71, P6719, DOI 10.1128/AEM.71.11.6719-6729.2005; Cheeke TE, 2013, APPL ENVIRON MICROB, V79, P4078, DOI 10.1128/AEM.00702-13; Cheeke TE, 2012, AM J BOT, V99, P700, DOI 10.3732/ajb.1100529; Cheeke TE, 2011, FEMS MICROBIOL ECOL, V75, P304, DOI 10.1111/j.1574-6941.2010.01013.x; Clark NM, 2009, J ARID ENVIRON, V73, P834, DOI 10.1016/j.jaridenv.2009.03.004; Cotton TEA, 2015, NEW PHYTOL, V205, P1598, DOI 10.1111/nph.13224; de Vaufleury A, 2007, PEDOBIOLOGIA, V51, P185, DOI 10.1016/j.pedobi.2007.04.005; Alguacil MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034887; Duineveld BM, 2001, APPL ENVIRON MICROB, V67, P172, DOI 10.1128/AEM.67.1.172-178.2001; Filion M, 2008, MICROB BIOTECHNOL, V1, P463, DOI 10.1111/j.1751-7915.2008.00047.x; Fliessbach A, 2012, BIOL FERT SOILS, V48, P315, DOI 10.1007/s00374-011-0625-6; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Girlanda M, 2008, FEMS MICROBIOL LETT, V288, P9, DOI 10.1111/j.1574-6968.2008.01306.x; Gong CY, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00041; Gosling P, 2013, NEW PHYTOL, V198, P546, DOI 10.1111/nph.12169; Hannula SE, 2014, BIOL FERT SOILS, V50, P433, DOI 10.1007/s00374-014-0895-x; Hannula SE, 2012, NEW PHYTOL, V194, P784, DOI 10.1111/j.1469-8137.2012.04089.x; Hannula SE, 2010, SOIL BIOL BIOCHEM, V42, P2211, DOI 10.1016/j.soilbio.2010.08.020; Hannula SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033819; Hattori R., 2014, International Journal of Agricultural Policy and Research, V2, P41; Higo M, 2014, BIOL FERT SOILS, V50, P913, DOI 10.1007/s00374-014-0912-0; IBM-SPSS, 2008, SPSS STAT WIND VERS; Isobe K, 2011, ADV MICROBIOL, V1, P13, DOI DOI 10.4236/AIM.2011.11003; Jie WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072898; Kaldorf M, 2002, PLANTA, V214, P653, DOI 10.1007/s004250100658; Knox OGG, 2008, FIELD CROP RES, V109, P57, DOI 10.1016/j.fcr.2008.06.005; KORMANIK PP, 1980, CAN J MICROBIOL, V26, P536, DOI 10.1139/m80-090; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Liang JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103343; Liu WK, 2010, ECOTOXICOLOGY, V19, P229, DOI 10.1007/s10646-009-0423-1; Liu Y, 2009, FEMS MICROBIOL ECOL, V67, P81, DOI 10.1111/j.1574-6941.2008.00597.x; Martinelli L, 2013, CROAT MED J, V54, P91, DOI 10.3325/cmj.2013.54.91; Meyer JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053825; Naghashzadeh M., 2013, Advances in Environmental Biology, V7, P4623; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Powell JR, 2007, APPL ENVIRON MICROB, V73, P4365, DOI 10.1128/AEM.00594-07; [浦传亮 Pu Chuanliang], 2012, [南京农业大学学报, Journal of Nanjing Agricultural University], V35, P8; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; Scheublin TR, 2006, NEW PHYTOL, V172, P732, DOI 10.1111/j.1469-8137.2006.01858.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Song SK, 2013, J EXP BOT, V64, P1917, DOI 10.1093/jxb/ert053; Tan FX, 2011, SOIL BIOL BIOCHEM, V43, P2473, DOI 10.1016/j.soilbio.2011.08.014; Turrini A, 2004, PLANT SOIL, V266, P69; Turrini A, 2015, RES MICROBIOL, V166, P121, DOI 10.1016/j.resmic.2015.02.006; Verbruggen E, 2012, APPL ENVIRON MICROB, V78, P7384, DOI 10.1128/AEM.01372-12; VIERHEILIG H, 1995, APPL ENVIRON MICROB, V61, P3031, DOI 10.1128/AEM.61.8.3031-3034.1995; Vilvert R. M., 2014, African Journal of Agricultural Research, V9, P2369; White CM, 2010, PLANT SOIL, V328, P507, DOI 10.1007/s11104-009-0131-x; Wrobel-Kwiatkowska M, 2012, MYCORRHIZA, V22, P493, DOI 10.1007/s00572-011-0427-6; Wu JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098394	60	32	36	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145001	10.1371/journal.pone.0145001	http://dx.doi.org/10.1371/journal.pone.0145001			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658560	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900164
J	Paulsen, D; Weber, O; Ruebsamen-Schaeff, H; Tennant, BC; Menne, S				Paulsen, Daniela; Weber, Olaf; Ruebsamen-Schaeff, Helga; Tennant, Bud C.; Menne, Stephan			AIC649 Induces a Bi-Phasic Treatment Response in the Woodchuck Model of Chronic Hepatitis B	PLOS ONE			English	Article							VIRUS-REPLICATION; DENDRITIC CELLS; ANTIGEN; ALPHA-2B; THERAPY; HBV; COMBINATION; INHIBITION; TOLERANCE; INFECTION	AIC649 has been shown to directly address the antigen presenting cell arm of the host immune defense leading to a regulated cytokine release and activation of T cell responses. In the present study we analyzed the antiviral efficacy of AIC649 as well as its potential to induce functional cure in animal models for chronic hepatitis B. Hepatitis B virus transgenic mice and chronically woodchuck hepatitis virus (WHV) infected woodchucks were treated with AIC649, respectively. In the mouse system AIC649 decreased the hepatitis B virus titer as effective as the "gold standard", Tenofovir. Interestingly, AIC649-treated chronically WHV infected woodchucks displayed a bi-phasic pattern of response: The marker for functional cure-hepatitis surface antigen-first increased but subsequently decreased even after cessation of treatment to significantly reduced levels. We hypothesize that the observed bi-phasic response pattern to AIC649 treatment reflects a physiologically "concerted", reconstituted immune response against WHV and therefore may indicate a potential for inducing functional cure in HBV-infected patients.	[Paulsen, Daniela; Ruebsamen-Schaeff, Helga] AiCuris GmbH & Co KG, Wuppertal, Germany; [Weber, Olaf] Bayer Aktiengesell, Leverkusen, Germany; [Tennant, Bud C.; Menne, Stephan] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA	Bayer AG; Cornell University	Paulsen, D (corresponding author), AiCuris GmbH & Co KG, Wuppertal, Germany.	daniela.paulsen@aicuris.com			Bayer; AiCuris	Bayer(Bayer AG); AiCuris	The work was financially supported by Bayer. DP and HRS are employees of AiCuris. OW is an employee of Bayer. AiCuris provided support in the form of salaries for authors DP and HRS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bayer provided support in the form of salaries for authors OW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckebaum S, 2003, IMMUNOLOGY, V109, P487, DOI 10.1046/j.1365-2567.2003.01699.x; Bertoletti A, 2006, J GEN VIROL, V87, P1439, DOI 10.1099/vir.0.81920-0; Buchmann P, 2013, VACCINE, V31, P1197, DOI 10.1016/j.vaccine.2012.12.074; Cavanaugh VJ, 1998, J VIROL, V72, P2630, DOI 10.1128/JVI.72.4.2630-2637.1998; Cavanaugh VJ, 1997, J VIROL, V71, P3236, DOI 10.1128/JVI.71.4.3236-3243.1997; Cote Paul J., 1993, Viral Immunology, V6, P161, DOI 10.1089/vim.1993.6.161; Cote PJ, 2000, HEPATOLOGY, V31, P190, DOI 10.1002/hep.510310128; Fletcher SP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005103; Fletcher SP, 2013, HEPATOLOGY, V57, P13, DOI 10.1002/hep.25954; Flink HJ, 2005, GUT, V54, P1604, DOI 10.1136/gut.2004.062208; Friebe A, 2011, J GEN VIROL, V92, P1571, DOI 10.1099/vir.0.028894-0; Gehring AJ, 2013, J CLIN INVEST, V123, P3766, DOI 10.1172/JCI66043; Guidotti LG, 2002, J VIROL, V76, P2617, DOI 10.1128/JVI.76.6.2617-2621.2002; Guidotti LG, 1996, P NATL ACAD SCI USA, V93, P4589, DOI 10.1073/pnas.93.10.4589; GUIDOTTI LG, 1994, J VIROL, V68, P1265, DOI 10.1128/JVI.68.3.1265-1270.1994; Hadziyannis SJ, 2012, GASTROENTEROLOGY, V143, P629, DOI 10.1053/j.gastro.2012.05.039; HORNBUCKLE WE, 1985, LAB ANIM SCI, V35, P376; Isogawa M, 2005, J VIROL, V79, P7269, DOI 10.1128/JVI.79.11.7269-7272.2005; Kimura K, 2002, J VIROL, V76, P10702, DOI 10.1128/JVI.76.21.10702-10707.2002; Kruse N, 2001, J VIROL, V75, P4699, DOI 10.1128/JVI.75.10.4699-4704.2001; Kwon H, 2011, NAT REV GASTRO HEPAT, V8, P275, DOI 10.1038/nrgastro.2011.33; Lambotin M, 2010, NAT REV MICROBIOL, V8, P350, DOI 10.1038/nrmicro2332; Liu KH, 2011, J VIROL, V85, P4853, DOI 10.1128/JVI.02437-10; Menne S, 2002, INTERVIROLOGY, V45, P237, DOI 10.1159/000067914; Menne S, 2002, VET IMMUNOL IMMUNOP, V87, P97, DOI 10.1016/S0165-2427(02)00121-6; Menne S, 2008, ANTIMICROB AGENTS CH, V52, P3617, DOI 10.1128/AAC.00654-08; Menne S, 2007, HEPATOLOGY, V45, P614, DOI 10.1002/hep.21558; Menne S, 2015, J HEPATOL, V62, P1237, DOI 10.1016/j.jhep.2014.12.026; Nowatzky J, 2013, HEPATOL RES, V43, P535, DOI 10.1111/j.1872-034X.2012.01086.x; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Paulsen D, 2014, PLOS ONE, V8; Protzer U, 1999, P NATL ACAD SCI USA, V96, P10818, DOI 10.1073/pnas.96.19.10818; Shi M, 2007, CLIN EXP IMMUNOL, V147, P277, DOI 10.1111/j.1365-2249.2006.03281.x; Siegemund S, 2009, J VIROL; Sonneveld MJ, 2013, HEPATOLOGY, V58, P872, DOI 10.1002/hep.26436; Sonneveld MJ, 2010, HEPATOLOGY, V52, P1251, DOI 10.1002/hep.23844; ter Borg MJ, 2006, HEPATOLOGY, V44, P721, DOI 10.1002/hep.21302; von Buttlar H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106188; Weber O, 2013, EUR J CLIN MICROBIOL, V32, P451, DOI 10.1007/s10096-012-1780-x; Weber O, 2003, J GEN VIROL, V84, P1843, DOI 10.1099/vir.0.19138-0; Weber O, 2002, ANTIVIR RES, V54, P69, DOI 10.1016/S0166-3542(01)00216-9; Wieland SF, 2005, J VIROL, V79, P9369, DOI 10.1128/JVI.79.15.9369-9380.2005; Zheng BJ, 2004, J VIRAL HEPATITIS, V11, P217, DOI 10.1111/j.1365-2893.2004.00497.x	43	16	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144383	10.1371/journal.pone.0144383	http://dx.doi.org/10.1371/journal.pone.0144383			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656974	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900042
J	Salgado, MF; Barral, M; Barrucand, L; Cavalcanti, IL; Vercosa, N				Salgado Filho, Marcello Fonseca; Barral, Marselha; Barrucand, Louis; Cavalcanti, Ismar Lima; Vercosa, Nubia			A Randomized Blinded Study of the Left Ventricular Myocardial Performance Index Comparing Epinephrine to Levosimendan following Cardiopulmonary Bypass	PLOS ONE			English	Article							CARDIAC-SURGERY; TEI INDEX; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; HEART-FAILURE; CORONARY; INOTROPES; REPLACEMENT; DOBUTAMINE; GUIDELINES; EVENTS	Background The objective was to evaluate the effect of epinephrine and levosimendan on the left ventricle myocardial performance index in patients undergoing on-pump coronary artery by-pass grafting (CABG). Methods In a double-blind, randomized clinical trial, 81 patients (age: 45-65 years) of both genders were randomly divided to receive either epinephrine at a dosage of 0.06 mcg. kg(1). min(-1) (epinephrine group, 39 patients) or levosimendan at 0.2 mcg. kg(1). min(-1) (levosimendan group, 42 patients) during the rewarming of cardiopulmonary by-pass (CPB). Hemodynamic data were collected 30 minutes after tracheal intubation, before chest open (pre-CPB) and 10 minutes after termination of protamine (post-CPB). As the primary outcome, we evaluated the left ventricle myocardial performance index by the Doppler echocardiography. The myocardial performance index is the sum of the isovolumetric contraction time and the isovolumetric relaxation time, divided by the ejection time. Secondary outcomes were systolic and diastolic evaluations of the left ventricle and postoperative troponin I and MB-CK levels. Results Of the 81 patients allocated to the research, we excluded 2 patients in the epinephrine group and 6 patients in the levosimendan group because they didn't wean from CPB in the first attempt. There was no statistical difference between the groups in terms of patient characteristics, risk factors, or CPB time. The epinephrine group had a lower left ventricle myocardial performance index (p = 0.0013), higher cardiac index (p = 0.03), lower systemic vascular resistance index (p = 0.01), and higher heart rate (p = 0.04) than the levosimendan group at the post-CPB period. There were no differences between the groups in diastolic dysfunction. The epinephrine group showed higher incidence of weaning from CPB in the first attempt (95% vs 85%, p = 0.0001) when compared to the levosimendan group and the norepinephrine requirement was higher in the levosimenandan group than epinephrine group (16% vs. 47%; p = 0.005) in post-CPB period. Twenty-four hours after surgery, the plasma levels of troponin I (epinephrine group: 4.5 +/- 5.7 vs. levosimendan group: 2.5 +/- 3.2 g/dl; p = 0.09) and MB-CK (epinephrine group: 50.7 +/- 31 vs. levosimendan group: 37 +/- 17.6 g/dl; p = 0.08) were not significantly different between the two groups. Conclusion When compared to levosimendan, patients treated with epinephrine had a lower left ventricle myocardial performance index in the immediate post-CPB period, encouraging an efficient weaning from CPB in patients undergoing on-pump CABG.	[Salgado Filho, Marcello Fonseca; Barrucand, Louis; Vercosa, Nubia] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Barral, Marselha] Fac Med Sci Juiz de Fora, Juiz De Fora, Brazil; [Cavalcanti, Ismar Lima] Univ Fed Fluminense, Niteroi, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense	Salgado, MF (corresponding author), Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.	mfonsecasalgado@hotmail.com						Anderson JL, 2011, CIRCULATION, V123, pE426, DOI 10.1161/CIR.0b013e318212bb8b; Antila S, 2007, CLIN PHARMACOKINET, V46, P535, DOI 10.2165/00003088-200746070-00001; Bajraktari G, 2008, EUR J ECHOCARDIOGR, V9, P779, DOI 10.1093/ejechocard/jen146; Blanchard DG, 2009, JACC-CARDIOVASC IMAG, V2, P143, DOI 10.1016/j.jcmg.2008.10.012; Bocchi EA, 2008, ARQ BRAS CARDIOL, V90, P201, DOI 10.1590/S0066-782X2008000300008; Carluccio E, 2012, ECHOCARDIOGR-J CARD, V29, P298, DOI 10.1111/j.1540-8175.2011.01575.x; D'Ascenzo F, 2014, CONTEMP CLIN TRIALS, V38, P51, DOI 10.1016/j.cct.2014.03.002; De Hert SG, 2007, ANESTH ANALG, V104, P766, DOI 10.1213/01.ane.0000256863.92050.d3; Douglas Pamela S, 2007, J Am Coll Cardiol, V50, P187, DOI 10.1016/j.jacc.2007.05.003; Duncan AM, 2004, INT J CARDIOL, V95, P211, DOI 10.1016/j.ijcard.2003.07.007; Eriksson HI, 2009, ANN THORAC SURG, V87, P448, DOI 10.1016/j.athoracsur.2008.10.029; Eris C, 2014, INT J CLIN EXP MED, V7, P219; Gandham R, 2013, ANN CARD ANAESTH, V16, P11, DOI 10.4103/0971-9784.105363; Harrison RW, 2013, J CARDIOTHOR VASC AN, V27, P1224, DOI 10.1053/j.jvca.2013.03.027; Hasenfuss G, 2011, EUR HEART J, V32, P1838, DOI 10.1093/eurheartj/ehr026; Javidi Daryoosh, 2008, Arch Iran Med, V11, P497; Karatzis EN, 2009, HELL J CARDIOL, V50, P60; Kodalli RK, 2013, ANN CARD ANAESTH, V16, P94, DOI 10.4103/0971-9784.109737; Lakoumentas John A, 2005, Hellenic J Cardiol, V46, P52; Landoni G, 2010, J CARDIOTHOR VASC AN, V24, P51, DOI 10.1053/j.jvca.2009.05.031; Lee EH, 2012, ANESTHESIOLOGY, V116, P362, DOI 10.1097/ALN.0b013e3182426ed6; Lobato EB, 2005, J CARDIOTHOR VASC AN, V19, P334, DOI 10.1053/j.jvca.2005.03.011; Maharaj R, 2012, J SAUDI HEART ASSOC, V24, P99, DOI 10.1016/j.jsha.2012.01.004; Maharaj R, 2011, CRIT CARE, V15, DOI 10.1186/cc10263; Maleki M, 2005, IRAN HEART J, V6, P26; Maslow AD, 2004, ANESTH ANALG, V98, P891, DOI 10.1213/01.ANE.0000107940.23783.33; Matyal R, 2011, ANESTH ANALG, V113, P449, DOI 10.1213/ANE.0b013e31822649ac; Mebazaa A, 2007, JAMA-J AM MED ASSOC, V297, P883; Papp Z, 2012, INT J CARDIOL, V159, P82, DOI 10.1016/j.ijcard.2011.07.022; Parissis JT, 2010, CURR OPIN CRIT CARE, V16, P432, DOI 10.1097/MCC.0b013e32833e10fb; Parthenakis FI, 2002, CHEST, V121, P1935, DOI 10.1378/chest.121.6.1935; Poelaert JI, 2005, CHEST, V127, P379, DOI 10.1378/chest.127.1.379; Raja SG, 2006, ANN THORAC SURG, V81, P1536, DOI 10.1016/j.athoracsur.2005.08.073; Rambihar S, 2010, CURR OPIN CARDIOL, V25, P456, DOI 10.1097/HCO.0b013e32833c7bf5; ROYSTER RL, 1991, ANESTH ANALG, V72, P729; Salgado AA, 2004, REV BR ECOCARD, V17, P69; Savaris N, 1998, REV BRAS ANESTESIOL, V48, P126; Severi L, 2011, J CARDIOTHOR VASC AN, V25, P632, DOI 10.1053/j.jvca.2011.03.001; Shanewise JS, 1999, J AM SOC ECHOCARDIOG, V12, P884, DOI 10.1016/S0894-7317(99)70199-9; Siirila-Waris K, 2005, J CARDIOTHOR VASC AN, V19, P345, DOI 10.1053/j.jvca.2005.03.012; Skubas N, 2011, COMPREHENSIVE TXB PE, P406; STEEN PA, 1978, CIRCULATION, V57, P378, DOI 10.1161/01.CIR.57.2.378; STRATTON JR, 1985, J APPL PHYSIOL, V58, P1199, DOI 10.1152/jappl.1985.58.4.1199; Thys DM, 2010, ANESTHESIOLOGY, V112, P1084, DOI 10.1097/ALN.0b013e3181c51e90; Tritapepe L, 2006, BRIT J ANAESTH, V96, P694, DOI 10.1093/bja/ael082	45	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0143315	10.1371/journal.pone.0143315	http://dx.doi.org/10.1371/journal.pone.0143315			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26655803	Green Published, gold			2022-12-27	WOS:000366715900008
J	Serra-Paya, N; Ensenyat, A; Castro-Vinuales, I; Real, J; Sinfreu-Bergues, X; Zapata, A; Mur, JM; Galindo-Ortego, G; Sole-Mir, E; Teixido, C				Serra-Paya, Noemi; Ensenyat, Assumpta; Castro-Vinuales, Ivan; Real, Jordi; Sinfreu-Bergues, Xenia; Zapata, Amalia; Maria Mur, Jose; Galindo-Ortego, Gisela; Sole-Mir, Eduard; Teixido, Concepcio			Effectiveness of a Multi-Component Intervention for Overweight and Obese Children (Nereu Program): A Randomized Controlled Trial	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; PHYSICAL-ACTIVITY; CHILDHOOD; PREVENTION; REPRODUCIBILITY; CONSUMPTION; VALIDATION; VEGETABLES; ADIPOSITY; DISEASE	Introduction Treatment of childhood obesity is a complex challenge for primary health care professionals. Objectives To evaluate the effectiveness of the Nereu Program in improving anthropometric parameters, physical activity and sedentary behaviours, and dietary intake. Methods Randomized, controlled, multicentre clinical trial comparing Nereu Program and usual counselling group interventions in primary care settings. The 8-month study recruited 113 children aged 6 to 12 years with overweight/obesity. Before recruitment, eligible participants were randomly allocated to an intensive, family-based multi-component behavioural intervention (Nereu Program group) or usual advice from their paediatrician on healthy eating and physical activity. Anthropometric parameters, objectively measured sedentary and physical activity behaviours, and dietary intake were evaluated pre- and post-intervention. Results At the end of the study period, both groups achieved a similar decrease in body mass index (BMIsd) compared to baseline. Nereu Program participants (n = 54) showed greater increases in moderate-intense physical activity (+6.27% vs. -0.61%, p<0.001) and daily fruit servings (+0.62 vs. +0.13, p<0.026), and decreased daily soft drinks consumption (-0.26 vs. -0.02, p<0.047), respectively, compared to the counselling group (n = 59). Conclusions At the end of the 8-month intervention, participants in the Nereu Program group showed improvement in physical activity and dietary behaviours, compared to the counselling group.	[Serra-Paya, Noemi; Castro-Vinuales, Ivan; Maria Mur, Jose] Reg Sanitaria Lleida, Asociac Nereu Alimentac Saludable & Ejercicio Fis, Lleida, Spain; [Serra-Paya, Noemi] Univ Pompeu Fabra, Escuela Super Ciencias Salud, TecnoCampus Mataro, Barcelona, Spain; [Serra-Paya, Noemi; Zapata, Amalia] Univ Lleida, Fac Enfermeria, Lleida, Spain; [Ensenyat, Assumpta] Univ Lleida, Natl Inst Phys Educ Catalonia INEFC Lleida, Lleida, Spain; [Real, Jordi; Galindo-Ortego, Gisela] USR IDIAP Jordi Gol, Unitat Suport Recerca Lleida, Inst Univ Invest Atencio Primaria Jordi Gol, Lleida, Spain; [Real, Jordi] Univ Int Catalunya, Fac Med & Ciencies Salut, Barcelona, Spain; [Sinfreu-Bergues, Xenia; Zapata, Amalia] Univ Lleida, Dept Nutr, Lleida, Spain; [Galindo-Ortego, Gisela; Teixido, Concepcio] Inst Catala Salut, Ctr Atencio Primaria Primer Maig, Lleida, Spain; [Sole-Mir, Eduard] Hosp Arnau Vilanova, Dept Paediat, Lleida, Spain; [Sole-Mir, Eduard] Univ Lleida, Dept Med, Lleida, Spain	Pompeu Fabra University; Universitat de Lleida; Universitat de Lleida; Universitat Internacional de Catalunya (UIC); Universitat de Lleida; University Hospital Arnau de Vilanova; Universitat de Lleida	Serra-Paya, N (corresponding author), Reg Sanitaria Lleida, Asociac Nereu Alimentac Saludable & Ejercicio Fis, Lleida, Spain.	noemiserra.paya@gmail.com	Serra, Noemi/AAB-7629-2019	Serra, Noemi/0000-0002-1048-9546; Real, Jordi/0000-0002-5979-8948	Instituto de Salud Carlos III in Spain; Ministry of Economy and Competitiveness - FEDER [PI12/02220]; Institute of Physical Education of Catalonia (INEFC), University of Lleida, Spain [VCP/3570/2010, VCP/28/2009, DOGC NUM. 5753, DOGC NUM. 5302]	Instituto de Salud Carlos III in Spain(Instituto de Salud Carlos III); Ministry of Economy and Competitiveness - FEDER; Institute of Physical Education of Catalonia (INEFC), University of Lleida, Spain	This research is partially funded by the Instituto de Salud Carlos III in Spain, from the Ministry of Economy and Competitiveness (Grant PI12/02220) cofunded by FEDER and the Institute of Physical Education of Catalonia (INEFC), University of Lleida, Spain, (Grants: VCP/3570/2010, 29th October, DOGC NUM. 5753 - 11.11.2010; VCP/28/2009, 14th January, DOGC NUM. 5302 - 22/01/2009).	Agencia Salut Publica, 2006, GEN CAT DEP SAL; Aguirre-Jaime A, 2008, REV ESP SALUD PUBLIC, V82, P509, DOI 10.1590/S1135-57272008000500006; Albright CL, 2000, AM J PREV MED, V18, P225, DOI 10.1016/S0749-3797(99)00155-5; Ariza C, 2015, ATEN PRIM, V47, P246, DOI 10.1016/j.aprim.2014.11.006; Aznar Lain S, 2006, GUIA TODAS PERS QUE; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Barja Y. Salesa, 2005, Rev. chil. pediatr., V76, P151; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Burriel FC, 2013, NUTR HOSP, V28, P438, DOI 10.3305/nh.2013.28.2.6303; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-24; Rovira AF, 2013, AN PEDIATR, V78, P157, DOI 10.1016/j.anpedi.2012.06.006; Field AE, 1999, PUBLIC HEALTH NUTR, V2, P293, DOI 10.1017/S1368980099000397; Heitor SFD, 2011, CIENC CUIDADO SAUDE, V10, P430, DOI [10.4025/ciencuidsaude.v10i3.11347, DOI 10.4025/CIENCUIDSAUDE.V10I3.11347]; Kolsgaard MLP, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-47; Lavelle HV, 2012, J PUBLIC HEALTH-UK, V34, P360, DOI 10.1093/pubmed/fdr116; Lock K, 2005, B WORLD HEALTH ORGAN, V83, P100; Lupash E, 2009, AM COLL SPORT MED; MARTINMORENO JM, 1993, INT J EPIDEMIOL, V22, P512, DOI 10.1093/ije/22.3.512; McCallum Z, 2005, J PAEDIATR CHILD H, V41, P488, DOI 10.1111/j.1440-1754.2005.00689.x; Norman AC, 2005, PEDIATRICS, V115, pE690, DOI 10.1542/peds.2004-1543; Ortega-Sanchez R, 2004, PREV MED, V38, P219, DOI 10.1016/j.ypmed.2003.09.042; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, V3, P1, DOI DOI 10.1002/14651858.CD001872.PUB2; Pacheco Perez WA, 2012, EFFECT REDUCTION SOD, V65, P6779; Peyrot N, 2009, J APPL PHYSIOL, V106, P1763, DOI 10.1152/japplphysiol.91240.2008; ROCKETT HRH, 1995, J AM DIET ASSOC, V95, P336, DOI 10.1016/S0002-8223(95)00086-0; Rubio AM, 2008, REV PEDIAT ATENCION, V10, P99; Rubio AM, 2008, REV PEDIAT ATENCION, V10, P139; Ruiz JR, 2011, AM J EPIDEMIOL, V174, P173, DOI 10.1093/aje/kwr068; SABATE J, 1993, MED CLIN-BARCELONA, V100, P591; Sargent GM, 2011, OBES REV, V12, pe219, DOI 10.1111/j.1467-789X.2010.00777.x; Serra Majem Ll, 2003, MED CLIN-BARCELONA, V121, P725; Serra-Paya N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1000; Spruijt-Metz D, 2011, J RES ADOLESCENCE, V21, P129, DOI 10.1111/j.1532-7795.2010.00719.x; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; van Sluijs EMF, 2010, BRIT J SPORT MED, V44, P747, DOI 10.1136/bjsm.2008.049783; van't Veer P, 2000, PUBLIC HEALTH NUTR, V3, P103, DOI 10.1017/S1368980000000136; Villaresa JM, 2008, REV PEDIAT ATENCION, V10, P165; Waters E, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001871.pub3; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Whitlock EP, 2010, EFFECTIVENESS PRIMAR; Wilfley DE, 2007, HEALTH PSYCHOL, V26, P521, DOI 10.1037/0278-6133.26.5.521; World Health Organization, 2010, REC MUND ACT FIS SAL; World Health Organization website, 2014, FACTSH; World Medical Association (WMA), 2013, ETH PRINC MED RES IN	47	19	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144502	10.1371/journal.pone.0144502	http://dx.doi.org/10.1371/journal.pone.0144502			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658988	gold, Green Published			2022-12-27	WOS:000366715900059
J	Wu, XY; Ji, PL; Zhang, L; Bu, GW; Gu, H; Wang, XJ; Xiong, YZ; Zuo, B				Wu, Xinyu; Ji, Panlong; Zhang, Liang; Bu, Guowei; Gu, Hao; Wang, Xiaojing; Xiong, Yuanzhu; Zuo, Bo			The Expression of Porcine Prdx6 Gene Is Up-Regulated by C/EBP beta and CREB	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; PEROXIREDOXIN 6 GENE; GROWTH-FACTOR; 1-CYS PEROXIREDOXIN; OXIDATIVE STRESS; GLUTATHIONE-PEROXIDASE; ANTIOXIDANT DEFENSE; CELL-DEATH; ENZYME; DIFFERENTIATION	Peroxiredoxin6 (Prdx6) is one of the peroxiredoxin (Prdxs) family members that play an important role in maintaining cell homeostasis. Our previous studies demonstrated that Prdx6 was significantly associated with pig meat quality, especially meat tenderness. However, the transcriptional regulation of porcine Prdx6 remains unclear. In this study, we determined the transcription start site (TSS) of porcine Prdx6 gene by 50 rapid-amplification of cDNA ends (50 RACE). Several regulatory elements including CCAAT/enhancer-binding protein beta (C/EBP beta), Myogenic Differentiation (MyoD), cAMP response element binding protein (CREB), stimulating protein1 (Sp1) and heat shock factor (HSF) binding sites were found by computational analyses together with luciferase reporter system. Overexpression and RNA interference experiments showed that C/EBP beta or CREB could up-regulate the expression of porcine Prdx6 gene at both mRNA and protein level. Electrophoretic mobility shift assays (EMSA) and chromatin immunoprecipitation assays (ChIP) confirmed that C/EBP beta and CREB could interact with Prdx6 promoter. Immuoprecipitation results also showed that C/EBP beta could interact with Prdx6 in vivo. Taken together, our findings identified C/EBP beta and CREB as the important regulators of porcine Prdx6 gene expression, and offered clues for further investigation of Prdx6 gene function.	[Wu, Xinyu; Ji, Panlong; Zhang, Liang; Bu, Guowei; Gu, Hao; Xiong, Yuanzhu; Zuo, Bo] Huazhong Agr Univ, Key Lab Swine Genet & Breeding, Minist Agr, Coll Anim Sci & Vet Med, Wuhan 430070, Peoples R China; [Wu, Xinyu; Ji, Panlong; Zhang, Liang; Bu, Guowei; Gu, Hao; Xiong, Yuanzhu; Zuo, Bo] Huazhong Agr Univ, Key Lab Agr Anim Genet & Breeding, Minist Educ, Coll Anim Sci & Vet Med, Wuhan 430070, Peoples R China; [Wang, Xiaojing] Huazhong Agr Univ, Dept Basic Vet Physiol, Wuhan 430070, Peoples R China; [Wang, Xiaojing] Huazhong Agr Univ, Biochem Lab, Wuhan 430070, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University	Zuo, B (corresponding author), Huazhong Agr Univ, Key Lab Swine Genet & Breeding, Minist Agr, Coll Anim Sci & Vet Med, Wuhan 430070, Peoples R China.	zuobo@mail.hzau.edu.cn			Key National High Technology Development Project of China [2011AA100301]; National Key Technology Support Program of China [2014BAD20B01]; Agricultural Innovation Fund of Hubei Province [2007-620]; Fundamental Research Funds for the Central Universities [2014PY038]; Key Project of Science and Technology of Zhejiang Province [2014C02010]	Key National High Technology Development Project of China; National Key Technology Support Program of China(National Key Technology R&D Program); Agricultural Innovation Fund of Hubei Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Project of Science and Technology of Zhejiang Province	This study was financially supported by the Key National High Technology Development Project of China (project no. 2011AA100301), the National Key Technology Support Program of China (grant no. 2014BAD20B01), the Agricultural Innovation Fund of Hubei Province (grant no. 2007-620), the Fundamental Research Funds for the Central Universities (grant no. 2014PY038) and the Key Project of Science and Technology of Zhejiang Province (grant no. 2014C02010).	Bai J, 2003, J NEUROSCI, V23, P503, DOI 10.1523/JNEUROSCI.23-02-00503.2003; Bedogni B, 2003, J BIOL CHEM, V278, P16510, DOI 10.1074/jbc.M301089200; BLAKE MC, 1990, MOL CELL BIOL, V10, P6632, DOI 10.1128/MCB.10.12.6632; Brinkmann C, 2013, J PHYSIOL SCI, V63, P1, DOI 10.1007/s12576-012-0237-4; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; CHAE HZ, 1993, J BIOL CHEM, V268, P16815; Chen JW, 2000, J BIOL CHEM, V275, P28421, DOI 10.1074/jbc.M005073200; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Chhunchha B, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.121; Chhunchha B, 2013, AM J PHYSIOL-CELL PH, V304, pC636, DOI 10.1152/ajpcell.00345.2012; Chowdhury I, 2014, ANTIOXID REDOX SIGN, V20, P391, DOI 10.1089/ars.2012.4634; Chowdhury I, 2009, FREE RADICAL BIO MED, V46, P146, DOI 10.1016/j.freeradbiomed.2008.09.027; El Eter E, 2014, CELL STRESS CHAPERON, V19, P173, DOI 10.1007/s12192-013-0442-y; Fatma N, 2009, J BIOL CHEM, V284, P22758, DOI 10.1074/jbc.M109.016071; Fisher AB, 1999, J BIOL CHEM, V274, P21326, DOI 10.1074/jbc.274.30.21326; Fisher AB, 2011, ANTIOXID REDOX SIGN, V15, P831, DOI 10.1089/ars.2010.3412; Fuchs NV, 2011, J VIROL, V85, P3436, DOI 10.1128/JVI.02539-10; Gummersbach C, 2009, DIFFERENTIATION, V77, P115, DOI 10.1016/j.diff.2008.09.009; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Huang C, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/601508; Jia X, 2009, J ANIM SCI, V87, P2391, DOI 10.2527/jas.2009-1792; Jo M, 2013, FREE RADICAL BIO MED, V61, P453, DOI 10.1016/j.freeradbiomed.2013.04.032; JOHNSON PF, 1994, LIVER GENE EXPRESSIO, P231; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kim TS, 1998, AM J PHYSIOL-LUNG C, V274, pL750, DOI 10.1152/ajplung.1998.274.5.L750; Kubo E, 2008, AM J PHYSIOL-CELL PH, V294, pC842, DOI 10.1152/ajpcell.00540.2007; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Liu FJ, 2014, ONCOL LETT, V7, P1851, DOI 10.3892/ol.2014.1978; Liu Yang, 2011, Yichuan, V33, P743, DOI 10.3724/SP.J.1005.2011.00743; Manevich Y, 2005, FREE RADICAL BIO MED, V38, P1422, DOI 10.1016/j.freeradbiomed.2005.02.011; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Monteiro G, 2007, P NATL ACAD SCI USA, V104, P4886, DOI 10.1073/pnas.0700481104; Payne VA, 2010, BIOCHEM J, V425, P215, DOI 10.1042/BJ20091112; Power JHT, 2008, ACTA NEUROPATHOL, V115, P611, DOI 10.1007/s00401-008-0373-3; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Rolfs F, 2013, CANCER RES, V73, P3460, DOI 10.1158/0008-5472.CAN-12-4369; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Seibold P, 2013, BREAST, V22, P817, DOI 10.1016/j.breast.2013.02.008; Singh AK, 1998, J BIOL CHEM, V273, P26171, DOI 10.1074/jbc.273.40.26171; Stewart R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024714; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Won H, 2012, ANTIOXID REDOX SIGN, V16, P245, DOI 10.1089/ars.2011.3952; Xia XL, 2016, GENE, V575, P551, DOI 10.1016/j.gene.2015.09.042; Yun HM, 2014, MOL NEUROBIOL, P1; Zhang Y-X, 2016, CELLULAR SIGNALLING, V28, P60; Zhou GX, 2010, MEAT SCI, V86, P440, DOI 10.1016/j.meatsci.2010.05.031; Zuloaga R, 2013, BIOCHEM BIOPH RES CO, V440, P258, DOI 10.1016/j.bbrc.2013.09.067	50	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144851	10.1371/journal.pone.0144851	http://dx.doi.org/10.1371/journal.pone.0144851			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659441	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900119
J	Yeung, P; Sin, HS; Chan, S; Chan, GCF; Chan, BP				Yeung, Pan; Sin, Hoi Shun; Chan, Shing; Chan, Godfrey Chi Fung; Chan, Barbara Pui			Microencapsulation of Neuroblastoma Cells and Mesenchymal Stromal Cells in Collagen Microspheres: A 3D Model for Cancer Cell Niche Study	PLOS ONE			English	Article							TUMOR-ASSOCIATED FIBROBLASTS; STEM-CELLS; BONE-MARROW; CROSS-TALK; MATRIX METALLOPROTEINASES; ENDOTHELIAL-CELLS; TISSUE-CULTURE; E-CADHERIN; BREAST; ANGIOGENESIS	There is a growing trend for researchers to use in vitro 3D models in cancer studies, as they can better recapitulate the complex in vivo situation. And the fact that the progression and development of tumor are closely associated to its stromal microenvironment has been increasingly recognized. The establishment of such tumor supportive niche is vital in understanding tumor progress and metastasis. The mesenchymal origin of many cells residing in the cancer niche provides the rationale to include MSCs in mimicking the niche in neuroblastoma. Here we co-encapsulate and co-culture NBCs and MSCs in a 3D in vitro model and investigate the morphology, growth kinetics and matrix remodeling in the reconstituted stromal environment. Results showed that the incorporation of MSCs in the model lead to accelerated growth of cancer cells as well as recapitulation of at least partially the tumor microenvironment in vivo. The current study therefore demonstrates the feasibility for the collagen microsphere to act as a 3D in vitro cancer model for various topics in cancer studies.	[Yeung, Pan; Sin, Hoi Shun; Chan, Barbara Pui] Univ Hong Kong, Dept Mech Engn, Tissue Engn Lab, Hong Kong, Hong Kong, Peoples R China; [Chan, Shing; Chan, Godfrey Chi Fung] Univ Hong Kong, Dept Adolescence Med & Paediat, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Chan, BP (corresponding author), Univ Hong Kong, Dept Mech Engn, Tissue Engn Lab, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	bpchan@hku.hk	Chan, Barbara Pui/AAM-7767-2020; Chan, Godfrey Chi Fung/C-4205-2009	Yeung, Pan/0000-0003-2416-5179; Chan, Godfrey Chi Fung/0000-0001-5032-8985; Chan, BP/0000-0001-5419-2472				Alemany-Ribes M, 2014, ADV DRUG DELIVER REV, V79-80, P40, DOI 10.1016/j.addr.2014.06.004; Alison MR, 2009, J PATHOL, V217, P144, DOI 10.1002/path.2498; American Cancer Society, 2015, CANCER FACTS FIGURES; Barcellos-de-Souza P, 2013, BBA-REV CANCER, V1836, P321, DOI 10.1016/j.bbcan.2013.10.004; Beierle EA, 2001, J SURG RES, V97, P34, DOI 10.1006/jsre.2001.6097; Benton G, 2014, ADV DRUG DELIVER REV, V79-80, P3, DOI 10.1016/j.addr.2014.06.005; Bergfeld SA, 2010, CANCER METAST REV, V29, P249, DOI 10.1007/s10555-010-9222-7; Bersini S, 2014, BIOMATERIALS, V35, P2454, DOI 10.1016/j.biomaterials.2013.11.050; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Blaheta RA, 2009, NEOPLASIA, V11, P1054, DOI 10.1593/neo.09762; Boomsma RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035685; Bray LJ, 2015, BIOMATERIALS, V53, P609, DOI 10.1016/j.biomaterials.2015.02.124; Bremnes RM, 2011, J THORAC ONCOL, V6, P209, DOI 10.1097/JTO.0b013e3181f8a1bd; Chan BP, 2007, BIOMATERIALS, V28, P4652, DOI 10.1016/j.biomaterials.2007.07.041; Chan BP, 2010, TISSUE ENG PART C-ME, V16, P225, DOI 10.1089/ten.tec.2008.0709; Chen MK, 1998, J SURG RES, V78, P123, DOI 10.1006/jsre.1998.5363; Cheng HW, 2009, TISSUE ENG PART C-ME, V15, P697, DOI [10.1089/ten.tec.2008.0635, 10.1089/ten.TEC.2008.0635]; Chwalek K, 2014, ADV DRUG DELIVER REV, V79-80, P30, DOI 10.1016/j.addr.2014.05.006; Chwalek K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04414; Crigler L, 2007, FASEB J, V21, P2050, DOI 10.1096/fj.06-5880com; De Luca A, 2012, J CELL BIOCHEM, V113, P3363, DOI 10.1002/jcb.24212; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; EAGLE H, 1958, CANCER RES, V18, P1017; Ehling J, 2014, AM J PATHOL, V184, P431, DOI 10.1016/j.ajpath.2013.10.014; Fang ST, 2011, J MOL CELL CARDIOL, V50, P290, DOI 10.1016/j.yjmcc.2010.10.024; Fang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075187; Fennema E, 2013, TRENDS BIOTECHNOL, V31, P108, DOI 10.1016/j.tibtech.2012.12.003; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Gill BJ, 2014, J BIOMECH, V47, P1969, DOI 10.1016/j.jbiomech.2013.09.029; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanania R, 2012, J BIOL CHEM, V287, P8468, DOI 10.1074/jbc.M111.290676; Herrmann D, 2014, CARCINOGENESIS, V35, P1671, DOI 10.1093/carcin/bgu108; Hickman JA, 2014, BIOTECHNOL J, V9, P1115, DOI 10.1002/biot.201300492; HIRSCHBERG E, 1958, CANCER RES, V18, P869; Huang SS, 2011, CELL REPROGRAM, V13, P465, DOI 10.1089/cell.2011.0045; Hui TY, 2008, BIOMATERIALS, V29, P3201, DOI 10.1016/j.biomaterials.2008.04.001; Hutmacher DW, 2015, CURR OPIN BIOTECH, V35, P127, DOI 10.1016/j.copbio.2015.06.001; Jaganathan H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06468; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Karagiannis GS, 2012, MOL CANCER RES, V10, P1403, DOI 10.1158/1541-7786.MCR-12-0307; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Kimlin LC, 2013, MOL CARCINOGEN, V52, P167, DOI 10.1002/mc.21844; Lai W, 2013, J TISSUE ENG, V4, DOI 10.1177/2041731413508668; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P677, DOI 10.1189/jlb.0506309; Li J, 2004, BRIT J HAEMATOL, V127, P326, DOI 10.1111/j.1365-2141.2004.05200.x; Li YY, 2014, TISSUE ENG PT A, V20, P1379, DOI [10.1089/ten.tea.2013.0498, 10.1089/ten.TEA.2013.0498]; Lin RZ, 2006, CELL TISSUE RES, V324, P411, DOI 10.1007/s00441-005-0148-2; Liu SQ, 2005, AM J PATHOL, V166, P891, DOI 10.1016/S0002-9440(10)62309-7; Loessner D, 2013, INTEGR BIOL-UK, V5, P597, DOI 10.1039/c3ib20252f; Loessner D, 2014, ADV DRUG DELIVER REV, V79-80, P193, DOI 10.1016/j.addr.2014.06.001; Loessner D, 2013, BIOMATERIALS, V34, P7389, DOI 10.1016/j.biomaterials.2013.06.009; Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064; Lopez JI, 2011, INTEGR BIOL-UK, V3, P910, DOI 10.1039/c1ib00043h; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Ma M, 2011, CANCER LETT, V312, P1, DOI 10.1016/j.canlet.2011.06.028; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; Merdad A, 2014, ANTICANCER RES, V34, P1355; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Mueller L, 2007, AM J PATHOL, V171, P1608, DOI 10.2353/ajpath.2007.060661; NOEL A, 1993, BRIT J CANCER, V68, P909, DOI 10.1038/bjc.1993.453; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pajtler KW, 2014, ONCOTARGET, V5, P11180, DOI 10.18632/oncotarget.2611; Paunescu V, 2011, J CELL MOL MED, V15, P635, DOI 10.1111/j.1582-4934.2010.01044.x; Phinney DG, 2002, J CELL BIOCHEM, P7, DOI 10.1002/jcb.10084; Rothenberg AB, 2009, PEDIATR RADIOL, V39, P155, DOI 10.1007/s00247-008-1062-z; Schinkothe T, 2008, STEM CELLS DEV, V17, P199, DOI 10.1089/scd.2007.0175; Shankar V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120069; Sohara Yasuyoshi, 2004, Proceedings of the American Association for Cancer Research Annual Meeting, V45, P1107; Song HHG, 2014, ADV DRUG DELIVER REV, V79-80, P19, DOI 10.1016/j.addr.2014.06.002; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Sugiura Y, 1998, CANCER RES, V58, P2209; Szot CS, 2013, TISSUE ENG PART C-ME, V19, P864, DOI [10.1089/ten.tec.2012.0684, 10.1089/ten.TEC.2012.0684]; van Kempen LCL, 2002, CANCER CELL, V2, P251, DOI 10.1016/S1535-6108(02)00157-5; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Weiswald LB, 2015, NEOPLASIA, V17, P1, DOI 10.1016/j.neo.2014.12.004; Wong HL, 2007, BIOMATERIALS, V28, P5369, DOI 10.1016/j.biomaterials.2007.08.016; Yeung CW, 2009, TISSUE ENG PT A, V15, P3071, DOI [10.1089/ten.tea.2008.0661, 10.1089/ten.TEA.2008.0661]; Yuan MT, 2011, SPINE J, V11, P947, DOI 10.1016/j.spinee.2011.07.004; Zhang T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt221	82	16	17	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144139	10.1371/journal.pone.0144139	http://dx.doi.org/10.1371/journal.pone.0144139			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26657086	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900028
J	Zhang, JB; Li, BJ; Gao, JL; Shi, HQ; Wang, X; Jiang, YL; Ming, QS; Gao, YD; Ma, R; Yao, SQ				Zhang, Jibiao; Li, Baojuan; Gao, Junling; Shi, Huqing; Wang, Xiang; Jiang, Yali; Ming, Qingsen; Gao, Yidian; Ma, Ren; Yao, Shuqiao			Impaired Frontal-Basal Ganglia Connectivity in Male Adolescents with Conduct Disorder	PLOS ONE			English	Article							DISRUPTIVE BEHAVIOR DISORDERS; OPPOSITIONAL DEFIANT DISORDER; RESPONSE-INHIBITION; ANTISOCIAL-BEHAVIOR; BRAIN ABNORMALITIES; CHINESE VERSION; EXPECTED VALUE; MOTOR AREA; IMPULSIVITY; BOYS	Alack of inhibition control has been found in subjects with conduct disorder (CD), but the underlying neuropathophysiology remains poorly understood. The current study investigated the different mechanism of inhibition control in adolescent-onset CD males (n = 29) and well-matched healthy controls (HCs) (n = 40) when performing a GoStop task by functional magnetic resonance images. Effective connectivity (EC) within the inhibition control network was analyzed using a stochastic dynamic causality model. We found that EC within the inhibition control network was significantly different in the CD group when compared to the HCs. Exploratory relationship analysis revealed significant negative associations between EC between the IFG and striatum and behavioral scale scores in the CD group. These results suggest for the first time that the failure of inhibition control in subjects with CD might be associated with aberrant connectivity of the frontal-basal ganglia pathways, especially between the IFG and striatum.	[Zhang, Jibiao] Jianghan Univ, Sch Educ, Dept Psychol, Wuhan, Hubei, Peoples R China; [Zhang, Jibiao; Wang, Xiang; Jiang, Yali; Ming, Qingsen; Gao, Yidian; Ma, Ren; Yao, Shuqiao] Cent S Univ, Xiangya Hosp 2, Inst Med Psychol, Changsha, Hunan, Peoples R China; [Li, Baojuan] Fourth Mil Med Univ, Sch Biomed Engn, Xian 710032, Shaanxi, Peoples R China; [Gao, Junling] Univ Hong Kong, Ctr Buddhist Studies, Hong Kong, Hong Kong, Peoples R China; [Shi, Huqing] Shanghai Normal Univ, Dept Psychol, Shanghai, Peoples R China; [Yao, Shuqiao] Natl Technol Inst Psychiat, Changsha, Hunan, Peoples R China	Jianghan University; Central South University; Air Force Military Medical University; University of Hong Kong; Shanghai Normal University	Yao, SQ (corresponding author), Cent S Univ, Xiangya Hosp 2, Inst Med Psychol, Changsha, Hunan, Peoples R China.	shuqiaoyao@163.com	Gao, Yidian/GYU-8714-2022; GAO, Junling/U-9633-2018	Gao, Yidian/0000-0002-5979-2677; GAO, Junling/0000-0003-4024-4694	National Key Technologies R&D Program of China's 11th 5-year Plan [2009BAI77B02]; National Natural Science Foundation of China (NSFC) [81471384]; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20130162110043]	National Key Technologies R&D Program of China's 11th 5-year Plan; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by grants from the National Key Technologies R&D Program of China's 11th 5-year Plan grant 2009BAI77B02, National Natural Science Foundation of China (NSFC) grant 81471384, and Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) grant 20130162110043. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Aoki Y, 2014, SOC COGN AFFECT NEUR, V9, P1223, DOI 10.1093/scan/nst104; Arnsten AFT, 2012, J AM ACAD CHILD PSY, V51, P356, DOI 10.1016/j.jaac.2012.01.008; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Blair RJR, 2014, NEW ENGL J MED, V371, P2207, DOI 10.1056/NEJMra1315612; Castellanos-Ryan N, 2011, ALCOHOL CLIN EXP RES, V35, P140, DOI 10.1111/j.1530-0277.2010.01331.x; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Coccaro EF, 2007, BIOL PSYCHIAT, V62, P168, DOI 10.1016/j.biopsych.2006.08.024; Cohn MD, 2015, BIOL PSYCHIAT, V78, P615, DOI 10.1016/j.biopsych.2014.08.017; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Dalwani MS, 2014, DRUG ALCOHOL DEPEN, V134, P242, DOI 10.1016/j.drugalcdep.2013.10.009; Daunizeau J, 2012, NEUROIMAGE, V62, P464, DOI 10.1016/j.neuroimage.2012.04.061; DeVito EE, 2013, NEUROPSYCHOPHARMACOL, V38, P1854, DOI 10.1038/npp.2013.92; Dougherty D.M., 2003, GOSTOP IMPULSIVITY P; Dougherty DM, 2003, J CHILD PSYCHOL PSYC, V44, P1145, DOI 10.1111/1469-7610.00197; Duann JR, 2009, J NEUROSCI, V29, P10171, DOI 10.1523/JNEUROSCI.1300-09.2009; Erskine HE, 2014, J CHILD PSYCHOL PSYC, V55, P328, DOI 10.1111/jcpp.12186; Fairchild G, 2011, AM J PSYCHIAT, V168, P624, DOI 10.1176/appi.ajp.2010.10081184; Finger EC, 2011, AM J PSYCHIAT, V168, P152, DOI 10.1176/appi.ajp.2010.10010129; First MB, 2002, STRUCTURED CLIN INTE; Friston KJ, 2011, NEUROIMAGE, V56, P1202, DOI 10.1016/j.neuroimage.2010.12.039; Friston KJ, 2010, MATH PROBL ENG, V2010, DOI 10.1155/2010/621670; Gong Y., 1993, WECHSLER INTELLIGENC; Herba CM, 2006, DEV NEUROPSYCHOL, V30, P659, DOI 10.1207/s15326942dn3002_2; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; Huebner T, 2008, J AM ACAD CHILD PSY, V47, P540, DOI 10.1097/CHI.0b013e3181676545; Hyde LW, 2013, DEV REV, V33, P168, DOI 10.1016/j.dr.2013.06.001; Jahfari S, 2011, J NEUROSCI, V31, P6891, DOI 10.1523/JNEUROSCI.5253-10.2011; Jones AP, 2009, AM J PSYCHIAT, V166, P95, DOI 10.1176/appi.ajp.2008.07071050; Li BJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05027; Li BJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00206; Lockwood PL, 2013, CURR BIOL, V23, P901, DOI 10.1016/j.cub.2013.04.018; Ma LS, 2015, BRAIN CONNECT, V5, P177, DOI 10.1089/brain.2014.0275; Matthys W, 2013, DEV PSYCHOPATHOL, V25, P193, DOI 10.1017/S0954579412000272; O'Muircheartaigh J, 2011, NEUROIMAGE, V54, P2020, DOI 10.1016/j.neuroimage.2010.09.054; Olsson M, 2009, NORD J PSYCHIAT, V63, P102, DOI 10.1080/08039480802626939; Rubia K, 2008, AM J PSYCHIAT, V165, P889, DOI 10.1176/appi.ajp.2008.07071084; Rubia K, 2009, AM J PSYCHIAT, V166, P83, DOI 10.1176/appi.ajp.2008.08020212; Sarkar S, 2015, EUR CHILD ADOLES PSY, V24, P909, DOI 10.1007/s00787-014-0639-3; Sebastian CL, 2012, ARCH GEN PSYCHIAT, V69, P814, DOI 10.1001/archgenpsychiatry.2011.2070; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Sterzer P, 2007, NEUROIMAGE, V37, P335, DOI 10.1016/j.neuroimage.2007.04.043; Stevens MC, 2012, J PSYCHIATR NEUROSCI, V37, P389, DOI 10.1503/jpn.110148; Swann NC, 2012, NEUROIMAGE, V59, P2860, DOI 10.1016/j.neuroimage.2011.09.049; Viding E, 2012, J ROY SOC MED, V105, P195, DOI 10.1258/jrsm.2011.110223; Vitacco MJ, 2003, ASSESSMENT, V10, P143, DOI 10.1177/1073191103010002005; Wallace GL, 2014, J AM ACAD CHILD PSY, V53, P456, DOI 10.1016/j.jaac.2013.12.008; Wang MC, 2013, J CLIN PSYCHOL, V69, P966, DOI 10.1002/jclp.21978; Whelan R, 2012, NAT NEUROSCI, V15, P920, DOI 10.1038/nn.3092; White SF, 2014, J AM ACAD CHILD PSY, V53, P579, DOI 10.1016/j.jaac.2013.12.023; White SF, 2013, AM J PSYCHIAT, V170, P315, DOI 10.1176/appi.ajp.2012.12060840; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Yao SQ, 2007, PERCEPT MOTOR SKILL, V104, P1169, DOI 10.2466/PMS.104.4.1169-1182; Yao SQ, 2007, CHILD PSYCHIAT HUM D, V38, P1, DOI 10.1007/s10578-006-0039-0; Yao SQ, 2009, J ADOLESCENT HEALTH, V45, P55, DOI 10.1016/j.jadohealth.2008.11.006; Zhang JB, 2014, J AM ACAD CHILD PSY, V53, P466, DOI 10.1016/j.jaac.2013.12.015; Zhong MT, 2011, BIOL PSYCHOL, V88, P233, DOI 10.1016/j.biopsycho.2011.08.007; Zhu Y, 2014, BRAIN IMAGING BEHAV, V8, P588, DOI 10.1007/s11682-013-9275-7	58	7	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145011	10.1371/journal.pone.0145011	http://dx.doi.org/10.1371/journal.pone.0145011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658732	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900166
J	Benavides, M; Moisander, PH; Berthelot, H; Dittmar, T; Grosso, O; Bonnet, S				Benavides, Mar; Moisander, Pia H.; Berthelot, Hugo; Dittmar, Thorsten; Grosso, Olivier; Bonnet, Sophie			Mesopelagic N-2 Fixation Related to Organic Matter Composition in the Solomon and Bismarck Seas (Southwest Pacific)	PLOS ONE			English	Article							NITROGEN; DIAZOTROPHS; DIVERSITY; WATERS; DISTRIBUTIONS; MICROORGANISMS; PHYLOTYPES; METABOLISM; EXPRESSION; ABUNDANCES	Dinitrogen (N-2) fixation was investigated together with organic matter composition in the mesopelagic zone of the Bismarck (Transect 1) and Solomon (Transect 2) Seas (Southwest Pacific). Transparent exopolymer particles (TEP) and the presence of compounds sharing molecular formulae with saturated fatty acids and sugars, as well as dissolved organic matter (DOM) compounds containing nitrogen (N) and phosphorus (P) were higher on Transect 1 than on Transect 2, while oxygen concentrations showed an opposite pattern. N-2 fixation rates (up to similar to 1 nmol N L-1 d(-1)) were higher in Transect 1 than in Transect 2, and correlated positively with TEP, suggesting a dependence of diazotroph activity on organic matter. The scores of the multivariate ordination of DOM molecular formulae and their relative abundance correlated negatively with bacterial abundances and positively with N-2 fixation rates, suggesting an active bacterial exploitation of DOM and its use to sustain diazotrophic activity. Sequences of the nifH gene clustered with Alpha-, Beta-, Gamma- and Deltaproteobacteria, and included representatives from Clusters I, III and IV. A third of the clone library included sequences close to the potentially anaerobic Cluster III, suggesting that N-2 fixation was partially supported by presumably particle-attached diazotrophs. Quantitative polymerase chain reaction (qPCR) primer-probe sets were designed for three phylotypes and showed low abundances, with a phylotype within Cluster III at up to 10(3) nifH gene copies L-1. These results provide new insights into the ecology of non-cyanobacterial diazotrophs and suggest that organic matter sustains their activity in the mesopelagic ocean.	[Benavides, Mar; Bonnet, Sophie] Univ Toulon & Var, IRD, Mediterranean Inst Oceanog MIO UM 110, Aix Marseille Univ,CNRS,INSU, Noumea 98848, New Caledonia; [Moisander, Pia H.] Univ Massachusetts, Dept Biol, N Dartmouth, MA 02747 USA; [Berthelot, Hugo; Grosso, Olivier] Univ Toulon & Var, Mediterranean Inst Oceanog MIO UM 110, Aix Marseille Univ, CNRS,INSU,IRD, F-13288 Marseille, France; [Dittmar, Thorsten] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Res Grp Marine Geochem, D-26129 Oldenburg, Germany	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; University of Massachusetts System; University Massachusetts Dartmouth; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Toulon; Carl von Ossietzky Universitat Oldenburg	Benavides, M (corresponding author), Univ Toulon & Var, IRD, Mediterranean Inst Oceanog MIO UM 110, Aix Marseille Univ,CNRS,INSU, Noumea 98848, New Caledonia.	mar.benavides@ird.fr	Dittmar, Thorsten/L-7796-2013; Bonnet, Sophie/I-6274-2015; Hugo, BERTHELOT/Y-7435-2018; Benavides, Mar/K-5323-2015	Dittmar, Thorsten/0000-0002-3462-0107; Bonnet, Sophie/0000-0002-9886-8216; Hugo, BERTHELOT/0000-0003-1028-5938; Benavides, Mar/0000-0001-9502-108X; Moisander, Pia/0000-0002-3262-3662	Institut de Recherche pour le Developpement; People Programme (Marie Sklodowska-Curie Actions) of the European Union's Seventh Framework Programme (FP7) under Research Executive Agency (REA) grant [625185]; US National Science Foundation (NSF) Division of Ocean Sciences (OCE) [1130495]; French Ministry of Research and Education; NSF OCE grant [1029487]; French Agence National de Recherche [ANR-09-BLAN-0233-01]; Les Enveloppes Fluides et l'Environnement (INSU/LEFE) project Solwara	Institut de Recherche pour le Developpement; People Programme (Marie Sklodowska-Curie Actions) of the European Union's Seventh Framework Programme (FP7) under Research Executive Agency (REA) grant; US National Science Foundation (NSF) Division of Ocean Sciences (OCE)(National Science Foundation (NSF)); French Ministry of Research and Education; NSF OCE grant(National Science Foundation (NSF)); French Agence National de Recherche(French National Research Agency (ANR)); Les Enveloppes Fluides et l'Environnement (INSU/LEFE) project Solwara	This research was funded by Institut de Recherche pour le Developpement. MB was funded by the People Programme (Marie Sklodowska-Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under Research Executive Agency (REA) grant agreement number 625185. PM was supported by funding from the US National Science Foundation (NSF) Division of Ocean Sciences (OCE) grant number 1130495. HB was supported by a PhD scholarship from the French Ministry of Research and Education. SPICE is a contribution to the CLIVAR and GEOTRACES International programs. The MoorSPICE cruise has been co-funded by NSF OCE grant number 1029487, by French Agence National de Recherche project ANR-09-BLAN-0233-01 and by Les Enveloppes Fluides et l'Environnement (INSU/LEFE) project Solwara.	Aristegui J, 2009, LIMNOL OCEANOGR, V54, P1501, DOI 10.4319/lo.2009.54.5.1501; Baltar F, 2009, LIMNOL OCEANOGR, V54, P182, DOI 10.4319/lo.2009.54.1.0182; Benavides M, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00040; Bentzon-Tilia M, 2015, MBIO, V6, DOI 10.1128/mBio.00929-15; Bentzon-Tilia M, 2015, ISME J, V9, P273, DOI 10.1038/ismej.2014.119; Bonnet S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081265; Bonnet S, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003439; Capone DG, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002331; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Church MJ, 2005, AQUAT MICROB ECOL, V38, P3, DOI 10.3354/ame038003; Codispoti LA, 2007, BIOGEOSCIENCES, V4, P233, DOI 10.5194/bg-4-233-2007; Dabundo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110335; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Dittmar T, 2008, LIMNOL OCEANOGR-METH, V6, P230, DOI 10.4319/lom.2008.6.230; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; FARNELID H, 2008, NITROGEN FIXATION RE, P409; Farnelid H, 2013, ISME J, V7, P1413, DOI 10.1038/ismej.2013.26; Farnelid H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019223; Fernandez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020539; Ganachaud A, 2014, J GEOPHYS RES-OCEANS, V119, P7660, DOI 10.1002/2013JC009678; Grenier M, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007477; Grossart HP, 2001, LIMNOL OCEANOGR, V46, P267, DOI 10.4319/lo.2001.46.2.0267; Grosskopf T, 2012, NATURE, V488, P361, DOI 10.1038/nature11338; Halm H, 2012, ISME J, V6, P1238, DOI 10.1038/ismej.2011.182; Hamersley MR, 2011, AQUAT MICROB ECOL, V63, P193, DOI 10.3354/ame01494; Heller P, 2014, BIOINFORMATICS, V30, P2883, DOI 10.1093/bioinformatics/btu417; Hewson I, 2007, AQUAT MICROB ECOL, V46, P15, DOI 10.3354/ame046015; Jayakumar A, 2012, FEMS MICROBIOL ECOL, V82, P597, DOI 10.1111/j.1574-6941.2012.01430.x; KANA TM, 1994, ANAL CHEM, V66, P4166, DOI 10.1021/ac00095a009; Knapp AN, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00374; Koch BP, 2007, ANAL CHEM, V79, P1758, DOI 10.1021/ac061949s; Kujawinski EB, 2011, ANNU REV MAR SCI, V3, P567, DOI 10.1146/annurev-marine-120308-081003; Langlois RJ, 2008, APPL ENVIRON MICROB, V74, P1922, DOI 10.1128/AEM.01720-07; Loscher C. R., 2014, ISME J, V8, P2180, DOI DOI 10.1038/ismej.2014.71; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Luo YW, 2012, EARTH SYST SCI DATA, V4, P47, DOI 10.5194/essd-4-47-2012; Mahaffey C, 2005, AM J SCI, V305, P546, DOI 10.2475/ajs.305.6-8.546; Moisander PH, 2008, ISME J, V2, P954, DOI 10.1038/ismej.2008.51; Moisander PH, 2014, ISME J, V8, P1962, DOI 10.1038/ismej.2014.49; Moisander PH, 2010, SCIENCE, V327, P1512, DOI 10.1126/science.1185468; PAERL HW, 1985, LIMNOL OCEANOGR, V30, P1246, DOI 10.4319/lo.1985.30.6.1246; PAERL HW, 1987, APPL ENVIRON MICROB, V53, P1078, DOI 10.1128/AEM.53.5.1078-1087.1987; Passow U, 1995, LIMNOL OCEANOGR, V40, P1326, DOI 10.4319/lo.1995.40.7.1326; Rahav E, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00227; Reinthaler T, 2013, GLOBAL BIOGEOCHEM CY, V27, P1151, DOI 10.1002/2013GB004634; Riedel T, 2014, ANAL CHEM, V86, P8376, DOI 10.1021/ac501946m; Riemann L, 2010, AQUAT MICROB ECOL, V61, P225, DOI 10.3354/ame01431; Santl-Temkiv T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053550; Slemons LO, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003693; Sohm JA, 2011, NAT REV MICROBIOL, V9, P499, DOI 10.1038/nrmicro2594; Turk-Kubo KA, 2014, ENVIRON MICROBIOL, V16, P3095, DOI 10.1111/1462-2920.12346; Zehr JP, 1998, APPL ENVIRON MICROB, V64, P3444; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x; Zehr JP, 2001, METHOD MICROBIOL, V30, P271, DOI 10.1016/S0580-9517(01)30049-1	54	33	34	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0143775	10.1371/journal.pone.0143775	http://dx.doi.org/10.1371/journal.pone.0143775			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659074	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903600015
J	Sharafeldin, TA; Mor, SK; Sobhy, NM; Xing, Z; Reed, KM; Goyal, SM; Porter, RE				Sharafeldin, Tamer A.; Mor, Sunil K.; Sobhy, Nader M.; Xing, Zheng; Reed, Kent M.; Goyal, Sagar M.; Porter, Robert E.			A Newly Emergent Turkey Arthritis Reovirus Shows Dominant Enteric Tropism and Induces Significantly Elevated Innate Antiviral and T Helper-1 Cytokine Responses	PLOS ONE			English	Article							POULT ENTERITIS; AVIAN REOVIRUSES; VIRUS DISTRIBUTION; ORIGIN REOVIRUSES; YOUNG TURKEYS; CHICKENS; INFECTION; TENOSYNOVITIS; PATHOGENESIS; PATHOGENICITY	Newly emergent turkey arthritis reoviruses (TARV) were isolated from tendons of lame 15-week-old tom turkeys that occasionally had ruptured leg tendons. Experimentally, these TARVs induced remarkable tenosynovitis in gastrocnemius tendons of turkey poults. The current study aimed to characterize the location and the extent of virus replication as well as the cytokine response induced by TARV during the first two weeks of infection. One-week-old male turkeys were inoculated orally with TARV (O'Neil strain). Copy numbers of viral genes were estimated in intestines, internal organs and tendons at 1/2, 1, 2, 3, 4, 7, 14 days Post inoculation (dpi). Cytokine profile was measured in intestines, spleen and leg tendons at 0, 4, 7 and 14 dpi. Viral copy number peaked in jejunum, cecum and bursa of Fabricius at 4 dpi. Copy numbers increased dramatically in leg tendons at 7 and 14 dpi while minimal copies were detected in internal organs and blood during the same period. Virus was detected in cloacal swabs at 1-2 dpi, and peaked at 14 dpi indicating enterotropism of the virus and its early shedding in feces. Elevation of IFN-alpha and IFN-beta was observed in intestines at 7 dpi as well as a prominent T helper-1 response (IFN-gamma) at 7 and 14 dpi. IFN-gamma and IL-6 were elevated in gastrocnemius tendons at 14 dpi. Elevation of antiviral cytokines in intestines occurred at 7dpi when a significant decline of viral replication in intestines was observed. T helper-1 response in intestines and leg tendons was the dominant T-helper response. These results suggest the possible correlation between viral replication and cytokine response in early infection of TARV in turkeys. Our findings provide novel insights which help elucidate viral pathogenesis in turkey tendons infected with TARV.	[Sharafeldin, Tamer A.; Mor, Sunil K.; Sobhy, Nader M.; Goyal, Sagar M.; Porter, Robert E.] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA; [Sharafeldin, Tamer A.; Mor, Sunil K.; Sobhy, Nader M.; Goyal, Sagar M.; Porter, Robert E.] Univ Minnesota, Minnesota Vet Diagnost Lab, St Paul, MN 55108 USA; [Xing, Zheng; Reed, Kent M.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Sharafeldin, Tamer A.] Zagazig Univ, Fac Vet Med, Dept Pathol, Zagazig 44519, Egypt; [Xing, Zheng] Nanjing Univ, Sch Med, Nanjing 210093, Jiangsu, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Egyptian Knowledge Bank (EKB); Zagazig University; Nanjing University	Sharafeldin, TA (corresponding author), Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA.	shara022@umn.edu	Xing, Zheng/O-3137-2015; Sharafeldin, Tamer/E-6495-2016; Sobhy, Nader/AAA-2339-2021; Mor, Sunil Kumar/M-6325-2018	Xing, Zheng/0000-0002-7288-0268; Sharafeldin, Tamer/0000-0001-6422-4730; Mor, Sunil Kumar/0000-0002-1112-088X; Sobhy, Nader/0000-0002-9834-9627	Rapid Agriculture Response Fund, University Of Minnesota (RARF); Rapid Agricultural Response Fund	Rapid Agriculture Response Fund, University Of Minnesota (RARF); Rapid Agricultural Response Fund	This work was supported by Rapid Agriculture Response Fund, University Of Minnesota (RARF), https://www.maes.umn.edu/research/rapid-ag to SG.; This study was funded in part by the Rapid Agricultural Response Fund, established by the Minnesota legislature and administered by the University of Minnesota Agricultural Experiment Station. We thank Dr. Jack Rosenberger for providing TARV-O'Neil for the study.	Al Afaleq AA, 1980, AVIAN PATHOL, V18, P433; ALAFALEQ A, 1994, RES VET SCI, V57, P96, DOI 10.1016/0034-5288(94)90088-4; Calvert AJ, 2012, LIGHT TURKEY SYNDROM; Day JM, 2008, AVIAN DIS, V52, P387, DOI 10.1637/8190-120607-Reg; Forrest JC, 2003, J VIROL, V77, P9109, DOI 10.1128/JVI.77.17.9109-9115.2003; Haritova A. M., 2012, Bulgarian Journal of Veterinary Medicine, V15, P13; Heggen-Peay CL, 2002, AVIAN DIS, V46, P32, DOI 10.1637/0005-2086(2002)046[0032:IOARFP]2.0.CO;2; Islam MR, 1988, AVIAN PATHOL, V17, P421; Jindal N, 2010, POULTRY SCI, V89, P217, DOI 10.3382/ps.2009-00424; Jindal N, 2009, AVIAN DIS, V53, P268, DOI 10.1637/8513-110308-Reg.1; JONES RC, 1984, AVIAN PATHOL, V13, P13, DOI 10.1080/03079458408418504; JONES RC, 1989, AVIAN PATHOL, V18, P239, DOI 10.1080/03079458908418599; KIBENGE FSB, 1987, AVIAN DIS, V31, P39, DOI 10.2307/1590769; KIBENGE FSB, 1985, AVIAN PATHOL, V14, P87, DOI 10.1080/03079458508436210; Komatsu N, 2015, INT J BIOCHEM CELL B, V58, P92, DOI 10.1016/j.biocel.2014.11.008; Lai CM, 2013, MBIO, V4, DOI [10.1128/mBio.00049-13, 10.1128/mBio.00405-13]; LEVISOHN S, 1980, AVIAN PATHOL, V9, P1, DOI 10.1080/03079458008418380; Liu HJ, 2008, MOL CELLS, V26, P396; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lojkic I, 2010, ACTA VET BRNO, V79, P91, DOI 10.2754/avb201079010091; Mor SK, 2014, AVIAN DIS, V58, P404, DOI 10.1637/10779-012314-Reg.1; Mor SK, 2013, AVIAN PATHOL, V42, P497, DOI 10.1080/03079457.2013.832145; Mor SK, 2013, AVIAN DIS, V57, P97, DOI 10.1637/10353-090712-Reg.1; NERSESSIAN BN, 1985, AVIAN DIS, V29, P963, DOI 10.2307/1590449; PAGE RK, 1982, AVIAN DIS, V26, P924, DOI 10.2307/1589881; Pantin-Jackwood MJ, 2007, VET PATHOL, V44, P185, DOI 10.1354/vp.44-2-185; SAHU SP, 1975, AM J VET RES, V36, P847; Sharafeldin TA, 2015, VET RES, V46, DOI 10.1186/s13567-015-0144-9; Sharafeldin TA, 2014, AVIAN PATHOL, V43, P371, DOI 10.1080/03079457.2014.940496; Shen Pin-Chun, 2014, Taiwan Veterinary Journal, V40, P29, DOI 10.1142/S1682648514500048; Spackman E, 2005, AVIAN PATHOL, V34, P291, DOI 10.1080/03079450500178501; WALKER ER, 1972, J ULTRA MOL STRUCT R, V41, P67, DOI 10.1016/S0022-5320(72)90039-1; Woolcock PR, 2008, AVIAN DIS, V52, P209, DOI 10.1637/8106-090607-Reg.1	33	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144085	10.1371/journal.pone.0144085	http://dx.doi.org/10.1371/journal.pone.0144085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659460	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903600021
J	Yu, XT; Wang, PY; Shi, ZM; Dong, K; Feng, P; Wang, HX; Wang, XJ				Yu, XiaoTong; Wang, PengYan; Shi, ZhengMing; Dong, Kun; Feng, Ping; Wang, HongXia; Wang, XueJiang			Urotensin-II-Mediated Reactive Oxygen Species Generation via NADPH Oxidase Pathway Contributes to Hepatic Oval Cell Proliferation	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; STEM-CELLS; GROWTH-FACTOR; LIVER-CANCER; RECEPTOR; EXPRESSION; RAT; RISE; BETA	Urotensin II (UII), a somatostatin-like cyclic peptide, is involved in tumor progression due to its mitogenic effect. Our previous study demonstrated that UII and its receptor UT were up-regulated in human hepatocellular carcinoma (HCC), and exogenous UII promoted proliferation of human hepatoma cell line BEL-7402. Hepatic progenitor cell (HPCs) are considered to be one of the origins of liver cancer cells, but their relationship with UII remains unclear. In this work, we aimed to investigate the effect of UII on ROS generation in HPCs and the mechanisms of UII-induced ROS in promoting cell proliferation. Human HCC samples were used to examine ROS level and expression of NADPH oxidase. Hepatic oval cell line WBF-344 was utilized to investigate the underlying mechanisms. ROS level was detected by dihydroethidium (DHE) or 2', 7'-dichlorofluorescein diacetate (DCF-DA) fluorescent probe. For HCC samples, ROS level and expression of NADPH oxidase were significantly up-regulated. In vitro, UII also increased ROS generation and expression of NADPH oxidase in WB-F344 cells. NADPH oxidase inhibitor apocynin pretreatment partially abolished UII-increased phosphorylation of PI3K/Akt and ERK, expression of cyclin E/cyclin-dependent kinase 2. Cell cycle was then analyzed by flow cytometry and UII-elevated S phase proportion was inhibited by apocynin pretreatment. Finally, bromodeoxyuridine (Brdu) incorporation assay showed that apocynin partially abolished UII induced cell proliferation. In conclusion, this study indicates that UII-increased ROS production via the NADPH oxidase pathway is partially associated with activation of the PI3K/Akt and ERK cascades, accelerates G1/S transition, and contributes to cell proliferation. These results showed that UII plays an important role in growth of HPCs, which provides novel evidence for the involvement of HPCs in the formation and pathogenesis of HCC.	[Yu, XiaoTong; Feng, Ping; Wang, HongXia; Wang, XueJiang] Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China; [Yu, XiaoTong; Feng, Ping; Wang, XueJiang] Capital Med Univ, Beijing Key Lab Canc Invas & Metastasis Res, Beijing, Peoples R China; [Wang, PengYan] Peking Union Med Hosp, Dept Pathol, Beijing, Peoples R China; [Shi, ZhengMing] Beijing Jishuitan Hosp, Dept Gen Surg, Beijing, Peoples R China; [Dong, Kun] Capital Med Univ, Beijing Youan Hosp, Dept Pathol, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Capital Medical University	Wang, XJ (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China.	xjwang@ccmu.edu.cn			National Natural Science Foundation of China [81272757]; Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges under Beijing Municipality [IDHT20150502]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges under Beijing Municipality	This work was supported by grants from National Natural Science Foundation of China (Grant No. 81272757) and the Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges under Beijing Municipality (Grant No. IDHT20150502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alison MR, 2005, STEM CELL REV, V1, P253, DOI 10.1385/SCR:1:3:253; Baek SH, 2015, IMMUNOPHARM IMMUNOT, V37, P265, DOI 10.3109/08923973.2015.1027916; Barrette Pierre-Olivier, 2012, Front Endocrinol (Lausanne), V3, P165, DOI 10.3389/fendo.2012.00165; Datla SR, 2007, ARTERIOSCL THROM VAS, V27, P2319, DOI 10.1161/ATVBAHA.107.149450; Djordjevic T, 2005, ARTERIOSCL THROM VAS, V25, P519, DOI 10.1161/01.ATV.0000154279.98244.eb; Ghosh D, 2012, CHEM-BIOL INTERACT, V195, P206, DOI 10.1016/j.cbi.2011.12.004; He J, 2012, EMBO REP, V13, P1116, DOI 10.1038/embor.2012.162; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Monika H, 2015, MOL CARCINOG, DOI [10.1002/mc.22255, DOI 10.1002/MC.22255]; Mori M, 1999, BIOCHEM BIOPH RES CO, V265, P123, DOI 10.1006/bbrc.1999.1640; Onan D, 2004, TRENDS ENDOCRIN MET, V15, P175, DOI 10.1016/j.tem.2004.03.007; PEARSON D, 1980, P NATL ACAD SCI-BIOL, V77, P5021, DOI 10.1073/pnas.77.8.5021; Qi L, 2013, BIOCHIM BIOPHYS ACTA, V1833, P3375, DOI [10.1016/j.bbamcr.2013.09.018 Epub 2013 Oct 8, DOI 10.1016/J.BBAMCR.2013.09.018]; Shih RH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-104; Sirica AE, 2005, HEPATOLOGY, V41, P5, DOI 10.1002/hep.20537; Takahashi K, 2003, PEPTIDES, V24, P301, DOI 10.1016/S0196-9781(03)00039-1; Tang Y, 2008, P NATL ACAD SCI USA, V105, P2445, DOI 10.1073/pnas.0705395105; TSAO MS, 1984, EXP CELL RES, V154, P38, DOI 10.1016/0014-4827(84)90666-9; Wang HX, 2013, FREE RADICAL BIO MED, V65, P897, DOI 10.1016/j.freeradbiomed.2013.08.179; Wang HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076796; Wang HX, 2011, PEPTIDES, V32, P382, DOI 10.1016/j.peptides.2010.10.032; Wong Robert, 2011, Gastroenterol Hepatol (N Y), V7, P16; Wu K, 2012, HEPATOLOGY, V56, P2255, DOI 10.1002/hep.26007; Xiao D, 2010, J BIOL CHEM, V285, P26558, DOI 10.1074/jbc.M109.063255; Xu Lei-Bo, 2014, World J Stem Cells, V6, P579, DOI 10.4252/wjsc.v6.i5.579; Xu RH, 2015, CLIN TRANSL ONCOL, V17, P230, DOI 10.1007/s12094-014-1218-2; Yoshimoto T, 2004, PEPTIDES, V25, P1775, DOI 10.1016/j.peptides.2004.03.028; Yu XT, 2014, MOLECULES, V19, P20768, DOI 10.3390/molecules191220768; Yun SP, 2014, BRIT J PHARMACOL, V171, P3283, DOI 10.1111/bph.12681; Zamule SM, 2011, CHEM-BIOL INTERACT, V190, P62, DOI 10.1016/j.cbi.2011.01.009; Zeng ZP, 2006, ANN NY ACAD SCI, V1073, P284, DOI 10.1196/annals.1353.032	31	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144433	10.1371/journal.pone.0144433	http://dx.doi.org/10.1371/journal.pone.0144433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658815	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903600044
J	Davis, CM; DeCicco-Skinner, KL; Hienz, RD				Davis, Catherine M.; DeCicco-Skinner, Kathleen L.; Hienz, Robert D.			Deficits in Sustained Attention and Changes in Dopaminergic Protein Levels following Exposure to Proton Radiation Are Related to Basal Dopaminergic Function	PLOS ONE			English	Article							HEAVY-PARTICLE IRRADIATION; WORKING-MEMORY; NEURODEGENERATIVE DISEASES; PARKINSONS-DISEASE; REACTIVE MICROGLIA; FE-56 PARTICLES; HZE PARTICLE; RATS; LEWIS; BEHAVIOR	The current report assessed the effects of low-level proton irradiation in inbred adult male Fischer 344 and Lewis rats performing an analog of the human Psychomotor Vigilance Test (PVT), commonly utilized as an object risk assessment tool to quantify fatigue and sustained attention in laboratory, clinical, and operational settings. These strains were used to determine if genetic differences in dopaminergic function would impact radiation-induced deficits in sustained attention. Exposure to head-only proton irradiation (25 or 100 cGy) disrupted rPVT performance in a strain-specific manner, with 25 cGy-exposed Fischer 344 rats displaying the most severe deficits in sustained attention (i.e., decreased accuracy and increased premature responding); Lewis rats did not display behavioral deficits following radiation. Fischer 344 rats displayed greater tyrosine hydroxylase and dopamine transporter levels in the frontal cortex compared to the Lewis rats, even though radiation exposure increased both of these proteins in the Lewis rats only. Tyrosine hydroxylase was decreased in the parietal cortex of both rat strains following radiation exposure, regardless of proton dose. Strain-specific cytokine changes were also found in the frontal cortex, with the Lewis rats displaying increased levels of putative neurotrophic cytokines (e.g., CNTF). These data support the hypothesis that basal dopaminergic function impacts the severity of radiation-induced deficits in sustained attention.	[Davis, Catherine M.; Hienz, Robert D.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Behav Biol, Baltimore, MD 21205 USA; [DeCicco-Skinner, Kathleen L.] Amer Univ, Dept Biol, Washington, DC 20016 USA	Johns Hopkins University; American University	Davis, CM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Behav Biol, Baltimore, MD 21205 USA.	cdavis91@jhmi.edu		Davis-Takacs, Catherine/0000-0002-2591-6352; DeCicco-Skinner, Kathleen/0000-0002-0256-5609	National Space Biomedical Research Institute (NSBRI) through NASA [NCC 9-58, NBPF01604, NBPF02802, NBPF04201, PF02602, EO00010]; NASA [NNX15AC71G]	National Space Biomedical Research Institute (NSBRI) through NASA; NASA(National Aeronautics & Space Administration (NASA))	Supported by the National Space Biomedical Research Institute (NSBRI) through NASA cooperative agreement NCC 9-58, grants NBPF01604 (RDH), NBPF02802 (RDH), NBPF04201 (RDH), PF02602 (CMD), EO00010 (CMD), and NASA NNX15AC71G (CMD).	Banda M, 2008, MUTAT RES-GEN TOX EN, V649, P126, DOI 10.1016/j.mrgentox.2007.08.005; Blatter K, 2006, BEHAV BRAIN RES, V168, P312, DOI 10.1016/j.bbr.2005.11.018; Caspi RR, 1996, J IMMUNOL, V157, P2668; Chamberlain SR, 2006, CURR OPIN NEUROL, V19, P607, DOI 10.1097/01.wco.0000247613.28859.77; Chinta SJ, 2005, INT J BIOCHEM CELL B, V37, P942, DOI 10.1016/j.biocel.2004.09.009; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; Davis CM, 2014, RADIAT RES, V181, P258, DOI 10.1667/RR13359.1; Davis CM, 2010, ANN NY ACAD SCI, V1187, P247, DOI 10.1111/j.1749-6632.2009.05147.x; Elenkov IJ, 2008, J IMMUNOL, V181, P1737, DOI 10.4049/jimmunol.181.3.1737; Emerich DF, 2014, ADV DRUG DELIVER REV, V67-68, P131, DOI 10.1016/j.addr.2013.07.008; Flores G, 1998, BRAIN RES, V814, P34, DOI 10.1016/S0006-8993(98)01011-7; Gulley JM, 2007, BRAIN RES, V1151, P32, DOI 10.1016/j.brainres.2007.03.009; Haile CN, 2001, SYNAPSE, V41, P179, DOI 10.1002/syn.1073; Higuchi Y, 2002, J RADIAT RES, V43, pS219; Hirsch EC, 2003, ANN NY ACAD SCI, V991, P214; JOSEPH JA, 1992, RADIAT RES, V130, P88, DOI 10.2307/3578484; Joseph JA, 1998, ADV SPACE RES, V22, P209, DOI 10.1016/S0273-1177(98)80012-4; JOSEPH JA, 1988, PHARMACOL BIOCHEM BE, V29, P335, DOI 10.1016/0091-3057(88)90166-9; Joseph JA, 2000, ADV SPACE RES, V25, P2057, DOI 10.1016/S0273-1177(99)01013-3; Koike Y, 2005, ACTA ASTRONAUT, V56, P367, DOI 10.1016/j.actaastro.2004.05.068; Kosten TA, 2002, PSYCHONEUROENDOCRINO, V27, P35, DOI 10.1016/S0306-4530(01)00035-X; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Lim J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033767; Macmillan N. A., 1991, DETECTION THEORY USE; McGeer PL, 1998, ALZ DIS ASSOC DIS, V12, pS1; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Mehta MA, 2004, PSYCHOPHARMACOLOGY, V176, P331, DOI 10.1007/s00213-004-1899-2; Mehta MA, 2006, CURR PHARM DESIGN, V12, P2487, DOI 10.2174/138161206777698891; Natelson BH, 2005, CLIN DIAGN LAB IMMUN, V12, P52, DOI 10.1128/CDLI.12.1.52-55.2005; Owen A M, 1999, Adv Neurol, V80, P49; Owen AM, 2004, NEUROSCIENTIST, V10, P525, DOI 10.1177/1073858404266776; Rabin BM, 2005, RADIAT RES, V164, P552, DOI 10.1667/RR3349.1; Rabin BM, 2004, ADV SPACE RES, V33, P1330, DOI 10.1016/j.asr.2003.09.051; Rabin BM, 2002, J RADIAT RES, V43, pS225; Rabin BM, 2001, PHYS MEDICA, V17, P196; Robbins TW, 2000, EXP BRAIN RES, V133, P130, DOI 10.1007/s002210000407; Sakamoto S, 2001, MICROBIOL IMMUNOL, V45, P373, DOI 10.1111/j.1348-0421.2001.tb02633.x; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Savage CR, 1997, PSYCHIAT CLIN N AM, V20, P911, DOI 10.1016/S0193-953X(05)70352-X; Shtemberg AS, 2015, NEUROCHEM J+, V9, P66, DOI 10.1134/S1819712415010109; Shukitt-Hale B, 2000, RADIAT RES, V154, P28, DOI 10.1667/0033-7587(2000)154[0028:SLAMDI]2.0.CO;2; Shukitt-Hale B, 2004, ADV SPACE RES-SERIES, V33, P1334, DOI 10.1016/j.asr.2003.10.038; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wersinger C, 2006, CURR MED CHEM, V13, P591, DOI 10.2174/092986706776055760; Williams GV, 2006, NEUROSCIENCE, V139, P263, DOI 10.1016/j.neuroscience.2005.09.028	45	32	33	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144556	10.1371/journal.pone.0144556	http://dx.doi.org/10.1371/journal.pone.0144556			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658810	Green Submitted, gold, Green Published			2022-12-27	WOS:000366903500040
J	Deng, XF; Chen, SJ; Bai, Y; Song, W; Chen, YC; Li, DX; Han, H; Liu, B				Deng, Xuefei; Chen, Shijun; Bai, Ya; Song, Wen; Chen, Yongchao; Li, Dongxue; Han, Hui; Liu, Bin			Vascular Complications of Intercavernous Sinuses during Transsphenoidal Surgery: An Anatomical Analysis Based on Autopsy and Magnetic Resonance Venography	PLOS ONE			English	Article							DIGITAL-SUBTRACTION-ANGIOGRAPHY; GIANT PITUITARY-ADENOMAS; TRANSCRANIAL RESECTION; SELLAR REGION; VENOUS SYSTEM; MACROADENOMA; MANAGEMENT; DIAGNOSIS; SUPERIOR; TUMORS	Purpose Vascular complications induced by intercavernous sinus injury during dural opening in the transsphenoidal surgery may contribute to incomplete tumour resections. Preoperative neuro-imaging is of crucial importance in planning surgical approach. The aim of this study is to correlate the microanatomy of intercavernous sinuses with its contrast-enhanced magnetic resonance venography (CE-MRV). Methods Eighteen human adult cadavers and 24 patients were examined based on autopsy and CE-MRV. Through dissection of the cadavers and CE-MRV, the location, shape, number, diameter and type of intercavernous sinuses were measured and compared. Results Different intercavernous sinuses were identified by their location and shape in all the cadavers and CE-MRV. Compared to the cadavers, CE-MRV revealed 37% of the anterior intercavernous sinus, 48% of the inferior intercavernous sinus, 30% of the posterior intercavernous sinus, 30% of the dorsum sellae sinus and 100% of the basilar sinus. The smaller intercavernous sinuses were not seen in the neuro-images. According to the presence of the anterior and inferior intercavernous sinus, four types of the intercavernous sinuses were identified in cadavers and CE-MRV, and the corresponding operative space in the transsphenoidal surgical approach was implemented. Conclusion Themorphology and classification of the cavernous sinus can be identified by CE-MRV, especially for the larger vessels, which cause bleeding more easily. Therefore, CE-MRV provides a reliable measure for individualized preoperative planning during transsphenoidal surgery.	[Deng, Xuefei; Chen, Shijun; Han, Hui] Anhui Med Univ, Dept Anat, Hefei, Anhui, Peoples R China; [Bai, Ya; Song, Wen; Liu, Bin] Anhui Med Univ, Affiliated Hosp 1, Dept Radiol, Hefei, Anhui, Peoples R China; [Chen, Yongchao] PLA, Hosp 105, Ultrason Ctr, Hefei, Anhui, Peoples R China; [Li, Dongxue] Anhui Prov Hosp, Dept Neurosurg, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Chen, YC (corresponding author), PLA, Hosp 105, Ultrason Ctr, Hefei, Anhui, Peoples R China.	chenyongchaosnn@163.com; llwind@ahmu.edu.cn			National Natural Science Foundation of China [81200895]; Medical and Health Foundation of Nanjing Military Area [12z12]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical and Health Foundation of Nanjing Military Area	The project was funded by the National Natural Science Foundation of China (Reference No: 81200895, XFD, URL: http://www.nsfc.gov.cn/) and the Medical and Health Foundation of Nanjing Military Area (Reference No: 12z12, YCC, URL: http://105yy.cn).	Agazzi S, 2010, SKULL BASE-INTERD AP, V20, P143, DOI 10.1055/s-0029-1246227; Alleyne CH, 2002, SURG NEUROL, V57, P380, DOI 10.1016/S0090-3019(02)00705-X; AQUINI MG, 1994, SKULL BASE SURG, V4, P145, DOI 10.1055/s-2008-1058966; Boxerman JL, 2010, AM J ROENTGENOL, V195, P720, DOI 10.2214/AJR.09.4128; Buchfelder M, 2008, PITUITARY, V11, P375, DOI 10.1007/s11102-008-0120-8; Burgers AMG, 2011, J CLIN ENDOCR METAB, V96, pE1163, DOI 10.1210/jc.2010-2673; Christian E, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.7.FOCUS14360; Di Somma A, 2014, RHINOLOGY, V52, P195, DOI [10.4193/Rhin13.165, 10.4193/Rhino13.165]; Gondim JA, 2015, J NEUROSURG, V123, P31, DOI 10.3171/2014.10.JNS14372; Guo FY, 2012, CLIN NEUROL NEUROSUR, V114, P885, DOI 10.1016/j.clineuro.2012.01.033; Han H, 2007, NEURORADIOLOGY, V49, P169, DOI 10.1007/s00234-006-0175-z; Han H, 2010, NEUROSURGERY, V67, P9, DOI 10.1227/01.NEU.0000381683.27324.14; Han Hui, 2008, Neurosurgery, V62, pONS289, DOI 10.1227/01.neu.0000326009.46197.ab; Hazer DB, 2013, J NEUROSURG, V119, P1467, DOI 10.3171/2013.8.JNS13224; Hong YA, 2010, NEUROL INDIA, V58, P33, DOI 10.4103/0028-3886.73742; Jahangiri A, 2016, J NEUROSURG, V124, P589, DOI 10.3171/2015.1.JNS141543; KAPLAN HA, 1976, J NEUROSURG, V45, P166, DOI 10.3171/jns.1976.45.2.0166; Kilic T, 2005, EUR J RADIOL, V56, P212, DOI 10.1016/j.ejrad.2005.05.003; Kim EH, 2009, ACTA NEUROCHIR, V151, P803, DOI 10.1007/s00701-009-0356-8; Komotar RJ, 2012, PITUITARY, V15, P150, DOI 10.1007/s11102-011-0359-3; Lee JM, 2005, SURG NEUROL, V64, P128, DOI 10.1016/j.surneu.2004.10.029; Liauw L, 2000, RADIOLOGY, V214, P678, DOI 10.1148/radiology.214.3.r00mr41678; Little AS, 2015, J NEUROSURG, V123, P799, DOI 10.3171/2014.10.JNS14921; Mason RB, 1997, J NEUROSURG, V87, P343, DOI 10.3171/jns.1997.87.3.0343; MEROLA B, 1988, WORLD J SURG, V12, P445, DOI 10.1007/BF01655415; Mizutani K, 2015, CLIN NEUROL NEUROSUR, V131, P31, DOI 10.1016/j.clineuro.2015.01.021; Orozco LD, 2012, NEUROSURGERY, V71, pE204, DOI 10.1227/NEU.0b013e31825b1eac; Pratheesh R, 2013, PITUITARY, V16, P419, DOI 10.1007/s11102-012-0439-z; RENN WH, 1975, J NEUROSURG, V43, P288, DOI 10.3171/jns.1975.43.3.0288; Svider PF, 2015, INT FORUM ALLERGY RH, V5, P659, DOI 10.1002/alr.21511; THERON J, 1979, NEURORADIOLOGY, V18, P23, DOI 10.1007/BF00346207; Tosaka M, 2015, NEUROL RES, V37, P951, DOI 10.1179/1743132815Y.0000000078; Tubbs RS, 2014, WORLD NEUROSURG, V82, pE475, DOI 10.1016/j.wneu.2012.11.052; Xiao DY, 2015, INT J CLIN EXP MED, V8, P5370; Zhou WG, 2009, CHINESE MED J-PEKING, V122, P1154, DOI 10.3760/cma.j.issn.0366-6999.2009.10.007	35	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144771	10.1371/journal.pone.0144771	http://dx.doi.org/10.1371/journal.pone.0144771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658152	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903500060
J	Rodriguez, JM; Penaloza, RE; Montoya, JM				Martin Rodriguez, Jorge; Enrique Penaloza, Rolando; Moreno Montoya, Jose			Road Traffic Injury Trends in the City of Valledupar, Colombia. A Time Series Study from 2008 to 2012	PLOS ONE			English	Article							MEXICO	Objective To analyze the behavior temporal of road-traffic injuries (RTI) in Valledupar, Colombia from January 2008 to December 2012. Methodology An observational study was conducted based on records from the Colombian National Legal Medicine and Forensic Sciences Institute regional office in Valledupar. Different variables were analyzed, such as the injured person's sex, age, education level, and type of road user; the timeframe, place and circumstances of crashes and the vehicles associated with the occurrence. Furthermore, a time series analysis was conducted using an auto-regressive integrated moving average. Results There were 105 events per month on an average, 64.9% of RTI involved men; 82.3% of the persons injured were from 18 to 59 years of age; the average age was 35.4 years of age; the road users most involved in RTI were motorcyclists (69%), followed by pedestrians (12%). 70% had up to upper-secondary education. Sunday was the day with the most RTI occurrences; 93% of the RTI occurred in the urban area. The time series showed a seasonal pattern and a significant trend effect. The modeling process verified the existence of both memory and extrinsic variables related. Conclusions An RTI occurrence pattern was identified, which showed an upward trend during the period analyzed. Motorcyclists were the main road users involved in RTI, which suggests the need to design and implement specific measures for that type of road user, from regulations for graduated licensing for young drivers to monitoring road user behavior for the promotion of road safety.	[Martin Rodriguez, Jorge; Enrique Penaloza, Rolando] Pontificia Univ Javeriana, Cendex, Bogota, Colombia; [Moreno Montoya, Jose] Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia	Pontificia Universidad Javeriana; Universidad del Rosario	Rodriguez, JM (corresponding author), Pontificia Univ Javeriana, Cendex, Bogota, Colombia.	jrodriguez.h@javeriana.edu.co	Moreno-Montoya, Jose/K-3169-2016; de Jesus Moreno Montoya, Jose/C-5635-2019	Moreno-Montoya, Jose/0000-0001-8446-1231; de Jesus Moreno Montoya, Jose/0000-0001-8446-1231; Rodriguez, Jorge Martin/0000-0002-7301-7706	PONTIFICIA UNIVERSIDAD JAVERIANA-Bogota; Departamento Administrativo de Ciencia y Tecnologia de Colombia: COLCIENCIAS; PONTIFICIA UNIVERSIDAD JAVERIANA-Bogota Center for Development Projects (Cendex); Colombian Science and Technology Administrative Department (Departamento Administrativo de Ciencia y Tecnologia de Colombia: COLCIENCIAS);  [PPTA 00005253]	PONTIFICIA UNIVERSIDAD JAVERIANA-Bogota; Departamento Administrativo de Ciencia y Tecnologia de Colombia: COLCIENCIAS; PONTIFICIA UNIVERSIDAD JAVERIANA-Bogota Center for Development Projects (Cendex); Colombian Science and Technology Administrative Department (Departamento Administrativo de Ciencia y Tecnologia de Colombia: COLCIENCIAS); 	This work was supported by the PONTIFICIA UNIVERSIDAD JAVERIANA-Bogota and The Departamento Administrativo de Ciencia y Tecnologia de Colombia: COLCIENCIAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the PONTIFICIA UNIVERSIDAD JAVERIANA-Bogota Center for Development Projects (Cendex) and by the Colombian Science and Technology Administrative Department (Departamento Administrativo de Ciencia y Tecnologia de Colombia: COLCIENCIAS). This article was derived from the research project with ID PPTA 00005253	[Anonymous], 2003, LIC SYST YOUNG DRIV; Brocwell P, 2004, INTRO TIME SERIES FO, P78; Cal y Mayor, 2007, INGENIERIA TRANSITO; De Armas L., 2012, EPIDEMIOLOGICAL PROF; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Ferrer A, 2013, METODOLOGIA ELABORAR; Forjuoh Samuel N, 2003, Inj Control Saf Promot, V10, P109, DOI 10.1076/icsp.10.1.109.14115; Fundacion Ciudad Humana & Fondo Nacional de Prevencion Vial, 2010, CAR MOT COL; HADDON W, 1968, AM J PUBLIC HEALTH N, V58, P1431, DOI 10.2105/AJPH.58.8.1431; Haddon W Jr, 1995, Inj Prev, V1, P40, DOI 10.1136/ip.1.1.40; Hijar M, 2004, ACCIDENT ANAL PREV, V36, P37, DOI 10.1016/S0001-4575(02)00112-4; Hyndman R., 2007, PHYTOPHARMACOLOGY, V6, P12; Rodriguez-Hernandez JM, 2011, SALUD PUBLICA MEXICO, V53, P320, DOI 10.1590/S0036-36342011000400006; Mayor Valledupar Colombia, ALC POL FOND PREV VI; Mohan D, 2002, INT J EPIDEMIOL, V31, P527, DOI 10.1093/ije/31.3.527; Nantulya Vinand M, 2003, Inj Control Saf Promot, V10, P3, DOI 10.1076/icsp.10.1.3.14109; Nantulya VM, 2002, BRIT MED J, V324, P1139, DOI 10.1136/bmj.324.7346.1139; National Departament of Statistic of Colombia (DANE), 2013, POP PROYECT COL 2013; National Institute of Sciences Forensis of Colombia. National Center Reference about Violence, 2012, NAT CTR REF VIOL FOR; Panamerican Health Organization, 2009, STAT REP ROAD SAF AM; Patino C., 2014, PRELIMINARY FINDING; Peden M., 2004, WORLD REPORT ROAD TR; Peek-Asa C, 2003, EPIDEMIOL REV, V25, P77, DOI 10.1093/epirev/mxg006; Retting RA, 2003, AM J PUBLIC HEALTH, V93, P1456, DOI 10.2105/AJPH.93.9.1456; Rodriguez JM, 2013, 21 C INT COM SEG MER; Rodriguez JM, 2012, CARACTERIZACION IDEN; Rodriguez JM, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2013-040776; Rodriguez-Contreras G., 2012, FORENSIS 2011 DATOS; Simpson HM, 2003, J SAFETY RES, V34, P25, DOI 10.1016/S0022-4375(02)00077-4; Francisco PMSB, 2013, REV PANAM SALUD PUBL, V34, P155; Williams AF, 2002, INJ PREV, V8, P9; World Health Organization (WHO), GLOB STAT REP ROAD S; Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062652; Zhang G, 2013, PLOS ONE, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]	34	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144002	10.1371/journal.pone.0144002	http://dx.doi.org/10.1371/journal.pone.0144002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657887	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903500011
J	Snoeck-Stroband, JB; Lapperre, TS; Sterk, PJ; Hiemstra, PS; Thiadens, HA; Boezen, HM; ten Hacken, NHT; Kerstjens, HAM; Postma, DS; Timens, W; Sont, JK				Snoeck-Stroband, Jiska B.; Lapperre, Therese S.; Sterk, Peter J.; Hiemstra, Pieter S.; Thiadens, Henk A.; Boezen, H. Marike; ten Hacken, Nick H. T.; Kerstjens, Huib A. M.; Postma, Dirkje S.; Timens, Wim; Sont, Jacob K.		GLUCOLD Study Grp	Prediction of Long-Term Benefits of Inhaled Steroids by Phenotypic Markers in Moderate-to-Severe COPD: A Randomized Controlled Trial	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LUNG-FUNCTION; FLUTICASONE PROPIONATE; CORTICOSTEROID TREATMENT; AIRWAY INFLAMMATION; SPUTUM-EOSINOPHILIA; BETA-AGONIST; FEV1 DECLINE; EXACERBATIONS; SALMETEROL	Background The decline in lung function can be reduced by long-term inhaled corticosteroid (ICS) treatment in subsets of patients with chronic obstructive pulmonary disease (COPD). We aimed to identify which clinical, physiological and non-invasive inflammatory characteristics predict the benefits of ICS on lung function decline in COPD. Methods Analysis was performed in 50 steroid-naive compliant patients with moderate to severe COPD (postbronchodilator forced expiratory volume in one second (FEV1), 30-80% of predicted, compatible with GOLD stages II-III), age 45-75 years, >10 packyears smoking and without asthma. Patients were treated with fluticasone propionate (500 mu g bid) or placebo for 2.5 years. Postbronchodilator FEV1, dyspnea and health status were measured every 3 months; lung volumes, airway hyperresponsiveness (PC20), and induced sputum at 0, 6 and 30 months. A linear mixed effect model was used for analysis of this hypothesis generating study. Results Significant predictors of attenuated FEV1-decline by fluticasone treatment compared to placebo were: fewer packyears smoking, preserved diffusion capacity, limited hyperinflation and lower inflammatory cell counts in induced sputum (p<0.04). Conclusions Long-term benefits of ICS on lung function decline in patients with moderate-to-severe COPD are most pronounced in patients with fewer packyears, and less severe emphysema and inflammation. These data generate novel hypotheses on phenotype-driven therapy in COPD.	[Snoeck-Stroband, Jiska B.; Thiadens, Henk A.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [Lapperre, Therese S.; Sterk, Peter J.; Hiemstra, Pieter S.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands; [Boezen, H. Marike] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [ten Hacken, Nick H. T.; Kerstjens, Huib A. M.; Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Timens, Wim] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands; [Sont, Jacob K.] Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; University of Groningen; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Snoeck-Stroband, JB (corresponding author), Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands.	J.B.Snoeck-Stroband@lumc.nl	Hiemstra, Pieter S/K-8587-2018; Kerstjens, Huib/N-4754-2017; Timens, Wim/K-5570-2013; Sont, Jacob K/J-8071-2015; Sterk, P.J./AAK-8175-2020; /V-8478-2019	Hiemstra, Pieter S/0000-0002-0238-5982; Kerstjens, Huib/0000-0001-7705-7927; Timens, Wim/0000-0002-4146-6363; Sont, Jacob K/0000-0002-5840-0651; Lapperre, Therese/0000-0002-5176-0101	Netherlands Organization for Scientific Research (NWO); Netherlands Asthma Foundation [3.4.93.96.3]; GlaxoSmithKline (The Netherlands); University Medical Center Groningen (UMCG); Leiden University Medical Center (LUMC)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Asthma Foundation; GlaxoSmithKline (The Netherlands)(Netherlands GovernmentGlaxoSmithKline); University Medical Center Groningen (UMCG); Leiden University Medical Center (LUMC)	The study was an investigator-initiated trial (registered as NCT00158847). The protocol was written by the GLUCOLD Study Group, and all procedures and analyses were carried out by the investigators only. The authors were fully independent from the sponsors of the study [the Netherlands Organization for Scientific Research (NWO) in a collaborative program with the Netherlands Asthma Foundation (grant 3.4.93.96.3), by GlaxoSmithKline (The Netherlands), and by the University Medical Center Groningen (UMCG) and the Leiden University Medical Center (LUMC)]. Therefore, the corresponding author has full access to all the data in the study and has final responsibility for the decision to submit for publication.	Agusti A, 2014, THORAX, V69, P857, DOI 10.1136/thoraxjnl-2014-205507; Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Altose MD, 2000, NEW ENGL J MED, V343, P1902; [Anonymous], 2003, APPL LONGITUDINAL AN; [Anonymous], 2011, INTERACTIVE TXB CLIN; Bafadhel M, 2012, AM J RESP CRIT CARE, V186, P48, DOI 10.1164/rccm.201108-1553OC; Barnes PJ, 2010, J STEROID BIOCHEM, V120, P76, DOI 10.1016/j.jsbmb.2010.02.018; Bleecker ER, 2008, PULM PHARMACOL THER, V21, P682, DOI 10.1016/j.pupt.2008.04.003; Brightling CE, 2000, LANCET, V356, P1480, DOI 10.1016/S0140-6736(00)02872-5; Brightling CE, 2005, THORAX, V60, P193, DOI 10.1136/thx.2004.032516; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Casanova C, 2011, AM J RESP CRIT CARE, V184, P1015, DOI 10.1164/rccm.201105-0831OC; Celli BR, 2008, AM J RESP CRIT CARE, V178, P332, DOI 10.1164/rccm.200712-1869OC; Cerveri I, 2013, COPD, V10, P55, DOI 10.3109/15412555.2012.727920; Decramer M, 2010, THORAX, V65, P837, DOI 10.1136/thx.2009.133355; Global Initiative for Chronic Obstructive Lung Disease, 2011, GLOBAL STRATEGY DIAG; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Hogg JC, 2013, CHEST, V143, P1436, DOI 10.1378/chest.12-1766; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; KERSTJENS HAM, 1993, EUR RESPIR J, V6, P868; KERSTJENS HAM, 1992, NEW ENGL J MED, V327, P1413, DOI 10.1056/NEJM199211123272003; Lapperre TS, 2009, ANN INTERN MED, V151, P517, DOI 10.7326/0003-4819-151-8-200910200-00004; Lapperre TS, 2004, AM J RESP CRIT CARE, V170, P499, DOI 10.1164/rccm.200401-112OC; Lee JH, 2010, RESP MED, V104, P542, DOI 10.1016/j.rmed.2009.10.024; Leigh R, 2006, EUR RESPIR J, V27, P964, DOI 10.1183/09031936.06.00072105; Leuppi JD, 2005, PULM PHARMACOL THER, V18, P83, DOI 10.1016/j.pupt.2004.10.005; Loke TK, 2006, J ALLERGY CLIN IMMUN, V118, P368, DOI 10.1016/j.jaci.2006.04.055; Magnussen H, 2014, NEW ENGL J MED, V371, P1285, DOI 10.1056/NEJMoa1407154; Mahler DA, 2002, AM J RESP CRIT CARE, V166, P1084, DOI 10.1164/rccm.2112055; McDonald VM, 2013, THORAX, V68, P691, DOI 10.1136/thoraxjnl-2012-202646; Meek PM, 1999, AM J RESP CRIT CARE, V159, P321; O'Donnell DE, 2006, CHEST, V130, P647, DOI 10.1378/chest.130.3.647; Pascoe S, 2015, LANCET RESP MED, V3, P435, DOI 10.1016/S2213-2600(15)00106-X; Pauwels RA, 1999, NEW ENGL J MED, V340, P1948, DOI 10.1056/NEJM199906243402503; POSTMA DS, 1986, AM REV RESPIR DIS, V134, P276; Postma DS, 2014, LANCET; Rabe KF, 2011, LANCET, V378, P1038, DOI 10.1016/S0140-6736(11)61295-6; Rennard SI, 2009, DRUGS, V69, P549, DOI 10.2165/00003495-200969050-00004; Rothman K, 1986, MODERN EPIDEMIOLOGY; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Siva R, 2007, EUR RESPIR J, V29, P906, DOI 10.1183/09031936.00146306; Soriano JB, 2007, CHEST, V131, P682, DOI 10.1378/chest.06-1696; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Tashkin DP, 2013, CURR OPIN PULM MED, V19, P116, DOI 10.1097/MCP.0b013e32835d8ea4; Tashkin DP, 1996, AM J RESP CRIT CARE, V153, P1802, DOI 10.1164/ajrccm.153.6.8665038; Thomas M, 2013, PRIM CARE RESP J, V22, P101, DOI 10.4104/pcrj.2013.00025; Thompson WH, 2002, LUNG, V180, P191, DOI 10.1007/s004080000093; van der Molen Thys, 2003, Health Qual Life Outcomes, V1, P13, DOI 10.1186/1477-7525-1-13; Verhoeven GT, 2002, THORAX, V57, P694, DOI 10.1136/thorax.57.8.694; Vestbo J, 1996, AM J RESP CRIT CARE, V153, P1530, DOI 10.1164/ajrccm.153.5.8630597; Vestbo J, 1999, LANCET, V353, P1819, DOI 10.1016/S0140-6736(98)10019-3; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Weiner P, 1999, J INTERN MED, V245, P83, DOI 10.1046/j.1365-2796.1999.00412.x; Woodruff PG, 2015, LANCET, V385, P1789, DOI 10.1016/S0140-6736(15)60693-6	56	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0143793	10.1371/journal.pone.0143793	http://dx.doi.org/10.1371/journal.pone.0143793			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26659582	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903500005
J	Apicella, A; Heunemann, P; Bolisetty, S; Marascio, M; Graf, AG; Garamszegi, L; Mezzenga, R; Fischer, P; Plummer, CJ; Manson, JA				Apicella, Alessandra; Heunemann, Peggy; Bolisetty, Sreenath; Marascio, Matteo; Graf, Anja Gemperli; Garamszegi, Laszlo; Mezzenga, Raffaele; Fischer, Peter; Plummer, Christopher J.; Manson, Jan-Anders			The Influence of Arginine on the Response of Enamel Matrix Derivative (EMD) Proteins to Thermal Stress: Towards Improving the Stability of EMD-Based Products	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; IN-VITRO; AGGREGATION; AMELOGENIN; PH; SOLUBILIZATION; PURIFICATION; EQUILIBRIUM; PREVENTION	In a current procedure for periodontal tissue regeneration, enamel matrix derivative (EMD), which is the active component, is mixed with a propylene glycol alginate (PGA) gel carrier and applied directly to the periodontal defect. Exposure of EMD to physiological conditions then causes it to precipitate. However, environmental changes during manufacture and storage may result in modifications to the conformation of the EMD proteins, and eventually premature phase separation of the gel and a loss in therapeutic effectiveness. The present work relates to efforts to improve the stability of EMD-based formulations such as Emdogain (TM) through the incorporation of arginine, a well-known protein stabilizer, but one that to our knowledge has not so far been considered for this purpose. Representative EMD-buffer solutions with and without arginine were analyzed by 3D-dynamic light scattering, UV-Vis spectroscopy, transmission electron microscopy and Fourier transform infrared spectroscopy at different acidic pH and temperatures, T, in order to simulate the effect of pH variations and thermal stress during manufacture and storage. The results provided evidence that arginine may indeed stabilize EMD against irreversible aggregation with respect to variations in pH and T under these conditions. Moreover, stopped-flow transmittance measurements indicated arginine addition not to suppress precipitation of EMD from either the buffers or the PGA gel carrier when the pH was raised to 7, a fundamental requirement for dental applications.	[Apicella, Alessandra; Marascio, Matteo; Plummer, Christopher J.; Manson, Jan-Anders] Ecole Polytech Fed Lausanne, Lab Technol Composites & Polymeres LTC, CH-1015 Lausanne, Switzerland; [Heunemann, Peggy; Fischer, Peter] ETH, Inst Food Nutr & Hlth, Food Proc Engn, CH-8092 Zurich, Switzerland; [Bolisetty, Sreenath; Mezzenga, Raffaele] ETH, Inst Food Nutr & Hlth, Food & Soft Mat Sci, CH-8092 Zurich, Switzerland; [Graf, Anja Gemperli; Garamszegi, Laszlo] Inst Straumann AG, CH-4052 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Institut Straumann AG	Fischer, P (corresponding author), ETH, Inst Food Nutr & Hlth, Food Proc Engn, CH-8092 Zurich, Switzerland.	peter.fischer@hest.ethz.ch; christopher.plummer@epfl.ch	plummer, christopher JG/B-1599-2014; Fischer, Peter/A-8740-2011	Fischer, Peter/0000-0002-2992-5037	Competence Center of Materials Science and Technology; Institut Straumann AG	Competence Center of Materials Science and Technology; Institut Straumann AG	Financial support for the academic partners was provided by the Competence Center of Materials Science and Technology (http://www.ccmx.ch/home/). The funding body had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Institut Straumann AG provided support in the form of salaries for authors AGG and LG, and materials costs, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are given in the 'author contributions' section.	Aichmayer B, 2010, BIOMACROMOLECULES, V11, P369, DOI 10.1021/bm900983b; Apicella A, 2013, MRS SPRING M EXH SAN; Arakawa T, 2003, BIOCHEM BIOPH RES CO, V304, P148, DOI 10.1016/S0006-291X(03)00578-3; Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Barth A, 2010, TENSIDE SURFACT DET, V47, P300, DOI 10.3139/113.110081; Baynes BM, 2005, BIOCHEMISTRY-US, V44, P4919, DOI 10.1021/bi047528r; Beniash E, 2012, J DENT RES, V91, P967, DOI 10.1177/0022034512457371; Block ID, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3518961; Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; Cairo F, 2008, J CLIN PERIODONTOL, V35, P136, DOI 10.1111/j.1600-051X.2008.01267.x; Chiti Fabrizio, 2006, PROTEIN MISFOLDING A, P43; Clem DS, 2011, INSIDE DENT, V7; Creighton T. E., 1993, PROTEINS STRUCTURES; Daneshegar P, 2012, J BRAZIL CHEM SOC, V23, P315, DOI 10.1590/S0103-50532012000200018; Dar TA, 2007, BIOPHYS CHEM, V127, P140, DOI 10.1016/j.bpc.2007.01.006; Das U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001176; Fang PA, 2011, P NATL ACAD SCI USA, V108, P14097, DOI 10.1073/pnas.1106228108; Fang PA, 2011, CELLS TISSUES ORGANS, V194, P166, DOI 10.1159/000324250; Farruggia B, 1997, INT J BIOL MACROMOL, V20, P43, DOI 10.1016/S0141-8130(96)01150-6; FINCHAM AG, 1994, J STRUCT BIOL, V112, P103, DOI 10.1006/jsbi.1994.1011; Garamszegi L, 2012, Straumann Holding AG, Patent No. [WO2012049324 A2 (CA2801332A1, EP2566504A2, WO2012049324A3), 201204934]; Garamszegi L, 2013, Straumann Holding, Patent No. [US 20130210735 A1, 20130210735]; Gokarn YR, 2006, EXCIPIENT DEV PHARM, P291; Gorza FDS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/872701; Hofmann A, 2014, METHODS OF MOLECULAR ANALYSIS IN THE LIFE SCIENCES, P1, DOI 10.1017/CBO9781107045224; Kim W, 2006, P NATL ACAD SCI USA, V103, P15824, DOI 10.1073/pnas.0605629103; Lee SH, 2006, PROTEIN SCI, V15, P304, DOI 10.1110/ps.051813506; Lossdorfer S, 2007, J DENT RES, V86, P980, DOI 10.1177/154405910708601012; Maciel RRG, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/461365; Margolis HC, 2006, J DENT RES, V85, P775, DOI 10.1177/154405910608500902; Melo A, 1999, J MOL STRUC-THEOCHEM, V463, P81, DOI 10.1016/S0166-1280(98)00396-0; Melo EP, 1997, J BIOCHEM BIOPH METH, V34, P45; Mezzenga R, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/4/046601; Moradian-Oldak J, 2000, J STRUCT BIOL, V131, P27, DOI 10.1006/jsbi.2000.4237; Moradian-Oldak J, 2001, MATRIX BIOL, V20, P293, DOI 10.1016/S0945-053X(01)00154-8; Nakakido M, 2009, CURR PHARM BIOTECHNO, V10, P415, DOI 10.2174/138920109788488824; Petrou Irene, 2009, J Clin Dent, V20, P23; Poklar N, 2000, J CHEM EDUC, V77, P380, DOI 10.1021/ed077p380; RENUGOPALAKRISHNAN V, 1986, BIOCHEMISTRY-US, V25, P4879, DOI 10.1021/bi00365a023; Shah D, 2011, BIOTECHNOL PROGR, V27, P513, DOI 10.1002/btpr.563; Shiraki K, 2002, J BIOCHEM, V132, P591, DOI 10.1093/oxfordjournals.jbchem.a003261; Stout BM, 2014, J PERIODONTOL, V85, pE9, DOI 10.1902/jop.2013.130264; Thomas B, 2004, DUNN SCH PATHOLOGY C; Trombelli L, 2008, J CLIN PERIODONTOL, V35, P117, DOI 10.1111/j.1600-051X.2008.01265.x; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; Venezia E, 2004, CRIT REV ORAL BIOL M, V15, P382, DOI 10.1177/154411130401500605; Wennstrom JL, 2002, J CLIN PERIODONTOL, V29, P9, DOI 10.1034/j.1600-051x.2002.290102.x; Wiedemann-Bidlack FB, 2007, J STRUCT BIOL, V160, P57, DOI 10.1016/j.jsb.2007.06.007	49	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144641	10.1371/journal.pone.0144641	http://dx.doi.org/10.1371/journal.pone.0144641			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670810	Green Published, Green Submitted, gold			2022-12-27	WOS:000366719300014
J	Grimaldi, A; Parada, C; Chai, Y				Grimaldi, Alexandre; Parada, Carolina; Chai, Yang			A Comprehensive Study of Soft Palate Development in Mice	PLOS ONE			English	Article							CRANIAL NEURAL CREST; LEVATOR VELI-PALATINI; CLEFT-PALATE; SUPERIOR CONSTRICTOR; MUSCLE DEVELOPMENT; PROGENITOR CELLS; INNERVATION; MECHANISMS; MYOGENESIS; GROWTH	Cleft palate is one of the most common congenital birth defects. Tremendous efforts have been made over the last decades towards understanding hard palate development. However, little is known about soft palate morphogenesis and myogenesis. Finding an appropriate surgical repair to restore physiological functions of the soft palate in patients with cleft palate is a major challenge for surgeons, and complete restoration is not always achievable. Here, we first analyzed the morphology, orientation and attachments of the four muscles of the murine soft palate and found that they are very similar to their counterparts in humans, validating the use of mus musculus as a model for future studies. Our data suggests that muscle differentiation extends from the lateral region to the midline following palatal fusion. We also detected an epithelial seam in the fusing soft palatal shelves, consistent with the process of fusion of the posterior palatal shelves, followed by degradation of the epithelial remnants. Innervation and vascularization are present mainly in the oral side of the soft palate, complementing the differentiated muscles. Cell lineage tracing using Wnt1-Cre; Zsgreen(fl/fl) mice indicated that all the tendons and mesenchyme embedding the soft palate muscles are neural crest-derived. We propose that the posterior attachment of the soft palate to the pharyngeal wall is an interface between the neural crest-and mesoderm-derived mesenchyme in the craniofacial region, and thus can serve as a potential model for the study of boundaries during development. Taken together, our study provides a comprehensive view of the development and morphology of the murine soft palate and serves as a reference for further molecular analyses.	[Grimaldi, Alexandre; Parada, Carolina; Chai, Yang] Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, Los Angeles, CA 90033 USA	University of Southern California	Chai, Y (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, 2250 Alcazar St, Los Angeles, CA 90033 USA.	ychai@usc.edu		Parada Borja, Carolina/0000-0003-2176-6729; GRIMALDI, Alexandre/0000-0002-5978-2057	National Institute of Dental and Craniofacial Research, NIH [R37 DE012711, U01 DE024421]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012711, U01DE024421] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by a grant from the National Institute of Dental and Craniofacial Research (http://www.nidcr.nih.gov/), NIH R37 DE012711; U01 DE024421, to Yang Chai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Julie Mayo and Bridget Samuels for critical reading of the manuscript, and Pedro Sanchez-Lara for discussing the clinical aspects of this work. This study was supported by grants from the National Institute of Dental and Craniofacial Research, NIH R37 DE012711; U01 DE024421, to Yang Chai.	Baggiolini A, 2015, CELL STEM CELL, V16, P314, DOI 10.1016/j.stem.2015.02.017; BURDI AR, 1967, AM J ANAT, V120, P149, DOI 10.1002/aja.1001200112; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Cho JH, 2013, LARYNGOSCOPE, V123, P2900, DOI 10.1002/lary.24067; COHEN SR, 1993, CLEFT PALATE-CRAN J, V30, P441, DOI 10.1597/1545-1569(1993)030<0441:SPMADF>2.3.CO;2; COHEN SR, 1994, CLEFT PALATE-CRAN J, V31, P345, DOI 10.1597/1545-1569(1994)031<0345:POAMIH>2.3.CO;2; COLEMAN RD, 1965, ANAT REC, V151, P107, DOI 10.1002/ar.1091510202; De la Cuadra Blanco Crotida, 2012, Cells Tissues Organs, V195, P392, DOI 10.1159/000329253; Eppig J, B6 CG TG WNT1 CRE 11; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; FURUSAWA K, 1991, BRAIN RES BULL, V26, P599, DOI 10.1016/0361-9230(91)90101-O; Gart MS, 2014, CLIN PLAST SURG, V41, P253, DOI 10.1016/j.cps.2013.12.010; Han A, 2014, MOL CELL BIOL, V34, P3120, DOI 10.1128/MCB.00623-14; Hilliard SA, 2005, J ANAT, V207, P655, DOI 10.1111/j.1469-7580.2005.00474.x; Hosokawa R, 2010, DEV BIOL, V341, P186, DOI 10.1016/j.ydbio.2010.02.030; Iwata J, 2014, DEVELOPMENT, V141, P909, DOI 10.1242/dev.103093; Kalcheim C, 1998, NEURAL CREST; KELLER JT, 1983, BRAIN RES, V270, P209, DOI 10.1016/0006-8993(83)90594-2; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; Knox SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2493; Liao YF, 2004, CLEFT PALATE-CRAN J, V41, P152, DOI 10.1597/02-162; Marrinan EM, 1998, CLEFT PALATE-CRAN J, V35, P95, DOI 10.1597/1545-1569(1998)035<0095:VFINCP>2.3.CO;2; Martinez-Alvarez C, 2000, DEV BIOL, V220, P343, DOI 10.1006/dbio.2000.9644; Monroy PLC, 2012, TISSUE ENG PART B-RE, V18, P468, DOI [10.1089/ten.TEB.2012.0049, 10.1089/ten.teb.2012.0049]; Oka K, 2012, J HISTOCHEM CYTOCHEM, V60, P57, DOI 10.1369/0022155411427059; Rinon A, 2007, DEVELOPMENT, V134, P3065, DOI 10.1242/dev.002501; Sakamoto Y, 2015, SURG RADIOL ANAT, V37, P649, DOI 10.1007/s00276-015-1444-5; Shimokawa T, 2004, SURG RADIOL ANAT, V26, P100, DOI 10.1007/s00276-003-0183-1; SMILEY GR, 1975, ARCH ORAL BIOL, V20, P297, DOI 10.1016/0003-9969(75)90127-2; Smith TM, 2013, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00488; Snider TN, 2014, BIRTH DEFECTS RES C, V102, P324, DOI 10.1002/bdrc.21075; Vacher C, 1997, CLEFT PALATE-CRAN J, V34, P189, DOI 10.1597/1545-1569(1997)034<0189:MOTSPC>2.3.CO;2; van der Sloot Paul G, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P225, DOI 10.1097/00020840-200308000-00001; VELASCO JRM, 1990, ARCH BIOL, V101, P447; Zhao H, 2014, CELL STEM CELL, V14, P160, DOI 10.1016/j.stem.2013.12.013	37	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145018	10.1371/journal.pone.0145018	http://dx.doi.org/10.1371/journal.pone.0145018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671681	Green Published, Green Submitted, gold			2022-12-27	WOS:000366719300040
J	Tun, S; Ithoi, I; Mahmud, R; Samsudin, NI; Heng, CK; Ling, LY				Tun, Sandee; Ithoi, Init; Mahmud, Rohela; Samsudin, Nur Izyan; Heng, Chua Kek; Ling, Lau Yee			Detection of Helminth Eggs and Identification of Hookworm Species in Stray Cats, Dogs and Soil from Klang Valley, Malaysia	PLOS ONE			English	Article							GASTROINTESTINAL PARASITES; ANCYLOSTOMA-CEYLANICUM; INTESTINAL PARASITES; TOXOCARA-MALAYSIENSIS; PREVALENCE; COMMUNITIES; INFECTIONS; URBAN; TRANSMISSION; POPULATIONS	The present study was conducted to determine the prevalence of helminth eggs excreted in the faeces of stray cats, dogs and in soil samples. A total of 505 fresh samples of faeces (from 227 dogs and 152 cats) and soil were collected. The egg stage was detected via microscopy after the application of formalin-ether concentration technique. Genomic DNA was extracted from the samples containing hookworm eggs and used for further identification to the species level using real-time polymerase chain reaction coupled with high resolution melting analysis. Microscopic observation showed that the overall prevalence of helminth eggs among stray cats and dogs was 75.7% (95% CI = 71.2%-79.9%), in which 87.7% of dogs and 57.9% of cats were infected with at least one parasite genus. Five genera of heliminth eggs were detected in the faecal samples, including hookworms (46.4%), Toxocara (11.1%), Trichuris (8.4%), Spirometra (7.4%) and Ascaris (2.4%). The prevalence of helminth infections among stray dogs was significantly higher than that among stray cats (p < 0.001). Only three genera of helminths were detected in soil samples with the prevalence of 23% (95% CI = 15.1%-31%), consisting of hookworms (16.6%), Ascaris (4%) and Toxocara (2.4%). The molecular identification of hookworm species revealed that Ancylostoma ceylanicum was dominant in both faecal and soil samples. The dog hookworm, Ancylostoma caninum, was also detected among cats, which is the first such occurrence reported in Malaysia till date. This finding indicated that there was a cross-infection of A. caninum between stray cats and dogs because of their coexistent within human communities. Taken together, these data suggest the potential role of stray cats and dogs as being the main sources of environmental contamination as well as for human infections.	[Tun, Sandee; Ithoi, Init; Mahmud, Rohela; Samsudin, Nur Izyan; Ling, Lau Yee] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Heng, Chua Kek] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Ithoi, I (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	init@um.edu.my	Lau, Yee Ling/C-6996-2009; Ithoi, Init/B-8660-2010; CHUA, KEK HENG/B-5261-2010	Lau, Yee Ling/0000-0002-2037-2165; Ithoi, Init/0000-0001-8698-4546; CHUA, KEK HENG/0000-0002-0452-9994	University of Malaya High Impact Research Grant HIR-MOHE [UM.C/625/1/HIR/MOHE/MED/18]	University of Malaya High Impact Research Grant HIR-MOHE	This study was supported by University of Malaya High Impact Research Grant HIR-MOHE (project UM.C/625/1/HIR/MOHE/MED/18). The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abu-Madi MA, 2010, VET PARASITOL, V168, P284, DOI 10.1016/j.vetpar.2009.11.027; Azian M. Y. Noor, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P205; Bahgat M, 1998, J EGYPTIAN SOC PARAS, V29, P873; BAKER MK, 1989, J S AFR VET ASSOC, V60, P139; Barutzki Dieter, 2011, Parasitol Res, V109 Suppl 1, pS45, DOI 10.1007/s00436-011-2402-8; Beiromvand M, 2013, PREV VET MED, V109, P162, DOI 10.1016/j.prevetmed.2012.09.009; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Bowman DD, 2010, TRENDS PARASITOL, V26, P162, DOI 10.1016/j.pt.2010.01.005; Bridger KE, 2009, VET PARASITOL, V162, P167, DOI 10.1016/j.vetpar.2009.02.016; Brooker S, 1999, T ROY SOC TROP MED H, V93, P240, DOI 10.1016/S0035-9203(99)90007-X; Calvete C, 1998, VET PARASITOL, V75, P235, DOI 10.1016/S0304-4017(97)00182-9; CHAN MS, 1994, PARASITOLOGY, V109, P373, DOI 10.1017/S0031182000078410; Choo J, 2000, T ROY SOC TROP MED H, V94, P21, DOI 10.1016/S0035-9203(00)90425-5; Costa AFDV, 2008, VET PARASITOL, V153, P277, DOI 10.1016/j.vetpar.2008.02.005; Deplazes P, 2011, VET PARASITOL, V182, P41, DOI 10.1016/j.vetpar.2011.07.014; DOS, 2006, BAS POP CHAR ADM DIS; ENGBAEK K, 1984, Z PARASITENKD, V70, P87, DOI 10.1007/BF00929578; Fisher M, 2003, TRENDS PARASITOL, V19, P167, DOI 10.1016/S1471-4922(03)00027-8; Gasser RB, 1998, MOL BIOCHEM PARASIT, V92, P303, DOI 10.1016/S0166-6851(98)00008-5; GHADIRIAN E, 1976, CAN J PUBLIC HEALTH, V67, P495; Giacometti A, 2000, EUR J EPIDEMIOL, V16, P1023, DOI 10.1023/A:1010853124085; Gibbons LM, 2001, J PARASITOL, V87, P660, DOI 10.1645/0022-3395(2001)087[0660:TMNSNA]2.0.CO;2; Hajipour N, 2015, J PARASITIC DIS, P1; Hsu YC, 2012, NEW ENGL J MED, V366, pE20, DOI 10.1056/NEJMicm1101717; Hu M, 2002, ELECTROPHORESIS, V23, P27, DOI [10.1002/1522-2683(200201)23:1<27::AID-ELPS27>3.0.CO;2-7, 10.1002/1522-2683(200201)23:1&lt;27::AID-ELPS27&gt;3.0.CO;2-7]; Inpankaew Tawin, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P247; Inpankaew T, 2014, EMERG INFECT DIS, V20, P976, DOI 10.3201/eid2006.131770; Jittapalapong S, 2007, KASETSART J NAT SCI, V41, P69; Khalafalla RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020283; KHOSHOO V, 1995, J PEDIATR GASTR NUTR, V21, P481, DOI 10.1097/00005176-199511000-00022; Krecek RC, 2010, VET PARASITOL, V172, P147, DOI 10.1016/j.vetpar.2010.04.033; Labarthe N, 2004, VET PARASITOL, V123, P133, DOI 10.1016/j.vetpar.2004.06.002; Landmann JK, 2003, MED J AUSTRALIA, V178, P69, DOI 10.5694/j.1326-5377.2003.tb05066.x; Lefkaditis MA, 2014, HELMINTHOLOGIA, V51, P73, DOI 10.2478/s11687-014-0211-1; Li MW, 2006, PARASITOL RES, V99, P554, DOI 10.1007/s00436-006-0194-z; Liu Y, 2013, BIOMED RES INT, P2013; Lorenzini G., 2007, Brazilian Journal of Veterinary Research and Animal Science, V44, P137; Lucio-Forster A, 2011, J FELINE MED SURG, V13, P300, DOI 10.1016/j.jfms.2010.12.013; Mahdy MAK, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-88; Martinez-Moreno FJ, 2007, VET PARASITOL, V143, P7, DOI 10.1016/j.vetpar.2006.08.004; Mizgajska H, 2001, J HELMINTHOL, V75, P147; Ngui R, 2014, ACTA PARASITOL, V59, P737, DOI 10.2478/s11686-014-0306-3; Ngui R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041996; Ngui R, 2012, AM J TROP MED HYG, V86, P837, DOI 10.4269/ajtmh.2012.11-0446; Ngui R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001522; Oge S, 2000, DEUT TIERARZTL WOCH, V107, P72; Oliveira-Sequeira TCG, 2002, VET PARASITOL, V103, P19, DOI 10.1016/S0304-4017(01)00575-1; Olsen A, 1998, T ROY SOC TROP MED H, V92, P643, DOI 10.1016/S0035-9203(98)90795-7; Palmer CS, 2008, VET PARASITOL, V151, P181, DOI 10.1016/j.vetpar.2007.10.015; Palmer CS, 2007, VET PARASITOL, V145, P304, DOI 10.1016/j.vetpar.2006.12.018; Prociv P, 1996, ACTA TROP, V62, P23, DOI 10.1016/S0001-706X(96)00016-2; Ramirez-Barrios RA, 2004, VET PARASITOL, V121, P11, DOI 10.1016/j.vetpar.2004.02.024; RITCHIE LAWRENCE S., 1948, BULL U S ARMY MED DEPT, V8, P326; Scorza AV, 2011, VET PARASITOL, V183, P178, DOI 10.1016/j.vetpar.2011.06.025; SETASUBAN P, 1976, Southeast Asian Journal of Tropical Medicine and Public Health, V7, P534; Shalaby HA, 2010, PARASITOL RES, V106, P1021, DOI 10.1007/s00436-010-1755-8; Stoltzfus RJ, 1997, AM J CLIN NUTR, V65, P153, DOI 10.1093/ajcn/65.1.153; Traub RJ, 2008, VET PARASITOL, V155, P67, DOI 10.1016/j.vetpar.2008.05.001; Traub RJ, 2014, VET PARASITOL, V205, P233, DOI 10.1016/j.vetpar.2014.06.037; Traub RJ, 2013, INT J PARASITOL, V43, P1009, DOI 10.1016/j.ijpara.2013.07.006; Traub RJ, 2004, VET PARASITOL, V123, P245, DOI 10.1016/j.vetpar.2004.05.026; Traub RJ, 2003, PARASITOL RES, V90, pS156, DOI 10.1007/s00436-003-0925-3; Ulukanligil M, 2001, MEM I OSWALDO CRUZ, V96, P903, DOI 10.1590/S0074-02762001000700004; Waap H, 2014, J HELMINTHOL, V88, P389, DOI 10.1017/S0022149X1300031X; Yamamoto Norishige, 2009, Kansenshogaku Zasshi, V83, P223; YOSHIDA Y, 1968, AM J TROP MED HYG, V17, P378, DOI 10.4269/ajtmh.1968.17.378; Zain SNM, 2013, VET PARASITOL, V196, P469, DOI 10.1016/j.vetpar.2013.03.030; Zibaei M, 2007, TROP BIOMED, V24, P39	68	25	26	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0142231	10.1371/journal.pone.0142231	http://dx.doi.org/10.1371/journal.pone.0142231			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671680	Green Submitted, Green Published, gold			2022-12-27	WOS:000366719300001
J	Bian, C; Xu, TD; Zhu, H; Pan, DF; Liu, Y; Luo, YY; Wu, P; Li, DY				Bian, Chen; Xu, Tongda; Zhu, Hong; Pan, Defeng; Liu, Yang; Luo, Yuanyuan; Wu, Pei; Li, Dongye			Luteolin Inhibits Ischemia/Reperfusion-Induced Myocardial Injury in Rats via Downregulation of microRNA-208b-3p	PLOS ONE			English	Article							INDUCED CARDIOMYOCYTE APOPTOSIS; ISCHEMIA-REPERFUSION; CONTRACTILE FUNCTION; INFARCTION; EXPRESSION; INFLAMMATION; MICRORNAS; MECHANISM; CELLS; ANTIOXIDANT	Background Luteolin (LUT), a kind of flavonoid which is extracted from a variety of diets, has been reported to convey protective effects of various diseases. Recent researches have suggested that LUT can carry out cardioprotective effects during ischemia/reperfusion (I/R). However, there have no reports on whether LUT can exert protective effects against myocardial I/R injury through the actions of specific microRNAs (miRs). The purpose of this study was to determine which miRs and target genes LUT exerted such function through. Methods Expression of various miRs in perfused rat hearts was detected using a gene chip. Target genes were predicted with TargetScan, MiRDB and MiRanda. Anoxia/reoxygenation was used to simulate I/R. Cells were transfected by miR-208b-3p mimic, inhibitor and small interfering RNA of Ets1 (avian erythroblastosis virus E26 (v ets) oncogene homolog 1). MiR208b-3p and Ets1 mRNA were quantified by real-time quantitative polymerase chain reaction. The percentage of apoptotic cells was detected by annexin V-fluorescein isothiocyanate/propidium iodide dyeing and flow cytometry. The protein expression levels of cleaved caspase-3, Bcl-2, Bax, and Ets1 were examined by western blot analysis. A luciferase reporter assay was used to verify the combination between miR-208b-3p and the 3'-untranslated region of Ets1. Results LUT pretreatment reduced miR-208b-3p expression in myocardial tissue, as compared to the I/R group. And LUT decreased miR-208b-3p expression and apoptosis caused by I/R. However, overexpression of miR-208b-3p further aggravated the changes caused by I/R and blocked all the effects of LUT. Knockdown of miR-208b-3p expression also attenuated apoptosis, while knockdown of Ets1 promoted apoptosis. Further, the luciferase reporter assay showed that miR-208b-3p could inhibit Ets1 expression. Conclusion LUT pretreatment conveys anti-apoptotic effects after myocardial I/R injury by decreasing miR-208b-3p and increasing Ets1 expression levels.	[Bian, Chen; Liu, Yang; Wu, Pei; Li, Dongye] Xuzhou Med Coll, Inst Cardiovasc Dis Res, Xuzhou, Jiangsu, Peoples R China; [Xu, Tongda; Zhu, Hong; Pan, Defeng; Luo, Yuanyuan; Li, Dongye] Xuzhou Med Coll, Affiliated Hosp, Cardiol, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Li, DY (corresponding author), Xuzhou Med Coll, Inst Cardiovasc Dis Res, Xuzhou, Jiangsu, Peoples R China.	dongyeli@medmail.com.cn	李, 东/GYA-4703-2022; 李, 东野/AAY-6410-2020	Xu, Tongda/0000-0002-5594-3992	National Natural Science Foundation of China [81570326]; China Postdoctoral Science Foundation [2014M551665]; Nature Science Foundation of Jiangsu Province [BK20141139]; Academic Degrees Committee; Department of Education of Jiangsu province [xyyc13-32]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Nature Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Academic Degrees Committee; Department of Education of Jiangsu province	This study was supported by National Natural Science Foundation of China (81570326), China Postdoctoral Science Foundation funded project (2014M551665), The Nature Science Foundation of Jiangsu Province (BK20141139), Academic Degrees Committee and the Department of Education of Jiangsu province (xyyc13-32).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Breving K, 2010, INT J BIOCHEM CELL B, V42, P1316, DOI 10.1016/j.biocel.2009.09.016; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Cheng YH, 2012, J MOL CELL CARDIOL, V53, P668, DOI 10.1016/j.yjmcc.2012.08.010; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Dong PX, 2013, NANOTOXICOLOGY, V7, P1028, DOI 10.3109/17435390.2012.694487; Fan F, 2013, CURR PHARM DESIGN, V19, P4865, DOI 10.2174/13816128113199990325; Fang F, 2011, PHARMACOLOGY, V88, P149, DOI 10.1159/000330068; Fang J, 2012, APOPTOSIS, V17, P410, DOI 10.1007/s10495-011-0683-0; Fliss H, 1996, CIRC RES, V79, P949, DOI 10.1161/01.RES.79.5.949; Garrett-Sinha LA, 2013, CELL MOL LIFE SCI, V70, P3375, DOI 10.1007/s00018-012-1243-7; Han L, 2012, BIOMATERIALS, V33, P8517, DOI 10.1016/j.biomaterials.2012.07.034; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; Hinkel R, 2013, CIRCULATION, V128, P1066, DOI 10.1161/CIRCULATIONAHA.113.001904; Jang SS, 2009, J PINEAL RES, V47, P147, DOI 10.1111/j.1600-079X.2009.00694.x; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Ji X, 2009, CLIN CHEM, V55, P1944, DOI 10.1373/clinchem.2009.125310; Kang DW, 2015, J EXP MED, V212, P1219, DOI 10.1084/jem.20141254; Kim DS, 2010, J PHARM PHARMACOL, V62, P197, DOI [10.1211/jpp.62.02.0007, 10.1211/jpp/62.02.0007]; Li B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090096; Li MY, 2014, GENET MOL RES, V13, P6981, DOI 10.4238/2014.April.14.13; Liao YH, 2012, J AM COLL CARDIOL, V59, P420, DOI 10.1016/j.jacc.2011.10.863; Liu H, 2014, GENE, V545, P149, DOI 10.1016/j.gene.2014.04.043; Lopez-Lazaro M, 2009, MINI-REV MED CHEM, V9, P31, DOI 10.2174/138955709787001712; Lv P, 2014, INT J MOL SCI, V15, P5774, DOI 10.3390/ijms15045774; Marniemi J, 2005, NUTR METAB CARDIOVAS, V15, P188, DOI 10.1016/j.numecd.2005.01.001; Meng XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094635; Minamino T, 2012, CIRC J, V76, P1074, DOI 10.1253/circj.CJ-12-0132; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Pan L, 2015, INT J MOL SCI, V16, P5420, DOI 10.3390/ijms16035420; Pan ZQ, 2014, J NEUROSCI, V34, P9476, DOI 10.1523/JNEUROSCI.5346-13.2014; Qi LL, 2011, EUR J PHARMACOL, V668, P201, DOI 10.1016/j.ejphar.2011.06.020; Seelinger G, 2008, PLANTA MED, V74, P1667, DOI 10.1055/s-0028-1088314; Suh JH, 2012, BIOCHEM BIOPH RES CO, V423, P404, DOI 10.1016/j.bbrc.2012.05.138; Sun DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033491; Takyar S, 2013, J EXP MED, V210, P1993, DOI 10.1084/jem.20121200; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Tu YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075872; Wang WK, 2014, J CELL MOL MED, V18, P2311, DOI 10.1111/jcmm.12399; Wei G, 2009, BLOOD, V114, P1123, DOI 10.1182/blood-2009-03-211391; Wu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082957; Yan S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8652; Yang Q, 2015, INT J CLIN EXP PATHO, V8, P3735; Zhan YM, 2005, J CLIN INVEST, V115, P2508, DOI 10.1172/JCI24403; Zhang BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100298; Zhang XD, 2014, CELL PHYSIOL BIOCHEM, V34, P1050, DOI 10.1159/000366320	47	35	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144877	10.1371/journal.pone.0144877	http://dx.doi.org/10.1371/journal.pone.0144877			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658785	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900129
J	Brodowska, AJ; Smigielski, K; Nowak, A; Czyzowska, A; Otlewska, A				Brodowska, Agnieszka Joanna; Smigielski, Krzysztof; Nowak, Agnieszka; Czyzowska, Agata; Otlewska, Anna			The Impact of Ozone Treatment in Dynamic Bed Parameters on Changes in Biologically Active Substances of Juniper Berries	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; PHENOLIC COMPOSITION; MACROCARPA SIBTH.; ESCHERICHIA-COLI; BACILLUS-CEREUS; SPICES; ROOT; OXYCEDRUS	The development of the parameters of ozone decontamination method assuring the least possible losses of biologically active substances (essential oils and polyphenols) and their activity in common juniper (Juniperus communis (L.)) berries was studied. Ozone treatment in dynamic bed was conducted 9 times. The process was conducted under different ozone concentrations (100.0; 130.0; 160.0 g O-3/m(3)) and times (30, 60, 90 min). After each decontamination, the microbiological profile of the juniper berries was studied, and the contaminating microflora was identified. Next to the microbiological profile, the phenolic profile, as well as antioxidant activity of extracts and essential oils were determined. The total polyphenol content (TPC), composition of essential oils, free radical-scavenging capacity, total antioxidant capacity, ferric-reducing antioxidant power (FRAP), beta-carotene bleaching test (BCB) and LC-MS polyphenol analysis were carried out. The study reveals that during short ozone contact times, higher amounts of TPC, 15.47 and 12.91 mg CE/g of extract, for samples 100/30 and 130/30, respectively, were demonstrated. Whereas samples 100/60, 130/60, 100/90, and 160/90 exhibited the lowest amount of phenolics. The highest antioxidant activity was found in the methanol extract obtained from ozonated berries which exhibited the lowest IC50 in all the antioxidant assays, such as DPPH, FRAP, and BCB assays. Ozone treatment showed noteworthy potential and its usage in food manufacturing and as an alternative decontamination method should be considered.	[Brodowska, Agnieszka Joanna; Smigielski, Krzysztof] Lodz Univ Technol, Fac Biotechnol & Food Sci, Inst Gen Food Chem, Lodz, Poland; [Nowak, Agnieszka; Czyzowska, Agata; Otlewska, Anna] Lodz Univ Technol, Fac Biotechnol & Food Sci, Inst Fermentat Technol & Microbiol, Lodz, Poland	Lodz University of Technology; Lodz University of Technology	Brodowska, AJ (corresponding author), Lodz Univ Technol, Fac Biotechnol & Food Sci, Inst Gen Food Chem, Lodz, Poland.	aga.brodowska17@gmail.com	Otlewska, Anna/N-6143-2018; Czyzowska, Agata/N-1837-2018; Nowak, Agnieszka/M-7663-2018; Brodowska, Agnieszka/AAE-9234-2020; Smigielski, Krzysztof Benedykt/N-6705-2018	Otlewska, Anna/0000-0002-3536-3560; Czyzowska, Agata/0000-0002-1098-1602; Nowak, Agnieszka/0000-0002-6390-8425; Smigielski, Krzysztof Benedykt/0000-0002-4213-7852	 [28/DzS/9184];  [I28/DzS/9184]	; 	Financial support of this work by Statute Funds No. 28/DzS/9184. Science Young Leaders Fund.; Financial support of this work by Statute Funds No. I28/DzS/9184. Science Young Leaders Fund.	Adams RP, 1995, IDENTIFICATION OF ES; Akbas MY, 2008, FOOD MICROBIOL, V25, P386, DOI 10.1016/j.fm.2007.09.007; Akbas MY, 2006, INT J FOOD SCI TECH, V41, P513, DOI 10.1111/j.1365-2621.2005.01099.x; Banerjee M, 2003, FOOD RES INT, V36, P469, DOI 10.1016/S0963-9969(02)00194-1; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Brodowska A, 2014, CHEMIK, V68, P100; Brodowska AJ, 2014, J FOOD SCI, V79, pC1649, DOI 10.1111/1750-3841.12591; Brodowska AJ, 2013, BIOTECHNOL FOOD SCI, V77, P37; Chaouche TM, 2015, IND CROP PROD, V64, P182, DOI 10.1016/j.indcrop.2014.10.051; Cheng WC, 2013, ENCY FORENSIC SCI, P280; Diao E., 2014, J FOOD NUTR RES, V2, P101, DOI [DOI 10.12691/JFNR-2-3-2, 10.12691/jfnr-2-3-2]; DYAS A, 1983, J CLIN PATHOL, V36, P1102, DOI 10.1136/jcp.36.10.1102; GARRIDO D, 1992, J FOOD PROTECT, V55, P451; Gonny M, 2006, FLAVOUR FRAG J, V21, P99, DOI 10.1002/ffj.1527; HATANO T, 1988, CHEM PHARM BULL, V36, P2090; International Commission on Microbiological Specification for Foods (ICMSF), 1974, MICR FOODS, V2; Kahkonen MP, 1999, J AGR FOOD CHEM, V47, P3954, DOI 10.1021/jf990146l; Khadre MA, 2001, J FOOD SCI, V66, P1242, DOI 10.1111/j.1365-2621.2001.tb15196.x; KOVATS E, 1958, HELV CHIM ACTA, V41, P1915, DOI 10.1002/hlca.19580410703; Kris-Etherton PM, 2002, AM J MED, V113, P71, DOI 10.1016/S0002-9343(01)00995-0; Kunicka - Styczyska A., 2011, PRZEMYSL SPOZYWCZY, V6, P50; Lesjak MM, 2014, J FUNCT FOODS, V7, P257, DOI 10.1016/j.jff.2014.02.003; Lesjak MM, 2013, LWT-FOOD SCI TECHNOL, V53, P530, DOI 10.1016/j.lwt.2013.03.010; Lesjak MM, 2011, FOOD CHEM, V124, P850, DOI 10.1016/j.foodchem.2010.07.006; MALLET JF, 1994, FOOD CHEM, V49, P61, DOI 10.1016/0308-8146(94)90233-X; MCKEE LH, 1995, FOOD SCI TECHNOL-LEB, V28, P1, DOI 10.1016/S0023-6438(95)80004-2; Miceli N, 2011, FOOD CHEM TOXICOL, V49, P2600, DOI 10.1016/j.fct.2011.07.004; Orhan N, 2011, FOOD CHEM TOXICOL, V49, P2305, DOI 10.1016/j.fct.2011.06.031; OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307; Pascual A, 2007, TRENDS FOOD SCI TECH, V18, pS29, DOI [10.1016/j.tifs.2006.10.006, 10.1016/j.tifs.2006.07.015]; Peterson SW, 2009, MYCOLOGIA, V101, P71, DOI 10.3852/08-036; Poljanowska M, 2007, ANN ACAD MED STETIN, V3, P114; Prasad N, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/154606; PRATT DE, 1980, AUTOXIDATION FOOD BI, P283; Sanchez-Rabaneda F, 2003, J MASS SPECTROM, V38, P35, DOI 10.1002/jms.395; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Smigielski K, 2014, Patent application, Patent No. 409933; Smigielski K, 2009, J ESSENT OIL BEAR PL, V12, P338, DOI 10.1080/0972060X.2009.10643729; Taviano MF, 2013, FOOD CHEM TOXICOL, V58, P22, DOI 10.1016/j.fct.2013.03.049; Young SB, 2004, J APPL MICROBIOL, V96, P1133, DOI 10.1111/j.1365-2672.2004.02236.x; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	42	19	20	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144855	10.1371/journal.pone.0144855	http://dx.doi.org/10.1371/journal.pone.0144855			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659905	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900120
J	Colson, P; Rolain, JM; Abat, C; Charrel, R; Fournier, PE; Raoult, D				Colson, Philippe; Rolain, Jean-Marc; Abat, Cedric; Charrel, Remi; Fournier, Pierre-Edouard; Raoult, Didier			EPIMIC: A Simple Homemade Computer Program for Real-Time EPIdemiological Surveillance and Alert Based on MICrobiological Data	PLOS ONE			English	Article							INFECTIOUS-DISEASES; FRANCE; MARSEILLES; HOSPITALS; ENGLAND; WALES; OUTBREAK; BURDEN; TRENDS	Background and Aims Infectious diseases (IDs) are major causes of morbidity and mortality and their surveillance is critical. In 2002, we implemented a simple and versatile homemade tool, named EPIMIC, for the real-time systematic automated surveillance of IDs at Marseille university hospitals, based on the data from our clinical microbiology laboratory, including clinical samples, tests and diagnoses. Methods This tool was specifically designed to detect abnormal events as IDs are rarely predicted and modeled. EPIMIC operates using Microsoft Excel software and requires no particular computer skills or resources. An abnormal event corresponds to an increase above, or a decrease below threshold values calculated based on the mean of historical data plus or minus 2 standard deviations, respectively. Results Between November 2002 and October 2013 (11 years), 293 items were surveyed weekly, including 38 clinical samples, 86 pathogens, 79 diagnosis tests, and 39 antibacterial resistance patterns. The mean duration of surveillance was 7.6 years (range, 1 month-10.9 years). A total of 108,427 Microsoft Excel file cells were filled with counts of clinical samples, and 110,017 cells were filled with counts of diagnoses. A total of 1,390,689 samples were analyzed. Among them, 172,180 were found to be positive for a pathogen. EPIMIC generated a mean number of 0.5 alert/week on abnormal events. Conclusions EPIMIC proved to be efficient for real-time automated laboratory-based surveillance and alerting at our university hospital clinical microbiology laboratory-scale. It is freely downloadable from the following URL: http://www.mediterranee-infection.com/article.php?larub=157&titre=bulletin-epidemiologique (last accessed: 20/11/2015).	[Colson, Philippe; Rolain, Jean-Marc; Charrel, Remi; Fournier, Pierre-Edouard; Raoult, Didier] CHU Timone, Assistance Publ Hop Marseille, Inst Hosp Univ IHU Mediterranee Infect, Pole Malad Infect & Trop Clin & Biol,Federat Bact, F-13385 Marseille 05, France; [Colson, Philippe; Rolain, Jean-Marc; Abat, Cedric; Fournier, Pierre-Edouard; Raoult, Didier] Aix Marseille Univ, URMITE, INSERM, UM 63,CNRS 7278,IRD,3R198,U1095, F-13385 Marseille 05, France; [Charrel, Remi] Aix Marseille Univ, IRD French Inst Res Dev, EHESP French Sch Publ Hlth, EPV UMR Emergence Pathol Virales D190, F-13385 Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Raoult, D (corresponding author), CHU Timone, Assistance Publ Hop Marseille, Inst Hosp Univ IHU Mediterranee Infect, Pole Malad Infect & Trop Clin & Biol,Federat Bact, 264 Rue St Pierre, F-13385 Marseille 05, France.	didier.raoult@gmail.com	RAOULT, Didier/A-8434-2008; Colson, Philippe/P-6355-2014; Rolain, Jean-Marc/Y-3788-2019; Fournier, Pierre-Edouard/AAC-6155-2021	RAOULT, Didier/0000-0002-0633-5974; Colson, Philippe/0000-0001-6285-0308; Rolain, Jean-Marc/0000-0002-2402-4467; Fournier, Pierre-Edouard/0000-0001-8463-8885				Abat C, 2015, INT J ANTIMICROB AG, V45, P144, DOI 10.1016/j.ijantimicag.2014.10.010; Aherfi S, 2014, CLIN MICROBIOL INFEC, V20, pO176, DOI 10.1111/1469-0691.12366; Anderson DJ, 2008, J INFECT DIS, V197, P752, DOI 10.1086/527486; Centers for Disease Control, 1981, MMWR-MORBID MORTAL W, V30, P250; Colson P, 2013, Euro Surveill, V18, P4; Colson P, 2013, EUROSURVEILLANCE, V18, P18; Colson P, 2012, EMERG INFECT DIS, V18, P1361, DOI 10.3201/eid1808.111827; Dab W, 1998, REV EPIDEMIOL SANTE, V46, P249; Enki DG, 2013, EMERG INFECT DIS, V19, P35, DOI 10.3201/eid1901.120493; Fauci AS, 2005, EMERG INFECT DIS, V11, P519, DOI 10.3201/eid1104.041167; Hartfield M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003277; Henning Kelly J, 2004, MMWR Suppl, V53, P5; Kempf M, 2013, APMIS, V121, P64, DOI 10.1111/j.1600-0463.2012.02935.x; Kman N. E., 2012, ADV PREV MED, V2012, DOI [10.1155/2012/301408, DOI 10.1155/2012/301408]; Lagier JC, 2013, INFECT CONT HOSP EP, V34, P1339, DOI 10.1086/673995; Lamagni TL, 2013, CLIN INFECT DIS, V57, P682, DOI 10.1093/cid/cit337; Meynard JB, 2008, REV EPIDEMIOL SANTE, V56, P11, DOI 10.1016/j.respe.2007.11.003; Nougairede A, 2011, EUR J EPIDEMIOL, V26, P183, DOI 10.1007/s10654-010-9533-6; Okike IO, 2014, LANCET INFECT DIS, V14, P301, DOI 10.1016/S1473-3099(13)70332-3; Parola P, 2011, EUROSURVEILLANCE, V16, P25; Raoult D, 2003, RAPPORT DE MISSION; Raoult D, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00025; Raoult D, 2011, SCIENCE, V331, P144, DOI 10.1126/science.331.6014.144-c; Rolain JM, 2015, CLIN MICROBIOL INFEC; Scaber J, 2011, EUROSURVEILLANCE, V16, P2; Sharrar RG, 1976, MMWR-MORBID MORTAL W, V25, P244; Soler MS, 2011, LANCET, V378, P1833, DOI 10.1016/S0140-6736(11)60834-9; Texier G, 2010, REV EPIDEMIOL SANTE, V58, P425, DOI 10.1016/j.respe.2010.06.169; Thacker S B, 1989, J Public Health Policy, V10, P187, DOI 10.2307/3342679; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; World Health Organization, 2014, TOP 10 CAUS DEATH; World health organization, 2013, WORLD HLTH STAT 2013	32	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144178	10.1371/journal.pone.0144178	http://dx.doi.org/10.1371/journal.pone.0144178			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658293	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900030
J	Sun, HF; Hu, PP; Shen, HC; Dong, W; Zhang, TH; Liu, Q; Du, JJ				Sun, Haifeng; Hu, Pingping; Shen, Hongchang; Dong, Wei; Zhang, Tiehong; Liu, Qi; Du, Jiajun			Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; C-REACTIVE PROTEIN; NUTRITIONAL-STATUS; SERUM-ALBUMIN; SURVIVAL; STATISTICS	Objectives It has been reported nutritional status and systemic inflammation were associated with the outcome of patients with malignancies. However, the prognostic value of combination of them was really scarce, especially in non-small cell lung cancer (NSCLC). In order to find a more simple and efficient predictor, we hypothesized that pretreatment albumin and neutrophil combined prognostic grade (ANPG) could offer an improved prognostic ability in NSCLC patients. Methods We collected pretreatment albumin and neutrophil, clinicopathological, treatment and follow-up data of 1033 consecutive NSCLC patients treated between 2006 and 2011 in this retrospective study. The ANPG was calculated according to pretreatment albumin and neutrophil levels dichotomized by the optimal cut-off values, the quartile values and the clinical reference values. Kaplan-Meier (K-M) curves and Cox proportional regression were used for survival analyses. All the data was analyzed by SPSS 20.0. Results According to optimal cut-off values and quartile values, significant differences were found in different pretreatment albumin, neutrophil levels and ANPG from the K-M curve (all p<0.05). Univariate analyses and multivariate analyses disclosed ANPG was a more sensitive independent predictor for both overall survival (OS) and progression free survival (PFS) than either albumin level or neutrophil level (HRs were higher for ANPG). As for clinical reference values, no significant difference of pretreatment albumin levels was found in K-M curve and univariate analyses. All three indexes lost their significance in multivariate analyses. Conclusion Higher ANPG predicts worse OS and PFS in NSCLC patients independently, and it is more sensitive than hypoalbuminaemia and neutrophilia. It might be used as a reliable, convenient and more sensitive predictor to assist the identification of patients with poor prognosis and be a hierarchical factor in the future NSCLC clinical trials.	[Sun, Haifeng; Hu, Pingping; Shen, Hongchang; Zhang, Tiehong; Liu, Qi; Du, Jiajun] Shandong Univ, Shandong Prov Hosp, Inst Oncol, Jinan 250100, Shandong, Peoples R China; [Dong, Wei; Du, Jiajun] Shandong Univ, Shandong Prov Hosp, Dept Thorac Surg, Jinan 250100, Shandong, Peoples R China; [Hu, Pingping] Shandong Univ, Qianfoshan Hosp, Dept Radiat Oncol, Jinan 250100, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Liu, Q (corresponding author), Shandong Univ, Shandong Prov Hosp, Inst Oncol, 324 Jingwu Rd, Jinan 250100, Shandong, Peoples R China.	liuqi66@sdu.edu.cn; dujiajun@sdu.edu.cn			National Natural Science Foundation of China [81301728]; Provincial Natural Science Foundation of Shandong [ZR2013HZ001, ZR2014HM100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province)	The work was supported by National Natural Science Foundation of China (81301728), Provincial Natural Science Foundation of Shandong (ZR2013HZ001), and Provincial Natural Science Foundation of Shandong (ZR2014HM100).	Al-Shaiba R, 2004, BRIT J CANCER, V91, P205, DOI 10.1038/sj.bjc.6601886; Alifano M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106914; Alifano M, 2011, J THORAC CARDIOV SUR, V142, P1161, DOI 10.1016/j.jtcvs.2011.07.021; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Boonpipattanapong T, 2006, J CLIN GASTROENTEROL, V40, P592, DOI 10.1097/00004836-200608000-00006; Donskov F, 2013, SEMIN CANCER BIOL, V23, P200, DOI 10.1016/j.semcancer.2013.02.001; Dumitru CA, 2013, SEMIN CANCER BIOL, V23, P141, DOI 10.1016/j.semcancer.2013.02.005; ESPINOSA E, 1995, LUNG CANCER, V12, P67, DOI 10.1016/0169-5002(95)00407-R; Forrest LM, 2003, BRIT J CANCER, V89, P1028, DOI 10.1038/sj.bjc.6601242; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Garcia-Luna PP, 2006, NUTR HOSP, V21, P10; Kishida Y, 2009, BRIT J CANCER, V101, P1537, DOI 10.1038/sj.bjc.6605348; Koch A, 2009, J THORAC ONCOL, V4, P326, DOI 10.1097/JTO.0b013e31819578c8; Laky B, 2007, EUR J CLIN NUTR, V61, P642, DOI 10.1038/sj.ejcn.1602540; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McArdle PA, 2010, UROL INT, V84, P430, DOI 10.1159/000313364; Negrier S, 2002, PROG UROL, V12, P703; Onate-Ocana LF, 2007, ANN SURG ONCOL, V14, P381, DOI 10.1245/s10434-006-9093-x; Pastore CA, 2014, NUTR HOSP, V29, P629, DOI [10.3305/nh.2014.29.3.7195, 10.3305/NH.2014.29.3.7195]; Rami-Porta R, 2015, J THORAC ONCOL, V10, P990, DOI 10.1097/JTO.0000000000000559; Richards CH, 2010, BRIT J CANCER, V103, P1356, DOI 10.1038/sj.bjc.6605919; Schmidt H, 2005, BRIT J CANCER, V93, P273, DOI 10.1038/sj.bjc.6602702; SHOENFELD Y, 1986, J CANCER RES CLIN, V111, P54, DOI 10.1007/BF00402777; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tomita M, 2014, ANTICANCER RES, V34, P3137; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Trinchieri G, 2012, ANNU REV IMMUNOL, V30, P677, DOI 10.1146/annurev-immunol-020711-075008; Yeun J Y, 1998, Am J Kidney Dis, V32, pS118, DOI 10.1016/S0272-6386(98)70174-X; Yildirim M, 2013, J BUON, V18, P728	30	17	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144663	10.1371/journal.pone.0144663	http://dx.doi.org/10.1371/journal.pone.0144663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26656866	gold, Green Published, Green Submitted			2022-12-27	WOS:000366715900082
J	Takeichi, Y; Sasahara, K; Suzuki, R; Arita, T				Takeichi, Yuki; Sasahara, Kazutoshi; Suzuki, Reiji; Arita, Takaya			Concurrent Bursty Behavior of Social Sensors in Sporting Events	PLOS ONE			English	Article							DYNAMICS	The advent of social media expands our ability to transmit information and connect with others instantly, which enables us to behave as "social sensors." Here, we studied concurrent bursty behavior of Twitter users during major sporting events to determine their function as social sensors. We show that the degree of concurrent bursts in tweets (posts) and retweets (re-posts) works as a strong indicator of winning or losing a game. More specifically, our simple tweet analysis of Japanese professional baseball games in 2013 revealed that social sensors can immediately react to positive and negative events through bursts of tweets, but that positive events are more likely to induce a subsequent burst of retweets. We confirm that these findings also hold true for tweets related to Major League Baseball games in 2015. Furthermore, we demonstrate active interactions among social sensors by constructing retweet networks during a baseball game. The resulting networks commonly exhibited user clusters depending on the baseball team, with a scale-free connectedness that is indicative of a substantial difference in user popularity as an information source. While previous studies have mainly focused on bursts of tweets as a simple indicator of a real-world event, the temporal correlation between tweets and retweets implies unique aspects of social sensors, offering new insights into human behavior in a highly connected world.	[Takeichi, Yuki; Sasahara, Kazutoshi; Suzuki, Reiji; Arita, Takaya] Nagoya Univ, Dept Complex Syst Sci, Chikusa Ku, Nagoya, Aichi 4588601, Japan	Nagoya University	Sasahara, K (corresponding author), Nagoya Univ, Dept Complex Syst Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4588601, Japan.	sasahara@nagoya-u.jp	Arita, Takaya/GLU-7953-2022; Suzuki, Reiji/M-5038-2014	Suzuki, Reiji/0000-0002-1953-2926; Sasahara, Kazutoshi/0000-0003-2572-0648	Hori Science and Arts Foundation Research Grant	Hori Science and Arts Foundation Research Grant	This work was supported by the Hori Science and Arts Foundation Research Grant 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bollen J, 2011, J COMPUT SCI-NETH, V2, P1, DOI 10.1016/j.jocs.2010.12.007; Bollen J, 2011, ARTIF LIFE, V17, P237, DOI 10.1162/artl_a_00034; Borge-Holthoefer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023883; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Conover MD, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds6; Corney David, 2014, Advances in Information Retrieval. 36th European Conference on IR Research, ECIR 2014. Proceedings: LNCS 8416, P449, DOI 10.1007/978-3-319-06028-6_40; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Fisher R. A., 1946, Statistical methods for research workers.; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Gonzalez-Bailon S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00197; Grabowicz PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029358; Kwak H., 2010, WWW, P591, DOI DOI 10.1145/1772690.1772751; Lanagan J, 2011, ARTIF INTELL, P542; Lehmann J., 2012, P 21 INT C WORLD WID, P251, DOI [10.1145/2187836.2187871, DOI 10.1145/2187836.2187871]; Merritt S, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds29; Miller G, 2011, SCIENCE, V333, P1814, DOI 10.1126/science.333.6051.1814; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Panisson A., 2014, P WORKSH MAK SENS MI, P3; Ren Y, 2006, ACAD MANAGEMENT P, V2006, pB1; Romero D. M., 2011, P 20 INT C WORLD WID, P695, DOI [10.1145/1963405.1963503, DOI 10.1145/1963405.1963503]; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [10.1145/1772690.1772777, DOI 10.1145/1772690.1772777, 10.1145/1772690.1772777.]; Sasahara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061823; Weng L, 2012, SCI REP-UK, V2, P1, DOI 10.1038/srep00335; Zhao S, 2011, ARXIV11064300	24	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144646	10.1371/journal.pone.0144646	http://dx.doi.org/10.1371/journal.pone.0144646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26659028	Green Submitted, Green Published, gold			2022-12-27	WOS:000366715900078
J	Taylor, SV; Burrack, HJ; Roe, RM; Bacheler, JS; Sorenson, CE				Taylor, Sally V.; Burrack, Hannah J.; Roe, R. Michael; Bacheler, Jack S.; Sorenson, Clyde E.			Systemic Imidacloprid Affects Intraguild Parasitoids Differently	PLOS ONE			English	Article							CAMPOLETIS-SONORENSIS HYMENOPTERA; HELIOTHIS-VIRESCENS LEPIDOPTERA; TOBACCO BUDWORM LEPIDOPTERA; CARDIOCHILES-NIGRICEPS; BIOLOGICAL-CONTROL; NATURAL ENEMIES; HOST; INSECTICIDES; NOCTUIDAE; GROWTH	Toxoneuron nigriceps (Viereck) (Hymenoptera, Braconidae) and Campoletis sonorensis (Cameron) (Hymenoptera, Ichneumonidae) are solitary endoparasitoids of the tobacco budworm, Heliothis virescens (Fabricius) (Lepidoptera, Noctuidae). They provide biological control of H. virescens populations in Southeastern US agricultural production systems. Field and greenhouse experiments conducted from 2011-2014 compared parasitism rates of parasitoids that developed inside H. virescens larvae fed on tobacco plants treated with and without imidacloprid. The parasitoids in our study did not have a similar response. Toxoneuron nigriceps had reduced parasitism rates, but parasitism rates of C. sonorensis were unaffected. Preliminary data indicate that adult female lifespans of T. nigriceps are also reduced. ELISA was used to measure concentrations of neonicotinoids, imidacloprid and imidacloprid metabolites in H. virescens larvae that fed on imidacloprid-treated plants and in the parasitoids that fed on these larvae. Concentrations were detectable in the whole bodies of parasitized H. virescens larvae, T. nigriceps larvae and T. nigriceps adults, but not in C. sonorensis larvae and adults. These findings suggest that there are effects of imidacloprid on multiple trophic levels, and that insecticide use may differentially affect natural enemies with similar feeding niches.	[Taylor, Sally V.; Burrack, Hannah J.; Roe, R. Michael; Bacheler, Jack S.; Sorenson, Clyde E.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Sorenson, CE (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	clyde_sorenson@ncsu.edu	Burrack, Hannah/CAJ-5730-2022	Burrack, Hannah/0000-0002-8460-8245; Roe, Richard/0000-0002-6386-0994	North Carolina Tobacco Research Commission	North Carolina Tobacco Research Commission	This work was funded by a grant from the North Carolina Tobacco Research Commission to CES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN IT, 1988, J CHEM ECOL, V14, P1113, DOI 10.1007/BF01019339; BARBOSA P, 1986, J CHEM ECOL, V12, P1319, DOI 10.1007/BF01012351; Barbosa P, 1982, P 5 INT S INS PLANT; Bethke JA, 1997, ANN APPL BIOL, V130, P397, DOI 10.1111/j.1744-7348.1997.tb07670.x; CALOW P, 1991, COMP BIOCHEM PHYS C, V100, P3, DOI 10.1016/0742-8413(91)90110-F; CAMPBELL BC, 1979, SCIENCE, V205, P700, DOI 10.1126/science.205.4407.700; Chamberlin FS, 1926, J AGRIC RES, V33, P0021; CROFT BA, 1975, ANNU REV ENTOMOL, V20, P285, DOI 10.1146/annurev.en.20.010175.001441; Croft BA, 1990, ARTHROPOD BIOL CONTR; DANKS HV, 1979, J GEORGIA ENTOMOL SO, V14, P36; De Moraes CM, 2005, ECOL ENTOMOL, V30, P564, DOI 10.1111/j.0307-6946.2005.00723.x; Dhammi A, 2010, THESIS; Douglas MR, 2015, J APPL ECOL, V52, P250, DOI 10.1111/1365-2664.12372; Fisher LR, 2007, FLUE CURED TABACCO G, P152; Grayson JM, 1944, J ECON ENTOMOL, V37, P712, DOI 10.1093/jee/37.5.712; GUILLOT FS, 1973, J INSECT PHYSIOL, V19, P2073, DOI 10.1016/0022-1910(73)90200-X; GUNASENA GH, 1989, ANN ENTOMOL SOC AM, V82, P187, DOI 10.1093/aesa/82.2.187; GUNASENA GH, 1990, J ECON ENTOMOL, V83, P1777, DOI 10.1093/jee/83.5.1777; Hu JS, 2000, ANN ENTOMOL SOC AM, V93, P220, DOI 10.1603/0013-8746(2000)093[0220:IBTLEC]2.0.CO;2; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; JOHNSON MT, 1992, ENVIRON ENTOMOL, V21, P586, DOI 10.1093/ee/21.3.586; KIRITANI K, 1973, BOTYU-KAGAKU, V38, P69; Krischik VA, 2007, ENVIRON ENTOMOL, V36, P1238, DOI 10.1603/0046-225X(2007)36[1238:SIITTN]2.0.CO;2; LAGADIC L, 1993, PESTIC SCI, V38, P323, DOI 10.1002/ps.2780380407; LEWIS WJ, 1968, J ECON ENTOMOL, V61, P673, DOI 10.1093/jee/61.3.673; Lewis WJ, 1970, ENVIRON ENTOMOL, V1, P468; LINGREN PD, 1970, J ECON ENTOMOL, V63, P518, DOI 10.1093/jee/63.2.518; METCALF RL, 1980, ANNU REV ENTOMOL, V25, P219, DOI 10.1146/annurev.en.25.010180.001251; Nauen R, 2005, ARCH INSECT BIOCHEM, V58, P200, DOI 10.1002/arch.20043; Paine TD, 2011, BIOL CONTROL, V56, P175, DOI 10.1016/j.biocontrol.2010.08.007; PENNACCHIO F, 1992, ARCH INSECT BIOCHEM, V19, P177, DOI 10.1002/arch.940190304; Price PW, 1992, INSECT ECOLOGY; Rabb RL, 1971, BIOL CONTROL, P294; Rogers ME, 2003, J ECON ENTOMOL, V96, P1412, DOI 10.1603/0022-0493-96.5.1412; SCHUSTER DJ, 1994, INT J PEST MANAGE, V40, P191, DOI 10.1080/09670879409371880; Stapel JO, 2000, BIOL CONTROL, V17, P243, DOI 10.1006/bcon.1999.0795; Stelinski LL, 2006, BIOL CONTROL, V36, P91, DOI 10.1016/j.biocontrol.2005.07.016; TAYLOR AD, 1988, J ANIM ECOL, V57, P163, DOI 10.2307/4770; Taylor David, 2015, THESIS; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Tran DH, 2004, APPL ENTOMOL ZOOL, V39, P435, DOI 10.1303/aez.2004.435; VINSON SB, 1972, J INSECT PHYSIOL, V18, P1509, DOI 10.1016/0022-1910(72)90229-6; VINSON SB, 1979, J INVERTEBR PATHOL, V34, P133, DOI 10.1016/0022-2011(79)90092-2; VINSON SB, 1970, J INSECT PHYSIOL, V16, P1329, DOI 10.1016/0022-1910(70)90132-0; Watanabe E, 2007, FOOD CHEM, V102, P745, DOI 10.1016/j.foodchem.2006.06.031	46	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144598	10.1371/journal.pone.0144598	http://dx.doi.org/10.1371/journal.pone.0144598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658677	Green Published, gold, Green Submitted			2022-12-27	WOS:000366715900070
J	Baden, MY; Fukui, K; Hosokawa, Y; Iwahashi, H; Imagawa, A; Shimomura, I				Baden, Megu Yamaguchi; Fukui, Kenji; Hosokawa, Yoshiya; Iwahashi, Hiromi; Imagawa, Akihisa; Shimomura, Iichiro			Examination of a Viral Infection Mimetic Model in Human iPS Cell-Derived Insulin-Producing Cells and the Anti-Apoptotic Effect of GLP-1 Analogue	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; PLURIPOTENT STEM-CELLS; TOLL-LIKE RECEPTOR-3; BETA-CELLS; ENTEROVIRUS INFECTION; IN-VITRO; INTERFERON; EXPRESSION; ACTIVATION; INDUCTION	Aims Viral infection is associated with pancreatic beta cell destruction in fulminant type 1 diabetes mellitus. The aim of this study was to investigate the acceleration and protective mechanisms of beta cell destruction by establishing a model of viral infection in pancreatic beta cells. Methods Polyinosinic: polycytidylic acid was transfected into MIN6 cells and insulin-producing cells differentiated from human induced pluripotent stem cells via small molecule applications. Gene expression was analyzed by real-time PCR, and apoptosis was evaluated by cas-pase-3 activity and TUNEL staining. The anti-apoptotic effect of Exendin-4 was also evaluated. Results Polyinosinic: polycytidylic acid transfection led to elevated expression of the genes encoding IFN alpha, IFN beta, CXCL10, Fas, viral receptors, and IFN-inducible antiviral effectors in MIN6 cells. Exendin-4 treatment suppressed the elevated gene expression levels and reduced polyinosinic: polycytidylic acid-induced apoptosis both in MIN6 cells and in insulin-producing cells from human induced pluripotent stem cells. Glucagon-like peptide-1 receptor, protein kinase A, and phosphatidylinositol-3 kinase inhibitors counteracted the anti-apoptotic effect of Exendin-4. Conclusions Polyinosinic: polycytidylic acid transfection can mimic viral infection, and Exendin-4 exerted an anti-apoptotic effect both in MIN6 and insulin-producing cells from human induced pluripotent stem cells.	[Baden, Megu Yamaguchi; Fukui, Kenji; Hosokawa, Yoshiya; Iwahashi, Hiromi; Imagawa, Akihisa; Shimomura, Iichiro] Osaka Univ, Dept Metab Med, Grad Sch Med, Suita, Osaka, Japan	Osaka University	Imagawa, A (corresponding author), Osaka Univ, Dept Metab Med, Grad Sch Med, Suita, Osaka, Japan.	aimagawa@endmet.med.osaka-u.ac.jp			JSPS KAKENHI [15K09429]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 15K09429 received by AI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2014, CYTOKINE GROWTH F R, V25, P57, DOI 10.1016/j.cytogfr.2014.01.006; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Blandino-Rosano M, 2008, J MOL ENDOCRINOL, V41, P35, DOI 10.1677/JME-07-0154; Buteau J, 2006, DIABETES, V55, P1190, DOI 10.2337/db05-0825; Buteau J, 2004, DIABETOLOGIA, V47, P806, DOI 10.1007/s00125-004-1379-6; Cho YM, 2007, DIABETOLOGIA, V50, P2276, DOI 10.1007/s00125-007-0812-z; Deng CL, 2006, WORLD J GASTROENTERO, V12, P1752, DOI 10.3748/wjg.v12.i11.1752; Dogusan Z, 2008, DIABETES, V57, P1236, DOI 10.2337/db07-0844; FIELD AK, 1967, P NATL ACAD SCI USA, V58, P2102, DOI 10.1073/pnas.58.5.2102; Hafner AM, 2013, ADV DRUG DELIVER REV, V65, P1386, DOI 10.1016/j.addr.2013.05.013; Hanafusa T, 2007, NAT CLIN PRACT ENDOC, V3, P36, DOI 10.1038/ncpendmet0351; Imagawa A, 2003, DIABETES CARE, V26, P2345, DOI 10.2337/diacare.26.8.2345; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kunisada Y, 2012, STEM CELL RES, V8, P274, DOI 10.1016/j.scr.2011.10.002; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mian MF, 2013, J LEUKOCYTE BIOL, V94, P1025, DOI 10.1189/jlb.0312125; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nair S, 2010, J MED VIROL, V82, P1950, DOI 10.1002/jmv.21900; Natalicchio A, 2010, ENDOCRINOLOGY, V151, P2019, DOI 10.1210/en.2009-1166; Nurminen Noora, 2012, Rev Diabet Stud, V9, P260, DOI 10.1900/RDS.2012.9.260; Olsson A, 2005, BIOCHEM BIOPH RES CO, V330, P571, DOI 10.1016/j.bbrc.2005.03.016; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Pugazhenthi U, 2010, DIABETOLOGIA, V53, P2357, DOI 10.1007/s00125-010-1849-y; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schulte BM, 2012, DIABETES, V61, P2030, DOI 10.2337/db11-1547; Shibasaki S, 2010, ENDOCR J, V57, P211, DOI 10.1507/endocrj.K09E-291; Soga Y, 2009, TOHOKU J EXP MED, V217, P175, DOI 10.1620/tjem.217.175; Tanaka S, 2009, DIABETES, V58, P2285, DOI 10.2337/db09-0091; Tews D, 2009, HORM METAB RES, V41, P294, DOI 10.1055/s-0028-1105911; Wang Q, 2002, DIABETOLOGIA, V45, P1263, DOI 10.1007/s00125-002-0828-3; Wei Q, 2012, PEPTIDES, V37, P18, DOI 10.1016/j.peptides.2012.06.018; Yoshida I, 2013, MICROBIOL IMMUNOL, V57, P329, DOI 10.1111/1348-0421.12050; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001	37	3	3	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144606	10.1371/journal.pone.0144606	http://dx.doi.org/10.1371/journal.pone.0144606			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26659307	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903600065
J	Li, DH; He, YC; Quinn, TJ; Liu, J				Li, Dun-Hui; He, Ya-Chao; Quinn, Thomas J.; Liu, Jun			Serum Insulin-Like Growth Factor-1 in Patients with De Novo, Drug Naive Parkinson's Disease: A Meta-Analysis	PLOS ONE			English	Article							IGF-I; APOPTOSIS; DIAGNOSIS; DOPAMINE; BINDING; STRESS	Objective Insulin-like growth factor-1 (IGF-1) is reported to be neuroprotective in the setting of Parkinson's disease (PD), and there is increasing interest in the possible association of serum IGF-1 levels with PD patients, but with conflicting results. Therefore, we conducted a meta-analysis to evaluate the association of serum IGF-1 levels in de novo, drug naive PD patients compared with healthy controls. Methods Pubmed, ISI Web of Science, OVID, EMBASE, and Cochrane library databases from 1966 to October 2014 were utilized to identify candidate studies using Medical Subjective Headings without language restriction. A random-effects model was chosen, with subgroup analysis and sensitivity analysis conducted to reveal underlying heterogeneity among the included studies. Results In this meta-analysis, we found that PD patients had higher serum IGF-1 levels compared with healthy controls (summary mean difference [MD] = 17.75, 95% CI = 6.01, 29.48). Subgroup analysis demonstrated that the source of heterogeneity was population differences within the total group. Sensitivity analysis showed that the combined MD was consistent at any time omitting any one study. Conclusions The results of this meta-analysis demonstrate that serum IGF-1 levels were significantly higher in de novo, drug-naive PD patients compared with healthy controls. Nevertheless, additional endeavors are required to further explore the association between serum IGF-1 levels and diagnosis, prognosis and early therapy for PD.	[Li, Dun-Hui; He, Ya-Chao; Liu, Jun] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Neurol, Shanghai 200025, Peoples R China; [Li, Dun-Hui; He, Ya-Chao; Liu, Jun] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Inst Neurol, Shanghai 200025, Peoples R China; [Quinn, Thomas J.] William Beaumont Hosp, Dept Radiat Oncol, Royal Oak, MI 48073 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Beaumont Health	Liu, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Neurol, Shanghai 200025, Peoples R China.	jly0520@hotmail.com	Quinn, Thomas/X-8440-2019	Li, Dunhui/0000-0002-1961-3689	National Natural Science Fund [81071024, 81171202, 30870879, 81228007, 81471287]; Shanghai Shuguang Program [11SG20]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Shanghai Shuguang Program	The work was supported by grants from National Natural Science Fund (81071024, 81171202, 30870879, 81228007, 81471287) and Shanghai Shuguang Program (11SG20).	Bellar D, 2011, NEUROSCIENCE, V178, P133, DOI 10.1016/j.neuroscience.2010.12.023; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; DeLellis K, 2004, CANCER EPIDEM BIOMAR, V13, P1444; Dik MG, 2003, NEUROBIOL AGING, V24, P573, DOI 10.1016/S0197-4580(02)00136-7; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feldman EL, 1997, NEUROBIOL DIS, V4, P201, DOI 10.1006/nbdi.1997.0156; Godau J, 2011, ARCH NEUROL-CHICAGO, V68, P925, DOI 10.1001/archneurol.2011.129; Godau J, 2010, J NEUROL NEUROSUR PS, V81, P536, DOI 10.1136/jnnp.2009.175752; Hewitt SC, 2010, J BIOL CHEM, V285, P2676, DOI 10.1074/jbc.M109.043471; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kim Y, 2012, INT J NEUROSCI, V122, P641, DOI 10.3109/00207454.2012.702821; Krishnamurthi R, 2004, NEUROREPORT, V15, P1601, DOI 10.1097/01.wnr.0000127461.15985.07; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Numao A, 2014, PARKINSONISM RELAT D, V20, P212, DOI 10.1016/j.parkreldis.2013.11.005; Offen D, 2001, NEUROSCI LETT, V316, P129, DOI 10.1016/S0304-3940(01)02344-8; Pellecchia MT, 2014, EUR J NEUROL, V21, P802, DOI 10.1111/ene.12137; Picillo Marina, 2013, J Neurol, V260, P1724, DOI 10.1007/s00415-013-6851-0; Quesada A, 2004, J NEUROSCI RES, V75, P107, DOI 10.1002/jnr.10833; Radi E, 2014, J ALZHEIMERS DIS, V42, pS125, DOI 10.3233/JAD-132738; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sterne JAC, 2011, COCHRANE HDB SYSTEMA; Wang L, 2010, APOPTOSIS, V15, P1470, DOI 10.1007/s10495-010-0547-z	23	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144755	10.1371/journal.pone.0144755	http://dx.doi.org/10.1371/journal.pone.0144755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657015	gold, Green Published			2022-12-27	WOS:000366903600086
J	Mnguni, AT; Engel, ME; Borkum, MS; Mayosi, BM				Mnguni, Ayanda Trevor; Engel, Mark E.; Borkum, Megan S.; Mayosi, Bongani M.			The Effects of Angiotensin Converting Enzyme Inhibitors (ACE-I) on Human N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (Ac-SDKP) Levels: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							PLASMA-LEVEL; ACSDKP; FIBROSIS; METABOLISM; PREVENTION; PRO	Background Tuberculous pericardial effusion is a pro-fibrotic condition that is complicated by constrictive pericarditis in 4% to 8% of cases. N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) is a ubiquitous tetrapeptide with anti-fibrotic properties that is low in tuberculous pericardial effusion, thus providing a potential mechanism for the heightened fibrotic state. Angiotensin-converting enzyme inhibitors (ACE-I), which increase Ac-SDKP levels with anti-fibrotic effects in animal models, are candidate drugs for preventing constrictive pericarditis if they can be shown to have similar effects on Ac-SDKP and fibrosis in human tissues. Objective To systematically review the effects of ACE-Is on Ac-SDKP levels in human tissues. Methods We searched five electronic databases (1996 to 2014) and conference abstracts with no language restrictions. Two reviewers independently selected studies, extracted data and assessed methodological quality. The protocol was registered in PROSPERO. Results Four studies with a total of 206 participants met the inclusion criteria. Three studies (106 participants) assessed the change in plasma levels of Ac-SDKP following ACE-I administration in healthy humans. The administration of an ACE-I was associated with an increase in Ac-SDKP levels (mean difference (MD) 5.07 pmol/ml (95% confidence intervals (CI) 0.64 pmol/ml to 9.51 pmol/ml)). Two studies with 100 participants further assessed the change in Ac-SDKP level in humans with renal failure using ACE-I. The administration of an ACE-I was associated with a significant increase in Ac-SDKP levels (MD 8.94 pmol/ml; 95% CI 2.55 to 15.33; I-2 = 44%). Conclusion ACE-I increased Ac-SDKP levels in human plasma. These findings provide the rationale for testing the impact of ACE-I on Ac-SDKP levels and fibrosis in tuberculous pericarditis.	[Mnguni, Ayanda Trevor] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; Groote Schuur Hosp, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Mnguni, AT (corresponding author), Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa.	trevormnguni@yahoo.com; mark.engel@uct.ac.za	Mnguni, Ayanda Trevor/HGC-2969-2022; Engel, Mark/AAP-6570-2020	Engel, Mark/0000-0002-1334-8829	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	MEE is supported by a grant from the Wellcome Trust.	Acharya KR, 2003, NAT REV DRUG DISCOV, V2, P891, DOI 10.1038/nrd1227; Azizi M, 2000, HYPERTENSION, V35, P1226, DOI 10.1161/01.HYP.35.6.1226; Azizi M, 1997, HYPERTENSION, V30, P1015, DOI 10.1161/01.HYP.30.5.1015; Azizi M, 2001, CLIN EXP PHARMACOL P, V28, P1066, DOI 10.1046/j.1440-1681.2001.03560.x; Azizi M, 1999, HYPERTENSION, V33, P879, DOI 10.1161/01.HYP.33.3.879; Azizi M, 1996, J CLIN INVEST, V97, P839, DOI 10.1172/JCI118484; Azizi M, 2006, DIABETES CARE, V29, P1331, DOI 10.2337/dc06-0255; BOGDEN AE, 1991, ANN NY ACAD SCI, V628, P126, DOI 10.1111/j.1749-6632.1991.tb17230.x; CASHMAN JD, 1994, BLOOD, V84, P1534, DOI 10.1182/blood.V84.5.1534.bloodjournal8451534; Cavasin MA, 2004, HYPERTENSION, V43, P1140, DOI 10.1161/01.HYP.0000126172.01673.84; Cavasin MA, 2007, HYPERTENSION, V50, P130, DOI 10.1161/HYPERTENSIONAHA.106.084103; Comte L, 1998, EUR J CLIN INVEST, V28, P856; Damasceno A, 2012, ARCH INTERN MED, V172, P1386, DOI 10.1001/archinternmed.2012.3310; Higgins J, 2009, COCHRANE HDB SYSTEMA, P276; Inoue K, 2011, J PHARMACEUT BIOMED, V54, P765, DOI 10.1016/j.jpba.2010.10.009; Li P, 2010, AM J PATHOL, V177, P1113, DOI 10.2353/ajpath.2010.081127; Lin CX, 2008, AM J PHYSIOL-HEART C, V295, pH1253, DOI 10.1152/ajpheart.00481.2008; Liu XJ, 2009, J BIOL CHEM, V284, P15564, DOI 10.1074/jbc.M806584200; Mayosi BM, 2014, NEW ENGL J MED, V371, P1121, DOI 10.1056/NEJMoa1407380; Mesmin C, 2012, RAPID COMMUN MASS SP, V26, P163, DOI 10.1002/rcm.5326; Mnguni T, 2014, PROSPERO INT PROSPEC, P1; Moher David, 2009, Open Med, V3, pe123; Mutyaba AK, 2014, J THORAC CARDIOV SUR, V148, P3058, DOI 10.1016/j.jtcvs.2014.07.065; Nakagawa P, 2012, AM J PHYSIOL-HEART C, V303, pH1114, DOI 10.1152/ajpheart.00300.2011; Ntsekhe M, 2012, HEART, V98, P1326, DOI 10.1136/heartjnl-2012-302196; Peng HM, 2003, HYPERTENSION, V42, P1164, DOI 10.1161/01.HYP.0000100423.24330.96; Rasoul S, 2004, J HYPERTENS, V22, P593, DOI 10.1097/00004872-200403000-00023; ROUSSEAU A, 1995, J BIOL CHEM, V270, P3656, DOI 10.1074/jbc.270.8.3656; Sliwa K, 2005, CIRCULATION, V112, P3577, DOI 10.1161/CIRCULATIONAHA.105.542894; Struthers AD, 1999, J AM COLL CARDIOL, V34, P2072, DOI 10.1016/S0735-1097(99)00439-8; Wang MG, 2010, INT J MOL MED, V26, P795, DOI 10.3892/ijmm_00000527; WEI L, 1991, J BIOL CHEM, V266, P9002; Zisman LS, 1998, CIRCULATION, V98, P2788, DOI 10.1161/01.CIR.98.25.2788	33	6	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0143338	10.1371/journal.pone.0143338	http://dx.doi.org/10.1371/journal.pone.0143338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656271	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903600011
J	Popova, AP; Cui, TX; Kaciroti, N; Goldsmith, AM; Linn, MJ; Pryhuber, GS; Hershenson, MB				Popova, Antonia P.; Cui, Tracy X.; Kaciroti, Niko; Goldsmith, Adam M.; Linn, Marisa J.; Pryhuber, Gloria S.; Hershenson, Marc B.			Tracheal Aspirate Levels of the Matricellular Protein SPARC Predict Development of Bronchopulmonary Dysplasia	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; INHALED NITRIC-OXIDE; CHRONIC LUNG-DISEASE; TRANSFORMING GROWTH-FACTOR-BETA-1; PREMATURE-INFANTS; NULL MICE; COLLAGEN FIBRILLOGENESIS; FACTOR-BETA; TGF-BETA; EXPRESSION	Background Isolation of tracheal aspirate mesenchymal stromal cells (MSCs) from premature infants has been associated with increased risk of bronchopulmonary dysplasia (BPD). MSCs show high levels of mRNAs encoding matricellular proteins, non-structural extracellular proteins that regulate cell-matrix interactions and participate in tissue remodeling. We hypothesized that lung matricellular protein expression predicts BPD development. Methods We collected tracheal aspirates and MSCs from mechanically-ventilated premature infants during the first week of life. Tracheal aspirate and MSC-conditioned media were analyzed for seven matricellular proteins including SPARC (for Secreted Protein, Acidic, Rich in Cysteine, also called osteonectin) and normalized to secretory component of IgA. A multiple logistic regression model was used to determine whether tracheal aspirate matricellular protein levels were independent predictors of BPD or death, controlling for gestational age (GA) and birth weight (BW). Results We collected aspirates from 89 babies (38 developed BPD, 16 died before 36 wks post-conceptual age). MSC-conditioned media showed no differences in matricellular protein abundance between cells from patients developing BPD and cells from patients who did not. However, SPARC levels were higher in tracheal aspirates from babies with an outcome of BPD or death (p<0.01). Further, our logistic model showed that tracheal aspirate SPARC (p<0.02) was an independent predictor of BPD/death. SPARC deposition was increased in the lungs of patients with BPD. Conclusions In mechanically-ventilated premature infants, tracheal aspirate SPARC levels predicted development of BPD or death. Further study is needed to determine the value of SPARC as a biomarker or therapeutic target in BPD.	[Popova, Antonia P.; Cui, Tracy X.; Goldsmith, Adam M.; Linn, Marisa J.; Hershenson, Marc B.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Hershenson, Marc B.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Kaciroti, Niko] Univ Michigan, Sch Med, Ctr Computat Med & Bioinformat, Ann Arbor, MI USA; [Kaciroti, Niko] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Pryhuber, Gloria S.] Univ Rochester, Dept Pediat, Rochester, NY USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Rochester	Hershenson, MB (corresponding author), Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA.	mhershen@umich.edu	Kaciroti, Niko/AAG-3988-2021; Kaciroti, Niko/AAI-2613-2021	Kaciroti, Niko/0000-0001-8843-8231; 	National Institutes of Health [R01 HL79339, K23 HL109149]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079339, K23HL109149] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health R01 HL79339 and National Institutes of Health K23 HL109149.	Bhatt AJ, 2001, AM J RESP CRIT CARE, V164, P1971, DOI 10.1164/ajrccm.164.10.2101140; Bonniaud P, 2004, AM J RESP CELL MOL, V31, P510, DOI 10.1165/rcmb.2004-0158OC; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P163, DOI 10.1007/s12079-009-0069-z; Bozyk PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031336; Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x; Bradshaw AD, 2003, P NATL ACAD SCI USA, V100, P6045, DOI 10.1073/pnas.1030790100; Brekken Rolf A., 2001, Matrix Biology, V19, P816; CHANDRASEKHAR S, 1994, BBA-MOL CELL RES, V1221, P7, DOI 10.1016/0167-4889(94)90209-7; Chang W, 2010, J BIOL CHEM, V285, P8196, DOI 10.1074/jbc.M109.025684; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chiodoni C, 2010, CANCER METAST REV, V29, P295, DOI 10.1007/s10555-010-9221-8; Daniel C, 2004, KIDNEY INT, V65, P459, DOI 10.1111/j.1523-1755.2004.00395.x; Dargaville PA, 1999, AM J RESP CRIT CARE, V160, P778, DOI 10.1164/ajrccm.160.3.9811049; Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783; Francki A, 1999, J BIOL CHEM, V274, P32145, DOI 10.1074/jbc.274.45.32145; Frangogiannis NG, 2012, PHYSIOL REV, V92, P635, DOI 10.1152/physrev.00008.2011; FUNK SE, 1991, P NATL ACAD SCI USA, V88, P2648, DOI 10.1073/pnas.88.7.2648; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Hennrick KT, 2007, AM J RESP CRIT CARE, V175, P1158, DOI 10.1164/rccm.200607-941OC; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; Husain AN, 1998, HUM PATHOL, V29, P710, DOI 10.1016/S0046-8177(98)90280-5; Johnson AH, 2002, NEW ENGL J MED, V347, P633, DOI 10.1056/NEJMoa020432; Jonsson B, 2000, ACTA PAEDIATR, V89, P1375, DOI 10.1080/080352500300002606; Kirpalani H, 2013, NEW ENGL J MED, V369, P611, DOI 10.1056/NEJMoa1214533; Kunig AM, 2005, AM J PHYSIOL-LUNG C, V289, pL529, DOI 10.1152/ajplung.00336.2004; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Lasky JA, 1998, AM J PHYSIOL-LUNG C, V275, pL365, DOI 10.1152/ajplung.1998.275.2.L365; Leask A, 2009, J CELL COMMUN SIGNAL, V3, P89, DOI 10.1007/s12079-009-0037-7; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; MURPHYULLRICH JE, 1992, MOL BIOL CELL, V3, P181, DOI 10.1091/mbc.3.2.181; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Parisi MS, 2006, BONE, V38, P671, DOI 10.1016/j.bone.2005.10.005; Popova AP, 2012, AM J PHYSIOL-LUNG C, V303, pL439, DOI 10.1152/ajplung.00408.2011; Popova AP, 2010, PEDIATRICS, V126, pE1127, DOI 10.1542/peds.2009-3445; Popova AP, 2010, AM J PHYSIOL-LUNG C, V298, pL735, DOI 10.1152/ajplung.00347.2009; REED MJ, 1994, J CELL PHYSIOL, V158, P169, DOI 10.1002/jcp.1041580121; Rentz TJ, 2007, J BIOL CHEM, V282, P22062, DOI 10.1074/jbc.M700167200; Sasaki T, 1998, EMBO J, V17, P1625, DOI 10.1093/emboj/17.6.1625; Schellings MWM, 2009, J EXP MED, V206, P113, DOI 10.1084/jem.20081244; Schreiber MD, 2003, NEW ENGL J MED, V349, P2099, DOI 10.1056/NEJMoa031154; SHENNAN AT, 1988, PEDIATRICS, V82, P527; Shi-Wen X, 2006, J BIOL CHEM, V281, P10715, DOI 10.1074/jbc.M511343200; Shibata S, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-6; Socha MJ, 2007, AM J PATHOL, V171, P1104, DOI 10.2353/ajpath.2007.061273; Strandjord TP, 1999, AM J PHYSIOL-LUNG C, V277, pL628, DOI 10.1152/ajplung.1999.277.3.L628; Thapa N, 2007, INT J BIOCHEM CELL B, V39, P2183, DOI 10.1016/j.biocel.2007.06.004; Toti P, 1997, PEDIATR PULM, V24, P22, DOI 10.1002/(SICI)1099-0496(199707)24:1<22::AID-PPUL4>3.0.CO;2-L; Van Meurs KP, 2005, NEW ENGL J MED, V353, P13, DOI 10.1056/NEJMoa043927; Vicencio AG, 2004, AM J RESP CELL MOL, V31, P650, DOI 10.1165/rcmb.2004-0092OC; Wallace MJ, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-19; Wen W, 2010, J DENT RES, V89, P1439, DOI 10.1177/0022034510378684; Wu S, 2010, AM J RESP CELL MOL, V42, P552, DOI 10.1165/rcmb.2009-0068OC; Zhang XF, 2009, FASEB J, V23, P3368, DOI 10.1096/fj.09-131649	55	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144122	10.1371/journal.pone.0144122	http://dx.doi.org/10.1371/journal.pone.0144122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656750	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903600024
J	Prinz, J; Karacivi, A; Stormanns, ER; Recks, MS; Kuerten, S				Prinz, Johanna; Karacivi, Aylin; Stormanns, Eva R.; Recks, Mascha S.; Kuerten, Stefanie			Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							MYELIN OLIGODENDROCYTE GLYCOPROTEIN; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; C57BL/6 MICE; ANIMAL-MODELS; SPINAL-CORD; CORTICAL PATHOLOGY; T-CELLS; DISEASE; DAMAGE	Background Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) characterized by inflammation, demyelination and axonal pathology. Myelin basic protein/proteolipid protein (MBP-PLP) fusion protein MP4 is capable of inducing chronic experimental autoimmune encephalomyelitis (EAE) in susceptible mouse strains mirroring diverse histopathological and immunological hallmarks of MS. Lack of human tissue underscores the importance of animal models to study the pathology of MS. Methods Twenty-two female C57BL/6 (B6) mice were immunized with MP4 and the clinical development of experimental autoimmune encephalomyelitis (EAE) was observed. Methylene blue-stained semi-thin and ultra-thin sections of the lumbar spinal cord were assessed at the peak of acute EAE, three months (chronic EAE) and six months after onset of EAE (long-term EAE). The extent of lesional area and inflammation were analyzed in semi-thin sections on a light microscopic level. The magnitude of demyelination and axonal damage were determined using electron microscopy. Emphasis was put on the ventrolateral tract (VLT) of the spinal cord. Results B6 mice demonstrated increasing demyelination and severe axonal pathology in the course of MP4-induced EAE. Additionally, mitochondrial swelling and a decrease in the nearest neighbor neurofilament distance (NNND) as early signs of axonal damage were evident with the onset of EAE. In semi-thin sections we observed the maximum of lesional area in the chronic state of EAE while inflammation was found to a similar extent in acute and chronic EAE. In contrast to the well-established myelin oligodendrocyte glycoprotein (MOG) model, disease stages of MP4-induced EAE could not be distinguished by assessing the extent of parenchymal edema or the grade of inflammation. Conclusions Our results complement our previous ultrastructural studies of B6 EAE models and suggest that B6 mice immunized with different antigens constitute useful instruments to study the diverse histopathological aspects of MS.	[Prinz, Johanna; Karacivi, Aylin; Stormanns, Eva R.] Univ Cologne, Dept Anat 1, D-50931 Cologne, Germany; [Recks, Mascha S.] Univ Cologne, Dept Anat 2, D-50931 Cologne, Germany; [Kuerten, Stefanie] Univ Wurzburg, Dept Anat & Cell Biol, D-97070 Wurzburg, Germany	University of Cologne; University of Cologne; University of Wurzburg	Kuerten, S (corresponding author), Univ Wurzburg, Dept Anat & Cell Biol, D-97070 Wurzburg, Germany.	stefanie.kuerten@uni-wuerzburg.de						Aloisi F, 2000, IMMUNOL TODAY, V21, P141, DOI 10.1016/S0167-5699(99)01512-1; Bernard CCA, 1997, J MOL MED-JMM, V75, P77, DOI 10.1007/s001090050092; BERNARD CCA, 1976, J IMMUNOGENET, V3, P263; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Calabrese M, 2010, NAT REV NEUROL, V6, P438, DOI 10.1038/nrneurol.2010.93; Chomiak T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007754; Clements CS, 2003, P NATL ACAD SCI USA, V100, P11059, DOI 10.1073/pnas.1833158100; De Stefano N, 1998, BRAIN, V121, P1469, DOI 10.1093/brain/121.8.1469; Dyer CA, 2002, NEUROCHEM RES, V27, P1279, DOI 10.1023/A:1021611430052; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Goverman J, 1996, LAB ANIM SCI, V46, P482; Gruppe TL, 2012, HISTOL HISTOPATHOL, V27, P1163, DOI 10.14670/HH-27.1163; GUY J, 1991, BRAIN, V114, P281; Handel AE, 2011, EUR J CLIN INVEST, V41, P1254, DOI 10.1111/j.1365-2362.2011.02519.x; Howell OW, 2011, BRAIN, V134, P2755, DOI 10.1093/brain/awr182; Kuerten S, 2011, FORTSCHR NEUROL PSYC, V79, P83, DOI 10.1055/s-0029-1245937; Kuerten S, 2008, ANN ANAT, V190, P1, DOI 10.1016/j.aanat.2007.11.001; Kuerten S, 2008, CLIN IMMUNOL, V129, P256, DOI 10.1016/j.clim.2008.07.016; Kuerten S, 2007, J NEUROIMMUNOL, V189, P31, DOI 10.1016/j.jneuroim.2007.06.016; Kuerten S, 2006, J NEUROIMMUNOL, V177, P99, DOI 10.1016/j.jneuroim.2006.03.021; Kuerten S, 2012, ACTA NEUROPATHOL, V124, P861, DOI 10.1007/s00401-012-1023-3; Kuerten S, 2011, APMIS, V119, P336, DOI 10.1111/j.1600-0463.2011.02744.x; Lassmann H, 1983, Schriftenr Neurol, V25, P1; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; Lunn MPT, 2002, BRAIN, V125, P904, DOI 10.1093/brain/awf072; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Mao PZ, 2010, BBA-MOL BASIS DIS, V1802, P66, DOI 10.1016/j.bbadis.2009.07.002; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Merrill JE, 1999, NEUROPATH APPL NEURO, V25, P435; Neumann H, 2002, TRENDS NEUROSCI, V25, P313, DOI 10.1016/S0166-2236(02)02154-9; Oliver AR, 2003, J IMMUNOL, V171, P462, DOI 10.4049/jimmunol.171.1.462; Petzold A, 2008, EXP NEUROL, V213, P326, DOI 10.1016/j.expneurol.2008.06.008; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; Recks MS, 2011, FORTSCHR NEUROL PSYC, V79, P161, DOI 10.1055/s-0029-1246014; Recks MS, 2013, CLIN IMMUNOL, V149, P32, DOI 10.1016/j.clim.2013.06.004; Recks MS, 2011, NEUROSCI LETT, V494, P227, DOI 10.1016/j.neulet.2011.03.021; Schmidt S, 1999, MULT SCLER J, V5, P147, DOI 10.1177/135245859900500303; Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Steinman L, 1999, NEURON, V24, P511, DOI 10.1016/S0896-6273(00)81107-1; Tompkins SM, 2002, J IMMUNOL, V168, P4173, DOI 10.4049/jimmunol.168.8.4173; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; WEKERLE H, 1994, ANN NEUROL, V36, pS47, DOI 10.1002/ana.410360714; ZAMVIL SS, 1986, NATURE, V324, P258, DOI 10.1038/324258a0	45	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144847	10.1371/journal.pone.0144847	http://dx.doi.org/10.1371/journal.pone.0144847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26658811	Green Submitted, gold, Green Published			2022-12-27	WOS:000366903600095
J	Jin, X; Ye, EM; Qi, JL; Wang, LB; Lei, Y; Chen, PH; Mi, GY; Zou, F; Shao, YC; Yang, Z				Jin, Xiao; Ye, Enmao; Qi, Jianlin; Wang, Lubin; Lei, Yu; Chen, Pinhong; Mi, Guiyun; Zou, Feng; Shao, Yongcong; Yang, Zheng			Recovery Sleep Reverses Impaired Response Inhibition due to Sleep Restriction: Evidence from a Visual Event Related Potentials Study	PLOS ONE			English	Article							ERP COMPONENTS; NEURAL BASIS; DEPRIVATION; TASKS; EEG	Objective To investigate response inhibition after total sleep deprivation (TSD) and the restorative effects of one night of recovery sleep (RS). Methods Fourteen healthy male participants performed a visual Go/NoGo task, and electroencephalogram recordings were conducted at five time points: (1) baseline, (2) after 12 h of TSD, (3) after 24 h of TSD, (4) after 36 h of TSD, and (5) following 8 h of RS. The dynamic changes in response inhibition during TSD and after 8 h of RS were investigated by examining the NoGo-N2 and NoGo-P3 event-related potential components. Results Compared with baseline, NoGo-P3 amplitudes were decreased, while the NoGo-N2 latency increased along with the awake time prolonged. NoGo anteriorization, which was minimized after 24 h of TSD, progressively decreased with increasing TSD. After 8 h of RS, recoveries of both the NoGo-P3 amplitude and NoGo-N2 latency in the prefrontal cortex were observed compared with the values after 36 h of TSD. Conclusion TSD induced a dose-dependent functional decline in the response inhibition of NoGo-N2 and NoGo-P3 on prefrontal cortex activation, and 8 h of RS resulted in recovery or maintenance of the response inhibition. However, it was not restored to baseline levels. Limitations Participants were chosen male college students only, thus the findings cannot be generalized to older people and women. Additionally, the sample size was small, and, thus, speculations on the meaning of the results of this study should be cautious. The EEG continuous recording should be employed to monitor the decline of alertness following TSD.	[Jin, Xiao; Ye, Enmao; Wang, Lubin; Lei, Yu; Chen, Pinhong; Mi, Guiyun; Shao, Yongcong; Yang, Zheng] Beijing Inst Basic Med Sci, Beijing, Peoples R China; [Jin, Xiao; Ye, Enmao; Wang, Lubin; Lei, Yu; Chen, Pinhong; Mi, Guiyun; Shao, Yongcong; Yang, Zheng] Cognit & Mental Hlth Res Ctr, Beijing, Peoples R China; [Qi, Jianlin] Air Force Gen Hosp, Dept Clin Psychol, Beijing, Peoples R China; [Zou, Feng] Chinese Peoples Liberat Army, Hosp 406, Clin 215, Dept Psychol, Dalian, Peoples R China	Academy of Military Medical Sciences - China; Air Force General Hospital PLA	Shao, YC (corresponding author), Beijing Inst Basic Med Sci, Beijing, Peoples R China.	budeshao@aliyun.com; yangzhengchina@aliyun.com			National Military Science Foundation of China [BWS11J045, 06z066, AWS11Z005-2, AWS12J003, 12xlz329, 2013BAHD2806]	National Military Science Foundation of China	The research reported in this article was supported by grants from the National Military Science Foundation of China, Grant No. BWS11J045, No. 06z066, No. AWS11Z005-2, No. AWS12J003, No. 12xlz329, and No. 2013BAHD2806. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokura H, 2001, CLIN NEUROPHYSIOL, V112, P2224, DOI 10.1016/S1388-2457(01)00691-5; BONNET MH, 1991, SLEEP, V14, P307, DOI 10.1093/sleep/14.4.307; BORBELY AA, 1981, ELECTROEN CLIN NEURO, V51, P483, DOI 10.1016/0013-4694(81)90225-X; Bruin KJ, 2002, CLIN NEUROPHYSIOL, V113, P1172, DOI 10.1016/S1388-2457(02)00141-4; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cajochen C, 1999, Sleep Res Online, V2, P65; Carskadon M. A., 2017, PRINCIPLES PRACTICE, P15, DOI [10.1016/B0-72-160797-7%2F50009-4, DOI 10.1016/C2012-0-03543-0, 10.1016/C2012-0-03543-0, DOI 10.1016/B978-1-4160-6645-3.00002-5]; Chuah YML, 2006, J NEUROSCI, V26, P7156, DOI 10.1523/JNEUROSCI.0906-06.2006; Derogatis L. R., 1977, SCL 90 MANUAL SCORIN; Drummond SPA, 2006, J SLEEP RES, V15, P261, DOI 10.1111/j.1365-2869.2006.00535.x; Drummond SPA, 2004, SLEEP, V27, P445; Drummond SPA, 2005, SLEEP, V28, P1059; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Fallgatter AJ, 2002, J NEURAL TRANSM, V109, P977, DOI 10.1007/s007020200080; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Goel M, 2013, CIRCADIAN RHYTHMS SL, V119, P155, DOI [10.1016/B978-0-12-396971-2.00007-5, DOI 10.1016/B978-0-12-396971-2.00007-5]; Gosselin A, 2005, CLIN NEUROPHYSIOL, V116, P211, DOI 10.1016/j.clinph.2004.07.033; Harrison Y, 1998, J SLEEP RES, V7, P95, DOI 10.1046/j.1365-2869.1998.00104.x; HASLAM DR, 1982, ERGONOMICS, V25, P163, DOI 10.1080/00140138208924935; Jennings JR, 2003, PSYCHOL SCI, V14, P473, DOI 10.1111/1467-9280.02456; Jones K, 2001, SLEEP MED REV, V5, P463, DOI 10.1053/smrv.2001.0203; Jonkman LM, 2006, BRAIN RES, V1097, P181, DOI 10.1016/j.brainres.2006.04.064; KALES A, 1970, PSYCHOSOM MED, V32, P189, DOI 10.1097/00006842-197003000-00005; KENEMANS JL, 1991, PSYCHOPHYSIOLOGY, V28, P114, DOI 10.1111/j.1469-8986.1991.tb03397.x; Kleitman N., 1963, SLEEP WAKEFULNESS; Konishi S, 1998, EUR J NEUROSCI, V10, P1209, DOI 10.1046/j.1460-9568.1998.00167.x; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; KOSLOWSKY M, 1992, CHRONOBIOL INT, V9, P132, DOI 10.3109/07420529209064524; Kreusch F, 2014, INT J PSYCHOPHYSIOL, V94, P92, DOI 10.1016/j.ijpsycho.2014.08.001; Lavie P, 2001, ANNU REV PSYCHOL, V52, P277, DOI 10.1146/annurev.psych.52.1.277; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; MONK TH, 1989, PSYCHIAT RES, V27, P89, DOI 10.1016/0165-1781(89)90013-9; MORRIS AM, 1992, J OCCUP ENVIRON MED, V34, P1143; Nieuwenhuis S, 2004, PSYCHOPHYSIOLOGY, V41, P157, DOI 10.1046/j.1469-8986.2003.00128.x; Nilsson JP, 2005, J SLEEP RES, V14, P1, DOI 10.1111/j.1365-2869.2005.00442.x; OPSTAD PK, 1987, PEPTIDES, V8, P175, DOI 10.1016/0196-9781(87)90183-5; Panjwani U, 2010, EUR J APPL PHYSIOL, V108, P549, DOI 10.1007/s00421-009-1222-3; Qi JL, 2010, SOC BEHAV PERSONAL, V38, P29, DOI 10.2224/sbp.2010.38.1.29; Raven JC, 1988, ADV PROGR MATRICES; Smith JL, 2007, CLIN NEUROPHYSIOL, V118, P343, DOI 10.1016/j.clinph.2006.09.027; Wu JC, 2006, NEUROPSYCHOPHARMACOL, V31, P2783, DOI 10.1038/sj.npp.1301166; Zhang QR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095653	43	13	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0142361	10.1371/journal.pone.0142361	http://dx.doi.org/10.1371/journal.pone.0142361			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YZ	26658074	gold, Green Submitted, Green Published			2022-12-27	WOS:000366903500002
J	Scholl, HPN; Moore, AT; Koenekoop, RK; Wen, YQ; Fishman, GA; van den Born, LI; Bittner, A; Bowles, K; Fletcher, EC; Collison, FT; Dagnelie, G; Degli Eposti, S; Michaelides, M; Saperstein, DA; Schuchard, RA; Barnes, C; Zein, W; Zobor, D; Birch, DG; Mendola, JD; Zrenner, E				Scholl, Hendrik P. N.; Moore, Anthony T.; Koenekoop, Robert K.; Wen, Yuquan; Fishman, Gerald A.; van den Born, L. Ingeborgh; Bittner, Ava; Bowles, Kristen; Fletcher, Emily C.; Collison, Frederick T.; Dagnelie, Gislin; Degli Eposti, Simona; Michaelides, Michel; Saperstein, David A.; Schuchard, Ronald A.; Barnes, Claire; Zein, Wadih; Zobor, Ditta; Birch, David G.; Mendola, Janine D.; Zrenner, Eberhart		RET IRD 01 Study Grp	Safety and Proof-of-Concept Study of Oral QLT091001 in Retinitis Pigmentosa Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin: Retinol Acyltransferase (LRAT)	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; OPTICAL COHERENCE TOMOGRAPHY; CELL INTRAOCULAR IMPLANTS; CHILDHOOD BLINDNESS; VISUAL-FIELDS; GENE-THERAPY; MOUSE MODEL; MUTATIONS; SENSITIVITY; DYSTROPHY	Restoring vision in inherited retinal degenerations remains an unmet medical need. In mice exhibiting a genetically engineered block of the visual cycle, vision was recently successfully restored by oral administration of 9-cis-retinyl acetate (QLT091001). Safety and visual outcomes of a once-daily oral dose of 40 mg/m(2)/day QLT091001 for 7 consecutive days was investigated in an international, multi-center, open-label, proof-of-concept study in 18 patients with RPE65- or LRAT-related retinitis pigmentosa. Eight of 18 patients (44%) showed a >= 20% increase and 4 of 18 (22%) showed a >= 40% increase in functional retinal area determined from Goldmann visual fields; 12 (67%) and 5 (28%) of 18 patients showed a >= 5 and >= 10 ETDRS letter score increase of visual acuity, respectively, in one or both eyes at two or more visits within 2 months of treatment. In two patients who underwent fMRI, a significant positive response was measured to stimuli of medium contrast, moving, pattern targets in both left and right hemispheres of the occipital cortex. There were no serious adverse events. Treatment-related adverse events were transient and the most common included headache, photophobia, nausea, vomiting, and minor biochemical abnormalities. Measuring the outer segment length of the photoreceptor layer with high-definition optical coherence tomography was highly predictive of treatment responses with responders having a significantly larger baseline outer segment thickness (11.7 +/- 4.8 mu m, mean +/- 95% CI) than non-responders (3.5 +/- 1.2 mu m). This structure-function relationship suggests that treatment with QLT091001 is more likely to be efficacious if there is sufficient photoreceptor integrity.	[Scholl, Hendrik P. N.; Bittner, Ava; Bowles, Kristen; Fletcher, Emily C.; Dagnelie, Gislin] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA; [Moore, Anthony T.; Degli Eposti, Simona; Michaelides, Michel] Moorfields Eye Hosp, London, England; [Moore, Anthony T.; Degli Eposti, Simona; Michaelides, Michel] UCL, Inst Ophthalmol, London, England; [Moore, Anthony T.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA; [Koenekoop, Robert K.; Mendola, Janine D.] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Wen, Yuquan; Birch, David G.] Retina Fdn Southwest, Dallas, TX USA; [Wen, Yuquan] Baylor Univ, Med Ctr, Baylor Visual Funct Ctr, Dallas, TX USA; [Fishman, Gerald A.; Collison, Frederick T.] Pangere Ctr Inherited Retinal Dis, Chicago Lighthouse, Chicago, IL USA; [van den Born, L. Ingeborgh] Rotterdam Eye Hosp, Rotterdam, Netherlands; [van den Born, L. Ingeborgh] Ophthalm Inst, Rotterdam, Netherlands; [Bittner, Ava] Nova SE Univ, Coll Optometry, Ft Lauderdale, FL 33314 USA; [Bowles, Kristen] Univ Houston, Coll Optometry, Houston, TX USA; [Fletcher, Emily C.] Gloucester Royal NHS Fdn Trust, Gloucester Royal Hosp, Gloucester, England; [Saperstein, David A.] Vitreoretinal Associates Washington, Seattle, WA USA; [Saperstein, David A.; Schuchard, Ronald A.; Barnes, Claire] QLT Inc, Vancouver, BC, Canada; [Schuchard, Ronald A.] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Barnes, Claire] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Zein, Wadih] NEI, Div Epidemiol & Clin Res, NIH, Bethesda, MD 20892 USA; [Zobor, Ditta; Zrenner, Eberhart] Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, Tubingen, Germany; [Birch, David G.] UT Southwestern, Ophthalmol, Dallas, TX USA	Johns Hopkins University; Johns Hopkins Medicine; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of California System; University of California San Francisco; McGill University; Retina Foundation of the Southwest; Baylor University; Baylor University Medical Center; Rotterdam Eye Hospital; Nova Southeastern University; University of Houston System; University of Houston; Gloucestershire Hospitals NHS Foundation Trust; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas	Scholl, HPN (corresponding author), Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA.	hscholl1@jhmi.edu	Bittner, Ava/AAK-8778-2021; Koenekoop, Robert/AAT-6676-2021	Bittner, Ava/0000-0002-9498-2230; 	QLT Inc. [QLT091001]; Wynn-Gund Translational Research Acceleration Program Enhanced Research and Clinical Training Award, National Neurovision Research Institute (NNRI) - Foundation Fighting Blindness (FFB) [NNCD-CL-0310.0049-JHU-WG]; Macular Degeneration Research Award, American Health Assistance Foundation/BrightFocus Foundation (AHAF) [M2010042]; Research to Prevent Blindness; Baylor-Johns Hopkins Center for Mendelian Genetics (National Human Genome Research Institute, NHGRI/NIH) [1U54HG006542-01]; Canadian Foundation Fighting Blindness; Canadian Institutes for Health Research; Fonds de la Recherche en Santee du Quebec; Reseau Vision; NIH; National Institute for Health Research UK (Moorfields Biomedical Research Centre); National Institute for Health Research [NF-SI-0507-10204] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER	QLT Inc.; Wynn-Gund Translational Research Acceleration Program Enhanced Research and Clinical Training Award, National Neurovision Research Institute (NNRI) - Foundation Fighting Blindness (FFB); Macular Degeneration Research Award, American Health Assistance Foundation/BrightFocus Foundation (AHAF)(BrightFocus Foundation); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Baylor-Johns Hopkins Center for Mendelian Genetics (National Human Genome Research Institute, NHGRI/NIH); Canadian Foundation Fighting Blindness; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Santee du Quebec; Reseau Vision; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research UK (Moorfields Biomedical Research Centre); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funding: This study was sponsored by QLT Inc., the developer of QLT091001. Dr. Scholl was supported by the Wynn-Gund Translational Research Acceleration Program Enhanced Research and Clinical Training Award, National Neurovision Research Institute (NNRI) - Foundation Fighting Blindness (FFB; NNCD-CL-0310.0049-JHU-WG); Macular Degeneration Research Award, American Health Assistance Foundation/BrightFocus Foundation (AHAF; M2010042); Unrestricted grant to the Wilmer Eye Institute from Research to Prevent Blindness; and Baylor-Johns Hopkins Center for Mendelian Genetics (National Human Genome Research Institute, NHGRI/NIH; 1U54HG006542-01). Dr. Scholl is the Dr. Frieda Derdeyn Bambas Professor of Ophthalmology. Dr. Koenekoop is supported by the Canadian Foundation Fighting Blindness, Canadian Institutes for Health Research, Fonds de la Recherche en Santee du Quebec, Reseau Vision and NIH. Dr Moore is supported by the National Institute for Health Research UK (Moorfields Biomedical Research Centre). Drs. Scholl, Moore, Koenekoop, Fishman, Bittner, Dagnelie, Saperstein, Schuchard, Barnes and Birch served as paid consultants for QLT Inc. The specific roles of these authors are articulated in the 'author contributions' section. QLT Inc. was involved in the study design, data collection and analysis. QLT also provided technical support for manuscript preparation, reviewed the manuscript and participated in the decision to publish.	Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; Birch DG, 2013, JAMA OPHTHALMOL, V131, P1143, DOI 10.1001/jamaophthalmol.2013.4160; Birch DG, 2013, AM J OPHTHALMOL, V156, P283, DOI 10.1016/j.ajo.2013.03.021; Birch DG, 2011, INVEST OPHTH VIS SCI, V52, P7141, DOI 10.1167/iovs.11-7509; Bittner AK, 2011, INVEST OPHTH VIS SCI, V52, P8042, DOI 10.1167/iovs.11-8321; Bramall AN, 2010, ANNU REV NEUROSCI, V33, P441, DOI 10.1146/annurev-neuro-060909-153227; Cideciyan AV, 2010, PROG RETIN EYE RES, V29, P398, DOI 10.1016/j.preteyeres.2010.04.002; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; DAGNELIE G, 1990, CLIN VISION SCI, V5, P95; Fan J, 2008, INVEST OPHTH VIS SCI, V49, P2384, DOI 10.1167/iovs.08-1727; Finger RP, 2011, BRIT J OPHTHALMOL, V95, P1061, DOI 10.1136/bjo.2010.194712; Fischer MD, 2008, INVEST OPHTH VIS SCI, V49, P3617, DOI 10.1167/iovs.08-2003; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Haim M, 2002, ACTA OPHTHALMOL SCAN, V80, P5; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Hartong Dyonne T, 2006, Lancet, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hood DC, 2011, BIOMED OPT EXPRESS, V2, P1106, DOI 10.1364/BOE.2.001106; Hood DC, 2009, INVEST OPHTH VIS SCI, V50, P2328, DOI 10.1167/iovs.08-2936; Iannaccone A, 2014, LANCET, V384, P1482, DOI 10.1016/S0140-6736(14)60956-9; Kiser AK, 2005, OPTOMETRY VISION SCI, V82, P946, DOI 10.1097/01.opx.0000187863.12609.7b; Kiser PD, 2014, CHEM REV, V114, P194, DOI 10.1021/cr400107q; Koenekoop RK, 2014, LANCET, V384, P1513, DOI 10.1016/S0140-6736(14)60153-7; Lorenz B, 2000, INVEST OPHTH VIS SCI, V41, P2735; Maeda T, 2013, INVEST OPHTH VIS SCI, V54, P455, DOI 10.1167/iovs.12-11152; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; McCulloch DL, 2015, DOC OPHTHALMOL, V130, P1, DOI 10.1007/s10633-014-9473-7; Palczewski K, 2010, TRENDS PHARMACOL SCI, V31, P284, DOI 10.1016/j.tips.2010.03.001; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Roman AJ, 2013, INVEST OPHTH VIS SCI, V54, P1378, DOI 10.1167/iovs.12-11341; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; Thompson DA, 2001, NAT GENET, V28, P123, DOI 10.1038/88828; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Van Hooser JP, 2002, J BIOL CHEM, V277, P19173, DOI 10.1074/jbc.M112384200; vonReinersdorff D, 1996, J LIPID RES, V37, P1875; WELEBER RG, 1986, AM J OPHTHALMOL, V101, P461, DOI 10.1016/0002-9394(86)90648-3; Wen R, 2012, PROG RETIN EYE RES, V31, P136, DOI 10.1016/j.preteyeres.2011.11.005; Wen Y, T VIS SCI T IN PRESS; Wen Y, 2012, INVEST OPHTH VIS SCI, V53, P833, DOI 10.1167/iovs.11-8410	42	45	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0143846	10.1371/journal.pone.0143846	http://dx.doi.org/10.1371/journal.pone.0143846			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26656277	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903500007
J	Steenbergen, L; Sellaro, R; Stock, AK; Beste, C; Colzato, LS				Steenbergen, Laura; Sellaro, Roberta; Stock, Ann-Kathrin; Beste, Christian; Colzato, Lorenza S.			Action Video Gaming and Cognitive Control: Playing First Person Shooter Games Is Associated with Improved Action Cascading but Not Inhibition	PLOS ONE			English	Article							WORKING-MEMORY IMPAIRMENTS; GENERAL FLUID INTELLIGENCE; EXECUTIVE CONTROL SKILLS; GOAL ACTIVATION; ATTENTIONAL CAPTURE; PERFORMANCE; EXPERIENCE; ALCOHOL; MODES; TASK	There is a constantly growing interest in developing efficient methods to enhance cognitive functioning and/or to ameliorate cognitive deficits. One particular line of research focuses on the possibly cognitive enhancing effects that action video game (AVG) playing may have on game players. Interestingly, AVGs, especially first person shooter games, require gamers to develop different action control strategies to rapidly react to fast moving visual and auditory stimuli, and to flexibly adapt their behaviour to the ever-changing context. This study investigated whether and to what extent experience with such videogames is associated with enhanced performance on cognitive control tasks that require similar abilities. Experienced action videogame-players (AVGPs) and individuals with little to no videogame experience (NVGPs) performed a stop-change paradigm that provides a relatively well-established diagnostic measure of action cascading and response inhibition. Replicating previous findings, AVGPs showed higher efficiency in response execution, but not improved response inhibition (i.e. inhibitory control), as compared to NVGPs. More importantly, compared to NVGPs, AVGPs showed enhanced action cascading processes when an interruption (stop) and a change towards an alternative response were required simultaneously, as well as when such a change had to occur after the completion of the stop process. Our findings suggest that playing AVGs is associated with enhanced action cascading and multi-component behaviour without affecting inhibitory control.	[Steenbergen, Laura; Sellaro, Roberta; Colzato, Lorenza S.] Leiden Univ, Inst Psychol Res, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Stock, Ann-Kathrin; Beste, Christian] Tech Univ Dresden, Cognit Neurophysiol, Dept Child & Adolescent Psychiat, Fac Med, Dresden, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Technische Universitat Dresden	Steenbergen, L (corresponding author), Leiden Univ, Inst Psychol Res, Leiden Inst Brain & Cognit, Leiden, Netherlands.	l.steenbergen@fsw.leidenuniv.nl	Stock, Ann-Kathrin/AAT-9168-2020; Stock, Ann-Kathrin/G-9536-2019; Sellaro, Roberta/AAD-5442-2019	Stock, Ann-Kathrin/0000-0001-7113-4020; Stock, Ann-Kathrin/0000-0001-7113-4020; Sellaro, Roberta/0000-0003-2316-9936; Steenbergen, Laura/0000-0002-2659-4981; Colzato, Lorenza/0000-0003-1735-1280	Netherlands Organization for Scientific Research (NWO) [452-12-001]; Deutsche Forschungsgemeinschaft (DFG) [BE4045/10-1, BE4045/10-2]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a research grant from the Netherlands Organization for Scientific Research (NWO; www.nwo.nl) awarded to LSC (Vidi grant: # 452-12-001) and from the Deutsche Forschungsgemeinschaft (DFG; www.dfg.de) awarded to CB (#BE4045/10-1 and 10-2). The NWO and DFG had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Ambrose ML, 2001, ALCOHOL CLIN EXP RES, V25, P185, DOI 10.1111/j.1530-0277.2001.tb02197.x; Andrews G., 2006, FRONT PSYCHOL, P145, DOI DOI 10.3389/FPSYG.2014.00069; Appelbaum LG, 2013, ATTEN PERCEPT PSYCHO, V75, P1161, DOI 10.3758/s13414-013-0472-7; Bejjanki VR, 2014, P NATL ACAD SCI USA, V111, P16961, DOI 10.1073/pnas.1417056111; Beste C, 2015, BRAIN STRUCT FUNCT, V220, P1437, DOI 10.1007/s00429-014-0735-7; Beste C, 2014, NEUROIMAGE, V102, P558, DOI 10.1016/j.neuroimage.2014.08.026; Boecker M, 2013, INT J PSYCHOPHYSIOL, V87, P234, DOI 10.1016/j.ijpsycho.2012.09.009; Boot WR, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00226; Boot WR, 2008, ACTA PSYCHOL, V129, P387, DOI 10.1016/j.actpsy.2008.09.005; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bowman ND, 2013, MEDIA PSYCHOL, V16, P39, DOI 10.1080/15213269.2012.742360; Buckley D, 2010, VISION RES, V50, P548, DOI 10.1016/j.visres.2009.11.018; Cain MS, 2012, ATTEN PERCEPT PSYCHO, V74, P641, DOI 10.3758/s13414-012-0284-1; Chamberlain SR, 2006, AM J PSYCHIAT, V163, P1282, DOI 10.1176/appi.ajp.163.7.1282; Chen R, 2015, J VIS, V15, P42, DOI [10. 1167/ 15. 12. 42, DOI 10.1167/15.12.42]; Chisholm JD, 2012, ATTEN PERCEPT PSYCHO, V74, P257, DOI 10.3758/s13414-011-0253-0; Chisholm JD, 2010, ATTEN PERCEPT PSYCHO, V72, P667, DOI 10.3758/APP.72.3.667; Chmielewski WX, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00193; Colzato LS, 2008, NEUROPSYCHOLOGIA, V46, P1542, DOI 10.1016/j.neuropsychologia.2008.01.006; Colzato LS, 2014, PSYCHOL RES-PSYCH FO, V78, P670, DOI 10.1007/s00426-013-0514-8; Colzato LS, 2013, PSYCHOL RES-PSYCH FO, V77, P234, DOI 10.1007/s00426-012-0415-2; Colzato LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020602; Colzato LS, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00008; Curtin JJ, 2003, J ABNORM PSYCHOL, V112, P424, DOI 10.1037/0021-843X.112.3.424; Dippel G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7587; Donohue SE, 2010, ATTEN PERCEPT PSYCHO, V72, P1120, DOI 10.3758/APP.72.4.1120; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Dye MWG, 2009, CURR DIR PSYCHOL SCI, V18, P321, DOI 10.1111/j.1467-8721.2009.01660.x; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; Ferguson CJ, 2011, J YOUTH ADOLESCENCE, V40, P377, DOI 10.1007/s10964-010-9610-x; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; Gauggel S, 2004, J NEUROL NEUROSUR PS, V75, P539; Gazzaley A., 2013, PRINCIPLES FRONTAL L; Gouzoulis-Mayfrank E, 2000, J NEUROL NEUROSUR PS, V68, P719, DOI 10.1136/jnnp.68.6.719; Gozli DG, 2014, HUM MOVEMENT SCI, V38, P152, DOI 10.1016/j.humov.2014.09.004; Green CS, 2007, PSYCHOL SCI, V18, P88, DOI 10.1111/j.1467-9280.2007.01853.x; Green CS, 2006, COGNITION, V101, P217, DOI 10.1016/j.cognition.2005.10.004; Green CS, 2006, J EXP PSYCHOL HUMAN, V32, P1465, DOI 10.1037/0096-1523.32.6.1465; Green CS, 2015, CURR OPIN BEHAV SCI, V4, P103, DOI 10.1016/j.cobeha.2015.04.012; Green CS, 2014, PSYCHOL RES-PSYCH FO, V78, P756, DOI 10.1007/s00426-013-0535-3; Green CS, 2012, COMPUT HUM BEHAV, V28, P984, DOI 10.1016/j.chb.2011.12.020; Green CS, 2010, CURR BIOL, V20, P1573, DOI 10.1016/j.cub.2010.07.040; Green CS, 2010, TOP COGN SCI, V2, P202, DOI 10.1111/j.1756-8765.2009.01054.x; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Hubert-Wallander B, 2011, ATTEN PERCEPT PSYCHO, V73, P2399, DOI 10.3758/s13414-011-0194-7; Hubert-Wallander B, 2011, WIRES COGN SCI, V2, P222, DOI 10.1002/wcs.116; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Karle JW, 2010, ACTA PSYCHOL, V134, P70, DOI 10.1016/j.actpsy.2009.12.007; Keizer AW, 2010, INT J PSYCHOPHYSIOL, V75, P25, DOI 10.1016/j.ijpsycho.2009.10.011; Ki King G, 2002, SCREENPLAY CINEMA VI; Konrad K, CHILD NEUROPSYCHOL, V200, P286; Konrad KN, 2000, BRAIN INJURY, V14, P859; Kristjansson A, 2013, ATTEN PERCEPT PSYCHO, V75, P667, DOI 10.3758/s13414-013-0427-z; Levy R, 1994, Int Psychogeriatr, V6, P63, DOI 10.1017/S1041610294001626; Li CSR, 2009, ALCOHOL CLIN EXP RES, V33, P740, DOI 10.1111/j.1530-0277.2008.00891.x; Li RJ, 2009, NAT NEUROSCI, V12, P549, DOI 10.1038/nn.2296; Logan GD, 1997, PSYCHOL SCI, V8, P60, DOI 10.1111/j.1467-9280.1997.tb00545.x; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Logan Gordon D., 1994, P189; Martinussen R, 2005, J AM ACAD CHILD PSY, V44, P377, DOI 10.1097/01.chi.0000153228.72591.73; McCann UD, 1999, PSYCHOPHARMACOLOGY, V143, P417, DOI 10.1007/s002130050967; Mishra J, 2011, J NEUROSCI, V31, P992, DOI 10.1523/JNEUROSCI.4834-10.2011; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Muckschel M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09992; Muckschel M, 2014, CEREB CORTEX, V24, P2120, DOI 10.1093/cercor/bht066; Nakao T, 2009, J PSYCHIATR RES, V43, P784, DOI 10.1016/j.jpsychires.2008.10.013; Pohl C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00070; Raven J. C., 1998, RAVENS PROGR MATRICE; Rogers R, 2015, COMPUT HUM BEHAV, V49, P588, DOI 10.1016/j.chb.2015.03.027; Schubert T, 2012, ACTA PSYCHOL, V141, P278, DOI 10.1016/j.actpsy.2012.06.010; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sherry J. L., 2006, ANN M INT COMM ASS D; Sherry JL, INT ENCY CO IN PRESS; Spence I, 2010, REV GEN PSYCHOL, V14, P92, DOI 10.1037/a0019491; Spence I, 2009, J EXP PSYCHOL LEARN, V35, P1097, DOI 10.1037/a0015641; Steenbergen L, 2015, SCI REP-UK, V5, DOI 10.1038/srep12770; Steenbergen L, 2015, EUR NEUROPSYCHOPHARM, V25, P773, DOI 10.1016/j.euroneuro.2015.03.015; Stock AK, 2016, BRAIN STRUCT FUNCT, V221, P2767, DOI 10.1007/s00429-015-1071-2; Stock AK, 2014, J NEUROSCI, V34, P5335, DOI 10.1523/JNEUROSCI.5140-13.2014; Stock AK, 2014, ARCH TOXICOL, V88, P9, DOI 10.1007/s00204-013-1172-8; Strobach T, 2012, ACTA PSYCHOL, V140, P13, DOI 10.1016/j.actpsy.2012.02.001; Verbruggen F, 2008, J EXP PSYCHOL HUMAN, V34, P1212, DOI 10.1037/0096-1523.34.5.1212; Verhaeghen P, 2003, HEALTH PSYCHOL, V22, P559, DOI 10.1037/0278-6133.22.6.559; Verhaeghen P, 2002, NEUROSCI BIOBEHAV R, V26, P849, DOI 10.1016/S0149-7634(02)00071-4; West GL, 2008, J VISION, V8, DOI 10.1167/8.16.13; Yildiz A, 2014, PSYCHONEUROENDOCRINO, V42, P178, DOI 10.1016/j.psyneuen.2014.01.022	87	28	30	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144364	10.1371/journal.pone.0144364	http://dx.doi.org/10.1371/journal.pone.0144364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YZ	26655929	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903500023
J	Hai, X; Landeras, V; Dobre, MA; DeOreo, P; Meyer, TW; Hostetter, TH				Hai, Xin; Landeras, Veeda; Dobre, Mirela A.; DeOreo, Peter; Meyer, Timothy W.; Hostetter, Thomas H.			Mechanism of Prominent Trimethylamine Oxide (TMAO) Accumulation in Hemodialysis Patients	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; GUT MICROBIOTA; N-OXIDE; METABOLISM; UREMIA; BLOOD; UREA; PHOSPHATIDYLCHOLINE; CREATININE; SOLUTES	Large size, protein binding and intracellular sequestration are well known to limit dialytic removal of compounds. In studying the normal renal and dialytic handling of trimethylamine oxide (TMAO), a molecule associated with cardiovascular disease in the general population, we discovered two largely unrecognized additional limitations to sustained reduction of a solute by chronic hemodialysis. We measured solute levels and handling in subjects on chronic hemodialysis (ESRD, n = 7) and compared these with levels and clearance in normal controls (NLS, n = 6). The ESRD patients had much higher peak predialysis plasma levels of TMAO than NLS (77 +/- 26 vs 2 +/- 1 mu M, mean +/- SD, p<0.05). For comparison, predialysis BUN levels in ESRD subjects were 45 +/- 11 mg/dl and 15 +/- 3 mg/dl in NLS. Thus TMAO levels in ESRD average about 40 fold those in NLS while BUN is 3 fold NLS. However, the fractional reduction of TMAO concentration during dialysis, was in fact greater than that of urea (86 +/- 3 vs 74 +/- 6%, TMAO vs urea, p < 0.05) and its dialytic clearance while somewhat lower than that of urea was comparable to creatinine's. Also production rates were similar (533 +/- 272 vs 606 +/- 220 mu moles/day, ESRD vs NLS, p>0.05). However, TMAO has a volume of distribution about one half that of urea. Also in NLS the urinary clearance of TMAO was high (219 +/- 78 ml/min) compared to the urinary urea and creatinine clearances (55 +/- 14 and 119 +/- 21 ml/min, respectively). Thus, TMAO levels achieve multiples of normal much greater than those of urea due mainly to 1) TMAO's high clearance by the normal kidney relative to urea and 2) its smaller volume of distribution. Modelling suggests that only much more frequent dialysis would be required to lower levels Thus, additional strategies such as reducing production should be explored. Furthermore, using urea as the sole marker of dialysis adequacy may be misleading since a molecule, TMAO, that is dialyzed readily accumulates to much higher multiples of normal with urea based dialysis prescriptions.	[Hai, Xin; Landeras, Veeda; Dobre, Mirela A.; DeOreo, Peter; Hostetter, Thomas H.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Meyer, Timothy W.] Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA	Case Western Reserve University; Stanford University	Hostetter, TH (corresponding author), Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA.	thomas.hostetter@uhhospitals.org	Dobre, Mirela/ABC-8901-2021	Dobre, Mirela/0000-0002-9059-9998	National Institutes of Health [RO1 DK 080123]; American Heart Association [FTF 15920005]; Rosenberg Foundation of the Centers for Dialysis Care; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Rosenberg Foundation of the Centers for Dialysis Care; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health RO1 DK 080123, THH and TWM; American Heart Association FTF 15920005, MAD; Rosenberg Foundation of the Centers for Dialysis Care, THH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain MA, 2006, NEPHROL DIAL TRANSPL, V21, P1300, DOI 10.1093/ndt/gfk056; Chasis H, 1938, J CLIN INVEST, V17, P347, DOI 10.1172/JCI100959; DESCOMBES E, 1993, CLIN NEPHROL, V40, P286; Eloot S, 2009, NEPHROL DIAL TRANSPL, V24, P2225, DOI 10.1093/ndt/gfp059; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; LANGSDORF LJ, 1993, BLOOD, V81, P820; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; Meyer TW, 2007, J AM SOC NEPHROL, V18, P868, DOI 10.1681/ASN.2006080863; Meyer TW, 2014, J AM SOC NEPHROL, V25, P2151, DOI 10.1681/ASN.2013121264; Schneditz D, 2009, HEMODIAL INT, V13, P215, DOI 10.1111/j.1542-4758.2009.00351.x; Sirich TL, 2014, J AM SOC NEPHROL, V25, P615, DOI 10.1681/ASN.2013060597; Tang WHW, 2015, CIRC RES, V116, P448, DOI 10.1161/CIRCRESAHA.116.305360; Tang WHW, 2014, J CLIN INVEST, V124, P4204, DOI 10.1172/JCI72331; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Vanholder R, 2015, SEMIN DIALYSIS, V28, P114, DOI 10.1111/sdi.12331; Walther JL, 2006, KIDNEY INT, V69, P1056, DOI 10.1038/sj.ki.5000196; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922	17	57	60	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143731	10.1371/journal.pone.0143731	http://dx.doi.org/10.1371/journal.pone.0143731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650937	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903300025
J	Johnson, TW; Mumford, AD; Scott, LJ; Mundell, S; Butler, M; Strange, JW; Rogers, CA; Reeves, BC; Baumbach, A				Johnson, Thomas W.; Mumford, Andrew D.; Scott, Lauren J.; Mundell, Stuart; Butler, Mark; Strange, Julian W.; Rogers, Chris A.; Reeves, Barnaby C.; Baumbach, Andreas			A Study of Platelet Inhibition, Using a 'Point of Care' Platelet Function Test, following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction [PINPOINT-PPCI]	PLOS ONE			English	Article							CLOPIDOGREL; PRASUGREL; BIVALIRUDIN; REACTIVITY; TICAGRELOR; HEPARIN; PCI; AGGREGATION; STANDARD; THERAPY	Background Rapid coronary recanalization following ST-elevation myocardial infarction (STEMI) requires effective anti-platelet and anti-thrombotic therapies. This study tested the impact of door to end of procedure ('door-to-end') time and baseline platelet activity on platelet inhibition within 24hours post-STEMI. Methods and Findings 108 patients, treated with prasugrel and procedural bivalirudin, underwent Multiplate (R) platelet function testing at baseline, 0, 1, 2 and 24hours post-procedure. Major adverse cardiac events (MACE), bleeding and stent thrombosis (ST) were recorded. Baseline ADP activity was high (88.3U [71.8-109.0]), procedural time and consequently bivalirudin infusion duration were short (median door-to-end time 55minutes [40-70] and infusion duration 30minutes [ 20-42]). Baseline ADP was observed to influence all subsequent measurements of ADP activity, whereas door-to-end time only influenced ADP immediately post-procedure. High residual platelet reactivity (HRPR ADP>46.8U) was observed in 75% of patients immediately post-procedure and persisted in 24% of patients at 2hours. Five patients suffered in-hospital MACE (4.6%). Acute ST occurred in 4 patients, all were <120mins post-procedure and had HRPR. No significant bleeding was observed. In a post-hoc analysis, pre-procedural morphine use was associated with significantly higher ADP activity following intervention. Conclusions Baseline platelet function, time to STEMI treatment and opiate use all significantly influence immediate post-procedural platelet activity.	[Johnson, Thomas W.; Strange, Julian W.; Baumbach, Andreas] Bristol Heart Inst, Bristol, Avon, England; [Mumford, Andrew D.; Scott, Lauren J.; Mundell, Stuart; Butler, Mark; Rogers, Chris A.; Reeves, Barnaby C.] Univ Bristol, Bristol, Avon, England	University of Bristol; University of Bristol	Johnson, TW (corresponding author), Bristol Heart Inst, Bristol, Avon, England.	tom.johnson@uhbristol.nhs.uk		Strange, Julian/0000-0003-0476-0886; Mundell, Stuart/0000-0001-7754-3271; mumford, andrew/0000-0002-5523-511X; Reeves, Barnaby/0000-0002-5101-9487; Johnson, Thomas/0000-0003-4638-601X	local charitable trust (Above Beyond); Medicines Company; National Institute for Health Research (NIHR) Bristol Biomedical Research Unit in Cardiovascular Disease; British Heart Foundation [FS/09/031/27599, FS/11/49/28751] Funding Source: researchfish	local charitable trust (Above Beyond); Medicines Company; National Institute for Health Research (NIHR) Bristol Biomedical Research Unit in Cardiovascular Disease(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation)	This study was supported by a local charitable trust (Above & Beyond), The Medicines Company, and a grant from the National Institute for Health Research (NIHR) Bristol Biomedical Research Unit in Cardiovascular Disease. This paper represents independent research. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the UK Department of Health. None of the funders had any involvement in the study design; in the collection, analysis and interpretation of the data; in the writing of the report; and in the decision to submit the paper for publication.	Alexopoulos D, 2014, CIRC-CARDIOVASC INTE, V7, P233, DOI 10.1161/CIRCINTERVENTIONS.113.001118; Bhatt DL, 2013, NEW ENGL J MED, V368, P1303, DOI 10.1056/NEJMoa1300815; Bonello L, 2011, J AM COLL CARDIOL, V58, P467, DOI 10.1016/j.jacc.2011.04.017; Brandt JT, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.10.010; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Heestermans AACM, 2008, THROMB RES, V122, P776, DOI 10.1016/j.thromres.2008.01.021; Hobl EL, 2014, J AM COLL CARDIOL, V63, P630, DOI 10.1016/j.jacc.2013.10.068; Jernberg T, 2006, EUR HEART J, V27, P1166, DOI 10.1093/eurheartj/ehi877; Johnson TW, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-44; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Montalescot G, 2014, NEW ENGL J MED, V371, P1016, DOI 10.1056/NEJMoa1407024; Montalescot G, 2014, CIRCULATION, V129, P2136, DOI 10.1161/CIRCULATIONAHA.113.007524; Parodi G, 2014, EUR HEART J, V35, P1030; Parodi G, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.001593; Parodi G, 2013, J AM COLL CARDIOL, V61, P1601, DOI 10.1016/j.jacc.2013.01.024; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; RAO AK, 1988, J AM COLL CARDIOL, V11, P1; Robson R, 2000, J INVASIVE CARDIOL, P1042; Schulz KF, 2005, LANCET, V365, P1591, DOI 10.1016/S0140-6736(05)66461-6; Schulz S, 2014, EUR HEART J, V35, P2285, DOI 10.1093/eurheartj/ehu182; Schulz S, 2014, CLIN CARDIOL, V37, P270, DOI 10.1002/clc.22268; Shahzad A, 2014, LANCET, V384, P1849, DOI 10.1016/S0140-6736(14)60924-7; Sibbing D, 2008, EUR HEART J, V29, P1504, DOI 10.1093/eurheartj/ehn195; Sibbing D, 2009, J AM COLL CARDIOL, V53, P849, DOI 10.1016/j.jacc.2008.11.030; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026	27	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144984	10.1371/journal.pone.0144984	http://dx.doi.org/10.1371/journal.pone.0144984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672598	Green Published, gold, Green Submitted			2022-12-27	WOS:000366722700081
J	Ma, HL; Wang, Y; Wu, JH; Wang, BX; Guo, SC; Luo, P; Han, BX				Ma, Hailin; Wang, Yan; Wu, Jianhui; Wang, Baoxi; Guo, Shichun; Luo, Ping; Han, Buxin			Long-Term Exposure to High Altitude Affects Conflict Control in the Conflict-Resolving Stage	PLOS ONE			English	Article							DECISION-MAKING; P300; ADAPTATION; BRAIN; COMPONENTS; RESIDENCE; HYPOXIA; N200; TASK	The neurocognitive basis of the effect of long-term high altitude exposure on conflict control is unclear. Event related potentials (ERPs) were recorded in a flanker task to investigate the influence of high altitude on conflict control in the high-altitude group (who had lived at high altitude for three years but were born at low altitude) and the low-altitude group (living in low altitude only). Although altitude effect was not significant at the behavioral level, ERPs showed cognitive conflict modulation. The interaction between group and trial type was significant: P3 amplitude was greater in the low-altitude group than in the high-altitude group in the incongruent trial. This result suggests that long-term exposure to high altitude affects conflict control in the conflict-resolving stage, and that attentional resources are decreased to resist the conflict control in the high-altitude group.	[Ma, Hailin; Wang, Yan; Han, Buxin] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Ma, Hailin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ma, Hailin; Luo, Ping] Tibet Univ, Inst Educ & Psychol, Tibet, Peoples R China; [Wu, Jianhui] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Wang, Baoxi] Jiangxi Normal Univ, Sch Psychol, Key Lab Jiangxi Prov Psychol & Cognit Sci, Nanchang, Peoples R China; [Guo, Shichun] Tsinghua Univ, Dept Psychol, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tibet University; Chinese Academy of Sciences; Institute of Psychology, CAS; Jiangxi Normal University; Tsinghua University	Wang, Y (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	wangyan@psych.ac.cn			National Natural Science Foundation of China [Y2JJ081004]; Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by the National Natural Science Foundation of China (Y2JJ081004) and Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences.; This research was supported by the National Natural Science Foundation of China (Y2JJ081004) and Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences.	Beall CM, 2000, HUM BIOL, V72, P201; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brydges CR, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00080; Clayson PE, 2011, NEUROPSYCHOLOGIA, V49, P1953, DOI 10.1016/j.neuropsychologia.2011.03.023; COLES MGH, 1995, OX PSYCH S, P86; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Hayashi R, 2005, CLIN NEUROPHYSIOL, V116, P1471, DOI 10.1016/j.clinph.2005.02.020; Heil M, 2000, J PSYCHOPHYSIOL, V14, P218, DOI 10.1027//0269-8803.14.4.218; HOCHACHKA PW, 1994, J CEREBR BLOOD F MET, V14, P671, DOI 10.1038/jcbfm.1994.84; Johnstone SJ, 2009, INT J PSYCHOPHYSIOL, V72, P145, DOI 10.1016/j.ijpsycho.2008.11.007; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; Larson MJ, 2014, INT J PSYCHOPHYSIOL, V93, P283, DOI 10.1016/j.ijpsycho.2014.06.007; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Luck SJ, 2012, OXFORD HDB EVENT REL; Ma HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep11524; Mennes M, 2008, PSYCHOPHYSIOLOGY, V45, P714, DOI 10.1111/j.1469-8986.2008.00678.x; Miller J, 1998, PSYCHOPHYSIOLOGY, V35, P99, DOI 10.1111/1469-8986.3510099; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Okumura A, 2003, HIGH ALT MED BIOL, V4, P349, DOI 10.1089/152702903769192304; Pascual-Marqui R.D., 2002, JPN J CLIN NEUROPHYS, V30, P81; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Richardson C, 2011, CLIN NEUROPHYSIOL, V122, P1726, DOI 10.1016/j.clinph.2011.02.001; Rueda MR, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-39; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Singh SB, 2004, INDIAN J MED RES, V120, P94; Thakur L, 2011, INDIAN J MED RES, V134, P113; Tillman CM, 2011, PSYCHOPHYSIOLOGY, V48, P1405, DOI 10.1111/j.1469-8986.2011.01203.x; Tulek B, 2013, J SLEEP RES, V22, P422, DOI 10.1111/jsr.12038; Ulrich R, 2001, PSYCHOPHYSIOLOGY, V38, P816, DOI 10.1111/1469-8986.3850816; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Virues-Ortega J, 2011, DEVELOPMENTAL SCI, V14, P1185, DOI 10.1111/j.1467-7687.2011.01064.x; Wang BX, 2013, BRAIN RES, V1490, P161, DOI 10.1016/j.brainres.2012.10.053; Wang YQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05459; Wesensten NJ, 1993, AVIAT SPACE ENV MED; Wu TY, 2006, HIGH ALT MED BIOL, V7, P193, DOI 10.1089/ham.2006.7.193; Yan XD, 2011, BRAIN COGNITION, V77, P53, DOI 10.1016/j.bandc.2011.06.002; Yan XD, 2010, BRAIN RES, V1348, P21, DOI 10.1016/j.brainres.2010.06.024; Zubieta-Calleja G., 2010, HUMAN ADAPTATION HIG	42	11	16	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145246	10.1371/journal.pone.0145246	http://dx.doi.org/10.1371/journal.pone.0145246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671280	gold, Green Published, Green Submitted			2022-12-27	WOS:000366719300057
J	Olsson, E; Winter, C; George, A; Chen, YL; Torngren, T; Bendahl, PO; Borg, A; Gruvberger-Saal, SK; Saal, LH				Olsson, Eleonor; Winter, Christof; George, Anthony; Chen, Yilun; Torngren, Therese; Bendahl, Par-Ola; Borg, Ake; Gruvberger-Saal, Sofia K.; Saal, Lao H.			Mutation Screening of 1,237 Cancer Genes across Six Model Cell Lines of Basal-Like Breast Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; DNA-SEQUENCING DATA; MOLECULAR PORTRAITS; COLORECTAL CANCERS; TUMOR-SUPPRESSOR; CARCINOMAS; PHENOTYPE; FRAMEWORK; PATTERNS; GENOMES	Basal-like breast cancer is an aggressive subtype generally characterized as poor prognosis and lacking the expression of the three most important clinical biomarkers, estrogen receptor, progesterone receptor, and HER2. Cell lines serve as useful model systems to study cancer biology in vitro and in vivo. We performed mutational profiling of six basal-like breast cancer cell lines (HCC38, HCC1143, HCC1187, HCC1395, HCC1954, and HCC1937) and their matched normal lymphocyte DNA using targeted capture and next-generation sequencing of 1,237 cancer-associated genes, including all exons, UTRs and upstream flanking regions. In total, 658 somatic variants were identified, of which 378 were non-silent (average 63 per cell line, range 37-146) and 315 were novel (not present in the Catalogue of Somatic Mutations in Cancer database; COSMIC). 125 novel mutations were confirmed by Sanger sequencing (59 exonic, 48 3'UTR and 10 5'UTR, 1 splicing), with a validation rate of 94% of high confidence variants. Of 36 mutations previously reported for these cell lines but not detected in our exome data, 36% could not be detected by Sanger sequencing. The base replacements C/G>A/T, C/G>G/C, C/G>T/A and A/T>G/C were significantly more frequent in the coding regions compared to the non-coding regions (OR 3.2, 95% CI 2.0-5.3, P<0.0001; OR 4.3, 95% CI 2.9-6.6, P<0.0001; OR 2.4, 95% CI 1.8-3.1, P<0.0001; OR 1.8, 95% CI 1.2-2.7, P = 0.024, respectively). The single nucleotide variants within the context of T[C] T/A[G] A and T[C] A/T[G] A were more frequent in the coding than in the non-coding regions (OR 3.7, 95% CI 2.2-6.1, P<0.0001; OR 3.8, 95% CI 2.0-7.2, P = 0.001, respectively). Copy number estimations were derived from the targeted regions and correlated well to Affymetrix SNP array copy number data (Pearson correlation 0.82 to 0.96 for all compared cell lines; P<0.0001). These mutation calls across 1,237 cancer-associated genes and identification of novel variants will aid in the design and interpretation of biological experiments using these six basal-like breast cancer cell lines.	[Olsson, Eleonor; Winter, Christof; George, Anthony; Chen, Yilun; Torngren, Therese; Bendahl, Par-Ola; Borg, Ake; Gruvberger-Saal, Sofia K.; Saal, Lao H.] Lund Univ, Dept Clin Sci, Div Oncol & Pathol, Lund, Sweden; [Olsson, Eleonor; Winter, Christof; George, Anthony; Chen, Yilun; Torngren, Therese; Borg, Ake; Gruvberger-Saal, Sofia K.; Saal, Lao H.] Lund Univ, Ctr Canc, Lund, Sweden; [Borg, Ake; Saal, Lao H.] Lund Univ, CREATE Hlth Strateg Ctr Translat Canc Res, Lund, Sweden	Lund University; Lund University; Lund University	Saal, LH (corresponding author), Lund Univ, Dept Clin Sci, Div Oncol & Pathol, Lund, Sweden.	lao.saal@med.lu.se	Winter, Christof/A-1887-2011; Olsson, Eleonor/AAF-1733-2020; Saal, Lao H/A-2919-2011; Winter, Christof/AAF-1860-2020	Winter, Christof/0000-0002-0253-9056; Saal, Lao H/0000-0002-0815-1896; Winter, Christof/0000-0002-0253-9056	Swedish Research Council; Swedish Cancer Society; Governmental Funding of Clinical Research within National Health Service; Crafoord Foundation; Mrs. Berta Kamprad Foundation; Lund University Medical Faculty; Gunnar Nilsson Cancer Foundation; Skane University Hospital Foundation; BioCARE Research Program; King Gustav Vth Jubilee Foundation; Krapperup Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Governmental Funding of Clinical Research within National Health Service; Crafoord Foundation; Mrs. Berta Kamprad Foundation; Lund University Medical Faculty; Gunnar Nilsson Cancer Foundation; Skane University Hospital Foundation; BioCARE Research Program; King Gustav Vth Jubilee Foundation; Krapperup Foundation	This study was funded by the Swedish Research Council, Swedish Cancer Society, Governmental Funding of Clinical Research within National Health Service, Crafoord Foundation, Mrs. Berta Kamprad Foundation, Lund University Medical Faculty, Gunnar Nilsson Cancer Foundation, Skane University Hospital Foundation, BioCARE Research Program, King Gustav Vth Jubilee Foundation, and the Krapperup Foundation. The funders had no role in study design, data gathering, data analysis, data interpretation, decision to publish, or writing of the report.	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Antoniou AC, 2014, NEW ENGL J MED, V371, P497, DOI [10.1056/NEJMoa1400382, 10.1056/NEJMc1410673]; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Da Silva L, 2007, J CLIN PATHOL, V60, P1328, DOI 10.1136/jcp.2006.041731; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ferlay J, 2012, INT J CANC; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Friebel TM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju091; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Galante PAF, 2011, NUCLEIC ACIDS RES, V39, P6056, DOI 10.1093/nar/gkr221; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hakansson S, 1997, AM J HUM GENET, V60, P1068; Han JX, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2875; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Hu Z, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2487; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2012, BIOINFORMATICS, V28, P1307, DOI 10.1093/bioinformatics/bts146; Li ST, 2013, GENOME RES, V23, P195, DOI 10.1101/gr.132480.111; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Lobry C, 2014, BLOOD, V123, P2451, DOI 10.1182/blood-2013-08-355818; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wistuba II, 1998, CLIN CANCER RES, V4, P2931; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231	54	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144528	10.1371/journal.pone.0144528	http://dx.doi.org/10.1371/journal.pone.0144528			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670335	Green Published, Green Submitted, gold			2022-12-27	WOS:000366719300010
J	Sujkowski, A; Rainier, S; Fink, JK; Wessells, RJ				Sujkowski, Alyson; Rainier, Shirley; Fink, John K.; Wessells, Robert J.			Delayed Induction of Human NTE (PNPLA6) Rescues Neurodegeneration and Mobility Defects of Drosophila swiss cheese (sws) Mutants	PLOS ONE			English	Article							NEUROPATHY TARGET ESTERASE; MUTATIONS; PHOSPHATIDYLCHOLINE; DEGENERATION; FAILURE; DECLINE; FORMS	Human PNPLA6 gene encodes Neuropathy Target Esterase protein (NTE). PNPLA6 gene mutations cause hereditary spastic paraplegia (SPG39 HSP), Gordon-Holmes syndrome, Boucher-Neuhauser syndromes, Laurence-Moon syndrome, and Oliver-McFarlane syndrome. Mutations in the Drosophila NTE homolog swiss cheese (sws) cause early-onset, progressive behavioral defects and neurodegeneration characterized by vacuole formation. We investigated sws(5) flies and show for the first time that this allele causes progressive vacuolar formation in the brain and progressive deterioration of negative geotaxis speed and endurance. We demonstrate that inducible, neuron-specific expression of full-length human wildtype NTE reduces vacuole formation and substantially rescues mobility. Indeed, neuron-specific expression of wildtype human NTE is capable of rescuing mobility defects after 10 days of adult life at 29 degrees C, when significant degeneration has already occurred, and significantly extends longevity of mutants at 25 degrees C. These results raise the exciting possibility that late induction of NTE function may reduce or ameliorate neurodegeneration in humans even after symptoms begin. In addition, these results highlight the utility of negative geotaxis endurance as a new assay for longitudinal tracking of degenerative phenotypes in Drosophila.	[Sujkowski, Alyson; Wessells, Robert J.] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Rainier, Shirley; Fink, John K.] Univ Michigan, Dept Neurol, Sch Med, Ann Arbor, MI 48109 USA; [Fink, John K.] Ann Arbor Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Ann Arbor, MI USA	Wayne State University; University of Michigan System; University of Michigan; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Fink, JK (corresponding author), Univ Michigan, Dept Neurol, Sch Med, Ann Arbor, MI 48109 USA.	jkfink@umich.edu; rwessell@med.wayne.edu	Wessells, Robert/AAG-3406-2020	Sujkowski, Alyson/0000-0002-9909-9279; Wessells, Robert/0000-0002-4516-3183	National Institutes of Health [R01 NS069700]; Department of Veterans Affairs (Merit Review Award); Spastic Paraplegia Foundation; Geriatric Research, Education, and Clinical Center; Ann Arbor Veterans Affairs Medical Center; Wayne State Department of Physiology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069700] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs (Merit Review Award)(US Department of Veterans Affairs); Spastic Paraplegia Foundation; Geriatric Research, Education, and Clinical Center; Ann Arbor Veterans Affairs Medical Center; Wayne State Department of Physiology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This investigation was supported by grants (to JKF) from the National Institutes of Health (R01 NS069700), Department of Veterans Affairs (Merit Review Award), the Spastic Paraplegia Foundation; the Geriatric Research, Education, and Clinical Center, Ann Arbor Veterans Affairs Medical Center, the Paul and Lois Katzman Family, and the generous contributions of private individuals and families and by support (to RJW) from the Wayne State Department of Physiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P5075, DOI 10.1073/pnas.0401030101; Barone MC, 2013, JOVE-J VIS EXP, DOI 10.3791/50339; Bazzell B, 2013, J EXP BIOL, V216, P859, DOI 10.1242/jeb.078758; da Cruz AB, 2008, J NEUROSCI, V28, P10885, DOI 10.1523/JNEUROSCI.3015-08.2008; Fink JK, 2002, NEUROL CLIN, V20, P711, DOI 10.1016/S0733-8619(02)00007-5; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Hein ND, 2010, TOXICOL LETT, V199, P1, DOI 10.1016/j.toxlet.2010.06.020; Hufnagel RB, 2015, J MED GENET, V52, P85, DOI 10.1136/jmedgenet-2014-102856; Kim M, 2013, AUTOPHAGY, V9, P1201, DOI 10.4161/auto.24811; Kmoch S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6614; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Kretzschmar Doris, 2005, Invertebrate Neuroscience, V5, P97, DOI 10.1007/s10158-005-0005-8; Makhaeva GF, 2010, CHEM-BIOL INTERACT, V187, P177, DOI 10.1016/j.cbi.2009.12.018; Makhaeva GF, 2014, J APPL TOXICOL, V34, P1426, DOI 10.1002/jat.2977; Moser M, 2004, MOL CELL BIOL, V24, P1667, DOI 10.1128/MCB.24.4.1667-1679.2004; Muhlig-Versen M, 2005, J NEUROSCI, V25, P2865, DOI 10.1523/JNEUROSCI.5097-04.2005; Petersen AJ, 2012, P NATL ACAD SCI USA, V109, pE656, DOI 10.1073/pnas.1110470109; Piazza N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005886; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Synofzik M, 2014, BRAIN, V137, P69, DOI 10.1093/brain/awt326; Tinkerhess MJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3786; Tinkerhess MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031633; Topaloglu AK, 2014, J CLIN ENDOCR METAB, V99, pE2067, DOI 10.1210/jc.2014-1836; Tsou WL, 2015, NEUROBIOL DIS, V82, P12, DOI 10.1016/j.nbd.2015.05.010; VILANOVA E, 1993, CHEM-BIOL INTERACT, V87, P369, DOI 10.1016/0009-2797(93)90065-7; Wentzell JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087526; Zaccheo O, 2004, J BIOL CHEM, V279, P24024, DOI 10.1074/jbc.M400830200; Zhang S, 2009, DIS MODEL MECH, V2, P247, DOI 10.1242/dmm.000653	29	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145356	10.1371/journal.pone.0145356	http://dx.doi.org/10.1371/journal.pone.0145356			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671664	gold, Green Submitted, Green Published			2022-12-27	WOS:000366719300060
J	Bernardo, BC; Sapra, G; Patterson, NL; Cemerlang, N; Kiriazis, H; Ueyama, T; Febbraio, MA; McMullen, JR				Bernardo, Bianca C.; Sapra, Geeta; Patterson, Natalie L.; Cemerlang, Nelly; Kiriazis, Helen; Ueyama, Tomomi; Febbraio, Mark A.; McMullen, Julie R.			Long-Term Overexpression of Hsp70 Does Not Protect against Cardiac Dysfunction and Adverse Remodeling in a MURC Transgenic Mouse Model with Chronic Heart Failure and Atrial Fibrillation	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; SHOCK-PROTEIN; IN-VIVO; HEAT-SHOCK-PROTEIN-70; GENE; SIZE; CARDIOPROTECTION; HYPERTROPHY; ASSOCIATION; MYOCARDIUM	Previous animal studies had shown that increasing heat shock protein 70 (Hsp70) using a transgenic, gene therapy or pharmacological approach provided cardiac protection in models of acute cardiac stress. Furthermore, clinical studies had reported associations between Hsp70 levels and protection against atrial fibrillation (AF). AF is the most common cardiac arrhythmia presenting in cardiology clinics and is associated with increased rates of heart failure and stroke. Improved therapies for AF and heart failure are urgently required. Despite promising observations in animal studies which targeted Hsp70, we recently reported that increasing Hsp70 was unable to attenuate cardiac dysfunction and pathology in a mouse model which develops heart failure and intermittent AF. Given our somewhat unexpected finding and the extensive literature suggesting Hsp70 provides cardiac protection, it was considered important to assess whether Hsp70 could provide protection in another mouse model of heart failure and AF. The aim of the current study was to determine whether increasing Hsp70 could attenuate adverse cardiac remodeling, cardiac dysfunction and episodes of arrhythmia in a mouse model of heart failure and AF due to overexpression of Muscle-Restricted Coiled-Coil (MURC). Cardiac function and pathology were assessed in mice at approximately 12 months of age. We report here, that chronic overexpression of Hsp70 was unable to provide protection against cardiac dysfunction, conduction abnormalities, fibrosis or characteristic molecular markers of the failing heart. In summary, elevated Hsp70 may provide protection in acute cardiac stress settings, but appears insufficient to protect the heart under chronic cardiac disease conditions.	[Bernardo, Bianca C.; Sapra, Geeta; Patterson, Natalie L.; Cemerlang, Nelly; Kiriazis, Helen; Febbraio, Mark A.; McMullen, Julie R.] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Ueyama, Tomomi] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiovasc Med, Kyoto 6028566, Japan; [Febbraio, Mark A.] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia	Baker Heart and Diabetes Institute; Kyoto Prefectural University of Medicine; Garvan Institute of Medical Research; St Vincents Hospital Sydney	McMullen, JR (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia.	julie.mcmullen@bakeridi.edu.au	Febbraio, Mark/AAE-9632-2019	Bernardo, Bianca Christine/0000-0002-4534-0549; Febbraio, Mark/0000-0002-9296-4418	National Health and Medical Research Council (NHMRC) [1008682]; Victorian Government's Operational Infrastructure Support Program; NHMRC Research Fellows [1021168-SPRF, 586604, 1078985-SRF]; Australia Research Council Future Fellowship [FT0001657]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; NHMRC Research Fellows(National Health and Medical Research Council (NHMRC) of Australia); Australia Research Council Future Fellowship(Australian Research Council)	This study was funded by a National Health and Medical Research Council (NHMRC) Project Grant (1008682 to JRM) and supported in part by the Victorian Government's Operational Infrastructure Support Program. MAF and JRM are NHMRC Research Fellows (IDs 1021168-PRF and 586604 & 1078985-SRF). JRM was also supported by an Australia Research Council Future Fellowship (FT0001657).; This study was funded by a National Health and Medical Research Council (NHMRC) Project Grant (1008682 to JRM) and supported in part by the Victorian Government's Operational Infrastructure Support Program. M.A.F. and J.R.M. are NHMRC Research Fellows (IDs 1021168-SPRF and 586604 & 1078985-SRF). J.R.M. was also supported by an Australia Research Council Future Fellowship (FT0001657). We thank Yow Keat Tham (Baker IDI) for technical assistance.	Afzal AR, 2008, CARDIOLOGY, V110, P45, DOI 10.1159/000109406; ANGELIDIS CE, 1996, TRANSGENICS, V2, P111; Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117; Bernardo BC, 2012, DRUG DISCOV TODAY TH, V9, pe163, DOI [10.1016/j.ddstr.2013.10.001, DOI 10.1016/J.DDSTR.2013.10.001]; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Boengler K, 2009, CARDIOVASC RES, V83, P247, DOI 10.1093/cvr/cvp033; Bristow MR, 2013, JACC-HEART FAIL, V1, P29, DOI 10.1016/j.jchf.2012.10.001; Brundel BJJM, 2006, CIRC RES, V99, P1394, DOI 10.1161/01.RES.0000252323.83137.fe; Brundel BJJM, 2006, J MOL CELL CARDIOL, V41, P555, DOI 10.1016/j.yjmcc.2006.06.068; Chang YWE, 2006, CANCER RES, V66, P11700, DOI 10.1158/0008-5472.CAN-06-1818; CURRIE RW, 1988, CIRC RES, V63, P543, DOI 10.1161/01.RES.63.3.543; Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hutchinson KR, 2010, J MOL CELL CARDIOL, V48, P564, DOI 10.1016/j.yjmcc.2009.06.001; Hutter JJ, 1996, CIRCULATION, V94, P1408, DOI 10.1161/01.CIR.94.6.1408; Kumar S, 2012, PROG BIOPHYS MOL BIO, V110, P278, DOI 10.1016/j.pbiomolbio.2012.07.011; Lanters EAH, 2015, NETH HEART J, V23, P327, DOI 10.1007/s12471-015-0699-0; Mandal K, 2005, ANN THORAC SURG, V79, P865, DOI 10.1016/j.athoracsur.2004.08.018; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; Mirkes PE, 1999, DEV DYNAM, V214, P159, DOI 10.1002/(SICI)1097-0177(199902)214:2<159::AID-AJA6>3.0.CO;2-Y; Naka KK, 2014, CELL STRESS CHAPERON, V19, P853, DOI 10.1007/s12192-014-0509-4; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; NITTA Y, 1994, AM J PHYSIOL-HEART C, V267, pH1795, DOI 10.1152/ajpheart.1994.267.5.H1795; Ogata T, 2008, MOL CELL BIOL, V28, P3424, DOI 10.1128/MCB.02186-07; Okubo S, 2001, CIRCULATION, V103, P877, DOI 10.1161/01.CIR.103.6.877; PLUMIER JCL, 1995, J CLIN INVEST, V95, P1854, DOI 10.1172/JCI117865; Radford NB, 1996, P NATL ACAD SCI USA, V93, P2339, DOI 10.1073/pnas.93.6.2339; Rienstra M, 2013, JACC-HEART FAIL, V1, P21, DOI 10.1016/j.jchf.2012.09.002; Sah VP, 1999, J CLIN INVEST, V103, P1627, DOI 10.1172/JCI6842; Sakabe M, 2008, CARDIOVASC RES, V78, P63, DOI 10.1093/cvr/cvn019; Sapra G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6705; Schafler AE, 2002, BASIC RES CARDIOL, V97, P258, DOI 10.1007/s003950200019; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Soti C, 2005, BRIT J PHARMACOL, V146, P769, DOI 10.1038/sj.bjp.0706396; St Rammos K, 2002, CARDIOVASC SURG, V10, P228; Suzuki K, 1997, J CLIN INVEST, V99, P1645, DOI 10.1172/JCI119327; Suzuki K, 2002, CIRCULATION, V106, pI270, DOI 10.1161/01.cir.0000032880.55215.92; Tham YK, 2015, ARCH TOXICOL, V89, P1401, DOI 10.1007/s00204-015-1477-x; Trost SU, 1998, J CLIN INVEST, V101, P855, DOI 10.1172/JCI265; Turner JG, 2007, J AM ASSOC LAB ANIM, V46, P10; Weeks KL, 2012, CIRC-HEART FAIL, V5, P523, DOI 10.1161/CIRCHEARTFAILURE.112.966622; WELCH WJ, 1992, PHYSIOL REV, V72, P1063, DOI 10.1152/physrev.1992.72.4.1063; Willis MS, 2013, NEW ENGL J MED, V368, P455, DOI 10.1056/NEJMra1106180; Willis MS, 2010, CIRCULATION, V122, P1740, DOI 10.1161/CIRCULATIONAHA.110.942250; Yamamoto S, 2003, J CLIN INVEST, V111, P1463, DOI 10.1172/JCI200317459; Yang M, 2007, CELL STRESS CHAPERON, V12, P142, DOI 10.1379/CSC-253R.1	46	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145173	10.1371/journal.pone.0145173	http://dx.doi.org/10.1371/journal.pone.0145173			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660322	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900190
J	Braun, M; Starkbaum, J; Dabrock, P				Braun, Matthias; Starkbaum, Johannes; Dabrock, Peter			Safe and Sound? Scientists' Understandings of Public Engagement in Emerging Biotechnologies	PLOS ONE			English	Article							SCIENCE	Science communication is a widely debated issue, particularly in the field of biotechnology. However, the views on the interface between science and society held by scientists who work in the field of emerging biotechnologies are currently insufficiently explored. Therefore filling this gap is one of the urgent desiderata in the further development of a dialogue-oriented model of science-public interaction. Against this background, this article addresses two main questions: (1) How do the persons who work in the field of science perceive the public and its involvement in science? (2) What preferred modes of communication are stressed by those scientists? This research is based on a set of interviews with full professors from the field of biotechnology with a special focus on synthetic biology. The results show that scientists perceive the public as holding a primarily risk-focused view of science. On the one hand, different forms of science communication are thereby either seen as a chance to improve the public acceptance of science in general and one field of research in particular. On the other hand, the exchange with the public is seen as a duty because the whole of society is affected by scientific innovation. Yet, some of the stakeholders' views discussed here conflict with debates on public engagement in technological innovation.	[Braun, Matthias; Dabrock, Peter] Univ Erlangen Nurnberg, Dept Systemat Theol Eth 2, D-91054 Erlangen, Germany; [Starkbaum, Johannes] Univ Vienna, Dept Sociol, Vienna, Austria	University of Erlangen Nuremberg; University of Vienna	Braun, M (corresponding author), Univ Erlangen Nurnberg, Dept Systemat Theol Eth 2, D-91054 Erlangen, Germany.	matthias.braun@fau.de		Starkbaum, Johannes/0000-0003-2514-3289; Braun, Matthias/0000-0002-6687-6027	Federal Ministry of Education and Research [031A359J]; Max-Planck-Society [031A359J]; Emerging Field Initiative of the Friedrich-Alexander-University Erlangen-Nurnberg	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Emerging Field Initiative of the Friedrich-Alexander-University Erlangen-Nurnberg	This work is part of Cluster D (grant number: 031A359J) of the MaxSynBio-Consortium which is jointly funded by the Federal Ministry of Education and Research and the Max-Planck-Society as well as part of the Emerging Field Initiative of the Friedrich-Alexander-University Erlangen-Nurnberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URLs: Federal Ministry of Education and Research: http://www.bmbf.de/en/index.php. Max-Planck-Society: http://www.mpg.de/en.Friedrich-Alexander-University Erlangen-Nurnberg: https://www.fau.eu.	Acatech, 2012, PERSP BIOT COMM CONT; [Anonymous], 2012, PRINC OV SYNTH BIOL; Bauer MW, 2011, PUBLIC UNDERST SCI, V20, P3, DOI 10.1177/0963662510394457; Bogner A, 2009, RES METHODS SER, P1; Brossard D, 2010, NEW AGENDAS COMMUN, P11; Bryman A., 2012, SOCIAL RES METHODS, DOI DOI 10.1007/978-1-349-21149-4_10; Davies SR, 2008, SCI COMMUN, V29, P413, DOI 10.1177/1075547008316222; Epstein Steven., 1996, IMPURE SCI; European Commission, 2011, REPORT; European Commission, 2012, GREEN PAP CIT SCI EU; FISCHER Frank, 2012, ARGUMENTATIVE TURN R; Froschauer U., 2003, QUALITATIVE INTERVIE; Gaskell G., 2010, EUROPEANS BIOTECHNOL, DOI DOI 10.2777/23393; Habermas J., 1985, THEORIE KOMMUNIKATIV; Hansen J, 2010, BIOTECHNOLOGY AND PUBLIC ENGAGEMENT IN EUROPE, P1, DOI 10.1057/9780230277502; House of Lords Select Committee on Science and Technology, 2000, SCI SOC; Institut fur Demoskopie Allensbach and Leopoldina German National Academy of Sciences, 2015, 3 I DEM ALL LEOP GER; Irwin A, 2014, PUBLIC ENGAGEMENT SC; Macnaghten P., 2015, J ENVIRON POL PLAN; Marris C, 2001, PUBLIC PERCEPTIONS A; Mayring P, 2014, QUALITATIVE CONTENT; Metcalfe J., 2014, 13 INT PUBL COMM SCI; Meuser M, 2009, RES METHODS SER, P17; Nuffield Council on Bioethics, 2012, EM BIOT TECHN CHOIC; Obama B, 2013, OPEN GOVT PARTNERSHI; Pauwels E, 2013, BIOSCIENCE, V63, P79, DOI 10.1525/bio.2013.63.2.4; Pauwels Eleonore, 2009, Syst Synth Biol, V3, P37, DOI 10.1007/s11693-009-9035-6; Pew Research Center, 2015, PUBL SCIENT VIEWS SC; Poliakoff E, 2007, SCI COMMUN, V29, P242, DOI 10.1177/1075547007308009; Prainsack B, 2014, THEOR TECH SOC, P147; The Royal Society of London, 2006, SCI COMM EXC SURV FA; van Est R, 2011, SCI ENG ETHICS, V17, P639, DOI 10.1007/s11948-011-9296-9; Wilsdon J., 2004, SEE THROUGH SCI WHY; Witzel A., 2000, FORUM QUALITATIVE SO, V1, DOI DOI 10.17169/FQS-1.1.1132; Wynne B., 1996, RISK ENV MODERNITY N, P44, DOI DOI 10.4135/9781446221983.N3	35	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145033	10.1371/journal.pone.0145033	http://dx.doi.org/10.1371/journal.pone.0145033			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660160	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900173
J	Yokoyama, Y; Miyagi, T; Hikita, H; Yoshioka, T; Mukai, K; Nawa, T; Sakamori, R; Ohkawa, K; Hiramatsu, N; Takahashi, T; Suemizu, H; Ryo, A; Tatsumi, T; Takehara, T				Yokoyama, Yoshinobu; Miyagi, Takuya; Hikita, Hayato; Yoshioka, Teppei; Mukai, Kaori; Nawa, Takatoshi; Sakamori, Ryotaro; Ohkawa, Kazuyoshi; Hiramatsu, Naoki; Takahashi, Takeshi; Suemizu, Hiroshi; Ryo, Akihide; Tatsumi, Tomohide; Takehara, Tetsuo			The Hepatitis B Virus Genotype Affects the Persistence of Viral Replication in Immunodeficient NOG Mice	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; MOUSE MODEL; X PROTEIN; HBV INFECTION; 2 SUBGROUPS; CELL-DEATH; DNA; HEPATOCYTES; JAPAN; EXPRESSION	Background & Aims At least eight genotypes of Hepatitis B virus (HBV) have been identified. HBV genotype C is the most common genotype in Japan, although the incidence of HBV genotype A is increasing. The reason underlying the differences in viral multiplication of the HBV genotypes is unclear, especially in vivo. The purpose of this study was to elucidate the differences in HBV load and the persistence of viremia in vivo between genotypes A and C. Methods Immunodeficient NOG mice were transfected by hydrodynamic injection with the HBV expression plasmids pHBA1.2 or pHBC1.2, which contain overlength (1.2-mer) copies of the genomes of HBV genotype A or C, respectively. Results One day after transfection, the number of HBcAg-positive hepatocytes and serum HBV DNA levels were similar between mice transfected with pHBA1.2 and pHBC1.2. Serum levels of HBV DNA, HBsAg and HBeAg in mice transfected with pHBA1.2 were maintained over 5 months. In contrast, those in mice with pHBC1.2 gradually decreased over time and reached undetectable levels within 3 months after transfection. HBcAg-stained hepatocytes were detected in mice transfected with pHBA1.2, but not pHBC1.2, 5 months post-transfection. Double-staining immunohistochemistry revealed that the number of cleaved caspase3- stained, HBcAg-positive hepatocytes in the pHBC1.2-transfected mice was higher than in the pHBA1.2-transfected mice 3 days post-transfection. Moreover, the plasmid DNA and covalently closed circular DNA levels were decreased in the livers of pHBC1.2-transfected mice. These results suggested that hepatocytes expressing HBV genotype C were eliminated by apoptosis in the absence of immune cells more often than in hepatocytes expressing HBV genotype A. Conclusions Immunodeficient mice transfected with HBV genotype A develop persistent viremia, whereas those transfected with HBV genotype C exhibit transient viremia accompanied by apoptosis of HBV-expressing hepatocytes. This differences may affect the clinical courses of patients infected with HBV genotypes A and C.	[Yokoyama, Yoshinobu; Miyagi, Takuya; Hikita, Hayato; Yoshioka, Teppei; Mukai, Kaori; Nawa, Takatoshi; Sakamori, Ryotaro; Ohkawa, Kazuyoshi; Hiramatsu, Naoki; Tatsumi, Tomohide; Takehara, Tetsuo] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka, Japan; [Takahashi, Takeshi; Suemizu, Hiroshi] Cent Inst Expt Anim, Lab Anim Res Dept, Kawasaki, Kanagawa, Japan; [Ryo, Akihide] Yokohama City Univ, Sch Med, Dept Microbiol, Yokohama, Kanagawa 232, Japan	Osaka University; Yokohama City University	Takehara, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka, Japan.	takehara@gh.med.osaka-u.ac.jp	Sakamori, Ryotaro/B-4406-2014	Sakamori, Ryotaro/0000-0002-1580-607X; Suemizu, Hiroshi/0000-0002-3706-2454	Ministry of Health, Labour and Welfare of Japan; Japan Agency for Medical Research and development	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and development(Japan Agency for Medical Research and Development (AMED))	This work was supported by a Grant-in-Aid for Research Program on Hepatitis from the Ministry of Health, Labour and Welfare of Japan, and Japan Agency for Medical Research and development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 1999, J CLIN MICROBIOL, V37, P2899, DOI 10.1128/JCM.37.9.2899-2903.1999; Busca A, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-22; Chan HLY, 2005, J INFECT DIS, V191, P2022, DOI 10.1086/430324; Chisari FV, 2010, PATHOL BIOL, V58, P258, DOI 10.1016/j.patbio.2009.11.001; Clippinger AJ, 2009, J VIROL, V83, P4718, DOI 10.1128/JVI.02590-08; Du J, 2009, CELL DEATH DIFFER, V16, P219, DOI 10.1038/cdd.2008.144; Ebert G, 2015, P NATL ACAD SCI USA, V112, P5803, DOI 10.1073/pnas.1502400112; Ebert G, 2015, P NATL ACAD SCI USA, V112, P5797, DOI 10.1073/pnas.1502390112; FUJIYAMA A, 1983, NUCLEIC ACIDS RES, V11, P4601, DOI 10.1093/nar/11.13.4601; Fung SK, 2004, HEPATOLOGY, V40, P790, DOI 10.1002/hep.20455; Han QJ, 2013, SEMIN IMMUNOPATHOL, V35, P23, DOI 10.1007/s00281-012-0331-y; Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042; Hikita H, 2009, HEPATOLOGY, V50, P1217, DOI 10.1002/hep.23126; Huy TTT, 2004, J GEN VIROL, V85, P283, DOI 10.1099/vir.0.19633-0; Ito K, 2016, J GASTROEN HEPATOL, V31, P180, DOI 10.1111/jgh.13030; Ito K, 2014, HEPATOLOGY, V59, P89, DOI 10.1002/hep.26635; Ito K, 2009, J VIROL, V83, P3507, DOI 10.1128/JVI.02348-08; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Kobayashi M, 2008, J MED VIROL, V80, P1880, DOI 10.1002/jmv.21309; Liang XH, 2008, BIOCHEM BIOPH RES CO, V369, P456, DOI 10.1016/j.bbrc.2008.02.035; Liang XH, 2007, APOPTOSIS, V12, P1827, DOI 10.1007/s10495-007-0114-4; Lu YW, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-117; Lucifora J, 2010, HEPATOLOGY, V51, P63, DOI 10.1002/hep.23230; Matsuura K, 2009, J CLIN MICROBIOL, V47, P1476, DOI 10.1128/JCM.02081-08; Rawat S, 2012, VIRUSES-BASEL, V4, P2945, DOI 10.3390/v4112945; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Rojas MD, 2014, J MED VIROL, V86, P496, DOI 10.1002/jmv.23859; Sugiyama M, 2006, HEPATOLOGY, V44, P915, DOI 10.1002/hep.21345; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V300, P784, DOI 10.1016/S0006-291X(02)02889-9; Takada S, 1999, ONCOGENE, V18, P6965, DOI 10.1038/sj.onc.1203188; Takehara T, 2006, J HEPATOL, V44, P267, DOI 10.1016/j.jhep.2005.07.030; Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019; Tamada Y, 2012, GUT, V61, P765, DOI 10.1136/gutjnl-2011-300832; Tanaka J, 2011, INTERVIROLOGY, V54, P185, DOI 10.1159/000324525; Tanaka Y, 2005, HEPATOL RES, V33, P216, DOI 10.1016/j.hepres.2005.08.006; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Yang PL, 2010, P NATL ACAD SCI USA, V107, P798, DOI 10.1073/pnas.0913498107	37	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144775	10.1371/journal.pone.0144775	http://dx.doi.org/10.1371/journal.pone.0144775			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658490	gold, Green Submitted, Green Published			2022-12-27	WOS:000366715900104
J	Zhu, CH; Schwarz, P; Abakumova, I; Aguzzi, A				Zhu, Caihong; Schwarz, Petra; Abakumova, Irina; Aguzzi, Adriano			Unaltered Prion Pathogenesis in a Mouse Model of High-Fat Diet-Induced Insulin Resistance	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; GROWTH-FACTOR EXPRESSION; PRP KNOCKOUT MICE; ALZHEIMERS-DISEASE; INTRANASAL INSULIN; AMYLOID-BETA; IMPROVES COGNITION; DIABETES-MELLITUS; GLUCOSE-TOLERANCE; TRUNCATED PRP	Epidemiological, clinical, and experimental animal studies suggest a strong correlation between insulin resistance and Alzheimer's disease. In fact, type-2 diabetes is considered an important risk factor of developing Alzheimer's disease. In addition, impaired insulin signaling in the Alzheimer's disease brain may promote A beta production, impair A beta clearance and induce tau hyperphosphorylation, thereby leading to deterioration of the disease. The pathological prion protein, PrPSc, deposits in the form of extracellular aggregates and leads to dementia, raising the question as to whether prion pathogenesis may also be affected by insulin resistance. We therefore established high-fat diet-induced insulin resistance in tga20 mice, which overexpress the prion protein. We then inoculated the insulin-resistant mice with prions. We found that insulin resistance in tga20 mice did not affect prion disease progression, PrPSc deposition, astrogliosis or microglial activation, and had no effect on survival. Our study demonstrates that in a mouse model, insulin resistance does not significantly contribute to prion pathogenesis.	[Zhu, Caihong; Schwarz, Petra; Abakumova, Irina; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch		Aguzzi, Adriano/0000-0002-0344-6708	Advanced Grant of the European Research Council (ERC) [250356]; European Union (PRIORITY, NEURINOX); Swiss National Foundation (SNF, including a Sinergia grant); Swiss Initiative in Systems Biology, SystemsX.ch (PrionX, SynucleiX); Novartis Institutes of Biomedical Research; Klinische Forschungsschwerpunkte (KFSPs) "small RNAs" and "Human Hemato-Lymphatic Diseases"; Young Scientist Stipend of the Ernst-Jung foundation	Advanced Grant of the European Research Council (ERC)(European Research Council (ERC)); European Union (PRIORITY, NEURINOX); Swiss National Foundation (SNF, including a Sinergia grant)(Swiss National Science Foundation (SNSF)); Swiss Initiative in Systems Biology, SystemsX.ch (PrionX, SynucleiX); Novartis Institutes of Biomedical Research; Klinische Forschungsschwerpunkte (KFSPs) "small RNAs" and "Human Hemato-Lymphatic Diseases"; Young Scientist Stipend of the Ernst-Jung foundation	A. Aguzzi is the recipient of an Advanced Grant of the European Research Council (ERC, No. 250356) and is supported by grants from the European Union (PRIORITY, NEURINOX), the Swiss National Foundation (SNF, including a Sinergia grant), the Swiss Initiative in Systems Biology, SystemsX.ch (PrionX, SynucleiX), the Novartis Institutes of Biomedical Research, and the Klinische Forschungsschwerpunkte (KFSPs) "small RNAs" and "Human Hemato-Lymphatic Diseases". C. Zhu is the recipient of a Young Scientist Stipend of the Ernst-Jung foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2013, NAT REV IMMUNOL, V13, P888, DOI 10.1038/nri3553; Aguzzi A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002651; Ahtiluoto S, 2010, NEUROLOGY, V75, P1195, DOI 10.1212/WNL.0b013e3181f4d7f8; Arnold SE, 2014, NEUROBIOL DIS, V67, P79, DOI 10.1016/j.nbd.2014.03.011; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225; Bedse G, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00204; Bhat NR, 2013, J ALZHEIMERS DIS, V36, P781, DOI 10.3233/JAD-2012-121030; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Claxton A, 2015, J ALZHEIMERS DIS, V44, P897, DOI 10.3233/JAD-141791; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Falsig J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002985; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Flechsig E, 2003, EMBO J, V22, P3095, DOI 10.1093/emboj/cdg285; Goldstein B.J., 2002, AM J CARDIOL, V90, p3G, DOI DOI 10.1016/S0002-9149(02)02553-5; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; Herrmann US, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1923; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Julien C, 2010, NEUROBIOL AGING, V31, P1516, DOI 10.1016/j.neurobiolaging.2008.08.022; Karapetyan YE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005730; Kuwahara C, 2000, BIOCHEM BIOPH RES CO, V268, P763, DOI 10.1006/bbrc.2000.2152; Ling X, 2002, J ALZHEIMERS DIS, V4, P369, DOI 10.3233/JAD-2002-4504; Liu Y, 2011, J PATHOL, V225, P54, DOI 10.1002/path.2912; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Mehla J, 2014, J ALZHEIMERS DIS, V39, P145, DOI 10.3233/JAD-131238; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Nielsen D, 2004, BIOCHEM J, V380, P571, DOI 10.1042/BJ20040010; Ohara T, 2011, NEUROLOGY, V77, P1126, DOI 10.1212/WNL.0b013e31822f0435; Okabayashi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117362; Ostlund P, 2001, MOL BRAIN RES, V97, P161, DOI 10.1016/S0169-328X(01)00316-3; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Petrov D, 2015, BBA-MOL BASIS DIS, V1852, P1687, DOI 10.1016/j.bbadis.2015.05.004; Pham N, 2014, BIOCHEM BIOPH RES CO, V448, P151, DOI 10.1016/j.bbrc.2014.04.071; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Reger MA, 2006, NEUROBIOL AGING, V27, P451, DOI 10.1016/j.neurobiolaging.2005.03.016; Reger MA, 2008, J ALZHEIMERS DIS, V13, P323, DOI 10.3233/jad-2008-13309; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Satoh J, 2000, AM J PATHOL, V157, P59, DOI 10.1016/S0002-9440(10)64517-8; Schrijvers EMC, 2010, NEUROLOGY, V75, P1982, DOI 10.1212/WNL.0b013e3181ffe4f6; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Sonati T, 2013, NATURE, V501, P102, DOI 10.1038/nature12402; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Strom A, 2011, PANCREAS, V40, P229, DOI 10.1097/MPA.0b013e3181f7e547; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tan ZS, 2011, DIABETES CARE, V34, P1766, DOI 10.2337/dc11-0308; Uchiyama K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2873; Vandal M, 2014, DIABETES, V63, P4291, DOI 10.2337/db14-0375; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Willette AA, 2015, JAMA NEUROL, V72, P1013, DOI 10.1001/jamaneurol.2015.0613; Willette AA, 2015, ALZHEIMERS DEMENT, V11, P504, DOI 10.1016/j.jalz.2014.03.011; Willette AA, 2013, DIABETES CARE, V36, P443, DOI 10.2337/dc12-0922; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Yamamoto N, 2012, J NEUROCHEM, V121, P619, DOI 10.1111/j.1471-4159.2012.07668.x; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com	65	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144983	10.1371/journal.pone.0144983	http://dx.doi.org/10.1371/journal.pone.0144983			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658276	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900162
J	Ababneh, QO; Tindall, AJ; Herman, JK				Ababneh, Qutaiba O.; Tindall, Amanda J.; Herman, Jennifer K.			A Secreted Factor Coordinates Environmental Quality with Bacillus Development	PLOS ONE			English	Article							FACTOR SIGMA-H; SUBTILIS SPORULATION; STATIONARY-PHASE; TRANSCRIPTION FACTOR; CELL COMMUNICATION; MASTER REGULATOR; TRANSPORT-SYSTEM; GENE-EXPRESSION; SPO0A REGULON; COMPETENCE	Entry into sporulation is governed by the master regulator Spo0A. Spo0A accumulates in its active form, Spo0A-P, as cells enter stationary phase. Prior reports have shown that the acute induction of constitutively active Spo0A during exponential growth does not result in sporulation. However, a subsequent study also found that a gradual increase in Spo0A-P, mediated through artificial expression of the kinase, KinA, during exponential growth, is sufficient to trigger sporulation. We report here that sporulation via KinA induction depends on the presence of an extracellular factor or factors (FacX) that only accumulates to active levels during post-exponential growth. FacX is retained by dialysis with a cutoff smaller than 500 Dalton, can be concentrated, and is susceptible to proteinase K digestion, similar to described quorum-sensing peptides shown to be involved in promoting sporulation. However, unlike previously characterized peptides, FacX activity does not require the Opp or App oligopeptide transporter systems. In addition, FacX activity does not depend on SigH, Spo0A, or ComX. Importantly, we find that in the presence of FacX, B. subtilis can be induced to sporulate following the artificial induction of constitutively active Spo0A. These results indicate that there is no formal requirement for gradual Spo0A-P accumulation and instead support the idea that sporulation requires both sufficient levels of active Spo0A and at least one other signal or condition.	[Ababneh, Qutaiba O.; Tindall, Amanda J.; Herman, Jennifer K.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Herman, JK (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, 2128 TAMU, College Stn, TX 77843 USA.	jkherman@tamu.edu	Ababneh, Qutaiba/GPW-9598-2022	Tindall, Amanda/0000-0003-0323-0795; Herman, Jennifer/0000-0003-4100-8167	Texas AM University; Center for Phage Technology at Texas AM University	Texas AM University; Center for Phage Technology at Texas AM University	This work was funded by start-up funding to JKH from Texas A&M University and the Center for Phage Technology at Texas A&M University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Ben-Yehuda S, 2003, SCIENCE, V299, P532, DOI 10.1126/science.1079914; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; Cutting SMHa CR, 1990, MOL BIOL METHODS BAC; Fujita M, 2005, GENE DEV, V19, P2236, DOI 10.1101/gad.1335705; Fujita M, 2005, J BACTERIOL, V187, P1357, DOI 10.1128/JB.187.4.1357-1368.2005; Fujita M, 2003, GENE DEV, V17, P1166, DOI 10.1101/gad.1078303; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GROSSMAN AD, 1988, P NATL ACAD SCI USA, V85, P4369, DOI 10.1073/pnas.85.12.4369; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Higgins D, 2012, FEMS MICROBIOL REV, V36, P131, DOI 10.1111/j.1574-6976.2011.00310.x; HOCH JA, 1993, ANNU REV MICROBIOL, V47, P441, DOI 10.1146/annurev.micro.47.1.441; IRETON K, 1993, GENE DEV, V7, P283, DOI 10.1101/gad.7.2.283; Jiang M, 2000, J BACTERIOL, V182, P303, DOI 10.1128/JB.182.2.303-310.2000; Jiang M, 2000, MOL MICROBIOL, V38, P535, DOI 10.1046/j.1365-2958.2000.02148.x; Kleerebezem M, 2001, PEPTIDES, V22, P1579, DOI 10.1016/S0196-9781(01)00493-4; KOIDE A, 1994, MOL MICROBIOL, V13, P417, DOI 10.1111/j.1365-2958.1994.tb00436.x; KUNST F, 1994, REGULATION OF BACTERIAL DIFFERENTIATION, P1; Lazazzera BA, 1999, J BACTERIOL, V181, P5193, DOI 10.1128/JB.181.17.5193-5200.1999; Lazazzera BA, 1998, TRENDS MICROBIOL, V6, P288, DOI 10.1016/S0966-842X(98)01313-4; Lazazzera BA, 1997, CELL, V89, P917, DOI 10.1016/S0092-8674(00)80277-9; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; LOPEZ JM, 1979, BIOCHIM BIOPHYS ACTA, V587, P238, DOI 10.1016/0304-4165(79)90357-X; LOPEZ JM, 1981, J BACTERIOL, V146, P605, DOI 10.1128/JB.146.2.605-613.1981; MAGNUSON R, 1994, CELL, V77, P207, DOI 10.1016/0092-8674(94)90313-1; McQuade RS, 2001, J BACTERIOL, V183, P4905, DOI 10.1128/JB.183.16.4905-4909.2001; Molle V, 2003, MOL MICROBIOL, V50, P1683, DOI 10.1046/j.1365-2958.2003.03818.x; Parsek MR, 1999, METHOD ENZYMOL, V310, P43; Perego M, 1996, P NATL ACAD SCI USA, V93, P1549, DOI 10.1073/pnas.93.4.1549; PEREGO M, 1991, MOL MICROBIOL, V5, P173, DOI 10.1111/j.1365-2958.1991.tb01838.x; Perego M, 2001, PEPTIDES, V22, P1541, DOI 10.1016/S0196-9781(01)00490-9; Phillips ZEV, 2002, CELL MOL LIFE SCI, V59, P392, DOI 10.1007/s00018-002-8431-9; Pottathil M, 2003, FRONT BIOSCI-LANDMRK, V8, pD32, DOI 10.2741/913; Rasband W., 2006, IMAGEJ; RUDNER DZ, 1991, J BACTERIOL, V173, P1388, DOI 10.1128/jb.173.4.1388-1398.1991; Rutherford ST, 2012, COLD SPRING HARB PER, V2; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; Shank EA, 2011, CURR OPIN MICROBIOL, V14, P741, DOI 10.1016/j.mib.2011.09.016; SOLOMON JM, 1995, GENE DEV, V9, P547, DOI 10.1101/gad.9.5.547; Solomon JM, 1996, TRENDS GENET, V12, P150, DOI 10.1016/0168-9525(96)10014-7; Thomson NR, 2000, MOL MICROBIOL, V36, P539, DOI 10.1046/j.1365-2958.2000.01872.x; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; YOUNGMAN PJ, 1983, P NATL ACAD SCI-BIOL, V80, P2305, DOI 10.1073/pnas.80.8.2305	45	2	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144168	10.1371/journal.pone.0144168	http://dx.doi.org/10.1371/journal.pone.0144168			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26657919	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903600026
J	Fryxell, RTT; Moore, JE; Collins, MD; Kwon, Y; Jean-Philippe, SR; Schaeffer, SM; Odoi, A; Kennedy, M; Houston, AE				Fryxell, R. T. Trout; Moore, J. E.; Collins, M. D.; Kwon, Y.; Jean-Philippe, S. R.; Schaeffer, S. M.; Odoi, A.; Kennedy, M.; Houston, A. E.			Habitat and Vegetation Variables Are Not Enough When Predicting Tick Populations in the Southeastern United States	PLOS ONE			English	Article							LONE STAR TICK; WHITE-TAILED DEER; IXODES-SCAPULARIS ACARI; DERMACENTOR-VARIABILIS ACARI; AMBLYOMMA-AMERICANUM ACARI; GULF-COAST TICK; BORRELIA-BURGDORFERI; DAMMINI ACARI; LYME-DISEASE; RICKETTSIA-PARKERI	Two tick-borne diseases with expanding case and vector distributions are ehrlichiosis (transmitted by Amblyomma americanum) and rickettiosis (transmitted by A. maculatum and Dermacentor variabilis). There is a critical need to identify the specific habitats where each of these species is likely to be encountered to classify and pinpoint risk areas. Consequently, an in-depth tick prevalence study was conducted on the dominant ticks in the southeast. Vegetation, soil, and remote sensing data were used to test the hypothesis that habitat and vegetation variables can predict tick abundances. No variables were significant predictors of A. americanum adult and nymph tick abundance, and no clustering was evident because this species was found throughout the study area. For A. maculatum adult tick abundance was predicted by NDVI and by the interaction between habitat type and plant diversity; two significant population clusters were identified in a heterogeneous area suitable for quail habitat. For D. variabilis no environmental variables were significant predictors of adult abundance; however, D. variabilis collections clustered in three significant areas best described as agriculture areas with defined edges. This study identified few landscape and vegetation variables associated with tick presence. While some variables were significantly associated with tick populations, the amount of explained variation was not useful for predicting reliably where ticks occur; consequently, additional research that includes multiple sampling seasons and locations throughout the southeast are warranted. This low amount of explained variation may also be due to the use of hosts for dispersal, and potentially to other abiotic and biotic variables. Host species play a large role in the establishment, maintenance, and dispersal of a tick species, as well as the maintenance of disease cycles, dispersal to new areas, and identification of risk areas.	[Fryxell, R. T. Trout] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Moore, J. E.] Christian Bros Univ, Dept Biol, Memphis, TN USA; [Collins, M. D.] Rhodes Coll, Dept Biol, Memphis, TN 38112 USA; [Kwon, Y.] Univ Memphis, Dept Earth Sci, Memphis, TN 38152 USA; [Jean-Philippe, S. R.; Houston, A. E.] Univ Tennessee, Dept Forestry Wildlife & Fisheries, Knoxville, TN USA; [Schaeffer, S. M.] Univ Tennessee, Dept Biosyst Engn & Soil Sci, Knoxville, TN USA; [Odoi, A.] Univ Tennessee, Dept Biomed & Diagnost Sci, Knoxville, TN USA; [Kennedy, M.] Univ Memphis, Dept Biol, Memphis, TN 38152 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Memphis; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Memphis	Fryxell, RTT (corresponding author), Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA.	RFryxell@utk.edu	Fiumefreddo, Andrea/T-2977-2019; Odoi, Agricola/I-9532-2019; Schaeffer, Sean M/G-5071-2012	Odoi, Agricola/0000-0001-5050-6737; Moore, James/0000-0003-0414-942X; Schaeffer, Sean/0000-0002-9684-2952; Trout Fryxell, Rebecca/0000-0003-2133-0220; Kwon, Youngsang/0000-0002-6955-8470	University of Tennessee; Department of Entomology and Plant Pathology; Ames Plantation Research and Education Center; Mellon Foundation; Rhodes College; AKC Canine Health Foundation [01864-A]; USDA Tennessee Hatch Project [TEN00433]	University of Tennessee; Department of Entomology and Plant Pathology; Ames Plantation Research and Education Center; Mellon Foundation; Rhodes College; AKC Canine Health Foundation; USDA Tennessee Hatch Project	This project was funded by the University of Tennessee and the Department of Entomology and Plant Pathology, Ames Plantation Research and Education Center, Mellon Foundation, Rhodes College, as well as AKC Canine Health Foundation (01864-A) and USDA Tennessee Hatch Project (TEN00433).	Adjemian JZ, 2009, AM J TROP MED HYG, V80, P72, DOI 10.4269/ajtmh.2009.80.72; [Anonymous], 2012, ARCGIS VERS 10 1; APPERSON CS, 1990, J WILDLIFE DIS, V26, P550, DOI 10.7589/0090-3558-26.4.550; Barre N, 2010, REV SCI TECH OIE, V29, P149; BISHOPP FC, 1945, J PARASITOL, V31, P1, DOI 10.2307/3273061; Bishopp FC, J EC ENTOMOL, V29, P1067; Bunnell JE, 2003, J MED ENTOMOL, V40, P570, DOI 10.1603/0022-2585-40.4.570; Burridge MJ, 2002, ANN NY ACAD SCI, V969, P269, DOI 10.1111/j.1749-6632.2002.tb04391.x; CALHOUN EL, 1954, AM J TROP MED HYG, V3, P360, DOI 10.4269/ajtmh.1954.3.360; CLYMER BC, 1970, J ECON ENTOMOL, V63, P504, DOI 10.1093/jee/63.2.504; Cohen SB, 2010, J MED ENTOMOL, V47, P415, DOI 10.1603/ME09065; Cortinas MR, 2006, J MED ENTOMOL, V43, P810, DOI 10.1603/0022-2585(2006)43[810:CSOWDI]2.0.CO;2; Cully JF, 1999, J RANGE MANAGE, V52, P139, DOI 10.2307/4003507; DUMLER JS, 1991, NEW ENGL J MED, V325, P1109, DOI 10.1056/NEJM199110103251517; Florin DA, 2014, SYST APPL ACAROL-UK, V19, P257, DOI 10.11158/saa.19.3.1; Frazer GW, 1999, GAP LIGHT ANAL GLA V; Ginsberg HS, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-394; Ginsberg HS, 2005, TICK-BORNE DISEASES OF HUMANS, P65; Gleim ER, 2013, J MED ENTOMOL, V50, P270, DOI 10.1603/ME12168; Goddard J, 2009, VET PARASITOL, V160, P1, DOI 10.1016/j.vetpar.2008.10.089; Gooley R. A., 1944, Journal of Parasitology New York, V30, P77; Guerra M, 2002, EMERG INFECT DIS, V8, P289, DOI 10.3201/eid0803.010166; Hasle G, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00048; Hendricks B., 2013, THESIS; HOCH AL, 1971, J MED ENTOMOL, V8, P731, DOI 10.1093/jmedent/8.6.731; HOCH AL, 1972, J MED ENTOMOL, V9, P446, DOI 10.1093/jmedent/9.5.446; HOPLA C E, 1960, South Med J, V53, P92, DOI 10.1097/00007611-196001000-00020; Jean-Philippe SR, 2011, ENVIRON POLLUT, V159, P2733, DOI 10.1016/j.envpol.2011.05.017; Jordan BE, 2009, J MED ENTOMOL, V46, P131, DOI 10.1603/033.046.0117; KEIRANS JE, 1989, J MED ENTOMOL, V26, P435, DOI 10.1093/jmedent/26.5.435; Keirans JE, 1998, J MED ENTOMOL, V35, P489, DOI 10.1093/jmedent/35.4.489; KOLLARS TM, 1993, J MED ENTOMOL, V30, P896, DOI 10.1093/jmedent/30.5.896; Kollars TM, 2001, J MED ENTOMOL, V38, P601, DOI 10.1603/0022-2585-38.4.601; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 2014, SATSCAN SOFTWARE VER; MAEDA K, 1987, NEW ENGL J MED, V316, P853, DOI 10.1056/NEJM198704023161406; MATHER TN, 1989, AM J EPIDEMIOL, V130, P143, DOI 10.1093/oxfordjournals.aje.a115306; MCENROE W. D., 1971, Environmental Pollution, V2, P135, DOI 10.1016/0013-9327(71)90016-4; Moncayo AC, 2010, AM J TROP MED HYG, V83, P653, DOI 10.4269/ajtmh.2010.09-0197; Ogden NH, 2009, EPIDEMICS-NETH, V1, P196, DOI 10.1016/j.epidem.2009.06.002; Ostfeld RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107387; Paddock CD, 2007, CURR TOP MICROBIOL, V315, P289; Pagac BB, 2014, EMERG INFECT DIS, V20, P1750, DOI 10.3201/eid2010.140175; PATRICK CD, 1978, J PARASITOL, V64, P1100, DOI 10.2307/3279735; Piesman J, 2004, PARASITOLOGY, V129, pS191, DOI 10.1017/S0031182003004694; PRICE WH, 1953, AM J HYG, V58, P248, DOI 10.1093/oxfordjournals.aje.a119604; Rand PW, 2003, J MED ENTOMOL, V40, P179, DOI 10.1603/0022-2585-40.2.179; Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419; RICHARDSON ML, 1992, J WILDLIFE DIS, V28, P485, DOI 10.7589/0090-3558-28.3.485; Savage HM, 2013, AM J TROP MED HYG, V89, P445, DOI 10.4269/ajtmh.13-0209; Scott JD, 2001, J MED ENTOMOL, V38, P493, DOI 10.1603/0022-2585-38.4.493; SEMTNER PJ, 1973, ANN ENTOMOL SOC AM, V66, P1264, DOI 10.1093/aesa/66.6.1264; Simon JA, 2014, EVOL APPL, V7, P750, DOI 10.1111/eva.12165; Sonenshine DE, 2005, TICK-BORNE DISEASES OF HUMANS, P12; Stromdahl EY, 2012, ZOONOSES PUBLIC HLTH, V59, P48, DOI 10.1111/j.1863-2378.2012.01475.x; Sumner JW, 2007, EMERG INFECT DIS, V13, P751, DOI 10.3201/eid1305.061468; Teel PD, 2010, J MED ENTOMOL, V47, P707, DOI 10.1603/ME10029; Trout RT, 2010, J ENTOMOL SCI, V45, P140, DOI 10.18474/0749-8004-45.2.140; Vail SG, 2002, J MED ENTOMOL, V39, P842, DOI 10.1603/0022-2585-39.6.842; Weiss E., 1988, P15; WILSON ML, 1985, ANN ENTOMOL SOC AM, V78, P172, DOI 10.1093/aesa/78.2.172; WILSON ML, 1986, J ECON ENTOMOL, V79, P693, DOI 10.1093/jee/79.3.693; WILSON ML, 1988, J MED ENTOMOL, V25, P224, DOI 10.1093/jmedent/25.4.224; Wylie BK, 2003, REMOTE SENS ENVIRON, V85, P243, DOI 10.1016/S0034-4257(03)00004-X; ZIMMERMAN RH, 1988, J MED ENTOMOL, V25, P461, DOI 10.1093/jmedent/25.6.461	66	27	27	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2015	10	12							e0144092	10.1371/journal.pone.0144092	http://dx.doi.org/10.1371/journal.pone.0144092			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1ZA	26656122	Green Submitted, Green Published, gold			2022-12-27	WOS:000366903600022
J	Green, AW; Bailey, LL				Green, Adam W.; Bailey, Larissa L.			Using Bayesian Population Viability Analysis to Define Relevant Conservation Objectives	PLOS ONE			English	Article							FROG RANA-SYLVATICA; WOOD FROG; AMPHIBIAN DECLINES; DEMOGRAPHIC-MODELS; DECISION-ANALYSIS; SITE OCCUPANCY; HABITAT USE; METAPOPULATION; UNCERTAINTY; EXTINCTION	Adaptive management provides a useful framework for managing natural resources in the face of uncertainty. An important component of adaptive management is identifying clear, measurable conservation objectives that reflect the desired outcomes of stakeholders. A common objective is to have a sustainable population, or metapopulation, but it can be difficult to quantify a threshold above which such a population is likely to persist. We performed a Bayesian metapopulation viability analysis (BMPVA) using a dynamic occupancy model to quantify the characteristics of two wood frog (Lithobates sylvatica) metapopulations resulting in sustainable populations, and we demonstrate how the results could be used to define meaningful objectives that serve as the basis of adaptive management. We explored scenarios involving metapopulations with different numbers of patches (pools) using estimates of breeding occurrence and successful metamorphosis from two study areas to estimate the probability of quasi-extinction and calculate the proportion of vernal pools producing metamorphs. Our results suggest that >= 50 pools are required to ensure long-term persistence with approximately 16% of pools producing metamorphs in stable metapopulations. We demonstrate one way to incorporate the BMPVA results into a utility function that balances the trade-offs between ecological and financial objectives, which can be used in an adaptive management framework to make optimal, transparent decisions. Our approach provides a framework for using a standard method (i.e., PVA) and available information to inform a formal decision process to determine optimal and timely management policies.	[Green, Adam W.; Bailey, Larissa L.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA	Colorado State University	Green, AW (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA.	adamgreenw@gmail.com	Green, Adam/AAH-2892-2019; Bailey, Larissa/ABH-3513-2020; Bailey, Larissa/A-2565-2009		USGS Amphibian and Reptile Monitoring Initiative competitive grant program	USGS Amphibian and Reptile Monitoring Initiative competitive grant program	This work was funded by the 2008 USGS Amphibian and Reptile Monitoring Initiative competitive grant program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064347; [Anonymous], 2014, LANG ENV STAT COMP; Armstrong DP, 2005, CONSERV BIOL, V19, P1402, DOI 10.1111/j.1523-1739.2005.00117.x; Bailey LL, 2004, ECOL APPL, V14, P692, DOI 10.1890/03-5012; Bakker VJ, 2009, FRONT ECOL ENVIRON, V7, P158, DOI 10.1890/070220; Baldwin RF, 2006, CAN J ZOOL, V84, P1604, DOI 10.1139/Z06-146; Bauder ET, 2005, FRESHWATER BIOL, V50, P2129, DOI 10.1111/j.1365-2427.2005.01471.x; Beissinger SR, 2002, POPULATION VIABILITY ANALYSIS, P5; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Bellman R., 1957, DYNAMIC PROGRAMMING; Ben-Haim Y., 2006, INFO GAP DECISION TH, V2; Berger J.O., 1993, STAT DECISION THEORY, V2nd ed.; BERVEN KA, 1995, AUST J ECOL, V20, P385, DOI 10.1111/j.1442-9993.1995.tb00554.x; BERVEN KA, 1982, EVOLUTION, V36, P962, DOI 10.1111/j.1558-5646.1982.tb05466.x; BERVEN KA, 1990, EVOLUTION, V44, P2047, DOI 10.1111/j.1558-5646.1990.tb04310.x; BERVEN KA, 1990, ECOLOGY, V71, P1599, DOI 10.2307/1938295; BLAUSTEIN AR, 1994, CONSERV BIOL, V8, P60, DOI 10.1046/j.1523-1739.1994.08010060.x; Boyce M.S., 1990, New York State Museum Bulletin, P133; BOYCE MS, 1992, ANNU REV ECOL SYST, V23, P481, DOI 10.1146/annurev.es.23.110192.002405; Brooks RT, 2004, WETLANDS, V24, P104, DOI 10.1672/0277-5212(2004)024[0104:WEOWVP]2.0.CO;2; Brooks RT, 2002, WETLANDS, V22, P247, DOI 10.1672/0277-5212(2002)022[0247:DAVAHR]2.0.CO;2; Calhoun AJK, 2003, WETLANDS, V23, P70, DOI 10.1672/0277-5212(2003)023[0070:EVPAAB]2.0.CO;2; Church DR, 2008, COPEIA, P115, DOI 10.1643/CE-05-258; Clark KE, 2006, WILDLIFE SOC B, V34, P419, DOI 10.2193/0091-7648(2006)34[419:AOMOSS]2.0.CO;2; Clemen R. T., 2013, MAKING HARD DECISION, V3; Conroy M. J., 2013, DECISION MAKING NATU; Coulson T, 2001, TRENDS ECOL EVOL, V16, P219, DOI 10.1016/S0169-5347(01)02137-1; Delbecq AL, 1975, J HUMAN SCI; EBERHARDT LL, 1977, J FISH RES BOARD CAN, V34, P183, DOI 10.1139/f77-028; Ellner SP, 2002, CONSERV BIOL, V16, P258, DOI 10.1046/j.1523-1739.2002.00553.x; FARQUHAR PH, 1984, MANAGE SCI, V30, P1283, DOI 10.1287/mnsc.30.11.1283; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Furman BLS, 2015, CONSERV GENET, V2015, P1; Green AW, 2015, POPUL ECOL, V57, P175, DOI 10.1007/s10144-014-0461-2; Green AW, 2013, J APPL ECOL, V50, P1116, DOI 10.1111/1365-2664.12121; Green DE, 2002, ANN NY ACAD SCI, V969, P323, DOI 10.1111/j.1749-6632.2002.tb04400.x; GREEN DM, 2005, DECLINING AMPHIBIANS, P58; Groom Martha J., 1998, P4; Guitouni A, 1998, EUR J OPER RES, V109, P501, DOI 10.1016/S0377-2217(98)00073-3; Halpern BS, 2006, ECOL LETT, V9, P2, DOI 10.1111/j.1461-0248.2005.00827.x; Hanski I, 1996, AM NAT, V147, P527, DOI 10.1086/285864; Heard GW, 2013, DIVERS DISTRIB, V19, P555, DOI 10.1111/ddi.12052; Higgins K, 2001, P NATL ACAD SCI USA, V98, P2928, DOI 10.1073/pnas.031358898; Holling C.S., 1978, ADAPTIVE ENV ASSESSM; HOPEY ME, 1994, COPEIA, P1023; Johnson FA, 2014, J WILDLIFE MANAGE, V78, P531, DOI 10.1002/jwmg.682; Keeney RL, 1993, DECISIONS MULTIPLE O, DOI DOI 10.1017/CBO9781139174084; Keith DA, 2011, BIOL CONSERV, V144, P1175, DOI 10.1016/j.biocon.2010.11.022; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; LANDE R, 1988, OECOLOGIA, V75, P601, DOI 10.1007/BF00776426; Levy JK, 2000, ECOL MODEL, V130, P79, DOI 10.1016/S0304-3800(00)00226-X; Lichko LE, 2003, ENVIRON MANAGE, V32, P141, DOI 10.1007/s00267-003-2967-9; Lubow BC, 1995, WILDLIFE SOC B, V23, P738; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marsh DM, 2001, CONSERV BIOL, V15, P40, DOI 10.1046/j.1523-1739.2001.00129.x; Martin J, 2009, ECOL APPL, V19, P1079, DOI 10.1890/08-0255.1; Martof B. S., 1959, AM MIDL NAT, V61, P350, DOI [10.2307/2422506, DOI 10.2307/2422506]; Mattfeldt SD, 2009, BIOL CONSERV, V142, P720, DOI 10.1016/j.biocon.2008.12.002; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; NICHOLS JD, 1995, ANNU REV ECOL SYST, V26, P177, DOI 10.1146/annurev.es.26.110195.001141; Nicholson E, 2007, ECOL APPL, V17, P251, DOI 10.1890/1051-0761(2007)017[0251:MCDUUF]2.0.CO;2; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Petranka JW, 2004, ECOL APPL, V14, P1065, DOI 10.1890/02-5394; Pilliod DS, 2010, DIVERS DISTRIB, V16, P959, DOI 10.1111/j.1472-4642.2010.00699.x; Polasky S, 2011, TRENDS ECOL EVOL, V26, P398, DOI 10.1016/j.tree.2011.04.007; Polsky C, 2000, CLIMATE RES, V14, P161; Possingham H. P., 1993, Pacific Conservation Biology, V1, P39; Possingham HP, 2002, POPULATION VIABILITY ANALYSIS, P470; Possingham HP, 2001, CONSERVATION BIOLOGY: RESEARCH PRIORITIES FOR THE NEXT DECADE, P225; Ralls K, 2002, POPULATION VIABILITY ANALYSIS, P521; Ralls Katherine, 1997, P228; Reed JM, 1998, WILDLIFE SOC B, V26, P244; Regosin JV, 2003, J HERPETOL, V37, P390, DOI 10.1670/0022-1511(2003)037[0390:THUAWD]2.0.CO;2; Rittenhouse TAG, 2007, J HERPETOL, V41, P645, DOI 10.1670/07-015.1; ROHLF DJ, 1991, CONSERV BIOL, V5, P273, DOI 10.1111/j.1523-1739.1991.tb00139.x; RUGGIERO LF, 1994, CONSERV BIOL, V8, P364, DOI 10.1046/j.1523-1739.1994.08020364.x; Schwartz B, 2002, J PERS SOC PSYCHOL, V83, P1178, DOI 10.1037//0022-3514.83.5.1178; Servanty S, 2014, ECOL APPL, V24, P927, DOI 10.1890/13-0559.1; SHAFFER ML, 1990, CONSERV BIOL, V4, P39, DOI 10.1111/j.1523-1739.1990.tb00265.x; SHAFFER ML, 1985, AM NAT, V125, P144, DOI 10.1086/284332; Shaffer ML, 1983, INT C BEAR RES MANAG, V5, P133; Skinner D.., 2001, INTRO DECISION ANAL, V2nd; Smith MA, 2005, ECOGRAPHY, V28, P110; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; SUCHY WJ, 1985, WILDLIFE SOC B, V13, P223; Van Meter R, 2008, WETLANDS, V28, P585, DOI 10.1672/07-237.1; Wade PR, 2002, POPULATION VIABILITY ANALYSIS, P213; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; WAKE DB, 1991, SCIENCE, V253, P860, DOI 10.1126/science.253.5022.860; Walters C., 1986, ADAPTIVE MANAGEMENT; Wang JJ, 2009, RENEW SUST ENERG REV, V13, P2263, DOI 10.1016/j.rser.2009.06.021; Waples RS, 2013, BIOSCIENCE, V63, P723, DOI 10.1525/bio.2013.63.9.8; Weir LA, 2005, J HERPETOL, V39, P627; White GC, 2000, METH C CONS, P288; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Williams B.K., 2009, ADAPTIVE MANAGEMENT; Yang JB, 2001, EUR J OPER RES, V131, P31, DOI 10.1016/S0377-2217(99)00441-5	98	9	9	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144786	10.1371/journal.pone.0144786	http://dx.doi.org/10.1371/journal.pone.0144786			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658734	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903500062
J	Song, W; Cao, Y; Wang, DD; Hou, GJ; Shen, ZH; Zhang, SB				Song, Wei; Cao, Yang; Wang, Dandan; Hou, Guojun; Shen, Zaihua; Zhang, Shuangbao			An Investigation on Formaldehyde Emission Characteristics of Wood Building Materials in Chinese Standard Tests: Product Emission Levels, Measurement Uncertainties, and Data Correlations between Various Tests	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; INITIAL EMITTABLE CONCENTRATION; MONTE-CARLO-SIMULATION; C-HISTORY METHOD; MOLE RATIO UF; SOLID WOOD; SEALING TREATMENT; DESICCATOR METHOD; COMPOSITE BOARDS; CHAMBER METHOD	As a large producer and consumer of wood building materials, China suffers product formaldehyde emissions (PFE) but lacks systematic investigations and basic data on Chinese standard emission tests (CST), so this paper presented a first effort on this issue. The PFE of fiberboards, particleboards, blockboards, floorings, and parquets manufactured in Beijing region were characterized by the perforator extraction method (PE), 9-11 L and 40 L desiccator methods (D9, D40), and environmental chamber method (EC) of the Chinese national standard GB 18580; based on statistics of PFE data, measurement uncertainties in CST were evaluated by the Monte Carlo method; moreover, PFE data correlations between tests were established. Results showed: (1) Different tests may give slightly different evaluations on product quality. In PE and D9 tests, blockboards and parquets reached E1 grade for PFE, which can be directly used in indoor environment; but in D40 and EC tests, floorings and parquets achieved E1. (2) In multiple tests, PFE data characterized by PE, D9, and D40 complied with Gaussian distributions, while those characterized by EC followed lognormal distributions. Uncertainties in CST were overall low, with uncertainties for 20 material- method combinations all below 7.5%, and the average uncertainty for each method under 3.5%, thus being acceptable in engineering application. A more complicated material structure and a larger test scale caused higher uncertainties. (3) Conventional linear models applied to correlating PFE values between PE, D9, and EC, with R-2 all over 0.840, while novel logarithmic (exponential) models can work better for correlations involving D40, with R-2 all beyond 0.901. This research preliminarily demonstrated the effectiveness of CST, where results for D40 presented greater similarities to EC-the currently most reliable test for PFE, thus highlighting the potential of Chinese D40 as a more practical approach in production control and risk assessment.	[Song, Wei; Cao, Yang; Wang, Dandan; Hou, Guojun; Zhang, Shuangbao] Beijing Forestry Univ, Beijing Key Lab Wood Sci & Engn, Beijing, Peoples R China; [Song, Wei; Zhang, Shuangbao] Beijing Forestry Univ, MOE Key Lab Wooden Mat Sci & Applicat, Beijing, Peoples R China; [Song, Wei; Zhang, Shuangbao] Beijing Forestry Univ, MOE Engn Res Ctr Forestry Biomass Mat & Bioenergy, Beijing, Peoples R China; [Shen, Zaihua] Zhejiang Chengzhu Adv Mat Technol Co Ltd, R&D Ctr Nat Fiber Composites & Environm Friendly, Shaoxing, Peoples R China	Beijing Forestry University; Beijing Forestry University; Beijing Forestry University	Zhang, SB (corresponding author), Beijing Forestry Univ, Beijing Key Lab Wood Sci & Engn, Beijing, Peoples R China.	shuangbaozhangj5@163.com		Cao, Yang/0000-0002-3318-4921	Co-built Foundation; Beijing Natural Science Foundation, China [16F10217]; Forest Certification Foundation of State Forestry Administration, China; Fundamental Research Funds for the Central Universities, China; Zhejiang Chengzhu Advanced Material Technology Co., Ltd; Beijing Municipal Commission of Education, China; Zhejiang Province, China [CZXC201410]	Co-built Foundation; Beijing Natural Science Foundation, China(Beijing Natural Science Foundation); Forest Certification Foundation of State Forestry Administration, China; Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities); Zhejiang Chengzhu Advanced Material Technology Co., Ltd; Beijing Municipal Commission of Education, China(Beijing Municipal Commission of Education); Zhejiang Province, China	This work was supported by Co-built Foundation with Beijing Municipal Commission of Education, China: SZ (www.bjedu.gov.cn), Co-built Foundation with Zhejiang Province, China (CZXC201410) "R & D on Natural Fiber Composites and Environmentally Friendly Adhesives": SZ (www.zjczxc.com), Beijing Natural Science Foundation, China (16F10217): SZ (www.bjnsf.org), Forest Certification Foundation of State Forestry Administration, China: SZ (www.forestry.gov.cn), and the Fundamental Research Funds for the Central Universities, China: WS (http://www.bjfu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Zhejiang Chengzhu Advanced Material Technology Co., Ltd provided support in the form of salaries for authors [ZS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Adams RI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128022; Amegah AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069181; Bohm M, 2012, J HAZARD MATER, V221, P68, DOI 10.1016/j.jhazmat.2012.04.013; Brito-Santos F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115866; Chen LO, 2014, BIORESOURCES, V9, P2975; Chen W, 2015, IEEE T GEOSCI REMOTE, V53, P2925, DOI 10.1109/TGRS.2014.2366779; Cheng HT, 2015, HOLZFORSCHUNG, V69, P215, DOI 10.1515/hf-2014-0020; Cheng HT, 2014, WOOD FIBER SCI, V46, P247; Cui Y, 2015, BIORESOURCES, V10, P3865; Deng QH, 2015, BUILD ENVIRON, V93, P84, DOI 10.1016/j.buildenv.2015.01.019; Ding WB, 2013, BIORESOURCES, V8, P2568; Du ZJ, 2014, ENVIRON INT, V73, P33, DOI 10.1016/j.envint.2014.06.014; Fang LN, 2014, THESIS; Ho KF, 2015, ENVIRON POLLUT, V197, P316, DOI 10.1016/j.envpol.2014.11.014; Huang LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079553; Huang SD, 2015, ENVIRON SCI TECHNOL, V49, P1537, DOI 10.1021/es5051875; Hwang GB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126481; Ji WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124238; Jin ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102685; Jung CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095791; Kadimaliev D, 2015, BIORESOURCES, V10, P1644; Kaminski M, 2015, COMPOS STRUCT, V123, P374, DOI 10.1016/j.compstruct.2014.12.063; Kim EH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119501; Kim J, 2015, J ADHES SCI TECHNOL, V29, P2090, DOI 10.1080/01694243.2015.1057394; Kim S, 2005, BIORESOURCE TECHNOL, V96, P1457, DOI 10.1016/j.biortech.2004.12.003; Kim S, 2007, INDOOR AIR, V17, P404, DOI 10.1111/j.1600-0668.2007.00488.x; Kim S, 2006, POLYM TEST, V25, P904, DOI 10.1016/j.polymertesting.2006.05.010; Kim S, 2010, BIORESOURCE TECHNOL, V101, P6562, DOI 10.1016/j.biortech.2010.03.059; Kumar RLV, 2015, COMPOS STRUCT, V121, P351, DOI 10.1016/j.compstruct.2014.11.029; Li LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128767; Li XN, 2015, BIORESOURCES, V10, P6624; Liang WH, 2015, ENVIRON SCI TECHNOL, V49, P10349, DOI 10.1021/acs.est.5b02217; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072445; Liu WW, 2013, CHINESE SCI BULL, V58, P3499, DOI 10.1007/s11434-013-5841-z; Liu WW, 2012, CHINESE SCI BULL, V57, P2533, DOI 10.1007/s11434-012-5208-x; Luo JL, 2015, BIORESOURCES, V10, P3265, DOI 10.15376/biores.10.2.3265-3276; Mao A, 2013, BIORESOURCES, V8, P4659; Mao A, 2013, BIORESOURCES, V8, P2470; Mao A, 2013, BIORESOURCES, V8, P2453; Nishimura Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132373; Park BD, 2011, EUR J WOOD WOOD PROD, V69, P311, DOI 10.1007/s00107-010-0446-6; Park CY, 2013, BIORESOURCES, V8, P5515; Park JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125251; Que ZL, 2013, COMPOS PART B-ENG, V49, P36, DOI 10.1016/j.compositesb.2013.01.008; Que ZL, 2013, COMPOS PART B-ENG, V47, P278, DOI 10.1016/j.compositesb.2012.11.019; Que ZL, 2013, J FORESTRY RES, V24, P137, DOI 10.1007/s11676-013-0333-1; Que Z, 2007, WOOD SCI TECHNOL, V41, P267, DOI 10.1007/s00226-006-0104-7; Ramos T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118207; Risholm-Sundman M, 1999, INDOOR AIR, V9, P268, DOI 10.1111/j.1600-0668.1999.00006.x; Risholm-Sundman M, 1999, HOLZ ROH WERKST, V57, P319, DOI 10.1007/s001070050351; Risholm-Sundman M, 2007, ATMOS ENVIRON, V41, P3193, DOI 10.1016/j.atmosenv.2006.10.079; Salem MZM, 2013, BIORESOURCES, V8, P4775; Salem MZM, 2013, BIORESOURCES, V8, P1199; Salem MZM, 2012, EUR J WOOD WOOD PROD, V70, P621, DOI 10.1007/s00107-011-0593-4; Salem MZM, 2012, BUILD ENVIRON, V49, P86, DOI 10.1016/j.buildenv.2011.09.011; Salem MZM, 2011, BUILD ENVIRON, V46, P1946, DOI 10.1016/j.buildenv.2011.04.004; Salthammer T, 2015, INT J HYG ENVIR HEAL, V218, P433, DOI 10.1016/j.ijheh.2015.02.005; Salthammer T, 2010, CHEM REV, V110, P2536, DOI 10.1021/cr800399g; Shangguan WW, 2014, BIORESOURCES, V9, P7073; Shin SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126960; Song W, 2015, BIORESOURCES, V10, P5049; Tang XJ, 2009, ENVIRON INT, V35, P1210, DOI 10.1016/j.envint.2009.06.002; Tao HT, 2015, BUILD ENVIRON, V85, P85, DOI 10.1016/j.buildenv.2014.11.017; Tohmura S, 2015, FOREST PROD J, V65, P31, DOI 10.13073/FPJ-D-14-00043; Wei WB, 2014, BIORESOURCES, V9, P6087; Wei WJ, 2015, BUILD ENVIRON, V92, P10, DOI 10.1016/j.buildenv.2015.03.035; Wei WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080736; Xiao QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117311; Xing F, 2014, THESIS; Xiong J, 2010, INDOOR AIR, V20, P523, DOI 10.1111/j.1600-0668.2010.00675.x; Xiong JY, 2013, ENVIRON SCI TECHNOL, V47, P8540, DOI 10.1021/es401173d; Xiong JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049342; Xiong JY, 2011, ENVIRON SCI TECHNOL, V45, P3584, DOI 10.1021/es200277p; Xiong JY, 2011, INDOOR BUILT ENVIRON, V20, P217, DOI 10.1177/1420326X10387480; Yang Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118141; Yao Y, 2011, THESIS; Yao Y, 2011, ATMOS ENVIRON, V45, P5602, DOI 10.1016/j.atmosenv.2011.04.033; Ye W, 2014, BUILD ENVIRON, V75, P58, DOI 10.1016/j.buildenv.2014.01.018; Zhang H, 2011, BIORESOURCES, V6, P4430; Zhang JZ, 2015, BIORESOURCES, V10, P782; Zhong Y, 2014, BIORESOURCES, V9, P7737	81	9	10	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144374	10.1371/journal.pone.0144374	http://dx.doi.org/10.1371/journal.pone.0144374			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26656316	gold, Green Published, Green Submitted			2022-12-27	WOS:000366903500024
J	Verdes, A; Cho, WY; Hossain, M; Brennan, PLR; Hanley, D; Grim, T; Hauber, ME; Holford, M				Verdes, Aida; Cho, Wooyoung; Hossain, Marouf; Brennan, Patricia L. R.; Hanley, Daniel; Grim, Tomas; Hauber, Mark E.; Holford, Mande			Nature's Palette: Characterization of Shared Pigments in Colorful Avian and Mollusk Shells	PLOS ONE			English	Article							EGGSHELL PIGMENTS; ADAPTIVE SIGNIFICANCE; COLORATION; EVOLUTION; BIRDS; MECHANISMS; LOCATION; MATRIX	Pigment-based coloration is a common trait found in a variety of organisms across the tree of life. For example, calcareous avian eggs are natural structures that vary greatly in color, yet just a handful of tetrapyrrole pigment compounds are responsible for generating this myriad of colors. To fully understand the diversity and constraints shaping nature's palette, it is imperative to characterize the similarities and differences in the types of compounds involved in color production across diverse lineages. Pigment composition was investigated in eggshells of eleven paleognath bird taxa, covering several extinct and extant lineages, and shells of four extant species of mollusks. Birds and mollusks are two distantly related, calcareous shell-building groups, thus characterization of pigments in their calcareous structures would provide insights to whether similar compounds are found in different phyla (Chordata and Mollusca). An ethylenediaminetetraacetic acid (EDTA) extraction protocol was used to analyze the presence and concentration of biliverdin and protoporphyrin, two known and ubiquitous tetrapyrrole avian eggshell pigments, in all avian and molluscan samples. Biliverdin was solely detected in birds, including the colorful eggshells of four tinamou species. In contrast, protoporphyrin was detected in both the eggshells of several avian species and in the shells of all mollusks. These findings support previous hypotheses about the ubiquitous deposition of tetrapyrroles in the eggshells of various bird lineages and provide evidence for its presence also across distantly related animal taxa.	[Verdes, Aida; Hauber, Mark E.; Holford, Mande] CUNY, Grad Ctr, New York, NY 10021 USA; [Verdes, Aida; Holford, Mande] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Cho, Wooyoung; Hossain, Marouf; Holford, Mande] CUNY, Dept Chem, New York, NY 10021 USA; [Brennan, Patricia L. R.] Univ Massachusetts, Dept Psychol, Amherst, MA 01003 USA; [Hanley, Daniel; Grim, Tomas] Palacky Univ, Dept Zool, CR-77147 Olomouc, Czech Republic; [Hanley, Daniel; Grim, Tomas] Palacky Univ, Ornithol Lab, CR-77147 Olomouc, Czech Republic; [Hauber, Mark E.] CUNY Hunter Coll, Dept Psychol, New York, NY 10021 USA	City University of New York (CUNY) System; American Museum of Natural History (AMNH); City University of New York (CUNY) System; University of Massachusetts System; University of Massachusetts Amherst; Palacky University Olomouc; Palacky University Olomouc; City University of New York (CUNY) System; Hunter College (CUNY)	Verdes, A (corresponding author), CUNY, Grad Ctr, New York, NY 10021 USA.	averdes@gradcenter.cuny.edu; mholford@hunter.cuny.edu	Hanley, Daniel/C-9080-2016; Grim, Tomas/A-2852-2008	Hanley, Daniel/0000-0003-0523-4335; Verdes, Aida/0000-0002-9193-9253; Hossain, Marouf/0000-0002-9312-7435; Holford, Mande/0000-0001-9476-2687; Grim, Tomas/0000-0002-5775-6269; Brennan, Patricia/0000-0002-1905-3327	Weissman School of Arts and Sciences of Baruch College; Hunter College; Graduate Center of the City University of New York; CUNY Summer Undergraduate Research Program; National Science Foundation CAREER program [NSF-CHE 1247550, NSF-MRI 1228921]; Camille Dreyfus Teacher-Scholar Award; European Social Fund; state budget of the Czech Republic [CZ.1.07/2.3.00/30.0041]; Human Frontier Science Program Young Investigator Award	Weissman School of Arts and Sciences of Baruch College; Hunter College; Graduate Center of the City University of New York; CUNY Summer Undergraduate Research Program; National Science Foundation CAREER program(National Science Foundation (NSF)); Camille Dreyfus Teacher-Scholar Award; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; Human Frontier Science Program Young Investigator Award(Human Frontier Science Program)	AV acknowledges funding from The Weissman School of Arts and Sciences of Baruch College, Hunter College and The Graduate Center of the City University of New York. Funding was also provided by CUNY Summer Undergraduate Research Program to WC. This project was supported by National Science Foundation CAREER program NSF-CHE 1247550, NSF-MRI 1228921, and Camille Dreyfus Teacher-Scholar Award to MH. The European Social Fund and the state budget of the Czech Republic (project no. CZ.1.07/2.3.00/30.0041) co-financed DH. Additional support came from a Human Frontier Science Program Young Investigator Award to MEH and TG.	Adamkewicz SL, 1997, MOL BIOL EVOL, V14, P619, DOI 10.1093/oxfordjournals.molbev.a025801; Aidala Z, 2010, NAT ED KNOWL, V3, P53; BANNISTER WH, 1968, COMP BIOCHEM PHYSIOL, V27, P451, DOI 10.1016/0010-406X(68)90244-2; BERTRAM BCR, 1981, IBIS, V123, P207, DOI 10.1111/j.1474-919X.1981.tb00927.x; Boettiger A, 2009, P NATL ACAD SCI USA, V106, P6837, DOI 10.1073/pnas.0810311106; Brennan PLR, 2010, J AVIAN BIOL, V41, P419, DOI 10.1111/j.1600-048X.2010.04999.x; Caro T, 2005, BIOSCIENCE, V55, P125, DOI 10.1641/0006-3568(2005)055[0125:TASOCI]2.0.CO;2; Cassey P, 2012, METHODS ECOL EVOL, V3, P450, DOI 10.1111/j.2041-210X.2011.00152.x; Cassey P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012054; Cherry MI, 2010, BIOL J LINN SOC, V100, P753, DOI 10.1111/j.1095-8312.2010.01457.x; COMFORT A, 1949, BIOCHEM J, V44, P111, DOI 10.1042/bj0440111; COMFORT A, 1951, BIOL REV, V26, P285, DOI 10.1111/j.1469-185X.1951.tb01358.x; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; Cunha RL, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-210; Davies SJJF., 2002, RATITES TINAMOUS TIN; Edwards SV, 2005, P ROY SOC B-BIOL SCI, V272, P979, DOI 10.1098/rspb.2004.3035; ERMENTROUT B, 1986, VELIGER, V28, P369; Fargallo JA, 2014, EVOL ECOL, V28, P627, DOI 10.1007/s10682-014-9700-4; Gong ZQ, 2012, P NATL ACAD SCI USA, V109, pE234, DOI 10.1073/pnas.1119859109; Gorchein A, 2009, BIOMED CHROMATOGR, V23, P602, DOI 10.1002/bmc.1158; Gosler AG, 2005, ECOL LETT, V8, P1105, DOI 10.1111/j.1461-0248.2005.00816.x; Hanley D, 2013, AVIAN BIOL RES, V6, P147, DOI 10.3184/175815513X13617279883973; Hanley D, 2013, EVOL ECOL, V27, P593, DOI 10.1007/s10682-012-9619-6; Harasewych G, 2010, BOOK SHELLS LIFE SIZ; Harshman J, 2008, P NATL ACAD SCI USA, V105, P13462, DOI 10.1073/pnas.0803242105; Hedegaard C, 2006, J MOLLUS STUD, V72, P157, DOI 10.1093/mollus/eyi062; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Hubbard JK, 2010, TRENDS GENET, V26, P231, DOI 10.1016/j.tig.2010.02.002; Igic B, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1210; Igic B, 2010, J FIELD ORNITHOL, V81, P402, DOI 10.1111/j.1557-9263.2010.00296.x; Igic B, 2010, CHEMOECOLOGY, V20, P43, DOI 10.1007/s00049-009-0038-2; JONES P, 1979, COMP BIOCHEM PHYS B, V63, P185, DOI 10.1016/0305-0491(79)90027-0; Keen A. M., 1971, SEA SHELLS TROPICAL, VSecond; KENNEDY GY, 1976, COMP BIOCHEM PHYS B, V55, P117, DOI 10.1016/0305-0491(76)90183-8; Kilner RM, 2006, BIOL REV, V81, P383, DOI 10.1017/S1464793106007044; LINDBERG DR, 1990, J EXP MAR BIOL ECOL, V140, P173, DOI 10.1016/0022-0981(90)90125-V; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Manceau M, 2010, PHILOS T R SOC B, V365, P2439, DOI 10.1098/rstb.2010.0104; Mathger LM, 2009, J R SOC INTERFACE, V6, pS149, DOI 10.1098/rsif.2008.0366.focus; Matsuno T, 2001, FISHERIES SCI, V67, P771, DOI 10.1046/j.1444-2906.2001.00323.x; McGraw KJ, 2005, ANIM BEHAV, V69, P757, DOI 10.1016/j.anbehav.2004.06.022; Miksik I, 1996, COMP BIOCHEM PHYS B, V113, P607, DOI 10.1016/0305-0491(95)02073-X; Miksik I, 2007, CONNECT TISSUE RES, V48, P1, DOI 10.1080/03008200601003116; MONTEVECCHI WA, 1976, BEHAVIOUR, V58, P26, DOI 10.1163/156853976X00226; Nys Y, 2004, CR PALEVOL, V3, P549, DOI 10.1016/j.crpv.2004.08.002; POPPE GT, 2008, PHILIPPINE MARINE 1, V1; Samiullah S, 2013, POULTRY SCI, V92, P2783, DOI 10.3382/ps.2013-03051; Shawkey MD, 2006, J R SOC INTERFACE, V3, P777, DOI 10.1098/rsif.2006.0131; Shimomura O, 2006, BIOLUMINESCENCE: CHEMICAL PRINCIPLES AND METHODS, P1; Sokolova IM, 2000, J EXP MAR BIOL ECOL, V245, P1, DOI 10.1016/S0022-0981(99)00132-X; Stemmer K, 2014, J MOLLUS STUD, V80, P365, DOI 10.1093/mollus/eyu033; Stoddard MC, 2011, BEHAV ECOL, V22, P1042, DOI 10.1093/beheco/arr088; Storfer A, 1999, EVOLUTION, V53, P889, DOI 10.1111/j.1558-5646.1999.tb05383.x; Wallace AR, 1923, DARWINISM EXPOSITION; Wang XT, 2009, POULTRY SCI, V88, P1735, DOI 10.3382/ps.2008-00434; Winkler FM, 2001, J HERED, V92, P521, DOI 10.1093/jhered/92.6.521; Wragg D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071393; Zhang ZQ, 2013, ZOOTAXA, V3703, P5	58	22	24	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143545	10.1371/journal.pone.0143545	http://dx.doi.org/10.1371/journal.pone.0143545			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650398	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903300020
J	Chu, TLH; Guan, QN; Nguan, CYC; Du, CG				Chu, Tony L. H.; Guan, Qiunong; Nguan, Christopher Y. C.; Du, Caigan			Halofuginone Synergistically Enhances Anti-Proliferation of Rapamycin in T Cells and Reduces Cytotoxicity of Cyclosporine in Cultured Renal Tubular Epithelial Cells	PLOS ONE			English	Article							HUMAN CANCER-CELLS; COMBINATION THERAPY; CALCINEURIN; CYCLOPHILIN; MTOR; INHIBITOR; APOPTOSIS; EFFICACY; IMMUNOSUPPRESSION; IDENTIFICATION	Both rapamycin (RAPA) and cyclosporin A (CsA) are commonly used for immunosuppression, however their adverse side effects limit their application. Thus, it is of interest to develop novel means to enhance or preserve the immunosuppressive activity of RAPA or CsA while reducing their toxicity. Halofuginone (HF) has been recently tested as a potential immunosuppressant. This study investigated the interaction of HF with RAPA or with CsA in cell cultures. Cell proliferation in cultures was determined using methylthiazol tetrazolium assay, and cell apoptosis assessed by flow cytometric analysis and Western blot. The drug-drug interaction was determined according to Loewe's equation or Bliss independence. Here, we showed that addition of HF to anti-CD 3 antibody-stimulated splenocyte cultures induced synergistic suppression of T cell proliferation in the presence of RAPA, indicated by an interaction index (gamma) value of < 1.0 between HF and RAPA, but not in those with CsA. The synergistic interaction of RAPA with HF in the suppression of T cell proliferation was also seen in a mixed lymphocyte reaction and Jurkat T cell growth, and was positively correlated with an increase in cell apoptosis, but not with proline depletion. In cultured kidney tubular epithelial cells, HF attenuated the cytotoxicity of CsA. In conclusion, these data indicate that HF synergistically enhances anti-T cell proliferation of RAPA and reduces the nephrotoxicity of CsA in vitro, suggesting the potential use of HF for enhancing anti-T cell proliferation of RAPA and reducing CsA-mediated nephrotoxicity.	[Chu, Tony L. H.; Guan, Qiunong; Nguan, Christopher Y. C.; Du, Caigan] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada; [Du, Caigan] Vancouver Coastal Hlth Res Inst, Immun & Infect Res Ctr, Vancouver, BC, Canada	University of British Columbia; Vancouver Coastal Health Research Institute	Du, CG (corresponding author), Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada.	caigan@mail.ubc.ca			Kidney Foundation of Canada; CIHR for Health Research Strategic Training Program in Transplantation Research; BC Proteomics Network Training programs	Kidney Foundation of Canada; CIHR for Health Research Strategic Training Program in Transplantation Research(Canadian Institutes of Health Research (CIHR)); BC Proteomics Network Training programs	This study was supported by a grant from the Kidney Foundation of Canada. TLHC received training awards from the CIHR for Health Research Strategic Training Program in Transplantation Research, and the BC Proteomics Network Training programs.; This study was supported by a grant from the Kidney Foundation of Canada. TLHC received training awards from the CIHR for Health Research Strategic Training Program in Transplantation Research, and the BC Proteomics Network Training programs. The authors are grateful to Mr. Jeffrey Helm (IIRC Research Manager, Vancouver, Canada) and Mr. Wayne H. Zhao for editorial assistance.	Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483; Augustine JJ, 2007, CURR OPIN NEPHROL HY, V16, P535, DOI 10.1097/MNH.0b013e3282f0b319; CABEL MC, 1991, POULTRY SCI, V70, P289, DOI 10.3382/ps.0700289; Caramelo C, 2004, NEPHROL DIAL TRANSPL, V19, P285, DOI 10.1093/ndt/gfg516; Cardenas M E, 1995, Curr Opin Nephrol Hypertens, V4, P472, DOI 10.1097/00041552-199511000-00002; Carlson TJ, 2014, J IMMUNOL, V192, P2167, DOI 10.4049/jimmunol.1302316; Cebrian C, 2001, J BIOL CHEM, V276, P29410, DOI 10.1074/jbc.M102916200; Chen YH, 2005, ONCOGENE, V24, P672, DOI 10.1038/sj.onc.1208099; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Chi Eun Young, 2013, Obstet Gynecol Sci, V56, P84, DOI 10.5468/OGS.2013.56.2.84; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Chu TLH, 2013, INT IMMUNOPHARMACOL, V16, P414, DOI 10.1016/j.intimp.2013.04.031; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; de Figueiredo-Pontes LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026713; De Waele V, 2010, PREV VET MED, V96, P143, DOI 10.1016/j.prevetmed.2010.06.017; Derici U, 2001, ACTA NEUROL BELG, V101, P124; Dong LH, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-53; Du CG, 2006, AM J PHYSIOL-RENAL, V290, pF1044, DOI 10.1152/ajprenal.00341.2005; Du CG, 2001, EXP BIOL MED, V226, P1051, DOI 10.1177/153537020122601113; Ernst RA, 1996, POULTRY SCI, V75, P1493, DOI 10.3382/ps.0751493; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; FOXWELL BMJ, 1988, BIOCHIM BIOPHYS ACTA, V938, P447, DOI 10.1016/0005-2736(88)90142-3; FRUMAN DA, 1992, P NATL ACAD SCI USA, V89, P3686, DOI 10.1073/pnas.89.9.3686; Gadir N, 2008, ONCOGENE, V27, P1055, DOI 10.1038/sj.onc.1210721; GRECO WR, 1995, PHARMACOL REV, V47, P331; Greco WR, 1996, J NATL CANCER I, V88, P699, DOI 10.1093/jnci/88.11.699; HEEG K, 1985, J IMMUNOL METHODS, V77, P237, DOI 10.1016/0022-1759(85)90036-5; Issa N, 2013, AM J NEPHROL, V37, P602, DOI 10.1159/000351648; JANG CS, 1948, NATURE, V161, P400, DOI 10.1038/161400b0; Jennings P, 2009, TOXICOL IN VITRO, V23, P486, DOI 10.1016/j.tiv.2008.12.023; Kaczmarek I, 2013, J HEART LUNG TRANSPL, V32, P277, DOI 10.1016/j.healun.2012.11.028; Kahan BD, 2009, TRANSPL P, V41, P1423, DOI 10.1016/j.transproceed.2009.05.001; Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI [10.1038/NCHEMBIO.790, 10.1038/nchembio.790]; Klein P, 2008, VET J, V177, P429, DOI 10.1016/j.tvjl.2007.05.007; Leiba M, 2006, J LEUKOCYTE BIOL, V80, P399, DOI 10.1189/jlb.0705409; Loewe S, 1926, N-S ARCH EX PATH PH, V114, P313; Malaekeh-Nikouei B, 2008, COLLOID SURFACE B, V67, P238, DOI 10.1016/j.colsurfb.2008.09.001; Marionnet AV, 1997, CELL BIOL TOXICOL, V13, P115, DOI 10.1023/B:CBTO.0000010396.88482.54; MARKS WH, 1991, TRANSPLANTATION, V52, P340, DOI 10.1097/00007890-199108000-00030; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Peddi VR, 2013, TRANSPLANT REV-ORLAN, V27, P97, DOI 10.1016/j.trre.2013.06.001; QUESNIAUX VFJ, 1987, EUR J IMMUNOL, V17, P1359, DOI 10.1002/eji.1830170921; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Rush D, 2013, TRANSPLANT REV-ORLAN, V27, P93, DOI 10.1016/j.trre.2013.04.003; Schonder KS, 2011, CRIT CARE NURS CLIN, V23, P405, DOI 10.1016/j.ccell.2011.06.001; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Tedesco D, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/230386; Trotz-Williams LA, 2011, VET REC, V168, DOI 10.1136/vr.d1492; Wang BB, 2012, TRANSPL IMMUNOL, V26, P50, DOI 10.1016/j.trim.2011.10.004; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Yellen P, 2011, CELL CYCLE, V10, P3948, DOI 10.4161/cc.10.22.18124; Zhao Liang, 2010, Front Biosci (Elite Ed), V2, P241, DOI 10.2741/e86	52	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144735	10.1371/journal.pone.0144735	http://dx.doi.org/10.1371/journal.pone.0144735			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671563	Green Published, Green Submitted, gold			2022-12-27	WOS:000366719300019
J	Useem, J; Brennan, A; LaValley, M; Vickery, M; Ameli, O; Reinen, N; Gill, CJ				Useem, Johanna; Brennan, Alana; LaValley, Michael; Vickery, Michelle; Ameli, Omid; Reinen, Nichole; Gill, Christopher J.			Systematic Differences between Cochrane and Non-Cochrane Meta-Analyses on the Same Topic: A Matched Pair Analysis	PLOS ONE			English	Article							PUBLICATION; BIAS	Background Meta-analyses conducted via the Cochrane Collaboration adhere to strict methodological and reporting standards aiming to minimize bias, maximize transparency/reproducibility, and improve the accuracy of summarized data. Whether this results in differences in the results reported by meta-analyses on the same topic conducted outside the Cochrane Collaboration is an open question. Methods We conducted a matched-pair analysis with individual meta-analyses as the unit of analysis, comparing Cochrane and non-Cochrane reviews. Using meta-analyses from the cardiovascular literature, we identified pairs that matched on intervention and outcome. The pairs were contrasted in terms of how frequently results disagreed between the Cochrane and non-Cochrane reviews, whether effect sizes and statistical precision differed systematically, and how these differences related to the frequency of secondary citations of those reviews. Results Our search yielded 40 matched pairs of reviews. The two sets were similar in terms of which was first to publication, how many studies were included, and average sample sizes. The paired reviews included a total of 344 individual clinical trials: 111 ( 32.3%) studies were included only in a Cochrane review, 104 ( 30.2%) only in a non-Cochrane review, and 129 ( 37.5%) in both. Stated another way, 62.5% of studies were only included in one or the other meta-analytic literature. Overall, 37.5% of pairs had discrepant results. The most common involved shifts in the width of 95% confidence intervals that would yield a different statistical interpretation of the significance of results (7 pairs). Additionally, 20% differed in the direction of the summary effect size (5 pairs) or reported greater than a 2-fold difference in its magnitude (3 pairs). Non-Cochrane reviews reported significantly higher effect sizes (P < 0.001) and lower precision (P < 0.001) than matched Cochrane reviews. Reviews reporting an effect size at least 2-fold greater than their matched pair were cited more frequently. Conclusion Though results between topic-matched Cochrane and non-Cochrane reviews were quite similar, discrepant results were frequent, and the overlap of included studies was surprisingly low. Non-Cochrane reviews report larger effect sizes with lower precision than Cochrane reviews, indicating systematic differences, likely reflective of methodology, between the two types of reviews that could generate different interpretations of the interventions under question.	[Useem, Johanna; Brennan, Alana] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Brennan, Alana; Gill, Christopher J.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Brennan, Alana] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off,Dept Internal Med, Johannesburg, South Africa; [Vickery, Michelle; Ameli, Omid; Reinen, Nichole; Gill, Christopher J.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA	Boston University; Boston University; University of Witwatersrand; Boston University	Gill, CJ (corresponding author), Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA.	cgill@bu.edu	LaValley, Michael/AAA-2030-2020; Ameli, Omid/G-1583-2013	Brennan, Alana/0000-0002-7746-0668; gill, christopher/0000-0003-3353-0617; LaValley, Michael/0000-0002-8488-5170; Ameli, Omid/0000-0001-7878-0551				Callaham M, 2002, JAMA-J AM MED ASSOC, V287, P2847, DOI 10.1001/jama.287.21.2847; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; Ha TC, 2006, ANN ACAD MED SINGAP, V35, P911; Helfer B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0317-4; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Jorgensen AW, 2006, BMJ-BRIT MED J, V333, P782, DOI 10.1136/bmj.38973.444699.0B; McKenzie JE, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-80; Moseley AM, 2009, J CLIN EPIDEMIOL, V62, P1021, DOI 10.1016/j.jclinepi.2008.09.018; Rosenbaum SE, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-34; Siontis KC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4501; Starr M, 2009, INT J TECHNOL ASSESS, V25, P182, DOI 10.1017/S026646230909062X; Tricco AC, 2009, J CLIN EPIDEMIOL, V62, P380, DOI 10.1016/j.jclinepi.2008.08.008	13	34	34	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144980	10.1371/journal.pone.0144980	http://dx.doi.org/10.1371/journal.pone.0144980			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671213	gold, Green Published, Green Submitted			2022-12-27	WOS:000366719300036
J	Chen, YH; Hsieh, TF; Lee, CC; Wu, MJ; Fu, YC				Chen, Yi-Hsin; Hsieh, Teng-Fu; Lee, Ching-Chih; Wu, Ming-Ju; Fu, Yun-Ching			Estrogen Therapy and Ischemic Stroke in Women with Diabetes Aged Over 55 Years: A Nation-Wide Prospective Population-Based Study in Taiwan	PLOS ONE			English	Article							HORMONE-REPLACEMENT THERAPY; ENDOTHELIAL NITRIC-OXIDE; FACTOR-V-LEIDEN; CARDIOVASCULAR-DISEASE; POSTMENOPAUSAL WOMEN; ATRIAL-FIBRILLATION; GENDER-DIFFERENCES; RISK-FACTOR; SEX-DIFFERENCES; MEDROXYPROGESTERONE ACETATE	This study explores the possible association between the risk of ischemic stroke and conjugated equine estrogen (CEE) use in women who are over 55 years old and have diabetes. Data from the National Health Insurance system of Taiwan were used to identify 428 women over 55 years old with diabetes who used CEE (0.625 mg daily) from 2003 to 2009. For comparison, 21026 women with diabetes who were from the same cohort and did not use estrogen were used as a control group, excluding patients with previous ischemic stroke at the baseline. The propensity score method was used to identify a 1: 3 ratio for the matched cohort (n = 1284). Covariates used for propensity score-matching included age and comorbidities. Cox's proportional hazard model was applied to estimate the relationship between CEE use and ischemic stroke. The overall incidence of ischemic stroke was significantly lower in patients using CEE than in the control group (0.9% compared with 3.0%, p = 0.016). Further analyses using Cox's proportional hazard model revealed that after adjusting for age, comorbidities, socioeconomic status, urbanization, and other medications associated with ischemic stroke, a lower risk was present in patients with CEE use (hazard ratio: 0.34; 95% confidence interval: 0.12-0.97). Time of menopause could not be identified because of the nature of the database. CEE might decrease the risk of ischemic stroke in women with diabetes aged over 55 years, according to this population-based study.	[Chen, Yi-Hsin; Wu, Ming-Ju; Fu, Yun-Ching] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Chen, Yi-Hsin] Taichung Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Nephrol, Taichung, Taiwan; [Hsieh, Teng-Fu] Taichung Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Urol, Taichung, Taiwan; [Chen, Yi-Hsin; Hsieh, Teng-Fu; Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Lee, Ching-Chih] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Ctr Clin Epidemiol & Biostat, Chiayi, Taiwan; [Wu, Ming-Ju] Taichung Vet Gen Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan; [Wu, Ming-Ju] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Wu, Ming-Ju] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Fu, Yun-Ching] Taichung Vet Gen Hosp, Dept Pediat, Pediat Cardiol Sect, Taichung, Taiwan	National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Tzu Chi University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Taichung Veterans General Hospital; Chung Shan Medical University; China Medical University Taiwan; Taichung Veterans General Hospital	Wu, MJ (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan.	wmj530@gmail.com						Adams MR, 1997, ARTERIOSCL THROM VAS, V17, P217, DOI 10.1161/01.ATV.17.1.217; Baba Y, 2010, MENOPAUSE, V17, P506, DOI 10.1097/gme.0b013e3181c7dd41; Barros RPA, 2009, AM J PHYSIOL-ENDOC M, V297, pE124, DOI 10.1152/ajpendo.00189.2009; BRITTON M, 1985, STROKE, V16, P182, DOI 10.1161/01.STR.16.2.182; Chiang CH, 2012, J BONE MINER RES, V27, P1951, DOI 10.1002/jbmr.1645; Chiang TL, 1997, HEALTH POLICY, V39, P225, DOI 10.1016/S0168-8510(96)00877-9; Chow SN, 1997, J FORMOS MED ASSOC, V96, P806; Ferrara A, 2003, CIRCULATION, V107, P43, DOI 10.1161/01.CIR.0000042701.17528.95; FINUCANE FF, 1993, ARCH INTERN MED, V153, P73, DOI 10.1001/archinte.153.1.73; FOLSOM AR, 1995, AM J PUBLIC HEALTH, V85, P1128, DOI 10.2105/AJPH.85.8_Pt_1.1128; Foryst-Ludwig A, 2010, J STEROID BIOCHEM, V122, P74, DOI 10.1016/j.jsbmb.2010.06.012; Franzini L, 2013, NUTR METAB CARDIOVAS, V23, P235, DOI 10.1016/j.numecd.2011.12.003; FRIEDMAN GD, 1968, CIRCULATION, V38, P533, DOI 10.1161/01.CIR.38.3.533; Fujishima M, 1996, DIABETES, V45, pS14, DOI 10.2337/diab.45.3.S14; Fung MM, 1999, J WOMENS HEALTH, V8, P359, DOI 10.1089/jwh.1999.8.359; Glader EL, 2003, STROKE, V34, P1970, DOI 10.1161/01.STR.0000083534.81284.C5; Gobl CS, 2010, GENDER MED, V7, P593, DOI 10.1016/j.genm.2010.11.003; GORDON T, 1978, ANN INTERN MED, V89, P157, DOI 10.7326/0003-4819-89-2-157; Goto T, 2007, ANESTH ANALG, V104, P1016, DOI 10.1213/01.ane.0000263279.07361.1f; Grodstein F, 1999, EPIDEMIOLOGY, V10, P476, DOI 10.1097/00001648-199909000-00003; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Grodstein F, 1997, NEW ENGL J MED, V336, P1769, DOI 10.1056/NEJM199706193362501; HAYASHI T, 1995, BIOCHEM BIOPH RES CO, V214, P847, DOI 10.1006/bbrc.1995.2364; HENDERSON BE, 1991, ARCH INTERN MED, V151, P75, DOI 10.1001/archinte.151.1.75; Hira B, 2003, BJOG-INT J OBSTET GY, V110, P327, DOI 10.1016/S1470-0328(02)01590-2; Humphrey LL, 2002, ANN INTERN MED, V137, P273, DOI 10.7326/0003-4819-137-4-200208200-00012; HUNT K, 1990, BRIT J OBSTET GYNAEC, V97, P1080, DOI 10.1111/j.1471-0528.1990.tb02494.x; Huxley RR, 2011, AM J CARDIOL, V108, P56, DOI 10.1016/j.amjcard.2011.03.004; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Kobashi G, 1999, SEMIN THROMB HEMOST, V25, P487, DOI 10.1055/s-2007-994955; Kuo DJ, 2007, MATURITAS, V58, P259, DOI 10.1016/j.maturitas.2007.08.013; Labiche LA, 2002, ANN EMERG MED, V40, P453, DOI 10.1067/mem.2002.128682; LINDENSTROM E, 1993, STROKE, V24, P1468, DOI 10.1161/01.STR.24.10.1468; Lisabeth LD, 2009, STROKE, V40, P1044, DOI 10.1161/STROKEAHA.108.542993; Mascarenhas-Melo F, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-61; McCrohon JA, 1999, CIRCULATION, V100, P2319, DOI 10.1161/01.CIR.100.23.2319; Meendering JR, 2008, AM J PHYSIOL-HEART C, V294, pH1630, DOI 10.1152/ajpheart.01314.2007; Miyazaki-Akita A, 2007, J PHARMACOL EXP THER, V320, P591, DOI 10.1124/jpet.106.111641; Morabia A, 1998, AM J EPIDEMIOL, V148, P1195, DOI 10.1093/oxfordjournals.aje.a009609; Nilsson PM, 2004, SCAND J PRIM HEALTH, V22, P27, DOI 10.1080/02813430310003264; Ohmichi M, 2005, ENDOCR J, V52, P161, DOI 10.1507/endocrj.52.161; Pedersen AT, 1997, LANCET, V350, P1277, DOI 10.1016/S0140-6736(97)06005-4; Penno G, 2013, J INTERN MED, V274, P176, DOI 10.1111/joim.12073; Peters SAE, 2014, LANCET, V383, P1973, DOI 10.1016/S0140-6736(14)60040-4; PETERSEN P, 1986, STROKE, V17, P622, DOI 10.1161/01.STR.17.4.622; Petitti DB, 1998, STROKE, V29, P23, DOI 10.1161/01.STR.29.1.23; Pilote L, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.051455; POSTHUMA WFM, 1994, BRIT MED J, V308, P1268; Rivellese AA, 2010, NUTR METAB CARDIOVAS, V20, P474, DOI 10.1016/j.numecd.2010.01.008; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, CARDIOVASC RES, V53, P550, DOI 10.1016/S0008-6363(01)00478-3; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Schairer C, 1997, EPIDEMIOLOGY, V8, P59, DOI 10.1097/00001648-199701000-00010; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; STURGEON SR, 1995, EPIDEMIOLOGY, V6, P227, DOI 10.1097/00001648-199505000-00006; Su IH, 2012, MENOPAUSE, V19, P931, DOI 10.1097/gme.0b013e31824362ff; Tchernof A, 1998, CORONARY ARTERY DIS, V9, P503, DOI 10.1097/00019501-199809080-00006; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605; Vaccaro O, 2008, ATHEROSCLEROSIS, V198, P396, DOI 10.1016/j.atherosclerosis.2007.10.026; Vina J, 2006, FREE RADICAL RES, V40, P111, DOI 10.1080/10715760500405778; WALDEN CE, 1984, NEW ENGL J MED, V311, P953, DOI 10.1056/NEJM198410113111505; Wannamethee SG, 2012, DIABETOLOGIA, V55, P80, DOI 10.1007/s00125-011-2284-4; Wassmann K, 2005, CIRC RES, V97, P1046, DOI 10.1161/01.RES.0000188212.57180.55; WILSON PWF, 1985, NEW ENGL J MED, V313, P1038, DOI 10.1056/NEJM198510243131702; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	69	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144910	10.1371/journal.pone.0144910	http://dx.doi.org/10.1371/journal.pone.0144910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658781	gold, Green Submitted, Green Published			2022-12-27	WOS:000366715900145
J	Liu, XH; Tang, LM; Yang, LX; Zhang, XL; Wang, LQ; Yu, FX; Liu, Y; Chen, Q; Liu, DW				Liu, Xuehui; Tang, Longmei; Yang, Lixue; Zhang, Xiaolin; Wang, Liqin; Yu, Fengxue; Liu, Yi; Chen, Qing; Liu, Dianwu			Genotoxicity Evaluation of Irrigative Wastewater from Shijiazhuang City in China	PLOS ONE			English	Article							HUMAN HEALTH-RISK; HEAVY-METAL; COMET ASSAY; ORGANIC POLLUTION; MICRONUCLEUS TEST; DNA-DAMAGE; EFFLUENTS; SEWAGE; METABOLITES; TOXICITY	In the present study, the wastewater sample collected from the Dongming discharging river in Shijiazhuang city was analysed using both chemical analysis and biological assays including the Salmonella mutagenicity test, micronucleus test and single-cell gel electrophoresis. Chemical analysis of the sample was performed using gas chromatography mass spectrometry and inductively coupled plasma mass spectrometry. The Salmonella mutagenicity test was performed on Salmonella typhimurium TA97, TA98, TA100 and TA102 strains with and without S9 mixture. The mice received the wastewater in natura through drinking water at concentrations of 25%, 50%, and 100%. One group of mice was exposed for 2 consecutive days, and the other group of mice was exposed for 15 consecutive days. To establish the levels of primary DNA damage, single-cell gel electrophoresis was performed on treated mouse liver cell. The concentrations of chromium and lead in the sample exceeded the national standard (GB20922-2007) by 0.78 and 0.43-fold, respectively. More than 30 organic compounds were detected, and some of the detected compounds were mutagens, carcinogens and environmental endocrine disrupters. A positive response for Salmonella typhimurium TA98 strain was observed. Mouse exposure via drinking water containing 50% and 100% of wastewater for 15 consecutive days caused a significant increase of MN frequencies in a dose-response manner. Mouse exposure via drinking water containing 50% and 100% of wastewater for 15 consecutive days caused a significant increase of the Olive tail moments in a dose-response manner. All the results indicated that the sample from the Dongming discharging river in Shijiazhuang city exhibited genotoxicity and might pose harmful effects on the local residents.	[Liu, Xuehui] Hebei Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Shijiazhuang 050017, Hebei, Peoples R China; [Tang, Longmei; Zhang, Xiaolin; Wang, Liqin; Liu, Dianwu] Hebei Med Univ, Sch Publ Hlth, Dept Epidemiol & Hyg Stat, Shijiazhuang 050017, Hebei, Peoples R China; [Yang, Lixue] Shijiazhuang Ctr Dis Control & Prevent, Dept Phys & Chem Inspect, Shijiazhuang 050011, Hebei, Peoples R China; [Yu, Fengxue] Hebei Med Univ, Div Gastroenterol, Hosp 2, Shijiazhuang 050000, Hebei, Peoples R China; [Liu, Yi] Hebei Med Univ, Sch Publ Hlth, Dept Toxicol, Shijiazhuang 050017, Hebei, Peoples R China; [Chen, Qing] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Reprod Med, Xian 710061, Shanxi, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei Medical University; Xi'an Jiaotong University	Liu, DW (corresponding author), Hebei Med Univ, Sch Publ Hlth, Dept Epidemiol & Hyg Stat, Zhongshan East Rd 361, Shijiazhuang 050017, Hebei, Peoples R China.	Dwliu1956@hotmail.com			Health Department Science Research Foundation of Hebei Province [20090057]	Health Department Science Research Foundation of Hebei Province	This research was supported by the Health Department Science Research Foundation of Hebei Province (Project No. 20090057).	AGARWAL DK, 1985, J TOXICOL ENV HEALTH, V16, P61, DOI 10.1080/15287398509530719; AMES BN, 1975, MUTAT RES, V31, P347, DOI 10.1016/0165-1161(75)90046-1; [Anonymous], 2012, STANDARD METHODS EXA; Brendler-Schwaab S, 2005, MUTAGENESIS, V20, P245, DOI 10.1093/mutage/gei033; Celik A, 2005, MUTAGENESIS, V20, P411, DOI 10.1093/mutage/gei055; Chen Y, 2005, ENVIRON INT, V31, P778, DOI 10.1016/j.envint.2005.05.024; DEFLORA S, 1990, MUTAT RES, V238, P99, DOI 10.1016/0165-1110(90)90007-X; Dong YR, 2010, ECOTOX ENVIRON SAFE, V73, P944, DOI 10.1016/j.ecoenv.2009.12.026; Durgo K, 2009, J APPL TOXICOL, V29, P42, DOI 10.1002/jat.1381; Ferk F, 2009, MUTAT RES-GEN TOX EN, V672, P69, DOI 10.1016/j.mrgentox.2008.08.022; FRACASSO ME, 1992, MUTAT RES, V298, P91; Gambelunghe A, 2003, TOXICOLOGY, V188, P187, DOI 10.1016/S0300-483X(03)00088-X; GAUTHIER L, 1993, SCI TOTAL ENVIRON, V138, P249, DOI 10.1016/0048-9697(93)90419-7; Gibb HJ, 2000, AM J IND MED, V38, P115, DOI 10.1002/1097-0274(200008)38:2<115::AID-AJIM1>3.3.CO;2-P; Ginsberg G, 2011, J TOXICOL ENV HEAL A, V74, P1175, DOI 10.1080/15287394.2011.586943; Hamilton AJ, 2007, VADOSE ZONE J, V6, P823, DOI 10.2136/vzj2007.0026; He PJ, 2001, WATER SCI TECHNOL, V43, P51; Huang C, 1984, ENV PROTECTION, V16, P34; Ingwersen J, 2006, J ENVIRON QUAL, V35, P1702, DOI 10.2134/jeq2005.0412; Jimenez B, 2008, SCI TECH REP SER, P1; JUNK GA, 1974, J CHROMATOGR, V99, P745, DOI 10.1016/S0021-9673(00)90900-2; Kabdasli I, 2010, WATER SCI TECHNOL, V61, P2617, DOI 10.2166/wst.2010.202; Khan MU, 2013, CHEMOSPHERE, V93, P2230, DOI 10.1016/j.chemosphere.2013.07.067; Kleinsasser NH, 2001, HNO, V49, P378, DOI 10.1007/s001060050766; Kobori H, 2009, ENVIRON MONIT ASSESS, V151, P243, DOI 10.1007/s10661-008-0265-y; Konca K, 2003, MUTAT RES-GEN TOX EN, V534, P15, DOI 10.1016/S1383-5718(02)00251-6; Krishnamurthi K, 2008, ARCH TOXICOL, V82, P965, DOI 10.1007/s00204-008-0380-0; LECURIEUX F, 1993, MUTAT RES, V319, P223, DOI 10.1016/0165-1218(93)90082-O; Lefebvre O, 2006, WATER RES, V40, P3671, DOI 10.1016/j.watres.2006.08.027; Liu JR, 2009, ENVIRON POLLUT, V157, P357, DOI 10.1016/j.envpol.2008.10.004; Llorente MT, 2012, WATER RES, V46, P6351, DOI 10.1016/j.watres.2012.08.039; Ma J., 2008, THESIS; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; Moller P, 2006, BASIC CLIN PHARMACOL, V98, P336, DOI 10.1111/j.1742-7843.2006.pto_167.x; Oliveira-Martins CR, 2009, GENET MOL BIOL, V32, P853, DOI 10.1590/S1415-47572009005000094; PHILLIPS BJ, 1982, MUTAT RES, V102, P297, DOI 10.1016/0165-1218(82)90139-2; Piao FY, 2007, IND HEALTH, V45, P546, DOI 10.2486/indhealth.45.546; Radic S, 2010, SCI TOTAL ENVIRON, V408, P1228, DOI 10.1016/j.scitotenv.2009.11.055; Robbiano L, 1999, TOXICOL APPL PHARM, V161, P153, DOI 10.1006/taap.1999.8796; Santos DB, 2009, MUTAT RES-GEN TOX EN, V676, P21, DOI 10.1016/j.mrgentox.2009.03.006; Sasaki YF, 1997, MUTAT RES-GEN TOX EN, V391, P201, DOI 10.1016/S1383-5718(97)00072-7; SCHMID P, 1985, XENOBIOTICA, V15, P251, DOI 10.3109/00498258509045356; SCHMID W, 1975, MUTAT RES, V31, P9, DOI 10.1016/0165-1161(75)90058-8; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Singh S, 2006, ENVIRON MONIT ASSESS, V120, P79, DOI 10.1007/s10661-005-9050-3; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; SUTOU S, 1990, MUTAT RES, V234, P205; Tapisso JT, 2009, MUTAT RES-GEN TOX EN, V678, P59, DOI 10.1016/j.mrgentox.2009.07.001; Thewes MR, 2011, GENET MOL BIOL, V34, P689, DOI 10.1590/S1415-47572011005000055; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Tu JC, 2012, ENVIRON MONIT ASSESS, V184, P1645, DOI 10.1007/s10661-011-2067-x; VONLEDEB.M, 1973, MUTAT RES, V19, P109, DOI 10.1016/0027-5107(73)90118-8; Wei N, 2006, WATER SAVING IRRIGAT, V1, P31; Xu JA, 2010, J HAZARD MATER, V183, P780, DOI 10.1016/j.jhazmat.2010.07.094	54	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144729	10.1371/journal.pone.0144729	http://dx.doi.org/10.1371/journal.pone.0144729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658348	Green Submitted, gold, Green Published			2022-12-27	WOS:000366715900096
J	Wei, HX; Zhao, X; Yuan, RH; Dai, XM; Li, YS; Liu, L				Wei, Hanxiao; Zhao, Xian; Yuan, Ruihong; Dai, Xiaoming; Li, Yisong; Liu, Liu			Effects of PB-EPCs on Homing Ability of Rabbit BMSCs via Endogenous SDF-1 and MCP-1	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; PERIPHERAL-BLOOD; BONE DEFECT; VASCULARIZATION; RECRUITMENT; MIGRATION; REPAIR; MOBILIZATION	Traumas, infections, tumors, and some congenital malformations can lead to bone defects or even bone loss. The goal of the present study was to investigate whether inclusion of endothelial progenitor cells derived from peripheral blood (PB-EPCs) in cell-seeded partially deproteinized bone (PDPB) implants would stimulate recruitment of systemically injected bone marrow stromal cells (BMSCs) to the implant. Methods: BMSCs were injected intravenously with lentiviral expression vector expressing enhanced green fluorescent protein (eGFP) for tracing. Recruitment of eGFP-positive BMSCs was tested for the following implant configurations: 1) seeded with both BMSC and PB-EPC, 2) BMSC alone, 3) PBEPC alone, and 4) unseeded PDPB. Protein and mRNA levels of endogenous stromal-derived factor-1 (SDF-1) and its receptor CXCR4, as well as monocyte chemotactic protein-1 (MCP-1) and its receptor CCR2, were evaluated on the 8th week. Immunohistochemical staining was performed to determine eGFP-positive areas at the defective sites. Masson's trichrome staining was conducted to observe the distribution of collagen deposition and evaluate the extent of osteogenesis. Results: The mRNA and protein levels of SDF-1 and CXCR4 in the co-culture group were higher than those in other groups (p < 0.05) 8 weeks after the surgery. MCP-1 mRNA level in the co-culture group was also higher than that in the other groups (p < 0.05). Immunohistochemical assays revealed that the area covered by eGFP-positive cells was larger in the co-culture group than in the other groups (p < 0.05) after 4 weeks. Masson's trichrome staining revealed better osteogenic potential of the co-culture group compared to the other groups (p < 0.05). Conclusion: These experiments demonstrate an association between PB-EPC and BMSC recruitment mediated by the SDF-1/CXCR4 axis that can enhance repair of bone defects.	[Wei, Hanxiao; Zhao, Xian; Yuan, Ruihong; Dai, Xiaoming; Li, Yisong; Liu, Liu] Kunming Med Univ, Dept Plast Surg, Affiliated Hosp 1, Kunming, Yunnan Province, Peoples R China	Kunming Medical University	Liu, L (corresponding author), Kunming Med Univ, Dept Plast Surg, Affiliated Hosp 1, Kunming, Yunnan Province, Peoples R China.	249121382@qq.com			Natural Science Foundation of China [81460298]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (Grant No: 81460298). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Amini AR, 2012, J ORTHOP RES, V30, P1507, DOI 10.1002/jor.22097; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Atesok K, 2010, J ORTHOP RES, V28, P1007, DOI 10.1002/jor.21083; Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003; Benameur T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012392; Caiado F, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-4; Chen FM, 2011, BIOMATERIALS, V32, P3189, DOI 10.1016/j.biomaterials.2010.12.032; Cheng M, 2015, J MOL CELL CARDIOL, V81, P49, DOI 10.1016/j.yjmcc.2015.01.024; Chiang CH, 2010, J CELL PHYSIOL, V223, P492, DOI 10.1002/jcp.22068; Dar A, 2011, LEUKEMIA, V25, P1286, DOI 10.1038/leu.2011.62; Duttenhoefer F, 2013, EUR CELLS MATER, V26, P49; Fu WL, 2015, TISSUE ENG PT A, V21, P948, DOI [10.1089/ten.TEA.2014.0267, 10.1089/ten.tea.2014.0267]; Fujio M, 2011, BONE, V49, P693, DOI 10.1016/j.bone.2011.06.024; Han YG, 2014, J VASC RES, V51, P369, DOI 10.1159/000368929; Hosogane N, 2010, INT J BIOCHEM CELL B, V42, P1132, DOI 10.1016/j.biocel.2010.03.020; Kaigler D, 2005, FASEB J, V19, P665, DOI 10.1096/fj.04-2529fje; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; Koga M, 2009, TISSUE ENG PT A, V15, P2727, DOI [10.1089/ten.tea.2008.0417, 10.1089/ten.TEA.2008.0417]; Kucia M, 2004, J MOL HISTOL, V35, P233; Lapidot T, 2002, LEUKEMIA, V16, P1992, DOI 10.1038/sj.leu.2402684; Neuss S, 2004, STEM CELLS, V22, P405, DOI 10.1634/stemcells.22-3-405; Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515; Papadimitropoulos A, 2011, EUR CELLS MATER, V21, P445, DOI 10.22203/eCM.v021a33; Penna C, 2013, J CELL MOL MED, V17, P192, DOI 10.1111/j.1582-4934.2012.01662.x; Pons J, 2008, BIOCHEM BIOPH RES CO, V376, P419, DOI 10.1016/j.bbrc.2008.09.003; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Rouwkema J, 2009, TISSUE ENG PT A, V15, P2015, DOI 10.1089/ten.tea.2008.0318; Ryu CH, 2010, BIOCHEM BIOPH RES CO, V398, P105, DOI 10.1016/j.bbrc.2010.06.043; Seebach C, 2010, TISSUE ENG PT A, V16, P1961, DOI 10.1089/ten.TEA.2009.0715; Shi Y, 2014, EUR CELLS MATER, V27, P64, DOI 10.22203/eCM.v027a06; Sierra MD, 2004, BLOOD, V103, P2452; Steingen C, 2008, J MOL CELL CARDIOL, V44, P1072, DOI 10.1016/j.yjmcc.2008.03.010; Sukegawa A, 2012, TISSUE ENG PT A, V18, P934, DOI [10.1089/ten.tea.2011.0380, 10.1089/ten.TEA.2011.0380]; Usami K, 2009, J BIOMED MATER RES A, V90A, P730, DOI 10.1002/jbm.a.32142; Varda-Bloom N, 2014, ISR MED ASSOC J, V16, P774; Wang JF, 2000, BLOOD, V95, P2505, DOI 10.1182/blood.V95.8.2505.008k24_2505_2513; Wang Y, 2008, BRAIN RES, V1195, P104, DOI 10.1016/j.brainres.2007.11.068; Zaruba MM, 2010, EXPERT OPIN BIOL TH, V10, P321, DOI 10.1517/14712590903460286; Zhu W, 2007, J BIOL CHEM, V282, P18676, DOI 10.1074/jbc.M610232200	40	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145044	10.1371/journal.pone.0145044	http://dx.doi.org/10.1371/journal.pone.0145044			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660527	Green Published, Green Submitted, gold			2022-12-27	WOS:000366715900175
J	Wondimu, A; Molla, F; Abrha, S; Mohammed, J; Demeke, B; Eticha, T; Assen, A; Melkam, W; Gebre-Samuel, N; Berhe, DF; Tadese, E; Endris, K				Wondimu, Abrham; Molla, Fantahun; Abrha, Solomon; Mohammed, Jemal; Demeke, Birhanu; Eticha, Tadele; Assen, Admassu; Melkam, Wondim; Gebre-Samuel, Naod; Berhe, Derbew Fikadu; Tadese, Ebisa; Endris, Kedir			Drug Use during Acute Illness in Tigray Region, Northern Ethiopia: A Household Study	PLOS ONE			English	Article							PATTERN	Background Drug use study in the community enables health authorities to understand pattern of drug utilization and its related aspects. This, in turn, can help to develop rational drug policies to be harmonized in accordance to the need of the community. Objective The aim of this study was to assess drug use during acute illness by the general population in Tigray region, Northern Ethiopia. Method A community based cross-sectional study was undertaken in April 2013 in Tigray Region, Ethiopia. A total of 1034 households were interviewed in the study. A multi-stage sampling technique was used to select households. Data were collected using a pre-tested structured questionnaire. Data were analyzed using descriptive statistics and bivariate and multivariate logistic regression model. Results Out of 1000 households, 210(21%) reported an episode of acute illness. The prevalence of acute illnesses in rural areas 126(25%) (AOR = 1.83, 95% CI: 1.21-2.76) was significantly higher than that of urban areas 84(17%). Cough, runny nose, sore throat, earache, fever and headache added up to 155(52%) of all reported symptoms of acute illnesses. The majority of the patients 162 (77%) took modern medications for the managements of their diseases. Half 105(50%) of the consumed medications were antibiotics. The large proportions 173(83%) of medicines for acute illness were taken orally. The greater proportions 150 (93%) of medications were prescribed by health professionals. Thirty-four households (21%) reported treatment discontinuation. Conclusion The prevalence of acute illnesses in this study was found to be 21%. Acute illnesses were more common in rural areas than urban areas. Antibiotics were the most frequently used drugs for acute illnesses.	[Wondimu, Abrham; Molla, Fantahun; Abrha, Solomon; Mohammed, Jemal; Demeke, Birhanu; Eticha, Tadele; Assen, Admassu; Melkam, Wondim; Gebre-Samuel, Naod; Berhe, Derbew Fikadu; Tadese, Ebisa] Mekelle Univ, Coll Hlth Sci, Dept Pharm, Mekelle, Ethiopia; [Endris, Kedir] Mekelle Univ, Coll Hlth Sci, Dept Nursing, Mekelle, Ethiopia	Mekelle University; Mekelle University	Wondimu, A (corresponding author), Mekelle Univ, Coll Hlth Sci, Dept Pharm, Mekelle, Ethiopia.	leabrham@gmail.com	Berhe, Derbew Fikadu/K-8802-2019	Berhe, Derbew Fikadu/0000-0002-0669-9241; Kassa, Fantahun Molla/0000-0002-4556-1245; Abrha, Solomon/0000-0002-8192-6985; Dagne, Abrham Wondimu/0000-0002-3922-287X	Mekelle University [CHS/RB/14/2012]	Mekelle University	This study is financially supported by Mekelle University (grant number is CHS/RB/14/2012). The author AW received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abula T., 2001, Ethiopian Journal of Health Development, V15, P25; Abula T., 2003, ETHIOP J HEALTH DEV, V3, P231; Amare G, 1997, E AFR MED J, V74, P362; Assen A., 2014, INT J PHARM SCI RES, V5, P777; Calva J, 1996, SOC SCI MED, V42, P1121, DOI 10.1016/0277-9536(95)00385-1; CSA, 2008, SUMM STAT REP 2007 P; Demeke B., 2015, IJPSR, V6, P343; Desalegn AA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-170; Desta Z, 1997, E AFR MED J, V74, P758; Eticha T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097464; Gottlieb H, 2000, MEDICATION NONADHERE; Gurbani N, 2011, PHARM TIMES, V43, P23; Kayode OM, 2012, J PHARM BIOMED SCI, V22, P1; Kloos H, CONTEXT MED DEV COUN, P81; KRISHNASWAMY K, 1985, EUR J CLIN PHARMACOL, V29, P363, DOI 10.1007/BF00544095; Le Grand A, 1999, HEALTH POLICY PLANN, V14, P89, DOI 10.1093/heapol/14.2.89; Ministry of Medical Services and Ministry of Public Health and Sanitation, 2009, ACC ESS MED KEN HOUS; Shankar P. R., 2003, SMJ Singapore Medical Journal, V44, P352; Thiruthopu Nimbagiri Swamy, 2014, Perspect Clin Res, V5, P178, DOI 10.4103/2229-3485.140558; WHO, 2009, PHIL PHARM SIT 2009; WHO, 2008, WHO LEV 2 HOUS SURV	21	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145007	10.1371/journal.pone.0145007	http://dx.doi.org/10.1371/journal.pone.0145007			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26658645	Green Published, gold			2022-12-27	WOS:000366715900165
J	Barsova, RM; Lvovs, D; Titov, BV; Matveeva, NA; Shakhnovich, RM; Sukhinina, TS; Kukava, NG; Ruda, MY; Karamova, IM; Nasibullin, TR; Mustafina, OE; Osmak, GJ; Tsareva, EY; Kulakova, OG; Favorov, AV; Favorova, OO				Barsova, Rosa M.; Lvovs, Dmitrijs; Titov, Boris V.; Matveeva, Natalia A.; Shakhnovich, Roman M.; Sukhinina, Tatiana S.; Kukava, Nino G.; Ruda, Mikhail Ya; Karamova, Irina M.; Nasibullin, Timur R.; Mustafina, Olga E.; Osmak, German J.; Tsareva, Ekaterina Yu; Kulakova, Olga G.; Favorov, Alexander V.; Favorova, Olga O.			Variants of the Coagulation and Inflammation Genes Are Replicably Associated with Myocardial Infarction and Epistatically Interact in Russians	PLOS ONE			English	Article							C-REACTIVE-PROTEIN; CORONARY-HEART-DISEASE; TRANSFORMING GROWTH-FACTOR-BETA-1 GENE; GENOME-WIDE ASSOCIATION; COMPLEMENT-FACTOR-H; CARDIOVASCULAR-DISEASE; ARTERY-DISEASE; POLYMORPHISMS; FIBRINOGEN; RISK	Background In spite of progress in cardiovascular genetics, data on genetic background of myocardial infarction are still limited and contradictory. This applies as well to the genes involved in inflammation and coagulation processes, which play a crucial role in the disease etiopathogenesis. Methods and Results In this study we found genetic variants of TGFB1, FGB and CRP genes associated with myocardial infarction in discovery and replication groups of Russian descent from the Moscow region and the Republic of Bashkortostan (325/185 and 220/197 samples, correspondingly). We also found and replicated biallelic combinations of TGFB1 with FGB, TGFB1 with CRP and IFNG with PTGS1 genetic variants associated with myocardial infarction providing a detectable cumulative effect. We proposed an original two-component procedure for the analysis of nonlinear (epistatic) interactions between the genes in biallelic combinations and confirmed the epistasis hypothesis for the set of alleles of IFNG with PTGS. The procedure is applicable to any pair of logical variables, e.g. carriage of two sets of alleles. The composite model that included three single gene variants and the epistatic pair has AUC of 0.66 both in discovery and replication groups. Conclusions The genetic impact of TGFB1, FGB, CRP, IFNG, and PTGS and/or their biallelic combinations on myocardial infarction was found and replicated in Russians. Evidence of epistatic interactions between IFNG with PTGS genes was obtained both in discovery and replication groups.	[Barsova, Rosa M.; Titov, Boris V.; Matveeva, Natalia A.; Tsareva, Ekaterina Yu; Kulakova, Olga G.; Favorova, Olga O.] Russian Cardiol Sci & Prod Ctr, Inst Expt Cardiol, Moscow, Russia; [Lvovs, Dmitrijs; Favorov, Alexander V.] Russian Acad Sci, Vavilov Inst Gen Genet, Dept Computat Biol, Moscow, Russia; [Titov, Boris V.; Matveeva, Natalia A.; Osmak, German J.; Tsareva, Ekaterina Yu; Kulakova, Olga G.; Favorova, Olga O.] Pirogov Russian Natl Res Med Univ, Dept Mol Biol & Med Biotechnol, Moscow, Russia; [Shakhnovich, Roman M.; Sukhinina, Tatiana S.; Kukava, Nino G.; Ruda, Mikhail Ya] Russian Cardiol Sci & Prod Ctr, Dept Emergency Cardiol, Moscow, Russia; [Karamova, Irina M.] Republican Cardiol Hlth Ctr, Div Cardiol, Ufa, The Republic Of, Russia; [Nasibullin, Timur R.; Mustafina, Olga E.] Russian Acad Sci, Dept Genom, Ufa Res Ctr, Inst Biochem & Genet, Ufa 450001, Russia; [Favorov, Alexander V.] Johns Hopkins Sch Med, Dept Oncol, Div Biostat & Bioinformat, Baltimore, MD USA	National Medical Research Center of Cardiology; Russian Academy of Sciences; Vavilov Institute of General Genetics; Pirogov Russian National Research Medical University; National Medical Research Center of Cardiology; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Johns Hopkins University; Johns Hopkins Medicine	Favorov, AV (corresponding author), Russian Acad Sci, Vavilov Inst Gen Genet, Dept Computat Biol, Moscow, Russia.	favorov@sensi.org	Nasibullin, Timur/C-2432-2017; Osmak, German/AAB-4101-2020; Favorova, Olga O/U-7912-2017; Titov, Boris V./N-3505-2016; Favorov, Alexander V/K-2699-2018; Kulakova, Olga/S-1426-2019; Tsareva, Ekaterina/AAO-6978-2020; Stefanadis, Christodoulos/ABH-2232-2020; Matveeva, Natalya A/AAH-6794-2020; Mustafina, Olga Evgenevna/A-4229-2016	Nasibullin, Timur/0000-0001-8823-8678; Titov, Boris V./0000-0002-2585-8471; Favorov, Alexander V/0000-0003-2595-1091; Tsareva, Ekaterina/0000-0003-2535-9450; Stefanadis, Christodoulos/0000-0001-5974-6454; Matveeva, Natalya A/0000-0002-4369-2882; Mustafina, Olga Evgenevna/0000-0002-5118-6533; Kulakova, Olga/0000-0002-5321-3101; Osmak, German/0000-0001-7839-9929; Favorova, Olga/0000-0002-5271-6698; Suhinina, Tat'ana/0000-0002-5509-6623	Russian Foundation for Basic Research [14-04-00984, 13-04-40279-H]; Russian Science Foundation [14-14-00605]; National Institutes of Health [P30 CA006973]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Russian Foundation for Basic Research (grants 14-04-00984 to RMB, BVT, RMS, OOF and 13-04-40279-H to AVF) [http://www.rfbr.ru/rffi/eng]; by the Russian Science Foundation (grant 14-14-00605 to NAM, EYuT, OGK) [http://rscf.ru/en/]; and by National Institutes of Health (P30 CA006973 to AVF) [http://www.nih.gov/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki A, 2011, J HUM GENET, V56, P47, DOI 10.1038/jhg.2010.141; Barsova RM, 2012, ACTA NATURAE, V4, P74, DOI 10.32607/20758251-2012-4-2-74-79; Cambien F, 1996, HYPERTENSION, V28, P881, DOI 10.1161/01.HYP.28.5.881; Carty CL, 2008, THROMB HAEMOSTASIS, V99, P388, DOI 10.1160/TH07-08-0523; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Cortina-Borja Mario, 2009, BMC Res Notes, V2, P105, DOI 10.1186/1756-0500-2-105; Crobu F, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-13; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Falk E, 2013, EUR HEART J, V34, P719, DOI 10.1093/eurheartj/ehs411; Favorov AV, 2005, GENETICS, V171, P2113, DOI 10.1534/genetics.105.048090; Gigante B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011300; Harvey EJ, 2005, CARDIOVASC RES, V67, P11, DOI 10.1016/j.cardiores.2005.04.019; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hermann M, 2012, ATHEROSCLEROSIS, V220, P172, DOI 10.1016/j.atherosclerosis.2011.10.019; Hirokawa M, 2015, EUR J HUM GENET, V23, P374, DOI 10.1038/ejhg.2014.110; Jylhava J, 2009, CLIN EXP IMMUNOL, V155, P53, DOI 10.1111/j.1365-2249.2008.03752.x; Kardys I, 2007, AM J CARDIOL, V100, P646, DOI 10.1016/j.amjcard.2007.03.079; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Koch W, 2006, ARTERIOSCL THROM VAS, V26, P1114, DOI 10.1161/01.ATV.0000217747.66517.11; Koch W, 2008, ARTERIOSCL THROM VAS, V28, P758, DOI 10.1161/ATVBAHA.107.157842; Lemaitre Rozenn N, 2009, Atherosclerosis, V204, pe58, DOI 10.1016/j.atherosclerosis.2008.10.011; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Licastro F, 2007, ANN NY ACAD SCI, V1119, P227, DOI 10.1196/annals.1404.004; Lu XF, 2008, CHINESE MED J-PEKING, V121, P1549, DOI 10.1097/00029330-200808020-00009; Lucas G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041730; Lvovs D, 2012, ACTA NATURAE, V4, P59, DOI 10.32607/20758251-2012-4-3-59-71; Maksimov V N, 2012, Vestn Ross Akad Med Nauk, P24; Mannila MN, 2006, THROMB HAEMOSTASIS, V95, P420, DOI 10.1160/TH05-11-0777; Nurgazieva D, 2015, J IMMUNOL, V194, P709, DOI 10.4049/jimmunol.1300272; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Roberts R, 2014, CIRC RES, V114, P1890, DOI 10.1161/CIRCRESAHA.114.302692; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V103, P506, DOI 10.1093/oxfordjournals.aje.a112252; Sambrook J, 1989, MOL CLONING; Shakhnovitch RM, 2010, KARDIOLOGIYA, V50, P4; Siegerink B, 2009, J THROMB HAEMOST, V7, P385, DOI 10.1111/j.1538-7836.2008.03266.x; Singh A, 2015, EUR J HUM GENET, V23, P854, DOI 10.1038/ejhg.2014.189; Singh P, 2014, MOL BIOL REP, V41, P5851, DOI 10.1007/s11033-014-3459-0; Tousoulis D, 2011, BLOOD REV, V25, P239, DOI 10.1016/j.blre.2011.05.001; Wei WH, 2014, NAT REV GENET, V15, P722, DOI 10.1038/nrg3747; White D.R., 1983, CROSS-CULT RES, V18, P103, DOI DOI 10.1177/106939718301800201.; Yamada Y, 2011, ATHEROSCLEROSIS, V215, P145, DOI 10.1016/j.atherosclerosis.2010.12.005; Yokota M, 2000, CIRCULATION, V101, P2783, DOI 10.1161/01.CIR.101.24.2783; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	45	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144190	10.1371/journal.pone.0144190	http://dx.doi.org/10.1371/journal.pone.0144190			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658659	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903500016
J	Galluzzi, G; Dufour, D; Thomas, E; van Zonneveld, M; Salamanca, AFE; Toro, AG; Rivera, A; Duque, HS; Baron, HS; Gallego, G; Scheldeman, X; Mejia, AG				Galluzzi, Gea; Dufour, Dominique; Thomas, Evert; van Zonneveld, Maarten; Escobar Salamanca, Andres Felipe; Giraldo Toro, Andres; Rivera, Andres; Salazar Duque, Hector; Suarez Baron, Harold; Gallego, Gerardo; Scheldeman, Xavier; Gonzalez Mejia, Alonso			An Integrated Hypothesis on the Domestication of Bactris gasipaes	PLOS ONE			English	Article							NUT BERTHOLLETIA-EXCELSA; CULTIVATED POPULATIONS; GENETIC-RESOURCES; NEW-WORLD; KUNTH; DIVERSITY; PATTERNS; PALMAE; AMAZON; WILD	Peach palm (Bactris gasipaes Kunth) has had a central place in the livelihoods of people in the Americas since pre-Columbian times, notably for its edible fruits and multi-purpose wood. The botanical taxon includes both domesticated and wild varieties. Domesticated var gasipaes is believed to derive from one or more of the three wild types of var. chichagui identified today, although the exact dynamics and location of the domestication are still uncertain. Drawing on a combination of molecular and phenotypic diversity data, modeling of past climate suitability and existing literature, we present an integrated hypothesis about peach palm's domestication. We support a single initial domestication event in south western Amazonia, giving rise to var. chichagui type 3, the putative incipient domesticate. We argue that subsequent dispersal by humans across western Amazonia, and possibly into Central America allowed for secondary domestication events through hybridization with resident wild populations, and differential human selection pressures, resulting in the diversity of present-day landraces. The high phenotypic diversity in the Ecuadorian and northern Peruvian Amazon suggest that human selection of different traits was particularly intense there. While acknowledging the need for further data collection, we believe that our results contribute new insights and tools to understand domestication and dispersal patterns of this important native staple, as well as to plan for its conservation.	[Galluzzi, Gea; Thomas, Evert; Scheldeman, Xavier] Biovers Int, Reg Off Amer, Cali, Valle Del Cauca, Colombia; [Dufour, Dominique] Ctr Cooperac Int invest Agron Desarrollo, CIRAD, Cali, Valle Del Cauca, Colombia; [van Zonneveld, Maarten] Biovers Int, Subreg Off Amer, Turrialba, Cartago, Costa Rica; [Escobar Salamanca, Andres Felipe; Giraldo Toro, Andres; Rivera, Andres; Gallego, Gerardo; Gonzalez Mejia, Alonso] Ctr Int Agr Trop, Cali, Valle Del Cauca, Colombia; [Salazar Duque, Hector] Univ Quindio, Programa Biol, Armenia, Colombia; [Suarez Baron, Harold] Univ Antioquia, Inst Biol, Medellin, Colombia	Alliance; Bioversity International; CIRAD; Alliance; Bioversity International; Alliance; International Center for Tropical Agriculture - CIAT; Universidad del Quindio; Universidad de Antioquia	Galluzzi, G (corresponding author), Biovers Int, Reg Off Amer, Cali, Valle Del Cauca, Colombia.	geagalluzzi@gmail.com	Toro, Andres Giraldo/AAF-2957-2019; Scheldeman, Xavier/AAF-7960-2021; Scheldeman, Xavier/ABE-9909-2021	Scheldeman, Xavier/0000-0001-7967-7361; Giraldo Toro, Andres/0000-0001-9208-4878	Amazon Initiative; MIDAS programme	Amazon Initiative; MIDAS programme	The authors are grateful to the Amazon Initiative and the MIDAS programme for the funding received for this study. The authors also wish to thank the CGIAR programme on Forest Trees and Agroforestry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adin A, 2004, THEOR APPL GENET, V108, P1564, DOI 10.1007/s00122-003-1581-9; Hernandez-Ugalde JA, 2011, GENET RESOUR CROP EV, V58, P571, DOI 10.1007/s10722-010-9600-6; [Anonymous], 2014, ETHNOLOGUE LANGUAGES; Arroyo C, 1996, PEJIBAYE, V5, P18; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Brush SB, 2000, GENES IN THE FIELD, P3; Casas A, 2006, BIODIVERS CONSERV, V15, P879, DOI 10.1007/s10531-004-2934-7; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Clement C, 2009, MOBILITY MIGRATION I, P115; Clement C. R., 1988, Advances in Economic Botany, V6, P155; CLEMENT C R, 1989, Boletim do Museu Paraense Emilio Goeldi Serie Botanica, V5, P39; Clement C. R., 2010, Diversity, V2, P72; Clement CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004564; Clement CR, 2004, AGROFOREST SYST, V61-2, P195, DOI 10.1023/B:AGFO.0000028999.84655.17; Clement CR, 1997, ECON BOT, V51, P149, DOI 10.1007/BF02893108; Clement CR, 1999, ECON BOT, V53, P203, DOI 10.1007/BF02866499; Clement CR, 1995, EVOLUTION CROP PLANT, P383; Clement CR, COMMUNICATION; Clement CR, 2001, ANN 3 S REC GEN AM L, P517; Cole DM, 2007, GENET RESOUR CROP EV, V54, P189, DOI 10.1007/s10722-005-3134-3; Corrales-Ulloa F, 1990, B PEJIBAYE GUILIELMA, V2, P1; Couvreur TLP, 2006, GENET RESOUR CROP EV, V53, P1361, DOI 10.1007/s10722-005-5033-z; De Cristo-Araujo M, 2013, TIPITI, V11, P74; de Cristo-Araujo M, 2015, CROP BREED APPL BIOT, V15, P18, DOI 10.1590/1984-70332015v15n1a3; ESRI, 2011, ARCGIS DESKT REL 10; Ferreira E, 1999, MEM NEW YORK BOTAN G, V83, P225; Frankel OH, 1995, CONSERVATION PLANT B; Graefe S, 2013, BIODIVERS CONSERV, V22, P269, DOI 10.1007/s10531-012-0402-3; Henderson A, 2000, FLORA NEOTROP, V79, P1; Ugalde JAH, 2008, REV BIOL TROP, V56, P217; Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1; Huber J, 1904, B MUSEU GOELDI HIST, V4, P375; Hughes CE, 2007, P NATL ACAD SCI USA, V104, P14389, DOI 10.1073/pnas.0702193104; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kindt R, 2005, TREE DIVERSITY ANAL, P197; Lahaye C, 2013, J ARCHAEOL SCI, V40, P2840, DOI 10.1016/j.jas.2013.02.019; Leeuwen J. van, 2005, Agrociencia (Montevideo), V9, P61; Martinez AK, 2002, MOL ECOL NOTES, V2, P408, DOI 10.1046/j.1471-8286.2002.00256.x; Meyer RS, 2012, NEW PHYTOL, V196, P29, DOI 10.1111/j.1469-8137.2012.04253.x; Mora S, 2003, U PITTSBURG LATIN AM; Mora Urpi J, 1999, PALMITO PEJIBAYE BAC, P17; Mora-Urpi J., 1997, PEACH PALM BACTRIS G; Mora-Urpi J, 1984, ORIGEN BIOL FLORAL M, P18; Mora-Urpi J, 1993, 4 C INT BIOL AGR IND, P21; Morcote-Rios G, 2001, BOT REV, V67, P309, DOI 10.1007/BF02858098; Morueta-Holme N, 2013, ECOL LETT, V16, P1446, DOI 10.1111/ele.12184; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Neves EG, 2004, AMAZONIAN DARK EARTHS: EXPLORATIONS IN SPACE AND TIME, P125; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Patino VM, 1963, PLANTAS CULTIVADAS A; Perrault-Archambault M, 2008, ECON BOT, V62, P109, DOI 10.1007/s12231-008-9010-2; Piperno D.R., 1998, ORIGINS AGR LOWLAND; Piperno DR, 2011, CURR ANTHROPOL, V52, pS453, DOI 10.1086/659998; Piperno DR, 2003, SCIENCE, V299, P1054, DOI 10.1126/science.1080365; Prance GT, 1984, PRECOLUMBIAN PLANT M, P85; R Core Team, 2021, R LANGUAGE ENV STAT; Ramirez Villegas J., 2010, DOWNSCALING GLOBAL C; Ranere AJ, 2003, CANOPY ARCHAEOLOGY T, P219; RIVAL L, 1993, MAN, V28, P635, DOI 10.2307/2803990; Rodrigues DP, 2004, GENET RESOUR CROP EV, V51, P871, DOI 10.1007/s10722-005-0774-2; Roosevelt AC, 2013, ANTHROPOCENE, V4, P69, DOI 10.1016/j.ancene.2014.05.001; Roosevelt AC, 1996, SCIENCE, V272, P373, DOI 10.1126/science.272.5260.373; Smith N, 2015, GEOBOT STUD, P1, DOI 10.1007/978-3-319-05509-1; Solorzano RGL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048438; Stone D, 1951, DEFINICION DISTINTAS, P353; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Thomas E., 2014, Boletim do Museu Paraense Emilio Goeldi, Ciencias Naturais, V9, P267; Thomas E, 2008, THESIS GHENT U; Thomas E, 2015, J BIOGEOGR, V42, P1367, DOI 10.1111/jbi.12540; Thomas E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047676; Thomas E, 2010, AGROFOREST SYST, V80, P131, DOI 10.1007/s10457-010-9315-x; Valdez F, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P865, DOI 10.1007/978-0-387-74907-5_43; van der Hammen T, 2000, QUATERNARY SCI REV, V19, P725, DOI 10.1016/S0277-3791(99)00024-4; van Zonneveld M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029845	75	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144644	10.1371/journal.pone.0144644	http://dx.doi.org/10.1371/journal.pone.0144644			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26658881	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903500051
J	Trier, NH; Dam, CE; Olsen, DT; Hansen, PR; Houen, G				Trier, Nicole Hartwig; Dam, Catharina Essendrup; Olsen, Dorthe Tange; Hansen, Paul Robert; Houen, Gunnar			Contribution of Peptide Backbone to Anti-Citrullinated Peptide Antibody Reactivity	PLOS ONE			English	Article							EARLY RHEUMATOID-ARTHRITIS; COLLAGEN TYPE-II; PROTEIN/PEPTIDE ANTIBODIES; PROTEIN ANTIBODY; ALPHA-ENOLASE; AUTOANTIBODIES; DISEASE; EPITOPES; IDENTIFICATION; DETERMINANTS	Rheumatoid arthritis (RA) is one of the most common autoimmune diseases, affecting approximately 1-2% of the world population. One of the characteristic features of RA is the presence of autoantibodies. Especially the highly specific anti-citrullinated peptide antibodies (ACPAs), which have been found in up to 70% of RA patients' sera, have received much attention. Several citrullinated proteins are associated with RA, suggesting that ACPAs may react with different sequence patterns, separating them from traditional antibodies, whose reactivity usually is specific towards a single target. As ACPAs have been suggested to be involved in the development of RA, knowledge about these antibodies may be crucial. In this study, we examined the influence of peptide backbone for ACPA reactivity in immunoassays. The antibodies were found to be reactive with a central Cit-Gly motif being essential for ACPA reactivity and to be cross-reactive between the selected citrullinated peptides. The remaining amino acids within the citrullinated peptides were found to be of less importance for antibody reactivity. Moreover, these findings indicated that the Cit-Gly motif in combination with peptide backbone is essential for antibody reactivity. Based on these findings it was speculated that any amino acid sequence, which brings the peptide into a properly folded structure for antibody recognition is sufficient for antibody reactivity. These findings are in accordance with the current hypothesis that structural homology rather than sequence homology are favored between citrullinated epitopes. These findings are important in relation to clarifying the etiology of RA and to determine the nature of ACPAs, e.g. why some Cit-Gly-containing sequences are not targeted by ACPAs.	[Trier, Nicole Hartwig; Dam, Catharina Essendrup; Olsen, Dorthe Tange; Houen, Gunnar] Statens Serum Inst, Dept Autoimmunol & Biomarkers, DK-2300 Copenhagen S, Denmark; [Hansen, Paul Robert] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, DK-2100 Copenhagen O, Denmark	Statens Serum Institut; University of Copenhagen	Trier, NH (corresponding author), Statens Serum Inst, Dept Autoimmunol & Biomarkers, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	nhp@ssi.dk	Trier, Nicole/AAA-5164-2020	Hansen, Paul Robert/0000-0001-9357-8001; Trier, Nicole/0000-0003-1548-2009				Burkhardt H, 2005, EUR J IMMUNOL, V35, P1643, DOI 10.1002/eji.200526000; Coenen D, 2007, CLIN CHEM, V53, P498, DOI 10.1373/clinchem.2006.078063; Girbal-Neuhauser E, 1999, J IMMUNOL, V162, P585; Ioan-Facsinay A, 2008, ARTHRITIS RHEUM-US, V58, P3000, DOI 10.1002/art.23763; Ioan-Facsinay A, 2011, ANN RHEUM DIS, V70, P188, DOI 10.1136/ard.2010.131102; Kinloch A, 2005, ARTHRITIS RES THER, V7, pR1421, DOI 10.1186/ar1845; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Lundberg K, 2008, ARTHRITIS RHEUM-US, V58, P3009, DOI 10.1002/art.23936; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Pedersen JK, 2009, RHEUMATOL INT, V29, P411, DOI 10.1007/s00296-008-0713-6; Perez ML, 2007, J MED CHEM, V50, P3573, DOI 10.1021/jm0701932; Ronnelid J, 2005, ANN RHEUM DIS, V64, P1744, DOI 10.1136/ard.2004.033571; Sangha O, 2000, RHEUMATOLOGY, V39, P3, DOI 10.1093/rheumatology/39.suppl_2.3; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Sebbag M, 2006, EUR J IMMUNOL, V36, P2250, DOI 10.1002/eji.200535790; Takizawa Y, 2006, ANN RHEUM DIS, V65, P1013, DOI 10.1136/ard.2005.044743; Trier NH, 2012, PROTEIN SCI, V21, P1929, DOI 10.1002/pro.2178; Trouw LA, 2009, ARTHRITIS RHEUM-US, V60, P1923, DOI 10.1002/art.24622; Union A, 2002, ARTHRITIS RHEUM, V46, P1185, DOI 10.1002/art.10229; Uysal H, 2010, IMMUNOL REV, V233, P9, DOI 10.1111/j.0105-2896.2009.00853.x; Uysal H, 2009, J EXP MED, V206, P449, DOI 10.1084/jem.20081862; van Boekel MAM, 2002, ARTHRITIS RES, V4, P87, DOI 10.1186/ar395; van der Woude D, 2010, ANN RHEUM DIS, V69, P1554, DOI 10.1136/ard.2009.124537; van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P709, DOI 10.1002/art.20044; van Venrooij WJ, 2002, NETH J MED, V60, P383; Vossenaar ER, 2004, ARTHRITIS RES THER, V6, pR142, DOI 10.1186/ar1149; Willemze A, 2012, NAT REV RHEUMATOL, V8, P144, DOI 10.1038/nrrheum.2011.204; Willemze A, 2012, ANN RHEUM DIS, V71, P268, DOI 10.1136/annrheumdis-2011-200421	30	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2015	10	12							e0144707	10.1371/journal.pone.0144707	http://dx.doi.org/10.1371/journal.pone.0144707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YZ	26657009	gold, Green Submitted, Green Published			2022-12-27	WOS:000366903500057
J	Campanharo, FF; Cecatti, JG; Haddad, SM; Parpinelli, MA; Born, D; Costa, ML; Mattar, R				Campanharo, Felipe F.; Cecatti, Jose G.; Haddad, Samira M.; Parpinelli, Mary A.; Born, Daniel; Costa, Maria L.; Mattar, Rosiane		Brazilian Network Surveillance	The Impact of Cardiac Diseases during Pregnancy on Severe Maternal Morbidity and Mortality in Brazil	PLOS ONE			English	Article							NEAR-MISS; SURVEILLANCE; OUTCOMES; NETWORK; COHORT; HEALTH; DEATH; WOMEN; CARE	Background To evaluate maternal heart disease as a cause or complicating factor for severe morbidity in the setting of the Brazilian Network for Surveillance of Severe Maternal Morbidity. Methods and Findings Secondary data analysis of this multicenter cross-sectional study was implemented in 27 referral obstetric units in Brazil. From July 2009 to June 2010, a prospective surveillance was conducted among all delivery hospitalizations to identify cases of severe maternal morbidity (SMM), including Potentially Life-Threatening Conditions (PLTC) and Maternal Near Miss (MNM), using the new criteria established by the WHO. The variables studied included: sociodemographic characteristics, clinical and obstetric history of the women; perinatal outcome and the occurrence of maternal outcomes (PLTC, MNM, MD) between groups of cardiac and non-cardiac patients. Only heart conditions with hemodynamic impact characterizing severity of maternal morbidity were considered. 9555 women were included in the Network with severe pregnancy-related complications: 770 maternal near miss cases and 140 maternal death cases. A total of 293 (3.6%) cases were related to heart disease and the condition was known before pregnancy in 82.6% of cases. Maternal near miss occurred in 15% of cardiac disease patients (most due to clinical-surgical causes, p<0.001) and 7.7% of non-cardiac patients (hemorrhagic and hypertensive causes, p<0.001). Maternal death occurred in 4.8% of cardiac patients and in 1.2% of non-cardiac patients, respectively. Conclusions In this study, heart disease was significantly associated with a higher occurrence of severe maternal outcomes, including maternal death and maternal near miss, among women presenting with any severe maternal morbidity.	[Campanharo, Felipe F.; Mattar, Rosiane] Fed Univ Sao Paulo UNIFESP, Dept Obstet, Sao Paulo, Brazil; [Cecatti, Jose G.; Haddad, Samira M.; Parpinelli, Mary A.; Costa, Maria L.] State Univ Campinas UNICAMP, Sch Med, Dept Obstet & Gynecol, Campinas, Brazil; [Born, Daniel] Fed Univ Sao Paulo UNIFESP, Discipline Cardiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP)	Campanharo, FF (corresponding author), Fed Univ Sao Paulo UNIFESP, Dept Obstet, Sao Paulo, Brazil.	favorette@hotmail.com	Moisés, Elaine C/A-5708-2015; Costa, Maria Laura/I-4980-2019; Amorim, Melania/C-5807-2013; Rudge, Marilza V C/C-8338-2012; Moisés, Elaine Christine Dantas/N-9522-2019; CORDIOLI, EDUARDO/AAR-6100-2020; Cecatti, Jose Guilherme/M-5945-2013; Nakamura-Pereira, Marcos/X-1107-2019; Souza, Joao Paulo/G-1982-2010; Peracoli, Jose Carlos/G-4923-2012	Moisés, Elaine C/0000-0001-9099-4544; Costa, Maria Laura/0000-0001-8280-3234; Amorim, Melania/0000-0003-1047-2514; Rudge, Marilza V C/0000-0002-9227-832X; Moisés, Elaine Christine Dantas/0000-0001-9099-4544; Cecatti, Jose Guilherme/0000-0003-1285-8445; Nakamura-Pereira, Marcos/0000-0002-4231-0205; CORDIOLI, EDUARDO/0000-0001-5405-9380; Souza, Joao Paulo/0000-0002-2288-4244; Peracoli, Jose Carlos/0000-0002-3273-3001	CNPq/DECIT (The National Research Council and the Department of Science and Technology of the Brazilian Ministry of Health) [402702/2008-5]	CNPq/DECIT (The National Research Council and the Department of Science and Technology of the Brazilian Ministry of Health)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was financially supported by CNPq/DECIT (The National Research Council and the Department of Science and Technology of the Brazilian Ministry of Health), grant number 402702/2008-5. The author(s) received no specific funding for the publication of this article. The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Gonzalez R, 2014, WOMENS HEALTH, V10, P79, DOI [10.2217/whe.13.70, 10.2217/WHE.13.70]; Brazil Ministry of Health, 2011, HLTH BRAZIL 2011, P345; Creanga AA, 2014, J WOMENS HEALTH, V23, P3, DOI 10.1089/jwh.2013.4617; Firoz T, 2013, B WORLD HEALTH ORGAN, V91, P794, DOI 10.2471/BLT.13.117564; Ganaba R, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-22; Haddad SM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-101; Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Huisman CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056494; Josefsson A, 2011, ACTA OBSTET GYN SCAN, V90, P659, DOI 10.1111/j.1600-0412.2011.01100.x; Kaye K., 2009, FOG ZONE MISPERCEPTI; Kuklina EV, 2011, BJOG-INT J OBSTET GY, V118, P345, DOI 10.1111/j.1471-0528.2010.02743.x; Le HH, 2014, INT J WOMENS HEALTH, V6, P663, DOI 10.2147/IJWH.S61543; Nanna M, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000712; Ngu K, 2014, INT J GYNECOL OBSTET, V126, P252, DOI 10.1016/j.ijgo.2014.03.032; Ouyang DW, 2010, INT J CARDIOL, V144, P195, DOI 10.1016/j.ijcard.2009.04.006; Pacagnella RC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-159; Parpinelli, 2009, REPROD HLTH, V24, P15, DOI [DOI 10.1186/1742-4755-6-15, 10.1186/1742-4755-6-15]; Pattinson RC, 2003, BRIT MED BULL, V67, P231, DOI 10.1093/bmb/ldg007; Regitz-Zagrosek V, 2011, DTSCH ARZTEBL INT, V108, P267, DOI 10.3238/arztebl.2011.0267; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Simpson LL, 2012, OBSTET GYNECOL, V119, P345, DOI 10.1097/AOG.0b013e318242e260; Small MJ, 2012, OBSTET GYNECOL, V119, P250, DOI 10.1097/AOG.0b013e31824265c7; Souza JP, 2014, BJOG-INT J OBSTET GY, V121, P1, DOI 10.1111/1471-0528.12735; Waksmonski CA, 2014, ACQUIRED HEART DIS P; WHO, 2012, EV QUAL CAR SEV PREG	27	12	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0144385	10.1371/journal.pone.0144385	http://dx.doi.org/10.1371/journal.pone.0144385			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650684	Green Published, Green Submitted, gold			2022-12-27	WOS:000366903300046
J	Pellecchia, U; Crestani, R; Decroo, T; Van den Bergh, R; Al-Kourdi, Y				Pellecchia, Umberto; Crestani, Rosa; Decroo, Tom; Van den Bergh, Rafael; Al-Kourdi, Yasmine			Social Consequences of Ebola Containment Measures in Liberia	PLOS ONE			English	Article							QUARANTINE	Introduction In the Ebola Virus Disease (EVD) outbreak in Liberia, two major emergency disease-control measures were cremation of bodies and enforcement of quarantine for asymptomatic individuals suspected of being in contact with a positive case. Enforced by State-related actors, these were promoted as the only method to curtail transmissions as soon as possible. However, as with other harsh measures witnessed by Liberian citizens, in many cases those measures elicited uncontrolled negative reactions within the communities (stigma; fear) that produced, in some cases, the opposite effect of that intended. Methodology The research has been conducted in two phases, for a total of 8 weeks. Ethnography of local practices was carried out in 7 neighbourhoods in Monrovia and 5 villages in Grand Cape Mount County in Liberia. 45 Focus Group Discussions (432 participants) and 30 semi-structured interviews sustained the observing participation. Randomly selected people from different social layers were targeted. The principal investigator worked with the help of two local assistants. Perceptions and practices were both analysed. Results Participants stressed how cremation perpetuated the social breakdown that started with the isolation for the sickness. Socio-economical divides were created by inequitable management of the dead: those who could bribe the burial teams obtained a burial in a private cemetery or the use of Funeral Homes. Conversely, those in economic disadvantage were forced to send their dead for cremation. State-enforced quarantine, with a mandatory prohibition of movement, raised condemnation, strengthened stigmatization and created serious socio-economic distress. Food was distributed intermittently and some houses shared latrines with non-quarantined neighbours. Escapes were also recorded. Study participants narrated how they adopted local measures of containment, through local task forces and socially-rooted control of outsiders. They also stressed how information that was not spread built up rumours and suspicion. Conclusions Populations experiencing an epidemic feel a high degree of social insecurity, in addition to the health hazards. Vertical and coercive measures increase mistrust and fear, producing a counter-productive effect in the containment of the epidemic. On the other hand, local communities show a will to be engaged and a high degree of flexibility in participating to the epidemic response. Efforts in the direction of awareness and community involvement could prove to be better strategy to control the epidemic and root the response on social participation.	[Pellecchia, Umberto] Med Sans Frontieres Operat Ctr Brussels, Liberia Mission, Monrovia, Liberia; [Crestani, Rosa] Med Sans Frontieres Operat Ctr Brussels, Operat Dept, Brussels, Belgium; [Decroo, Tom; Van den Bergh, Rafael; Al-Kourdi, Yasmine] Med Sans Frontieres Operat Ctr Brussels, Dept Med, Brussels, Belgium		Pellecchia, U (corresponding author), Med Sans Frontieres Operat Ctr Brussels, Liberia Mission, Monrovia, Liberia.	u.pellecchia@gmail.com	Decroo, Tom/AAV-7208-2020	Decroo, Tom/0000-0002-1205-1484; Van den Bergh, Rafael/0000-0001-6277-8713				Abramowitz S., 2014, 10 THINGS ANTHR CAN; ACAPS, 2015, EB OUTBR W AFR LESS; American Anthropological Association, 2012, THE ETHICS FORUM; American Anthropological Association, 2014, STRENGTH W AFR HLTH; [Anonymous], 2008, EBOLA CULTURE POLITI; [Anonymous], 2014, LANCET INFECT DIS, V14, P1163, DOI [10.1016/S1473-3099(14)71020-5, DOI 10.1016/S1473-3099(14)71020-5]; Campbell Dave, 2011, Mcgill J Med, V13, P76; Chandler C, 2015, LANCET, V385, P1275, DOI 10.1016/S0140-6736(14)62382-5; DiGiovanni C, 2004, BIOSECUR BIOTERROR, V2, P265, DOI 10.1089/bsp.2004.2.265; Flynn G, 2014, SMUGGLED BUSHMEAT IS; Gold McLean D., 2014, HIST TODAY, V64; Gostin LO, 2003, JAMA-J AM MED ASSOC, V290, P3229, DOI 10.1001/jama.290.24.3229; Guerrier G, 2015, LANCET, V385, P603, DOI 10.1016/S0140-6736(15)60231-8; Haglage A, 2014, KISSING CORPSES EBOL; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Markovits D, 2005, J LAW MED ETHICS, V33, P323, DOI 10.1111/j.1748-720X.2005.tb00497.x; McGovern M., 2014, BUSHMEAT POLITICS DI; McNeil DG, 2014, USING TACTIC UNSEEN; Mullan Z, 2014, LANCET GLOB HEALTH, V2, pE550, DOI 10.1016/S2214-109X(14)70278-5; Press Union of Liberia, 2014, IM BATH DEAD BOD; Richards P., 2014, DO FUNERALS SPREAD E; Richards P, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003567; Rothstein MA, 2015, INDIANA HLT IN PRESS, V12; Rothstein MA, 2015, HASTINGS CENT REP, V45, P5, DOI 10.1002/hast.411; Snyder RE, 2014, LANCET GLOB HEALTH, V2, pE685, DOI 10.1016/S2214-109X(14)70339-0; Upshur R, 2003, VIRTUAL MENTOR VM, V5; Wesley PJ, 2014, LIBERIAS EBOLA EPIDE; World Health Organization (WHO), 2015, EB SIT REP 3 JUN 201	28	128	130	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2015	10	12							e0143036	10.1371/journal.pone.0143036	http://dx.doi.org/10.1371/journal.pone.0143036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YX	26650630	Green Published, gold, Green Submitted			2022-12-27	WOS:000366903300010
